<SEC-DOCUMENT>0000883984-23-000022.txt : 20230509
<SEC-HEADER>0000883984-23-000022.hdr.sgml : 20230509
<ACCEPTANCE-DATETIME>20230508173432
ACCESSION NUMBER:		0000883984-23-000022
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		116
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230509
DATE AS OF CHANGE:		20230508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICU MEDICAL INC/DE
		CENTRAL INDEX KEY:			0000883984
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330022692
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34634
		FILM NUMBER:		23899130

	BUSINESS ADDRESS:	
		STREET 1:		951 CALLE AMANECER
		CITY:			SAN CLEMENTE
		STATE:			CA
		ZIP:			92763-6212
		BUSINESS PHONE:		949-366-2183

	MAIL ADDRESS:	
		STREET 1:		951 CALLE AMANECER
		CITY:			SAN CLEMENTE
		STATE:			CA
		ZIP:			92763-6212
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>icui-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:ba7fdc33-2522-46f7-8674-20ba10b1b2fc,g:4240e31b-a7e9-4337-b7b1-c2e4a3947117,d:f1f54ab03e0c44ba84b642c022c86fca--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:icui="http://www.icumed.com/20230331" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>icui-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80L2ZyYWc6N2Y2ZGIyNDQ5MDEyNGYzOGI0ZWY5NjhjYmFlZTM2ZTkvdGFibGU6MjZlZjhhMjc0M2Q4NDc3ZjlhZjZiNzI4ZWFkMTUxMmMvdGFibGVyYW5nZToyNmVmOGEyNzQzZDg0NzdmOWFmNmI3MjhlYWQxNTEyY18yLTEtMS0xLTExMjI5MQ_3c21152a-88d7-4b17-bd00-d229ee69626a">0000883984</ix:nonNumeric><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80L2ZyYWc6N2Y2ZGIyNDQ5MDEyNGYzOGI0ZWY5NjhjYmFlZTM2ZTkvdGFibGU6MjZlZjhhMjc0M2Q4NDc3ZjlhZjZiNzI4ZWFkMTUxMmMvdGFibGVyYW5nZToyNmVmOGEyNzQzZDg0NzdmOWFmNmI3MjhlYWQxNTEyY18zLTEtMS0xLTExMjI5MQ_52ac48eb-3ae0-4382-8a8e-572c69b64c2e">ICU MEDICAL INC/DE</ix:nonNumeric><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80L2ZyYWc6N2Y2ZGIyNDQ5MDEyNGYzOGI0ZWY5NjhjYmFlZTM2ZTkvdGFibGU6MjZlZjhhMjc0M2Q4NDc3ZjlhZjZiNzI4ZWFkMTUxMmMvdGFibGVyYW5nZToyNmVmOGEyNzQzZDg0NzdmOWFmNmI3MjhlYWQxNTEyY180LTEtMS0xLTExMjI5MQ_10b1f244-5e9d-4bac-b144-6e8e29681e72">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80L2ZyYWc6N2Y2ZGIyNDQ5MDEyNGYzOGI0ZWY5NjhjYmFlZTM2ZTkvdGFibGU6MjZlZjhhMjc0M2Q4NDc3ZjlhZjZiNzI4ZWFkMTUxMmMvdGFibGVyYW5nZToyNmVmOGEyNzQzZDg0NzdmOWFmNmI3MjhlYWQxNTEyY181LTEtMS0xLTExMjI5MQ_a239f44e-c4cc-4c6d-9fb7-78b3787dffc4">December 31</ix:nonNumeric><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80L2ZyYWc6N2Y2ZGIyNDQ5MDEyNGYzOGI0ZWY5NjhjYmFlZTM2ZTkvdGFibGU6MjZlZjhhMjc0M2Q4NDc3ZjlhZjZiNzI4ZWFkMTUxMmMvdGFibGVyYW5nZToyNmVmOGEyNzQzZDg0NzdmOWFmNmI3MjhlYWQxNTEyY182LTEtMS0xLTExMjI5MQ_8678c3b9-9fba-4dfd-8c68-b36473b2ab93">2023</ix:nonNumeric><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80L2ZyYWc6N2Y2ZGIyNDQ5MDEyNGYzOGI0ZWY5NjhjYmFlZTM2ZTkvdGFibGU6MjZlZjhhMjc0M2Q4NDc3ZjlhZjZiNzI4ZWFkMTUxMmMvdGFibGVyYW5nZToyNmVmOGEyNzQzZDg0NzdmOWFmNmI3MjhlYWQxNTEyY183LTEtMS0xLTExMjI5MQ_c232117c-14aa-4f54-8f86-c79b9112095f">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjc3NQ_c58be461-15cc-4ce0-9461-a1f586d03baa">P9Y</ix:nonNumeric><ix:nonNumeric contextRef="if4dc12115f6e4ef7a1e347d0b33880e4_D20230101-20230331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjg1NA_dbc618ca-f89e-4749-ab68-262b22ebc7e6">P8Y</ix:nonNumeric><ix:nonNumeric contextRef="i73bd4bbae85843dcad72b0d7b43e60a5_D20230101-20230331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjg5MQ_cbdceafc-7a31-4a27-b09c-41ac0c8d87ec">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="icb891162132d4866b63cbc65bb9e5978_D20230101-20230331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjkyNg_15a93537-17a8-41e6-a1fe-d867b9347f66">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="ie5653183732045d196de37183c40dd18_D20230101-20230331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjk3NA_5b7a1829-90b2-4109-8983-d52f0d255b2e">P6Y</ix:nonNumeric><ix:nonNumeric contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" name="us-gaap:DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNC0wLTEtMS0xMTIyOTE_cfaec65c-7e6a-4276-963b-bd9a55c586b9">http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" name="us-gaap:DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNS0wLTEtMS0xMTIyOTE_a381aeb8-d171-4550-9ed5-50b193801e56">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" name="us-gaap:DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOC0wLTEtMS0xMTIyOTE_31479843-5a18-4da4-b2e9-8a0ab42c6b76">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" name="us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOS0wLTEtMS0xMTIyOTE_0314024e-19ca-42c9-bda0-6b9963e62d6c">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" name="us-gaap:DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTMtMC0xLTEtMTEyMjkx_b4e70733-51f6-4cf5-a4f0-4e3344743eed">http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" name="us-gaap:DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTQtMC0xLTEtMTEyMjkx_c7f29940-14d5-49dd-8334-2995d9c76144">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" name="us-gaap:DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTctMC0xLTEtMTEyMjkx_6e89f792-0047-409f-ae97-92f90a1a3b54">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" name="us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTgtMC0xLTEtMTEyMjkx_e58a7954-fa23-4f46-8db3-028044ca9ce7">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i974e647072aa44e980b4ed61c129befa_D20230101-20230331" name="us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNC0yLTEtMS0xMTIyOTE_f380e986-354b-4ae5-be66-0d8180b7e6bd">http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerExcludingAssessedTax</ix:nonNumeric><ix:nonNumeric contextRef="i48a10cc5a2694f10b44bf1877ec9bebc_D20230101-20230331" name="us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNS0yLTEtMS0xMTIyOTE_e0200ea4-951a-4f15-aa0d-730e8294b71c">http://fasb.org/us-gaap/2022#CostOfRevenue</ix:nonNumeric><ix:nonNumeric contextRef="i12ebce1f4c61414eb59c03244fef43b4_D20230101-20230331" name="us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNy0yLTEtMS0xMTIyOTE_faab4624-13eb-4610-aa53-f7352f932ffd">http://fasb.org/us-gaap/2022#InterestExpense</ix:nonNumeric><ix:nonNumeric contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" name="us-gaap:DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTAtMC0xLTEtMTEyMjkx_f14ce4d4-85f2-4d23-a88b-1739598efd81">http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" name="us-gaap:DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTEtMC0xLTEtMTEyMjkx_d56c9d3d-0932-4348-b69d-8f57de5603f9">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" name="us-gaap:DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTUtMC0xLTEtMTEyMjkx_6bcfe6ca-ff2c-4a0b-9003-1212bc82d7dd">http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" name="us-gaap:DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTYtMC0xLTEtMTEyMjkx_308e7868-3fa9-4233-8466-3e1183fa8b50">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" name="us-gaap:DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjMtMC0xLTEtMTEyMjkx_5523e65b-55dc-41c6-8709-df1a94648036">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" name="us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjQtMC0xLTEtMTIwNzE1_62efbfc3-1b08-43d2-b4de-0ebc769246ce">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" name="us-gaap:DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNy0wLTEtMS0xMTIyOTE_50321293-4bf5-432f-9a23-856af180772d">http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" name="us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTgtMC0xLTEtMTEyMjkx_38c2c727-8408-4048-b07a-938ff12e83e6">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="icui-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d8acfe084474d409043528e4b35689c_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ic896526384424866b5b8be38ae18f2f6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i843ff99f0a184bdf9191fac242ba630e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07f6b061c66845509e4e6c7ff5cbe7bc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5638b072e2c74cecb680e1eeeb816a7f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic36e92a4a4e041d789fd1e15a96fb89d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f732bf16f8943de8310b4900638904c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i905ef664618549b79a2604ba36989fa1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2876aa14e8a049c888a7c1a7d0b9add5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f675125f08545ed853c555497efd555_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i157787461be54c729a371db9e5f0b870_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i553e7d37da95492bb56ab18d405def24_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i076bb8ec7f8a4200aaa3d2d05b180bb7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92f1bb64c23547f8be008ab8d3bb642a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85d17593813847138c47bd6a52b84d0d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54b39f23877a4f0d862e5916dd5e87c8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59687ae95c8c4f548a9c5ed00de7213f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieccf8d651a8d422e91523860913a0c81_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id319fa0bb715447db5d21adda1569f95_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8121720b12924aeaa2d7f2161161fdc6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e09221885284788959b95412b6214f4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10ebf268d4574d988d0c464474155fe0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i097914f4b8e14986872f2b29ed1ef69e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie149bde323634e0093914839ee8ac148_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bc26a59bd7142798a8bbabd7a8aebf6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic079464d6d0c45109f1b5fdae21f379e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i720c98b0bc6c4647b5ec2b08163c165c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fd0c26c71db4e4cb0b929a7689fb683_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i864f233d9281416ea0ce16b7edf44f57_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c0c21e62a5645398a5ae491f1716ab4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39df97d162224e7ead2e7587ce51c1c5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica718d655f94421fb3eeafd5ac5288be_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b0ee62d61be45c0aee4a548c96a0697_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f9b480e0479472aab56012880bdecd6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a406cdd295d4bae87e1e8ec6e5620dc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a153016e3f444b4a7339a82e88bc93e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i966e762ecf634e718045d1a26327c012_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i135dbadf645845ba84e91cb70245f896_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b4d6b0874b84330ab118d8d72f89852_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1adc8956afab4a2c82b48740ffa3c5f4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57ae4b72e9574e4ebf63f3473590fe05_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c6fdad0ae1f42cdb0e49e14d48fc939_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4e4d6b3c14144aca5091606533105a7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad76217923724df7af4e6c43d299c300_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">icui:DevelopedTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4201cfae6384d12823ab684fa4f93a9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3908b880a83e477b9d7b162246382114_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4dc12115f6e4ef7a1e347d0b33880e4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73bd4bbae85843dcad72b0d7b43e60a5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb891162132d4866b63cbc65bb9e5978_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5653183732045d196de37183c40dd18_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2be2d8334179424c9dae8ef69e51861a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2988acfe0dcd4e17a14143d0e3743733_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie97b4a8feb974d7180f4613667a93acb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98a8c58853e84468b76e94c8be56aa32_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i382a53a05af54e50ba7efcb611be9988_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6b3ba685fe640b2bf1d136426bd89dc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if672ca85f58b4f10ac0adfe442433dba_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i430bf7f21dc340cc98e845a1549c6ba2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie942e6605043489884a694f3c56a4f24_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i425342db1c344b6f8cc10da8ee02d87b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3e783fa8bb34a5494c0d5d949242f64_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VitalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i638825fa0f98497b948ffb1c01d0e19e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VitalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b683b00bad4432ea43529d2de73711d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc639aa88692474fa875253ce1c84b6e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3d0e8e0a5bb4a63b8430aaa2a4f8b17_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd9ef9dff7c545ad9f948e39c002b2bc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf5cc17211a944c486c24f771e6a195c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45b3d6f3d0644e7d8963c40933520643_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie82e694fdb9d4433a97ad09856242b4a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad04b3344f3d466bba0994502f1196e8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f5153aa5ab442638a5c8de9a45fba7d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4de9a8d7bfc44cdfae663c1ba5da07c8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if70bbd6b2087429f879753468a264309_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida61c1e26c5d42a6a66daca8551246ff_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1779a7129f64c9d9abc575b38200d77_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i316bfaa281dd4708b1bdb8f0f4449ed0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0115d314b99743fa9bbb604242dd25a1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i908fb323327c4154bd1568d75d6f2552_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie30632948bb140989b06da9c57314a0e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i261befa46c644eb8a0b97033247d3bad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29c2d40d68d54fa78c2000befa7864fd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34e4e4f1c2754f669c44df080318aa88_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81bf02eca70549c38a41eb91ac257f95_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54a3f930a4e54803850c70dc786e2c62_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5138e2e1587f44e48d749663aa9643f9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaf177153834401cb429ff7ce5049e03_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i961a433f9f954f7a83f394eb9db23739_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fed4ca7522348e09634e4fad1da85ca_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica8e78475e314beda5cd3faaa0ce02d4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40f728bd623845f9b4ce1cfdaf7c303f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i104614519533468cb1d3f4a1f7ede191_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieed1db1afe2e4864acbe51f8f742e903_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica866edd3bbb4be194fb9fbe70eab0c3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CZK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98371e0ede62423e94e012fb74cce6db_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cacbfb1e2ec47f181ee075ab70cca83_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05b8d7e5a0c94ec0abe63ce8b2a92789_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c884f97d3444f6ea4dcd4b55692fdb4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f2b698f9db545af9bce00c8273f5099_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8321aa0d52a040748fa39ebb30857208_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:Srt_MultipleCurrencyAxisAxis">icui:OtherCurrenciesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32a51ec3c4454197ad187d461dff39ee_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="mxn"><xbrli:measure>iso4217:MXN</xbrli:measure></xbrli:unit><xbrli:context id="id1c83cae5660471ba0a2606a294d663d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41865436086741dba4582ecb29b5d80f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86157d0618294ee89c1fc6807b08141e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7f51fd80feb455d9784516bdd6b7c63_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6bcc5cb934c484085e4c9d001608c4b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc4d8e7ceb96467cae741d1df3ad1fbf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i631e83ee61b74e3abeaa5ad6e7bab2b1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc9bb67f131a49a8b919336073869658_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e60d283c38e4b35bb0be9fcf2699bec_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c2531beb9494ed7a57f1659c8d16d2a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f7f6f4d53994f44b8df01e0704834c5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i974e647072aa44e980b4ed61c129befa_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45dae7757b124552a2b2f3b01ce6c186_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:TradingRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b5bae88141345639dcc3eac627c0799_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:TradingRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48a10cc5a2694f10b44bf1877ec9bebc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i108862c46a0d4e1295be73061c8600e8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c8639dba4434deab359b7b242f47fbd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12ebce1f4c61414eb59c03244fef43b4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73bc74286d9f4e128411e29701d4efc8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c48ae5abe2f4e6caf6fbf46c2c6e69a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22bda3a55c764257a1a89a08923962af_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id05515fe4472496ab29e975ca6d18184_I20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9945fc3bd5d4b24a1e69091bf0384fd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia818e4969fa7407895eb98d2469bf054_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb3a2f75275841ddb552fdb5a627b2b2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb41da7d968840ea810ecb453fece23f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1ae61222e1b43a5acfc276574f10056_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c52854a73b14fd6ae1828bd91e30fb1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03a2467fbfc445cf8500c8ee1e6396ee_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbd969b02ac748cd9474589aab428a62_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9540454f8784e5f990147c6b769dfe8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd441dae5eb1464ebef86ea40463485d_I20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia32accdc410f475aacf8dd5d7b0e4cf3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73f519574f6f4c26956379467aefa3d5_I20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56f6562b611449eeb241cfb061a8fc81_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1a170696eee4e9abdb23c78710d0758_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97cdcc7aea824b1db81b342d252b23dd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie91c21fa692e4850bf5756c81c2f5f58_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb57c90226d949769fdebc2b3c886a84_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74a47211e1504bfbbb2e56947d6359bc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ee355f953e44036b2c9823f0ddf9545_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7db2b58ce0df41e787b7b142992d9f0a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id251cb4f372c42deb49b98c56f091af2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00e9c526d8a14de587543cd4d43d84ff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95e85068b35c4e25b71a9f1dde7f01cf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3677cc922444caa877f9554bf61388c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie75c1ba3ea0845429dc5b1f441156886_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib014b4c6ffba42ecba26116f0b36d255_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b55b633207e4c77a409427f88b494ae_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied46de2d5cdb4f3287c1a51b1fda5f2f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e83be36630a4315aa61f938a15ed93c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73643551546848cf924dc74653a7ab10_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ff489ffd4484b05893332bc86bb5da4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id49337d44fff49da85c4746c25de0cfa_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefcb7fb7c4af44bd86feb62b7205f1f3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28c30abbbc564beab22d3baeae8ce04c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83c7a5461f164badbda9aed1e171b545_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f06c69e01fa4e4f8ab8986b188ec125_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bc9662c059e4bda801cb06360c4c046_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4517f24d47284d07aec33cb915f14ec9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97bd4045255248b7a6ad2e2738cf4991_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic88a0d75c4324efe964e2e67a57a9956_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66bd23e34133401591e928370dd3aae3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec00d0e32787463fa02c2beb859e4088_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61a628145a154dd4b608eda8fef5317b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2421f17f678943faa6f08a99e77342d2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51723405dbf94ff6823b0cfe6cd7a8f4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb5b0d8817344f0eb58f57ded4f69d76_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic825a9792c0c4bb3932a15194babe436_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6739e8ed9384ce4a0f3da9edab4d0ef_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13ee862b60df4a8182330aca4aabe86e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a1abf01d00d48a5868de1e621f7cae5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4c34b949f374399ba510212f11790c7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d76827e236145bfa0a5caf2d4857d5c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a5293ddbff54b3d8db5d3716b9193fb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5222d9d8a2924eddae7d0a5f40052ea5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56274c1ac4014325b45d30ae7ad441aa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2d0c73330a84bb0bf6431fe51b3afda_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia30501eaa28f4a95a929526d40bc93df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42bd702cc395459f81747c0a9d029d07_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia089dfcea16a47c7a301086d94a998c0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3032b40999034d9c8ace19cc47d82a6c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3344b2eee9a439b99d11085a8bad5a2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i459536a397ec41e98471e9be9d5f85de_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e94d92e01474cfeb2beeaedbd0abe84_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0cf77942cd1443eacbf40c493fe858d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6080af93170148688d13de3d59d12ab7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b13a58d0b3c4453995ec99b1cfe364a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica1daf3e26514068beac02afe7124cc3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib414b19de28a44c7b4896fcc6b6b46e3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab01ecb2b6ac4acc8ebcb12fdb8f8e51_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79e95f455b32497bbff95f508a232d72_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib903abaa897142e6870b5c981c0190f9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4f553481cb44e628e33717df32e0afc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae888c38b8234f5abfc0397b9219a434_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib538cde976ef4ac38c558a67c9a7b8c1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2300372e953438fb46cce4511c00fdf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i600c673eafe24f7a99360ebe80c6bd12_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24988b3dea184cdd8f48759556bc2274_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89428e5fde134e38a53ca4bcdc2ca0ae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc34907535374c3da7784002505ffd72_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00116957d0924008b381688d18b90256_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i513c2936b35e4be19a4d05480a1af429_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25f3594cd8a446f7810b2e62cde2b514_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfbfe2784d674d028ea89497f6d11184_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbc93354f6f64dd887efe82a4a92a59c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25eb893c69d64ec8916421287d40d7dc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82ea280e29894ab9a463eb6fa58461c3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedc9227893204f5fb8adfe568b84f804_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e3979b3c1734fa6bf0c57b31b79d949_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86423b3966d94fd191b5c9416094b60c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic165dae88e744691bcce8d47fec9dbdb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id77de8d44cca4f389a04a8b86d7c1607_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96b4b6ca22c9441d8fd7c31c022b4666_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i579e1337f5894b6e9f97f1483abeb705_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">icui:NonPublicCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fef98ce304042888df7d376a7476354_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia69844c22aaf40cbb2a42781ead60e61_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic24eeaf2cdd54ba28cf13e1eed409bf3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie470f6c922764b86925b02b2d25bd068_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66a11824ed414a45824aa3f42692576a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:MoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8748d9089ac04b8bb47719b0717b5a2b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:MoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ed218cedf4f4e30aacfc291c713a4ff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d4e73ec88b842f7b49cf0a4ba9fa984_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bc8a01c792a4c0cba943cbaa9683dc5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99bbc561eaf74c0bb03cf3b2367770b5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i759eb770637645338c5cb3c69ad883ed_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icae7fd56151f4362ba49944b6babf4d5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9431fa63e03f4c39828dd6f5c2874b77_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45abd7fc6cb041539c2690484538f401_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf6dc92130324e248c5bccc98319a7dd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9ddae410dbb4da9b5bbab71cde7e71a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dee8f10404243bfb8a21715c53d5167_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie66a2d4ccf9f4810ab62a157c417c4a0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd805b98cb0e420da9a33f629e95ab71_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79338c5b72624f9e86c8250b5030dbc1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie931f544d5844a66997a310a1d04e1f4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4325a768bae8472fb7bfb255f0e35276_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb7e987c2bb9440db23dae317f15ad47_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f298d4ded0646038f7f4958576511b8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i179a00f6e8ed4a8eb5aab9eade675698_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0a7b4c978594fa7ac242ade5c6e7a65_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i369d015daca1416f8f0547c55b9d625b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic041286ae4d64457a61d949e2a01e553_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia31355a5a0a34e42adb367500b2d5d1c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5119a978c7084a25a248c39ee1944803_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9faa2994ef5c4d8cb43ac97f50785f0e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92753141dc8f4c78b24dcbf4e0913b77_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaba17e9a9dce424287c2e009d986cffd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2084d5b4c664907b48055fe916dc52e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id56f1f6ec46947599bc7bfc1ffe9d195_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89af7b8cd3d0498cbb978e49c788ff06_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74ff728885fb420389d379cc16b1717f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43a9c2ae467547f8811c5f92ca52a728_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d8fe8f65713456c8f35230f74bceb87_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cb7cc5f691a49e8b4265215896d8c03_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5601a8c75d144a43a8365d2d70291f2f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f8a9cb1a64e44a89d9d73f6ad8eba74_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8a1a1ffc693445c9e79c6e34870c622_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59eb5fecde424d39a6b4b8dce858b9f7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i514b0dbe6eac49eea9224b92e51b766b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80d837b89c2344e393ee4d383e5cc11b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:Greaterthan400to100Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27b3017a55814b6597ba4e68980a344f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:Greaterthan400to100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i881696e2df5749c38024d0875b7c80db_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo400To100ButGreaterThan300To100Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d76d9c6767b4229b51c37407f83df06_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo400To100ButGreaterThan300To100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8990fbda10824f619dc9e0bb423e9432_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqual300To100ButGreaterThan250to100Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if94f4bdedbf04eb0aae885e9867154ae_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqual300To100ButGreaterThan250to100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i645c0fc8e6a548c1a7a520e2f4a6728a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo250To100ButGreaterThan200To100Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83eb7320045f4ac9af9a0028ac179e5d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo250To100ButGreaterThan200To100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i975e28cedc80423c9627a97bb37a9a95_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo200To100Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76e51a168e7a435c861495b1388612d0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo200To100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i808fda9aa5364d5593b95ed5ff583af5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:GreaterThan275To100Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e764926d4b14681809efb21b544fa30_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThan275To100Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50e84852d3ab4f408186915e7cf4e655_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fdf26eb4e87495fbabffe1de604c690_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i934b1e4c20bc460c88d531ba8e887800_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica3646f151fa444e82e1e515a33e0f7a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1881f550800444d3981abc4acd458059_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21016b61e07645e9888301254ab114fa_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i053a7aa68c99417ca271343168d82c1d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib548663bfdd74230aa02cd84a0db6361_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i114116d7f6da48e49ecb98fac66b8e6e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9142596d6f484bf2be0ed3d89cd30684_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07609ad4dfd84093853a23ea3364cd22_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7be1d8f7f3cf4eacaeeabf9eda19e43f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i857399bd08c745988830c1cc09e54a50_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4768bcc3c288464a9796a77d8e9884aa_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c285e71c3d74e8c898cbe0851162f27_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1e39a1ea3fe47daba9453de67fe8e1b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia762d86224bd46f5b6f22478b80f66dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86546ad81144448d9f4a7e7d42d02105_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ac4813a471b49ff9271b2d9e810c0a1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb13edf15748489f92eee0507a1fb77f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cf0fb2f948444dbbf455bbc0c6a8057_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa41f9bbd9164a17afef3d0f715104cf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa95f20692ed474d949298d55e4d9445_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e5490aa9392486e8d4e7fa173e87574_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4164284555e9406180057f15e0c21bc7_I20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4dcda0568fa4318a8aa6122af8e00b9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e28dd363d7d40519a83284765f9a3fd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTUtMy0xLTEtMTEyMjkx_05e3014b-2fc3-4b5a-8baf-57b8e024aeb5 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzItMy0xLTEtMTEyMjkx_6471ee0c-00a4-42c7-ba9d-ec57d5196909 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNS0zLTEtMS0xMTIyOTE_9e1c5a15-8b30-41b4-b008-d1882d344a74 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzQtMy0xLTEtMTEyMjkx_4da36b68-c1fc-494d-820b-9fb637b9022a id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNi0zLTEtMS0xMTIyOTE_b4b42f79-adc9-433b-8f62-7db731f52deb id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjgtMy0xLTEtMTEyMjkx_846aab52-7cc5-405a-bbec-efe479d462f6 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjMtMy0xLTEtMTEyMjkx_a94bd12d-e31f-4bdd-b136-251cf57b6140 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfOS0zLTEtMS0xMTIyOTE_beb57dd6-7fe1-4dee-bf23-6d0d9d0616fc id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDUtMy0xLTEtMTEyMjkx_dded447b-f585-4c32-9b07-42383de17643 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTAtMy0xLTEtMTEyMjkx_7d7d037a-f223-449f-903b-ffe31ed2d335 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzctMy0xLTEtMTEyMjkx_324fc7b1-d4a4-45c7-8174-045af2b5112b id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDYtMS0xLTEtMTEyMjkx_7f5fdd0d-259f-4a0c-97a1-43e46e1c0483 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDgtMy0xLTEtMTEyMjkx_d6e2a135-c2fa-450f-a554-f6e3457190e7 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNC0zLTEtMS0xMTIyOTE_7f5fdd0d-259f-4a0c-97a1-43e46e1c0483 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzgtMy0xLTEtMTEyMjkx_debccfde-4123-4698-b79f-854066c2b056 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDMtMy0xLTEtMTEyMjkx_75047be6-0dd1-47ed-9798-da330c8b02bf id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzAtMy0xLTEtMTEyMjkx_15d626ce-74fa-4454-86b8-9b4572ac66f0 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTYtMy0xLTEtMTEyMjkx_14b6f9fc-686b-45bd-bd84-0ea1ea93f551 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNy0zLTEtMS0xMTIyOTE_4572b495-5d90-4b8e-9ee8-0a59ebbf46f5 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjctMy0xLTEtMTEyMjkx_4921cb4d-3853-4114-b725-5db1dd93f9f8 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDctMy0xLTEtMTEyMjkx_01fae28f-4563-4565-bfe8-b29d7a556285 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjItMy0xLTEtMTEyMjkx_6f9f325f-393a-47ff-ad08-b307a627d1bf id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMy0xLTEtMTEyMjkx_35b338bd-0580-44c2-9fe3-deae3f5f796b id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjAtMy0xLTEtMTEyMjkx_229ef6be-ce62-4921-b18f-79a60092ec04 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzktMy0xLTEtMTEyMjkx_4a1282af-9c82-4f9b-89f2-ff2e628b50ae id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTktMy0xLTEtMTEyMjkx_6ecf80d1-750c-4390-81b5-f5f1ac8cc377 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfOC0zLTEtMS0xMTIyOTE_0fe1c3ef-a99e-4fd0-ba6b-891b764bc690 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMy0xLTEtMTEyMjkx_fc1bc812-1b18-4fb7-bf12-d0b72275a81e id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTMtMy0xLTEtMTEyMjkx_76d15de6-be5b-43b2-96c5-524893474b9d id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDYtMy0xLTEtMTEyMjkx_b11da195-db32-4106-b8f6-91d7659faf25 id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDQtMy0xLTEtMTEyMjkx_d6fa66ab-3258-4c34-a51f-118afd81ca95" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b" order="1"></ix:relationship></ix:resources></ix:header></div><div id="if1f54ab03e0c44ba84b642c022c86fca_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGV4dHJlZ2lvbjpkMzAxNGQ3Njc4OGU0ZTBlOWJlNDg3MWMzMmE4NWJlNl8xOTgy_2ab729a5-d012-407a-93fc-40e83807b0c0">10-Q</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.465%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6YWRhYjJkNDkwYTRlNDc1YTk3ODhhMzJhM2Q3MjMzZmIvdGFibGVyYW5nZTphZGFiMmQ0OTBhNGU0NzVhOTc4OGEzMmEzZDcyMzNmYl8wLTAtMS0xLTExMjI5MQ_b96fd052-eaca-400c-bc29-ab8d158caa7b">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the quarterly period ended: <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGV4dHJlZ2lvbjpkMzAxNGQ3Njc4OGU0ZTBlOWJlNDg3MWMzMmE4NWJlNl8xMjQ_21b82a53-e6a6-4627-aaca-1437fa83d263">March&#160;31, 2023</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.465%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6YTk1NWRkYjIzODFmNGNkZDg5MDc5OWIzZmM1YTA0MGMvdGFibGVyYW5nZTphOTU1ZGRiMjM4MWY0Y2RkODkwNzk5YjNmYzVhMDQwY18wLTAtMS0xLTExMjI5MQ_5d1faff5-ff58-4353-afa3-63d81a407c78">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File No.:&#160;<ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGV4dHJlZ2lvbjpkMzAxNGQ3Njc4OGU0ZTBlOWJlNDg3MWMzMmE4NWJlNl8xOTgz_3256bbbe-5af8-49b3-9b9d-f70335800f19">001-34634</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICU MEDICAL,&#160;INC. </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.908%"><tr><td style="width:1.0%"></td><td style="width:47.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.029%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6OTI2YTQwMGRiN2YwNDVhZjk3NTRiZWVmZjQyN2RiMjgvdGFibGVyYW5nZTo5MjZhNDAwZGI3ZjA0NWFmOTc1NGJlZWZmNDI3ZGIyOF8wLTAtMS0xLTExMjI5MQ_f27ce77c-37fd-4006-ab77-2265d4ba50d3">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6OTI2YTQwMGRiN2YwNDVhZjk3NTRiZWVmZjQyN2RiMjgvdGFibGVyYW5nZTo5MjZhNDAwZGI3ZjA0NWFmOTc1NGJlZWZmNDI3ZGIyOF8wLTItMS0xLTExMjI5MQ_b1c04993-a3f1-4e38-9fdf-99e213784c9c">33-0022692</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.043%"><tr><td style="width:1.0%"></td><td style="width:16.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.639%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6ZjZhNzUwMmI0NzRjNGNlMmJmYTM3NzNiYWU3NGE5ZjMvdGFibGVyYW5nZTpmNmE3NTAyYjQ3NGM0Y2UyYmZhMzc3M2JhZTc0YTlmM18wLTAtMS0xLTExMjI5MQ_7f1a52b1-add3-491a-b552-9dbf5cb87bac">951 Calle Amanecer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6ZjZhNzUwMmI0NzRjNGNlMmJmYTM3NzNiYWU3NGE5ZjMvdGFibGVyYW5nZTpmNmE3NTAyYjQ3NGM0Y2UyYmZhMzc3M2JhZTc0YTlmM18wLTItMS0xLTExMjI5MQ_69ceee34-5766-43dd-ac6a-d5dbbf4f4321">San Clemente</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6ZjZhNzUwMmI0NzRjNGNlMmJmYTM3NzNiYWU3NGE5ZjMvdGFibGVyYW5nZTpmNmE3NTAyYjQ3NGM0Y2UyYmZhMzc3M2JhZTc0YTlmM18wLTQtMS0xLTExMjI5MQ_e7131c95-2f8d-4790-8aaf-527f5a27ad36">California</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6ZjZhNzUwMmI0NzRjNGNlMmJmYTM3NzNiYWU3NGE5ZjMvdGFibGVyYW5nZTpmNmE3NTAyYjQ3NGM0Y2UyYmZhMzc3M2JhZTc0YTlmM18wLTYtMS0xLTExMjI5MQ_5eda3fc6-d519-4944-a563-7002616453e2">92673</ix:nonNumeric></span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGV4dHJlZ2lvbjpkMzAxNGQ3Njc4OGU0ZTBlOWJlNDg3MWMzMmE4NWJlNl8xOTg0_d1ab7e45-d4be-4557-ba1a-a064dc72a1ca">949</ix:nonNumeric>) <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGV4dHJlZ2lvbjpkMzAxNGQ3Njc4OGU0ZTBlOWJlNDg3MWMzMmE4NWJlNl8xOTg1_8ece9285-2fa2-4038-bd17-f2629c98c001">366-2183</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.908%"><tr><td style="width:1.0%"></td><td style="width:42.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6NjdhNjlmM2RlODRmNDFmMzlhZjVkZjg3YzE3YjFjZjAvdGFibGVyYW5nZTo2N2E2OWYzZGU4NGY0MWYzOWFmNWRmODdjMTdiMWNmMF8xLTAtMi0xLTEyMDQ2Ng_1b658b1a-05db-4eac-8e8d-123a18a0aa0b">Common stock, par value $0.10 per share</ix:nonNumeric></span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6NjdhNjlmM2RlODRmNDFmMzlhZjVkZjg3YzE3YjFjZjAvdGFibGVyYW5nZTo2N2E2OWYzZGU4NGY0MWYzOWFmNWRmODdjMTdiMWNmMF8xLTEtMi0xLTEyMDQ2Ng_d3166011-c397-45a5-a782-c164a55ad2da">ICUI</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6NjdhNjlmM2RlODRmNDFmMzlhZjVkZjg3YzE3YjFjZjAvdGFibGVyYW5nZTo2N2E2OWYzZGU4NGY0MWYzOWFmNWRmODdjMTdiMWNmMF8xLTItMS0xLTEyMDQ2OQ_e3a3f395-17b8-4215-8cf6-91cacad89e34">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Global Select Market)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160; <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGV4dHJlZ2lvbjpkMzAxNGQ3Njc4OGU0ZTBlOWJlNDg3MWMzMmE4NWJlNl8xOTg2_3a0f792a-aa9c-425e-8481-1f2845aaf8d8">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160; <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGV4dHJlZ2lvbjpkMzAxNGQ3Njc4OGU0ZTBlOWJlNDg3MWMzMmE4NWJlNl8xOTg3_7e7759a3-039b-4147-8f62-265f7404bdad">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.059%"><tr><td style="width:1.0%"></td><td style="width:26.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.148%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6ZjQ3YmMxZDY3MTc0NGU5ZGFhNmM5N2M1MzdhMTAxMDgvdGFibGVyYW5nZTpmNDdiYzFkNjcxNzQ0ZTlkYWE2Yzk3YzUzN2ExMDEwOF8wLTAtMS0xLTExMjI5MQ_2c62ee01-2e74-47c8-b4f7-f3da633a5100">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6ZjQ3YmMxZDY3MTc0NGU5ZGFhNmM5N2M1MzdhMTAxMDgvdGFibGVyYW5nZTpmNDdiYzFkNjcxNzQ0ZTlkYWE2Yzk3YzUzN2ExMDEwOF8yLTQtMS0xLTExMjI5MQ_ad7e229d-eaa5-489a-a05c-f4d9f2c06ec7">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6ZjQ3YmMxZDY3MTc0NGU5ZGFhNmM5N2M1MzdhMTAxMDgvdGFibGVyYW5nZTpmNDdiYzFkNjcxNzQ0ZTlkYWE2Yzk3YzUzN2ExMDEwOF80LTQtMS0xLTExMjI5MQ_0049abeb-1aae-4223-85b0-a2c0d8f2968b">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act):&#160; Yes&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGV4dHJlZ2lvbjpkMzAxNGQ3Njc4OGU0ZTBlOWJlNDg3MWMzMmE4NWJlNl8xOTgx_ba24f3b7-a08f-4481-9b22-41e549cc1714">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date:</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.908%"><tr><td style="width:1.0%"></td><td style="width:42.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Outstanding&#160;at April 30, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d8acfe084474d409043528e4b35689c_I20230430" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6NGUyNzE5NDRiMGMyNGZlMzk1MzQzYjE5NjU5YzgzMDYvdGFibGVyYW5nZTo0ZTI3MTk0NGIwYzI0ZmUzOTUzNDNiMTk2NTljODMwNl8xLTItMS0xLTExMjI5MQ_781c09b2-cd78-4f45-a737-55813e184d8d">24,064,364</ix:nonFraction></span></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="if1f54ab03e0c44ba84b642c022c86fca_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2023</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page&#160;Number</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_1183">Forward Looking Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_1183">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">PART I.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_10">Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_13">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_16">Condensed Consolidated Balance Sheets at </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_16">Mar</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_16">ch 31</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_16">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_16">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_16"> and December&#160;31,&#160;202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_16">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_16">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_19">Condensed Consolidated Statements of Operations for the Three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_19">Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_19">March 31</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_19">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_19">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_19"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_19">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_19">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_22">Condensed Consolidated Statements of Comprehensive </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_22">Income </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_22">(Loss) </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_22">for the Three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_22">Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_22">March 31, 2023</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_22"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_22">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_22">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_25">Condensed Consolidated Statements of Stockholders' Equity for the Three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_25">Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_25">March 31</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_25">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_25">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_25"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_25">2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_25">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_28">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_28">Three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_28"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_28">March 31, 2023</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_28"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_28">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_28">10</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_31">12</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_94">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_94">40</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_109">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_109">51</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_112">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_112">52</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">PART II.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_115">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_118">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_118">53</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_121">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_121">53</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_124">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_124">53</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_127">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_127">54</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_130">Signature</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_130">55</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="if1f54ab03e0c44ba84b642c022c86fca_1183"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various portions of this Quarterly Report on Form 10-Q, including this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, describe trends in our business and finances that we perceive and state some of our expectations and beliefs about our future. These statements about the future are &#8220;forward-looking statements,&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and we may identify them by using words such as "anticipate," "believe," "expect," "estimate," "intend," "plan," "will," "continue," "could," "may," and by similar expressions and statements about aims, goals and plans. The forward-looking statements are based on the information currently available to us and assumptions that we believe are reasonable, but we do not intend the statements to be representations as to future results. They include, without limitation, statements about:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our future growth; future operating results and</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial condition (including, among other things, anticipated sales; accruals for restructuring charges, production costs; gross margins; litigation expense; future SG&amp;A and R&amp;D expenses; manufacturing expenses; our expectations regarding liquidity and capital resources over the next twelve months; capital expenditures;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; source of funds for capital purchases and operations; future tax rates; alternative sources of capital or financing; changes in working capital items such as receivables and inventory; use of treasury stock; realizable value of our investment securities; future investment alternatives; foreign currency denominated financial instruments; and income taxes;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">factors affecting operating results, such as </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the impact of an increase in shipping costs; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">loss of a strategic relationship; change in demand for our products; domestic and international sales; expansion in international markets, future increases or decreases in sales of certain products and in certain markets and distribution channels; maintaining strategic relationships and securing long-term and multi-product contracts with large healthcare providers and major buying organizations; increases in systems capabilities; introduction, development and sales of new products, benefits of our products over competing systems; qualification of our new products for the expedited Section 510(k) clearance procedure; possibility of lengthier clearance process for new products; planned increases in marketing; warranty claims; rebates; product returns; bad debt expense; amortization expense; inventory requirements; lives of property and equipment; manufacturing efficiencies and cost savings; unit manufacturing costs; establishment or expansion of production facilities inside or outside of the United States; planned new orders for semi-automated or fully automated assembly machines for new products; adequacy of production capacity; results of R&amp;D; our plans to repurchase shares of our common stock; asset impairment losses; relocation of manufacturing facilities and personnel; effect of expansion of manufacturing facilities on production efficiencies and resolution of production inefficiencies; the effect of costs to customers and delivery times; business seasonality and fluctuations in quarterly results; customer ordering patterns and the effects of new accounting pronouncements;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new or extended contracts with manufacturers and buying organizations; dependence on a small number of customers; loss of larger distributors and the ability to locate other distributors; the outcome of our strategic initiatives; regulatory approvals and compliance; including the work necessary to achieve regulatory clearance with respect to the Smiths Medical Warning Letter; outcome of litigation; patent protection and intellectual property landscape; patent infringement claims and the impact of newly issued patents on other medical devices; competitive and market factors, including continuing development of competing products by other manufacturers; improved production processes and higher volume production; innovation requirements; consolidation of the healthcare provider market and downward pressure on selling prices; distribution or financial capabilities of competitors; healthcare reform legislation; foreign exchange risk; commodity price risk; plans to convert existing space; acquisitions of other businesses or product lines, and </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of acquisitions and the integration of acquired businesses and product lines (including the Smiths Medical business).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward looking statements in this Quarterly Report on Form 10-Q are only predictions and are based largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. These forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, including without limitation, the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our dependence on single and limited source third-party suppliers, which subjects our business and results of operations to risks of supplier business interruptions, and a loss or degradation in performance in our suppliers;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">damage to any of our manufacturing facilities or disruption to our supply chain network;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prolonged periods of inflation, rising interest rates and the impact of foreign currency exchange rates as a result of the current global macroeconomic and geopolitical conditions;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the COVID-19 pandemic on the way we, our suppliers and our customers operate and the duration, and the extent to which this will impact our business, future results of operations, liquidity and overall financial performance;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant sales through our distributors;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure to achieve expected operating efficiencies or expense reductions associated with cost reduction and restructuring efforts;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure to compete successfully with our competitors and maintain market share;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to fund substantial investment in product development and recover such investment through commercial product sales;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant decline in demand for our products;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continuing pressures to reduce healthcare costs and inadequate coverage and reimbursement; </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to protect our information technology systems against security breaches, service interruptions, or misappropriation of data;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruptions at the FDA, other government agencies or notified bodies caused by funding shortages or global health concerns;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or perceived failures to comply with foreign, federal, and state data privacy and security laws, regulations and standards, or certain fraud and abuse and transparency laws;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure to defend and enforce our patents or other proprietary rights and the cost of enforcing and of defending patent claims or claims of other proprietary rights; and expiration of our patents;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our exposure to risks related to foreign currency exchange rates;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any significant changes in U.S. trade, tax or other policies that restrict imports or increase import tariffs;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additional risks from international sales, related to competition with larger international companies and established local companies and our possibly higher cost structure;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure to effectively manage our growth and change to our business resulting from the Smiths Medical acquisition or any other future acquisitions;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the actual impact of the Smiths Medical acquisition on our financial results and our use of a significant portion of our cash on hand and incurrence of a substantial amount of debt to finance the Smiths Medical acquisition, which could adversely affect our business, including by restricting our ability to engage in additional transactions or incur additional indebtedness.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a more detailed discussion of these factors, see the information under the sections entitled &#8220;Summary Risk Factors,&#8221; Part I. Item 1A. &#8220;Risk Factors&#8221; and Part II. Item 7 &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our 2022 Annual Report, and the sections in this Quarterly Report on Form 10-Q entitled Part II. Item 1A &#8220;Risk Factors&#8221; and Part I. Item 2 &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; in each case as updated by our periodic filings with the SEC.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">management to predict all risk factors and uncertainties. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="if1f54ab03e0c44ba84b642c022c86fca_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_13"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.52pt;text-decoration:underline">Financial Statements (Unaudited)</span></div><div><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(In thousands, except par value data and treasury shares)&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CURRENT ASSETS:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNC0xLTEtMS0xMTIyOTE_a902b203-d724-45eb-b499-b2adbc891fda">220,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNC0zLTEtMS0xMTIyOTE_7f5fdd0d-259f-4a0c-97a1-43e46e1c0483">208,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNS0xLTEtMS0xMTIyOTE_8e957137-d20b-4a73-8c42-bbc95302aca6">3,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNS0zLTEtMS0xMTIyOTE_9e1c5a15-8b30-41b4-b008-d1882d344a74">4,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENT SECURITIES</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNi0xLTEtMS0xMTIyOTE_217ea4e4-2f9f-44ce-a0f4-7682f54a53bd">224,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNi0zLTEtMS0xMTIyOTE_b4b42f79-adc9-433b-8f62-7db731f52deb">213,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for doubtful accounts $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNy0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjoyNTVhYjg3ZGU4MjI0NjUzYWQyYjk4YTU5MzgxMTBiMF82Nw_674edd53-1060-434a-8b92-194019815da6">10,337</ix:nonFraction> at March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNy0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjoyNTVhYjg3ZGU4MjI0NjUzYWQyYjk4YTU5MzgxMTBiMF84MA_8723ca6f-02c4-4c72-98ef-58b1761d2d72">8,530</ix:nonFraction> at December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNy0xLTEtMS0xMTIyOTE_58be837c-dde3-4c34-9b8f-763caf8c4979">139,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNy0zLTEtMS0xMTIyOTE_4572b495-5d90-4b8e-9ee8-0a59ebbf46f5">221,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfOC0xLTEtMS0xMTIyOTE_a955d0db-8d5b-470c-973e-7fd8ea9d4488">747,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfOC0zLTEtMS0xMTIyOTE_0fe1c3ef-a99e-4fd0-ba6b-891b764bc690">696,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfOS0xLTEtMS0xMTIyOTE_2fcf7ca1-4783-4d65-9ac6-22ea1655b011">14,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfOS0zLTEtMS0xMTIyOTE_beb57dd6-7fe1-4dee-bf23-6d0d9d0616fc">15,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTAtMS0xLTEtMTEyMjkx_335500a5-02a9-4f2f-94d7-8efc175e6833">87,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTAtMy0xLTEtMTEyMjkx_7d7d037a-f223-449f-903b-ffe31ed2d335">88,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL CURRENT ASSETS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTMtMS0xLTEtMTEyMjkx_014816c1-cf23-44df-8376-53d76dfd9cbd">1,213,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTMtMy0xLTEtMTEyMjkx_76d15de6-be5b-43b2-96c5-524893474b9d">1,235,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PROPERTY, PLANT AND EQUIPMENT, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTUtMS0xLTEtMTEyMjkx_c6d15127-bdfe-485a-a74d-b4fd0711da5b">624,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTUtMy0xLTEtMTEyMjkx_05e3014b-2fc3-4b5a-8baf-57b8e024aeb5">636,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPERATING LEASE RIGHT-OF-USE ASSETS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTYtMS0xLTEtMTEyMjkx_03c55f6a-b95d-47c7-b7f7-51ae19f85464">79,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTYtMy0xLTEtMTEyMjkx_14b6f9fc-686b-45bd-bd84-0ea1ea93f551">74,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LONG-TERM INVESTMENT SECURITIES</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTgtMS0xLTEtMTEyMjkx_c138d21b-2295-409d-ba58-2005f88badba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTgtMy0xLTEtMTEyMjkx_a1e60399-4e6d-4788-bcb2-f4e4514ba393">516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GOODWILL</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTktMS0xLTEtMTEyMjkx_42de5a2f-d781-4db5-8085-4dd47d175d1c">1,462,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTktMy0xLTEtMTEyMjkx_6ecf80d1-750c-4390-81b5-f5f1ac8cc377">1,449,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">INTANGIBLE ASSETS, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjAtMS0xLTEtMTEyMjkx_b3a79896-9dc2-4cbd-9dca-765769c4bcfc">957,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjAtMy0xLTEtMTEyMjkx_229ef6be-ce62-4921-b18f-79a60092ec04">982,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DEFERRED INCOME TAXES</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjEtMS0xLTEtMTEyMjkx_79dde476-4565-4957-99ea-94020a39b418">31,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjEtMy0xLTEtMTEyMjkx_70335eec-0ed7-4001-b332-17522ace5f9c">31,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OTHER ASSETS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjItMS0xLTEtMTEyMjkx_c9fa74ef-ead0-4932-a4cf-07dba7eea7dd">101,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjItMy0xLTEtMTEyMjkx_6f9f325f-393a-47ff-ad08-b307a627d1bf">105,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjMtMS0xLTEtMTEyMjkx_7d75a430-0fa6-42d2-b6b2-1f9ad338050a">4,470,632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjMtMy0xLTEtMTEyMjkx_a94bd12d-e31f-4bdd-b136-251cf57b6140">4,515,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CURRENT LIABILITIES:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjctMS0xLTEtMTEyMjkx_e3d4035c-9b36-4b44-9eb0-860b19e45e91">186,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjctMy0xLTEtMTEyMjkx_4921cb4d-3853-4114-b725-5db1dd93f9f8">215,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjgtMS0xLTEtMTEyMjkx_1bae557d-c5cd-4ee9-b1b0-67eaf84341e9">235,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjgtMy0xLTEtMTEyMjkx_846aab52-7cc5-405a-bbec-efe479d462f6">242,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjktMS0xLTEtMTEyMjkx_db16944b-ab79-42a3-b033-b504711934da">35,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjktMy0xLTEtMTEyMjkx_0358ed67-d452-4d84-aef6-070833d84020">29,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzAtMS0xLTEtMTEyMjkx_ff4b9ad0-704b-4240-8432-553c9c4e694e">5,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzAtMy0xLTEtMTEyMjkx_15d626ce-74fa-4454-86b8-9b4572ac66f0">6,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL CURRENT LIABILITIES</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzItMS0xLTEtMTEyMjkx_473205f3-2de9-42f7-8af9-3afaa76951e1">462,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzItMy0xLTEtMTEyMjkx_6471ee0c-00a4-42c7-ba9d-ec57d5196909">494,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CONTINGENT EARN-OUT LIABILITY</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzQtMS0xLTEtMTEyMjkx_2f012091-a90f-4f7e-91c4-619e662d923f">24,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzQtMy0xLTEtMTEyMjkx_4da36b68-c1fc-494d-820b-9fb637b9022a">25,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LONG-TERM DEBT</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzUtMS0xLTEtMTEyMjkx_83099930-2f04-41d1-aa43-9c978ca9a3dd">1,612,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzUtMy0xLTEtMTEyMjkx_51c484db-ce1a-4cb3-abe8-d3f215b4770a">1,623,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OTHER LONG-TERM LIABILITIES</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzYtMS0xLTEtMTEyMjkx_53f462fd-f5ba-4a78-a2a1-8f6f606f7134">114,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzYtMy0xLTEtMTEyMjkx_3804cf2f-b8ca-49e5-9aa8-e8ee14773d44">114,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DEFERRED INCOME TAXES</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzctMS0xLTEtMTEyMjkx_b8a108f0-4a2f-4d97-b1d2-a8fe4360bd2f">114,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzctMy0xLTEtMTEyMjkx_324fc7b1-d4a4-45c7-8174-045af2b5112b">126,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">INCOME TAX LIABILITY</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzgtMS0xLTEtMTEyMjkx_2d466a83-8271-4384-83d4-36416465ca69">42,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzgtMy0xLTEtMTEyMjkx_debccfde-4123-4698-b79f-854066c2b056">41,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COMMITMENTS AND CONTINGENCIES (Note 19)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzktMS0xLTEtMTEyMjkx_291681df-3547-4474-94e6-ef19c2f63f15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzktMy0xLTEtMTEyMjkx_4a1282af-9c82-4f9b-89f2-ff2e628b50ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">STOCKHOLDERS&#8217; EQUITY:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Convertible preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMC0xLTEtMTEyMjkxL3RleHRyZWdpb246NWM1NTFhNTQ2MDBlNDRjYmEzNzQzYjk3OWE3M2JhYTBfMzM_3ac2993e-a200-47a5-bfb6-e08d384a9fd6">1.00</ix:nonFraction> par value; Authorized &#8212; <ix:nonFraction unitRef="shares" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMC0xLTEtMTEyMjkxL3RleHRyZWdpb246NWM1NTFhNTQ2MDBlNDRjYmEzNzQzYjk3OWE3M2JhYTBfNjA_862a0f5f-53b7-4a63-9384-e88b270e3f3b">500</ix:nonFraction> shares; Issued and outstanding &#8212; <ix:nonFraction unitRef="shares" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMC0xLTEtMTEyMjkxL3RleHRyZWdpb246NWM1NTFhNTQ2MDBlNDRjYmEzNzQzYjk3OWE3M2JhYTBfOTY_31348818-0e12-48f7-8550-bfd51ce3a835"><ix:nonFraction unitRef="shares" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMC0xLTEtMTEyMjkxL3RleHRyZWdpb246NWM1NTFhNTQ2MDBlNDRjYmEzNzQzYjk3OWE3M2JhYTBfOTY_e4f13a58-36ad-4616-be0a-86fb9bf5dfaf"><ix:nonFraction unitRef="shares" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMC0xLTEtMTEyMjkxL3RleHRyZWdpb246NWM1NTFhNTQ2MDBlNDRjYmEzNzQzYjk3OWE3M2JhYTBfOTY_f39772f4-c226-4e8c-af4d-92b695ca60d8"><ix:nonFraction unitRef="shares" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMC0xLTEtMTEyMjkxL3RleHRyZWdpb246NWM1NTFhNTQ2MDBlNDRjYmEzNzQzYjk3OWE3M2JhYTBfOTY_f8119b68-123f-4918-a141-33a9a4815083">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMS0xLTEtMTEyMjkx_3e49cc8a-2ac0-47ac-99ca-0d3d903516ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMy0xLTEtMTEyMjkx_fc1bc812-1b18-4fb7-bf12-d0b72275a81e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMC0xLTEtMTEyMjkxL3RleHRyZWdpb246YTA5MDkxODdmYTFhNGQ2MmI5MWQxY2IwZTQxMjZhYzNfMTk_e78b0a82-43d8-4279-81b1-229a047c7067">0.10</ix:nonFraction> par value; Authorized &#8212; <ix:nonFraction unitRef="shares" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMC0xLTEtMTEyMjkxL3RleHRyZWdpb246YTA5MDkxODdmYTFhNGQ2MmI5MWQxY2IwZTQxMjZhYzNfNDY_f7d0b1d5-59a7-478d-b1e0-1bf4b0ffcdcc">80,000</ix:nonFraction> shares; Issued &#8212; <ix:nonFraction unitRef="shares" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMC0xLTEtMTEyMjkxL3RleHRyZWdpb246YTA5MDkxODdmYTFhNGQ2MmI5MWQxY2IwZTQxMjZhYzNfNjY_36f29b65-c195-4b8c-81fc-03712d95882a">24,114</ix:nonFraction> shares at March&#160;31, 2023 and <ix:nonFraction unitRef="shares" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMC0xLTEtMTEyMjkxL3RleHRyZWdpb246YTA5MDkxODdmYTFhNGQ2MmI5MWQxY2IwZTQxMjZhYzNfODY_1f83e968-acc6-4e90-a148-b59f2d7bd099">23,995</ix:nonFraction> shares at December&#160;31, 2022; and outstanding &#8212; <ix:nonFraction unitRef="shares" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMC0xLTEtMTEyMjkxL3RleHRyZWdpb246YTA5MDkxODdmYTFhNGQ2MmI5MWQxY2IwZTQxMjZhYzNfMTIx_41b32b1f-8ab4-44b7-9ffe-830574fc2542">24,064</ix:nonFraction> shares at March&#160;31, 2023 and <ix:nonFraction unitRef="shares" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMC0xLTEtMTEyMjkxL3RleHRyZWdpb246YTA5MDkxODdmYTFhNGQ2MmI5MWQxY2IwZTQxMjZhYzNfMTQx_36e3de95-7714-4623-b23b-e9f62182ccfa">23,993</ix:nonFraction> shares at December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMS0xLTEtMTEyMjkx_c81567b8-ccba-4c42-938e-a7988607d681">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMy0xLTEtMTEyMjkx_35b338bd-0580-44c2-9fe3-deae3f5f796b">2,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDMtMS0xLTEtMTEyMjkx_8fdbb92f-6a89-442b-baae-1e15f6b5e4d9">1,339,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDMtMy0xLTEtMTEyMjkx_75047be6-0dd1-47ed-9798-da330c8b02bf">1,331,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock, at cost (<ix:nonFraction unitRef="shares" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="0" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDQtMC0xLTEtMTEyMjkxL3RleHRyZWdpb246NWE0ZjUwY2UwMjVjNDkxYjllNjFjODM1MWZmNDkzNjJfMjk_b0d2dc7e-35cc-4ad3-92a2-b3c6ff630af1">50,374</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="0" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDQtMC0xLTEtMTEyMjkxL3RleHRyZWdpb246NWE0ZjUwY2UwMjVjNDkxYjllNjFjODM1MWZmNDkzNjJfMzY_318d06a2-38ff-496a-b94c-11787c8d8229">1,633</ix:nonFraction> shares, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDQtMS0xLTEtMTEyMjkx_f3587eac-ab6a-4257-a9ba-1082dabc3dc3">8,006</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDQtMy0xLTEtMTEyMjkx_d6fa66ab-3258-4c34-a51f-118afd81ca95">243</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDUtMS0xLTEtMTEyMjkx_af68e64e-482a-4e30-ad1d-e23634e4ff7c">827,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDUtMy0xLTEtMTEyMjkx_dded447b-f585-4c32-9b07-42383de17643">837,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDYtMS0xLTEtMTEyMjkx_cd643b7f-9db0-4d1d-b266-f353dda0f7fe">61,603</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDYtMy0xLTEtMTEyMjkx_b11da195-db32-4106-b8f6-91d7659faf25">80,978</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL STOCKHOLDERS' EQUITY</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDctMS0xLTEtMTEyMjkx_74788469-b7b8-4448-a944-3abe4c715e2a">2,100,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDctMy0xLTEtMTEyMjkx_01fae28f-4563-4565-bfe8-b29d7a556285">2,089,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDgtMS0xLTEtMTEyMjkx_ba9907eb-5c96-4213-90a6-9d788402b444">4,470,632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDgtMy0xLTEtMTEyMjkx_d6e2a135-c2fa-450f-a554-f6e3457190e7">4,515,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;<ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b" footnoteRole="http://www.xbrl.org/2003/role/footnote">December&#160;31, 2022 balances were derived from audited consolidated financial statements.</ix:footnote></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="if1f54ab03e0c44ba84b642c022c86fca_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:73.789%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.090%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL REVENUES</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMi0xLTEtMS0xMTIyOTE_dd7f000a-99bf-4f4a-8bc9-865c3b88a5b7">568,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMi0zLTEtMS0xMTIyOTE_0ff78064-84f5-4f89-bc9c-ba859f22a1ac">543,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COST OF GOODS SOLD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMy0xLTEtMS0xMTIyOTE_d630ddab-648f-4692-b1b9-a83e22e7f333">376,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMy0zLTEtMS0xMTIyOTE_a0f11336-e1da-4cbc-a192-7452389cb5fd">374,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GROSS PROFIT</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfNC0xLTEtMS0xMTIyOTE_e96b950a-8ef6-481a-925c-2b6968f5feef">192,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfNC0zLTEtMS0xMTIyOTE_77ec4db2-c390-4b89-b370-79d0ccb14782">168,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OPERATING EXPENSES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfNi0xLTEtMS0xMTIyOTE_85316666-446e-4614-9222-e5ecf114cb13">152,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfNi0zLTEtMS0xMTIyOTE_8eb2b90f-e945-4e07-81e1-8f12c3fbc933">153,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfNy0xLTEtMS0xMTIyOTE_6dbe2613-1134-4c82-abed-20c633780d9d">19,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfNy0zLTEtMS0xMTIyOTE_c6c82eeb-053d-4efc-a9a0-0f2a152ca9a8">23,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, strategic transaction and integration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="icui:Restructuringandstrategictransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfOC0xLTEtMS0xMTIyOTE_f01fc735-66ae-46f0-9109-c8a6b7d0fa45">11,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="icui:Restructuringandstrategictransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfOC0zLTEtMS0xMTIyOTE_795c9e60-06ef-4fac-90d4-d9e6dd8408df">33,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent earn-out</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfOS0xLTEtMS0xMTIyOTE_254baedf-4bf7-4ca8-9ae7-50b5057bf054">700</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfOS0zLTEtMS0xMTIyOTE_6a0893aa-a6f0-49a1-845e-aa5de24f4a7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL OPERATING EXPENSES</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTEtMS0xLTEtMTEyMjkx_e806a3d5-a4ce-4205-a912-b9bb7e15ce55">182,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTEtMy0xLTEtMTEyMjkx_03758d19-7e0d-4baa-9527-0680a56bcb0b">210,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INCOME (LOSS) FROM OPERATIONS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTItMS0xLTEtMTEyMjkx_842529a2-c826-484d-bd7e-61c8a20cd149">9,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTItMy0xLTEtMTEyMjkx_74929eb6-d8f6-4ae3-81f1-26c30ccc95be">42,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INTEREST EXPENSE, NET</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTQtMS0xLTEtMTEyMjkx_67365c1b-0884-4fce-8492-61dc828682ec">22,515</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTQtMy0xLTEtMTEyMjkx_c5ea7971-58e8-4602-b211-6d6c909ed80f">13,055</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTHER (EXPENSE) INCOME, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTUtMS0xLTEtMTEyMjkx_6e9fd739-7195-44f4-8979-990e2b2b725f">269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTUtMy0xLTEtMTEyMjkx_fb5987b1-b358-44c5-a36c-2b39398b71c6">415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LOSS BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTYtMS0xLTEtMTEyMjkx_a5767825-2d7b-468a-ba0a-74fe681af2cc">13,389</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTYtMy0xLTEtMTEyMjkx_0baf675d-3d63-4838-af6d-2958dd9936bd">54,801</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BENEFIT FOR INCOME TAXES</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTctMS0xLTEtMTEyMjkx_8f0086fe-10a9-43d2-affc-827a02fd4314">3,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTctMy0xLTEtMTEyMjkx_c6f326e7-a94c-45ae-8143-27083b293cd2">16,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET LOSS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTgtMS0xLTEtMTEyMjkx_2abfca0e-a125-4853-b8d0-c2a760139d66">9,812</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTgtMy0xLTEtMTEyMjkx_9d4d3106-a20c-4875-a285-0bcb14655000">38,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET LOSS PER SHARE</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMjAtMS0xLTEtMTEyMjkx_9a7b3877-e10a-4d39-93d3-33bda71aba10">0.41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMjAtMy0xLTEtMTEyMjkx_37e50950-f578-44bf-b639-b3af140353b0">1.61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMjEtMS0xLTEtMTEyMjkx_70f31aa3-322a-4093-9d33-b9ecd4cc012b">0.41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMjEtMy0xLTEtMTEyMjkx_ca2fda44-52d8-44f5-a167-dd38e9a03f4b">1.61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WEIGHTED AVERAGE NUMBER OF SHARES</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMjMtMS0xLTEtMTEyMjkx_953a4ee0-6c05-4536-9a36-585f6fed5d46">24,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMjMtMy0xLTEtMTEyMjkx_40bdc8d8-215d-45c8-ac25-b0cd5d208281">23,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMjQtMS0xLTEtMTEyMjkx_3ef814a0-902f-4462-be25-4bec5fef27d2">24,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMjQtMy0xLTEtMTEyMjkx_007b1072-5343-4150-997c-531f245ffaa2">23,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="if1f54ab03e0c44ba84b642c022c86fca_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.134%"><tr><td style="width:1.0%"></td><td style="width:70.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.828%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET LOSS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfMi0xLTEtMS0xMTIyOTE_393701f2-7f9c-4152-86db-ac0271562008">9,812</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfMi0zLTEtMS0xMTIyOTE_701093ac-10a9-43e3-a5fb-d2686ae496fd">38,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge adjustments, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNC0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjozNGUwZjQ2MWYxMmE0OGE2YjliODcyYzA5YWQwYTMzMV80Nw_cf83eb64-f8f7-499c-bd31-bdd013482a3e">1,744</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNC0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjozNGUwZjQ2MWYxMmE0OGE2YjliODcyYzA5YWQwYTMzMV81NA_5979fd18-f1b1-4c4a-9a50-06b3ea77b00b">7,312</ix:nonFraction>) for the three months ended March 31, 2023 and 2022, respectively.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNC0xLTEtMS0xMTIyOTE_7f5d8b6d-820a-4e6c-8c27-103bb2283ef2">5,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNC0zLTEtMS0xMTIyOTE_f3f4848c-be29-4239-908f-431a82c9039e">23,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment, net of tax of $<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNS0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjo2MjAxM2I5Mzg1NzI0NjU4ODRkODZhNGJiZWY4YmE2ZF81OQ_1a9d3f83-11c3-40e0-87be-9043c5154ed0"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNS0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjo2MjAxM2I5Mzg1NzI0NjU4ODRkODZhNGJiZWY4YmE2ZF81OQ_3b75eadc-1153-42ed-938b-0cd7e775485a"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNS0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjo2MjAxM2I5Mzg1NzI0NjU4ODRkODZhNGJiZWY4YmE2ZF81OQ_5e9cca33-7884-4efd-a7e1-8b96f8740be4"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNS0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjo2MjAxM2I5Mzg1NzI0NjU4ODRkODZhNGJiZWY4YmE2ZF81OQ_bd27325f-fc1f-4460-ae76-5a47c0fc0283">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> for all periods</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNS0xLTEtMS0xMTIyOTE_2768fa25-131b-4172-ad72-cb0a4936e684">24,983</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNS0zLTEtMS0xMTIyOTE_014ec6c3-31e9-4b0c-b06c-ba94edc7173b">4,946</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNi0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjo1MmQyYzM0YzhjN2M0ZDRlYjI2OTY4Y2M0ZWY0MzNhMF8zNw_01ae756c-4053-47db-bbfd-9a914fb69875"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNi0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjo1MmQyYzM0YzhjN2M0ZDRlYjI2OTY4Y2M0ZWY0MzNhMF8zNw_70a13ec6-233f-41fc-b926-d1e14459437e"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNi0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjo1MmQyYzM0YzhjN2M0ZDRlYjI2OTY4Y2M0ZWY0MzNhMF8zNw_769abbb1-4834-4fc0-bed9-a9a1ff517655"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNi0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjo1MmQyYzM0YzhjN2M0ZDRlYjI2OTY4Y2M0ZWY0MzNhMF8zNw_95c8cbf0-9f94-4719-af61-860e7853f684">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> for all periods</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNi0xLTEtMS0xMTIyOTE_7898d8fc-b888-4e1c-a132-d8d38fe3d0a6">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNi0zLTEtMS0xMTIyOTE_cd57c7fb-187f-438b-ae6b-92cd64e41b56">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNy0xLTEtMS0xMTIyOTE_2e85cf6f-dffa-4966-b35a-36b31c94b4d6">19,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNy0zLTEtMS0xMTIyOTE_c29f5367-c149-4d9a-b293-6650ce53fb6b">18,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COMPREHENSIVE INCOME (LOSS)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfOC0xLTEtMS0xMTIyOTE_e531424e-9431-4f50-a0d0-837be5cf5a91">9,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfOC0zLTEtMS0xMTIyOTE_cf522752-259c-41fd-9a9f-7824e5bbc7cc">19,427</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="if1f54ab03e0c44ba84b642c022c86fca_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICU MEDICAL,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.783%"><tr><td style="width:1.0%"></td><td style="width:38.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.431%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.902%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.878%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.280%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>(Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07f6b061c66845509e4e6c7ff5cbe7bc_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMi0yLTEtMS0xMTIyOTE_2441adc2-293d-4387-b1c8-1cd656e4de0d">23,995</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5638b072e2c74cecb680e1eeeb816a7f_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMi00LTEtMS0xMTIyOTE_ee9c0602-5abe-40d4-bf26-966cdbe6b3dc">2,399</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36e92a4a4e041d789fd1e15a96fb89d_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMi02LTEtMS0xMTIyOTE_a1cd0e5d-11f8-4a5c-b516-44eb5a1e592d">1,331,249</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f732bf16f8943de8310b4900638904c_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMi04LTEtMS0xMTIyOTE_6543a881-13b4-4135-839e-4e3394b51cb1">243</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i905ef664618549b79a2604ba36989fa1_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMi0xMC0xLTEtMTEyMjkx_849a1dde-0d95-4e58-a823-4b119dc831e1">837,501</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2876aa14e8a049c888a7c1a7d0b9add5_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMi0xMi0xLTEtMTEyMjkx_5f5292a4-0c5c-49f0-9b9a-ec29108fd7a5">80,978</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMi0xNC0xLTEtMTEyMjkx_771e18e5-b6ab-44eb-81a6-39f93a0129fb">2,089,928</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock and exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f675125f08545ed853c555497efd555_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMy0yLTEtMS0xMTIyOTE_66b01a08-a5b7-4cdf-9df7-dcba5f76b0f5">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i157787461be54c729a371db9e5f0b870_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMy00LTEtMS0xMTIyOTE_8e05e36b-94b7-4f32-8cab-c26b90d6c290">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i553e7d37da95492bb56ab18d405def24_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMy02LTEtMS0xMTIyOTE_996605a0-ea91-4bb8-87a3-bfefcf96543e">503</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i076bb8ec7f8a4200aaa3d2d05b180bb7_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMy04LTEtMS0xMTIyOTE_6d6fdb23-8feb-414a-8eef-cc25f810e979">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMy0xNC0xLTEtMTEyMjkx_c55c5ee1-4c3f-481e-8598-ed415b611b6b">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0f675125f08545ed853c555497efd555_D20230101-20230331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfNC0yLTEtMS0xMTIyOTE_8f8f4e55-5ee3-4d5b-91d0-c6def46bf195">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i076bb8ec7f8a4200aaa3d2d05b180bb7_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfNC04LTEtMS0xMTIyOTE_6aa3cd74-0b38-478d-a525-30bffef7c1f6">8,425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfNC0xNC0xLTEtMTEyMjkx_dc1a3c89-71a3-47bf-afd5-2e060ddd90d3">8,425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553e7d37da95492bb56ab18d405def24_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfNi02LTEtMS0xMTIyOTE_b2d30d48-c906-4f6f-b925-5e0cf859d7b7">9,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfNi0xNC0xLTEtMTEyMjkx_9d948159-77a7-44b4-883a-14fc4135c4a9">9,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553e7d37da95492bb56ab18d405def24_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfNy02LTEtMS0xMjA3ODY_9393a496-4e32-4f7f-871e-cd3394bd4873">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92f1bb64c23547f8be008ab8d3bb642a_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfNy0xMi0xLTEtMTEyMjkx_aad307bb-f0e5-43ed-b6f7-d9a070021038">19,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfNy0xNC0xLTEtMTEyMjkx_67d59a06-3a3a-4f65-a137-d81e776971cc">19,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85d17593813847138c47bd6a52b84d0d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOC0xMC0xLTEtMTEyMjkx_509abf3d-6443-47d9-9083-2d8027016862">9,812</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOC0xNC0xLTEtMTEyMjkx_537cd16f-d91c-4285-9b83-0ee775380aac">9,812</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54b39f23877a4f0d862e5916dd5e87c8_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOS0yLTEtMS0xMTIyOTE_3855a152-a496-440c-aed8-8025808efe97">24,114</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59687ae95c8c4f548a9c5ed00de7213f_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOS00LTEtMS0xMTIyOTE_e7f485e3-7e85-40c4-b6e9-895202fba196">2,411</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieccf8d651a8d422e91523860913a0c81_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOS02LTEtMS0xMTIyOTE_3b048bb7-8f39-428c-8ebe-8806cd22cb88">1,339,908</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id319fa0bb715447db5d21adda1569f95_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOS04LTEtMS0xMTIyOTE_70e9c40e-9d53-4604-8cb6-b60f16eaa874">8,006</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8121720b12924aeaa2d7f2161161fdc6_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOS0xMC0xLTEtMTEyMjkx_0ffd339b-5f41-487a-aaa8-6239c10b2705">827,689</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e09221885284788959b95412b6214f4_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOS0xMi0xLTEtMTEyMjkx_5b9a6b15-4e2e-48f0-bbca-7975e1f39dcb">61,603</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOS0xNC0xLTEtMTEyMjkx_75852e00-21bb-45a0-898a-387e7a807208">2,100,399</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.783%"><tr><td style="width:1.0%"></td><td style="width:38.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.431%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.902%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.878%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.280%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>(Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10ebf268d4574d988d0c464474155fe0_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMi0yLTEtMS0xMTIyOTE_59e110a8-aa66-49e1-ad92-0441731cfad1">21,280</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i097914f4b8e14986872f2b29ed1ef69e_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMi00LTEtMS0xMTIyOTE_6e6e8d2d-cd65-4942-8679-3a1611812c4f">2,128</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie149bde323634e0093914839ee8ac148_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMi02LTEtMS0xMTIyOTE_8e01e30b-527a-4f1e-9382-ab00b906d631">721,412</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc26a59bd7142798a8bbabd7a8aebf6_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMi04LTEtMS0xMTIyOTE_4493da52-0e3b-44bb-9c1d-24cfe2256ee4">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic079464d6d0c45109f1b5fdae21f379e_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMi0xMC0xLTEtMTEyMjkx_afa6e231-fd00-4e86-893d-3578e98ed808">911,787</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i720c98b0bc6c4647b5ec2b08163c165c_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMi0xMi0xLTEtMTEyMjkx_358f2ac9-1784-469e-86db-eea3ddc396f9">19,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fd0c26c71db4e4cb0b929a7689fb683_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMi0xNC0xLTEtMTEyMjkx_3b017bb7-6a1e-415e-a1ab-c0c1224f2b1a">1,616,031</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock and exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i864f233d9281416ea0ce16b7edf44f57_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMy0yLTEtMS0xMTIyOTE_1a7212a7-0a22-48ee-8708-70e21f089a99">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0c21e62a5645398a5ae491f1716ab4_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMy00LTEtMS0xMTIyOTE_14c4c2a0-8407-4bb3-bd26-80615657ce2a">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39df97d162224e7ead2e7587ce51c1c5_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMy02LTEtMS0xMTIyOTE_f2059827-cce7-4f09-adda-f34b8936a425">2,965</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica718d655f94421fb3eeafd5ac5288be_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMy04LTEtMS0xMTIyOTE_4e67328c-5745-4f20-923d-ebea6d75ea26">5,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMy0xNC0xLTEtMTEyMjkx_1433ccf6-4a3b-43ab-b17f-7d33466bed1b">2,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i864f233d9281416ea0ce16b7edf44f57_D20220101-20220331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNC0yLTEtMS0xMTIyOTE_c2a03016-a00c-4cc3-b25e-5faaf67062d7">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica718d655f94421fb3eeafd5ac5288be_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNC04LTEtMS0xMTIyOTE_09873203-6291-4992-b52a-aa966463b349">8,743</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNC0xNC0xLTEtMTEyMjkx_935c00f0-3991-466b-be9b-bbca13969eaf">8,743</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNS0yLTEtMS0xMjA3OTM_5cc83d55-bd3b-455f-a4f8-224e3947d6d2">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0c21e62a5645398a5ae491f1716ab4_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNS00LTEtMS0xMjA3OTY_21d0036b-75b8-4c05-8360-8ce26e6b112b">250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39df97d162224e7ead2e7587ce51c1c5_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNS02LTEtMS0xMjA4MDA_18ee23dd-8bdb-42b8-b9bf-c35c175934ac">575,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNS0xNC0xLTEtMTIwODAz_daf39d7e-e15a-438c-a5c3-95f73d0c6881">575,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39df97d162224e7ead2e7587ce51c1c5_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNS02LTEtMS0xMTIyOTE_f895a3f0-1c60-4d8e-9afb-d2989a05b45d">12,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNS0xNC0xLTEtMTEyMjkx_587c69ce-2f21-4d9c-8bf9-e4bacc1ea92c">12,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b0ee62d61be45c0aee4a548c96a0697_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNi0xMi0xLTEtMTEyMjkx_9a91a8b1-51c6-467f-b5d5-612d79ed6742">18,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNi0xNC0xLTEtMTEyMjkx_ced6ba49-2239-4328-b3b8-c7f7bbcfb97a">18,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f9b480e0479472aab56012880bdecd6_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNy0xMC0xLTEtMTEyMjkx_7e8b77ac-f4a5-4303-bf74-b33b5cea6885">38,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNy0xNC0xLTEtMTEyMjkx_a5fa03c5-c596-49b5-9a1f-b003e72e1ef2">38,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a406cdd295d4bae87e1e8ec6e5620dc_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfOC0yLTEtMS0xMTIyOTE_c52360fc-7a07-49bc-a2ca-bbb49f9b63ce">23,897</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a153016e3f444b4a7339a82e88bc93e_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfOC00LTEtMS0xMTIyOTE_49f5c952-0825-4c2f-9645-3542146d05e3">2,390</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i966e762ecf634e718045d1a26327c012_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfOC02LTEtMS0xMTIyOTE_c8850a5f-e6c8-4958-83fa-25f9eb6f37ae">1,306,264</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i135dbadf645845ba84e91cb70245f896_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfOC04LTEtMS0xMTIyOTE_cb99768a-c05d-4cee-b565-36afc8174429">2,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b4d6b0874b84330ab118d8d72f89852_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfOC0xMC0xLTEtMTEyMjkx_fb842368-10d0-4efa-a0ee-5c0ffcf699b4">873,719</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1adc8956afab4a2c82b48740ffa3c5f4_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfOC0xMi0xLTEtMTEyMjkx_5497addd-a581-464d-b33a-dbdf02ff5013">628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57ae4b72e9574e4ebf63f3473590fe05_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfOC0xNC0xLTEtMTEyMjkx_f7b6ac1c-31f5-41b9-be90-5a64033a276b">2,178,902</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="if1f54ab03e0c44ba84b642c022c86fca_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(In thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMy0xLTEtMS0xMTIyOTE_4ffbaa88-9756-476f-95df-9735d231b3a7">9,812</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMy0zLTEtMS0xMTIyOTE_bd4ea782-375f-4ce3-b340-a362ff83e874">38,068</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNS0xLTEtMS0xMTIyOTE_03b9fccf-fda5-44f0-8b34-fdbdfe33ec53">55,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNS0zLTEtMS0xMTIyOTE_b550fc00-76a3-4da1-867e-37b756ef6055">53,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of inventory step-up</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="icui:AmortizationOfInventoryStepUp" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNi0xLTEtMS0xMTIyOTE_a05fb4ae-8ffe-4922-a2d4-8e9fc085dbb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="icui:AmortizationOfInventoryStepUp" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNi0zLTEtMS0xMTIyOTE_7c46112d-253c-4ecf-8ef0-c345001608b6">14,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNy0xLTEtMS0xMTIyOTE_1803e7cc-82e7-4287-bb41-608b70b53c1a">5,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNy0zLTEtMS0xMTIyOTE_485b4c2e-cbd7-47b5-a3cf-45d2d2922e4c">5,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfOC0xLTEtMS0xMTIyOTE_1f48df1b-b9bd-4e1d-b870-2b3811ec89be">666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfOC0zLTEtMS0xMTIyOTE_39f9ca5d-bcc6-4ab6-a08a-8d7d6894cbe2">548</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for warranty, returns and field action</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="icui:ProvisionForWarrantyAndReturns" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfOS0xLTEtMS0xMTIyOTE_17a29aa0-a76f-4cd7-81d6-2db45b8175a3">3,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="icui:ProvisionForWarrantyAndReturns" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfOS0zLTEtMS0xMTIyOTE_bc01b11c-d4bc-4537-a75e-aebbeef97c72">726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTAtMS0xLTEtMTEyMjkx_c4e553cf-902f-40aa-af1e-9aebfe71647a">9,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTAtMy0xLTEtMTEyMjkx_15d195e4-19b7-4c18-a2c2-e0bc6f74d377">12,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on disposal of property, plant and equipment and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTEtMS0xLTEtMTEyMjkx_a123253b-d2e6-449e-ad26-5bb35fcacdeb">367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTEtMy0xLTEtMTEyMjkx_b7df588c-6ce0-4566-a0c2-1e130c02ffb6">596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bond premium amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:InvestmentIncomeAmortizationOfPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTItMS0xLTEtMTEyMjkx_52ab6f1d-734c-40df-9d85-fdca2d5e3cd1">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:InvestmentIncomeAmortizationOfPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTItMy0xLTEtMTEyMjkx_27ed57d5-5ec4-4c08-b810-52824108030c">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt issuance costs amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTMtMS0xLTEtMTEyMjkx_593a0ddb-da61-4040-b774-dc8743a54cbd">1,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTMtMy0xLTEtMTEyMjkx_5be56901-d027-4566-8c1b-e318f8fd2608">1,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of contingent earn-out</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTQtMS0xLTEtMTEyMjkx_2b277a38-7c7b-45a4-b9d5-134b0d058827">700</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTQtMy0xLTEtMTEyMjkx_65af5d23-ebbd-4a4d-9e1a-5297835d56ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Usage of spare parts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="icui:Sparepartsusage" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTYtMS0xLTEtMTEyMjkx_128a6ca1-6ff2-46c2-852f-348688e48b51">4,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="icui:Sparepartsusage" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTYtMy0xLTEtMTEyMjkx_dfc6b940-98d8-4016-9a6d-8a5784e04e9e">2,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTctMS0xLTEtMTEyMjkx_436271cc-3c83-4860-a8f7-6042dfd7bde6">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTctMy0xLTEtMTEyMjkx_8a95ff3c-4785-49e9-92ef-a4c60bb366cc">1,649</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of amounts acquired:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTktMS0xLTEtMTEyMjkx_76565d0c-66cb-4914-8ed9-9c786536f598">82,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTktMy0xLTEtMTEyMjkx_3cb7cb8f-b491-48c7-b726-6cec61ff11b6">22,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjAtMS0xLTEtMTEyMjkx_36260575-4c27-4302-90f1-33b5cc14197e">49,370</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjAtMy0xLTEtMTEyMjkx_9b57f6b6-32db-408f-8906-bfb46f33f984">36,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjEtMS0xLTEtMTEyMjkx_8bcb929d-2c8c-48ba-aef9-309117541955">1,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjEtMy0xLTEtMTEyMjkx_bcd1465c-7000-404c-bd87-5e9ee039b7a6">2,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjItMS0xLTEtMTEyMjkx_7d8ba295-2599-488a-8569-1ff1cce9fef3">6,448</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjItMy0xLTEtMTEyMjkx_8fab9ef8-ac17-43f4-8b00-4895c377c83d">14,371</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjMtMS0xLTEtMTEyMjkx_08012a10-b1ab-46fe-95e3-852a2e4c9551">27,525</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjMtMy0xLTEtMTEyMjkx_acbab4e1-e438-479b-8942-638efdd35058">19,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjQtMS0xLTEtMTEyMjkx_514628a0-ae00-476a-8906-6bb6796b6b4d">21,099</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjQtMy0xLTEtMTEyMjkx_1c7fe842-1bc0-457b-8565-5904f375328a">19,238</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes, including excess tax benefits and deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjUtMS0xLTEtMTEyMjkx_3cf039dd-ee86-4026-b8f0-1566b6a65bf7">9,328</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjUtMy0xLTEtMTEyMjkx_3faa60f2-91a2-4f3c-b216-2fe0f6b01e46">26,102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjYtMS0xLTEtMTEyMjkx_034a82b1-af89-46f0-81dd-76bdabcfb290">41,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjYtMy0xLTEtMTEyMjkx_5097f8cd-3e8a-4e61-87bc-691a5472d0b1">1,342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjgtMS0xLTEtMTEyMjkx_129d9081-4f66-4370-86eb-1105e459e38d">14,205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjgtMy0xLTEtMTEyMjkx_87665c4e-45ff-446a-b5fa-5820fef782bd">23,606</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjktMS0xLTEtMTEyMjkx_bfbd3a95-6556-4773-a4b1-a15e82c45a67">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjktMy0xLTEtMTEyMjkx_54a49228-9b02-43a5-ac3d-e1aa8e6db1da">900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzAtMS0xLTEtMTEyMjkx_1078f6a9-ca28-44d1-a95f-6d68bd893d37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzAtMy0xLTEtMTEyMjkx_6cc2c95c-35f2-4c37-b86d-44712ba9d679">1,844,164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible asset additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzEtMS0xLTEtMTEyMjkx_bf2b6a68-f41c-4877-aefc-e94b02afc9ad">2,532</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzEtMy0xLTEtMTEyMjkx_4ffceaf0-28ab-4ac5-a7b1-dec39549e3fa">2,387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzMtMS0xLTEtMTEyMjkx_557d5851-09dc-4cc0-b27a-88ba9da2000e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzMtMy0xLTEtMTEyMjkx_d3483334-ad24-4c6b-9475-f756fcdb7c81">1,993</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale and maturities of investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzQtMS0xLTEtMTEyMjkx_c0488bf2-b449-4c77-998f-718d35b7f5b0">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzQtMy0xLTEtMTEyMjkx_50e61ac8-40e7-4c31-ac26-c349e1adc8d6">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzUtMS0xLTEtMTEyMjkx_4e627ac4-767e-40f2-b960-22b982145cb8">15,183</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzUtMy0xLTEtMTEyMjkx_55f0e3cd-c650-4aa8-82dc-5af4a79fe6a5">1,867,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt, net of lender debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzctMS0xLTEtMTEyMjkx_7b5d0c0d-af04-4cd0-8316-3ed1f286ab3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzctMy0xLTEtMTEyMjkx_d6d4eaf5-a803-4d6e-92ca-47b6a918540b">1,672,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Principal repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzgtMS0xLTEtMTEyMjkx_145ee1b6-b143-4920-b173-302b15262678">7,375</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzgtMy0xLTEtMTEyMjkx_90d9af59-420f-441b-9933-996d69aff522">16,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of third-party debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzktMS0xLTEtMTEyMjkx_ef9e6b54-f634-4141-9e55-67149a2836b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzktMy0xLTEtMTEyMjkx_cdf47492-b434-41bb-b6f3-a775a02f495b">1,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDAtMS0xLTEtMTEyMjkx_b56d9c8a-7505-4f5a-8968-526d590e61df">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDAtMy0xLTEtMTEyMjkx_00f7b398-087c-483b-a018-a51688fd0c61">2,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDEtMS0xLTEtMTEyMjkx_724eaa46-e0cf-433a-b694-aec551fc4a1f">208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDEtMy0xLTEtMTEyMjkx_b4e50d21-8f45-4db8-95c2-519f4d7b9eda">160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDItMS0xLTEtMTEyMjkx_c55c1226-1606-4fed-b208-971041a81054">8,425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDItMy0xLTEtMTEyMjkx_f6147bd8-5608-4b35-bd4c-868c4cb61475">8,743</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDMtMS0xLTEtMTEyMjkx_f0d97967-d0ae-4034-94c1-f350b6aa1996">15,837</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDMtMy0xLTEtMTEyMjkx_7dab6f78-6613-4d9f-aa5c-bdb489dcc21b">1,648,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDQtMS0xLTEtMTEyMjkx_443e466c-88fe-454b-baf1-5f0aab36d982">1,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDQtMy0xLTEtMTEyMjkx_bf0d273d-23e9-4469-baeb-992a311a5821">3,224</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDUtMS0xLTEtMTEyMjkx_47490ee8-e4f1-4036-98d0-2fce9e866950">12,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDUtMy0xLTEtMTEyMjkx_a927f4f4-5b41-47d3-aa8f-97edc508d075">223,399</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDYtMS0xLTEtMTEyMjkx_7f5fdd0d-259f-4a0c-97a1-43e46e1c0483">208,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fd0c26c71db4e4cb0b929a7689fb683_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDYtMy0xLTEtMTEyMjkx_b4dc493d-ebce-4040-8924-dfbda689cea0">552,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH AND CASH EQUIVALENTS, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDctMS0xLTEtMTEyMjkx_ac4007be-6073-470f-9b28-250a339aa255">220,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57ae4b72e9574e4ebf63f3473590fe05_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDctMy0xLTEtMTEyMjkx_196250c5-6617-4862-ada1-0a7cd8127fd2">329,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICU MEDICAL,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:73.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Accounts payable for property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOjIyZDdlZjk3NmQzMjQ2M2ViNThjMDgyYTVhMWIzZjgxL3RhYmxlcmFuZ2U6MjJkN2VmOTc2ZDMyNDYzZWI1OGMwODJhNWExYjNmODFfNy0xLTEtMS0xMTIyOTE_857729af-8ba1-4e59-af10-b6a5e8aabb25">2,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOjIyZDdlZjk3NmQzMjQ2M2ViNThjMDgyYTVhMWIzZjgxL3RhYmxlcmFuZ2U6MjJkN2VmOTc2ZDMyNDYzZWI1OGMwODJhNWExYjNmODFfNy0zLTEtMS0xMTIyOTE_720969a2-1e91-4310-a5f2-b5636c78f531">5,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Detail of assets acquired and liabilities assumed in acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331" decimals="-3" name="us-gaap:FairValueOfAssetsAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOjIyZDdlZjk3NmQzMjQ2M2ViNThjMDgyYTVhMWIzZjgxL3RhYmxlcmFuZ2U6MjJkN2VmOTc2ZDMyNDYzZWI1OGMwODJhNWExYjNmODFfMTItMy0xLTEtMTIwODA4_7501329f-9721-4a6d-9b1a-ef2a421c14f3">1,594,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for acquisitions, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331" decimals="-3" name="icui:NetCashPaidReceivedforcurrentandprioracquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOjIyZDdlZjk3NmQzMjQ2M2ViNThjMDgyYTVhMWIzZjgxL3RhYmxlcmFuZ2U6MjJkN2VmOTc2ZDMyNDYzZWI1OGMwODJhNWExYjNmODFfMTMtMy0xLTEtMTIwODA4_726f0984-15b7-4d88-80aa-ccc73a78f61d">1,844,164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock for acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOjIyZDdlZjk3NmQzMjQ2M2ViNThjMDgyYTVhMWIzZjgxL3RhYmxlcmFuZ2U6MjJkN2VmOTc2ZDMyNDYzZWI1OGMwODJhNWExYjNmODFfMTQtMy0xLTEtMTIwODA4_13993e3a-1ee6-43de-9207-1b35bc1036a7">575,975</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6fdad0ae1f42cdb0e49e14d48fc939_I20220331" decimals="-3" name="us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOjIyZDdlZjk3NmQzMjQ2M2ViNThjMDgyYTVhMWIzZjgxL3RhYmxlcmFuZ2U6MjJkN2VmOTc2ZDMyNDYzZWI1OGMwODJhNWExYjNmODFfMTUtMy0xLTEtMTIwODA4_8b47153d-d1ac-48e6-b7ca-e72eaa1ef9d0">55,158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill, acquired/adjusted during period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331" decimals="-3" name="us-gaap:GoodwillPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOjIyZDdlZjk3NmQzMjQ2M2ViNThjMDgyYTVhMWIzZjgxL3RhYmxlcmFuZ2U6MjJkN2VmOTc2ZDMyNDYzZWI1OGMwODJhNWExYjNmODFfMTYtMy0xLTEtMTIwODA4_1f4cab32-696c-47d3-83f5-cd3201e2fbe0">1,485,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities assumed/Adjustments to liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331" decimals="-3" name="us-gaap:LiabilitiesAssumed1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOjIyZDdlZjk3NmQzMjQ2M2ViNThjMDgyYTVhMWIzZjgxL3RhYmxlcmFuZ2U6MjJkN2VmOTc2ZDMyNDYzZWI1OGMwODJhNWExYjNmODFfMTctMy0xLTEtMTIwODA4_f2d4c81a-ec17-407c-a1d9-acf45923b819">605,466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="if1f54ab03e0c44ba84b642c022c86fca_31"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)</span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_34"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.19pt"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8zNC9mcmFnOjIzMWQ0OWQ1NTAyYzQwNTM4MTczNWRkYzljZjVjYTExL3RleHRyZWdpb246MjMxZDQ5ZDU1MDJjNDA1MzgxNzM1ZGRjOWNmNWNhMTFfMjg4Mg_148ea8f3-8bed-41ea-99fb-046f120a8341" continuedAt="i8a95f43763154028962cf6184f13c788" escape="true">Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="i8a95f43763154028962cf6184f13c788"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited interim condensed consolidated financial statements of ICU Medical, Inc., ("ICU" or the "Company"), a Delaware corporation, have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S.") and pursuant to the rules&#160;and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and reflect all adjustments, consisting of only normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the consolidated results for the interim periods presented. Results for the interim period are not necessarily indicative of results for the full year. Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules&#160;and regulations. The condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report on Form&#160;10-K of ICU for the year ended December&#160;31, 2022. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, manufacture and sell innovative medical products used in infusion therapy, vascular access, and vital care applications. ICU's product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. We sell the majority of our products through our direct sales force and through independent distributors throughout the U.S. and internationally.&#160;We also sell certain products on an original equipment manufacturer basis to other medical device manufacturers. All subsidiaries are wholly owned and are included in the condensed consolidated financial statements.&#160;All intercompany balances and transactions have been eliminated.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to the prior year financial statements and footnotes to conform to the presentation used in the current year. In the statements of operations we reclassified interest income to interest (expense) income, net from other (expense) income, net and in Note 5: Revenues, certain reclassifications were made to revenues disaggregated by product line and by geography. Also, in Note 9: Fair Value Measurements the table indicating the Level inputs for the assets and liabilities measured at fair value on a recurring basis was updated to correct the Level input identified for the hedge assets and liabilities.  These reclassifications had no impact on total revenues, net loss, shareholder's equity or cash flows as previously reported.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8zNy9mcmFnOmE3NTc2YTA3ZGYzZjRhYjdhNjc0NGQ5NTJiNDIxYWFlL3RleHRyZWdpb246YTc1NzZhMDdkZjNmNGFiN2E2NzQ0ZDk1MmI0MjFhYWVfMjU3NA_4d55563b-a682-466e-a9e2-79bee68502cb" continuedAt="i7341d892a00d4bb399d8d1447275ad16" escape="true">New Accounting Pronouncements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7341d892a00d4bb399d8d1447275ad16"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional guidance for a limited period of time to ease the potential burden for reference rate reform on financial reporting. Due to concerns about structural risks of interbank offered rates and, particularly, the risk of cessation of the London Interbank Offered Rate ("LIBOR"), regulators around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction-based and less susceptible to manipulation. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued as a result of reference rate reform. Optional expedients may be applied to contracts that are modified as a result of the reference rate reform. Modifications of contracts within the scope of Topic 470, Debt, should be accounted for by prospectively adjusting the effective interest rate. Modifications of contracts within the scope of ASC 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate (incremental borrowing rate). Exceptions to Topic 815, Derivatives and Hedging, results in not having a dedesignation of a hedging relationship if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. ASU No. 2022-06, Reference Rate Reform: Deferral of the Sunset Date of Topic 848 deferred the sunset date to December 31, 2024. In November 2021, we entered into two forward-starting swaps whereby the variable leg of the swap referenced LIBOR. These swaps were amended in early 2022 to transition to an alternative reference rate (see Note 8: Derivatives and Hedging Activities). The amendments in this ASU allow for certain expedients that will allow us to assume that our hedged interest payments are probable of occurring regardless of any expected modification in their terms related to reference rate reform and will allow us to continue hedge accounting for a cash flow hedge for which the hedged interest rate risk changes if the hedge is highly effective under ASC 815, Derivatives and Hedging, or the optional expedient under this ASU is elected. The impact of this ASU on our contracts has not been and is not expected to be material.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNTQ5NzU1ODI2NTQ5_a4517a46-f0e3-4c69-a753-cf4d6b1cc7ac" continuedAt="i80c6adbbaf574bea890e4f97c1ee2c27" escape="true">Acquisitions</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i80c6adbbaf574bea890e4f97c1ee2c27" continuedAt="i12ab85662935454e9148a38e591053b2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Acquisition</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired <ix:nonFraction unitRef="number" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="0" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNzc_a40df5b6-26de-4e7c-9e6e-3379861c8f11">100.0</ix:nonFraction>% of the equity interests in Smiths Medical, the holding company of Smiths Group plc's global medical device business, from Smiths Group International Holdings Limited (&#8220;Smiths&#8221;). The acquisition of Smiths Medical aligns with our strategic growth plans, enabling us to broaden our product offerings to include syringe and ambulatory infusion devices, vascular access, and vital care products and to strengthen and expand our global market reach.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash consideration for the acquisition was $<ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="icui:BusinessCombinationConsiderationTransferredCash" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNTc0_26590035-5d6e-4b90-9510-73b738643d35">1.9</ix:nonFraction>&#160;billion, which was financed with existing cash balances and proceeds from the credit agreement entered into on January 6, 2022 (see Note 17: Long-Term Debt). We also issued share consideration to Smiths of <ix:nonFraction unitRef="shares" contextRef="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNzc1_0cfc7e34-ba18-4f09-a91e-a895a527325b">2.5</ix:nonFraction>&#160;million shares of our common stock. The fair value of the common shares issued to Smiths was determined based on the opening market price of our common stock on the acquisition date. Smiths may be entitled to an additional $<ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfOTkz_2ef7fee7-61fe-4b74-aede-8b1ac7a5f63b">100.0</ix:nonFraction>&#160;million in cash consideration contingent on our common stock achieving certain price targets for certain periods after closing in accordance with the terms of the Share Sale and Purchase Agreement (the "Purchase Agreement"). In the event that (a) on or prior to the third anniversary of closing the 30-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="INF" name="icui:MinimumStockPriceTargetForEarnOutPayment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMTQwMg_6856e233-3f0e-491f-97d7-9aa21623f261">300.00</ix:nonFraction> per share or (b) on or prior to the fourth anniversary of closing the 45-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="INF" name="icui:MinimumStockPriceTargetForEarnOutPayment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMTU5MA_5df35495-43f4-4e6d-a211-a56b62c2280b">300.00</ix:nonFraction> per share (each a "Price Target"), and provided Smiths beneficially owns at least <ix:nonFraction unitRef="number" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="1" name="icui:RequiredShareHoldingOfStockIssuedAtAcquisition" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMTY3NQ_495d4c21-99ec-4500-8643-983f1c02015f">50.0</ix:nonFraction>% of the shares of common stock issued at closing at the time the Price Target is achieved, then Smiths will be entitled to receive the additional $<ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMTgyMw_2ef7fee7-61fe-4b74-aede-8b1ac7a5f63b">100.0</ix:nonFraction>&#160;million in cash consideration. The fair value of the contingent consideration was determined using an option pricing model, specifically the Monte Carlo Simulation. In the analysis, the determinants of payout are simulated in a risk neutral framework over a large number of simulation paths. The fair value of the contingent consideration is then calculated as the average present value across all simulated paths. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smiths became a related party to us when we issued <ix:nonFraction unitRef="shares" contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNTQ5NzU1ODI2NTM3_6809886b-63b4-4e63-8ff1-6336c1b4a958">2.5</ix:nonFraction>&#160;million shares of our common stock as partial consideration for the acquisition of Smiths Medical. Additionally, we entered into a transition services agreement ("TSA") with certain members of Smiths Group, plc. The TSA includes certain information technology, human resource and tax support services for an initial term of twelve months with the option to extend up to 24 months. During the three months ended March 31, 2023, we expensed $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-5" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNTQ5NzU1ODI2NTA5_4887978f-284c-4617-bf0b-244e8148022a">4.0</ix:nonFraction>&#160;million for services provided under the TSA. As of March 31, 2023, we have $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-5" name="us-gaap:RelatedPartyTransactionDueFromToRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNTQ5NzU1ODI2NTIz_6db4e246-e8d2-4874-b279-62902927c852">1.5</ix:nonFraction>&#160;million in open payables related to the services received under the TSA.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Final Purchase Price Allocation</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNzYxMw_70cbad78-31b3-4196-842e-391fec058b33" continuedAt="iaa77ff41dc3542009cf35881bde235d3" escape="true">The following table summarizes the final purchase price and the final allocation of the purchase price related to the assets acquired and liabilities assumed (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i12ab85662935454e9148a38e591053b2" continuedAt="i31e6f5f85cd04c9095b11169e771a8b4"><ix:continuation id="iaa77ff41dc3542009cf35881bde235d3"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated cash consideration for acquired assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMC0yLTEtMS0xMTIyOTE_0a4df32e-32cc-47e4-a4ef-73fab4a7b06a">1,922,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration payable to Smiths</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMS0yLTEtMS0xMTIyOTE_c9d72299-6e4c-4611-8127-13fd0e36eec6">53,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of ICU Medical, Inc. common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331" decimals="-3" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfNC0yLTEtMS0xMTIyOTE_accdf407-08f2-4ac8-8595-dccf187ee160">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Price per share (ICU's opening market price on the acquisition date)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfNS0yLTEtMS0xMTIyOTE_07515a16-e5b9-4519-ba8d-73f503d1b59f">230.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of ICU shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfNi0yLTEtMS0xMTIyOTE_5a0d48a3-2d30-4032-9950-6faa937e56c8">575,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfNy0yLTEtMS0xMTIyOTE_fbad058d-988b-44d2-846f-8186ef3ddfd8">2,552,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase Price Allocation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTAtMi0xLTEtMTEyMjkx_ae5721de-2cfc-48c6-8223-398891c3a6f6">78,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTEtMi0xLTEtMTEyMjkx_10bd0ae1-8747-4ecc-8aaa-2d809d9a6649">106,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTItMi0xLTEtMTEyMjkx_2a6e896f-c8c4-4b58-b1a2-7fdc5385323b">228,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTMtMi0xLTEtMTEyMjkx_1c6f8330-9909-477b-bc6a-2956f4c10f1b">53,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTQtMi0xLTEtMTEyMjkx_aaf2a957-3e7d-4ae0-bf71-862d162def61">206,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="icui:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTUtMi0xLTEtMTEyMjkx_f8857afe-535c-4f31-94f1-a81ef969a489">55,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTYtMi0xLTEtMTEyMjkx_222f9c97-a1ae-4888-b49f-dcf96258e09d">945,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTgtMi0xLTEtMTEyMjkx_3723e8a9-daf9-454b-bf1d-83b46cdf78e3">379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTktMi0xLTEtMTEyMjkx_4c0588e2-ee2e-4b54-97e4-aba6c11e3473">105,291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMjAtMi0xLTEtMTEyMjkx_431571ac-3acd-4a89-b294-00cd2ac363f5">173,151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="icui:BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMjEtMi0xLTEtMTEyMjkx_2649a1d9-8928-4c01-89fd-5557e5f3ea65">40,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMjItMi0xLTEtMTEyMjkx_4cc312d0-95d7-42f1-9fc2-378abb16f03a">85,490</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMjMtMi0xLTEtMTEyMjkx_1de2f85d-41a0-44d1-8204-aba97981c85b">187,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMjQtMi0xLTEtMTEyMjkx_7d38eaea-d77e-4651-be09-67167876020b">1,082,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - not tax deductible</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-3" name="icui:BusinessCombinationGoodwillNonDeductible" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMjUtMi0xLTEtMTEyMjkx_ca9e8cb2-4b58-480f-b1de-0e35993bdceb">1,469,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated Purchase Consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMjYtMi0xLTEtMTEyMjkx_90323c1e-c64d-4abb-9fd9-303cb3c4cd11">2,552,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Identifiable intangible assets include $<ix:nonFraction unitRef="usd" contextRef="ib4e4d6b3c14144aca5091606533105a7_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjU0Ng_acad6819-0716-499a-934e-4cd3ec86a754">510.0</ix:nonFraction>&#160;million of customer relationships, $<ix:nonFraction unitRef="usd" contextRef="iad76217923724df7af4e6c43d299c300_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjU3Ng_cc24ebec-a734-48cd-a410-df70733de001">400.0</ix:nonFraction>&#160;million of developed technology, $<ix:nonFraction unitRef="usd" contextRef="ib4201cfae6384d12823ab684fa4f93a9_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjYwNA_e609dc92-f71a-4633-a796-7381a9457c24">30.0</ix:nonFraction>&#160;million of internally developed software, and $<ix:nonFraction unitRef="usd" contextRef="i3908b880a83e477b9d7b162246382114_I20230331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjY0NQ_5b3602a5-4438-46d0-a3b1-edaf0b131e18">5.0</ix:nonFraction>&#160;million of trademark. The estimated weighted-average amortization period for the total identifiable intangible assets is approximately <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjc3NQ_c58be461-15cc-4ce0-9461-a1f586d03baa">nine</span> years, and, for each identifiable intangible asset is estimated as follows: <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjg1NA_dbc618ca-f89e-4749-ab68-262b22ebc7e6">eight</span> years for customer relationships, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjg5MQ_cbdceafc-7a31-4a27-b09c-41ac0c8d87ec">ten</span> years for developed technology, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjkyNg_15a93537-17a8-41e6-a1fe-d867b9347f66">five</span> years for internally developed software, and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjk3NA_5b7a1829-90b2-4109-8983-d52f0d255b2e">six</span> months for the trademark. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued liabilities includes, among other things, accrued warranty reserves, accrued restructuring initiatives, accrued salaries and related benefits, deferred revenue and accrued sales and use taxes.</span></div></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The identifiable intangible assets and other long-lived assets acquired have been valued utilizing Level 3 inputs as defined in Note 9: Fair Value Measurements. The fair value of identifiable intangible assets was generally developed using the income approach and are based on critical estimates, judgments and assumptions derived from: analysis of market conditions; discount rate; discounted cash flows; royalty rates; customer retention rates; and/or estimated useful lives. Certain other intangible assets were valued using a cost to replace method, estimating the labor and non-labor costs required to replace the asset under the premise that it was not part of the transaction. Property, plant and equipment was valued with the consideration of remaining economic lives. The raw materials inventory was valued at historical cost and adjusted for any obsolescence which we estimate to approximate replacement cost, the work in process inventory was valued at estimated sales proceeds less costs to complete and costs to sell, and finished goods inventory was valued at estimated sales proceeds less costs to sell. The prepaid expenses and other current assets and assumed liabilities were recorded at their carrying values as of the date of the acquisition, as their carrying values approximated their fair values due to their short-term nature.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Information</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smiths Medical is included in our consolidated results beginning on January 7, 2022. Total revenues and net loss attributable to Smiths Medical for the period from January 7, 2022 to March 31, 2022 were estimated to be $<ix:nonFraction unitRef="usd" contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNDk5NA_31d7faea-9f8e-4d53-9f42-89230c2c0f2f">214.9</ix:nonFraction>&#160;million and </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div><ix:continuation id="i31e6f5f85cd04c9095b11169e771a8b4" continuedAt="i41769b0f461b4cf785f8f49b431156e5"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNTAwMQ_e97644cc-9775-40ae-98ce-2a6502ba78b8">40.4</ix:nonFraction>&#160;million. The following unaudited pro forma financial information presents the combined results of operations of ICU and Smiths Medical as if the acquisition had occurred on January 1, 2022. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place on the date indicated or of results that may occur in the future. </span><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNzYxNA_8c37fb11-1110-4c37-9493-00a7f38ce6f7" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.421%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjQ2MDc1YWU3YWE3NTRmOWJhOTYyNjlhYTRiM2RkMmFkL3RhYmxlcmFuZ2U6NDYwNzVhZTdhYTc1NGY5YmE5NjI2OWFhNGIzZGQyYWRfMi0xLTEtMS0xMTIyOTE_53b91693-5a9c-4e05-8d73-f67e52fd7618">563,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjQ2MDc1YWU3YWE3NTRmOWJhOTYyNjlhYTRiM2RkMmFkL3RhYmxlcmFuZ2U6NDYwNzVhZTdhYTc1NGY5YmE5NjI2OWFhNGIzZGQyYWRfMy0xLTEtMS0xMTIyOTE_166578af-8250-4d3b-84f5-7be8013db520">34,994</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></ix:continuation></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i41769b0f461b4cf785f8f49b431156e5">The unaudited pro forma results presented above include the impact of the following adjustments: incremental amortization expense on intangible assets acquired of $<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="icui:ProFormaAdjustmentAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNTcxMw_8ec29843-8276-46e2-9755-ebad4748594b">3.3</ix:nonFraction>&#160;million for the three months ended March 31, 2022, incremental interest expense, including amortization of debt discount and debt issuance costs, on the Senior Secured Credit Facilities (as defined in Note 17: Long-Term Debt) of $<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="icui:ProFormaAdjustmentFinanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNTk3MA_ccda8a2e-9d41-4ea6-aa3d-c19b977cf558">0.8</ix:nonFraction>&#160;million for the three months ended March 31, 2022. The unaudited pro forma results include IFRS to U.S. GAAP adjustments for Smiths Medical's historical results and adjustments for accounting policy alignment, which were materially similar to the Company. Any differences in accounting policies were adjusted to reflect the accounting policies of the Company in the unaudited pro forma results presented.</ix:continuation> </span></div><div style="text-indent:36pt"><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4:  <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RleHRyZWdpb246M2NkNjliMmZmZjQ5NGM4ZjlhNmVlNzE2ODYxNDg5YTJfMjA1MQ_54fcfa48-ed5f-4998-95f1-905e23744eba" continuedAt="i17883138f2764691b2c41b05db1ff6d2" escape="true">Restructuring, Strategic Transaction and Integration</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i17883138f2764691b2c41b05db1ff6d2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Restructuring, strategic transaction and integration expenses were $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="icui:Restructuringstrategictransactionandintegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RleHRyZWdpb246M2NkNjliMmZmZjQ5NGM4ZjlhNmVlNzE2ODYxNDg5YTJfMTM2_fd6175ff-a3aa-4b79-b986-8d0f92106f5a">11.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="icui:Restructuringstrategictransactionandintegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RleHRyZWdpb246M2NkNjliMmZmZjQ5NGM4ZjlhNmVlNzE2ODYxNDg5YTJfMTQz_c69f5207-89c0-4880-9cd9-e4cd6333f1c2">33.9</ix:nonFraction> million for the three months ended March 31, 2023 and 2022, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended March&#160;31, 2023 and 2022, restructuring charges were $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RleHRyZWdpb246M2NkNjliMmZmZjQ5NGM4ZjlhNmVlNzE2ODYxNDg5YTJfMzQw_ddfb468e-dbd6-42aa-9cae-2511b1c3830d">2.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RleHRyZWdpb246M2NkNjliMmZmZjQ5NGM4ZjlhNmVlNzE2ODYxNDg5YTJfNTQ5NzU1ODE2Mzky_64568a30-56c8-444e-a7d5-f19c6996e8ec">3.2</ix:nonFraction>&#160;million, respectively and were primarily related to severance costs. &#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RleHRyZWdpb246M2NkNjliMmZmZjQ5NGM4ZjlhNmVlNzE2ODYxNDg5YTJfMjA1Mw_3855adb4-7788-4060-a5bc-212d24bec731" continuedAt="i1201d4fcc0f34042ac48b7acf16ece7a" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity in our restructuring-related accrual by major type of cost for the three months ended March&#160;31, 2023 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.840%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Severance Pay and Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retention and Facility Closure Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be2d8334179424c9dae8ef69e51861a_I20221231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfMS0yLTEtMS0xMTIyOTE_4f7464c8-6d2c-4602-a68e-f1fceefcba1a">4,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2988acfe0dcd4e17a14143d0e3743733_I20221231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfMS02LTEtMS0xMTIyOTE_e97cb8d8-99a7-4d35-a32d-9b4e74660506">1,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfMS04LTEtMS0xMTIyOTE_e56d917b-c559-416d-93ca-e3a19ce335d3">5,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges incurred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie97b4a8feb974d7180f4613667a93acb_D20230101-20230331" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfMy0yLTEtMS0xMTIyOTE_154709f4-8d0d-444e-b86f-6970f600cea0">2,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a8c58853e84468b76e94c8be56aa32_D20230101-20230331" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfMy02LTEtMS0xMTIyOTE_ab660d09-dc6f-4180-a978-b193d8a1203a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfMy04LTEtMS0xMTIyOTE_ff8b774a-d9d1-475f-992d-05db6478e4a2">2,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie97b4a8feb974d7180f4613667a93acb_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNC0yLTEtMS0xMTIyOTE_0a45addb-8e53-482d-bd2e-b587c2df3c4a">1,284</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a8c58853e84468b76e94c8be56aa32_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNC02LTEtMS0xMTIyOTE_c5659334-421e-4b03-8645-8c0ace6bd39e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNC04LTEtMS0xMTIyOTE_6c8700d0-fc04-452b-8bb7-1941fb83712b">1,284</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie97b4a8feb974d7180f4613667a93acb_D20230101-20230331" decimals="-3" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNS0yLTEtMS0xMjA4MzE_7b459637-283d-4abe-953a-c7f8163039cc">291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a8c58853e84468b76e94c8be56aa32_D20230101-20230331" decimals="-3" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNS02LTEtMS0xMTg5NTk_0c79b03d-1b1d-49a2-8f0c-9402a04dc308">620</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNS04LTEtMS0xMjA4MzY_381137eb-e311-4a22-b127-9d53f912eb3c">911</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie97b4a8feb974d7180f4613667a93acb_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNS0yLTEtMS0xMTIyOTE_bd084845-d8b3-4d9c-a57f-adbf28defea6">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a8c58853e84468b76e94c8be56aa32_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNS02LTEtMS0xMTIyOTE_68a51fb8-4e28-408d-be35-d8dd7080b82e">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNS04LTEtMS0xMTIyOTE_f0a7eb7c-c9c7-43db-a636-08e9c82b58c6">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i382a53a05af54e50ba7efcb611be9988_I20230331" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNi0yLTEtMS0xMTIyOTE_77d90389-d757-4dc7-b4f6-cc1e396bd656">5,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6b3ba685fe640b2bf1d136426bd89dc_I20230331" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNi02LTEtMS0xMTIyOTE_3987e670-1c51-4779-abae-82ffc45d834b">903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNi04LTEtMS0xMTIyOTE_12a15140-5b7f-4f00-a734-e68a5e1b50b6">6,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">__________________________</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"><ix:continuation id="i1201d4fcc0f34042ac48b7acf16ece7a" continuedAt="i7c8de4c9285542f78ef7f82eaf9fa44e">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7c8de4c9285542f78ef7f82eaf9fa44e"> Other, primarily relates to prior year accrued restructuring charges for estimated facility closure costs that were reversed during the three months ended March 31, 2023.</ix:continuation> </span></div><div><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic Transaction and Integration Expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We incurred and expensed $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-5" name="icui:StrategicTransactionandIntegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RleHRyZWdpb246M2NkNjliMmZmZjQ5NGM4ZjlhNmVlNzE2ODYxNDg5YTJfOTA4_de5e584e-cdab-4eb7-8e03-4f3dfc8d5e82">8.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-5" name="icui:StrategicTransactionandIntegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RleHRyZWdpb246M2NkNjliMmZmZjQ5NGM4ZjlhNmVlNzE2ODYxNDg5YTJfOTE1_50276b5f-8348-46ef-9f42-e39bee2c4527">30.7</ix:nonFraction> million in strategic transaction and integration expenses during the three months ended March 31, 2023 and 2022, respectively, which are included in restructuring, strategic transaction and integration expenses in our condensed consolidated statements of operations. The strategic transaction and integration expenses during the three months ended March&#160;31, 2023 were primarily related to consulting expenses and employee costs incurred to integrate our Smiths Medical business acquired in 2022. The strategic transaction and integration expenses for the three months ended March 31, 2022 were primarily related to transaction and integration expenses associated with our acquisition of Smiths Medical (see Note 3: Acquisitions) which primarily included legal expenses, bank fees, a United Kingdom stamp tax, and employee costs.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="if1f54ab03e0c44ba84b642c022c86fca_46"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5:  <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RleHRyZWdpb246ZjI5YjljYWM4MTU2NDkwMjhlYThhYmRhYzdmMTVjYWRfMzQxNA_5531e78e-adf1-4d82-8b45-990e2fe8db48" continuedAt="id54cc3a62c834ba7a782b2986f4e86bb" escape="true">Revenue</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id54cc3a62c834ba7a782b2986f4e86bb" continuedAt="i51d9658ef824444c99436ade7c561d2d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As part of the integration of our acquisition of Smiths Medical, we have now migrated to our new business unit structure of Consumables, Infusion Systems and Vital Care. The vast majority of our sales of products within these business units are made on a stand-alone basis to hospitals and distributors. Revenue is typically recognized upon transfer of control of the products, which we deem to be at point of shipment. However, for purposes of revenue recognition for our software licenses and renewals, we consider the control of these products to be transferred to a customer at a certain point in time; therefore, we recognize revenue at the start of the applicable license term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Payment is typically due in full within 30 days of delivery or the start of the contract term.  Revenue is recorded in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We offer certain volume-based rebates to our distribution customers, which we record as variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between the prices we charge our distribution customers and the contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts in order to determine the transaction price, we use information available at the time, including our historical experience.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We also warranty products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available at that time and our historical experience. We also provide for extended service-type warranties, which we consider to be separate performance obligations. We allocate a portion of the transaction price to the extended service-type warranty based on its estimated relative selling price, and recognize revenue over the period the warranty service is provided. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue disaggregated</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our revenues disaggregated by product line (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product line</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if672ca85f58b4f10ac0adfe442433dba_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjU5NDA5YzYxM2Y2NzQ1ZWViNTZlYWI5OWNhNDZhZjc0L3RhYmxlcmFuZ2U6NTk0MDljNjEzZjY3NDVlZWI1NmVhYjk5Y2E0NmFmNzRfMi0xLTEtMS0xMTIyOTE_a33adf76-8f00-4a34-a86e-6b9b4b4f08d7">236,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430bf7f21dc340cc98e845a1549c6ba2_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjU5NDA5YzYxM2Y2NzQ1ZWViNTZlYWI5OWNhNDZhZjc0L3RhYmxlcmFuZ2U6NTk0MDljNjEzZjY3NDVlZWI1NmVhYjk5Y2E0NmFmNzRfMi0zLTEtMS0xMTIyOTE_2fe3618b-4cf1-4f2f-9822-9cc75f790c21">240,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie942e6605043489884a694f3c56a4f24_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjU5NDA5YzYxM2Y2NzQ1ZWViNTZlYWI5OWNhNDZhZjc0L3RhYmxlcmFuZ2U6NTk0MDljNjEzZjY3NDVlZWI1NmVhYjk5Y2E0NmFmNzRfMy0xLTEtMS0xMTIyOTE_bd264067-b10c-4ac6-a543-b3507e0c82fb">161,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425342db1c344b6f8cc10da8ee02d87b_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjU5NDA5YzYxM2Y2NzQ1ZWViNTZlYWI5OWNhNDZhZjc0L3RhYmxlcmFuZ2U6NTk0MDljNjEzZjY3NDVlZWI1NmVhYjk5Y2E0NmFmNzRfMy0zLTEtMS0xMTIyOTE_3e6176a4-2a33-40f1-bdff-d676c8d17846">138,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vital Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3e783fa8bb34a5494c0d5d949242f64_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjU5NDA5YzYxM2Y2NzQ1ZWViNTZlYWI5OWNhNDZhZjc0L3RhYmxlcmFuZ2U6NTk0MDljNjEzZjY3NDVlZWI1NmVhYjk5Y2E0NmFmNzRfNC0xLTEtMS0xMTIyOTE_81fa12db-c851-4bc7-95c4-8e89056467c7">170,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i638825fa0f98497b948ffb1c01d0e19e_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjU5NDA5YzYxM2Y2NzQ1ZWViNTZlYWI5OWNhNDZhZjc0L3RhYmxlcmFuZ2U6NTk0MDljNjEzZjY3NDVlZWI1NmVhYjk5Y2E0NmFmNzRfNC0zLTEtMS0xMTIyOTE_3cac7f4b-bc39-4de7-b3bb-458a9958ba43">164,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjU5NDA5YzYxM2Y2NzQ1ZWViNTZlYWI5OWNhNDZhZjc0L3RhYmxlcmFuZ2U6NTk0MDljNjEzZjY3NDVlZWI1NmVhYjk5Y2E0NmFmNzRfOS0xLTEtMS0xMTIyOTE_b7da833e-86fc-4748-a2c5-9c132677b13d">568,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjU5NDA5YzYxM2Y2NzQ1ZWViNTZlYWI5OWNhNDZhZjc0L3RhYmxlcmFuZ2U6NTk0MDljNjEzZjY3NDVlZWI1NmVhYjk5Y2E0NmFmNzRfOS0zLTEtMS0xMTIyOTE_a7306438-efe1-4977-b6c9-518d40b4888f">543,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023 and 2022, net sales to Medline made up approximately 15% of total revenues.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RleHRyZWdpb246ZjI5YjljYWM4MTU2NDkwMjhlYThhYmRhYzdmMTVjYWRfMzQwNg_b8cf9129-81f7-40aa-b99c-29829f53213b" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our revenues disaggregated by geography (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:66.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.931%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geography</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b683b00bad4432ea43529d2de73711d_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfMi0xLTEtMS0xMTIyOTE_c2166156-7177-4f31-80cc-0c3d68909b9d">359,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc639aa88692474fa875253ce1c84b6e_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfMi0zLTEtMS0xMTIyOTE_bdcb102a-486c-4b99-a598-97dc1c7a8141">347,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d0e8e0a5bb4a63b8430aaa2a4f8b17_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfMy0xLTEtMS0xMTY1MDc_e5f63959-45fa-4f69-af66-c134abf16ba8">98,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd9ef9dff7c545ad9f948e39c002b2bc_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfMy0zLTEtMS0xMTY1MDc_ea76a7ca-7a5c-41b8-9e89-8311d724525f">86,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf5cc17211a944c486c24f771e6a195c_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfNC0xLTEtMS0xMTY1MTE_9d683856-1fc3-4f58-9eba-3b6b031c569e">58,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45b3d6f3d0644e7d8963c40933520643_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfNC0zLTEtMS0xMTY1MTE_669d74ce-e8c1-487c-b93e-b8d2ad5d071e">64,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie82e694fdb9d4433a97ad09856242b4a_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfMy0xLTEtMS0xMTIyOTE_a35c3571-4d17-4bad-ac46-8a433c626d9d">51,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad04b3344f3d466bba0994502f1196e8_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfMy0zLTEtMS0xMTIyOTE_ee951ebf-de93-407a-8c65-ff565fbc9f34">44,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfOC0xLTEtMS0xMTIyOTE_f6ee66ae-96b2-491c-84bd-a08719d16db6">568,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfOC0zLTEtMS0xMTIyOTE_2b00f068-5e6f-437f-aa69-8c10d155cb2d">543,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i51d9658ef824444c99436ade7c561d2d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract balances</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RleHRyZWdpb246ZjI5YjljYWM4MTU2NDkwMjhlYThhYmRhYzdmMTVjYWRfMzQwNw_13a13e9f-032e-41bf-9ca6-44bb1320ab21" continuedAt="iff49bccf127244daace49c580453e837" escape="true">The following table presents the changes in our contract balances for the three months ended March 31, 2023 and 2022 (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="iff49bccf127244daace49c580453e837"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMS0xLTEtMS0xMTIyOTE_077db409-c84a-458c-9ec9-f694b92dad12">45,866</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5153aa5ab442638a5c8de9a45fba7d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMy0xLTEtMS0xMTIyOTE_14ff30e9-52f4-48c4-8d3c-b219e15d418d">5,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f5153aa5ab442638a5c8de9a45fba7d_D20230101-20230331" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfNC0xLTEtMS0xMTIyOTE_b56ae71a-1a6c-4453-984a-774122401885">7,236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de9a8d7bfc44cdfae663c1ba5da07c8_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfNS0xLTEtMS0xMTIyOTE_a6dfe98b-30c5-417e-a0cb-bd03027137f0">4,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de9a8d7bfc44cdfae663c1ba5da07c8_D20230101-20230331" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfNi0xLTEtMS0xMTIyOTE_8597d7f0-1d79-4719-8676-5415d6a5c983">5,362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if70bbd6b2087429f879753468a264309_D20230101-20230331" decimals="-3" name="us-gaap:DeferredRevenueAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfNy0xLTEtMS0xMTIyOTE_36d16ee3-62ce-40a0-88aa-a02d2ab0e42a">861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70bbd6b2087429f879753468a264309_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfOC0xLTEtMS0xMTIyOTE_b4c7742d-41f4-406a-92de-ff1f0aba8b27">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida61c1e26c5d42a6a66daca8551246ff_D20230101-20230331" decimals="-3" name="us-gaap:DeferredRevenueAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfOS0xLTEtMS0xMTIyOTE_98f1ef6d-929b-4fee-96a2-35e4b080ec19">403</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida61c1e26c5d42a6a66daca8551246ff_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTAtMS0xLTEtMTEyMjkx_111bb3a3-8489-4dfd-8655-7235feb90af0">1,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, March 31, 2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTEtMS0xLTEtMTEyMjkx_044ee895-7a75-4437-9c81-9b2a73a5f146">47,511</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fd0c26c71db4e4cb0b929a7689fb683_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTMtMS0xLTEtMTEyMjkx_785d32f4-49e1-4a33-a524-85db6a13ac27">7,461</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of acquired deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6fdad0ae1f42cdb0e49e14d48fc939_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTQtMS0xLTEtMTIwODQ0_77132df3-4c6b-4af2-9cf9-b72c2a7ceb16">51,245</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1779a7129f64c9d9abc575b38200d77_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTQtMS0xLTEtMTEyMjkx_451df34c-0ffa-4cfa-ba99-a942c4f1d494">5,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1779a7129f64c9d9abc575b38200d77_D20220101-20220331" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTUtMS0xLTEtMTEyMjkx_7298687e-ec5d-4355-8d2a-3e571c201aec">3,447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i316bfaa281dd4708b1bdb8f0f4449ed0_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTYtMS0xLTEtMTEyMjkx_159551ce-7c50-40cb-8965-f2b60d060397">4,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i316bfaa281dd4708b1bdb8f0f4449ed0_D20220101-20220331" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTctMS0xLTEtMTEyMjkx_a82d7996-a8bb-41b8-a8d3-b67a57f74023">4,777</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0115d314b99743fa9bbb604242dd25a1_D20220101-20220331" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTktMS0xLTEtMTIwODQw_1ee57b74-a66d-43e9-88c5-6e0d7f57873b">2,266</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0115d314b99743fa9bbb604242dd25a1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMjAtMS0xLTEtMTIwODQw_8ae02b78-58b5-4b90-b818-f815434809c8">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i908fb323327c4154bd1568d75d6f2552_D20220101-20220331" decimals="-3" name="us-gaap:DeferredRevenueAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMjEtMS0xLTEtMTIwODQw_710487c2-a5a8-44bf-831f-50e62e7df76f">767</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i908fb323327c4154bd1568d75d6f2552_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMjItMS0xLTEtMTIwODQw_3e0faae8-413f-4451-8aac-acb788c788b5">1,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57ae4b72e9574e4ebf63f3473590fe05_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTgtMS0xLTEtMTEyMjkx_f536853f-512a-461b-b821-20cf5cd55e53">58,236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract liabilities are included in accrued liabilities or other long-term liabilities in our condensed consolidated balance sheet based on the expected timing of payments.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, revenue from remaining performance obligations is as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.516%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recognition Timing</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&lt; 12 Months</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&gt; 12 Months</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie30632948bb140989b06da9c57314a0e_I20230331" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfMi0xLTEtMS0xMTIyOTE_44f73b2d-abda-4266-ab60-4efbafdfc723">17,464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i261befa46c644eb8a0b97033247d3bad_I20230331" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfMi0zLTEtMS0xMTIyOTE_7438510c-0981-46f5-8526-1321e2f09425">1,327</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29c2d40d68d54fa78c2000befa7864fd_I20230331" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfMy0xLTEtMS0xMTIyOTE_00840e02-bf24-4baa-b713-8a7c07beabb4">8,323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34e4e4f1c2754f669c44df080318aa88_I20230331" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfMy0zLTEtMS0xMTIyOTE_979a4a5e-6449-4286-93bd-130bdd66aad3">829</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81bf02eca70549c38a41eb91ac257f95_I20230331" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfNC0xLTEtMS0xMTIyOTE_c68a7045-c47d-47cc-be75-9836f929e592">1,422</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54a3f930a4e54803850c70dc786e2c62_I20230331" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfNC0zLTEtMS0xMTIyOTE_34ebe538-b032-4a73-ab0e-a04af7c3db86">13,441</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5138e2e1587f44e48d749663aa9643f9_I20230331" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfNS0xLTEtMS0xMTIyOTE_f8a92f47-e340-4612-9a36-f6fc17fabd80">3,711</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibaf177153834401cb429ff7ce5049e03_I20230331" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfNS0zLTEtMS0xMTIyOTE_7a6ee286-5a20-4d76-9dd3-11156e93286b">994</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961a433f9f954f7a83f394eb9db23739_I20230331" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfNi0xLTEtMS0xMTIyOTE_1ea5c6a3-2ffb-435b-a4a1-eeef370da123">30,920</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fed4ca7522348e09634e4fad1da85ca_I20230331" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfNi0zLTEtMS0xMTIyOTE_074256d1-cd1c-4020-b80f-386eea4f1da5">16,591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Other deferred revenue includes pump development programs, purchased training and extended warranty.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6:  <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RleHRyZWdpb246MjViYWY5NzJjZjBlNGJjMGEzYzc2YzAzNTVlOGE3MzRfMjc1OQ_bd65faa6-fef0-47b8-8f45-23999345197e" continuedAt="i54e2a3fbf8304652be61603338c78e97" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="i54e2a3fbf8304652be61603338c78e97" continuedAt="i1b11a0c507c649f7b3ad34134fa1c420"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception. Our operating lease assets are separately stated in operating lease right-of-use ("ROU") assets and our financing lease assets are included in other assets on our condensed consolidated balance sheets. Our lease liabilities are included in accrued liabilities and other long-term liabilities on our condensed </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i1b11a0c507c649f7b3ad34134fa1c420" continuedAt="i99bba14d20e045139242146e444cd539"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated balance sheets. We have elected not to recognize an ROU asset and lease liability for leases with terms of twelve months or less.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Lease ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Most of our leases do not provide an implicit rate, therefore we use our incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term based on the information available at commencement date. Our lease ROU assets exclude lease incentives and initial direct costs incurred. Our lease terms include options to extend when it is reasonably certain that we will exercise that option. All of our leases have stated lease payments, which may include fixed rental increases. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our leases are for corporate, research and development and sales and support offices, distribution facilities, device service centers and certain equipment. Our leases have original lease terms of <ix:nonNumeric contextRef="ica8e78475e314beda5cd3faaa0ce02d4_I20230331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RleHRyZWdpb246MjViYWY5NzJjZjBlNGJjMGEzYzc2YzAzNTVlOGE3MzRfMTUxNA_c11659a9-7ac2-4b6b-9537-055f590939de">one year</ix:nonNumeric> to <ix:nonNumeric contextRef="i40f728bd623845f9b4ce1cfdaf7c303f_I20230331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RleHRyZWdpb246MjViYWY5NzJjZjBlNGJjMGEzYzc2YzAzNTVlOGE3MzRfMTUyMA_28fee6a0-a0a7-41a7-b537-1a4c77c8022e">fifteen years</ix:nonNumeric>, some of which include options to extend the leases for up to an additional <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="icui:Optiontoextendinyears" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RleHRyZWdpb246MjViYWY5NzJjZjBlNGJjMGEzYzc2YzAzNTVlOGE3MzRfMTU5OQ_ebd518d3-f64e-4816-967f-0e23ae82b121">five years</ix:nonNumeric>. For all of our leases, we do not include optional periods of extension in our current lease terms for the exercise of options to extend is not reasonably certain.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RleHRyZWdpb246MjViYWY5NzJjZjBlNGJjMGEzYzc2YzAzNTVlOGE3MzRfMjc2OA_5a0edaa9-e453-4957-84e8-24c90af8053b" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of our lease cost (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:66.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.931%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfMi0xLTEtMS0xMTIyOTE_f28ed3d4-68c9-4cee-b534-aa53a366ecdd">6,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfMi0zLTEtMS0xMTIyOTE_d8e9e6e2-7f14-43c8-8928-67cc65a5fe9e">5,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfMy0xLTEtMS0xMTIyOTE_42f2eeb6-02b8-4f82-9135-ee4c43587f93">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfMy0zLTEtMS0xMTIyOTE_4aafc712-6e42-4977-ab20-ef71c5b7b0e2">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; reduction of ROU asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfNC0xLTEtMS0xMTIyOTE_4ecaf86f-73e0-44e3-98a2-85d516d0618f">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfNC0zLTEtMS0xMTIyOTE_9d0e3540-6f09-4a7e-b0b1-8ff743114bae">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfNS0xLTEtMS0xMTIyOTE_b8498dd3-69f4-4a68-b6d5-8a5cba9a5784">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfNS0zLTEtMS0xMTIyOTE_68dd1b02-fccf-4a3d-bebe-0ea90ce7948b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfOC0xLTEtMS0xMTIyOTE_38316761-cb8b-43b2-ae80-3107e9ae93be">6,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfOC0zLTEtMS0xMTIyOTE_04c02d76-fef4-46f6-a266-a15361e98545">5,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense on our finance leases is included in interest expense, net in our condensed consolidated statements of operations. The reduction of the operating and finance ROU assets is included as noncash lease expense in selling, general and administrative expenses in our condensed consolidated statements of operations.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RleHRyZWdpb246MjViYWY5NzJjZjBlNGJjMGEzYzc2YzAzNTVlOGE3MzRfMjc2MA_e0c92106-52d4-4705-99c5-e939cb41886e" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental cash flow information related to our leases (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjU0YmE0OTNiY2U3MDRlZGNiZDc4YWRmOWE5ZTcwMzFlL3RhYmxlcmFuZ2U6NTRiYTQ5M2JjZTcwNGVkY2JkNzhhZGY5YTllNzAzMWVfMy0xLTEtMS0xMTIyOTE_47e33e32-9fdd-4dda-b338-06019f2a0a98">6,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjU0YmE0OTNiY2U3MDRlZGNiZDc4YWRmOWE5ZTcwMzFlL3RhYmxlcmFuZ2U6NTRiYTQ5M2JjZTcwNGVkY2JkNzhhZGY5YTllNzAzMWVfMy0zLTEtMS0xMTIyOTE_075dffc5-51ad-48a9-bcaa-e2fbad713d64">6,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjU0YmE0OTNiY2U3MDRlZGNiZDc4YWRmOWE5ZTcwMzFlL3RhYmxlcmFuZ2U6NTRiYTQ5M2JjZTcwNGVkY2JkNzhhZGY5YTllNzAzMWVfNC0xLTEtMS0xMTIyOTE_2a1f6464-4d0f-483b-b615-fd7d34dbd3bc">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjU0YmE0OTNiY2U3MDRlZGNiZDc4YWRmOWE5ZTcwMzFlL3RhYmxlcmFuZ2U6NTRiYTQ5M2JjZTcwNGVkY2JkNzhhZGY5YTllNzAzMWVfNC0zLTEtMS0xMTIyOTE_f5d03029-ced0-497f-a739-e57002d16335">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjU0YmE0OTNiY2U3MDRlZGNiZDc4YWRmOWE5ZTcwMzFlL3RhYmxlcmFuZ2U6NTRiYTQ5M2JjZTcwNGVkY2JkNzhhZGY5YTllNzAzMWVfNy0xLTEtMS0xMTIyOTE_ed19dc4c-0da2-4d25-8c5a-b15d0cd5576b">8,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjU0YmE0OTNiY2U3MDRlZGNiZDc4YWRmOWE5ZTcwMzFlL3RhYmxlcmFuZ2U6NTRiYTQ5M2JjZTcwNGVkY2JkNzhhZGY5YTllNzAzMWVfNy0zLTEtMS0xMTIyOTE_0e57a590-b5e5-4c8c-98b5-2d95a21730f0">1,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjU0YmE0OTNiY2U3MDRlZGNiZDc4YWRmOWE5ZTcwMzFlL3RhYmxlcmFuZ2U6NTRiYTQ5M2JjZTcwNGVkY2JkNzhhZGY5YTllNzAzMWVfOC0xLTEtMS0xMTIyOTE_31704ab2-9def-41a0-bc33-4f79fdaa3c82">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjU0YmE0OTNiY2U3MDRlZGNiZDc4YWRmOWE5ZTcwMzFlL3RhYmxlcmFuZ2U6NTRiYTQ5M2JjZTcwNGVkY2JkNzhhZGY5YTllNzAzMWVfOC0zLTEtMS0xMTIyOTE_ecba7657-389c-4755-84a6-dd4763f3cb19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i99bba14d20e045139242146e444cd539" continuedAt="i75181fb23178400498fc19c853c111ba"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="icui:AssetsandLiabilitiesLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RleHRyZWdpb246MjViYWY5NzJjZjBlNGJjMGEzYzc2YzAzNTVlOGE3MzRfMjc3MA_e0a67e48-b93a-4360-8eb9-763a65430f9b" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfMy0xLTEtMS0xMTIyOTE_fd006fa4-9307-471d-97b3-e5f225bb7a98">79,736</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfMy0zLTEtMS0xMTIyOTE_67387f33-c998-4795-a25f-976819a41e11">74,864</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfNS0xLTEtMS0xMTIyOTE_663eda60-8aa3-4a48-b302-b3dbc797265e">20,150</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfNS0zLTEtMS0xMTIyOTE_abd28bcf-5dac-4058-b54a-c83f3f85f6a8">18,169</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfNi0xLTEtMS0xMTIyOTE_fde7a494-189b-4179-9a6d-d7b574a7857c">63,062</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfNi0zLTEtMS0xMTIyOTE_33ccac95-a491-451d-a782-b09a7a660ab3">60,916</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfNy0xLTEtMS0xMTIyOTE_228fa2cd-3cce-45dc-af7f-d10ae2d5726c">83,212</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfNy0zLTEtMS0xMTIyOTE_c1389bbe-ca4e-4cfe-8085-49fbdfa377c1">79,085</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfMTAtMS0xLTEtMTEyMjkx_51f03898-86ad-420b-a6d1-7a944421f6d0">6.0</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfMTAtMy0xLTEtMTEyMjkx_92792b6f-519e-4772-8afc-6644b019d70b">6.1</ix:nonNumeric> years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfMTMtMS0xLTEtMTEyMjkx_8323bdfe-7124-4406-a596-71d5d11897f0">4.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfMTMtMy0xLTEtMTEyMjkx_1689a59a-d8ab-4422-bf7a-cb748f1d4e61">4.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfMy0xLTEtMS0xMTIyOTE_7bdfef41-d370-47f2-83d1-983b3a05487c">2,758</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfMy0zLTEtMS0xMTIyOTE_5195af09-37cc-4ba7-8194-ed98dc155949">2,598</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfNS0xLTEtMS0xMTIyOTE_b5ce3579-de84-465c-92d5-44e4eb9098b5">903</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfNS0zLTEtMS0xMTIyOTE_32996467-441e-47ec-96af-0433d5ca11dc">816</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfNi0xLTEtMS0xMTIyOTE_a9f5b97f-f801-47d3-9d5a-98061167a5d4">1,939</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfNi0zLTEtMS0xMTIyOTE_6be90806-52f5-40cb-856e-30ff04fce30c">1,855</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfNy0xLTEtMS0xMTIyOTE_f0364fa9-6c66-4e04-92a6-18ca86be94bf">2,842</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfNy0zLTEtMS0xMTIyOTE_87f15943-c029-48d9-9371-7f6df0c89a5d">2,671</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfMTAtMS0xLTEtMTEyMjkx_0271c212-1e35-4ae3-8132-b83385dfb396">4.5</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfMTAtMy0xLTEtMTEyMjkx_b9a045ec-be05-443b-9a09-6053c8915fb4">4.8</ix:nonNumeric> years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfMTMtMS0xLTEtMTEyMjkx_5e602dae-d861-4546-86a3-0f2ae4897d5e">4.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfMTMtMy0xLTEtMTEyMjkx_10c63588-2b38-4137-900a-e04324d14148">4.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i75181fb23178400498fc19c853c111ba"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RleHRyZWdpb246MjViYWY5NzJjZjBlNGJjMGEzYzc2YzAzNTVlOGE3MzRfMjc2NQ_8c93af69-7a01-43db-a78d-9d5d4fa440bb" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfMS0xLTEtMS0xMTIyOTE_9c520374-24f5-4338-a3d7-f2e0a4a34747">17,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfMS0zLTEtMS0xMTIyOTE_e7fcb3e3-c610-4e56-ac1c-b4390adce258">778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfMi0xLTEtMS0xMTIyOTE_d94e5e82-7d24-47f3-8a37-e4ec30b1263f">20,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfMi0zLTEtMS0xMTIyOTE_6f3c7cfc-b371-4792-a410-6b5c1122db5d">766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfMy0xLTEtMS0xMTIyOTE_01c6d535-4c52-4359-89cd-fb7f309cec91">14,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfMy0zLTEtMS0xMTIyOTE_de5aa8d9-f0dd-439d-beb9-c73acbf66e48">545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfNC0xLTEtMS0xMTIyOTE_0185dd42-6b1d-4d7e-b109-0435111e15f4">13,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfNC0zLTEtMS0xMTIyOTE_85446c97-14a5-4eb3-9a24-c3804b88432f">423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfNS0xLTEtMS0xMTIyOTE_0091bcd4-4b30-4e45-b258-ff05aa8c5089">9,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfNS0zLTEtMS0xMTIyOTE_835081fa-37c6-4c76-b45b-57f71a1ee3ca">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfNi0xLTEtMS0xMTIyOTE_eec0b432-0c36-4060-a419-2340cffc2bdd">14,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfNi0zLTEtMS0xMTIyOTE_fbb540fd-1e46-4077-9902-9203fa39c480">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfNy0xLTEtMS0xMTIyOTE_86cd3954-0f1b-48f4-b940-ba89c223d5d0">3,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfNy0zLTEtMS0xMTIyOTE_6e7eb4c1-27e0-4e84-876a-50fff923e1cf">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfOC0xLTEtMS0xMTIyOTE_ac6603c0-9b53-46fd-9831-b8f03fa05bef">93,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfOC0zLTEtMS0xMTIyOTE_d372d702-c4df-46a2-9227-11dfabd13e5e">3,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfOS0xLTEtMS0xMTIyOTE_1c79f8a1-2cfd-4aaf-8dd4-5ba3e61cd7aa">10,499</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfOS0zLTEtMS0xMTIyOTE_38d1d41a-a609-41e4-9452-2f64b4983bd0">294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfMTAtMS0xLTEtMTEyMjkx_cfe9e460-9251-4ae6-be0b-6cb316aad4c0">83,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfMTAtMy0xLTEtMTEyMjkx_07273474-064b-4891-aa02-9044937d4b6f">2,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RleHRyZWdpb246OTY4OGYxMTdjNDFmNDVhZjhmNDExZDg4MzhkNjg5OTZfMTQzOQ_6b5f7ae7-7bc3-43ae-90e9-f63b972153ee" continuedAt="i94ef871c9a4149b282b71476ec87ac98" escape="true">Net Income Per Share</ix:nonNumeric></span></div><ix:continuation id="i94ef871c9a4149b282b71476ec87ac98"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period plus dilutive securities. Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options and restricted stock units that are anti-dilutive are not included in the treasury stock method calculation. Due to the net loss for the three months ended March&#160;31, 2023 and 2022, any potentially dilutive common shares were not included in the computation of diluted earnings per share as they would have had an anti-dilutive effect; therefore, basic and diluted net loss per share are equal for each of the three months ended March 31, 2023 and 2022. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RleHRyZWdpb246OTY4OGYxMTdjNDFmNDVhZjhmNDExZDg4MzhkNjg5OTZfMTQzNw_655b687e-e99b-4821-9102-1da8d577c969" continuedAt="ia71f42bc55cc4ca49752bac902d7f59d" escape="true">The following table presents the calculation of net earnings per common share (&#8220;EPS&#8221;) &#8212; basic and diluted (in thousands, except per share data):&#160; </ix:nonNumeric></span></div><ix:continuation id="ia71f42bc55cc4ca49752bac902d7f59d"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfMi0xLTEtMS0xMTIyOTE_393701f2-7f9c-4152-86db-ac0271562008">9,812</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfMi0zLTEtMS0xMTIyOTE_701093ac-10a9-43e3-a5fb-d2686ae496fd">38,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding (basic)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfMy0xLTEtMS0xMTIyOTE_953a4ee0-6c05-4536-9a36-585f6fed5d46">24,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfMy0zLTEtMS0xMTIyOTE_40bdc8d8-215d-45c8-ac25-b0cd5d208281">23,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfNC0xLTEtMS0xMTIyOTE_ee56ccfe-e09f-4273-afea-aca37b66f0fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfNC0zLTEtMS0xMTIyOTE_76533f5a-b790-40ff-9b00-1def22dedcb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common and common equivalent shares outstanding (diluted)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfNS0xLTEtMS0xMTIyOTE_1a12ce0e-4622-4736-8639-cbd6364cae4f">24,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfNS0zLTEtMS0xMTIyOTE_099018d0-4903-4bd3-9f60-4537fff9c727">23,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfNi0xLTEtMS0xMTIyOTE_01d4ae51-955a-4ba9-ba2d-e0552e67e204">0.41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfNi0zLTEtMS0xMTIyOTE_769b0b4d-9d6b-44b3-92a4-45cd6fbf90cc">1.61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfNy0xLTEtMS0xMTIyOTE_cf739c99-2b8e-433f-8986-2c361c487fac">0.41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfNy0zLTEtMS0xMTIyOTE_99ee1efa-d5da-44b8-a645-fbe0af6548d9">1.61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the net loss for the three months ended March 31, 2023 and 2022, there are no potentially dilutive common shares included in the computation of diluted earnings per share.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNjA3NQ_ac17a367-9485-4584-b60b-6a09df1e5694" continuedAt="ia7d073e8030c4afc886e758a2a0122db" escape="true">Derivatives and Hedging Activities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia7d073e8030c4afc886e758a2a0122db" continuedAt="ib8582df304b14518b8dd836f50a8f5be"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Accounting and Hedging Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The purposes of our cash flow hedging programs are to manage the foreign currency exchange rate risk on forecasted revenues and expenses denominated in currencies other than the functional currency of the operating unit, and to manage floating interest rate risk associated with future interest payments on the variable-rate term loans issued in January 2022. We do not issue derivatives for trading or speculative purposes.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="ib8582df304b14518b8dd836f50a8f5be" continuedAt="ieb19cd159226417291825b4b06283209"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions. The derivative instruments we utilize, including various foreign exchange contracts and interest rate swaps, are designated and qualify as cash flow hedges. Our derivative instruments are recorded at fair value on the condensed consolidated balance sheets and are classified based on the instrument's maturity date. We record gains or losses from changes in the fair values of the derivative instruments as a component of other comprehensive income (loss) and we reclassify those gains or losses into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. If the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, we reclassify the gain or loss on the related derivative instrument from accumulated other comprehensive loss into earnings immediately.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Forward Contracts</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign exchange forward contracts to hedge a portion of our forecasted foreign currency-denominated revenues and expenses to minimize the effect of foreign exchange rate movements on the related cash flows. These contracts are agreements to buy or sell a quantity of a currency at a predetermined future date and at a predetermined exchange rate. Our foreign exchange forward contracts hedge exposures principally denominated in Mexican Pesos ("MXN"), Euros, Czech Koruna ("CZK"), Japanese Yen ("JPY"), Swedish Krona ("SEK"), Chinese Renminbi ("CNH"), Canadian Dollar ("CAD") and Australian Dollar ("AUD") and have varying maturities with an average term of approximately twelve months. The total notional amount of these outstanding derivative contracts as of March&#160;31, 2023 was $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjQ5Mg_cb54a3f4-a475-49d2-8584-921df3d78809">101.8</ix:nonFraction>&#160;million, which included the notional equivalent of $<ix:nonFraction unitRef="usd" contextRef="i104614519533468cb1d3f4a1f7ede191_I20230331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjUzOA_47107cbd-ef54-4ff1-9073-12bf46c911e3">3.6</ix:nonFraction>&#160;million in MXN, $<ix:nonFraction unitRef="usd" contextRef="ieed1db1afe2e4864acbe51f8f742e903_I20230331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjU0OQ_2085ae0a-6dab-4af4-9dca-4f025d809ee0">26.4</ix:nonFraction>&#160;million in Euros, $<ix:nonFraction unitRef="usd" contextRef="ica866edd3bbb4be194fb9fbe70eab0c3_I20230331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjU2Mg_08b8f831-6f23-4108-a364-f67df83c8e28">4.7</ix:nonFraction>&#160;million in CZK, $<ix:nonFraction unitRef="usd" contextRef="i98371e0ede62423e94e012fb74cce6db_I20230331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjU3Mw_922e673d-eb6f-4ec1-aad7-4dfda2841c7e">21.2</ix:nonFraction>&#160;million in JPY, $<ix:nonFraction unitRef="usd" contextRef="i7cacbfb1e2ec47f181ee075ab70cca83_I20230331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjU4NA_97458820-7705-4d7a-baeb-aab2118682ed">14.8</ix:nonFraction>&#160;million in CNH, $<ix:nonFraction unitRef="usd" contextRef="i05b8d7e5a0c94ec0abe63ce8b2a92789_I20230331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjU5NQ_53bde34c-3b89-42b7-b8fb-380b2f956f36">2.7</ix:nonFraction>&#160;million in SEK, $<ix:nonFraction unitRef="usd" contextRef="i8c884f97d3444f6ea4dcd4b55692fdb4_I20230331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjYwNg_6d164dba-15a7-48a5-8a1e-bf65b4e37483">13.1</ix:nonFraction>&#160;million in CAD, $<ix:nonFraction unitRef="usd" contextRef="i0f2b698f9db545af9bce00c8273f5099_I20230331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjYxNw_2f092522-6a33-420d-9480-3d82b3ef36d8">13.1</ix:nonFraction>&#160;million in AUD and $<ix:nonFraction unitRef="usd" contextRef="i8321aa0d52a040748fa39ebb30857208_I20230331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjYzMQ_00ae2a01-ac09-48ce-8cc2-2daa4b790a24">2.2</ix:nonFraction>&#160;million in other foreign currencies, with terms currently through June 2024. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cross-currency Par Forward Contracts</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into cross-currency par forward contracts to hedge a portion of our Mexico forecasted expenses denominated in MXN. These contracts are agreements to exchange cash flows from one currency to another at specified intervals over the contract term with all exchanges occurring at the same predetermined rate. In November 2021, we entered into a one-year cross-currency par forward contract with a term from December 1, 2021 to December 1, 2022. The total notional amount of this outstanding derivative as of March 31, 2022 was approximately <ix:nonFraction unitRef="mxn" contextRef="i32a51ec3c4454197ad187d461dff39ee_I20221231" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMzM3Ng_753da41a-20fd-461d-810a-61803e4095e1">311.6</ix:nonFraction>&#160;million MXN. This derivative instrument matures in equal monthly amounts at a fixed forward rate of <ix:nonFraction unitRef="number" contextRef="id1c83cae5660471ba0a2606a294d663d_I20230331" decimals="2" name="us-gaap:DerivativeForwardExchangeRate1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMzQ4NA_aceac7dd-4f6f-47b3-8cc7-769e4ae1840a">21.60</ix:nonFraction> MXN/USD.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Floating Interest Rate Risk</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, in anticipation of entering into the new senior secured credit facilities in January 2022, which includes a variable-rate term loan A and a variable-rate term loan B (see Note 17: Long-Term Debt), we entered into two forward-starting interest rate swaps. In February 2022, certain terms under the agreements were amended to reflect the transition from LIBOR to the Secured Overnight Financing Rate ("SOFR"), an alternative reference rate. Under the interest rate swap agreements, we exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount. Effective March 30, 2022, the term loan A swap, as amended, has an initial notional amount of $<ix:nonFraction unitRef="usd" contextRef="i41865436086741dba4582ecb29b5d80f_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNDQ4MQ_abf78f58-34f8-4b71-9737-9bbb4284a2dd">300.0</ix:nonFraction>&#160;million, reducing to $<ix:nonFraction unitRef="usd" contextRef="i41865436086741dba4582ecb29b5d80f_I20230331" decimals="-6" name="icui:InterestRateSwapEndingNotionalValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNDQ5Nw_b1613fee-03b0-4f49-b38b-6969bf817abb">150.0</ix:nonFraction>&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2027. We will pay a fixed rate of <ix:nonFraction unitRef="number" contextRef="i41865436086741dba4582ecb29b5d80f_I20230331" decimals="6" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNDYwNA_c85587ac-d51d-46e7-8251-c07e97c13e8d">1.32</ix:nonFraction>% and will receive the greater of 3-month USD SOFR or (<ix:nonFraction unitRef="number" contextRef="i41865436086741dba4582ecb29b5d80f_I20230331" decimals="4" sign="-" name="icui:DerivativeVariableRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNDY1OQ_68a0572c-72e8-41a4-8a28-62c4f14875d6">0.15</ix:nonFraction>)%. Effective March 30, 2022, the term loan B swap, as amended, has an initial notional amount of $<ix:nonFraction unitRef="usd" contextRef="i86157d0618294ee89c1fc6807b08141e_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNDc1Nw_aaf6da9c-862d-4760-ba38-56b74e990301">750.0</ix:nonFraction>&#160;million, reducing to $<ix:nonFraction unitRef="usd" contextRef="i86157d0618294ee89c1fc6807b08141e_I20230331" decimals="-3" name="icui:InterestRateSwapEndingNotionalValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNDc3Mw_ed434747-e686-4e01-b7d6-71158f09bc17">46.9</ix:nonFraction>&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2026. We will pay a fixed rate of <ix:nonFraction unitRef="number" contextRef="i86157d0618294ee89c1fc6807b08141e_I20230331" decimals="6" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNDg4MA_be9cbcac-639b-4387-a500-6279dcc43351">1.17</ix:nonFraction>% and will receive the greater of 3-month USD SOFR or <ix:nonFraction unitRef="number" contextRef="i86157d0618294ee89c1fc6807b08141e_I20230331" decimals="4" name="icui:DerivativeVariableRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNDkzNQ_81d22bfa-3b4c-4c54-a139-d60388acf54f">0.35</ix:nonFraction>%. These swaps effectively convert the relevant portion of the floating-rate term loans to fixed rates.&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNjA3Mw_366091e2-7e79-42f8-a5f3-e206bc53ad7f" continuedAt="id4d4a92d381e466fa66fd1fe20a7bdba" escape="true">The following table presents the fair values of our derivative instruments included within the Condensed Consolidated Balance Sheets (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="ieb19cd159226417291825b4b06283209" continuedAt="ic1268738950449a780a70e6758e1dd51"><ix:continuation id="id4d4a92d381e466fa66fd1fe20a7bdba"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March&#160;31, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNC0wLTEtMS0xMTIyOTE_cfaec65c-7e6a-4276-963b-bd9a55c586b9">Prepaid expenses and other current assets</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7f51fd80feb455d9784516bdd6b7c63_I20230331" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNC0yLTEtMS0xMTIyOTE_492d0d59-2cd7-4f9b-8fc5-f76846d2bd5a">7,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcc5cb934c484085e4c9d001608c4b_I20230331" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNC00LTEtMS0xMTIyOTE_93791020-f837-40e1-96db-01efc3506be9">25,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNC02LTEtMS0xMTIyOTE_49e05355-da5a-4320-934a-8b1a4626ebb1">32,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNS0wLTEtMS0xMTIyOTE_a381aeb8-d171-4550-9ed5-50b193801e56">Other assets</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7f51fd80feb455d9784516bdd6b7c63_I20230331" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNS0yLTEtMS0xMTIyOTE_a02863f2-9040-4dd3-8f36-fbe1b57027f0">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcc5cb934c484085e4c9d001608c4b_I20230331" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNS00LTEtMS0xMTIyOTE_97905e10-db86-424c-9da1-3ca9fefa988e">19,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNS02LTEtMS0xMTIyOTE_0f07bb9e-4f9e-42a1-877a-67137b9d8c3c">19,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7f51fd80feb455d9784516bdd6b7c63_I20230331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNi0yLTEtMS0xMTIyOTE_f3a171ed-dd8f-4279-9349-994ad08fb747">7,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcc5cb934c484085e4c9d001608c4b_I20230331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNi00LTEtMS0xMTIyOTE_c2551578-f43b-465b-aa9b-b2dcc76fce93">45,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNi02LTEtMS0xMTIyOTE_74cc03d3-00da-493c-aec4-ee0bb64a04ca">52,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOC0wLTEtMS0xMTIyOTE_31479843-5a18-4da4-b2e9-8a0ab42c6b76">Accrued liabilities</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7f51fd80feb455d9784516bdd6b7c63_I20230331" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOC0yLTEtMS0xMTIyOTE_82034d12-92a9-422a-97d1-e3ac3504c0e7">2,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcc5cb934c484085e4c9d001608c4b_I20230331" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOC00LTEtMS0xMTIyOTE_99ebd993-97cf-40ab-bfea-acfddcfc23e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOC02LTEtMS0xMTIyOTE_d56fef2c-697d-4521-bafc-2694ed98974d">2,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOS0wLTEtMS0xMTIyOTE_0314024e-19ca-42c9-bda0-6b9963e62d6c">Other long-term liabilities</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7f51fd80feb455d9784516bdd6b7c63_I20230331" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOS0yLTEtMS0xMTIyOTE_95783636-5759-4b8d-b104-6a0587b269fc">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcc5cb934c484085e4c9d001608c4b_I20230331" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOS00LTEtMS0xMTIyOTE_d60751e0-fb73-45ca-84c0-f1a4ee2eb468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOS02LTEtMS0xMTIyOTE_13bb880b-64b2-4ef6-975d-2d692b9fd8db">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7f51fd80feb455d9784516bdd6b7c63_I20230331" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTAtMi0xLTEtMTEyMjkx_5be3df7d-d723-4ab1-8663-d2c2583b3f54">2,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcc5cb934c484085e4c9d001608c4b_I20230331" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTAtNC0xLTEtMTEyMjkx_0aff8bc3-1d22-4e6b-a599-2b80d5ffa6fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTAtNi0xLTEtMTEyMjkx_96b5d8ee-1c76-41b3-8021-586b8cf69e72">2,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTMtMC0xLTEtMTEyMjkx_b4e70733-51f6-4cf5-a4f0-4e3344743eed">Prepaid expenses and other current assets</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc4d8e7ceb96467cae741d1df3ad1fbf_I20221231" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTMtMi0xLTEtMTEyMjkx_4479e4aa-dfe5-4cde-a8e3-fc3edb664cac">4,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i631e83ee61b74e3abeaa5ad6e7bab2b1_I20221231" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTMtNC0xLTEtMTEyMjkx_bf4eaab2-1061-4d0e-ade9-169f7008960d">28,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTMtNi0xLTEtMTEyMjkx_f76b1afb-0973-4b57-ad1b-d27d8111a0fb">33,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTQtMC0xLTEtMTEyMjkx_c7f29940-14d5-49dd-8334-2995d9c76144">Other assets</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc4d8e7ceb96467cae741d1df3ad1fbf_I20221231" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTQtMi0xLTEtMTEyMjkx_a0153dc0-8959-47e9-8b9e-4311270fb5ea">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i631e83ee61b74e3abeaa5ad6e7bab2b1_I20221231" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTQtNC0xLTEtMTEyMjkx_88c40b9e-dc62-4a21-81ae-7eab4774af58">26,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTQtNi0xLTEtMTEyMjkx_a02d04af-5e72-4980-a4d8-10ad40790f0a">26,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc4d8e7ceb96467cae741d1df3ad1fbf_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTUtMi0xLTEtMTEyMjkx_95d2abb4-89c2-4087-9435-839664dc93e6">4,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i631e83ee61b74e3abeaa5ad6e7bab2b1_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTUtNC0xLTEtMTEyMjkx_5f415341-c18f-4d0c-b079-eff66bb7e8c3">55,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTUtNi0xLTEtMTEyMjkx_2c37c608-b345-4a7d-88d9-eb47c1910839">60,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTctMC0xLTEtMTEyMjkx_6e89f792-0047-409f-ae97-92f90a1a3b54">Accrued liabilities</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc4d8e7ceb96467cae741d1df3ad1fbf_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTctMi0xLTEtMTEyMjkx_8a842ac8-aa7e-44d0-bf7b-ae01b1b9f9ec">1,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i631e83ee61b74e3abeaa5ad6e7bab2b1_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTctNC0xLTEtMTEyMjkx_a008117a-f3fb-494f-afde-579dd978fe18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTctNi0xLTEtMTEyMjkx_450f988e-3a98-4ca5-9eb2-3da2442d3627">1,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTgtMC0xLTEtMTEyMjkx_e58a7954-fa23-4f46-8db3-028044ca9ce7">Other long-term liabilities</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc4d8e7ceb96467cae741d1df3ad1fbf_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTgtMi0xLTEtMTEyMjkx_17d67151-904f-43f7-8d4c-df3c6d448ed5">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i631e83ee61b74e3abeaa5ad6e7bab2b1_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTgtNC0xLTEtMTEyMjkx_4490d8cc-f6b9-4606-9a99-d6e6814fa892">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTgtNi0xLTEtMTEyMjkx_a8a0e18b-741c-4843-aef3-d34e71f5ea98">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc4d8e7ceb96467cae741d1df3ad1fbf_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTktMi0xLTEtMTEyMjkx_b2181a8b-ef66-4091-b0e3-d5375731b870">2,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i631e83ee61b74e3abeaa5ad6e7bab2b1_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTktNC0xLTEtMTEyMjkx_3f347b23-12e8-43d8-bf24-d07ff9e02915">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTktNi0xLTEtMTEyMjkx_8d3197d4-8905-4da6-93c3-2ec9ce2e3c3e">2,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized the following gains on our derivative instruments designated as cash flow hedges in other comprehensive income before reclassifications to net loss (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.037%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc9bb67f131a49a8b919336073869658_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmUzNzZhYjdjZTg4NjRmZGQ4MTY5Nzc0YTA2ZjhmOWZmL3RhYmxlcmFuZ2U6ZTM3NmFiN2NlODg2NGZkZDgxNjk3NzRhMDZmOGY5ZmZfNC0yLTEtMS0xMTIyOTE_19db966a-1d02-4dbc-ad07-fcf341782e32">2,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e60d283c38e4b35bb0be9fcf2699bec_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmUzNzZhYjdjZTg4NjRmZGQ4MTY5Nzc0YTA2ZjhmOWZmL3RhYmxlcmFuZ2U6ZTM3NmFiN2NlODg2NGZkZDgxNjk3NzRhMDZmOGY5ZmZfNC00LTEtMS0xMTIyOTE_26267762-f3cb-4d8e-9a87-f2fffc62bb37">3,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c2531beb9494ed7a57f1659c8d16d2a_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmUzNzZhYjdjZTg4NjRmZGQ4MTY5Nzc0YTA2ZjhmOWZmL3RhYmxlcmFuZ2U6ZTM3NmFiN2NlODg2NGZkZDgxNjk3NzRhMDZmOGY5ZmZfNS0yLTEtMS0xMTIyOTE_8c08f0fc-ac2c-4b27-b152-6d48e03e7c28">2,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f7f6f4d53994f44b8df01e0704834c5_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmUzNzZhYjdjZTg4NjRmZGQ4MTY5Nzc0YTA2ZjhmOWZmL3RhYmxlcmFuZ2U6ZTM3NmFiN2NlODg2NGZkZDgxNjk3NzRhMDZmOGY5ZmZfNS00LTEtMS0xMTIyOTE_d006b1d1-6b47-4138-aeef-099a1cbad983">30,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmUzNzZhYjdjZTg4NjRmZGQ4MTY5Nzc0YTA2ZjhmOWZmL3RhYmxlcmFuZ2U6ZTM3NmFiN2NlODg2NGZkZDgxNjk3NzRhMDZmOGY5ZmZfNi0yLTEtMS0xMTIyOTE_5a3d041c-b0fa-4e98-bac4-2e4af2bd4692">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmUzNzZhYjdjZTg4NjRmZGQ4MTY5Nzc0YTA2ZjhmOWZmL3RhYmxlcmFuZ2U6ZTM3NmFiN2NlODg2NGZkZDgxNjk3NzRhMDZmOGY5ZmZfNi00LTEtMS0xMTIyOTE_5bf56bbd-c87c-4131-9fbe-fa89199c4c03">33,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="ic1268738950449a780a70e6758e1dd51" continuedAt="i6bd612d7615745ada77dd94c11054840"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNjA2NA_2f129156-1e71-46c9-891b-482b1384abb3" continuedAt="id4efdfd78b184b3ea0b63074bb7529fe" escape="true"><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:50.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.358%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Reclassified From Accumulated Other Comprehensive (Loss) Income into Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNC0yLTEtMS0xMTIyOTE_f380e986-354b-4ae5-be66-0d8180b7e6bd">Total revenues</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45dae7757b124552a2b2f3b01ce6c186_D20230101-20230331" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNC00LTEtMS0xMTIyOTE_0b8db45d-aaa5-4fa2-b201-e08f321c03ef">1,922</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5bae88141345639dcc3eac627c0799_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNC02LTEtMS0xMTIyOTE_e1fed420-5029-42c6-98a6-2d42fc98e784">2,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNS0yLTEtMS0xMTIyOTE_e0200ea4-951a-4f15-aa0d-730e8294b71c">Cost of goods sold</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48a10cc5a2694f10b44bf1877ec9bebc_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNS00LTEtMS0xMTIyOTE_7f915987-58e7-4a51-9dd6-70a5a4207144">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i108862c46a0d4e1295be73061c8600e8_D20220101-20220331" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNS02LTEtMS0xMTIyOTE_d8d3ab8b-ff89-4e81-8675-3084ca952097">513</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:DerivativeNetHedgeIneffectivenessGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNi00LTEtMS0xMjA4NDc_fcbd74b1-894a-498d-a28f-1b8fd3943e6e">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:DerivativeNetHedgeIneffectivenessGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNi02LTEtMS0xMjA4NDk_7c4c5bb2-36db-4dbb-be28-caeaa11f0fe3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i974e647072aa44e980b4ed61c129befa_D20230101-20230331" decimals="-3" name="us-gaap:GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNi00LTEtMS0xMTIyOTE_921634aa-4afe-4b96-a6ef-634c002ada7f">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c8639dba4434deab359b7b242f47fbd_D20220101-20220331" decimals="-3" name="us-gaap:GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNi02LTEtMS0xMTIyOTE_adeee894-48e3-4ed4-93af-64dc8ed012dc">249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNy0yLTEtMS0xMTIyOTE_faab4624-13eb-4610-aa53-f7352f932ffd">Interest expense</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12ebce1f4c61414eb59c03244fef43b4_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNy00LTEtMS0xMTIyOTE_1dc80291-fba3-4906-b6e1-6d9a929ab2ed">7,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73bc74286d9f4e128411e29701d4efc8_D20220101-20220331" decimals="-3" name="us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNy02LTEtMS0xMTIyOTE_8620e4d2-ac41-4925-b334-e2c62a739728">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c48ae5abe2f4e6caf6fbf46c2c6e69a_D20230101-20230331" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfOC00LTEtMS0xMTIyOTE_28fb5022-8106-46ba-8018-8885bbb3326b">7,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22bda3a55c764257a1a89a08923962af_D20220101-20220331" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfOC02LTEtMS0xMTIyOTE_4871ce08-4a26-4ed4-a311-27b9bbd6d418">2,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents location of gain reclassified from accumulated other comprehensive income into income as a result of ineffectiveness.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents location of gain reclassified from accumulated other comprehensive income into income as a result of forecasted transactions no longer probable of occurring.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6bd612d7615745ada77dd94c11054840"><ix:continuation id="id4efdfd78b184b3ea0b63074bb7529fe">As of March&#160;31, 2023, we expect an estimated $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNTc0MQ_ce9ed75a-614a-43ab-b7ef-1b528fa20438">5.3</ix:nonFraction>&#160;million in deferred gains on the outstanding foreign exchange contracts and an estimated $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNTgyNQ_dcd43b1a-e997-4693-8472-2d34ce6f8352">26.3</ix:nonFraction>&#160;million in deferred gains on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.</ix:continuation></ix:continuation>&#160;&#160;&#160;&#160;</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:19.736%"><div><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_58"></div></div><div style="display:inline-block;max-width:7.017%;min-width:6.684%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:19.736%"></div><div style="display:inline-block;max-width:7.017%;min-width:6.684%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:19.736%"></div><div style="display:inline-block;max-width:7.017%;min-width:6.684%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:19.741%"></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfNzgwNg_829d8e57-c575-42f4-b875-74e1d100331c" continuedAt="i9231f777232b45ad835dd47160f0b4e6" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i9231f777232b45ad835dd47160f0b4e6" continuedAt="i4301ab210971484093f784a1bbde0d12"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. There are three levels of inputs that may be used to measure fair value:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1:  quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2:  inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3:  unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Earn-out Liabilities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired Smiths Medical with a combination of cash consideration and share consideration issued at closing. Total consideration for the acquisition includes a potential earn-out payment of $<ix:nonFraction unitRef="usd" contextRef="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMTE4MQ_2718a2ef-51d7-4b1b-9075-8893b0a27a63">100.0</ix:nonFraction>&#160;million in cash contingent on our common stock achieving certain Price Targets from the closing date to either the third or fourth anniversary of closing (see Note 3: Acquisitions for additional information) and provided Smiths beneficially owns at least <ix:nonFraction unitRef="number" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="8" name="icui:OwnershipRequirementForEarnoutPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMTQzMQ_1eabdd33-8df3-43d6-af2b-325ce5bcdf22">50.0</ix:nonFraction>% of the shares of common stock issued at closing at the time the Price Target is achieved. The initial estimated fair value of the earn-out was determined to be $<ix:nonFraction unitRef="usd" contextRef="id05515fe4472496ab29e975ca6d18184_I20220106" decimals="-4" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMTU5NA_58699d49-d0e0-43b7-bf23-a34a1e451b9e">53.5</ix:nonFraction>&#160;million. The initial fair value of the earn-out was determined using a Monte Carlo simulation model. The model utilized several assumptions including volatility and the risk-free interest rate. The assumed volatility is based on the average of the historical volatility of our common stock price and the implied volatility of certain at-the-money traded options. The risk-free interest rate is equal to the yield on U.S. Treasury securities at constant maturity for the period commensurate with the term of the earn-out. At each reporting date subsequent to the acquisition, we will remeasure the earn-out liability and recognize any changes in its fair value in our consolidated statements of operations. If the probability of achieving the Price Targets during their respective measurement periods is significantly greater than initially anticipated, the realization of an additional liability and related expense will have a significant impact on our consolidated financial statements in the period recognized. As of March&#160;31, 2023, the estimated fair value of the contingent earn-out is $<ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-4" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMjY2OA_01aa70b4-e9d7-4200-9410-e84f3af2bb91">20.3</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i4301ab210971484093f784a1bbde0d12" continuedAt="i19d41a987f45446cae63ef5b1fbdae12"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $<ix:nonFraction unitRef="usd" contextRef="ie9945fc3bd5d4b24a1e69091bf0384fd_D20230101-20230331" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMjgzNw_e10307a7-f5ec-4707-b669-78854c78f822">2.5</ix:nonFraction>&#160;million, consisting of (i) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-6" name="icui:ContingentConsiderationGrossST" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMjg3Nw_c35eb2fb-3f26-4987-8569-b0918ed966ec">1.0</ix:nonFraction>&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-5" name="icui:ContingentConsiderationGrossLT" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMzAyNA_c463bf09-1317-4a22-8eb1-bf56695860d9">1.5</ix:nonFraction>&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of December 31, 2022, the measurement period related to (i) above ended, and based on the actual revenue achieved during the measurement period we determined that the fair value of the contingent earn-out was zero as the minimum threshold for earning the earn-out was not met. As of March&#160;31, 2023, the estimated fair value for the contingent earn-out related to certain product-related regulatory certifications was estimated to be $<ix:nonFraction unitRef="usd" contextRef="ia818e4969fa7407895eb98d2469bf054_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMzE4OA_fda4c46b-a969-4ccb-b01e-1aa8e015a1a7">1.5</ix:nonFraction>&#160;million. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out payment shall not exceed $<ix:nonFraction unitRef="usd" contextRef="ifb3a2f75275841ddb552fdb5a627b2b2_D20230101-20230331" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMzUzMw_7375c233-bace-45fe-bf0d-9721a630db20">6.0</ix:nonFraction>&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of both March 31, 2023 and December 31, 2022, the estimated fair value of the contingent earn-out is $<ix:nonFraction unitRef="usd" contextRef="ifb41da7d968840ea810ecb453fece23f_I20230331" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMzk2Mw_4712af82-7045-4023-95a7-396b54cad560">2.6</ix:nonFraction>&#160;million. The estimated fair value of the contingent earn-out is calculated using a probability-weighted cash flow model based on historical revenue streams and the likelihood that the revenue targets will be met.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our contingent earn-out liabilities are separately stated on our condensed consolidated balance sheets.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfNzc5NQ_0bcc0d6f-7c6c-4e31-933d-58d0fa8ad2fc" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a reconciliation of the Level 3 earn-out liabilities measured at estimated fair value (in thousands):  </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmRmZjk2YWVlYTA3MDRlZTZhODYwODhmNDhkM2QzZjQ3L3RhYmxlcmFuZ2U6ZGZmOTZhZWVhMDcwNGVlNmE4NjA4OGY0OGQzZDNmNDdfMS0yLTEtMS0xMTIyOTE_ca0e38ab-0d06-4251-b009-2f93a0decbb0">25,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of earn-out (included in income from operations as a separate line item)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmRmZjk2YWVlYTA3MDRlZTZhODYwODhmNDhkM2QzZjQ3L3RhYmxlcmFuZ2U6ZGZmOTZhZWVhMDcwNGVlNmE4NjA4OGY0OGQzZDNmNDdfMy0yLTEtMS0xMTIyOTE_ff4770ef-7497-440d-95f8-d128674df06f">700</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="icui:CurrencyTranslationOnEarnOut" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmRmZjk2YWVlYTA3MDRlZTZhODYwODhmNDhkM2QzZjQ3L3RhYmxlcmFuZ2U6ZGZmOTZhZWVhMDcwNGVlNmE4NjA4OGY0OGQzZDNmNDdfNC0yLTEtMS0xMTIyOTE_ba510633-7b92-4fbb-8bb3-4503c78850b1">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ae61222e1b43a5acfc276574f10056_I20220930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmRmZjk2YWVlYTA3MDRlZTZhODYwODhmNDhkM2QzZjQ3L3RhYmxlcmFuZ2U6ZGZmOTZhZWVhMDcwNGVlNmE4NjA4OGY0OGQzZDNmNDdfNS0yLTEtMS0xMTIyOTE_3dc15564-51e5-4e17-b6b5-a985ec0d2c0c">24,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c52854a73b14fd6ae1828bd91e30fb1_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOjU4YzVjYTI4MTNlMDQ4N2VhMTRhYTc0YmM5OWE0YWUyL3RhYmxlcmFuZ2U6NThjNWNhMjgxM2UwNDg3ZWExNGFhNzRiYzk5YTRhZTJfMS0yLTEtMS0xMTIyOTE_c98b9742-55aa-4bed-98b3-c09845ddd36c">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition date fair value estimate of earn-out</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOjU4YzVjYTI4MTNlMDQ4N2VhMTRhYTc0YmM5OWE0YWUyL3RhYmxlcmFuZ2U6NThjNWNhMjgxM2UwNDg3ZWExNGFhNzRiYzk5YTRhZTJfMi0yLTEtMS0xMjA4NTk_dbbd4791-e211-4625-a28b-5fe2a04e60b6">55,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="icui:CurrencyTranslationOnEarnOut" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOjU4YzVjYTI4MTNlMDQ4N2VhMTRhYTc0YmM5OWE0YWUyL3RhYmxlcmFuZ2U6NThjNWNhMjgxM2UwNDg3ZWExNGFhNzRiYzk5YTRhZTJfNC0yLTEtMS0xMjA4NjI_fa2802ab-7bee-47bd-bf17-575c1d0024ff">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a2467fbfc445cf8500c8ee1e6396ee_I20210930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOjU4YzVjYTI4MTNlMDQ4N2VhMTRhYTc0YmM5OWE0YWUyL3RhYmxlcmFuZ2U6NThjNWNhMjgxM2UwNDg3ZWExNGFhNzRiYzk5YTRhZTJfNC0yLTEtMS0xMTIyOTE_c8379908-4238-469b-882a-9e4fc0ef6a9c">57,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Primarily relates to Smiths Medical.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfOTE0Ng_1d70c050-233d-466f-820f-17cde8691e7e">53.5</ix:nonFraction>&#160;million relates to our acquisition of Smiths Medical and $<ix:nonFraction unitRef="usd" contextRef="icbd969b02ac748cd9474589aab428a62_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfOTE1NA_93463654-0772-41f2-a122-fbe7b5b5e1c4">1.6</ix:nonFraction>&#160;million relates to our acquisition of a small foreign infusions systems supplier in the fourth quarter of 2021 (see Note 3: Acquisitions).</span></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfNzgwOA_f6ff948d-f4be-407b-bdf0-2d45e837fc56" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide quantitative information about Level 3 inputs for fair value measurement of our earn-out liabilities related to Smiths Medical:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smiths Medical Earn-out Liability</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.736%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id9540454f8784e5f990147c6b769dfe8_I20230331" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOjAwYzM5NGZkMmRkZjQyZDFiNmJkNzVlZWQ4YTViOTMyL3RhYmxlcmFuZ2U6MDBjMzk0ZmQyZGRmNDJkMWI2YmQ3NWVlZDhhNWI5MzJfMS00LTEtMS0xMjA4Njc_44f249b4-1bc8-49cd-9c3b-4de79170ada1">36.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icd441dae5eb1464ebef86ea40463485d_I20220106" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOjAwYzM5NGZkMmRkZjQyZDFiNmJkNzVlZWQ4YTViOTMyL3RhYmxlcmFuZ2U6MDBjMzk0ZmQyZGRmNDJkMWI2YmQ3NWVlZDhhNWI5MzJfMS00LTEtMS0xMTIyOTE_79eb1b53-a096-4a3e-b142-885f2bc85f31">38.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-Free Rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia32accdc410f475aacf8dd5d7b0e4cf3_I20230331" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOjAwYzM5NGZkMmRkZjQyZDFiNmJkNzVlZWQ4YTViOTMyL3RhYmxlcmFuZ2U6MDBjMzk0ZmQyZGRmNDJkMWI2YmQ3NWVlZDhhNWI5MzJfMi00LTEtMS0xMjA4Njc_1d06c0f3-a4df-40f3-a4e8-fdd8b0a2735d">3.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73f519574f6f4c26956379467aefa3d5_I20220106" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOjAwYzM5NGZkMmRkZjQyZDFiNmJkNzVlZWQ4YTViOTMyL3RhYmxlcmFuZ2U6MDBjMzk0ZmQyZGRmNDJkMWI2YmQ3NWVlZDhhNWI5MzJfMi00LTEtMS0xMTIyOTE_c8826a61-62b4-4829-b93e-c8db3bca492a">4.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i19d41a987f45446cae63ef5b1fbdae12" continuedAt="i246b443861cb4452b40c88ff547f4e14"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments, Foreign Exchange Contracts and Interest Rate Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our investments consist of corporate bonds and U.S treasury securities. The fair value of our corporate bonds is estimated using observable market-based inputs such as quoted prices, interest rates and yield curves or Level 2 inputs. The fair value of our U.S. treasury securities are based on quoted market prices in active markets and are included in the Level 1 fair value hierarchy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair value of our Level 2 foreign exchange contracts, including forward contracts and cross-currency par forward contracts, is estimated using observable market inputs such as known notional value amounts, spot and forward exchange rates. These inputs relate to liquid, heavily traded currencies with active markets which are available for the full term of the derivative.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our Level 2 interest rate swaps is estimated using a pricing model that reflects the terms of the contracts, including the period to maturity, and relies on observable market inputs such as known notional value amounts and USD interest rate curves.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfNzc5MA_e539a143-bcd4-4d83-86b7-c3fe8afab7a9" continuedAt="i4cdb850dab494ad480973b2d8e06f40b" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our assets and liabilities measured at fair value on a recurring basis consisted of the following Level 1, 2 and 3 inputs as defined above (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56f6562b611449eeb241cfb061a8fc81_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNC0xLTEtMS0xMTIyOTE_ffda1023-ff61-42cf-8bf6-35f589b7ee6d">1,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a170696eee4e9abdb23c78710d0758_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNC0zLTEtMS0xMTIyOTE_70ee93dc-2a94-4e6a-85fd-dd4019242a43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97cdcc7aea824b1db81b342d252b23dd_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNC01LTEtMS0xMTIyOTE_6b319711-654b-49b1-8400-e4ec51dcde64">1,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91c21fa692e4850bf5756c81c2f5f58_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNC03LTEtMS0xMTIyOTE_053323c0-0207-4e01-b3e5-c0b5ca077c68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb57c90226d949769fdebc2b3c886a84_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNS0xLTEtMS0xMTIyOTE_511a9132-63ef-47a5-962f-78e4c8607e08">1,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a47211e1504bfbbb2e56947d6359bc_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNS0zLTEtMS0xMTIyOTE_b6ca1da3-02c5-4af8-84fc-15ac41cabf51">1,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ee355f953e44036b2c9823f0ddf9545_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNS01LTEtMS0xMTIyOTE_779973a5-c267-4879-b962-3ecdcc0e8a2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7db2b58ce0df41e787b7b142992d9f0a_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNS03LTEtMS0xMTIyOTE_3657ea37-1943-4ce0-a7d2-c188f8cbf1fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id251cb4f372c42deb49b98c56f091af2_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNy0xLTEtMS0xMTIyOTE_456e161b-da7b-43ac-9a42-f7299f3f9c39">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e9c526d8a14de587543cd4d43d84ff_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNy0zLTEtMS0xMTIyOTE_924a282c-65ba-425e-bba1-9a6ede451608">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95e85068b35c4e25b71a9f1dde7f01cf_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNy01LTEtMS0xMTIyOTE_2fcc8fc4-abdf-40ba-af86-dc7e9d2d4513">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3677cc922444caa877f9554bf61388c_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNy03LTEtMS0xMTIyOTE_1950a43b-70cd-4563-af11-2d19e37b7c18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTAtMC0xLTEtMTEyMjkx_f14ce4d4-85f2-4d23-a88b-1739598efd81">Prepaid expenses and other current assets</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75c1ba3ea0845429dc5b1f441156886_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTAtMS0xLTEtMTEyMjkx_5f9904f1-3c90-4e1a-a820-3c4d0dc0a1be">7,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib014b4c6ffba42ecba26116f0b36d255_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTAtMy0xLTEtMTEyMjkx_e1864872-39ff-4658-ac3a-b040beb8cece">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b55b633207e4c77a409427f88b494ae_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTAtNS0xLTEtMTEyMjkx_bf6106a7-2113-458c-992f-ee58e81c84ef">7,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied46de2d5cdb4f3287c1a51b1fda5f2f_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTAtNy0xLTEtMTEyMjkx_cd95b55e-c66b-4068-a6f9-0bc8886844f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTEtMC0xLTEtMTEyMjkx_d56c9d3d-0932-4348-b69d-8f57de5603f9">Other assets</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e83be36630a4315aa61f938a15ed93c_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTEtMS0xLTEtMTEyMjkx_a485759d-3296-481e-a6e5-2bae23974275">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73643551546848cf924dc74653a7ab10_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTEtMy0xLTEtMTEyMjkx_ba397a4e-99cd-4efa-b67a-4b05a5e1efe5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff489ffd4484b05893332bc86bb5da4_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTEtNS0xLTEtMTEyMjkx_a9e3a712-0b80-4294-983f-91fed48901e6">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id49337d44fff49da85c4746c25de0cfa_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTEtNy0xLTEtMTEyMjkx_00902aa5-03a4-4319-9931-d3de69383aee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTUtMC0xLTEtMTEyMjkx_6bcfe6ca-ff2c-4a0b-9003-1212bc82d7dd">Prepaid expenses and other current assets</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75c1ba3ea0845429dc5b1f441156886_I20230331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTUtMS0xLTEtMTEyMjkx_ee77c835-6daa-4f07-a256-44fe5a2616ab">25,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib014b4c6ffba42ecba26116f0b36d255_I20230331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTUtMy0xLTEtMTEyMjkx_eaa64b3b-5705-402e-993f-045d0b1298cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b55b633207e4c77a409427f88b494ae_I20230331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTUtNS0xLTEtMTEyMjkx_51a457a3-0453-4864-b49c-c2a4defd9167">25,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied46de2d5cdb4f3287c1a51b1fda5f2f_I20230331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTUtNy0xLTEtMTEyMjkx_bf0a8245-eaf2-4478-9cc6-293ec4fb3724">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTYtMC0xLTEtMTEyMjkx_308e7868-3fa9-4233-8466-3e1183fa8b50">Other assets</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e83be36630a4315aa61f938a15ed93c_I20230331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTYtMS0xLTEtMTEyMjkx_112d163f-18b7-424d-9cd8-0ca42b5f2b17">19,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73643551546848cf924dc74653a7ab10_I20230331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTYtMy0xLTEtMTEyMjkx_2fa253fb-2698-4bac-8c8c-1e344ff3e2bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff489ffd4484b05893332bc86bb5da4_I20230331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTYtNS0xLTEtMTEyMjkx_6e5a287c-1b00-48da-84ed-336ee2557b72">19,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id49337d44fff49da85c4746c25de0cfa_I20230331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTYtNy0xLTEtMTEyMjkx_4d5f4f80-3b77-48db-ba3f-6e5d903f3de4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTctMS0xLTEtMTEyMjkx_0023dcc4-fe8c-4f81-ac41-6b0b8fa97006">55,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefcb7fb7c4af44bd86feb62b7205f1f3_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTctMy0xLTEtMTEyMjkx_2764d376-8057-48de-9131-919b222acfc0">1,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28c30abbbc564beab22d3baeae8ce04c_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTctNS0xLTEtMTEyMjkx_b2d1639d-dd01-4624-a3cb-42da0d53f327">54,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83c7a5461f164badbda9aed1e171b545_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTctNy0xLTEtMTEyMjkx_ba149beb-ef7e-4dea-8a21-b63b0e493a39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f06c69e01fa4e4f8ab8986b188ec125_I20230331" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjEtMS0xLTEtMTEyMjkx_4f79b2e0-b0cf-4cef-b3c4-ecafa66e7c2b">24,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc9662c059e4bda801cb06360c4c046_I20230331" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjEtMy0xLTEtMTEyMjkx_8f0a6ba1-1714-4a8b-9986-abd68e02e499">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4517f24d47284d07aec33cb915f14ec9_I20230331" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjEtNS0xLTEtMTEyMjkx_fff70e89-abfa-4042-be14-153b68b2d919">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97bd4045255248b7a6ad2e2738cf4991_I20230331" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjEtNy0xLTEtMTEyMjkx_72421364-ed98-4c7a-b116-71f5caed7c24">24,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjMtMC0xLTEtMTEyMjkx_5523e65b-55dc-41c6-8709-df1a94648036">Accrued liabilities</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75c1ba3ea0845429dc5b1f441156886_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjMtMS0xLTEtMTEyMjkx_67fca38c-6ba1-4aa8-8cf0-ecdc65e97d48">2,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib014b4c6ffba42ecba26116f0b36d255_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjMtMy0xLTEtMTEyMjkx_52cd584a-8df0-4a50-bdeb-d6c89e07b2a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b55b633207e4c77a409427f88b494ae_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjMtNS0xLTEtMTEyMjkx_6615a824-0750-4e39-977b-d7e4a5de6d40">2,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied46de2d5cdb4f3287c1a51b1fda5f2f_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjMtNy0xLTEtMTEyMjkx_86a252e0-c5c1-4635-b783-657d3348400a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjQtMC0xLTEtMTIwNzE1_62efbfc3-1b08-43d2-b4de-0ebc769246ce">Other long-term liabilities</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e83be36630a4315aa61f938a15ed93c_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjQtMS0xLTEtMTEyMjkx_6b517775-780f-400c-b44d-636a8ea88bd4">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73643551546848cf924dc74653a7ab10_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjQtMy0xLTEtMTEyMjkx_e6e4edb4-6ef4-4ead-a653-d70172b75a1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff489ffd4484b05893332bc86bb5da4_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjQtNS0xLTEtMTEyMjkx_017789c5-605e-4770-a038-0fdb6f24ec8f">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id49337d44fff49da85c4746c25de0cfa_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjQtNy0xLTEtMTEyMjkx_04b57c85-f2a4-4147-9015-47fad2ce07cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic88a0d75c4324efe964e2e67a57a9956_I20230331" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjctMS0xLTEtMTEyMjkx_d6405878-624d-41dc-ac71-bd5bca7c9129">27,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66bd23e34133401591e928370dd3aae3_I20230331" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjctMy0xLTEtMTEyMjkx_c2cb35bb-d7bc-45cb-9654-504d9be88905">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec00d0e32787463fa02c2beb859e4088_I20230331" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjctNS0xLTEtMTEyMjkx_a24f4f18-2e87-41c2-8cee-e3fe38424580">2,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a628145a154dd4b608eda8fef5317b_I20230331" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjctNy0xLTEtMTEyMjkx_3c957b4a-c0d4-4713-afac-88a7cae63a06">24,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:center"><ix:continuation id="i246b443861cb4452b40c88ff547f4e14"><ix:continuation id="i4cdb850dab494ad480973b2d8e06f40b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2421f17f678943faa6f08a99e77342d2_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNC0xLTEtMS0xMTIyOTE_2cfa484e-e509-4501-8fee-b76c15273cf4">2,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51723405dbf94ff6823b0cfe6cd7a8f4_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNC0zLTEtMS0xMTIyOTE_4629f4fb-b516-4d48-8e94-d2826fb3a941">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb5b0d8817344f0eb58f57ded4f69d76_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNC01LTEtMS0xMTIyOTE_b602ea4b-0662-4b1a-9dc6-0512ec6d4777">2,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic825a9792c0c4bb3932a15194babe436_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNC03LTEtMS0xMTIyOTE_9a4fdbb8-e416-4978-a329-870c83ff3f2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6739e8ed9384ce4a0f3da9edab4d0ef_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNS0xLTEtMS0xMjA3NjI_f20ccb98-0a5f-4d3b-a846-f395d8ff6593">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13ee862b60df4a8182330aca4aabe86e_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNS0zLTEtMS0xMjA3NzA_b763cf42-e868-44a5-a722-78a724491ec5">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1abf01d00d48a5868de1e621f7cae5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNS01LTEtMS0xMjA3NzA_af918f3a-ef95-4f24-a51b-189d1fee3f1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c34b949f374399ba510212f11790c7_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNS03LTEtMS0xMjA3NzA_a65c1fe3-5df7-4d29-b272-62209f51e94f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d76827e236145bfa0a5caf2d4857d5c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNi0xLTEtMS0xMjA4NzQ_fb5bad47-b2f0-4e0a-8f07-27103bca383b">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a5293ddbff54b3d8db5d3716b9193fb_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNi0zLTEtMS0xMjA4NzQ_453955ba-2a67-4dd2-aaed-055d4c8e1352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5222d9d8a2924eddae7d0a5f40052ea5_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNi01LTEtMS0xMjA4NzQ_e20f41d8-4995-40e7-b6c5-56d0e53e91ae">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56274c1ac4014325b45d30ae7ad441aa_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNi03LTEtMS0xMjA4NzQ_aef440c4-2261-454a-b8b7-b6c8f393abde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNS0xLTEtMS0xMTIyOTE_aa927d35-9449-4af7-9c8b-d45b125ffc6e">516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2d0c73330a84bb0bf6431fe51b3afda_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNS0zLTEtMS0xMTIyOTE_edcf207c-028d-490a-814d-cf1e689630ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia30501eaa28f4a95a929526d40bc93df_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNS01LTEtMS0xMTIyOTE_3e00f959-763b-4244-8727-d2f087988df1">516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42bd702cc395459f81747c0a9d029d07_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNS03LTEtMS0xMTIyOTE_304be1d7-86d3-4e3b-a833-bebb97e10edf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forwards:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNy0wLTEtMS0xMTIyOTE_50321293-4bf5-432f-9a23-856af180772d">Prepaid expenses and other current assets</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia089dfcea16a47c7a301086d94a998c0_I20221231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNy0xLTEtMS0xMTIyOTE_724a3914-44e4-445f-98fe-e9b529a7a0f1">4,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3032b40999034d9c8ace19cc47d82a6c_I20221231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNy0zLTEtMS0xMTIyOTE_8d6040f0-3250-4fde-98db-539c35904104">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3344b2eee9a439b99d11085a8bad5a2_I20221231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNy01LTEtMS0xMTIyOTE_c7308f45-c516-484e-8ce8-cb9a32c5862a">4,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i459536a397ec41e98471e9be9d5f85de_I20221231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNy03LTEtMS0xMTIyOTE_8eae4f0a-7134-47df-8dbc-d8f59b85a74c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e94d92e01474cfeb2beeaedbd0abe84_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTEtMS0xLTEtMTIwODcy_97ededae-cdef-46cc-9d2a-77527bb7f4c4">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0cf77942cd1443eacbf40c493fe858d_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTEtMy0xLTEtMTIwODcy_841021cd-35c5-4bdc-9f33-c86af85538f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6080af93170148688d13de3d59d12ab7_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTEtNS0xLTEtMTIwODcy_9b9572dd-cdaf-41f5-ba26-6afd6ab5fce8">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b13a58d0b3c4453995ec99b1cfe364a_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTEtNy0xLTEtMTIwODcy_30737d16-08e4-42e4-a1c9-4d952cfda249">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica1daf3e26514068beac02afe7124cc3_I20220331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTMtMS0xLTEtMTIwODcw_65d47aa5-389b-4a99-9702-533c89aeec16">28,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib414b19de28a44c7b4896fcc6b6b46e3_I20220331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTMtMy0xLTEtMTIwODcw_0d52b4b3-da14-4165-b656-3f91b58a4852">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab01ecb2b6ac4acc8ebcb12fdb8f8e51_I20220331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTMtNS0xLTEtMTIwODcw_9a9cd943-d597-494f-9cbf-3e9ea0127d28">28,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79e95f455b32497bbff95f508a232d72_I20220331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTMtNy0xLTEtMTIwODcw_ad730c5e-49b1-414c-b6a1-41976931485f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e94d92e01474cfeb2beeaedbd0abe84_I20220331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTQtMS0xLTEtMTIwODcw_4e59e122-d93c-4a05-bc11-8248e550ab0f">26,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0cf77942cd1443eacbf40c493fe858d_I20220331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTQtMy0xLTEtMTIwODcw_2f664d53-b35a-4310-822e-ab29271bbc9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6080af93170148688d13de3d59d12ab7_I20220331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTQtNS0xLTEtMTIwODcw_1fce36f3-f3c0-44d6-beae-d6c9c4569fa9">26,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b13a58d0b3c4453995ec99b1cfe364a_I20220331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTQtNy0xLTEtMTIwODcw_e9eac0a3-fe1d-4bcb-bfca-b507b2850b51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTAtMS0xLTEtMTEyMjkx_14c8cde8-c71e-4a28-999f-974d486569e4">64,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2d0c73330a84bb0bf6431fe51b3afda_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTAtMy0xLTEtMTEyMjkx_32dfb651-069a-4739-950f-295fd4ca4228">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia30501eaa28f4a95a929526d40bc93df_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTAtNS0xLTEtMTEyMjkx_46a95b0b-e0ee-4262-9bc3-08d419b660c1">63,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42bd702cc395459f81747c0a9d029d07_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTAtNy0xLTEtMTEyMjkx_6c454e64-c3c8-4eba-9786-0c6ec09e7b6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib903abaa897142e6870b5c981c0190f9_I20221231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTMtMS0xLTEtMTEyMjkx_732f9c6b-3f99-46a7-96d2-c16153374ab1">25,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f553481cb44e628e33717df32e0afc_I20221231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTMtMy0xLTEtMTEyMjkx_c044242e-3eaa-4246-b7b5-c71df5ace894">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae888c38b8234f5abfc0397b9219a434_I20221231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTMtNS0xLTEtMTEyMjkx_41c2175e-2380-41d4-a7af-9309c8805599">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib538cde976ef4ac38c558a67c9a7b8c1_I20221231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTMtNy0xLTEtMTEyMjkx_fdb4bf38-f0b4-4d61-a7f2-3c0b40b61d65">25,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia089dfcea16a47c7a301086d94a998c0_I20221231" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMjQtMS0xLTEtMTIwNzUw_a4e1ccc1-a250-4a6e-a365-b82cd6fecedb">1,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3032b40999034d9c8ace19cc47d82a6c_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMjQtMy0xLTEtMTIwNzUy_55f6255d-bfdd-4fea-81f7-4ac8d6596832">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3344b2eee9a439b99d11085a8bad5a2_I20221231" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMjQtNS0xLTEtMTIwNzU3_76ba8dd6-00d6-4f08-a4db-1cb9424f2be5">1,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i459536a397ec41e98471e9be9d5f85de_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMjQtNy0xLTEtMTIwNzU5_b7bf1f50-4fad-4bd0-ba37-7ceca1d59505">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTgtMC0xLTEtMTEyMjkx_38c2c727-8408-4048-b07a-938ff12e83e6">Other long-term liabilities</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2300372e953438fb46cce4511c00fdf_I20221231" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTgtMS0xLTEtMTEyMjkx_bf0cd2df-04aa-4718-a6fd-1489da9bc67b">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i600c673eafe24f7a99360ebe80c6bd12_I20221231" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTgtMy0xLTEtMTEyMjkx_9afef98f-a1d3-4e24-b48d-273c0f6898ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24988b3dea184cdd8f48759556bc2274_I20221231" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTgtNS0xLTEtMTEyMjkx_06bd552d-da8b-4624-b45b-2c179cea615c">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89428e5fde134e38a53ca4bcdc2ca0ae_I20221231" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTgtNy0xLTEtMTEyMjkx_e8e35111-161b-4f8f-892b-96ccfb47a31c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc34907535374c3da7784002505ffd72_I20221231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTktMS0xLTEtMTEyMjkx_a1b19ced-67ca-47d0-9881-a87aea377de6">27,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00116957d0924008b381688d18b90256_I20221231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTktMy0xLTEtMTEyMjkx_71d8aa39-2f17-488f-bfc1-b3bd4efe93f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513c2936b35e4be19a4d05480a1af429_I20221231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTktNS0xLTEtMTEyMjkx_40c2f2a3-df4e-4c01-a5d5-6dd69f506826">2,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25f3594cd8a446f7810b2e62cde2b514_I20221231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTktNy0xLTEtMTEyMjkx_356cfca4-564a-4ceb-a56a-d49d24f44cbc">25,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10:  <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="icui:InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RleHRyZWdpb246YWNmN2MxNmIxN2FlNDM1MzhlZjI0MWZmMzA3ZjZiOGVfNDQxNg_10ca9b85-cbd8-48ae-ae5d-123b64d56dee" continuedAt="ifc3146ab59be48cfaa41edd2b9f33418" escape="true">Investment Securities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ifc3146ab59be48cfaa41edd2b9f33418" continuedAt="i7ccd565d0ccb4be38d0396acf23b56a8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Available-for-sale Securities</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our available-for-sale investment securities currently consist of short-term and long-term corporate bonds, short-term U.S. treasury securities and long-term government bonds and are considered &#8220;investment grade&#8221; and are carried at fair value. We assess our investment in available-for-sale debt securities for impairment each reporting period. If an unrealized loss exists, we determine whether any portion of the decline in fair value below the amortized cost basis is credit-related by reviewing several factors, including, but not limited to, the extent of the fair value decline and changes in the financial condition of the issuer. We record an impairment for credit-related losses through an allowance, limited to the amount of the unrealized loss. If we either intend to sell or it is more likely than not we will be required to sell the debt security before its anticipated recovery, any allowance is written off and the amortized cost basis is written down to fair value through a charge against net earnings. Unrealized gains and non-credit-related unrealized losses are recorded, net of tax, in other comprehensive income (loss). We did not have any investments in available-for-sale debt securities in unrealized loss positions as of March&#160;31, 2023 or December 31, 2022.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost of the debt securities are adjusted for the amortization of premiums computed under the effective interest method. Such amortization is included in interest expense, net in our condensed consolidated statements of operations. Realized gains and losses are accounted for on the specific identification method. There have been <ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-6" name="us-gaap:GainLossOnSaleOfInvestments" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RleHRyZWdpb246YWNmN2MxNmIxN2FlNDM1MzhlZjI0MWZmMzA3ZjZiOGVfNDQyMw_d368a622-289e-4b3e-b277-598532759755">no</ix:nonFraction> realized gains or losses </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i7ccd565d0ccb4be38d0396acf23b56a8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the disposal of these investments. The scheduled maturities of the debt securities are between 2022 and 2024. All short-term investment securities are callable within one year.  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RleHRyZWdpb246YWNmN2MxNmIxN2FlNDM1MzhlZjI0MWZmMzA3ZjZiOGVfNDQyMA_feb0a646-c373-4aea-8bba-8b0577988608" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.301%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March&#160;31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding <br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbfe2784d674d028ea89497f6d11184_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMi0xLTEtMS0xMTIyOTE_72b485ca-caec-4191-b694-e5e8380d5696">1,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc93354f6f64dd887efe82a4a92a59c_D20230101-20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMi0zLTEtMS0xMTIyOTE_4adaa28a-bd62-45e4-bc7e-33cea773cb3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbfe2784d674d028ea89497f6d11184_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMi01LTEtMS0xMTIyOTE_eb0f3bed-838b-4a22-9e25-ea35973297e2">1,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb57c90226d949769fdebc2b3c886a84_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMy0xLTEtMS0xMTIyOTE_68d90ed4-a836-4445-bedd-7baae46d275e">1,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25eb893c69d64ec8916421287d40d7dc_D20230101-20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMy0zLTEtMS0xMTIyOTE_26492e94-a505-439f-be1f-7b890f49bcfb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb57c90226d949769fdebc2b3c886a84_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMy01LTEtMS0xMTIyOTE_78c17e61-fb78-45dc-a2b6-d9be8e7d7ef1">1,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id251cb4f372c42deb49b98c56f091af2_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfNC0xLTEtMS0xMjA4NzY_4fbf281f-3211-481a-8ecf-2651c7e69884">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82ea280e29894ab9a463eb6fa58461c3_D20230101-20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfNC0zLTEtMS0xMjA4NzY_4c6fb0dd-5b1a-42e0-9533-0419c5e937f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id251cb4f372c42deb49b98c56f091af2_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfNC01LTEtMS0xMjA4NzY_1472568e-53af-490e-a682-d077c72f1607">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfNi0xLTEtMS0xMTIyOTE_9b038477-ff4e-4650-a347-4e469bb656f6">3,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfNi0zLTEtMS0xMTIyOTE_fbc21b63-7de4-4ead-9eb0-dcc31e55e3d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfNi01LTEtMS0xMTIyOTE_81ba4bcc-1adf-42d5-8d7a-e8eb6e73a93b">3,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding<br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedc9227893204f5fb8adfe568b84f804_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTAtMS0xLTEtMTEyMjkx_56a3a186-da47-443b-b207-bab16d651f04">2,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e3979b3c1734fa6bf0c57b31b79d949_D20220101-20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTAtMy0xLTEtMTEyMjkx_30cee687-7276-4776-9d22-be58495ac9c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedc9227893204f5fb8adfe568b84f804_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTAtNS0xLTEtMTEyMjkx_76faff4b-c1f1-4603-b721-53d642f73b67">2,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6739e8ed9384ce4a0f3da9edab4d0ef_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTEtMS0xLTEtMTIwODgw_a7aa9f2d-c140-4650-b449-ab98405935c4">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86423b3966d94fd191b5c9416094b60c_D20220101-20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTEtMy0xLTEtMTIwODgw_3700e6b1-3a08-4478-9cb9-97603653434e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6739e8ed9384ce4a0f3da9edab4d0ef_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTEtNS0xLTEtMTIwODgw_0fa7d538-ed0d-4755-bc08-3a8d402486ba">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic165dae88e744691bcce8d47fec9dbdb_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTItMS0xLTEtMTIwODc4_221b7276-3f9d-4336-b5ed-25c19304d978">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id77de8d44cca4f389a04a8b86d7c1607_D20220101-20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTItMy0xLTEtMTIwODc4_d4f70fb9-4120-4a14-bd41-f145742ab65f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic165dae88e744691bcce8d47fec9dbdb_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTItNS0xLTEtMTIwODc4_bb72682d-95c6-4085-95d5-a421b3f68aed">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedc9227893204f5fb8adfe568b84f804_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTEtMS0xLTEtMTEyMjkx_fa81d186-c2bb-448d-ba78-e9f05691d310">516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e3979b3c1734fa6bf0c57b31b79d949_D20220101-20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTEtMy0xLTEtMTEyMjkx_4b5f655e-3663-4d16-86a6-a8e8bbe89407">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedc9227893204f5fb8adfe568b84f804_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTEtNS0xLTEtMTEyMjkx_4b619373-c3be-4f90-9221-e518ec478c32">516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTItMS0xLTEtMTEyMjkx_f4b2e605-5533-475b-b7ee-689516053d8a">4,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96b4b6ca22c9441d8fd7c31c022b4666_D20220101-20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTItMy0xLTEtMTEyMjkx_7ec27726-3b86-4ded-94bc-917ad16db857">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTItNS0xLTEtMTEyMjkx_fd928f41-e1f9-4296-9422-d56cb2a971a8">4,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Non-Marketable Equity Securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, we acquired an approximate <ix:nonFraction unitRef="number" contextRef="i579e1337f5894b6e9f97f1483abeb705_I20230331" decimals="1" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RleHRyZWdpb246YWNmN2MxNmIxN2FlNDM1MzhlZjI0MWZmMzA3ZjZiOGVfMjEzOA_f6b9a7d5-a0eb-4825-89b1-c8d45e72d7f0">20</ix:nonFraction>% non-marketable equity interest in a nonpublic company and entered into a three-year distribution agreement where we have the exclusive rights to market, sell and distribute the company's products in exchange for a cash payment of $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RleHRyZWdpb246YWNmN2MxNmIxN2FlNDM1MzhlZjI0MWZmMzA3ZjZiOGVfMjM3MQ_2da434b9-df64-41cd-9ef3-aef1f1b1f991">3.3</ix:nonFraction>&#160;million. In addition, we were granted an exclusive license for all of the seller's intellectual property. At the expiration of the distribution agreement we have the right but not the obligation to acquire the remaining interest in the business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the equity method of accounting for investments when we determine we have a significant influence, but not a controlling interest in the investee. We determine whether we have significant influence by considering key factors such as ownership interest, representation on the board of directors, participation in policy making decisions, business relationship and material intra-entity transactions, among other factors. Our equity method investment is reported at cost and adjusted each period for our share of the investee's income or (loss) and dividend paid, if any. We eliminate any intra-entity profits to the extent of our beneficial interest. We record our share of the investee's income or (loss) on a one quarter lag. We report our proportionate share of the investee's income or (loss) resulting from this investment in other income, net in our condensed consolidated statements of operations. The carrying value of our equity method investment is reported in other assets on our condensed consolidated balance sheets (see Note 11: Prepaid Expenses and Other Current Assets and Other Assets). We assess our equity method investments for impairment on an annual basis or whenever events or circumstances indicate that the carrying value of the investment may not be recoverable. Our recorded share of the investee's loss was not material for the three months ended March&#160;31, 2023 and 2022. We did not receive any dividend distributions from this investment during the three months ended March&#160;31, 2023 and 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RleHRyZWdpb246YWNmN2MxNmIxN2FlNDM1MzhlZjI0MWZmMzA3ZjZiOGVfNDQyNQ_68db19ba-65d1-42d4-9f15-001d7df858ce" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-marketable equity method investment consists of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.839%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOjYzYWQ1ZjgxNWEyMzRkZmE5ZmQyMzVjZWI2NjY3MmM4L3RhYmxlcmFuZ2U6NjNhZDVmODE1YTIzNGRmYTlmZDIzNWNlYjY2NjcyYzhfMi0yLTEtMS0xMTIyOTE_0f9ea671-1c4f-4370-bd80-cdcf3b576402">3,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOjYzYWQ1ZjgxNWEyMzRkZmE5ZmQyMzVjZWI2NjY3MmM4L3RhYmxlcmFuZ2U6NjNhZDVmODE1YTIzNGRmYTlmZDIzNWNlYjY2NjcyYzhfMi00LTEtMS0xMTIyOTE_4ca0cf7e-60e2-4ed7-8ea8-75ce1383d140">3,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="if1f54ab03e0c44ba84b642c022c86fca_64"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="icui:PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RleHRyZWdpb246Yzk3ZTRlMDQxMzFlNGM4YjlkMzJlMzE1Mzk0OWQ3MWJfMjI1_0484c790-b64f-426c-baaa-ac4909783cda" continuedAt="iea1fb732b8ed418aaa2b3d7563d2abf7" escape="true">Prepaid Expenses and Other Current Assets and Other Assets</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iea1fb732b8ed418aaa2b3d7563d2abf7"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RleHRyZWdpb246Yzk3ZTRlMDQxMzFlNGM4YjlkMzJlMzE1Mzk0OWQ3MWJfMjE4_78d9393c-0182-4aa9-839f-49cc29dad5ac" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.839%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses and receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:OtherPrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMi0yLTEtMS0xMTIyOTE_2cf453d1-324c-4e4e-a5db-5d3ab80babfc">26,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:OtherPrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMi00LTEtMS0xMTIyOTE_acde3c6e-bec7-44cd-8236-807271464944">21,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid vendor expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="icui:PrepaidVendorExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMy0yLTEtMS0xMTIyOTE_5d34f77e-472d-4251-b0fa-181b63b1b42d">1,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="icui:PrepaidVendorExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMy00LTEtMS0xMTIyOTE_40ec7063-c12c-4e08-b4e1-d75238562f82">3,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:DeferredCostsAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfNC0yLTEtMS0xMTIyOTE_2cc70ff4-4d0c-43d7-a2fd-7985dd24b083">3,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:DeferredCostsAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfNC00LTEtMS0xMTIyOTE_717f71ca-a062-49aa-805a-f9fbfad42432">2,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance and property taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="icui:Prepaidinsuranceandpropertytaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfNS0yLTEtMS0xMTIyOTE_dbb813c8-ddb0-445c-9cf3-b5c74b0a23b9">10,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="icui:Prepaidinsuranceandpropertytaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfNS00LTEtMS0xMTIyOTE_6a9990ea-69a7-46af-88f0-3fb7b454af44">16,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT/GST receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="icui:Prepaidothertaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfNi0yLTEtMS0xMTIyOTE_1ab37ac3-b32c-491b-a1d6-82721be377ce">3,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="icui:Prepaidothertaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfNi00LTEtMS0xMTIyOTE_30dc071d-e410-4105-acb6-6735a166145a">3,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax charge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="icui:Deferredtaxcharge" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfNy0yLTEtMS0xMTIyOTE_320ce422-2592-4598-bbda-9b2a3b9d855a">3,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="icui:Deferredtaxcharge" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfNy00LTEtMS0xMTIyOTE_68a6ed8c-91ed-4f71-8954-2d7e7db5ad9f">3,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fef98ce304042888df7d376a7476354_I20230331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfOC0yLTEtMS0xMTIyOTE_85a3f4bc-5937-45d9-b7d6-1495e9af7bc6">7,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia69844c22aaf40cbb2a42781ead60e61_I20221231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfOC00LTEtMS0xMTIyOTE_e5c82c8f-9a47-4929-a900-0f21d3f96eab">4,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fef98ce304042888df7d376a7476354_I20230331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfOS0yLTEtMS0xMTIyOTE_4c128b2d-4f0d-41b1-bf7b-ec5529051713">25,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia69844c22aaf40cbb2a42781ead60e61_I20221231" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfOS00LTEtMS0xMTIyOTE_ac5e95a7-39c0-45d2-a857-35a8431d690a">28,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:DepositAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMTEtMi0xLTEtMTEyMjkx_32314530-d0d1-405e-98da-5f90aff327c6">1,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:DepositAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMTEtNC0xLTEtMTEyMjkx_1f21af23-edd9-4f96-84b7-381377c38d49">1,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMTItMi0xLTEtMTEyMjkx_37d0e562-4fe7-42cf-8143-6729f05c18ee">3,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMTItNC0xLTEtMTEyMjkx_a568a2f2-d0c4-4812-852d-80598e1899b3">3,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMTMtMi0xLTEtMTEyMjkx_3eafa8b7-61e0-458c-907c-58af473b75b4">87,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMTMtNC0xLTEtMTEyMjkx_83e13409-37d4-4aed-87ad-d8f6fe805635">88,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RleHRyZWdpb246Yzk3ZTRlMDQxMzFlNGM4YjlkMzJlMzE1Mzk0OWQ3MWJfMjIx_e01ff0f7-26f3-447d-a0fe-da46e783fee4" escape="true"><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.839%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pump lease receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfMi0yLTEtMS0xMTIyOTE_c916c0d6-86e5-4cf9-9031-4dec338aa1dd">28,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfMi00LTEtMS0xMTIyOTE_b4ad03cc-d069-42e5-896d-3502c4a30d22">27,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spare parts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="icui:SpareParts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfMy0yLTEtMS0xMTIyOTE_ab81baef-c20c-4e3b-acea-33b24853f252">40,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="icui:SpareParts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfMy00LTEtMS0xMTIyOTE_d0015f23-16d2-43e5-ae8f-805070b4b456">38,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfNC0yLTEtMS0xMTIyOTE_84b36bb3-ab56-4188-a5df-6a136a80a0fc">3,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfNC00LTEtMS0xMTIyOTE_b85fd41b-7adb-4c27-8887-d60bc583e9cc">3,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfNS0yLTEtMS0xMTIyOTE_da4728b6-0164-461f-abf3-136d52c29983">4,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfNS00LTEtMS0xMTIyOTE_56d6f854-9600-4bc8-a0f2-a9366e0503de">5,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfNi0yLTEtMS0xMTIyOTE_14c692dc-7410-4955-a45f-2c5bfef186b1">2,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfNi00LTEtMS0xMTIyOTE_1bfedeb4-bd6f-4677-8546-cfebd10ee12f">2,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcc5cb934c484085e4c9d001608c4b_I20230331" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfNy0yLTEtMS0xMTIyOTE_0a5e9f57-f900-4dd8-8ac5-e8f5d75f1354">19,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i631e83ee61b74e3abeaa5ad6e7bab2b1_I20221231" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfNy00LTEtMS0xMTIyOTE_0099ee44-b183-4a76-9a5a-e7a171041a96">26,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfOS0yLTEtMS0xMTIyOTE_4d291371-fbb4-4d4c-aa95-225afd7ea73d">2,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfOS00LTEtMS0xMTIyOTE_591e39db-dd28-4b7e-a806-ecb9b27ecd52">2,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfMTAtMi0xLTEtMTEyMjkx_542bb8fe-fe06-4fa1-8a5b-86d3b719cd86">101,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfMTAtNC0xLTEtMTEyMjkx_f74f18ca-ee60-4c17-9033-371223e54674">105,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12:  <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RleHRyZWdpb246ODIyNGRjMjA2YjcxNDM5NzhkNjI0YjZjOTliNzY4NDFfNTYz_e53d5684-7363-4fb8-acfd-e0ed82e8b0b1" continuedAt="i039834b7d8294aa1be078d5e92fed463" escape="true">Inventories</ix:nonNumeric></span></div><ix:continuation id="i039834b7d8294aa1be078d5e92fed463"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method. Inventory costs include material, labor and overhead related to the manufacturing of our products. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RleHRyZWdpb246ODIyNGRjMjA2YjcxNDM5NzhkNjI0YjZjOTliNzY4NDFfNTcx_80566e6f-ddfa-4ff8-a056-c6c1eb8836b5" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RhYmxlOjEwNjQ5NjFlYTk0NTQ5NWI5YzQ2OGU1MDIwYWRiOGYxL3RhYmxlcmFuZ2U6MTA2NDk2MWVhOTQ1NDk1YjljNDY4ZTUwMjBhZGI4ZjFfMi0xLTEtMS0xMTIyOTE_5e5e3165-ac0d-4fbe-a283-42eb8615509e">317,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RhYmxlOjEwNjQ5NjFlYTk0NTQ5NWI5YzQ2OGU1MDIwYWRiOGYxL3RhYmxlcmFuZ2U6MTA2NDk2MWVhOTQ1NDk1YjljNDY4ZTUwMjBhZGI4ZjFfMi0zLTEtMS0xMTIyOTE_b8858946-d2f1-43f0-8fd5-7157568f3a8f">286,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RhYmxlOjEwNjQ5NjFlYTk0NTQ5NWI5YzQ2OGU1MDIwYWRiOGYxL3RhYmxlcmFuZ2U6MTA2NDk2MWVhOTQ1NDk1YjljNDY4ZTUwMjBhZGI4ZjFfMy0xLTEtMS0xMTIyOTE_945f91b5-e582-4176-983b-2277bc909a0b">73,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RhYmxlOjEwNjQ5NjFlYTk0NTQ5NWI5YzQ2OGU1MDIwYWRiOGYxL3RhYmxlcmFuZ2U6MTA2NDk2MWVhOTQ1NDk1YjljNDY4ZTUwMjBhZGI4ZjFfMy0zLTEtMS0xMTIyOTE_4056ae76-a53e-4b5a-875c-83d9cfceb6b2">73,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RhYmxlOjEwNjQ5NjFlYTk0NTQ5NWI5YzQ2OGU1MDIwYWRiOGYxL3RhYmxlcmFuZ2U6MTA2NDk2MWVhOTQ1NDk1YjljNDY4ZTUwMjBhZGI4ZjFfNC0xLTEtMS0xMTIyOTE_a175da1f-3e05-4bb5-860b-11765826c49b">356,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RhYmxlOjEwNjQ5NjFlYTk0NTQ5NWI5YzQ2OGU1MDIwYWRiOGYxL3RhYmxlcmFuZ2U6MTA2NDk2MWVhOTQ1NDk1YjljNDY4ZTUwMjBhZGI4ZjFfNC0zLTEtMS0xMTIyOTE_72242301-f9b6-4269-aded-238deee622fa">335,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RhYmxlOjEwNjQ5NjFlYTk0NTQ5NWI5YzQ2OGU1MDIwYWRiOGYxL3RhYmxlcmFuZ2U6MTA2NDk2MWVhOTQ1NDk1YjljNDY4ZTUwMjBhZGI4ZjFfNS0xLTEtMS0xMTIyOTE_b3794eff-76ae-4cae-a58d-8cea5317611f">747,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RhYmxlOjEwNjQ5NjFlYTk0NTQ5NWI5YzQ2OGU1MDIwYWRiOGYxL3RhYmxlcmFuZ2U6MTA2NDk2MWVhOTQ1NDk1YjljNDY4ZTUwMjBhZGI4ZjFfNS0zLTEtMS0xMTIyOTE_a12bce29-be6e-408b-b2e8-248446f336f8">696,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="if1f54ab03e0c44ba84b642c022c86fca_70"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RleHRyZWdpb246ZDBiMjU0MDIxMzI4NGJlYWE4NGUzMjBjYTY5MDAyYTlfNjg3_f53d55c5-0cee-4888-b394-3b7beac3276b" continuedAt="icd3fdb30e4734ed19ec5e1a1a62d4ccc" escape="true">Property, Plant and Equipment</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="icd3fdb30e4734ed19ec5e1a1a62d4ccc" continuedAt="i3fa3d92208b34b4fa664c23e43183261"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RleHRyZWdpb246ZDBiMjU0MDIxMzI4NGJlYWE4NGUzMjBjYTY5MDAyYTlfNjky_ffe1e99c-6665-4ab5-9f5b-b114ddf48aed" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consists of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfMi0xLTEtMS0xMTIyOTE_efbb65ab-9f6e-4831-aa1b-bbbdc4d56b95">430,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfMi0zLTEtMS0xMTIyOTE_179e62d8-d272-413a-824c-408aeb9b7501">414,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, building and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic24eeaf2cdd54ba28cf13e1eed409bf3_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfMy0xLTEtMS0xMTIyOTE_ea89c9aa-6d7c-4cfc-ae41-d28b9bbab465">275,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie470f6c922764b86925b02b2d25bd068_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfMy0zLTEtMS0xMTIyOTE_2cde25cf-622d-47cd-aa9e-08af5b45b86c">274,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a11824ed414a45824aa3f42692576a_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfNC0xLTEtMS0xMTIyOTE_62048b3b-3ecf-47f8-afcd-9e2c5cedee14">77,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8748d9089ac04b8bb47719b0717b5a2b_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfNC0zLTEtMS0xMTIyOTE_00a8a00a-acf6-4be4-a39a-0e4ddf3a5cd4">77,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed218cedf4f4e30aacfc291c713a4ff_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfNS0xLTEtMS0xMTIyOTE_84f92a13-167a-4000-aea9-b6aad7db09b8">119,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d4e73ec88b842f7b49cf0a4ba9fa984_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfNS0zLTEtMS0xMTIyOTE_d33bdd8a-4069-4f63-b02d-e40c599d60b0">115,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfNi0xLTEtMS0xMTIyOTE_007a76d1-44a7-4f33-b1cd-e03ad37b56a1">30,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfNi0zLTEtMS0xMTIyOTE_32a6660a-c8ee-4b88-b005-da008e5157f7">29,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments placed with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc8a01c792a4c0cba943cbaa9683dc5_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfNy0xLTEtMS0xMTIyOTE_455da63b-eccd-409e-b146-907af43e21d5">102,666</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99bbc561eaf74c0bb03cf3b2367770b5_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfNy0zLTEtMS0xMTIyOTE_f34b60d0-ee29-42e1-8f09-8230409882ef">98,481</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfOC0xLTEtMS0xMTIyOTE_5cf47f12-74c0-4f0d-ae34-4c859d5bd44c">138,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfOC0zLTEtMS0xMTIyOTE_aaa273f0-af66-4e8b-b098-efcad75cc6e1">152,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfOS0xLTEtMS0xMTIyOTE_d9f8df83-50e1-4a59-a27f-bb5d004aa220">1,174,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfOS0zLTEtMS0xMTIyOTE_fa7a3091-6be6-4475-9cf5-9d9d73a2d9cc">1,162,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfMTAtMS0xLTEtMTEyMjkx_0e0143bb-6240-4d9b-861d-e9e73690017e">550,432</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfMTAtMy0xLTEtMTEyMjkx_4742a091-2871-494b-b824-116162ca818a">526,444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfMTEtMS0xLTEtMTEyMjkx_b369ce5e-883f-40e2-a9cd-725270ba51bd">624,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfMTEtMy0xLTEtMTEyMjkx_a496fec1-804a-49ec-9694-ebfd93be34f8">636,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Instruments placed with customers consist of drug-delivery and monitoring systems placed with customers under operating leases.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3fa3d92208b34b4fa664c23e43183261">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RleHRyZWdpb246ZDBiMjU0MDIxMzI4NGJlYWE4NGUzMjBjYTY5MDAyYTlfMzEz_907cffa1-619d-4c76-b552-3015fde0d451">23.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RleHRyZWdpb246ZDBiMjU0MDIxMzI4NGJlYWE4NGUzMjBjYTY5MDAyYTlfMzIw_a32893f7-6137-4a7b-a466-6bf0666829ef">21.4</ix:nonFraction>&#160;million for the three months ended March&#160;31, 2023 and 2022, respectively.</ix:continuation> </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14:  <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RleHRyZWdpb246ZjVkYjI1OWZiZjk0NDczNTliNjRiYWE5MzNkZDYwZTBfMTU0Mw_0323ae8a-5ebb-43b8-b2d6-6e3a00c0aeaf" continuedAt="id4a327763288449e8de949ab7aebe9f4" escape="true">Goodwill and Intangible Assets, Net</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id4a327763288449e8de949ab7aebe9f4" continuedAt="i2a009b508418471caa4008c567b1807d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RleHRyZWdpb246ZjVkYjI1OWZiZjk0NDczNTliNjRiYWE5MzNkZDYwZTBfMTUzMw_f31ee35e-cefe-4562-abac-31d400001ab0" continuedAt="ic444eb386387460a9e2fcbe10a84ed22" escape="true">The following table presents the changes in the carrying amount of our goodwill (in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:5pt"><ix:continuation id="ic444eb386387460a9e2fcbe10a84ed22"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjk4YTc0YmUzZDEzZDRiNTlhNzFkYzZiYTIyZmU1MzU1L3RhYmxlcmFuZ2U6OThhNzRiZTNkMTNkNGI1OWE3MWRjNmJhMjJmZTUzNTVfMS0yLTEtMS0xMTIyOTE_dfcc8ca9-5a7a-47f6-a7da-ff8931ad936a">1,449,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjk4YTc0YmUzZDEzZDRiNTlhNzFkYzZiYTIyZmU1MzU1L3RhYmxlcmFuZ2U6OThhNzRiZTNkMTNkNGI1OWE3MWRjNmJhMjJmZTUzNTVfNC0yLTEtMS0xMTIyOTE_4137f72e-5ddb-4cc6-9581-2f781977df95">13,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjk4YTc0YmUzZDEzZDRiNTlhNzFkYzZiYTIyZmU1MzU1L3RhYmxlcmFuZ2U6OThhNzRiZTNkMTNkNGI1OWE3MWRjNmJhMjJmZTUzNTVfNS0yLTEtMS0xMTIyOTE_d1d7e146-9ecc-4afc-8823-07704a04c8f0">1,462,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RleHRyZWdpb246ZjVkYjI1OWZiZjk0NDczNTliNjRiYWE5MzNkZDYwZTBfMTUzNQ_1ce3056e-0f2b-4e67-b9f6-0c9b8f56f719" continuedAt="i2671e7c2101c4eb9898a35959b35b2e2" escape="true">Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i2a009b508418471caa4008c567b1807d" continuedAt="i1835d68c37e54a3a8ba9e8f9e099cdc0"><ix:continuation id="i2671e7c2101c4eb9898a35959b35b2e2"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.362%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life&#160;in&#160;Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i759eb770637645338c5cb3c69ad883ed_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMi0yLTEtMS0xMTIyOTE_4934a6ad-7715-457d-8db4-c7d5c2cdb19a">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae7fd56151f4362ba49944b6babf4d5_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMi00LTEtMS0xMTIyOTE_9927d8ad-34d6-4bb9-bbe8-4f354781c376">30,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae7fd56151f4362ba49944b6babf4d5_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMi02LTEtMS0xMTIyOTE_815d6e76-c3ce-4798-92a5-3eedd92774bb">19,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae7fd56151f4362ba49944b6babf4d5_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMi04LTEtMS0xMTIyOTE_12589bf4-8141-4302-8710-e027f9520bf6">11,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9431fa63e03f4c39828dd6f5c2874b77_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMy0yLTEtMS0xMTIyOTE_afd718ad-abec-4309-bce8-6c8f64c3d8a6">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45abd7fc6cb041539c2690484538f401_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMy00LTEtMS0xMTIyOTE_f0ce16bd-8d6a-451f-b4a8-3641503652fa">10,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45abd7fc6cb041539c2690484538f401_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMy02LTEtMS0xMTIyOTE_bca40b42-0458-42b3-81c5-6a2df8d0e579">6,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45abd7fc6cb041539c2690484538f401_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMy04LTEtMS0xMTIyOTE_9aa71289-1f97-46bc-896a-1575ab778d9e">3,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaf6dc92130324e248c5bccc98319a7dd_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNC0yLTEtMS0xMTIyOTE_400ff4a7-e886-4e1b-bd8b-f686795bb1b1">8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ddae410dbb4da9b5bbab71cde7e71a_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNC00LTEtMS0xMTIyOTE_88c606e5-c67a-41bc-99cf-b2568ebfb7ef">550,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ddae410dbb4da9b5bbab71cde7e71a_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNC02LTEtMS0xMTIyOTE_d4d7a9b7-8531-48c5-9a31-05216b1192b1">118,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ddae410dbb4da9b5bbab71cde7e71a_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNC04LTEtMS0xMTIyOTE_a24d6fac-7b0c-4be6-b1f8-158432ba0665">432,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie5653183732045d196de37183c40dd18_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNS0yLTEtMS0xMTIyOTE_1cd43886-ee01-4045-a46e-bd544fb8b218">1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dee8f10404243bfb8a21715c53d5167_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNS00LTEtMS0xMTIyOTE_a3e7fc9d-1d91-4f4f-bd0c-a1924309b9da">5,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dee8f10404243bfb8a21715c53d5167_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNS02LTEtMS0xMTIyOTE_423c3ef3-db6c-49d3-a452-62b0d7f5a764">5,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dee8f10404243bfb8a21715c53d5167_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNS04LTEtMS0xMTIyOTE_4376a38a-b7c9-47ad-9468-c21e53190d3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie66a2d4ccf9f4810ab62a157c417c4a0_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNi0yLTEtMS0xMTIyOTE_877440dc-ad29-4418-8114-bfa90c62c463">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd805b98cb0e420da9a33f629e95ab71_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNi00LTEtMS0xMTIyOTE_ae0f29ec-9e78-470d-9f8d-76487d463f36">18,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd805b98cb0e420da9a33f629e95ab71_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNi02LTEtMS0xMTIyOTE_d27356e0-8e3f-449f-b2b2-277ddf38ab72">6,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd805b98cb0e420da9a33f629e95ab71_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNi04LTEtMS0xMTIyOTE_0b54f35b-543a-479a-be5b-e6ed70078529">12,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i79338c5b72624f9e86c8250b5030dbc1_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNy0yLTEtMS0xMTIyOTE_1a56a53a-1447-45bd-94fb-7af4c6cdcb0e">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931f544d5844a66997a310a1d04e1f4_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNy00LTEtMS0xMTIyOTE_97978ed2-37fc-45c2-80e1-97c5b5ab37e2">584,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931f544d5844a66997a310a1d04e1f4_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNy02LTEtMS0xMTIyOTE_0bb1c3d5-0287-4675-a866-bc34287c9434">123,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie931f544d5844a66997a310a1d04e1f4_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNy04LTEtMS0xMTIyOTE_cfe9881d-f143-4594-946f-cb65533db639">461,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4325a768bae8472fb7bfb255f0e35276_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfOC0yLTEtMS0xMTIyOTE_6b16473c-8cfd-4bd4-98af-b38290aa9bf1">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb7e987c2bb9440db23dae317f15ad47_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfOC00LTEtMS0xMTIyOTE_3b9c0f7e-43ae-4133-8608-caa7641b8fc4">9,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb7e987c2bb9440db23dae317f15ad47_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfOC02LTEtMS0xMTIyOTE_735eeae4-36fc-48b1-a2fb-9edf612ffbd7">5,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb7e987c2bb9440db23dae317f15ad47_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfOC04LTEtMS0xMTIyOTE_d914fae4-e786-40be-8fad-bcd094bd6e2f">3,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfOS00LTEtMS0xMTIyOTE_307fa50f-bc21-450c-94af-d2483cd15844">1,209,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfOS02LTEtMS0xMTIyOTE_ffe8be40-914c-4163-86f9-d096e8a1209a">285,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfOS04LTEtMS0xMTIyOTE_b111db33-b5e4-40cb-a38e-6b5b1f62df24">924,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMTEtNC0xLTEtMTEyMjkx_77f51338-2c84-466e-a69b-7b68e2d0fb51">33,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMTEtOC0xLTEtMTEyMjkx_563ee444-aee7-4957-a256-811864eabcef">33,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMTMtNC0xLTEtMTEyMjkx_9b8eb8ec-98c3-4051-9f09-7f8f1fda82a4">1,242,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMTMtNi0xLTEtMTEyMjkx_03d2e529-be4f-434e-bfca-e57a78a4a61c">285,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMTMtOC0xLTEtMTEyMjkx_3851701e-f093-42a1-a7a2-8316915f2f98">957,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.362%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life in Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0f298d4ded0646038f7f4958576511b8_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMi0yLTEtMS0xMTIyOTE_b017d50d-870d-4233-83ba-06716e9ab427">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i179a00f6e8ed4a8eb5aab9eade675698_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMi00LTEtMS0xMTIyOTE_002e0915-73b0-44d5-88ee-c7e54bd3f8e2">29,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i179a00f6e8ed4a8eb5aab9eade675698_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMi02LTEtMS0xMTIyOTE_4ac06282-23a8-4781-a414-3aad5a43135e">18,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i179a00f6e8ed4a8eb5aab9eade675698_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMi04LTEtMS0xMTIyOTE_93f68428-b0d9-47fa-8d4c-5748e9d99181">11,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id0a7b4c978594fa7ac242ade5c6e7a65_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMy0yLTEtMS0xMTIyOTE_e6223103-0665-4f6d-b067-245ad1398d31">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369d015daca1416f8f0547c55b9d625b_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMy00LTEtMS0xMTIyOTE_9690846e-f268-42ec-8d21-a76969802a1b">10,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369d015daca1416f8f0547c55b9d625b_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMy02LTEtMS0xMTIyOTE_c14cce80-9f6d-4cc6-be44-181703e85507">6,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369d015daca1416f8f0547c55b9d625b_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMy04LTEtMS0xMTIyOTE_21bdaaa4-244e-4364-98d6-43c06c57f05d">3,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic041286ae4d64457a61d949e2a01e553_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNC0yLTEtMS0xMTIyOTE_2ed113b4-4e24-481c-99c7-2a914aa1b7c1">8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31355a5a0a34e42adb367500b2d5d1c_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNC00LTEtMS0xMTIyOTE_b32493b6-08c1-48aa-a60c-c07fdfdfdcca">546,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31355a5a0a34e42adb367500b2d5d1c_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNC02LTEtMS0xMTIyOTE_76f907bd-80f3-4519-ba2f-1f066fadcfc8">101,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31355a5a0a34e42adb367500b2d5d1c_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNC04LTEtMS0xMTIyOTE_a85d769e-8e79-42ca-b87e-a9f88401259a">445,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5119a978c7084a25a248c39ee1944803_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNS0yLTEtMS0xMTIyOTE_042ec9ae-9d8c-4541-8563-8e9e750c16c3">1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9faa2994ef5c4d8cb43ac97f50785f0e_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNS00LTEtMS0xMTIyOTE_12771316-3888-4a5f-9590-857809b93ae6">5,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9faa2994ef5c4d8cb43ac97f50785f0e_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNS02LTEtMS0xMTIyOTE_46c16af6-db82-49f4-a6eb-c0234aed757c">5,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9faa2994ef5c4d8cb43ac97f50785f0e_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNS04LTEtMS0xMTIyOTE_bc9d65d3-30b2-4ba8-a5e4-e2c046d8ce15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i92753141dc8f4c78b24dcbf4e0913b77_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNi0yLTEtMS0xMTIyOTE_70c017f0-2351-4a57-9cd4-4ebd19bf3b33">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba17e9a9dce424287c2e009d986cffd_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNi00LTEtMS0xMTIyOTE_40195036-a03a-4e5e-b375-fe85b86e6674">18,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba17e9a9dce424287c2e009d986cffd_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNi02LTEtMS0xMTIyOTE_ca96a10f-cf21-4aa3-8ef9-5ec0c7f8fecc">5,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba17e9a9dce424287c2e009d986cffd_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNi04LTEtMS0xMTIyOTE_ad0c6bd4-db9a-4ad3-8782-f751027659fc">12,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic2084d5b4c664907b48055fe916dc52e_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNy0yLTEtMS0xMTIyOTE_c4c469d0-9b5b-4b28-9e86-bad09008d5f9">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id56f1f6ec46947599bc7bfc1ffe9d195_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNy00LTEtMS0xMTIyOTE_099d2fcf-d9e8-4506-a021-566da0590ca8">583,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id56f1f6ec46947599bc7bfc1ffe9d195_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNy02LTEtMS0xMTIyOTE_87e974bf-dfb5-4451-9e5f-d6f4453fb79e">108,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id56f1f6ec46947599bc7bfc1ffe9d195_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNy04LTEtMS0xMTIyOTE_4bc3b73b-76dc-4d4d-be5e-b35b50e74e66">474,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i89af7b8cd3d0498cbb978e49c788ff06_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfOC0yLTEtMS0xMTIyOTE_b3f8888e-9ac3-403d-b645-933d6e2c6f3a">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74ff728885fb420389d379cc16b1717f_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfOC00LTEtMS0xMTIyOTE_e83289bf-8814-4254-b456-970488fb859d">9,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74ff728885fb420389d379cc16b1717f_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfOC02LTEtMS0xMTIyOTE_d4c3460c-ed59-44b2-8293-26cb4bd0ecc7">5,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74ff728885fb420389d379cc16b1717f_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfOC04LTEtMS0xMTIyOTE_7c95438b-eb41-4f68-93e9-970e4f807b31">3,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfOS00LTEtMS0xMTIyOTE_60f97eee-de5a-4e31-8fe3-2d6a763f693b">1,202,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfOS02LTEtMS0xMTIyOTE_2f4f5f78-697e-49a5-b082-e0b4b1fa5ccd">251,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfOS04LTEtMS0xMTIyOTE_1c05ac0f-e27c-4945-a5f3-898698a52c99">950,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMTEtNC0xLTEtMTEyMjkx_247e74c6-df16-43bf-9a54-5279c15156b5">31,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMTEtOC0xLTEtMTEyMjkx_f75ef94e-78e7-4a47-a40a-64628a93a2a2">31,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMTMtNC0xLTEtMTEyMjkx_3b933a80-34b4-47f3-b42e-c71dea1e760b">1,234,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMTMtNi0xLTEtMTEyMjkx_07aaa1a8-d7b1-4ebd-ae32-0fecd14861e9">251,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMTMtOC0xLTEtMTEyMjkx_fa96602c-cd9e-4a3b-b950-c0584d2bbf6f">982,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with definite lives are amortized on a straight-line basis over their estimated useful lives. During the three months ended March&#160;31, 2023 and 2022, intangible asset amortization expense was $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="INF" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RleHRyZWdpb246ZjVkYjI1OWZiZjk0NDczNTliNjRiYWE5MzNkZDYwZTBfMTA2OA_34e798e4-7163-4b32-887d-ddc787df9017">32.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="INF" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RleHRyZWdpb246ZjVkYjI1OWZiZjk0NDczNTliNjRiYWE5MzNkZDYwZTBfMTA3NQ_bbacfa9a-4bea-42ed-a4f0-87dbcc197cd2">31.7</ix:nonFraction> million, respectively.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RleHRyZWdpb246ZjVkYjI1OWZiZjk0NDczNTliNjRiYWE5MzNkZDYwZTBfMTU0Nw_fe8118d2-3a71-4fe5-83b5-b29d6227cd55" continuedAt="i6e0a43585e0c4e0dbc2212ca4273fde3" escape="true">As of March&#160;31, 2023 estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div style="margin-top:5pt"><ix:continuation id="i1835d68c37e54a3a8ba9e8f9e099cdc0"><ix:continuation id="i6e0a43585e0c4e0dbc2212ca4273fde3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjE2ODkyYThmMWMwZDQ5MTdiNGNhOGU2MzNjZjFmYjlmL3RhYmxlcmFuZ2U6MTY4OTJhOGYxYzBkNDkxN2I0Y2E4ZTYzM2NmMWZiOWZfMC0yLTEtMS0xMTIyOTE_585dfe11-bd4b-4cd7-be8d-eb9b99c0b759">98,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjE2ODkyYThmMWMwZDQ5MTdiNGNhOGU2MzNjZjFmYjlmL3RhYmxlcmFuZ2U6MTY4OTJhOGYxYzBkNDkxN2I0Y2E4ZTYzM2NmMWZiOWZfMS0yLTEtMS0xMTIyOTE_bebb3caa-d346-4828-9e82-363f1c990479">131,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjE2ODkyYThmMWMwZDQ5MTdiNGNhOGU2MzNjZjFmYjlmL3RhYmxlcmFuZ2U6MTY4OTJhOGYxYzBkNDkxN2I0Y2E4ZTYzM2NmMWZiOWZfMi0yLTEtMS0xMTIyOTE_f5126283-f436-4792-8a44-47e0ee1e2183">124,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjE2ODkyYThmMWMwZDQ5MTdiNGNhOGU2MzNjZjFmYjlmL3RhYmxlcmFuZ2U6MTY4OTJhOGYxYzBkNDkxN2I0Y2E4ZTYzM2NmMWZiOWZfMy0yLTEtMS0xMTIyOTE_07ff39b6-41f1-4428-8196-16f476b82133">123,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjE2ODkyYThmMWMwZDQ5MTdiNGNhOGU2MzNjZjFmYjlmL3RhYmxlcmFuZ2U6MTY4OTJhOGYxYzBkNDkxN2I0Y2E4ZTYzM2NmMWZiOWZfNC0yLTEtMS0xMTIyOTE_a9f20816-f960-42c2-964d-cf941e6d6a88">117,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjE2ODkyYThmMWMwZDQ5MTdiNGNhOGU2MzNjZjFmYjlmL3RhYmxlcmFuZ2U6MTY4OTJhOGYxYzBkNDkxN2I0Y2E4ZTYzM2NmMWZiOWZfNS0yLTEtMS0xMTIyOTE_0c1d95db-ed34-406f-b181-d23104b6ab94">110,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjE2ODkyYThmMWMwZDQ5MTdiNGNhOGU2MzNjZjFmYjlmL3RhYmxlcmFuZ2U6MTY4OTJhOGYxYzBkNDkxN2I0Y2E4ZTYzM2NmMWZiOWZfNi0yLTEtMS0xMTIyOTE_5dc2ac10-b10e-4eb8-9f67-f06f97321bee">218,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjE2ODkyYThmMWMwZDQ5MTdiNGNhOGU2MzNjZjFmYjlmL3RhYmxlcmFuZ2U6MTY4OTJhOGYxYzBkNDkxN2I0Y2E4ZTYzM2NmMWZiOWZfNy0yLTEtMS0xMTIyOTE_8a426761-5178-49e6-963c-70b85ba6009e">924,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-top:5pt"><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RleHRyZWdpb246YjM3N2YzNjg3ZTk4NDE3ZmI3ZmZjOTQ5NTE0MTA0NjVfODQ3_c3fb1a8b-5632-47c9-bc2d-9c1f8296d4c1" continuedAt="i539135798a5046bbbd7758cd9547e956" escape="true">Accrued Liabilities and Other Long-Term Liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i539135798a5046bbbd7758cd9547e956" continuedAt="i85ff8be5a7b34124b41e25d2853839e5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RleHRyZWdpb246YjM3N2YzNjg3ZTk4NDE3ZmI3ZmZjOTQ5NTE0MTA0NjVfODUz_184b37cf-e7b7-4714-8dae-4f7330c67ac8" continuedAt="ifdb1bb5a8b044cbbbb840f91b60184bc" escape="true">Accrued liabilities consist of the following (in thousands):&#160;</ix:nonNumeric></span></div><ix:continuation id="ifdb1bb5a8b044cbbbb840f91b60184bc" continuedAt="i726aaa8bbe1746dd981413590b94c3ff"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="icui:AccruedSalariesAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMi0xLTEtMS0xMTIyOTE_fd074c5e-4f39-4c97-a5b9-c382138955cc">47,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="icui:AccruedSalariesAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMi0zLTEtMS0xMTIyOTE_b7aadbd9-edd6-4fbc-943e-fa8a2d3b9afc">44,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incentive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AccruedBonusesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMy0xLTEtMS0xMTIyOTE_c95ec600-ccc7-4032-8f21-43719d30a600">22,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AccruedBonusesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMy0zLTEtMS0xMTIyOTE_76efd27c-6d4b-43cd-ab55-4f93a40b7f0e">30,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-ST</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfNS0xLTEtMS0xMTIyOTE_be7b2395-1b06-47b8-8ee7-767f910cc1d1">20,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfNS0zLTEtMS0xMTIyOTE_3b137b39-262b-438b-8db6-b45f2add035e">18,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfOS0xLTEtMS0xMTIyOTE_6897eb71-1f27-462f-8129-ca46f7fe5de3">6,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfOS0zLTEtMS0xMTIyOTE_4485d688-fe1b-4f0c-a964-ee1d36c6515c">5,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:RestructuringReserveCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTAtMS0xLTEtMTEyMjkx_905f7676-312d-443a-a691-f1db27938970">6,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:RestructuringReserveCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTAtMy0xLTEtMTEyMjkx_37330170-6c17-4955-ad16-7991483a4177">5,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="icui:UnfavorablecontractliabilityST" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTItMS0xLTEtMTEyMjkx_48bc676e-9752-4840-958f-ee9dc97a5fbc">30,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="icui:UnfavorablecontractliabilityST" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTItMy0xLTEtMTEyMjkx_462cc668-39ab-4e01-8a18-6b0a6c21e568">30,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="icui:Accruedothertaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTMtMS0xLTEtMTEyMjkx_c8c49549-6f6b-4143-986c-5c5f82cec9e9">2,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="icui:Accruedothertaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTMtMy0xLTEtMTEyMjkx_2a7312c9-3824-4130-ad15-4b1530b514cc">5,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTQtMS0xLTEtMTEyMjkx_b9324ca0-301b-408b-8cff-0e0098606c29">6,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTQtMy0xLTEtMTEyMjkx_300375c1-a008-42e1-a7f8-2b829c68fc03">5,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="icui:Accruedlegalfees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTUtMS0xLTEtMTEyMjkx_33377b71-ebfa-445b-8e81-b01829f29996">3,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="icui:Accruedlegalfees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTUtMy0xLTEtMTEyMjkx_39b0f588-7569-44f4-861a-ea7c0254737c">3,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="icui:Outsidesalescommissions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTctMS0xLTEtMTEyMjkx_8e8e838a-8124-4dc4-a795-60d4bdb9bf8c">11,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="icui:Outsidesalescommissions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTctMy0xLTEtMTEyMjkx_f6e3d93a-c31a-45c7-999d-7f91a3f5552e">17,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties and returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTgtMS0xLTEtMTEyMjkx_9be8db53-b82e-4e0b-a2ff-d3166900b606">3,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTgtMy0xLTEtMTEyMjkx_e799b35d-05f7-4c1e-82f7-33ab84629502">3,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Field service corrective action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="icui:FieldServiceCorrectiveAction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTktMS0xLTEtMTEyMjkx_1826a475-cedd-4d82-860e-46f3918ed447">27,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="icui:FieldServiceCorrectiveAction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTktMy0xLTEtMTEyMjkx_6e44f973-a560-4bd5-bf5e-4cddaf8fcc82">24,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="icui:Accruedfreight" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjAtMS0xLTEtMTEyMjkx_bc26f4aa-9f25-484d-8ac2-f4607a7c9dad">11,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="icui:Accruedfreight" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjAtMy0xLTEtMTEyMjkx_cd9553e4-71d0-44c0-a882-b7052ac67948">17,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43a9c2ae467547f8811c5f92ca52a728_I20230331" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjEtMS0xLTEtMTEyMjkx_da3a29c9-741d-4ef1-bb44-826b39235b0b">2,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8fe8f65713456c8f35230f74bceb87_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjEtMy0xLTEtMTEyMjkx_9de727d8-63aa-40c2-9d53-ca67331e35cf">1,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="icui:AccruedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjMtMS0xLTEtMTEyMjkx_642688e2-0418-432a-9794-153727401beb">6,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="icui:AccruedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjMtMy0xLTEtMTEyMjkx_da6b8bb8-e24f-44bc-a13f-3241ed0fbd00">3,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued audit fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="icui:AccruedAuditFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjYtMS0xLTEtMTEyMjkx_c3284d96-0ba5-406a-a85c-69512904fb0d">6,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="icui:AccruedAuditFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjYtMy0xLTEtMTEyMjkx_eefd3b40-54de-439c-8c68-2a72137ae692">6,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjctMS0xLTEtMTEyMjkx_cfb495fc-905f-44d1-8eae-b1008085980f">2,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjctMy0xLTEtMTEyMjkx_04671f7b-3965-445d-9a8f-169f13be2ac7">2,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:InterestPayableCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjktMS0xLTEtMTEyMjkx_4c00a774-49b9-4531-8db5-185cf56d9ebb">693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:InterestPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjktMy0xLTEtMTEyMjkx_32a8f86a-be92-49b2-97d3-481d44653f1b">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMzAtMS0xLTEtMTEyMjkx_62e03b94-59d1-4f4b-b0da-7800df627d06">16,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMzAtMy0xLTEtMTEyMjkx_b2a65854-5cdf-48af-8cf3-a804687a4752">14,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMzEtMS0xLTEtMTEyMjkx_ab2d73cb-a8c0-4bae-9bd1-a196139402e9">235,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMzEtMy0xLTEtMTEyMjkx_81fdf2d4-7677-43dd-ad16-d616cad12a0d">242,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to field service corrective actions associated with certain products in connection with a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i85ff8be5a7b34124b41e25d2853839e5" continuedAt="iffddcc6c92724ec8ae723c634ee3285b"><ix:continuation id="i726aaa8bbe1746dd981413590b94c3ff" continuedAt="idc881613662747c7acfb5b6f05b622d7">Other long-term liabilities consist of the following (in thousands):&#160;</ix:continuation></ix:continuation></span></div><div style="margin-bottom:3pt;margin-top:5pt"><ix:continuation id="iffddcc6c92724ec8ae723c634ee3285b"><ix:continuation id="idc881613662747c7acfb5b6f05b622d7"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-LT</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMy0xLTEtMS0xMTIyOTE_568086a8-62c5-4d71-85b9-09b2f5f09121">63,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMy0zLTEtMS0xMTIyOTE_16b6060b-d696-4b4c-a9fd-f8260b96bf92">60,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfNC0xLTEtMS0xMTIyOTE_9b2ff81a-d1de-47ee-9aa8-dca6093a78c3">5,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfNC0zLTEtMS0xMTIyOTE_e22a6a6f-0e11-463c-ad89-89c0c4a06f46">5,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:AccruedRentCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfNS0xLTEtMS0xMTIyOTE_426c56d1-6279-4f15-87ee-bea81482a3ef">955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:AccruedRentCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfNS0zLTEtMS0xMTIyOTE_156b69fe-964c-409f-99fa-1a2c5b89a648">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liability-LT</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTAtMS0xLTEtMTEyMjkx_eab66f78-7a24-4104-8e87-2b8e29548f56">1,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTAtMy0xLTEtMTEyMjkx_78a0ef8b-ef99-4f4c-91c3-9da18a5c8d6c">1,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTEtMS0xLTEtMTEyMjkx_ef8530da-5c86-43aa-a8c6-8c56a49a1d8f">16,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTEtMy0xLTEtMTEyMjkx_1bc45fec-a449-494f-b2a4-c7fb7a7923e7">16,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Field service corrective action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fed4ca7522348e09634e4fad1da85ca_I20230331" decimals="-3" name="us-gaap:ProductLiabilityAccrualComponentAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTItMS0xLTEtMTEyMjkx_7bb51cca-6315-4a79-b16c-30e0ca4d0c8a">25,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb7cc5f691a49e8b4265215896d8c03_I20221231" decimals="-3" name="us-gaap:ProductLiabilityAccrualComponentAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTItMy0xLTEtMTEyMjkx_f59efe83-9907-4ccf-b8cf-164af213f1a0">25,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTMtMS0xLTEtMTEyMjkx_f7c5478d-8983-4893-a677-5454c392981d">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTMtMy0xLTEtMTEyMjkx_3503659c-68bf-4760-b8a3-7ea36fbbeb8a">3,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTQtMS0xLTEtMTEyMjkx_20541897-69a1-4a8a-ad77-8b27587e8a48">114,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTQtMy0xLTEtMTEyMjkx_cbcd38b8-d8b9-48e0-bf13-ac05f92c2149">114,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to field service corrective actions associated with certain products in connection with a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 16:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfMTgyNA_de8b5177-7cbc-4b53-9065-ff9d7dcc105b" continuedAt="i463cf039e91643d3b24f6e597ac2ded4" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i463cf039e91643d3b24f6e597ac2ded4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes were accrued at an estimated effective tax rate of <ix:nonFraction unitRef="number" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfOTU_d0bbc956-4df8-44e2-995b-763ccd1fb1f5">27</ix:nonFraction>% for the three months ended March&#160;31, 2023, as compared to <ix:nonFraction unitRef="number" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfMTc0_f250621e-8265-4f09-8137-0096eb722081">31</ix:nonFraction>% for the three months ended March 31, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective tax rate for the three months ended March 31, 2023 differs from the federal statutory rate of <ix:nonFraction unitRef="number" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="2" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfMzM4_18c9dd86-0e6b-49cc-b103-9ac6f04af275">21</ix:nonFraction>% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, section 162(m) excess compensation, foreign-derived intangible income ("FDII") and tax credits and the following discrete items recognized during the interim period:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Excess tax provision recognized on stock option exercises and the vesting of restricted stock units during the three months ended March&#160;31, 2023 of $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfNzQ2_7d762627-d7c7-4c50-943c-a45b2eb27496">0.7</ix:nonFraction>&#160;million. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The revaluation of the contingent consideration during the three months ended March&#160;31, 2023 of $<ix:nonFraction unitRef="usd" contextRef="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfODY1_6752bc96-0744-4903-9faa-79fe1853451e">0.7</ix:nonFraction>&#160;million, resulted in a tax expense of $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-6" name="icui:ContingentConsiderationTaxExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfOTE5_ef661030-41e2-4559-a68a-4c5706898c20">0.0&#160;million</ix:nonFraction>. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective tax rate for the three months ended March 31, 2022 differs from the federal statutory rate of <ix:nonFraction unitRef="number" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="2" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfMTAzMA_32abda4b-51ca-4bca-82c4-4f893bf7a3fc">21</ix:nonFraction>% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, section 162(m) excess compensation, FDII and tax credits. The effective tax rate during the three months ended March 31, 2022 included a discrete tax benefit of $<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfMTMxMQ_4e151af3-22a8-4232-b1d7-68c412fb94bb">2.6</ix:nonFraction>&#160;million related to excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period.</span></div></ix:continuation><div><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 17:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTEzMjc_9ef79482-9250-44cf-9e31-3516adfeec36" continuedAt="ie572f5df3d9b4ce89d12d99b7b429ecf" escape="true">Long-Term Debt</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie572f5df3d9b4ce89d12d99b7b429ecf" continuedAt="i98e3bc8f5b5441dcba98837a0edf2cb2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Credit Agreement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, in connection with the acquisition of Smiths Medical, we entered into a Credit Agreement (the "Credit Agreement") with Wells Fargo Bank, National Association, Wells Fargo Securities, LLC, Barclays Bank PLC and certain other financial institutions (the &#8220;Lenders&#8221;) for $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-6" name="icui:TotalSeniorSecuredCreditFacility" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMzQy_d9910577-2746-45fd-ad38-e02b95cb2b54">2.2</ix:nonFraction>&#160;billion of senior secured credit facilities. The senior secured credit facilities include (i) a five-year Tranche A term loan of $<ix:nonFraction unitRef="usd" contextRef="i5601a8c75d144a43a8365d2d70291f2f_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNDY2_249fb8c5-e7c6-4855-a9f7-b672ccb8a3b3">850.0</ix:nonFraction>&#160;million (the "Term Loan A"), (ii) a seven-year Tranche B term loan of $<ix:nonFraction unitRef="usd" contextRef="i6f8a9cb1a64e44a89d9d73f6ad8eba74_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNTMx_7c2d9e83-83a0-49cc-83b8-d9beaf6bff85">850.0</ix:nonFraction>&#160;million (the "Term Loan B") and (iii) a five-year revolving credit facility of $<ix:nonFraction unitRef="usd" contextRef="ie8a1a1ffc693445c9e79c6e34870c622_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNjA1_87c3ecfb-ea8a-4f5a-a464-523fb72ed80f">500.0</ix:nonFraction>&#160;million (the "Revolving Credit Facility"), with separate sub-limits of $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-6" name="icui:RevolverSubLimits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNjcx_3da9a4fb-2e03-47b9-8246-cf7cc049a696">50.0</ix:nonFraction>&#160;million for letters of credit and swingline loans (collectively, the "Senior Secured Credit Facilities"). We used the proceeds from borrowings under the Term Loan A and the Term Loan B (collectively, the "Term Loans") to fund a portion of the cash consideration for the purchase of Smiths Medical and the related fees and expenses incurred in connection with the acquisition. We did not incur borrowings under the Revolving Credit Facility on the closing date of the acquisition. The proceeds from any future borrowings under the Revolving Credit Facility may be used for working capital and other general corporate purposes.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i98e3bc8f5b5441dcba98837a0edf2cb2" continuedAt="ib325f04bd83d44f4abf284a1e693d56c"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with entering into the Credit Agreement, during the period ended March 31, 2022, we incurred $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTQwMA_99b625d9-f993-4dec-9cf4-b0743cb8a24d">37.8</ix:nonFraction> million in debt discount and issuance costs, which were allocated to the Term Loan A, the Term Loan B and the Revolving Credit Facility based on lender commitment amounts relative to each type of fees paid. The lender and third-party discount and issuance costs allocated to the Term Loan A and the Term Loan B were $<ix:nonFraction unitRef="usd" contextRef="i59eb5fecde424d39a6b4b8dce858b9f7_I20230331" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTcxMQ_41153552-42d5-4645-a5c0-5b21ead18ecd">15.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i514b0dbe6eac49eea9224b92e51b766b_I20230331" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTcxOA_e9b85425-268d-492e-984e-519a5dbb9b36">13.4</ix:nonFraction> million, respectively, and are reflected as a direct deduction from the face amount of the corresponding term loans on the condensed consolidated balance sheet. These costs are being amortized to interest expense over the respective terms of the loans using the effective interest method. The issuance costs allocated to the Revolving Credit Facility were $<ix:nonFraction unitRef="usd" contextRef="ie8a1a1ffc693445c9e79c6e34870c622_I20230331" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMjA2OQ_0173a2e6-69c7-4650-977a-ee8b36cb5774">8.6</ix:nonFraction> million, which are capitalized and included in prepaid expenses and other current assets and other assets on our condensed consolidated balance sheets. These costs are being amortized to interest expense over the term of the Revolving Credit Facility using the straight-line method. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net funds received from the Term Loan A and the Term Loan B, after deducting debt issuance costs, were $<ix:nonFraction unitRef="usd" contextRef="i59eb5fecde424d39a6b4b8dce858b9f7_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMjQ1Ng_0f33e687-1f60-496f-af1d-b0961da47a75">834.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i514b0dbe6eac49eea9224b92e51b766b_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMjQ2Mw_52006fd8-2983-44de-8867-838e2e759eaf">836.6</ix:nonFraction> million, respectively.   </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity Dates</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity date for the Term Loan A and the Revolving Credit Facility is <ix:nonNumeric contextRef="i5601a8c75d144a43a8365d2d70291f2f_D20230101-20230331" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMjU3Ng_506a0046-51c7-47a1-9463-9303f8d09edb">January 6, 2027</ix:nonNumeric>, and the maturity date for the Term Loan B is <ix:nonNumeric contextRef="i6f8a9cb1a64e44a89d9d73f6ad8eba74_D20230101-20230331" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMjYyNQ_18650771-7a24-45fc-aec8-e0627220ac57">January 6, 2029</ix:nonNumeric>. Pursuant to the terms and conditions of the Credit Agreement, the maturity dates of the Term Loans and the Revolving Credit Facility may be extended upon our request, subject to the consent of the Lenders.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Terms</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, the Term Loans and borrowings under the Revolving Credit Facility denominated in U.S. dollars bear interest, at our option, on either: (1) the Base Rate, as defined below, plus the applicable margin, as indicated below ("Base Rate Loans") or (2) the Adjusted Term Secured Overnight Financing Rate ("Adjusted Term SOFR"), as defined below, plus the applicable margin, as indicated below ("Term SOFR Loans"). </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Base Rate is defined as the highest of (a) the Prime Rate, (b) the Federal Funds Rate plus <ix:nonFraction unitRef="number" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="3" name="icui:InterestPercentageAddedToFederalFundsRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMzM3Mw_3b777c4b-861b-4fb8-95ba-52c45756dfd6">0.50</ix:nonFraction>% and (c) Adjusted Term SOFR (as defined below) for a one-month period plus, in each case, <ix:nonFraction unitRef="number" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="2" name="icui:InterestPercentageAddedToBaseRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMzQ2NQ_48eb8743-e04e-4b02-a509-fc9fe8dd0022">1.00</ix:nonFraction>%.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted Term SOFR is the rate per annum equal to (a) the Term SOFR plus (b) the Term SOFR Adjustment. Term SOFR is the forward-looking term rate based on SOFR and is calculated separately for Term SOFR Loans and Base Rate Loans, as specified in the Credit Agreement. The Term SOFR Adjustment is a percentage per annum of <ix:nonFraction unitRef="number" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="3" name="icui:TerSOFRInterestRateAdjustmentForBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMzc5Mg_2b634830-c88c-4b38-82f2-54f1a8d2ac83">0.10</ix:nonFraction>% for Base Rate Loans and between <ix:nonFraction unitRef="number" contextRef="ica8e78475e314beda5cd3faaa0ce02d4_I20230331" decimals="3" name="icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMzgyNw_edb9ffc0-3030-4add-81c3-30f18e8e1104">0.10</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i40f728bd623845f9b4ce1cfdaf7c303f_I20230331" decimals="8" name="icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMzgzMw_61042d42-32b5-45bb-8613-45e97242fd7e">0.25</ix:nonFraction>% for Term SOFR Loans based on the applicable interest period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility Commitment Fee</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility has a per annum commitment fee at an initial rate of <ix:nonFraction unitRef="number" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNDAyMw_7e9242fa-157a-437f-8adb-f74a1d2bbcbf">0.25</ix:nonFraction>% which is applied to the available amount of the Revolving Credit Facility. Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the commitment fee will be determined by reference to the leverage ratio in effect from time to time as set forth in the table below.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Applicable Interest Margins</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan A and borrowings under the Revolving Credit Facility have an initial applicable margin of <ix:nonFraction unitRef="number" contextRef="i59eb5fecde424d39a6b4b8dce858b9f7_I20230331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNDUwMw_b1695915-c8f1-450f-ad12-5f46a4ae637c">0.75</ix:nonFraction>% per annum for Base Rate Loans and <ix:nonFraction unitRef="number" contextRef="i59eb5fecde424d39a6b4b8dce858b9f7_I20230331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNDU0MA_e6768f4e-da96-47d1-8945-85d5337f3537">1.75</ix:nonFraction>% per annum for Term SOFR Loans.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="icui:ApplicableMarginBasedOnLeverageRatioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTEzMjY_64c473c1-bc0c-4d19-8ae7-a8f839c2e797" continuedAt="i80cba9aeb5cf4679aff3047b482f6fc9" escape="true">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan A and borrowings under the Revolving Credit Facility will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: </ix:nonNumeric></span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="ib325f04bd83d44f4abf284a1e693d56c" continuedAt="i6a2af356ba2145b3b186092768cdbcba"><div style="text-align:center;text-indent:36pt"><ix:continuation id="i80cba9aeb5cf4679aff3047b482f6fc9"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitment Fee Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 4.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i80d837b89c2344e393ee4d383e5cc11b_I20230331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMS0xLTEtMS0xMTIyOTE_dc99b6ff-3152-4f1f-b9ee-59c723d492f3">2.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i80d837b89c2344e393ee4d383e5cc11b_I20230331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMS0yLTEtMS0xMTIyOTE_140f7a44-1deb-4180-912e-1ca078cfce1b">1.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i27b3017a55814b6597ba4e68980a344f_D20230101-20230331" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMS0zLTEtMS0xMTIyOTE_877206eb-00c1-4dc7-b228-dc3364ae245c">0.35</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 4.00 to 1.0 but greater than 3.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i881696e2df5749c38024d0875b7c80db_I20230331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMi0xLTEtMS0xMTIyOTE_958939c5-617a-4099-8fef-1a09c3e97e3a">2.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i881696e2df5749c38024d0875b7c80db_I20230331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMi0yLTEtMS0xMTIyOTE_c6877486-b76e-4612-87d3-51438736a997">1.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0d76d9c6767b4229b51c37407f83df06_D20230101-20230331" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMi0zLTEtMS0xMTIyOTE_d751dc2d-8598-44a3-970e-bbccd784c839">0.30</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 3.00 to 1.0 but greater than 2.50 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8990fbda10824f619dc9e0bb423e9432_I20230331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMy0xLTEtMS0xMTIyOTE_90af05d2-0ad5-4b17-aeb5-15ebdc30ddae">1.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8990fbda10824f619dc9e0bb423e9432_I20230331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMy0yLTEtMS0xMTIyOTE_d8231b2d-eb33-4096-81d7-7977556e20f6">0.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if94f4bdedbf04eb0aae885e9867154ae_D20230101-20230331" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMy0zLTEtMS0xMTIyOTE_b193a662-464a-4663-8ce6-bdfda6bd081a">0.25</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.50 to 1.0 but greater than 2.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i645c0fc8e6a548c1a7a520e2f4a6728a_I20230331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfNC0xLTEtMS0xMTIyOTE_2f18ba2b-e7fc-4265-8fa6-01faf5754a6a">1.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i645c0fc8e6a548c1a7a520e2f4a6728a_I20230331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfNC0yLTEtMS0xMTIyOTE_3bdcf6f0-fb74-4149-9a71-22fb2d125454">0.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i83eb7320045f4ac9af9a0028ac179e5d_D20230101-20230331" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfNC0zLTEtMS0xMTIyOTE_3a00f909-796f-4b65-b51a-fbfdfeef9fdf">0.20</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i975e28cedc80423c9627a97bb37a9a95_I20230331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfNS0xLTEtMS0xMTIyOTE_e2f3e4af-722e-43e0-92c6-49c0e2ab92f5">1.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i975e28cedc80423c9627a97bb37a9a95_I20230331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfNS0yLTEtMS0xMTIyOTE_8333278d-b716-42f5-a367-21e38f914fe7">0.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i76e51a168e7a435c861495b1388612d0_D20230101-20230331" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfNS0zLTEtMS0xMTIyOTE_52d5f334-f26e-42de-bd93-381c89d4a223">0.15</ix:nonFraction>%</span></td></tr></table></ix:continuation></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan B has an initial applicable margin of <ix:nonFraction unitRef="number" contextRef="i514b0dbe6eac49eea9224b92e51b766b_I20230331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNDk3OA_c472061e-36c2-4a13-b40d-1cff372e76d7">1.5</ix:nonFraction>% per annum for Base Rate Loans and <ix:nonFraction unitRef="number" contextRef="i514b0dbe6eac49eea9224b92e51b766b_I20230331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNTAxNQ_ca87892a-ee59-4160-a1ba-855ed76ccf7a">2.5</ix:nonFraction>% per annum for Term SOFR Loans.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan B will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: </span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.368%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 2.75 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i808fda9aa5364d5593b95ed5ff583af5_I20230331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjFiZWU0OTQ4ODBkMTRhOGJiZTllZTBmMjUwYmY5MDM3L3RhYmxlcmFuZ2U6MWJlZTQ5NDg4MGQxNGE4YmJlOWVlMGYyNTBiZjkwMzdfMS0xLTEtMS0xMTIyOTE_5e7dc0d7-cdfd-46f1-b31d-1f72fb1b169b">2.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i808fda9aa5364d5593b95ed5ff583af5_I20230331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjFiZWU0OTQ4ODBkMTRhOGJiZTllZTBmMjUwYmY5MDM3L3RhYmxlcmFuZ2U6MWJlZTQ5NDg4MGQxNGE4YmJlOWVlMGYyNTBiZjkwMzdfMS0yLTEtMS0xMTIyOTE_bb6060c3-725b-4d93-856c-e910ec469618">1.50</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.75 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2e764926d4b14681809efb21b544fa30_I20230331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjFiZWU0OTQ4ODBkMTRhOGJiZTllZTBmMjUwYmY5MDM3L3RhYmxlcmFuZ2U6MWJlZTQ5NDg4MGQxNGE4YmJlOWVlMGYyNTBiZjkwMzdfMi0xLTEtMS0xMTIyOTE_e70627d6-a51e-4508-80c1-6fb64cbc4956">2.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2e764926d4b14681809efb21b544fa30_I20230331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjFiZWU0OTQ4ODBkMTRhOGJiZTllZTBmMjUwYmY5MDM3L3RhYmxlcmFuZ2U6MWJlZTQ5NDg4MGQxNGE4YmJlOWVlMGYyNTBiZjkwMzdfMi0yLTEtMS0xMTIyOTE_cb939c47-5c31-4694-8409-d4b32b5df25b">1.25</ix:nonFraction>%</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal Payments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on the Term Loans are due on the last day of each calendar quarter commencing on June 30, 2022. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan A will amortize in nineteen consecutive quarterly installments in an amount equal to <ix:nonFraction unitRef="number" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="3" name="icui:TermAPrincipalPaymentFirst2Years" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNTU4Ng_2b614844-c60b-494e-9afc-e75ce077543e">2.50</ix:nonFraction>% of the original principal amount in each of the first two years, <ix:nonFraction unitRef="number" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="8" name="icui:TermAPrincipalPaymentYear3And4" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNTY1NA_81108e25-8366-4149-9c2f-c5c7c9e6571d">5.00</ix:nonFraction>% in each of the third and fourth years and <ix:nonFraction unitRef="number" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="3" name="icui:TermAPrincipalPaymentInYear5" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNTY5OQ_a56c791e-8755-45f7-a6ae-8ac7762c6f68">7.50</ix:nonFraction>% in the fifth year, with a final payment of the remaining outstanding principal balance due on the maturity date.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan B matures in twenty-seven consecutive quarterly installments in an amount equal to <ix:nonFraction unitRef="number" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="4" name="icui:TermLoanBPrincipalPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNTkxNQ_ae9d6e46-3619-40bb-9c6e-7daaaae1f26c">0.25</ix:nonFraction>% of the original principal amount, with a final payment of the remaining outstanding principal balance due on the maturity date.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may borrow, prepay and re-borrow amounts under the Revolving Credit Facility, in accordance with the terms and conditions of the Credit Agreement, with all outstanding amounts due at maturity. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2022, we prepaid $<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="INF" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNjI3NQ_31d63ca3-40c6-4f48-9a2a-34ec8fe2feb0">16.0</ix:nonFraction> million in principal payments on the Term Loan A principal balance. For the three months ended March 31, 2023, we paid  total of $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNjQwMg_0fc2e750-b70e-47e6-8e5b-3e88d669fd93">7.4</ix:nonFraction>&#160;million in principal payments on both Term Loans.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Payments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest payments on Base Rate Loans are payable quarterly in arrears on the last business day of each calendar quarter and the applicable maturity date. Interest periods on Term SOFR Loans will be determined, at our option, as either one, three or six months and will be payable on the last day of each interest period and the applicable maturity date. In the case of any interest periods of more than three months' duration, the interest payment will be payable on each day prior to the last day of such interest period that occurs at three-month intervals.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commitment fee on the Revolving Credit Facility is payable quarterly in arrears on the third business day following the last day of each calendar quarter and at the maturity date. The commitment fee is included in interest expense in our condensed consolidated statements of operations.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantors and Collateral</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i6a2af356ba2145b3b186092768cdbcba" continuedAt="i2f1780127c7549328b12392c53f6b8de"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Credit Agreement are unconditionally guaranteed, on a joint and several basis, by ICU Medical, Inc. and certain of our existing subsidiaries. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Covenants</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains affirmative and negative covenants, including certain financial covenants. The negative covenants include restrictions regarding the incurrence of liens and indebtedness, certain merger and acquisition transactions, asset sales and other dispositions, other investments, dividends, share purchases and payments affecting subsidiaries, changes in nature of business, fiscal year or organizational documents, prepayments and redemptions of subordinated and other junior debt, transactions with affiliates, and other matters.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenants include the Senior Secured Leverage Ratio and the Interest Coverage Ratio, both defined below, and pertain to the Term Loan A and the Revolving Credit Facility.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Secured Leverage Ratio is defined, at any measurement date, as the ratio of: (a) all Funded Debt, as defined in the Credit Agreement, that is secured by a lien on any asset or property minus the lesser of (i) all unrestricted cash and cash equivalents and (ii) $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-6" name="icui:LeverageRatioCalculationCeilingSubtractedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfODU0Ng_5194fa49-8605-4a95-9118-4dba887454f7">500.0</ix:nonFraction>&#160;million, to (b) Consolidated EBITDA, as defined in the Credit Agreement, for the most recently completed four fiscal quarters, calculated on a pro forma basis. The maximum Senior Secured Leverage Ratio is 4.50 to 1.00 until June 30, 2024. Thereafter, the maximum Senior Secured Leverage Ratio is 4.00 to 1.00, with limited permitted exception.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Interest Coverage ratio is defined, at any measurement date, as the ratio of Consolidated EBITDA, as defined in the Credit Agreement, to Consolidated Interest Expense, as defined in the Credit Agreement, paid or payable in cash, for the most recently completed four fiscal quarters. The minimum Interest Coverage ratio is 3.00 to 1.00.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were in compliance with all financial covenants as of March&#160;31, 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary events of default, including, among others: non-payments of principal and interest; breach of representations and warranties; covenant defaults; cross-defaults and cross-acceleration to certain other material indebtedness; the existence of bankruptcy or insolvency proceedings; certain events under ERISA; material judgments; and a change of control. If an event of default occurs and is not cured within any applicable grace period or is not waived, the administrative agent and the Lenders are entitled to take various actions, including, without limitation, the acceleration of all amounts due and the termination of commitments under the Senior Secured Credit Facilities.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2017 Credit Facility</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On November 8, 2017, we entered into a five-year senior secured revolving credit facility with various lenders for $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTAxMzM_cbaa2855-8cdf-42c2-8bdf-55c1d225a45c">150.0</ix:nonFraction> million, with Wells Fargo Bank, National Association as the administrative agent, swingline lender and issuing lender (the "Prior Credit Facility"). The Prior Credit Facility, which was set to mature on <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:LineOfCreditFacilityExpirationDate1" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTAzMzE_0fb26cfe-8bf5-4e5e-9850-86559276a5fc">November 8, 2022</ix:nonNumeric>, was terminated in connection with entering into the Credit Agreement on January 6, 2022. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTEzMjk_f3a2952e-5b7f-40e1-bc2b-2ee1a7f397f4" continuedAt="ie0d25a4f924248e3ad1608f0c91c9cf8" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of our long-term debt consist of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:35.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.775%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.778%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5601a8c75d144a43a8365d2d70291f2f_D20230101-20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfMy0xLTEtMS0xMTIyOTE_acfb018d-46c1-4e99-a317-ae97deaee061">7.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59eb5fecde424d39a6b4b8dce858b9f7_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfMy0zLTEtMS0xMTIyOTE_831acf29-119a-41ba-985d-0c5a98cc8d6e">828,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i50e84852d3ab4f408186915e7cf4e655_D20220101-20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfMy01LTEtMS0xMjA4ODQ_5500ca41-4ea0-4224-aba2-c4b7ebc8f2c3">3.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fdf26eb4e87495fbabffe1de604c690_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfMy03LTEtMS0xMjA4ODQ_583ef2d8-3c59-473e-8ddb-19bf83c79a2d">834,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B &#8212; principal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6f8a9cb1a64e44a89d9d73f6ad8eba74_D20230101-20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNC0xLTEtMS0xMTIyOTE_6f2abef4-8600-4678-9341-fc7b25410062">7.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i514b0dbe6eac49eea9224b92e51b766b_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNC0zLTEtMS0xMTIyOTE_3f4965c3-4a1f-4532-92ce-deeeb9f04bcd">841,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i934b1e4c20bc460c88d531ba8e887800_D20220101-20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNC01LTEtMS0xMjA4ODQ_7d31e864-2af2-4de2-bc04-3c4b30f9de0b">4.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica3646f151fa444e82e1e515a33e0f7a_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNC03LTEtMS0xMjA4ODQ_e3d3eb6f-7b49-42db-8e2e-f150c7832120">843,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1881f550800444d3981abc4acd458059_D20230101-20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNS0xLTEtMS0xMTIyOTE_96c05078-459c-4961-abf1-7be91acf6592">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNS0zLTEtMS0xMTIyOTE_7a732604-c1c1-4aea-9084-8363a86e753e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i21016b61e07645e9888301254ab114fa_D20220101-20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNS01LTEtMS0xMjA4ODQ_fd76ef0d-eedc-46fd-90b6-2fda6c8184ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNS03LTEtMS0xMjA4ODQ_f73d63ca-1813-4466-8c5f-780fca799b7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less unamortized debt issuance costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="INF" sign="-" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNi0zLTEtMS0xMTIyOTE_96330163-85eb-48e0-bab4-c03aa8531cbe">22,991</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="INF" sign="-" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNi03LTEtMS0xMjA4ODQ_5aa4647f-9c83-4c04-89dc-ec257e100efc">24,262</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNy0zLTEtMS0xMTIyOTE_4ee31589-2981-48b1-8401-efd37863a54d">1,647,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNy03LTEtMS0xMjA4ODQ_25f387e4-51e9-4da9-b260-074fbf016559">1,653,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfOC0zLTEtMS0xMTIyOTE_15ba9e09-4d69-4ecf-9181-5c64d8994bc7">35,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfOC03LTEtMS0xMjA4ODQ_7e3af31a-087d-4731-96a0-5f5edf2edb24">29,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfOS0zLTEtMS0xMTIyOTE_8615952b-1717-4d87-9183-be2bf0f139b7">1,612,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfOS03LTEtMS0xMjA4ODQ_b8ff2de6-f259-43ce-9da1-f852a37308ad">1,623,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i2f1780127c7549328b12392c53f6b8de"><div style="padding-left:18pt;text-indent:-18pt"><ix:continuation id="ie0d25a4f924248e3ad1608f0c91c9cf8"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprised of $<ix:nonFraction unitRef="usd" contextRef="i59eb5fecde424d39a6b4b8dce858b9f7_I20230331" decimals="INF" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTA5NjQ_e4668c64-ff93-4b14-88b2-5a44d67d6b4f">11.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i514b0dbe6eac49eea9224b92e51b766b_I20230331" decimals="INF" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTA5NzE_af92c971-f0ac-4d1a-b904-d1996f10afc1">11.2</ix:nonFraction> million relating to the Term Loan A and the Term Loan B, respectively, as of March 31, 2023.</span></ix:continuation></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTEzMjM_d800c9d1-13d7-4c92-93fb-87abe9b97a20" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years is approximately (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjNkNGRiZDg3MWNjZDRkZGJiNjNkNWQ3MDBiOGM1MjBkL3RhYmxlcmFuZ2U6M2Q0ZGJkODcxY2NkNGRkYmI2M2Q1ZDcwMGI4YzUyMGRfMC0yLTEtMS0xMTIyOTE_99b14850-2bc5-44fb-9ccf-1b3356de7707">22,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjNkNGRiZDg3MWNjZDRkZGJiNjNkNWQ3MDBiOGM1MjBkL3RhYmxlcmFuZ2U6M2Q0ZGJkODcxY2NkNGRkYmI2M2Q1ZDcwMGI4YzUyMGRfMS0yLTEtMS0xMTIyOTE_1c37b365-ee46-4c68-80c5-a4d6e17c2539">51,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjNkNGRiZDg3MWNjZDRkZGJiNjNkNWQ3MDBiOGM1MjBkL3RhYmxlcmFuZ2U6M2Q0ZGJkODcxY2NkNGRkYmI2M2Q1ZDcwMGI4YzUyMGRfMi0yLTEtMS0xMTIyOTE_d72e4514-1d34-4be2-9919-94e7a111a1ff">51,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjNkNGRiZDg3MWNjZDRkZGJiNjNkNWQ3MDBiOGM1MjBkL3RhYmxlcmFuZ2U6M2Q0ZGJkODcxY2NkNGRkYmI2M2Q1ZDcwMGI4YzUyMGRfMy0yLTEtMS0xMTIyOTE_017d0302-4b07-4858-829e-97b43ea5e1cd">72,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjNkNGRiZDg3MWNjZDRkZGJiNjNkNWQ3MDBiOGM1MjBkL3RhYmxlcmFuZ2U6M2Q0ZGJkODcxY2NkNGRkYmI2M2Q1ZDcwMGI4YzUyMGRfNC0yLTEtMS0xMTIyOTE_404af28b-1f6e-4ab9-b632-31106918a64f">672,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjNkNGRiZDg3MWNjZDRkZGJiNjNkNWQ3MDBiOGM1MjBkL3RhYmxlcmFuZ2U6M2Q0ZGJkODcxY2NkNGRkYmI2M2Q1ZDcwMGI4YzUyMGRfNS0yLTEtMS0xMTIyOTE_e8ce722a-24c4-432c-85bc-2ee859fad880">8,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjNkNGRiZDg3MWNjZDRkZGJiNjNkNWQ3MDBiOGM1MjBkL3RhYmxlcmFuZ2U6M2Q0ZGJkODcxY2NkNGRkYmI2M2Q1ZDcwMGI4YzUyMGRfNi0yLTEtMS0xMTIyOTE_1fe10258-b907-4a2a-9932-5503bb747103">792,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjNkNGRiZDg3MWNjZDRkZGJiNjNkNWQ3MDBiOGM1MjBkL3RhYmxlcmFuZ2U6M2Q0ZGJkODcxY2NkNGRkYmI2M2Q1ZDcwMGI4YzUyMGRfNy0yLTEtMS0xMTIyOTE_8925facb-f196-4f2a-bf93-a94f002054db">1,670,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="icui:InterestExpenseOnLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTEzMjQ_ced79af5-da6d-4771-8acd-a41e1499a749" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total interest expense related to our long-term debt (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:66.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.931%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="INF" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmU0NTM4YjE0MWQ5NzQ0NDY5N2EwNmU2ZmMyZWQzNjY4L3RhYmxlcmFuZ2U6ZTQ1MzhiMTQxZDk3NDQ0Njk3YTA2ZTZmYzJlZDM2NjhfMi0xLTEtMS0xMTIyOTE_2c2364b2-03cf-44cc-bb25-7b7d20f0f5ca">29,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="INF" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmU0NTM4YjE0MWQ5NzQ0NDY5N2EwNmU2ZmMyZWQzNjY4L3RhYmxlcmFuZ2U6ZTQ1MzhiMTQxZDk3NDQ0Njk3YTA2ZTZmYzJlZDM2NjhfMi0zLTEtMS0xMTIyOTE_92273d1b-8e60-410d-aa1f-3047245db027">10,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="INF" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmU0NTM4YjE0MWQ5NzQ0NDY5N2EwNmU2ZmMyZWQzNjY4L3RhYmxlcmFuZ2U6ZTQ1MzhiMTQxZDk3NDQ0Njk3YTA2ZTZmYzJlZDM2NjhfMy0xLTEtMS0xMTIyOTE_9f207187-598a-4e38-b422-427d5ee3e6a5">1,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="INF" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmU0NTM4YjE0MWQ5NzQ0NDY5N2EwNmU2ZmMyZWQzNjY4L3RhYmxlcmFuZ2U6ZTQ1MzhiMTQxZDk3NDQ0Njk3YTA2ZTZmYzJlZDM2NjhfMy0zLTEtMS0xMTIyOTE_f6e7e761-0416-4cd9-9748-cb7404e92d07">1,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment fee &#8212; Revolving Credit Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmU0NTM4YjE0MWQ5NzQ0NDY5N2EwNmU2ZmMyZWQzNjY4L3RhYmxlcmFuZ2U6ZTQ1MzhiMTQxZDk3NDQ0Njk3YTA2ZTZmYzJlZDM2NjhfNC0xLTEtMS0xMTIyOTE_15857e5f-5c51-4130-8975-3e1dd1dd6cfb">368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmU0NTM4YjE0MWQ5NzQ0NDY5N2EwNmU2ZmMyZWQzNjY4L3RhYmxlcmFuZ2U6ZTQ1MzhiMTQxZDk3NDQ0Njk3YTA2ZTZmYzJlZDM2NjhfNC0zLTEtMS0xMTIyOTE_2ab588d1-ae15-44bd-b6fb-df2f5db68521">351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt-related  interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="INF" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmU0NTM4YjE0MWQ5NzQ0NDY5N2EwNmU2ZmMyZWQzNjY4L3RhYmxlcmFuZ2U6ZTQ1MzhiMTQxZDk3NDQ0Njk3YTA2ZTZmYzJlZDM2NjhfNS0xLTEtMS0xMTIyOTE_94851b95-b626-408d-a119-bb5b3797577a">31,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="INF" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmU0NTM4YjE0MWQ5NzQ0NDY5N2EwNmU2ZmMyZWQzNjY4L3RhYmxlcmFuZ2U6ZTQ1MzhiMTQxZDk3NDQ0Njk3YTA2ZTZmYzJlZDM2NjhfNS0zLTEtMS0xMTIyOTE_808dc466-aa2c-4eff-8bba-f51c5241d834">12,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 18:  <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMjU0Mw_9fcd1c92-8ca0-46c5-83ab-d8d8b692a5b1" continuedAt="i2c6f251a67df41b4a93c7de68f201075" escape="true">Stockholders' Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2c6f251a67df41b4a93c7de68f201075" continuedAt="id0967b23139048898c741e41dd80b936"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shareholders Agreement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the completion of the Smiths Medical acquisition on January 6, 2022, Smiths owned approximately <ix:nonFraction unitRef="number" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="3" name="icui:SmithsGroupOwnershipAcquisitionSharesIssued" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMTU5_294ef648-0d56-4f21-abbf-a0a205c8f854">10.5</ix:nonFraction>% of the total outstanding shares of our common stock (see Note 3: Acquisitions). At closing, in connection with the issuance of the share consideration, we entered into a Shareholders Agreement (the &#8220;Shareholders Agreement&#8221;) with Smiths. The Shareholders Agreement imposes certain restrictions on Smiths including prohibiting certain transfers of the shares of our common stock issued (i) for 6 months following the closing of the acquisition and (ii) to certain of our competitors and certain other parties, as well as customary standstill limitations. The Shareholders Agreement also permits Smiths to designate one individual for election to our Board of Directors (the "Board") so long as Smiths beneficially owns at least <ix:nonFraction unitRef="number" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="2" name="icui:SmithsGroupOwnershipRequiredForBoardRepresentation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfODg4_0d95334b-0e5c-4b12-abb9-3bfc99715c9a">5.0</ix:nonFraction>% of the total outstanding shares of our common stock. On February 1, 2022, our Board appointed a new director designated by Smiths pursuant to the Shareholders Agreement who was elected to the Board at the 2022 Annual Meeting of Stockholders held in May 2022. This appointment expanded the size of our Board from eight to nine members. See our Current Report on Form 8-K filed on February 1, 2022 for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In August 2019, our Board approved a share purchase plan to purchase up to $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-5" name="icui:TreasuryStockPurchasePlan" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMTQwOA_425aaaa1-a0c6-482a-9227-fbbf60c14253">100.0</ix:nonFraction> million of our common stock. This plan has no expiration date. During the three months ended March&#160;31, 2023, we did not purchase any shares of our common stock under our share purchase plan. As of March&#160;31, 2023, all of the $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMTYwMw_81479bac-381f-4a44-a695-6440a8c9163f">100.0</ix:nonFraction> million available for purchase was remaining under the plan. We are currently limited on share purchases in accordance with the terms and conditions of our Credit Agreement (see Note 17: Long-Term Debt).  </span></div><div><span><br/></span></div><div><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, we withheld <ix:nonFraction unitRef="shares" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="0" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMTg0OA_74a20dee-bd24-4b2a-8b4e-aa87dbeb6ddd">52,764</ix:nonFraction> shares of our common stock from employee vested restricted stock units in consideration for $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMTk0Mw_d5029728-0172-4435-be56-e132b41562f3">8.4</ix:nonFraction> million in payments made on the employees' behalf for their minimum statutory </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="id0967b23139048898c741e41dd80b936"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">income tax withholding obligations. For the three months ended March 31, 2022, we withheld&#160;<ix:nonFraction unitRef="shares" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="0" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMjExMA_e4eeb73b-8fe5-4478-ad46-41d13cfc5cd1">37,279</ix:nonFraction>&#160;shares of our common stock from employee vested restricted stock units in consideration for&#160;$<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMjIwNQ_3676f057-f45f-4633-ab77-ab85f8e8b791">8.7</ix:nonFraction> million&#160;in payments made on the employees' behalf for their minimum statutory income tax withholding obligations. Treasury stock is used to issue shares for stock option exercises and restricted stock grants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive (Loss) Income ("AOCI")</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMjU0Mg_279ca156-8432-406d-8d95-4430f4461bbf" continuedAt="id27a747ddc7d4b76a6ea096416d93e8e" escape="true">The components of AOCI, net of tax, were as follows (in thousands):</ix:nonNumeric></span></div><ix:continuation id="id27a747ddc7d4b76a6ea096416d93e8e"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:39.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Losses) Gains on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i053a7aa68c99417ca271343168d82c1d_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMS0yLTEtMS0xMTIyOTE_6cd6bdf3-2c86-4731-831c-80bb1022b83b">122,973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib548663bfdd74230aa02cd84a0db6361_I20221231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMS00LTEtMS0xMTIyOTE_baf7c814-a462-4073-9e6d-1dd86933d730">40,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i114116d7f6da48e49ecb98fac66b8e6e_I20221231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMS02LTEtMS0xMTIyOTE_8ce39d3e-183e-4cb1-8b35-b36a0ccacb06">1,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMS04LTEtMS0xMTIyOTE_6af5562e-4e51-4007-8fcb-d3c7aae4e0ce">80,978</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9142596d6f484bf2be0ed3d89cd30684_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMi0yLTEtMS0xMTIyOTE_4df936e2-aaaa-4d49-9acf-9dba9bfc504a">24,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07609ad4dfd84093853a23ea3364cd22_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMi00LTEtMS0xMTIyOTE_ab1eb070-b1cf-4adb-99f6-15621e301236">113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7be1d8f7f3cf4eacaeeabf9eda19e43f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMi02LTEtMS0xMTIyOTE_ae21d1e3-b997-4be1-9a7a-05767dd9e3b2">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMi04LTEtMS0xMTIyOTE_d6957eaa-7668-4f53-ae85-c981ab2f3552">24,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9142596d6f484bf2be0ed3d89cd30684_D20230101-20230331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMy0yLTEtMS0xMTIyOTE_d571c4dc-abb7-4038-8a0a-06bdaa47f91f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07609ad4dfd84093853a23ea3364cd22_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMy00LTEtMS0xMTIyOTE_7c3a0b35-33f8-48a6-9eb1-28c9d916df30">5,464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7be1d8f7f3cf4eacaeeabf9eda19e43f_D20230101-20230331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMy02LTEtMS0xMTIyOTE_09b48d67-3a47-4b7d-92e5-9be6fd77f250">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMy04LTEtMS0xMTIyOTE_ab69bc1b-df05-4ece-8ec4-af0779800873">5,464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9142596d6f484bf2be0ed3d89cd30684_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfNC0yLTEtMS0xMTIyOTE_b3ae3865-aa1a-485f-af1b-775d98414407">24,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07609ad4dfd84093853a23ea3364cd22_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfNC00LTEtMS0xMTIyOTE_0f3f5412-566a-481d-9223-ad4bb055d693">5,577</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7be1d8f7f3cf4eacaeeabf9eda19e43f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfNC02LTEtMS0xMTIyOTE_225817ae-1154-4ac4-ac01-51f380e9021d">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfNC04LTEtMS0xMTIyOTE_a13a50dd-6b27-496d-a04c-d140c2c031e5">19,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i857399bd08c745988830c1cc09e54a50_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfNS0yLTEtMS0xMTIyOTE_0cf856c4-3830-483e-be4f-e890bf96fb41">97,990</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4768bcc3c288464a9796a77d8e9884aa_I20230331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfNS00LTEtMS0xMTIyOTE_bd7f47c2-ac60-4cfd-864d-305e4fd4a0f1">35,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c285e71c3d74e8c898cbe0851162f27_I20230331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfNS02LTEtMS0xMTIyOTE_1a1701c7-2599-4b18-97d8-552381f6988e">1,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfNS04LTEtMS0xMTIyOTE_e6bef493-be7e-46a0-9199-506e339787f3">61,603</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:39.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Losses) Gains on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1e39a1ea3fe47daba9453de67fe8e1b_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMS0yLTEtMS0xMTIyOTE_abe3714a-62e1-435a-a212-e1db1d91dd74">19,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia762d86224bd46f5b6f22478b80f66dd_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMS00LTEtMS0xMTIyOTE_af5ee00d-7191-4222-b8bc-f302b33e8def">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86546ad81144448d9f4a7e7d42d02105_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMS02LTEtMS0xMTIyOTE_7a123a99-31a1-4cc7-acc8-b84ddf038345">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fd0c26c71db4e4cb0b929a7689fb683_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMS04LTEtMS0xMTIyOTE_f5ec8761-161b-485f-aefc-81c82f4ee724">19,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ac4813a471b49ff9271b2d9e810c0a1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMi0yLTEtMS0xMTIyOTE_65437fbb-9e85-4006-a288-7fe41e1dcd57">4,946</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb13edf15748489f92eee0507a1fb77f_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMi00LTEtMS0xMTIyOTE_e91f7305-c909-47df-a1ab-17835b82d7ad">25,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cf0fb2f948444dbbf455bbc0c6a8057_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMi02LTEtMS0xMTIyOTE_3fb7ecc9-1466-4c95-a4f5-cdaa140a40e7">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMi04LTEtMS0xMTIyOTE_463be4aa-8dcf-4c3e-b6f5-e3666d9ecdaa">20,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ac4813a471b49ff9271b2d9e810c0a1_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMy0yLTEtMS0xMTIyOTE_9ffe989e-587d-4116-8cbc-4d864c44be89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb13edf15748489f92eee0507a1fb77f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMy00LTEtMS0xMTIyOTE_4e93ed54-8173-45d1-91df-251ebc1d7aa1">2,210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cf0fb2f948444dbbf455bbc0c6a8057_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMy02LTEtMS0xMTIyOTE_b2ecb1ee-9708-42a3-a7f5-c9d684fd1e9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMy04LTEtMS0xMTIyOTE_270fa99f-7cca-41d0-854e-342b867ce4e0">2,210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ac4813a471b49ff9271b2d9e810c0a1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfNC0yLTEtMS0xMTIyOTE_41741228-06de-48c6-a687-7dd594c51f42">4,946</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb13edf15748489f92eee0507a1fb77f_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfNC00LTEtMS0xMTIyOTE_60c062ca-6206-4597-ba4a-c986f5328b89">23,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cf0fb2f948444dbbf455bbc0c6a8057_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfNC02LTEtMS0xMTIyOTE_c36bd949-fce9-47c3-9cb8-e3304a0a7f67">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfNC04LTEtMS0xMTIyOTE_890c79c2-4598-4671-bd14-568692588d68">18,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa41f9bbd9164a17afef3d0f715104cf_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfNS0yLTEtMS0xMTIyOTE_3e1fe1c6-5f8f-478b-84a1-68294d79919b">23,991</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa95f20692ed474d949298d55e4d9445_I20220331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfNS00LTEtMS0xMTIyOTE_659ed33d-3414-4936-848b-2ea0636d62e7">23,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5490aa9392486e8d4e7fa173e87574_I20220331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfNS02LTEtMS0xMTIyOTE_8a630ded-3030-470a-ad5f-2632b1d2f5b2">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57ae4b72e9574e4ebf63f3473590fe05_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfNS04LTEtMS0xMTIyOTE_8ad257a0-f94a-4f7c-b34d-8e737a037f8d">628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 19:  <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMzcxNg_57598969-7bb2-465c-bc84-a4225f4968f2" continuedAt="i90c64c8ca3dc408c9b2e5c3c8167e98f" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i90c64c8ca3dc408c9b2e5c3c8167e98f" continuedAt="ifeadaee2bf1d4d138e0e646cc31421f8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in various legal proceedings, most of which are routine litigation, in the normal course of business.&#160;Our management does not believe that the resolution of the unsettled legal proceedings that we are involved with will have a material adverse impact on our financial position or results of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters or other matters related to sales of our products.&#160;There is no maximum limit on the indemnification that may be required under these agreements.&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we can provide no assurances, we have never incurred, nor do we expect to incur, any material liability for indemnification.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired Smiths Medical. Total consideration for the acquisition includes a potential earn-out payment of $<ix:nonFraction unitRef="usd" contextRef="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMTA3NA_13fef6b2-c00f-4e9a-8b83-da856246a7cf">100.0</ix:nonFraction>&#160;million in cash contingent on our common stock achieving a certain volume-weighted average price from the closing date to either the third or fourth anniversary of closing. As of March&#160;31, 2023, the estimated fair value of the contingent earn-out is $<ix:nonFraction unitRef="usd" contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331" decimals="-4" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMTMwNw_31dc9cd2-6c14-481d-b3cf-9d54a622437f">20.3</ix:nonFraction>&#160;million (see Note 9: Fair Value Measurements).</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="ifeadaee2bf1d4d138e0e646cc31421f8" continuedAt="i59fa00c3751e46ecbb37e2d0707c50bf"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to being acquired, during 2021, Smiths Medical received a Warning Letter from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility. The Warning Letter cited, among other things, failures to comply with FDA's medical device reporting requirements and failures to comply with applicable portions of the Quality System Regulation. A provision for the estimated costs related to the field service corrective action was recorded on the opening acquired balance sheet of Smiths Medical in the amount of $<ix:nonFraction unitRef="usd" contextRef="i4164284555e9406180057f15e0c21bc7_I20220106" decimals="-5" name="us-gaap:ProductLiabilityAccrualComponentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMTg4MA_0e6946c8-1f2b-476f-8bae-3099ed44f31a">55.1</ix:nonFraction>&#160;million. The initial estimate recorded was based on a probability-weighted estimate of the costs required to settle the obligation. The actual costs to be incurred are dependent upon the scope of the work necessary to achieve regulatory clearance and could differ from the original estimate. The estimated field service corrective action recorded at March&#160;31, 2023 is $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-5" name="us-gaap:ProductLiabilityAccrualComponentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMjIzMQ_6338fb86-1f34-490a-a008-464d310371ba">48.6</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $<ix:nonFraction unitRef="usd" contextRef="ie9945fc3bd5d4b24a1e69091bf0384fd_D20230101-20230331" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMjQwMA_a6317547-0b5a-497e-8e89-d234bbf79328">2.5</ix:nonFraction>&#160;million, consisting of (i) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-6" name="icui:ContingentConsiderationGrossST" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMjQ0MA_c066f9f0-a892-4ee4-854a-ab63bfbd94ff">1.0</ix:nonFraction>&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-5" name="icui:ContingentConsiderationGrossLT" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMjU4Nw_9aa08e1f-4886-4b50-a207-23ebbaf4757e">1.5</ix:nonFraction>&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of December 31, 2022, the measurement period related to (i) above ended and based on the actual revenue achieved during the measurement period we determined that the fair value of the contingent earn-out was zero as the minimum threshold for earning the earn-out was not met. As of March&#160;31, 2023, the estimated fair value of the contingent earn-out related to certain product-related regulatory certification was estimated to be $<ix:nonFraction unitRef="usd" contextRef="ia818e4969fa7407895eb98d2469bf054_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMjc0NQ_b6987a70-edc7-41d2-9e42-38d68c6356d4">1.5</ix:nonFraction>&#160;million (see Note 9: Fair Value Measurements).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out shall not exceed $<ix:nonFraction unitRef="usd" contextRef="id4dcda0568fa4318a8aa6122af8e00b9_D20230101-20230331" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMzExOQ_11ff8664-47ad-4b5f-b3b7-fbf493f2603c">6.0</ix:nonFraction>&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of March&#160;31, 2023, the estimated fair value of the contingent earn-out is $<ix:nonFraction unitRef="usd" contextRef="i7e28dd363d7d40519a83284765f9a3fd_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMzUwNg_44fa32a8-0f2c-4ca0-8950-84621fed7b17">2.6</ix:nonFraction>&#160;million (see Note 9: Fair Value Measurements).</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="i59fa00c3751e46ecbb37e2d0707c50bf" continuedAt="ie9c7cbfbf42643039aac9effadc2a0ba">&#160;&#160;&#160;&#160;</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie9c7cbfbf42643039aac9effadc2a0ba">We have non-cancelable operating lease agreements where we are contractually obligated to pay certain lease payment amounts (see Note 6: Leases).</ix:continuation> </span></div><div><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 20:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV85MS9mcmFnOjUwMDhjMGJhMDA4ZDRkY2NhYjFiMzA0ZjJhODg4NGIyL3RleHRyZWdpb246NTAwOGMwYmEwMDhkNGRjY2FiMWIzMDRmMmE4ODg0YjJfMTk1NQ_4f4e3aa1-5c51-4623-b82a-7a9c8fa32bd2" continuedAt="i7dd6873abd6d4e48a3ff8c65023c688f" escape="true">Collaborative and Other Arrangements</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7dd6873abd6d4e48a3ff8c65023c688f">&#160;&#160;&#160;&#160;On February 3, 2017, we entered into two Manufacturing and Supply Agreements ("MSAs") whereby (i) Pfizer will manufacture and supply us with certain agreed upon products for an initial five-year term with a one-time two-year option to extend and (ii) we will manufacture and supply Pfizer certain agreed upon products for a term of five or ten years depending on the product, also with a one-time two-year option to extend. The MSAs provide each party with mutually beneficial interests and both of the MSAs are to be jointly managed by both Pfizer and ICU. The initial supply price, which is subject to an annual update, is in full consideration for all costs associated with the manufacture, documentation, packaging and certification of the products. On January 1, 2021, we amended our MSA with Pfizer, whereby we manufacture and supply certain agreed upon products to Pfizer. The amendments included a change to the term of the agreement to end on December 31, 2024 with Pfizer's unilateral election to extend through December 31, 2025. Other changes to the terms of the MSA included (i) amendments to our level of supply of products to Pfizer, (ii) certain changes to our manufacturing lines, (iii) updates to our supply price with added volume price tiers for annual periods and (iv) certain minimum purchase requirements for certain products. On February 1, 2022, effective as of January 1, 2022, upon our request, Pfizer executed a Product Addendum (the "Product Addendum") to our MSA, whereby Pfizer manufactures and supplies to us certain agreed upon products. The Product Addendum includes the supply of additional product to us subject to certain time and pricing terms and conditions. The Product Addendum includes a minimum purchase obligation of $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-5" name="us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV85MS9mcmFnOjUwMDhjMGJhMDA4ZDRkY2NhYjFiMzA0ZjJhODg4NGIyL3RleHRyZWdpb246NTAwOGMwYmEwMDhkNGRjY2FiMWIzMDRmMmE4ODg0YjJfMTgxNg_180e9c38-e273-4bde-97c3-a9c3ec35f647">29.6</ix:nonFraction>&#160;million and expired on November 30, 2022. As of November 30, 2022, we have satisfied the minimum purchase obligations under the Product Addendum.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="if1f54ab03e0c44ba84b642c022c86fca_1174"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 21: <ix:nonNumeric contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" name="us-gaap:TransfersAndServicingOfFinancialAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xMTc0L2ZyYWc6ZjY1YjQ1YTRjNWQ1NGRiMjhmNTk2ZjEyZTdiODJhZjIvdGV4dHJlZ2lvbjpmNjViNDVhNGM1ZDU0ZGIyOGY1OTZmMTJlN2I4MmFmMl81NDk3NTU4MTkxMTI_9ae865e1-8970-441a-954a-e3142e24e1d9" continuedAt="i2dbdbdc9300e4bb8aaf71221af061172" escape="true">Accounts Receivable Purchase Program</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2dbdbdc9300e4bb8aaf71221af061172"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 19, 2023, we entered into a revolving $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-6" name="us-gaap:FinancingReceivableRevolving" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xMTc0L2ZyYWc6ZjY1YjQ1YTRjNWQ1NGRiMjhmNTk2ZjEyZTdiODJhZjIvdGV4dHJlZ2lvbjpmNjViNDVhNGM1ZDU0ZGIyOGY1OTZmMTJlN2I4MmFmMl81NDk3NTU4MTkxOTA_36922587-9507-4a44-aa5d-f54049dee045">150</ix:nonFraction>&#160;million uncommitted receivables purchase agreement with Bank of The West ("BOW") which provides for a less expensive form of capital. The discount rate applied to the sold receivables equals a rate per annum equal to the sum of (i) an applicable margin of 1.75%, plus (ii) Term SOFR for a period equal to the discount period which is calculated with respect to the payment terms of the specific receivable. The accounts receivable sold have payment terms ranging between 30 and 60 days, and are related to customer accounts with good credit history. The transfer of the purchased accounts receivable under the agreement is intended to be an absolute and irrevocable transfer constituting a true sale as the transferred receivables have been isolated beyond the reach of the Company and our creditors, even in bankruptcy or other receivership. We do not retain effective control over the sold receivables and BOW has the right upon purchase to pledge and/or exchange the transferred assets without restrictions. The Company acts as collection agent for BOW and collection services are undertaken by our accounts receivable personnel in their normal course of business and collected funds are remitted to BOW. We do not have any continuing involvement with the sold receivables other than the collection services which does not provide us with more than a trivial benefit. The discount rate has been negotiated net of consideration for the collection services, the cost of collection is immaterial to the Company; therefore, we did not separately record any related servicing assets or liabilities as of March 31, 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, the carrying value of trade receivables sold to BOW in connection with the purchase program was $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-5" name="us-gaap:AccountsReceivableSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xMTc0L2ZyYWc6ZjY1YjQ1YTRjNWQ1NGRiMjhmNTk2ZjEyZTdiODJhZjIvdGV4dHJlZ2lvbjpmNjViNDVhNGM1ZDU0ZGIyOGY1OTZmMTJlN2I4MmFmMl81NDk3NTU4MTkxMzA_d610ac68-6396-481f-bc1f-31aac4f448e3">139.6</ix:nonFraction>&#160;million.  In exchange for the sale of trade receivables, we received cash of $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-5" name="us-gaap:ProceedsFromSaleAndCollectionOfReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xMTc0L2ZyYWc6ZjY1YjQ1YTRjNWQ1NGRiMjhmNTk2ZjEyZTdiODJhZjIvdGV4dHJlZ2lvbjpmNjViNDVhNGM1ZDU0ZGIyOGY1OTZmMTJlN2I4MmFmMl81NDk3NTU4MTkxMTQ_c7ad7ef1-b485-4668-8fcb-42b85e037545">138.8</ix:nonFraction>&#160;million. The sale of the receivables resulted in a loss of $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-5" name="us-gaap:GainLossOnSaleOfAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xMTc0L2ZyYWc6ZjY1YjQ1YTRjNWQ1NGRiMjhmNTk2ZjEyZTdiODJhZjIvdGV4dHJlZ2lvbjpmNjViNDVhNGM1ZDU0ZGIyOGY1OTZmMTJlN2I4MmFmMl81NDk3NTU4MTkxNDY_22216ced-a834-43df-b4af-837958fa7542">0.8</ix:nonFraction>&#160;million recorded in other (expense) income, net in our condensed consolidated statement of operations. For the three months ended March 31, 2023, we have collected and remitted $<ix:nonFraction unitRef="usd" contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331" decimals="-5" name="icui:CashRemittedToPurchaser" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xMTc0L2ZyYWc6ZjY1YjQ1YTRjNWQ1NGRiMjhmNTk2ZjEyZTdiODJhZjIvdGV4dHJlZ2lvbjpmNjViNDVhNGM1ZDU0ZGIyOGY1OTZmMTJlN2I4MmFmMl81NDk3NTU4MTkxNjA_2f856619-6692-48fe-85e3-1f1aacda7dc8">81.6</ix:nonFraction>&#160;million in cash to BOW. As of March 31, 2023, cash remaining to be collected on behalf of BOW was $<ix:nonFraction unitRef="usd" contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331" decimals="-5" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xMTc0L2ZyYWc6ZjY1YjQ1YTRjNWQ1NGRiMjhmNTk2ZjEyZTdiODJhZjIvdGV4dHJlZ2lvbjpmNjViNDVhNGM1ZDU0ZGIyOGY1OTZmMTJlN2I4MmFmMl81NDk3NTU4MTkxNzU_1024b469-771c-45e3-b307-faac2cfabef3">58.0</ix:nonFraction>&#160;million, which has been removed from our condensed consolidated balance sheet as of March 31, 2023 and is reflected as cash provided by operating activities in the condensed consolidated statement of cash flows. There were no such balances at December 31, 2022. The carrying value of the sold receivables approximated the fair value at March 31, 2023.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="if1f54ab03e0c44ba84b642c022c86fca_94"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 2.  Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations together with the condensed consolidated financial statements and accompanying notes in this Quarterly Report on Form 10-Q, as well as the audited consolidated financial statements and related notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. This discussion contains forward-looking statements based upon current plans, expectations and beliefs involving risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under the caption entitled &#8220;Forward-Looking Statements&#8221; in this section and Part I, Item 1A. &#8220;Risk Factors&#8221; in our 2022 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">When used in this report, the terms &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to ICU Medical, Inc. ("ICU") and its consolidated subsidiaries included in our condensed consolidated financial statements unless context requires otherwise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Business Overview and Highlights</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We develop, manufacture, and sell infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. Our product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and nondedicated IV sets and needlefree connectors designed to help meet clinical, safety and workflow goals. In addition, we manufacture automated pharmacy IV compounding systems with workflow technology, closed system</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">transfer devices for preparing and administering hazardous IV drugs and cardiac monitoring systems for critically ill patients. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, our primary product offerings have been classified into our new business units as listed below. We have presented our financial results in accordance with these product lines: </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consumables</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Consumables business unit includes Infusion Therapy, Oncology, Vascular Access and Tracheostomy products.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Infusion Therapy</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Infusion Therapy products include non-dedicated infusion sets, extension sets, needle-free connectors, and disinfection caps. Infusion sets used in hospitals and ambulatory clinics consist of flexible sterile tubing running from an IV bag or bottle containing a drug product or solution to a catheter inserted in a patient&#8217;s vein that may or may not be used with an infusion pump. Disinfection caps are used to actively disinfect access points into the infusion sets and catheters. Our primary Infusion Therapy products are:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Clave&#8482; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">needlefree products, including the MicroClave, MicroClave Clear, and NanoClave</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand of connectors, accessories, extension and administration sets used for the administration of IV fluids and medications and the Neutron catheter patency device, used to help maintain patency of central venous catheters;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Neutron&#8482; catheter patency device, used to help maintain patency of central venous catheters;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Tego&#8482; needlefree connector utilized to access catheters for hemodialysis and apheresis applications; and</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">ClearGuard&#8482;, SwabCap&#8482; and SwabTip&#8482; disinfection caps.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oncology</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Closed System Transfer Devices ("CSTD") and hazardous drug compounding systems are used to prepare and deliver hazardous IV medications such as those used in chemotherapy, which, if released, can have harmful effects on the healthcare worker and environment.&#160;Our primary Oncology products are:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">ChemoLock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CSTD, which utilizes a proprietary needlefree connection method, is used for the preparation and administration of hazardous drugs. ChemoLock is used to limit the escape of hazardous drug or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">ChemoClave</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an ISO Connection standard and universally compatible CSTD used for the preparation and administration of hazardous drugs. ChemoClave utilizes standard ISO luer locking connections, making it compatible with all brands of needlefree connectors and pump delivery systems. ChemoClave also is used to limit the escape of hazardous drug or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminate the risk of needlestick injury; and</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">GRIPPER</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> non-coring needles for portal access.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of hazardous drugs typically takes place in a pharmacy where drugs are removed from vials and prepared for delivery to a patient. Those prepared drugs are then transferred to a nursing unit where the chemotherapy is administered via an infusion pump set to a patient. Components of the ChemoClave and ChemoLock product lines are used both in pharmacies and on the nursing floors for the preparation and administration of hazardous drugs. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vascular Access</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our vascular access products allow clinicians to safely access the patients' bloodstream to deliver fluids and medication or to obtain blood samples. Our primary Vascular Access products are:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Jelco</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> safety and conventional peripheral IV catheters and sharps safety devices for hypodermic injection, designed to help prevent accidental needlestick injury;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Safe-T Wing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">venipuncture and blood collection devices;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Port-A-Cath</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">implantable ports;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">DELTEC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> implantable ports;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Portex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> arterial blood sampling syringes;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.8pt">PowerWand</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> midline catheters; and</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.8pt">Cleo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subcutaneous infusion catheters and sets.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tracheostomy</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our tracheostomy products enable placement of a secure airway using both surgical and percutaneous insertion techniques. Our primary Tracheostomy products includes:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Portex BLUselect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> PVC tracheostomy tubes feature an inner cannula as well as a Suctionaid option for above the cuff suctioning and vocalization capability;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Portex Bivona</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> silicone tracheostomy tubes offer the added benefits of comfort and mobility and come in a variety of configurations suited to meet the clinical needs of neonatal through adult patients; and</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Portex BLUperc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> percutaneous insertion kits allow for safe placement of the tracheostomy tube at the bedside.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Systems</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We offer a wide range of infusion pumps, dedicated IV sets, software and professional services. Our primary Infusion System products are:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Large Volume Pump ("LVP") Hardware and Dedicated IV Sets:</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Plum 360&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plum 360&#8482; infusion pump is an ICU Medical MedNet&#8482; ready large volume infusion pump with an extensive drug library and wireless capability. The pumps work with dedicated IC sets. Plum 360 was named the 2018, 2019, 2020, and 2022 Best in KLAS winner as top-performing IV smart pump and was the first medical device to be awarded UL Cybersecurity Assurance Program Certification. Also, in 2021 and 2022, the Plum 360 won the award as the top-performing Smart Pump EMR-Integrated.</span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ambulatory Infusion Hardware:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">CADD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ambulatory infusion pumps and disposables, including administration sets and medication cassette reservoirs, support a variety of IV pain management therapies across clinical care areas from hospital to outpatient treatment. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Syringe Infusion Hardware:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Medfusion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> syringe infusion pumps are designed for the administration of fluids and medication requiring precisely controlled infusion rates from a variety of syringe sizes in acute care settings. </span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV Medication Safety Software:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">ICU Medical MedNet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;: ICU Medical MedNet is an enterprise-class medication management platform for any sized healthcare system that can help reduce medication errors, improve quality of care, streamline workflows and maximize revenue capture. ICU Medical MedNet connects our industry-leading smart pumps to a hospital&#8217;s EHR, asset tracking systems, and alarm notification platforms with the largest array of integration partners. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">PharmGuard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Safety Software for Medfusion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4000 syringe and CADD&#8482; Solis pumps allows for customized drug libraries to support the standardization of protocols for medication administration throughout the facility. </span></div><div style="padding-left:72pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Professional Services: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In addition to the products above, our teams of clinical, information technology, and professional services experts work with customers to develop and deliver safe and efficient infusion systems, providing customized and personalized configuration, implementation, and data analytics services to complement our infusion hardware and software.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vital Care</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Vital Care business unit includes IV Solutions, Critical Care, General Anesthesia and Respiratory, Temperature Management Solutions and Regional Anesthesia/Pain Management products. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV Solutions</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our IV Solutions products include a broad portfolio of injection, irrigation, nutrition and specialty IV solutions including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV Therapy and Diluents:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Including Sodium Chloride, Dextrose, Balanced Electrolyte Solutions, Lactated Ringer's, Ringer's, Mannitol, Sodium Chloride/Dextrose and Sterile Water.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Irrigation:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Including Sodium Chloride Irrigation, Sterile Water Irrigation, Physiologic Solutions, Ringer's Irrigation, Acetic Acid Irrigation, Glycine Irrigation, Sorbitol-Mannitol Irrigation, Flexible Containers and Pour Bottle Options.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hemodynamic Monitoring</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Hemodynamic Monitoring products help clinicians get accurate real-time access to patients&#8217; hemodynamic and cardiac status with an extensive portfolio of monitoring systems and advanced sensors &amp; catheters.&#160;Measurements provided by our systems help clinicians determine how well the heart is pumping blood and how efficiently oxygen from the blood is being used by the tissues. Our Hemodynamic Monitoring products include:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cogent&#8482; 2-in-1 hemodynamic monitoring system;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CardioFlo&#8482; hemodynamic monitoring system;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">TDQ&#8482; and OptiQ&#8482; cardiac output monitoring catheters;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">TriOx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">venous oximetry catheters;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Transpac&#8482; blood pressure transducers; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SafeSet&#8482; closed blood sampling and conservation system.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">MEDEX&#174; LogiCal&#174; Pressure Monitoring System and components.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General Anesthesia &amp; Respiratory</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer a broad range of anesthesia systems and devices and breathing circuits, ventilation, respiratory and specialty airway products that maintain patients&#8217; airways before, during and after surgery.  Our primary Anesthesia &amp; Respiratory products are:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Portex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">acapella</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> bronchial hygiene products used to mobilize pulmonary secretions to facilitate the opening of airways in patients with chronic respiratory diseases such as chronic obstructive pulmonary disease, or COPD, asthma and cystic fibrosis.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Temperature Management Solutions</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Temperature Management solutions systems are used in perioperative and critical care settings to help monitor and regulate patient temperature. Our primary Temperature Management products include:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> rapid infusion, fluid warming, routine blood and fluid warming, irrigation fluid warming, convective patient warming and temperature probes.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regional Anesthesia/Pain Management Trays</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We offer a comprehensive range of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Portex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">regional anesthesia/pain management trays and components. Our primary products include:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Epidural Trays;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Spinal Trays;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Combined (CSE) Trays;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Peripheral Nerve Block Trays; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Specialty Trays (Lumbar Puncture, Amniocentesis, Myelogram).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S. a substantial amount of our products are sold to group purchasing organization member hospitals. We believe that as healthcare providers continue to either consolidate or join major buying organizations, the success of our products will depend, in part, on our ability, either independently or through strategic relationships, to secure long-term contracts with large healthcare providers and major buying organizations.&#160;Although we believe that we are not dependent on any single distributor, large healthcare provider or major buying organization for distribution of our products, the loss of a strategic relationship with any one of these organizations or a decline in the demand for our products could have a material adverse effect on our operating results.&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">COVID-19 Pandemic and other Global Geopolitical Events</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our business operations have been, and we may continue to be, impacted by the novel coronavirus and its variants ("COVID-19"), which has caused lower hospital admissions and medical procedure volumes and by the continuing conflict between Russia and Ukraine. These events have resulted in global economic challenges, and impacts to us and our business, such as rising inflation, especially with respect to freight costs driven by the higher fuel prices, increased cost of raw materials as well as shortages, and supply chain disruptions which negatively impacted our gross profit margin during 2022. The rising interest rates and foreign currency impact due to the strengthening of the U.S. dollar have also impacted our results of operations during 2022 and 2023.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">While we continually monitor the ongoing and evolving impact of the above events on our operations the overall impact remains uncertain and may not be fully reflected until future periods. The overall impact to our results of operations will depend on factors such as the duration and extent of the impact from the COVID-19 pandemic, the conflict in the Ukraine and the related global economic challenges, none of which can be fully predicted at this time. See &#8220;Part I. Item 1A. Risk Factors&#8221; in our 2022 Annual Report on Form 10K for a discussion of risks and uncertainties.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We present income statement data in Part I, Item 1. "Financial Statements." The following table shows, for the three months ended March&#160;31, 2023 and 2022, the percentages of each income statement caption in relation to total revenue:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, strategic transaction and integration expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent earn-out</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Seasonality/Quarterly Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                There are no significant seasonal aspects to our business. We can experience fluctuations in net sales as a result of variations in the ordering patterns of our largest customers, which may be driven more by production scheduling and customer inventory levels, and less by seasonality . Our expenses often do not fluctuate in the same manner as net sales, which may cause fluctuations in operating income that are disproportionate to fluctuations in our revenue.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to comparing changes in revenue on a U.S. GAAP basis, we also compare the changes in revenue from one period to another using constant currency. The presentation of revenues on a constant currency basis is a non-GAAP financial measure that excludes the impact of fluctuations in foreign currency exchange rates that occurred between the comparative periods. We provide constant currency information to enhance the visibility of underlying business trends, excluding the effects of changes in foreign currency translation rates. We believe this information is useful to investors to facilitate comparisons and better identify trends in our business. Our constant currency revenues reflect current period local currency revenues at prior period's average exchange rates. We consistently apply this approach to revenues for all currencies where the functional currency is not the U.S. dollar. These results should be considered in addition to, not as a substitute for, results reported in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accordance with GAAP. Results on a constant currency basis, as we present them, may not be comparable to similarly titled measures used by other companies and are not measures of performance presented in accordance with GAAP.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consumables</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes our total Infusion Consumables revenue (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.433%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">236.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">240.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Consumables revenue decreased for the three months ended March&#160;31, 2023,  as compared to the same period in the prior year, primarily due to a decrease in our Vascular Access revenues and the impact of foreign exchange rate changes. These decreases were partially offset by an increase in Infusion Therapy and Tracheostomy revenues and the impact on revenue of an additional eight billing days in the current quarter related to Smiths Medical which was acquired on January 6, 2022. On a constant currency basis, Consumables revenue was $241.9 million, an increase of $1.7 million or 0.7% during the three months ended March&#160;31, 2023, as compared to the same period in the prior year. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Systems</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes our total Infusion Systems revenue (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:57.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.741%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Infusion Systems</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Infusion Systems revenue increased for the three months ended March&#160;31, 2023, as compared to the same period in the prior year, primarily due to higher sales of our ambulatory infusion and syringe pump products and the impact on revenue of an additional eight billing days in the current quarter related to Smiths Medical which was acquired January 6, 2022, these increases were partially offset by the impact of foreign exchange rate changes. On a constant currency basis, Infusion Systems revenue was $166.9 million, an increase of $28.7 million or 20.7% for the three months ended March&#160;31, 2023, as compared to the same period in the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vital Care</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes our total Vital Care revenue (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:57.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.741%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vital Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Vital Care revenue increased  for the three months ended March&#160;31, 2023, as compared to the same period in the prior year, primarily due to higher sales of our critical care and temperature management products and the impact on revenue of an additional eight billing days in the current quarter related to Smiths Medical which was acquired January 6, 2022, these increases were partially offset by the impact of foreign exchange rate changes. On a constant currency basis, Vital Care revenue was $174.9 million, an increase of $10.2 million or 6.2% for the three months ended March 31, 2023, as compared to the same period in the prior year.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Margins</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023 and 2022, gross margins were 33.8% and 31.1%, respectively. The increase in gross margins for the three months ended March&#160;31, 2023, as compared to the same period in the prior year, was primarily driven by</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the cost recognition of the purchase accounting write-up of inventory in 2022, the impact of foreign exchange rate changes and lower freight costs for the three months ended March 31, 2023 as compared to the same period in the prior year.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative (&#8220;SG&amp;A&#8221;) Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total SG&amp;A Expenses (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:57.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.770%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expenses slightly decreased for the three months&#160;ended March&#160;31, 2023, as compared to the same period in the prior year. For the three months ended March&#160;31, 2023, dealer fees decreased $4.7 million and stock compensation decreased $3.4 million. These decreases were mostly offset by an increase of $2.6 million in compensation costs, an increase of $1.7 million in commissions and an increase of $1.5 million in depreciation and amortization. Dealer fees decreased due to a decrease in revenues to distributors. Stock based compensation decreased due to additional compensation expense recorded in the same period in the prior year due to changes in the probability of performance shares expected to be earned. Compensation costs increased over the same period in the prior year primarily due to an increase in incentive compensation which was based on a larger employee population in the current year period. Commissions increased due to the increase in revenues and depreciation and amortization increased based on the depreciation of higher fixed asset balances and a full quarter of both depreciation expense and amortization expense related to Smith's Medical acquired at the beginning of 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development (&#8220;R&amp;D&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total R&amp;D Expenses (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:57.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.741%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&amp;D</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses decreased for the three months ended March&#160;31, 2023, as compared to the same period in the prior year. R&amp;D expenses during both periods primarily relate to headcount and employment expense in support of ongoing R&amp;D projects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring, Strategic Transaction and Integration Expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, strategic transaction and integration expenses were $11.0 million and $33.9 million for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring charges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Restructuring charges were $2.7 million and $3.2 million for the three months ended March&#160;31, 2023 and 2022, respectively, and were primarily related to severance costs. We expect to pay the majority of unpaid restructuring charges as of  March 31, 2023 during the remainder of 2023 and 2024. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic transaction and integration expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Strategic transaction and integration expenses were $8.3 million and $30.7 million for the three months ended March&#160;31, 2023 and 2022, respectively. The strategic transaction and integration expenses during the three months ended March&#160;31, 2023 were primarily related to consulting expenses and employee costs incurred to integrate our Smiths Medical business acquired in 2022. The strategic transaction and integration expenses for the three months ended March 31, 2022 were primarily related to transaction and integration expenses associated with our acquisition of Smiths Medical on January 6, 2022 which primarily included legal expenses, bank fees, a United Kingdom stamp tax and employee costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in Fair Value of Contingent Earn-out</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the three months ended March 31, 2023 there was a gain of $0.7 million primarily related to the change in fair value of contingent earn-out related to the Smiths Medical acquisition. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense, net</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents interest expense, net (in thousands):&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,266)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,644)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,515)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,055)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net for the three months ended March&#160;31, 2023 and 2022 primarily includes the contractual interest incurred on borrowings under the Credit Agreement, the per annum commitment fee charged on the available amount of the revolving credit facility contained in the Credit Agreement and the amortization of debt issuance costs incurred in connection with entering into the Credit Agreement (see Note 17: Long-Term Debt in our accompanying condensed consolidated financial statements for additional information). The interest expense increased for the three months ended March 31, 2023, as compared to March 31, 2022, primarily due to increases in the applicable SOFR reference rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other (Expense) Income, net</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents other (expense) income, net (in thousands):&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gains, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposition of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(297)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other miscellaneous (expense) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023 and 2022, income taxes were accrued at an estimated effective tax rate of 27% and 31%, respectively. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effective tax rate for the three months ended March&#160;31, 2023 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, section 162(m) excess compensation, foreign-derived intangible income ("FDII") and tax credits. The effective tax rate during the three months ended March&#160;31, 2023 included a tax provision of $0.7 million related to the excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effective tax rate for the three months ended March&#160;31, 2023 also included a nil tax impact related to the revaluation of contingent consideration of $0.7 million.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective tax rate for the three months ended March 31, 2022 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, section 162(m) excess compensation, foreign-derived intangible income ("FDII") and tax credits. The effective tax rate during the three months ended March 31, 2022 included a tax benefit of $2.6 million related to the excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period. </span></div><div style="margin-bottom:5pt"><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Liquidity and Capital Resources</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly evaluate our liquidity and capital resources, including our access to external capital, to assess our ability to meet our principal cash requirements, which include working capital requirements, planned capital investments in our business, commitments, acquisition restructuring and integration expenses, investments in quality systems and quality compliance objectives, payment of interest expense, repayment of outstanding borrowings, income tax obligations and acquisition opportunities in accordance with our growth strategy.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary sources of liquidity are cash and cash equivalents, our short-term investment portfolio, cash flows from our operations and access to borrowing arrangements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Funds generated from operations are held in cash and cash equivalents and investment securities. During the three months ended March&#160;31, 2023, our cash and cash equivalents and short-term investment securities increased by $11.2 million from $213.0 million at December&#160;31, 2022 to $224.2 million at March&#160;31, 2023. This increase was primarily due to cash generated from operations. Our short-term investment portfolio consists of investment-grade corporate and federal bonds and U.S. treasury securities and is primarily intended to facilitate capital preservation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Credit Agreement and Access to Capital</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 17: Long-Term Debt to our accompanying condensed consolidated financial statements, we entered into the Credit Agreement with various lenders on January 6, 2022 in connection with the closing of the Smiths Medical acquisition. The Credit Agreement provides for a five-year term loan A facility of $850.0 million (the "Term Loan A"), a seven-year term loan B facility of $850.0 million (the "Term Loan B") and a five-year revolving credit facility of $500.0 million (the "Revolving Credit Facility") (collectively, the "Senior Secured Credit Facilities"). The proceeds from the term loans were used to finance a portion of the cash consideration for the Smiths Medical acquisition. The outstanding aggregate principal amount of the term loans is $1.7 billion as of March&#160;31, 2023, which includes the Term Loan A that will mature in January 2027 and the Term Loan B that will mature in January 2029. The proceeds of future borrowings under the Revolving Credit Facility, which expires in January 2027, may be used as a source of liquidity to support our ongoing working capital requirements and other general corporate purposes. There are no outstanding borrowings under the Revolving Credit Facility as of March&#160;31, 2023. As part of entering into the Senior Secured Credit Facilities, we were assigned issuer and Term Loan B credit ratings. At the date of issuance of this report, our issuer and Term Loan B credit ratings assigned and outlook were as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuer/Term Loan B <br/>Credit Ratings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outlook</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Moody's</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ba3/Ba3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fitch</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BB/BBB-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Negative</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Standard &amp; Poor's</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BB-/BB-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains financial covenants that pertain to the Term Loan A and the Revolving Credit Facility. Specifically, we are required to maintain a Senior Secured Leverage Ratio of no more than 4.50 to 1.00 until June 30, 2024, with stepdowns to 4.00 to 1.00 thereafter, and an Interest Coverage Ratio of no less than 3.00 to 1.00 (defined and discussed in greater detail in Note 17: Long-Term Debt to our accompanying condensed consolidated financial statements). We were in compliance with these financial covenants as of March&#160;31, 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash and cash equivalents along with cash flows expected to be generated from future operations including the cash received from our uncommitted trade accounts receivable purchase facility and the funds received and accessible under the Senior Secured Credit Facilities will provide us with sufficient liquidity to finance our cash requirements for the next twelve months. In the event that we experience downturns, cyclical fluctuations in our business that are more severe or longer than anticipated, fail to achieve anticipated revenue and expense levels, or have significant unplanned cash expenditures, we may need to obtain or seek alternative sources of capital or financing, and we can provide no assurances that the terms of such capital or financing will be available to us on favorable terms, if at all. Our ability to generate cash flows from operations, issue debt or enter into other financing arrangements on acceptable terms could be adversely affected if there is a material decline in the demand for our products or in the solvency of our customers or suppliers, deterioration in our key financial ratios or credit ratings or other significantly unfavorable changes in economic conditions. See Part I. Item 1A. "Risk Factors&#8221; in our 2022 Annual Report on Form 10-K for discussion of the risks and uncertainties associated with our debt financing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uses of Liquidity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital Expenditures</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, there have been no material changes to our estimate for 2023 planned capital expenditures from the estimate previously disclosed in our 2022 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Obligations</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal commitments at March&#160;31, 2023 include both short and long-term future obligations. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have non-cancelable operating lease agreements where we are contractually obligated for certain lease payment amounts. We assumed additional operating leases as a result of our acquisition of Smiths Medical. For more information regarding our operating lease obligations, (see Note 6: Leases to our accompanying condensed consolidated financial statements). </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we incurred borrowings under Senior Secured Credit Facilities. The principal repayment obligations and estimated interest payments on the term loans and estimated commitment fee payments on the revolver are estimated in the table below. Interest payments on the term loans were estimated using an Adjusted Term SOFR rate and an initial applicable margin of 1.75% for Term Loan A and 2.50% for Term Loan B and the revolver commitment fees were estimated using the initial rate of 0.25%. The applicable margin rate and commitment fee rate will change from time to time in accordance with a preset pricing grid based on the leverage ratio (see Note 17: Long-Term Debt to our accompanying condensed consolidated financial statements for pricing grids related to the Senior Secured Credit Facilities). We expect to fund these obligations with our existing cash and cash equivalents and cash generated from our future operations. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:26.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.298%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remainder of 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A Principal Payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A Interest Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B Principal Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B Interest Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver Commitment Fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Future Capital Investments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, there have been no material changes to our estimate for restructuring and integration expenses along with spending to support quality systems and quality compliance objectives, as previously disclosed in our 2022 Annual Report on Form 10-K. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnifications </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters related to sales of our products. There is no maximum limit on the indemnification that may be required under these agreements.&#160;Although we can provide no assurances, we have never incurred, nor do we expect to incur, any liability for indemnification.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Historical Cash Flows</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net cash provided by operations for the three months ended March&#160;31, 2023 was $41.2 million. Net income plus adjustments for non-cash net expenses contributed $71.1 million. Net cash used in operations as a result of changes in operating assets and liabilities was $29.8 million.&#160;The changes in operating assets and liabilities included a $49.4 million increase in inventories, a $6.4 million increase in other assets, a $21.1 million decrease in accrued liabilities, a $27.5 million decrease in accounts payable, and $9.3 million in net changes in income taxes, including excess tax benefits and deferred income taxes. Offsetting these amounts was a $82.0 million decrease in accounts receivable and a $1.9 million decrease in prepaid expenses and other current assets. The increase in inventory was primarily to build inventory safety stock levels. The increase in other assets was due to the purchase of spare parts. The decrease in accrued liabilities was primarily due to the payout of annual bonuses, payment of accrued freight charges and payment of distribution fees. The decrease in accounts payable was due to the timing of payments. The net changes in income taxes was a result of recording the current deferred provision and the timing of payments. The decrease in accounts receivable was primarily due to the sale of accounts receivable as part of our accounts receivable purchase program with Bank of the West (see Note 21: Accounts Receivable Purchase Program).       </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net cash provided by operations for the three months ended March&#160;31, 2022 was $1.3 million. Net income plus adjustments for non-cash net expenses contributed $49.9 million. Net cash used in operations as a result of changes in operating assets and liabilities was $51.3 million.  The changes in operating assets and liabilities included a $36.2 million increase in inventories, a $14.4 million increase in other assets, a $19.2 million decrease in accrued liabilities and $26.1 million in net changes in income taxes, including excess tax benefits and deferred income taxes. Offsetting these amounts was a $22.5 million decrease in accounts receivable, a $2.6 million decrease in prepaid expenses and other current assets and a $19.5 million increase in accounts payable. The increase in inventory was primarily due to the increase in safety stock. The increase in other assets was due to the purchase of spare parts and the capitalization of debt issuance costs allocated to the revolving credit facility. The decrease in accrued liabilities was primarily due to the payout of annual bonuses. The net changes in income taxes was a result of the timing of payments. The decrease in accounts receivable was primarily due to collection efforts and the timing of revenue. The net decrease in prepaid expenses and other current assets was primarily due to a decrease in deferred costs mostly offset by capitalized debt issuance costs allocated to the revolving credit facility. The increase in accounts payable was due to the timing of payments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes the changes in our investing cash flows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(846)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,844,164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,844,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,532)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,183)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,867,750)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,852,567&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Our purchases of property, plant and equipment will also vary from period to period based on additional investments needed to support new and existing products and expansion of our manufacturing facilities.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Our business acquisitions will vary from period to period based upon our current growth strategy and our ability to execute on desirable target companies. On January 6, 2022, we completed the acquisition of Smiths Medical. The cash consideration for the transaction was $1.9 billion, which was financed with existing cash balances and borrowings under the Credit Agreement. Acquired cash was $78.8 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchases of investment securities will vary from period to period based on current cash needs, planning for known future transactions and changes in our investment strategy. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Proceeds from the sale of our investment securities will vary from period to period based on the maturity dates of the investments. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in our financing cash flows (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt, net of lender debt issuance costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,672,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,672,698)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments on long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,375)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of third-party debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,803)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,425)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,743)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,837)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648,917&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,664,754)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we borrowed an aggregate of $1.7 billion under the Senior Secured Credit Facilities to partially finance our acquisition of Smiths Medical (see Note 17: Long-Term Debt to our accompanying condensed consolidated financial statements for additional information). The proceeds were net of $27.3 million in payments of lender debt issuance costs.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March 31, 2023, relates to scheduled principal payments on the Senior Secured Credit Facilities. For the three months ended March 31, 2022, relates to payment of $16.0 million of principal payments on the Senior Secured Credit Facilities and $1.9 million in third-party debt issuance costs.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Proceeds from the exercise of stock options will vary from period to period based on the volume of options exercised and the exercise price of the specific options exercised.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)      </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, our employees surrendered 52,764 shares of our common stock from vested restricted stock unit awards as consideration for approximately $8.4 million in minimum statutory withholding obligations paid on their behalf. During the three months ended March 31, 2022, our employees surrendered 37,279 shares of our common stock from vested restricted stock unit awards as consideration for approximately $8.7 million in minimum statutory withholding obligations paid on their behalf.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock purchase plan, which authorized the repurchase of up to $100.0 million of our common stock, was approved by our Board of Directors in August 2019. This plan has no expiration date.&#160;As of March&#160;31, 2023, all of the $100.0 million available for purchase was remaining under the plan. </span></div><div style="margin-bottom:5pt"><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our 2022 Annual Report on Form 10-K, we identified the critical accounting policies which affect our more significant estimates and assumptions used in preparing our consolidated financial statements. There have been no material changes to our critical accounting policies from those previously disclosed in our 2022 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2: New Accounting Pronouncements in Part&#160;I,&#160;Item 1. "Financial Statements."</span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_109"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt;text-decoration:underline">Quantitative and Qualitative Disclosures about Market Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Facility</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the Smiths Medical acquisition on January 6, 2022 we entered into the Senior Secured Credit Facilities totaling approximately $2.2 billion consisting of a variable-rate term loan A facility of $850.0 million, a variable-rate term loan B facility of $850.0 million and a revolving credit facility of $500.0 million. We are exposed to changes in interest rates on all of these variable-rate debt instruments. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term loan A facility currently bears interest based on Adjusted Term SOFR plus an initial applicable margin of 1.75% per year. The term loan B facility currently bears interest based on Adjusted Term SOFR subject to a 0.50% floor plus an initial applicable margin of 2.5%. We used a sensitivity analysis to measure our interest rate risk exposure. If the SOFR rate increases or decreases 1% from March&#160;31, 2023, the additional annual interest expense or savings related to the term loans would amount to approximately $16.7 million. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to mitigate and offset a portion of this interest rate risk exposure associated with these debt instruments we entered into interest rate swaps to achieve a targeted mix of fixed and variable-rate debt. The term loan A swap has an initial notional amount of $300.0&#160;million, reducing to $150.0&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2027 and we will pay a fixed rate of 1.32% and will receive the greater of 3-month USD SOFR or (0.15)%. The term loan B swap has an initial notional amount of $750.0&#160;million, reducing to $46.9&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2026 and we will pay a fixed rate of 1.17% and will receive the greater of 3-month USD SOFR or 0.35%. See Note 8: Derivatives and Hedging Activities to the condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Purchase Program</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our accounts receivable purchase program with Bank of the West bears discount rates tied to SOFR. These variable discount rates would affect the amount of factoring costs we incur, and the amount of cash we receive upon the sales of accounts receivable under this program. A 1% increase in SOFR rates on the accounts receivable sales would not have a material impact on our results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Rate Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We transact business globally in multiple currencies, some of which are considered volatile. Our international revenues and expenses and working capital positions denominated in these foreign currencies expose us to the risk of fluctuations in foreign currency exchange rates against the U.S. dollar. As the receiver of foreign currencies we are adversely affected by the strengthening of the U.S. dollar and other currencies relative to the operating unit functional currency. Our hedging policy attempts to manage these risks to an acceptable level. We manage our foreign currency exposures on a consolidated basis to take advantage of net exposures and natural offsets, which are then further reduced by the gains and losses of our hedging instruments. Gains and losses on the hedging instruments offset gains and losses on the hedged forecasted transactions and reduce the earnings volatility related to foreign exchange, however we do not hedge our entire foreign exchange exposure and are still subject to earnings volatility due to foreign currency exchange rate risk.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency exchange forward contracts hedge a portion of our forecasted foreign currency-denominated revenues and expenses (principally Mexican Pesos, Euros, Czech Koruna, Japanese Yen, U.S. Dollar, Chinese Renminbi, Canadian Dollar, Swedish Krona and Australian Dollar) that differ from the functional currency of the operating unit. These derivative contracts are designated and qualify as cash flow hedges (see Note 8: Derivatives and Hedging Activities to the condensed consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q). We performed a sensitivity analysis to estimate changes in the fair value of our foreign exchange derivatives due to potential changes in near-term foreign currency exchange rates. At March&#160;31, 2023, the effect of a hypothetical 10% weakening in the actual foreign currency exchange rates used for the applicable currencies would result in an estimated decrease in the fair value of these outstanding derivative contracts by approximately $1.5 million.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_112"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt;text-decoration:underline">Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Limitations on Effectiveness of Controls and Procedures</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In designing and evaluating our disclosure controls and procedures, management recognizes that any controls</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are resource constraints, and that management is required to apply judgment in evaluating the benefits of possible</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">controls and procedures relative to their costs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")), as of the end of the period covered by this Quarterly Report.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the evaluation, our principal executive officer and principal financial officer concluded that, as of March 31, 2023, our disclosure controls and procedures were effective at the reasonable assurance level. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended March&#160;31, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="text-indent:36pt"><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_115"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II - OTHER INFORMATION</span></div><div><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_118"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt;text-decoration:underline">Legal Proceedings</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain legal proceedings in which we are involved are discussed in Part I, Item 1. "Financial Statements" of this Form 10-Q in Note 19. Commitments and Contingencies to the Condensed Consolidated Financial Statements, and is incorporated herein by reference. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_121"></div><div style="padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.8pt;text-decoration:underline">Risk Factors</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In evaluating an investment in our common stock, investors should consider carefully, among other things, the risk factors previously disclosed in Part&#160;I,&#160;Item 1A of our 2022 Annual Report on Form&#160;10-K, as well as the information contained in this Quarterly Report, in each case as updated by our periodic reports and registration statements filed with the SEC. There have been no material changes to the risk factors disclosed in Part I. Item 1A of our 2022 Annual Report on Form 10-K.</span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_124"></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt;text-decoration:underline">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase of Equity Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following is a summary of our stock repurchasing activity during the first quarter of 2023:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total number of shares<br/>purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>price&#160;paid<br/>per&#160;share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total number of shares<br/>purchased&#160;as<br/>part&#160;of&#160;a<br/>publicly<br/>announced<br/>program</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">dollar&#160;value&#160;that</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">may&#160;yet&#160;be</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">purchased&#160;under</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">the&#160;program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">01/01/2023 &#8212; 01/31/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">02/01/2023 &#8212; 02/28/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">03/01/2023 &#8212; 03/31/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First quarter of 2023 total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">____________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock purchase plan, which authorized the repurchase of up to $100.0 million of our common stock, was authorized by our Board of Directors and publicly announced in August, 2019.&#160;This plan has no expiration date.  We are not obligated to make any purchases under our stock purchase program. Subject to applicable state and federal corporate and securities laws, purchases under a stock purchase program may be made at such times and in such amounts as we deem appropriate. Purchases made under our stock purchase program can be discontinued at any time we feel additional purchases are not warranted.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div id="if1f54ab03e0c44ba84b642c022c86fca_127"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 6.  Exhibits</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit&#160;Index</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.490%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="icui-ex31133123.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Executive Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="icui-ex31233123.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Financial Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="icui-ex32133123.htm">32.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit10133123.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-employee director compensation.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - this instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="if1f54ab03e0c44ba84b642c022c86fca_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if1f54ab03e0c44ba84b642c022c86fca_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signature</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICU Medical,&#160;Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.146%"><tr><td style="width:1.0%"></td><td style="width:64.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.165%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Brian M. Bonnell</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian M. Bonnell</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Authorized Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit10133123.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ia1848be25e7e4ea29ca686c9c6bca49d_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;10.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Employee Director Compensation</font></div><div style="text-align:center"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently pay our non-employee directors the following&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">annual retainer of $98,500 for the Lead Director  </font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">annual retainer of $102,000 for the Chairperson of the Audit Committee</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">annual retainer of $92,500 for the Chairperson of the Compensation Committee</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">annual retainer of $85,000 for the Chairperson of the Nominating and Governance Committee</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The equity component of the director's compensation is valued at $180,000.  The annual equity package consists of restricted stock units. The restricted stock units vest one year from the grant date or on the date of the Annual Meeting, whichever is earlier.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>icui-ex31133123.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id1b26d44f09a4db9b4712d9d065b35d8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Vivek Jain, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this quarterly report on Form&#160;10-Q of ICU Medical,&#160;Inc.&#59;</font></div><div style="padding-left:36pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:108pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.728%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Vivek Jain</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>icui-ex31233123.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7470cd64afb842d7b569b3d156dc8a4a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian M. Bonnell, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%;padding-left:24pt">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I have reviewed this quarterly report on Form&#160;10-Q of ICU Medical,&#160;Inc.&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt"> Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt"> The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:4.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.547%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brian M. Bonnell</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="text-align:right;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:right;text-indent:36pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>icui-ex32133123.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie4db2ec482d642028f1fae91660456d2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of ICU Medical,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended March&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Vivek Jain, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167;&#160;1350, as adopted pursuant to &#167;&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.189%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.814%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Vivek Jain</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vivek Jain</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(principal executive officer)</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of ICU Medical,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended March&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Brian M. Bonnell, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167;&#160;1350, as adopted pursuant to &#167;&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.189%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.814%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brian M. Bonnell</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian M. Bonnell</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(principal financial officer)</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>icui-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ba7fdc33-2522-46f7-8674-20ba10b1b2fc,g:4240e31b-a7e9-4337-b7b1-c2e4a3947117-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:icui="http://www.icumed.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.icumed.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DEIDocument" roleURI="http://www.icumed.com/role/DEIDocument">
        <link:definition>0000001 - Document - DEI Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>0000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofIncome" roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome">
        <link:definition>0000004 - Statement - Condensed Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome">
        <link:definition>0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical" roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical">
        <link:definition>0000006 - Statement - Condensed Consolidated Statements of Comprehensive Income (Paranthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityStatement" roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement">
        <link:definition>0000007 - Statement - Condensed Consolidated Statements of Stockholders' Equity Statement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>0000008 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.icumed.com/role/BasisofPresentation">
        <link:definition>0000009 - Disclosure - Basis of Presentation:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.icumed.com/role/NewAccountingPronouncements">
        <link:definition>0000010 - Disclosure - New Accounting Pronouncements:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitions" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions">
        <link:definition>0000011 - Disclosure - Business Combinations and Asset Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationNotes" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes">
        <link:definition>0000012 - Disclosure - Restructuring, Strategic Transaction and Integration (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNotes" roleURI="http://www.icumed.com/role/RevenueNotes">
        <link:definition>0000013 - Disclosure - Revenue (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNotes" roleURI="http://www.icumed.com/role/LeasesNotes">
        <link:definition>0000014 - Disclosure - Leases (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShare" roleURI="http://www.icumed.com/role/NetIncomePerShare">
        <link:definition>0000015 - Disclosure - Net Income Per Share:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsNotes" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes">
        <link:definition>0000016 - Disclosure - Derivative Financial Instruments (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresNotes" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes">
        <link:definition>0000017 - Disclosure - Fair Value Measures and Disclosures (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesNotes" roleURI="http://www.icumed.com/role/InvestmentSecuritiesNotes">
        <link:definition>0000018 - Disclosure - Investment Securities (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidsandOtherCurrentAssetsNotes" roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes">
        <link:definition>0000019 - Disclosure - Prepaids and Other Current Assets (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.icumed.com/role/Inventories">
        <link:definition>0000020 - Disclosure - Inventories:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://www.icumed.com/role/PropertyandEquipment">
        <link:definition>0000021 - Disclosure - Property and Equipment:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNotes" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes">
        <link:definition>0000022 - Disclosure - Goodwill and Intangible Assets (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesNotes" roleURI="http://www.icumed.com/role/AccruedLiabilitiesNotes">
        <link:definition>0000023 - Disclosure - Accrued Liabilities (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.icumed.com/role/IncomeTaxes">
        <link:definition>0000024 - Disclosure - Income Taxes:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsNotes" roleURI="http://www.icumed.com/role/LongTermObligationsNotes">
        <link:definition>0000025 - Disclosure - Long-Term Obligations (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.icumed.com/role/CommitmentsandContingencies">
        <link:definition>0000026 - Disclosure - Commitments and Contingencies:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeandOtherArrangementsNotes" roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes">
        <link:definition>0000027 - Disclosure - Collaborative and Other Arrangements (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Equity" roleURI="http://www.icumed.com/role/Equity">
        <link:definition>0000028 - Disclosure - Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TransfersandServicing" roleURI="http://www.icumed.com/role/TransfersandServicing">
        <link:definition>0000029 - Disclosure - Transfers and Servicing</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsNewAccountingPronouncementsAdoptedPolicies" roleURI="http://www.icumed.com/role/NewAccountingPronouncementsNewAccountingPronouncementsAdoptedPolicies">
        <link:definition>0000030 - Disclosure - New Accounting Pronouncements New Accounting Pronouncements Adopted (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitionsTables" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables">
        <link:definition>0000031 - Disclosure - Business Combinations and Asset Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationTables" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables">
        <link:definition>0000032 - Disclosure - Restructuring, Strategic Transaction and Integration (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.icumed.com/role/RevenueTables">
        <link:definition>0000033 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.icumed.com/role/LeasesTables">
        <link:definition>0000034 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareTables" roleURI="http://www.icumed.com/role/NetIncomePerShareTables">
        <link:definition>0000035 - Disclosure - Net Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsTables" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsTables">
        <link:definition>0000036 - Disclosure - Derivative Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresTables" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables">
        <link:definition>0000037 - Disclosure - Fair Value Measures and Disclosures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesTables" roleURI="http://www.icumed.com/role/InvestmentSecuritiesTables">
        <link:definition>0000038 - Disclosure - Investment Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidsandOtherCurrentAssetsTables" roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables">
        <link:definition>0000039 - Disclosure - Prepaids and Other Current Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.icumed.com/role/InventoriesTables">
        <link:definition>0000040 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://www.icumed.com/role/PropertyandEquipmentTables">
        <link:definition>0000041 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>0000042 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesTables" roleURI="http://www.icumed.com/role/AccruedLiabilitiesTables">
        <link:definition>0000043 - Disclosure - Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsTables" roleURI="http://www.icumed.com/role/LongTermObligationsTables">
        <link:definition>0000044 - Disclosure - Long-Term Obligations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeandOtherArrangementsTables" roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsTables">
        <link:definition>0000045 - Disclosure - Collaborative and Other Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityTables" roleURI="http://www.icumed.com/role/EquityTables">
        <link:definition>0000046 - Disclosure - Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TransfersandServicingTables" roleURI="http://www.icumed.com/role/TransfersandServicingTables">
        <link:definition>0000047 - Disclosure - Transfers and Servicing (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails">
        <link:definition>0000048 - Disclosure - Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitionsDetails" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails">
        <link:definition>0000049 - Disclosure - Business Combinations and Asset Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails">
        <link:definition>0000050 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails">
        <link:definition>0000051 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationRestructuringDetails" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails">
        <link:definition>0000052 - Disclosure - Restructuring, Strategic Transaction and Integration Restructuring (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationLiabilityDetails" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails">
        <link:definition>0000053 - Disclosure - Restructuring, Strategic Transaction and Integration Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StrategicTransactionandIntegrationDetails" roleURI="http://www.icumed.com/role/StrategicTransactionandIntegrationDetails">
        <link:definition>0000054 - Disclosure - Strategic Transaction and Integration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDetails" roleURI="http://www.icumed.com/role/RevenueDetails">
        <link:definition>0000055 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregatedRevenuebyGeographyDetails" roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails">
        <link:definition>0000056 - Disclosure - Revenue Disaggregated Revenue by Geography (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregatedRevenuebyProductLineDetails" roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails">
        <link:definition>0000057 - Disclosure - Revenue Disaggregated Revenue by Product Line (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueContractLiabilitiesDetails" roleURI="http://www.icumed.com/role/RevenueContractLiabilitiesDetails">
        <link:definition>0000058 - Disclosure - Revenue Contract Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTextDetails" roleURI="http://www.icumed.com/role/LeasesTextDetails">
        <link:definition>0000059 - Disclosure - Leases Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetails" roleURI="http://www.icumed.com/role/LeasesDetails">
        <link:definition>0000060 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCashFlowOperatingActivitiesLesseeDetails" roleURI="http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails">
        <link:definition>0000061 - Disclosure - Leases Cash Flow, Operating Activities, Lessee (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAssetsandLiabilitiesLesseeDetails" roleURI="http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails">
        <link:definition>0000062 - Disclosure - Leases Assets and Liabilities, Lessee (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturityDetails" roleURI="http://www.icumed.com/role/LeasesMaturityDetails">
        <link:definition>0000063 - Disclosure - Leases Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareDetails" roleURI="http://www.icumed.com/role/NetIncomePerShareDetails">
        <link:definition>0000064 - Disclosure - Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareDetails1" roleURI="http://www.icumed.com/role/NetIncomePerShareDetails1">
        <link:definition>0000065 - Disclosure - Net Income Per Share (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails">
        <link:definition>0000066 - Disclosure - Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails">
        <link:definition>0000067 - Disclosure - Derivative Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsInterestRateSwapsDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails">
        <link:definition>0000068 - Disclosure - Derivative Financial Instruments Interest Rate Swaps (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails">
        <link:definition>0000069 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>0000070 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails">
        <link:definition>0000071 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresDetails" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails">
        <link:definition>0000072 - Disclosure - Fair Value Measures and Disclosures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails">
        <link:definition>0000073 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails">
        <link:definition>0000074 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails">
        <link:definition>0000075 - Disclosure - Fair Value Measures and Disclosures Liability Measurement Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails">
        <link:definition>0000076 - Disclosure - Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesDetails" roleURI="http://www.icumed.com/role/InvestmentSecuritiesDetails">
        <link:definition>0000077 - Disclosure - Investment Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesTableDetails" roleURI="http://www.icumed.com/role/InvestmentSecuritiesTableDetails">
        <link:definition>0000078 - Disclosure - Investment Securities Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestmentsDetails" roleURI="http://www.icumed.com/role/EquityMethodInvestmentsDetails">
        <link:definition>0000079 - Disclosure - Equity Method Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails" roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails">
        <link:definition>0000080 - Disclosure - Prepaids and Other Current Assets Prepaids and Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsNoncurrentDetails" roleURI="http://www.icumed.com/role/OtherAssetsNoncurrentDetails">
        <link:definition>0000081 - Disclosure - Other Assets Noncurrent(Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.icumed.com/role/InventoriesDetails">
        <link:definition>0000082 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentDetails" roleURI="http://www.icumed.com/role/PropertyandEquipmentDetails">
        <link:definition>0000083 - Disclosure - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTextDetails" roleURI="http://www.icumed.com/role/PropertyandEquipmentTextDetails">
        <link:definition>0000084 - Disclosure - Property and Equipment Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsGoodwillTableDetails" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails">
        <link:definition>0000085 - Disclosure - Goodwill and Intangible Assets Goodwill Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsIntangiblesTableDetails" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails">
        <link:definition>0000086 - Disclosure - Goodwill and Intangible Assets Intangibles Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTextDetails" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails">
        <link:definition>0000087 - Disclosure - Goodwill and Intangible Assets Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets5YearAmortizationDetails" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails">
        <link:definition>0000088 - Disclosure - Goodwill and Intangible Assets 5-Year Amortization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesDetails" roleURI="http://www.icumed.com/role/AccruedLiabilitiesDetails">
        <link:definition>0000089 - Disclosure - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesLongtermliabilitiesDetails" roleURI="http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails">
        <link:definition>0000090 - Disclosure - Accrued Liabilities Long-term liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectivetaxrateDetails" roleURI="http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails">
        <link:definition>0000091 - Disclosure - Income Taxes Effective tax rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsDetails" roleURI="http://www.icumed.com/role/LongTermObligationsDetails">
        <link:definition>0000092 - Disclosure - Long-Term Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsInterestRateTermsDetails" roleURI="http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails">
        <link:definition>0000093 - Disclosure - Long-Term Obligations Interest Rate Terms (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsTerminatedCreditAgreementDetails" roleURI="http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails">
        <link:definition>0000094 - Disclosure - Long-Term Obligations Terminated Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsTableDetails" roleURI="http://www.icumed.com/role/LongTermObligationsTableDetails">
        <link:definition>0000095 - Disclosure - Long-Term Obligations Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsScheduleofMaturitiesDetails" roleURI="http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails">
        <link:definition>0000096 - Disclosure - Long-Term Obligations Schedule of Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsInterestExpenseDetails" roleURI="http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails">
        <link:definition>0000097 - Disclosure - Long-Term Obligations Interest Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsPrincipalPaymentDetails" roleURI="http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails">
        <link:definition>0000098 - Disclosure - Long-Term Obligations Principal Payment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesContingencyDetails" roleURI="http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails">
        <link:definition>0000099 - Disclosure - Commitments and Contingencies Contingency (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeandOtherArrangementsDetails" roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails">
        <link:definition>0000100 - Disclosure - Collaborative and Other Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityDetails" roleURI="http://www.icumed.com/role/EquityDetails">
        <link:definition>0000101 - Disclosure - Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>0000102 - Disclosure - Equity Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TransfersandServicingDetails" roleURI="http://www.icumed.com/role/TransfersandServicingDetails">
        <link:definition>0000103 - Disclosure - Transfers and Servicing (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="icui_ApplicableMarginBaseRateLoans" abstract="false" name="ApplicableMarginBaseRateLoans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_CurrentMember" abstract="true" name="CurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_SmithsGroupOwnershipAcquisitionSharesIssued" abstract="false" name="SmithsGroupOwnershipAcquisitionSharesIssued" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_PursuitVascularInc.Member" abstract="true" name="PursuitVascularInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_VitalCareMember" abstract="true" name="VitalCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_DevelopedTechnologyMember" abstract="true" name="DevelopedTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ProFormaAdjustmentFinanceCosts" abstract="false" name="ProFormaAdjustmentFinanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_RevolverSubLimits" abstract="false" name="RevolverSubLimits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Restructuringstrategictransactionandintegration" abstract="false" name="Restructuringstrategictransactionandintegration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ApplicableMarginBasedOnLeverageRatioTable" abstract="true" name="ApplicableMarginBasedOnLeverageRatioTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_SmithsGroupOwnershipRequiredForBoardRepresentation" abstract="false" name="SmithsGroupOwnershipRequiredForBoardRepresentation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_SoftwarerevenueMember" abstract="true" name="SoftwarerevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TimingAxis" abstract="true" name="TimingAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" abstract="false" name="IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Optiontoextendinyears" abstract="false" name="Optiontoextendinyears" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="icui_OwnershipRequirementForEarnoutPayment" abstract="false" name="OwnershipRequirementForEarnoutPayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_TermLoanBPrincipalPayment" abstract="false" name="TermLoanBPrincipalPayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_RequiredShareHoldingOfStockIssuedAtAcquisition" abstract="false" name="RequiredShareHoldingOfStockIssuedAtAcquisition" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" abstract="false" name="BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_LeverageRatioLevelDomain" abstract="true" name="LeverageRatioLevelDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_GovernmentGrantRevenueMember" abstract="true" name="GovernmentGrantRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_AccruedResearchAndDevelopment" abstract="false" name="AccruedResearchAndDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Greaterthan400to100Member" abstract="true" name="Greaterthan400to100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_AssetsandLiabilitiesLeasesTableTextBlock" abstract="false" name="AssetsandLiabilitiesLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_ShortTermMember" abstract="true" name="ShortTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_LOngTermObligationsDisclosureAbstract" abstract="true" name="LOngTermObligationsDisclosureAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_TermLoanAxis" abstract="true" name="TermLoanAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_ContractassetandliabilitybalancesLineItems" abstract="true" name="ContractassetandliabilitybalancesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_NoncurrentMember" abstract="true" name="NoncurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_AccruedSalariesAndBenefits" abstract="false" name="AccruedSalariesAndBenefits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ProvisionForWarrantyAndReturns" abstract="false" name="ProvisionForWarrantyAndReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Prepaidothertaxes" abstract="false" name="Prepaidothertaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Prepaidinsuranceandpropertytaxes" abstract="false" name="Prepaidinsuranceandpropertytaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_CommonStockSharesMember" abstract="true" name="CommonStockSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Accruedfreight" abstract="false" name="Accruedfreight" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_AccruedAuditFees" abstract="false" name="AccruedAuditFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Deferredtaxcharge" abstract="false" name="Deferredtaxcharge" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_LongTermMember" abstract="true" name="LongTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ProFormaAdjustmentAmortization" abstract="false" name="ProFormaAdjustmentAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_InstrumentsPlacedwithCustomersMember" abstract="true" name="InstrumentsPlacedwithCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ClassificationDomain" abstract="true" name="ClassificationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ComputerEquipmentAndSoftwareMember" abstract="true" name="ComputerEquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Restructuringandstrategictransaction" abstract="false" name="Restructuringandstrategictransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_AmortizationOfInventoryStepUp" abstract="false" name="AmortizationOfInventoryStepUp" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_LeverageRatioCalculationCeilingSubtractedAmount" abstract="false" name="LeverageRatioCalculationCeilingSubtractedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_InternationalDistributorMember" abstract="true" name="InternationalDistributorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_CashRemittedToPurchaser" abstract="false" name="CashRemittedToPurchaser" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_InfusionConsumablesMember" abstract="true" name="InfusionConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ContractassetandliabilitybalancesTable" abstract="true" name="ContractassetandliabilitybalancesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_InterestRateSwapEndingNotionalValue" abstract="false" name="InterestRateSwapEndingNotionalValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TermLoanDomain" abstract="true" name="TermLoanDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Outsidesalescommissions" abstract="false" name="Outsidesalescommissions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TermLoanBMember" abstract="true" name="TermLoanBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_NetCashPaidReceivedforcurrentandprioracquisitions" abstract="false" name="NetCashPaidReceivedforcurrentandprioracquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_LessThan275To100Member" abstract="true" name="LessThan275To100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Accruedothertaxes" abstract="false" name="Accruedothertaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Accruedlegalfees" abstract="false" name="Accruedlegalfees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" abstract="false" name="ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_StrategicTransactionandIntegration" abstract="false" name="StrategicTransactionandIntegration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_BusinessCombinationGoodwillNonDeductible" abstract="false" name="BusinessCombinationGoodwillNonDeductible" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TermAPrincipalPaymentFirst2Years" abstract="false" name="TermAPrincipalPaymentFirst2Years" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_Srt_MultipleCurrencyAxisDomain" abstract="true" name="Srt_MultipleCurrencyAxisDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_EarnoutliabilityMember" abstract="true" name="EarnoutliabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" abstract="true" name="LessThanOrEqualTo400To100ButGreaterThan300To100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" abstract="false" name="PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_InterestPercentageAddedToBaseRate" abstract="false" name="InterestPercentageAddedToBaseRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_SmithsMedicalMember" abstract="true" name="SmithsMedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ContingentConsiderationTaxExpense" abstract="false" name="ContingentConsiderationTaxExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_GreaterThan275To100Member" abstract="true" name="GreaterThan275To100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_DerivativeVariableRateFloor" abstract="false" name="DerivativeVariableRateFloor" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_OtherCurrenciesMember" abstract="true" name="OtherCurrenciesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_MinimumStockPriceTargetForEarnOutPayment" abstract="false" name="MinimumStockPriceTargetForEarnOutPayment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_FieldServiceCorrectiveAction" abstract="false" name="FieldServiceCorrectiveAction" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Contingentconsiderationgross" abstract="false" name="Contingentconsiderationgross" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_OtherDeferredRevenueMember" abstract="true" name="OtherDeferredRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TotalSeniorSecuredCreditFacility" abstract="false" name="TotalSeniorSecuredCreditFacility" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_BusinessCombinationConsiderationTransferredCash" abstract="false" name="BusinessCombinationConsiderationTransferredCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ApplicableMarginTermSOFRLoans" abstract="false" name="ApplicableMarginTermSOFRLoans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_ForeignInfusionSystemSupplierMember" abstract="true" name="ForeignInfusionSystemSupplierMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_InfusionSystemsMember" abstract="true" name="InfusionSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_EquipmentrevenueMember" abstract="true" name="EquipmentrevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" abstract="false" name="TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_ApplicableMarginBasedOnLeverageRatioLineItems" abstract="true" name="ApplicableMarginBasedOnLeverageRatioLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_Srt_MultipleCurrencyAxisAxis" abstract="true" name="Srt_MultipleCurrencyAxisAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_SpareParts" abstract="false" name="SpareParts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_PrepaidVendorExpenses" abstract="false" name="PrepaidVendorExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Hedge2Member" abstract="true" name="Hedge2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ContingentConsiderationGrossST" abstract="false" name="ContingentConsiderationGrossST" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TreasuryStockPurchasePlan" abstract="false" name="TreasuryStockPurchasePlan" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_LessThanOrEqual300To100ButGreaterThan250to100Member" abstract="true" name="LessThanOrEqual300To100ButGreaterThan250to100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_OtherforeigncountriesMember" abstract="true" name="OtherforeigncountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_InterestPercentageAddedToFederalFundsRate" abstract="false" name="InterestPercentageAddedToFederalFundsRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_LessThanOrEqualTo200To100Member" abstract="true" name="LessThanOrEqualTo200To100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TermLoanAMember" abstract="true" name="TermLoanAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_MoldsMember" abstract="true" name="MoldsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" abstract="false" name="ApplicableMarginBasedOnLeverageRatioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_CurrencyTranslationOnEarnOut" abstract="false" name="CurrencyTranslationOnEarnOut" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_UnfavorablecontractliabilityST" abstract="false" name="UnfavorablecontractliabilityST" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_NonPublicCompanyMember" abstract="true" name="NonPublicCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" abstract="false" name="InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" abstract="false" name="TerSOFRInterestRateAdjustmentForBaseRateLoans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_TermAPrincipalPaymentYear3And4" abstract="false" name="TermAPrincipalPaymentYear3And4" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_TermAPrincipalPaymentInYear5" abstract="false" name="TermAPrincipalPaymentInYear5" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_ClassificationAxis" abstract="true" name="ClassificationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_InterestExpenseOnLongTermDebtTableTextBlock" abstract="false" name="InterestExpenseOnLongTermDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_DocumentAndEntityInformationAbstract" abstract="true" name="DocumentAndEntityInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_TimingDomain" abstract="true" name="TimingDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ContingentConsiderationGrossLT" abstract="false" name="ContingentConsiderationGrossLT" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_LeverageRatioLevelAxis" abstract="true" name="LeverageRatioLevelAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" abstract="true" name="LessThanOrEqualTo250To100ButGreaterThan200To100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Sparepartsusage" abstract="false" name="Sparepartsusage" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>icui-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ba7fdc33-2522-46f7-8674-20ba10b1b2fc,g:4240e31b-a7e9-4337-b7b1-c2e4a3947117-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="icui-20230331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8d873580-b8be-40c8-9d24-6d61656be955" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a17001f6-5203-44c6-ace1-9b50e10e8ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8d873580-b8be-40c8-9d24-6d61656be955" xlink:to="loc_us-gaap_AccountsPayableCurrent_a17001f6-5203-44c6-ace1-9b50e10e8ef8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4f59e08b-708d-496f-9737-20d70d5a61df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8d873580-b8be-40c8-9d24-6d61656be955" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4f59e08b-708d-496f-9737-20d70d5a61df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_12a9c699-fd85-4c49-912c-8f06f6213929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8d873580-b8be-40c8-9d24-6d61656be955" xlink:to="loc_us-gaap_LongTermDebtCurrent_12a9c699-fd85-4c49-912c-8f06f6213929" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_70da2724-08cc-45be-98a3-b0398101a079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8d873580-b8be-40c8-9d24-6d61656be955" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_70da2724-08cc-45be-98a3-b0398101a079" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_411e3521-1817-4318-9f04-53adb1e4f076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_8dbfb7f1-26c0-4b5d-aa3f-157f342e0b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_411e3521-1817-4318-9f04-53adb1e4f076" xlink:to="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_8dbfb7f1-26c0-4b5d-aa3f-157f342e0b89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a48de06b-a2e4-41c6-8eae-ff9ba85768de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_411e3521-1817-4318-9f04-53adb1e4f076" xlink:to="loc_us-gaap_CommonStockValue_a48de06b-a2e4-41c6-8eae-ff9ba85768de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4a36db33-f75d-4c19-94f5-8cadef7f684a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_411e3521-1817-4318-9f04-53adb1e4f076" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4a36db33-f75d-4c19-94f5-8cadef7f684a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_438ddc67-87f8-45d6-a192-96d0e6aeea63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_411e3521-1817-4318-9f04-53adb1e4f076" xlink:to="loc_us-gaap_TreasuryStockValue_438ddc67-87f8-45d6-a192-96d0e6aeea63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_dcd176d4-40a2-43cb-a87e-78e10eff3381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_411e3521-1817-4318-9f04-53adb1e4f076" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_dcd176d4-40a2-43cb-a87e-78e10eff3381" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_eb19e948-c34a-4116-b7e7-3cc49ec6f0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_411e3521-1817-4318-9f04-53adb1e4f076" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_eb19e948-c34a-4116-b7e7-3cc49ec6f0e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_14a0ddc5-7bef-42da-870b-ecf5bcbc6b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_28698f02-7997-4a5b-b3b2-d6a85d876a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_14a0ddc5-7bef-42da-870b-ecf5bcbc6b89" xlink:to="loc_us-gaap_AssetsCurrent_28698f02-7997-4a5b-b3b2-d6a85d876a3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4014ce2f-3a5f-4253-82cd-53313144320a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_14a0ddc5-7bef-42da-870b-ecf5bcbc6b89" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4014ce2f-3a5f-4253-82cd-53313144320a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1c86b656-f597-40e7-992a-1033e4a97655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_14a0ddc5-7bef-42da-870b-ecf5bcbc6b89" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1c86b656-f597-40e7-992a-1033e4a97655" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_55e572a2-3e2e-4c6c-aa1c-3e7d09689e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_14a0ddc5-7bef-42da-870b-ecf5bcbc6b89" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_55e572a2-3e2e-4c6c-aa1c-3e7d09689e1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_81c0e4a2-1959-4047-a2c0-d6b3daba8348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_14a0ddc5-7bef-42da-870b-ecf5bcbc6b89" xlink:to="loc_us-gaap_Goodwill_81c0e4a2-1959-4047-a2c0-d6b3daba8348" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1926ccff-45b9-4d10-99a2-c77a3a17d9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_14a0ddc5-7bef-42da-870b-ecf5bcbc6b89" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1926ccff-45b9-4d10-99a2-c77a3a17d9bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_6e122bd6-1579-4044-9996-44c02a8ac7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_14a0ddc5-7bef-42da-870b-ecf5bcbc6b89" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_6e122bd6-1579-4044-9996-44c02a8ac7ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_0a3863eb-cc6f-4abe-ab8d-b4fcb2510a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_14a0ddc5-7bef-42da-870b-ecf5bcbc6b89" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_0a3863eb-cc6f-4abe-ab8d-b4fcb2510a0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_60700be8-296a-41a8-8486-f0645715169b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_f5e5b216-6d4f-448d-a4c8-5ee5bb62253a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_60700be8-296a-41a8-8486-f0645715169b" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_f5e5b216-6d4f-448d-a4c8-5ee5bb62253a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2b51c3de-7f82-457a-b852-cafdb53dfe2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_60700be8-296a-41a8-8486-f0645715169b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_2b51c3de-7f82-457a-b852-cafdb53dfe2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f9447d4a-af3e-4b68-ab4b-13b3fdb2789f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_60700be8-296a-41a8-8486-f0645715169b" xlink:to="loc_us-gaap_InventoryNet_f9447d4a-af3e-4b68-ab4b-13b3fdb2789f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_b1329a81-73c7-435d-83a1-9d7a9c959528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_60700be8-296a-41a8-8486-f0645715169b" xlink:to="loc_us-gaap_PrepaidTaxes_b1329a81-73c7-435d-83a1-9d7a9c959528" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cf16ce2d-494d-4a71-a316-c760cbe9a07c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_60700be8-296a-41a8-8486-f0645715169b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cf16ce2d-494d-4a71-a316-c760cbe9a07c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_f08fd3e4-6e7e-40ee-8997-90a51242a70d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b28262d2-b433-48ae-aebb-1c5b9d70c07b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_f08fd3e4-6e7e-40ee-8997-90a51242a70d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b28262d2-b433-48ae-aebb-1c5b9d70c07b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_f1a0ca1e-2d50-406e-b403-5b2f3b96162d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_f08fd3e4-6e7e-40ee-8997-90a51242a70d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_f1a0ca1e-2d50-406e-b403-5b2f3b96162d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9d792d6-7aa1-4953-bcf3-b2f0ce656ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a2947ec3-17e5-4538-bb2c-702239ab221f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9d792d6-7aa1-4953-bcf3-b2f0ce656ffb" xlink:to="loc_us-gaap_LiabilitiesCurrent_a2947ec3-17e5-4538-bb2c-702239ab221f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_6bf88ee1-9129-401e-8cbf-081d36181fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9d792d6-7aa1-4953-bcf3-b2f0ce656ffb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_6bf88ee1-9129-401e-8cbf-081d36181fdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f282564b-8fba-4e19-947f-84e31684d995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9d792d6-7aa1-4953-bcf3-b2f0ce656ffb" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f282564b-8fba-4e19-947f-84e31684d995" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_cc354bed-8105-4944-a5dc-d455e98b2c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9d792d6-7aa1-4953-bcf3-b2f0ce656ffb" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_cc354bed-8105-4944-a5dc-d455e98b2c36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_08a6fece-ec13-40fa-826a-223764f78806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9d792d6-7aa1-4953-bcf3-b2f0ce656ffb" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_08a6fece-ec13-40fa-826a-223764f78806" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_2a8c4c00-2b2d-48ca-8863-8624be14666d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9d792d6-7aa1-4953-bcf3-b2f0ce656ffb" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_2a8c4c00-2b2d-48ca-8863-8624be14666d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e7b23f9-d6fa-4ba8-aca7-4d4b7c667fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9d792d6-7aa1-4953-bcf3-b2f0ce656ffb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e7b23f9-d6fa-4ba8-aca7-4d4b7c667fb6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="icui-20230331.xsd#CondensedConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_fadb6de2-8998-4c5e-8cfd-dd20afcfbdc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ffa47cb4-c211-4985-8f2e-a2b50581fec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_fadb6de2-8998-4c5e-8cfd-dd20afcfbdc2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ffa47cb4-c211-4985-8f2e-a2b50581fec4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_92aafd26-52a7-4657-bec2-8291518082b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_fadb6de2-8998-4c5e-8cfd-dd20afcfbdc2" xlink:to="loc_us-gaap_CostOfRevenue_92aafd26-52a7-4657-bec2-8291518082b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_2ac2ebdf-77eb-4d9c-9b0f-5ec60e47f1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0ee19c9f-764c-4b52-a839-5b4cb22e5104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2ac2ebdf-77eb-4d9c-9b0f-5ec60e47f1c5" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0ee19c9f-764c-4b52-a839-5b4cb22e5104" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_9d481181-081e-4674-a31c-88443b8594e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2ac2ebdf-77eb-4d9c-9b0f-5ec60e47f1c5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_9d481181-081e-4674-a31c-88443b8594e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransaction_70e23fa7-fc2e-465b-aa68-63b00ac442ab" xlink:href="icui-20230331.xsd#icui_Restructuringandstrategictransaction"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2ac2ebdf-77eb-4d9c-9b0f-5ec60e47f1c5" xlink:to="loc_icui_Restructuringandstrategictransaction_70e23fa7-fc2e-465b-aa68-63b00ac442ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b0961b7e-c896-48f8-a5e6-1a98395b33fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2ac2ebdf-77eb-4d9c-9b0f-5ec60e47f1c5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b0961b7e-c896-48f8-a5e6-1a98395b33fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_73812560-1767-44a7-9635-8c94ab1e04aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_77cef05e-604b-4edc-9109-97407dd1afd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_73812560-1767-44a7-9635-8c94ab1e04aa" xlink:to="loc_us-gaap_GrossProfit_77cef05e-604b-4edc-9109-97407dd1afd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_b5c057c8-57a4-4689-aa52-56ff6d5d1ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_73812560-1767-44a7-9635-8c94ab1e04aa" xlink:to="loc_us-gaap_OperatingExpenses_b5c057c8-57a4-4689-aa52-56ff6d5d1ce9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ea2ba7c7-2809-4011-9b76-9542f09366de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_688817fd-23b2-449a-ba7d-481456cf74a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ea2ba7c7-2809-4011-9b76-9542f09366de" xlink:to="loc_us-gaap_OperatingIncomeLoss_688817fd-23b2-449a-ba7d-481456cf74a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_97b0f69b-a5ac-4dca-a1f6-78b901ea50ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ea2ba7c7-2809-4011-9b76-9542f09366de" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_97b0f69b-a5ac-4dca-a1f6-78b901ea50ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_afa9d699-e045-4e47-947f-c201868e48db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ea2ba7c7-2809-4011-9b76-9542f09366de" xlink:to="loc_us-gaap_InterestExpense_afa9d699-e045-4e47-947f-c201868e48db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6389d77f-ab0e-401f-9941-75a1e1ccb539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_268f229b-25c2-4e22-8a69-da45a5d8cc77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_6389d77f-ab0e-401f-9941-75a1e1ccb539" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_268f229b-25c2-4e22-8a69-da45a5d8cc77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5468ce4c-9abf-4b23-b92a-cacd18f8fc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_6389d77f-ab0e-401f-9941-75a1e1ccb539" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5468ce4c-9abf-4b23-b92a-cacd18f8fc6c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="icui-20230331.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_58027f93-88c3-42f9-b5ed-c3d48b3aed4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_13a19d57-99b7-45e3-a827-afc6ed10a157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_58027f93-88c3-42f9-b5ed-c3d48b3aed4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_13a19d57-99b7-45e3-a827-afc6ed10a157" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_feb9c2e9-a0d8-4cc1-b879-9061acfab568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_58027f93-88c3-42f9-b5ed-c3d48b3aed4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_feb9c2e9-a0d8-4cc1-b879-9061acfab568" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_8b09498a-91a0-4e12-b80a-fa6678e4c25e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_58027f93-88c3-42f9-b5ed-c3d48b3aed4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_8b09498a-91a0-4e12-b80a-fa6678e4c25e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e1e2704a-e5bd-4785-8da7-ac617ab31f03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6c0f237d-32b7-4c70-9ec5-d40d32f7aa95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e1e2704a-e5bd-4785-8da7-ac617ab31f03" xlink:to="loc_us-gaap_ProfitLoss_6c0f237d-32b7-4c70-9ec5-d40d32f7aa95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9de4f38a-35d6-4c5e-b2c8-c38d6472b1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e1e2704a-e5bd-4785-8da7-ac617ab31f03" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9de4f38a-35d6-4c5e-b2c8-c38d6472b1b5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="icui-20230331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aed2ae91-4f9c-4d4e-a865-1b1433900498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_d670b06b-e94e-4a39-803c-2ff3abdd430f" xlink:href="icui-20230331.xsd#icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aed2ae91-4f9c-4d4e-a865-1b1433900498" xlink:to="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_d670b06b-e94e-4a39-803c-2ff3abdd430f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2d008a7b-7e92-4f9f-a59c-c813a4940cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aed2ae91-4f9c-4d4e-a865-1b1433900498" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_2d008a7b-7e92-4f9f-a59c-c813a4940cd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_17f9e693-31a7-4ad8-8b88-30ffe9172599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aed2ae91-4f9c-4d4e-a865-1b1433900498" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_17f9e693-31a7-4ad8-8b88-30ffe9172599" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_c9780042-46e6-4f25-9730-03e5e30f9c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aed2ae91-4f9c-4d4e-a865-1b1433900498" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_c9780042-46e6-4f25-9730-03e5e30f9c04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_fa8f46b0-2d0d-4414-88ac-cad31c0c739e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aed2ae91-4f9c-4d4e-a865-1b1433900498" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_fa8f46b0-2d0d-4414-88ac-cad31c0c739e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_723cc0cc-fa55-4249-ad43-4baeeeee70dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aed2ae91-4f9c-4d4e-a865-1b1433900498" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_723cc0cc-fa55-4249-ad43-4baeeeee70dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c14dbb29-f768-4c05-b01d-b88820351a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_933f7105-a6bb-4313-819e-fb25a8a040c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c14dbb29-f768-4c05-b01d-b88820351a49" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_933f7105-a6bb-4313-819e-fb25a8a040c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_b7b23ef4-3639-46da-aa96-ed8447edf167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c14dbb29-f768-4c05-b01d-b88820351a49" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_b7b23ef4-3639-46da-aa96-ed8447edf167" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_466e67d2-8251-438e-b356-0f999cef342c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c14dbb29-f768-4c05-b01d-b88820351a49" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_466e67d2-8251-438e-b356-0f999cef342c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_51ccfcf1-2578-48d1-8fb1-92af45fed5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c14dbb29-f768-4c05-b01d-b88820351a49" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_51ccfcf1-2578-48d1-8fb1-92af45fed5ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_c541397c-9e4c-428e-a19f-e604c0089cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c14dbb29-f768-4c05-b01d-b88820351a49" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_c541397c-9e4c-428e-a19f-e604c0089cf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_05e958d3-e451-4ce7-a3f0-eb1f8be67295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c14dbb29-f768-4c05-b01d-b88820351a49" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_05e958d3-e451-4ce7-a3f0-eb1f8be67295" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d2856663-94b3-40f2-9368-7fcac2bf341f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1b77172a-1902-4ba1-b934-54e3cd08176c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d2856663-94b3-40f2-9368-7fcac2bf341f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1b77172a-1902-4ba1-b934-54e3cd08176c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8c48ac9e-32b8-4f3b-b344-3db69321d889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d2856663-94b3-40f2-9368-7fcac2bf341f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8c48ac9e-32b8-4f3b-b344-3db69321d889" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ce5bf4ae-fc2f-4ed0-a908-8e0c4983c47e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d2856663-94b3-40f2-9368-7fcac2bf341f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ce5bf4ae-fc2f-4ed0-a908-8e0c4983c47e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6d1d0d72-63f2-47e3-8dc3-2cb2c16a8b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d2856663-94b3-40f2-9368-7fcac2bf341f" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6d1d0d72-63f2-47e3-8dc3-2cb2c16a8b89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d530f978-e25f-409b-8931-8eee7580aff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_us-gaap_ProfitLoss_d530f978-e25f-409b-8931-8eee7580aff7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ac6c73e1-2bed-4126-81c9-777f37550f22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ac6c73e1-2bed-4126-81c9-777f37550f22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AmortizationOfInventoryStepUp_653a85bb-558b-4fd3-b99c-a00f460a1a29" xlink:href="icui-20230331.xsd#icui_AmortizationOfInventoryStepUp"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_icui_AmortizationOfInventoryStepUp_653a85bb-558b-4fd3-b99c-a00f460a1a29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_021f36fd-5d80-4da5-b611-404985ddc38b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_021f36fd-5d80-4da5-b611-404985ddc38b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_761f2e6f-bb81-4117-9a42-75ed8a4cbf9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_761f2e6f-bb81-4117-9a42-75ed8a4cbf9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProvisionForWarrantyAndReturns_8ed25994-bda8-49fc-85b6-13888731037c" xlink:href="icui-20230331.xsd#icui_ProvisionForWarrantyAndReturns"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_icui_ProvisionForWarrantyAndReturns_8ed25994-bda8-49fc-85b6-13888731037c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7b8ce1a5-cb93-42e3-87b5-994c62aeb947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_us-gaap_ShareBasedCompensation_7b8ce1a5-cb93-42e3-87b5-994c62aeb947" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_f41e6caa-10ad-4cba-872d-cc76b69eac3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_f41e6caa-10ad-4cba-872d-cc76b69eac3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_0a9efd9c-776e-4805-99c8-ac01ce571660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_0a9efd9c-776e-4805-99c8-ac01ce571660" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_b0dc0327-588d-4389-b9a8-7c0a82a798d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_b0dc0327-588d-4389-b9a8-7c0a82a798d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sparepartsusage_3cf4236d-62ce-42d6-91fe-f311a05447b3" xlink:href="icui-20230331.xsd#icui_Sparepartsusage"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_icui_Sparepartsusage_3cf4236d-62ce-42d6-91fe-f311a05447b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_77ed2f1e-a0e4-4951-9227-521040539e30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_77ed2f1e-a0e4-4951-9227-521040539e30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f0e46e84-b500-4c54-9014-c2ac456eb0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f0e46e84-b500-4c54-9014-c2ac456eb0e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_5784a34c-85c7-4fbe-8651-156c113cfcc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_5784a34c-85c7-4fbe-8651-156c113cfcc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b2e0b82c-83d1-4667-b681-841da398ead8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b2e0b82c-83d1-4667-b681-841da398ead8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_18c748f4-81f5-4c0d-bad3-b0abd95b11dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_18c748f4-81f5-4c0d-bad3-b0abd95b11dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_57845e35-e138-4b0b-8c09-2f4cc0d16160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_57845e35-e138-4b0b-8c09-2f4cc0d16160" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_ecfe6d80-9d48-4e6f-a3e7-04dd04811238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_ecfe6d80-9d48-4e6f-a3e7-04dd04811238" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_50a10d1d-ac1b-4c79-9899-b4773ed64f62" xlink:href="icui-20230331.xsd#icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_50a10d1d-ac1b-4c79-9899-b4773ed64f62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c9695a2d-416e-49c9-b02c-ab00e9e6e1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_575bffe3-fded-446e-bfaa-e890c83da0b2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c9695a2d-416e-49c9-b02c-ab00e9e6e1f4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InventoriesDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_21e0f324-e323-4d56-9eb4-ecdc20c6c534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_3b59122c-0181-47f2-b419-435f33d711c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_21e0f324-e323-4d56-9eb4-ecdc20c6c534" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_3b59122c-0181-47f2-b419-435f33d711c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_0b11ec89-1ab0-4f21-a775-332c48af0790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_21e0f324-e323-4d56-9eb4-ecdc20c6c534" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_0b11ec89-1ab0-4f21-a775-332c48af0790" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_eed20866-dfe3-4dcb-b99f-2b3a1fe0ed81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_21e0f324-e323-4d56-9eb4-ecdc20c6c534" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_eed20866-dfe3-4dcb-b99f-2b3a1fe0ed81" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#PropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3fe08b25-05cf-45c5-be5f-b72d42e63df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c029292c-e589-43fa-86ff-55e2539ffcf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_3fe08b25-05cf-45c5-be5f-b72d42e63df9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c029292c-e589-43fa-86ff-55e2539ffcf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d70ba170-a804-49ff-832f-44c7f407497c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_3fe08b25-05cf-45c5-be5f-b72d42e63df9" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d70ba170-a804-49ff-832f-44c7f407497c" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>icui-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ba7fdc33-2522-46f7-8674-20ba10b1b2fc,g:4240e31b-a7e9-4337-b7b1-c2e4a3947117-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="icui-20230331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" id="i54ee5f3c66df4e628f255b029e267509_CondensedConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b3cd2f82-4464-4f5d-9b11-52bf469fd2be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b3cd2f82-4464-4f5d-9b11-52bf469fd2be" xlink:to="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_53899daf-ee73-4a50-9987-e949652918aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_53899daf-ee73-4a50-9987-e949652918aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3dbb83cc-7adb-424e-89ad-39bf66170d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3dbb83cc-7adb-424e-89ad-39bf66170d1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_b6178c8d-2a71-48e1-8beb-7d1d1d9e0b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_b6178c8d-2a71-48e1-8beb-7d1d1d9e0b6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_5253215a-d88e-4580-bdd3-810be2641455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_5253215a-d88e-4580-bdd3-810be2641455" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0396eac6-74ba-4baa-8e20-a0495507ff08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:to="loc_us-gaap_InventoryNet_0396eac6-74ba-4baa-8e20-a0495507ff08" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_5e030a96-714a-46f7-b3f4-8e2dc812c864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:to="loc_us-gaap_PrepaidTaxes_5e030a96-714a-46f7-b3f4-8e2dc812c864" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a71c26c2-66f7-4708-a98a-e923edc63e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a71c26c2-66f7-4708-a98a-e923edc63e02" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1476e5f2-2c8b-48ac-a9f9-be1047fdc7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:to="loc_us-gaap_AssetsCurrent_1476e5f2-2c8b-48ac-a9f9-be1047fdc7e1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_70d669c2-0876-49ca-a3d3-7feff8029702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_70d669c2-0876-49ca-a3d3-7feff8029702" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b712f687-3e4f-477f-b236-3f34281b81d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b712f687-3e4f-477f-b236-3f34281b81d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_7a94d4f0-1bc1-48ad-8da9-ebcf4c585657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_7a94d4f0-1bc1-48ad-8da9-ebcf4c585657" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_53c87b6c-3880-4d46-b7e7-3855f5e66ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_Goodwill_53c87b6c-3880-4d46-b7e7-3855f5e66ad2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d1df6a56-f378-408a-a73c-1bed423e6e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d1df6a56-f378-408a-a73c-1bed423e6e36" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_315a71d9-da2f-4eab-99ae-f2186e7f00c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_315a71d9-da2f-4eab-99ae-f2186e7f00c7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_90386152-71f5-44c8-8b90-4f4299a519cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_90386152-71f5-44c8-8b90-4f4299a519cc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_336fbf6f-e133-4fa2-ba7c-071a4a3d2474" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_Assets_336fbf6f-e133-4fa2-ba7c-071a4a3d2474" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b3cd2f82-4464-4f5d-9b11-52bf469fd2be" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_8824228e-16ea-49f6-b878-6c4861cf9600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_8824228e-16ea-49f6-b878-6c4861cf9600" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7ac28d4b-1963-4367-bb11-c86df3572011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8824228e-16ea-49f6-b878-6c4861cf9600" xlink:to="loc_us-gaap_AccountsPayableCurrent_7ac28d4b-1963-4367-bb11-c86df3572011" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a5b16eb7-49dc-474f-9631-e8a52eaccd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8824228e-16ea-49f6-b878-6c4861cf9600" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a5b16eb7-49dc-474f-9631-e8a52eaccd75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_10d4b200-876c-4546-ae22-5a603ff17f79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8824228e-16ea-49f6-b878-6c4861cf9600" xlink:to="loc_us-gaap_LongTermDebtCurrent_10d4b200-876c-4546-ae22-5a603ff17f79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_2a99b405-d5a6-40d0-902e-c293da7d1f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8824228e-16ea-49f6-b878-6c4861cf9600" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_2a99b405-d5a6-40d0-902e-c293da7d1f02" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bcfa9e8e-5c10-497c-82d5-ccaaeb5efc90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8824228e-16ea-49f6-b878-6c4861cf9600" xlink:to="loc_us-gaap_LiabilitiesCurrent_bcfa9e8e-5c10-497c-82d5-ccaaeb5efc90" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_9bc498a1-0402-47db-8c41-a988d56df35b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_9bc498a1-0402-47db-8c41-a988d56df35b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_43dd2094-1086-40df-9957-d0ec22395c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_43dd2094-1086-40df-9957-d0ec22395c85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ee1566ff-dac8-4ad6-82e4-ddeac3d08b77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ee1566ff-dac8-4ad6-82e4-ddeac3d08b77" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e718010f-51bb-4649-a3c7-917a157e6210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e718010f-51bb-4649-a3c7-917a157e6210" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_fe117053-0be1-463c-8203-48a7f1faa215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_fe117053-0be1-463c-8203-48a7f1faa215" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_407fea32-643c-484d-9705-7fbc405a14b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_CommitmentsAndContingencies_407fea32-643c-484d-9705-7fbc405a14b8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_1ad0f934-b1af-45ef-b6d3-cfbb47d53567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:to="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_1ad0f934-b1af-45ef-b6d3-cfbb47d53567" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_10d9dbb3-5989-44dd-ae97-fa91a0b7fc95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:to="loc_us-gaap_CommonStockValue_10d9dbb3-5989-44dd-ae97-fa91a0b7fc95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9e317374-35ec-485b-903f-62acd0534c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9e317374-35ec-485b-903f-62acd0534c0e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_75995a2d-bc41-4343-a62d-f66f236cd130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:to="loc_us-gaap_TreasuryStockValue_75995a2d-bc41-4343-a62d-f66f236cd130" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b51c9b2b-8a5b-4c04-b979-d4081dc4d36f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b51c9b2b-8a5b-4c04-b979-d4081dc4d36f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_59819ab2-5c83-4386-a64d-51f6d5783e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_59819ab2-5c83-4386-a64d-51f6d5783e4e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3e822015-3edf-43d0-851c-68ceac2684c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3e822015-3edf-43d0-851c-68ceac2684c7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b4a43951-da77-49db-a44d-7c604164e60c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_b4a43951-da77-49db-a44d-7c604164e60c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_d7ea5a97-3c99-4902-95da-907b3b02bce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b3cd2f82-4464-4f5d-9b11-52bf469fd2be" xlink:to="loc_us-gaap_TreasuryStockShares_d7ea5a97-3c99-4902-95da-907b3b02bce4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dca6d551-5e7b-45fb-be32-09fc52726c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b3cd2f82-4464-4f5d-9b11-52bf469fd2be" xlink:to="loc_us-gaap_StatementTable_dca6d551-5e7b-45fb-be32-09fc52726c7b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_dff4e71a-4c25-401e-a1f6-fff0b8cec333" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_dca6d551-5e7b-45fb-be32-09fc52726c7b" xlink:to="loc_srt_StatementScenarioAxis_dff4e71a-4c25-401e-a1f6-fff0b8cec333" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_dff4e71a-4c25-401e-a1f6-fff0b8cec333_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_dff4e71a-4c25-401e-a1f6-fff0b8cec333" xlink:to="loc_srt_ScenarioUnspecifiedDomain_dff4e71a-4c25-401e-a1f6-fff0b8cec333_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ec4176d8-1f6e-4252-912d-a272f278b7c0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_dff4e71a-4c25-401e-a1f6-fff0b8cec333" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ec4176d8-1f6e-4252-912d-a272f278b7c0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="icui-20230331.xsd#CondensedConsolidatedStatementsofIncome"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended" id="ia25cfb9670b342d4841ceeda9fa5a648_CondensedConsolidatedStatementsofIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_13253a80-194f-4512-b87e-0619d56ca3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_RevenuesAbstract_13253a80-194f-4512-b87e-0619d56ca3ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5fd02b05-6f5b-4cb6-a366-4d136abf746f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_13253a80-194f-4512-b87e-0619d56ca3ed" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5fd02b05-6f5b-4cb6-a366-4d136abf746f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_c85f0955-d5cf-4099-b1ba-90cebd398037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_13253a80-194f-4512-b87e-0619d56ca3ed" xlink:to="loc_us-gaap_CostOfRevenue_c85f0955-d5cf-4099-b1ba-90cebd398037" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_05fe0542-0670-4e27-98a6-28aa96e5fbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_13253a80-194f-4512-b87e-0619d56ca3ed" xlink:to="loc_us-gaap_GrossProfit_05fe0542-0670-4e27-98a6-28aa96e5fbd3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_5a3d1344-aebb-4d5b-adfd-73706e574df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_OperatingExpensesAbstract_5a3d1344-aebb-4d5b-adfd-73706e574df7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_73d8375c-e5e3-4f37-8d5d-3f6bd268a4da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5a3d1344-aebb-4d5b-adfd-73706e574df7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_73d8375c-e5e3-4f37-8d5d-3f6bd268a4da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d2395739-983d-4126-bfa0-44dbdd20df1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5a3d1344-aebb-4d5b-adfd-73706e574df7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d2395739-983d-4126-bfa0-44dbdd20df1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransaction_29f233c7-8c5f-4d4e-913b-6e1f8a0e2fdd" xlink:href="icui-20230331.xsd#icui_Restructuringandstrategictransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5a3d1344-aebb-4d5b-adfd-73706e574df7" xlink:to="loc_icui_Restructuringandstrategictransaction_29f233c7-8c5f-4d4e-913b-6e1f8a0e2fdd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_07e66e9f-cabb-42f0-bf86-18d1fbc48f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5a3d1344-aebb-4d5b-adfd-73706e574df7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_07e66e9f-cabb-42f0-bf86-18d1fbc48f3e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6d50322d-0f29-44bb-96a9-644cbcb56c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5a3d1344-aebb-4d5b-adfd-73706e574df7" xlink:to="loc_us-gaap_OperatingExpenses_6d50322d-0f29-44bb-96a9-644cbcb56c8e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e02b484a-fcfb-49bf-9c27-06eb042a4253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_OperatingIncomeLoss_e02b484a-fcfb-49bf-9c27-06eb042a4253" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2b13940f-153a-4f48-8594-8fafab99ed93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_InterestExpense_2b13940f-153a-4f48-8594-8fafab99ed93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_53ef93ec-bc12-47b5-aac0-325413218068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_53ef93ec-bc12-47b5-aac0-325413218068" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d5f307ce-a0b3-4cdd-88fe-aa954fee90db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d5f307ce-a0b3-4cdd-88fe-aa954fee90db" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f4a4dbe2-19d1-410c-9ab2-6dde7370144c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f4a4dbe2-19d1-410c-9ab2-6dde7370144c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5374aca2-7c45-438f-b871-f54a602e9d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_ProfitLoss_5374aca2-7c45-438f-b871-f54a602e9d3a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e999b5c9-cffb-48e1-935b-1998156d7eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_EarningsPerShareAbstract_e999b5c9-cffb-48e1-935b-1998156d7eb5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_7b0c73b2-6ffb-43b4-9e80-3e28eed4593e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e999b5c9-cffb-48e1-935b-1998156d7eb5" xlink:to="loc_us-gaap_EarningsPerShareBasic_7b0c73b2-6ffb-43b4-9e80-3e28eed4593e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7af85907-355a-4cda-9039-5e74dff8b2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e999b5c9-cffb-48e1-935b-1998156d7eb5" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7af85907-355a-4cda-9039-5e74dff8b2ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6d98283e-9ccb-4128-9815-f606ac4c8ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6d98283e-9ccb-4128-9815-f606ac4c8ae7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_118d9b6c-aa54-46f1-b235-d051b01a1735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6d98283e-9ccb-4128-9815-f606ac4c8ae7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_118d9b6c-aa54-46f1-b235-d051b01a1735" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1117dbd7-6a03-491f-b0bd-5e99e67682cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6d98283e-9ccb-4128-9815-f606ac4c8ae7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1117dbd7-6a03-491f-b0bd-5e99e67682cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_824bf33d-9943-4a4d-894c-22b4af076941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_StatementTable_824bf33d-9943-4a4d-894c-22b4af076941" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9403c02f-d405-46db-af47-5e6471a842d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_824bf33d-9943-4a4d-894c-22b4af076941" xlink:to="loc_srt_ProductOrServiceAxis_9403c02f-d405-46db-af47-5e6471a842d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9403c02f-d405-46db-af47-5e6471a842d4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9403c02f-d405-46db-af47-5e6471a842d4" xlink:to="loc_srt_ProductsAndServicesDomain_9403c02f-d405-46db-af47-5e6471a842d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_38a77444-22a5-401a-9f3a-ad5de908a398" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9403c02f-d405-46db-af47-5e6471a842d4" xlink:to="loc_srt_ProductsAndServicesDomain_38a77444-22a5-401a-9f3a-ad5de908a398" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="icui-20230331.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended" id="i0a9f57e5fd7b4baeb6f6ff0858fae286_CondensedConsolidatedStatementsofComprehensiveIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_28302172-3ef7-43d7-996f-e71f6247ce4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_dfb0ddd8-0da0-46c4-a337-ab5ee62cb9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_28302172-3ef7-43d7-996f-e71f6247ce4d" xlink:to="loc_us-gaap_ProfitLoss_dfb0ddd8-0da0-46c4-a337-ab5ee62cb9d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_196155a6-e36e-48a8-be1b-9905ea7f6192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_28302172-3ef7-43d7-996f-e71f6247ce4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_196155a6-e36e-48a8-be1b-9905ea7f6192" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cc804342-bd3e-4ee2-b2e8-e29b5668c843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_196155a6-e36e-48a8-be1b-9905ea7f6192" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cc804342-bd3e-4ee2-b2e8-e29b5668c843" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_70036c18-d14b-4c98-bcb0-72deac53c590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_196155a6-e36e-48a8-be1b-9905ea7f6192" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_70036c18-d14b-4c98-bcb0-72deac53c590" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_fdf40574-1605-4006-bef4-22cb679c1b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_196155a6-e36e-48a8-be1b-9905ea7f6192" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_fdf40574-1605-4006-bef4-22cb679c1b46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9d373ff5-6d9e-4cfa-b114-579c61ec2537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_196155a6-e36e-48a8-be1b-9905ea7f6192" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9d373ff5-6d9e-4cfa-b114-579c61ec2537" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a20b2bf4-cd9f-4efb-8ce2-e7ce3eaded16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_28302172-3ef7-43d7-996f-e71f6247ce4d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_a20b2bf4-cd9f-4efb-8ce2-e7ce3eaded16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1ba89451-793c-46c0-9040-67fabc6bfc20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_28302172-3ef7-43d7-996f-e71f6247ce4d" xlink:to="loc_us-gaap_StatementTable_1ba89451-793c-46c0-9040-67fabc6bfc20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_0dc08bc1-7266-4208-907e-62ee5eb467e9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1ba89451-793c-46c0-9040-67fabc6bfc20" xlink:to="loc_srt_StatementScenarioAxis_0dc08bc1-7266-4208-907e-62ee5eb467e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0dc08bc1-7266-4208-907e-62ee5eb467e9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_0dc08bc1-7266-4208-907e-62ee5eb467e9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0dc08bc1-7266-4208-907e-62ee5eb467e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_83083492-823f-4e2f-a61f-922bd2885e7e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_0dc08bc1-7266-4208-907e-62ee5eb467e9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_83083492-823f-4e2f-a61f-922bd2885e7e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement" xlink:type="simple" xlink:href="icui-20230331.xsd#CondensedConsolidatedStatementsofStockholdersEquityStatement"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement" xlink:type="extended" id="i0677416ab70a4d5fa199d2f9c149b8be_CondensedConsolidatedStatementsofStockholdersEquityStatement">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2d0df48e-6cfb-4fe2-84c3-6df2a262d03b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2d0df48e-6cfb-4fe2-84c3-6df2a262d03b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_93006ada-5c46-4fe4-9d9f-030ca5ec0d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_93006ada-5c46-4fe4-9d9f-030ca5ec0d0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4ebe1fb8-1bd2-433b-9e21-6d1b2f365b77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_StockholdersEquity_4ebe1fb8-1bd2-433b-9e21-6d1b2f365b77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0e339cd5-73c3-46fe-a98b-37073aee9365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0e339cd5-73c3-46fe-a98b-37073aee9365" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d52ef0d8-1f0f-4a6b-b866-c2958b2fa18f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d52ef0d8-1f0f-4a6b-b866-c2958b2fa18f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_7ea9454c-3969-4a41-95b8-b1b6c8c5fb80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_7ea9454c-3969-4a41-95b8-b1b6c8c5fb80" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_43390e52-bb07-4f2c-8640-94d7a0b0814b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_43390e52-bb07-4f2c-8640-94d7a0b0814b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_cb354b6e-6b70-47e6-8737-3121da28ed47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_cb354b6e-6b70-47e6-8737-3121da28ed47" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9ddb693d-84c5-4084-9664-d004458209a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9ddb693d-84c5-4084-9664-d004458209a9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_97e963e4-31d2-4ff1-9303-9edb8101f1da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_97e963e4-31d2-4ff1-9303-9edb8101f1da" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_77ede7de-95b3-4332-bf30-64077d5eb2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_NetIncomeLoss_77ede7de-95b3-4332-bf30-64077d5eb2f1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1160cd67-779e-4245-b7be-d87b8a41f839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1fea4b3c-5be7-43c0-97d9-0cbf30ef41a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_098857f9-9942-4d8e-ace8-2ee42b7b1be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_098857f9-9942-4d8e-ace8-2ee42b7b1be3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2e970aae-5a7c-4125-8e50-bf6d2c6d2760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2d0df48e-6cfb-4fe2-84c3-6df2a262d03b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2e970aae-5a7c-4125-8e50-bf6d2c6d2760" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_d7a11ecd-b786-4275-86bd-fbc4c3679c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2d0df48e-6cfb-4fe2-84c3-6df2a262d03b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_d7a11ecd-b786-4275-86bd-fbc4c3679c80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_edb5887b-8f42-4221-aa01-fe69a5f396a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2d0df48e-6cfb-4fe2-84c3-6df2a262d03b" xlink:to="loc_us-gaap_StatementTable_edb5887b-8f42-4221-aa01-fe69a5f396a4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0b9451c7-53b7-4357-8852-a8c84d279e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_edb5887b-8f42-4221-aa01-fe69a5f396a4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0b9451c7-53b7-4357-8852-a8c84d279e0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0b9451c7-53b7-4357-8852-a8c84d279e0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0b9451c7-53b7-4357-8852-a8c84d279e0e" xlink:to="loc_us-gaap_EquityComponentDomain_0b9451c7-53b7-4357-8852-a8c84d279e0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_765b9589-205f-436f-8eb1-c5cb64c007ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0b9451c7-53b7-4357-8852-a8c84d279e0e" xlink:to="loc_us-gaap_EquityComponentDomain_765b9589-205f-436f-8eb1-c5cb64c007ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CommonStockSharesMember_a4ee1557-10b9-4f92-8d1e-bcd86a391d1a" xlink:href="icui-20230331.xsd#icui_CommonStockSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_765b9589-205f-436f-8eb1-c5cb64c007ba" xlink:to="loc_icui_CommonStockSharesMember_a4ee1557-10b9-4f92-8d1e-bcd86a391d1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_54d482d1-6c5b-4a2f-96cb-6513bd8ee301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_765b9589-205f-436f-8eb1-c5cb64c007ba" xlink:to="loc_us-gaap_CommonStockMember_54d482d1-6c5b-4a2f-96cb-6513bd8ee301" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a6071eea-ba9e-41ed-bdb8-841113068276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_765b9589-205f-436f-8eb1-c5cb64c007ba" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a6071eea-ba9e-41ed-bdb8-841113068276" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_e0ff9754-5e2c-49c0-8c48-1076fba6062e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_765b9589-205f-436f-8eb1-c5cb64c007ba" xlink:to="loc_us-gaap_TreasuryStockMember_e0ff9754-5e2c-49c0-8c48-1076fba6062e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c88054a3-f35d-437c-9320-157884461126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_765b9589-205f-436f-8eb1-c5cb64c007ba" xlink:to="loc_us-gaap_RetainedEarningsMember_c88054a3-f35d-437c-9320-157884461126" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_63f410a7-b070-4241-b4c0-e409845ffeee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_765b9589-205f-436f-8eb1-c5cb64c007ba" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_63f410a7-b070-4241-b4c0-e409845ffeee" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="icui-20230331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended" id="i25217263e568460d998337aa05f6d06e_CondensedConsolidatedStatementsofCashFlows">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_70e9512b-1726-47c3-bdde-c2c7e80ce593" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_3a7d0792-2df0-4251-b2f0-d889606820d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e9512b-1726-47c3-bdde-c2c7e80ce593" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_3a7d0792-2df0-4251-b2f0-d889606820d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_bb61e388-ad26-4f3e-87e2-c167fe13c331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_3a7d0792-2df0-4251-b2f0-d889606820d2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_bb61e388-ad26-4f3e-87e2-c167fe13c331" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_bb61e388-ad26-4f3e-87e2-c167fe13c331" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_995e29c7-f58b-4948-962b-eea26c9a29aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_ProfitLoss_995e29c7-f58b-4948-962b-eea26c9a29aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e1b4a9d0-b041-431a-998d-248bbadbe515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e1b4a9d0-b041-431a-998d-248bbadbe515" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AmortizationOfInventoryStepUp_a7ade647-d797-4dc1-9c31-9a8d0e7ae5fb" xlink:href="icui-20230331.xsd#icui_AmortizationOfInventoryStepUp"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_icui_AmortizationOfInventoryStepUp_a7ade647-d797-4dc1-9c31-9a8d0e7ae5fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_3ac35d18-f733-4b1c-b238-268763348bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_3ac35d18-f733-4b1c-b238-268763348bd4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_1f79a5cc-f20e-4ced-b50b-dbd80f28b572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_1f79a5cc-f20e-4ced-b50b-dbd80f28b572" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProvisionForWarrantyAndReturns_95b95e57-baee-4ea3-9f0f-db47da4372be" xlink:href="icui-20230331.xsd#icui_ProvisionForWarrantyAndReturns"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_icui_ProvisionForWarrantyAndReturns_95b95e57-baee-4ea3-9f0f-db47da4372be" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_400287ee-e693-4a88-8613-367425a915d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_ShareBasedCompensation_400287ee-e693-4a88-8613-367425a915d9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_e978517b-2414-4719-8fc8-39acea001fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_e978517b-2414-4719-8fc8-39acea001fd1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_26a14678-4e43-47e2-9815-bc8b96317eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_26a14678-4e43-47e2-9815-bc8b96317eb0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_491e396b-57cc-4781-aea0-71e732ab748a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_491e396b-57cc-4781-aea0-71e732ab748a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dbba3de4-e58f-4a25-a0fd-90c0b62e8e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dbba3de4-e58f-4a25-a0fd-90c0b62e8e21" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sparepartsusage_366ee344-6218-4684-b39a-81ffa6475bc2" xlink:href="icui-20230331.xsd#icui_Sparepartsusage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_icui_Sparepartsusage_366ee344-6218-4684-b39a-81ffa6475bc2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_dd13774c-171a-48d7-8d18-04b16c7da18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_dd13774c-171a-48d7-8d18-04b16c7da18d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d346cba8-cc8f-49af-a512-c03b4c6b9217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d346cba8-cc8f-49af-a512-c03b4c6b9217" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_e952d891-7bf2-492d-b35a-ea70967124af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_e952d891-7bf2-492d-b35a-ea70967124af" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ab5d652d-aecf-4b10-87ff-9593247c4c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ab5d652d-aecf-4b10-87ff-9593247c4c0b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e4e7f41e-b07f-4e7e-afff-d1ef238c2856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e4e7f41e-b07f-4e7e-afff-d1ef238c2856" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c317d8e9-291f-411c-a3e3-3e1c1044a67e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c317d8e9-291f-411c-a3e3-3e1c1044a67e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c5452c20-3ca4-4a85-9511-7297913d0bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c5452c20-3ca4-4a85-9511-7297913d0bde" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_88b15398-583d-4ecc-8cdc-33ead1425df3" xlink:href="icui-20230331.xsd#icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_88b15398-583d-4ecc-8cdc-33ead1425df3" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f29c238e-9b70-4e78-986f-adcc97850993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f29c238e-9b70-4e78-986f-adcc97850993" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_87ec7fad-1c4b-48c5-87f8-1f351a5679ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_bb61e388-ad26-4f3e-87e2-c167fe13c331" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_87ec7fad-1c4b-48c5-87f8-1f351a5679ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_52309da9-7520-42c8-9373-9ecc7317907c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_87ec7fad-1c4b-48c5-87f8-1f351a5679ed" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_52309da9-7520-42c8-9373-9ecc7317907c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_94419fba-14d9-4033-9486-a3b42bb9b19c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_87ec7fad-1c4b-48c5-87f8-1f351a5679ed" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_94419fba-14d9-4033-9486-a3b42bb9b19c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_54cb3034-b91c-4151-802d-8c723f6ee1ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_87ec7fad-1c4b-48c5-87f8-1f351a5679ed" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_54cb3034-b91c-4151-802d-8c723f6ee1ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_cfd1624c-6d61-4c31-b932-15d4cdc24adb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_87ec7fad-1c4b-48c5-87f8-1f351a5679ed" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_cfd1624c-6d61-4c31-b932-15d4cdc24adb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_7e04a793-e53a-416e-8857-896d2b4efac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_87ec7fad-1c4b-48c5-87f8-1f351a5679ed" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_7e04a793-e53a-416e-8857-896d2b4efac8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ba95a698-3a14-491d-b55a-b3789c8ca345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_87ec7fad-1c4b-48c5-87f8-1f351a5679ed" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ba95a698-3a14-491d-b55a-b3789c8ca345" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_bb61e388-ad26-4f3e-87e2-c167fe13c331" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_cd3fcd3d-8cd5-447d-ad5c-7558846d9453" xlink:href="icui-20230331.xsd#icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:to="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_cd3fcd3d-8cd5-447d-ad5c-7558846d9453" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_d6287a59-1566-487c-9ea4-7052c5b67b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_d6287a59-1566-487c-9ea4-7052c5b67b26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_aa83fcd1-a517-474c-b0ff-5fcc9321265c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_aa83fcd1-a517-474c-b0ff-5fcc9321265c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_a3b0744a-9ed7-49ca-bb4e-823368557dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_a3b0744a-9ed7-49ca-bb4e-823368557dc2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_6cc933b8-6d28-4c09-9ca2-f1725233c9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_6cc933b8-6d28-4c09-9ca2-f1725233c9cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a2589cd3-8396-435a-b966-64d6c4d91309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a2589cd3-8396-435a-b966-64d6c4d91309" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_18b5e8e2-9419-433e-8dd6-17e547c09b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_18b5e8e2-9419-433e-8dd6-17e547c09b1c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_bebcb609-84f8-4d29-999c-c068559ef21a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_3a7d0792-2df0-4251-b2f0-d889606820d2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_bebcb609-84f8-4d29-999c-c068559ef21a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fe4392ed-ca75-4030-ae7a-41db15053c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_bebcb609-84f8-4d29-999c-c068559ef21a" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fe4392ed-ca75-4030-ae7a-41db15053c6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5e6dcc29-5cfa-4c3c-b26e-a34051dd1fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e9512b-1726-47c3-bdde-c2c7e80ce593" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5e6dcc29-5cfa-4c3c-b26e-a34051dd1fc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_75c15269-bcf4-4615-8d64-548e3ceaccab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e9512b-1726-47c3-bdde-c2c7e80ce593" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_75c15269-bcf4-4615-8d64-548e3ceaccab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_24e058ea-64a6-45b0-9597-f1684d35ac81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e9512b-1726-47c3-bdde-c2c7e80ce593" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_24e058ea-64a6-45b0-9597-f1684d35ac81" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_426eb2fa-104c-4057-a61b-0a3afb941522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_24e058ea-64a6-45b0-9597-f1684d35ac81" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_426eb2fa-104c-4057-a61b-0a3afb941522" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e9512b-1726-47c3-bdde-c2c7e80ce593" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d5f56d94-a285-4fb2-a4c8-3965b58280a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d5f56d94-a285-4fb2-a4c8-3965b58280a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_e28d4b50-3a2b-4e8f-afdd-4e3a93c3e55e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_e28d4b50-3a2b-4e8f-afdd-4e3a93c3e55e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NetCashPaidReceivedforcurrentandprioracquisitions_154f3473-4d71-4531-a129-a9751d2c4f6c" xlink:href="icui-20230331.xsd#icui_NetCashPaidReceivedforcurrentandprioracquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:to="loc_icui_NetCashPaidReceivedforcurrentandprioracquisitions_154f3473-4d71-4531-a129-a9751d2c4f6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_3258a0e2-c01c-4e31-a756-d48e35abf1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_3258a0e2-c01c-4e31-a756-d48e35abf1fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_cf09bbfd-93e2-4a23-83a0-a09015235a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:to="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_cf09bbfd-93e2-4a23-83a0-a09015235a6a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_4818c0d3-8f21-4de0-83bd-765c4cdf90c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_4818c0d3-8f21-4de0-83bd-765c4cdf90c7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_47a838f7-7265-4b83-a35c-33c174bcc4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:to="loc_us-gaap_LiabilitiesAssumed1_47a838f7-7265-4b83-a35c-33c174bcc4a9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f15a7ce8-99a2-4378-8f87-16c00cd62858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_70e9512b-1726-47c3-bdde-c2c7e80ce593" xlink:to="loc_us-gaap_StatementTable_f15a7ce8-99a2-4378-8f87-16c00cd62858" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_b305b7ed-627e-4c2e-997c-247402581dcb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f15a7ce8-99a2-4378-8f87-16c00cd62858" xlink:to="loc_srt_StatementScenarioAxis_b305b7ed-627e-4c2e-997c-247402581dcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b305b7ed-627e-4c2e-997c-247402581dcb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_b305b7ed-627e-4c2e-997c-247402581dcb" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b305b7ed-627e-4c2e-997c-247402581dcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_6ee5bf15-78c7-4a17-8a6b-b2e7cc1ca799" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_b305b7ed-627e-4c2e-997c-247402581dcb" xlink:to="loc_srt_ScenarioUnspecifiedDomain_6ee5bf15-78c7-4a17-8a6b-b2e7cc1ca799" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_077faebb-d95d-491f-bb13-98605956e5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f15a7ce8-99a2-4378-8f87-16c00cd62858" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_077faebb-d95d-491f-bb13-98605956e5c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_077faebb-d95d-491f-bb13-98605956e5c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_077faebb-d95d-491f-bb13-98605956e5c8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_077faebb-d95d-491f-bb13-98605956e5c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4c7e1145-4a55-4c09-8784-9b14671bde1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_077faebb-d95d-491f-bb13-98605956e5c8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4c7e1145-4a55-4c09-8784-9b14671bde1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_082891fe-466b-4da1-b716-6ff48181b1db" xlink:href="icui-20230331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4c7e1145-4a55-4c09-8784-9b14671bde1a" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_082891fe-466b-4da1-b716-6ff48181b1db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_8c36767c-8cea-4b35-8250-0aa526ec8c87" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4c7e1145-4a55-4c09-8784-9b14671bde1a" xlink:to="loc_icui_SmithsMedicalMember_8c36767c-8cea-4b35-8250-0aa526ec8c87" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails" xlink:type="extended" id="ib41b93717191499ebd3a3611bf33b118_BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ccf0f0f6-4bf8-4125-b257-579ac61d22a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_f9ac3054-ad27-4644-affa-50d349506212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccf0f0f6-4bf8-4125-b257-579ac61d22a3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_f9ac3054-ad27-4644-affa-50d349506212" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_f70e89bb-ce56-47ed-b606-4902ee3f315a" xlink:href="icui-20230331.xsd#icui_Contingentconsiderationgross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccf0f0f6-4bf8-4125-b257-579ac61d22a3" xlink:to="loc_icui_Contingentconsiderationgross_f70e89bb-ce56-47ed-b606-4902ee3f315a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_98840dd7-fb14-4d63-9b3c-9e6e106c7e0d" xlink:href="icui-20230331.xsd#icui_ContingentConsiderationGrossST"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccf0f0f6-4bf8-4125-b257-579ac61d22a3" xlink:to="loc_icui_ContingentConsiderationGrossST_98840dd7-fb14-4d63-9b3c-9e6e106c7e0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_f0d9ff02-2cf8-4b75-b1ab-f81738116218" xlink:href="icui-20230331.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccf0f0f6-4bf8-4125-b257-579ac61d22a3" xlink:to="loc_icui_ContingentConsiderationGrossLT_f0d9ff02-2cf8-4b75-b1ab-f81738116218" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a3a55ed0-dac6-4502-b430-b99d2831fd04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccf0f0f6-4bf8-4125-b257-579ac61d22a3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a3a55ed0-dac6-4502-b430-b99d2831fd04" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61738cb1-19ff-4776-86a8-20d89146ef56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccf0f0f6-4bf8-4125-b257-579ac61d22a3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61738cb1-19ff-4776-86a8-20d89146ef56" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2b46f5b2-c2c0-4a77-8bb9-c10eb599ccd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61738cb1-19ff-4776-86a8-20d89146ef56" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2b46f5b2-c2c0-4a77-8bb9-c10eb599ccd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b46f5b2-c2c0-4a77-8bb9-c10eb599ccd7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2b46f5b2-c2c0-4a77-8bb9-c10eb599ccd7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b46f5b2-c2c0-4a77-8bb9-c10eb599ccd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a44c1de5-1266-4dca-abd9-82b6c2ef7c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2b46f5b2-c2c0-4a77-8bb9-c10eb599ccd7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a44c1de5-1266-4dca-abd9-82b6c2ef7c46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_d2a9b38b-a497-425e-9dec-c1f71681ccf4" xlink:href="icui-20230331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a44c1de5-1266-4dca-abd9-82b6c2ef7c46" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_d2a9b38b-a497-425e-9dec-c1f71681ccf4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#BusinessCombinationsandAssetAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails" xlink:type="extended" id="i4de86d46c44e48e48e3ff9ba8ec72387_BusinessCombinationsandAssetAcquisitionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ee2a937f-4cc5-4859-a50a-328b2aef9d68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ee2a937f-4cc5-4859-a50a-328b2aef9d68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationTransferredCash_1d813172-4b06-4f87-9537-746bcd2a6ec0" xlink:href="icui-20230331.xsd#icui_BusinessCombinationConsiderationTransferredCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_icui_BusinessCombinationConsiderationTransferredCash_1d813172-4b06-4f87-9537-746bcd2a6ec0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_0865ac4a-9fad-4f91-9e1f-6b916dd34183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_0865ac4a-9fad-4f91-9e1f-6b916dd34183" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_45782c37-8497-4a6f-999b-3c15747c175e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_45782c37-8497-4a6f-999b-3c15747c175e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MinimumStockPriceTargetForEarnOutPayment_a2fe5228-31c3-4297-b22f-18597678c4a0" xlink:href="icui-20230331.xsd#icui_MinimumStockPriceTargetForEarnOutPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_icui_MinimumStockPriceTargetForEarnOutPayment_a2fe5228-31c3-4297-b22f-18597678c4a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_0de35cd3-0ac9-4c30-a783-497df4cb8c60" xlink:href="icui-20230331.xsd#icui_RequiredShareHoldingOfStockIssuedAtAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_0de35cd3-0ac9-4c30-a783-497df4cb8c60" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_54dfb818-5fac-425b-adea-6e3d45d4ac59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_54dfb818-5fac-425b-adea-6e3d45d4ac59" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedParty_adadf7a7-70db-400f-a48c-7265a6714658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedParty_adadf7a7-70db-400f-a48c-7265a6714658" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e57ad856-47de-41d2-b0f3-5492c91bc581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e57ad856-47de-41d2-b0f3-5492c91bc581" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3b226500-301b-47cb-b3fe-21c40a927aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e57ad856-47de-41d2-b0f3-5492c91bc581" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3b226500-301b-47cb-b3fe-21c40a927aa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b226500-301b-47cb-b3fe-21c40a927aa1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3b226500-301b-47cb-b3fe-21c40a927aa1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b226500-301b-47cb-b3fe-21c40a927aa1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_381c7dad-2b23-4692-a0fc-80956f4c6035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3b226500-301b-47cb-b3fe-21c40a927aa1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_381c7dad-2b23-4692-a0fc-80956f4c6035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_1668659d-3170-4ec8-a7ab-9d3739dd69f6" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_381c7dad-2b23-4692-a0fc-80956f4c6035" xlink:to="loc_icui_SmithsMedicalMember_1668659d-3170-4ec8-a7ab-9d3739dd69f6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails" xlink:type="extended" id="ic02e37068d3a4099afb26d400377ce8c_BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_147a04d7-9909-4930-9a5b-97dd6b040857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_147a04d7-9909-4930-9a5b-97dd6b040857" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b5064e38-e2fe-4804-b57d-473703d4a53b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b5064e38-e2fe-4804-b57d-473703d4a53b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2393f4ca-90ae-4b10-be90-8077b1738913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2393f4ca-90ae-4b10-be90-8077b1738913" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_d721a52a-0531-424b-9c2f-aa780a443c62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_d721a52a-0531-424b-9c2f-aa780a443c62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_b3deee96-d36c-469a-a1b1-471b676aab42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_b3deee96-d36c-469a-a1b1-471b676aab42" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0a1fd369-465b-49c3-96a3-6f8a4998a99d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0a1fd369-465b-49c3-96a3-6f8a4998a99d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_51995bdc-f4da-47d9-935e-5d990e536bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_51995bdc-f4da-47d9-935e-5d990e536bea" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_96eb92e7-3f19-40e7-b5cb-fa7763d3be35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_96eb92e7-3f19-40e7-b5cb-fa7763d3be35" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_159d0662-ccb8-4af3-8b8a-931bbc764723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_159d0662-ccb8-4af3-8b8a-931bbc764723" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4d3f78b4-afe4-4e9d-a458-17171679e127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4d3f78b4-afe4-4e9d-a458-17171679e127" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_4a9841cc-d105-4303-815d-1d9b6f218e4e" xlink:href="icui-20230331.xsd#icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_4a9841cc-d105-4303-815d-1d9b6f218e4e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ea31f9d4-172b-4739-932e-e5441da7663c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ea31f9d4-172b-4739-932e-e5441da7663c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_2d4285ac-1a5c-4d91-9550-3ebcda9efeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_2d4285ac-1a5c-4d91-9550-3ebcda9efeb9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c1fec463-1d48-41bb-a5a5-3f2f1ae825ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c1fec463-1d48-41bb-a5a5-3f2f1ae825ce" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_796b1b29-52ea-4717-96d2-3438958cd0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_796b1b29-52ea-4717-96d2-3438958cd0f6" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_6cc53777-de40-4dd1-b945-54c54d8cc584" xlink:href="icui-20230331.xsd#icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_6cc53777-de40-4dd1-b945-54c54d8cc584" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_5a9ccd23-ea9d-4071-a405-23ed6b888511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_5a9ccd23-ea9d-4071-a405-23ed6b888511" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2d6ba994-54c0-4b5b-b410-e982f11c750a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2d6ba994-54c0-4b5b-b410-e982f11c750a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_4e673050-1f72-4e41-a880-2dd6faf1e021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_4e673050-1f72-4e41-a880-2dd6faf1e021" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationGoodwillNonDeductible_50cbf5dd-6e55-4155-ae5f-a83a1c8e7e16" xlink:href="icui-20230331.xsd#icui_BusinessCombinationGoodwillNonDeductible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_icui_BusinessCombinationGoodwillNonDeductible_50cbf5dd-6e55-4155-ae5f-a83a1c8e7e16" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a8cd192d-af6a-47e4-87a8-f985e0f9a0de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a8cd192d-af6a-47e4-87a8-f985e0f9a0de" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c9911251-6ca8-4c43-b86b-86b0101cffbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c9911251-6ca8-4c43-b86b-86b0101cffbd" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_487096f3-8d9f-4bf8-b58b-05ea3cdc25d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_487096f3-8d9f-4bf8-b58b-05ea3cdc25d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9ae112be-b5dc-4cbf-9c07-4f8418cf042e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_487096f3-8d9f-4bf8-b58b-05ea3cdc25d4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9ae112be-b5dc-4cbf-9c07-4f8418cf042e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ae112be-b5dc-4cbf-9c07-4f8418cf042e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9ae112be-b5dc-4cbf-9c07-4f8418cf042e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ae112be-b5dc-4cbf-9c07-4f8418cf042e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d41c1699-0d02-449d-8e89-1208e99bbec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9ae112be-b5dc-4cbf-9c07-4f8418cf042e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d41c1699-0d02-449d-8e89-1208e99bbec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_8cc15c10-f26e-4dec-bed1-77343ab6c87b" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d41c1699-0d02-449d-8e89-1208e99bbec6" xlink:to="loc_icui_SmithsMedicalMember_8cc15c10-f26e-4dec-bed1-77343ab6c87b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97c1d9e6-0993-4a4d-b1a7-a64d13a255ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_487096f3-8d9f-4bf8-b58b-05ea3cdc25d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97c1d9e6-0993-4a4d-b1a7-a64d13a255ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_97c1d9e6-0993-4a4d-b1a7-a64d13a255ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97c1d9e6-0993-4a4d-b1a7-a64d13a255ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_97c1d9e6-0993-4a4d-b1a7-a64d13a255ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97c1d9e6-0993-4a4d-b1a7-a64d13a255ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_15481407-734d-4789-8066-25345428e947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:to="loc_us-gaap_CustomerRelationshipsMember_15481407-734d-4789-8066-25345428e947" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DevelopedTechnologyMember_ae039b4c-d9d4-473e-88f9-b5f1dec0b4c6" xlink:href="icui-20230331.xsd#icui_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:to="loc_icui_DevelopedTechnologyMember_ae039b4c-d9d4-473e-88f9-b5f1dec0b4c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_a5db9010-bb17-4902-a5e6-5c3d706cc101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_a5db9010-bb17-4902-a5e6-5c3d706cc101" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_f49f2774-f44c-4e95-98a5-daef1ed06486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_f49f2774-f44c-4e95-98a5-daef1ed06486" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_dbef7099-710c-4b97-9611-12b039340335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_dbef7099-710c-4b97-9611-12b039340335" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_ac663cf3-93e7-4dfe-bfda-ec4b71c88b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_ac663cf3-93e7-4dfe-bfda-ec4b71c88b5b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_8c5b0dc4-f281-41c2-a080-64f4dc2e1a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:to="loc_us-gaap_TrademarksMember_8c5b0dc4-f281-41c2-a080-64f4dc2e1a13" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails" xlink:type="extended" id="i11680e901b5747108dd1e8401c4ffdb4_BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6f619a6a-4387-40b9-b284-15f7e750059e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_44c3e4e0-ed26-46fb-b2ba-9c493a460219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6f619a6a-4387-40b9-b284-15f7e750059e" xlink:to="loc_us-gaap_Revenues_44c3e4e0-ed26-46fb-b2ba-9c493a460219" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1321e030-f0bf-4bad-b582-bb379ac8c2df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6f619a6a-4387-40b9-b284-15f7e750059e" xlink:to="loc_us-gaap_ProfitLoss_1321e030-f0bf-4bad-b582-bb379ac8c2df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d775c386-7e4b-4d36-98a5-1ce216affd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6f619a6a-4387-40b9-b284-15f7e750059e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d775c386-7e4b-4d36-98a5-1ce216affd75" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1d8f4520-feb9-4578-80a3-33fc8dd4823b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d775c386-7e4b-4d36-98a5-1ce216affd75" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1d8f4520-feb9-4578-80a3-33fc8dd4823b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d8f4520-feb9-4578-80a3-33fc8dd4823b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d8f4520-feb9-4578-80a3-33fc8dd4823b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d8f4520-feb9-4578-80a3-33fc8dd4823b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3689c445-e681-4c3c-8690-f63dea04414c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d8f4520-feb9-4578-80a3-33fc8dd4823b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3689c445-e681-4c3c-8690-f63dea04414c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_570b8635-8fa4-4752-b968-7f13e3d2c297" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3689c445-e681-4c3c-8690-f63dea04414c" xlink:to="loc_icui_SmithsMedicalMember_570b8635-8fa4-4752-b968-7f13e3d2c297" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7f70aca5-c2fc-4f5c-9ba9-b708d58584c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ca6f157e-aa00-4903-8b6b-2fbadd068ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a5d7ea48-8105-4894-9960-c60c1159aba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bfb3a757-b6c6-4619-9d83-5cd22521c711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4d525204-f89a-4ce9-93af-c91d0aae0930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d525204-f89a-4ce9-93af-c91d0aae0930_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0abb1433-6bd5-4a12-a72f-73ba5fbaaecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_0c2003f5-40e6-4a55-87f2-d6d967f10b90" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#RestructuringStrategicTransactionandIntegrationLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails" xlink:type="extended" id="i13c0ae08d8864f9c85ea88286829549a_RestructuringStrategicTransactionandIntegrationLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_dbd52065-d994-4320-bc3c-76d01d759197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_fc8f43f5-549c-4aa5-b25a-afd3f6763fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dbd52065-d994-4320-bc3c-76d01d759197" xlink:to="loc_us-gaap_RestructuringReserve_fc8f43f5-549c-4aa5-b25a-afd3f6763fad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_64008d66-5a82-4b9c-8d6d-79759da1609c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dbd52065-d994-4320-bc3c-76d01d759197" xlink:to="loc_us-gaap_RestructuringCharges_64008d66-5a82-4b9c-8d6d-79759da1609c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_d3dbde56-907d-41b8-9ffc-8d4924936294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dbd52065-d994-4320-bc3c-76d01d759197" xlink:to="loc_us-gaap_PaymentsForRestructuring_d3dbde56-907d-41b8-9ffc-8d4924936294" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_4311b385-ebf1-42b3-b2ec-ce4c22f08624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dbd52065-d994-4320-bc3c-76d01d759197" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_4311b385-ebf1-42b3-b2ec-ce4c22f08624" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_f43c735e-2dda-4b7f-b52a-4e29994ac55a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_423f09cd-ced1-4db8-823b-b61cf777d027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dbd52065-d994-4320-bc3c-76d01d759197" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_423f09cd-ced1-4db8-823b-b61cf777d027" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_de77e776-3f61-49ef-a5dc-175043c88071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dbd52065-d994-4320-bc3c-76d01d759197" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_de77e776-3f61-49ef-a5dc-175043c88071" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_d214d39c-65fd-4479-b52e-29ea0027a191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_de77e776-3f61-49ef-a5dc-175043c88071" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_d214d39c-65fd-4479-b52e-29ea0027a191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_d214d39c-65fd-4479-b52e-29ea0027a191_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_d214d39c-65fd-4479-b52e-29ea0027a191" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_d214d39c-65fd-4479-b52e-29ea0027a191_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_49e8fc1e-f48e-4a79-9a3f-5c43635e2bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_d214d39c-65fd-4479-b52e-29ea0027a191" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_49e8fc1e-f48e-4a79-9a3f-5c43635e2bcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_43325eb7-7121-4189-af44-0bf0f92c9758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_49e8fc1e-f48e-4a79-9a3f-5c43635e2bcc" xlink:to="loc_us-gaap_EmployeeSeveranceMember_43325eb7-7121-4189-af44-0bf0f92c9758" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_6dce92a1-60ac-4716-9a93-b1623e65f689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FacilityClosingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_49e8fc1e-f48e-4a79-9a3f-5c43635e2bcc" xlink:to="loc_us-gaap_FacilityClosingMember_6dce92a1-60ac-4716-9a93-b1623e65f689" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#RevenueDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RevenueDetails" xlink:type="extended" id="ibac0fef9f7854604bb8b88d4d5bf8ee8_RevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c183e290-17af-403d-9f77-6309fba648ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_de632793-3568-4a54-aec2-8759fdfe0bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c183e290-17af-403d-9f77-6309fba648ad" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_de632793-3568-4a54-aec2-8759fdfe0bdd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_7730d3c3-63c9-4d17-b3f6-5dfbe2275811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c183e290-17af-403d-9f77-6309fba648ad" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_7730d3c3-63c9-4d17-b3f6-5dfbe2275811" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6c284617-37d4-4b3d-bc53-f454275c6d7b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7730d3c3-63c9-4d17-b3f6-5dfbe2275811" xlink:to="loc_srt_ProductOrServiceAxis_6c284617-37d4-4b3d-bc53-f454275c6d7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6c284617-37d4-4b3d-bc53-f454275c6d7b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6c284617-37d4-4b3d-bc53-f454275c6d7b" xlink:to="loc_srt_ProductsAndServicesDomain_6c284617-37d4-4b3d-bc53-f454275c6d7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dc7fbf29-79e2-4a82-9852-d67ffa8d9bf9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6c284617-37d4-4b3d-bc53-f454275c6d7b" xlink:to="loc_srt_ProductsAndServicesDomain_dc7fbf29-79e2-4a82-9852-d67ffa8d9bf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember_3c0d5789-e10c-41d5-ae2b-861bd50aa5b4" xlink:href="icui-20230331.xsd#icui_InfusionSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dc7fbf29-79e2-4a82-9852-d67ffa8d9bf9" xlink:to="loc_icui_InfusionSystemsMember_3c0d5789-e10c-41d5-ae2b-861bd50aa5b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember_1f13677e-2dde-4b41-a544-fdecab3341af" xlink:href="icui-20230331.xsd#icui_EquipmentrevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dc7fbf29-79e2-4a82-9852-d67ffa8d9bf9" xlink:to="loc_icui_EquipmentrevenueMember_1f13677e-2dde-4b41-a544-fdecab3341af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember_1f025280-a975-4b65-b2d5-037f130d7704" xlink:href="icui-20230331.xsd#icui_SoftwarerevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dc7fbf29-79e2-4a82-9852-d67ffa8d9bf9" xlink:to="loc_icui_SoftwarerevenueMember_1f025280-a975-4b65-b2d5-037f130d7704" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#RevenueDisaggregatedRevenuebyGeographyDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails" xlink:type="extended" id="ic510b6528dc041d3b9432b958a4a4099_RevenueDisaggregatedRevenuebyGeographyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c5273e51-f5aa-4832-b197-23946710c373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_94931288-435e-4462-83d4-79f0dca6a17f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c5273e51-f5aa-4832-b197-23946710c373" xlink:to="loc_us-gaap_Revenues_94931288-435e-4462-83d4-79f0dca6a17f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_0ed12e7a-8620-4b30-9c33-85a874c5a633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c5273e51-f5aa-4832-b197-23946710c373" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_0ed12e7a-8620-4b30-9c33-85a874c5a633" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_993975da-d1e1-4c9f-946c-f74686efb6ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0ed12e7a-8620-4b30-9c33-85a874c5a633" xlink:to="loc_srt_StatementGeographicalAxis_993975da-d1e1-4c9f-946c-f74686efb6ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_993975da-d1e1-4c9f-946c-f74686efb6ba_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_993975da-d1e1-4c9f-946c-f74686efb6ba" xlink:to="loc_srt_SegmentGeographicalDomain_993975da-d1e1-4c9f-946c-f74686efb6ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4b3be033-a6d2-4be5-baba-037986cb664e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_993975da-d1e1-4c9f-946c-f74686efb6ba" xlink:to="loc_srt_SegmentGeographicalDomain_4b3be033-a6d2-4be5-baba-037986cb664e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_d63962df-6926-451b-b690-792762db6741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4b3be033-a6d2-4be5-baba-037986cb664e" xlink:to="loc_us-gaap_EMEAMember_d63962df-6926-451b-b690-792762db6741" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_46ab0f76-d58f-44ff-8f9d-a98a4ad4f1bc" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4b3be033-a6d2-4be5-baba-037986cb664e" xlink:to="loc_country_US_46ab0f76-d58f-44ff-8f9d-a98a4ad4f1bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_c40b8a47-5057-4afb-a62d-53b5eb572b86" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4b3be033-a6d2-4be5-baba-037986cb664e" xlink:to="loc_srt_AsiaPacificMember_c40b8a47-5057-4afb-a62d-53b5eb572b86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherforeigncountriesMember_83365fee-bf07-41bc-b905-1ea39dcc4865" xlink:href="icui-20230331.xsd#icui_OtherforeigncountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4b3be033-a6d2-4be5-baba-037986cb664e" xlink:to="loc_icui_OtherforeigncountriesMember_83365fee-bf07-41bc-b905-1ea39dcc4865" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#RevenueDisaggregatedRevenuebyProductLineDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails" xlink:type="extended" id="ib9bde53b87a94ab5a5a39ed3a996b41b_RevenueDisaggregatedRevenuebyProductLineDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_533dfd72-da6c-41bc-a2f3-2ca5ef0b8dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9e434e5e-366e-4ab3-9a5c-83b3a39f74c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_533dfd72-da6c-41bc-a2f3-2ca5ef0b8dd8" xlink:to="loc_us-gaap_Revenues_9e434e5e-366e-4ab3-9a5c-83b3a39f74c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_21ca8a19-1d05-4bc8-a5ae-88842287c4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_533dfd72-da6c-41bc-a2f3-2ca5ef0b8dd8" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_21ca8a19-1d05-4bc8-a5ae-88842287c4cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d00bfc0d-cdbd-4fbc-ba93-749c0d788e3f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_21ca8a19-1d05-4bc8-a5ae-88842287c4cd" xlink:to="loc_srt_ProductOrServiceAxis_d00bfc0d-cdbd-4fbc-ba93-749c0d788e3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d00bfc0d-cdbd-4fbc-ba93-749c0d788e3f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d00bfc0d-cdbd-4fbc-ba93-749c0d788e3f" xlink:to="loc_srt_ProductsAndServicesDomain_d00bfc0d-cdbd-4fbc-ba93-749c0d788e3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0f3f814b-52eb-49bd-bfeb-61340f75499d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d00bfc0d-cdbd-4fbc-ba93-749c0d788e3f" xlink:to="loc_srt_ProductsAndServicesDomain_0f3f814b-52eb-49bd-bfeb-61340f75499d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesMember_b1986283-4eb4-4466-a305-2020b8d3b58d" xlink:href="icui-20230331.xsd#icui_InfusionConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0f3f814b-52eb-49bd-bfeb-61340f75499d" xlink:to="loc_icui_InfusionConsumablesMember_b1986283-4eb4-4466-a305-2020b8d3b58d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember_a1e05b08-8040-4004-9b4a-d2e4dafe1fb2" xlink:href="icui-20230331.xsd#icui_InfusionSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0f3f814b-52eb-49bd-bfeb-61340f75499d" xlink:to="loc_icui_InfusionSystemsMember_a1e05b08-8040-4004-9b4a-d2e4dafe1fb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_VitalCareMember_6d50790d-9c66-44d9-a804-f3b26882e907" xlink:href="icui-20230331.xsd#icui_VitalCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0f3f814b-52eb-49bd-bfeb-61340f75499d" xlink:to="loc_icui_VitalCareMember_6d50790d-9c66-44d9-a804-f3b26882e907" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueContractLiabilitiesDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#RevenueContractLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RevenueContractLiabilitiesDetails" xlink:type="extended" id="i91acd1a98f104b4ba58b1292db56543e_RevenueContractLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesLineItems_3d8eac9d-647f-4a67-8220-b5fb5a784a3f" xlink:href="icui-20230331.xsd#icui_ContractassetandliabilitybalancesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInDeferredRevenueRollForward_548c3f63-6256-4c2d-99c4-a86ef8f7d23e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInDeferredRevenueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_3d8eac9d-647f-4a67-8220-b5fb5a784a3f" xlink:to="loc_us-gaap_MovementInDeferredRevenueRollForward_548c3f63-6256-4c2d-99c4-a86ef8f7d23e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_fe68e37c-630e-4d85-9e50-8da3d39bdd37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_3d8eac9d-647f-4a67-8220-b5fb5a784a3f" xlink:to="loc_us-gaap_ContractWithCustomerLiability_fe68e37c-630e-4d85-9e50-8da3d39bdd37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_91b0fd39-46f6-403d-8ea0-e86ed915f659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_3d8eac9d-647f-4a67-8220-b5fb5a784a3f" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_91b0fd39-46f6-403d-8ea0-e86ed915f659" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueAdditions_ad88ed46-95ad-4065-9547-2c6397ef7ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_3d8eac9d-647f-4a67-8220-b5fb5a784a3f" xlink:to="loc_us-gaap_DeferredRevenueAdditions_ad88ed46-95ad-4065-9547-2c6397ef7ebc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_734d0426-4195-4612-ba33-3eff9cd67b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_ee722d68-7fe1-4763-a2c5-437e92101f30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_3d8eac9d-647f-4a67-8220-b5fb5a784a3f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_ee722d68-7fe1-4763-a2c5-437e92101f30" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesTable_effe4862-9e61-4ade-a26f-c35a483d21f4" xlink:href="icui-20230331.xsd#icui_ContractassetandliabilitybalancesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_3d8eac9d-647f-4a67-8220-b5fb5a784a3f" xlink:to="loc_icui_ContractassetandliabilitybalancesTable_effe4862-9e61-4ade-a26f-c35a483d21f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c60f5244-6fed-466e-974a-26b6f883ebf6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_effe4862-9e61-4ade-a26f-c35a483d21f4" xlink:to="loc_srt_ProductOrServiceAxis_c60f5244-6fed-466e-974a-26b6f883ebf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c60f5244-6fed-466e-974a-26b6f883ebf6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c60f5244-6fed-466e-974a-26b6f883ebf6" xlink:to="loc_srt_ProductsAndServicesDomain_c60f5244-6fed-466e-974a-26b6f883ebf6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7774bdb2-1765-4190-8443-3966584b1d20" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c60f5244-6fed-466e-974a-26b6f883ebf6" xlink:to="loc_srt_ProductsAndServicesDomain_7774bdb2-1765-4190-8443-3966584b1d20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember_00fe5d42-1785-45ac-a2b3-b3a7fbfd0dde" xlink:href="icui-20230331.xsd#icui_EquipmentrevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7774bdb2-1765-4190-8443-3966584b1d20" xlink:to="loc_icui_EquipmentrevenueMember_00fe5d42-1785-45ac-a2b3-b3a7fbfd0dde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember_c271c4d6-7b1a-45c3-9e1d-41b6425020b6" xlink:href="icui-20230331.xsd#icui_SoftwarerevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7774bdb2-1765-4190-8443-3966584b1d20" xlink:to="loc_icui_SoftwarerevenueMember_c271c4d6-7b1a-45c3-9e1d-41b6425020b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GovernmentGrantRevenueMember_207e5fef-fe6d-41f5-ae6e-415fe8ca50f9" xlink:href="icui-20230331.xsd#icui_GovernmentGrantRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7774bdb2-1765-4190-8443-3966584b1d20" xlink:to="loc_icui_GovernmentGrantRevenueMember_207e5fef-fe6d-41f5-ae6e-415fe8ca50f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherDeferredRevenueMember_d68e9ece-912a-4b21-b2bc-b192e5df1c8b" xlink:href="icui-20230331.xsd#icui_OtherDeferredRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7774bdb2-1765-4190-8443-3966584b1d20" xlink:to="loc_icui_OtherDeferredRevenueMember_d68e9ece-912a-4b21-b2bc-b192e5df1c8b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6c29b8fc-b92f-4f73-aa0e-f46916f2f8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_effe4862-9e61-4ade-a26f-c35a483d21f4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6c29b8fc-b92f-4f73-aa0e-f46916f2f8d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6c29b8fc-b92f-4f73-aa0e-f46916f2f8d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6c29b8fc-b92f-4f73-aa0e-f46916f2f8d6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6c29b8fc-b92f-4f73-aa0e-f46916f2f8d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc9b5c91-655b-4c26-adbc-0303bcc0b64c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6c29b8fc-b92f-4f73-aa0e-f46916f2f8d6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc9b5c91-655b-4c26-adbc-0303bcc0b64c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_2ee92cbc-3c71-45e5-8255-915ca7c7f3ac" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc9b5c91-655b-4c26-adbc-0303bcc0b64c" xlink:to="loc_icui_SmithsMedicalMember_2ee92cbc-3c71-45e5-8255-915ca7c7f3ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_ccdd5c53-1be0-4fc7-8613-e5ceb9c6b7ca" xlink:href="icui-20230331.xsd#icui_TimingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_effe4862-9e61-4ade-a26f-c35a483d21f4" xlink:to="loc_icui_TimingAxis_ccdd5c53-1be0-4fc7-8613-e5ceb9c6b7ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_ccdd5c53-1be0-4fc7-8613-e5ceb9c6b7ca_default" xlink:href="icui-20230331.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TimingAxis_ccdd5c53-1be0-4fc7-8613-e5ceb9c6b7ca" xlink:to="loc_icui_TimingDomain_ccdd5c53-1be0-4fc7-8613-e5ceb9c6b7ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_2a2dc6f8-c3de-460f-9fa6-9bbcc629bd3b" xlink:href="icui-20230331.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TimingAxis_ccdd5c53-1be0-4fc7-8613-e5ceb9c6b7ca" xlink:to="loc_icui_TimingDomain_2a2dc6f8-c3de-460f-9fa6-9bbcc629bd3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermMember_3b802677-759e-4c20-99a4-2c680b37d4f0" xlink:href="icui-20230331.xsd#icui_ShortTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TimingDomain_2a2dc6f8-c3de-460f-9fa6-9bbcc629bd3b" xlink:to="loc_icui_ShortTermMember_3b802677-759e-4c20-99a4-2c680b37d4f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermMember_953dd635-29a4-4990-9812-71365cb6156c" xlink:href="icui-20230331.xsd#icui_LongTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TimingDomain_2a2dc6f8-c3de-460f-9fa6-9bbcc629bd3b" xlink:to="loc_icui_LongTermMember_953dd635-29a4-4990-9812-71365cb6156c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesTextDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#LeasesTextDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/LeasesTextDetails" xlink:type="extended" id="i5354083420af4aa68ef37aeab5f48706_LeasesTextDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_7a158a1a-b99b-424a-93a0-9568e63a6b51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Optiontoextendinyears_82a98c5a-b1e2-4ac3-aeb6-d0048c9930c9" xlink:href="icui-20230331.xsd#icui_Optiontoextendinyears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7a158a1a-b99b-424a-93a0-9568e63a6b51" xlink:to="loc_icui_Optiontoextendinyears_82a98c5a-b1e2-4ac3-aeb6-d0048c9930c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_8eb9a58e-8f71-4626-bed1-cd98875e7ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7a158a1a-b99b-424a-93a0-9568e63a6b51" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_8eb9a58e-8f71-4626-bed1-cd98875e7ba4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_9378c173-efa8-4338-b922-d1cd1d814540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7a158a1a-b99b-424a-93a0-9568e63a6b51" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_9378c173-efa8-4338-b922-d1cd1d814540" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d522147e-fdd7-4956-8fd7-0a10ca6e7d5b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_9378c173-efa8-4338-b922-d1cd1d814540" xlink:to="loc_srt_RangeAxis_d522147e-fdd7-4956-8fd7-0a10ca6e7d5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d522147e-fdd7-4956-8fd7-0a10ca6e7d5b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d522147e-fdd7-4956-8fd7-0a10ca6e7d5b" xlink:to="loc_srt_RangeMember_d522147e-fdd7-4956-8fd7-0a10ca6e7d5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_adf37431-4528-4641-b219-7f69eef8b4ff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d522147e-fdd7-4956-8fd7-0a10ca6e7d5b" xlink:to="loc_srt_RangeMember_adf37431-4528-4641-b219-7f69eef8b4ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_fde23c6d-b6a1-4f76-bb32-0f5845b5e427" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_adf37431-4528-4641-b219-7f69eef8b4ff" xlink:to="loc_srt_MaximumMember_fde23c6d-b6a1-4f76-bb32-0f5845b5e427" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_db468022-e32e-420c-bc1a-376bfb459688" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_adf37431-4528-4641-b219-7f69eef8b4ff" xlink:to="loc_srt_MinimumMember_db468022-e32e-420c-bc1a-376bfb459688" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#NetIncomePerShareDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/NetIncomePerShareDetails" xlink:type="extended" id="i6238517e472543dc8c1b5fb670abe496_NetIncomePerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edc94de0-9fd1-4e6c-94f7-e5c578ea14db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9704244a-4682-4665-90d4-31996c1566d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edc94de0-9fd1-4e6c-94f7-e5c578ea14db" xlink:to="loc_us-gaap_ProfitLoss_9704244a-4682-4665-90d4-31996c1566d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_75941ec9-46ed-4abb-91c5-94dc11969ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edc94de0-9fd1-4e6c-94f7-e5c578ea14db" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_75941ec9-46ed-4abb-91c5-94dc11969ce8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a9f8975d-2e82-4775-b58e-e91177816a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edc94de0-9fd1-4e6c-94f7-e5c578ea14db" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a9f8975d-2e82-4775-b58e-e91177816a7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7c0c5f2b-0a37-455c-91e3-649345eac297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edc94de0-9fd1-4e6c-94f7-e5c578ea14db" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7c0c5f2b-0a37-455c-91e3-649345eac297" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c45c941a-fefd-4233-bcbe-dec15a5fd9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edc94de0-9fd1-4e6c-94f7-e5c578ea14db" xlink:to="loc_us-gaap_EarningsPerShareBasic_c45c941a-fefd-4233-bcbe-dec15a5fd9ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f2df943d-2540-4a4e-8c02-1dbaf5fed3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edc94de0-9fd1-4e6c-94f7-e5c578ea14db" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f2df943d-2540-4a4e-8c02-1dbaf5fed3da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6de5b74c-4894-47ec-bc0f-79ba3ef6d5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edc94de0-9fd1-4e6c-94f7-e5c578ea14db" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6de5b74c-4894-47ec-bc0f-79ba3ef6d5a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3e72414e-8aa8-4058-8b87-a6cd45ec0a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6de5b74c-4894-47ec-bc0f-79ba3ef6d5a6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3e72414e-8aa8-4058-8b87-a6cd45ec0a42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3e72414e-8aa8-4058-8b87-a6cd45ec0a42_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3e72414e-8aa8-4058-8b87-a6cd45ec0a42" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3e72414e-8aa8-4058-8b87-a6cd45ec0a42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b93b1931-e421-4ee0-8412-06c55222a9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3e72414e-8aa8-4058-8b87-a6cd45ec0a42" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b93b1931-e421-4ee0-8412-06c55222a9b4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails" xlink:type="extended" id="i30d91adb15d04e87a2371e9a8b58a8f5_DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_01fe53e6-5e2f-48fc-8df8-e49d0545b60a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_c1fb5082-efb8-4bd4-a9a0-885902c838d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_01fe53e6-5e2f-48fc-8df8-e49d0545b60a" xlink:to="loc_us-gaap_DerivativeNotionalAmount_c1fb5082-efb8-4bd4-a9a0-885902c838d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_4bd205e8-6644-4c52-8a2f-816d37db672c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_01fe53e6-5e2f-48fc-8df8-e49d0545b60a" xlink:to="loc_us-gaap_DerivativeTable_4bd205e8-6644-4c52-8a2f-816d37db672c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_c3b6e9df-14f8-4f1c-878a-5e7ec83753d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4bd205e8-6644-4c52-8a2f-816d37db672c" xlink:to="loc_srt_CurrencyAxis_c3b6e9df-14f8-4f1c-878a-5e7ec83753d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_c3b6e9df-14f8-4f1c-878a-5e7ec83753d8_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_c3b6e9df-14f8-4f1c-878a-5e7ec83753d8" xlink:to="loc_currency_AllCurrenciesDomain_c3b6e9df-14f8-4f1c-878a-5e7ec83753d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_c3b6e9df-14f8-4f1c-878a-5e7ec83753d8" xlink:to="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN_31cc48b7-2fa9-4fef-accb-ac1c1d0d33fc" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_MXN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:to="loc_currency_MXN_31cc48b7-2fa9-4fef-accb-ac1c1d0d33fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_7df16b07-b442-4408-9fbe-25885431df32" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:to="loc_currency_EUR_7df16b07-b442-4408-9fbe-25885431df32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CZK_7e718f4e-9f1c-48c4-927c-2b2924349899" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CZK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:to="loc_currency_CZK_7e718f4e-9f1c-48c4-927c-2b2924349899" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_3c747cc7-40ee-4adf-b83d-24059c71edc4" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:to="loc_currency_JPY_3c747cc7-40ee-4adf-b83d-24059c71edc4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_37966327-1985-4c8d-b48a-6aae16034657" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:to="loc_currency_CAD_37966327-1985-4c8d-b48a-6aae16034657" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD_52b0a91a-a92d-47be-9aae-f460a6b76cd6" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AUD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:to="loc_currency_AUD_52b0a91a-a92d-47be-9aae-f460a6b76cd6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SEK_a0070c52-ebdd-4124-a1fe-a40715a8736c" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SEK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:to="loc_currency_SEK_a0070c52-ebdd-4124-a1fe-a40715a8736c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisAxis_ac110c0e-4931-409f-9cf8-a2e51b98c592" xlink:href="icui-20230331.xsd#icui_Srt_MultipleCurrencyAxisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4bd205e8-6644-4c52-8a2f-816d37db672c" xlink:to="loc_icui_Srt_MultipleCurrencyAxisAxis_ac110c0e-4931-409f-9cf8-a2e51b98c592" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisDomain_ac110c0e-4931-409f-9cf8-a2e51b98c592_default" xlink:href="icui-20230331.xsd#icui_Srt_MultipleCurrencyAxisDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_Srt_MultipleCurrencyAxisAxis_ac110c0e-4931-409f-9cf8-a2e51b98c592" xlink:to="loc_icui_Srt_MultipleCurrencyAxisDomain_ac110c0e-4931-409f-9cf8-a2e51b98c592_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisDomain_ad0f2daf-2b84-42f5-b824-249630435538" xlink:href="icui-20230331.xsd#icui_Srt_MultipleCurrencyAxisDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_Srt_MultipleCurrencyAxisAxis_ac110c0e-4931-409f-9cf8-a2e51b98c592" xlink:to="loc_icui_Srt_MultipleCurrencyAxisDomain_ad0f2daf-2b84-42f5-b824-249630435538" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherCurrenciesMember_f14c04fa-82f1-41be-a338-30daf9b6ff19" xlink:href="icui-20230331.xsd#icui_OtherCurrenciesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_Srt_MultipleCurrencyAxisDomain_ad0f2daf-2b84-42f5-b824-249630435538" xlink:to="loc_icui_OtherCurrenciesMember_f14c04fa-82f1-41be-a338-30daf9b6ff19" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#DerivativeFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails" xlink:type="extended" id="ib204a9c758ea4f57b12d4dc1ffc8baaa_DerivativeFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_163bb857-9aae-4b81-ae7c-440d8c133d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeForwardExchangeRate1_064dfe70-a06c-4bd2-a661-abd14187d70e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeForwardExchangeRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_163bb857-9aae-4b81-ae7c-440d8c133d3c" xlink:to="loc_us-gaap_DerivativeForwardExchangeRate1_064dfe70-a06c-4bd2-a661-abd14187d70e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_e9543104-3d1e-464f-b427-233128713362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_163bb857-9aae-4b81-ae7c-440d8c133d3c" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_e9543104-3d1e-464f-b427-233128713362" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_72188eaf-306e-408a-9844-0ac8608aee99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_163bb857-9aae-4b81-ae7c-440d8c133d3c" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_72188eaf-306e-408a-9844-0ac8608aee99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a0b6a357-c832-4b93-ae8a-3218f2598120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_163bb857-9aae-4b81-ae7c-440d8c133d3c" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a0b6a357-c832-4b93-ae8a-3218f2598120" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_4f55a9ac-f154-493b-a210-78b3ecaf725f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_163bb857-9aae-4b81-ae7c-440d8c133d3c" xlink:to="loc_us-gaap_DerivativeTable_4f55a9ac-f154-493b-a210-78b3ecaf725f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f14f1455-5144-4381-b017-737f84ec6f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4f55a9ac-f154-493b-a210-78b3ecaf725f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f14f1455-5144-4381-b017-737f84ec6f95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f14f1455-5144-4381-b017-737f84ec6f95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f14f1455-5144-4381-b017-737f84ec6f95" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f14f1455-5144-4381-b017-737f84ec6f95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fd069170-ee47-49e8-9c7d-db7f7d18e6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f14f1455-5144-4381-b017-737f84ec6f95" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fd069170-ee47-49e8-9c7d-db7f7d18e6fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge2Member_e35d095d-672a-42df-b94c-28b1e81285ab" xlink:href="icui-20230331.xsd#icui_Hedge2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_fd069170-ee47-49e8-9c7d-db7f7d18e6fe" xlink:to="loc_icui_Hedge2Member_e35d095d-672a-42df-b94c-28b1e81285ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_97621ba4-228d-41b6-8280-1c5c03301c9d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4f55a9ac-f154-493b-a210-78b3ecaf725f" xlink:to="loc_srt_CurrencyAxis_97621ba4-228d-41b6-8280-1c5c03301c9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_97621ba4-228d-41b6-8280-1c5c03301c9d_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_97621ba4-228d-41b6-8280-1c5c03301c9d" xlink:to="loc_currency_AllCurrenciesDomain_97621ba4-228d-41b6-8280-1c5c03301c9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_8a4c5284-7eb5-4b6a-9666-6ae9b3330ff9" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_97621ba4-228d-41b6-8280-1c5c03301c9d" xlink:to="loc_currency_AllCurrenciesDomain_8a4c5284-7eb5-4b6a-9666-6ae9b3330ff9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN_53166ae3-5667-44ee-97de-52cef61338e8" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_MXN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_8a4c5284-7eb5-4b6a-9666-6ae9b3330ff9" xlink:to="loc_currency_MXN_53166ae3-5667-44ee-97de-52cef61338e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_393221e2-5b47-45c1-95e5-e96f7c7e5530" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CNY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_8a4c5284-7eb5-4b6a-9666-6ae9b3330ff9" xlink:to="loc_currency_CNY_393221e2-5b47-45c1-95e5-e96f7c7e5530" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#DerivativeFinancialInstrumentsInterestRateSwapsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails" xlink:type="extended" id="if807bb59ec2149f7a91255d87423384a_DerivativeFinancialInstrumentsInterestRateSwapsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_7d9295d6-f362-4199-a26b-d431de54914a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_6206447e-65b1-4eca-b421-e643879e4d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_7d9295d6-f362-4199-a26b-d431de54914a" xlink:to="loc_us-gaap_DerivativeNotionalAmount_6206447e-65b1-4eca-b421-e643879e4d0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestRateSwapEndingNotionalValue_73c175b4-3f0d-459a-af03-2786171febb1" xlink:href="icui-20230331.xsd#icui_InterestRateSwapEndingNotionalValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_7d9295d6-f362-4199-a26b-d431de54914a" xlink:to="loc_icui_InterestRateSwapEndingNotionalValue_73c175b4-3f0d-459a-af03-2786171febb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_9c8ad3e7-a0ee-4bfa-abc9-5f374f80be14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_7d9295d6-f362-4199-a26b-d431de54914a" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_9c8ad3e7-a0ee-4bfa-abc9-5f374f80be14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DerivativeVariableRateFloor_b3f1d222-b304-4cbf-a6c4-14da7f87327c" xlink:href="icui-20230331.xsd#icui_DerivativeVariableRateFloor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_7d9295d6-f362-4199-a26b-d431de54914a" xlink:to="loc_icui_DerivativeVariableRateFloor_b3f1d222-b304-4cbf-a6c4-14da7f87327c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_196b348d-37aa-4b1a-aa79-9a69031365de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_7d9295d6-f362-4199-a26b-d431de54914a" xlink:to="loc_us-gaap_DerivativeTable_196b348d-37aa-4b1a-aa79-9a69031365de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_19820c97-77f3-4172-9341-f40788a9f5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_196b348d-37aa-4b1a-aa79-9a69031365de" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_19820c97-77f3-4172-9341-f40788a9f5b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_19820c97-77f3-4172-9341-f40788a9f5b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_19820c97-77f3-4172-9341-f40788a9f5b2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_19820c97-77f3-4172-9341-f40788a9f5b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cfd49e59-e53c-42da-b5de-19665bb4490c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_19820c97-77f3-4172-9341-f40788a9f5b2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cfd49e59-e53c-42da-b5de-19665bb4490c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e8e244d3-3bd4-4897-b513-0387958173ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cfd49e59-e53c-42da-b5de-19665bb4490c" xlink:to="loc_us-gaap_InterestRateSwapMember_e8e244d3-3bd4-4897-b513-0387958173ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_5042df2d-3f0d-4e0b-bd16-d0042b173d6e" xlink:href="icui-20230331.xsd#icui_TermLoanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_196b348d-37aa-4b1a-aa79-9a69031365de" xlink:to="loc_icui_TermLoanAxis_5042df2d-3f0d-4e0b-bd16-d0042b173d6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_5042df2d-3f0d-4e0b-bd16-d0042b173d6e_default" xlink:href="icui-20230331.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TermLoanAxis_5042df2d-3f0d-4e0b-bd16-d0042b173d6e" xlink:to="loc_icui_TermLoanDomain_5042df2d-3f0d-4e0b-bd16-d0042b173d6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_b831e191-fdbe-480e-a2a7-65b25fce55ca" xlink:href="icui-20230331.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TermLoanAxis_5042df2d-3f0d-4e0b-bd16-d0042b173d6e" xlink:to="loc_icui_TermLoanDomain_b831e191-fdbe-480e-a2a7-65b25fce55ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_c57b274a-2abd-4b95-bac8-4a23e4df1d2b" xlink:href="icui-20230331.xsd#icui_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_b831e191-fdbe-480e-a2a7-65b25fce55ca" xlink:to="loc_icui_TermLoanAMember_c57b274a-2abd-4b95-bac8-4a23e4df1d2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_76c7e624-c4b2-48a4-a2f0-9d8cd939af94" xlink:href="icui-20230331.xsd#icui_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_b831e191-fdbe-480e-a2a7-65b25fce55ca" xlink:to="loc_icui_TermLoanBMember_76c7e624-c4b2-48a4-a2f0-9d8cd939af94" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails" xlink:type="extended" id="ied7a0f21c38f4ead953080b9d8df0047_DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_80795a92-b432-4e4a-9bf7-d091dacf423e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeAssets_80795a92-b432-4e4a-9bf7-d091dacf423e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_00e0dd4c-0b8f-41ef-87bc-b5bea3f8bf29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_00e0dd4c-0b8f-41ef-87bc-b5bea3f8bf29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_9bb35668-1fa4-467b-b9ba-e57014e827d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_9bb35668-1fa4-467b-b9ba-e57014e827d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_65126898-f776-4c90-940b-594683e533aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_65126898-f776-4c90-940b-594683e533aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_187a6d7a-ac05-4dde-80bc-134451e1e7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_187a6d7a-ac05-4dde-80bc-134451e1e7c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration_7e6fd470-a146-4b4c-b988-c0fb3c2c367a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration_7e6fd470-a146-4b4c-b988-c0fb3c2c367a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_80fe8c9f-05b7-4969-a517-18d6c8207c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_80fe8c9f-05b7-4969-a517-18d6c8207c06" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_34d56c97-0b7e-4170-aba8-031706423dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeLiabilities_34d56c97-0b7e-4170-aba8-031706423dee" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration_5d79ca51-b12f-47fa-b7e6-757c19aa1f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration_5d79ca51-b12f-47fa-b7e6-757c19aa1f73" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration_5162e997-1886-49b8-9bfe-9070b89deacc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration_5162e997-1886-49b8-9bfe-9070b89deacc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3b5e003-0796-440a-b14c-bdd46b01a6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3b5e003-0796-440a-b14c-bdd46b01a6d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4e36e456-f659-4292-9ed2-632e7b34046b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3b5e003-0796-440a-b14c-bdd46b01a6d4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4e36e456-f659-4292-9ed2-632e7b34046b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4e36e456-f659-4292-9ed2-632e7b34046b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4e36e456-f659-4292-9ed2-632e7b34046b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4e36e456-f659-4292-9ed2-632e7b34046b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0c6d7d93-6239-40a8-ab8a-d968bfa70737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4e36e456-f659-4292-9ed2-632e7b34046b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0c6d7d93-6239-40a8-ab8a-d968bfa70737" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_8e78adf1-7def-49d6-bb85-012e6d48398e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0c6d7d93-6239-40a8-ab8a-d968bfa70737" xlink:to="loc_us-gaap_ForeignExchangeContractMember_8e78adf1-7def-49d6-bb85-012e6d48398e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6869a661-e1d2-48c9-99dd-13264418270b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0c6d7d93-6239-40a8-ab8a-d968bfa70737" xlink:to="loc_us-gaap_InterestRateSwapMember_6869a661-e1d2-48c9-99dd-13264418270b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7fe79ba0-8a28-44f4-906d-5ff8a68e36af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3b5e003-0796-440a-b14c-bdd46b01a6d4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7fe79ba0-8a28-44f4-906d-5ff8a68e36af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7fe79ba0-8a28-44f4-906d-5ff8a68e36af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7fe79ba0-8a28-44f4-906d-5ff8a68e36af" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7fe79ba0-8a28-44f4-906d-5ff8a68e36af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2031dabc-3d85-40bb-9efa-33eba8aa370c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7fe79ba0-8a28-44f4-906d-5ff8a68e36af" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2031dabc-3d85-40bb-9efa-33eba8aa370c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i9b74257c041144e985eeb0d0967becae_DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c88fa29f-eedb-4c7f-9c38-3c62a6188df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_1e6ce1d8-530f-449f-be32-9b0180bb9582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c88fa29f-eedb-4c7f-9c38-3c62a6188df9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_1e6ce1d8-530f-449f-be32-9b0180bb9582" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b14cf244-b322-4b25-9b58-e9802f3999df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c88fa29f-eedb-4c7f-9c38-3c62a6188df9" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b14cf244-b322-4b25-9b58-e9802f3999df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9aac20f9-43cf-4daf-8838-212c05ba5ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b14cf244-b322-4b25-9b58-e9802f3999df" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9aac20f9-43cf-4daf-8838-212c05ba5ebe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9aac20f9-43cf-4daf-8838-212c05ba5ebe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9aac20f9-43cf-4daf-8838-212c05ba5ebe" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9aac20f9-43cf-4daf-8838-212c05ba5ebe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f5e830d5-dfb6-46ca-bb5c-b3beb38e0ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9aac20f9-43cf-4daf-8838-212c05ba5ebe" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f5e830d5-dfb6-46ca-bb5c-b3beb38e0ad4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_b6f3f25c-1ab3-4fd4-8f17-67e6700d2cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f5e830d5-dfb6-46ca-bb5c-b3beb38e0ad4" xlink:to="loc_us-gaap_ForeignExchangeContractMember_b6f3f25c-1ab3-4fd4-8f17-67e6700d2cfb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1de65b38-22fc-443e-ab96-65a9bbc6db68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f5e830d5-dfb6-46ca-bb5c-b3beb38e0ad4" xlink:to="loc_us-gaap_InterestRateSwapMember_1de65b38-22fc-443e-ab96-65a9bbc6db68" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" xlink:type="extended" id="iba92b852c7a6432488e9306210187ceb_DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_a2883e2e-fd0d-46fe-94aa-60a8538ff318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_a2883e2e-fd0d-46fe-94aa-60a8538ff318" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_4deef9c0-b455-43b1-af03-d5f8709a927d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_4deef9c0-b455-43b1-af03-d5f8709a927d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_85bba5ca-9460-4583-afd7-a93496fa46d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_85bba5ca-9460-4583-afd7-a93496fa46d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_32fa8616-0d34-4d88-9ea4-6c60bdefdd46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_32fa8616-0d34-4d88-9ea4-6c60bdefdd46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_ce52767e-e48f-4cdf-a7ae-d04ebbf1d8da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_ce52767e-e48f-4cdf-a7ae-d04ebbf1d8da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring_775596bc-9882-4832-8f04-020eb2f62a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring_775596bc-9882-4832-8f04-020eb2f62a4a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_b105db80-cf6a-4683-b93a-4fd64e163e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_b105db80-cf6a-4683-b93a-4fd64e163e96" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_96aecf3f-fe5c-40c3-8343-eb96d9d8b621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNetHedgeIneffectivenessGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_96aecf3f-fe5c-40c3-8343-eb96d9d8b621" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2afe86af-71ca-4cab-80be-284724f97418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2afe86af-71ca-4cab-80be-284724f97418" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_117237b5-dc13-404d-9257-7caf387b2d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2afe86af-71ca-4cab-80be-284724f97418" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_117237b5-dc13-404d-9257-7caf387b2d7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_117237b5-dc13-404d-9257-7caf387b2d7c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_117237b5-dc13-404d-9257-7caf387b2d7c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_117237b5-dc13-404d-9257-7caf387b2d7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5f2780b0-6f70-46d3-946f-46029d5b58ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_117237b5-dc13-404d-9257-7caf387b2d7c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5f2780b0-6f70-46d3-946f-46029d5b58ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_3690a5a7-6840-458a-9a1e-b11fe5916c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5f2780b0-6f70-46d3-946f-46029d5b58ed" xlink:to="loc_us-gaap_ForeignExchangeContractMember_3690a5a7-6840-458a-9a1e-b11fe5916c8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d6b17ffa-cdfc-4f1f-b994-6457f77e7bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5f2780b0-6f70-46d3-946f-46029d5b58ed" xlink:to="loc_us-gaap_InterestRateSwapMember_d6b17ffa-cdfc-4f1f-b994-6457f77e7bd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4a5a1367-6327-4046-b3aa-ccd0e9d393c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2afe86af-71ca-4cab-80be-284724f97418" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4a5a1367-6327-4046-b3aa-ccd0e9d393c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4a5a1367-6327-4046-b3aa-ccd0e9d393c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4a5a1367-6327-4046-b3aa-ccd0e9d393c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4a5a1367-6327-4046-b3aa-ccd0e9d393c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8297dbf8-b38c-4b32-9981-2321128bc74e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4a5a1367-6327-4046-b3aa-ccd0e9d393c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8297dbf8-b38c-4b32-9981-2321128bc74e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingRevenueMember_6e0bd33f-3a90-439b-8cf9-f12361ec4dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8297dbf8-b38c-4b32-9981-2321128bc74e" xlink:to="loc_us-gaap_TradingRevenueMember_6e0bd33f-3a90-439b-8cf9-f12361ec4dfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_101e273b-e3b5-4319-aad5-f88a85ee6a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8297dbf8-b38c-4b32-9981-2321128bc74e" xlink:to="loc_us-gaap_CostOfSalesMember_101e273b-e3b5-4319-aad5-f88a85ee6a3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5e1fc13a-f520-47ef-bc6c-4cd39fc5c12b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2afe86af-71ca-4cab-80be-284724f97418" xlink:to="loc_us-gaap_HedgingDesignationAxis_5e1fc13a-f520-47ef-bc6c-4cd39fc5c12b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5e1fc13a-f520-47ef-bc6c-4cd39fc5c12b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_5e1fc13a-f520-47ef-bc6c-4cd39fc5c12b" xlink:to="loc_us-gaap_HedgingDesignationDomain_5e1fc13a-f520-47ef-bc6c-4cd39fc5c12b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_49d6df8e-bc1d-44d8-b355-aade4225c4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_5e1fc13a-f520-47ef-bc6c-4cd39fc5c12b" xlink:to="loc_us-gaap_HedgingDesignationDomain_49d6df8e-bc1d-44d8-b355-aade4225c4e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1a3e0486-0b21-45d7-89ff-20f605906a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2afe86af-71ca-4cab-80be-284724f97418" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1a3e0486-0b21-45d7-89ff-20f605906a8f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1a3e0486-0b21-45d7-89ff-20f605906a8f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1a3e0486-0b21-45d7-89ff-20f605906a8f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1a3e0486-0b21-45d7-89ff-20f605906a8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9725819c-5c1e-458c-aa83-d22b48a5cca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1a3e0486-0b21-45d7-89ff-20f605906a8f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9725819c-5c1e-458c-aa83-d22b48a5cca0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_d8d6262f-0a79-4f6d-a5ec-7acea53f7615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9725819c-5c1e-458c-aa83-d22b48a5cca0" xlink:to="loc_us-gaap_CashFlowHedgingMember_d8d6262f-0a79-4f6d-a5ec-7acea53f7615" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#FairValueMeasuresandDisclosuresDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails" xlink:type="extended" id="i4a790d1719e14efe9c22e10a759879cd_FairValueMeasuresandDisclosuresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_df6271e6-12f8-4d0f-b4d4-43006c3fa3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_84dc4fb1-f772-489a-b865-5623d791e24e" xlink:href="icui-20230331.xsd#icui_Contingentconsiderationgross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_df6271e6-12f8-4d0f-b4d4-43006c3fa3e0" xlink:to="loc_icui_Contingentconsiderationgross_84dc4fb1-f772-489a-b865-5623d791e24e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1cc20207-b5fb-4244-a34a-152791843eda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_df6271e6-12f8-4d0f-b4d4-43006c3fa3e0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1cc20207-b5fb-4244-a34a-152791843eda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_b2fc9929-c9f5-46a9-bd36-b12d934bb516" xlink:href="icui-20230331.xsd#icui_ContingentConsiderationGrossST"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_df6271e6-12f8-4d0f-b4d4-43006c3fa3e0" xlink:to="loc_icui_ContingentConsiderationGrossST_b2fc9929-c9f5-46a9-bd36-b12d934bb516" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_a1c0c361-ea5c-404b-81b9-46ae78c700f6" xlink:href="icui-20230331.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_df6271e6-12f8-4d0f-b4d4-43006c3fa3e0" xlink:to="loc_icui_ContingentConsiderationGrossLT_a1c0c361-ea5c-404b-81b9-46ae78c700f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6afe2f1b-a316-4fed-b667-727461766c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_df6271e6-12f8-4d0f-b4d4-43006c3fa3e0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6afe2f1b-a316-4fed-b667-727461766c32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OwnershipRequirementForEarnoutPayment_89ee5471-ccaa-4882-9a57-d7625cf7013b" xlink:href="icui-20230331.xsd#icui_OwnershipRequirementForEarnoutPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_df6271e6-12f8-4d0f-b4d4-43006c3fa3e0" xlink:to="loc_icui_OwnershipRequirementForEarnoutPayment_89ee5471-ccaa-4882-9a57-d7625cf7013b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_74de47b3-f343-44d9-8651-dc192a49bdf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_df6271e6-12f8-4d0f-b4d4-43006c3fa3e0" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_74de47b3-f343-44d9-8651-dc192a49bdf9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3d0f42b6-fa78-4b91-9350-186932f08c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_74de47b3-f343-44d9-8651-dc192a49bdf9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3d0f42b6-fa78-4b91-9350-186932f08c69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3d0f42b6-fa78-4b91-9350-186932f08c69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3d0f42b6-fa78-4b91-9350-186932f08c69" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3d0f42b6-fa78-4b91-9350-186932f08c69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d6e0f00-4766-42d7-9c5b-f9d22bb79aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3d0f42b6-fa78-4b91-9350-186932f08c69" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d6e0f00-4766-42d7-9c5b-f9d22bb79aea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_7c60cacd-76fe-441d-9bf6-19a04b351dfd" xlink:href="icui-20230331.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d6e0f00-4766-42d7-9c5b-f9d22bb79aea" xlink:to="loc_icui_PursuitVascularInc.Member_7c60cacd-76fe-441d-9bf6-19a04b351dfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_2dc54a40-4882-4b5a-9875-697c523c7fac" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d6e0f00-4766-42d7-9c5b-f9d22bb79aea" xlink:to="loc_icui_SmithsMedicalMember_2dc54a40-4882-4b5a-9875-697c523c7fac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_fd33f87d-14b7-46ef-885a-41cb176be4ca" xlink:href="icui-20230331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d6e0f00-4766-42d7-9c5b-f9d22bb79aea" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_fd33f87d-14b7-46ef-885a-41cb176be4ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_c83f3d5d-3c70-450c-9968-1ab22c957fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_74de47b3-f343-44d9-8651-dc192a49bdf9" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_c83f3d5d-3c70-450c-9968-1ab22c957fd3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_c83f3d5d-3c70-450c-9968-1ab22c957fd3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_c83f3d5d-3c70-450c-9968-1ab22c957fd3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_c83f3d5d-3c70-450c-9968-1ab22c957fd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_4e49ed19-5eaa-4782-853d-3b8d9fd0b669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_c83f3d5d-3c70-450c-9968-1ab22c957fd3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_4e49ed19-5eaa-4782-853d-3b8d9fd0b669" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_47fb8742-c62a-4823-970d-78dd15c34a51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_4e49ed19-5eaa-4782-853d-3b8d9fd0b669" xlink:to="loc_us-gaap_LiabilityMember_47fb8742-c62a-4823-970d-78dd15c34a51" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails" xlink:type="extended" id="i7abd9aa54b5146a7bc76e3f08483ebcb_FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_118c5d61-2528-45f4-9cbc-51733c372490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e931210e-f86e-4fd7-87bc-eebf18331f67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_118c5d61-2528-45f4-9cbc-51733c372490" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e931210e-f86e-4fd7-87bc-eebf18331f67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_44d09565-ef50-43ae-9d7f-ae3510b38c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_118c5d61-2528-45f4-9cbc-51733c372490" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_44d09565-ef50-43ae-9d7f-ae3510b38c5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_273a56a1-6e81-4dde-9257-a79247a3f88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_118c5d61-2528-45f4-9cbc-51733c372490" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_273a56a1-6e81-4dde-9257-a79247a3f88d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CurrencyTranslationOnEarnOut_e2137bc1-8029-4ec0-afc7-1dd2a8054972" xlink:href="icui-20230331.xsd#icui_CurrencyTranslationOnEarnOut"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_118c5d61-2528-45f4-9cbc-51733c372490" xlink:to="loc_icui_CurrencyTranslationOnEarnOut_e2137bc1-8029-4ec0-afc7-1dd2a8054972" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_efe6b176-c68f-4fce-8a6e-47e8218e8214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_118c5d61-2528-45f4-9cbc-51733c372490" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_efe6b176-c68f-4fce-8a6e-47e8218e8214" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_414bd8de-afae-4fbb-9d82-ef17395ab23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_efe6b176-c68f-4fce-8a6e-47e8218e8214" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_414bd8de-afae-4fbb-9d82-ef17395ab23a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_414bd8de-afae-4fbb-9d82-ef17395ab23a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_414bd8de-afae-4fbb-9d82-ef17395ab23a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_414bd8de-afae-4fbb-9d82-ef17395ab23a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42ec5d78-11ff-44d9-ab7b-f92e4b7a6749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_414bd8de-afae-4fbb-9d82-ef17395ab23a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42ec5d78-11ff-44d9-ab7b-f92e4b7a6749" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_85a38a67-0eb2-4028-ae46-b00bb9144b41" xlink:href="icui-20230331.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42ec5d78-11ff-44d9-ab7b-f92e4b7a6749" xlink:to="loc_icui_PursuitVascularInc.Member_85a38a67-0eb2-4028-ae46-b00bb9144b41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_e3914efe-350e-4dcf-8bd2-a2d5f32261ca" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42ec5d78-11ff-44d9-ab7b-f92e4b7a6749" xlink:to="loc_icui_SmithsMedicalMember_e3914efe-350e-4dcf-8bd2-a2d5f32261ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_9bbd9356-af36-4a6b-8a41-d0f3cec14629" xlink:href="icui-20230331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42ec5d78-11ff-44d9-ab7b-f92e4b7a6749" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_9bbd9356-af36-4a6b-8a41-d0f3cec14629" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails" xlink:type="extended" id="i08261bfcb5084161a3c5b4094a3688e7_FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_da57bcd1-81f1-4488-9d12-fe5e84a4f22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_dd88f65f-46d2-4dfa-9c60-0117ef70c383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_da57bcd1-81f1-4488-9d12-fe5e84a4f22c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_dd88f65f-46d2-4dfa-9c60-0117ef70c383" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_a367cdca-f2ea-4de8-959f-25ba7a2d512d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_da57bcd1-81f1-4488-9d12-fe5e84a4f22c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_a367cdca-f2ea-4de8-959f-25ba7a2d512d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_2301316f-9973-4ded-b984-30c934faa8df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_da57bcd1-81f1-4488-9d12-fe5e84a4f22c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_2301316f-9973-4ded-b984-30c934faa8df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CurrencyTranslationOnEarnOut_e3aa0b9a-7d62-41c8-8b55-2c6d84d73296" xlink:href="icui-20230331.xsd#icui_CurrencyTranslationOnEarnOut"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_da57bcd1-81f1-4488-9d12-fe5e84a4f22c" xlink:to="loc_icui_CurrencyTranslationOnEarnOut_e3aa0b9a-7d62-41c8-8b55-2c6d84d73296" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a2a301ab-8705-464f-a18e-c950870a0f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_da57bcd1-81f1-4488-9d12-fe5e84a4f22c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a2a301ab-8705-464f-a18e-c950870a0f9c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_66d53276-57ef-445c-b057-472635461727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a2a301ab-8705-464f-a18e-c950870a0f9c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_66d53276-57ef-445c-b057-472635461727" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66d53276-57ef-445c-b057-472635461727_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_66d53276-57ef-445c-b057-472635461727" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66d53276-57ef-445c-b057-472635461727_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f8b95a1d-849f-4f7d-95bd-b8845e237eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_66d53276-57ef-445c-b057-472635461727" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f8b95a1d-849f-4f7d-95bd-b8845e237eeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_88fa4b5f-e0ee-4f50-a064-f6820ee58618" xlink:href="icui-20230331.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f8b95a1d-849f-4f7d-95bd-b8845e237eeb" xlink:to="loc_icui_PursuitVascularInc.Member_88fa4b5f-e0ee-4f50-a064-f6820ee58618" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalDistributorMember_bd71a9d5-8f84-460e-b781-f96fc79a58f9" xlink:href="icui-20230331.xsd#icui_InternationalDistributorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f8b95a1d-849f-4f7d-95bd-b8845e237eeb" xlink:to="loc_icui_InternationalDistributorMember_bd71a9d5-8f84-460e-b781-f96fc79a58f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_032467af-3e4b-4eab-9700-383d372ef7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a2a301ab-8705-464f-a18e-c950870a0f9c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_032467af-3e4b-4eab-9700-383d372ef7bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_032467af-3e4b-4eab-9700-383d372ef7bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_032467af-3e4b-4eab-9700-383d372ef7bc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_032467af-3e4b-4eab-9700-383d372ef7bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c6f73219-6a1a-4f68-a74d-10bf4f676805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_032467af-3e4b-4eab-9700-383d372ef7bc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c6f73219-6a1a-4f68-a74d-10bf4f676805" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_1c2310ab-96e5-401a-8456-a490c360edc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a2a301ab-8705-464f-a18e-c950870a0f9c" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_1c2310ab-96e5-401a-8456-a490c360edc6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1c2310ab-96e5-401a-8456-a490c360edc6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1c2310ab-96e5-401a-8456-a490c360edc6" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1c2310ab-96e5-401a-8456-a490c360edc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e4fec677-8bdd-4831-ace5-a08765aca464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1c2310ab-96e5-401a-8456-a490c360edc6" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e4fec677-8bdd-4831-ace5-a08765aca464" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_495626c0-8e91-456a-9f99-0ced01523be5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a2a301ab-8705-464f-a18e-c950870a0f9c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_495626c0-8e91-456a-9f99-0ced01523be5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_495626c0-8e91-456a-9f99-0ced01523be5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_495626c0-8e91-456a-9f99-0ced01523be5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_495626c0-8e91-456a-9f99-0ced01523be5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_75a306d5-78bf-4965-aef5-3001300a0199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_495626c0-8e91-456a-9f99-0ced01523be5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_75a306d5-78bf-4965-aef5-3001300a0199" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails" xlink:type="extended" id="i81080be802c6408b98cb7f430cfe10d4_FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5034a6f2-2e4c-4104-a23a-0d3a9cc6d838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9bd79b07-e615-486d-a10d-8c66ed25f0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5034a6f2-2e4c-4104-a23a-0d3a9cc6d838" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9bd79b07-e615-486d-a10d-8c66ed25f0ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_b77ec4dd-d9a9-4f99-96cb-2be4a326313b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5034a6f2-2e4c-4104-a23a-0d3a9cc6d838" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_b77ec4dd-d9a9-4f99-96cb-2be4a326313b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9bbd73af-17ff-4e99-a55c-21e3d9dacabc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_b77ec4dd-d9a9-4f99-96cb-2be4a326313b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9bbd73af-17ff-4e99-a55c-21e3d9dacabc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9bbd73af-17ff-4e99-a55c-21e3d9dacabc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9bbd73af-17ff-4e99-a55c-21e3d9dacabc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9bbd73af-17ff-4e99-a55c-21e3d9dacabc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d2c118a0-a313-4534-88a2-5117f88847b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9bbd73af-17ff-4e99-a55c-21e3d9dacabc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d2c118a0-a313-4534-88a2-5117f88847b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_4dd542cd-00f5-4864-a043-7b56c83bf981" xlink:href="icui-20230331.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d2c118a0-a313-4534-88a2-5117f88847b9" xlink:to="loc_icui_PursuitVascularInc.Member_4dd542cd-00f5-4864-a043-7b56c83bf981" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_87c9b71c-f8ec-443e-9b66-e820dc02105a" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d2c118a0-a313-4534-88a2-5117f88847b9" xlink:to="loc_icui_SmithsMedicalMember_87c9b71c-f8ec-443e-9b66-e820dc02105a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_bb6df5e3-f7a0-47ae-9306-4ae31efba6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_b77ec4dd-d9a9-4f99-96cb-2be4a326313b" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_bb6df5e3-f7a0-47ae-9306-4ae31efba6b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_bb6df5e3-f7a0-47ae-9306-4ae31efba6b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_bb6df5e3-f7a0-47ae-9306-4ae31efba6b3" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_bb6df5e3-f7a0-47ae-9306-4ae31efba6b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_11abe2bb-2232-4cc7-827b-9cef1c5c3c98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_bb6df5e3-f7a0-47ae-9306-4ae31efba6b3" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_11abe2bb-2232-4cc7-827b-9cef1c5c3c98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_46dc773b-6f3e-41d5-a8af-f583eb32bf14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_11abe2bb-2232-4cc7-827b-9cef1c5c3c98" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_46dc773b-6f3e-41d5-a8af-f583eb32bf14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_bcb9af6f-5e52-41e0-bd4a-a575227aac4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_11abe2bb-2232-4cc7-827b-9cef1c5c3c98" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_bcb9af6f-5e52-41e0-bd4a-a575227aac4a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails" xlink:type="extended" id="ieb499899308b4a16bf6d6879db1bc5c0_FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_08c5d57e-1d64-4877-9923-139c50fa69cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_08c5d57e-1d64-4877-9923-139c50fa69cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_16522ea8-0c7b-4358-9ba7-0fa9a0eb4e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_16522ea8-0c7b-4358-9ba7-0fa9a0eb4e0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_0cf2ffea-f287-4eb8-9ced-d66859ea02bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_0cf2ffea-f287-4eb8-9ced-d66859ea02bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_f519865b-3b47-42d5-ab59-360faa419f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateDerivativeAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_f519865b-3b47-42d5-ab59-360faa419f29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d8ff1c13-c531-408a-8136-a8ed591d55d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d8ff1c13-c531-408a-8136-a8ed591d55d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_30d0cc64-ab86-412d-9637-e65807f59ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonfinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_30d0cc64-ab86-412d-9637-e65807f59ec4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_37184e99-36c8-4473-aa40-615e48a465cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_37184e99-36c8-4473-aa40-615e48a465cc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_f9090f6c-4b80-4b74-afdb-4e8ad9bdbc48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_f9090f6c-4b80-4b74-afdb-4e8ad9bdbc48" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration_0420a675-075e-4710-b7a3-bd85fee076e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration_0420a675-075e-4710-b7a3-bd85fee076e5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration_ebf21f9a-937e-4aa1-93ae-2fe036a5d06c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration_ebf21f9a-937e-4aa1-93ae-2fe036a5d06c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_ae9d071c-7104-4328-a6a4-54be5f03fba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_ae9d071c-7104-4328-a6a4-54be5f03fba6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration_70bab0ca-e487-4cf1-ba38-e4e5ece47a91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration_70bab0ca-e487-4cf1-ba38-e4e5ece47a91" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c2924ccd-652f-4888-b590-0c7a4e389dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c2924ccd-652f-4888-b590-0c7a4e389dde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c2924ccd-652f-4888-b590-0c7a4e389dde_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c2924ccd-652f-4888-b590-0c7a4e389dde" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c2924ccd-652f-4888-b590-0c7a4e389dde_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9d1b7bbf-17d8-43b9-8d11-49b653f88382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c2924ccd-652f-4888-b590-0c7a4e389dde" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9d1b7bbf-17d8-43b9-8d11-49b653f88382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_896ff55a-b290-4471-9314-d0c1ab920ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9d1b7bbf-17d8-43b9-8d11-49b653f88382" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_896ff55a-b290-4471-9314-d0c1ab920ef7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_54b3e919-b849-4f17-bfeb-17fc92133153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9d1b7bbf-17d8-43b9-8d11-49b653f88382" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_54b3e919-b849-4f17-bfeb-17fc92133153" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_85c269b6-e407-4715-b939-33cad14df135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9d1b7bbf-17d8-43b9-8d11-49b653f88382" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_85c269b6-e407-4715-b939-33cad14df135" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f2e88f30-4e9b-4990-84fa-239d9ed693e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f2e88f30-4e9b-4990-84fa-239d9ed693e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f2e88f30-4e9b-4990-84fa-239d9ed693e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f2e88f30-4e9b-4990-84fa-239d9ed693e7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f2e88f30-4e9b-4990-84fa-239d9ed693e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_30636f6a-99b1-4277-b373-8a405990e2be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f2e88f30-4e9b-4990-84fa-239d9ed693e7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_30636f6a-99b1-4277-b373-8a405990e2be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c339fa9d-8b4f-4405-b135-30aa80be203b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_30636f6a-99b1-4277-b373-8a405990e2be" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c339fa9d-8b4f-4405-b135-30aa80be203b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_40080f59-ed70-438b-9225-7b18d90317da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_40080f59-ed70-438b-9225-7b18d90317da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_40080f59-ed70-438b-9225-7b18d90317da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_40080f59-ed70-438b-9225-7b18d90317da" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_40080f59-ed70-438b-9225-7b18d90317da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fe2e68c7-9785-44b6-802b-26b454d59e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_40080f59-ed70-438b-9225-7b18d90317da" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fe2e68c7-9785-44b6-802b-26b454d59e06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EarnoutliabilityMember_4b72e729-cf94-42e3-84f7-0185b5bf4f76" xlink:href="icui-20230331.xsd#icui_EarnoutliabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fe2e68c7-9785-44b6-802b-26b454d59e06" xlink:to="loc_icui_EarnoutliabilityMember_4b72e729-cf94-42e3-84f7-0185b5bf4f76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesTotalMember_70dfb981-5cb5-4c96-8562-0b7cdaf63085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesTotalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fe2e68c7-9785-44b6-802b-26b454d59e06" xlink:to="loc_us-gaap_LiabilitiesTotalMember_70dfb981-5cb5-4c96-8562-0b7cdaf63085" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_1f7aec06-1285-4446-99bc-c281d5d442fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:to="loc_us-gaap_InvestmentTypeAxis_1f7aec06-1285-4446-99bc-c281d5d442fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_1f7aec06-1285-4446-99bc-c281d5d442fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_1f7aec06-1285-4446-99bc-c281d5d442fc" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_1f7aec06-1285-4446-99bc-c281d5d442fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ccd1f8a3-9539-48d5-bb9f-05e42914dfd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_1f7aec06-1285-4446-99bc-c281d5d442fc" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ccd1f8a3-9539-48d5-bb9f-05e42914dfd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_0a1b57a6-2828-4ea0-9c22-63ba09c6e5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ccd1f8a3-9539-48d5-bb9f-05e42914dfd9" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_0a1b57a6-2828-4ea0-9c22-63ba09c6e5f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_54a56183-c786-4c7f-a3a3-17e246842e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ccd1f8a3-9539-48d5-bb9f-05e42914dfd9" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_54a56183-c786-4c7f-a3a3-17e246842e44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_c0aa376e-54f3-4939-b657-1385da868946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ccd1f8a3-9539-48d5-bb9f-05e42914dfd9" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_c0aa376e-54f3-4939-b657-1385da868946" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8763077f-5c8f-405b-bd8e-2fad182a6a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8763077f-5c8f-405b-bd8e-2fad182a6a9e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8763077f-5c8f-405b-bd8e-2fad182a6a9e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8763077f-5c8f-405b-bd8e-2fad182a6a9e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8763077f-5c8f-405b-bd8e-2fad182a6a9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d40ab363-026a-473c-a5da-69b69eed4839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8763077f-5c8f-405b-bd8e-2fad182a6a9e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d40ab363-026a-473c-a5da-69b69eed4839" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_749d4faa-ff69-4b3c-ae66-17680996d525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d40ab363-026a-473c-a5da-69b69eed4839" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_749d4faa-ff69-4b3c-ae66-17680996d525" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_eef2ea86-1100-4d0b-88c5-a7d11c5fd581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d40ab363-026a-473c-a5da-69b69eed4839" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_eef2ea86-1100-4d0b-88c5-a7d11c5fd581" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_b7c9cc63-2716-4b17-9d6a-6ebe5c75f5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d40ab363-026a-473c-a5da-69b69eed4839" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_b7c9cc63-2716-4b17-9d6a-6ebe5c75f5d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ClassificationAxis_915eefa0-f652-4465-b0cf-6584cfacece5" xlink:href="icui-20230331.xsd#icui_ClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:to="loc_icui_ClassificationAxis_915eefa0-f652-4465-b0cf-6584cfacece5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ClassificationDomain_915eefa0-f652-4465-b0cf-6584cfacece5_default" xlink:href="icui-20230331.xsd#icui_ClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_ClassificationAxis_915eefa0-f652-4465-b0cf-6584cfacece5" xlink:to="loc_icui_ClassificationDomain_915eefa0-f652-4465-b0cf-6584cfacece5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ClassificationDomain_95b47e48-dc9a-4479-abc5-740d518cd22d" xlink:href="icui-20230331.xsd#icui_ClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_ClassificationAxis_915eefa0-f652-4465-b0cf-6584cfacece5" xlink:to="loc_icui_ClassificationDomain_95b47e48-dc9a-4479-abc5-740d518cd22d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CurrentMember_2f69e8a9-98f5-4155-9edc-90805b4e7e35" xlink:href="icui-20230331.xsd#icui_CurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ClassificationDomain_95b47e48-dc9a-4479-abc5-740d518cd22d" xlink:to="loc_icui_CurrentMember_2f69e8a9-98f5-4155-9edc-90805b4e7e35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentMember_3efdcbc2-8db5-48c6-b0cd-894c56bcfcd3" xlink:href="icui-20230331.xsd#icui_NoncurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ClassificationDomain_95b47e48-dc9a-4479-abc5-740d518cd22d" xlink:to="loc_icui_NoncurrentMember_3efdcbc2-8db5-48c6-b0cd-894c56bcfcd3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InvestmentSecuritiesTableDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#InvestmentSecuritiesTableDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/InvestmentSecuritiesTableDetails" xlink:type="extended" id="i120417488b414c8a894ec89ddd29461d_InvestmentSecuritiesTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_d3ddad4d-09b0-43e2-a7e7-2b1b7cadf3df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_d3ddad4d-09b0-43e2-a7e7-2b1b7cadf3df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_800b5493-a6bb-4bb2-8b10-751a5430aec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_800b5493-a6bb-4bb2-8b10-751a5430aec9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7f2b6703-438f-4e2a-912b-ec64983ede77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7f2b6703-438f-4e2a-912b-ec64983ede77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_4d962131-8648-49b8-89ee-47bfbe506bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_4d962131-8648-49b8-89ee-47bfbe506bd7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_ad6858f2-3291-4e48-a311-5a0e17c6e6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_ad6858f2-3291-4e48-a311-5a0e17c6e6f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_3da922fd-ed50-4943-978f-ff8f8e06a933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_3da922fd-ed50-4943-978f-ff8f8e06a933" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1e192c1c-c850-40ba-a63e-76780ae159e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1e192c1c-c850-40ba-a63e-76780ae159e3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f6c7ad5b-cc5b-4195-b7ba-92d41b000d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f6c7ad5b-cc5b-4195-b7ba-92d41b000d2a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ae1ef462-860a-4640-b459-cb17f1e4ad84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f6c7ad5b-cc5b-4195-b7ba-92d41b000d2a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ae1ef462-860a-4640-b459-cb17f1e4ad84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ae1ef462-860a-4640-b459-cb17f1e4ad84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ae1ef462-860a-4640-b459-cb17f1e4ad84" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ae1ef462-860a-4640-b459-cb17f1e4ad84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b83a91a1-8eae-4a10-8dea-4ae4532cccee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ae1ef462-860a-4640-b459-cb17f1e4ad84" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b83a91a1-8eae-4a10-8dea-4ae4532cccee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_dc1caa0e-7364-4fbe-a9f3-86611a083f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b83a91a1-8eae-4a10-8dea-4ae4532cccee" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_dc1caa0e-7364-4fbe-a9f3-86611a083f60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_07d02c83-69e5-49ac-9fe1-353323a800db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b83a91a1-8eae-4a10-8dea-4ae4532cccee" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_07d02c83-69e5-49ac-9fe1-353323a800db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_e2b38f6e-1a0b-4838-af5a-5baf6636f5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b83a91a1-8eae-4a10-8dea-4ae4532cccee" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_e2b38f6e-1a0b-4838-af5a-5baf6636f5aa" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/EquityMethodInvestmentsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#EquityMethodInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/EquityMethodInvestmentsDetails" xlink:type="extended" id="i8a8ba67a1ec8435fad7fc00a4c22c32b_EquityMethodInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_b661e076-a54e-4d94-849f-4e5ba7f965e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4d7c1bf4-a823-420c-bcb8-79e60f52183b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_b661e076-a54e-4d94-849f-4e5ba7f965e1" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4d7c1bf4-a823-420c-bcb8-79e60f52183b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_a3c5e736-b3a8-4834-b314-b2fa99c987c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_b661e076-a54e-4d94-849f-4e5ba7f965e1" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_a3c5e736-b3a8-4834-b314-b2fa99c987c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_0b3173f5-bb31-49e1-b806-b7c576a1e092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_b661e076-a54e-4d94-849f-4e5ba7f965e1" xlink:to="loc_us-gaap_EquityMethodInvestments_0b3173f5-bb31-49e1-b806-b7c576a1e092" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_8bd3f0f3-8e43-401d-91b6-30482c7c96d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_b661e076-a54e-4d94-849f-4e5ba7f965e1" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_8bd3f0f3-8e43-401d-91b6-30482c7c96d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_92aef4ed-8ba5-4d77-ad03-4bde8c50fdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_8bd3f0f3-8e43-401d-91b6-30482c7c96d8" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_92aef4ed-8ba5-4d77-ad03-4bde8c50fdd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_92aef4ed-8ba5-4d77-ad03-4bde8c50fdd5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_92aef4ed-8ba5-4d77-ad03-4bde8c50fdd5" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_92aef4ed-8ba5-4d77-ad03-4bde8c50fdd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_9feaeddf-233e-4d70-8432-94d12ba211d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_92aef4ed-8ba5-4d77-ad03-4bde8c50fdd5" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_9feaeddf-233e-4d70-8432-94d12ba211d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NonPublicCompanyMember_24d56d45-f5b0-49a5-a723-38fc7cf73e5e" xlink:href="icui-20230331.xsd#icui_NonPublicCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_9feaeddf-233e-4d70-8432-94d12ba211d7" xlink:to="loc_icui_NonPublicCompanyMember_24d56d45-f5b0-49a5-a723-38fc7cf73e5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9fd95fc3-298b-491f-a295-81834d6c3cc9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_8bd3f0f3-8e43-401d-91b6-30482c7c96d8" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9fd95fc3-298b-491f-a295-81834d6c3cc9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9fd95fc3-298b-491f-a295-81834d6c3cc9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9fd95fc3-298b-491f-a295-81834d6c3cc9" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9fd95fc3-298b-491f-a295-81834d6c3cc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_60a7d7d6-a059-4736-9ff9-c3615b660756" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9fd95fc3-298b-491f-a295-81834d6c3cc9" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_60a7d7d6-a059-4736-9ff9-c3615b660756" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NonPublicCompanyMember_5ae83d2f-f662-48ca-a4bb-c0dd3cb05a38" xlink:href="icui-20230331.xsd#icui_NonPublicCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_60a7d7d6-a059-4736-9ff9-c3615b660756" xlink:to="loc_icui_NonPublicCompanyMember_5ae83d2f-f662-48ca-a4bb-c0dd3cb05a38" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails" xlink:type="extended" id="i27cee6eab0f64327be40a5d90dee40fc_PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_1ca5eaa5-8c13-4b4b-b178-ea2ce5b7717a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_588415f7-d8d1-4007-b4ab-5ced270924cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1ca5eaa5-8c13-4b4b-b178-ea2ce5b7717a" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_588415f7-d8d1-4007-b4ab-5ced270924cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_dc369645-9e25-44ae-82a0-f7c3438435d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_1ca5eaa5-8c13-4b4b-b178-ea2ce5b7717a" xlink:to="loc_us-gaap_DerivativeTable_dc369645-9e25-44ae-82a0-f7c3438435d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_081bbd72-b473-47f9-a70f-7d8db4177d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_dc369645-9e25-44ae-82a0-f7c3438435d3" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_081bbd72-b473-47f9-a70f-7d8db4177d0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_081bbd72-b473-47f9-a70f-7d8db4177d0b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_081bbd72-b473-47f9-a70f-7d8db4177d0b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_081bbd72-b473-47f9-a70f-7d8db4177d0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b2a63c04-9b7a-440a-95e0-eb3c1c6d1f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_081bbd72-b473-47f9-a70f-7d8db4177d0b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b2a63c04-9b7a-440a-95e0-eb3c1c6d1f69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_abc3dda3-0908-4768-b065-62d908109bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b2a63c04-9b7a-440a-95e0-eb3c1c6d1f69" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_abc3dda3-0908-4768-b065-62d908109bf3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/OtherAssetsNoncurrentDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#OtherAssetsNoncurrentDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/OtherAssetsNoncurrentDetails" xlink:type="extended" id="i1441e0bea14046ddad982ae94512a0f6_OtherAssetsNoncurrentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_87b74628-0260-4b62-a348-1024276a39ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_5e433973-dc60-4b69-b9f2-6b373f883b80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_87b74628-0260-4b62-a348-1024276a39ec" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_5e433973-dc60-4b69-b9f2-6b373f883b80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_de89c738-e017-4cd7-a493-02aeaf5862d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_87b74628-0260-4b62-a348-1024276a39ec" xlink:to="loc_us-gaap_DerivativeTable_de89c738-e017-4cd7-a493-02aeaf5862d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3d0695ba-8e32-46f4-a09a-ef83224eb879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_de89c738-e017-4cd7-a493-02aeaf5862d2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3d0695ba-8e32-46f4-a09a-ef83224eb879" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3d0695ba-8e32-46f4-a09a-ef83224eb879_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3d0695ba-8e32-46f4-a09a-ef83224eb879" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3d0695ba-8e32-46f4-a09a-ef83224eb879_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_eafefdd4-0c7a-40c0-866b-83d295c0e38c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3d0695ba-8e32-46f4-a09a-ef83224eb879" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_eafefdd4-0c7a-40c0-866b-83d295c0e38c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e4410a42-44a7-4cce-9e57-ba50b2bf1aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eafefdd4-0c7a-40c0-866b-83d295c0e38c" xlink:to="loc_us-gaap_InterestRateSwapMember_e4410a42-44a7-4cce-9e57-ba50b2bf1aa9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_ac228291-3c8a-4046-9510-adaf8b5e9c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eafefdd4-0c7a-40c0-866b-83d295c0e38c" xlink:to="loc_us-gaap_ForeignExchangeMember_ac228291-3c8a-4046-9510-adaf8b5e9c86" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#PropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="extended" id="ifccfc7b0ca5e44a9adfebc3a038783e3_PropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_59198350-37a7-480f-a176-5228d6c80756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_18e9dba4-f15a-4034-900b-bb3416ce5a41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_59198350-37a7-480f-a176-5228d6c80756" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_18e9dba4-f15a-4034-900b-bb3416ce5a41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4f1d23e4-46aa-4824-bdca-86fa00124fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_59198350-37a7-480f-a176-5228d6c80756" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4f1d23e4-46aa-4824-bdca-86fa00124fd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1d296ea9-180d-4bfa-af08-665f6f41e509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_59198350-37a7-480f-a176-5228d6c80756" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1d296ea9-180d-4bfa-af08-665f6f41e509" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_c4c3fa8b-5e34-4bda-afac-2baed850a158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_59198350-37a7-480f-a176-5228d6c80756" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_c4c3fa8b-5e34-4bda-afac-2baed850a158" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_d6464b46-b175-4b95-a09c-00a5e2cc4874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_59198350-37a7-480f-a176-5228d6c80756" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_d6464b46-b175-4b95-a09c-00a5e2cc4874" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_492b911c-d5ff-49ee-9eb7-be1e20f30536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_59198350-37a7-480f-a176-5228d6c80756" xlink:to="loc_us-gaap_ConstructionInProgressGross_492b911c-d5ff-49ee-9eb7-be1e20f30536" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2ceedda0-e731-4b4e-96f3-2c5837a756c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_59198350-37a7-480f-a176-5228d6c80756" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2ceedda0-e731-4b4e-96f3-2c5837a756c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79cf9391-00b5-4df7-b45a-c1e45c940069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2ceedda0-e731-4b4e-96f3-2c5837a756c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79cf9391-00b5-4df7-b45a-c1e45c940069" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_79cf9391-00b5-4df7-b45a-c1e45c940069_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79cf9391-00b5-4df7-b45a-c1e45c940069" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_79cf9391-00b5-4df7-b45a-c1e45c940069_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_30e9e439-5c2c-4782-b56e-7d591ce9799f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79cf9391-00b5-4df7-b45a-c1e45c940069" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_30e9e439-5c2c-4782-b56e-7d591ce9799f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember_84d3fb94-f115-4f32-b3e6-0a570bb4ba47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_30e9e439-5c2c-4782-b56e-7d591ce9799f" xlink:to="loc_us-gaap_LandBuildingsAndImprovementsMember_84d3fb94-f115-4f32-b3e6-0a570bb4ba47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MoldsMember_55632b8e-5759-44cb-917a-2c08b2d2854c" xlink:href="icui-20230331.xsd#icui_MoldsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_30e9e439-5c2c-4782-b56e-7d591ce9799f" xlink:to="loc_icui_MoldsMember_55632b8e-5759-44cb-917a-2c08b2d2854c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ComputerEquipmentAndSoftwareMember_92ecf592-9e34-408a-900b-902bcfbeec5b" xlink:href="icui-20230331.xsd#icui_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_30e9e439-5c2c-4782-b56e-7d591ce9799f" xlink:to="loc_icui_ComputerEquipmentAndSoftwareMember_92ecf592-9e34-408a-900b-902bcfbeec5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InstrumentsPlacedwithCustomersMember_00b20398-e22f-485e-a0cb-b745a53e325a" xlink:href="icui-20230331.xsd#icui_InstrumentsPlacedwithCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_30e9e439-5c2c-4782-b56e-7d591ce9799f" xlink:to="loc_icui_InstrumentsPlacedwithCustomersMember_00b20398-e22f-485e-a0cb-b745a53e325a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#GoodwillandIntangibleAssetsIntangiblesTableDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails" xlink:type="extended" id="i235fe1fafaf0468f8d49700b6a93d6e5_GoodwillandIntangibleAssetsIntangiblesTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_cdbb42be-7bfb-4eb7-b8ba-bbe8fc9dc64f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_cdbb42be-7bfb-4eb7-b8ba-bbe8fc9dc64f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_57d4bfbc-5f40-43a1-a00b-365c30183ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_57d4bfbc-5f40-43a1-a00b-365c30183ecf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cc49e575-e404-4716-96aa-b5b995f91997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cc49e575-e404-4716-96aa-b5b995f91997" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c0ca2325-0edf-4393-8551-6ef06b0a3cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c0ca2325-0edf-4393-8551-6ef06b0a3cfa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_cb73df0a-9f1f-44b9-ad08-439e96c14416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_cb73df0a-9f1f-44b9-ad08-439e96c14416" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2934efe6-a60e-4be1-a9c0-e20d5c7a1940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2934efe6-a60e-4be1-a9c0-e20d5c7a1940" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_41bb3638-c4b4-43cb-9c6e-4f4a9988cfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_41bb3638-c4b4-43cb-9c6e-4f4a9988cfc6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24087203-a317-4503-8785-658efd06bdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24087203-a317-4503-8785-658efd06bdd5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f7825fdd-59e7-4214-b53e-001d11fafde2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24087203-a317-4503-8785-658efd06bdd5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f7825fdd-59e7-4214-b53e-001d11fafde2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f7825fdd-59e7-4214-b53e-001d11fafde2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f7825fdd-59e7-4214-b53e-001d11fafde2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f7825fdd-59e7-4214-b53e-001d11fafde2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f7825fdd-59e7-4214-b53e-001d11fafde2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_9cbf4916-fb50-4463-926f-9b7a3ff4e029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:to="loc_us-gaap_PatentsMember_9cbf4916-fb50-4463-926f-9b7a3ff4e029" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_8e70f431-c23e-41d8-9be7-d987a95939e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:to="loc_us-gaap_CustomerContractsMember_8e70f431-c23e-41d8-9be7-d987a95939e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_93a220d8-5028-4961-9023-5dcc7c17507b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_93a220d8-5028-4961-9023-5dcc7c17507b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_c02e77b0-3332-4d03-9481-754cc8aaf918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:to="loc_us-gaap_TrademarksMember_c02e77b0-3332-4d03-9481-754cc8aaf918" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_fd34976d-308e-404e-9a2e-29ed452590da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:to="loc_us-gaap_TradeNamesMember_fd34976d-308e-404e-9a2e-29ed452590da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_945ab130-f974-461b-9f2f-66dadac16812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_945ab130-f974-461b-9f2f-66dadac16812" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_5577cf2f-af1b-4d26-a08c-26d47782ec7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_5577cf2f-af1b-4d26-a08c-26d47782ec7e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_37b62d3e-aec0-4bfd-b0e0-85efb787305e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24087203-a317-4503-8785-658efd06bdd5" xlink:to="loc_srt_ConsolidationItemsAxis_37b62d3e-aec0-4bfd-b0e0-85efb787305e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_37b62d3e-aec0-4bfd-b0e0-85efb787305e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_37b62d3e-aec0-4bfd-b0e0-85efb787305e" xlink:to="loc_srt_ConsolidationItemsDomain_37b62d3e-aec0-4bfd-b0e0-85efb787305e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_32904ccf-beb7-470f-8282-97f8c45532c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_37b62d3e-aec0-4bfd-b0e0-85efb787305e" xlink:to="loc_srt_ConsolidationItemsDomain_32904ccf-beb7-470f-8282-97f8c45532c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f4004fed-f3e2-4690-abcc-92d35940a1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24087203-a317-4503-8785-658efd06bdd5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f4004fed-f3e2-4690-abcc-92d35940a1b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f4004fed-f3e2-4690-abcc-92d35940a1b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f4004fed-f3e2-4690-abcc-92d35940a1b5" xlink:to="loc_us-gaap_SegmentDomain_f4004fed-f3e2-4690-abcc-92d35940a1b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_52aee556-c5a0-4c77-8ac2-13da624b4395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f4004fed-f3e2-4690-abcc-92d35940a1b5" xlink:to="loc_us-gaap_SegmentDomain_52aee556-c5a0-4c77-8ac2-13da624b4395" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a87d0ab8-44cc-4d6b-86fe-58e4b4d43a2e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24087203-a317-4503-8785-658efd06bdd5" xlink:to="loc_srt_RangeAxis_a87d0ab8-44cc-4d6b-86fe-58e4b4d43a2e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a87d0ab8-44cc-4d6b-86fe-58e4b4d43a2e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a87d0ab8-44cc-4d6b-86fe-58e4b4d43a2e" xlink:to="loc_srt_RangeMember_a87d0ab8-44cc-4d6b-86fe-58e4b4d43a2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6cbd002e-142a-4dc3-b6f2-0e09ba3f576c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a87d0ab8-44cc-4d6b-86fe-58e4b4d43a2e" xlink:to="loc_srt_RangeMember_6cbd002e-142a-4dc3-b6f2-0e09ba3f576c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#AccruedLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesDetails" xlink:type="extended" id="idf12db93f1914d4daa687dc00b34b120_AccruedLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e9f32277-ba2b-4d8b-9722-50a354e52754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_ac69069d-5887-47bd-811c-4f0f9cedab2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e9f32277-ba2b-4d8b-9722-50a354e52754" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_ac69069d-5887-47bd-811c-4f0f9cedab2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ad4da061-e3f2-493e-aa5d-ebf30a2b3fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_e9f32277-ba2b-4d8b-9722-50a354e52754" xlink:to="loc_us-gaap_DerivativeTable_ad4da061-e3f2-493e-aa5d-ebf30a2b3fcd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c94f3c09-2c00-41e4-8076-e7f8cca52350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ad4da061-e3f2-493e-aa5d-ebf30a2b3fcd" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c94f3c09-2c00-41e4-8076-e7f8cca52350" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c94f3c09-2c00-41e4-8076-e7f8cca52350_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c94f3c09-2c00-41e4-8076-e7f8cca52350" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c94f3c09-2c00-41e4-8076-e7f8cca52350_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d936596e-8f4a-4bf2-b399-21b3a388370f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c94f3c09-2c00-41e4-8076-e7f8cca52350" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d936596e-8f4a-4bf2-b399-21b3a388370f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_ed9c0e89-16ef-4332-9366-a3dc76c64f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d936596e-8f4a-4bf2-b399-21b3a388370f" xlink:to="loc_us-gaap_ForeignExchangeMember_ed9c0e89-16ef-4332-9366-a3dc76c64f75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_f4c7edbf-3723-4c50-94b2-2de65a403699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_214d9b80-df50-4d59-b3cb-3a443a4a185c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_f4c7edbf-3723-4c50-94b2-2de65a403699" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_214d9b80-df50-4d59-b3cb-3a443a4a185c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_00f097a7-c4f9-4454-a111-bfdd0e84e3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_f4c7edbf-3723-4c50-94b2-2de65a403699" xlink:to="loc_us-gaap_ProductLiabilityContingencyTable_00f097a7-c4f9-4454-a111-bfdd0e84e3ac" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_75b5e8c4-e9cb-451d-a131-566b3eee0a4c" xlink:href="icui-20230331.xsd#icui_TimingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_00f097a7-c4f9-4454-a111-bfdd0e84e3ac" xlink:to="loc_icui_TimingAxis_75b5e8c4-e9cb-451d-a131-566b3eee0a4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_75b5e8c4-e9cb-451d-a131-566b3eee0a4c_default" xlink:href="icui-20230331.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TimingAxis_75b5e8c4-e9cb-451d-a131-566b3eee0a4c" xlink:to="loc_icui_TimingDomain_75b5e8c4-e9cb-451d-a131-566b3eee0a4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_5b0dbd16-c108-4d58-a5f7-d2a6218de6f5" xlink:href="icui-20230331.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TimingAxis_75b5e8c4-e9cb-451d-a131-566b3eee0a4c" xlink:to="loc_icui_TimingDomain_5b0dbd16-c108-4d58-a5f7-d2a6218de6f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermMember_e4ac0246-e562-4e9d-a0e9-a3614a193058" xlink:href="icui-20230331.xsd#icui_ShortTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TimingDomain_5b0dbd16-c108-4d58-a5f7-d2a6218de6f5" xlink:to="loc_icui_ShortTermMember_e4ac0246-e562-4e9d-a0e9-a3614a193058" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#AccruedLiabilitiesLongtermliabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails" xlink:type="extended" id="i39dc88a7fb2942dda22fd94257748361_AccruedLiabilitiesLongtermliabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_26346f37-fcc5-4046-a15a-428e3c1fb9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_0fc9a249-dd51-4a43-8ce7-59f1ba445460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_26346f37-fcc5-4046-a15a-428e3c1fb9f3" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_0fc9a249-dd51-4a43-8ce7-59f1ba445460" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ab0cdce8-861c-4721-b70d-0bb42997f139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_26346f37-fcc5-4046-a15a-428e3c1fb9f3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ab0cdce8-861c-4721-b70d-0bb42997f139" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_f247a883-ad42-4ae6-97b3-4cf9424be6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_26346f37-fcc5-4046-a15a-428e3c1fb9f3" xlink:to="loc_us-gaap_ProductLiabilityContingencyTable_f247a883-ad42-4ae6-97b3-4cf9424be6a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_a9b79dea-8837-4620-a7a7-e36e2f633ebf" xlink:href="icui-20230331.xsd#icui_TimingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_f247a883-ad42-4ae6-97b3-4cf9424be6a0" xlink:to="loc_icui_TimingAxis_a9b79dea-8837-4620-a7a7-e36e2f633ebf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_a9b79dea-8837-4620-a7a7-e36e2f633ebf_default" xlink:href="icui-20230331.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TimingAxis_a9b79dea-8837-4620-a7a7-e36e2f633ebf" xlink:to="loc_icui_TimingDomain_a9b79dea-8837-4620-a7a7-e36e2f633ebf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_beb680d3-9098-44fa-8875-3ebae682240c" xlink:href="icui-20230331.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TimingAxis_a9b79dea-8837-4620-a7a7-e36e2f633ebf" xlink:to="loc_icui_TimingDomain_beb680d3-9098-44fa-8875-3ebae682240c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermMember_a289a6c3-2904-414a-b770-7e40e565ad45" xlink:href="icui-20230331.xsd#icui_LongTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TimingDomain_beb680d3-9098-44fa-8875-3ebae682240c" xlink:to="loc_icui_LongTermMember_a289a6c3-2904-414a-b770-7e40e565ad45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6d36a32a-094a-486d-87b9-b3e6b138677e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_90d892a6-a599-430d-b3b7-0527aff9e209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6d36a32a-094a-486d-87b9-b3e6b138677e" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_90d892a6-a599-430d-b3b7-0527aff9e209" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_dd7e330b-ac14-4d91-b8f9-ee2cef02f912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_6d36a32a-094a-486d-87b9-b3e6b138677e" xlink:to="loc_us-gaap_DerivativeTable_dd7e330b-ac14-4d91-b8f9-ee2cef02f912" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7cb939cb-71da-4908-9559-ae144cdd332e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_dd7e330b-ac14-4d91-b8f9-ee2cef02f912" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7cb939cb-71da-4908-9559-ae144cdd332e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7cb939cb-71da-4908-9559-ae144cdd332e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7cb939cb-71da-4908-9559-ae144cdd332e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7cb939cb-71da-4908-9559-ae144cdd332e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_81e1a532-6ecc-4197-99a4-7d5f5cb6991b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7cb939cb-71da-4908-9559-ae144cdd332e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_81e1a532-6ecc-4197-99a4-7d5f5cb6991b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_6aa80249-f94d-406a-b75c-0c7776453adf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_81e1a532-6ecc-4197-99a4-7d5f5cb6991b" xlink:to="loc_us-gaap_ForeignExchangeMember_6aa80249-f94d-406a-b75c-0c7776453adf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#IncomeTaxesEffectivetaxrateDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails" xlink:type="extended" id="i4f0b772e40114bb6b5c938c7f4d80c14_IncomeTaxesEffectivetaxrateDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_4eae2150-6606-4f51-8208-5ec1957f3699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7c188d84-ebad-4785-a3b5-d0467e0cf41e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_4eae2150-6606-4f51-8208-5ec1957f3699" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7c188d84-ebad-4785-a3b5-d0467e0cf41e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b98bde4a-dae7-4fd0-a315-f6fa917faa95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_4eae2150-6606-4f51-8208-5ec1957f3699" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b98bde4a-dae7-4fd0-a315-f6fa917faa95" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0356554a-f0f2-4e72-99b3-8c7a459df7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b98bde4a-dae7-4fd0-a315-f6fa917faa95" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0356554a-f0f2-4e72-99b3-8c7a459df7cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0356554a-f0f2-4e72-99b3-8c7a459df7cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0356554a-f0f2-4e72-99b3-8c7a459df7cb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0356554a-f0f2-4e72-99b3-8c7a459df7cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2557b676-1a67-46a0-a355-f6754282f764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0356554a-f0f2-4e72-99b3-8c7a459df7cb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2557b676-1a67-46a0-a355-f6754282f764" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_5daba09d-5d7a-4c2b-8e73-3681d109984d" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2557b676-1a67-46a0-a355-f6754282f764" xlink:to="loc_icui_SmithsMedicalMember_5daba09d-5d7a-4c2b-8e73-3681d109984d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#LongTermObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/LongTermObligationsDetails" xlink:type="extended" id="i3400ec009aab45e18a5e9bdc334b38ed_LongTermObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TotalSeniorSecuredCreditFacility_3608fa7f-2cee-4907-a60d-7af4fd730ad9" xlink:href="icui-20230331.xsd#icui_TotalSeniorSecuredCreditFacility"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_icui_TotalSeniorSecuredCreditFacility_3608fa7f-2cee-4907-a60d-7af4fd730ad9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_018aa3ef-36fe-4ee7-b377-90ba70c29592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_018aa3ef-36fe-4ee7-b377-90ba70c29592" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_5176c41c-d2d9-477e-9643-cfb907da7f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_5176c41c-d2d9-477e-9643-cfb907da7f6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RevolverSubLimits_15577c11-e6bd-47cc-94cb-25a8558c49b8" xlink:href="icui-20230331.xsd#icui_RevolverSubLimits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_icui_RevolverSubLimits_15577c11-e6bd-47cc-94cb-25a8558c49b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_bed77236-b5bf-4683-9ef9-3794b4206055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_bed77236-b5bf-4683-9ef9-3794b4206055" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_9382fd7e-f270-4de8-bbb7-960d17c5309a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_us-gaap_LongTermDebt_9382fd7e-f270-4de8-bbb7-960d17c5309a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_02a17135-985e-481b-ab6b-727260effad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_02a17135-985e-481b-ab6b-727260effad3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount_8405f0b4-c8a9-4f7e-b528-885fc22cb615" xlink:href="icui-20230331.xsd#icui_LeverageRatioCalculationCeilingSubtractedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount_8405f0b4-c8a9-4f7e-b528-885fc22cb615" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5fdd9a87-bd69-4b43-971f-83b122e19a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_us-gaap_DebtInstrumentTable_5fdd9a87-bd69-4b43-971f-83b122e19a05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7443d872-15d2-4c56-9a6b-0aa20026d887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5fdd9a87-bd69-4b43-971f-83b122e19a05" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7443d872-15d2-4c56-9a6b-0aa20026d887" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7443d872-15d2-4c56-9a6b-0aa20026d887_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7443d872-15d2-4c56-9a6b-0aa20026d887" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7443d872-15d2-4c56-9a6b-0aa20026d887_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5df13115-f468-4da1-a8ad-8eb6fa785476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7443d872-15d2-4c56-9a6b-0aa20026d887" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5df13115-f468-4da1-a8ad-8eb6fa785476" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_53f7e3e8-b04f-42e2-8ce3-e0f7b1ab71a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5df13115-f468-4da1-a8ad-8eb6fa785476" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_53f7e3e8-b04f-42e2-8ce3-e0f7b1ab71a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_459a49e3-c333-4053-9aca-0d8332ebccb7" xlink:href="icui-20230331.xsd#icui_TermLoanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5fdd9a87-bd69-4b43-971f-83b122e19a05" xlink:to="loc_icui_TermLoanAxis_459a49e3-c333-4053-9aca-0d8332ebccb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_459a49e3-c333-4053-9aca-0d8332ebccb7_default" xlink:href="icui-20230331.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TermLoanAxis_459a49e3-c333-4053-9aca-0d8332ebccb7" xlink:to="loc_icui_TermLoanDomain_459a49e3-c333-4053-9aca-0d8332ebccb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_c4ebc92d-e170-4f7b-9dc8-7622e1785456" xlink:href="icui-20230331.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TermLoanAxis_459a49e3-c333-4053-9aca-0d8332ebccb7" xlink:to="loc_icui_TermLoanDomain_c4ebc92d-e170-4f7b-9dc8-7622e1785456" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_b23763c6-f361-45a3-bed2-ee318a0f152b" xlink:href="icui-20230331.xsd#icui_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_c4ebc92d-e170-4f7b-9dc8-7622e1785456" xlink:to="loc_icui_TermLoanAMember_b23763c6-f361-45a3-bed2-ee318a0f152b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_e958e43a-3a2b-4808-8cfb-4fa74725dacd" xlink:href="icui-20230331.xsd#icui_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_c4ebc92d-e170-4f7b-9dc8-7622e1785456" xlink:to="loc_icui_TermLoanBMember_e958e43a-3a2b-4808-8cfb-4fa74725dacd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#LongTermObligationsInterestRateTermsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails" xlink:type="extended" id="i5f683ec05a3a4e96842ee7beff04ef58_LongTermObligationsInterestRateTermsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_e3cc1f17-3e61-438a-8a40-49fa3815980b" xlink:href="icui-20230331.xsd#icui_ApplicableMarginBasedOnLeverageRatioLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBaseRateLoans_975838a3-937a-4495-82e3-cd1175d47975" xlink:href="icui-20230331.xsd#icui_ApplicableMarginBaseRateLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_e3cc1f17-3e61-438a-8a40-49fa3815980b" xlink:to="loc_icui_ApplicableMarginBaseRateLoans_975838a3-937a-4495-82e3-cd1175d47975" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginTermSOFRLoans_07770893-d941-47fc-ae37-7343c3295e87" xlink:href="icui-20230331.xsd#icui_ApplicableMarginTermSOFRLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_e3cc1f17-3e61-438a-8a40-49fa3815980b" xlink:to="loc_icui_ApplicableMarginTermSOFRLoans_07770893-d941-47fc-ae37-7343c3295e87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_936e2396-9879-458f-881c-e4ba40bfa3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_e3cc1f17-3e61-438a-8a40-49fa3815980b" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_936e2396-9879-458f-881c-e4ba40bfa3ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_48643485-13f8-475c-85eb-5d9236ec3b8c" xlink:href="icui-20230331.xsd#icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_e3cc1f17-3e61-438a-8a40-49fa3815980b" xlink:to="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_48643485-13f8-475c-85eb-5d9236ec3b8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_fa312cb1-4521-4460-b49a-917fe2e670e7" xlink:href="icui-20230331.xsd#icui_ApplicableMarginBasedOnLeverageRatioTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_e3cc1f17-3e61-438a-8a40-49fa3815980b" xlink:to="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_fa312cb1-4521-4460-b49a-917fe2e670e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_04f90943-46f9-4e6d-a49c-bc5481e9cac4" xlink:href="icui-20230331.xsd#icui_TermLoanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_fa312cb1-4521-4460-b49a-917fe2e670e7" xlink:to="loc_icui_TermLoanAxis_04f90943-46f9-4e6d-a49c-bc5481e9cac4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_04f90943-46f9-4e6d-a49c-bc5481e9cac4_default" xlink:href="icui-20230331.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TermLoanAxis_04f90943-46f9-4e6d-a49c-bc5481e9cac4" xlink:to="loc_icui_TermLoanDomain_04f90943-46f9-4e6d-a49c-bc5481e9cac4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_15a98372-bf55-4f5d-b895-90a0cba7620f" xlink:href="icui-20230331.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TermLoanAxis_04f90943-46f9-4e6d-a49c-bc5481e9cac4" xlink:to="loc_icui_TermLoanDomain_15a98372-bf55-4f5d-b895-90a0cba7620f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_0ee8eac1-cd1d-4aef-aeef-073c9740ea7f" xlink:href="icui-20230331.xsd#icui_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_15a98372-bf55-4f5d-b895-90a0cba7620f" xlink:to="loc_icui_TermLoanAMember_0ee8eac1-cd1d-4aef-aeef-073c9740ea7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_3655e18c-5b39-48d4-973a-8393d1348ae8" xlink:href="icui-20230331.xsd#icui_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_15a98372-bf55-4f5d-b895-90a0cba7620f" xlink:to="loc_icui_TermLoanBMember_3655e18c-5b39-48d4-973a-8393d1348ae8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelAxis_ef21a2a9-f337-4cd1-aad9-cce2cc294e34" xlink:href="icui-20230331.xsd#icui_LeverageRatioLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_fa312cb1-4521-4460-b49a-917fe2e670e7" xlink:to="loc_icui_LeverageRatioLevelAxis_ef21a2a9-f337-4cd1-aad9-cce2cc294e34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelDomain_ef21a2a9-f337-4cd1-aad9-cce2cc294e34_default" xlink:href="icui-20230331.xsd#icui_LeverageRatioLevelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_LeverageRatioLevelAxis_ef21a2a9-f337-4cd1-aad9-cce2cc294e34" xlink:to="loc_icui_LeverageRatioLevelDomain_ef21a2a9-f337-4cd1-aad9-cce2cc294e34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:href="icui-20230331.xsd#icui_LeverageRatioLevelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_LeverageRatioLevelAxis_ef21a2a9-f337-4cd1-aad9-cce2cc294e34" xlink:to="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Greaterthan400to100Member_f79fb10c-090d-4f56-918b-e4e2153fb3e8" xlink:href="icui-20230331.xsd#icui_Greaterthan400to100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:to="loc_icui_Greaterthan400to100Member_f79fb10c-090d-4f56-918b-e4e2153fb3e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_9fa7c719-dfff-4cd9-96b0-86e75af646c1" xlink:href="icui-20230331.xsd#icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:to="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_9fa7c719-dfff-4cd9-96b0-86e75af646c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_7101b746-c5dd-4fc6-a9f1-86e5bbcbc950" xlink:href="icui-20230331.xsd#icui_LessThanOrEqual300To100ButGreaterThan250to100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:to="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_7101b746-c5dd-4fc6-a9f1-86e5bbcbc950" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_28c2dd0c-3da5-44ee-a005-99806623c7a9" xlink:href="icui-20230331.xsd#icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:to="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_28c2dd0c-3da5-44ee-a005-99806623c7a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo200To100Member_7d9f8106-d904-4250-a68a-357e09190975" xlink:href="icui-20230331.xsd#icui_LessThanOrEqualTo200To100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:to="loc_icui_LessThanOrEqualTo200To100Member_7d9f8106-d904-4250-a68a-357e09190975" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GreaterThan275To100Member_9f3c9d6b-bb09-4dd2-9614-ffa3e79e2986" xlink:href="icui-20230331.xsd#icui_GreaterThan275To100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:to="loc_icui_GreaterThan275To100Member_9f3c9d6b-bb09-4dd2-9614-ffa3e79e2986" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThan275To100Member_4ba147fb-d1e0-4957-995b-b483fe9b5c69" xlink:href="icui-20230331.xsd#icui_LessThan275To100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:to="loc_icui_LessThan275To100Member_4ba147fb-d1e0-4957-995b-b483fe9b5c69" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c1dc3cf2-5fac-4b50-b3c3-c2f794ea4036" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_fa312cb1-4521-4460-b49a-917fe2e670e7" xlink:to="loc_srt_RangeAxis_c1dc3cf2-5fac-4b50-b3c3-c2f794ea4036" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c1dc3cf2-5fac-4b50-b3c3-c2f794ea4036_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c1dc3cf2-5fac-4b50-b3c3-c2f794ea4036" xlink:to="loc_srt_RangeMember_c1dc3cf2-5fac-4b50-b3c3-c2f794ea4036_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6453c3c8-2e9b-40a0-9f72-f3cdc9d7db5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c1dc3cf2-5fac-4b50-b3c3-c2f794ea4036" xlink:to="loc_srt_RangeMember_6453c3c8-2e9b-40a0-9f72-f3cdc9d7db5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9c866f7a-3edd-49cd-b887-3107ca199c6f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6453c3c8-2e9b-40a0-9f72-f3cdc9d7db5c" xlink:to="loc_srt_MaximumMember_9c866f7a-3edd-49cd-b887-3107ca199c6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7276879c-4639-4b70-a64e-e706f5f6c8ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6453c3c8-2e9b-40a0-9f72-f3cdc9d7db5c" xlink:to="loc_srt_MinimumMember_7276879c-4639-4b70-a64e-e706f5f6c8ef" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsTableDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#LongTermObligationsTableDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/LongTermObligationsTableDetails" xlink:type="extended" id="ie5bcd95da8e94986b9cfc10eb56d2fc5_LongTermObligationsTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3ecadf3f-c8b7-4e3f-9c45-e0b64fe87967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3ecadf3f-c8b7-4e3f-9c45-e0b64fe87967" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_51a8c2aa-56e8-4025-9ea6-e94191b2001e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_51a8c2aa-56e8-4025-9ea6-e94191b2001e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_55b01a9e-ff5a-4828-8209-2573025d6b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_55b01a9e-ff5a-4828-8209-2573025d6b44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_d4432d3e-20e7-47dc-ba95-ac6899389d56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_d4432d3e-20e7-47dc-ba95-ac6899389d56" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_2f2c7384-2418-4213-86ec-bb97e4e2c1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:to="loc_us-gaap_DebtCurrent_2f2c7384-2418-4213-86ec-bb97e4e2c1f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_273cc152-8b6a-4799-81a6-be7e4b5ec051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_273cc152-8b6a-4799-81a6-be7e4b5ec051" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_17326066-01f3-474a-9651-8ae2949d59bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_17326066-01f3-474a-9651-8ae2949d59bd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7b94d53c-c854-416c-8c79-7a3b12cc66be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:to="loc_us-gaap_DebtInstrumentTable_7b94d53c-c854-416c-8c79-7a3b12cc66be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_1147c14d-31b5-4418-87cc-7af8dd507aab" xlink:href="icui-20230331.xsd#icui_TermLoanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7b94d53c-c854-416c-8c79-7a3b12cc66be" xlink:to="loc_icui_TermLoanAxis_1147c14d-31b5-4418-87cc-7af8dd507aab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_1147c14d-31b5-4418-87cc-7af8dd507aab_default" xlink:href="icui-20230331.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TermLoanAxis_1147c14d-31b5-4418-87cc-7af8dd507aab" xlink:to="loc_icui_TermLoanDomain_1147c14d-31b5-4418-87cc-7af8dd507aab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_5d151157-e4fb-400b-8b9e-3784b0abeb02" xlink:href="icui-20230331.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TermLoanAxis_1147c14d-31b5-4418-87cc-7af8dd507aab" xlink:to="loc_icui_TermLoanDomain_5d151157-e4fb-400b-8b9e-3784b0abeb02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_dae921c0-025b-4bff-8dde-165d3615ea92" xlink:href="icui-20230331.xsd#icui_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_5d151157-e4fb-400b-8b9e-3784b0abeb02" xlink:to="loc_icui_TermLoanAMember_dae921c0-025b-4bff-8dde-165d3615ea92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_9f490af0-35b8-499e-9587-46f8c5e1290a" xlink:href="icui-20230331.xsd#icui_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_5d151157-e4fb-400b-8b9e-3784b0abeb02" xlink:to="loc_icui_TermLoanBMember_9f490af0-35b8-499e-9587-46f8c5e1290a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a0d6fee8-386b-4d8f-9adb-d4ad93bd4c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7b94d53c-c854-416c-8c79-7a3b12cc66be" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a0d6fee8-386b-4d8f-9adb-d4ad93bd4c2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a0d6fee8-386b-4d8f-9adb-d4ad93bd4c2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a0d6fee8-386b-4d8f-9adb-d4ad93bd4c2b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a0d6fee8-386b-4d8f-9adb-d4ad93bd4c2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9476d100-7562-4b78-a371-b67f03765bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a0d6fee8-386b-4d8f-9adb-d4ad93bd4c2b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9476d100-7562-4b78-a371-b67f03765bcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1b954db9-143e-4c2e-8f9e-e4cf6e673be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9476d100-7562-4b78-a371-b67f03765bcc" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1b954db9-143e-4c2e-8f9e-e4cf6e673be3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#CommitmentsandContingenciesContingencyDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails" xlink:type="extended" id="ia9c7ff106c474bd4abdab96527e2917c_CommitmentsandContingenciesContingencyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_b07d1124-058e-47b2-a85a-0c6c6a36bd24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_d420bed2-63ee-4cbe-9a3e-88d6315f1524" xlink:href="icui-20230331.xsd#icui_Contingentconsiderationgross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_b07d1124-058e-47b2-a85a-0c6c6a36bd24" xlink:to="loc_icui_Contingentconsiderationgross_d420bed2-63ee-4cbe-9a3e-88d6315f1524" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_04fd3220-c428-4bf1-aace-5799d3fcd855" xlink:href="icui-20230331.xsd#icui_ContingentConsiderationGrossST"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_b07d1124-058e-47b2-a85a-0c6c6a36bd24" xlink:to="loc_icui_ContingentConsiderationGrossST_04fd3220-c428-4bf1-aace-5799d3fcd855" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_8ffbfeb0-9ec8-46ad-852b-6bd364a0f88e" xlink:href="icui-20230331.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_b07d1124-058e-47b2-a85a-0c6c6a36bd24" xlink:to="loc_icui_ContingentConsiderationGrossLT_8ffbfeb0-9ec8-46ad-852b-6bd364a0f88e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8a137234-f414-4261-9ec2-362251969fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_b07d1124-058e-47b2-a85a-0c6c6a36bd24" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8a137234-f414-4261-9ec2-362251969fe1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_322000fd-3561-4c39-bcf1-fd8b6fb6054b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_b07d1124-058e-47b2-a85a-0c6c6a36bd24" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_322000fd-3561-4c39-bcf1-fd8b6fb6054b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_9440f723-c122-4f6a-8d3e-7ced622e07ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_b07d1124-058e-47b2-a85a-0c6c6a36bd24" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_9440f723-c122-4f6a-8d3e-7ced622e07ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_34cf0f3e-4d69-450d-b7fc-626fa002147e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_9440f723-c122-4f6a-8d3e-7ced622e07ea" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_34cf0f3e-4d69-450d-b7fc-626fa002147e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34cf0f3e-4d69-450d-b7fc-626fa002147e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34cf0f3e-4d69-450d-b7fc-626fa002147e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34cf0f3e-4d69-450d-b7fc-626fa002147e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6f3ff937-0ebf-4a76-b6fc-7f9f2a2031bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34cf0f3e-4d69-450d-b7fc-626fa002147e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6f3ff937-0ebf-4a76-b6fc-7f9f2a2031bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_fcd82901-87e1-47e6-8397-0051f0043459" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6f3ff937-0ebf-4a76-b6fc-7f9f2a2031bc" xlink:to="loc_icui_SmithsMedicalMember_fcd82901-87e1-47e6-8397-0051f0043459" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_de1f83c4-daf2-4a14-adac-08db80865e22" xlink:href="icui-20230331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6f3ff937-0ebf-4a76-b6fc-7f9f2a2031bc" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_de1f83c4-daf2-4a14-adac-08db80865e22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalDistributorMember_0f0fc5a7-95e4-44c6-aacc-d02df323adb4" xlink:href="icui-20230331.xsd#icui_InternationalDistributorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6f3ff937-0ebf-4a76-b6fc-7f9f2a2031bc" xlink:to="loc_icui_InternationalDistributorMember_0f0fc5a7-95e4-44c6-aacc-d02df323adb4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#EquityAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i65cf7441053a42f2ae8acae01a1bd863_EquityAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_df753584-2f76-4e89-9a84-80bc04f73ede" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d47b73c0-6a5a-4178-9b4e-1ba6cc30d92a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_df753584-2f76-4e89-9a84-80bc04f73ede" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d47b73c0-6a5a-4178-9b4e-1ba6cc30d92a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_91f48a06-b17a-4329-886a-889167acb1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_df753584-2f76-4e89-9a84-80bc04f73ede" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_91f48a06-b17a-4329-886a-889167acb1ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7e23c963-c35e-4508-98fd-c03ea9e7a069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_df753584-2f76-4e89-9a84-80bc04f73ede" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7e23c963-c35e-4508-98fd-c03ea9e7a069" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7db6938f-06f6-45de-883c-a64356020bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_df753584-2f76-4e89-9a84-80bc04f73ede" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7db6938f-06f6-45de-883c-a64356020bea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_beb2d5b1-42b1-440f-b3dd-589728be5914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_df753584-2f76-4e89-9a84-80bc04f73ede" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_beb2d5b1-42b1-440f-b3dd-589728be5914" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e15473a8-c1b3-486f-a882-247734919f35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_df753584-2f76-4e89-9a84-80bc04f73ede" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e15473a8-c1b3-486f-a882-247734919f35" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9dbf06a5-92bc-4a71-9ef9-2fd956a0fdc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e15473a8-c1b3-486f-a882-247734919f35" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9dbf06a5-92bc-4a71-9ef9-2fd956a0fdc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9dbf06a5-92bc-4a71-9ef9-2fd956a0fdc9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9dbf06a5-92bc-4a71-9ef9-2fd956a0fdc9" xlink:to="loc_us-gaap_EquityComponentDomain_9dbf06a5-92bc-4a71-9ef9-2fd956a0fdc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7be506e2-8992-4de1-92d0-b8f6035882c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9dbf06a5-92bc-4a71-9ef9-2fd956a0fdc9" xlink:to="loc_us-gaap_EquityComponentDomain_7be506e2-8992-4de1-92d0-b8f6035882c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_15a3749f-5900-46ed-b209-403a9a69fb15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7be506e2-8992-4de1-92d0-b8f6035882c8" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_15a3749f-5900-46ed-b209-403a9a69fb15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_c6ffef46-74a9-4c8d-8603-f3c3ad3d8aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7be506e2-8992-4de1-92d0-b8f6035882c8" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_c6ffef46-74a9-4c8d-8603-f3c3ad3d8aef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b9b5d9e0-7133-4575-805e-a656d2456041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7be506e2-8992-4de1-92d0-b8f6035882c8" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b9b5d9e0-7133-4575-805e-a656d2456041" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>icui-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ba7fdc33-2522-46f7-8674-20ba10b1b2fc,g:4240e31b-a7e9-4337-b7b1-c2e4a3947117-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_975fda52-807c-4907-a290-d826834405f6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_9dee0e03-a4e5-475f-a548-cc93d8752bf1_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LessThan275To100Member_9a05f3dc-e4d5-4aea-8b9d-4fbab69ecc7f_terseLabel_en-US" xlink:label="lab_icui_LessThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessthan2point75to1</link:label>
    <link:label id="lab_icui_LessThan275To100Member_label_en-US" xlink:label="lab_icui_LessThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than 2.75 to1.00 [Member]</link:label>
    <link:label id="lab_icui_LessThan275To100Member_documentation_en-US" xlink:label="lab_icui_LessThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than 2.75:1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThan275To100Member" xlink:href="icui-20230331.xsd#icui_LessThan275To100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LessThan275To100Member" xlink:to="lab_icui_LessThan275To100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b861c13a-4cd6-4c64-bb02-c81476f4b651_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Accruedfreight_354a13c3-e740-4037-b338-84bb6ffed078_terseLabel_en-US" xlink:label="lab_icui_Accruedfreight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued freight</link:label>
    <link:label id="lab_icui_Accruedfreight_label_en-US" xlink:label="lab_icui_Accruedfreight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued freight</link:label>
    <link:label id="lab_icui_Accruedfreight_documentation_en-US" xlink:label="lab_icui_Accruedfreight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued freight</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedfreight" xlink:href="icui-20230331.xsd#icui_Accruedfreight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Accruedfreight" xlink:to="lab_icui_Accruedfreight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_53bafee0-04a7-40a6-bf5a-fb6cfdde60fa_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_a7d6f7d5-8faa-4739-88be-cf1dac814d21_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET (LOSS) INCOME</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_9de39020-f54c-4183-a77d-ad4564cffe34_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (Loss) Income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_f7561be6-3810-43fd-b6af-4781362b61e9_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_337e167c-bad4-4348-a98b-69d9e39bf27c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_f02dea93-b886-46fe-86fe-d63b5c274d91_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanBPrincipalPayment_a4cd30a5-f732-4616-a28c-0fe6eafab24a_terseLabel_en-US" xlink:label="lab_icui_TermLoanBPrincipalPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Principal Payment %</link:label>
    <link:label id="lab_icui_TermLoanBPrincipalPayment_label_en-US" xlink:label="lab_icui_TermLoanBPrincipalPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Principal Payment %</link:label>
    <link:label id="lab_icui_TermLoanBPrincipalPayment_documentation_en-US" xlink:label="lab_icui_TermLoanBPrincipalPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Principal Payment %</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBPrincipalPayment" xlink:href="icui-20230331.xsd#icui_TermLoanBPrincipalPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanBPrincipalPayment" xlink:to="lab_icui_TermLoanBPrincipalPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_4d56ed2a-8abf-4edb-8def-350bfcde4c48_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_d87e9be4-1ae0-489e-acc3-dc5e4cf55878_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InternationalDistributorMember_36f3ca91-8cba-48c6-9196-bba0203c45c6_terseLabel_en-US" xlink:label="lab_icui_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Distributor</link:label>
    <link:label id="lab_icui_InternationalDistributorMember_label_en-US" xlink:label="lab_icui_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Distributor [Member]</link:label>
    <link:label id="lab_icui_InternationalDistributorMember_documentation_en-US" xlink:label="lab_icui_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Distributor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalDistributorMember" xlink:href="icui-20230331.xsd#icui_InternationalDistributorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InternationalDistributorMember" xlink:to="lab_icui_InternationalDistributorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock_c6a8ebf3-50b8-44a9-85e7-9ce5d449ca47_terseLabel_en-US" xlink:label="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">investments in Debt and Marketable Equity Securities and Equity Method Investments [Text Block]</link:label>
    <link:label id="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">investments in Debt and Marketable Equity Securities and Equity Method Investments [Text Block]</link:label>
    <link:label id="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock_documentation_en-US" xlink:label="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">investments in Debt and Marketable Equity Securities and Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:href="icui-20230331.xsd#icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:to="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_78a81b0c-9621-40f5-a886-189963d1e613_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:to="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_a04539be-2c41-42d8-b260-df8026fe402b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_6de29408-d2c4-44ba-b114-e511acfcb23e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, outstanding shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_5adfd1b1-4b88-4738-8bbb-64a716588bcd_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_d4bfb731-e038-4c67-875e-67b985096590_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment, cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_8187bbaf-19d4-451e-9b71-cdf50eedc24b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_de3d414b-0c78-4beb-8d1a-96dd451b27c1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans_d84595be-1d97-4447-9e03-fdb0a9d3800f_terseLabel_en-US" xlink:label="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ter SOFR Interest Rate % Adjustment for Base Rate Loans</link:label>
    <link:label id="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans_label_en-US" xlink:label="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ter SOFR Interest Rate % Adjustment for Base Rate Loans</link:label>
    <link:label id="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans_documentation_en-US" xlink:label="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ter SOFR Interest Rate % Adjustment for Base Rate Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:href="icui-20230331.xsd#icui_TerSOFRInterestRateAdjustmentForBaseRateLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:to="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_c821d5c4-bb16-4a28-a892-c7006ba2a92d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_001d822b-6df9-4c7a-b0c1-2e10ea48b632_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_5d7e1028-582d-4055-a7a9-d6cc40345022_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_890f7b8a-2afb-4181-ba94-555fd6518a8a_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_0fe53886-e52d-4648-b233-67e7325ddd71_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_63738e6b-0a43-4f09-8d65-0977642828f7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Loss) Income, Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OtherCurrenciesMember_28bfd099-e589-4d80-ba51-f4e94e6bc42b_terseLabel_en-US" xlink:label="lab_icui_OtherCurrenciesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">other currencies</link:label>
    <link:label id="lab_icui_OtherCurrenciesMember_label_en-US" xlink:label="lab_icui_OtherCurrenciesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">other currencies [Member]</link:label>
    <link:label id="lab_icui_OtherCurrenciesMember_documentation_en-US" xlink:label="lab_icui_OtherCurrenciesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">other currencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherCurrenciesMember" xlink:href="icui-20230331.xsd#icui_OtherCurrenciesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OtherCurrenciesMember" xlink:to="lab_icui_OtherCurrenciesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_2feca8fa-c63f-4c56-8568-a60e7d9c810e_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfAccountsReceivable_d8d06378-1870-469d-84e1-53a0fd6d26df_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfAccountsReceivable" xlink:to="lab_us-gaap_GainLossOnSaleOfAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AccruedAuditFees_551c071b-0ff0-4961-994e-06845e8e8f1f_terseLabel_en-US" xlink:label="lab_icui_AccruedAuditFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued audit fees</link:label>
    <link:label id="lab_icui_AccruedAuditFees_label_en-US" xlink:label="lab_icui_AccruedAuditFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued audit fees</link:label>
    <link:label id="lab_icui_AccruedAuditFees_documentation_en-US" xlink:label="lab_icui_AccruedAuditFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued audit fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedAuditFees" xlink:href="icui-20230331.xsd#icui_AccruedAuditFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AccruedAuditFees" xlink:to="lab_icui_AccruedAuditFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fce1626-6c0e-4755-bd73-f214cbf1d9c3_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InterestRateSwapEndingNotionalValue_0320a83c-b6e1-46cc-abf5-ded073de89e9_terseLabel_en-US" xlink:label="lab_icui_InterestRateSwapEndingNotionalValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Ending Notional Value</link:label>
    <link:label id="lab_icui_InterestRateSwapEndingNotionalValue_label_en-US" xlink:label="lab_icui_InterestRateSwapEndingNotionalValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Ending Notional Value</link:label>
    <link:label id="lab_icui_InterestRateSwapEndingNotionalValue_documentation_en-US" xlink:label="lab_icui_InterestRateSwapEndingNotionalValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Ending Notional Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestRateSwapEndingNotionalValue" xlink:href="icui-20230331.xsd#icui_InterestRateSwapEndingNotionalValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InterestRateSwapEndingNotionalValue" xlink:to="lab_icui_InterestRateSwapEndingNotionalValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_d4abd768-e18c-4e60-b0ca-f66090628232_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_c58bb212-a3b1-457a-b154-d71c94ac11c5_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_3ea1e8f8-5396-42bb-b650-eb0a2197fb27_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_9d2f8a00-d841-4e0d-92ef-4028bf7946bb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_9bc1bec8-015e-4709-89fa-f82bd569c2d5_negatedTerseLabel_en-US" xlink:label="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable</link:label>
    <link:label id="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_label_en-US" xlink:label="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable</link:label>
    <link:label id="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_documentation_en-US" xlink:label="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:href="icui-20230331.xsd#icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:to="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_f46ff0c7-01ec-48ad-b1d5-1fcb12665aba_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fc1a9743-702f-453c-8d13-f0feedb8602b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_4fd10ffa-c059-4d6b-a751-5de446c5d6a6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SoftwarerevenueMember_87ccd154-f41f-4530-8b87-65894e7b6e8d_terseLabel_en-US" xlink:label="lab_icui_SoftwarerevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software revenue [Member]</link:label>
    <link:label id="lab_icui_SoftwarerevenueMember_label_en-US" xlink:label="lab_icui_SoftwarerevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software revenue [Member]</link:label>
    <link:label id="lab_icui_SoftwarerevenueMember_documentation_en-US" xlink:label="lab_icui_SoftwarerevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember" xlink:href="icui-20230331.xsd#icui_SoftwarerevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SoftwarerevenueMember" xlink:to="lab_icui_SoftwarerevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_5a9d2b74-5df4-495b-ae0f-4de4f335da24_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f13fee15-5858-442e-8b69-6c0d43592474_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_4ffdb89b-2cd6-4e59-98ee-8979d553e5a3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_91490246-f434-4029-9495-ae37bb954d19_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_9fa665f7-b754-4c2f-9d39-fd94646291ef_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_44e0c62f-1979-438c-8fc9-99f727d65050_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_0bb8bae3-b0bd-49aa-abec-abe557912787_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_05965ebb-87a2-4a9a-9584-ca21d8ecc3cd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_636d584a-64d5-4c5c-b00d-d038e50f4a95_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_c5eb4342-75da-400f-9ba7-58e4365efd59_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_43048995-9db0-49d7-88f3-428fd4df0eeb_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1df37f7c-18a3-4c50-8821-c1d024453c3b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9e2e14fb-dff4-4150-ab6d-58896c3eaebe_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_8cf30db9-c458-4e29-b0b5-31a8d1bca163_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_82725385-6303-44ae-9534-51a4a7211875_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_880ce174-fce5-47a5-8150-84f99250e466_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_9b4613ae-c89c-481c-9882-029fd18e2bab_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_2f21b409-e67e-4db4-8044-47aa2863921a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems_e5dbbf4d-02a8-44e7-a51a-053cad73af26_terseLabel_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Line Items]</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems_label_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Line Items]</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems_documentation_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:href="icui-20230331.xsd#icui_ApplicableMarginBasedOnLeverageRatioLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:to="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e444a1db-8203-4e0d-beb7-e8da7c07ad90_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_ccdc574f-caff-439b-9766-4c1308fd7674_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_28f75547-5e3a-408a-818c-ba874b3a0233_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Deferredtaxcharge_374cc652-6645-49e5-bb96-acd08bce9c0f_terseLabel_en-US" xlink:label="lab_icui_Deferredtaxcharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax charge</link:label>
    <link:label id="lab_icui_Deferredtaxcharge_label_en-US" xlink:label="lab_icui_Deferredtaxcharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax charge</link:label>
    <link:label id="lab_icui_Deferredtaxcharge_documentation_en-US" xlink:label="lab_icui_Deferredtaxcharge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Deferredtaxcharge" xlink:href="icui-20230331.xsd#icui_Deferredtaxcharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Deferredtaxcharge" xlink:to="lab_icui_Deferredtaxcharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_728eda95-836d-4f79-8382-3eb517392db3_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_9e904734-5ad7-4c9f-aec5-28dc1a3af7c9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_406a43f0-ba0d-465f-9291-5c2f71e310cf_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_2353aab6-abb2-43fd-8dc1-e501b525a8a9_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InterestPercentageAddedToBaseRate_2c0f55c5-fabc-4dea-b1ce-72ff801cc133_terseLabel_en-US" xlink:label="lab_icui_InterestPercentageAddedToBaseRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Base Rate</link:label>
    <link:label id="lab_icui_InterestPercentageAddedToBaseRate_label_en-US" xlink:label="lab_icui_InterestPercentageAddedToBaseRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Base Rate</link:label>
    <link:label id="lab_icui_InterestPercentageAddedToBaseRate_documentation_en-US" xlink:label="lab_icui_InterestPercentageAddedToBaseRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Base Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestPercentageAddedToBaseRate" xlink:href="icui-20230331.xsd#icui_InterestPercentageAddedToBaseRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InterestPercentageAddedToBaseRate" xlink:to="lab_icui_InterestPercentageAddedToBaseRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_1910bd3c-7a8c-4cf8-b3a7-0f666a61f974_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_f741a62e-53d8-4bf7-9184-718f158571d1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_0ff33236-e6e3-45cb-9e13-59cdfc14e412_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_ca012f1c-6035-4085-abc5-ac5a3676a9a8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TreasuryStockPurchasePlan_4cc29d04-9955-459b-b9b3-3be06165e4d6_terseLabel_en-US" xlink:label="lab_icui_TreasuryStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Purchase Plan</link:label>
    <link:label id="lab_icui_TreasuryStockPurchasePlan_label_en-US" xlink:label="lab_icui_TreasuryStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Purchase Plan</link:label>
    <link:label id="lab_icui_TreasuryStockPurchasePlan_documentation_en-US" xlink:label="lab_icui_TreasuryStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TreasuryStockPurchasePlan" xlink:href="icui-20230331.xsd#icui_TreasuryStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TreasuryStockPurchasePlan" xlink:to="lab_icui_TreasuryStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_369c255d-2211-4c74-bb89-06c86b25eac7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeMember_d9e6e92b-99c6-4acc-8f68-2eb12f73f4d3_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeMember" xlink:to="lab_us-gaap_ForeignExchangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_518b35ef-1365-4c57-b215-f672b73081a4_terseLabel_en-US" xlink:label="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessthanorequal3to1butgreaterthan2point5to1</link:label>
    <link:label id="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_label_en-US" xlink:label="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal 3.00 to 1.00 but greater than 2.50to1.00 [Member]</link:label>
    <link:label id="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_documentation_en-US" xlink:label="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal 3.00 to 1.00 but greater than 2.50to1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:href="icui-20230331.xsd#icui_LessThanOrEqual300To100ButGreaterThan250to100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:to="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0e0abc41-c729-4ae4-9be7-9a54564f5ea0_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Restructuringandstrategictransaction_f5ffb724-5812-498c-b609-b47ea03773df_terseLabel_en-US" xlink:label="lab_icui_Restructuringandstrategictransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, strategic transaction and integration</link:label>
    <link:label id="lab_icui_Restructuringandstrategictransaction_label_en-US" xlink:label="lab_icui_Restructuringandstrategictransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and strategic transaction</link:label>
    <link:label id="lab_icui_Restructuringandstrategictransaction_documentation_en-US" xlink:label="lab_icui_Restructuringandstrategictransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and strategic transaction expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransaction" xlink:href="icui-20230331.xsd#icui_Restructuringandstrategictransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Restructuringandstrategictransaction" xlink:to="lab_icui_Restructuringandstrategictransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_NetCashPaidReceivedforcurrentandprioracquisitions_8f6b05f9-b2d9-4ad5-8f05-73d6ae34af9f_negatedTerseLabel_en-US" xlink:label="lab_icui_NetCashPaidReceivedforcurrentandprioracquisitions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Paid (Received) for current and prior acquisitions</link:label>
    <link:label id="lab_icui_NetCashPaidReceivedforcurrentandprioracquisitions_label_en-US" xlink:label="lab_icui_NetCashPaidReceivedforcurrentandprioracquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Paid (Received) for current and prior acquisitions</link:label>
    <link:label id="lab_icui_NetCashPaidReceivedforcurrentandprioracquisitions_documentation_en-US" xlink:label="lab_icui_NetCashPaidReceivedforcurrentandprioracquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Paid (Received) for current and prior acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NetCashPaidReceivedforcurrentandprioracquisitions" xlink:href="icui-20230331.xsd#icui_NetCashPaidReceivedforcurrentandprioracquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_NetCashPaidReceivedforcurrentandprioracquisitions" xlink:to="lab_icui_NetCashPaidReceivedforcurrentandprioracquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_b87e50f2-3108-4ac4-b021-4e88aa130599_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRentCurrentAndNoncurrent_8cf1207f-694b-4610-a967-0d5ce7240d03_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rent</link:label>
    <link:label id="lab_us-gaap_AccruedRentCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRentCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_773480cc-40d9-48f1-a023-65145d258011_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_660724a4-2a9f-4bb2-98ab-144d1ded45e9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_11b54ab5-54ef-4749-a502-d309f5549ec6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_44e3b93a-e075-4761-93c5-36964949683b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_EarnoutliabilityMember_40057779-d930-4534-9802-0fc79d36561d_terseLabel_en-US" xlink:label="lab_icui_EarnoutliabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out liability [Member]</link:label>
    <link:label id="lab_icui_EarnoutliabilityMember_label_en-US" xlink:label="lab_icui_EarnoutliabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out liability [Member]</link:label>
    <link:label id="lab_icui_EarnoutliabilityMember_documentation_en-US" xlink:label="lab_icui_EarnoutliabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EarnoutliabilityMember" xlink:href="icui-20230331.xsd#icui_EarnoutliabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_EarnoutliabilityMember" xlink:to="lab_icui_EarnoutliabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_0c3423f3-63e2-4c1a-b103-288c9a27ba6b_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_cecd0a64-e690-494b-a187-5f1a144e4911_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_b04113bc-f1c8-4a76-b4eb-63ca602ef695_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_875461a0-3b81-4cbe-a41a-785b75689c26_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_8131ed09-f2aa-4381-a226-29bbbbb2882f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_32b290da-6b9d-44d9-91ef-c6a858c8cdab_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_8a68921e-fb70-4e00-a1ab-dbe204c404b3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_90add65e-5d8c-413b-abb8-dbb31804c3f1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_7cdaee47-8864-42e2-8502-29e5c12796f7_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5b441d1f-fa2a-47c0-bed6-1abb6cc2922c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_cacfd1a2-f9b5-4b95-b68c-4f50e31f9ce6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_70439579-4aae-417f-9bd8-4a642c550576_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_cbc232fd-88de-4987-a459-95e3f6d97cc7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_3f19c647-d4e1-409d-b41c-51a5783a1581_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Outsidesalescommissions_6c686749-6d06-4e5f-b3d6-71eb913c4998_terseLabel_en-US" xlink:label="lab_icui_Outsidesalescommissions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Fees</link:label>
    <link:label id="lab_icui_Outsidesalescommissions_label_en-US" xlink:label="lab_icui_Outsidesalescommissions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside sales commissions</link:label>
    <link:label id="lab_icui_Outsidesalescommissions_documentation_en-US" xlink:label="lab_icui_Outsidesalescommissions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside sales commissions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Outsidesalescommissions" xlink:href="icui-20230331.xsd#icui_Outsidesalescommissions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Outsidesalescommissions" xlink:to="lab_icui_Outsidesalescommissions" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued_1ecd3151-5692-456f-845c-bd8e692cb0e1_terseLabel_en-US" xlink:label="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Acquisition Shares Issued</link:label>
    <link:label id="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued_label_en-US" xlink:label="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Acquisition Shares Issued</link:label>
    <link:label id="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued_documentation_en-US" xlink:label="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Acquisition Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:href="icui-20230331.xsd#icui_SmithsGroupOwnershipAcquisitionSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:to="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_15e311b6-2aa9-4016-bd87-24b77c3c473b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ec73257a-18fe-41d7-b704-9d0b5c40e087_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_f02b5c48-1059-47d7-9052-6f54352b8cf2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Current</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a6f9cb4b-5ce3-4e0c-92dd-503d2bbf2e12_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_d0e5a855-793d-477a-82de-862f0717a7f4_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_55312396-32eb-4937-9abd-9457104ca7da_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_9613f04b-ee06-4fba-bc0b-d9c2ea7c3884_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investment securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableSale_6afd9bfe-0f3a-4a37-834d-09eaddc6e561_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Sale</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableSale_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableSale" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableSale" xlink:to="lab_us-gaap_AccountsReceivableSale" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AUD_4d37544c-52e4-4f20-bd55-aef98833bf0a_terseLabel_en-US" xlink:label="lab_currency_AUD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia, Dollars</link:label>
    <link:label id="lab_currency_AUD_label_en-US" xlink:label="lab_currency_AUD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AUD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AUD" xlink:to="lab_currency_AUD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_6fe9b134-e357-4172-9212-61d735004b77_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_fdabaa9f-1c0b-402d-84b3-badbb96b4a54_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, issued shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ad4087af-0ef0-4acc-9132-8c529acfce8f_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_38fb6812-9884-45e1-8ac1-cfe3f3274ae3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_7ed53eae-5134-4229-8a9e-25a9f076cb2e_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_ce734cff-0c55-4435-bc0b-f1c4cc63b5a7_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c4a739f5-cc3c-4ece-b165-7d0a386d1442_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeForwardExchangeRate1_03e13714-d887-4b8f-95c0-db13a3e45611_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeForwardExchangeRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Forward Exchange Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeForwardExchangeRate1_label_en-US" xlink:label="lab_us-gaap_DerivativeForwardExchangeRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Forward Exchange Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeForwardExchangeRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeForwardExchangeRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeForwardExchangeRate1" xlink:to="lab_us-gaap_DerivativeForwardExchangeRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_e623b5b7-5a40-4c18-a811-4fa9481b4552_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanBMember_8498d54a-6dcd-43e9-9c5d-92a2aaa80d86_terseLabel_en-US" xlink:label="lab_icui_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B</link:label>
    <link:label id="lab_icui_TermLoanBMember_label_en-US" xlink:label="lab_icui_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B [Member]</link:label>
    <link:label id="lab_icui_TermLoanBMember_documentation_en-US" xlink:label="lab_icui_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember" xlink:href="icui-20230331.xsd#icui_TermLoanBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanBMember" xlink:to="lab_icui_TermLoanBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_7fd20ea7-aa65-4b5a-b353-875a5d269f29_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_35bbe282-db1e-4b54-956d-baae56740395_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_31f354a4-0d43-4aa9-8b9c-fd3876cafba8_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InfusionConsumablesMember_1bcc8d69-2e53-4345-96f2-2d7e8f5d51ee_terseLabel_en-US" xlink:label="lab_icui_InfusionConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables [Member]</link:label>
    <link:label id="lab_icui_InfusionConsumablesMember_label_en-US" xlink:label="lab_icui_InfusionConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables [Member]</link:label>
    <link:label id="lab_icui_InfusionConsumablesMember_documentation_en-US" xlink:label="lab_icui_InfusionConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesMember" xlink:href="icui-20230331.xsd#icui_InfusionConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InfusionConsumablesMember" xlink:to="lab_icui_InfusionConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_4046495b-7287-4457-b3ee-de96e7e2c502_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_ecfbc501-0f76-4f1f-a04b-554fabb7c1e0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5e44dd16-9a4b-457a-94e1-c559b42e83e4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_253847ed-7d96-4f1c-a41c-65e935a3b1d2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_c5ecfe96-7f19-489d-8732-607f98f0d240_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_dee8e773-89e9-4ee8-8239-1df45f2ad5b0_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1f5b82f0-3088-410d-9a78-757e39c4e0a6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_da9a88b6-9a12-43ff-9065-a04bfff78549_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_bd1eba57-c604-4a39-b57b-5d7af05c3f4c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_5215b308-53c7-4cb6-a6ea-2eb3e94e67ad_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_87bfa77f-7652-4889-b1c4-cb90b87dff26_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_1f1bdb94-6c9b-4b2a-b0c7-1895a7119f63_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, $1.00 par value Authorized-500 shares; Issued and outstanding - none</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:to="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_5a28a247-59b6-4f49-8c31-bf2f0afb4757_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranties and returns</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_d9d43b43-39be-4df7-b4e1-fd1a5362625b_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OtherDeferredRevenueMember_f4732146-bc55-4861-a15e-c7ca24bf8115_terseLabel_en-US" xlink:label="lab_icui_OtherDeferredRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other deferred revenue</link:label>
    <link:label id="lab_icui_OtherDeferredRevenueMember_label_en-US" xlink:label="lab_icui_OtherDeferredRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other deferred revenue [Member]</link:label>
    <link:label id="lab_icui_OtherDeferredRevenueMember_documentation_en-US" xlink:label="lab_icui_OtherDeferredRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other deferred revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherDeferredRevenueMember" xlink:href="icui-20230331.xsd#icui_OtherDeferredRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OtherDeferredRevenueMember" xlink:to="lab_icui_OtherDeferredRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_3d85b81d-badb-4fe0-80ff-ea283ae25cd2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_38f46edb-1954-4bd4-9d2c-eabe19c35c01_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_ed0dd8bf-e9f0-43e4-9388-76d4f6c49c3a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0c89e3f1-cf85-4587-8306-f349c82aeb84_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_fbc531e2-8960-4fc6-b81d-d51065618e03_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_fcca8099-45ee-458b-ad4b-8cafe06d55b9_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CZK_22e297c5-2f68-4fb9-9367-36ce139ea7b4_terseLabel_en-US" xlink:label="lab_currency_CZK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Czech Republic, Koruny</link:label>
    <link:label id="lab_currency_CZK_label_en-US" xlink:label="lab_currency_CZK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Czech Republic, Koruny</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CZK" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CZK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CZK" xlink:to="lab_currency_CZK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_6258e805-aa4f-4d81-8cea-8100c7033fc8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_981683aa-adf7-45fc-9159-4e019ddcc4b1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_fd12556b-fa76-4833-91eb-ec9ac89c7f18_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d20104e0-d256-408b-85e7-31db1356490a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_f2dfa5fc-3b4c-46ac-8f5a-cd9c36626c23_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_97dd52a6-3536-4c0b-a799-ca7e8b0220cd_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_861f90bf-0eca-49b1-b0dd-4746aef7463d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_BusinessCombinationGoodwillNonDeductible_cf8c51d8-be3c-42bb-967e-45d1a0f57011_terseLabel_en-US" xlink:label="lab_icui_BusinessCombinationGoodwillNonDeductible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, goodwill- non deductible</link:label>
    <link:label id="lab_icui_BusinessCombinationGoodwillNonDeductible_label_en-US" xlink:label="lab_icui_BusinessCombinationGoodwillNonDeductible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, goodwill- non deductible</link:label>
    <link:label id="lab_icui_BusinessCombinationGoodwillNonDeductible_documentation_en-US" xlink:label="lab_icui_BusinessCombinationGoodwillNonDeductible" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, goodwill- non deductible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationGoodwillNonDeductible" xlink:href="icui-20230331.xsd#icui_BusinessCombinationGoodwillNonDeductible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_BusinessCombinationGoodwillNonDeductible" xlink:to="lab_icui_BusinessCombinationGoodwillNonDeductible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_8594b13a-0210-4449-b6e5-5885694d7afa_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9d2ddc2f-fc8e-4d46-87c5-5050a45c4507_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_34ee6759-44c5-41d4-9489-4efc0a5c987a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_22871846-3b79-4e35-8b6d-85a748199ec7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_StrategicTransactionandIntegration_97222da7-f00c-48f3-8373-2b820cdf0014_terseLabel_en-US" xlink:label="lab_icui_StrategicTransactionandIntegration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Transaction and Integration</link:label>
    <link:label id="lab_icui_StrategicTransactionandIntegration_label_en-US" xlink:label="lab_icui_StrategicTransactionandIntegration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Transaction and Integration</link:label>
    <link:label id="lab_icui_StrategicTransactionandIntegration_documentation_en-US" xlink:label="lab_icui_StrategicTransactionandIntegration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Transaction and Integration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_StrategicTransactionandIntegration" xlink:href="icui-20230331.xsd#icui_StrategicTransactionandIntegration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_StrategicTransactionandIntegration" xlink:to="lab_icui_StrategicTransactionandIntegration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_63a28a15-07ba-475f-b5ee-8205dbff1c82_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) Income from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_85dccd2b-44d8-4dbc-b4b5-39fecc148943_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_24874adb-c542-419b-8dd8-da981716fb3d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_d9c3802b-4847-46e6-833b-ffd858b2ea79_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_b504bcb7-12ef-44a6-8eb1-f32d28b00179_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share [Text Block]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_15ef31cc-ec47-4a26-bd1d-6fbc90a3441b_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_ed9ae5fb-73ba-46df-854e-ec2e9d16e7a3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_f81a0618-9c3c-4bb9-b8cd-2b062dac8b58_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_bdee0d68-8d55-4f5f-82ae-724925dbe458_terseLabel_en-US" xlink:label="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids, other current assets and other noncurrent assets [Text Block]</link:label>
    <link:label id="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_label_en-US" xlink:label="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids, other current assets and other noncurrent assets [Text Block]</link:label>
    <link:label id="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_documentation_en-US" xlink:label="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids, other current assets and other noncurrent assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:href="icui-20230331.xsd#icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:to="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ShortTermMember_cac96e79-eef3-4e44-8999-d2b88f226603_terseLabel_en-US" xlink:label="lab_icui_ShortTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term</link:label>
    <link:label id="lab_icui_ShortTermMember_label_en-US" xlink:label="lab_icui_ShortTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term [Member]</link:label>
    <link:label id="lab_icui_ShortTermMember_documentation_en-US" xlink:label="lab_icui_ShortTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermMember" xlink:href="icui-20230331.xsd#icui_ShortTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ShortTermMember" xlink:to="lab_icui_ShortTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_6ae274a3-4321-493c-a75f-129b4e46b2ee_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_5ce17181-9bb4-4fc6-b2dd-c91267dc7b26_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_091fe780-0b65-42ea-9bc2-d112526c5990_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_a0198fe0-ba0a-4551-963e-c345c1f361d2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_e89b92e8-7180-43d5-9b5c-8754f20a9c10_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandBuildingsAndImprovementsMember_3359493d-99b1-45c2-99ad-d9c763ed8aa8_terseLabel_en-US" xlink:label="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, Buildings and Improvements [Member]</link:label>
    <link:label id="lab_us-gaap_LandBuildingsAndImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, Buildings and Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandBuildingsAndImprovementsMember" xlink:to="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_f751ba1d-3336-4fa0-b43d-7a3d59ec5dea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent[TableTextBlock]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_86fd0c06-49a1-46fc-bf6d-d995445d1865_verboseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a581f622-535b-4e10-86a1-c21165698226_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount_010d9e8a-eee9-4a23-87c6-e1a9693edc47_terseLabel_en-US" xlink:label="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Calculation Ceiling Subtracted Amount</link:label>
    <link:label id="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount_label_en-US" xlink:label="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Calculation Ceiling Subtracted Amount</link:label>
    <link:label id="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount_documentation_en-US" xlink:label="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Calculation Ceiling Subtracted Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:href="icui-20230331.xsd#icui_LeverageRatioCalculationCeilingSubtractedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:to="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0e172eb8-3658-4aff-90f6-85e61fe66843_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_00654583-5d81-4f2b-b3b3-55283945926f_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c6280685-8dfe-439a-8b06-4b3fa31b29e6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_7f70561f-b177-4e24-9405-53caa0b9b9e0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_f2dec1df-848a-4950-9b93-30206f4ae4e9_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefits</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_dc29ecba-91e3-486f-8d67-05a83cc4e387_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OtherforeigncountriesMember_575c8511-8b58-4c1d-9acd-151b99d0e207_terseLabel_en-US" xlink:label="lab_icui_OtherforeigncountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:label id="lab_icui_OtherforeigncountriesMember_label_en-US" xlink:label="lab_icui_OtherforeigncountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:label id="lab_icui_OtherforeigncountriesMember_documentation_en-US" xlink:label="lab_icui_OtherforeigncountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherforeigncountriesMember" xlink:href="icui-20230331.xsd#icui_OtherforeigncountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OtherforeigncountriesMember" xlink:to="lab_icui_OtherforeigncountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_cdbf42c6-4fbc-4e97-b71b-1675db9f782f_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProFormaAdjustmentAmortization_9b48659b-6dbb-487b-acdc-3d3594c745cc_terseLabel_en-US" xlink:label="lab_icui_ProFormaAdjustmentAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Amortization</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentAmortization_label_en-US" xlink:label="lab_icui_ProFormaAdjustmentAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Amortization</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentAmortization_documentation_en-US" xlink:label="lab_icui_ProFormaAdjustmentAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentAmortization" xlink:href="icui-20230331.xsd#icui_ProFormaAdjustmentAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProFormaAdjustmentAmortization" xlink:to="lab_icui_ProFormaAdjustmentAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_53d0a178-6890-4744-bd42-d1a6d15f506e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_NoncurrentMember_fd3687b5-d081-4a49-b96b-de67385484b0_terseLabel_en-US" xlink:label="lab_icui_NoncurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">noncurrent</link:label>
    <link:label id="lab_icui_NoncurrentMember_label_en-US" xlink:label="lab_icui_NoncurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">noncurrent [Member]</link:label>
    <link:label id="lab_icui_NoncurrentMember_documentation_en-US" xlink:label="lab_icui_NoncurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentMember" xlink:href="icui-20230331.xsd#icui_NoncurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_NoncurrentMember" xlink:to="lab_icui_NoncurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_db31ff82-3a6b-4b2d-a6e4-a68aa705c453_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_0ed9b644-88b4-49d3-9af2-7e8d69e4445d_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_GreaterThan275To100Member_acc0dd7e-6742-4574-b8dc-aa4999b4ed4e_terseLabel_en-US" xlink:label="lab_icui_GreaterThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greaterthan2point75to1</link:label>
    <link:label id="lab_icui_GreaterThan275To100Member_label_en-US" xlink:label="lab_icui_GreaterThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greater than 2.75 to1.00 [Member]</link:label>
    <link:label id="lab_icui_GreaterThan275To100Member_documentation_en-US" xlink:label="lab_icui_GreaterThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greater than 2.75 to1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GreaterThan275To100Member" xlink:href="icui-20230331.xsd#icui_GreaterThan275To100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_GreaterThan275To100Member" xlink:to="lab_icui_GreaterThan275To100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_67563d6e-bfc7-4a8d-8c8b-6943d9de828d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING EXPENSES:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_6c105fe9-93a9-46d1-b5bb-b7667da00556_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_61e13310-025d-4760-8a72-2b1ebf5269bc_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_MXN_c02a59a3-8776-405b-b570-424f7be052bc_terseLabel_en-US" xlink:label="lab_currency_MXN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexico, Pesos</link:label>
    <link:label id="lab_currency_MXN_label_en-US" xlink:label="lab_currency_MXN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexico, Pesos</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_MXN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_MXN" xlink:to="lab_currency_MXN" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_2d2e7d95-75f0-49c4-ad98-445caa16d8ad_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_8b4486c9-d580-4b34-9a63-b9fa40156f2c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_e74e1635-e3be-4202-83b0-f4564efeb096_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_f35f9ce0-2c5d-4dc4-927c-0a0842d53984_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_1382a7f3-f2e1-46f0-8857-16a3cc3ed845_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermAPrincipalPaymentFirst2Years_037c6b07-a102-4eb0-82b9-72da43ff5c12_terseLabel_en-US" xlink:label="lab_icui_TermAPrincipalPaymentFirst2Years" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A principal payment % First 2 Years</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentFirst2Years_label_en-US" xlink:label="lab_icui_TermAPrincipalPaymentFirst2Years" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A principal payment % First 2 Years</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentFirst2Years_documentation_en-US" xlink:label="lab_icui_TermAPrincipalPaymentFirst2Years" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A principal payment % First 2 Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentFirst2Years" xlink:href="icui-20230331.xsd#icui_TermAPrincipalPaymentFirst2Years"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermAPrincipalPaymentFirst2Years" xlink:to="lab_icui_TermAPrincipalPaymentFirst2Years" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_85c53168-8da7-4a33-9bcc-3eee57b8a00a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7be22452-2933-4775-8698-5dc1850dbb9d_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_93c6afc2-430b-4af6-aab8-abad38a0b14e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_97df59e2-0b45-461b-90b8-113743d676c9_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_cd5a0536-fc41-47a1-8679-40098fb58c0a_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LeverageRatioLevelDomain_850bf059-5cdf-4821-970d-7aac43735bed_terseLabel_en-US" xlink:label="lab_icui_LeverageRatioLevelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level [Domain]</link:label>
    <link:label id="lab_icui_LeverageRatioLevelDomain_label_en-US" xlink:label="lab_icui_LeverageRatioLevelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level [Domain]</link:label>
    <link:label id="lab_icui_LeverageRatioLevelDomain_documentation_en-US" xlink:label="lab_icui_LeverageRatioLevelDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelDomain" xlink:href="icui-20230331.xsd#icui_LeverageRatioLevelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LeverageRatioLevelDomain" xlink:to="lab_icui_LeverageRatioLevelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialAssetsTextBlock_3be4da54-f001-41da-acde-30d8185d3081_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers and Servicing of Financial Assets</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers and Servicing of Financial Assets [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialAssetsTextBlock" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b210ab3f-77fd-4464-93ae-ed83f88b4628_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_80a70ab7-d829-4e2b-926d-736f5b5c79d2_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d46bf7d8-8a60-4d61-b012-8ef6c9ca17c2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_2a848e9d-e2dd-4bdb-b807-c10bf45efd07_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_bccca383-e8e5-4c94-b036-adac04d0c0e6_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1ad7a803-b86e-45ef-b812-ee1e38a7032e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0bfb9a29-2e08-441a-801a-c4dcb7e240ff_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_938a4293-ebad-4db3-b137-6e42258474be_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_ee296230-bc49-4d9d-a97b-eb94a770a21a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Collection of Receivables</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Collection of Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndCollectionOfReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:to="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_dc4edfb6-b174-4309-864b-cc5d7a5fe68c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_8b443be9-2c6c-48a8-854a-0531f473effe_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_VitalCareMember_fda0ac4c-5c06-4a49-8a34-c15663ee8c7d_terseLabel_en-US" xlink:label="lab_icui_VitalCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vital Care</link:label>
    <link:label id="lab_icui_VitalCareMember_label_en-US" xlink:label="lab_icui_VitalCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vital Care [Member]</link:label>
    <link:label id="lab_icui_VitalCareMember_documentation_en-US" xlink:label="lab_icui_VitalCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vital Care</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_VitalCareMember" xlink:href="icui-20230331.xsd#icui_VitalCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_VitalCareMember" xlink:to="lab_icui_VitalCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_e6aeb4e2-7dfe-4ffb-b062-e0c7d7ea9c82_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_f845d47e-1890-4093-b7c6-cd3236393c6a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTable_0ea834de-dc47-487b-9ee8-7b8caf9e1771_terseLabel_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Table]</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTable_label_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Table]</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTable_documentation_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:href="icui-20230331.xsd#icui_ApplicableMarginBasedOnLeverageRatioTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:to="lab_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d5c22118-ca03-4798-a59b-a0ec9554bda1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTINGENT EARN-OUT LIABILITY</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyLineItems_a9c21b28-5aee-4cb8-9221-8b9b203c90a6_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems" xlink:to="lab_us-gaap_ProductLiabilityContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_abb55d11-e29d-46ed-9ac7-b2369240648b_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c3aa20b7-d44f-4aa8-bbbf-cc7af1cb374c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_e0b966ce-b0aa-4999-967e-e39251a6a44e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_1cc6ff38-c067-4250-bfcf-3bc8c1d1c811_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_SEK_5bb14f54-090d-40c1-94ff-409a4529b3b4_terseLabel_en-US" xlink:label="lab_currency_SEK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sweden, Kronor</link:label>
    <link:label id="lab_currency_SEK_label_en-US" xlink:label="lab_currency_SEK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sweden, Kronor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SEK" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SEK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_SEK" xlink:to="lab_currency_SEK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_35808b3c-1165-4a6a-9cbf-2dbf70583e1a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_8f4c83e7-def7-4654-b382-c12fc4765ed8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_48e3d61c-d591-4511-afe9-2ee3297a4a70_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_bd631cd0-5b78-412b-98f1-2f1a6a4a7eb6_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_41193f3e-340b-4de0-bd08-2acd870bb3c4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8d226f1e-6307-4436-a9e4-d1cd7a2455ab_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_6cc69aec-229b-4e91-ab83-e8c9f41e1090_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPS - basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fee5c4e5-4063-40ad-a9e6-7a0459064338_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_0177abc3-a616-41d4-bbcb-84626313b31b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-term and Short-term, Combined Amount</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-Term and Short-Term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_bcf175e3-4b6b-41ed-8be1-ae396f5c395f_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDueFromToRelatedParty_98dd7baa-cd96-44bf-8543-dbc34fe43b80_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Due from (to) Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDueFromToRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Due from (to) Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b69a1236-52f1-464c-8aba-e2f0e9243339_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b4ddfbcb-3b7d-4e6b-b47c-fdce15700448_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SmithsMedicalMember_a71a9a82-0493-43d6-8300-b5ec99a45e98_terseLabel_en-US" xlink:label="lab_icui_SmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmithsMedical</link:label>
    <link:label id="lab_icui_SmithsMedicalMember_label_en-US" xlink:label="lab_icui_SmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmithsMedical [Member]</link:label>
    <link:label id="lab_icui_SmithsMedicalMember_documentation_en-US" xlink:label="lab_icui_SmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmithsMedical</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SmithsMedicalMember" xlink:to="lab_icui_SmithsMedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Contingentconsiderationgross_d60bf38d-498e-4ba0-97d9-9d46e36671cd_terseLabel_en-US" xlink:label="lab_icui_Contingentconsiderationgross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration gross</link:label>
    <link:label id="lab_icui_Contingentconsiderationgross_label_en-US" xlink:label="lab_icui_Contingentconsiderationgross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration gross</link:label>
    <link:label id="lab_icui_Contingentconsiderationgross_documentation_en-US" xlink:label="lab_icui_Contingentconsiderationgross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross" xlink:href="icui-20230331.xsd#icui_Contingentconsiderationgross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Contingentconsiderationgross" xlink:to="lab_icui_Contingentconsiderationgross" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ClassificationAxis_16bafd01-2f6c-4d91-aa92-624bc220311c_terseLabel_en-US" xlink:label="lab_icui_ClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">classification [Axis]</link:label>
    <link:label id="lab_icui_ClassificationAxis_label_en-US" xlink:label="lab_icui_ClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">classification [Axis]</link:label>
    <link:label id="lab_icui_ClassificationAxis_documentation_en-US" xlink:label="lab_icui_ClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">classification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ClassificationAxis" xlink:href="icui-20230331.xsd#icui_ClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ClassificationAxis" xlink:to="lab_icui_ClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_360e77cc-b2cf-41a9-8b0c-864ab0a90dd4_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_79644fc9-e7fa-40d3-9cb0-643b1725f78f_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_ae532c7a-2dff-4ab0-bb20-d7afeda87833_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_e9999d9d-da82-4fae-8349-da83faf9d24f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_bcf846d9-a565-4916-b558-17ad781c9b94_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeAmortizationOfPremium_3dd1e61d-f896-46cf-a247-d76ed4f5bebb_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bond premium amortization</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeAmortizationOfPremium_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Amortization of Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:to="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ApplicableMarginTermSOFRLoans_632dea42-da3a-4cfc-8e5e-6bbbf14427f1_terseLabel_en-US" xlink:label="lab_icui_ApplicableMarginTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Term SOFR Loans</link:label>
    <link:label id="lab_icui_ApplicableMarginTermSOFRLoans_label_en-US" xlink:label="lab_icui_ApplicableMarginTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Term SOFR Loans</link:label>
    <link:label id="lab_icui_ApplicableMarginTermSOFRLoans_documentation_en-US" xlink:label="lab_icui_ApplicableMarginTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Term SOFR Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginTermSOFRLoans" xlink:href="icui-20230331.xsd#icui_ApplicableMarginTermSOFRLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ApplicableMarginTermSOFRLoans" xlink:to="lab_icui_ApplicableMarginTermSOFRLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_2948f707-4c63-4156-9a21-64ea7ac15907_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_54ed02c9-589b-4297-ba68-afed1fac29de_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bad9dd86-2cd9-4ba5-bd92-259226dce7ee_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_10630e5f-39d4-4be1-8a00-9a74b15b6b06_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_74616972-5992-4b99-bed5-829a5b654186_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3054d027-c653-410f-b6fa-be38a0c06b0b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositAssets_21d71da6-cc85-4cb2-aab6-b68908792609_terseLabel_en-US" xlink:label="lab_us-gaap_DepositAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit Assets</link:label>
    <link:label id="lab_us-gaap_DepositAssets_label_en-US" xlink:label="lab_us-gaap_DepositAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositAssets" xlink:to="lab_us-gaap_DepositAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_2cb37e74-c555-4dce-8ea0-099f6f2e0a7d_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0ff357c0-f73a-4b59-95ed-7c0264b04934_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_5f9b8d4e-2f71-473a-8d98-10651683e67c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_bd5acb0a-ff56-45bb-9e59-449819f19cf9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_cbd67382-a238-412a-8d88-524f235d759e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsAndOtherAssets_bbc1dd9f-6995-49fe-a3e7-7f849d70e1ff_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs and Other Assets</link:label>
    <link:label id="lab_us-gaap_DeferredCostsAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCostsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsAndOtherAssets" xlink:to="lab_us-gaap_DeferredCostsAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_69817187-126f-445f-a250-9bb655d0641e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_b419a817-81a7-4fcd-a040-05962d151ef2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_1c4f8511-dab4-44ff-8175-c5df374318f3_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_07d891fe-a725-4e91-a945-f498e9508032_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_8340e2c6-8313-4fb4-9fa9-db82ad6766a4_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_1e5cc2de-a2de-48c7-b150-0ba1ba251bc5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_4e6b4b71-83db-49a6-b7c7-5264df4445f7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_7c5c93a2-7e0d-479b-a924-81d49bdcfd60_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_4f3f73c4-14e1-408b-9b59-2e0960fcd0f9_terseLabel_en-US" xlink:label="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes, including excess tax benefits and deferred income taxes</link:label>
    <link:label id="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_label_en-US" xlink:label="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease in income taxes, including excess tax benefits and deferred income taxes</link:label>
    <link:label id="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_documentation_en-US" xlink:label="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net change during the reporting period in the carrying amount as of the balance sheet date of payments made for taxes. Also includes the net change during the reporting period in the account that represents the temporary difference that results from income (loss) that is recognized for accounting purposes but not for tax purposes and vice versa.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:href="icui-20230331.xsd#icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:to="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_ab41ced8-1720-42c6-a877-b666fb7ad509_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL CASH, CASH EQUIVALENTS AND INVESTMENT SECURITIES</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_311ec3ab-117d-4b3a-85eb-fd424e54f3c0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_192f0ab8-fad6-4e0a-a91b-031fa6b17d99_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_bf307877-687e-43ba-a378-467dbf91ad88_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT ASSETS:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9a8e048c-4201-45ff-a764-b94e8527a257_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_db3910d9-d990-4cf6-a2db-61c5ea1f2fbc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_b648f544-9023-471b-a908-70da9244a774_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_b5cae4f3-ad68-4600-aeb1-f60ad49dae90_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InterestPercentageAddedToFederalFundsRate_8e58fb07-e3a7-41db-8b2c-a9aaf2c602fa_terseLabel_en-US" xlink:label="lab_icui_InterestPercentageAddedToFederalFundsRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Federal Funds Rate</link:label>
    <link:label id="lab_icui_InterestPercentageAddedToFederalFundsRate_label_en-US" xlink:label="lab_icui_InterestPercentageAddedToFederalFundsRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Federal Funds Rate</link:label>
    <link:label id="lab_icui_InterestPercentageAddedToFederalFundsRate_documentation_en-US" xlink:label="lab_icui_InterestPercentageAddedToFederalFundsRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Federal Funds Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestPercentageAddedToFederalFundsRate" xlink:href="icui-20230331.xsd#icui_InterestPercentageAddedToFederalFundsRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InterestPercentageAddedToFederalFundsRate" xlink:to="lab_icui_InterestPercentageAddedToFederalFundsRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_24ee481a-655c-463d-807e-dc0be7de2483_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b610d5f2-0363-484d-91f0-87d952db5088_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_7278dda4-8694-4cf1-bde1-ec4e70996b78_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_fa580ece-6c10-4477-a153-83e0eecfc9a7_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_67b8950b-ccfe-4ab6-bcd0-a0ef13a5033f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityMember_08a78fa3-c082-4003-ba8b-b7ce962e81ba_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_LiabilityMember_label_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityMember" xlink:to="lab_us-gaap_LiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_21cf711c-133e-45fd-9264-6a2ff278c4f4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investment securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_78ffe941-c1ad-498f-923f-f3d156827961_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_5bac612c-81bf-4fc8-a78c-ddf245b61d2a_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_7534614e-d0e2-4b40-827c-698bae56391a_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Restructuringstrategictransactionandintegration_52b8e890-adaf-493a-b38f-6977c3a7e328_terseLabel_en-US" xlink:label="lab_icui_Restructuringstrategictransactionandintegration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, strategic transaction and integration</link:label>
    <link:label id="lab_icui_Restructuringstrategictransactionandintegration_label_en-US" xlink:label="lab_icui_Restructuringstrategictransactionandintegration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, strategic transaction and integration</link:label>
    <link:label id="lab_icui_Restructuringstrategictransactionandintegration_documentation_en-US" xlink:label="lab_icui_Restructuringstrategictransactionandintegration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, strategic transaction and integration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringstrategictransactionandintegration" xlink:href="icui-20230331.xsd#icui_Restructuringstrategictransactionandintegration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Restructuringstrategictransactionandintegration" xlink:to="lab_icui_Restructuringstrategictransactionandintegration" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisAxis_dc154694-b6b3-4aec-ab4e-ddb2d409aa0e_terseLabel_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis [Axis]</link:label>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisAxis_label_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis [Axis]</link:label>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisAxis_documentation_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisAxis" xlink:href="icui-20230331.xsd#icui_Srt_MultipleCurrencyAxisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Srt_MultipleCurrencyAxisAxis" xlink:to="lab_icui_Srt_MultipleCurrencyAxisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TotalSeniorSecuredCreditFacility_be965a0d-b0df-410e-83d1-b53e148ee00b_terseLabel_en-US" xlink:label="lab_icui_TotalSeniorSecuredCreditFacility" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TotalSeniorSecuredCreditFacility</link:label>
    <link:label id="lab_icui_TotalSeniorSecuredCreditFacility_label_en-US" xlink:label="lab_icui_TotalSeniorSecuredCreditFacility" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TotalSeniorSecuredCreditFacility</link:label>
    <link:label id="lab_icui_TotalSeniorSecuredCreditFacility_documentation_en-US" xlink:label="lab_icui_TotalSeniorSecuredCreditFacility" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TotalSeniorSecuredCreditFacility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TotalSeniorSecuredCreditFacility" xlink:href="icui-20230331.xsd#icui_TotalSeniorSecuredCreditFacility"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TotalSeniorSecuredCreditFacility" xlink:to="lab_icui_TotalSeniorSecuredCreditFacility" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_0c861acf-aca6-4255-ac6f-a6fe553eacff_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_3c34143e-6476-4fb1-8824-2886dd81f70e_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d8c7bcfc-8799-4330-a17f-4406b75dc100_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_30549154-a498-4311-965f-17a050e8be81_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_61e96fc7-1f0e-4f5d-bfc8-9d0fc6aa9879_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6072324f-15c0-49ed-b6a2-3ace6b3537ef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_5839bad2-da03-4e47-b04e-0ba321335d51_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_40452b5f-86fa-4585-8efc-696496022e3d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:to="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PursuitVascularInc.Member_5ccad5b4-cbef-491d-a60b-71ce12ece311_terseLabel_en-US" xlink:label="lab_icui_PursuitVascularInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pursuit Vascular, Inc. [Member]</link:label>
    <link:label id="lab_icui_PursuitVascularInc.Member_label_en-US" xlink:label="lab_icui_PursuitVascularInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pursuit Vascular, Inc. [Member]</link:label>
    <link:label id="lab_icui_PursuitVascularInc.Member_documentation_en-US" xlink:label="lab_icui_PursuitVascularInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pursuit Vascular, Inc. [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member" xlink:href="icui-20230331.xsd#icui_PursuitVascularInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PursuitVascularInc.Member" xlink:to="lab_icui_PursuitVascularInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueAdditions_4a437e1b-d225-4490-a59b-cf8e67cf998a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueAdditions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Additions</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueAdditions_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueAdditions" xlink:to="lab_us-gaap_DeferredRevenueAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_86df5c1c-5922-441a-aefc-8302e6106dc7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_4ce0af5c-4335-48fd-ab68-42bcbc302b5b_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER (EXPENSE) INCOME, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_fa83d610-f8fb-4ed1-8096-965f5599cee7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_d338820b-4c98-4730-94b7-d58d85a1493d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_eef09ebf-8ce2-42c6-bd8e-d318438326b9_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContingentConsiderationTaxExpense_7937d153-61a3-42fd-aae8-7fe8bc9f91e6_terseLabel_en-US" xlink:label="lab_icui_ContingentConsiderationTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration, tax expense</link:label>
    <link:label id="lab_icui_ContingentConsiderationTaxExpense_label_en-US" xlink:label="lab_icui_ContingentConsiderationTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration, tax expense</link:label>
    <link:label id="lab_icui_ContingentConsiderationTaxExpense_documentation_en-US" xlink:label="lab_icui_ContingentConsiderationTaxExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration, tax expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationTaxExpense" xlink:href="icui-20230331.xsd#icui_ContingentConsiderationTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContingentConsiderationTaxExpense" xlink:to="lab_icui_ContingentConsiderationTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CAD_288ff8a1-08b5-47fd-83a9-641ce652700d_terseLabel_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada, Dollars</link:label>
    <link:label id="lab_currency_CAD_label_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CAD" xlink:to="lab_currency_CAD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_8007ccf7-6cc7-4e58-9728-65068151dedb_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Text Block]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f616cf96-f27e-448f-bec7-066f1e2c270c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent earn-out</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_01fa210e-ecc3-4dba-b87e-252d87606167_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_24903e1a-d519-417a-a180-0b952d9cfcef_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AmortizationOfInventoryStepUp_5eba42ff-ac05-400b-bca4-36fe57ca47bc_terseLabel_en-US" xlink:label="lab_icui_AmortizationOfInventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Inventory Step-up</link:label>
    <link:label id="lab_icui_AmortizationOfInventoryStepUp_label_en-US" xlink:label="lab_icui_AmortizationOfInventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Inventory Step-up</link:label>
    <link:label id="lab_icui_AmortizationOfInventoryStepUp_documentation_en-US" xlink:label="lab_icui_AmortizationOfInventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Inventory Step-up</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AmortizationOfInventoryStepUp" xlink:href="icui-20230331.xsd#icui_AmortizationOfInventoryStepUp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AmortizationOfInventoryStepUp" xlink:to="lab_icui_AmortizationOfInventoryStepUp" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_97636488-75e9-4ffc-830c-e201ec8cb8c3_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_0b349e12-25f9-4574-9a7d-7f1f030bfb1d_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_c46b8813-80ff-4279-a699-c79dd5820229_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_fea3bbaa-0519-4442-8930-a5bdbbcff20d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_5014b70e-5faf-46e1-908e-d7f0f0f9db4f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d8eb59b2-65e3-421c-8bec-7d4ce24f0289_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(LOSS) INCOME FROM OPERATIONS</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_41ad534c-947e-4cc8-ba86-33a6d5e4755f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LessThanOrEqualTo200To100Member_32b18818-c9fe-4fed-bf12-a1644f865b69_terseLabel_en-US" xlink:label="lab_icui_LessThanOrEqualTo200To100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessthanorequalto2to1</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo200To100Member_label_en-US" xlink:label="lab_icui_LessThanOrEqualTo200To100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 2.00 to 1.00 [Member]</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo200To100Member_documentation_en-US" xlink:label="lab_icui_LessThanOrEqualTo200To100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 2.00 to 1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo200To100Member" xlink:href="icui-20230331.xsd#icui_LessThanOrEqualTo200To100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LessThanOrEqualTo200To100Member" xlink:to="lab_icui_LessThanOrEqualTo200To100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_a587bb18-a5d8-4f9a-a1c0-158b813d5093_terseLabel_en-US" xlink:label="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</link:label>
    <link:label id="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_label_en-US" xlink:label="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</link:label>
    <link:label id="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_documentation_en-US" xlink:label="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:href="icui-20230331.xsd#icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:to="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5cca9ddb-8ffb-492b-abf0-e94d68ebb52e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductLiabilityAccrualComponentAmount_3e11cafe-6914-4761-bc33-1e002f472ed3_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityAccrualComponentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Accrual, Component Amount</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityAccrualComponentAmount_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityAccrualComponentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Accrual, Component Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityAccrualComponentAmount" xlink:to="lab_us-gaap_ProductLiabilityAccrualComponentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TimingAxis_8f0ef8b7-a7d9-4f14-952e-64cb5769f220_terseLabel_en-US" xlink:label="lab_icui_TimingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing [Axis]</link:label>
    <link:label id="lab_icui_TimingAxis_label_en-US" xlink:label="lab_icui_TimingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing [Axis]</link:label>
    <link:label id="lab_icui_TimingAxis_documentation_en-US" xlink:label="lab_icui_TimingAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis" xlink:href="icui-20230331.xsd#icui_TimingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TimingAxis" xlink:to="lab_icui_TimingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_14f26b9b-540e-4f6d-9afa-4b939e33d892_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6a9025d8-81ca-45a2-96ae-34754559d34b_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_d620f7c9-086c-4a64-9bc8-70b4dec10ebf_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Optiontoextendinyears_7bd1566b-4b26-44a8-9095-64a9e790e035_terseLabel_en-US" xlink:label="lab_icui_Optiontoextendinyears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option to Extend</link:label>
    <link:label id="lab_icui_Optiontoextendinyears_label_en-US" xlink:label="lab_icui_Optiontoextendinyears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optiontoextendinyears</link:label>
    <link:label id="lab_icui_Optiontoextendinyears_documentation_en-US" xlink:label="lab_icui_Optiontoextendinyears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optiontoextendinyears</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Optiontoextendinyears" xlink:href="icui-20230331.xsd#icui_Optiontoextendinyears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Optiontoextendinyears" xlink:to="lab_icui_Optiontoextendinyears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_e66e66f3-5dfd-4d42-9b73-2292b50d1205_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_1f59553f-5a90-463a-add6-668a9008588e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_f09ff64c-368c-4275-b3aa-4293d83fbc18_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_64cc86f0-bfa4-4c3b-b335-199d92a40391_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_CommonStockSharesMember_cf3b4dd7-1d3c-45ca-8676-e8be278311f6_terseLabel_en-US" xlink:label="lab_icui_CommonStockSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Shares [Member]</link:label>
    <link:label id="lab_icui_CommonStockSharesMember_label_en-US" xlink:label="lab_icui_CommonStockSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Shares [Member]</link:label>
    <link:label id="lab_icui_CommonStockSharesMember_documentation_en-US" xlink:label="lab_icui_CommonStockSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CommonStockSharesMember" xlink:href="icui-20230331.xsd#icui_CommonStockSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_CommonStockSharesMember" xlink:to="lab_icui_CommonStockSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration_2f14e655-fe8e-48a3-9c25-6dbd57633bfd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ApplicableMarginBaseRateLoans_b6393733-f2a2-49f1-aa7d-61c092c69feb_terseLabel_en-US" xlink:label="lab_icui_ApplicableMarginBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Base Rate Loans</link:label>
    <link:label id="lab_icui_ApplicableMarginBaseRateLoans_label_en-US" xlink:label="lab_icui_ApplicableMarginBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Base Rate Loans</link:label>
    <link:label id="lab_icui_ApplicableMarginBaseRateLoans_documentation_en-US" xlink:label="lab_icui_ApplicableMarginBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Base Rate Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBaseRateLoans" xlink:href="icui-20230331.xsd#icui_ApplicableMarginBaseRateLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ApplicableMarginBaseRateLoans" xlink:to="lab_icui_ApplicableMarginBaseRateLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_463c45dc-2f19-43e5-a988-7eebac15d2db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_88bb3cfd-ba81-475a-84e9-b441ac395ce1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Accruedothertaxes_241f60b9-3d74-4c68-bf8d-89bfdaae03ce_terseLabel_en-US" xlink:label="lab_icui_Accruedothertaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued other taxes</link:label>
    <link:label id="lab_icui_Accruedothertaxes_label_en-US" xlink:label="lab_icui_Accruedothertaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued other taxes</link:label>
    <link:label id="lab_icui_Accruedothertaxes_documentation_en-US" xlink:label="lab_icui_Accruedothertaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued other taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedothertaxes" xlink:href="icui-20230331.xsd#icui_Accruedothertaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Accruedothertaxes" xlink:to="lab_icui_Accruedothertaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_b1c7cf1c-e174-4b93-87be-912590ab12cf_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BENEFIT (PROVISION) FOR INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyTable_c8970014-bab0-498c-b5d5-703b9ad1edbd_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyTable_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable" xlink:to="lab_us-gaap_ProductLiabilityContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_3cb5a19f-8127-476e-9554-ffdac6680823_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_11156d32-072f-4ee1-a64b-681fbd58cbc6_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_2a05f3cb-f432-49c2-910f-c0cf7a373203_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_3ee7d563-494c-468c-9ec0-303f4bdd9d2e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEFERRED INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_03f19097-681a-40e5-b163-37458f545f40_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, par value</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ca075f50-0ce2-4b04-840a-0f0e9a5b80af_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_771cf6f9-9a24-4737-8bae-b5759c27591e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9432f70e-3edd-4a1f-9bb0-00fb6fff4510_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_2ce46594-cda8-4ba4-9d9d-4f76d123a6d7_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_fe4b4dc6-f6ef-40a9-aacb-8e0a01bcf914_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_4d217615-0f44-4443-90a3-0bcf34b088ef_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_MoldsMember_e8c1045b-4e8e-4020-8535-1a85234e27e3_terseLabel_en-US" xlink:label="lab_icui_MoldsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molds [Member]</link:label>
    <link:label id="lab_icui_MoldsMember_label_en-US" xlink:label="lab_icui_MoldsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molds [Member]</link:label>
    <link:label id="lab_icui_MoldsMember_documentation_en-US" xlink:label="lab_icui_MoldsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MoldsMember" xlink:href="icui-20230331.xsd#icui_MoldsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_MoldsMember" xlink:to="lab_icui_MoldsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesTotalMember_08b6e77a-307f-486e-a948-c7e824fbe658_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesTotalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Total [Member]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesTotalMember_label_en-US" xlink:label="lab_us-gaap_LiabilitiesTotalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Total [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesTotalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesTotalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesTotalMember" xlink:to="lab_us-gaap_LiabilitiesTotalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_391ecb50-f1b5-4dcc-8a7a-c0ea2d947deb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c6343639-f848-459a-bf47-6a196b40aab9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1f0b638c-da32-4605-82b4-1925ec1e45da_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_216c4bf0-c23c-4113-9fb6-bc1d9dacc934_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_5218def5-fac7-4452-b552-f7310cc7be79_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_b454677a-54e2-4f2d-97ed-96e0ff77126a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f91e4b73-70b9-4e45-9a89-80a73263a26d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_1063bd23-698f-4ae1-80bc-b2e586b20695_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_DocumentAndEntityInformationAbstract_4adc7dcc-5ed0-4133-9105-164b0822e7b3_terseLabel_en-US" xlink:label="lab_icui_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
    <link:label id="lab_icui_DocumentAndEntityInformationAbstract_label_en-US" xlink:label="lab_icui_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
    <link:label id="lab_icui_DocumentAndEntityInformationAbstract_documentation_en-US" xlink:label="lab_icui_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DocumentAndEntityInformationAbstract" xlink:href="icui-20230331.xsd#icui_DocumentAndEntityInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_DocumentAndEntityInformationAbstract" xlink:to="lab_icui_DocumentAndEntityInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_92bd7007-750d-4e53-ba71-7032fe75057d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_f60f4a8e-cf4e-4ad4-a0bc-ee0fb6ad7668_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.10 par value - Authorized-80,000 shares; Issued 23,899 shares at June 30,2022 and 21,280 shares at December 31, 2021 and outstanding 23,898 shares at June 30, 2022 and 21,280 shares at December 31, 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_7868404a-9ce5-4d34-9357-0f9003e05531_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TimingDomain_85a2ae46-3191-4592-a352-690a2aa9ac1c_terseLabel_en-US" xlink:label="lab_icui_TimingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing [Domain]</link:label>
    <link:label id="lab_icui_TimingDomain_label_en-US" xlink:label="lab_icui_TimingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing [Domain]</link:label>
    <link:label id="lab_icui_TimingDomain_documentation_en-US" xlink:label="lab_icui_TimingDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain" xlink:href="icui-20230331.xsd#icui_TimingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TimingDomain" xlink:to="lab_icui_TimingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_130cb094-51d6-4d03-bb64-fd9c40465846_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_12272984-fc12-49ec-9360-ef198019ea5d_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_cbbd8762-96c9-4b36-a068-8b41bb705904_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_3e6f3e9c-bedf-4c0a-81a6-b44ca5af918f_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_FieldServiceCorrectiveAction_eb21574c-bac5-42a9-9ca5-8e1307c07661_terseLabel_en-US" xlink:label="lab_icui_FieldServiceCorrectiveAction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Field service corrective action</link:label>
    <link:label id="lab_icui_FieldServiceCorrectiveAction_label_en-US" xlink:label="lab_icui_FieldServiceCorrectiveAction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Field service corrective action</link:label>
    <link:label id="lab_icui_FieldServiceCorrectiveAction_documentation_en-US" xlink:label="lab_icui_FieldServiceCorrectiveAction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Field service corrective action</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_FieldServiceCorrectiveAction" xlink:href="icui-20230331.xsd#icui_FieldServiceCorrectiveAction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_FieldServiceCorrectiveAction" xlink:to="lab_icui_FieldServiceCorrectiveAction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_8059ede7-6cc3-4610-9e22-2a45673cc343_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_13723d2c-24b3-4ae0-987e-cb1b81cfc32f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_6c3b066e-94a2-4062-ad7e-81e655d8baee_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, authorized shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_78f5ac2b-bb1a-4fd8-b1df-c3eca54ce424_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_8863fb4d-d45a-4ce8-a5b2-36882bc75562_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment, net of taxes of $0 for all periods</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedBonusesCurrent_79df618a-c486-4a1e-80cd-6755ccd2c535_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive compensation</link:label>
    <link:label id="lab_us-gaap_AccruedBonusesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Bonuses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedBonusesCurrent" xlink:to="lab_us-gaap_AccruedBonusesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_83988b79-af5a-4e96-b07c-bdf79f1a071a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies [Text Block]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_33c9b541-aa24-422e-8268-3890d7d5dc44_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT LIABILITIES:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_61b9ba60-e774-4ce5-8324-b55fa181f724_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_eaa917b1-a987-4b9f-b6dd-ee2e84a43451_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_dbd9b3da-c093-465c-a027-b0a0040f9e4b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_e016eac3-b892-4002-86b8-818a3973c230_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingRevenueMember_f3ea6d78-1bf8-4a1d-b828-08b2b21e27ac_terseLabel_en-US" xlink:label="lab_us-gaap_TradingRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Revenue</link:label>
    <link:label id="lab_us-gaap_TradingRevenueMember_label_en-US" xlink:label="lab_us-gaap_TradingRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingRevenueMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingRevenueMember" xlink:to="lab_us-gaap_TradingRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_fa62d8a4-3716-4d5f-88ea-57693f114fd9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_59a673b6-cac8-478c-8c85-1e808f315e3c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_735bdf0a-e97d-460d-ac06-e4100b26527f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8a8beb56-0e83-49da-b19c-a01c2a671bec_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_0925fe87-743a-4a48-ac43-bf52c60fbed3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_df1eeec1-94c3-4b6f-a282-1bf3c982b429_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_1ba40d3b-49e0-43fa-a36e-5d8aafde0204_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FacilityClosingMember_0aa163f0-c0e2-496e-9c3f-b2642a7cf82e_terseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_label_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FacilityClosingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FacilityClosingMember" xlink:to="lab_us-gaap_FacilityClosingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_4579ebaf-b22c-48b8-8935-0641d087c73d_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_22928c44-bb38-44b6-af0f-6eae4fe47ac9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_c299e305-cc34-481c-927a-93576f4384ca_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_988090ed-6ed1-46e7-a062-39385288ee4c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_8f5c1c22-a213-464f-a4c3-9b987582ab63_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_77d2695d-6824-4b20-800b-f0b69daf89cb_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e3321d8a-8969-4ab1-885b-830185bc2f15_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive income (loss), net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_37ed33ef-9da3-4ef1-a8ae-be63e137cd5b_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_dd4e6edf-7bca-48c8-b795-b4bc048483db_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_c6397f68-3552-4f75-a0a5-ba17f3585fa8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring accrual</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_b8855332-95fc-4528-a51f-32fccf426dff_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_d539ffa5-f8fd-43e5-b6ee-8565469075b6_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0f8b11b0-c8f8-4292-9071-4d21a7599f70_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_274a137a-487e-4045-b97e-0680a5828330_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_70491707-3ca8-4894-997d-a91745f00154_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER ASSETS</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContingentConsiderationGrossST_eb68b48c-020b-40bc-a336-7f5e91198a18_terseLabel_en-US" xlink:label="lab_icui_ContingentConsiderationGrossST" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross ST</link:label>
    <link:label id="lab_icui_ContingentConsiderationGrossST_label_en-US" xlink:label="lab_icui_ContingentConsiderationGrossST" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross ST</link:label>
    <link:label id="lab_icui_ContingentConsiderationGrossST_documentation_en-US" xlink:label="lab_icui_ContingentConsiderationGrossST" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross ST</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST" xlink:href="icui-20230331.xsd#icui_ContingentConsiderationGrossST"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContingentConsiderationGrossST" xlink:to="lab_icui_ContingentConsiderationGrossST" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_CurrencyTranslationOnEarnOut_d9642e76-9bba-4a06-8fcf-77369183f556_negatedTerseLabel_en-US" xlink:label="lab_icui_CurrencyTranslationOnEarnOut" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation on earn-out</link:label>
    <link:label id="lab_icui_CurrencyTranslationOnEarnOut_label_en-US" xlink:label="lab_icui_CurrencyTranslationOnEarnOut" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation on earn-out</link:label>
    <link:label id="lab_icui_CurrencyTranslationOnEarnOut_documentation_en-US" xlink:label="lab_icui_CurrencyTranslationOnEarnOut" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation on earn-out</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CurrencyTranslationOnEarnOut" xlink:href="icui-20230331.xsd#icui_CurrencyTranslationOnEarnOut"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_CurrencyTranslationOnEarnOut" xlink:to="lab_icui_CurrencyTranslationOnEarnOut" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_db802c43-791d-47c2-86c3-432ee2f9ba2b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash [Abstract]</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_3119d9fa-a329-4283-9139-5cbb06f51128_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInDeferredRevenueRollForward_b5366da0-f314-4a71-a141-2f22ae781522_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInDeferredRevenueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Deferred Revenue [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInDeferredRevenueRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInDeferredRevenueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Deferred Revenue [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInDeferredRevenueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInDeferredRevenueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInDeferredRevenueRollForward" xlink:to="lab_us-gaap_MovementInDeferredRevenueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_7388a719-5767-4c52-9f2b-7b071f2bc7ce_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Purchases from Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Purchases from Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d08f40f2-b2db-4565-bf80-e3318c20f44e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_59d339d5-b59b-465b-89ba-02f9b66dab4d_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CNY_baf633a0-251c-442c-933a-76a12fa9264e_terseLabel_en-US" xlink:label="lab_currency_CNY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China, Yuan Renminbi</link:label>
    <link:label id="lab_currency_CNY_label_en-US" xlink:label="lab_currency_CNY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China, Yuan Renminbi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CNY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CNY" xlink:to="lab_currency_CNY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_6fc868b4-85aa-4891-b5f1-46e3a7c49e73_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_659ea3ec-0fda-4435-a521-0442808d98cc_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_9355fef9-5d45-4a9a-9c16-ca49d03ec67d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_CurrentMember_06cca9e1-ad02-46f0-9395-c7b9c566acdf_terseLabel_en-US" xlink:label="lab_icui_CurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">current</link:label>
    <link:label id="lab_icui_CurrentMember_label_en-US" xlink:label="lab_icui_CurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">current [Member]</link:label>
    <link:label id="lab_icui_CurrentMember_documentation_en-US" xlink:label="lab_icui_CurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CurrentMember" xlink:href="icui-20230331.xsd#icui_CurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_CurrentMember" xlink:to="lab_icui_CurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_17554914-325e-47f4-99f6-fa82a1aef169_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, after Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_47c54972-9d78-4d01-af63-30a69f76534e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContractassetandliabilitybalancesTable_4783a518-0813-4aa0-bd16-d0287bf88b9d_terseLabel_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Table]</link:label>
    <link:label id="lab_icui_ContractassetandliabilitybalancesTable_label_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Table]</link:label>
    <link:label id="lab_icui_ContractassetandliabilitybalancesTable_documentation_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesTable" xlink:href="icui-20230331.xsd#icui_ContractassetandliabilitybalancesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContractassetandliabilitybalancesTable" xlink:to="lab_icui_ContractassetandliabilitybalancesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1502041e-ebd8-40e9-9441-2c1edbf302c2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_cd56be5a-69d9-4df1-a089-22338fa97540_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_acc325e7-7598-4145-aa1d-41ffdd014a72_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_ca85d5d9-9dc3-45d5-891d-49e6fdb8ee5d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_de8f6237-a43a-47f8-bcae-f9038690421d_terseLabel_en-US" xlink:label="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonfinancial Liabilities Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonfinancial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonfinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_c747c2f9-9186-4307-800a-35f472f32e35_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_898b834a-e36d-4600-94ed-8c07ec144d9a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_48662309-3d14-4a32-adbc-be3db1a5ed34_terseLabel_en-US" xlink:label="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt, net of lender debt issuance costs</link:label>
    <link:label id="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_label_en-US" xlink:label="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt, net of lender debt issuance costs</link:label>
    <link:label id="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_documentation_en-US" xlink:label="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt, net of lender debt issuance costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:href="icui-20230331.xsd#icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:to="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b9c013b7-1414-4ba3-b40e-21623889723e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_a5f248c7-0318-49ba-a5d2-5a3d0cc7fc92_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_GovernmentGrantRevenueMember_929f7b16-befb-4143-adc6-fcbc212c0910_terseLabel_en-US" xlink:label="lab_icui_GovernmentGrantRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Revenue</link:label>
    <link:label id="lab_icui_GovernmentGrantRevenueMember_label_en-US" xlink:label="lab_icui_GovernmentGrantRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Revenue [Member]</link:label>
    <link:label id="lab_icui_GovernmentGrantRevenueMember_documentation_en-US" xlink:label="lab_icui_GovernmentGrantRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GovernmentGrantRevenueMember" xlink:href="icui-20230331.xsd#icui_GovernmentGrantRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_GovernmentGrantRevenueMember" xlink:to="lab_icui_GovernmentGrantRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Greaterthan400to100Member_0ff47f35-9b86-4ceb-a139-73ab160b459e_terseLabel_en-US" xlink:label="lab_icui_Greaterthan400to100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greaterthan 4to1</link:label>
    <link:label id="lab_icui_Greaterthan400to100Member_label_en-US" xlink:label="lab_icui_Greaterthan400to100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greaterthan4.00to1.00 [Member]</link:label>
    <link:label id="lab_icui_Greaterthan400to100Member_documentation_en-US" xlink:label="lab_icui_Greaterthan400to100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greaterthan4.00to1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Greaterthan400to100Member" xlink:href="icui-20230331.xsd#icui_Greaterthan400to100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Greaterthan400to100Member" xlink:to="lab_icui_Greaterthan400to100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d8d76fff-dce0-416d-8ad8-4fd1ec5e914a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b570090e-7e97-4396-b434-4b911150d33b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_99458b64-b228-4321-9dd0-2141227cc0e0_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_b579429a-bb7b-42b3-96bd-ff72cbee4632_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_f3bd950e-9416-4488-ba0a-366d635cd845_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_bc6e2601-8a88-4aae-a217-4c036d975c3c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_57c14b89-a883-4e05-be64-895f0e9acf4a_terseLabel_en-US" xlink:label="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required Share Holding Of Stock Issued At Acquisition</link:label>
    <link:label id="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_label_en-US" xlink:label="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required Share Holding Of Stock Issued At Acquisition</link:label>
    <link:label id="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_documentation_en-US" xlink:label="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required Share Holding Of Stock Issued At Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:href="icui-20230331.xsd#icui_RequiredShareHoldingOfStockIssuedAtAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:to="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_da2481b8-9a99-4a4e-b2ff-91531000c6ad_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_2b4d0525-e0d6-4fec-99ba-6e81fcd709e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_0edbeba8-be26-4c1d-ab4b-7f9b7ad2eb55_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, at cost (12,684 and 119 shares, respectively)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_82231d01-f6dc-4814-ba44-17ec075fa5dd_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Other Adjustments, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingAbstract_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers and Servicing [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingAbstract" xlink:to="lab_us-gaap_TransfersAndServicingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LOngTermObligationsDisclosureAbstract_62cd41f0-bb49-45d7-96bb-3dbbff18628f_terseLabel_en-US" xlink:label="lab_icui_LOngTermObligationsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOng-Term Obligations Disclosure [Abstract]</link:label>
    <link:label id="lab_icui_LOngTermObligationsDisclosureAbstract_label_en-US" xlink:label="lab_icui_LOngTermObligationsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOng-Term Obligations Disclosure [Abstract]</link:label>
    <link:label id="lab_icui_LOngTermObligationsDisclosureAbstract_documentation_en-US" xlink:label="lab_icui_LOngTermObligationsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOng-Term Obligations Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LOngTermObligationsDisclosureAbstract" xlink:href="icui-20230331.xsd#icui_LOngTermObligationsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract" xlink:to="lab_icui_LOngTermObligationsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_47d05fcc-6ab9-4fda-9092-d4f08a70f179_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_94cf328b-c0eb-4331-9136-442083537173_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_e2c4ed63-2195-43a7-814e-d478e139f328_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_ff699705-086a-4683-8c61-c7a12255700a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_ef6f0403-c4b0-4b82-84d1-3b60903c81e9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Earn-Out Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0c16ca75-1ced-40ea-80c6-dc5726768094_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_6e7f360c-b568-4e9e-aef6-aab328d4ab76_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax liability</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_c63a758f-fee8-474c-ba4d-7f8256f39767_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL OPERATING EXPENSES</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_af8780ef-0db6-4498-9282-317b551afde8_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_49184dc2-011e-494f-a145-c6758ffe91a7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_92be4c06-063b-481e-81e7-55770c4cd70b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisDomain_e096bdbe-73df-4fdb-b2b0-5eadfb85cf2c_terseLabel_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis [Domain]</link:label>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisDomain_label_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis [Domain]</link:label>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisDomain_documentation_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisDomain" xlink:href="icui-20230331.xsd#icui_Srt_MultipleCurrencyAxisDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Srt_MultipleCurrencyAxisDomain" xlink:to="lab_icui_Srt_MultipleCurrencyAxisDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_5a8ccdf5-4b9d-4621-8cfc-b1eb17eacf38_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1054e1df-5b07-4621-8cfa-8b34f3d4b97c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_888a39a7-4343-45a8-aef4-ac7d27e94457_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL CURRENT ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_dc7add3b-689e-4439-8fd1-ac572c3dede1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_us-gaap_DebtInstrumentMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_a22c77a1-2703-4432-8a47-a1ae7696f1ac_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7057057e-6232-4cee-be59-c0deae435f50_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanAMember_b661d78e-8261-4250-9a70-a1e36aa809b5_terseLabel_en-US" xlink:label="lab_icui_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A</link:label>
    <link:label id="lab_icui_TermLoanAMember_label_en-US" xlink:label="lab_icui_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A [Member]</link:label>
    <link:label id="lab_icui_TermLoanAMember_documentation_en-US" xlink:label="lab_icui_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember" xlink:href="icui-20230331.xsd#icui_TermLoanAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanAMember" xlink:to="lab_icui_TermLoanAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_864335ef-a030-4df9-ab3e-398c1a614cb7_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_48c8e1a0-c17a-489c-ab6d-8304d6c94e38_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableRevolving_1b3d8cd1-72f0-432b-a9fe-60c64e109027_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableRevolving" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Revolving</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableRevolving_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableRevolving" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Revolving</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRevolving" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRevolving"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableRevolving" xlink:to="lab_us-gaap_FinancingReceivableRevolving" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_92f9578d-d06b-425a-807b-7981e57bb1a5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_975745db-a7ba-4457-8ac8-bba494beab45_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock_59190675-cb53-4905-ba2b-49e512001275_terseLabel_en-US" xlink:label="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on long term debt</link:label>
    <link:label id="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on long term debt [Table Text Block]</link:label>
    <link:label id="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock_documentation_en-US" xlink:label="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on long term debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:href="icui-20230331.xsd#icui_InterestExpenseOnLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:to="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration_83c6c1ff-342f-4041-aebe-ca172ba33118_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProFormaAdjustmentFinanceCosts_fe5902f7-121d-41af-853f-57aec2e60a75_terseLabel_en-US" xlink:label="lab_icui_ProFormaAdjustmentFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Finance Costs</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentFinanceCosts_label_en-US" xlink:label="lab_icui_ProFormaAdjustmentFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Finance Costs</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentFinanceCosts_documentation_en-US" xlink:label="lab_icui_ProFormaAdjustmentFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Finance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentFinanceCosts" xlink:href="icui-20230331.xsd#icui_ProFormaAdjustmentFinanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProFormaAdjustmentFinanceCosts" xlink:to="lab_icui_ProFormaAdjustmentFinanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_b51ba316-e6d6-4b01-8f9e-3fd198f2a2f3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_80b2d08c-2cec-48dd-a954-3299e51c8024_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment [Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_c4483623-e212-4077-a5a3-20f75ef02518_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_c31f6b1a-cdcf-4f04-88bb-a7d2983e96ea_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_a9673b7d-02af-416c-a939-6e59f72a7a3b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_f3704975-eb3a-4f72-a978-190edd37c0c6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_c83b9151-7567-4faf-b6cd-986c5b13e775_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_MinimumStockPriceTargetForEarnOutPayment_9f1a4baf-7bbc-4c5a-a398-a7032aa27609_terseLabel_en-US" xlink:label="lab_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Stock Price Target for Earn-out Payment</link:label>
    <link:label id="lab_icui_MinimumStockPriceTargetForEarnOutPayment_label_en-US" xlink:label="lab_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Stock Price Target for Earn-out Payment</link:label>
    <link:label id="lab_icui_MinimumStockPriceTargetForEarnOutPayment_documentation_en-US" xlink:label="lab_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Stock Price Target for Earn-out Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:href="icui-20230331.xsd#icui_MinimumStockPriceTargetForEarnOutPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:to="lab_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_a9f0b440-b87c-4c00-9547-fdfc773486b6_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Text Block]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_0c0f7186-6c87-4ad8-b5cd-e4529cccc59c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER LONG-TERM LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Other than Long-Term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation_bb0af34a-89ac-423d-894c-8587f86a8a27_terseLabel_en-US" xlink:label="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Required for Board Representation</link:label>
    <link:label id="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation_label_en-US" xlink:label="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Required for Board Representation</link:label>
    <link:label id="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation_documentation_en-US" xlink:label="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Required for Board Representation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:href="icui-20230331.xsd#icui_SmithsGroupOwnershipRequiredForBoardRepresentation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:to="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_286d6672-625d-4154-a80b-daa7827b4034_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_6aaaeb0a-1f72-4018-b0d5-6bbfd00a2eea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:to="lab_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_669d6659-d550-4073-83f2-596ce3384df3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsNoncurrent" xlink:to="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_e551ef4f-aaba-4a50-b20e-8c6ba371ec94_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_8933253a-a48a-4263-854e-8c5fbfcb8659_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_004fcdc8-b103-485c-b3ae-00b47816f549_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_5733a09c-6060-48b0-8608-d3efd497beba_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_44dd2a33-4716-477e-9066-72e644ac623b_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_UnfavorablecontractliabilityST_02181b93-4f3f-485b-b1fd-d65e4655093a_terseLabel_en-US" xlink:label="lab_icui_UnfavorablecontractliabilityST" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnfavorablecontractliabilityST</link:label>
    <link:label id="lab_icui_UnfavorablecontractliabilityST_label_en-US" xlink:label="lab_icui_UnfavorablecontractliabilityST" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnfavorablecontractliabilityST</link:label>
    <link:label id="lab_icui_UnfavorablecontractliabilityST_documentation_en-US" xlink:label="lab_icui_UnfavorablecontractliabilityST" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnfavorablecontractliabilityST</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_UnfavorablecontractliabilityST" xlink:href="icui-20230331.xsd#icui_UnfavorablecontractliabilityST"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_UnfavorablecontractliabilityST" xlink:to="lab_icui_UnfavorablecontractliabilityST" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_12ae7f17-44c7-463b-9c97-1f74b5e0d093_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_2c553f17-332a-4c3e-9dd7-a7e579f31827_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_eeb1835d-83d4-40e8-a1e0-0b924402e045_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_34ac1f4b-6c8e-468e-8345-91e7ffd0cdba_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanAxis_0126fcf9-7ed2-4345-9ffd-1253b957feee_terseLabel_en-US" xlink:label="lab_icui_TermLoanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Axis]</link:label>
    <link:label id="lab_icui_TermLoanAxis_label_en-US" xlink:label="lab_icui_TermLoanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Axis]</link:label>
    <link:label id="lab_icui_TermLoanAxis_documentation_en-US" xlink:label="lab_icui_TermLoanAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis" xlink:href="icui-20230331.xsd#icui_TermLoanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanAxis" xlink:to="lab_icui_TermLoanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_bc972504-7a51-41a1-89bd-f9fe54bc2dfe_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_4a20345d-acb6-4144-b078-0c45993ca9da_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_05454e94-867f-4a2a-a8ce-3c812727f70a_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payments to be Received</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_DerivativeVariableRateFloor_ebb5e180-8b70-4e1e-90e8-0c2ed8c1cdbf_terseLabel_en-US" xlink:label="lab_icui_DerivativeVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">derivative variable rate floor</link:label>
    <link:label id="lab_icui_DerivativeVariableRateFloor_label_en-US" xlink:label="lab_icui_DerivativeVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">derivative variable rate floor</link:label>
    <link:label id="lab_icui_DerivativeVariableRateFloor_documentation_en-US" xlink:label="lab_icui_DerivativeVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">derivative variable rate floor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DerivativeVariableRateFloor" xlink:href="icui-20230331.xsd#icui_DerivativeVariableRateFloor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_DerivativeVariableRateFloor" xlink:to="lab_icui_DerivativeVariableRateFloor" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_84987dcd-fa9c-47fb-81cc-65d4e88adcff_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_9e3fbf79-8687-42cc-a9dc-4685befb5855_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a28b1491-9909-47d7-a0ea-8446600379fb_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Hedge2Member_cab19274-c6cb-460d-89ed-80dfb2f3e1e3_terseLabel_en-US" xlink:label="lab_icui_Hedge2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 2 [Member]</link:label>
    <link:label id="lab_icui_Hedge2Member_label_en-US" xlink:label="lab_icui_Hedge2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 2 [Member]</link:label>
    <link:label id="lab_icui_Hedge2Member_documentation_en-US" xlink:label="lab_icui_Hedge2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge2Member" xlink:href="icui-20230331.xsd#icui_Hedge2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Hedge2Member" xlink:to="lab_icui_Hedge2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_0f93eced-b90c-4a46-9c78-4077a2bea140_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets additions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_a3cb3537-6f18-413c-b8f4-183685db2dfe_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InstrumentsPlacedwithCustomersMember_43fb4680-e14e-4cd0-a798-0503441b596f_terseLabel_en-US" xlink:label="lab_icui_InstrumentsPlacedwithCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments Placed with Customers [Member]</link:label>
    <link:label id="lab_icui_InstrumentsPlacedwithCustomersMember_label_en-US" xlink:label="lab_icui_InstrumentsPlacedwithCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments Placed with Customers [Member]</link:label>
    <link:label id="lab_icui_InstrumentsPlacedwithCustomersMember_documentation_en-US" xlink:label="lab_icui_InstrumentsPlacedwithCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments Placed with Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InstrumentsPlacedwithCustomersMember" xlink:href="icui-20230331.xsd#icui_InstrumentsPlacedwithCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InstrumentsPlacedwithCustomersMember" xlink:to="lab_icui_InstrumentsPlacedwithCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0d98825c-46f4-42bb-868c-dccdbbc91a5d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEIGHTED AVERAGE NUMBER OF SHARES</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_6ada5feb-9b14-4c17-9f69-41bb1dc9aafa_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_b114497a-2dd9-4244-8a12-5065f8b451e5_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_cb81cc25-004c-4cfb-abbb-f0b0b0289c6d_terseLabel_en-US" xlink:label="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessthanorequalto2point5to1butgreaterthan2to1</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_label_en-US" xlink:label="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 2.50 to1.00 but greater than 2.00 to1.00 [Member]</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_documentation_en-US" xlink:label="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 2.50 to1.00 but greater than 2.00 to1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:href="icui-20230331.xsd#icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:to="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_017128d8-fcce-47e3-9c2d-fbcf941790c9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_424345bd-2f7e-47bb-bda3-c4490b04f6ab_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_7d3edf15-1590-441e-87b2-0701468ce66e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount_4ef6a947-cb12-485b-8f5f-03e35072024d_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_228e211c-2430-4545-a7d4-f3dbb5df6399_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_cefb31cc-1b62-4ffd-acb0-9ad74a898814_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Liabilities Arising from Contingencies, Amount Recognized</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Liabilities Arising from Contingencies, Amount Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:to="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ForeignInfusionSystemSupplierMember_993840f1-6afc-4d5e-9283-6727c6006bf2_terseLabel_en-US" xlink:label="lab_icui_ForeignInfusionSystemSupplierMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Infusion System Supplier</link:label>
    <link:label id="lab_icui_ForeignInfusionSystemSupplierMember_label_en-US" xlink:label="lab_icui_ForeignInfusionSystemSupplierMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Infusion System Supplier [Member]</link:label>
    <link:label id="lab_icui_ForeignInfusionSystemSupplierMember_documentation_en-US" xlink:label="lab_icui_ForeignInfusionSystemSupplierMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Infusion System Supplier</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember" xlink:href="icui-20230331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ForeignInfusionSystemSupplierMember" xlink:to="lab_icui_ForeignInfusionSystemSupplierMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_08d14718-9901-4f53-9aae-82eb289d0491_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_f8008061-552f-405e-9915-54d2b3b163a0_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_e338ef79-d5b5-4500-9c39-243d4285db1d_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_098f3de6-3726-4445-b6e1-7d03dfd8a184_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ed4a0bef-7f10-4ccd-bf44-0698433883e4_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_765f938a-8d12-4563-a6da-86a35b426d37_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding (for basic calculation)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f0b9cad2-2a3a-4efb-9d06-3931d3c42f98_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_da85d309-c16c-4054-bd11-8bb8ebc1ab1d_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_BusinessCombinationConsiderationTransferredCash_88fbf619-46dd-448b-a81d-6dcbc09e97d6_terseLabel_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationTransferredCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash</link:label>
    <link:label id="lab_icui_BusinessCombinationConsiderationTransferredCash_label_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationTransferredCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash</link:label>
    <link:label id="lab_icui_BusinessCombinationConsiderationTransferredCash_documentation_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationTransferredCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationTransferredCash" xlink:href="icui-20230331.xsd#icui_BusinessCombinationConsiderationTransferredCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_BusinessCombinationConsiderationTransferredCash" xlink:to="lab_icui_BusinessCombinationConsiderationTransferredCash" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_EquipmentrevenueMember_311f77c3-ce0d-4514-bcfc-35158d2bd4d5_terseLabel_en-US" xlink:label="lab_icui_EquipmentrevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment revenue [Member]</link:label>
    <link:label id="lab_icui_EquipmentrevenueMember_label_en-US" xlink:label="lab_icui_EquipmentrevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment revenue [Member]</link:label>
    <link:label id="lab_icui_EquipmentrevenueMember_documentation_en-US" xlink:label="lab_icui_EquipmentrevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember" xlink:href="icui-20230331.xsd#icui_EquipmentrevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_EquipmentrevenueMember" xlink:to="lab_icui_EquipmentrevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_0e1ca3a1-af73-4f0f-9348-9602409259f1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_05ab4390-1b54-4ffd-b6a0-08e3d38b753a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NON-CASH INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_472eb4f8-302a-4307-843a-db170760a3cb_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_cb23c21f-2e20-49cf-b3d3-afc8988b9ac7_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a26d3f42-61dd-48ff-bff5-086f7af0fab8_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_9c39192a-1602-4104-abfd-564cadd726bb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_30ad4e66-9567-4807-81c0-75a8460e1a98_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_f3322744-e293-47a7-a113-120565ea9273_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_cb8b26bc-4e43-434b-b19c-ea504bb8667c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1816326f-b85a-4645-a36f-d6aab871cd8f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_330693c9-125e-46e9-b925-fd6f85045108_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4840661a-1e87-4990-92ab-3d45fa17d572_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SpareParts_35768d72-efeb-4e7e-87b6-103a7df68aa3_terseLabel_en-US" xlink:label="lab_icui_SpareParts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spare parts</link:label>
    <link:label id="lab_icui_SpareParts_label_en-US" xlink:label="lab_icui_SpareParts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spare parts</link:label>
    <link:label id="lab_icui_SpareParts_documentation_en-US" xlink:label="lab_icui_SpareParts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spare parts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SpareParts" xlink:href="icui-20230331.xsd#icui_SpareParts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SpareParts" xlink:to="lab_icui_SpareParts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue_81e75158-dc6e-449b-bcc8-08cfa1535d0e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Assets, at Fair Value</link:label>
    <link:label id="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Assets, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateDerivativeAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:to="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_824c6ac8-1a1e-4799-aaaa-be6187d4485f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_81b205d5-c7cb-4650-a8d4-d9698fed9601_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ComputerEquipmentAndSoftwareMember_7ac6d8d0-9318-428f-b560-8b244c5b397c_terseLabel_en-US" xlink:label="lab_icui_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:label id="lab_icui_ComputerEquipmentAndSoftwareMember_label_en-US" xlink:label="lab_icui_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:label id="lab_icui_ComputerEquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_icui_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ComputerEquipmentAndSoftwareMember" xlink:href="icui-20230331.xsd#icui_ComputerEquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ComputerEquipmentAndSoftwareMember" xlink:to="lab_icui_ComputerEquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_0c193a0f-0d3d-4a75-a4de-db45a6fd6413_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_2b33f893-2446-4dbc-8326-660636f4dbba_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investment securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_41c8ba68-0b60-4173-8328-746a0c6f49da_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_96ec86db-ce28-4b11-bcba-ebe6a9dbe65c_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_3ec7a0a5-9242-4334-a7bc-9bf91aed2c19_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_770d27f5-be29-46e9-894b-5d232a181f67_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_c4cd70db-800d-40af-ac6a-b28acfe5156e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_5af4fdad-cc93-4268-8f32-4fff63a169ca_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Debt Securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_0336d74f-39f3-40bd-83a8-b174cbcb7e46_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_f3372471-187a-4a2d-9e4e-6878d54eb994_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsCurrent" xlink:to="lab_us-gaap_DerivativeAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_3144debc-9132-4e00-b494-aac02c6d61aa_terseLabel_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales taxes</link:label>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Excise Tax Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ClassificationDomain_81dedb77-e1cb-4ceb-9355-3cba2ab5ba2d_terseLabel_en-US" xlink:label="lab_icui_ClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">classification [Domain]</link:label>
    <link:label id="lab_icui_ClassificationDomain_label_en-US" xlink:label="lab_icui_ClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">classification [Domain]</link:label>
    <link:label id="lab_icui_ClassificationDomain_documentation_en-US" xlink:label="lab_icui_ClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ClassificationDomain" xlink:href="icui-20230331.xsd#icui_ClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ClassificationDomain" xlink:to="lab_icui_ClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_66ff81e5-a51a-4b18-9d68-9ebbc3cbaa85_terseLabel_en-US" xlink:label="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">business combination, recognized identifiable asset acquired and liability assumed,</link:label>
    <link:label id="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_label_en-US" xlink:label="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">business combination, recognized identifiable asset acquired and liability assumed,</link:label>
    <link:label id="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_documentation_en-US" xlink:label="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">business combination, recognized identifiable asset acquired and liability assumed,</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:href="icui-20230331.xsd#icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:to="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock_eea3de76-2477-4bc0-99c5-ffb28ac7ed5c_terseLabel_en-US" xlink:label="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Leases [Table Text Block]</link:label>
    <link:label id="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock_label_en-US" xlink:label="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Leases [Table Text Block]</link:label>
    <link:label id="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock_documentation_en-US" xlink:label="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Leases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:href="icui-20230331.xsd#icui_AssetsandLiabilitiesLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:to="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_89a9409e-cd9d-4e1c-8a8b-04ee1cdd44f9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_0f04cea9-a01d-46d1-8cce-32db107390f9_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProvisionForWarrantyAndReturns_8d2ab89a-1eaa-472e-aae2-96a11eb63177_terseLabel_en-US" xlink:label="lab_icui_ProvisionForWarrantyAndReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for warranty and returns</link:label>
    <link:label id="lab_icui_ProvisionForWarrantyAndReturns_label_en-US" xlink:label="lab_icui_ProvisionForWarrantyAndReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for warranty and returns</link:label>
    <link:label id="lab_icui_ProvisionForWarrantyAndReturns_documentation_en-US" xlink:label="lab_icui_ProvisionForWarrantyAndReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for warranty and returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProvisionForWarrantyAndReturns" xlink:href="icui-20230331.xsd#icui_ProvisionForWarrantyAndReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProvisionForWarrantyAndReturns" xlink:to="lab_icui_ProvisionForWarrantyAndReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_79c9d774-f70e-4196-b128-324e261cd420_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_f2640c75-4f69-4453-8273-714370ba363d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_2ec393bd-6465-4b1d-9a0f-a23c4b3a9a83_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_77b8299f-15b0-470b-8189-5f99e83cfb84_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive securities</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5a8eff26-5388-4b37-a138-aa866bdd9097_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerContractsMember_5a7d312b-e6a9-4208-a16b-71bc785463e5_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerContractsMember_label_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerContractsMember" xlink:to="lab_us-gaap_CustomerContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContingentConsiderationGrossLT_0c36fd47-2d27-422b-a00d-f4f925b1c8b7_terseLabel_en-US" xlink:label="lab_icui_ContingentConsiderationGrossLT" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross LT</link:label>
    <link:label id="lab_icui_ContingentConsiderationGrossLT_label_en-US" xlink:label="lab_icui_ContingentConsiderationGrossLT" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross LT</link:label>
    <link:label id="lab_icui_ContingentConsiderationGrossLT_documentation_en-US" xlink:label="lab_icui_ContingentConsiderationGrossLT" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross LT</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT" xlink:href="icui-20230331.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContingentConsiderationGrossLT" xlink:to="lab_icui_ContingentConsiderationGrossLT" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_012ec455-da92-4529-9876-4968c991b44f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_1fa58c3d-e6c6-4871-8a25-02aecd3445b9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_7bae0024-2c04-4d25-b6f4-4a34977df041_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_901d671f-76bb-4f2c-8841-f14be03bc2de_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e253a63a-536e-43ae-87c4-c70ef5acb1c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_7e8e62a2-2b7d-4a0a-ab9b-91f69f0796a6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_fd69c870-1f61-4014-97c0-29b9194906f3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_c5f66025-3397-4e0d-8847-bfd6a4ae2e08_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (In dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_5467f8c7-d486-4d14-b235-6b3dd3e711a0_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INTANGIBLE ASSETS, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_990865b4-1e8e-4b8a-8bfb-adfd133fe209_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of asset</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_199638c9-7917-4a22-9bdf-c1786f169aae_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_324c1404-94a5-4e77-88f1-d0c87e424242_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_f3dc045d-d498-4c4b-b1e0-7b370ac4de5a_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_38faaf51-7b8b-4148-8125-5136c63c82ce_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_b28188cc-503d-46be-ae87-ccc12cccdda6_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_627a1f84-2786-47ee-a7c7-a8b31de7bac2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL CURRENT LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_e7b6718b-d190-45f6-8b83-36e4aef70aef_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4d627471-5c8f-42fc-914d-8e07b1617634_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_67334b9d-1200-4bc8-9785-80489406df32_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAX LIABILITY</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_a18d14bf-5970-4f7b-8c7f-8090b6563402_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InfusionSystemsMember_7ec16993-53db-4144-8dea-22dbb8b8c298_terseLabel_en-US" xlink:label="lab_icui_InfusionSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Systems [Member]</link:label>
    <link:label id="lab_icui_InfusionSystemsMember_label_en-US" xlink:label="lab_icui_InfusionSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Systems [Member]</link:label>
    <link:label id="lab_icui_InfusionSystemsMember_documentation_en-US" xlink:label="lab_icui_InfusionSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember" xlink:href="icui-20230331.xsd#icui_InfusionSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InfusionSystemsMember" xlink:to="lab_icui_InfusionSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Sparepartsusage_6ea7193d-81be-45bc-b14e-78b8225319b4_terseLabel_en-US" xlink:label="lab_icui_Sparepartsusage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sparepartsusage</link:label>
    <link:label id="lab_icui_Sparepartsusage_label_en-US" xlink:label="lab_icui_Sparepartsusage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sparepartsusage</link:label>
    <link:label id="lab_icui_Sparepartsusage_documentation_en-US" xlink:label="lab_icui_Sparepartsusage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sparepartsusage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sparepartsusage" xlink:href="icui-20230331.xsd#icui_Sparepartsusage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Sparepartsusage" xlink:to="lab_icui_Sparepartsusage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_62796137-5d1d-4722-b5a1-42b94e47117c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Prepaidinsuranceandpropertytaxes_c30897f4-3255-4770-ab76-75949a4c7c62_terseLabel_en-US" xlink:label="lab_icui_Prepaidinsuranceandpropertytaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid insurance and property taxes</link:label>
    <link:label id="lab_icui_Prepaidinsuranceandpropertytaxes_label_en-US" xlink:label="lab_icui_Prepaidinsuranceandpropertytaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid insurance and property taxes</link:label>
    <link:label id="lab_icui_Prepaidinsuranceandpropertytaxes_documentation_en-US" xlink:label="lab_icui_Prepaidinsuranceandpropertytaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid insurance and property taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidinsuranceandpropertytaxes" xlink:href="icui-20230331.xsd#icui_Prepaidinsuranceandpropertytaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Prepaidinsuranceandpropertytaxes" xlink:to="lab_icui_Prepaidinsuranceandpropertytaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_RevolverSubLimits_508e8bc2-7cf9-4b82-889d-feb6a371b7d5_terseLabel_en-US" xlink:label="lab_icui_RevolverSubLimits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver Sub limits</link:label>
    <link:label id="lab_icui_RevolverSubLimits_label_en-US" xlink:label="lab_icui_RevolverSubLimits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver Sub limits</link:label>
    <link:label id="lab_icui_RevolverSubLimits_documentation_en-US" xlink:label="lab_icui_RevolverSubLimits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver Sub limits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RevolverSubLimits" xlink:href="icui-20230331.xsd#icui_RevolverSubLimits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_RevolverSubLimits" xlink:to="lab_icui_RevolverSubLimits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_7bbb56a1-7c24-48fc-b99e-dd9d5d6101fd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_a4bf36ed-7588-46ef-8e37-3432cab2dfc5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_ef3bb486-3b2b-46d3-8d5c-32b297c0572c_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_794c9a2f-bdcc-4f3c-abf8-7329f3c3ad5d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Net Hedge Ineffectiveness Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_label_en-US" xlink:label="lab_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Net Hedge Ineffectiveness Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNetHedgeIneffectivenessGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:to="lab_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_25b1b047-460e-44e5-b694-0aae3c7163ad_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7232ba45-d46d-4e83-a4b2-1a3a3b6f34bb_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_66b2f5a0-d078-4f60-a6cf-565ccdeed2af_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LongTermMember_3299036a-5adb-4f75-b469-f51613c4f645_terseLabel_en-US" xlink:label="lab_icui_LongTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term</link:label>
    <link:label id="lab_icui_LongTermMember_label_en-US" xlink:label="lab_icui_LongTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term [Member]</link:label>
    <link:label id="lab_icui_LongTermMember_documentation_en-US" xlink:label="lab_icui_LongTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermMember" xlink:href="icui-20230331.xsd#icui_LongTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LongTermMember" xlink:to="lab_icui_LongTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_7e29a712-b43b-4645-9fa9-601a1d09f9bd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_5b75b5fe-7fd2-4235-861f-c08d4bb42101_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_CashRemittedToPurchaser_0543e289-4179-41dc-a368-816d474f19b1_terseLabel_en-US" xlink:label="lab_icui_CashRemittedToPurchaser" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Remitted to Purchaser</link:label>
    <link:label id="lab_icui_CashRemittedToPurchaser_label_en-US" xlink:label="lab_icui_CashRemittedToPurchaser" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Remitted to Purchaser</link:label>
    <link:label id="lab_icui_CashRemittedToPurchaser_documentation_en-US" xlink:label="lab_icui_CashRemittedToPurchaser" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Remitted to Purchaser</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CashRemittedToPurchaser" xlink:href="icui-20230331.xsd#icui_CashRemittedToPurchaser"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_CashRemittedToPurchaser" xlink:to="lab_icui_CashRemittedToPurchaser" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_015a280a-eb56-4b9e-b6a4-7f57122a22cc_terseLabel_en-US" xlink:label="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessthan4to1butgreaterthan3to1</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_label_en-US" xlink:label="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 4.00 to 1.00 but greater than 3.00 to100 [Member]</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_documentation_en-US" xlink:label="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 4.00 to 1.00 but greater than 3.00 to100</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:href="icui-20230331.xsd#icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:to="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_b41340df-e1fc-4de9-b9e1-779c28d0f118_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_5ff99f10-c473-465d-9aff-03e08e84b9f3_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermAPrincipalPaymentInYear5_8ffee64b-5e64-47a3-8488-d8391440894e_terseLabel_en-US" xlink:label="lab_icui_TermAPrincipalPaymentInYear5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % in Year 5</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentInYear5_label_en-US" xlink:label="lab_icui_TermAPrincipalPaymentInYear5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % in Year 5</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentInYear5_documentation_en-US" xlink:label="lab_icui_TermAPrincipalPaymentInYear5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % in Year 5</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentInYear5" xlink:href="icui-20230331.xsd#icui_TermAPrincipalPaymentInYear5"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermAPrincipalPaymentInYear5" xlink:to="lab_icui_TermAPrincipalPaymentInYear5" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_560d78dd-7e89-4f52-b6c7-d8f8f4cc87be_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_6467a708-901b-446f-b7c7-447cc8fbcc90_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_48c105a9-707d-4b20-9328-f56cd3b3dffe_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_47fb9fe7-56f0-4f9d-8736-1e1ff9a3bdf9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_e91b162d-9248-4481-8334-e955681a0d03_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_97dac41e-ff1b-4539-b5ce-d76a77e1c04b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock_382ef5e2-36a4-4c85-be62-dd8921f59d0b_terseLabel_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock_label_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Table Text Block]</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock_documentation_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:href="icui-20230331.xsd#icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:to="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bb4249a7-48da-4e78-96e5-9d1058d1f022_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_1af43dc1-d46c-470d-a15e-23645f059f4c_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_62c45a41-7bba-4632-8a63-5e9f0a43d6f5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_09655edc-ec6e-4507-9cce-32a11998bae5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_31c94e19-920a-4bda-8dd9-0bf7b25839b0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories [Text Block]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_226d111d-9336-4646-92a2-87b96893eeeb_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value [Table]</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_fe2db610-fb2b-4133-9619-dd12298e10cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_d5be67ea-a969-4f8b-8e60-5203feff9aa9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PrepaidVendorExpenses_74667bd4-87a4-4a19-829b-8c2cc906d26c_terseLabel_en-US" xlink:label="lab_icui_PrepaidVendorExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid vendor expenses</link:label>
    <link:label id="lab_icui_PrepaidVendorExpenses_label_en-US" xlink:label="lab_icui_PrepaidVendorExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid vendor expenses</link:label>
    <link:label id="lab_icui_PrepaidVendorExpenses_documentation_en-US" xlink:label="lab_icui_PrepaidVendorExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid vendor expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PrepaidVendorExpenses" xlink:href="icui-20230331.xsd#icui_PrepaidVendorExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PrepaidVendorExpenses" xlink:to="lab_icui_PrepaidVendorExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f311d879-b8c2-4eaf-afb2-4aa27642b318_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_459a5b7e-ad1c-4af9-92e4-ea8e4b9ca15f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_af98055e-3b97-4d33-8311-66dbbdc76083_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_05387d3c-e886-472c-bf3f-722b9844161e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanDomain_a9291542-6b21-45cb-a99f-97127e689f6d_terseLabel_en-US" xlink:label="lab_icui_TermLoanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Domain]</link:label>
    <link:label id="lab_icui_TermLoanDomain_label_en-US" xlink:label="lab_icui_TermLoanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Domain]</link:label>
    <link:label id="lab_icui_TermLoanDomain_documentation_en-US" xlink:label="lab_icui_TermLoanDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain" xlink:href="icui-20230331.xsd#icui_TermLoanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanDomain" xlink:to="lab_icui_TermLoanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_736cf25b-9095-4966-b16a-302f264e0d8f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_818a55ac-98dc-4c02-8796-dede5053b07d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_31eda5aa-5fcd-4466-b474-8267044957f5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OwnershipRequirementForEarnoutPayment_64d6ddf9-8af3-499c-9408-fddd8b787835_terseLabel_en-US" xlink:label="lab_icui_OwnershipRequirementForEarnoutPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership requirement for Earnout Payment</link:label>
    <link:label id="lab_icui_OwnershipRequirementForEarnoutPayment_label_en-US" xlink:label="lab_icui_OwnershipRequirementForEarnoutPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership requirement for Earnout Payment</link:label>
    <link:label id="lab_icui_OwnershipRequirementForEarnoutPayment_documentation_en-US" xlink:label="lab_icui_OwnershipRequirementForEarnoutPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership requirement for Earnout Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OwnershipRequirementForEarnoutPayment" xlink:href="icui-20230331.xsd#icui_OwnershipRequirementForEarnoutPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OwnershipRequirementForEarnoutPayment" xlink:to="lab_icui_OwnershipRequirementForEarnoutPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_d513f3c0-eb4c-4c94-a5bd-77c8e7c42232_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_af8ce7d9-bbf1-4772-963e-938ee38c9d20_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_57859fcf-48c4-49b5-b0d8-18052e638920_negatedLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_31092b07-668c-42dd-a8f5-511539ac663d_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_9eacd8ab-d7ef-4ff8-98aa-ad1fa68d4c05_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_c7b6e2a0-5490-4b6d-bac4-33eeb29d4e14_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:to="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_185e09ac-589f-4ee8-9e8a-7a8dac8a08cf_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Accruedlegalfees_f7e5aa83-9a3a-4a71-8ca4-f2ee3ccb6e96_terseLabel_en-US" xlink:label="lab_icui_Accruedlegalfees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal accrual</link:label>
    <link:label id="lab_icui_Accruedlegalfees_label_en-US" xlink:label="lab_icui_Accruedlegalfees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued legal fees</link:label>
    <link:label id="lab_icui_Accruedlegalfees_documentation_en-US" xlink:label="lab_icui_Accruedlegalfees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued legal fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedlegalfees" xlink:href="icui-20230331.xsd#icui_Accruedlegalfees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Accruedlegalfees" xlink:to="lab_icui_Accruedlegalfees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring_29529d73-331b-4a39-8fa6-824aba137866_terseLabel_en-US" xlink:label="lab_us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Discontinuation of Cash Flow Hedge Due to Forecasted Transaction Probable of Not Occurring</link:label>
    <link:label id="lab_us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring_label_en-US" xlink:label="lab_us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Discontinuation of Cash Flow Hedge Due to Forecasted Transaction Probable of Not Occurring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring" xlink:to="lab_us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e23b0770-0a33-4137-8206-6c0babd60f15_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_a64f57d3-09bc-4cd6-beb9-c3c5b69e8ea7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_080afb39-34d2-4605-98c9-77921dec9c99_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_064e1a69-f6a0-4084-bac0-7c8573e8c7cb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AccruedSalariesAndBenefits_7b008d57-2c5f-4ede-ac17-a8dfc5c105fb_terseLabel_en-US" xlink:label="lab_icui_AccruedSalariesAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salaries and benefits</link:label>
    <link:label id="lab_icui_AccruedSalariesAndBenefits_label_en-US" xlink:label="lab_icui_AccruedSalariesAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued salaries and benefits</link:label>
    <link:label id="lab_icui_AccruedSalariesAndBenefits_documentation_en-US" xlink:label="lab_icui_AccruedSalariesAndBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued salaries and benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedSalariesAndBenefits" xlink:href="icui-20230331.xsd#icui_AccruedSalariesAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AccruedSalariesAndBenefits" xlink:to="lab_icui_AccruedSalariesAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_fa3b45eb-2b7c-4a92-b618-fd13b200e3f9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Prepaidothertaxes_4ffcccd0-1750-44b7-8a70-14ce6ecb3bd1_terseLabel_en-US" xlink:label="lab_icui_Prepaidothertaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:label id="lab_icui_Prepaidothertaxes_label_en-US" xlink:label="lab_icui_Prepaidothertaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid other taxes</link:label>
    <link:label id="lab_icui_Prepaidothertaxes_documentation_en-US" xlink:label="lab_icui_Prepaidothertaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid other taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidothertaxes" xlink:href="icui-20230331.xsd#icui_Prepaidothertaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Prepaidothertaxes" xlink:to="lab_icui_Prepaidothertaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_451edd59-9a61-4861-9acc-c0338ce1e3eb_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_7a4214b1-6b83-44c1-a484-9aa3cd25d909_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_345adb01-6c7b-4f0a-97fb-3775aa579404_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_0cebc557-13c1-4f2d-8619-12353b859c49_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_c11ad333-e5e6-478e-a98b-6133fcb73cad_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_8e9a29c0-65c0-4138-a79f-a09858708ed4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationDate1_3e2f8828-7a58-4ec4-aae3-144aa9ab8bf1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Date</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationDate1_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_8a72597e-f028-40f7-9ef8-8396f17e097f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_54fb44e1-a4ea-4fae-970d-2bfb8ed0307e_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_e3389b46-8b4e-43e9-9e23-c8e448e1561f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_d12d8723-0bc5-41e4-8894-51af829e73ef_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_82c7331c-ccf7-48c1-bda0-9083d254ed9b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_892e45e8-9865-4363-9417-6a6d1ea6b0c5_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_NonPublicCompanyMember_ac189f50-5221-4ec4-b73f-4283ae629712_terseLabel_en-US" xlink:label="lab_icui_NonPublicCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Public Company</link:label>
    <link:label id="lab_icui_NonPublicCompanyMember_label_en-US" xlink:label="lab_icui_NonPublicCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Public Company [Member]</link:label>
    <link:label id="lab_icui_NonPublicCompanyMember_documentation_en-US" xlink:label="lab_icui_NonPublicCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Public Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NonPublicCompanyMember" xlink:href="icui-20230331.xsd#icui_NonPublicCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_NonPublicCompanyMember" xlink:to="lab_icui_NonPublicCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_f413e153-57b9-425b-859e-c03b511b2e0c_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_718b76f6-7b5b-466e-b2fd-9c4399b0fee5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_e9d35322-367e-45c6-8745-38e7cbcb4663_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:to="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07b09cfa-b1f4-4edc-a104-d8729e6827e8_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermAPrincipalPaymentYear3And4_4d3735ce-6cea-4634-a2ed-90faadb3c23a_terseLabel_en-US" xlink:label="lab_icui_TermAPrincipalPaymentYear3And4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % Year 3 and 4</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentYear3And4_label_en-US" xlink:label="lab_icui_TermAPrincipalPaymentYear3And4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % Year 3 and 4</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentYear3And4_documentation_en-US" xlink:label="lab_icui_TermAPrincipalPaymentYear3And4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % Year 3 and 4</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentYear3And4" xlink:href="icui-20230331.xsd#icui_TermAPrincipalPaymentYear3And4"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermAPrincipalPaymentYear3And4" xlink:to="lab_icui_TermAPrincipalPaymentYear3And4" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_e49dbf00-2ccf-41ea-ae5a-9e26e43c62a7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_6e69aec0-1e13-4ebd-b872-3ac569424c62_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_639fe2cc-a602-4127-9258-9abee0dafb18_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ed15cc53-e2b6-47ef-a9f7-370ac7752eba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LeverageRatioLevelAxis_9d2fcc34-a2e8-49d0-9684-1284f83fea14_terseLabel_en-US" xlink:label="lab_icui_LeverageRatioLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level [Axis]</link:label>
    <link:label id="lab_icui_LeverageRatioLevelAxis_label_en-US" xlink:label="lab_icui_LeverageRatioLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level [Axis]</link:label>
    <link:label id="lab_icui_LeverageRatioLevelAxis_documentation_en-US" xlink:label="lab_icui_LeverageRatioLevelAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelAxis" xlink:href="icui-20230331.xsd#icui_LeverageRatioLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LeverageRatioLevelAxis" xlink:to="lab_icui_LeverageRatioLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_DevelopedTechnologyMember_8fec6bb0-78cb-44c6-a661-9550df2a232e_terseLabel_en-US" xlink:label="lab_icui_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">developed technology</link:label>
    <link:label id="lab_icui_DevelopedTechnologyMember_label_en-US" xlink:label="lab_icui_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">developed technology [Member]</link:label>
    <link:label id="lab_icui_DevelopedTechnologyMember_documentation_en-US" xlink:label="lab_icui_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">developed technology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DevelopedTechnologyMember" xlink:href="icui-20230331.xsd#icui_DevelopedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_DevelopedTechnologyMember" xlink:to="lab_icui_DevelopedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_29dd7a7c-84ab-4e31-802e-0aa578ea30e9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_fc2497a4-21ee-4077-ae8b-2fba82a95315_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContractassetandliabilitybalancesLineItems_6e1c8b3b-3622-4c1e-aa1a-9a6e4ab46a8d_terseLabel_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Line Items]</link:label>
    <link:label id="lab_icui_ContractassetandliabilitybalancesLineItems_label_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Line Items]</link:label>
    <link:label id="lab_icui_ContractassetandliabilitybalancesLineItems_documentation_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Contract asset and liability balances [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesLineItems" xlink:href="icui-20230331.xsd#icui_ContractassetandliabilitybalancesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems" xlink:to="lab_icui_ContractassetandliabilitybalancesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AccruedResearchAndDevelopment_5df7466f-b31d-4fce-9d60-deccfb5e71f1_terseLabel_en-US" xlink:label="lab_icui_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">accrued research and development</link:label>
    <link:label id="lab_icui_AccruedResearchAndDevelopment_label_en-US" xlink:label="lab_icui_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">accrued research and development</link:label>
    <link:label id="lab_icui_AccruedResearchAndDevelopment_documentation_en-US" xlink:label="lab_icui_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">accrued research and development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedResearchAndDevelopment" xlink:href="icui-20230331.xsd#icui_AccruedResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AccruedResearchAndDevelopment" xlink:to="lab_icui_AccruedResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration_eb852fd4-1284-4368-adf6-15edeaad2d6a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0e790102-b16c-425b-b4b2-a8e59551c5c4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_2d4da64c-48cf-4da6-800b-814fce9d75bc_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_b776539f-fd74-4315-b5f5-383480d90569_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_636d933f-a178-4d86-9d60-36f57656c096_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Remaining Minimum Amount Committed</link:label>
    <link:label id="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_label_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Remaining Minimum Amount Committed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:to="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_eaa1fe99-2ac1-4454-be35-8f5510fe5e24_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_679d83d8-4767-480f-bfab-3bfe2d343d48_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due after Year Five</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_25d66429-41b0-4e55-8b99-39b2fef62f06_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_0812ca3b-24b6-462e-8ff0-cdd15fa38efe_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_a01d8112-023d-4d02-8aa2-ded5c83b8601_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3a4e1016-bc37-413c-b95d-ff0313de0808_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_d192b224-0088-4301-81f0-ab7e0ce3645c_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_529b36f8-478d-4be1-b9be-7ae33e89e6a7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>icui-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ba7fdc33-2522-46f7-8674-20ba10b1b2fc,g:4240e31b-a7e9-4337-b7b1-c2e4a3947117-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.icumed.com/role/DEIDocument" xlink:type="simple" xlink:href="icui-20230331.xsd#DEIDocument"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DEIDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:href="icui-20230331.xsd#icui_DocumentAndEntityInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c81be10e-efb1-41c7-a3a4-6b0b06ebe702" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_DocumentType_c81be10e-efb1-41c7-a3a4-6b0b06ebe702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_48aaac23-d13d-4331-b68f-392b0f61d2f6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_DocumentQuarterlyReport_48aaac23-d13d-4331-b68f-392b0f61d2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_da9f3f08-89d4-4c5f-a8b1-8cad45e2d394" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_DocumentPeriodEndDate_da9f3f08-89d4-4c5f-a8b1-8cad45e2d394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_0ca70b0b-0ca1-4391-a476-492cd0a1fc92" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_DocumentTransitionReport_0ca70b0b-0ca1-4391-a476-492cd0a1fc92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3f6e438a-13bf-492d-85a3-f4324c2ed2ea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_EntityFileNumber_3f6e438a-13bf-492d-85a3-f4324c2ed2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e7cc53c8-4d27-4d67-91a8-d5406e4cd7df" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e7cc53c8-4d27-4d67-91a8-d5406e4cd7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_69ff8ea2-beef-4a95-9bfe-a5033c442af1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_EntityTaxIdentificationNumber_69ff8ea2-beef-4a95-9bfe-a5033c442af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_0b3f9824-bcc2-42d4-ac1e-7f5ec30edbae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_EntityAddressAddressLine1_0b3f9824-bcc2-42d4-ac1e-7f5ec30edbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_5e59c598-5c39-4744-9cf6-c204449a33cf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_EntityAddressCityOrTown_5e59c598-5c39-4744-9cf6-c204449a33cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_56b8149d-c49c-4d35-85cb-cd637e1151a1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_EntityAddressStateOrProvince_56b8149d-c49c-4d35-85cb-cd637e1151a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2a0e2b6b-8c05-466b-9892-7482a303d3b0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_EntityAddressPostalZipCode_2a0e2b6b-8c05-466b-9892-7482a303d3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2ca813b4-b2ee-42f1-90bc-ba5aed72ed0b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_CityAreaCode_2ca813b4-b2ee-42f1-90bc-ba5aed72ed0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ca4daadd-64e4-434b-b6be-0f22e94fe19d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_LocalPhoneNumber_ca4daadd-64e4-434b-b6be-0f22e94fe19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_88fcafe5-7da5-4795-9542-31c46213a2fa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_EntityCurrentReportingStatus_88fcafe5-7da5-4795-9542-31c46213a2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_920c2026-1f2d-4ed1-9940-2bd2b9435043" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_EntityInteractiveDataCurrent_920c2026-1f2d-4ed1-9940-2bd2b9435043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_0a2d7a35-5c94-4788-bca2-e9bd65fd5d60" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_EntityFilerCategory_0a2d7a35-5c94-4788-bca2-e9bd65fd5d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_4007dd09-c33f-4627-a5ef-ddf207db949f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_EntitySmallBusiness_4007dd09-c33f-4627-a5ef-ddf207db949f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_fb668098-54e9-4449-acc9-9346e41a68dc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_EntityEmergingGrowthCompany_fb668098-54e9-4449-acc9-9346e41a68dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f991b183-2345-40ae-a8a8-0c144d122623" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_EntityShellCompany_f991b183-2345-40ae-a8a8-0c144d122623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_873750cb-f9a1-4f99-83d5-d8640f959ba1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_Security12bTitle_873750cb-f9a1-4f99-83d5-d8640f959ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_c9c9e24d-bc34-457f-9a0a-74ac130f5aa8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_TradingSymbol_c9c9e24d-bc34-457f-9a0a-74ac130f5aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_e3fdab5f-b426-4d14-b7c8-4b6ea8157280" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_SecurityExchangeName_e3fdab5f-b426-4d14-b7c8-4b6ea8157280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_b4bc92dd-ca9c-47c6-b429-b62903bc47d8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_b4bc92dd-ca9c-47c6-b429-b62903bc47d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e0decd04-0fac-490c-b2ac-2e1138e33172" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_EntityCentralIndexKey_e0decd04-0fac-490c-b2ac-2e1138e33172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_3077b518-1d7d-499b-9d92-01b121db47d7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_EntityRegistrantName_3077b518-1d7d-499b-9d92-01b121db47d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a2f2538e-3286-4428-9c4f-106e830a75d4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_AmendmentFlag_a2f2538e-3286-4428-9c4f-106e830a75d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_fd217bb2-e302-44c8-ad7c-3a4670da4e22" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_CurrentFiscalYearEndDate_fd217bb2-e302-44c8-ad7c-3a4670da4e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_dcf85c82-17e3-403e-93e5-8cda31307bb8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_DocumentFiscalYearFocus_dcf85c82-17e3-403e-93e5-8cda31307bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_6857fb3d-4e6c-4f20-89eb-0498de81576b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_74dc3cb7-f78a-4867-91c9-c316767f2249" xlink:to="loc_dei_DocumentFiscalPeriodFocus_6857fb3d-4e6c-4f20-89eb-0498de81576b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="icui-20230331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6c38ecc8-70b4-4f87-99c1-30169fc03091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dca6d551-5e7b-45fb-be32-09fc52726c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6c38ecc8-70b4-4f87-99c1-30169fc03091" xlink:to="loc_us-gaap_StatementTable_dca6d551-5e7b-45fb-be32-09fc52726c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_dff4e71a-4c25-401e-a1f6-fff0b8cec333" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dca6d551-5e7b-45fb-be32-09fc52726c7b" xlink:to="loc_srt_StatementScenarioAxis_dff4e71a-4c25-401e-a1f6-fff0b8cec333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ec4176d8-1f6e-4252-912d-a272f278b7c0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_dff4e71a-4c25-401e-a1f6-fff0b8cec333" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ec4176d8-1f6e-4252-912d-a272f278b7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b3cd2f82-4464-4f5d-9b11-52bf469fd2be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dca6d551-5e7b-45fb-be32-09fc52726c7b" xlink:to="loc_us-gaap_StatementLineItems_b3cd2f82-4464-4f5d-9b11-52bf469fd2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b3cd2f82-4464-4f5d-9b11-52bf469fd2be" xlink:to="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_53899daf-ee73-4a50-9987-e949652918aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_53899daf-ee73-4a50-9987-e949652918aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3dbb83cc-7adb-424e-89ad-39bf66170d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3dbb83cc-7adb-424e-89ad-39bf66170d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_b6178c8d-2a71-48e1-8beb-7d1d1d9e0b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_b6178c8d-2a71-48e1-8beb-7d1d1d9e0b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_5253215a-d88e-4580-bdd3-810be2641455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_5253215a-d88e-4580-bdd3-810be2641455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0396eac6-74ba-4baa-8e20-a0495507ff08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:to="loc_us-gaap_InventoryNet_0396eac6-74ba-4baa-8e20-a0495507ff08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_5e030a96-714a-46f7-b3f4-8e2dc812c864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:to="loc_us-gaap_PrepaidTaxes_5e030a96-714a-46f7-b3f4-8e2dc812c864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a71c26c2-66f7-4708-a98a-e923edc63e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a71c26c2-66f7-4708-a98a-e923edc63e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1476e5f2-2c8b-48ac-a9f9-be1047fdc7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f612726d-6e50-481d-a2a1-4cf881413d69" xlink:to="loc_us-gaap_AssetsCurrent_1476e5f2-2c8b-48ac-a9f9-be1047fdc7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_70d669c2-0876-49ca-a3d3-7feff8029702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_70d669c2-0876-49ca-a3d3-7feff8029702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b712f687-3e4f-477f-b236-3f34281b81d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b712f687-3e4f-477f-b236-3f34281b81d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_7a94d4f0-1bc1-48ad-8da9-ebcf4c585657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_7a94d4f0-1bc1-48ad-8da9-ebcf4c585657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_53c87b6c-3880-4d46-b7e7-3855f5e66ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_Goodwill_53c87b6c-3880-4d46-b7e7-3855f5e66ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d1df6a56-f378-408a-a73c-1bed423e6e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d1df6a56-f378-408a-a73c-1bed423e6e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_315a71d9-da2f-4eab-99ae-f2186e7f00c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_315a71d9-da2f-4eab-99ae-f2186e7f00c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_90386152-71f5-44c8-8b90-4f4299a519cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_90386152-71f5-44c8-8b90-4f4299a519cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_336fbf6f-e133-4fa2-ba7c-071a4a3d2474" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_de4505e4-7280-4116-b106-e471d8163c04" xlink:to="loc_us-gaap_Assets_336fbf6f-e133-4fa2-ba7c-071a4a3d2474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b3cd2f82-4464-4f5d-9b11-52bf469fd2be" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_8824228e-16ea-49f6-b878-6c4861cf9600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_8824228e-16ea-49f6-b878-6c4861cf9600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7ac28d4b-1963-4367-bb11-c86df3572011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8824228e-16ea-49f6-b878-6c4861cf9600" xlink:to="loc_us-gaap_AccountsPayableCurrent_7ac28d4b-1963-4367-bb11-c86df3572011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a5b16eb7-49dc-474f-9631-e8a52eaccd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8824228e-16ea-49f6-b878-6c4861cf9600" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a5b16eb7-49dc-474f-9631-e8a52eaccd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_10d4b200-876c-4546-ae22-5a603ff17f79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8824228e-16ea-49f6-b878-6c4861cf9600" xlink:to="loc_us-gaap_LongTermDebtCurrent_10d4b200-876c-4546-ae22-5a603ff17f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_2a99b405-d5a6-40d0-902e-c293da7d1f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8824228e-16ea-49f6-b878-6c4861cf9600" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_2a99b405-d5a6-40d0-902e-c293da7d1f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bcfa9e8e-5c10-497c-82d5-ccaaeb5efc90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8824228e-16ea-49f6-b878-6c4861cf9600" xlink:to="loc_us-gaap_LiabilitiesCurrent_bcfa9e8e-5c10-497c-82d5-ccaaeb5efc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_9bc498a1-0402-47db-8c41-a988d56df35b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_9bc498a1-0402-47db-8c41-a988d56df35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_43dd2094-1086-40df-9957-d0ec22395c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_43dd2094-1086-40df-9957-d0ec22395c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ee1566ff-dac8-4ad6-82e4-ddeac3d08b77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ee1566ff-dac8-4ad6-82e4-ddeac3d08b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e718010f-51bb-4649-a3c7-917a157e6210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e718010f-51bb-4649-a3c7-917a157e6210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_fe117053-0be1-463c-8203-48a7f1faa215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_fe117053-0be1-463c-8203-48a7f1faa215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_407fea32-643c-484d-9705-7fbc405a14b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_CommitmentsAndContingencies_407fea32-643c-484d-9705-7fbc405a14b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_1ad0f934-b1af-45ef-b6d3-cfbb47d53567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:to="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_1ad0f934-b1af-45ef-b6d3-cfbb47d53567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_10d9dbb3-5989-44dd-ae97-fa91a0b7fc95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:to="loc_us-gaap_CommonStockValue_10d9dbb3-5989-44dd-ae97-fa91a0b7fc95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9e317374-35ec-485b-903f-62acd0534c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9e317374-35ec-485b-903f-62acd0534c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_75995a2d-bc41-4343-a62d-f66f236cd130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:to="loc_us-gaap_TreasuryStockValue_75995a2d-bc41-4343-a62d-f66f236cd130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b51c9b2b-8a5b-4c04-b979-d4081dc4d36f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b51c9b2b-8a5b-4c04-b979-d4081dc4d36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_59819ab2-5c83-4386-a64d-51f6d5783e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_59819ab2-5c83-4386-a64d-51f6d5783e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3e822015-3edf-43d0-851c-68ceac2684c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_7a831053-0290-4491-879f-5438b66e4f13" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3e822015-3edf-43d0-851c-68ceac2684c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b4a43951-da77-49db-a44d-7c604164e60c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_535656cb-2898-427f-a75d-13dff93e7a53" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_b4a43951-da77-49db-a44d-7c604164e60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_d7ea5a97-3c99-4902-95da-907b3b02bce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b3cd2f82-4464-4f5d-9b11-52bf469fd2be" xlink:to="loc_us-gaap_TreasuryStockShares_d7ea5a97-3c99-4902-95da-907b3b02bce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="icui-20230331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_74b784eb-d0f8-4ef1-9014-8279bd443727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_bd7c95ef-a06d-4c16-a9bf-86c32c0bca1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_74b784eb-d0f8-4ef1-9014-8279bd443727" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_bd7c95ef-a06d-4c16-a9bf-86c32c0bca1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f599d92d-d08c-4752-9a8a-e0b50d089369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_74b784eb-d0f8-4ef1-9014-8279bd443727" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f599d92d-d08c-4752-9a8a-e0b50d089369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_a2ac4e43-b528-46cc-baa1-ade965b2fff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_74b784eb-d0f8-4ef1-9014-8279bd443727" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_a2ac4e43-b528-46cc-baa1-ade965b2fff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_7f725f9b-4047-47c5-bf91-72dc2dc473f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_74b784eb-d0f8-4ef1-9014-8279bd443727" xlink:to="loc_us-gaap_PreferredStockSharesIssued_7f725f9b-4047-47c5-bf91-72dc2dc473f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_fc67bbf9-584f-4375-92dc-059a8e8b1c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_74b784eb-d0f8-4ef1-9014-8279bd443727" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_fc67bbf9-584f-4375-92dc-059a8e8b1c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4bc95ff4-cbb0-404a-aaa1-42782346c9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_74b784eb-d0f8-4ef1-9014-8279bd443727" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4bc95ff4-cbb0-404a-aaa1-42782346c9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_bc521078-a9ff-46c8-92fa-f4bd43f9ab64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_74b784eb-d0f8-4ef1-9014-8279bd443727" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_bc521078-a9ff-46c8-92fa-f4bd43f9ab64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_5e20cbdb-0002-44c1-85fa-3924b7b48cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_74b784eb-d0f8-4ef1-9014-8279bd443727" xlink:to="loc_us-gaap_CommonStockSharesIssued_5e20cbdb-0002-44c1-85fa-3924b7b48cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_21e3cfa4-65bd-45af-95e1-96747320021f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_74b784eb-d0f8-4ef1-9014-8279bd443727" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_21e3cfa4-65bd-45af-95e1-96747320021f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_6ccc537f-0673-4d0c-b9d1-1fa1e1c15cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_74b784eb-d0f8-4ef1-9014-8279bd443727" xlink:to="loc_us-gaap_TreasuryStockShares_6ccc537f-0673-4d0c-b9d1-1fa1e1c15cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="icui-20230331.xsd#CondensedConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_94e069b2-34bb-4d6f-8df8-dd43c1e5fb0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_824bf33d-9943-4a4d-894c-22b4af076941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_94e069b2-34bb-4d6f-8df8-dd43c1e5fb0d" xlink:to="loc_us-gaap_StatementTable_824bf33d-9943-4a4d-894c-22b4af076941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9403c02f-d405-46db-af47-5e6471a842d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_824bf33d-9943-4a4d-894c-22b4af076941" xlink:to="loc_srt_ProductOrServiceAxis_9403c02f-d405-46db-af47-5e6471a842d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_38a77444-22a5-401a-9f3a-ad5de908a398" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9403c02f-d405-46db-af47-5e6471a842d4" xlink:to="loc_srt_ProductsAndServicesDomain_38a77444-22a5-401a-9f3a-ad5de908a398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_824bf33d-9943-4a4d-894c-22b4af076941" xlink:to="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_13253a80-194f-4512-b87e-0619d56ca3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_RevenuesAbstract_13253a80-194f-4512-b87e-0619d56ca3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5fd02b05-6f5b-4cb6-a366-4d136abf746f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_13253a80-194f-4512-b87e-0619d56ca3ed" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5fd02b05-6f5b-4cb6-a366-4d136abf746f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_c85f0955-d5cf-4099-b1ba-90cebd398037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_13253a80-194f-4512-b87e-0619d56ca3ed" xlink:to="loc_us-gaap_CostOfRevenue_c85f0955-d5cf-4099-b1ba-90cebd398037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_05fe0542-0670-4e27-98a6-28aa96e5fbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_13253a80-194f-4512-b87e-0619d56ca3ed" xlink:to="loc_us-gaap_GrossProfit_05fe0542-0670-4e27-98a6-28aa96e5fbd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_5a3d1344-aebb-4d5b-adfd-73706e574df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_OperatingExpensesAbstract_5a3d1344-aebb-4d5b-adfd-73706e574df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_73d8375c-e5e3-4f37-8d5d-3f6bd268a4da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5a3d1344-aebb-4d5b-adfd-73706e574df7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_73d8375c-e5e3-4f37-8d5d-3f6bd268a4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d2395739-983d-4126-bfa0-44dbdd20df1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5a3d1344-aebb-4d5b-adfd-73706e574df7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d2395739-983d-4126-bfa0-44dbdd20df1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransaction_29f233c7-8c5f-4d4e-913b-6e1f8a0e2fdd" xlink:href="icui-20230331.xsd#icui_Restructuringandstrategictransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5a3d1344-aebb-4d5b-adfd-73706e574df7" xlink:to="loc_icui_Restructuringandstrategictransaction_29f233c7-8c5f-4d4e-913b-6e1f8a0e2fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_07e66e9f-cabb-42f0-bf86-18d1fbc48f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5a3d1344-aebb-4d5b-adfd-73706e574df7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_07e66e9f-cabb-42f0-bf86-18d1fbc48f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6d50322d-0f29-44bb-96a9-644cbcb56c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5a3d1344-aebb-4d5b-adfd-73706e574df7" xlink:to="loc_us-gaap_OperatingExpenses_6d50322d-0f29-44bb-96a9-644cbcb56c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e02b484a-fcfb-49bf-9c27-06eb042a4253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_OperatingIncomeLoss_e02b484a-fcfb-49bf-9c27-06eb042a4253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2b13940f-153a-4f48-8594-8fafab99ed93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_InterestExpense_2b13940f-153a-4f48-8594-8fafab99ed93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_53ef93ec-bc12-47b5-aac0-325413218068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_53ef93ec-bc12-47b5-aac0-325413218068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d5f307ce-a0b3-4cdd-88fe-aa954fee90db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d5f307ce-a0b3-4cdd-88fe-aa954fee90db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f4a4dbe2-19d1-410c-9ab2-6dde7370144c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f4a4dbe2-19d1-410c-9ab2-6dde7370144c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5374aca2-7c45-438f-b871-f54a602e9d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_ProfitLoss_5374aca2-7c45-438f-b871-f54a602e9d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e999b5c9-cffb-48e1-935b-1998156d7eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_EarningsPerShareAbstract_e999b5c9-cffb-48e1-935b-1998156d7eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_7b0c73b2-6ffb-43b4-9e80-3e28eed4593e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e999b5c9-cffb-48e1-935b-1998156d7eb5" xlink:to="loc_us-gaap_EarningsPerShareBasic_7b0c73b2-6ffb-43b4-9e80-3e28eed4593e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7af85907-355a-4cda-9039-5e74dff8b2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e999b5c9-cffb-48e1-935b-1998156d7eb5" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7af85907-355a-4cda-9039-5e74dff8b2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6d98283e-9ccb-4128-9815-f606ac4c8ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2a4b69b-9234-493a-8aed-af490b977276" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6d98283e-9ccb-4128-9815-f606ac4c8ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_118d9b6c-aa54-46f1-b235-d051b01a1735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6d98283e-9ccb-4128-9815-f606ac4c8ae7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_118d9b6c-aa54-46f1-b235-d051b01a1735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1117dbd7-6a03-491f-b0bd-5e99e67682cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6d98283e-9ccb-4128-9815-f606ac4c8ae7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1117dbd7-6a03-491f-b0bd-5e99e67682cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="icui-20230331.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d6ace8a1-c551-4142-99f1-3d54b5df08c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1ba89451-793c-46c0-9040-67fabc6bfc20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d6ace8a1-c551-4142-99f1-3d54b5df08c8" xlink:to="loc_us-gaap_StatementTable_1ba89451-793c-46c0-9040-67fabc6bfc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_0dc08bc1-7266-4208-907e-62ee5eb467e9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1ba89451-793c-46c0-9040-67fabc6bfc20" xlink:to="loc_srt_StatementScenarioAxis_0dc08bc1-7266-4208-907e-62ee5eb467e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_83083492-823f-4e2f-a61f-922bd2885e7e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_0dc08bc1-7266-4208-907e-62ee5eb467e9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_83083492-823f-4e2f-a61f-922bd2885e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_28302172-3ef7-43d7-996f-e71f6247ce4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1ba89451-793c-46c0-9040-67fabc6bfc20" xlink:to="loc_us-gaap_StatementLineItems_28302172-3ef7-43d7-996f-e71f6247ce4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_dfb0ddd8-0da0-46c4-a337-ab5ee62cb9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_28302172-3ef7-43d7-996f-e71f6247ce4d" xlink:to="loc_us-gaap_ProfitLoss_dfb0ddd8-0da0-46c4-a337-ab5ee62cb9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_196155a6-e36e-48a8-be1b-9905ea7f6192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_28302172-3ef7-43d7-996f-e71f6247ce4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_196155a6-e36e-48a8-be1b-9905ea7f6192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cc804342-bd3e-4ee2-b2e8-e29b5668c843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_196155a6-e36e-48a8-be1b-9905ea7f6192" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cc804342-bd3e-4ee2-b2e8-e29b5668c843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_70036c18-d14b-4c98-bcb0-72deac53c590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_196155a6-e36e-48a8-be1b-9905ea7f6192" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_70036c18-d14b-4c98-bcb0-72deac53c590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_fdf40574-1605-4006-bef4-22cb679c1b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_196155a6-e36e-48a8-be1b-9905ea7f6192" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_fdf40574-1605-4006-bef4-22cb679c1b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9d373ff5-6d9e-4cfa-b114-579c61ec2537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_196155a6-e36e-48a8-be1b-9905ea7f6192" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9d373ff5-6d9e-4cfa-b114-579c61ec2537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a20b2bf4-cd9f-4efb-8ce2-e7ce3eaded16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_28302172-3ef7-43d7-996f-e71f6247ce4d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_a20b2bf4-cd9f-4efb-8ce2-e7ce3eaded16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical" xlink:type="simple" xlink:href="icui-20230331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b0fb6b08-0fac-4acd-a1d5-47b801ec882f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_e0ed8fa7-e71a-4bb5-afb6-8c004a425697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b0fb6b08-0fac-4acd-a1d5-47b801ec882f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_e0ed8fa7-e71a-4bb5-afb6-8c004a425697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_5d754aec-0153-4747-86bc-67802ad3bcef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b0fb6b08-0fac-4acd-a1d5-47b801ec882f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_5d754aec-0153-4747-86bc-67802ad3bcef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_1801db41-d437-42e5-a32f-c1361222149b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b0fb6b08-0fac-4acd-a1d5-47b801ec882f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_1801db41-d437-42e5-a32f-c1361222149b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement" xlink:type="simple" xlink:href="icui-20230331.xsd#CondensedConsolidatedStatementsofStockholdersEquityStatement"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_cb705ecd-4abb-4d43-b266-e7a8fb2249f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_edb5887b-8f42-4221-aa01-fe69a5f396a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_cb705ecd-4abb-4d43-b266-e7a8fb2249f5" xlink:to="loc_us-gaap_StatementTable_edb5887b-8f42-4221-aa01-fe69a5f396a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0b9451c7-53b7-4357-8852-a8c84d279e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_edb5887b-8f42-4221-aa01-fe69a5f396a4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0b9451c7-53b7-4357-8852-a8c84d279e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_765b9589-205f-436f-8eb1-c5cb64c007ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0b9451c7-53b7-4357-8852-a8c84d279e0e" xlink:to="loc_us-gaap_EquityComponentDomain_765b9589-205f-436f-8eb1-c5cb64c007ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CommonStockSharesMember_a4ee1557-10b9-4f92-8d1e-bcd86a391d1a" xlink:href="icui-20230331.xsd#icui_CommonStockSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_765b9589-205f-436f-8eb1-c5cb64c007ba" xlink:to="loc_icui_CommonStockSharesMember_a4ee1557-10b9-4f92-8d1e-bcd86a391d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_54d482d1-6c5b-4a2f-96cb-6513bd8ee301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_765b9589-205f-436f-8eb1-c5cb64c007ba" xlink:to="loc_us-gaap_CommonStockMember_54d482d1-6c5b-4a2f-96cb-6513bd8ee301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a6071eea-ba9e-41ed-bdb8-841113068276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_765b9589-205f-436f-8eb1-c5cb64c007ba" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a6071eea-ba9e-41ed-bdb8-841113068276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_e0ff9754-5e2c-49c0-8c48-1076fba6062e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_765b9589-205f-436f-8eb1-c5cb64c007ba" xlink:to="loc_us-gaap_TreasuryStockMember_e0ff9754-5e2c-49c0-8c48-1076fba6062e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c88054a3-f35d-437c-9320-157884461126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_765b9589-205f-436f-8eb1-c5cb64c007ba" xlink:to="loc_us-gaap_RetainedEarningsMember_c88054a3-f35d-437c-9320-157884461126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_63f410a7-b070-4241-b4c0-e409845ffeee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_765b9589-205f-436f-8eb1-c5cb64c007ba" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_63f410a7-b070-4241-b4c0-e409845ffeee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2d0df48e-6cfb-4fe2-84c3-6df2a262d03b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_edb5887b-8f42-4221-aa01-fe69a5f396a4" xlink:to="loc_us-gaap_StatementLineItems_2d0df48e-6cfb-4fe2-84c3-6df2a262d03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2d0df48e-6cfb-4fe2-84c3-6df2a262d03b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_93006ada-5c46-4fe4-9d9f-030ca5ec0d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_93006ada-5c46-4fe4-9d9f-030ca5ec0d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4ebe1fb8-1bd2-433b-9e21-6d1b2f365b77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_StockholdersEquity_4ebe1fb8-1bd2-433b-9e21-6d1b2f365b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0e339cd5-73c3-46fe-a98b-37073aee9365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0e339cd5-73c3-46fe-a98b-37073aee9365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d52ef0d8-1f0f-4a6b-b866-c2958b2fa18f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d52ef0d8-1f0f-4a6b-b866-c2958b2fa18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_7ea9454c-3969-4a41-95b8-b1b6c8c5fb80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_7ea9454c-3969-4a41-95b8-b1b6c8c5fb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_43390e52-bb07-4f2c-8640-94d7a0b0814b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_43390e52-bb07-4f2c-8640-94d7a0b0814b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_cb354b6e-6b70-47e6-8737-3121da28ed47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_cb354b6e-6b70-47e6-8737-3121da28ed47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9ddb693d-84c5-4084-9664-d004458209a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9ddb693d-84c5-4084-9664-d004458209a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_97e963e4-31d2-4ff1-9303-9edb8101f1da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_97e963e4-31d2-4ff1-9303-9edb8101f1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_77ede7de-95b3-4332-bf30-64077d5eb2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_NetIncomeLoss_77ede7de-95b3-4332-bf30-64077d5eb2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1160cd67-779e-4245-b7be-d87b8a41f839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_StockholdersEquity_1160cd67-779e-4245-b7be-d87b8a41f839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1fea4b3c-5be7-43c0-97d9-0cbf30ef41a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1fea4b3c-5be7-43c0-97d9-0cbf30ef41a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_098857f9-9942-4d8e-ace8-2ee42b7b1be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_998e387d-fa0b-4864-83a6-248888cba08e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_098857f9-9942-4d8e-ace8-2ee42b7b1be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2e970aae-5a7c-4125-8e50-bf6d2c6d2760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2d0df48e-6cfb-4fe2-84c3-6df2a262d03b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2e970aae-5a7c-4125-8e50-bf6d2c6d2760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_d7a11ecd-b786-4275-86bd-fbc4c3679c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2d0df48e-6cfb-4fe2-84c3-6df2a262d03b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_d7a11ecd-b786-4275-86bd-fbc4c3679c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="icui-20230331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_d360b976-a231-4f8f-a7de-fac15ee5a438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f15a7ce8-99a2-4378-8f87-16c00cd62858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d360b976-a231-4f8f-a7de-fac15ee5a438" xlink:to="loc_us-gaap_StatementTable_f15a7ce8-99a2-4378-8f87-16c00cd62858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_b305b7ed-627e-4c2e-997c-247402581dcb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f15a7ce8-99a2-4378-8f87-16c00cd62858" xlink:to="loc_srt_StatementScenarioAxis_b305b7ed-627e-4c2e-997c-247402581dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_6ee5bf15-78c7-4a17-8a6b-b2e7cc1ca799" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_b305b7ed-627e-4c2e-997c-247402581dcb" xlink:to="loc_srt_ScenarioUnspecifiedDomain_6ee5bf15-78c7-4a17-8a6b-b2e7cc1ca799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_077faebb-d95d-491f-bb13-98605956e5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f15a7ce8-99a2-4378-8f87-16c00cd62858" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_077faebb-d95d-491f-bb13-98605956e5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4c7e1145-4a55-4c09-8784-9b14671bde1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_077faebb-d95d-491f-bb13-98605956e5c8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4c7e1145-4a55-4c09-8784-9b14671bde1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_082891fe-466b-4da1-b716-6ff48181b1db" xlink:href="icui-20230331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4c7e1145-4a55-4c09-8784-9b14671bde1a" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_082891fe-466b-4da1-b716-6ff48181b1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_8c36767c-8cea-4b35-8250-0aa526ec8c87" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4c7e1145-4a55-4c09-8784-9b14671bde1a" xlink:to="loc_icui_SmithsMedicalMember_8c36767c-8cea-4b35-8250-0aa526ec8c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_70e9512b-1726-47c3-bdde-c2c7e80ce593" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f15a7ce8-99a2-4378-8f87-16c00cd62858" xlink:to="loc_us-gaap_StatementLineItems_70e9512b-1726-47c3-bdde-c2c7e80ce593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_3a7d0792-2df0-4251-b2f0-d889606820d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e9512b-1726-47c3-bdde-c2c7e80ce593" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_3a7d0792-2df0-4251-b2f0-d889606820d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_bb61e388-ad26-4f3e-87e2-c167fe13c331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_3a7d0792-2df0-4251-b2f0-d889606820d2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_bb61e388-ad26-4f3e-87e2-c167fe13c331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_bb61e388-ad26-4f3e-87e2-c167fe13c331" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_995e29c7-f58b-4948-962b-eea26c9a29aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_ProfitLoss_995e29c7-f58b-4948-962b-eea26c9a29aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e1b4a9d0-b041-431a-998d-248bbadbe515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e1b4a9d0-b041-431a-998d-248bbadbe515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AmortizationOfInventoryStepUp_a7ade647-d797-4dc1-9c31-9a8d0e7ae5fb" xlink:href="icui-20230331.xsd#icui_AmortizationOfInventoryStepUp"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_icui_AmortizationOfInventoryStepUp_a7ade647-d797-4dc1-9c31-9a8d0e7ae5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_3ac35d18-f733-4b1c-b238-268763348bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_3ac35d18-f733-4b1c-b238-268763348bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_1f79a5cc-f20e-4ced-b50b-dbd80f28b572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_1f79a5cc-f20e-4ced-b50b-dbd80f28b572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProvisionForWarrantyAndReturns_95b95e57-baee-4ea3-9f0f-db47da4372be" xlink:href="icui-20230331.xsd#icui_ProvisionForWarrantyAndReturns"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_icui_ProvisionForWarrantyAndReturns_95b95e57-baee-4ea3-9f0f-db47da4372be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_400287ee-e693-4a88-8613-367425a915d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_ShareBasedCompensation_400287ee-e693-4a88-8613-367425a915d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_e978517b-2414-4719-8fc8-39acea001fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_e978517b-2414-4719-8fc8-39acea001fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_26a14678-4e43-47e2-9815-bc8b96317eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_26a14678-4e43-47e2-9815-bc8b96317eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_491e396b-57cc-4781-aea0-71e732ab748a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_491e396b-57cc-4781-aea0-71e732ab748a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dbba3de4-e58f-4a25-a0fd-90c0b62e8e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dbba3de4-e58f-4a25-a0fd-90c0b62e8e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sparepartsusage_366ee344-6218-4684-b39a-81ffa6475bc2" xlink:href="icui-20230331.xsd#icui_Sparepartsusage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_icui_Sparepartsusage_366ee344-6218-4684-b39a-81ffa6475bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_dd13774c-171a-48d7-8d18-04b16c7da18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_dd13774c-171a-48d7-8d18-04b16c7da18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d346cba8-cc8f-49af-a512-c03b4c6b9217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d346cba8-cc8f-49af-a512-c03b4c6b9217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_e952d891-7bf2-492d-b35a-ea70967124af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_e952d891-7bf2-492d-b35a-ea70967124af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ab5d652d-aecf-4b10-87ff-9593247c4c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ab5d652d-aecf-4b10-87ff-9593247c4c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e4e7f41e-b07f-4e7e-afff-d1ef238c2856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e4e7f41e-b07f-4e7e-afff-d1ef238c2856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c317d8e9-291f-411c-a3e3-3e1c1044a67e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c317d8e9-291f-411c-a3e3-3e1c1044a67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c5452c20-3ca4-4a85-9511-7297913d0bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c5452c20-3ca4-4a85-9511-7297913d0bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_88b15398-583d-4ecc-8cdc-33ead1425df3" xlink:href="icui-20230331.xsd#icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_88b15398-583d-4ecc-8cdc-33ead1425df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f29c238e-9b70-4e78-986f-adcc97850993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e2f5586b-ae8c-4dea-a6ad-399da7244e16" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f29c238e-9b70-4e78-986f-adcc97850993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_87ec7fad-1c4b-48c5-87f8-1f351a5679ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_bb61e388-ad26-4f3e-87e2-c167fe13c331" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_87ec7fad-1c4b-48c5-87f8-1f351a5679ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_52309da9-7520-42c8-9373-9ecc7317907c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_87ec7fad-1c4b-48c5-87f8-1f351a5679ed" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_52309da9-7520-42c8-9373-9ecc7317907c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_94419fba-14d9-4033-9486-a3b42bb9b19c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_87ec7fad-1c4b-48c5-87f8-1f351a5679ed" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_94419fba-14d9-4033-9486-a3b42bb9b19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_54cb3034-b91c-4151-802d-8c723f6ee1ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_87ec7fad-1c4b-48c5-87f8-1f351a5679ed" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_54cb3034-b91c-4151-802d-8c723f6ee1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_cfd1624c-6d61-4c31-b932-15d4cdc24adb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_87ec7fad-1c4b-48c5-87f8-1f351a5679ed" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_cfd1624c-6d61-4c31-b932-15d4cdc24adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_7e04a793-e53a-416e-8857-896d2b4efac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_87ec7fad-1c4b-48c5-87f8-1f351a5679ed" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_7e04a793-e53a-416e-8857-896d2b4efac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ba95a698-3a14-491d-b55a-b3789c8ca345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_87ec7fad-1c4b-48c5-87f8-1f351a5679ed" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ba95a698-3a14-491d-b55a-b3789c8ca345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_bb61e388-ad26-4f3e-87e2-c167fe13c331" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_cd3fcd3d-8cd5-447d-ad5c-7558846d9453" xlink:href="icui-20230331.xsd#icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:to="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_cd3fcd3d-8cd5-447d-ad5c-7558846d9453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_d6287a59-1566-487c-9ea4-7052c5b67b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_d6287a59-1566-487c-9ea4-7052c5b67b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_aa83fcd1-a517-474c-b0ff-5fcc9321265c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_aa83fcd1-a517-474c-b0ff-5fcc9321265c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_a3b0744a-9ed7-49ca-bb4e-823368557dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_a3b0744a-9ed7-49ca-bb4e-823368557dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_6cc933b8-6d28-4c09-9ca2-f1725233c9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_6cc933b8-6d28-4c09-9ca2-f1725233c9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a2589cd3-8396-435a-b966-64d6c4d91309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a2589cd3-8396-435a-b966-64d6c4d91309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_18b5e8e2-9419-433e-8dd6-17e547c09b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c9b4b34-e68b-468f-b55e-7c05a58071c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_18b5e8e2-9419-433e-8dd6-17e547c09b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_bebcb609-84f8-4d29-999c-c068559ef21a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_3a7d0792-2df0-4251-b2f0-d889606820d2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_bebcb609-84f8-4d29-999c-c068559ef21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fe4392ed-ca75-4030-ae7a-41db15053c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_bebcb609-84f8-4d29-999c-c068559ef21a" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fe4392ed-ca75-4030-ae7a-41db15053c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5e6dcc29-5cfa-4c3c-b26e-a34051dd1fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e9512b-1726-47c3-bdde-c2c7e80ce593" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5e6dcc29-5cfa-4c3c-b26e-a34051dd1fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_75c15269-bcf4-4615-8d64-548e3ceaccab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e9512b-1726-47c3-bdde-c2c7e80ce593" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_75c15269-bcf4-4615-8d64-548e3ceaccab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_24e058ea-64a6-45b0-9597-f1684d35ac81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e9512b-1726-47c3-bdde-c2c7e80ce593" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_24e058ea-64a6-45b0-9597-f1684d35ac81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_426eb2fa-104c-4057-a61b-0a3afb941522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_24e058ea-64a6-45b0-9597-f1684d35ac81" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_426eb2fa-104c-4057-a61b-0a3afb941522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e9512b-1726-47c3-bdde-c2c7e80ce593" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d5f56d94-a285-4fb2-a4c8-3965b58280a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d5f56d94-a285-4fb2-a4c8-3965b58280a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_e28d4b50-3a2b-4e8f-afdd-4e3a93c3e55e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_e28d4b50-3a2b-4e8f-afdd-4e3a93c3e55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NetCashPaidReceivedforcurrentandprioracquisitions_154f3473-4d71-4531-a129-a9751d2c4f6c" xlink:href="icui-20230331.xsd#icui_NetCashPaidReceivedforcurrentandprioracquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:to="loc_icui_NetCashPaidReceivedforcurrentandprioracquisitions_154f3473-4d71-4531-a129-a9751d2c4f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_3258a0e2-c01c-4e31-a756-d48e35abf1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_3258a0e2-c01c-4e31-a756-d48e35abf1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_cf09bbfd-93e2-4a23-83a0-a09015235a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:to="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_cf09bbfd-93e2-4a23-83a0-a09015235a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_4818c0d3-8f21-4de0-83bd-765c4cdf90c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_4818c0d3-8f21-4de0-83bd-765c4cdf90c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_47a838f7-7265-4b83-a35c-33c174bcc4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_da952ce9-0a60-43e0-89b8-5d2f66c81bab" xlink:to="loc_us-gaap_LiabilitiesAssumed1_47a838f7-7265-4b83-a35c-33c174bcc4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BasisofPresentation" xlink:type="simple" xlink:href="icui-20230331.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3ea9d748-7d04-44ee-8c50-4887c725c48c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_e6d77d40-4a8a-4d6a-8b0b-caade4401f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3ea9d748-7d04-44ee-8c50-4887c725c48c" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_e6d77d40-4a8a-4d6a-8b0b-caade4401f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="icui-20230331.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_a20ce523-29fd-40ea-98a2-69274fd4ae53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_2aa31a2e-5d86-429d-ad9d-2a9150e1a152" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_a20ce523-29fd-40ea-98a2-69274fd4ae53" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_2aa31a2e-5d86-429d-ad9d-2a9150e1a152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_73f2b40c-1329-4004-b9df-93ad4bbceaf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions" xlink:type="simple" xlink:href="icui-20230331.xsd#BusinessCombinationsandAssetAcquisitions"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d0a9d48b-a48f-4da4-bf40-028063067887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_14fc7249-4364-497b-87c6-a7223a3e89cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d0a9d48b-a48f-4da4-bf40-028063067887" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_14fc7249-4364-497b-87c6-a7223a3e89cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes" xlink:type="simple" xlink:href="icui-20230331.xsd#RestructuringStrategicTransactionandIntegrationNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_39983a88-d166-47c1-8721-c731f933ccc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_6c667a11-9c31-46ea-b652-f24dfd94c15f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_39983a88-d166-47c1-8721-c731f933ccc6" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_6c667a11-9c31-46ea-b652-f24dfd94c15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueNotes" xlink:type="simple" xlink:href="icui-20230331.xsd#RevenueNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3fabb2c3-9e08-4612-8af6-c922cec6df8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_77363791-896e-465d-a28e-fd94051aaf16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3fabb2c3-9e08-4612-8af6-c922cec6df8c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_77363791-896e-465d-a28e-fd94051aaf16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesNotes" xlink:type="simple" xlink:href="icui-20230331.xsd#LeasesNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9b2241f4-65b1-4681-b3f5-4e2aed924286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_22e7cd08-070c-47bf-b752-28966f721706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9b2241f4-65b1-4681-b3f5-4e2aed924286" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_22e7cd08-070c-47bf-b752-28966f721706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="icui-20230331.xsd#NetIncomePerShare"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NetIncomePerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6e91cde0-642c-4a89-9599-3d3312d1e49c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_16c23abb-1265-42f7-aa00-37c78f1ae351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6e91cde0-642c-4a89-9599-3d3312d1e49c" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_16c23abb-1265-42f7-aa00-37c78f1ae351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes" xlink:type="simple" xlink:href="icui-20230331.xsd#DerivativeFinancialInstrumentsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4deb1e5e-756b-4c90-a01d-0190274a1739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_fa835209-7abe-4057-9010-2cc060386304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4deb1e5e-756b-4c90-a01d-0190274a1739" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_fa835209-7abe-4057-9010-2cc060386304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes" xlink:type="simple" xlink:href="icui-20230331.xsd#FairValueMeasuresandDisclosuresNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d3a8eca8-3494-4bf4-97a9-e4ff8c7a8165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_3f270dce-782f-4b06-a1a4-6b1df726f0e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d3a8eca8-3494-4bf4-97a9-e4ff8c7a8165" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_3f270dce-782f-4b06-a1a4-6b1df726f0e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InvestmentSecuritiesNotes" xlink:type="simple" xlink:href="icui-20230331.xsd#InvestmentSecuritiesNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InvestmentSecuritiesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f7fd0063-a487-4769-badd-ff9ad96e1e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock_2267ad15-7682-4505-b5ce-86ff9f70335c" xlink:href="icui-20230331.xsd#icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f7fd0063-a487-4769-badd-ff9ad96e1e1e" xlink:to="loc_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock_2267ad15-7682-4505-b5ce-86ff9f70335c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes" xlink:type="simple" xlink:href="icui-20230331.xsd#PrepaidsandOtherCurrentAssetsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_6712db32-feac-4c00-8491-4fe6025f31c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_df106aa3-752a-43cd-9e24-e05700f867fb" xlink:href="icui-20230331.xsd#icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_6712db32-feac-4c00-8491-4fe6025f31c7" xlink:to="loc_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_df106aa3-752a-43cd-9e24-e05700f867fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/Inventories" xlink:type="simple" xlink:href="icui-20230331.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_f24bc649-d532-4186-bbd3-36f95716caea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_5fdf33ce-6ee4-4304-9acc-9b58b1187d34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_f24bc649-d532-4186-bbd3-36f95716caea" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_5fdf33ce-6ee4-4304-9acc-9b58b1187d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="icui-20230331.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_9f6011d1-7b91-4bce-9bb8-b9ec0f1bf252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_7f1a810e-b7b2-4cef-8bec-c01485c7c370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_9f6011d1-7b91-4bce-9bb8-b9ec0f1bf252" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_7f1a810e-b7b2-4cef-8bec-c01485c7c370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes" xlink:type="simple" xlink:href="icui-20230331.xsd#GoodwillandIntangibleAssetsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3fa8af49-8e80-47d9-a0d8-75d98405e5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_412d084e-0b90-4b70-9f5b-821a384a67d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3fa8af49-8e80-47d9-a0d8-75d98405e5a2" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_412d084e-0b90-4b70-9f5b-821a384a67d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesNotes" xlink:type="simple" xlink:href="icui-20230331.xsd#AccruedLiabilitiesNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_064452cc-66a8-4227-abd5-2941a72651a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_6c2eb97d-e8be-434d-8d8a-dfd6594ac773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_064452cc-66a8-4227-abd5-2941a72651a7" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_6c2eb97d-e8be-434d-8d8a-dfd6594ac773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxes" xlink:type="simple" xlink:href="icui-20230331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8a2c015d-c4dd-4d67-bf30-3fe320c27571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_c63c62a1-4bf3-43aa-b120-8a0d1ed1cd34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8a2c015d-c4dd-4d67-bf30-3fe320c27571" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_c63c62a1-4bf3-43aa-b120-8a0d1ed1cd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsNotes" xlink:type="simple" xlink:href="icui-20230331.xsd#LongTermObligationsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_LOngTermObligationsDisclosureAbstract_3cc99df8-e3f4-456a-8271-97a1c193d684" xlink:href="icui-20230331.xsd#icui_LOngTermObligationsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_7a032f7c-6e2e-46c8-9c65-3ef76230f91c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_3cc99df8-e3f4-456a-8271-97a1c193d684" xlink:to="loc_us-gaap_LongTermDebtTextBlock_7a032f7c-6e2e-46c8-9c65-3ef76230f91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="icui-20230331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_444d8f2a-3dc9-45a2-817b-68ed4bdb38d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ba977594-1f39-4ee8-8b8d-855b467070c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_444d8f2a-3dc9-45a2-817b-68ed4bdb38d0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ba977594-1f39-4ee8-8b8d-855b467070c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes" xlink:type="simple" xlink:href="icui-20230331.xsd#CollaborativeandOtherArrangementsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e73b4069-dd5f-4f2c-8c15-a516153d9bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_ea00fada-1d06-4751-9a16-43014301fb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e73b4069-dd5f-4f2c-8c15-a516153d9bd7" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_ea00fada-1d06-4751-9a16-43014301fb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/Equity" xlink:type="simple" xlink:href="icui-20230331.xsd#Equity"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/Equity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e7cbb0ba-65df-4486-b5c2-ae072b568a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_379526d6-353d-4cc9-8816-600804b26173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e7cbb0ba-65df-4486-b5c2-ae072b568a3a" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_379526d6-353d-4cc9-8816-600804b26173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/TransfersandServicing" xlink:type="simple" xlink:href="icui-20230331.xsd#TransfersandServicing"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/TransfersandServicing" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingAbstract_1c307091-559c-4dbe-9d87-a4a5dd131a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialAssetsTextBlock_874678ce-5494-4e53-b2c2-a8cd3fdbcd43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingAbstract_1c307091-559c-4dbe-9d87-a4a5dd131a5a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialAssetsTextBlock_874678ce-5494-4e53-b2c2-a8cd3fdbcd43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NewAccountingPronouncementsNewAccountingPronouncementsAdoptedPolicies" xlink:type="simple" xlink:href="icui-20230331.xsd#NewAccountingPronouncementsNewAccountingPronouncementsAdoptedPolicies"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NewAccountingPronouncementsNewAccountingPronouncementsAdoptedPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables" xlink:type="simple" xlink:href="icui-20230331.xsd#BusinessCombinationsandAssetAcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d21c3f88-3ad9-4c4b-a163-b06560c657ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_f731f49a-d7b4-461b-ad51-afa67aaf139a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d21c3f88-3ad9-4c4b-a163-b06560c657ee" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_f731f49a-d7b4-461b-ad51-afa67aaf139a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_36ca129a-41f5-403b-b521-127f6b067a90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d21c3f88-3ad9-4c4b-a163-b06560c657ee" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_36ca129a-41f5-403b-b521-127f6b067a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables" xlink:type="simple" xlink:href="icui-20230331.xsd#RestructuringStrategicTransactionandIntegrationTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_98eb7d69-c7b4-45ab-afe2-7f517e86e214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_8caa0eae-0f93-4fc2-ac7d-058eeaac4254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_98eb7d69-c7b4-45ab-afe2-7f517e86e214" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_8caa0eae-0f93-4fc2-ac7d-058eeaac4254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueTables" xlink:type="simple" xlink:href="icui-20230331.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a38a0002-0623-4a6b-a9d0-3d7cc36888c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_6ea149d9-91f8-487f-9b05-4749e38df310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a38a0002-0623-4a6b-a9d0-3d7cc36888c3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_6ea149d9-91f8-487f-9b05-4749e38df310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_5bac81a1-56ac-4ccc-b45c-d7a7e8078163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a38a0002-0623-4a6b-a9d0-3d7cc36888c3" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_5bac81a1-56ac-4ccc-b45c-d7a7e8078163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesTables" xlink:type="simple" xlink:href="icui-20230331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_01f93293-c563-438c-afe0-a1ce27a20e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_586a9298-5919-4e4b-85a6-b1a9baa17ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_01f93293-c563-438c-afe0-a1ce27a20e90" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_586a9298-5919-4e4b-85a6-b1a9baa17ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_c45da447-1706-4d83-80da-784577b4ec14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_01f93293-c563-438c-afe0-a1ce27a20e90" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_c45da447-1706-4d83-80da-784577b4ec14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AssetsandLiabilitiesLeasesTableTextBlock_70e580ab-cc52-4ba1-92af-25a518c625bb" xlink:href="icui-20230331.xsd#icui_AssetsandLiabilitiesLeasesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_01f93293-c563-438c-afe0-a1ce27a20e90" xlink:to="loc_icui_AssetsandLiabilitiesLeasesTableTextBlock_70e580ab-cc52-4ba1-92af-25a518c625bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_03487051-d7d4-4149-9c87-57cd9b9f874f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_01f93293-c563-438c-afe0-a1ce27a20e90" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_03487051-d7d4-4149-9c87-57cd9b9f874f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="icui-20230331.xsd#NetIncomePerShareTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NetIncomePerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_24c18343-7301-4edd-9fcc-6e5929b95812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5fd861a8-76f6-4ed8-a73d-9f9ea754a619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_24c18343-7301-4edd-9fcc-6e5929b95812" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5fd861a8-76f6-4ed8-a73d-9f9ea754a619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="icui-20230331.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f8df02c8-f0d1-43a1-a614-13f6cefe1ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_05db9f7b-bd9b-4bc2-8e8c-eeed8b5f1657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f8df02c8-f0d1-43a1-a614-13f6cefe1ffc" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_05db9f7b-bd9b-4bc2-8e8c-eeed8b5f1657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_75d06548-ce1e-4b1c-a6f0-b9b22f298da0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f8df02c8-f0d1-43a1-a614-13f6cefe1ffc" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_75d06548-ce1e-4b1c-a6f0-b9b22f298da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables" xlink:type="simple" xlink:href="icui-20230331.xsd#FairValueMeasuresandDisclosuresTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_364b2522-464e-4458-ae98-2d39e642b85c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_ddb3b87f-4d17-4211-ae00-de5ad9481b11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_364b2522-464e-4458-ae98-2d39e642b85c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_ddb3b87f-4d17-4211-ae00-de5ad9481b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_ede413c2-ff41-46b6-adc7-12c574d0ec27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_364b2522-464e-4458-ae98-2d39e642b85c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_ede413c2-ff41-46b6-adc7-12c574d0ec27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_8a9a17ac-3719-4ff0-8c15-70f1f726636d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_364b2522-464e-4458-ae98-2d39e642b85c" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_8a9a17ac-3719-4ff0-8c15-70f1f726636d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InvestmentSecuritiesTables" xlink:type="simple" xlink:href="icui-20230331.xsd#InvestmentSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InvestmentSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_401c7f43-79ee-41dd-9251-6bc31a842a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_186edaf9-bf82-402b-b9ea-720402ee46fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_401c7f43-79ee-41dd-9251-6bc31a842a5b" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_186edaf9-bf82-402b-b9ea-720402ee46fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_3581ca01-4c68-40d4-b8ad-712a563ce4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_401c7f43-79ee-41dd-9251-6bc31a842a5b" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_3581ca01-4c68-40d4-b8ad-712a563ce4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables" xlink:type="simple" xlink:href="icui-20230331.xsd#PrepaidsandOtherCurrentAssetsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_6841fe58-93e0-4b40-b6dd-66baf6a8f03f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_b2dd7825-a980-48fc-bef0-81cdd249ac6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_6841fe58-93e0-4b40-b6dd-66baf6a8f03f" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_b2dd7825-a980-48fc-bef0-81cdd249ac6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_73267633-435c-4ee8-9a26-9796837fd771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_6841fe58-93e0-4b40-b6dd-66baf6a8f03f" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_73267633-435c-4ee8-9a26-9796837fd771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InventoriesTables" xlink:type="simple" xlink:href="icui-20230331.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_acc2544c-7423-4e0c-9858-2d72bd5aa6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_9769eb37-5c30-4525-ac95-189c3473b0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_acc2544c-7423-4e0c-9858-2d72bd5aa6ed" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_9769eb37-5c30-4525-ac95-189c3473b0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="icui-20230331.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d7d138e8-fbcf-491a-839f-45eafd1cf83a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7a2df11d-47b0-4433-bab3-590200be0abe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d7d138e8-fbcf-491a-839f-45eafd1cf83a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7a2df11d-47b0-4433-bab3-590200be0abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="icui-20230331.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_78d81594-5abf-4ade-ab67-51e9615e6646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_60b70166-072f-43ef-b3b2-f25c7692764e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_78d81594-5abf-4ade-ab67-51e9615e6646" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_60b70166-072f-43ef-b3b2-f25c7692764e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_e686af2b-cbb6-40ea-a2ad-5a36ece53a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_78d81594-5abf-4ade-ab67-51e9615e6646" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_e686af2b-cbb6-40ea-a2ad-5a36ece53a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_395f1c9a-b4a3-42ae-8055-39c972aebb86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_78d81594-5abf-4ade-ab67-51e9615e6646" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_395f1c9a-b4a3-42ae-8055-39c972aebb86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="icui-20230331.xsd#AccruedLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_521d1e6b-caed-4cff-b2f4-d81206bfcac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_fde9c7fc-2eb2-4bc5-9ac2-28ebcba9b9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_521d1e6b-caed-4cff-b2f4-d81206bfcac3" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_fde9c7fc-2eb2-4bc5-9ac2-28ebcba9b9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsTables" xlink:type="simple" xlink:href="icui-20230331.xsd#LongTermObligationsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_LOngTermObligationsDisclosureAbstract_c7c9e23c-2bef-49a1-8bb7-fd3996d275eb" xlink:href="icui-20230331.xsd#icui_LOngTermObligationsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9515cc7b-26e8-441e-abf7-2b4b61219e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_c7c9e23c-2bef-49a1-8bb7-fd3996d275eb" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9515cc7b-26e8-441e-abf7-2b4b61219e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_032d9384-26b5-4ae3-90d9-d2f744f269b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_c7c9e23c-2bef-49a1-8bb7-fd3996d275eb" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_032d9384-26b5-4ae3-90d9-d2f744f269b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestExpenseOnLongTermDebtTableTextBlock_060f046b-29f2-45db-8609-bc05f8a159a1" xlink:href="icui-20230331.xsd#icui_InterestExpenseOnLongTermDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_c7c9e23c-2bef-49a1-8bb7-fd3996d275eb" xlink:to="loc_icui_InterestExpenseOnLongTermDebtTableTextBlock_060f046b-29f2-45db-8609-bc05f8a159a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock_feda0124-4b62-411c-b036-6778dca51433" xlink:href="icui-20230331.xsd#icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_c7c9e23c-2bef-49a1-8bb7-fd3996d275eb" xlink:to="loc_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock_feda0124-4b62-411c-b036-6778dca51433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsTables" xlink:type="simple" xlink:href="icui-20230331.xsd#CollaborativeandOtherArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CollaborativeandOtherArrangementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.icumed.com/role/EquityTables" xlink:type="simple" xlink:href="icui-20230331.xsd#EquityTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/EquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e386cbc5-2ba4-42de-a2e3-230d349c515d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2869f092-a9d5-4923-a7f2-6d0a95650a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e386cbc5-2ba4-42de-a2e3-230d349c515d" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2869f092-a9d5-4923-a7f2-6d0a95650a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/TransfersandServicingTables" xlink:type="simple" xlink:href="icui-20230331.xsd#TransfersandServicingTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/TransfersandServicingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingAbstract_1e4a5a4e-e4d4-4760-a188-783a03633bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_956b3af0-69fc-4f78-8ad4-ea2a22453f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61738cb1-19ff-4776-86a8-20d89146ef56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_956b3af0-69fc-4f78-8ad4-ea2a22453f0c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61738cb1-19ff-4776-86a8-20d89146ef56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2b46f5b2-c2c0-4a77-8bb9-c10eb599ccd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61738cb1-19ff-4776-86a8-20d89146ef56" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2b46f5b2-c2c0-4a77-8bb9-c10eb599ccd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a44c1de5-1266-4dca-abd9-82b6c2ef7c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2b46f5b2-c2c0-4a77-8bb9-c10eb599ccd7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a44c1de5-1266-4dca-abd9-82b6c2ef7c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_d2a9b38b-a497-425e-9dec-c1f71681ccf4" xlink:href="icui-20230331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a44c1de5-1266-4dca-abd9-82b6c2ef7c46" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_d2a9b38b-a497-425e-9dec-c1f71681ccf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ccf0f0f6-4bf8-4125-b257-579ac61d22a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_61738cb1-19ff-4776-86a8-20d89146ef56" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ccf0f0f6-4bf8-4125-b257-579ac61d22a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_f9ac3054-ad27-4644-affa-50d349506212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccf0f0f6-4bf8-4125-b257-579ac61d22a3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_f9ac3054-ad27-4644-affa-50d349506212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_f70e89bb-ce56-47ed-b606-4902ee3f315a" xlink:href="icui-20230331.xsd#icui_Contingentconsiderationgross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccf0f0f6-4bf8-4125-b257-579ac61d22a3" xlink:to="loc_icui_Contingentconsiderationgross_f70e89bb-ce56-47ed-b606-4902ee3f315a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_98840dd7-fb14-4d63-9b3c-9e6e106c7e0d" xlink:href="icui-20230331.xsd#icui_ContingentConsiderationGrossST"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccf0f0f6-4bf8-4125-b257-579ac61d22a3" xlink:to="loc_icui_ContingentConsiderationGrossST_98840dd7-fb14-4d63-9b3c-9e6e106c7e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_f0d9ff02-2cf8-4b75-b1ab-f81738116218" xlink:href="icui-20230331.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccf0f0f6-4bf8-4125-b257-579ac61d22a3" xlink:to="loc_icui_ContingentConsiderationGrossLT_f0d9ff02-2cf8-4b75-b1ab-f81738116218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a3a55ed0-dac6-4502-b430-b99d2831fd04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccf0f0f6-4bf8-4125-b257-579ac61d22a3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a3a55ed0-dac6-4502-b430-b99d2831fd04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#BusinessCombinationsandAssetAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a82d8a07-f37f-47a9-a1d7-1d1de1f0acc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e57ad856-47de-41d2-b0f3-5492c91bc581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a82d8a07-f37f-47a9-a1d7-1d1de1f0acc5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e57ad856-47de-41d2-b0f3-5492c91bc581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3b226500-301b-47cb-b3fe-21c40a927aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e57ad856-47de-41d2-b0f3-5492c91bc581" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3b226500-301b-47cb-b3fe-21c40a927aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_381c7dad-2b23-4692-a0fc-80956f4c6035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3b226500-301b-47cb-b3fe-21c40a927aa1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_381c7dad-2b23-4692-a0fc-80956f4c6035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_1668659d-3170-4ec8-a7ab-9d3739dd69f6" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_381c7dad-2b23-4692-a0fc-80956f4c6035" xlink:to="loc_icui_SmithsMedicalMember_1668659d-3170-4ec8-a7ab-9d3739dd69f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e57ad856-47de-41d2-b0f3-5492c91bc581" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ee2a937f-4cc5-4859-a50a-328b2aef9d68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ee2a937f-4cc5-4859-a50a-328b2aef9d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationTransferredCash_1d813172-4b06-4f87-9537-746bcd2a6ec0" xlink:href="icui-20230331.xsd#icui_BusinessCombinationConsiderationTransferredCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_icui_BusinessCombinationConsiderationTransferredCash_1d813172-4b06-4f87-9537-746bcd2a6ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_0865ac4a-9fad-4f91-9e1f-6b916dd34183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_0865ac4a-9fad-4f91-9e1f-6b916dd34183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_45782c37-8497-4a6f-999b-3c15747c175e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_45782c37-8497-4a6f-999b-3c15747c175e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MinimumStockPriceTargetForEarnOutPayment_a2fe5228-31c3-4297-b22f-18597678c4a0" xlink:href="icui-20230331.xsd#icui_MinimumStockPriceTargetForEarnOutPayment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_icui_MinimumStockPriceTargetForEarnOutPayment_a2fe5228-31c3-4297-b22f-18597678c4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_0de35cd3-0ac9-4c30-a783-497df4cb8c60" xlink:href="icui-20230331.xsd#icui_RequiredShareHoldingOfStockIssuedAtAcquisition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_0de35cd3-0ac9-4c30-a783-497df4cb8c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_54dfb818-5fac-425b-adea-6e3d45d4ac59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_54dfb818-5fac-425b-adea-6e3d45d4ac59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedParty_adadf7a7-70db-400f-a48c-7265a6714658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedParty"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b17721e7-c8b8-4ce5-b857-bc0901d25e4c" xlink:to="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedParty_adadf7a7-70db-400f-a48c-7265a6714658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_451739d9-9c7c-444f-9fe7-10782faa9cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_487096f3-8d9f-4bf8-b58b-05ea3cdc25d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_451739d9-9c7c-444f-9fe7-10782faa9cb5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_487096f3-8d9f-4bf8-b58b-05ea3cdc25d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9ae112be-b5dc-4cbf-9c07-4f8418cf042e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_487096f3-8d9f-4bf8-b58b-05ea3cdc25d4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9ae112be-b5dc-4cbf-9c07-4f8418cf042e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d41c1699-0d02-449d-8e89-1208e99bbec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9ae112be-b5dc-4cbf-9c07-4f8418cf042e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d41c1699-0d02-449d-8e89-1208e99bbec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_8cc15c10-f26e-4dec-bed1-77343ab6c87b" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d41c1699-0d02-449d-8e89-1208e99bbec6" xlink:to="loc_icui_SmithsMedicalMember_8cc15c10-f26e-4dec-bed1-77343ab6c87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97c1d9e6-0993-4a4d-b1a7-a64d13a255ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_487096f3-8d9f-4bf8-b58b-05ea3cdc25d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97c1d9e6-0993-4a4d-b1a7-a64d13a255ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97c1d9e6-0993-4a4d-b1a7-a64d13a255ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_15481407-734d-4789-8066-25345428e947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:to="loc_us-gaap_CustomerRelationshipsMember_15481407-734d-4789-8066-25345428e947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DevelopedTechnologyMember_ae039b4c-d9d4-473e-88f9-b5f1dec0b4c6" xlink:href="icui-20230331.xsd#icui_DevelopedTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:to="loc_icui_DevelopedTechnologyMember_ae039b4c-d9d4-473e-88f9-b5f1dec0b4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_a5db9010-bb17-4902-a5e6-5c3d706cc101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_a5db9010-bb17-4902-a5e6-5c3d706cc101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_f49f2774-f44c-4e95-98a5-daef1ed06486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_f49f2774-f44c-4e95-98a5-daef1ed06486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_dbef7099-710c-4b97-9611-12b039340335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_dbef7099-710c-4b97-9611-12b039340335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_ac663cf3-93e7-4dfe-bfda-ec4b71c88b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_ac663cf3-93e7-4dfe-bfda-ec4b71c88b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_8c5b0dc4-f281-41c2-a080-64f4dc2e1a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_837a3709-ddea-4d0a-a280-0728f4ecf0c6" xlink:to="loc_us-gaap_TrademarksMember_8c5b0dc4-f281-41c2-a080-64f4dc2e1a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_487096f3-8d9f-4bf8-b58b-05ea3cdc25d4" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_147a04d7-9909-4930-9a5b-97dd6b040857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_147a04d7-9909-4930-9a5b-97dd6b040857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b5064e38-e2fe-4804-b57d-473703d4a53b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b5064e38-e2fe-4804-b57d-473703d4a53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2393f4ca-90ae-4b10-be90-8077b1738913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2393f4ca-90ae-4b10-be90-8077b1738913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_d721a52a-0531-424b-9c2f-aa780a443c62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_d721a52a-0531-424b-9c2f-aa780a443c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_b3deee96-d36c-469a-a1b1-471b676aab42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_b3deee96-d36c-469a-a1b1-471b676aab42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0a1fd369-465b-49c3-96a3-6f8a4998a99d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0a1fd369-465b-49c3-96a3-6f8a4998a99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_51995bdc-f4da-47d9-935e-5d990e536bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_51995bdc-f4da-47d9-935e-5d990e536bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_96eb92e7-3f19-40e7-b5cb-fa7763d3be35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_96eb92e7-3f19-40e7-b5cb-fa7763d3be35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_159d0662-ccb8-4af3-8b8a-931bbc764723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_159d0662-ccb8-4af3-8b8a-931bbc764723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4d3f78b4-afe4-4e9d-a458-17171679e127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4d3f78b4-afe4-4e9d-a458-17171679e127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_4a9841cc-d105-4303-815d-1d9b6f218e4e" xlink:href="icui-20230331.xsd#icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_4a9841cc-d105-4303-815d-1d9b6f218e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ea31f9d4-172b-4739-932e-e5441da7663c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ea31f9d4-172b-4739-932e-e5441da7663c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_2d4285ac-1a5c-4d91-9550-3ebcda9efeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_2d4285ac-1a5c-4d91-9550-3ebcda9efeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c1fec463-1d48-41bb-a5a5-3f2f1ae825ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c1fec463-1d48-41bb-a5a5-3f2f1ae825ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_796b1b29-52ea-4717-96d2-3438958cd0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_796b1b29-52ea-4717-96d2-3438958cd0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_6cc53777-de40-4dd1-b945-54c54d8cc584" xlink:href="icui-20230331.xsd#icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_6cc53777-de40-4dd1-b945-54c54d8cc584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_5a9ccd23-ea9d-4071-a405-23ed6b888511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_5a9ccd23-ea9d-4071-a405-23ed6b888511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2d6ba994-54c0-4b5b-b410-e982f11c750a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2d6ba994-54c0-4b5b-b410-e982f11c750a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_4e673050-1f72-4e41-a880-2dd6faf1e021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_4e673050-1f72-4e41-a880-2dd6faf1e021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationGoodwillNonDeductible_50cbf5dd-6e55-4155-ae5f-a83a1c8e7e16" xlink:href="icui-20230331.xsd#icui_BusinessCombinationGoodwillNonDeductible"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_icui_BusinessCombinationGoodwillNonDeductible_50cbf5dd-6e55-4155-ae5f-a83a1c8e7e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a8cd192d-af6a-47e4-87a8-f985e0f9a0de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a8cd192d-af6a-47e4-87a8-f985e0f9a0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c9911251-6ca8-4c43-b86b-86b0101cffbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_edef37dc-cc32-4c22-bc7b-e4d90f801f86" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c9911251-6ca8-4c43-b86b-86b0101cffbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_552fbc01-3869-42cb-9547-ac5255b153d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_849d8952-1c5d-4044-84c6-87e733392b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_552fbc01-3869-42cb-9547-ac5255b153d5" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_849d8952-1c5d-4044-84c6-87e733392b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d775c386-7e4b-4d36-98a5-1ce216affd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_849d8952-1c5d-4044-84c6-87e733392b0f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d775c386-7e4b-4d36-98a5-1ce216affd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1d8f4520-feb9-4578-80a3-33fc8dd4823b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d775c386-7e4b-4d36-98a5-1ce216affd75" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1d8f4520-feb9-4578-80a3-33fc8dd4823b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3689c445-e681-4c3c-8690-f63dea04414c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d8f4520-feb9-4578-80a3-33fc8dd4823b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3689c445-e681-4c3c-8690-f63dea04414c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_570b8635-8fa4-4752-b968-7f13e3d2c297" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3689c445-e681-4c3c-8690-f63dea04414c" xlink:to="loc_icui_SmithsMedicalMember_570b8635-8fa4-4752-b968-7f13e3d2c297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6f619a6a-4387-40b9-b284-15f7e750059e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d775c386-7e4b-4d36-98a5-1ce216affd75" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_6f619a6a-4387-40b9-b284-15f7e750059e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_44c3e4e0-ed26-46fb-b2ba-9c493a460219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6f619a6a-4387-40b9-b284-15f7e750059e" xlink:to="loc_us-gaap_Revenues_44c3e4e0-ed26-46fb-b2ba-9c493a460219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1321e030-f0bf-4bad-b582-bb379ac8c2df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6f619a6a-4387-40b9-b284-15f7e750059e" xlink:to="loc_us-gaap_ProfitLoss_1321e030-f0bf-4bad-b582-bb379ac8c2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_454d7d47-2abb-46a3-8f4b-04cb90d4c16c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_552fbc01-3869-42cb-9547-ac5255b153d5" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_454d7d47-2abb-46a3-8f4b-04cb90d4c16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentAmortization_b3796aa1-56f0-48fb-aa05-8d0c92d9856c" xlink:href="icui-20230331.xsd#icui_ProFormaAdjustmentAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_552fbc01-3869-42cb-9547-ac5255b153d5" xlink:to="loc_icui_ProFormaAdjustmentAmortization_b3796aa1-56f0-48fb-aa05-8d0c92d9856c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentFinanceCosts_dba0c9a2-75de-4762-8577-741f77c39f82" xlink:href="icui-20230331.xsd#icui_ProFormaAdjustmentFinanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_552fbc01-3869-42cb-9547-ac5255b153d5" xlink:to="loc_icui_ProFormaAdjustmentFinanceCosts_dba0c9a2-75de-4762-8577-741f77c39f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bfb3a757-b6c6-4619-9d83-5cd22521c711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_552fbc01-3869-42cb-9547-ac5255b153d5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bfb3a757-b6c6-4619-9d83-5cd22521c711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4d525204-f89a-4ce9-93af-c91d0aae0930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0abb1433-6bd5-4a12-a72f-73ba5fbaaecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_0c2003f5-40e6-4a55-87f2-d6d967f10b90" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7f70aca5-c2fc-4f5c-9ba9-b708d58584c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ca6f157e-aa00-4903-8b6b-2fbadd068ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a5d7ea48-8105-4894-9960-c60c1159aba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#RestructuringStrategicTransactionandIntegrationRestructuringDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f1d73da3-dee9-4ec0-ad83-6f563b363a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringstrategictransactionandintegration_3fea0305-18a0-4626-a50b-052efa7ccb41" xlink:href="icui-20230331.xsd#icui_Restructuringstrategictransactionandintegration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f1d73da3-dee9-4ec0-ad83-6f563b363a23" xlink:to="loc_icui_Restructuringstrategictransactionandintegration_3fea0305-18a0-4626-a50b-052efa7ccb41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_c058e49c-6503-4475-a3b0-8af6616ed06a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f1d73da3-dee9-4ec0-ad83-6f563b363a23" xlink:to="loc_us-gaap_RestructuringCosts_c058e49c-6503-4475-a3b0-8af6616ed06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#RestructuringStrategicTransactionandIntegrationLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_fb2cbef1-705c-4f7f-b4ee-ba42ddfec3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_de77e776-3f61-49ef-a5dc-175043c88071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_fb2cbef1-705c-4f7f-b4ee-ba42ddfec3e3" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_de77e776-3f61-49ef-a5dc-175043c88071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_d214d39c-65fd-4479-b52e-29ea0027a191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_de77e776-3f61-49ef-a5dc-175043c88071" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_d214d39c-65fd-4479-b52e-29ea0027a191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_49e8fc1e-f48e-4a79-9a3f-5c43635e2bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_d214d39c-65fd-4479-b52e-29ea0027a191" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_49e8fc1e-f48e-4a79-9a3f-5c43635e2bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_43325eb7-7121-4189-af44-0bf0f92c9758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_49e8fc1e-f48e-4a79-9a3f-5c43635e2bcc" xlink:to="loc_us-gaap_EmployeeSeveranceMember_43325eb7-7121-4189-af44-0bf0f92c9758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_6dce92a1-60ac-4716-9a93-b1623e65f689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FacilityClosingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_49e8fc1e-f48e-4a79-9a3f-5c43635e2bcc" xlink:to="loc_us-gaap_FacilityClosingMember_6dce92a1-60ac-4716-9a93-b1623e65f689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_dbd52065-d994-4320-bc3c-76d01d759197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_de77e776-3f61-49ef-a5dc-175043c88071" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_dbd52065-d994-4320-bc3c-76d01d759197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_fc8f43f5-549c-4aa5-b25a-afd3f6763fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dbd52065-d994-4320-bc3c-76d01d759197" xlink:to="loc_us-gaap_RestructuringReserve_fc8f43f5-549c-4aa5-b25a-afd3f6763fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_64008d66-5a82-4b9c-8d6d-79759da1609c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dbd52065-d994-4320-bc3c-76d01d759197" xlink:to="loc_us-gaap_RestructuringCharges_64008d66-5a82-4b9c-8d6d-79759da1609c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_d3dbde56-907d-41b8-9ffc-8d4924936294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dbd52065-d994-4320-bc3c-76d01d759197" xlink:to="loc_us-gaap_PaymentsForRestructuring_d3dbde56-907d-41b8-9ffc-8d4924936294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_4311b385-ebf1-42b3-b2ec-ce4c22f08624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dbd52065-d994-4320-bc3c-76d01d759197" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_4311b385-ebf1-42b3-b2ec-ce4c22f08624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_f43c735e-2dda-4b7f-b52a-4e29994ac55a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dbd52065-d994-4320-bc3c-76d01d759197" xlink:to="loc_us-gaap_RestructuringReserve_f43c735e-2dda-4b7f-b52a-4e29994ac55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_423f09cd-ced1-4db8-823b-b61cf777d027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dbd52065-d994-4320-bc3c-76d01d759197" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_423f09cd-ced1-4db8-823b-b61cf777d027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/StrategicTransactionandIntegrationDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#StrategicTransactionandIntegrationDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/StrategicTransactionandIntegrationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_554a586e-c368-4438-8176-9bdb68141a74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_StrategicTransactionandIntegration_b796a3e2-04c1-4687-9ea0-057445bcd67f" xlink:href="icui-20230331.xsd#icui_StrategicTransactionandIntegration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_554a586e-c368-4438-8176-9bdb68141a74" xlink:to="loc_icui_StrategicTransactionandIntegration_b796a3e2-04c1-4687-9ea0-057445bcd67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#RevenueDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cb5ac070-b1eb-4e4e-aaf1-7278de06c0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_7730d3c3-63c9-4d17-b3f6-5dfbe2275811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cb5ac070-b1eb-4e4e-aaf1-7278de06c0bd" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_7730d3c3-63c9-4d17-b3f6-5dfbe2275811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6c284617-37d4-4b3d-bc53-f454275c6d7b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7730d3c3-63c9-4d17-b3f6-5dfbe2275811" xlink:to="loc_srt_ProductOrServiceAxis_6c284617-37d4-4b3d-bc53-f454275c6d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dc7fbf29-79e2-4a82-9852-d67ffa8d9bf9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6c284617-37d4-4b3d-bc53-f454275c6d7b" xlink:to="loc_srt_ProductsAndServicesDomain_dc7fbf29-79e2-4a82-9852-d67ffa8d9bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember_3c0d5789-e10c-41d5-ae2b-861bd50aa5b4" xlink:href="icui-20230331.xsd#icui_InfusionSystemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dc7fbf29-79e2-4a82-9852-d67ffa8d9bf9" xlink:to="loc_icui_InfusionSystemsMember_3c0d5789-e10c-41d5-ae2b-861bd50aa5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember_1f13677e-2dde-4b41-a544-fdecab3341af" xlink:href="icui-20230331.xsd#icui_EquipmentrevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dc7fbf29-79e2-4a82-9852-d67ffa8d9bf9" xlink:to="loc_icui_EquipmentrevenueMember_1f13677e-2dde-4b41-a544-fdecab3341af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember_1f025280-a975-4b65-b2d5-037f130d7704" xlink:href="icui-20230331.xsd#icui_SoftwarerevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dc7fbf29-79e2-4a82-9852-d67ffa8d9bf9" xlink:to="loc_icui_SoftwarerevenueMember_1f025280-a975-4b65-b2d5-037f130d7704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c183e290-17af-403d-9f77-6309fba648ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7730d3c3-63c9-4d17-b3f6-5dfbe2275811" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_c183e290-17af-403d-9f77-6309fba648ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_de632793-3568-4a54-aec2-8759fdfe0bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c183e290-17af-403d-9f77-6309fba648ad" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_de632793-3568-4a54-aec2-8759fdfe0bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#RevenueDisaggregatedRevenuebyGeographyDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_df2bd148-456c-4fae-973f-8d02bef916a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_0ed12e7a-8620-4b30-9c33-85a874c5a633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_df2bd148-456c-4fae-973f-8d02bef916a9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_0ed12e7a-8620-4b30-9c33-85a874c5a633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_993975da-d1e1-4c9f-946c-f74686efb6ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0ed12e7a-8620-4b30-9c33-85a874c5a633" xlink:to="loc_srt_StatementGeographicalAxis_993975da-d1e1-4c9f-946c-f74686efb6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4b3be033-a6d2-4be5-baba-037986cb664e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_993975da-d1e1-4c9f-946c-f74686efb6ba" xlink:to="loc_srt_SegmentGeographicalDomain_4b3be033-a6d2-4be5-baba-037986cb664e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_d63962df-6926-451b-b690-792762db6741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4b3be033-a6d2-4be5-baba-037986cb664e" xlink:to="loc_us-gaap_EMEAMember_d63962df-6926-451b-b690-792762db6741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_46ab0f76-d58f-44ff-8f9d-a98a4ad4f1bc" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4b3be033-a6d2-4be5-baba-037986cb664e" xlink:to="loc_country_US_46ab0f76-d58f-44ff-8f9d-a98a4ad4f1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_c40b8a47-5057-4afb-a62d-53b5eb572b86" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4b3be033-a6d2-4be5-baba-037986cb664e" xlink:to="loc_srt_AsiaPacificMember_c40b8a47-5057-4afb-a62d-53b5eb572b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherforeigncountriesMember_83365fee-bf07-41bc-b905-1ea39dcc4865" xlink:href="icui-20230331.xsd#icui_OtherforeigncountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4b3be033-a6d2-4be5-baba-037986cb664e" xlink:to="loc_icui_OtherforeigncountriesMember_83365fee-bf07-41bc-b905-1ea39dcc4865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c5273e51-f5aa-4832-b197-23946710c373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0ed12e7a-8620-4b30-9c33-85a874c5a633" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_c5273e51-f5aa-4832-b197-23946710c373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_94931288-435e-4462-83d4-79f0dca6a17f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c5273e51-f5aa-4832-b197-23946710c373" xlink:to="loc_us-gaap_Revenues_94931288-435e-4462-83d4-79f0dca6a17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#RevenueDisaggregatedRevenuebyProductLineDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7f5fa411-4d5b-4b32-9cac-bed66a3e0e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_21ca8a19-1d05-4bc8-a5ae-88842287c4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7f5fa411-4d5b-4b32-9cac-bed66a3e0e47" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_21ca8a19-1d05-4bc8-a5ae-88842287c4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d00bfc0d-cdbd-4fbc-ba93-749c0d788e3f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_21ca8a19-1d05-4bc8-a5ae-88842287c4cd" xlink:to="loc_srt_ProductOrServiceAxis_d00bfc0d-cdbd-4fbc-ba93-749c0d788e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0f3f814b-52eb-49bd-bfeb-61340f75499d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d00bfc0d-cdbd-4fbc-ba93-749c0d788e3f" xlink:to="loc_srt_ProductsAndServicesDomain_0f3f814b-52eb-49bd-bfeb-61340f75499d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesMember_b1986283-4eb4-4466-a305-2020b8d3b58d" xlink:href="icui-20230331.xsd#icui_InfusionConsumablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0f3f814b-52eb-49bd-bfeb-61340f75499d" xlink:to="loc_icui_InfusionConsumablesMember_b1986283-4eb4-4466-a305-2020b8d3b58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember_a1e05b08-8040-4004-9b4a-d2e4dafe1fb2" xlink:href="icui-20230331.xsd#icui_InfusionSystemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0f3f814b-52eb-49bd-bfeb-61340f75499d" xlink:to="loc_icui_InfusionSystemsMember_a1e05b08-8040-4004-9b4a-d2e4dafe1fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_VitalCareMember_6d50790d-9c66-44d9-a804-f3b26882e907" xlink:href="icui-20230331.xsd#icui_VitalCareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0f3f814b-52eb-49bd-bfeb-61340f75499d" xlink:to="loc_icui_VitalCareMember_6d50790d-9c66-44d9-a804-f3b26882e907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_533dfd72-da6c-41bc-a2f3-2ca5ef0b8dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_21ca8a19-1d05-4bc8-a5ae-88842287c4cd" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_533dfd72-da6c-41bc-a2f3-2ca5ef0b8dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9e434e5e-366e-4ab3-9a5c-83b3a39f74c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_533dfd72-da6c-41bc-a2f3-2ca5ef0b8dd8" xlink:to="loc_us-gaap_Revenues_9e434e5e-366e-4ab3-9a5c-83b3a39f74c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueContractLiabilitiesDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#RevenueContractLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6a65de97-65d8-4f1f-9c3f-36b32af23222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesTable_effe4862-9e61-4ade-a26f-c35a483d21f4" xlink:href="icui-20230331.xsd#icui_ContractassetandliabilitybalancesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6a65de97-65d8-4f1f-9c3f-36b32af23222" xlink:to="loc_icui_ContractassetandliabilitybalancesTable_effe4862-9e61-4ade-a26f-c35a483d21f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c60f5244-6fed-466e-974a-26b6f883ebf6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_effe4862-9e61-4ade-a26f-c35a483d21f4" xlink:to="loc_srt_ProductOrServiceAxis_c60f5244-6fed-466e-974a-26b6f883ebf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7774bdb2-1765-4190-8443-3966584b1d20" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c60f5244-6fed-466e-974a-26b6f883ebf6" xlink:to="loc_srt_ProductsAndServicesDomain_7774bdb2-1765-4190-8443-3966584b1d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember_00fe5d42-1785-45ac-a2b3-b3a7fbfd0dde" xlink:href="icui-20230331.xsd#icui_EquipmentrevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7774bdb2-1765-4190-8443-3966584b1d20" xlink:to="loc_icui_EquipmentrevenueMember_00fe5d42-1785-45ac-a2b3-b3a7fbfd0dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember_c271c4d6-7b1a-45c3-9e1d-41b6425020b6" xlink:href="icui-20230331.xsd#icui_SoftwarerevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7774bdb2-1765-4190-8443-3966584b1d20" xlink:to="loc_icui_SoftwarerevenueMember_c271c4d6-7b1a-45c3-9e1d-41b6425020b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GovernmentGrantRevenueMember_207e5fef-fe6d-41f5-ae6e-415fe8ca50f9" xlink:href="icui-20230331.xsd#icui_GovernmentGrantRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7774bdb2-1765-4190-8443-3966584b1d20" xlink:to="loc_icui_GovernmentGrantRevenueMember_207e5fef-fe6d-41f5-ae6e-415fe8ca50f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherDeferredRevenueMember_d68e9ece-912a-4b21-b2bc-b192e5df1c8b" xlink:href="icui-20230331.xsd#icui_OtherDeferredRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7774bdb2-1765-4190-8443-3966584b1d20" xlink:to="loc_icui_OtherDeferredRevenueMember_d68e9ece-912a-4b21-b2bc-b192e5df1c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6c29b8fc-b92f-4f73-aa0e-f46916f2f8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_effe4862-9e61-4ade-a26f-c35a483d21f4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6c29b8fc-b92f-4f73-aa0e-f46916f2f8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc9b5c91-655b-4c26-adbc-0303bcc0b64c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6c29b8fc-b92f-4f73-aa0e-f46916f2f8d6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc9b5c91-655b-4c26-adbc-0303bcc0b64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_2ee92cbc-3c71-45e5-8255-915ca7c7f3ac" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc9b5c91-655b-4c26-adbc-0303bcc0b64c" xlink:to="loc_icui_SmithsMedicalMember_2ee92cbc-3c71-45e5-8255-915ca7c7f3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_ccdd5c53-1be0-4fc7-8613-e5ceb9c6b7ca" xlink:href="icui-20230331.xsd#icui_TimingAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_effe4862-9e61-4ade-a26f-c35a483d21f4" xlink:to="loc_icui_TimingAxis_ccdd5c53-1be0-4fc7-8613-e5ceb9c6b7ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_2a2dc6f8-c3de-460f-9fa6-9bbcc629bd3b" xlink:href="icui-20230331.xsd#icui_TimingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingAxis_ccdd5c53-1be0-4fc7-8613-e5ceb9c6b7ca" xlink:to="loc_icui_TimingDomain_2a2dc6f8-c3de-460f-9fa6-9bbcc629bd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermMember_3b802677-759e-4c20-99a4-2c680b37d4f0" xlink:href="icui-20230331.xsd#icui_ShortTermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingDomain_2a2dc6f8-c3de-460f-9fa6-9bbcc629bd3b" xlink:to="loc_icui_ShortTermMember_3b802677-759e-4c20-99a4-2c680b37d4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermMember_953dd635-29a4-4990-9812-71365cb6156c" xlink:href="icui-20230331.xsd#icui_LongTermMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingDomain_2a2dc6f8-c3de-460f-9fa6-9bbcc629bd3b" xlink:to="loc_icui_LongTermMember_953dd635-29a4-4990-9812-71365cb6156c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesLineItems_3d8eac9d-647f-4a67-8220-b5fb5a784a3f" xlink:href="icui-20230331.xsd#icui_ContractassetandliabilitybalancesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_effe4862-9e61-4ade-a26f-c35a483d21f4" xlink:to="loc_icui_ContractassetandliabilitybalancesLineItems_3d8eac9d-647f-4a67-8220-b5fb5a784a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInDeferredRevenueRollForward_548c3f63-6256-4c2d-99c4-a86ef8f7d23e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInDeferredRevenueRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_3d8eac9d-647f-4a67-8220-b5fb5a784a3f" xlink:to="loc_us-gaap_MovementInDeferredRevenueRollForward_548c3f63-6256-4c2d-99c4-a86ef8f7d23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_fe68e37c-630e-4d85-9e50-8da3d39bdd37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_3d8eac9d-647f-4a67-8220-b5fb5a784a3f" xlink:to="loc_us-gaap_ContractWithCustomerLiability_fe68e37c-630e-4d85-9e50-8da3d39bdd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_91b0fd39-46f6-403d-8ea0-e86ed915f659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_3d8eac9d-647f-4a67-8220-b5fb5a784a3f" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_91b0fd39-46f6-403d-8ea0-e86ed915f659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueAdditions_ad88ed46-95ad-4065-9547-2c6397ef7ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueAdditions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_3d8eac9d-647f-4a67-8220-b5fb5a784a3f" xlink:to="loc_us-gaap_DeferredRevenueAdditions_ad88ed46-95ad-4065-9547-2c6397ef7ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_734d0426-4195-4612-ba33-3eff9cd67b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_3d8eac9d-647f-4a67-8220-b5fb5a784a3f" xlink:to="loc_us-gaap_ContractWithCustomerLiability_734d0426-4195-4612-ba33-3eff9cd67b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_ee722d68-7fe1-4763-a2c5-437e92101f30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_3d8eac9d-647f-4a67-8220-b5fb5a784a3f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_ee722d68-7fe1-4763-a2c5-437e92101f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesTextDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#LeasesTextDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ba0fcae9-1754-46f0-a21f-84e0065c9ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_9378c173-efa8-4338-b922-d1cd1d814540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ba0fcae9-1754-46f0-a21f-84e0065c9ddf" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_9378c173-efa8-4338-b922-d1cd1d814540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d522147e-fdd7-4956-8fd7-0a10ca6e7d5b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_9378c173-efa8-4338-b922-d1cd1d814540" xlink:to="loc_srt_RangeAxis_d522147e-fdd7-4956-8fd7-0a10ca6e7d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_adf37431-4528-4641-b219-7f69eef8b4ff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d522147e-fdd7-4956-8fd7-0a10ca6e7d5b" xlink:to="loc_srt_RangeMember_adf37431-4528-4641-b219-7f69eef8b4ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_fde23c6d-b6a1-4f76-bb32-0f5845b5e427" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_adf37431-4528-4641-b219-7f69eef8b4ff" xlink:to="loc_srt_MaximumMember_fde23c6d-b6a1-4f76-bb32-0f5845b5e427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_db468022-e32e-420c-bc1a-376bfb459688" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_adf37431-4528-4641-b219-7f69eef8b4ff" xlink:to="loc_srt_MinimumMember_db468022-e32e-420c-bc1a-376bfb459688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_7a158a1a-b99b-424a-93a0-9568e63a6b51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_9378c173-efa8-4338-b922-d1cd1d814540" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_7a158a1a-b99b-424a-93a0-9568e63a6b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Optiontoextendinyears_82a98c5a-b1e2-4ac3-aeb6-d0048c9930c9" xlink:href="icui-20230331.xsd#icui_Optiontoextendinyears"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7a158a1a-b99b-424a-93a0-9568e63a6b51" xlink:to="loc_icui_Optiontoextendinyears_82a98c5a-b1e2-4ac3-aeb6-d0048c9930c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_8eb9a58e-8f71-4626-bed1-cd98875e7ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7a158a1a-b99b-424a-93a0-9568e63a6b51" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_8eb9a58e-8f71-4626-bed1-cd98875e7ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#LeasesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_909cf38e-722f-4ace-95ce-42d28e6c54b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_947507a8-858a-4e05-92cf-d0a5f4b7d8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_909cf38e-722f-4ace-95ce-42d28e6c54b4" xlink:to="loc_us-gaap_OperatingLeaseCost_947507a8-858a-4e05-92cf-d0a5f4b7d8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_fb525758-c5e8-4cc5-8e9d-c91ec3871973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_909cf38e-722f-4ace-95ce-42d28e6c54b4" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_fb525758-c5e8-4cc5-8e9d-c91ec3871973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6d5a0ecb-11ed-488f-88eb-00799a371f49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_909cf38e-722f-4ace-95ce-42d28e6c54b4" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6d5a0ecb-11ed-488f-88eb-00799a371f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_06ac47dd-f76b-4d23-b927-8486a22875bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_909cf38e-722f-4ace-95ce-42d28e6c54b4" xlink:to="loc_us-gaap_ShortTermLeaseCost_06ac47dd-f76b-4d23-b927-8486a22875bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_076c6e7b-9254-4200-aab0-625e55095c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_909cf38e-722f-4ace-95ce-42d28e6c54b4" xlink:to="loc_us-gaap_LeaseCost_076c6e7b-9254-4200-aab0-625e55095c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#LeasesCashFlowOperatingActivitiesLesseeDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_15ccd6e8-8004-46b2-8549-47e98d70c668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_5f913fc0-72e4-49c5-a039-b9e28f28de46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_15ccd6e8-8004-46b2-8549-47e98d70c668" xlink:to="loc_us-gaap_OperatingLeasePayments_5f913fc0-72e4-49c5-a039-b9e28f28de46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_9c453509-8896-4e74-a6fc-7c1af4194335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_15ccd6e8-8004-46b2-8549-47e98d70c668" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_9c453509-8896-4e74-a6fc-7c1af4194335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_74329171-14fa-4c90-80f3-a4a4c30b62eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_15ccd6e8-8004-46b2-8549-47e98d70c668" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_74329171-14fa-4c90-80f3-a4a4c30b62eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_d5293b91-347e-418b-b902-154a73024430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_15ccd6e8-8004-46b2-8549-47e98d70c668" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_d5293b91-347e-418b-b902-154a73024430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#LeasesAssetsandLiabilitiesLesseeDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_730ad377-ceb6-4fdd-81d1-c32e7a370e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_d431886e-7be6-4747-9fa3-ce9e702962b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_730ad377-ceb6-4fdd-81d1-c32e7a370e5b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_d431886e-7be6-4747-9fa3-ce9e702962b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_410d81c4-5881-4c07-ad9f-252989eff113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_730ad377-ceb6-4fdd-81d1-c32e7a370e5b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_410d81c4-5881-4c07-ad9f-252989eff113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b6f80136-6c25-4035-b95b-cb8f56048a45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_730ad377-ceb6-4fdd-81d1-c32e7a370e5b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b6f80136-6c25-4035-b95b-cb8f56048a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_5bfd0479-4d8b-4421-b76d-352ce134f40d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_730ad377-ceb6-4fdd-81d1-c32e7a370e5b" xlink:to="loc_us-gaap_OperatingLeaseLiability_5bfd0479-4d8b-4421-b76d-352ce134f40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1cb7f78b-d093-468f-a37a-2044f49ae509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_730ad377-ceb6-4fdd-81d1-c32e7a370e5b" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1cb7f78b-d093-468f-a37a-2044f49ae509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_39fcbba7-cf16-49b9-9101-d198657fcf7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_730ad377-ceb6-4fdd-81d1-c32e7a370e5b" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_39fcbba7-cf16-49b9-9101-d198657fcf7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_9f7bfbd2-12ea-48ec-9044-c36092518ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_730ad377-ceb6-4fdd-81d1-c32e7a370e5b" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_9f7bfbd2-12ea-48ec-9044-c36092518ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_d5a1bbbb-b4f7-426b-b492-9d862d3ef140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_730ad377-ceb6-4fdd-81d1-c32e7a370e5b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_d5a1bbbb-b4f7-426b-b492-9d862d3ef140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c48f2c81-c07a-4898-aaff-2ded36ed2c82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_730ad377-ceb6-4fdd-81d1-c32e7a370e5b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c48f2c81-c07a-4898-aaff-2ded36ed2c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_13287fef-5ed0-4cf8-b046-4f1a5a0801e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_730ad377-ceb6-4fdd-81d1-c32e7a370e5b" xlink:to="loc_us-gaap_FinanceLeaseLiability_13287fef-5ed0-4cf8-b046-4f1a5a0801e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_56b97c3f-7fc6-4ac3-9bae-bb5055be9772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_730ad377-ceb6-4fdd-81d1-c32e7a370e5b" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_56b97c3f-7fc6-4ac3-9bae-bb5055be9772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_48e669df-8717-4eb5-97e8-664a3317ee53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_730ad377-ceb6-4fdd-81d1-c32e7a370e5b" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_48e669df-8717-4eb5-97e8-664a3317ee53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesMaturityDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#LeasesMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_f8b5b4dd-09d2-4515-a004-c8d6c2999416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_f8b5b4dd-09d2-4515-a004-c8d6c2999416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a74055f7-84de-4b00-99de-81a31aa02f15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a74055f7-84de-4b00-99de-81a31aa02f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5106302b-2002-4093-814e-f94924bbcb66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5106302b-2002-4093-814e-f94924bbcb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2a14438c-7dc6-4645-8553-99622e8c5fae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2a14438c-7dc6-4645-8553-99622e8c5fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2f8f64b9-faa8-4c56-81d4-8b79fc451ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2f8f64b9-faa8-4c56-81d4-8b79fc451ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4bb2d184-6e54-4cd2-94dd-c26c27e68d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4bb2d184-6e54-4cd2-94dd-c26c27e68d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9d5e75a9-3e5e-4358-a867-e95e0816bfc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9d5e75a9-3e5e-4358-a867-e95e0816bfc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d8abe909-ad45-4b06-ae97-c84aef351c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d8abe909-ad45-4b06-ae97-c84aef351c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6579dd51-8a42-4395-8b10-8c7cd67ec746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6579dd51-8a42-4395-8b10-8c7cd67ec746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0b02a50f-195e-4bb6-9f08-718a331d1b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_OperatingLeaseLiability_0b02a50f-195e-4bb6-9f08-718a331d1b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_c8e52af5-4838-4e82-8f3b-2a19dcebec20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_c8e52af5-4838-4e82-8f3b-2a19dcebec20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c49477c5-923a-4147-8de4-f6ddff03e61c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c49477c5-923a-4147-8de4-f6ddff03e61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_c83af308-32ac-4893-937a-b9c6cf57547c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_c83af308-32ac-4893-937a-b9c6cf57547c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_ba22e81f-d3af-4d9d-bc35-e5221385ddc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_ba22e81f-d3af-4d9d-bc35-e5221385ddc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_c0c84808-5219-4b6d-94ca-19fc7ad7ad2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_c0c84808-5219-4b6d-94ca-19fc7ad7ad2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_3ab510a2-6d9e-4148-b3f9-32f6972199cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_3ab510a2-6d9e-4148-b3f9-32f6972199cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_893fb2ca-ae0e-42c7-ba89-376c42982266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_893fb2ca-ae0e-42c7-ba89-376c42982266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_fe7ada99-34ea-4977-8b4e-aa755d5f5bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_fe7ada99-34ea-4977-8b4e-aa755d5f5bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_3636da58-1f73-4de0-a88b-e1af077cf95a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_3636da58-1f73-4de0-a88b-e1af077cf95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_fd0366df-fad8-49d6-a555-c8fc0372da22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_915da8f0-256c-413f-b40b-5ba73d579f76" xlink:to="loc_us-gaap_FinanceLeaseLiability_fd0366df-fad8-49d6-a555-c8fc0372da22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#NetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_64f08be2-b4aa-4cf4-90f3-40681a1fbf92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6de5b74c-4894-47ec-bc0f-79ba3ef6d5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_64f08be2-b4aa-4cf4-90f3-40681a1fbf92" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6de5b74c-4894-47ec-bc0f-79ba3ef6d5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3e72414e-8aa8-4058-8b87-a6cd45ec0a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6de5b74c-4894-47ec-bc0f-79ba3ef6d5a6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3e72414e-8aa8-4058-8b87-a6cd45ec0a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b93b1931-e421-4ee0-8412-06c55222a9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3e72414e-8aa8-4058-8b87-a6cd45ec0a42" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b93b1931-e421-4ee0-8412-06c55222a9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edc94de0-9fd1-4e6c-94f7-e5c578ea14db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6de5b74c-4894-47ec-bc0f-79ba3ef6d5a6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edc94de0-9fd1-4e6c-94f7-e5c578ea14db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9704244a-4682-4665-90d4-31996c1566d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edc94de0-9fd1-4e6c-94f7-e5c578ea14db" xlink:to="loc_us-gaap_ProfitLoss_9704244a-4682-4665-90d4-31996c1566d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_75941ec9-46ed-4abb-91c5-94dc11969ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edc94de0-9fd1-4e6c-94f7-e5c578ea14db" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_75941ec9-46ed-4abb-91c5-94dc11969ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a9f8975d-2e82-4775-b58e-e91177816a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edc94de0-9fd1-4e6c-94f7-e5c578ea14db" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a9f8975d-2e82-4775-b58e-e91177816a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7c0c5f2b-0a37-455c-91e3-649345eac297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edc94de0-9fd1-4e6c-94f7-e5c578ea14db" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7c0c5f2b-0a37-455c-91e3-649345eac297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c45c941a-fefd-4233-bcbe-dec15a5fd9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edc94de0-9fd1-4e6c-94f7-e5c578ea14db" xlink:to="loc_us-gaap_EarningsPerShareBasic_c45c941a-fefd-4233-bcbe-dec15a5fd9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f2df943d-2540-4a4e-8c02-1dbaf5fed3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edc94de0-9fd1-4e6c-94f7-e5c578ea14db" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f2df943d-2540-4a4e-8c02-1dbaf5fed3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NetIncomePerShareDetails1" xlink:type="simple" xlink:href="icui-20230331.xsd#NetIncomePerShareDetails1"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NetIncomePerShareDetails1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_fbec11bc-7c7a-49c2-ad31-2061b47fc3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8b43194b-4447-4beb-ba48-4abf6fafc8df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fbec11bc-7c7a-49c2-ad31-2061b47fc3d6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8b43194b-4447-4beb-ba48-4abf6fafc8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_485418d4-476f-4959-9109-d1fb33d20513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fbec11bc-7c7a-49c2-ad31-2061b47fc3d6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_485418d4-476f-4959-9109-d1fb33d20513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_bbb349ec-8868-4de9-8a48-e4937da0f63e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fbec11bc-7c7a-49c2-ad31-2061b47fc3d6" xlink:to="loc_us-gaap_EarningsPerShareBasic_bbb349ec-8868-4de9-8a48-e4937da0f63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2ce9fa7b-aa77-4499-a1ce-ca654f50090f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fbec11bc-7c7a-49c2-ad31-2061b47fc3d6" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2ce9fa7b-aa77-4499-a1ce-ca654f50090f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a4057fa4-fbff-40bb-8d27-0c9967356ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_4bd205e8-6644-4c52-8a2f-816d37db672c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a4057fa4-fbff-40bb-8d27-0c9967356ca5" xlink:to="loc_us-gaap_DerivativeTable_4bd205e8-6644-4c52-8a2f-816d37db672c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_c3b6e9df-14f8-4f1c-878a-5e7ec83753d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4bd205e8-6644-4c52-8a2f-816d37db672c" xlink:to="loc_srt_CurrencyAxis_c3b6e9df-14f8-4f1c-878a-5e7ec83753d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_c3b6e9df-14f8-4f1c-878a-5e7ec83753d8" xlink:to="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN_31cc48b7-2fa9-4fef-accb-ac1c1d0d33fc" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_MXN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:to="loc_currency_MXN_31cc48b7-2fa9-4fef-accb-ac1c1d0d33fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_7df16b07-b442-4408-9fbe-25885431df32" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:to="loc_currency_EUR_7df16b07-b442-4408-9fbe-25885431df32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CZK_7e718f4e-9f1c-48c4-927c-2b2924349899" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CZK"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:to="loc_currency_CZK_7e718f4e-9f1c-48c4-927c-2b2924349899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_3c747cc7-40ee-4adf-b83d-24059c71edc4" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:to="loc_currency_JPY_3c747cc7-40ee-4adf-b83d-24059c71edc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_37966327-1985-4c8d-b48a-6aae16034657" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:to="loc_currency_CAD_37966327-1985-4c8d-b48a-6aae16034657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD_52b0a91a-a92d-47be-9aae-f460a6b76cd6" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AUD"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:to="loc_currency_AUD_52b0a91a-a92d-47be-9aae-f460a6b76cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SEK_a0070c52-ebdd-4124-a1fe-a40715a8736c" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SEK"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_09efbe02-8bca-4894-8c27-e13b81d73a5a" xlink:to="loc_currency_SEK_a0070c52-ebdd-4124-a1fe-a40715a8736c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisAxis_ac110c0e-4931-409f-9cf8-a2e51b98c592" xlink:href="icui-20230331.xsd#icui_Srt_MultipleCurrencyAxisAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4bd205e8-6644-4c52-8a2f-816d37db672c" xlink:to="loc_icui_Srt_MultipleCurrencyAxisAxis_ac110c0e-4931-409f-9cf8-a2e51b98c592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisDomain_ad0f2daf-2b84-42f5-b824-249630435538" xlink:href="icui-20230331.xsd#icui_Srt_MultipleCurrencyAxisDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_Srt_MultipleCurrencyAxisAxis_ac110c0e-4931-409f-9cf8-a2e51b98c592" xlink:to="loc_icui_Srt_MultipleCurrencyAxisDomain_ad0f2daf-2b84-42f5-b824-249630435538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherCurrenciesMember_f14c04fa-82f1-41be-a338-30daf9b6ff19" xlink:href="icui-20230331.xsd#icui_OtherCurrenciesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_Srt_MultipleCurrencyAxisDomain_ad0f2daf-2b84-42f5-b824-249630435538" xlink:to="loc_icui_OtherCurrenciesMember_f14c04fa-82f1-41be-a338-30daf9b6ff19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_01fe53e6-5e2f-48fc-8df8-e49d0545b60a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4bd205e8-6644-4c52-8a2f-816d37db672c" xlink:to="loc_us-gaap_DerivativeLineItems_01fe53e6-5e2f-48fc-8df8-e49d0545b60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_c1fb5082-efb8-4bd4-a9a0-885902c838d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_01fe53e6-5e2f-48fc-8df8-e49d0545b60a" xlink:to="loc_us-gaap_DerivativeNotionalAmount_c1fb5082-efb8-4bd4-a9a0-885902c838d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#DerivativeFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2f1aad26-615c-4b35-a435-8f1de1f350a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_4f55a9ac-f154-493b-a210-78b3ecaf725f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2f1aad26-615c-4b35-a435-8f1de1f350a2" xlink:to="loc_us-gaap_DerivativeTable_4f55a9ac-f154-493b-a210-78b3ecaf725f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f14f1455-5144-4381-b017-737f84ec6f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4f55a9ac-f154-493b-a210-78b3ecaf725f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f14f1455-5144-4381-b017-737f84ec6f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fd069170-ee47-49e8-9c7d-db7f7d18e6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f14f1455-5144-4381-b017-737f84ec6f95" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fd069170-ee47-49e8-9c7d-db7f7d18e6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge2Member_e35d095d-672a-42df-b94c-28b1e81285ab" xlink:href="icui-20230331.xsd#icui_Hedge2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_fd069170-ee47-49e8-9c7d-db7f7d18e6fe" xlink:to="loc_icui_Hedge2Member_e35d095d-672a-42df-b94c-28b1e81285ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_97621ba4-228d-41b6-8280-1c5c03301c9d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4f55a9ac-f154-493b-a210-78b3ecaf725f" xlink:to="loc_srt_CurrencyAxis_97621ba4-228d-41b6-8280-1c5c03301c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_8a4c5284-7eb5-4b6a-9666-6ae9b3330ff9" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_97621ba4-228d-41b6-8280-1c5c03301c9d" xlink:to="loc_currency_AllCurrenciesDomain_8a4c5284-7eb5-4b6a-9666-6ae9b3330ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN_53166ae3-5667-44ee-97de-52cef61338e8" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_MXN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_8a4c5284-7eb5-4b6a-9666-6ae9b3330ff9" xlink:to="loc_currency_MXN_53166ae3-5667-44ee-97de-52cef61338e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_393221e2-5b47-45c1-95e5-e96f7c7e5530" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CNY"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_8a4c5284-7eb5-4b6a-9666-6ae9b3330ff9" xlink:to="loc_currency_CNY_393221e2-5b47-45c1-95e5-e96f7c7e5530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_163bb857-9aae-4b81-ae7c-440d8c133d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4f55a9ac-f154-493b-a210-78b3ecaf725f" xlink:to="loc_us-gaap_DerivativeLineItems_163bb857-9aae-4b81-ae7c-440d8c133d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeForwardExchangeRate1_064dfe70-a06c-4bd2-a661-abd14187d70e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeForwardExchangeRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_163bb857-9aae-4b81-ae7c-440d8c133d3c" xlink:to="loc_us-gaap_DerivativeForwardExchangeRate1_064dfe70-a06c-4bd2-a661-abd14187d70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_e9543104-3d1e-464f-b427-233128713362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_163bb857-9aae-4b81-ae7c-440d8c133d3c" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_e9543104-3d1e-464f-b427-233128713362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_72188eaf-306e-408a-9844-0ac8608aee99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_163bb857-9aae-4b81-ae7c-440d8c133d3c" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_72188eaf-306e-408a-9844-0ac8608aee99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a0b6a357-c832-4b93-ae8a-3218f2598120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_163bb857-9aae-4b81-ae7c-440d8c133d3c" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a0b6a357-c832-4b93-ae8a-3218f2598120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#DerivativeFinancialInstrumentsInterestRateSwapsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_db717457-b938-46ff-b608-293fb0859b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_196b348d-37aa-4b1a-aa79-9a69031365de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_db717457-b938-46ff-b608-293fb0859b27" xlink:to="loc_us-gaap_DerivativeTable_196b348d-37aa-4b1a-aa79-9a69031365de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_19820c97-77f3-4172-9341-f40788a9f5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_196b348d-37aa-4b1a-aa79-9a69031365de" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_19820c97-77f3-4172-9341-f40788a9f5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cfd49e59-e53c-42da-b5de-19665bb4490c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_19820c97-77f3-4172-9341-f40788a9f5b2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cfd49e59-e53c-42da-b5de-19665bb4490c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e8e244d3-3bd4-4897-b513-0387958173ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cfd49e59-e53c-42da-b5de-19665bb4490c" xlink:to="loc_us-gaap_InterestRateSwapMember_e8e244d3-3bd4-4897-b513-0387958173ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_5042df2d-3f0d-4e0b-bd16-d0042b173d6e" xlink:href="icui-20230331.xsd#icui_TermLoanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_196b348d-37aa-4b1a-aa79-9a69031365de" xlink:to="loc_icui_TermLoanAxis_5042df2d-3f0d-4e0b-bd16-d0042b173d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_b831e191-fdbe-480e-a2a7-65b25fce55ca" xlink:href="icui-20230331.xsd#icui_TermLoanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAxis_5042df2d-3f0d-4e0b-bd16-d0042b173d6e" xlink:to="loc_icui_TermLoanDomain_b831e191-fdbe-480e-a2a7-65b25fce55ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_c57b274a-2abd-4b95-bac8-4a23e4df1d2b" xlink:href="icui-20230331.xsd#icui_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_b831e191-fdbe-480e-a2a7-65b25fce55ca" xlink:to="loc_icui_TermLoanAMember_c57b274a-2abd-4b95-bac8-4a23e4df1d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_76c7e624-c4b2-48a4-a2f0-9d8cd939af94" xlink:href="icui-20230331.xsd#icui_TermLoanBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_b831e191-fdbe-480e-a2a7-65b25fce55ca" xlink:to="loc_icui_TermLoanBMember_76c7e624-c4b2-48a4-a2f0-9d8cd939af94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_7d9295d6-f362-4199-a26b-d431de54914a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_196b348d-37aa-4b1a-aa79-9a69031365de" xlink:to="loc_us-gaap_DerivativeLineItems_7d9295d6-f362-4199-a26b-d431de54914a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_6206447e-65b1-4eca-b421-e643879e4d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_7d9295d6-f362-4199-a26b-d431de54914a" xlink:to="loc_us-gaap_DerivativeNotionalAmount_6206447e-65b1-4eca-b421-e643879e4d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestRateSwapEndingNotionalValue_73c175b4-3f0d-459a-af03-2786171febb1" xlink:href="icui-20230331.xsd#icui_InterestRateSwapEndingNotionalValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_7d9295d6-f362-4199-a26b-d431de54914a" xlink:to="loc_icui_InterestRateSwapEndingNotionalValue_73c175b4-3f0d-459a-af03-2786171febb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_9c8ad3e7-a0ee-4bfa-abc9-5f374f80be14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_7d9295d6-f362-4199-a26b-d431de54914a" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_9c8ad3e7-a0ee-4bfa-abc9-5f374f80be14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DerivativeVariableRateFloor_b3f1d222-b304-4cbf-a6c4-14da7f87327c" xlink:href="icui-20230331.xsd#icui_DerivativeVariableRateFloor"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_7d9295d6-f362-4199-a26b-d431de54914a" xlink:to="loc_icui_DerivativeVariableRateFloor_b3f1d222-b304-4cbf-a6c4-14da7f87327c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_050a8fc1-3e01-4612-972a-23152337fcec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3b5e003-0796-440a-b14c-bdd46b01a6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_050a8fc1-3e01-4612-972a-23152337fcec" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3b5e003-0796-440a-b14c-bdd46b01a6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4e36e456-f659-4292-9ed2-632e7b34046b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3b5e003-0796-440a-b14c-bdd46b01a6d4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4e36e456-f659-4292-9ed2-632e7b34046b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0c6d7d93-6239-40a8-ab8a-d968bfa70737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4e36e456-f659-4292-9ed2-632e7b34046b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0c6d7d93-6239-40a8-ab8a-d968bfa70737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_8e78adf1-7def-49d6-bb85-012e6d48398e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0c6d7d93-6239-40a8-ab8a-d968bfa70737" xlink:to="loc_us-gaap_ForeignExchangeContractMember_8e78adf1-7def-49d6-bb85-012e6d48398e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6869a661-e1d2-48c9-99dd-13264418270b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0c6d7d93-6239-40a8-ab8a-d968bfa70737" xlink:to="loc_us-gaap_InterestRateSwapMember_6869a661-e1d2-48c9-99dd-13264418270b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7fe79ba0-8a28-44f4-906d-5ff8a68e36af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3b5e003-0796-440a-b14c-bdd46b01a6d4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7fe79ba0-8a28-44f4-906d-5ff8a68e36af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2031dabc-3d85-40bb-9efa-33eba8aa370c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7fe79ba0-8a28-44f4-906d-5ff8a68e36af" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2031dabc-3d85-40bb-9efa-33eba8aa370c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a3b5e003-0796-440a-b14c-bdd46b01a6d4" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_80795a92-b432-4e4a-9bf7-d091dacf423e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeAssets_80795a92-b432-4e4a-9bf7-d091dacf423e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_00e0dd4c-0b8f-41ef-87bc-b5bea3f8bf29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_00e0dd4c-0b8f-41ef-87bc-b5bea3f8bf29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_9bb35668-1fa4-467b-b9ba-e57014e827d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_9bb35668-1fa4-467b-b9ba-e57014e827d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_65126898-f776-4c90-940b-594683e533aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_65126898-f776-4c90-940b-594683e533aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_187a6d7a-ac05-4dde-80bc-134451e1e7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_187a6d7a-ac05-4dde-80bc-134451e1e7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration_7e6fd470-a146-4b4c-b988-c0fb3c2c367a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration_7e6fd470-a146-4b4c-b988-c0fb3c2c367a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_80fe8c9f-05b7-4969-a517-18d6c8207c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_80fe8c9f-05b7-4969-a517-18d6c8207c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_34d56c97-0b7e-4170-aba8-031706423dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeLiabilities_34d56c97-0b7e-4170-aba8-031706423dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration_5d79ca51-b12f-47fa-b7e6-757c19aa1f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration_5d79ca51-b12f-47fa-b7e6-757c19aa1f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration_5162e997-1886-49b8-9bfe-9070b89deacc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4eb47e63-3c56-4ada-bb43-c697c6c4fec1" xlink:to="loc_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration_5162e997-1886-49b8-9bfe-9070b89deacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2a64224c-dfc4-4718-aae3-1f10dceb0890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b14cf244-b322-4b25-9b58-e9802f3999df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2a64224c-dfc4-4718-aae3-1f10dceb0890" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b14cf244-b322-4b25-9b58-e9802f3999df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9aac20f9-43cf-4daf-8838-212c05ba5ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b14cf244-b322-4b25-9b58-e9802f3999df" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9aac20f9-43cf-4daf-8838-212c05ba5ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f5e830d5-dfb6-46ca-bb5c-b3beb38e0ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9aac20f9-43cf-4daf-8838-212c05ba5ebe" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f5e830d5-dfb6-46ca-bb5c-b3beb38e0ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_b6f3f25c-1ab3-4fd4-8f17-67e6700d2cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f5e830d5-dfb6-46ca-bb5c-b3beb38e0ad4" xlink:to="loc_us-gaap_ForeignExchangeContractMember_b6f3f25c-1ab3-4fd4-8f17-67e6700d2cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1de65b38-22fc-443e-ab96-65a9bbc6db68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f5e830d5-dfb6-46ca-bb5c-b3beb38e0ad4" xlink:to="loc_us-gaap_InterestRateSwapMember_1de65b38-22fc-443e-ab96-65a9bbc6db68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c88fa29f-eedb-4c7f-9c38-3c62a6188df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b14cf244-b322-4b25-9b58-e9802f3999df" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c88fa29f-eedb-4c7f-9c38-3c62a6188df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_1e6ce1d8-530f-449f-be32-9b0180bb9582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c88fa29f-eedb-4c7f-9c38-3c62a6188df9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_1e6ce1d8-530f-449f-be32-9b0180bb9582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_35ce5070-efde-413f-92a4-8c058202c621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2afe86af-71ca-4cab-80be-284724f97418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_35ce5070-efde-413f-92a4-8c058202c621" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2afe86af-71ca-4cab-80be-284724f97418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_117237b5-dc13-404d-9257-7caf387b2d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2afe86af-71ca-4cab-80be-284724f97418" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_117237b5-dc13-404d-9257-7caf387b2d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5f2780b0-6f70-46d3-946f-46029d5b58ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_117237b5-dc13-404d-9257-7caf387b2d7c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5f2780b0-6f70-46d3-946f-46029d5b58ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_3690a5a7-6840-458a-9a1e-b11fe5916c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5f2780b0-6f70-46d3-946f-46029d5b58ed" xlink:to="loc_us-gaap_ForeignExchangeContractMember_3690a5a7-6840-458a-9a1e-b11fe5916c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d6b17ffa-cdfc-4f1f-b994-6457f77e7bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5f2780b0-6f70-46d3-946f-46029d5b58ed" xlink:to="loc_us-gaap_InterestRateSwapMember_d6b17ffa-cdfc-4f1f-b994-6457f77e7bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4a5a1367-6327-4046-b3aa-ccd0e9d393c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2afe86af-71ca-4cab-80be-284724f97418" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4a5a1367-6327-4046-b3aa-ccd0e9d393c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8297dbf8-b38c-4b32-9981-2321128bc74e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4a5a1367-6327-4046-b3aa-ccd0e9d393c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8297dbf8-b38c-4b32-9981-2321128bc74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingRevenueMember_6e0bd33f-3a90-439b-8cf9-f12361ec4dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8297dbf8-b38c-4b32-9981-2321128bc74e" xlink:to="loc_us-gaap_TradingRevenueMember_6e0bd33f-3a90-439b-8cf9-f12361ec4dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_101e273b-e3b5-4319-aad5-f88a85ee6a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8297dbf8-b38c-4b32-9981-2321128bc74e" xlink:to="loc_us-gaap_CostOfSalesMember_101e273b-e3b5-4319-aad5-f88a85ee6a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5e1fc13a-f520-47ef-bc6c-4cd39fc5c12b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2afe86af-71ca-4cab-80be-284724f97418" xlink:to="loc_us-gaap_HedgingDesignationAxis_5e1fc13a-f520-47ef-bc6c-4cd39fc5c12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_49d6df8e-bc1d-44d8-b355-aade4225c4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_5e1fc13a-f520-47ef-bc6c-4cd39fc5c12b" xlink:to="loc_us-gaap_HedgingDesignationDomain_49d6df8e-bc1d-44d8-b355-aade4225c4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1a3e0486-0b21-45d7-89ff-20f605906a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2afe86af-71ca-4cab-80be-284724f97418" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1a3e0486-0b21-45d7-89ff-20f605906a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9725819c-5c1e-458c-aa83-d22b48a5cca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1a3e0486-0b21-45d7-89ff-20f605906a8f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9725819c-5c1e-458c-aa83-d22b48a5cca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_d8d6262f-0a79-4f6d-a5ec-7acea53f7615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9725819c-5c1e-458c-aa83-d22b48a5cca0" xlink:to="loc_us-gaap_CashFlowHedgingMember_d8d6262f-0a79-4f6d-a5ec-7acea53f7615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_2afe86af-71ca-4cab-80be-284724f97418" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_a2883e2e-fd0d-46fe-94aa-60a8538ff318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_a2883e2e-fd0d-46fe-94aa-60a8538ff318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_4deef9c0-b455-43b1-af03-d5f8709a927d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_4deef9c0-b455-43b1-af03-d5f8709a927d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_85bba5ca-9460-4583-afd7-a93496fa46d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_85bba5ca-9460-4583-afd7-a93496fa46d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_32fa8616-0d34-4d88-9ea4-6c60bdefdd46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_32fa8616-0d34-4d88-9ea4-6c60bdefdd46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_ce52767e-e48f-4cdf-a7ae-d04ebbf1d8da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_ce52767e-e48f-4cdf-a7ae-d04ebbf1d8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring_775596bc-9882-4832-8f04-020eb2f62a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring_775596bc-9882-4832-8f04-020eb2f62a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_b105db80-cf6a-4683-b93a-4fd64e163e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_b105db80-cf6a-4683-b93a-4fd64e163e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_96aecf3f-fe5c-40c3-8343-eb96d9d8b621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNetHedgeIneffectivenessGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8ce1d3fa-b72f-4d32-872c-1e3d1966182e" xlink:to="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_96aecf3f-fe5c-40c3-8343-eb96d9d8b621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#FairValueMeasuresandDisclosuresDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4544b725-653d-4f9b-8a10-cfc7f9c96617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_74de47b3-f343-44d9-8651-dc192a49bdf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4544b725-653d-4f9b-8a10-cfc7f9c96617" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_74de47b3-f343-44d9-8651-dc192a49bdf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3d0f42b6-fa78-4b91-9350-186932f08c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_74de47b3-f343-44d9-8651-dc192a49bdf9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3d0f42b6-fa78-4b91-9350-186932f08c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d6e0f00-4766-42d7-9c5b-f9d22bb79aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3d0f42b6-fa78-4b91-9350-186932f08c69" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d6e0f00-4766-42d7-9c5b-f9d22bb79aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_7c60cacd-76fe-441d-9bf6-19a04b351dfd" xlink:href="icui-20230331.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d6e0f00-4766-42d7-9c5b-f9d22bb79aea" xlink:to="loc_icui_PursuitVascularInc.Member_7c60cacd-76fe-441d-9bf6-19a04b351dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_2dc54a40-4882-4b5a-9875-697c523c7fac" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d6e0f00-4766-42d7-9c5b-f9d22bb79aea" xlink:to="loc_icui_SmithsMedicalMember_2dc54a40-4882-4b5a-9875-697c523c7fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_fd33f87d-14b7-46ef-885a-41cb176be4ca" xlink:href="icui-20230331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d6e0f00-4766-42d7-9c5b-f9d22bb79aea" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_fd33f87d-14b7-46ef-885a-41cb176be4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_c83f3d5d-3c70-450c-9968-1ab22c957fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_74de47b3-f343-44d9-8651-dc192a49bdf9" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_c83f3d5d-3c70-450c-9968-1ab22c957fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_4e49ed19-5eaa-4782-853d-3b8d9fd0b669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_c83f3d5d-3c70-450c-9968-1ab22c957fd3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_4e49ed19-5eaa-4782-853d-3b8d9fd0b669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_47fb8742-c62a-4823-970d-78dd15c34a51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_4e49ed19-5eaa-4782-853d-3b8d9fd0b669" xlink:to="loc_us-gaap_LiabilityMember_47fb8742-c62a-4823-970d-78dd15c34a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_df6271e6-12f8-4d0f-b4d4-43006c3fa3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_74de47b3-f343-44d9-8651-dc192a49bdf9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_df6271e6-12f8-4d0f-b4d4-43006c3fa3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_84dc4fb1-f772-489a-b865-5623d791e24e" xlink:href="icui-20230331.xsd#icui_Contingentconsiderationgross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_df6271e6-12f8-4d0f-b4d4-43006c3fa3e0" xlink:to="loc_icui_Contingentconsiderationgross_84dc4fb1-f772-489a-b865-5623d791e24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1cc20207-b5fb-4244-a34a-152791843eda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_df6271e6-12f8-4d0f-b4d4-43006c3fa3e0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1cc20207-b5fb-4244-a34a-152791843eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_b2fc9929-c9f5-46a9-bd36-b12d934bb516" xlink:href="icui-20230331.xsd#icui_ContingentConsiderationGrossST"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_df6271e6-12f8-4d0f-b4d4-43006c3fa3e0" xlink:to="loc_icui_ContingentConsiderationGrossST_b2fc9929-c9f5-46a9-bd36-b12d934bb516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_a1c0c361-ea5c-404b-81b9-46ae78c700f6" xlink:href="icui-20230331.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_df6271e6-12f8-4d0f-b4d4-43006c3fa3e0" xlink:to="loc_icui_ContingentConsiderationGrossLT_a1c0c361-ea5c-404b-81b9-46ae78c700f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6afe2f1b-a316-4fed-b667-727461766c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_df6271e6-12f8-4d0f-b4d4-43006c3fa3e0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6afe2f1b-a316-4fed-b667-727461766c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OwnershipRequirementForEarnoutPayment_89ee5471-ccaa-4882-9a57-d7625cf7013b" xlink:href="icui-20230331.xsd#icui_OwnershipRequirementForEarnoutPayment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_df6271e6-12f8-4d0f-b4d4-43006c3fa3e0" xlink:to="loc_icui_OwnershipRequirementForEarnoutPayment_89ee5471-ccaa-4882-9a57-d7625cf7013b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ca11454e-c9b2-4401-8495-f1f82cc79fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_efe6b176-c68f-4fce-8a6e-47e8218e8214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ca11454e-c9b2-4401-8495-f1f82cc79fc9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_efe6b176-c68f-4fce-8a6e-47e8218e8214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_414bd8de-afae-4fbb-9d82-ef17395ab23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_efe6b176-c68f-4fce-8a6e-47e8218e8214" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_414bd8de-afae-4fbb-9d82-ef17395ab23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42ec5d78-11ff-44d9-ab7b-f92e4b7a6749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_414bd8de-afae-4fbb-9d82-ef17395ab23a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42ec5d78-11ff-44d9-ab7b-f92e4b7a6749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_85a38a67-0eb2-4028-ae46-b00bb9144b41" xlink:href="icui-20230331.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42ec5d78-11ff-44d9-ab7b-f92e4b7a6749" xlink:to="loc_icui_PursuitVascularInc.Member_85a38a67-0eb2-4028-ae46-b00bb9144b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_e3914efe-350e-4dcf-8bd2-a2d5f32261ca" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42ec5d78-11ff-44d9-ab7b-f92e4b7a6749" xlink:to="loc_icui_SmithsMedicalMember_e3914efe-350e-4dcf-8bd2-a2d5f32261ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_9bbd9356-af36-4a6b-8a41-d0f3cec14629" xlink:href="icui-20230331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42ec5d78-11ff-44d9-ab7b-f92e4b7a6749" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_9bbd9356-af36-4a6b-8a41-d0f3cec14629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_118c5d61-2528-45f4-9cbc-51733c372490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_efe6b176-c68f-4fce-8a6e-47e8218e8214" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_118c5d61-2528-45f4-9cbc-51733c372490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e931210e-f86e-4fd7-87bc-eebf18331f67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_118c5d61-2528-45f4-9cbc-51733c372490" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e931210e-f86e-4fd7-87bc-eebf18331f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_44d09565-ef50-43ae-9d7f-ae3510b38c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_118c5d61-2528-45f4-9cbc-51733c372490" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_44d09565-ef50-43ae-9d7f-ae3510b38c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_273a56a1-6e81-4dde-9257-a79247a3f88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_118c5d61-2528-45f4-9cbc-51733c372490" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_273a56a1-6e81-4dde-9257-a79247a3f88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CurrencyTranslationOnEarnOut_e2137bc1-8029-4ec0-afc7-1dd2a8054972" xlink:href="icui-20230331.xsd#icui_CurrencyTranslationOnEarnOut"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_118c5d61-2528-45f4-9cbc-51733c372490" xlink:to="loc_icui_CurrencyTranslationOnEarnOut_e2137bc1-8029-4ec0-afc7-1dd2a8054972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_802ef519-8915-45a6-96a6-19e3226b4f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a2a301ab-8705-464f-a18e-c950870a0f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_802ef519-8915-45a6-96a6-19e3226b4f7c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a2a301ab-8705-464f-a18e-c950870a0f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_66d53276-57ef-445c-b057-472635461727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a2a301ab-8705-464f-a18e-c950870a0f9c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_66d53276-57ef-445c-b057-472635461727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f8b95a1d-849f-4f7d-95bd-b8845e237eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_66d53276-57ef-445c-b057-472635461727" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f8b95a1d-849f-4f7d-95bd-b8845e237eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_88fa4b5f-e0ee-4f50-a064-f6820ee58618" xlink:href="icui-20230331.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f8b95a1d-849f-4f7d-95bd-b8845e237eeb" xlink:to="loc_icui_PursuitVascularInc.Member_88fa4b5f-e0ee-4f50-a064-f6820ee58618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalDistributorMember_bd71a9d5-8f84-460e-b781-f96fc79a58f9" xlink:href="icui-20230331.xsd#icui_InternationalDistributorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f8b95a1d-849f-4f7d-95bd-b8845e237eeb" xlink:to="loc_icui_InternationalDistributorMember_bd71a9d5-8f84-460e-b781-f96fc79a58f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_032467af-3e4b-4eab-9700-383d372ef7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a2a301ab-8705-464f-a18e-c950870a0f9c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_032467af-3e4b-4eab-9700-383d372ef7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c6f73219-6a1a-4f68-a74d-10bf4f676805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_032467af-3e4b-4eab-9700-383d372ef7bc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c6f73219-6a1a-4f68-a74d-10bf4f676805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_1c2310ab-96e5-401a-8456-a490c360edc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a2a301ab-8705-464f-a18e-c950870a0f9c" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_1c2310ab-96e5-401a-8456-a490c360edc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e4fec677-8bdd-4831-ace5-a08765aca464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1c2310ab-96e5-401a-8456-a490c360edc6" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e4fec677-8bdd-4831-ace5-a08765aca464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_495626c0-8e91-456a-9f99-0ced01523be5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a2a301ab-8705-464f-a18e-c950870a0f9c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_495626c0-8e91-456a-9f99-0ced01523be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_75a306d5-78bf-4965-aef5-3001300a0199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_495626c0-8e91-456a-9f99-0ced01523be5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_75a306d5-78bf-4965-aef5-3001300a0199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_da57bcd1-81f1-4488-9d12-fe5e84a4f22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_a2a301ab-8705-464f-a18e-c950870a0f9c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_da57bcd1-81f1-4488-9d12-fe5e84a4f22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_dd88f65f-46d2-4dfa-9c60-0117ef70c383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_da57bcd1-81f1-4488-9d12-fe5e84a4f22c" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_dd88f65f-46d2-4dfa-9c60-0117ef70c383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_a367cdca-f2ea-4de8-959f-25ba7a2d512d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_da57bcd1-81f1-4488-9d12-fe5e84a4f22c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_a367cdca-f2ea-4de8-959f-25ba7a2d512d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_2301316f-9973-4ded-b984-30c934faa8df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_da57bcd1-81f1-4488-9d12-fe5e84a4f22c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_2301316f-9973-4ded-b984-30c934faa8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CurrencyTranslationOnEarnOut_e3aa0b9a-7d62-41c8-8b55-2c6d84d73296" xlink:href="icui-20230331.xsd#icui_CurrencyTranslationOnEarnOut"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_da57bcd1-81f1-4488-9d12-fe5e84a4f22c" xlink:to="loc_icui_CurrencyTranslationOnEarnOut_e3aa0b9a-7d62-41c8-8b55-2c6d84d73296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_08a497db-f680-468d-98f9-7ad6f2bb3566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_b77ec4dd-d9a9-4f99-96cb-2be4a326313b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_08a497db-f680-468d-98f9-7ad6f2bb3566" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_b77ec4dd-d9a9-4f99-96cb-2be4a326313b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9bbd73af-17ff-4e99-a55c-21e3d9dacabc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_b77ec4dd-d9a9-4f99-96cb-2be4a326313b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9bbd73af-17ff-4e99-a55c-21e3d9dacabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d2c118a0-a313-4534-88a2-5117f88847b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9bbd73af-17ff-4e99-a55c-21e3d9dacabc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d2c118a0-a313-4534-88a2-5117f88847b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_4dd542cd-00f5-4864-a043-7b56c83bf981" xlink:href="icui-20230331.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d2c118a0-a313-4534-88a2-5117f88847b9" xlink:to="loc_icui_PursuitVascularInc.Member_4dd542cd-00f5-4864-a043-7b56c83bf981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_87c9b71c-f8ec-443e-9b66-e820dc02105a" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d2c118a0-a313-4534-88a2-5117f88847b9" xlink:to="loc_icui_SmithsMedicalMember_87c9b71c-f8ec-443e-9b66-e820dc02105a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_bb6df5e3-f7a0-47ae-9306-4ae31efba6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_b77ec4dd-d9a9-4f99-96cb-2be4a326313b" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_bb6df5e3-f7a0-47ae-9306-4ae31efba6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_11abe2bb-2232-4cc7-827b-9cef1c5c3c98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_bb6df5e3-f7a0-47ae-9306-4ae31efba6b3" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_11abe2bb-2232-4cc7-827b-9cef1c5c3c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_46dc773b-6f3e-41d5-a8af-f583eb32bf14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_11abe2bb-2232-4cc7-827b-9cef1c5c3c98" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_46dc773b-6f3e-41d5-a8af-f583eb32bf14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_bcb9af6f-5e52-41e0-bd4a-a575227aac4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_11abe2bb-2232-4cc7-827b-9cef1c5c3c98" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_bcb9af6f-5e52-41e0-bd4a-a575227aac4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5034a6f2-2e4c-4104-a23a-0d3a9cc6d838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_b77ec4dd-d9a9-4f99-96cb-2be4a326313b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5034a6f2-2e4c-4104-a23a-0d3a9cc6d838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9bd79b07-e615-486d-a10d-8c66ed25f0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_5034a6f2-2e4c-4104-a23a-0d3a9cc6d838" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9bd79b07-e615-486d-a10d-8c66ed25f0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5712458f-ce1d-417c-9049-fd4a35f347f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5712458f-ce1d-417c-9049-fd4a35f347f2" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c2924ccd-652f-4888-b590-0c7a4e389dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c2924ccd-652f-4888-b590-0c7a4e389dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9d1b7bbf-17d8-43b9-8d11-49b653f88382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c2924ccd-652f-4888-b590-0c7a4e389dde" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9d1b7bbf-17d8-43b9-8d11-49b653f88382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_896ff55a-b290-4471-9314-d0c1ab920ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9d1b7bbf-17d8-43b9-8d11-49b653f88382" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_896ff55a-b290-4471-9314-d0c1ab920ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_54b3e919-b849-4f17-bfeb-17fc92133153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9d1b7bbf-17d8-43b9-8d11-49b653f88382" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_54b3e919-b849-4f17-bfeb-17fc92133153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_85c269b6-e407-4715-b939-33cad14df135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9d1b7bbf-17d8-43b9-8d11-49b653f88382" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_85c269b6-e407-4715-b939-33cad14df135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f2e88f30-4e9b-4990-84fa-239d9ed693e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f2e88f30-4e9b-4990-84fa-239d9ed693e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_30636f6a-99b1-4277-b373-8a405990e2be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f2e88f30-4e9b-4990-84fa-239d9ed693e7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_30636f6a-99b1-4277-b373-8a405990e2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c339fa9d-8b4f-4405-b135-30aa80be203b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_30636f6a-99b1-4277-b373-8a405990e2be" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c339fa9d-8b4f-4405-b135-30aa80be203b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_40080f59-ed70-438b-9225-7b18d90317da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_40080f59-ed70-438b-9225-7b18d90317da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fe2e68c7-9785-44b6-802b-26b454d59e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_40080f59-ed70-438b-9225-7b18d90317da" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fe2e68c7-9785-44b6-802b-26b454d59e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EarnoutliabilityMember_4b72e729-cf94-42e3-84f7-0185b5bf4f76" xlink:href="icui-20230331.xsd#icui_EarnoutliabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fe2e68c7-9785-44b6-802b-26b454d59e06" xlink:to="loc_icui_EarnoutliabilityMember_4b72e729-cf94-42e3-84f7-0185b5bf4f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesTotalMember_70dfb981-5cb5-4c96-8562-0b7cdaf63085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesTotalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fe2e68c7-9785-44b6-802b-26b454d59e06" xlink:to="loc_us-gaap_LiabilitiesTotalMember_70dfb981-5cb5-4c96-8562-0b7cdaf63085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_1f7aec06-1285-4446-99bc-c281d5d442fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:to="loc_us-gaap_InvestmentTypeAxis_1f7aec06-1285-4446-99bc-c281d5d442fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ccd1f8a3-9539-48d5-bb9f-05e42914dfd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_1f7aec06-1285-4446-99bc-c281d5d442fc" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ccd1f8a3-9539-48d5-bb9f-05e42914dfd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_0a1b57a6-2828-4ea0-9c22-63ba09c6e5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ccd1f8a3-9539-48d5-bb9f-05e42914dfd9" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_0a1b57a6-2828-4ea0-9c22-63ba09c6e5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_54a56183-c786-4c7f-a3a3-17e246842e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ccd1f8a3-9539-48d5-bb9f-05e42914dfd9" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_54a56183-c786-4c7f-a3a3-17e246842e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_c0aa376e-54f3-4939-b657-1385da868946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ccd1f8a3-9539-48d5-bb9f-05e42914dfd9" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_c0aa376e-54f3-4939-b657-1385da868946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8763077f-5c8f-405b-bd8e-2fad182a6a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8763077f-5c8f-405b-bd8e-2fad182a6a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d40ab363-026a-473c-a5da-69b69eed4839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8763077f-5c8f-405b-bd8e-2fad182a6a9e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d40ab363-026a-473c-a5da-69b69eed4839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_749d4faa-ff69-4b3c-ae66-17680996d525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d40ab363-026a-473c-a5da-69b69eed4839" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_749d4faa-ff69-4b3c-ae66-17680996d525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_eef2ea86-1100-4d0b-88c5-a7d11c5fd581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d40ab363-026a-473c-a5da-69b69eed4839" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_eef2ea86-1100-4d0b-88c5-a7d11c5fd581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_b7c9cc63-2716-4b17-9d6a-6ebe5c75f5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d40ab363-026a-473c-a5da-69b69eed4839" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_b7c9cc63-2716-4b17-9d6a-6ebe5c75f5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ClassificationAxis_915eefa0-f652-4465-b0cf-6584cfacece5" xlink:href="icui-20230331.xsd#icui_ClassificationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:to="loc_icui_ClassificationAxis_915eefa0-f652-4465-b0cf-6584cfacece5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ClassificationDomain_95b47e48-dc9a-4479-abc5-740d518cd22d" xlink:href="icui-20230331.xsd#icui_ClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ClassificationAxis_915eefa0-f652-4465-b0cf-6584cfacece5" xlink:to="loc_icui_ClassificationDomain_95b47e48-dc9a-4479-abc5-740d518cd22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CurrentMember_2f69e8a9-98f5-4155-9edc-90805b4e7e35" xlink:href="icui-20230331.xsd#icui_CurrentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ClassificationDomain_95b47e48-dc9a-4479-abc5-740d518cd22d" xlink:to="loc_icui_CurrentMember_2f69e8a9-98f5-4155-9edc-90805b4e7e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NoncurrentMember_3efdcbc2-8db5-48c6-b0cd-894c56bcfcd3" xlink:href="icui-20230331.xsd#icui_NoncurrentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ClassificationDomain_95b47e48-dc9a-4479-abc5-740d518cd22d" xlink:to="loc_icui_NoncurrentMember_3efdcbc2-8db5-48c6-b0cd-894c56bcfcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4a739567-7da7-43be-9fbd-bc13cb68f0f2" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_08c5d57e-1d64-4877-9923-139c50fa69cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_08c5d57e-1d64-4877-9923-139c50fa69cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_16522ea8-0c7b-4358-9ba7-0fa9a0eb4e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_16522ea8-0c7b-4358-9ba7-0fa9a0eb4e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_0cf2ffea-f287-4eb8-9ced-d66859ea02bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_0cf2ffea-f287-4eb8-9ced-d66859ea02bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_f519865b-3b47-42d5-ab59-360faa419f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateDerivativeAssetsAtFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_f519865b-3b47-42d5-ab59-360faa419f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d8ff1c13-c531-408a-8136-a8ed591d55d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d8ff1c13-c531-408a-8136-a8ed591d55d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_30d0cc64-ab86-412d-9637-e65807f59ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonfinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_30d0cc64-ab86-412d-9637-e65807f59ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_37184e99-36c8-4473-aa40-615e48a465cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_37184e99-36c8-4473-aa40-615e48a465cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_f9090f6c-4b80-4b74-afdb-4e8ad9bdbc48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_f9090f6c-4b80-4b74-afdb-4e8ad9bdbc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration_0420a675-075e-4710-b7a3-bd85fee076e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration_0420a675-075e-4710-b7a3-bd85fee076e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration_ebf21f9a-937e-4aa1-93ae-2fe036a5d06c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration_ebf21f9a-937e-4aa1-93ae-2fe036a5d06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_ae9d071c-7104-4328-a6a4-54be5f03fba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_ae9d071c-7104-4328-a6a4-54be5f03fba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration_70bab0ca-e487-4cf1-ba38-e4e5ece47a91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c43355bc-cf58-4d85-960c-0ba3951d18b2" xlink:to="loc_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration_70bab0ca-e487-4cf1-ba38-e4e5ece47a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InvestmentSecuritiesDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#InvestmentSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InvestmentSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_78bfbafa-6361-4fc6-8670-c1119163a37f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_1a14f573-e145-414e-9094-e92fdfe7ec14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_78bfbafa-6361-4fc6-8670-c1119163a37f" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_1a14f573-e145-414e-9094-e92fdfe7ec14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InvestmentSecuritiesTableDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#InvestmentSecuritiesTableDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InvestmentSecuritiesTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9b585b43-ee41-4d60-be6b-fa3373db65a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f6c7ad5b-cc5b-4195-b7ba-92d41b000d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9b585b43-ee41-4d60-be6b-fa3373db65a6" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f6c7ad5b-cc5b-4195-b7ba-92d41b000d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ae1ef462-860a-4640-b459-cb17f1e4ad84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f6c7ad5b-cc5b-4195-b7ba-92d41b000d2a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ae1ef462-860a-4640-b459-cb17f1e4ad84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b83a91a1-8eae-4a10-8dea-4ae4532cccee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ae1ef462-860a-4640-b459-cb17f1e4ad84" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b83a91a1-8eae-4a10-8dea-4ae4532cccee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_dc1caa0e-7364-4fbe-a9f3-86611a083f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b83a91a1-8eae-4a10-8dea-4ae4532cccee" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_dc1caa0e-7364-4fbe-a9f3-86611a083f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_07d02c83-69e5-49ac-9fe1-353323a800db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b83a91a1-8eae-4a10-8dea-4ae4532cccee" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_07d02c83-69e5-49ac-9fe1-353323a800db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_e2b38f6e-1a0b-4838-af5a-5baf6636f5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b83a91a1-8eae-4a10-8dea-4ae4532cccee" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_e2b38f6e-1a0b-4838-af5a-5baf6636f5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f6c7ad5b-cc5b-4195-b7ba-92d41b000d2a" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_d3ddad4d-09b0-43e2-a7e7-2b1b7cadf3df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_d3ddad4d-09b0-43e2-a7e7-2b1b7cadf3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_800b5493-a6bb-4bb2-8b10-751a5430aec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_800b5493-a6bb-4bb2-8b10-751a5430aec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7f2b6703-438f-4e2a-912b-ec64983ede77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7f2b6703-438f-4e2a-912b-ec64983ede77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_4d962131-8648-49b8-89ee-47bfbe506bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_4d962131-8648-49b8-89ee-47bfbe506bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_ad6858f2-3291-4e48-a311-5a0e17c6e6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_ad6858f2-3291-4e48-a311-5a0e17c6e6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_3da922fd-ed50-4943-978f-ff8f8e06a933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_3da922fd-ed50-4943-978f-ff8f8e06a933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1e192c1c-c850-40ba-a63e-76780ae159e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1704c9ac-8357-4d2d-95a6-269a1b94ccca" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1e192c1c-c850-40ba-a63e-76780ae159e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/EquityMethodInvestmentsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#EquityMethodInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/EquityMethodInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5f59a97a-3e21-417e-a2ad-67e268489b92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_8bd3f0f3-8e43-401d-91b6-30482c7c96d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5f59a97a-3e21-417e-a2ad-67e268489b92" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_8bd3f0f3-8e43-401d-91b6-30482c7c96d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_92aef4ed-8ba5-4d77-ad03-4bde8c50fdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_8bd3f0f3-8e43-401d-91b6-30482c7c96d8" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_92aef4ed-8ba5-4d77-ad03-4bde8c50fdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_9feaeddf-233e-4d70-8432-94d12ba211d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_92aef4ed-8ba5-4d77-ad03-4bde8c50fdd5" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_9feaeddf-233e-4d70-8432-94d12ba211d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NonPublicCompanyMember_24d56d45-f5b0-49a5-a723-38fc7cf73e5e" xlink:href="icui-20230331.xsd#icui_NonPublicCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_9feaeddf-233e-4d70-8432-94d12ba211d7" xlink:to="loc_icui_NonPublicCompanyMember_24d56d45-f5b0-49a5-a723-38fc7cf73e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9fd95fc3-298b-491f-a295-81834d6c3cc9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_8bd3f0f3-8e43-401d-91b6-30482c7c96d8" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9fd95fc3-298b-491f-a295-81834d6c3cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_60a7d7d6-a059-4736-9ff9-c3615b660756" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9fd95fc3-298b-491f-a295-81834d6c3cc9" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_60a7d7d6-a059-4736-9ff9-c3615b660756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_NonPublicCompanyMember_5ae83d2f-f662-48ca-a4bb-c0dd3cb05a38" xlink:href="icui-20230331.xsd#icui_NonPublicCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_60a7d7d6-a059-4736-9ff9-c3615b660756" xlink:to="loc_icui_NonPublicCompanyMember_5ae83d2f-f662-48ca-a4bb-c0dd3cb05a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_b661e076-a54e-4d94-849f-4e5ba7f965e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable_8bd3f0f3-8e43-401d-91b6-30482c7c96d8" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_b661e076-a54e-4d94-849f-4e5ba7f965e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4d7c1bf4-a823-420c-bcb8-79e60f52183b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_b661e076-a54e-4d94-849f-4e5ba7f965e1" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4d7c1bf4-a823-420c-bcb8-79e60f52183b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_a3c5e736-b3a8-4834-b314-b2fa99c987c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_b661e076-a54e-4d94-849f-4e5ba7f965e1" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_a3c5e736-b3a8-4834-b314-b2fa99c987c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_0b3173f5-bb31-49e1-b806-b7c576a1e092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems_b661e076-a54e-4d94-849f-4e5ba7f965e1" xlink:to="loc_us-gaap_EquityMethodInvestments_0b3173f5-bb31-49e1-b806-b7c576a1e092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_8c1a89a8-edda-4146-83a5-8fd812a96464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_b4d3583a-e2d4-4eca-9a7b-dc97df093887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_8c1a89a8-edda-4146-83a5-8fd812a96464" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_b4d3583a-e2d4-4eca-9a7b-dc97df093887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PrepaidVendorExpenses_2b93c316-41de-477d-bd93-dda8e27e543c" xlink:href="icui-20230331.xsd#icui_PrepaidVendorExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_8c1a89a8-edda-4146-83a5-8fd812a96464" xlink:to="loc_icui_PrepaidVendorExpenses_2b93c316-41de-477d-bd93-dda8e27e543c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsAndOtherAssets_0aa783c6-de26-406f-8920-30fe4846b35b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_8c1a89a8-edda-4146-83a5-8fd812a96464" xlink:to="loc_us-gaap_DeferredCostsAndOtherAssets_0aa783c6-de26-406f-8920-30fe4846b35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidinsuranceandpropertytaxes_c7ddc421-eebd-4958-9226-5c83cef0d120" xlink:href="icui-20230331.xsd#icui_Prepaidinsuranceandpropertytaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_8c1a89a8-edda-4146-83a5-8fd812a96464" xlink:to="loc_icui_Prepaidinsuranceandpropertytaxes_c7ddc421-eebd-4958-9226-5c83cef0d120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidothertaxes_039b7531-8da4-4f0e-b863-aec2c917df69" xlink:href="icui-20230331.xsd#icui_Prepaidothertaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_8c1a89a8-edda-4146-83a5-8fd812a96464" xlink:to="loc_icui_Prepaidothertaxes_039b7531-8da4-4f0e-b863-aec2c917df69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Deferredtaxcharge_1c95e00f-58b7-43e3-b5ae-dbbafe216108" xlink:href="icui-20230331.xsd#icui_Deferredtaxcharge"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_8c1a89a8-edda-4146-83a5-8fd812a96464" xlink:to="loc_icui_Deferredtaxcharge_1c95e00f-58b7-43e3-b5ae-dbbafe216108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_a792c455-fdf4-4032-922a-4b7c513a724b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_8c1a89a8-edda-4146-83a5-8fd812a96464" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_a792c455-fdf4-4032-922a-4b7c513a724b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositAssets_fdbedfd3-9106-4ce5-9b58-ce369d4db952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_8c1a89a8-edda-4146-83a5-8fd812a96464" xlink:to="loc_us-gaap_DepositAssets_fdbedfd3-9106-4ce5-9b58-ce369d4db952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_6bb3bd23-13c7-48c2-a189-b1697297d413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_8c1a89a8-edda-4146-83a5-8fd812a96464" xlink:to="loc_us-gaap_OtherAssetsCurrent_6bb3bd23-13c7-48c2-a189-b1697297d413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0b4c75d0-6063-4315-8e50-6cea2daa09a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_8c1a89a8-edda-4146-83a5-8fd812a96464" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0b4c75d0-6063-4315-8e50-6cea2daa09a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_aba923f6-7323-4899-a4b9-2ff904c82b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateDerivativeAssetsAtFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_8c1a89a8-edda-4146-83a5-8fd812a96464" xlink:to="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_aba923f6-7323-4899-a4b9-2ff904c82b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_dc369645-9e25-44ae-82a0-f7c3438435d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_8c1a89a8-edda-4146-83a5-8fd812a96464" xlink:to="loc_us-gaap_DerivativeTable_dc369645-9e25-44ae-82a0-f7c3438435d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_081bbd72-b473-47f9-a70f-7d8db4177d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dc369645-9e25-44ae-82a0-f7c3438435d3" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_081bbd72-b473-47f9-a70f-7d8db4177d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b2a63c04-9b7a-440a-95e0-eb3c1c6d1f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_081bbd72-b473-47f9-a70f-7d8db4177d0b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b2a63c04-9b7a-440a-95e0-eb3c1c6d1f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_abc3dda3-0908-4768-b065-62d908109bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b2a63c04-9b7a-440a-95e0-eb3c1c6d1f69" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_abc3dda3-0908-4768-b065-62d908109bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_1ca5eaa5-8c13-4b4b-b178-ea2ce5b7717a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dc369645-9e25-44ae-82a0-f7c3438435d3" xlink:to="loc_us-gaap_DerivativeLineItems_1ca5eaa5-8c13-4b4b-b178-ea2ce5b7717a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_588415f7-d8d1-4007-b4ab-5ced270924cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1ca5eaa5-8c13-4b4b-b178-ea2ce5b7717a" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_588415f7-d8d1-4007-b4ab-5ced270924cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/OtherAssetsNoncurrentDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#OtherAssetsNoncurrentDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/OtherAssetsNoncurrentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9489a051-6c17-4b84-aa2d-e0a2085a9e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_de89c738-e017-4cd7-a493-02aeaf5862d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9489a051-6c17-4b84-aa2d-e0a2085a9e0f" xlink:to="loc_us-gaap_DerivativeTable_de89c738-e017-4cd7-a493-02aeaf5862d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3d0695ba-8e32-46f4-a09a-ef83224eb879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_de89c738-e017-4cd7-a493-02aeaf5862d2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3d0695ba-8e32-46f4-a09a-ef83224eb879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_eafefdd4-0c7a-40c0-866b-83d295c0e38c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3d0695ba-8e32-46f4-a09a-ef83224eb879" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_eafefdd4-0c7a-40c0-866b-83d295c0e38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e4410a42-44a7-4cce-9e57-ba50b2bf1aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eafefdd4-0c7a-40c0-866b-83d295c0e38c" xlink:to="loc_us-gaap_InterestRateSwapMember_e4410a42-44a7-4cce-9e57-ba50b2bf1aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_ac228291-3c8a-4046-9510-adaf8b5e9c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_eafefdd4-0c7a-40c0-866b-83d295c0e38c" xlink:to="loc_us-gaap_ForeignExchangeMember_ac228291-3c8a-4046-9510-adaf8b5e9c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_87b74628-0260-4b62-a348-1024276a39ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_de89c738-e017-4cd7-a493-02aeaf5862d2" xlink:to="loc_us-gaap_DerivativeLineItems_87b74628-0260-4b62-a348-1024276a39ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_5e433973-dc60-4b69-b9f2-6b373f883b80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_87b74628-0260-4b62-a348-1024276a39ec" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_5e433973-dc60-4b69-b9f2-6b373f883b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_cf23d403-6327-4fd1-9d08-0671a3f4b189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9489a051-6c17-4b84-aa2d-e0a2085a9e0f" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_cf23d403-6327-4fd1-9d08-0671a3f4b189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SpareParts_a03435b2-cebb-4dd3-a0dc-4755a1eba9a8" xlink:href="icui-20230331.xsd#icui_SpareParts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9489a051-6c17-4b84-aa2d-e0a2085a9e0f" xlink:to="loc_icui_SpareParts_a03435b2-cebb-4dd3-a0dc-4755a1eba9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_994b68f8-33a8-4052-82b0-d7b959616226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9489a051-6c17-4b84-aa2d-e0a2085a9e0f" xlink:to="loc_us-gaap_EquityMethodInvestments_994b68f8-33a8-4052-82b0-d7b959616226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_02a65a04-f519-4a4f-aa6d-24ad8926c6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9489a051-6c17-4b84-aa2d-e0a2085a9e0f" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_02a65a04-f519-4a4f-aa6d-24ad8926c6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_2ce70c12-d008-47a8-a4b3-3e8ec2f188ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9489a051-6c17-4b84-aa2d-e0a2085a9e0f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_2ce70c12-d008-47a8-a4b3-3e8ec2f188ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_7435090f-deb5-4269-a443-4682936913f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9489a051-6c17-4b84-aa2d-e0a2085a9e0f" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_7435090f-deb5-4269-a443-4682936913f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_6bb5098f-79b7-4e86-8650-d5c38a1ab99f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9489a051-6c17-4b84-aa2d-e0a2085a9e0f" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_6bb5098f-79b7-4e86-8650-d5c38a1ab99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_93d712b9-7def-4ff3-a394-0e4993d71f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9489a051-6c17-4b84-aa2d-e0a2085a9e0f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_93d712b9-7def-4ff3-a394-0e4993d71f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InventoriesDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_fe635d7f-5c21-4366-a58d-e92fe685e5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_06427f0d-bf5d-4888-9d9c-cd471ba0e308" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_fe635d7f-5c21-4366-a58d-e92fe685e5b8" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_06427f0d-bf5d-4888-9d9c-cd471ba0e308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8626ff95-4454-49d2-814d-5d41f43089c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_fe635d7f-5c21-4366-a58d-e92fe685e5b8" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8626ff95-4454-49d2-814d-5d41f43089c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2bcc6646-ff2e-492a-a797-113a45bef50a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_fe635d7f-5c21-4366-a58d-e92fe685e5b8" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2bcc6646-ff2e-492a-a797-113a45bef50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e4ecb374-5370-4a80-aa3b-85905838af7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_fe635d7f-5c21-4366-a58d-e92fe685e5b8" xlink:to="loc_us-gaap_InventoryNet_e4ecb374-5370-4a80-aa3b-85905838af7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#PropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f2c0dffa-8797-4c4a-b38a-d31c1c90c776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2ceedda0-e731-4b4e-96f3-2c5837a756c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f2c0dffa-8797-4c4a-b38a-d31c1c90c776" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2ceedda0-e731-4b4e-96f3-2c5837a756c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79cf9391-00b5-4df7-b45a-c1e45c940069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2ceedda0-e731-4b4e-96f3-2c5837a756c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79cf9391-00b5-4df7-b45a-c1e45c940069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_30e9e439-5c2c-4782-b56e-7d591ce9799f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79cf9391-00b5-4df7-b45a-c1e45c940069" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_30e9e439-5c2c-4782-b56e-7d591ce9799f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember_84d3fb94-f115-4f32-b3e6-0a570bb4ba47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_30e9e439-5c2c-4782-b56e-7d591ce9799f" xlink:to="loc_us-gaap_LandBuildingsAndImprovementsMember_84d3fb94-f115-4f32-b3e6-0a570bb4ba47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MoldsMember_55632b8e-5759-44cb-917a-2c08b2d2854c" xlink:href="icui-20230331.xsd#icui_MoldsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_30e9e439-5c2c-4782-b56e-7d591ce9799f" xlink:to="loc_icui_MoldsMember_55632b8e-5759-44cb-917a-2c08b2d2854c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ComputerEquipmentAndSoftwareMember_92ecf592-9e34-408a-900b-902bcfbeec5b" xlink:href="icui-20230331.xsd#icui_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_30e9e439-5c2c-4782-b56e-7d591ce9799f" xlink:to="loc_icui_ComputerEquipmentAndSoftwareMember_92ecf592-9e34-408a-900b-902bcfbeec5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InstrumentsPlacedwithCustomersMember_00b20398-e22f-485e-a0cb-b745a53e325a" xlink:href="icui-20230331.xsd#icui_InstrumentsPlacedwithCustomersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_30e9e439-5c2c-4782-b56e-7d591ce9799f" xlink:to="loc_icui_InstrumentsPlacedwithCustomersMember_00b20398-e22f-485e-a0cb-b745a53e325a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_59198350-37a7-480f-a176-5228d6c80756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2ceedda0-e731-4b4e-96f3-2c5837a756c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_59198350-37a7-480f-a176-5228d6c80756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_18e9dba4-f15a-4034-900b-bb3416ce5a41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_59198350-37a7-480f-a176-5228d6c80756" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_18e9dba4-f15a-4034-900b-bb3416ce5a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4f1d23e4-46aa-4824-bdca-86fa00124fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_59198350-37a7-480f-a176-5228d6c80756" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4f1d23e4-46aa-4824-bdca-86fa00124fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1d296ea9-180d-4bfa-af08-665f6f41e509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_59198350-37a7-480f-a176-5228d6c80756" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1d296ea9-180d-4bfa-af08-665f6f41e509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_c4c3fa8b-5e34-4bda-afac-2baed850a158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_59198350-37a7-480f-a176-5228d6c80756" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_c4c3fa8b-5e34-4bda-afac-2baed850a158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_d6464b46-b175-4b95-a09c-00a5e2cc4874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_59198350-37a7-480f-a176-5228d6c80756" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_d6464b46-b175-4b95-a09c-00a5e2cc4874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_492b911c-d5ff-49ee-9eb7-be1e20f30536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_59198350-37a7-480f-a176-5228d6c80756" xlink:to="loc_us-gaap_ConstructionInProgressGross_492b911c-d5ff-49ee-9eb7-be1e20f30536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipmentTextDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#PropertyandEquipmentTextDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PropertyandEquipmentTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_491a8bf6-e5e1-45c1-af47-aaa2fb1abab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_bd2399db-79c0-4168-b662-eb31f26bc98c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_491a8bf6-e5e1-45c1-af47-aaa2fb1abab3" xlink:to="loc_us-gaap_Depreciation_bd2399db-79c0-4168-b662-eb31f26bc98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#GoodwillandIntangibleAssetsGoodwillTableDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a06ee8a-ce75-4ffa-b35d-816834ec1ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0902ab6f-5783-43c4-8f6b-2f3281959172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a06ee8a-ce75-4ffa-b35d-816834ec1ce8" xlink:to="loc_us-gaap_Goodwill_0902ab6f-5783-43c4-8f6b-2f3281959172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c6e0a169-a4d0-472b-be9a-a1e60267cfa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a06ee8a-ce75-4ffa-b35d-816834ec1ce8" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c6e0a169-a4d0-472b-be9a-a1e60267cfa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#GoodwillandIntangibleAssetsIntangiblesTableDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6cb1d6a4-060d-4e48-89d2-b6bcb00764a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24087203-a317-4503-8785-658efd06bdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6cb1d6a4-060d-4e48-89d2-b6bcb00764a9" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24087203-a317-4503-8785-658efd06bdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f7825fdd-59e7-4214-b53e-001d11fafde2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24087203-a317-4503-8785-658efd06bdd5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f7825fdd-59e7-4214-b53e-001d11fafde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f7825fdd-59e7-4214-b53e-001d11fafde2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_9cbf4916-fb50-4463-926f-9b7a3ff4e029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:to="loc_us-gaap_PatentsMember_9cbf4916-fb50-4463-926f-9b7a3ff4e029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_8e70f431-c23e-41d8-9be7-d987a95939e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:to="loc_us-gaap_CustomerContractsMember_8e70f431-c23e-41d8-9be7-d987a95939e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_93a220d8-5028-4961-9023-5dcc7c17507b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_93a220d8-5028-4961-9023-5dcc7c17507b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_c02e77b0-3332-4d03-9481-754cc8aaf918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:to="loc_us-gaap_TrademarksMember_c02e77b0-3332-4d03-9481-754cc8aaf918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_fd34976d-308e-404e-9a2e-29ed452590da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:to="loc_us-gaap_TradeNamesMember_fd34976d-308e-404e-9a2e-29ed452590da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_945ab130-f974-461b-9f2f-66dadac16812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_945ab130-f974-461b-9f2f-66dadac16812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_5577cf2f-af1b-4d26-a08c-26d47782ec7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_55c3e764-f47b-4fc2-b974-da3f8fe8ce7c" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_5577cf2f-af1b-4d26-a08c-26d47782ec7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_37b62d3e-aec0-4bfd-b0e0-85efb787305e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24087203-a317-4503-8785-658efd06bdd5" xlink:to="loc_srt_ConsolidationItemsAxis_37b62d3e-aec0-4bfd-b0e0-85efb787305e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_32904ccf-beb7-470f-8282-97f8c45532c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_37b62d3e-aec0-4bfd-b0e0-85efb787305e" xlink:to="loc_srt_ConsolidationItemsDomain_32904ccf-beb7-470f-8282-97f8c45532c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f4004fed-f3e2-4690-abcc-92d35940a1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24087203-a317-4503-8785-658efd06bdd5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f4004fed-f3e2-4690-abcc-92d35940a1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_52aee556-c5a0-4c77-8ac2-13da624b4395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f4004fed-f3e2-4690-abcc-92d35940a1b5" xlink:to="loc_us-gaap_SegmentDomain_52aee556-c5a0-4c77-8ac2-13da624b4395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a87d0ab8-44cc-4d6b-86fe-58e4b4d43a2e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24087203-a317-4503-8785-658efd06bdd5" xlink:to="loc_srt_RangeAxis_a87d0ab8-44cc-4d6b-86fe-58e4b4d43a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6cbd002e-142a-4dc3-b6f2-0e09ba3f576c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a87d0ab8-44cc-4d6b-86fe-58e4b4d43a2e" xlink:to="loc_srt_RangeMember_6cbd002e-142a-4dc3-b6f2-0e09ba3f576c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24087203-a317-4503-8785-658efd06bdd5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_cdbb42be-7bfb-4eb7-b8ba-bbe8fc9dc64f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_cdbb42be-7bfb-4eb7-b8ba-bbe8fc9dc64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_57d4bfbc-5f40-43a1-a00b-365c30183ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_57d4bfbc-5f40-43a1-a00b-365c30183ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cc49e575-e404-4716-96aa-b5b995f91997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cc49e575-e404-4716-96aa-b5b995f91997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c0ca2325-0edf-4393-8551-6ef06b0a3cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c0ca2325-0edf-4393-8551-6ef06b0a3cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_cb73df0a-9f1f-44b9-ad08-439e96c14416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_cb73df0a-9f1f-44b9-ad08-439e96c14416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2934efe6-a60e-4be1-a9c0-e20d5c7a1940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2934efe6-a60e-4be1-a9c0-e20d5c7a1940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_41bb3638-c4b4-43cb-9c6e-4f4a9988cfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5a61e11-820d-40d2-a3c5-241626b37a22" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_41bb3638-c4b4-43cb-9c6e-4f4a9988cfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#GoodwillandIntangibleAssetsTextDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_47382cf1-94b5-479d-b87c-99c9d5cbf345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ed16b6b9-d60c-436b-ba77-d173f0ab4354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_47382cf1-94b5-479d-b87c-99c9d5cbf345" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ed16b6b9-d60c-436b-ba77-d173f0ab4354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#GoodwillandIntangibleAssets5YearAmortizationDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cb53aa51-8ba2-486a-8698-f665daa3009b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3dd77da7-a09d-4e2f-bb6c-1117b5dba03e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cb53aa51-8ba2-486a-8698-f665daa3009b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3dd77da7-a09d-4e2f-bb6c-1117b5dba03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_bb551e17-408e-475d-b5c2-d2be319976af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cb53aa51-8ba2-486a-8698-f665daa3009b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_bb551e17-408e-475d-b5c2-d2be319976af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c710352c-8693-4c33-9ed7-bc99cec76d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cb53aa51-8ba2-486a-8698-f665daa3009b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c710352c-8693-4c33-9ed7-bc99cec76d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_11b661e2-660b-48e9-81cf-1146cf23f141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cb53aa51-8ba2-486a-8698-f665daa3009b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_11b661e2-660b-48e9-81cf-1146cf23f141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ee98b7f4-f785-413c-874b-efda6be45205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cb53aa51-8ba2-486a-8698-f665daa3009b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ee98b7f4-f785-413c-874b-efda6be45205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_a8989299-51a2-4a66-8719-916de7901034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cb53aa51-8ba2-486a-8698-f665daa3009b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_a8989299-51a2-4a66-8719-916de7901034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_15785408-b317-4246-a369-9a438d856a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cb53aa51-8ba2-486a-8698-f665daa3009b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_15785408-b317-4246-a369-9a438d856a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d7bc7b5e-5d72-4f52-8a66-1e28fafcaf1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cb53aa51-8ba2-486a-8698-f665daa3009b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d7bc7b5e-5d72-4f52-8a66-1e28fafcaf1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#AccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedSalariesAndBenefits_d76016ec-ac0a-42a4-a458-64fb18b1abc1" xlink:href="icui-20230331.xsd#icui_AccruedSalariesAndBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_icui_AccruedSalariesAndBenefits_d76016ec-ac0a-42a4-a458-64fb18b1abc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent_043f8bd5-9f7b-4cf5-b93d-a662e12d475e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_us-gaap_AccruedBonusesCurrent_043f8bd5-9f7b-4cf5-b93d-a662e12d475e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d599a059-c431-485c-9428-15db92dd12ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d599a059-c431-485c-9428-15db92dd12ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_234533bc-22f9-4539-9e9a-5e436d9e4fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_234533bc-22f9-4539-9e9a-5e436d9e4fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_601e6b1b-583a-47c2-974c-de25f367e4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_us-gaap_RestructuringReserveCurrent_601e6b1b-583a-47c2-974c-de25f367e4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_UnfavorablecontractliabilityST_31a39162-5623-4f07-869e-7d75dcc18abf" xlink:href="icui-20230331.xsd#icui_UnfavorablecontractliabilityST"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_icui_UnfavorablecontractliabilityST_31a39162-5623-4f07-869e-7d75dcc18abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedothertaxes_87142879-29cf-4129-80d5-42b6fa8cef41" xlink:href="icui-20230331.xsd#icui_Accruedothertaxes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_icui_Accruedothertaxes_87142879-29cf-4129-80d5-42b6fa8cef41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_e42eddea-5c44-47c4-bb4e-ea0457ecd34e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_e42eddea-5c44-47c4-bb4e-ea0457ecd34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedlegalfees_51e7cc52-7a11-4092-88cc-01a7f820b0b9" xlink:href="icui-20230331.xsd#icui_Accruedlegalfees"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_icui_Accruedlegalfees_51e7cc52-7a11-4092-88cc-01a7f820b0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Outsidesalescommissions_713b39d3-7d41-4aa0-84cc-ac0137ca4e11" xlink:href="icui-20230331.xsd#icui_Outsidesalescommissions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_icui_Outsidesalescommissions_713b39d3-7d41-4aa0-84cc-ac0137ca4e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_5378d15f-9a7a-4ebe-b94f-27474c39ed4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_5378d15f-9a7a-4ebe-b94f-27474c39ed4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_FieldServiceCorrectiveAction_61a6205a-dfc0-47d5-bf64-3946dcb08d64" xlink:href="icui-20230331.xsd#icui_FieldServiceCorrectiveAction"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_icui_FieldServiceCorrectiveAction_61a6205a-dfc0-47d5-bf64-3946dcb08d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedfreight_4b5557f2-bc40-4918-9097-78d377e42648" xlink:href="icui-20230331.xsd#icui_Accruedfreight"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_icui_Accruedfreight_4b5557f2-bc40-4918-9097-78d377e42648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_81044b64-9377-4125-889a-7c541a6e8b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_81044b64-9377-4125-889a-7c541a6e8b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d14dfdca-e435-471f-b1a6-b71e6d418792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d14dfdca-e435-471f-b1a6-b71e6d418792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_04ca4659-9d1a-46d0-9e50-7ddf4ef704c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_04ca4659-9d1a-46d0-9e50-7ddf4ef704c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_61d68759-3a91-4a8b-bb6e-d2f224cf9702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_61d68759-3a91-4a8b-bb6e-d2f224cf9702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedAuditFees_da5e742c-5f5f-45ad-85ec-18937202d01b" xlink:href="icui-20230331.xsd#icui_AccruedAuditFees"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_icui_AccruedAuditFees_da5e742c-5f5f-45ad-85ec-18937202d01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ad4da061-e3f2-493e-aa5d-ebf30a2b3fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_us-gaap_DerivativeTable_ad4da061-e3f2-493e-aa5d-ebf30a2b3fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c94f3c09-2c00-41e4-8076-e7f8cca52350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ad4da061-e3f2-493e-aa5d-ebf30a2b3fcd" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c94f3c09-2c00-41e4-8076-e7f8cca52350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d936596e-8f4a-4bf2-b399-21b3a388370f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c94f3c09-2c00-41e4-8076-e7f8cca52350" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d936596e-8f4a-4bf2-b399-21b3a388370f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_ed9c0e89-16ef-4332-9366-a3dc76c64f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d936596e-8f4a-4bf2-b399-21b3a388370f" xlink:to="loc_us-gaap_ForeignExchangeMember_ed9c0e89-16ef-4332-9366-a3dc76c64f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e9f32277-ba2b-4d8b-9722-50a354e52754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ad4da061-e3f2-493e-aa5d-ebf30a2b3fcd" xlink:to="loc_us-gaap_DerivativeLineItems_e9f32277-ba2b-4d8b-9722-50a354e52754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_ac69069d-5887-47bd-811c-4f0f9cedab2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e9f32277-ba2b-4d8b-9722-50a354e52754" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_ac69069d-5887-47bd-811c-4f0f9cedab2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_00f097a7-c4f9-4454-a111-bfdd0e84e3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_us-gaap_ProductLiabilityContingencyTable_00f097a7-c4f9-4454-a111-bfdd0e84e3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_75b5e8c4-e9cb-451d-a131-566b3eee0a4c" xlink:href="icui-20230331.xsd#icui_TimingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_00f097a7-c4f9-4454-a111-bfdd0e84e3ac" xlink:to="loc_icui_TimingAxis_75b5e8c4-e9cb-451d-a131-566b3eee0a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_5b0dbd16-c108-4d58-a5f7-d2a6218de6f5" xlink:href="icui-20230331.xsd#icui_TimingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingAxis_75b5e8c4-e9cb-451d-a131-566b3eee0a4c" xlink:to="loc_icui_TimingDomain_5b0dbd16-c108-4d58-a5f7-d2a6218de6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermMember_e4ac0246-e562-4e9d-a0e9-a3614a193058" xlink:href="icui-20230331.xsd#icui_ShortTermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingDomain_5b0dbd16-c108-4d58-a5f7-d2a6218de6f5" xlink:to="loc_icui_ShortTermMember_e4ac0246-e562-4e9d-a0e9-a3614a193058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_f4c7edbf-3723-4c50-94b2-2de65a403699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_00f097a7-c4f9-4454-a111-bfdd0e84e3ac" xlink:to="loc_us-gaap_ProductLiabilityContingencyLineItems_f4c7edbf-3723-4c50-94b2-2de65a403699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_214d9b80-df50-4d59-b3cb-3a443a4a185c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_f4c7edbf-3723-4c50-94b2-2de65a403699" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_214d9b80-df50-4d59-b3cb-3a443a4a185c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_f5e06eaf-f781-48dd-bbbc-1a5bd3df165a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_f5e06eaf-f781-48dd-bbbc-1a5bd3df165a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedResearchAndDevelopment_6bd6bfb2-4085-4c2a-bcc3-418f8afd7d50" xlink:href="icui-20230331.xsd#icui_AccruedResearchAndDevelopment"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_62c1b281-c3ed-4a71-8283-b5d719f77e59" xlink:to="loc_icui_AccruedResearchAndDevelopment_6bd6bfb2-4085-4c2a-bcc3-418f8afd7d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#AccruedLiabilitiesLongtermliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_61ff5e98-4d44-4e7c-9b1c-30fa4b7fc34f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b1c303bf-c89a-44b9-87a0-3471f2fae595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_61ff5e98-4d44-4e7c-9b1c-30fa4b7fc34f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b1c303bf-c89a-44b9-87a0-3471f2fae595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_021c78dd-4ff8-4dd8-b79f-805c17ca9626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_61ff5e98-4d44-4e7c-9b1c-30fa4b7fc34f" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_021c78dd-4ff8-4dd8-b79f-805c17ca9626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRentCurrentAndNoncurrent_ee89e155-643c-4a8a-b809-aa2312af9cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRentCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_61ff5e98-4d44-4e7c-9b1c-30fa4b7fc34f" xlink:to="loc_us-gaap_AccruedRentCurrentAndNoncurrent_ee89e155-643c-4a8a-b809-aa2312af9cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_31269318-7290-484b-8b2f-3fc9ea1ea376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_61ff5e98-4d44-4e7c-9b1c-30fa4b7fc34f" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_31269318-7290-484b-8b2f-3fc9ea1ea376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_4a05615e-73a1-445b-9b9e-589fdfbb6064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_61ff5e98-4d44-4e7c-9b1c-30fa4b7fc34f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_4a05615e-73a1-445b-9b9e-589fdfbb6064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_13e67f07-2bf0-48dc-8650-9aadcf24f725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_61ff5e98-4d44-4e7c-9b1c-30fa4b7fc34f" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_13e67f07-2bf0-48dc-8650-9aadcf24f725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_15506506-62ae-42b8-8bde-b402fc8d51af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_61ff5e98-4d44-4e7c-9b1c-30fa4b7fc34f" xlink:to="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_15506506-62ae-42b8-8bde-b402fc8d51af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_7b266185-b5d5-470f-85bd-6cd993b10f68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_61ff5e98-4d44-4e7c-9b1c-30fa4b7fc34f" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_7b266185-b5d5-470f-85bd-6cd993b10f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_f247a883-ad42-4ae6-97b3-4cf9424be6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_61ff5e98-4d44-4e7c-9b1c-30fa4b7fc34f" xlink:to="loc_us-gaap_ProductLiabilityContingencyTable_f247a883-ad42-4ae6-97b3-4cf9424be6a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_a9b79dea-8837-4620-a7a7-e36e2f633ebf" xlink:href="icui-20230331.xsd#icui_TimingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_f247a883-ad42-4ae6-97b3-4cf9424be6a0" xlink:to="loc_icui_TimingAxis_a9b79dea-8837-4620-a7a7-e36e2f633ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_beb680d3-9098-44fa-8875-3ebae682240c" xlink:href="icui-20230331.xsd#icui_TimingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingAxis_a9b79dea-8837-4620-a7a7-e36e2f633ebf" xlink:to="loc_icui_TimingDomain_beb680d3-9098-44fa-8875-3ebae682240c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermMember_a289a6c3-2904-414a-b770-7e40e565ad45" xlink:href="icui-20230331.xsd#icui_LongTermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingDomain_beb680d3-9098-44fa-8875-3ebae682240c" xlink:to="loc_icui_LongTermMember_a289a6c3-2904-414a-b770-7e40e565ad45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_26346f37-fcc5-4046-a15a-428e3c1fb9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_f247a883-ad42-4ae6-97b3-4cf9424be6a0" xlink:to="loc_us-gaap_ProductLiabilityContingencyLineItems_26346f37-fcc5-4046-a15a-428e3c1fb9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_0fc9a249-dd51-4a43-8ce7-59f1ba445460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_26346f37-fcc5-4046-a15a-428e3c1fb9f3" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_0fc9a249-dd51-4a43-8ce7-59f1ba445460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ab0cdce8-861c-4721-b70d-0bb42997f139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_26346f37-fcc5-4046-a15a-428e3c1fb9f3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ab0cdce8-861c-4721-b70d-0bb42997f139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_dd7e330b-ac14-4d91-b8f9-ee2cef02f912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_61ff5e98-4d44-4e7c-9b1c-30fa4b7fc34f" xlink:to="loc_us-gaap_DerivativeTable_dd7e330b-ac14-4d91-b8f9-ee2cef02f912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7cb939cb-71da-4908-9559-ae144cdd332e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dd7e330b-ac14-4d91-b8f9-ee2cef02f912" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7cb939cb-71da-4908-9559-ae144cdd332e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_81e1a532-6ecc-4197-99a4-7d5f5cb6991b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7cb939cb-71da-4908-9559-ae144cdd332e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_81e1a532-6ecc-4197-99a4-7d5f5cb6991b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_6aa80249-f94d-406a-b75c-0c7776453adf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_81e1a532-6ecc-4197-99a4-7d5f5cb6991b" xlink:to="loc_us-gaap_ForeignExchangeMember_6aa80249-f94d-406a-b75c-0c7776453adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6d36a32a-094a-486d-87b9-b3e6b138677e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dd7e330b-ac14-4d91-b8f9-ee2cef02f912" xlink:to="loc_us-gaap_DerivativeLineItems_6d36a32a-094a-486d-87b9-b3e6b138677e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_90d892a6-a599-430d-b3b7-0527aff9e209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6d36a32a-094a-486d-87b9-b3e6b138677e" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_90d892a6-a599-430d-b3b7-0527aff9e209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#IncomeTaxesEffectivetaxrateDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f08ce667-045a-44b9-8ab4-7813c81fa592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b98bde4a-dae7-4fd0-a315-f6fa917faa95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f08ce667-045a-44b9-8ab4-7813c81fa592" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b98bde4a-dae7-4fd0-a315-f6fa917faa95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0356554a-f0f2-4e72-99b3-8c7a459df7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b98bde4a-dae7-4fd0-a315-f6fa917faa95" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0356554a-f0f2-4e72-99b3-8c7a459df7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2557b676-1a67-46a0-a355-f6754282f764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0356554a-f0f2-4e72-99b3-8c7a459df7cb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2557b676-1a67-46a0-a355-f6754282f764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_5daba09d-5d7a-4c2b-8e73-3681d109984d" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2557b676-1a67-46a0-a355-f6754282f764" xlink:to="loc_icui_SmithsMedicalMember_5daba09d-5d7a-4c2b-8e73-3681d109984d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_4eae2150-6606-4f51-8208-5ec1957f3699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b98bde4a-dae7-4fd0-a315-f6fa917faa95" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_4eae2150-6606-4f51-8208-5ec1957f3699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7c188d84-ebad-4785-a3b5-d0467e0cf41e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_4eae2150-6606-4f51-8208-5ec1957f3699" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7c188d84-ebad-4785-a3b5-d0467e0cf41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4062409b-c501-48bb-bfd1-03ec3aed2bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f08ce667-045a-44b9-8ab4-7813c81fa592" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4062409b-c501-48bb-bfd1-03ec3aed2bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_02e86a3d-bef8-47d8-afc9-705e822da624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f08ce667-045a-44b9-8ab4-7813c81fa592" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_02e86a3d-bef8-47d8-afc9-705e822da624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_f27c4faa-0d68-4390-a96d-38759fdb1329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f08ce667-045a-44b9-8ab4-7813c81fa592" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_f27c4faa-0d68-4390-a96d-38759fdb1329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationTaxExpense_72f28039-1aa4-4cc7-b800-b198a1e72134" xlink:href="icui-20230331.xsd#icui_ContingentConsiderationTaxExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f08ce667-045a-44b9-8ab4-7813c81fa592" xlink:to="loc_icui_ContingentConsiderationTaxExpense_72f28039-1aa4-4cc7-b800-b198a1e72134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#LongTermObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_LOngTermObligationsDisclosureAbstract_113ce923-ddfc-400b-b1e1-761587a2f8a2" xlink:href="icui-20230331.xsd#icui_LOngTermObligationsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5fdd9a87-bd69-4b43-971f-83b122e19a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_113ce923-ddfc-400b-b1e1-761587a2f8a2" xlink:to="loc_us-gaap_DebtInstrumentTable_5fdd9a87-bd69-4b43-971f-83b122e19a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7443d872-15d2-4c56-9a6b-0aa20026d887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5fdd9a87-bd69-4b43-971f-83b122e19a05" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7443d872-15d2-4c56-9a6b-0aa20026d887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5df13115-f468-4da1-a8ad-8eb6fa785476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7443d872-15d2-4c56-9a6b-0aa20026d887" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5df13115-f468-4da1-a8ad-8eb6fa785476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_53f7e3e8-b04f-42e2-8ce3-e0f7b1ab71a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5df13115-f468-4da1-a8ad-8eb6fa785476" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_53f7e3e8-b04f-42e2-8ce3-e0f7b1ab71a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_459a49e3-c333-4053-9aca-0d8332ebccb7" xlink:href="icui-20230331.xsd#icui_TermLoanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5fdd9a87-bd69-4b43-971f-83b122e19a05" xlink:to="loc_icui_TermLoanAxis_459a49e3-c333-4053-9aca-0d8332ebccb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_c4ebc92d-e170-4f7b-9dc8-7622e1785456" xlink:href="icui-20230331.xsd#icui_TermLoanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAxis_459a49e3-c333-4053-9aca-0d8332ebccb7" xlink:to="loc_icui_TermLoanDomain_c4ebc92d-e170-4f7b-9dc8-7622e1785456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_b23763c6-f361-45a3-bed2-ee318a0f152b" xlink:href="icui-20230331.xsd#icui_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_c4ebc92d-e170-4f7b-9dc8-7622e1785456" xlink:to="loc_icui_TermLoanAMember_b23763c6-f361-45a3-bed2-ee318a0f152b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_e958e43a-3a2b-4808-8cfb-4fa74725dacd" xlink:href="icui-20230331.xsd#icui_TermLoanBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_c4ebc92d-e170-4f7b-9dc8-7622e1785456" xlink:to="loc_icui_TermLoanBMember_e958e43a-3a2b-4808-8cfb-4fa74725dacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5fdd9a87-bd69-4b43-971f-83b122e19a05" xlink:to="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TotalSeniorSecuredCreditFacility_3608fa7f-2cee-4907-a60d-7af4fd730ad9" xlink:href="icui-20230331.xsd#icui_TotalSeniorSecuredCreditFacility"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_icui_TotalSeniorSecuredCreditFacility_3608fa7f-2cee-4907-a60d-7af4fd730ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_018aa3ef-36fe-4ee7-b377-90ba70c29592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_018aa3ef-36fe-4ee7-b377-90ba70c29592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_5176c41c-d2d9-477e-9643-cfb907da7f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_5176c41c-d2d9-477e-9643-cfb907da7f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RevolverSubLimits_15577c11-e6bd-47cc-94cb-25a8558c49b8" xlink:href="icui-20230331.xsd#icui_RevolverSubLimits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_icui_RevolverSubLimits_15577c11-e6bd-47cc-94cb-25a8558c49b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_bed77236-b5bf-4683-9ef9-3794b4206055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_bed77236-b5bf-4683-9ef9-3794b4206055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_9382fd7e-f270-4de8-bbb7-960d17c5309a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_us-gaap_LongTermDebt_9382fd7e-f270-4de8-bbb7-960d17c5309a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_02a17135-985e-481b-ab6b-727260effad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_02a17135-985e-481b-ab6b-727260effad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount_8405f0b4-c8a9-4f7e-b528-885fc22cb615" xlink:href="icui-20230331.xsd#icui_LeverageRatioCalculationCeilingSubtractedAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67f1a7f8-6ee2-44b5-b1cf-0c36589f728a" xlink:to="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount_8405f0b4-c8a9-4f7e-b528-885fc22cb615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#LongTermObligationsInterestRateTermsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_63609c80-5b8a-43f1-90b7-48012f5df4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestPercentageAddedToFederalFundsRate_ce9aee66-56eb-4c87-8f8e-cbd5384d750b" xlink:href="icui-20230331.xsd#icui_InterestPercentageAddedToFederalFundsRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_63609c80-5b8a-43f1-90b7-48012f5df4c1" xlink:to="loc_icui_InterestPercentageAddedToFederalFundsRate_ce9aee66-56eb-4c87-8f8e-cbd5384d750b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestPercentageAddedToBaseRate_e6d55cdf-9a6e-442a-aa32-94f11ea67bfc" xlink:href="icui-20230331.xsd#icui_InterestPercentageAddedToBaseRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_63609c80-5b8a-43f1-90b7-48012f5df4c1" xlink:to="loc_icui_InterestPercentageAddedToBaseRate_e6d55cdf-9a6e-442a-aa32-94f11ea67bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans_7643e9e0-9275-43c7-87db-b78ee980d619" xlink:href="icui-20230331.xsd#icui_TerSOFRInterestRateAdjustmentForBaseRateLoans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_63609c80-5b8a-43f1-90b7-48012f5df4c1" xlink:to="loc_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans_7643e9e0-9275-43c7-87db-b78ee980d619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_81b12557-aab1-4905-aaa9-0ecc09aa449a" xlink:href="icui-20230331.xsd#icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_63609c80-5b8a-43f1-90b7-48012f5df4c1" xlink:to="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_81b12557-aab1-4905-aaa9-0ecc09aa449a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_da4110e0-bce1-4b68-917f-1e3a32903dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_63609c80-5b8a-43f1-90b7-48012f5df4c1" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_da4110e0-bce1-4b68-917f-1e3a32903dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBaseRateLoans_c18692f8-8504-43bd-ae5d-b94214c3e543" xlink:href="icui-20230331.xsd#icui_ApplicableMarginBaseRateLoans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_63609c80-5b8a-43f1-90b7-48012f5df4c1" xlink:to="loc_icui_ApplicableMarginBaseRateLoans_c18692f8-8504-43bd-ae5d-b94214c3e543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginTermSOFRLoans_80b3a05d-293e-468c-8bc4-e1cee80f3aad" xlink:href="icui-20230331.xsd#icui_ApplicableMarginTermSOFRLoans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_63609c80-5b8a-43f1-90b7-48012f5df4c1" xlink:to="loc_icui_ApplicableMarginTermSOFRLoans_80b3a05d-293e-468c-8bc4-e1cee80f3aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_fa312cb1-4521-4460-b49a-917fe2e670e7" xlink:href="icui-20230331.xsd#icui_ApplicableMarginBasedOnLeverageRatioTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_63609c80-5b8a-43f1-90b7-48012f5df4c1" xlink:to="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_fa312cb1-4521-4460-b49a-917fe2e670e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_04f90943-46f9-4e6d-a49c-bc5481e9cac4" xlink:href="icui-20230331.xsd#icui_TermLoanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_fa312cb1-4521-4460-b49a-917fe2e670e7" xlink:to="loc_icui_TermLoanAxis_04f90943-46f9-4e6d-a49c-bc5481e9cac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_15a98372-bf55-4f5d-b895-90a0cba7620f" xlink:href="icui-20230331.xsd#icui_TermLoanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAxis_04f90943-46f9-4e6d-a49c-bc5481e9cac4" xlink:to="loc_icui_TermLoanDomain_15a98372-bf55-4f5d-b895-90a0cba7620f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_0ee8eac1-cd1d-4aef-aeef-073c9740ea7f" xlink:href="icui-20230331.xsd#icui_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_15a98372-bf55-4f5d-b895-90a0cba7620f" xlink:to="loc_icui_TermLoanAMember_0ee8eac1-cd1d-4aef-aeef-073c9740ea7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_3655e18c-5b39-48d4-973a-8393d1348ae8" xlink:href="icui-20230331.xsd#icui_TermLoanBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_15a98372-bf55-4f5d-b895-90a0cba7620f" xlink:to="loc_icui_TermLoanBMember_3655e18c-5b39-48d4-973a-8393d1348ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelAxis_ef21a2a9-f337-4cd1-aad9-cce2cc294e34" xlink:href="icui-20230331.xsd#icui_LeverageRatioLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_fa312cb1-4521-4460-b49a-917fe2e670e7" xlink:to="loc_icui_LeverageRatioLevelAxis_ef21a2a9-f337-4cd1-aad9-cce2cc294e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:href="icui-20230331.xsd#icui_LeverageRatioLevelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelAxis_ef21a2a9-f337-4cd1-aad9-cce2cc294e34" xlink:to="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Greaterthan400to100Member_f79fb10c-090d-4f56-918b-e4e2153fb3e8" xlink:href="icui-20230331.xsd#icui_Greaterthan400to100Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:to="loc_icui_Greaterthan400to100Member_f79fb10c-090d-4f56-918b-e4e2153fb3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_9fa7c719-dfff-4cd9-96b0-86e75af646c1" xlink:href="icui-20230331.xsd#icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:to="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_9fa7c719-dfff-4cd9-96b0-86e75af646c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_7101b746-c5dd-4fc6-a9f1-86e5bbcbc950" xlink:href="icui-20230331.xsd#icui_LessThanOrEqual300To100ButGreaterThan250to100Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:to="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_7101b746-c5dd-4fc6-a9f1-86e5bbcbc950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_28c2dd0c-3da5-44ee-a005-99806623c7a9" xlink:href="icui-20230331.xsd#icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:to="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_28c2dd0c-3da5-44ee-a005-99806623c7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo200To100Member_7d9f8106-d904-4250-a68a-357e09190975" xlink:href="icui-20230331.xsd#icui_LessThanOrEqualTo200To100Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:to="loc_icui_LessThanOrEqualTo200To100Member_7d9f8106-d904-4250-a68a-357e09190975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GreaterThan275To100Member_9f3c9d6b-bb09-4dd2-9614-ffa3e79e2986" xlink:href="icui-20230331.xsd#icui_GreaterThan275To100Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:to="loc_icui_GreaterThan275To100Member_9f3c9d6b-bb09-4dd2-9614-ffa3e79e2986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThan275To100Member_4ba147fb-d1e0-4957-995b-b483fe9b5c69" xlink:href="icui-20230331.xsd#icui_LessThan275To100Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_d6f6799d-cb12-4c0f-9b40-1473c13d003d" xlink:to="loc_icui_LessThan275To100Member_4ba147fb-d1e0-4957-995b-b483fe9b5c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c1dc3cf2-5fac-4b50-b3c3-c2f794ea4036" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_fa312cb1-4521-4460-b49a-917fe2e670e7" xlink:to="loc_srt_RangeAxis_c1dc3cf2-5fac-4b50-b3c3-c2f794ea4036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6453c3c8-2e9b-40a0-9f72-f3cdc9d7db5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c1dc3cf2-5fac-4b50-b3c3-c2f794ea4036" xlink:to="loc_srt_RangeMember_6453c3c8-2e9b-40a0-9f72-f3cdc9d7db5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9c866f7a-3edd-49cd-b887-3107ca199c6f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6453c3c8-2e9b-40a0-9f72-f3cdc9d7db5c" xlink:to="loc_srt_MaximumMember_9c866f7a-3edd-49cd-b887-3107ca199c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7276879c-4639-4b70-a64e-e706f5f6c8ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6453c3c8-2e9b-40a0-9f72-f3cdc9d7db5c" xlink:to="loc_srt_MinimumMember_7276879c-4639-4b70-a64e-e706f5f6c8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_e3cc1f17-3e61-438a-8a40-49fa3815980b" xlink:href="icui-20230331.xsd#icui_ApplicableMarginBasedOnLeverageRatioLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_fa312cb1-4521-4460-b49a-917fe2e670e7" xlink:to="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_e3cc1f17-3e61-438a-8a40-49fa3815980b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBaseRateLoans_975838a3-937a-4495-82e3-cd1175d47975" xlink:href="icui-20230331.xsd#icui_ApplicableMarginBaseRateLoans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_e3cc1f17-3e61-438a-8a40-49fa3815980b" xlink:to="loc_icui_ApplicableMarginBaseRateLoans_975838a3-937a-4495-82e3-cd1175d47975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginTermSOFRLoans_07770893-d941-47fc-ae37-7343c3295e87" xlink:href="icui-20230331.xsd#icui_ApplicableMarginTermSOFRLoans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_e3cc1f17-3e61-438a-8a40-49fa3815980b" xlink:to="loc_icui_ApplicableMarginTermSOFRLoans_07770893-d941-47fc-ae37-7343c3295e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_936e2396-9879-458f-881c-e4ba40bfa3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_e3cc1f17-3e61-438a-8a40-49fa3815980b" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_936e2396-9879-458f-881c-e4ba40bfa3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_48643485-13f8-475c-85eb-5d9236ec3b8c" xlink:href="icui-20230331.xsd#icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_e3cc1f17-3e61-438a-8a40-49fa3815980b" xlink:to="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_48643485-13f8-475c-85eb-5d9236ec3b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#LongTermObligationsTerminatedCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9ed0f8ad-9d25-48fd-84e0-26d0e63cbca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d3e56b1f-e6ba-4dd7-8892-e82bc2b25393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9ed0f8ad-9d25-48fd-84e0-26d0e63cbca7" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d3e56b1f-e6ba-4dd7-8892-e82bc2b25393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1_393206f9-38a7-40c8-8323-a4a31ea5c6b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9ed0f8ad-9d25-48fd-84e0-26d0e63cbca7" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationDate1_393206f9-38a7-40c8-8323-a4a31ea5c6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsTableDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#LongTermObligationsTableDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b98db5f7-3a74-45d1-9649-887c12fbf2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7b94d53c-c854-416c-8c79-7a3b12cc66be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b98db5f7-3a74-45d1-9649-887c12fbf2fb" xlink:to="loc_us-gaap_DebtInstrumentTable_7b94d53c-c854-416c-8c79-7a3b12cc66be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_1147c14d-31b5-4418-87cc-7af8dd507aab" xlink:href="icui-20230331.xsd#icui_TermLoanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7b94d53c-c854-416c-8c79-7a3b12cc66be" xlink:to="loc_icui_TermLoanAxis_1147c14d-31b5-4418-87cc-7af8dd507aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_5d151157-e4fb-400b-8b9e-3784b0abeb02" xlink:href="icui-20230331.xsd#icui_TermLoanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAxis_1147c14d-31b5-4418-87cc-7af8dd507aab" xlink:to="loc_icui_TermLoanDomain_5d151157-e4fb-400b-8b9e-3784b0abeb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_dae921c0-025b-4bff-8dde-165d3615ea92" xlink:href="icui-20230331.xsd#icui_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_5d151157-e4fb-400b-8b9e-3784b0abeb02" xlink:to="loc_icui_TermLoanAMember_dae921c0-025b-4bff-8dde-165d3615ea92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_9f490af0-35b8-499e-9587-46f8c5e1290a" xlink:href="icui-20230331.xsd#icui_TermLoanBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_5d151157-e4fb-400b-8b9e-3784b0abeb02" xlink:to="loc_icui_TermLoanBMember_9f490af0-35b8-499e-9587-46f8c5e1290a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a0d6fee8-386b-4d8f-9adb-d4ad93bd4c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7b94d53c-c854-416c-8c79-7a3b12cc66be" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a0d6fee8-386b-4d8f-9adb-d4ad93bd4c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9476d100-7562-4b78-a371-b67f03765bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a0d6fee8-386b-4d8f-9adb-d4ad93bd4c2b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9476d100-7562-4b78-a371-b67f03765bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1b954db9-143e-4c2e-8f9e-e4cf6e673be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9476d100-7562-4b78-a371-b67f03765bcc" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1b954db9-143e-4c2e-8f9e-e4cf6e673be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7b94d53c-c854-416c-8c79-7a3b12cc66be" xlink:to="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3ecadf3f-c8b7-4e3f-9c45-e0b64fe87967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3ecadf3f-c8b7-4e3f-9c45-e0b64fe87967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_51a8c2aa-56e8-4025-9ea6-e94191b2001e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_51a8c2aa-56e8-4025-9ea6-e94191b2001e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_55b01a9e-ff5a-4828-8209-2573025d6b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_55b01a9e-ff5a-4828-8209-2573025d6b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_d4432d3e-20e7-47dc-ba95-ac6899389d56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_d4432d3e-20e7-47dc-ba95-ac6899389d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_2f2c7384-2418-4213-86ec-bb97e4e2c1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:to="loc_us-gaap_DebtCurrent_2f2c7384-2418-4213-86ec-bb97e4e2c1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_273cc152-8b6a-4799-81a6-be7e4b5ec051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_273cc152-8b6a-4799-81a6-be7e4b5ec051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_17326066-01f3-474a-9651-8ae2949d59bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc0cb5b0-4c36-4ee0-8a45-f302b095b294" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_17326066-01f3-474a-9651-8ae2949d59bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#LongTermObligationsScheduleofMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_LOngTermObligationsDisclosureAbstract_a13cd454-26a8-487c-bed2-92df3931bdeb" xlink:href="icui-20230331.xsd#icui_LOngTermObligationsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_63a9eb19-ba80-4a17-8240-e71e36fd6ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_a13cd454-26a8-487c-bed2-92df3931bdeb" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_63a9eb19-ba80-4a17-8240-e71e36fd6ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_027bf8c7-6136-44e2-aff6-70b4ef3948ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_a13cd454-26a8-487c-bed2-92df3931bdeb" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_027bf8c7-6136-44e2-aff6-70b4ef3948ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6f227c04-6141-47d2-98aa-d068a7e63c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_a13cd454-26a8-487c-bed2-92df3931bdeb" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6f227c04-6141-47d2-98aa-d068a7e63c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_508f9d28-6f8c-4e60-a50b-e4e8630a6460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_a13cd454-26a8-487c-bed2-92df3931bdeb" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_508f9d28-6f8c-4e60-a50b-e4e8630a6460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_73423064-1026-4556-98d3-67997a8817bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_a13cd454-26a8-487c-bed2-92df3931bdeb" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_73423064-1026-4556-98d3-67997a8817bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_26ee9670-65d6-443a-9019-cc0782320c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_a13cd454-26a8-487c-bed2-92df3931bdeb" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_26ee9670-65d6-443a-9019-cc0782320c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_721e514c-5665-42dd-9f37-b5c5e80f7bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_a13cd454-26a8-487c-bed2-92df3931bdeb" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_721e514c-5665-42dd-9f37-b5c5e80f7bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_70b3de30-14a8-4add-a45b-452ea89b6b87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_a13cd454-26a8-487c-bed2-92df3931bdeb" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_70b3de30-14a8-4add-a45b-452ea89b6b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#LongTermObligationsInterestExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5673f79a-5a8c-430c-b5fb-712072f98c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_5c986d63-d09e-4261-a209-96e01c699626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5673f79a-5a8c-430c-b5fb-712072f98c2d" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_5c986d63-d09e-4261-a209-96e01c699626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2bd20f3c-2ea7-4ffd-a02b-443717b65524" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5673f79a-5a8c-430c-b5fb-712072f98c2d" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2bd20f3c-2ea7-4ffd-a02b-443717b65524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_677e47cc-c458-481a-a5b7-0ccb84e2e07f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5673f79a-5a8c-430c-b5fb-712072f98c2d" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_677e47cc-c458-481a-a5b7-0ccb84e2e07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_9c23ba81-eb29-4d7a-b215-312aa1a61e78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5673f79a-5a8c-430c-b5fb-712072f98c2d" xlink:to="loc_us-gaap_InterestExpenseDebt_9c23ba81-eb29-4d7a-b215-312aa1a61e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#LongTermObligationsPrincipalPaymentDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3285fc89-0fca-4f40-8606-f539483b8d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentFirst2Years_751a9a5d-b849-4e61-82ce-f59b6cd03c0b" xlink:href="icui-20230331.xsd#icui_TermAPrincipalPaymentFirst2Years"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3285fc89-0fca-4f40-8606-f539483b8d7c" xlink:to="loc_icui_TermAPrincipalPaymentFirst2Years_751a9a5d-b849-4e61-82ce-f59b6cd03c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentYear3And4_7c623478-0725-4770-a515-8ef73e6edb3c" xlink:href="icui-20230331.xsd#icui_TermAPrincipalPaymentYear3And4"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3285fc89-0fca-4f40-8606-f539483b8d7c" xlink:to="loc_icui_TermAPrincipalPaymentYear3And4_7c623478-0725-4770-a515-8ef73e6edb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentInYear5_e8d6ac31-b772-48c8-bc2d-8bb32790ad24" xlink:href="icui-20230331.xsd#icui_TermAPrincipalPaymentInYear5"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3285fc89-0fca-4f40-8606-f539483b8d7c" xlink:to="loc_icui_TermAPrincipalPaymentInYear5_e8d6ac31-b772-48c8-bc2d-8bb32790ad24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBPrincipalPayment_c3595baa-9ca1-4ee0-a0a7-5e0df9b8c8d8" xlink:href="icui-20230331.xsd#icui_TermLoanBPrincipalPayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3285fc89-0fca-4f40-8606-f539483b8d7c" xlink:to="loc_icui_TermLoanBPrincipalPayment_c3595baa-9ca1-4ee0-a0a7-5e0df9b8c8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1cc81709-1351-4733-8cd1-3a8eaca9e365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3285fc89-0fca-4f40-8606-f539483b8d7c" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1cc81709-1351-4733-8cd1-3a8eaca9e365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#CommitmentsandContingenciesContingencyDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_097ba615-b90c-4bd5-a53a-fb60afe22a90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_9440f723-c122-4f6a-8d3e-7ced622e07ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_097ba615-b90c-4bd5-a53a-fb60afe22a90" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_9440f723-c122-4f6a-8d3e-7ced622e07ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_34cf0f3e-4d69-450d-b7fc-626fa002147e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_9440f723-c122-4f6a-8d3e-7ced622e07ea" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_34cf0f3e-4d69-450d-b7fc-626fa002147e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6f3ff937-0ebf-4a76-b6fc-7f9f2a2031bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34cf0f3e-4d69-450d-b7fc-626fa002147e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6f3ff937-0ebf-4a76-b6fc-7f9f2a2031bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_fcd82901-87e1-47e6-8397-0051f0043459" xlink:href="icui-20230331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6f3ff937-0ebf-4a76-b6fc-7f9f2a2031bc" xlink:to="loc_icui_SmithsMedicalMember_fcd82901-87e1-47e6-8397-0051f0043459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_de1f83c4-daf2-4a14-adac-08db80865e22" xlink:href="icui-20230331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6f3ff937-0ebf-4a76-b6fc-7f9f2a2031bc" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_de1f83c4-daf2-4a14-adac-08db80865e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalDistributorMember_0f0fc5a7-95e4-44c6-aacc-d02df323adb4" xlink:href="icui-20230331.xsd#icui_InternationalDistributorMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6f3ff937-0ebf-4a76-b6fc-7f9f2a2031bc" xlink:to="loc_icui_InternationalDistributorMember_0f0fc5a7-95e4-44c6-aacc-d02df323adb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_b07d1124-058e-47b2-a85a-0c6c6a36bd24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_9440f723-c122-4f6a-8d3e-7ced622e07ea" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_b07d1124-058e-47b2-a85a-0c6c6a36bd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_d420bed2-63ee-4cbe-9a3e-88d6315f1524" xlink:href="icui-20230331.xsd#icui_Contingentconsiderationgross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_b07d1124-058e-47b2-a85a-0c6c6a36bd24" xlink:to="loc_icui_Contingentconsiderationgross_d420bed2-63ee-4cbe-9a3e-88d6315f1524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_04fd3220-c428-4bf1-aace-5799d3fcd855" xlink:href="icui-20230331.xsd#icui_ContingentConsiderationGrossST"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_b07d1124-058e-47b2-a85a-0c6c6a36bd24" xlink:to="loc_icui_ContingentConsiderationGrossST_04fd3220-c428-4bf1-aace-5799d3fcd855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_8ffbfeb0-9ec8-46ad-852b-6bd364a0f88e" xlink:href="icui-20230331.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_b07d1124-058e-47b2-a85a-0c6c6a36bd24" xlink:to="loc_icui_ContingentConsiderationGrossLT_8ffbfeb0-9ec8-46ad-852b-6bd364a0f88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8a137234-f414-4261-9ec2-362251969fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_b07d1124-058e-47b2-a85a-0c6c6a36bd24" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8a137234-f414-4261-9ec2-362251969fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_322000fd-3561-4c39-bcf1-fd8b6fb6054b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_b07d1124-058e-47b2-a85a-0c6c6a36bd24" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_322000fd-3561-4c39-bcf1-fd8b6fb6054b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#CollaborativeandOtherArrangementsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_200cfd47-e926-4442-b77c-48f79c503960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_4a1dfbf8-8b31-4fba-b9d3-8336692d2241" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_200cfd47-e926-4442-b77c-48f79c503960" xlink:to="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_4a1dfbf8-8b31-4fba-b9d3-8336692d2241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/EquityDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#EquityDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/EquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5e9ad937-4f24-49e8-9a09-548e9a7e217a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TreasuryStockPurchasePlan_8d6fa1cc-0abf-4b00-b525-7e08df933afa" xlink:href="icui-20230331.xsd#icui_TreasuryStockPurchasePlan"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5e9ad937-4f24-49e8-9a09-548e9a7e217a" xlink:to="loc_icui_TreasuryStockPurchasePlan_8d6fa1cc-0abf-4b00-b525-7e08df933afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_a176c2c6-9784-4dc2-8030-b3cf68659797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5e9ad937-4f24-49e8-9a09-548e9a7e217a" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_a176c2c6-9784-4dc2-8030-b3cf68659797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_cf6bca5a-265e-4503-ad13-6203c2827545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5e9ad937-4f24-49e8-9a09-548e9a7e217a" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_cf6bca5a-265e-4503-ad13-6203c2827545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_bff93f41-6208-49fd-91a2-7f97e889da23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5e9ad937-4f24-49e8-9a09-548e9a7e217a" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_bff93f41-6208-49fd-91a2-7f97e889da23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsGroupOwnershipAcquisitionSharesIssued_32d61020-102b-48b5-b65b-0b95a32b348f" xlink:href="icui-20230331.xsd#icui_SmithsGroupOwnershipAcquisitionSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5e9ad937-4f24-49e8-9a09-548e9a7e217a" xlink:to="loc_icui_SmithsGroupOwnershipAcquisitionSharesIssued_32d61020-102b-48b5-b65b-0b95a32b348f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsGroupOwnershipRequiredForBoardRepresentation_52d5775b-a94b-4238-bdf1-ddc7971f9254" xlink:href="icui-20230331.xsd#icui_SmithsGroupOwnershipRequiredForBoardRepresentation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5e9ad937-4f24-49e8-9a09-548e9a7e217a" xlink:to="loc_icui_SmithsGroupOwnershipRequiredForBoardRepresentation_52d5775b-a94b-4238-bdf1-ddc7971f9254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#EquityAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7b514219-bbc7-4fb4-82ef-a48a5bea1b97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e15473a8-c1b3-486f-a882-247734919f35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7b514219-bbc7-4fb4-82ef-a48a5bea1b97" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e15473a8-c1b3-486f-a882-247734919f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9dbf06a5-92bc-4a71-9ef9-2fd956a0fdc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e15473a8-c1b3-486f-a882-247734919f35" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9dbf06a5-92bc-4a71-9ef9-2fd956a0fdc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7be506e2-8992-4de1-92d0-b8f6035882c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9dbf06a5-92bc-4a71-9ef9-2fd956a0fdc9" xlink:to="loc_us-gaap_EquityComponentDomain_7be506e2-8992-4de1-92d0-b8f6035882c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_15a3749f-5900-46ed-b209-403a9a69fb15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7be506e2-8992-4de1-92d0-b8f6035882c8" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_15a3749f-5900-46ed-b209-403a9a69fb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_c6ffef46-74a9-4c8d-8603-f3c3ad3d8aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7be506e2-8992-4de1-92d0-b8f6035882c8" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_c6ffef46-74a9-4c8d-8603-f3c3ad3d8aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b9b5d9e0-7133-4575-805e-a656d2456041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7be506e2-8992-4de1-92d0-b8f6035882c8" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b9b5d9e0-7133-4575-805e-a656d2456041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_df753584-2f76-4e89-9a84-80bc04f73ede" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e15473a8-c1b3-486f-a882-247734919f35" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_df753584-2f76-4e89-9a84-80bc04f73ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d47b73c0-6a5a-4178-9b4e-1ba6cc30d92a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_df753584-2f76-4e89-9a84-80bc04f73ede" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d47b73c0-6a5a-4178-9b4e-1ba6cc30d92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_91f48a06-b17a-4329-886a-889167acb1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_df753584-2f76-4e89-9a84-80bc04f73ede" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_91f48a06-b17a-4329-886a-889167acb1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7e23c963-c35e-4508-98fd-c03ea9e7a069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_df753584-2f76-4e89-9a84-80bc04f73ede" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7e23c963-c35e-4508-98fd-c03ea9e7a069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7db6938f-06f6-45de-883c-a64356020bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_df753584-2f76-4e89-9a84-80bc04f73ede" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7db6938f-06f6-45de-883c-a64356020bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_beb2d5b1-42b1-440f-b3dd-589728be5914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_df753584-2f76-4e89-9a84-80bc04f73ede" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_beb2d5b1-42b1-440f-b3dd-589728be5914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/TransfersandServicingDetails" xlink:type="simple" xlink:href="icui-20230331.xsd#TransfersandServicingDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/TransfersandServicingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingAbstract_9caddf69-477a-4f35-9c3a-276f7aebeca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount_cd46b1b8-e59e-405f-883f-a6078d618fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingAbstract_9caddf69-477a-4f35-9c3a-276f7aebeca4" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount_cd46b1b8-e59e-405f-883f-a6078d618fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_c4bd75aa-ac1e-4163-b821-711830f2af6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndCollectionOfReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingAbstract_9caddf69-477a-4f35-9c3a-276f7aebeca4" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_c4bd75aa-ac1e-4163-b821-711830f2af6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CashRemittedToPurchaser_b10571ab-ab2a-4040-adfe-be29ce42c5fb" xlink:href="icui-20230331.xsd#icui_CashRemittedToPurchaser"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingAbstract_9caddf69-477a-4f35-9c3a-276f7aebeca4" xlink:to="loc_icui_CashRemittedToPurchaser_b10571ab-ab2a-4040-adfe-be29ce42c5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableSale_2899d274-6103-4f79-b2c8-062865c3d342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableSale"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingAbstract_9caddf69-477a-4f35-9c3a-276f7aebeca4" xlink:to="loc_us-gaap_AccountsReceivableSale_2899d274-6103-4f79-b2c8-062865c3d342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfAccountsReceivable_37f2fe55-0b28-4f77-9c83-4b0747bb81c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingAbstract_9caddf69-477a-4f35-9c3a-276f7aebeca4" xlink:to="loc_us-gaap_GainLossOnSaleOfAccountsReceivable_37f2fe55-0b28-4f77-9c83-4b0747bb81c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRevolving_45e6e8e1-13b4-493c-ba51-eea4d5e033be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRevolving"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingAbstract_9caddf69-477a-4f35-9c3a-276f7aebeca4" xlink:to="loc_us-gaap_FinancingReceivableRevolving_45e6e8e1-13b4-493c-ba51-eea4d5e033be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572241961952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEI Document - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0022692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">951 Calle Amanecer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Clemente<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">366-2183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.10 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ICUI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,064,364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000883984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ICU MEDICAL INC/DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Document And Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240772816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">$ 220,947<span></span>
</td>
<td class="nump">$ 208,784<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">3,235<span></span>
</td>
<td class="nump">4,224<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">TOTAL CASH, CASH EQUIVALENTS AND INVESTMENT SECURITIES</a></td>
<td class="nump">224,182<span></span>
</td>
<td class="nump">213,008<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for doubtful accounts</a></td>
<td class="nump">139,459<span></span>
</td>
<td class="nump">221,719<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">747,965<span></span>
</td>
<td class="nump">696,009<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">14,294<span></span>
</td>
<td class="nump">15,528<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">87,125<span></span>
</td>
<td class="nump">88,932<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">TOTAL CURRENT ASSETS</a></td>
<td class="nump">1,213,025<span></span>
</td>
<td class="nump">1,235,196<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">PROPERTY AND EQUIPMENT, net</a></td>
<td class="nump">624,112<span></span>
</td>
<td class="nump">636,113<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">79,736<span></span>
</td>
<td class="nump">74,864<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">516<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">GOODWILL</a></td>
<td class="nump">1,462,726<span></span>
</td>
<td class="nump">1,449,258<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">INTANGIBLE ASSETS, net</a></td>
<td class="nump">957,682<span></span>
</td>
<td class="nump">982,766<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred Income Tax Assets</a></td>
<td class="nump">31,466<span></span>
</td>
<td class="nump">31,466<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">OTHER ASSETS</a></td>
<td class="nump">101,885<span></span>
</td>
<td class="nump">105,462<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">4,470,632<span></span>
</td>
<td class="nump">4,515,641<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">186,420<span></span>
</td>
<td class="nump">215,902<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">235,167<span></span>
</td>
<td class="nump">242,769<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term Debt, Current Maturities</a></td>
<td class="nump">35,063<span></span>
</td>
<td class="nump">29,688<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax liability</a></td>
<td class="nump">5,527<span></span>
</td>
<td class="nump">6,200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">TOTAL CURRENT LIABILITIES</a></td>
<td class="nump">462,177<span></span>
</td>
<td class="nump">494,559<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent Earn-Out Liability, Noncurrent</a></td>
<td class="nump">24,905<span></span>
</td>
<td class="nump">25,572<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">1,612,196<span></span>
</td>
<td class="nump">1,623,675<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">114,227<span></span>
</td>
<td class="nump">114,104<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">DEFERRED INCOME TAXES</a></td>
<td class="nump">114,594<span></span>
</td>
<td class="nump">126,007<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">INCOME TAX LIABILITY</a></td>
<td class="nump">42,134<span></span>
</td>
<td class="nump">41,796<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>STOCKHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue', window );">Convertible preferred stock, $1.00 par value Authorized-500 shares; Issued and outstanding - none</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.10 par value - Authorized-80,000 shares; Issued 23,899 shares at June 30,2022 and 21,280 shares at December 31, 2021 and outstanding 23,898 shares at June 30, 2022 and 21,280 shares at December 31, 2021</a></td>
<td class="nump">2,411<span></span>
</td>
<td class="nump">2,399<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,339,908<span></span>
</td>
<td class="nump">1,331,249<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury Stock, at cost (12,684 and 119 shares, respectively)</a></td>
<td class="num">(8,006)<span></span>
</td>
<td class="num">(243)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">827,689<span></span>
</td>
<td class="nump">837,501<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(61,603)<span></span>
</td>
<td class="num">(80,978)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">TOTAL STOCKHOLDERS' EQUITY</a></td>
<td class="nump">2,100,399<span></span>
</td>
<td class="nump">2,089,928<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 4,470,632<span></span>
</td>
<td class="nump">$ 4,515,641<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">50,374<span></span>
</td>
<td class="nump">1,633<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2022 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding nonredeemable convertible preferred stock or outstanding convertible preferred stock that is redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240218368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="nump">$ 10,337<span></span>
</td>
<td class="nump">$ 8,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock, par value</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock, authorized shares</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible preferred stock, issued shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock, outstanding shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">24,114,000<span></span>
</td>
<td class="nump">23,995,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">24,064,000<span></span>
</td>
<td class="nump">23,993,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">50,374<span></span>
</td>
<td class="nump">1,633<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240932144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Income - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">$ 568,649<span></span>
</td>
<td class="nump">$ 543,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of goods sold</a></td>
<td class="nump">376,608<span></span>
</td>
<td class="nump">374,295<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">192,041<span></span>
</td>
<td class="nump">168,827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">152,572<span></span>
</td>
<td class="nump">153,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">19,761<span></span>
</td>
<td class="nump">23,871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Restructuringandstrategictransaction', window );">Restructuring, strategic transaction and integration</a></td>
<td class="nump">11,013<span></span>
</td>
<td class="nump">33,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent earn-out</a></td>
<td class="num">(700)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">TOTAL OPERATING EXPENSES</a></td>
<td class="nump">182,646<span></span>
</td>
<td class="nump">210,988<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">(LOSS) INCOME FROM OPERATIONS</a></td>
<td class="nump">9,395<span></span>
</td>
<td class="num">(42,161)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="num">(22,515)<span></span>
</td>
<td class="num">(13,055)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">OTHER (EXPENSE) INCOME, net</a></td>
<td class="num">(269)<span></span>
</td>
<td class="nump">415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) Income from Continuing Operations before Income Taxes, Noncontrolling Interest</a></td>
<td class="num">(13,389)<span></span>
</td>
<td class="num">(54,801)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">BENEFIT (PROVISION) FOR INCOME TAXES</a></td>
<td class="nump">3,577<span></span>
</td>
<td class="nump">16,733<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET (LOSS) INCOME</a></td>
<td class="num">$ (9,812)<span></span>
</td>
<td class="num">$ (38,068)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>NET INCOME PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.41)<span></span>
</td>
<td class="num">$ (1.61)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.41)<span></span>
</td>
<td class="num">$ (1.61)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>WEIGHTED AVERAGE NUMBER OF SHARES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">24,014<span></span>
</td>
<td class="nump">23,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">24,014<span></span>
</td>
<td class="nump">23,646<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Restructuringandstrategictransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring and strategic transaction expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Restructuringandstrategictransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572243747440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (Loss) Income</a></td>
<td class="num">$ (9,812)<span></span>
</td>
<td class="num">$ (38,068)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</a></td>
<td class="num">(5,577)<span></span>
</td>
<td class="nump">23,572<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of taxes of $0 for all periods</a></td>
<td class="nump">24,983<span></span>
</td>
<td class="num">(4,946)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Other Adjustments, after Tax</a></td>
<td class="num">(31)<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="nump">19,375<span></span>
</td>
<td class="nump">18,641<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Income</a></td>
<td class="nump">$ 9,563<span></span>
</td>
<td class="num">$ (19,427)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240236864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Paranthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</a></td>
<td class="nump">$ 1,744<span></span>
</td>
<td class="num">$ (7,312)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242052720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock Shares [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,280,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Dec. 31, 2021</a></td>
<td class="nump">$ 1,616,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,128<span></span>
</td>
<td class="nump">$ 721,412<span></span>
</td>
<td class="num">$ (27)<span></span>
</td>
<td class="nump">$ 911,787<span></span>
</td>
<td class="num">$ (19,269)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">$ 2,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(2,965)<span></span>
</td>
<td class="nump">5,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</a></td>
<td class="num">(37,279)<span></span>
</td>
<td class="num">(37,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</a></td>
<td class="num">$ (8,743)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,743)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="nump">12,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other Comprehensive (Loss) Income, Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</a></td>
<td class="nump">18,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income Attributable to Parent</a></td>
<td class="num">(38,068)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38,068)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Mar. 31, 2022</a></td>
<td class="nump">2,178,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,390<span></span>
</td>
<td class="nump">1,306,264<span></span>
</td>
<td class="num">(2,843)<span></span>
</td>
<td class="nump">873,719<span></span>
</td>
<td class="num">(628)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,897,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="nump">$ 18,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock Issued During Period, Shares, Acquisitions</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Stock Issued During Period, Value, Acquisitions</a></td>
<td class="nump">$ 575,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="nump">575,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Dec. 31, 2022</a></td>
<td class="nump">23,993,000<span></span>
</td>
<td class="nump">23,995,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Dec. 31, 2022</a></td>
<td class="nump">$ 2,089,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,399<span></span>
</td>
<td class="nump">1,331,249<span></span>
</td>
<td class="num">(243)<span></span>
</td>
<td class="nump">837,501<span></span>
</td>
<td class="num">(80,978)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">$ 171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(503)<span></span>
</td>
<td class="nump">662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Adjustments to Additional Paid in Capital, Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</a></td>
<td class="num">(52,764)<span></span>
</td>
<td class="num">(53,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</a></td>
<td class="num">$ (8,425)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,425)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="nump">9,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other Comprehensive (Loss) Income, Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</a></td>
<td class="nump">19,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income Attributable to Parent</a></td>
<td class="num">(9,812)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,812)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Mar. 31, 2023</a></td>
<td class="nump">$ 2,100,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,411<span></span>
</td>
<td class="nump">$ 1,339,908<span></span>
</td>
<td class="num">$ (8,006)<span></span>
</td>
<td class="nump">$ 827,689<span></span>
</td>
<td class="num">(61,603)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Mar. 31, 2023</a></td>
<td class="nump">24,064,000<span></span>
</td>
<td class="nump">24,114,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="nump">$ 19,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,375<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572236062560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (Loss) Income</a></td>
<td class="num">$ (9,812)<span></span>
</td>
<td class="num">$ (38,068)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">55,744<span></span>
</td>
<td class="nump">53,138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_AmortizationOfInventoryStepUp', window );">Amortization of Inventory Step-up</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Noncash lease expense</a></td>
<td class="nump">5,656<span></span>
</td>
<td class="nump">5,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">666<span></span>
</td>
<td class="num">(548)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ProvisionForWarrantyAndReturns', window );">Provision for warranty and returns</a></td>
<td class="nump">3,951<span></span>
</td>
<td class="nump">726<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation</a></td>
<td class="nump">9,158<span></span>
</td>
<td class="nump">12,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="nump">367<span></span>
</td>
<td class="nump">596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeAmortizationOfPremium', window );">Bond premium amortization</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Debt Issuance Costs amortization</a></td>
<td class="nump">1,701<span></span>
</td>
<td class="nump">1,643<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent earn-out</a></td>
<td class="num">(700)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Sparepartsusage', window );">Sparepartsusage</a></td>
<td class="nump">4,384<span></span>
</td>
<td class="nump">2,223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other Noncash Income (Expense)</a></td>
<td class="num">(40)<span></span>
</td>
<td class="num">(1,649)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">82,028<span></span>
</td>
<td class="nump">22,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(49,370)<span></span>
</td>
<td class="num">(36,170)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">1,907<span></span>
</td>
<td class="nump">2,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Increase (Decrease) in Other Operating Assets</a></td>
<td class="num">(6,448)<span></span>
</td>
<td class="num">(14,371)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(27,525)<span></span>
</td>
<td class="nump">19,504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(21,099)<span></span>
</td>
<td class="num">(19,238)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes', window );">Income taxes, including excess tax benefits and deferred income taxes</a></td>
<td class="num">(9,328)<span></span>
</td>
<td class="num">(26,102)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">41,245<span></span>
</td>
<td class="num">(1,342)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(14,205)<span></span>
</td>
<td class="num">(23,606)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of asset</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Intangible assets additions</a></td>
<td class="num">(2,532)<span></span>
</td>
<td class="num">(2,387)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,993)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sale of investment securities</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(15,183)<span></span>
</td>
<td class="num">(1,867,750)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts', window );">Proceeds from issuance of long-term debt, net of lender debt issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,672,698<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of Long-term Debt</a></td>
<td class="nump">7,375<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of Debt Issuance Costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,852)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">2,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance Lease, Principal Payments</a></td>
<td class="num">(208)<span></span>
</td>
<td class="num">(160)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment, Tax Withholding, Share-based Payment Arrangement</a></td>
<td class="nump">8,425<span></span>
</td>
<td class="nump">8,743<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(15,837)<span></span>
</td>
<td class="nump">1,648,917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract', window );"><strong>Effect of Exchange Rate on Cash [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</a></td>
<td class="nump">1,938<span></span>
</td>
<td class="num">(3,224)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</a></td>
<td class="nump">12,163<span></span>
</td>
<td class="num">(223,399)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">220,947<span></span>
</td>
<td class="nump">329,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital Expenditures Incurred but Not yet Paid</a></td>
<td class="nump">2,223<span></span>
</td>
<td class="nump">5,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>NON-CASH INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,844,164)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (Loss) Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent earn-out</a></td>
<td class="num">$ (700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>NON-CASH INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair Value of Assets Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,594,776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_NetCashPaidReceivedforcurrentandprioracquisitions', window );">Net Cash Paid (Received) for current and prior acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,844,164)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(575,975)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized', window );">Business Combination, Liabilities Arising from Contingencies, Amount Recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,158)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Goodwill, Period Increase (Decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,485,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Liabilities Assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (605,466)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_AmortizationOfInventoryStepUp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of Inventory Step-up</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_AmortizationOfInventoryStepUp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change during the reporting period in the carrying amount as of the balance sheet date of payments made for taxes. Also includes the net change during the reporting period in the account that represents the temporary difference that results from income (loss) that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_NetCashPaidReceivedforcurrentandprioracquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Cash Paid (Received) for current and prior acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_NetCashPaidReceivedforcurrentandprioracquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of long-term debt, net of lender debt issuance costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProvisionForWarrantyAndReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Provision for warranty and returns</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProvisionForWarrantyAndReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Sparepartsusage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sparepartsusage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Sparepartsusage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeAmortizationOfPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of purchase premium on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeAmortizationOfPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572246950384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation:<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Basis of Presentation [Text Block]</a></td>
<td class="text">Basis of Presentation<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited interim condensed consolidated financial statements of ICU Medical, Inc., ("ICU" or the "Company"), a Delaware corporation, have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S.") and pursuant to the rules&#160;and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and reflect all adjustments, consisting of only normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the consolidated results for the interim periods presented. Results for the interim period are not necessarily indicative of results for the full year. Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules&#160;and regulations. The condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report on Form&#160;10-K of ICU for the year ended December&#160;31, 2022. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, manufacture and sell innovative medical products used in infusion therapy, vascular access, and vital care applications. ICU's product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. We sell the majority of our products through our direct sales force and through independent distributors throughout the U.S. and internationally.&#160;We also sell certain products on an original equipment manufacturer basis to other medical device manufacturers. All subsidiaries are wholly owned and are included in the condensed consolidated financial statements.&#160;All intercompany balances and transactions have been eliminated.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to the prior year financial statements and footnotes to conform to the presentation used in the current year. In the statements of operations we reclassified interest income to interest (expense) income, net from other (expense) income, net and in Note 5: Revenues, certain reclassifications were made to revenues disaggregated by product line and by geography. Also, in Note 9: Fair Value Measurements the table indicating the Level inputs for the assets and liabilities measured at fair value on a recurring basis was updated to correct the Level input identified for the hedge assets and liabilities.  These reclassifications had no impact on total revenues, net loss, shareholder's equity or cash flows as previously reported.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572244347808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements:<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Pronouncements and Changes in Accounting Principles [Text Block]</a></td>
<td class="text">New Accounting Pronouncements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional guidance for a limited period of time to ease the potential burden for reference rate reform on financial reporting. Due to concerns about structural risks of interbank offered rates and, particularly, the risk of cessation of the London Interbank Offered Rate ("LIBOR"), regulators around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction-based and less susceptible to manipulation. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued as a result of reference rate reform. Optional expedients may be applied to contracts that are modified as a result of the reference rate reform. Modifications of contracts within the scope of Topic 470, Debt, should be accounted for by prospectively adjusting the effective interest rate. Modifications of contracts within the scope of ASC 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate (incremental borrowing rate). Exceptions to Topic 815, Derivatives and Hedging, results in not having a dedesignation of a hedging relationship if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. ASU No. 2022-06, Reference Rate Reform: Deferral of the Sunset Date of Topic 848 deferred the sunset date to December 31, 2024. In November 2021, we entered into two forward-starting swaps whereby the variable leg of the swap referenced LIBOR. These swaps were amended in early 2022 to transition to an alternative reference rate (see Note 8: Derivatives and Hedging Activities). The amendments in this ASU allow for certain expedients that will allow us to assume that our hedged interest payments are probable of occurring regardless of any expected modification in their terms related to reference rate reform and will allow us to continue hedge accounting for a cash flow hedge for which the hedged interest rate risk changes if the hedge is highly effective under ASC 815, Derivatives and Hedging, or the optional expedient under this ASU is elected. The impact of this ASU on our contracts has not been and is not expected to be material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242439808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination Disclosure</a></td>
<td class="text">Acquisitions<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Acquisition</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired 100.0% of the equity interests in Smiths Medical, the holding company of Smiths Group plc's global medical device business, from Smiths Group International Holdings Limited (&#8220;Smiths&#8221;). The acquisition of Smiths Medical aligns with our strategic growth plans, enabling us to broaden our product offerings to include syringe and ambulatory infusion devices, vascular access, and vital care products and to strengthen and expand our global market reach.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash consideration for the acquisition was $1.9&#160;billion, which was financed with existing cash balances and proceeds from the credit agreement entered into on January 6, 2022 (see Note 17: Long-Term Debt). We also issued share consideration to Smiths of 2.5&#160;million shares of our common stock. The fair value of the common shares issued to Smiths was determined based on the opening market price of our common stock on the acquisition date. Smiths may be entitled to an additional $100.0&#160;million in cash consideration contingent on our common stock achieving certain price targets for certain periods after closing in accordance with the terms of the Share Sale and Purchase Agreement (the "Purchase Agreement"). In the event that (a) on or prior to the third anniversary of closing the 30-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $300.00 per share or (b) on or prior to the fourth anniversary of closing the 45-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $300.00 per share (each a "Price Target"), and provided Smiths beneficially owns at least 50.0% of the shares of common stock issued at closing at the time the Price Target is achieved, then Smiths will be entitled to receive the additional $100.0&#160;million in cash consideration. The fair value of the contingent consideration was determined using an option pricing model, specifically the Monte Carlo Simulation. In the analysis, the determinants of payout are simulated in a risk neutral framework over a large number of simulation paths. The fair value of the contingent consideration is then calculated as the average present value across all simulated paths. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smiths became a related party to us when we issued 2.5&#160;million shares of our common stock as partial consideration for the acquisition of Smiths Medical. Additionally, we entered into a transition services agreement ("TSA") with certain members of Smiths Group, plc. The TSA includes certain information technology, human resource and tax support services for an initial term of twelve months with the option to extend up to 24 months. During the three months ended March 31, 2023, we expensed $4.0&#160;million for services provided under the TSA. As of March 31, 2023, we have $1.5&#160;million in open payables related to the services received under the TSA.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Final Purchase Price Allocation</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final purchase price and the final allocation of the purchase price related to the assets acquired and liabilities assumed (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated cash consideration for acquired assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration payable to Smiths</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of ICU Medical, Inc. common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Price per share (ICU's opening market price on the acquisition date)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of ICU shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,552,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase Price Allocation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173,151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,490)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187,455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082,570&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - not tax deductible</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,469,880&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated Purchase Consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,552,450&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Identifiable intangible assets include $510.0&#160;million of customer relationships, $400.0&#160;million of developed technology, $30.0&#160;million of internally developed software, and $5.0&#160;million of trademark. The estimated weighted-average amortization period for the total identifiable intangible assets is approximately <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjc3NQ_c58be461-15cc-4ce0-9461-a1f586d03baa">nine</span> years, and, for each identifiable intangible asset is estimated as follows: <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjg1NA_dbc618ca-f89e-4749-ab68-262b22ebc7e6">eight</span> years for customer relationships, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjg5MQ_cbdceafc-7a31-4a27-b09c-41ac0c8d87ec">ten</span> years for developed technology, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjkyNg_15a93537-17a8-41e6-a1fe-d867b9347f66">five</span> years for internally developed software, and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjk3NA_5b7a1829-90b2-4109-8983-d52f0d255b2e">six</span> months for the trademark. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued liabilities includes, among other things, accrued warranty reserves, accrued restructuring initiatives, accrued salaries and related benefits, deferred revenue and accrued sales and use taxes.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The identifiable intangible assets and other long-lived assets acquired have been valued utilizing Level 3 inputs as defined in Note 9: Fair Value Measurements. The fair value of identifiable intangible assets was generally developed using the income approach and are based on critical estimates, judgments and assumptions derived from: analysis of market conditions; discount rate; discounted cash flows; royalty rates; customer retention rates; and/or estimated useful lives. Certain other intangible assets were valued using a cost to replace method, estimating the labor and non-labor costs required to replace the asset under the premise that it was not part of the transaction. Property, plant and equipment was valued with the consideration of remaining economic lives. The raw materials inventory was valued at historical cost and adjusted for any obsolescence which we estimate to approximate replacement cost, the work in process inventory was valued at estimated sales proceeds less costs to complete and costs to sell, and finished goods inventory was valued at estimated sales proceeds less costs to sell. The prepaid expenses and other current assets and assumed liabilities were recorded at their carrying values as of the date of the acquisition, as their carrying values approximated their fair values due to their short-term nature.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Information</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smiths Medical is included in our consolidated results beginning on January 7, 2022. Total revenues and net loss attributable to Smiths Medical for the period from January 7, 2022 to March 31, 2022 were estimated to be $214.9&#160;million and </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$40.4&#160;million. The following unaudited pro forma financial information presents the combined results of operations of ICU and Smiths Medical as if the acquisition had occurred on January 1, 2022. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place on the date indicated or of results that may occur in the future. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.421%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>The unaudited pro forma results presented above include the impact of the following adjustments: incremental amortization expense on intangible assets acquired of $3.3&#160;million for the three months ended March 31, 2022, incremental interest expense, including amortization of debt discount and debt issuance costs, on the Senior Secured Credit Facilities (as defined in Note 17: Long-Term Debt) of $0.8&#160;million for the three months ended March 31, 2022. The unaudited pro forma results include IFRS to U.S. GAAP adjustments for Smiths Medical's historical results and adjustments for accounting policy alignment, which were materially similar to the Company. Any differences in accounting policies were adjusted to reflect the accounting policies of the Company in the unaudited pro forma results presented.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242250464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Related Activities Disclosure</a></td>
<td class="text">Restructuring, Strategic Transaction and Integration<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Restructuring, strategic transaction and integration expenses were $11.0 million and $33.9 million for the three months ended March 31, 2023 and 2022, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended March&#160;31, 2023 and 2022, restructuring charges were $2.7&#160;million and $3.2&#160;million, respectively and were primarily related to severance costs. &#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity in our restructuring-related accrual by major type of cost for the three months ended March&#160;31, 2023 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.840%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Severance Pay and Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retention and Facility Closure Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,507&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges incurred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(911)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,643&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,546&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">__________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other, primarily relates to prior year accrued restructuring charges for estimated facility closure costs that were reversed during the three months ended March 31, 2023. </span></div><div><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic Transaction and Integration Expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We incurred and expensed $8.3 million and $30.7 million in strategic transaction and integration expenses during the three months ended March 31, 2023 and 2022, respectively, which are included in restructuring, strategic transaction and integration expenses in our condensed consolidated statements of operations. The strategic transaction and integration expenses during the three months ended March&#160;31, 2023 were primarily related to consulting expenses and employee costs incurred to integrate our Smiths Medical business acquired in 2022. The strategic transaction and integration expenses for the three months ended March 31, 2022 were primarily related to transaction and integration expenses associated with our acquisition of Smiths Medical (see Note 3: Acquisitions) which primarily included legal expenses, bank fees, a United Kingdom stamp tax, and employee costs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242373872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer [Text Block]</a></td>
<td class="text">Revenue<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As part of the integration of our acquisition of Smiths Medical, we have now migrated to our new business unit structure of Consumables, Infusion Systems and Vital Care. The vast majority of our sales of products within these business units are made on a stand-alone basis to hospitals and distributors. Revenue is typically recognized upon transfer of control of the products, which we deem to be at point of shipment. However, for purposes of revenue recognition for our software licenses and renewals, we consider the control of these products to be transferred to a customer at a certain point in time; therefore, we recognize revenue at the start of the applicable license term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Payment is typically due in full within 30 days of delivery or the start of the contract term.  Revenue is recorded in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We offer certain volume-based rebates to our distribution customers, which we record as variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between the prices we charge our distribution customers and the contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts in order to determine the transaction price, we use information available at the time, including our historical experience.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We also warranty products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available at that time and our historical experience. We also provide for extended service-type warranties, which we consider to be separate performance obligations. We allocate a portion of the transaction price to the extended service-type warranty based on its estimated relative selling price, and recognize revenue over the period the warranty service is provided. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue disaggregated</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our revenues disaggregated by product line (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product line</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vital Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568,649&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543,122&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023 and 2022, net sales to Medline made up approximately 15% of total revenues.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our revenues disaggregated by geography (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:66.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.931%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geography</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568,649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543,122&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract balances</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the changes in our contract balances for the three months ended March 31, 2023 and 2022 (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,866)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(861)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, March 31, 2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,511)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,461)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of acquired deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,266)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(767)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,236)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract liabilities are included in accrued liabilities or other long-term liabilities in our condensed consolidated balance sheet based on the expected timing of payments.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, revenue from remaining performance obligations is as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.516%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recognition Timing</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&lt; 12 Months</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&gt; 12 Months</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,464)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,327)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(829)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,422)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,441)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,711)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,920)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,591)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Other deferred revenue includes pump development programs, purchased training and extended warranty.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242320832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Lessee, Operating Leases [Text Block]</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception. Our operating lease assets are separately stated in operating lease right-of-use ("ROU") assets and our financing lease assets are included in other assets on our condensed consolidated balance sheets. Our lease liabilities are included in accrued liabilities and other long-term liabilities on our condensed </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated balance sheets. We have elected not to recognize an ROU asset and lease liability for leases with terms of twelve months or less.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Lease ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Most of our leases do not provide an implicit rate, therefore we use our incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term based on the information available at commencement date. Our lease ROU assets exclude lease incentives and initial direct costs incurred. Our lease terms include options to extend when it is reasonably certain that we will exercise that option. All of our leases have stated lease payments, which may include fixed rental increases. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our leases are for corporate, research and development and sales and support offices, distribution facilities, device service centers and certain equipment. Our leases have original lease terms of one year to fifteen years, some of which include options to extend the leases for up to an additional five years. For all of our leases, we do not include optional periods of extension in our current lease terms for the exercise of options to extend is not reasonably certain.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of our lease cost (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:66.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.931%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; reduction of ROU asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,380&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense on our finance leases is included in interest expense, net in our condensed consolidated statements of operations. The reduction of the operating and finance ROU assets is included as noncash lease expense in selling, general and administrative expenses in our condensed consolidated statements of operations.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental cash flow information related to our leases (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,736</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,864</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,150</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,169</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,062</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,916</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,212</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,085</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,598</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,842</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,671</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,711&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,499)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,212&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,842&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240200352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share:<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share [Text Block]</a></td>
<td class="text">Net Income Per Share<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period plus dilutive securities. Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options and restricted stock units that are anti-dilutive are not included in the treasury stock method calculation. Due to the net loss for the three months ended March&#160;31, 2023 and 2022, any potentially dilutive common shares were not included in the computation of diluted earnings per share as they would have had an anti-dilutive effect; therefore, basic and diluted net loss per share are equal for each of the three months ended March 31, 2023 and 2022. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the calculation of net earnings per common share (&#8220;EPS&#8221;) &#8212; basic and diluted (in thousands, except per share data):&#160; </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,812)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,068)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding (basic)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common and common equivalent shares outstanding (diluted)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,014&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,646&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.41)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.61)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the net loss for the three months ended March 31, 2023 and 2022, there are no potentially dilutive common shares included in the computation of diluted earnings per share.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572244415472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments and Hedging Activities Disclosure [Text Block]</a></td>
<td class="text">Derivatives and Hedging Activities<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Accounting and Hedging Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The purposes of our cash flow hedging programs are to manage the foreign currency exchange rate risk on forecasted revenues and expenses denominated in currencies other than the functional currency of the operating unit, and to manage floating interest rate risk associated with future interest payments on the variable-rate term loans issued in January 2022. We do not issue derivatives for trading or speculative purposes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions. The derivative instruments we utilize, including various foreign exchange contracts and interest rate swaps, are designated and qualify as cash flow hedges. Our derivative instruments are recorded at fair value on the condensed consolidated balance sheets and are classified based on the instrument's maturity date. We record gains or losses from changes in the fair values of the derivative instruments as a component of other comprehensive income (loss) and we reclassify those gains or losses into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. If the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, we reclassify the gain or loss on the related derivative instrument from accumulated other comprehensive loss into earnings immediately.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Forward Contracts</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign exchange forward contracts to hedge a portion of our forecasted foreign currency-denominated revenues and expenses to minimize the effect of foreign exchange rate movements on the related cash flows. These contracts are agreements to buy or sell a quantity of a currency at a predetermined future date and at a predetermined exchange rate. Our foreign exchange forward contracts hedge exposures principally denominated in Mexican Pesos ("MXN"), Euros, Czech Koruna ("CZK"), Japanese Yen ("JPY"), Swedish Krona ("SEK"), Chinese Renminbi ("CNH"), Canadian Dollar ("CAD") and Australian Dollar ("AUD") and have varying maturities with an average term of approximately twelve months. The total notional amount of these outstanding derivative contracts as of March&#160;31, 2023 was $101.8&#160;million, which included the notional equivalent of $3.6&#160;million in MXN, $26.4&#160;million in Euros, $4.7&#160;million in CZK, $21.2&#160;million in JPY, $14.8&#160;million in CNH, $2.7&#160;million in SEK, $13.1&#160;million in CAD, $13.1&#160;million in AUD and $2.2&#160;million in other foreign currencies, with terms currently through June 2024. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cross-currency Par Forward Contracts</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into cross-currency par forward contracts to hedge a portion of our Mexico forecasted expenses denominated in MXN. These contracts are agreements to exchange cash flows from one currency to another at specified intervals over the contract term with all exchanges occurring at the same predetermined rate. In November 2021, we entered into a one-year cross-currency par forward contract with a term from December 1, 2021 to December 1, 2022. The total notional amount of this outstanding derivative as of March 31, 2022 was approximately 311.6&#160;million MXN. This derivative instrument matures in equal monthly amounts at a fixed forward rate of 21.60 MXN/USD.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Floating Interest Rate Risk</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, in anticipation of entering into the new senior secured credit facilities in January 2022, which includes a variable-rate term loan A and a variable-rate term loan B (see Note 17: Long-Term Debt), we entered into two forward-starting interest rate swaps. In February 2022, certain terms under the agreements were amended to reflect the transition from LIBOR to the Secured Overnight Financing Rate ("SOFR"), an alternative reference rate. Under the interest rate swap agreements, we exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount. Effective March 30, 2022, the term loan A swap, as amended, has an initial notional amount of $300.0&#160;million, reducing to $150.0&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2027. We will pay a fixed rate of 1.32% and will receive the greater of 3-month USD SOFR or (0.15)%. Effective March 30, 2022, the term loan B swap, as amended, has an initial notional amount of $750.0&#160;million, reducing to $46.9&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2026. We will pay a fixed rate of 1.17% and will receive the greater of 3-month USD SOFR or 0.35%. These swaps effectively convert the relevant portion of the floating-rate term loans to fixed rates.&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair values of our derivative instruments included within the Condensed Consolidated Balance Sheets (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:48.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March&#160;31, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNC0wLTEtMS0xMTIyOTE_cfaec65c-7e6a-4276-963b-bd9a55c586b9">Prepaid expenses and other current assets</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNS0wLTEtMS0xMTIyOTE_a381aeb8-d171-4550-9ed5-50b193801e56">Other assets</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,716&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOC0wLTEtMS0xMTIyOTE_31479843-5a18-4da4-b2e9-8a0ab42c6b76">Accrued liabilities</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOS0wLTEtMS0xMTIyOTE_0314024e-19ca-42c9-bda0-6b9963e62d6c">Other long-term liabilities</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTMtMC0xLTEtMTEyMjkx_b4e70733-51f6-4cf5-a4f0-4e3344743eed">Prepaid expenses and other current assets</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTQtMC0xLTEtMTEyMjkx_c7f29940-14d5-49dd-8334-2995d9c76144">Other assets</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,954&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,184&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,138&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTctMC0xLTEtMTEyMjkx_6e89f792-0047-409f-ae97-92f90a1a3b54">Accrued liabilities</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTgtMC0xLTEtMTEyMjkx_e58a7954-fa23-4f46-8db3-028044ca9ce7">Other long-term liabilities</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,014&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,014&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized the following gains on our derivative instruments designated as cash flow hedges in other comprehensive income before reclassifications to net loss (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.037%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,163&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:50.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.358%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Reclassified From Accumulated Other Comprehensive (Loss) Income into Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNC0yLTEtMS0xMTIyOTE_f380e986-354b-4ae5-be66-0d8180b7e6bd">Total revenues</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNS0yLTEtMS0xMTIyOTE_e0200ea4-951a-4f15-aa0d-730e8294b71c">Cost of goods sold</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNy0yLTEtMS0xMTIyOTE_faab4624-13eb-4610-aa53-f7352f932ffd">Interest expense</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,189&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents location of gain reclassified from accumulated other comprehensive income into income as a result of ineffectiveness.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents location of gain reclassified from accumulated other comprehensive income into income as a result of forecasted transactions no longer probable of occurring.</span></div>As of March&#160;31, 2023, we expect an estimated $5.3&#160;million in deferred gains on the outstanding foreign exchange contracts and an estimated $26.3&#160;million in deferred gains on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242260016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. There are three levels of inputs that may be used to measure fair value:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1:  quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2:  inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3:  unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Earn-out Liabilities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired Smiths Medical with a combination of cash consideration and share consideration issued at closing. Total consideration for the acquisition includes a potential earn-out payment of $100.0&#160;million in cash contingent on our common stock achieving certain Price Targets from the closing date to either the third or fourth anniversary of closing (see Note 3: Acquisitions for additional information) and provided Smiths beneficially owns at least 50.0% of the shares of common stock issued at closing at the time the Price Target is achieved. The initial estimated fair value of the earn-out was determined to be $53.5&#160;million. The initial fair value of the earn-out was determined using a Monte Carlo simulation model. The model utilized several assumptions including volatility and the risk-free interest rate. The assumed volatility is based on the average of the historical volatility of our common stock price and the implied volatility of certain at-the-money traded options. The risk-free interest rate is equal to the yield on U.S. Treasury securities at constant maturity for the period commensurate with the term of the earn-out. At each reporting date subsequent to the acquisition, we will remeasure the earn-out liability and recognize any changes in its fair value in our consolidated statements of operations. If the probability of achieving the Price Targets during their respective measurement periods is significantly greater than initially anticipated, the realization of an additional liability and related expense will have a significant impact on our consolidated financial statements in the period recognized. As of March&#160;31, 2023, the estimated fair value of the contingent earn-out is $20.3&#160;million.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of December 31, 2022, the measurement period related to (i) above ended, and based on the actual revenue achieved during the measurement period we determined that the fair value of the contingent earn-out was zero as the minimum threshold for earning the earn-out was not met. As of March&#160;31, 2023, the estimated fair value for the contingent earn-out related to certain product-related regulatory certifications was estimated to be $1.5&#160;million. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out payment shall not exceed $6.0&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of both March 31, 2023 and December 31, 2022, the estimated fair value of the contingent earn-out is $2.6&#160;million. The estimated fair value of the contingent earn-out is calculated using a probability-weighted cash flow model based on historical revenue streams and the likelihood that the revenue targets will be met.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our contingent earn-out liabilities are separately stated on our condensed consolidated balance sheets.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a reconciliation of the Level 3 earn-out liabilities measured at estimated fair value (in thousands):  </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of earn-out (included in income from operations as a separate line item)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,905&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition date fair value estimate of earn-out</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Primarily relates to Smiths Medical.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$53.5&#160;million relates to our acquisition of Smiths Medical and $1.6&#160;million relates to our acquisition of a small foreign infusions systems supplier in the fourth quarter of 2021 (see Note 3: Acquisitions).</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide quantitative information about Level 3 inputs for fair value measurement of our earn-out liabilities related to Smiths Medical:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smiths Medical Earn-out Liability</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.736%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-Free Rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments, Foreign Exchange Contracts and Interest Rate Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our investments consist of corporate bonds and U.S treasury securities. The fair value of our corporate bonds is estimated using observable market-based inputs such as quoted prices, interest rates and yield curves or Level 2 inputs. The fair value of our U.S. treasury securities are based on quoted market prices in active markets and are included in the Level 1 fair value hierarchy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair value of our Level 2 foreign exchange contracts, including forward contracts and cross-currency par forward contracts, is estimated using observable market inputs such as known notional value amounts, spot and forward exchange rates. These inputs relate to liquid, heavily traded currencies with active markets which are available for the full term of the derivative.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our Level 2 interest rate swaps is estimated using a pricing model that reflects the terms of the contracts, including the period to maturity, and relies on observable market inputs such as known notional value amounts and USD interest rate curves.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our assets and liabilities measured at fair value on a recurring basis consisted of the following Level 1, 2 and 3 inputs as defined above (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTAtMC0xLTEtMTEyMjkx_f14ce4d4-85f2-4d23-a88b-1739598efd81">Prepaid expenses and other current assets</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTEtMC0xLTEtMTEyMjkx_d56c9d3d-0932-4348-b69d-8f57de5603f9">Other assets</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTUtMC0xLTEtMTEyMjkx_6bcfe6ca-ff2c-4a0b-9003-1212bc82d7dd">Prepaid expenses and other current assets</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTYtMC0xLTEtMTEyMjkx_308e7868-3fa9-4233-8466-3e1183fa8b50">Other assets</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjMtMC0xLTEtMTEyMjkx_5523e65b-55dc-41c6-8709-df1a94648036">Accrued liabilities</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjQtMC0xLTEtMTIwNzE1_62efbfc3-1b08-43d2-b4de-0ebc769246ce">Other long-term liabilities</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,078&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,173&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,905&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forwards:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNy0wLTEtMS0xMTIyOTE_50321293-4bf5-432f-9a23-856af180772d">Prepaid expenses and other current assets</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTgtMC0xLTEtMTEyMjkx_38c2c727-8408-4048-b07a-938ff12e83e6">Other long-term liabilities</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,572&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572244338848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock', window );">investments in Debt and Marketable Equity Securities and Equity Method Investments [Text Block]</a></td>
<td class="text">Investment Securities<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Available-for-sale Securities</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our available-for-sale investment securities currently consist of short-term and long-term corporate bonds, short-term U.S. treasury securities and long-term government bonds and are considered &#8220;investment grade&#8221; and are carried at fair value. We assess our investment in available-for-sale debt securities for impairment each reporting period. If an unrealized loss exists, we determine whether any portion of the decline in fair value below the amortized cost basis is credit-related by reviewing several factors, including, but not limited to, the extent of the fair value decline and changes in the financial condition of the issuer. We record an impairment for credit-related losses through an allowance, limited to the amount of the unrealized loss. If we either intend to sell or it is more likely than not we will be required to sell the debt security before its anticipated recovery, any allowance is written off and the amortized cost basis is written down to fair value through a charge against net earnings. Unrealized gains and non-credit-related unrealized losses are recorded, net of tax, in other comprehensive income (loss). We did not have any investments in available-for-sale debt securities in unrealized loss positions as of March&#160;31, 2023 or December 31, 2022.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost of the debt securities are adjusted for the amortization of premiums computed under the effective interest method. Such amortization is included in interest expense, net in our condensed consolidated statements of operations. Realized gains and losses are accounted for on the specific identification method. There have been no realized gains or losses </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the disposal of these investments. The scheduled maturities of the debt securities are between 2022 and 2024. All short-term investment securities are callable within one year.  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.301%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March&#160;31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding <br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,235&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,235&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding<br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Non-Marketable Equity Securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, we acquired an approximate 20% non-marketable equity interest in a nonpublic company and entered into a three-year distribution agreement where we have the exclusive rights to market, sell and distribute the company's products in exchange for a cash payment of $3.3&#160;million. In addition, we were granted an exclusive license for all of the seller's intellectual property. At the expiration of the distribution agreement we have the right but not the obligation to acquire the remaining interest in the business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the equity method of accounting for investments when we determine we have a significant influence, but not a controlling interest in the investee. We determine whether we have significant influence by considering key factors such as ownership interest, representation on the board of directors, participation in policy making decisions, business relationship and material intra-entity transactions, among other factors. Our equity method investment is reported at cost and adjusted each period for our share of the investee's income or (loss) and dividend paid, if any. We eliminate any intra-entity profits to the extent of our beneficial interest. We record our share of the investee's income or (loss) on a one quarter lag. We report our proportionate share of the investee's income or (loss) resulting from this investment in other income, net in our condensed consolidated statements of operations. The carrying value of our equity method investment is reported in other assets on our condensed consolidated balance sheets (see Note 11: Prepaid Expenses and Other Current Assets and Other Assets). We assess our equity method investments for impairment on an annual basis or whenever events or circumstances indicate that the carrying value of the investment may not be recoverable. Our recorded share of the investee's loss was not material for the three months ended March&#160;31, 2023 and 2022. We did not receive any dividend distributions from this investment during the three months ended March&#160;31, 2023 and 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-marketable equity method investment consists of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>investments in Debt and Marketable Equity Securities and Equity Method Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242468000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaids and Other Current Assets (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock', window );">Prepaids, other current assets and other noncurrent assets [Text Block]</a></td>
<td class="text">Prepaid Expenses and Other Current Assets and Other Assets<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses and receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,332&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid vendor expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance and property taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT/GST receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax charge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,125&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,932&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pump lease receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,821&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spare parts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,885&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaids, other current assets and other noncurrent assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572243908560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories:<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories [Text Block]</a></td>
<td class="text">Inventories<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method. Inventory costs include material, labor and overhead related to the manufacturing of our products. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747,965&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696,009&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240150800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment:<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment [Text Block]</a></td>
<td class="text">Property, Plant and Equipment<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consists of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414,811&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, building and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments placed with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,666&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,481&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,174,544&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162,557&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(550,432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(526,444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624,112&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636,113&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Instruments placed with customers consist of drug-delivery and monitoring systems placed with customers under operating leases.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>Depreciation expense was $23.4 million and $21.4&#160;million for the three months ended March&#160;31, 2023 and 2022, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572244338848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets Disclosure [Text Block]</a></td>
<td class="text">Goodwill and Intangible Assets, Net<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amount of our goodwill (in thousands):</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,449,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,462,726&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life&#160;in&#160;Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,092&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">550,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">584,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">461,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,209,215&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285,135&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">924,080&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,242,817&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285,135&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,682&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,998&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">546,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">445,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">583,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,202,911&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,951&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950,960&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,234,717&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,951&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">982,766&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with definite lives are amortized on a straight-line basis over their estimated useful lives. During the three months ended March&#160;31, 2023 and 2022, intangible asset amortization expense was $32.3 million and $31.7 million, respectively.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242311072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</a></td>
<td class="text">Accrued Liabilities and Other Long-Term Liabilities<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Accrued liabilities consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,808&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incentive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-ST</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties and returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Field service corrective action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued audit fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,167&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,769&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to field service corrective actions associated with certain products in connection with a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.</span></div>Other long-term liabilities consist of the following (in thousands):&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-LT</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,062&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,916&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liability-LT</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Field service corrective action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,227&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,104&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572243908560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes:<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
<td class="text">Income Taxes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes were accrued at an estimated effective tax rate of 27% for the three months ended March&#160;31, 2023, as compared to 31% for the three months ended March 31, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective tax rate for the three months ended March 31, 2023 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, section 162(m) excess compensation, foreign-derived intangible income ("FDII") and tax credits and the following discrete items recognized during the interim period:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Excess tax provision recognized on stock option exercises and the vesting of restricted stock units during the three months ended March&#160;31, 2023 of $0.7&#160;million. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The revaluation of the contingent consideration during the three months ended March&#160;31, 2023 of $0.7&#160;million, resulted in a tax expense of $0.0&#160;million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective tax rate for the three months ended March 31, 2022 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, section 162(m) excess compensation, FDII and tax credits. The effective tax rate during the three months ended March 31, 2022 included a discrete tax benefit of $2.6&#160;million related to excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572244398528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_LOngTermObligationsDisclosureAbstract', window );"><strong>LOng-Term Obligations Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-term Debt [Text Block]</a></td>
<td class="text">Long-Term Debt<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Credit Agreement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, in connection with the acquisition of Smiths Medical, we entered into a Credit Agreement (the "Credit Agreement") with Wells Fargo Bank, National Association, Wells Fargo Securities, LLC, Barclays Bank PLC and certain other financial institutions (the &#8220;Lenders&#8221;) for $2.2&#160;billion of senior secured credit facilities. The senior secured credit facilities include (i) a five-year Tranche A term loan of $850.0&#160;million (the "Term Loan A"), (ii) a seven-year Tranche B term loan of $850.0&#160;million (the "Term Loan B") and (iii) a five-year revolving credit facility of $500.0&#160;million (the "Revolving Credit Facility"), with separate sub-limits of $50.0&#160;million for letters of credit and swingline loans (collectively, the "Senior Secured Credit Facilities"). We used the proceeds from borrowings under the Term Loan A and the Term Loan B (collectively, the "Term Loans") to fund a portion of the cash consideration for the purchase of Smiths Medical and the related fees and expenses incurred in connection with the acquisition. We did not incur borrowings under the Revolving Credit Facility on the closing date of the acquisition. The proceeds from any future borrowings under the Revolving Credit Facility may be used for working capital and other general corporate purposes.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with entering into the Credit Agreement, during the period ended March 31, 2022, we incurred $37.8 million in debt discount and issuance costs, which were allocated to the Term Loan A, the Term Loan B and the Revolving Credit Facility based on lender commitment amounts relative to each type of fees paid. The lender and third-party discount and issuance costs allocated to the Term Loan A and the Term Loan B were $15.8 million and $13.4 million, respectively, and are reflected as a direct deduction from the face amount of the corresponding term loans on the condensed consolidated balance sheet. These costs are being amortized to interest expense over the respective terms of the loans using the effective interest method. The issuance costs allocated to the Revolving Credit Facility were $8.6 million, which are capitalized and included in prepaid expenses and other current assets and other assets on our condensed consolidated balance sheets. These costs are being amortized to interest expense over the term of the Revolving Credit Facility using the straight-line method. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net funds received from the Term Loan A and the Term Loan B, after deducting debt issuance costs, were $834.2 million and $836.6 million, respectively.   </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity Dates</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity date for the Term Loan A and the Revolving Credit Facility is January 6, 2027, and the maturity date for the Term Loan B is January 6, 2029. Pursuant to the terms and conditions of the Credit Agreement, the maturity dates of the Term Loans and the Revolving Credit Facility may be extended upon our request, subject to the consent of the Lenders.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Terms</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, the Term Loans and borrowings under the Revolving Credit Facility denominated in U.S. dollars bear interest, at our option, on either: (1) the Base Rate, as defined below, plus the applicable margin, as indicated below ("Base Rate Loans") or (2) the Adjusted Term Secured Overnight Financing Rate ("Adjusted Term SOFR"), as defined below, plus the applicable margin, as indicated below ("Term SOFR Loans"). </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Base Rate is defined as the highest of (a) the Prime Rate, (b) the Federal Funds Rate plus 0.50% and (c) Adjusted Term SOFR (as defined below) for a one-month period plus, in each case, 1.00%.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted Term SOFR is the rate per annum equal to (a) the Term SOFR plus (b) the Term SOFR Adjustment. Term SOFR is the forward-looking term rate based on SOFR and is calculated separately for Term SOFR Loans and Base Rate Loans, as specified in the Credit Agreement. The Term SOFR Adjustment is a percentage per annum of 0.10% for Base Rate Loans and between 0.10% to 0.25% for Term SOFR Loans based on the applicable interest period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility Commitment Fee</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility has a per annum commitment fee at an initial rate of 0.25% which is applied to the available amount of the Revolving Credit Facility. Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the commitment fee will be determined by reference to the leverage ratio in effect from time to time as set forth in the table below.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Applicable Interest Margins</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan A and borrowings under the Revolving Credit Facility have an initial applicable margin of 0.75% per annum for Base Rate Loans and 1.75% per annum for Term SOFR Loans.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan A and borrowings under the Revolving Credit Facility will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: </span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitment Fee Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 4.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 4.00 to 1.0 but greater than 3.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 3.00 to 1.0 but greater than 2.50 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.50 to 1.0 but greater than 2.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15%</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan B has an initial applicable margin of 1.5% per annum for Base Rate Loans and 2.5% per annum for Term SOFR Loans.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan B will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: </span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.368%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.665%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 2.75 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.75 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal Payments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on the Term Loans are due on the last day of each calendar quarter commencing on June 30, 2022. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan A will amortize in nineteen consecutive quarterly installments in an amount equal to 2.50% of the original principal amount in each of the first two years, 5.00% in each of the third and fourth years and 7.50% in the fifth year, with a final payment of the remaining outstanding principal balance due on the maturity date.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan B matures in twenty-seven consecutive quarterly installments in an amount equal to 0.25% of the original principal amount, with a final payment of the remaining outstanding principal balance due on the maturity date.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may borrow, prepay and re-borrow amounts under the Revolving Credit Facility, in accordance with the terms and conditions of the Credit Agreement, with all outstanding amounts due at maturity. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2022, we prepaid $16.0 million in principal payments on the Term Loan A principal balance. For the three months ended March 31, 2023, we paid  total of $7.4&#160;million in principal payments on both Term Loans.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Payments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest payments on Base Rate Loans are payable quarterly in arrears on the last business day of each calendar quarter and the applicable maturity date. Interest periods on Term SOFR Loans will be determined, at our option, as either one, three or six months and will be payable on the last day of each interest period and the applicable maturity date. In the case of any interest periods of more than three months' duration, the interest payment will be payable on each day prior to the last day of such interest period that occurs at three-month intervals.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commitment fee on the Revolving Credit Facility is payable quarterly in arrears on the third business day following the last day of each calendar quarter and at the maturity date. The commitment fee is included in interest expense in our condensed consolidated statements of operations.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantors and Collateral</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Credit Agreement are unconditionally guaranteed, on a joint and several basis, by ICU Medical, Inc. and certain of our existing subsidiaries. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Covenants</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains affirmative and negative covenants, including certain financial covenants. The negative covenants include restrictions regarding the incurrence of liens and indebtedness, certain merger and acquisition transactions, asset sales and other dispositions, other investments, dividends, share purchases and payments affecting subsidiaries, changes in nature of business, fiscal year or organizational documents, prepayments and redemptions of subordinated and other junior debt, transactions with affiliates, and other matters.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenants include the Senior Secured Leverage Ratio and the Interest Coverage Ratio, both defined below, and pertain to the Term Loan A and the Revolving Credit Facility.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Secured Leverage Ratio is defined, at any measurement date, as the ratio of: (a) all Funded Debt, as defined in the Credit Agreement, that is secured by a lien on any asset or property minus the lesser of (i) all unrestricted cash and cash equivalents and (ii) $500.0&#160;million, to (b) Consolidated EBITDA, as defined in the Credit Agreement, for the most recently completed four fiscal quarters, calculated on a pro forma basis. The maximum Senior Secured Leverage Ratio is 4.50 to 1.00 until June 30, 2024. Thereafter, the maximum Senior Secured Leverage Ratio is 4.00 to 1.00, with limited permitted exception.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Interest Coverage ratio is defined, at any measurement date, as the ratio of Consolidated EBITDA, as defined in the Credit Agreement, to Consolidated Interest Expense, as defined in the Credit Agreement, paid or payable in cash, for the most recently completed four fiscal quarters. The minimum Interest Coverage ratio is 3.00 to 1.00.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were in compliance with all financial covenants as of March&#160;31, 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary events of default, including, among others: non-payments of principal and interest; breach of representations and warranties; covenant defaults; cross-defaults and cross-acceleration to certain other material indebtedness; the existence of bankruptcy or insolvency proceedings; certain events under ERISA; material judgments; and a change of control. If an event of default occurs and is not cured within any applicable grace period or is not waived, the administrative agent and the Lenders are entitled to take various actions, including, without limitation, the acceleration of all amounts due and the termination of commitments under the Senior Secured Credit Facilities.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2017 Credit Facility</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On November 8, 2017, we entered into a five-year senior secured revolving credit facility with various lenders for $150.0 million, with Wells Fargo Bank, National Association as the administrative agent, swingline lender and issuing lender (the "Prior Credit Facility"). The Prior Credit Facility, which was set to mature on November 8, 2022, was terminated in connection with entering into the Credit Agreement on January 6, 2022. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of our long-term debt consist of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:35.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.775%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.778%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B &#8212; principal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less unamortized debt issuance costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,991)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,647,259&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,653,363&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,612,196&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,623,675&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprised of $11.8 million and $11.2 million relating to the Term Loan A and the Term Loan B, respectively, as of March 31, 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years is approximately (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,670,250&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total interest expense related to our long-term debt (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:66.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.931%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment fee &#8212; Revolving Credit Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt-related  interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,332&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,011&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LOngTermObligationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>LOng-Term Obligations Disclosure [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LOngTermObligationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572244338848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies:<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies [Text Block]</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in various legal proceedings, most of which are routine litigation, in the normal course of business.&#160;Our management does not believe that the resolution of the unsettled legal proceedings that we are involved with will have a material adverse impact on our financial position or results of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters or other matters related to sales of our products.&#160;There is no maximum limit on the indemnification that may be required under these agreements.&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we can provide no assurances, we have never incurred, nor do we expect to incur, any material liability for indemnification.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired Smiths Medical. Total consideration for the acquisition includes a potential earn-out payment of $100.0&#160;million in cash contingent on our common stock achieving a certain volume-weighted average price from the closing date to either the third or fourth anniversary of closing. As of March&#160;31, 2023, the estimated fair value of the contingent earn-out is $20.3&#160;million (see Note 9: Fair Value Measurements).</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to being acquired, during 2021, Smiths Medical received a Warning Letter from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility. The Warning Letter cited, among other things, failures to comply with FDA's medical device reporting requirements and failures to comply with applicable portions of the Quality System Regulation. A provision for the estimated costs related to the field service corrective action was recorded on the opening acquired balance sheet of Smiths Medical in the amount of $55.1&#160;million. The initial estimate recorded was based on a probability-weighted estimate of the costs required to settle the obligation. The actual costs to be incurred are dependent upon the scope of the work necessary to achieve regulatory clearance and could differ from the original estimate. The estimated field service corrective action recorded at March&#160;31, 2023 is $48.6&#160;million.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of December 31, 2022, the measurement period related to (i) above ended and based on the actual revenue achieved during the measurement period we determined that the fair value of the contingent earn-out was zero as the minimum threshold for earning the earn-out was not met. As of March&#160;31, 2023, the estimated fair value of the contingent earn-out related to certain product-related regulatory certification was estimated to be $1.5&#160;million (see Note 9: Fair Value Measurements).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out shall not exceed $6.0&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of March&#160;31, 2023, the estimated fair value of the contingent earn-out is $2.6&#160;million (see Note 9: Fair Value Measurements).</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments</span></div>&#160;&#160;&#160;&#160;We have non-cancelable operating lease agreements where we are contractually obligated to pay certain lease payment amounts (see Note 6: Leases).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572243908560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborative and Other Arrangements (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaborative Arrangement Disclosure [Text Block]</a></td>
<td class="text">Collaborative and Other Arrangements&#160;&#160;&#160;&#160;On February 3, 2017, we entered into two Manufacturing and Supply Agreements ("MSAs") whereby (i) Pfizer will manufacture and supply us with certain agreed upon products for an initial five-year term with a one-time two-year option to extend and (ii) we will manufacture and supply Pfizer certain agreed upon products for a term of five or ten years depending on the product, also with a one-time two-year option to extend. The MSAs provide each party with mutually beneficial interests and both of the MSAs are to be jointly managed by both Pfizer and ICU. The initial supply price, which is subject to an annual update, is in full consideration for all costs associated with the manufacture, documentation, packaging and certification of the products. On January 1, 2021, we amended our MSA with Pfizer, whereby we manufacture and supply certain agreed upon products to Pfizer. The amendments included a change to the term of the agreement to end on December 31, 2024 with Pfizer's unilateral election to extend through December 31, 2025. Other changes to the terms of the MSA included (i) amendments to our level of supply of products to Pfizer, (ii) certain changes to our manufacturing lines, (iii) updates to our supply price with added volume price tiers for annual periods and (iv) certain minimum purchase requirements for certain products. On February 1, 2022, effective as of January 1, 2022, upon our request, Pfizer executed a Product Addendum (the "Product Addendum") to our MSA, whereby Pfizer manufactures and supplies to us certain agreed upon products. The Product Addendum includes the supply of additional product to us subject to certain time and pricing terms and conditions. The Product Addendum includes a minimum purchase obligation of $29.6&#160;million and expired on November 30, 2022. As of November 30, 2022, we have satisfied the minimum purchase obligations under the Product Addendum.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI https://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242263872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure</a></td>
<td class="text">Stockholders' Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shareholders Agreement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the completion of the Smiths Medical acquisition on January 6, 2022, Smiths owned approximately 10.5% of the total outstanding shares of our common stock (see Note 3: Acquisitions). At closing, in connection with the issuance of the share consideration, we entered into a Shareholders Agreement (the &#8220;Shareholders Agreement&#8221;) with Smiths. The Shareholders Agreement imposes certain restrictions on Smiths including prohibiting certain transfers of the shares of our common stock issued (i) for 6 months following the closing of the acquisition and (ii) to certain of our competitors and certain other parties, as well as customary standstill limitations. The Shareholders Agreement also permits Smiths to designate one individual for election to our Board of Directors (the "Board") so long as Smiths beneficially owns at least 5.0% of the total outstanding shares of our common stock. On February 1, 2022, our Board appointed a new director designated by Smiths pursuant to the Shareholders Agreement who was elected to the Board at the 2022 Annual Meeting of Stockholders held in May 2022. This appointment expanded the size of our Board from eight to nine members. See our Current Report on Form 8-K filed on February 1, 2022 for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In August 2019, our Board approved a share purchase plan to purchase up to $100.0 million of our common stock. This plan has no expiration date. During the three months ended March&#160;31, 2023, we did not purchase any shares of our common stock under our share purchase plan. As of March&#160;31, 2023, all of the $100.0 million available for purchase was remaining under the plan. We are currently limited on share purchases in accordance with the terms and conditions of our Credit Agreement (see Note 17: Long-Term Debt).  </span></div><div><span><br/></span></div><div><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, we withheld 52,764 shares of our common stock from employee vested restricted stock units in consideration for $8.4 million in payments made on the employees' behalf for their minimum statutory </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">income tax withholding obligations. For the three months ended March 31, 2022, we withheld&#160;37,279&#160;shares of our common stock from employee vested restricted stock units in consideration for&#160;$8.7 million&#160;in payments made on the employees' behalf for their minimum statutory income tax withholding obligations. Treasury stock is used to issue shares for stock option exercises and restricted stock grants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive (Loss) Income ("AOCI")</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of AOCI, net of tax, were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Losses) Gains on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122,973)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,978)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,983&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,577)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97,990)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,202&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,603)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Losses) Gains on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,045)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,946)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,946)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,572&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,641&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,991)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,335&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(628)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242373872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Transfers and Servicing<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransfersAndServicingAbstract', window );"><strong>Transfers and Servicing [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransfersAndServicingOfFinancialAssetsTextBlock', window );">Transfers and Servicing of Financial Assets</a></td>
<td class="text">Accounts Receivable Purchase Program<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 19, 2023, we entered into a revolving $150&#160;million uncommitted receivables purchase agreement with Bank of The West ("BOW") which provides for a less expensive form of capital. The discount rate applied to the sold receivables equals a rate per annum equal to the sum of (i) an applicable margin of 1.75%, plus (ii) Term SOFR for a period equal to the discount period which is calculated with respect to the payment terms of the specific receivable. The accounts receivable sold have payment terms ranging between 30 and 60 days, and are related to customer accounts with good credit history. The transfer of the purchased accounts receivable under the agreement is intended to be an absolute and irrevocable transfer constituting a true sale as the transferred receivables have been isolated beyond the reach of the Company and our creditors, even in bankruptcy or other receivership. We do not retain effective control over the sold receivables and BOW has the right upon purchase to pledge and/or exchange the transferred assets without restrictions. The Company acts as collection agent for BOW and collection services are undertaken by our accounts receivable personnel in their normal course of business and collected funds are remitted to BOW. We do not have any continuing involvement with the sold receivables other than the collection services which does not provide us with more than a trivial benefit. The discount rate has been negotiated net of consideration for the collection services, the cost of collection is immaterial to the Company; therefore, we did not separately record any related servicing assets or liabilities as of March 31, 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, the carrying value of trade receivables sold to BOW in connection with the purchase program was $139.6&#160;million.  In exchange for the sale of trade receivables, we received cash of $138.8&#160;million. The sale of the receivables resulted in a loss of $0.8&#160;million recorded in other (expense) income, net in our condensed consolidated statement of operations. For the three months ended March 31, 2023, we have collected and remitted $81.6&#160;million in cash to BOW. As of March 31, 2023, cash remaining to be collected on behalf of BOW was $58.0&#160;million, which has been removed from our condensed consolidated balance sheet as of March 31, 2023 and is reflected as cash provided by operating activities in the condensed consolidated statement of cash flows. There were no such balances at December 31, 2022. The carrying value of the sold receivables approximated the fair value at March 31, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransfersAndServicingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransfersAndServicingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransfersAndServicingOfFinancialAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a transferor's continuing involvement in financial assets that it has transferred in a securitization or asset-backed financing arrangement, the nature of any restrictions on assets reported by an entity in its statement of financial position that relate to a transferred financial asset (including the carrying amounts of such assets), how servicing assets and servicing liabilities are reported, and (for securitization or asset-backed financing arrangements accounted for as sales) when a transferor has continuing involvement with the transferred financial assets and transfers of financial assets accounted for as secured borrowings, how the transfer of financial assets affects an entity's financial position, financial performance, and cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109249958&amp;loc=SL6224234-111729<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109249958&amp;loc=SL6224234-111729<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=d3e107207-111719<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=d3e107207-111719<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128311188&amp;loc=d3e122596-111746<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=128311188&amp;loc=d3e122625-111746<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=d3e107207-111719<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128311188&amp;loc=d3e122739-111746<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=d3e107207-111719<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109249958&amp;loc=SL34722452-111729<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(4)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128311188&amp;loc=d3e122625-111746<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=d3e107314-111719<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128311188&amp;loc=d3e122625-111746<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=d3e107314-111719<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -URI https://asc.fasb.org/topic&amp;trid=2197590<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=128311188&amp;loc=d3e122739-111746<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(5)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=d3e107314-111719<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128311188&amp;loc=d3e122596-111746<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 50<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128311188&amp;loc=d3e122596-111746<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransfersAndServicingOfFinancialAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240205760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text">The following table summarizes the final purchase price and the final allocation of the purchase price related to the assets acquired and liabilities assumed (in thousands):<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated cash consideration for acquired assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration payable to Smiths</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of ICU Medical, Inc. common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Price per share (ICU's opening market price on the acquisition date)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of ICU shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,552,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase Price Allocation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173,151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,490)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187,455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082,570&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - not tax deductible</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,469,880&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated Purchase Consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,552,450&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Identifiable intangible assets include $510.0&#160;million of customer relationships, $400.0&#160;million of developed technology, $30.0&#160;million of internally developed software, and $5.0&#160;million of trademark. The estimated weighted-average amortization period for the total identifiable intangible assets is approximately <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjc3NQ_c58be461-15cc-4ce0-9461-a1f586d03baa">nine</span> years, and, for each identifiable intangible asset is estimated as follows: <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjg1NA_dbc618ca-f89e-4749-ab68-262b22ebc7e6">eight</span> years for customer relationships, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjg5MQ_cbdceafc-7a31-4a27-b09c-41ac0c8d87ec">ten</span> years for developed technology, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjkyNg_15a93537-17a8-41e6-a1fe-d867b9347f66">five</span> years for internally developed software, and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjk3NA_5b7a1829-90b2-4109-8983-d52f0d255b2e">six</span> months for the trademark. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued liabilities includes, among other things, accrued warranty reserves, accrued restructuring initiatives, accrued salaries and related benefits, deferred revenue and accrued sales and use taxes.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.421%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572245674048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity in our restructuring-related accrual by major type of cost for the three months ended March&#160;31, 2023 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.840%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Severance Pay and Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retention and Facility Closure Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,507&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges incurred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(911)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,643&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,546&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">__________________________</span></div>(1) Other, primarily relates to prior year accrued restructuring charges for estimated facility closure costs that were reversed during the three months ended March 31, 2023.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242415552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our revenues disaggregated by geography (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:66.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.931%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geography</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568,649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543,122&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract with Customer, Asset and Liability [Table Text Block]</a></td>
<td class="text">The following table presents the changes in our contract balances for the three months ended March 31, 2023 and 2022 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,866)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(861)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, March 31, 2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,511)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,461)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of acquired deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,266)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(767)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,236)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240914912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of our lease cost (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:66.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.931%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; reduction of ROU asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,380&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Cash Flow, Supplemental Disclosures [Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental cash flow information related to our leases (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_AssetsandLiabilitiesLeasesTableTextBlock', window );">Assets and Liabilities, Leases [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,736</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,864</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,150</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,169</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,062</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,916</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,212</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,085</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,598</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,842</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,671</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,711&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,499)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,212&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,842&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_AssetsandLiabilitiesLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets and Liabilities, Leases [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_AssetsandLiabilitiesLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI https://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572246661232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</a></td>
<td class="text">The following table presents the calculation of net earnings per common share (&#8220;EPS&#8221;) &#8212; basic and diluted (in thousands, except per share data):&#160; <div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,812)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,068)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding (basic)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common and common equivalent shares outstanding (diluted)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,014&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,646&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.41)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.61)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the net loss for the three months ended March 31, 2023 and 2022, there are no potentially dilutive common shares included in the computation of diluted earnings per share.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572243267712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</a></td>
<td class="text">The following table presents the fair values of our derivative instruments included within the Condensed Consolidated Balance Sheets (in thousands):<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:48.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March&#160;31, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNC0wLTEtMS0xMTIyOTE_cfaec65c-7e6a-4276-963b-bd9a55c586b9">Prepaid expenses and other current assets</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNS0wLTEtMS0xMTIyOTE_a381aeb8-d171-4550-9ed5-50b193801e56">Other assets</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,716&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOC0wLTEtMS0xMTIyOTE_31479843-5a18-4da4-b2e9-8a0ab42c6b76">Accrued liabilities</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOS0wLTEtMS0xMTIyOTE_0314024e-19ca-42c9-bda0-6b9963e62d6c">Other long-term liabilities</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTMtMC0xLTEtMTEyMjkx_b4e70733-51f6-4cf5-a4f0-4e3344743eed">Prepaid expenses and other current assets</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTQtMC0xLTEtMTEyMjkx_c7f29940-14d5-49dd-8334-2995d9c76144">Other assets</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,954&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,184&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,138&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTctMC0xLTEtMTEyMjkx_6e89f792-0047-409f-ae97-92f90a1a3b54">Accrued liabilities</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTgtMC0xLTEtMTEyMjkx_e58a7954-fa23-4f46-8db3-028044ca9ce7">Other long-term liabilities</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,014&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,014&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized the following gains on our derivative instruments designated as cash flow hedges in other comprehensive income before reclassifications to net loss (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.037%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,163&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:50.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.358%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Reclassified From Accumulated Other Comprehensive (Loss) Income into Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNC0yLTEtMS0xMTIyOTE_f380e986-354b-4ae5-be66-0d8180b7e6bd">Total revenues</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNS0yLTEtMS0xMTIyOTE_e0200ea4-951a-4f15-aa0d-730e8294b71c">Cost of goods sold</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNy0yLTEtMS0xMTIyOTE_faab4624-13eb-4610-aa53-f7352f932ffd">Interest expense</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,189&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents location of gain reclassified from accumulated other comprehensive income into income as a result of ineffectiveness.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Represents location of gain reclassified from accumulated other comprehensive income into income as a result of forecasted transactions no longer probable of occurring.</span></div>As of March&#160;31, 2023, we expect an estimated $5.3&#160;million in deferred gains on the outstanding foreign exchange contracts and an estimated $26.3&#160;million in deferred gains on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572236021968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a reconciliation of the Level 3 earn-out liabilities measured at estimated fair value (in thousands):  </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of earn-out (included in income from operations as a separate line item)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,905&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition date fair value estimate of earn-out</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Primarily relates to Smiths Medical.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$53.5&#160;million relates to our acquisition of Smiths Medical and $1.6&#160;million relates to our acquisition of a small foreign infusions systems supplier in the fourth quarter of 2021 (see Note 3: Acquisitions).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide quantitative information about Level 3 inputs for fair value measurement of our earn-out liabilities related to Smiths Medical:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smiths Medical Earn-out Liability</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.736%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-Free Rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Fair Value, by Balance Sheet Grouping</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our assets and liabilities measured at fair value on a recurring basis consisted of the following Level 1, 2 and 3 inputs as defined above (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTAtMC0xLTEtMTEyMjkx_f14ce4d4-85f2-4d23-a88b-1739598efd81">Prepaid expenses and other current assets</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTEtMC0xLTEtMTEyMjkx_d56c9d3d-0932-4348-b69d-8f57de5603f9">Other assets</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTUtMC0xLTEtMTEyMjkx_6bcfe6ca-ff2c-4a0b-9003-1212bc82d7dd">Prepaid expenses and other current assets</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTYtMC0xLTEtMTEyMjkx_308e7868-3fa9-4233-8466-3e1183fa8b50">Other assets</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjMtMC0xLTEtMTEyMjkx_5523e65b-55dc-41c6-8709-df1a94648036">Accrued liabilities</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjQtMC0xLTEtMTIwNzE1_62efbfc3-1b08-43d2-b4de-0ebc769246ce">Other long-term liabilities</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,078&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,173&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,905&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forwards:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNy0wLTEtMS0xMTIyOTE_50321293-4bf5-432f-9a23-856af180772d">Prepaid expenses and other current assets</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTgtMC0xLTEtMTEyMjkx_38c2c727-8408-4048-b07a-938ff12e83e6">Other long-term liabilities</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,572&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572241976480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.301%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March&#160;31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding <br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,235&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,235&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding<br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term U.S. treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Method Investments [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-marketable equity method investment consists of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572243111552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaids and Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Prepaid Expenses and Other Current Assets [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses and receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,332&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid vendor expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance and property taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT/GST receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax charge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,125&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,932&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of Other Assets, Noncurrent[TableTextBlock]</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pump lease receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,821&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spare parts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,885&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572244415472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747,965&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696,009&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572244338848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consists of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414,811&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, building and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments placed with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,666&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,481&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,174,544&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162,557&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(550,432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(526,444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624,112&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636,113&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572244402784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill [Table Text Block]</a></td>
<td class="text">The following table presents the changes in the carrying amount of our goodwill (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,449,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,462,726&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text">Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life&#160;in&#160;Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,092&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">550,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">584,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">461,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,209,215&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285,135&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">924,080&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,242,817&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285,135&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,682&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,998&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">546,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">445,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">583,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,202,911&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,951&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950,960&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,234,717&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,951&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">982,766&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</a></td>
<td class="text">As of March&#160;31, 2023 estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572244220848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities [Table Text Block]</a></td>
<td class="text">Accrued liabilities consist of the following (in thousands):&#160;<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,808&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incentive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-ST</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties and returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Field service corrective action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued audit fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,167&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,769&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to field service corrective actions associated with certain products in connection with a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.</span></div>Other long-term liabilities consist of the following (in thousands):&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-LT</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,062&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,916&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liability-LT</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Field service corrective action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,227&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,104&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240235152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_LOngTermObligationsDisclosureAbstract', window );"><strong>LOng-Term Obligations Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of our long-term debt consist of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:35.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.775%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.778%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B &#8212; principal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less unamortized debt issuance costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,991)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,647,259&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,653,363&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,612,196&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,623,675&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprised of $11.8 million and $11.2 million relating to the Term Loan A and the Term Loan B, respectively, as of March 31, 2023.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years is approximately (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,670,250&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_InterestExpenseOnLongTermDebtTableTextBlock', window );">Interest expense on long term debt</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total interest expense related to our long-term debt (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:66.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.931%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment fee &#8212; Revolving Credit Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt-related  interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,332&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,011&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock', window );">Applicable Margin Based on Leverage Ratio</a></td>
<td class="text">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan A and borrowings under the Revolving Credit Facility will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitment Fee Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 4.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 4.00 to 1.0 but greater than 3.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 3.00 to 1.0 but greater than 2.50 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.50 to 1.0 but greater than 2.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Applicable Margin Based on Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InterestExpenseOnLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest expense on long term debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InterestExpenseOnLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LOngTermObligationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>LOng-Term Obligations Disclosure [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LOngTermObligationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242411360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">The components of AOCI, net of tax, were as follows (in thousands):<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Losses) Gains on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122,973)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,978)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,983&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,577)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97,990)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,202&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,603)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Losses) Gains on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,045)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,946)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,946)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,572&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,641&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,991)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,335&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(628)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572236005952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="nump">$ 1,922,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ContingentConsiderationGrossST', window );">Contingent Consideration, Gross ST</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ContingentConsiderationGrossLT', window );">Contingent Consideration, Gross LT</a></td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember', window );">Foreign Infusion System Supplier</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">$ 2,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossLT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross LT</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossLT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossST">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross ST</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossST</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contingentconsiderationgross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>contingent consideration gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contingentconsiderationgross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242009344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions (Details) - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent Earn-Out Liability, Noncurrent</a></td>
<td class="nump">$ 24,905,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="nump">$ 25,572,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_MinimumStockPriceTargetForEarnOutPayment', window );">Minimum Stock Price Target for Earn-out Payment</a></td>
<td class="nump">$ 300.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_RequiredShareHoldingOfStockIssuedAtAcquisition', window );">Required Share Holding Of Stock Issued At Acquisition</a></td>
<td class="nump">0.500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Related Party Transaction, Purchases from Related Party</a></td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDueFromToRelatedParty', window );">Related Party Transaction, Due from (to) Related Party</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business Acquisition, Percentage of Voting Interests Acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_BusinessCombinationConsiderationTransferredCash', window );">Business Combination, Consideration Transferred, Cash</a></td>
<td class="nump">$ 1,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent Earn-Out Liability, Noncurrent</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2022 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_BusinessCombinationConsiderationTransferredCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_BusinessCombinationConsiderationTransferredCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_MinimumStockPriceTargetForEarnOutPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum Stock Price Target for Earn-out Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_MinimumStockPriceTargetForEarnOutPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_RequiredShareHoldingOfStockIssuedAtAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Required Share Holding Of Stock Issued At Acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_RequiredShareHoldingOfStockIssuedAtAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDueFromToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDueFromToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572236309968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions Smiths Medical (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="nump">$ 1,922,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Software Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="nump">$ 53,520<span></span>
</td>
<td class="nump">$ 53,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business Acquisition, Share Price</a></td>
<td class="nump">$ 230.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</a></td>
<td class="nump">$ 575,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</a></td>
<td class="nump">78,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</a></td>
<td class="nump">106,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="nump">228,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</a></td>
<td class="nump">53,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="nump">206,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed', window );">business combination, recognized identifiable asset acquired and liability assumed,</a></td>
<td class="nump">55,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">945,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="nump">379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</a></td>
<td class="nump">105,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</a></td>
<td class="nump">173,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable', window );">Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable</a></td>
<td class="num">(40,312)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</a></td>
<td class="num">(85,490)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="num">(187,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</a></td>
<td class="nump">1,082,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_BusinessCombinationGoodwillNonDeductible', window );">Business combination, goodwill- non deductible</a></td>
<td class="nump">1,469,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="nump">2,552,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical | developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical | Trademarks and Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical | Software and Software Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_BusinessCombinationGoodwillNonDeductible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination, goodwill- non deductible</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_BusinessCombinationGoodwillNonDeductible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>business combination, recognized identifiable asset acquired and liability assumed,</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=icui_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=icui_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240446704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business Acquisition, Pro Forma Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 563,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 568,649<span></span>
</td>
<td class="nump">543,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (Loss) Income</a></td>
<td class="num">(9,812)<span></span>
</td>
<td class="num">(38,068)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Business Acquisition, Pro Forma Net Income (Loss)</a></td>
<td class="num">$ (34,994)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ProFormaAdjustmentAmortization', window );">Pro Forma Adjustment - Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ProFormaAdjustmentFinanceCosts', window );">Pro Forma Adjustment - Finance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (Loss) Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProFormaAdjustmentAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pro Forma Adjustment - Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProFormaAdjustmentAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProFormaAdjustmentFinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pro Forma Adjustment - Finance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProFormaAdjustmentFinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240813696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration Restructuring (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Restructuringstrategictransactionandintegration', window );">Restructuring, strategic transaction and integration</a></td>
<td class="nump">$ 11,000<span></span>
</td>
<td class="nump">$ 33,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring Costs</a></td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="nump">$ 3,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Restructuringstrategictransactionandintegration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring, strategic transaction and integration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Restructuringstrategictransactionandintegration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240698528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration Liability (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">$ 5,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">2,732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="nump">1,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">(86)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">6,546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="num">(911)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">4,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">2,732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="nump">1,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">5,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="num">(291)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember', window );">Facility Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">1,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="num">$ (620)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572243098432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Transaction and Integration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_StrategicTransactionandIntegration', window );">Strategic Transaction and Integration</a></td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="nump">$ 30.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_StrategicTransactionandIntegration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Strategic Transaction and Integration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_StrategicTransactionandIntegration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572327196720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Disaggregated Revenue by Geography (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 568,649<span></span>
</td>
<td class="nump">$ 543,122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">EMEA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">98,986<span></span>
</td>
<td class="nump">86,204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">359,187<span></span>
</td>
<td class="nump">347,791<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">58,624<span></span>
</td>
<td class="nump">64,831<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=icui_OtherforeigncountriesMember', window );">Other foreign countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 51,852<span></span>
</td>
<td class="nump">$ 44,296<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=icui_OtherforeigncountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=icui_OtherforeigncountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240437088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Disaggregated Revenue by Product Line (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 568,649<span></span>
</td>
<td class="nump">$ 543,122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_InfusionConsumablesMember', window );">Infusion Consumables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">236,122<span></span>
</td>
<td class="nump">240,189<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_InfusionSystemsMember', window );">Infusion Systems [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">161,713<span></span>
</td>
<td class="nump">138,227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_VitalCareMember', window );">Vital Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 170,814<span></span>
</td>
<td class="nump">$ 164,706<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_InfusionConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_InfusionConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_InfusionSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_InfusionSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_VitalCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_VitalCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572236079504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Contract Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="num">$ (45,866)<span></span>
</td>
<td class="num">$ (7,461)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="num">(47,511)<span></span>
</td>
<td class="num">(58,236)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TimingAxis=icui_ShortTermMember', window );">Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(30,920)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TimingAxis=icui_LongTermMember', window );">Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(16,591)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,245)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_EquipmentrevenueMember', window );">Equipment revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="nump">5,976<span></span>
</td>
<td class="nump">5,574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Deferred Revenue, Additions</a></td>
<td class="num">(7,236)<span></span>
</td>
<td class="num">(3,447)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_EquipmentrevenueMember', window );">Equipment revenue [Member] | Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(17,464)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_EquipmentrevenueMember', window );">Equipment revenue [Member] | Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(1,327)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_SoftwarerevenueMember', window );">Software revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="nump">4,108<span></span>
</td>
<td class="nump">4,299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Deferred Revenue, Additions</a></td>
<td class="num">(5,362)<span></span>
</td>
<td class="num">(4,777)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_SoftwarerevenueMember', window );">Software revenue [Member] | Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(8,323)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_SoftwarerevenueMember', window );">Software revenue [Member] | Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(829)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_GovernmentGrantRevenueMember', window );">Government Grant Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Deferred Revenue, Additions</a></td>
<td class="num">(861)<span></span>
</td>
<td class="num">(2,266)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_GovernmentGrantRevenueMember', window );">Government Grant Revenue | Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(1,422)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_GovernmentGrantRevenueMember', window );">Government Grant Revenue | Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(13,441)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_OtherDeferredRevenueMember', window );">Other deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="nump">1,915<span></span>
</td>
<td class="nump">1,683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Deferred Revenue, Additions</a></td>
<td class="num">(403)<span></span>
</td>
<td class="num">$ (767)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_OtherDeferredRevenueMember', window );">Other deferred revenue | Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">(3,711)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_OtherDeferredRevenueMember', window );">Other deferred revenue | Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="num">$ (994)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInDeferredRevenueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInDeferredRevenueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TimingAxis=icui_ShortTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TimingAxis=icui_ShortTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TimingAxis=icui_LongTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TimingAxis=icui_LongTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_EquipmentrevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_EquipmentrevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_SoftwarerevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_SoftwarerevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_GovernmentGrantRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_GovernmentGrantRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_OtherDeferredRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_OtherDeferredRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572243054016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Text (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Optiontoextendinyears', window );">Lessee, Operating Lease, Option to Extend</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Optiontoextendinyears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Optiontoextendinyears</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Optiontoextendinyears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572243011680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="nump">$ 6,150<span></span>
</td>
<td class="nump">$ 5,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Finance Lease, Interest Expense</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance Lease, Right-of-Use Asset, Amortization</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term Lease, Cost</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease, Cost</a></td>
<td class="nump">$ 6,417<span></span>
</td>
<td class="nump">$ 5,380<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240818480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Cash Flow, Operating Activities, Lessee (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="nump">$ 6,051<span></span>
</td>
<td class="nump">$ 6,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Finance Lease, Interest Payment on Liability</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</a></td>
<td class="nump">8,979<span></span>
</td>
<td class="nump">1,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</a></td>
<td class="nump">$ 340<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242195296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Assets and Liabilities, Lessee (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">$ 79,736<span></span>
</td>
<td class="nump">$ 74,864<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">20,150<span></span>
</td>
<td class="nump">18,169<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">63,062<span></span>
</td>
<td class="nump">60,916<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">$ 83,212<span></span>
</td>
<td class="nump">$ 79,085<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">4.27%<span></span>
</td>
<td class="nump">4.34%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="nump">$ 2,758<span></span>
</td>
<td class="nump">$ 2,598<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance Lease, Liability, Current</a></td>
<td class="nump">903<span></span>
</td>
<td class="nump">816<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">1,939<span></span>
</td>
<td class="nump">1,855<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">$ 2,842<span></span>
</td>
<td class="nump">$ 2,671<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">4.47%<span></span>
</td>
<td class="nump">4.23%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2022 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240448224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year</a></td>
<td class="nump">$ 17,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months</a></td>
<td class="nump">20,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Lessee, Operating Lease, Liability, Payments, Due Year Two</a></td>
<td class="nump">14,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Lessee, Operating Lease, Liability, Payments, Due Year Three</a></td>
<td class="nump">13,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Lessee, Operating Lease, Liability, Payments, Due Year Four</a></td>
<td class="nump">9,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Lessee, Operating Lease, Liability, Payments, Due Year Five</a></td>
<td class="nump">14,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Lessee, Operating Lease, Liability, Payments, Due after Year Five</a></td>
<td class="nump">3,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Lessee, Operating Lease, Liability, Payments, Due</a></td>
<td class="nump">93,711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</a></td>
<td class="num">(10,499)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">83,212<span></span>
</td>
<td class="nump">$ 79,085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Finance Lease, Liability, Payments, Remainder of Fiscal Year</a></td>
<td class="nump">778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Finance Lease, Liability, Payments, Due Next Twelve Months</a></td>
<td class="nump">766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">Finance Lease, Liability, Payments, Due Year Two</a></td>
<td class="nump">545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">Finance Lease, Liability, Payments, Due Year Three</a></td>
<td class="nump">423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">Finance Lease, Liability, Payments, Due Year Four</a></td>
<td class="nump">198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">Finance Lease, Liability, Payments, Due Year Five</a></td>
<td class="nump">189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Finance Lease, Liability, Payments, Due after Year Five</a></td>
<td class="nump">237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Finance Lease, Liability, Payment, Due</a></td>
<td class="nump">3,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Finance Lease, Liability, Undiscounted Excess Amount</a></td>
<td class="num">(294)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">$ 2,842<span></span>
</td>
<td class="nump">$ 2,671<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572245861472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (Loss) Income</a></td>
<td class="num">$ (9,812)<span></span>
</td>
<td class="num">$ (38,068)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding (for basic calculation)</a></td>
<td class="nump">24,014<span></span>
</td>
<td class="nump">23,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">24,014<span></span>
</td>
<td class="nump">23,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">EPS - basic</a></td>
<td class="num">$ (0.41)<span></span>
</td>
<td class="num">$ (1.61)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (In dollars per share)</a></td>
<td class="num">$ (0.41)<span></span>
</td>
<td class="num">$ (1.61)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240914912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Details 1) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">24,014<span></span>
</td>
<td class="nump">23,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.41)<span></span>
</td>
<td class="num">$ (1.61)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.41)<span></span>
</td>
<td class="num">$ (1.61)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240671408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 101,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Srt_MultipleCurrencyAxisAxis=icui_OtherCurrenciesMember', window );">other currencies</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">2,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_MXN', window );">Mexico, Pesos</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">3,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">26,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CZK', window );">Czech Republic, Koruny</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">4,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">Japan, Yen</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">21,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CAD', window );">Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">13,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_AUD', window );">Australia, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">13,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_SEK', window );">Sweden, Kronor</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 2,700,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Srt_MultipleCurrencyAxisAxis=icui_OtherCurrenciesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Srt_MultipleCurrencyAxisAxis=icui_OtherCurrenciesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_MXN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_MXN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CZK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CZK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_AUD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_AUD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_SEK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_SEK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572236127952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>MXN ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</a></td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">101,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_MXN', window );">Mexico, Pesos</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CNY', window );">China, Yuan Renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 14,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge2Member', window );">Hedge 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeForwardExchangeRate1', window );">Derivative, Forward Exchange Rate</a></td>
<td class="nump">21.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative Asset, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 311,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeForwardExchangeRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual rate at which a foreign currency can be purchased or sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeForwardExchangeRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_MXN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_MXN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CNY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CNY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572236048608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments Interest Rate Swaps (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 101,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_InterestRateSwapEndingNotionalValue', window );">Interest Rate Swap Ending Notional Value</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative, Fixed Interest Rate</a></td>
<td class="nump">1.32%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_DerivativeVariableRateFloor', window );">derivative variable rate floor</a></td>
<td class="num">(0.0015)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Term Loan B</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_InterestRateSwapEndingNotionalValue', window );">Interest Rate Swap Ending Notional Value</a></td>
<td class="nump">$ 46,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative, Fixed Interest Rate</a></td>
<td class="nump">1.17%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_DerivativeVariableRateFloor', window );">derivative variable rate floor</a></td>
<td class="nump">0.0035<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_DerivativeVariableRateFloor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>derivative variable rate floor</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_DerivativeVariableRateFloor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InterestRateSwapEndingNotionalValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Rate Swap Ending Notional Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InterestRateSwapEndingNotionalValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572243384160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">$ 52,716<span></span>
</td>
<td class="nump">$ 60,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="text">Accrued liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">$ 32,993<span></span>
</td>
<td class="nump">$ 33,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">19,723<span></span>
</td>
<td class="nump">26,847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">$ 2,132<span></span>
</td>
<td class="nump">$ 1,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">$ 2,173<span></span>
</td>
<td class="nump">$ 2,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Prepaid expenses and other current assets<span></span>
</td>
<td class="text">Prepaid expenses and other current assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">OTHER ASSETS<span></span>
</td>
<td class="text">OTHER ASSETS<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">$ 7,484<span></span>
</td>
<td class="nump">$ 4,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">7,433<span></span>
</td>
<td class="nump">4,860<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">2,132<span></span>
</td>
<td class="nump">1,847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">2,173<span></span>
</td>
<td class="nump">2,014<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">45,232<span></span>
</td>
<td class="nump">55,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">25,560<span></span>
</td>
<td class="nump">28,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">19,672<span></span>
</td>
<td class="nump">26,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative asset classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative asset classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative liability classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative liability classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240776864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income (Loss), before Tax</a></td>
<td class="num">$ (133)<span></span>
</td>
<td class="nump">$ 33,163<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income (Loss), before Tax</a></td>
<td class="nump">2,451<span></span>
</td>
<td class="nump">3,112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income (Loss), before Tax</a></td>
<td class="num">$ (2,584)<span></span>
</td>
<td class="nump">$ 30,051<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572243382192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</a></td>
<td class="nump">$ 5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</a></td>
<td class="nump">26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss', window );">Derivative, Net Hedge Ineffectiveness Gain (Loss)</a></td>
<td class="nump">229<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion', window );">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</a></td>
<td class="nump">7,189<span></span>
</td>
<td class="nump">2,279<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring', window );">Gain on Discontinuation of Cash Flow Hedge Due to Forecasted Transaction Probable of Not Occurring</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Revenue from Contract with Customer, Excluding Assessed Tax<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Trading Revenue | Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="nump">$ 1,922<span></span>
</td>
<td class="num">(2,543)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Cost of Sales [Member] | Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="num">$ (1,500)<span></span>
</td>
<td class="nump">513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Cost of goods sold<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion', window );">Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="num">$ (7,369)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Interest Expense<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes gain (loss) from effective portion of derivative instrument reclassified from accumulated other comprehensive income (AOCI) into income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective portion of gain reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective portion of loss reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the ineffectiveness of the hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNetHedgeIneffectivenessGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of gain reclassified into earnings in the period when cash flow hedge is discontinued because it is probable that the original forecasted transactions will not occur by the end of the original period or an additional two month time period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_TradingRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_TradingRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240943072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 06, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,572<span></span>
</td>
<td class="nump">$ 24,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ContingentConsiderationGrossST', window );">Contingent Consideration, Gross ST</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ContingentConsiderationGrossLT', window );">Contingent Consideration, Gross LT</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_OwnershipRequirementForEarnoutPayment', window );">Ownership requirement for Earnout Payment</a></td>
<td class="nump">0.500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=us-gaap_LiabilityMember', window );">Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="nump">$ 57,701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">20,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember', window );">Foreign Infusion System Supplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossLT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross LT</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossLT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossST">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross ST</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossST</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contingentconsiderationgross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>contingent consideration gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contingentconsiderationgross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_OwnershipRequirementForEarnoutPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ownership requirement for Earnout Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_OwnershipRequirementForEarnoutPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240538304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,572<span></span>
</td>
<td class="nump">$ 24,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</a></td>
<td class="num">$ (700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_CurrencyTranslationOnEarnOut', window );">Currency translation on earn-out</a></td>
<td class="nump">33<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="nump">$ 57,701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="nump">$ 53,520<span></span>
</td>
<td class="nump">53,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember', window );">Foreign Infusion System Supplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_CurrencyTranslationOnEarnOut">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Currency translation on earn-out</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_CurrencyTranslationOnEarnOut</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3) and still held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240774432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,572<span></span>
</td>
<td class="nump">$ 24,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</a></td>
<td class="num">$ (700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_CurrencyTranslationOnEarnOut', window );">Currency translation on earn-out</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="num">$ (46)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="nump">$ 57,701<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_CurrencyTranslationOnEarnOut">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Currency translation on earn-out</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_CurrencyTranslationOnEarnOut</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3) and still held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240252736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures Liability Measurement Inputs (Details) - SmithsMedical<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jan. 06, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="nump">0.0383<span></span>
</td>
<td class="nump">0.0417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">Measurement Input, Price Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="nump">0.3600<span></span>
</td>
<td class="nump">0.3800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572234357536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">$ 3,235<span></span>
</td>
<td class="nump">$ 4,224<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">516<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">$ 55,951<span></span>
</td>
<td class="nump">$ 64,878<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Prepaid expenses and other current assets<span></span>
</td>
<td class="text">Prepaid expenses and other current assets<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">OTHER ASSETS<span></span>
</td>
<td class="text">OTHER ASSETS<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ClassificationAxis=icui_CurrentMember', window );">current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">$ 7,433<span></span>
</td>
<td class="nump">$ 4,860<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">25,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 28,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">2,132<span></span>
</td>
<td class="nump">1,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ClassificationAxis=icui_NoncurrentMember', window );">noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">19,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,753<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate Bond Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">1,320<span></span>
</td>
<td class="nump">2,314<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">US Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">1,417<span></span>
</td>
<td class="nump">1,412<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">US Government Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">498<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=icui_EarnoutliabilityMember', window );">Earn-out liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">24,905<span></span>
</td>
<td class="nump">25,572<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilitiesTotalMember', window );">Liabilities, Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,586<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure</a></td>
<td class="nump">27,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">7,433<span></span>
</td>
<td class="nump">4,860<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">25,560<span></span>
</td>
<td class="nump">28,431<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">1,417<span></span>
</td>
<td class="nump">1,412<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Corporate Bond Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | US Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">1,417<span></span>
</td>
<td class="nump">1,412<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | US Government Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Earn-out liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Liabilities, Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">516<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">54,534<span></span>
</td>
<td class="nump">63,466<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">7,433<span></span>
</td>
<td class="nump">4,860<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">25,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">28,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">2,132<span></span>
</td>
<td class="nump">1,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">19,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,753<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Corporate Bond Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">1,320<span></span>
</td>
<td class="nump">2,314<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | US Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | US Government Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">498<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Earn-out liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Liabilities, Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,014<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure</a></td>
<td class="nump">2,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Corporate Bond Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | US Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | US Government Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Earn-out liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">24,905<span></span>
</td>
<td class="nump">25,572<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Liabilities, Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,572<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure</a></td>
<td class="nump">$ 24,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2022 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative asset classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative asset classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative liability classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative liability classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateDerivativeAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of interest rate derivative assets, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateDerivativeAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations not classified as financial liabilities. Includes, but is not limited to, accounts payable and accrued liabilities, commitments, obligations, and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonfinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ClassificationAxis=icui_CurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ClassificationAxis=icui_CurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ClassificationAxis=icui_NoncurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ClassificationAxis=icui_NoncurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=icui_EarnoutliabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=icui_EarnoutliabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilitiesTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilitiesTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572246899504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Gain (Loss) on Sale of Investments</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572236149920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities Table (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">$ 3,235<span></span>
</td>
<td class="nump">$ 4,740<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">3,235<span></span>
</td>
<td class="nump">4,224<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">516<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">3,235<span></span>
</td>
<td class="nump">4,740<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent', window );">Debt Securities, Available-for-sale, Amortized Cost, Current</a></td>
<td class="nump">1,320<span></span>
</td>
<td class="nump">2,314<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent', window );">Debt Securities, Available-for-sale, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">516<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">1,320<span></span>
</td>
<td class="nump">2,314<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">516<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">US Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent', window );">Debt Securities, Available-for-sale, Amortized Cost, Current</a></td>
<td class="nump">1,417<span></span>
</td>
<td class="nump">1,412<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">1,417<span></span>
</td>
<td class="nump">1,412<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">US Government Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent', window );">Debt Securities, Available-for-sale, Amortized Cost, Current</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">$ 498<span></span>
</td>
<td class="nump">$ 498<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 498<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2022 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572236288512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity Method Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems', window );"><strong>Equity Securities without Readily Determinable Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Equity Method Investment, Aggregate Cost</a></td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">$ 3,166<span></span>
</td>
<td class="nump">$ 3,178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=icui_NonPublicCompanyMember', window );">Non Public Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems', window );"><strong>Equity Securities without Readily Determinable Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=icui_NonPublicCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=icui_NonPublicCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572243314000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaids and Other Current Assets Prepaids and Other Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other Prepaid Expense, Current</a></td>
<td class="nump">$ 26,332<span></span>
</td>
<td class="nump">$ 21,635<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_PrepaidVendorExpenses', window );">Prepaid vendor expenses</a></td>
<td class="nump">1,862<span></span>
</td>
<td class="nump">3,052<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsAndOtherAssets', window );">Deferred Costs and Other Assets</a></td>
<td class="nump">3,638<span></span>
</td>
<td class="nump">2,395<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Prepaidinsuranceandpropertytaxes', window );">Prepaid insurance and property taxes</a></td>
<td class="nump">10,638<span></span>
</td>
<td class="nump">16,322<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Prepaidothertaxes', window );">Prepaid Taxes</a></td>
<td class="nump">3,030<span></span>
</td>
<td class="nump">3,546<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Deferredtaxcharge', window );">Deferred tax charge</a></td>
<td class="nump">3,830<span></span>
</td>
<td class="nump">3,830<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositAssets', window );">Deposit Assets</a></td>
<td class="nump">1,263<span></span>
</td>
<td class="nump">1,329<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other Assets, Current</a></td>
<td class="nump">3,539<span></span>
</td>
<td class="nump">3,532<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">87,125<span></span>
</td>
<td class="nump">88,932<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">7,433<span></span>
</td>
<td class="nump">4,860<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">25,560<span></span>
</td>
<td class="nump">28,431<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">$ 7,433<span></span>
</td>
<td class="nump">$ 4,860<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2022 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Deferredtaxcharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax charge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Deferredtaxcharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_PrepaidVendorExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid vendor expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_PrepaidVendorExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Prepaidinsuranceandpropertytaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid insurance and property taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Prepaidinsuranceandpropertytaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Prepaidothertaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid other taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Prepaidothertaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred cost assets and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateDerivativeAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of interest rate derivative assets, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateDerivativeAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572235858704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets Noncurrent(Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">$ 19,723<span></span>
</td>
<td class="nump">$ 26,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Lessor, Operating Lease, Payments to be Received</a></td>
<td class="nump">28,821<span></span>
</td>
<td class="nump">27,086<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_SpareParts', window );">Spare parts</a></td>
<td class="nump">40,598<span></span>
</td>
<td class="nump">38,498<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">3,166<span></span>
</td>
<td class="nump">3,178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Debt Issuance Costs, Noncurrent, Net</a></td>
<td class="nump">4,727<span></span>
</td>
<td class="nump">5,156<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="nump">2,758<span></span>
</td>
<td class="nump">2,598<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">19,723<span></span>
</td>
<td class="nump">26,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other Assets, Miscellaneous, Noncurrent</a></td>
<td class="nump">2,143<span></span>
</td>
<td class="nump">2,193<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">OTHER ASSETS</a></td>
<td class="nump">101,885<span></span>
</td>
<td class="nump">105,462<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">19,672<span></span>
</td>
<td class="nump">26,753<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">$ 19,672<span></span>
</td>
<td class="nump">$ 26,753<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2022 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_SpareParts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Spare parts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_SpareParts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payments to be received by lessor for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572327179376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Inventory, Raw Materials, Net of Reserves</a></td>
<td class="nump">$ 317,340<span></span>
</td>
<td class="nump">$ 286,964<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Inventory, Work in Process, Net of Reserves</a></td>
<td class="nump">73,708<span></span>
</td>
<td class="nump">73,795<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Inventory, Finished Goods, Net of Reserves</a></td>
<td class="nump">356,917<span></span>
</td>
<td class="nump">335,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 747,965<span></span>
</td>
<td class="nump">$ 696,009<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2022 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240551168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">$ 1,174,544<span></span>
</td>
<td class="nump">$ 1,162,557<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(550,432)<span></span>
</td>
<td class="num">(526,444)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net property and equipment</a></td>
<td class="nump">624,112<span></span>
</td>
<td class="nump">636,113<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and Equipment, Gross</a></td>
<td class="nump">430,258<span></span>
</td>
<td class="nump">414,811<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and Fixtures, Gross</a></td>
<td class="nump">30,166<span></span>
</td>
<td class="nump">29,876<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in Progress, Gross</a></td>
<td class="nump">138,996<span></span>
</td>
<td class="nump">152,909<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember', window );">Land, Buildings and Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">275,463<span></span>
</td>
<td class="nump">274,063<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_MoldsMember', window );">Molds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">77,557<span></span>
</td>
<td class="nump">77,203<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_ComputerEquipmentAndSoftwareMember', window );">Computer Equipment and Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">119,438<span></span>
</td>
<td class="nump">115,214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_InstrumentsPlacedwithCustomersMember', window );">Instruments Placed with Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">$ 102,666<span></span>
</td>
<td class="nump">$ 98,481<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2022 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_MoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_MoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_InstrumentsPlacedwithCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_InstrumentsPlacedwithCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572244415472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment Text (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 23.4<span></span>
</td>
<td class="nump">$ 21.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572235981760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Goodwill Table (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">GOODWILL</a></td>
<td class="nump">$ 1,462,726<span></span>
</td>
<td colspan="2" class="nump">$ 1,449,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Goodwill, Foreign Currency Translation Gain (Loss)</a></td>
<td class="nump">$ 13,468<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2022 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240463520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Intangibles Table (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 1,209,215<span></span>
</td>
<td class="nump">$ 1,202,911<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">285,135<span></span>
</td>
<td class="nump">251,951<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">924,080<span></span>
</td>
<td class="nump">950,960<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">33,602<span></span>
</td>
<td class="nump">31,806<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">1,242,817<span></span>
</td>
<td class="nump">1,234,717<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">INTANGIBLE ASSETS, net</a></td>
<td class="nump">$ 957,682<span></span>
</td>
<td class="nump">$ 982,766<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 30,735<span></span>
</td>
<td class="nump">$ 29,998<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">19,092<span></span>
</td>
<td class="nump">18,610<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 11,643<span></span>
</td>
<td class="nump">$ 11,388<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Customer Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 10,046<span></span>
</td>
<td class="nump">$ 10,026<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">6,527<span></span>
</td>
<td class="nump">6,443<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 3,519<span></span>
</td>
<td class="nump">$ 3,583<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-Related Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 550,703<span></span>
</td>
<td class="nump">$ 546,935<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">118,687<span></span>
</td>
<td class="nump">101,556<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 432,016<span></span>
</td>
<td class="nump">$ 445,379<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 5,425<span></span>
</td>
<td class="nump">$ 5,425<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">5,425<span></span>
</td>
<td class="nump">5,425<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 18,249<span></span>
</td>
<td class="nump">$ 18,251<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">6,247<span></span>
</td>
<td class="nump">5,959<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 12,002<span></span>
</td>
<td class="nump">$ 12,292<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 584,957<span></span>
</td>
<td class="nump">$ 583,176<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">123,357<span></span>
</td>
<td class="nump">108,708<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 461,600<span></span>
</td>
<td class="nump">$ 474,468<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">5,800<span></span>
</td>
<td class="nump">5,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="nump">$ 3,850<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2022 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242439808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Text (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 32,300,000<span></span>
</td>
<td class="nump">$ 31,700,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572236058240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets 5-Year Amortization (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</a></td>
<td class="nump">$ 98,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</a></td>
<td class="nump">131,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Two</a></td>
<td class="nump">124,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Four</a></td>
<td class="nump">123,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Five</a></td>
<td class="nump">117,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Five</a></td>
<td class="nump">110,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Finite-Lived Intangible Assets, Amortization Expense, after Year Five</a></td>
<td class="nump">218,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 924,080<span></span>
</td>
<td class="nump">$ 950,960<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572236847824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 06, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_AccruedSalariesAndBenefits', window );">Salaries and benefits</a></td>
<td class="nump">$ 47,808<span></span>
</td>
<td class="nump">$ 44,304<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrent', window );">Incentive compensation</a></td>
<td class="nump">22,579<span></span>
</td>
<td class="nump">30,254<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">20,150<span></span>
</td>
<td class="nump">18,169<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent', window );">Sales taxes</a></td>
<td class="nump">6,158<span></span>
</td>
<td class="nump">5,844<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Restructuring accrual</a></td>
<td class="nump">6,546<span></span>
</td>
<td class="nump">5,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_UnfavorablecontractliabilityST', window );">UnfavorablecontractliabilityST</a></td>
<td class="nump">30,991<span></span>
</td>
<td class="nump">30,838<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Accruedothertaxes', window );">Accrued other taxes</a></td>
<td class="nump">2,524<span></span>
</td>
<td class="nump">5,794<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Accrued Professional Fees</a></td>
<td class="nump">6,823<span></span>
</td>
<td class="nump">5,317<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Accruedlegalfees', window );">Legal accrual</a></td>
<td class="nump">3,137<span></span>
</td>
<td class="nump">3,137<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Outsidesalescommissions', window );">Distribution Fees</a></td>
<td class="nump">11,502<span></span>
</td>
<td class="nump">17,063<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent', window );">Warranties and returns</a></td>
<td class="nump">3,201<span></span>
</td>
<td class="nump">3,097<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_FieldServiceCorrectiveAction', window );">Field service corrective action</a></td>
<td class="nump">27,898<span></span>
</td>
<td class="nump">24,517<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Accruedfreight', window );">Accrued freight</a></td>
<td class="nump">11,116<span></span>
</td>
<td class="nump">17,988<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">2,132<span></span>
</td>
<td class="nump">1,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">16,018<span></span>
</td>
<td class="nump">14,899<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">235,167<span></span>
</td>
<td class="nump">242,769<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Liability, Defined Benefit Plan, Current</a></td>
<td class="nump">2,974<span></span>
</td>
<td class="nump">2,928<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_AccruedAuditFees', window );">Accrued audit fees</a></td>
<td class="nump">6,355<span></span>
</td>
<td class="nump">6,279<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">2,132<span></span>
</td>
<td class="nump">1,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductLiabilityContingencyLineItems', window );"><strong>Product Liability Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">48,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 55,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Interest Payable</a></td>
<td class="nump">693<span></span>
</td>
<td class="nump">1,033<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_AccruedResearchAndDevelopment', window );">accrued research and development</a></td>
<td class="nump">6,562<span></span>
</td>
<td class="nump">3,538<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember', window );">Foreign Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">2,132<span></span>
</td>
<td class="nump">1,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">$ 2,132<span></span>
</td>
<td class="nump">$ 1,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2022 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_AccruedAuditFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued audit fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_AccruedAuditFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_AccruedResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>accrued research and development</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_AccruedResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_AccruedSalariesAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued salaries and benefits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_AccruedSalariesAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Accruedfreight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued freight</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Accruedfreight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Accruedlegalfees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued legal fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Accruedlegalfees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Accruedothertaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued other taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Accruedothertaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_FieldServiceCorrectiveAction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Field service corrective action</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_FieldServiceCorrectiveAction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Outsidesalescommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Outside sales commissions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Outsidesalescommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_UnfavorablecontractliabilityST">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>UnfavorablecontractliabilityST</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_UnfavorablecontractliabilityST</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityAccrualComponentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recorded amount of the accrual for a material component of a product liability contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityAccrualComponentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12524-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126907644&amp;loc=d3e11281-110244<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572236312160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities Long-term liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 06, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 63,062<span></span>
</td>
<td class="nump">$ 60,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent', window );">Accrued Employee Benefits</a></td>
<td class="nump">5,252<span></span>
</td>
<td class="nump">5,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedRentCurrentAndNoncurrent', window );">Accrued Rent</a></td>
<td class="nump">955<span></span>
</td>
<td class="nump">997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">1,939<span></span>
</td>
<td class="nump">1,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other Accrued Liabilities, Noncurrent</a></td>
<td class="nump">1,134<span></span>
</td>
<td class="nump">3,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent', window );">OTHER LONG-TERM LIABILITIES</a></td>
<td class="nump">114,227<span></span>
</td>
<td class="nump">114,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">48,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductLiabilityContingencyLineItems', window );"><strong>Product Liability Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">48,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Contract with Customer, Liability, Noncurrent</a></td>
<td class="nump">16,591<span></span>
</td>
<td class="nump">16,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TimingAxis=icui_LongTermMember', window );">Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">25,294<span></span>
</td>
<td class="nump">25,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductLiabilityContingencyLineItems', window );"><strong>Product Liability Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">$ 25,294<span></span>
</td>
<td class="nump">$ 25,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRentCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRentCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityAccrualComponentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recorded amount of the accrual for a material component of a product liability contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityAccrualComponentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TimingAxis=icui_LongTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TimingAxis=icui_LongTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572236046928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Effective tax rate (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent earn-out</a></td>
<td class="num">$ (700)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Share-based Payment Arrangement, Expense, Tax Benefit</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ContingentConsiderationTaxExpense', window );">contingent consideration, tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent earn-out</a></td>
<td class="num">$ (700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>contingent consideration, tax expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionContingentConsiderationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240873184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TotalSeniorSecuredCreditFacility', window );">TotalSeniorSecuredCreditFacility</a></td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">1,670,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_RevolverSubLimits', window );">Revolver Sub limits</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs, Gross</a></td>
<td class="nump">37,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_LeverageRatioCalculationCeilingSubtractedAmount', window );">Leverage Ratio Calculation Ceiling Subtracted Amount</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from Issuance of Debt</a></td>
<td class="nump">850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">828,750<span></span>
</td>
<td class="nump">$ 834,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs, Gross</a></td>
<td class="nump">15,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">$ 834,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Jan.  06,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanBMember', window );">Term Loan B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from Issuance of Debt</a></td>
<td class="nump">$ 850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">841,500<span></span>
</td>
<td class="nump">$ 843,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs, Gross</a></td>
<td class="nump">13,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">$ 836,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Jan.  06,  2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs, Gross</a></td>
<td class="nump">$ 8,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioCalculationCeilingSubtractedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Leverage Ratio Calculation Ceiling Subtracted Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioCalculationCeilingSubtractedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_RevolverSubLimits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revolver Sub limits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_RevolverSubLimits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TotalSeniorSecuredCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>TotalSeniorSecuredCreditFacility</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TotalSeniorSecuredCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572236538064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations Interest Rate Terms (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_InterestPercentageAddedToFederalFundsRate', window );">Interest Percentage Added to Federal Funds Rate</a></td>
<td class="nump">0.0050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_InterestPercentageAddedToBaseRate', window );">Interest Percentage Added to Base Rate</a></td>
<td class="nump">0.0100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans', window );">Ter SOFR Interest Rate % Adjustment for Base Rate Loans</a></td>
<td class="nump">0.0010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans', window );">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</a></td>
<td class="nump">0.0025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans', window );">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</a></td>
<td class="nump">0.0025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans', window );">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</a></td>
<td class="nump">0.0010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans', window );">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</a></td>
<td class="nump">0.0010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_LeverageRatioLevelAxis=icui_Greaterthan400to100Member', window );">greaterthan 4to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member', window );">lessthan4to1butgreaterthan3to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqual300To100ButGreaterThan250to100Member', window );">lessthanorequal3to1butgreaterthan2point5to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member', window );">lessthanorequalto2point5to1butgreaterthan2to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo200To100Member', window );">lessthanorequalto2to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.15%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.15%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A | greaterthan 4to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A | lessthan4to1butgreaterthan3to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A | lessthanorequal3to1butgreaterthan2point5to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A | lessthanorequalto2point5to1butgreaterthan2to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A | lessthanorequalto2to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanBMember', window );">Term Loan B</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanBMember', window );">Term Loan B | greaterthan2point75to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanBMember', window );">Term Loan B | lessthan2point75to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0225<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ApplicableMarginBaseRateLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Applicable Margin Base Rate Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ApplicableMarginBaseRateLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Applicable Margin Based on Leverage Ratio [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ApplicableMarginBasedOnLeverageRatioLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ApplicableMarginTermSOFRLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Applicable Margin Term SOFR Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ApplicableMarginTermSOFRLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InterestPercentageAddedToBaseRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Percentage Added to Base Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InterestPercentageAddedToBaseRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InterestPercentageAddedToFederalFundsRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Percentage Added to Federal Funds Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InterestPercentageAddedToFederalFundsRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ter SOFR Interest Rate % Adjustment for Base Rate Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TerSOFRInterestRateAdjustmentForBaseRateLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_Greaterthan400to100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_Greaterthan400to100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqual300To100ButGreaterThan250to100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_LessThanOrEqual300To100ButGreaterThan250to100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo200To100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo200To100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_GreaterThan275To100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_GreaterThan275To100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_LessThan275To100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_LessThan275To100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242408048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations Terminated Credit Agreement (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 150.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Line of Credit Facility, Expiration Date</a></td>
<td class="text">Nov.  08,  2022<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240775152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations Table (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 1,670,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of Credit Facility, Fair Value of Amount Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="num">(22,991,000)<span></span>
</td>
<td class="num">(24,262,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Debt, Long-term and Short-term, Combined Amount</a></td>
<td class="nump">1,647,259,000<span></span>
</td>
<td class="nump">1,653,363,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="nump">35,063,000<span></span>
</td>
<td class="nump">29,688,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">1,612,196,000<span></span>
</td>
<td class="nump">$ 1,623,675,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 828,750,000<span></span>
</td>
<td class="nump">$ 834,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="nump">$ 11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">7.42%<span></span>
</td>
<td class="nump">3.99%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanBMember', window );">Term Loan B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 841,500,000<span></span>
</td>
<td class="nump">$ 843,625,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="nump">$ 11,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">7.76%<span></span>
</td>
<td class="nump">4.61%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242165392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Obligations Schedule of Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_LOngTermObligationsDisclosureAbstract', window );"><strong>LOng-Term Obligations Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">Long-Term Debt, Maturity, Remainder of Fiscal Year</a></td>
<td class="nump">$ 22,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Long-Term Debt, Maturity, Year One</a></td>
<td class="nump">51,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Long-Term Debt, Maturity, Year Two</a></td>
<td class="nump">51,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Long-Term Debt, Maturity, Year Three</a></td>
<td class="nump">72,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">Long-Term Debt, Maturity, Year Four</a></td>
<td class="nump">672,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">Long-Term Debt, Maturity, Year Five</a></td>
<td class="nump">8,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Long-Term Debt, Maturity, after Year Five</a></td>
<td class="nump">792,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 1,670,250<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LOngTermObligationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>LOng-Term Obligations Disclosure [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LOngTermObligationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572245651680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations Interest Expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Interest Expense, Debt, Excluding Amortization</a></td>
<td class="nump">$ 29,263,000<span></span>
</td>
<td class="nump">$ 10,017,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of Debt Issuance Costs and Discounts</a></td>
<td class="nump">1,701,000<span></span>
</td>
<td class="nump">1,643,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount', window );">Line of Credit Facility, Commitment Fee Amount</a></td>
<td class="nump">368,000<span></span>
</td>
<td class="nump">351,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="nump">$ 31,332,000<span></span>
</td>
<td class="nump">$ 12,011,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572327193920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations Principal Payment (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermAPrincipalPaymentFirst2Years', window );">Term A principal payment % First 2 Years</a></td>
<td class="nump">0.0250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermAPrincipalPaymentYear3And4', window );">Term A Principal Payment % Year 3 and 4</a></td>
<td class="nump">0.0500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermAPrincipalPaymentInYear5', window );">Term A Principal Payment % in Year 5</a></td>
<td class="nump">0.0750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TermLoanBPrincipalPayment', window );">Term Loan B Principal Payment %</a></td>
<td class="nump">0.0025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt Instrument, Periodic Payment, Principal</a></td>
<td class="nump">$ 7,400,000<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermAPrincipalPaymentFirst2Years">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term A principal payment % First 2 Years</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermAPrincipalPaymentFirst2Years</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermAPrincipalPaymentInYear5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term A Principal Payment % in Year 5</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermAPrincipalPaymentInYear5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermAPrincipalPaymentYear3And4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term A Principal Payment % Year 3 and 4</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermAPrincipalPaymentYear3And4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanBPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term Loan B Principal Payment %</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanBPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242096016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies Contingency (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jan. 06, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ContingentConsiderationGrossST', window );">Contingent Consideration, Gross ST</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_ContingentConsiderationGrossLT', window );">Contingent Consideration, Gross LT</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">48,600<span></span>
</td>
<td class="nump">$ 55,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">20,300<span></span>
</td>
<td class="nump">$ 53,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember', window );">Foreign Infusion System Supplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_InternationalDistributorMember', window );">International Distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossLT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross LT</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossLT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossST">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross ST</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossST</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contingentconsiderationgross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>contingent consideration gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contingentconsiderationgross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionContingentConsiderationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityAccrualComponentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recorded amount of the accrual for a material component of a product liability contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityAccrualComponentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_InternationalDistributorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_InternationalDistributorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572242379072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaborative and Other Arrangements (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted', window );">Purchase Commitment, Remaining Minimum Amount Committed</a></td>
<td class="nump">$ 29.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240252896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_TreasuryStockPurchasePlan', window );">Treasury Stock Purchase Plan</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock Repurchase Program, Remaining Authorized Repurchase Amount</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation | shares</a></td>
<td class="nump">52,764<span></span>
</td>
<td class="nump">37,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment, Tax Withholding, Share-based Payment Arrangement</a></td>
<td class="nump">$ 8,425<span></span>
</td>
<td class="nump">$ 8,743<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_SmithsGroupOwnershipAcquisitionSharesIssued', window );">Smiths Group Ownership % Acquisition Shares Issued</a></td>
<td class="nump">0.105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_SmithsGroupOwnershipRequiredForBoardRepresentation', window );">Smiths Group Ownership % Required for Board Representation</a></td>
<td class="nump">0.050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_SmithsGroupOwnershipAcquisitionSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Smiths Group Ownership % Acquisition Shares Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_SmithsGroupOwnershipAcquisitionSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_SmithsGroupOwnershipRequiredForBoardRepresentation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Smiths Group Ownership % Required for Board Representation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_SmithsGroupOwnershipRequiredForBoardRepresentation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TreasuryStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock Purchase Plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TreasuryStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240622032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">$ (61,603)<span></span>
</td>
<td class="num">$ (628)<span></span>
</td>
<td class="num">$ (80,978)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (19,269)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="nump">24,839<span></span>
</td>
<td class="nump">20,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="num">(5,464)<span></span>
</td>
<td class="num">(2,210)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="nump">19,375<span></span>
</td>
<td class="nump">18,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(97,990)<span></span>
</td>
<td class="num">(23,991)<span></span>
</td>
<td class="num">(122,973)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(19,045)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="nump">24,983<span></span>
</td>
<td class="num">(4,946)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="nump">24,983<span></span>
</td>
<td class="num">(4,946)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="nump">35,202<span></span>
</td>
<td class="nump">23,335<span></span>
</td>
<td class="nump">40,779<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(237)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="num">(113)<span></span>
</td>
<td class="nump">25,782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="num">(5,464)<span></span>
</td>
<td class="num">(2,210)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="num">(5,577)<span></span>
</td>
<td class="nump">23,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="nump">1,185<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">$ 1,216<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="num">(31)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</a></td>
<td class="num">$ (31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2022 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140572240196384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Transfers and Servicing (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransfersAndServicingAbstract', window );"><strong>Transfers and Servicing [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount', window );">Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount</a></td>
<td class="nump">$ 58.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndCollectionOfReceivables', window );">Proceeds from Sale and Collection of Receivables</a></td>
<td class="nump">138.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_icui_CashRemittedToPurchaser', window );">Cash Remitted to Purchaser</a></td>
<td class="nump">81.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableSale', window );">Accounts Receivable, Sale</a></td>
<td class="nump">139.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfAccountsReceivable', window );">Gain (Loss) on Sale of Accounts Receivable</a></td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRevolving', window );">Financing Receivable, Revolving</a></td>
<td class="nump">$ 150.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_CashRemittedToPurchaser">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Remitted to Purchaser</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_CashRemittedToPurchaser</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease from sale of accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRevolving">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of financing receivable that can be withdrawn, repaid, and redrawn.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 79<br> -URI https://asc.fasb.org/extlink&amp;oid=124267575&amp;loc=SL82922352-210448<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRevolving</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale of accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=d3e107425-111719<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndCollectionOfReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the proceeds from sale and collection of receivables during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndCollectionOfReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before counterparty netting, of cash proceeds received in transfers of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransfersAndServicingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransfersAndServicingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>icui-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:icui="http://www.icumed.com/20230331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="icui-20230331.xsd" xlink:type="simple"/>
    <context id="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1d8acfe084474d409043528e4b35689c_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ic896526384424866b5b8be38ae18f2f6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i843ff99f0a184bdf9191fac242ba630e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i07f6b061c66845509e4e6c7ff5cbe7bc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5638b072e2c74cecb680e1eeeb816a7f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic36e92a4a4e041d789fd1e15a96fb89d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5f732bf16f8943de8310b4900638904c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i905ef664618549b79a2604ba36989fa1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2876aa14e8a049c888a7c1a7d0b9add5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0f675125f08545ed853c555497efd555_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i157787461be54c729a371db9e5f0b870_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i553e7d37da95492bb56ab18d405def24_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i076bb8ec7f8a4200aaa3d2d05b180bb7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i92f1bb64c23547f8be008ab8d3bb642a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i85d17593813847138c47bd6a52b84d0d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i54b39f23877a4f0d862e5916dd5e87c8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i59687ae95c8c4f548a9c5ed00de7213f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ieccf8d651a8d422e91523860913a0c81_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id319fa0bb715447db5d21adda1569f95_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8121720b12924aeaa2d7f2161161fdc6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8e09221885284788959b95412b6214f4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i10ebf268d4574d988d0c464474155fe0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i097914f4b8e14986872f2b29ed1ef69e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie149bde323634e0093914839ee8ac148_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5bc26a59bd7142798a8bbabd7a8aebf6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic079464d6d0c45109f1b5fdae21f379e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i720c98b0bc6c4647b5ec2b08163c165c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9fd0c26c71db4e4cb0b929a7689fb683_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i864f233d9281416ea0ce16b7edf44f57_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6c0c21e62a5645398a5ae491f1716ab4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i39df97d162224e7ead2e7587ce51c1c5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ica718d655f94421fb3eeafd5ac5288be_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4b0ee62d61be45c0aee4a548c96a0697_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7f9b480e0479472aab56012880bdecd6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7a406cdd295d4bae87e1e8ec6e5620dc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9a153016e3f444b4a7339a82e88bc93e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i966e762ecf634e718045d1a26327c012_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i135dbadf645845ba84e91cb70245f896_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9b4d6b0874b84330ab118d8d72f89852_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1adc8956afab4a2c82b48740ffa3c5f4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i57ae4b72e9574e4ebf63f3473590fe05_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0c6fdad0ae1f42cdb0e49e14d48fc939_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib4e4d6b3c14144aca5091606533105a7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iad76217923724df7af4e6c43d299c300_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">icui:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib4201cfae6384d12823ab684fa4f93a9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3908b880a83e477b9d7b162246382114_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if4dc12115f6e4ef7a1e347d0b33880e4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i73bd4bbae85843dcad72b0d7b43e60a5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icb891162132d4866b63cbc65bb9e5978_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie5653183732045d196de37183c40dd18_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2be2d8334179424c9dae8ef69e51861a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2988acfe0dcd4e17a14143d0e3743733_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie97b4a8feb974d7180f4613667a93acb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i98a8c58853e84468b76e94c8be56aa32_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i382a53a05af54e50ba7efcb611be9988_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie6b3ba685fe640b2bf1d136426bd89dc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if672ca85f58b4f10ac0adfe442433dba_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i430bf7f21dc340cc98e845a1549c6ba2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie942e6605043489884a694f3c56a4f24_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i425342db1c344b6f8cc10da8ee02d87b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib3e783fa8bb34a5494c0d5d949242f64_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VitalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i638825fa0f98497b948ffb1c01d0e19e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VitalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4b683b00bad4432ea43529d2de73711d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibc639aa88692474fa875253ce1c84b6e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib3d0e8e0a5bb4a63b8430aaa2a4f8b17_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifd9ef9dff7c545ad9f948e39c002b2bc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idf5cc17211a944c486c24f771e6a195c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i45b3d6f3d0644e7d8963c40933520643_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie82e694fdb9d4433a97ad09856242b4a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iad04b3344f3d466bba0994502f1196e8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6f5153aa5ab442638a5c8de9a45fba7d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4de9a8d7bfc44cdfae663c1ba5da07c8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if70bbd6b2087429f879753468a264309_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ida61c1e26c5d42a6a66daca8551246ff_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id1779a7129f64c9d9abc575b38200d77_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i316bfaa281dd4708b1bdb8f0f4449ed0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0115d314b99743fa9bbb604242dd25a1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i908fb323327c4154bd1568d75d6f2552_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie30632948bb140989b06da9c57314a0e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i261befa46c644eb8a0b97033247d3bad_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i29c2d40d68d54fa78c2000befa7864fd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i34e4e4f1c2754f669c44df080318aa88_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i81bf02eca70549c38a41eb91ac257f95_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i54a3f930a4e54803850c70dc786e2c62_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5138e2e1587f44e48d749663aa9643f9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibaf177153834401cb429ff7ce5049e03_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i961a433f9f954f7a83f394eb9db23739_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8fed4ca7522348e09634e4fad1da85ca_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ica8e78475e314beda5cd3faaa0ce02d4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i40f728bd623845f9b4ce1cfdaf7c303f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i104614519533468cb1d3f4a1f7ede191_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ieed1db1afe2e4864acbe51f8f742e903_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ica866edd3bbb4be194fb9fbe70eab0c3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CZK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i98371e0ede62423e94e012fb74cce6db_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7cacbfb1e2ec47f181ee075ab70cca83_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i05b8d7e5a0c94ec0abe63ce8b2a92789_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8c884f97d3444f6ea4dcd4b55692fdb4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0f2b698f9db545af9bce00c8273f5099_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8321aa0d52a040748fa39ebb30857208_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:Srt_MultipleCurrencyAxisAxis">icui:OtherCurrenciesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i32a51ec3c4454197ad187d461dff39ee_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id1c83cae5660471ba0a2606a294d663d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i41865436086741dba4582ecb29b5d80f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i86157d0618294ee89c1fc6807b08141e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie7f51fd80feb455d9784516bdd6b7c63_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id6bcc5cb934c484085e4c9d001608c4b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icc4d8e7ceb96467cae741d1df3ad1fbf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i631e83ee61b74e3abeaa5ad6e7bab2b1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icc9bb67f131a49a8b919336073869658_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3e60d283c38e4b35bb0be9fcf2699bec_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0c2531beb9494ed7a57f1659c8d16d2a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8f7f6f4d53994f44b8df01e0704834c5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i974e647072aa44e980b4ed61c129befa_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i45dae7757b124552a2b2f3b01ce6c186_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:TradingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8b5bae88141345639dcc3eac627c0799_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:TradingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i48a10cc5a2694f10b44bf1877ec9bebc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i108862c46a0d4e1295be73061c8600e8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0c8639dba4434deab359b7b242f47fbd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i12ebce1f4c61414eb59c03244fef43b4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i73bc74286d9f4e128411e29701d4efc8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9c48ae5abe2f4e6caf6fbf46c2c6e69a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i22bda3a55c764257a1a89a08923962af_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id05515fe4472496ab29e975ca6d18184_I20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-06</instant>
        </period>
    </context>
    <context id="ie9945fc3bd5d4b24a1e69091bf0384fd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia818e4969fa7407895eb98d2469bf054_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifb3a2f75275841ddb552fdb5a627b2b2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifb41da7d968840ea810ecb453fece23f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic1ae61222e1b43a5acfc276574f10056_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6c52854a73b14fd6ae1828bd91e30fb1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i03a2467fbfc445cf8500c8ee1e6396ee_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icbd969b02ac748cd9474589aab428a62_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id9540454f8784e5f990147c6b769dfe8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icd441dae5eb1464ebef86ea40463485d_I20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-06</instant>
        </period>
    </context>
    <context id="ia32accdc410f475aacf8dd5d7b0e4cf3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i73f519574f6f4c26956379467aefa3d5_I20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-06</instant>
        </period>
    </context>
    <context id="i56f6562b611449eeb241cfb061a8fc81_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie1a170696eee4e9abdb23c78710d0758_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i97cdcc7aea824b1db81b342d252b23dd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie91c21fa692e4850bf5756c81c2f5f58_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icb57c90226d949769fdebc2b3c886a84_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i74a47211e1504bfbbb2e56947d6359bc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8ee355f953e44036b2c9823f0ddf9545_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7db2b58ce0df41e787b7b142992d9f0a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id251cb4f372c42deb49b98c56f091af2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i00e9c526d8a14de587543cd4d43d84ff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i95e85068b35c4e25b71a9f1dde7f01cf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie3677cc922444caa877f9554bf61388c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie75c1ba3ea0845429dc5b1f441156886_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib014b4c6ffba42ecba26116f0b36d255_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7b55b633207e4c77a409427f88b494ae_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ied46de2d5cdb4f3287c1a51b1fda5f2f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1e83be36630a4315aa61f938a15ed93c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i73643551546848cf924dc74653a7ab10_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2ff489ffd4484b05893332bc86bb5da4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id49337d44fff49da85c4746c25de0cfa_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iefcb7fb7c4af44bd86feb62b7205f1f3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i28c30abbbc564beab22d3baeae8ce04c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i83c7a5461f164badbda9aed1e171b545_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8f06c69e01fa4e4f8ab8986b188ec125_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5bc9662c059e4bda801cb06360c4c046_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4517f24d47284d07aec33cb915f14ec9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i97bd4045255248b7a6ad2e2738cf4991_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic88a0d75c4324efe964e2e67a57a9956_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i66bd23e34133401591e928370dd3aae3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iec00d0e32787463fa02c2beb859e4088_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i61a628145a154dd4b608eda8fef5317b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2421f17f678943faa6f08a99e77342d2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i51723405dbf94ff6823b0cfe6cd7a8f4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibb5b0d8817344f0eb58f57ded4f69d76_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic825a9792c0c4bb3932a15194babe436_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if6739e8ed9384ce4a0f3da9edab4d0ef_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i13ee862b60df4a8182330aca4aabe86e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0a1abf01d00d48a5868de1e621f7cae5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic4c34b949f374399ba510212f11790c7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8d76827e236145bfa0a5caf2d4857d5c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4a5293ddbff54b3d8db5d3716b9193fb_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5222d9d8a2924eddae7d0a5f40052ea5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i56274c1ac4014325b45d30ae7ad441aa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib2d0c73330a84bb0bf6431fe51b3afda_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia30501eaa28f4a95a929526d40bc93df_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i42bd702cc395459f81747c0a9d029d07_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia089dfcea16a47c7a301086d94a998c0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3032b40999034d9c8ace19cc47d82a6c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id3344b2eee9a439b99d11085a8bad5a2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i459536a397ec41e98471e9be9d5f85de_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2e94d92e01474cfeb2beeaedbd0abe84_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib0cf77942cd1443eacbf40c493fe858d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6080af93170148688d13de3d59d12ab7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7b13a58d0b3c4453995ec99b1cfe364a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ica1daf3e26514068beac02afe7124cc3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib414b19de28a44c7b4896fcc6b6b46e3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iab01ecb2b6ac4acc8ebcb12fdb8f8e51_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i79e95f455b32497bbff95f508a232d72_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib903abaa897142e6870b5c981c0190f9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib4f553481cb44e628e33717df32e0afc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iae888c38b8234f5abfc0397b9219a434_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib538cde976ef4ac38c558a67c9a7b8c1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie2300372e953438fb46cce4511c00fdf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i600c673eafe24f7a99360ebe80c6bd12_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i24988b3dea184cdd8f48759556bc2274_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i89428e5fde134e38a53ca4bcdc2ca0ae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:ClassificationAxis">icui:NoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifc34907535374c3da7784002505ffd72_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i00116957d0924008b381688d18b90256_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i513c2936b35e4be19a4d05480a1af429_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i25f3594cd8a446f7810b2e62cde2b514_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibfbfe2784d674d028ea89497f6d11184_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idbc93354f6f64dd887efe82a4a92a59c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i25eb893c69d64ec8916421287d40d7dc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i82ea280e29894ab9a463eb6fa58461c3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iedc9227893204f5fb8adfe568b84f804_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6e3979b3c1734fa6bf0c57b31b79d949_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i86423b3966d94fd191b5c9416094b60c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic165dae88e744691bcce8d47fec9dbdb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id77de8d44cca4f389a04a8b86d7c1607_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i96b4b6ca22c9441d8fd7c31c022b4666_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i579e1337f5894b6e9f97f1483abeb705_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">icui:NonPublicCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7fef98ce304042888df7d376a7476354_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia69844c22aaf40cbb2a42781ead60e61_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic24eeaf2cdd54ba28cf13e1eed409bf3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie470f6c922764b86925b02b2d25bd068_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i66a11824ed414a45824aa3f42692576a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:MoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8748d9089ac04b8bb47719b0717b5a2b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:MoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4ed218cedf4f4e30aacfc291c713a4ff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8d4e73ec88b842f7b49cf0a4ba9fa984_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9bc8a01c792a4c0cba943cbaa9683dc5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i99bbc561eaf74c0bb03cf3b2367770b5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i759eb770637645338c5cb3c69ad883ed_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icae7fd56151f4362ba49944b6babf4d5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9431fa63e03f4c39828dd6f5c2874b77_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i45abd7fc6cb041539c2690484538f401_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaf6dc92130324e248c5bccc98319a7dd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id9ddae410dbb4da9b5bbab71cde7e71a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4dee8f10404243bfb8a21715c53d5167_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie66a2d4ccf9f4810ab62a157c417c4a0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idd805b98cb0e420da9a33f629e95ab71_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i79338c5b72624f9e86c8250b5030dbc1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie931f544d5844a66997a310a1d04e1f4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4325a768bae8472fb7bfb255f0e35276_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifb7e987c2bb9440db23dae317f15ad47_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0f298d4ded0646038f7f4958576511b8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i179a00f6e8ed4a8eb5aab9eade675698_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id0a7b4c978594fa7ac242ade5c6e7a65_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i369d015daca1416f8f0547c55b9d625b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic041286ae4d64457a61d949e2a01e553_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia31355a5a0a34e42adb367500b2d5d1c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5119a978c7084a25a248c39ee1944803_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9faa2994ef5c4d8cb43ac97f50785f0e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i92753141dc8f4c78b24dcbf4e0913b77_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaba17e9a9dce424287c2e009d986cffd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic2084d5b4c664907b48055fe916dc52e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id56f1f6ec46947599bc7bfc1ffe9d195_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i89af7b8cd3d0498cbb978e49c788ff06_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i74ff728885fb420389d379cc16b1717f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i43a9c2ae467547f8811c5f92ca52a728_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5d8fe8f65713456c8f35230f74bceb87_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6cb7cc5f691a49e8b4265215896d8c03_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5601a8c75d144a43a8365d2d70291f2f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6f8a9cb1a64e44a89d9d73f6ad8eba74_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie8a1a1ffc693445c9e79c6e34870c622_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i59eb5fecde424d39a6b4b8dce858b9f7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i514b0dbe6eac49eea9224b92e51b766b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i80d837b89c2344e393ee4d383e5cc11b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:Greaterthan400to100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i27b3017a55814b6597ba4e68980a344f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:Greaterthan400to100Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i881696e2df5749c38024d0875b7c80db_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo400To100ButGreaterThan300To100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0d76d9c6767b4229b51c37407f83df06_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo400To100ButGreaterThan300To100Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8990fbda10824f619dc9e0bb423e9432_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqual300To100ButGreaterThan250to100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if94f4bdedbf04eb0aae885e9867154ae_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqual300To100ButGreaterThan250to100Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i645c0fc8e6a548c1a7a520e2f4a6728a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo250To100ButGreaterThan200To100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i83eb7320045f4ac9af9a0028ac179e5d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo250To100ButGreaterThan200To100Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i975e28cedc80423c9627a97bb37a9a95_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo200To100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i76e51a168e7a435c861495b1388612d0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo200To100Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i808fda9aa5364d5593b95ed5ff583af5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:GreaterThan275To100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2e764926d4b14681809efb21b544fa30_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThan275To100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i50e84852d3ab4f408186915e7cf4e655_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9fdf26eb4e87495fbabffe1de604c690_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i934b1e4c20bc460c88d531ba8e887800_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ica3646f151fa444e82e1e515a33e0f7a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1881f550800444d3981abc4acd458059_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i21016b61e07645e9888301254ab114fa_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i053a7aa68c99417ca271343168d82c1d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib548663bfdd74230aa02cd84a0db6361_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i114116d7f6da48e49ecb98fac66b8e6e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9142596d6f484bf2be0ed3d89cd30684_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i07609ad4dfd84093853a23ea3364cd22_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7be1d8f7f3cf4eacaeeabf9eda19e43f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i857399bd08c745988830c1cc09e54a50_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4768bcc3c288464a9796a77d8e9884aa_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8c285e71c3d74e8c898cbe0851162f27_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic1e39a1ea3fe47daba9453de67fe8e1b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia762d86224bd46f5b6f22478b80f66dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i86546ad81144448d9f4a7e7d42d02105_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5ac4813a471b49ff9271b2d9e810c0a1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icb13edf15748489f92eee0507a1fb77f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3cf0fb2f948444dbbf455bbc0c6a8057_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaa41f9bbd9164a17afef3d0f715104cf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaa95f20692ed474d949298d55e4d9445_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5e5490aa9392486e8d4e7fa173e87574_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4164284555e9406180057f15e0c21bc7_I20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2022-01-06</instant>
        </period>
    </context>
    <context id="id4dcda0568fa4318a8aa6122af8e00b9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7e28dd363d7d40519a83284765f9a3fd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="mxn">
        <measure>iso4217:MXN</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80L2ZyYWc6N2Y2ZGIyNDQ5MDEyNGYzOGI0ZWY5NjhjYmFlZTM2ZTkvdGFibGU6MjZlZjhhMjc0M2Q4NDc3ZjlhZjZiNzI4ZWFkMTUxMmMvdGFibGVyYW5nZToyNmVmOGEyNzQzZDg0NzdmOWFmNmI3MjhlYWQxNTEyY18yLTEtMS0xLTExMjI5MQ_3c21152a-88d7-4b17-bd00-d229ee69626a">0000883984</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80L2ZyYWc6N2Y2ZGIyNDQ5MDEyNGYzOGI0ZWY5NjhjYmFlZTM2ZTkvdGFibGU6MjZlZjhhMjc0M2Q4NDc3ZjlhZjZiNzI4ZWFkMTUxMmMvdGFibGVyYW5nZToyNmVmOGEyNzQzZDg0NzdmOWFmNmI3MjhlYWQxNTEyY18zLTEtMS0xLTExMjI5MQ_52ac48eb-3ae0-4382-8a8e-572c69b64c2e">ICU MEDICAL INC/DE</dei:EntityRegistrantName>
    <dei:AmendmentFlag
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80L2ZyYWc6N2Y2ZGIyNDQ5MDEyNGYzOGI0ZWY5NjhjYmFlZTM2ZTkvdGFibGU6MjZlZjhhMjc0M2Q4NDc3ZjlhZjZiNzI4ZWFkMTUxMmMvdGFibGVyYW5nZToyNmVmOGEyNzQzZDg0NzdmOWFmNmI3MjhlYWQxNTEyY180LTEtMS0xLTExMjI5MQ_10b1f244-5e9d-4bac-b144-6e8e29681e72">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80L2ZyYWc6N2Y2ZGIyNDQ5MDEyNGYzOGI0ZWY5NjhjYmFlZTM2ZTkvdGFibGU6MjZlZjhhMjc0M2Q4NDc3ZjlhZjZiNzI4ZWFkMTUxMmMvdGFibGVyYW5nZToyNmVmOGEyNzQzZDg0NzdmOWFmNmI3MjhlYWQxNTEyY181LTEtMS0xLTExMjI5MQ_a239f44e-c4cc-4c6d-9fb7-78b3787dffc4">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80L2ZyYWc6N2Y2ZGIyNDQ5MDEyNGYzOGI0ZWY5NjhjYmFlZTM2ZTkvdGFibGU6MjZlZjhhMjc0M2Q4NDc3ZjlhZjZiNzI4ZWFkMTUxMmMvdGFibGVyYW5nZToyNmVmOGEyNzQzZDg0NzdmOWFmNmI3MjhlYWQxNTEyY182LTEtMS0xLTExMjI5MQ_8678c3b9-9fba-4dfd-8c68-b36473b2ab93">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80L2ZyYWc6N2Y2ZGIyNDQ5MDEyNGYzOGI0ZWY5NjhjYmFlZTM2ZTkvdGFibGU6MjZlZjhhMjc0M2Q4NDc3ZjlhZjZiNzI4ZWFkMTUxMmMvdGFibGVyYW5nZToyNmVmOGEyNzQzZDg0NzdmOWFmNmI3MjhlYWQxNTEyY183LTEtMS0xLTExMjI5MQ_c232117c-14aa-4f54-8f86-c79b9112095f">Q1</dei:DocumentFiscalPeriodFocus>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjc3NQ_c58be461-15cc-4ce0-9461-a1f586d03baa">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if4dc12115f6e4ef7a1e347d0b33880e4_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjg1NA_dbc618ca-f89e-4749-ab68-262b22ebc7e6">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i73bd4bbae85843dcad72b0d7b43e60a5_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjg5MQ_cbdceafc-7a31-4a27-b09c-41ac0c8d87ec">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="icb891162132d4866b63cbc65bb9e5978_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjkyNg_15a93537-17a8-41e6-a1fe-d867b9347f66">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ie5653183732045d196de37183c40dd18_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjk3NA_5b7a1829-90b2-4109-8983-d52f0d255b2e">P6Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNC0wLTEtMS0xMTIyOTE_cfaec65c-7e6a-4276-963b-bd9a55c586b9">http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent</us-gaap:DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNS0wLTEtMS0xMTIyOTE_a381aeb8-d171-4550-9ed5-50b193801e56">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOC0wLTEtMS0xMTIyOTE_31479843-5a18-4da4-b2e9-8a0ab42c6b76">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</us-gaap:DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOS0wLTEtMS0xMTIyOTE_0314024e-19ca-42c9-bda0-6b9963e62d6c">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTMtMC0xLTEtMTEyMjkx_b4e70733-51f6-4cf5-a4f0-4e3344743eed">http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent</us-gaap:DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTQtMC0xLTEtMTEyMjkx_c7f29940-14d5-49dd-8334-2995d9c76144">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTctMC0xLTEtMTEyMjkx_6e89f792-0047-409f-ae97-92f90a1a3b54">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</us-gaap:DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTgtMC0xLTEtMTEyMjkx_e58a7954-fa23-4f46-8db3-028044ca9ce7">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="i974e647072aa44e980b4ed61c129befa_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNC0yLTEtMS0xMTIyOTE_f380e986-354b-4ae5-be66-0d8180b7e6bd">http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerExcludingAssessedTax</us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="i48a10cc5a2694f10b44bf1877ec9bebc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNS0yLTEtMS0xMTIyOTE_e0200ea4-951a-4f15-aa0d-730e8294b71c">http://fasb.org/us-gaap/2022#CostOfRevenue</us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="i12ebce1f4c61414eb59c03244fef43b4_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNy0yLTEtMS0xMTIyOTE_faab4624-13eb-4610-aa53-f7352f932ffd">http://fasb.org/us-gaap/2022#InterestExpense</us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTAtMC0xLTEtMTEyMjkx_f14ce4d4-85f2-4d23-a88b-1739598efd81">http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent</us-gaap:DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTEtMC0xLTEtMTEyMjkx_d56c9d3d-0932-4348-b69d-8f57de5603f9">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTUtMC0xLTEtMTEyMjkx_6bcfe6ca-ff2c-4a0b-9003-1212bc82d7dd">http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent</us-gaap:DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTYtMC0xLTEtMTEyMjkx_308e7868-3fa9-4233-8466-3e1183fa8b50">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjMtMC0xLTEtMTEyMjkx_5523e65b-55dc-41c6-8709-df1a94648036">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</us-gaap:DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjQtMC0xLTEtMTIwNzE1_62efbfc3-1b08-43d2-b4de-0ebc769246ce">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNy0wLTEtMS0xMTIyOTE_50321293-4bf5-432f-9a23-856af180772d">http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent</us-gaap:DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTgtMC0xLTEtMTEyMjkx_38c2c727-8408-4048-b07a-938ff12e83e6">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration>
    <dei:DocumentType
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGV4dHJlZ2lvbjpkMzAxNGQ3Njc4OGU0ZTBlOWJlNDg3MWMzMmE4NWJlNl8xOTgy_2ab729a5-d012-407a-93fc-40e83807b0c0">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6YWRhYjJkNDkwYTRlNDc1YTk3ODhhMzJhM2Q3MjMzZmIvdGFibGVyYW5nZTphZGFiMmQ0OTBhNGU0NzVhOTc4OGEzMmEzZDcyMzNmYl8wLTAtMS0xLTExMjI5MQ_b96fd052-eaca-400c-bc29-ab8d158caa7b">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGV4dHJlZ2lvbjpkMzAxNGQ3Njc4OGU0ZTBlOWJlNDg3MWMzMmE4NWJlNl8xMjQ_21b82a53-e6a6-4627-aaca-1437fa83d263">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6YTk1NWRkYjIzODFmNGNkZDg5MDc5OWIzZmM1YTA0MGMvdGFibGVyYW5nZTphOTU1ZGRiMjM4MWY0Y2RkODkwNzk5YjNmYzVhMDQwY18wLTAtMS0xLTExMjI5MQ_5d1faff5-ff58-4353-afa3-63d81a407c78">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGV4dHJlZ2lvbjpkMzAxNGQ3Njc4OGU0ZTBlOWJlNDg3MWMzMmE4NWJlNl8xOTgz_3256bbbe-5af8-49b3-9b9d-f70335800f19">001-34634</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6OTI2YTQwMGRiN2YwNDVhZjk3NTRiZWVmZjQyN2RiMjgvdGFibGVyYW5nZTo5MjZhNDAwZGI3ZjA0NWFmOTc1NGJlZWZmNDI3ZGIyOF8wLTAtMS0xLTExMjI5MQ_f27ce77c-37fd-4006-ab77-2265d4ba50d3">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6OTI2YTQwMGRiN2YwNDVhZjk3NTRiZWVmZjQyN2RiMjgvdGFibGVyYW5nZTo5MjZhNDAwZGI3ZjA0NWFmOTc1NGJlZWZmNDI3ZGIyOF8wLTItMS0xLTExMjI5MQ_b1c04993-a3f1-4e38-9fdf-99e213784c9c">33-0022692</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6ZjZhNzUwMmI0NzRjNGNlMmJmYTM3NzNiYWU3NGE5ZjMvdGFibGVyYW5nZTpmNmE3NTAyYjQ3NGM0Y2UyYmZhMzc3M2JhZTc0YTlmM18wLTAtMS0xLTExMjI5MQ_7f1a52b1-add3-491a-b552-9dbf5cb87bac">951 Calle Amanecer</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6ZjZhNzUwMmI0NzRjNGNlMmJmYTM3NzNiYWU3NGE5ZjMvdGFibGVyYW5nZTpmNmE3NTAyYjQ3NGM0Y2UyYmZhMzc3M2JhZTc0YTlmM18wLTItMS0xLTExMjI5MQ_69ceee34-5766-43dd-ac6a-d5dbbf4f4321">San Clemente</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6ZjZhNzUwMmI0NzRjNGNlMmJmYTM3NzNiYWU3NGE5ZjMvdGFibGVyYW5nZTpmNmE3NTAyYjQ3NGM0Y2UyYmZhMzc3M2JhZTc0YTlmM18wLTQtMS0xLTExMjI5MQ_e7131c95-2f8d-4790-8aaf-527f5a27ad36">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6ZjZhNzUwMmI0NzRjNGNlMmJmYTM3NzNiYWU3NGE5ZjMvdGFibGVyYW5nZTpmNmE3NTAyYjQ3NGM0Y2UyYmZhMzc3M2JhZTc0YTlmM18wLTYtMS0xLTExMjI5MQ_5eda3fc6-d519-4944-a563-7002616453e2">92673</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGV4dHJlZ2lvbjpkMzAxNGQ3Njc4OGU0ZTBlOWJlNDg3MWMzMmE4NWJlNl8xOTg0_d1ab7e45-d4be-4557-ba1a-a064dc72a1ca">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGV4dHJlZ2lvbjpkMzAxNGQ3Njc4OGU0ZTBlOWJlNDg3MWMzMmE4NWJlNl8xOTg1_8ece9285-2fa2-4038-bd17-f2629c98c001">366-2183</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6NjdhNjlmM2RlODRmNDFmMzlhZjVkZjg3YzE3YjFjZjAvdGFibGVyYW5nZTo2N2E2OWYzZGU4NGY0MWYzOWFmNWRmODdjMTdiMWNmMF8xLTAtMi0xLTEyMDQ2Ng_1b658b1a-05db-4eac-8e8d-123a18a0aa0b">Common stock, par value $0.10 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6NjdhNjlmM2RlODRmNDFmMzlhZjVkZjg3YzE3YjFjZjAvdGFibGVyYW5nZTo2N2E2OWYzZGU4NGY0MWYzOWFmNWRmODdjMTdiMWNmMF8xLTEtMi0xLTEyMDQ2Ng_d3166011-c397-45a5-a782-c164a55ad2da">ICUI</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6NjdhNjlmM2RlODRmNDFmMzlhZjVkZjg3YzE3YjFjZjAvdGFibGVyYW5nZTo2N2E2OWYzZGU4NGY0MWYzOWFmNWRmODdjMTdiMWNmMF8xLTItMS0xLTEyMDQ2OQ_e3a3f395-17b8-4215-8cf6-91cacad89e34">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGV4dHJlZ2lvbjpkMzAxNGQ3Njc4OGU0ZTBlOWJlNDg3MWMzMmE4NWJlNl8xOTg2_3a0f792a-aa9c-425e-8481-1f2845aaf8d8">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGV4dHJlZ2lvbjpkMzAxNGQ3Njc4OGU0ZTBlOWJlNDg3MWMzMmE4NWJlNl8xOTg3_7e7759a3-039b-4147-8f62-265f7404bdad">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6ZjQ3YmMxZDY3MTc0NGU5ZGFhNmM5N2M1MzdhMTAxMDgvdGFibGVyYW5nZTpmNDdiYzFkNjcxNzQ0ZTlkYWE2Yzk3YzUzN2ExMDEwOF8wLTAtMS0xLTExMjI5MQ_2c62ee01-2e74-47c8-b4f7-f3da633a5100">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6ZjQ3YmMxZDY3MTc0NGU5ZGFhNmM5N2M1MzdhMTAxMDgvdGFibGVyYW5nZTpmNDdiYzFkNjcxNzQ0ZTlkYWE2Yzk3YzUzN2ExMDEwOF8yLTQtMS0xLTExMjI5MQ_ad7e229d-eaa5-489a-a05c-f4d9f2c06ec7">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6ZjQ3YmMxZDY3MTc0NGU5ZGFhNmM5N2M1MzdhMTAxMDgvdGFibGVyYW5nZTpmNDdiYzFkNjcxNzQ0ZTlkYWE2Yzk3YzUzN2ExMDEwOF80LTQtMS0xLTExMjI5MQ_0049abeb-1aae-4223-85b0-a2c0d8f2968b">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGV4dHJlZ2lvbjpkMzAxNGQ3Njc4OGU0ZTBlOWJlNDg3MWMzMmE4NWJlNl8xOTgx_ba24f3b7-a08f-4481-9b22-41e549cc1714">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i1d8acfe084474d409043528e4b35689c_I20230430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xL2ZyYWc6ZDMwMTRkNzY3ODhlNGUwZTliZTQ4NzFjMzJhODViZTYvdGFibGU6NGUyNzE5NDRiMGMyNGZlMzk1MzQzYjE5NjU5YzgzMDYvdGFibGVyYW5nZTo0ZTI3MTk0NGIwYzI0ZmUzOTUzNDNiMTk2NTljODMwNl8xLTItMS0xLTExMjI5MQ_781c09b2-cd78-4f45-a737-55813e184d8d"
      unitRef="shares">24064364</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNC0xLTEtMS0xMTIyOTE_a902b203-d724-45eb-b499-b2adbc891fda"
      unitRef="usd">220947000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNC0zLTEtMS0xMTIyOTE_7f5fdd0d-259f-4a0c-97a1-43e46e1c0483"
      unitRef="usd">208784000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNS0xLTEtMS0xMTIyOTE_8e957137-d20b-4a73-8c42-bbc95302aca6"
      unitRef="usd">3235000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNS0zLTEtMS0xMTIyOTE_9e1c5a15-8b30-41b4-b008-d1882d344a74"
      unitRef="usd">4224000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNi0xLTEtMS0xMTIyOTE_217ea4e4-2f9f-44ce-a0f4-7682f54a53bd"
      unitRef="usd">224182000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNi0zLTEtMS0xMTIyOTE_b4b42f79-adc9-433b-8f62-7db731f52deb"
      unitRef="usd">213008000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNy0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjoyNTVhYjg3ZGU4MjI0NjUzYWQyYjk4YTU5MzgxMTBiMF82Nw_674edd53-1060-434a-8b92-194019815da6"
      unitRef="usd">10337000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNy0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjoyNTVhYjg3ZGU4MjI0NjUzYWQyYjk4YTU5MzgxMTBiMF84MA_8723ca6f-02c4-4c72-98ef-58b1761d2d72"
      unitRef="usd">8530000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNy0xLTEtMS0xMTIyOTE_58be837c-dde3-4c34-9b8f-763caf8c4979"
      unitRef="usd">139459000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNy0zLTEtMS0xMTIyOTE_4572b495-5d90-4b8e-9ee8-0a59ebbf46f5"
      unitRef="usd">221719000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfOC0xLTEtMS0xMTIyOTE_a955d0db-8d5b-470c-973e-7fd8ea9d4488"
      unitRef="usd">747965000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfOC0zLTEtMS0xMTIyOTE_0fe1c3ef-a99e-4fd0-ba6b-891b764bc690"
      unitRef="usd">696009000</us-gaap:InventoryNet>
    <us-gaap:PrepaidTaxes
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfOS0xLTEtMS0xMTIyOTE_2fcf7ca1-4783-4d65-9ac6-22ea1655b011"
      unitRef="usd">14294000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfOS0zLTEtMS0xMTIyOTE_beb57dd6-7fe1-4dee-bf23-6d0d9d0616fc"
      unitRef="usd">15528000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTAtMS0xLTEtMTEyMjkx_335500a5-02a9-4f2f-94d7-8efc175e6833"
      unitRef="usd">87125000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTAtMy0xLTEtMTEyMjkx_7d7d037a-f223-449f-903b-ffe31ed2d335"
      unitRef="usd">88932000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTMtMS0xLTEtMTEyMjkx_014816c1-cf23-44df-8376-53d76dfd9cbd"
      unitRef="usd">1213025000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTMtMy0xLTEtMTEyMjkx_76d15de6-be5b-43b2-96c5-524893474b9d"
      unitRef="usd">1235196000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTUtMS0xLTEtMTEyMjkx_c6d15127-bdfe-485a-a74d-b4fd0711da5b"
      unitRef="usd">624112000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTUtMy0xLTEtMTEyMjkx_05e3014b-2fc3-4b5a-8baf-57b8e024aeb5"
      unitRef="usd">636113000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTYtMS0xLTEtMTEyMjkx_03c55f6a-b95d-47c7-b7f7-51ae19f85464"
      unitRef="usd">79736000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTYtMy0xLTEtMTEyMjkx_14b6f9fc-686b-45bd-bd84-0ea1ea93f551"
      unitRef="usd">74864000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTgtMS0xLTEtMTEyMjkx_c138d21b-2295-409d-ba58-2005f88badba"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTgtMy0xLTEtMTEyMjkx_a1e60399-4e6d-4788-bcb2-f4e4514ba393"
      unitRef="usd">516000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:Goodwill
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTktMS0xLTEtMTEyMjkx_42de5a2f-d781-4db5-8085-4dd47d175d1c"
      unitRef="usd">1462726000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTktMy0xLTEtMTEyMjkx_6ecf80d1-750c-4390-81b5-f5f1ac8cc377"
      unitRef="usd">1449258000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjAtMS0xLTEtMTEyMjkx_b3a79896-9dc2-4cbd-9dca-765769c4bcfc"
      unitRef="usd">957682000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjAtMy0xLTEtMTEyMjkx_229ef6be-ce62-4921-b18f-79a60092ec04"
      unitRef="usd">982766000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjEtMS0xLTEtMTEyMjkx_79dde476-4565-4957-99ea-94020a39b418"
      unitRef="usd">31466000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjEtMy0xLTEtMTEyMjkx_70335eec-0ed7-4001-b332-17522ace5f9c"
      unitRef="usd">31466000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjItMS0xLTEtMTEyMjkx_c9fa74ef-ead0-4932-a4cf-07dba7eea7dd"
      unitRef="usd">101885000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjItMy0xLTEtMTEyMjkx_6f9f325f-393a-47ff-ad08-b307a627d1bf"
      unitRef="usd">105462000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjMtMS0xLTEtMTEyMjkx_7d75a430-0fa6-42d2-b6b2-1f9ad338050a"
      unitRef="usd">4470632000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjMtMy0xLTEtMTEyMjkx_a94bd12d-e31f-4bdd-b136-251cf57b6140"
      unitRef="usd">4515641000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjctMS0xLTEtMTEyMjkx_e3d4035c-9b36-4b44-9eb0-860b19e45e91"
      unitRef="usd">186420000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjctMy0xLTEtMTEyMjkx_4921cb4d-3853-4114-b725-5db1dd93f9f8"
      unitRef="usd">215902000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjgtMS0xLTEtMTEyMjkx_1bae557d-c5cd-4ee9-b1b0-67eaf84341e9"
      unitRef="usd">235167000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjgtMy0xLTEtMTEyMjkx_846aab52-7cc5-405a-bbec-efe479d462f6"
      unitRef="usd">242769000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjktMS0xLTEtMTEyMjkx_db16944b-ab79-42a3-b033-b504711934da"
      unitRef="usd">35063000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjktMy0xLTEtMTEyMjkx_0358ed67-d452-4d84-aef6-070833d84020"
      unitRef="usd">29688000</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzAtMS0xLTEtMTEyMjkx_ff4b9ad0-704b-4240-8432-553c9c4e694e"
      unitRef="usd">5527000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzAtMy0xLTEtMTEyMjkx_15d626ce-74fa-4454-86b8-9b4572ac66f0"
      unitRef="usd">6200000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzItMS0xLTEtMTEyMjkx_473205f3-2de9-42f7-8af9-3afaa76951e1"
      unitRef="usd">462177000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzItMy0xLTEtMTEyMjkx_6471ee0c-00a4-42c7-ba9d-ec57d5196909"
      unitRef="usd">494559000</us-gaap:LiabilitiesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzQtMS0xLTEtMTEyMjkx_2f012091-a90f-4f7e-91c4-619e662d923f"
      unitRef="usd">24905000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzQtMy0xLTEtMTEyMjkx_4da36b68-c1fc-494d-820b-9fb637b9022a"
      unitRef="usd">25572000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzUtMS0xLTEtMTEyMjkx_83099930-2f04-41d1-aa43-9c978ca9a3dd"
      unitRef="usd">1612196000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzUtMy0xLTEtMTEyMjkx_51c484db-ce1a-4cb3-abe8-d3f215b4770a"
      unitRef="usd">1623675000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzYtMS0xLTEtMTEyMjkx_53f462fd-f5ba-4a78-a2a1-8f6f606f7134"
      unitRef="usd">114227000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzYtMy0xLTEtMTEyMjkx_3804cf2f-b8ca-49e5-9aa8-e8ee14773d44"
      unitRef="usd">114104000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzctMS0xLTEtMTEyMjkx_b8a108f0-4a2f-4d97-b1d2-a8fe4360bd2f"
      unitRef="usd">114594000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzctMy0xLTEtMTEyMjkx_324fc7b1-d4a4-45c7-8174-045af2b5112b"
      unitRef="usd">126007000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzgtMS0xLTEtMTEyMjkx_2d466a83-8271-4384-83d4-36416465ca69"
      unitRef="usd">42134000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzgtMy0xLTEtMTEyMjkx_debccfde-4123-4698-b79f-854066c2b056"
      unitRef="usd">41796000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzktMS0xLTEtMTEyMjkx_291681df-3547-4474-94e6-ef19c2f63f15"
      unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzktMy0xLTEtMTEyMjkx_4a1282af-9c82-4f9b-89f2-ff2e628b50ae"
      unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMC0xLTEtMTEyMjkxL3RleHRyZWdpb246NWM1NTFhNTQ2MDBlNDRjYmEzNzQzYjk3OWE3M2JhYTBfMzM_3ac2993e-a200-47a5-bfb6-e08d384a9fd6"
      unitRef="usdPerShare">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMC0xLTEtMTEyMjkxL3RleHRyZWdpb246NWM1NTFhNTQ2MDBlNDRjYmEzNzQzYjk3OWE3M2JhYTBfNjA_862a0f5f-53b7-4a63-9384-e88b270e3f3b"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMC0xLTEtMTEyMjkxL3RleHRyZWdpb246NWM1NTFhNTQ2MDBlNDRjYmEzNzQzYjk3OWE3M2JhYTBfOTY_31348818-0e12-48f7-8550-bfd51ce3a835"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMC0xLTEtMTEyMjkxL3RleHRyZWdpb246NWM1NTFhNTQ2MDBlNDRjYmEzNzQzYjk3OWE3M2JhYTBfOTY_e4f13a58-36ad-4616-be0a-86fb9bf5dfaf"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMC0xLTEtMTEyMjkxL3RleHRyZWdpb246NWM1NTFhNTQ2MDBlNDRjYmEzNzQzYjk3OWE3M2JhYTBfOTY_f39772f4-c226-4e8c-af4d-92b695ca60d8"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMC0xLTEtMTEyMjkxL3RleHRyZWdpb246NWM1NTFhNTQ2MDBlNDRjYmEzNzQzYjk3OWE3M2JhYTBfOTY_f8119b68-123f-4918-a141-33a9a4815083"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMS0xLTEtMTEyMjkx_3e49cc8a-2ac0-47ac-99ca-0d3d903516ff"
      unitRef="usd">0</us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue>
    <us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMy0xLTEtMTEyMjkx_fc1bc812-1b18-4fb7-bf12-d0b72275a81e"
      unitRef="usd">0</us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMC0xLTEtMTEyMjkxL3RleHRyZWdpb246YTA5MDkxODdmYTFhNGQ2MmI5MWQxY2IwZTQxMjZhYzNfMTk_e78b0a82-43d8-4279-81b1-229a047c7067"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMC0xLTEtMTEyMjkxL3RleHRyZWdpb246YTA5MDkxODdmYTFhNGQ2MmI5MWQxY2IwZTQxMjZhYzNfNDY_f7d0b1d5-59a7-478d-b1e0-1bf4b0ffcdcc"
      unitRef="shares">80000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMC0xLTEtMTEyMjkxL3RleHRyZWdpb246YTA5MDkxODdmYTFhNGQ2MmI5MWQxY2IwZTQxMjZhYzNfNjY_36f29b65-c195-4b8c-81fc-03712d95882a"
      unitRef="shares">24114000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMC0xLTEtMTEyMjkxL3RleHRyZWdpb246YTA5MDkxODdmYTFhNGQ2MmI5MWQxY2IwZTQxMjZhYzNfODY_1f83e968-acc6-4e90-a148-b59f2d7bd099"
      unitRef="shares">23995000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMC0xLTEtMTEyMjkxL3RleHRyZWdpb246YTA5MDkxODdmYTFhNGQ2MmI5MWQxY2IwZTQxMjZhYzNfMTIx_41b32b1f-8ab4-44b7-9ffe-830574fc2542"
      unitRef="shares">24064000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMC0xLTEtMTEyMjkxL3RleHRyZWdpb246YTA5MDkxODdmYTFhNGQ2MmI5MWQxY2IwZTQxMjZhYzNfMTQx_36e3de95-7714-4623-b23b-e9f62182ccfa"
      unitRef="shares">23993000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMS0xLTEtMTEyMjkx_c81567b8-ccba-4c42-938e-a7988607d681"
      unitRef="usd">2411000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMy0xLTEtMTEyMjkx_35b338bd-0580-44c2-9fe3-deae3f5f796b"
      unitRef="usd">2399000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDMtMS0xLTEtMTEyMjkx_8fdbb92f-6a89-442b-baae-1e15f6b5e4d9"
      unitRef="usd">1339908000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDMtMy0xLTEtMTEyMjkx_75047be6-0dd1-47ed-9798-da330c8b02bf"
      unitRef="usd">1331249000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:TreasuryStockShares
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDQtMC0xLTEtMTEyMjkxL3RleHRyZWdpb246NWE0ZjUwY2UwMjVjNDkxYjllNjFjODM1MWZmNDkzNjJfMjk_b0d2dc7e-35cc-4ad3-92a2-b3c6ff630af1"
      unitRef="shares">50374</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDQtMC0xLTEtMTEyMjkxL3RleHRyZWdpb246NWE0ZjUwY2UwMjVjNDkxYjllNjFjODM1MWZmNDkzNjJfMzY_318d06a2-38ff-496a-b94c-11787c8d8229"
      unitRef="shares">1633</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDQtMS0xLTEtMTEyMjkx_f3587eac-ab6a-4257-a9ba-1082dabc3dc3"
      unitRef="usd">8006000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDQtMy0xLTEtMTEyMjkx_d6fa66ab-3258-4c34-a51f-118afd81ca95"
      unitRef="usd">243000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDUtMS0xLTEtMTEyMjkx_af68e64e-482a-4e30-ad1d-e23634e4ff7c"
      unitRef="usd">827689000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDUtMy0xLTEtMTEyMjkx_dded447b-f585-4c32-9b07-42383de17643"
      unitRef="usd">837501000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDYtMS0xLTEtMTEyMjkx_cd643b7f-9db0-4d1d-b266-f353dda0f7fe"
      unitRef="usd">-61603000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDYtMy0xLTEtMTEyMjkx_b11da195-db32-4106-b8f6-91d7659faf25"
      unitRef="usd">-80978000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDctMS0xLTEtMTEyMjkx_74788469-b7b8-4448-a944-3abe4c715e2a"
      unitRef="usd">2100399000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDctMy0xLTEtMTEyMjkx_01fae28f-4563-4565-bfe8-b29d7a556285"
      unitRef="usd">2089928000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDgtMS0xLTEtMTEyMjkx_ba9907eb-5c96-4213-90a6-9d788402b444"
      unitRef="usd">4470632000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDgtMy0xLTEtMTEyMjkx_d6e2a135-c2fa-450f-a554-f6e3457190e7"
      unitRef="usd">4515641000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMi0xLTEtMS0xMTIyOTE_dd7f000a-99bf-4f4a-8bc9-865c3b88a5b7"
      unitRef="usd">568649000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMi0zLTEtMS0xMTIyOTE_0ff78064-84f5-4f89-bc9c-ba859f22a1ac"
      unitRef="usd">543122000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMy0xLTEtMS0xMTIyOTE_d630ddab-648f-4692-b1b9-a83e22e7f333"
      unitRef="usd">376608000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMy0zLTEtMS0xMTIyOTE_a0f11336-e1da-4cbc-a192-7452389cb5fd"
      unitRef="usd">374295000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfNC0xLTEtMS0xMTIyOTE_e96b950a-8ef6-481a-925c-2b6968f5feef"
      unitRef="usd">192041000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfNC0zLTEtMS0xMTIyOTE_77ec4db2-c390-4b89-b370-79d0ccb14782"
      unitRef="usd">168827000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfNi0xLTEtMS0xMTIyOTE_85316666-446e-4614-9222-e5ecf114cb13"
      unitRef="usd">152572000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfNi0zLTEtMS0xMTIyOTE_8eb2b90f-e945-4e07-81e1-8f12c3fbc933"
      unitRef="usd">153212000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfNy0xLTEtMS0xMTIyOTE_6dbe2613-1134-4c82-abed-20c633780d9d"
      unitRef="usd">19761000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfNy0zLTEtMS0xMTIyOTE_c6c82eeb-053d-4efc-a9a0-0f2a152ca9a8"
      unitRef="usd">23871000</us-gaap:ResearchAndDevelopmentExpense>
    <icui:Restructuringandstrategictransaction
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfOC0xLTEtMS0xMTIyOTE_f01fc735-66ae-46f0-9109-c8a6b7d0fa45"
      unitRef="usd">11013000</icui:Restructuringandstrategictransaction>
    <icui:Restructuringandstrategictransaction
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfOC0zLTEtMS0xMTIyOTE_795c9e60-06ef-4fac-90d4-d9e6dd8408df"
      unitRef="usd">33905000</icui:Restructuringandstrategictransaction>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfOS0xLTEtMS0xMTIyOTE_254baedf-4bf7-4ca8-9ae7-50b5057bf054"
      unitRef="usd">-700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfOS0zLTEtMS0xMTIyOTE_6a0893aa-a6f0-49a1-845e-aa5de24f4a7c"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OperatingExpenses
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTEtMS0xLTEtMTEyMjkx_e806a3d5-a4ce-4205-a912-b9bb7e15ce55"
      unitRef="usd">182646000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTEtMy0xLTEtMTEyMjkx_03758d19-7e0d-4baa-9527-0680a56bcb0b"
      unitRef="usd">210988000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTItMS0xLTEtMTEyMjkx_842529a2-c826-484d-bd7e-61c8a20cd149"
      unitRef="usd">9395000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTItMy0xLTEtMTEyMjkx_74929eb6-d8f6-4ae3-81f1-26c30ccc95be"
      unitRef="usd">-42161000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTQtMS0xLTEtMTEyMjkx_67365c1b-0884-4fce-8492-61dc828682ec"
      unitRef="usd">22515000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTQtMy0xLTEtMTEyMjkx_c5ea7971-58e8-4602-b211-6d6c909ed80f"
      unitRef="usd">13055000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTUtMS0xLTEtMTEyMjkx_6e9fd739-7195-44f4-8979-990e2b2b725f"
      unitRef="usd">-269000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTUtMy0xLTEtMTEyMjkx_fb5987b1-b358-44c5-a36c-2b39398b71c6"
      unitRef="usd">415000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTYtMS0xLTEtMTEyMjkx_a5767825-2d7b-468a-ba0a-74fe681af2cc"
      unitRef="usd">-13389000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTYtMy0xLTEtMTEyMjkx_0baf675d-3d63-4838-af6d-2958dd9936bd"
      unitRef="usd">-54801000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTctMS0xLTEtMTEyMjkx_8f0086fe-10a9-43d2-affc-827a02fd4314"
      unitRef="usd">-3577000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTctMy0xLTEtMTEyMjkx_c6f326e7-a94c-45ae-8143-27083b293cd2"
      unitRef="usd">-16733000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTgtMS0xLTEtMTEyMjkx_2abfca0e-a125-4853-b8d0-c2a760139d66"
      unitRef="usd">-9812000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMTgtMy0xLTEtMTEyMjkx_9d4d3106-a20c-4875-a285-0bcb14655000"
      unitRef="usd">-38068000</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMjAtMS0xLTEtMTEyMjkx_9a7b3877-e10a-4d39-93d3-33bda71aba10"
      unitRef="usdPerShare">-0.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMjAtMy0xLTEtMTEyMjkx_37e50950-f578-44bf-b639-b3af140353b0"
      unitRef="usdPerShare">-1.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMjEtMS0xLTEtMTEyMjkx_70f31aa3-322a-4093-9d33-b9ecd4cc012b"
      unitRef="usdPerShare">-0.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMjEtMy0xLTEtMTEyMjkx_ca2fda44-52d8-44f5-a167-dd38e9a03f4b"
      unitRef="usdPerShare">-1.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMjMtMS0xLTEtMTEyMjkx_953a4ee0-6c05-4536-9a36-585f6fed5d46"
      unitRef="shares">24014000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMjMtMy0xLTEtMTEyMjkx_40bdc8d8-215d-45c8-ac25-b0cd5d208281"
      unitRef="shares">23646000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMjQtMS0xLTEtMTEyMjkx_3ef814a0-902f-4462-be25-4bec5fef27d2"
      unitRef="shares">24014000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xOS9mcmFnOjA5MzkzNTAyMWQzMDQ5MjU5YzcwZWNkNDUwZjRkZjM3L3RhYmxlOjA2ODFiOWQyZDBiMDQ2NDNhMGYxYzU1ZWI0ODQwODA4L3RhYmxlcmFuZ2U6MDY4MWI5ZDJkMGIwNDY0M2EwZjFjNTVlYjQ4NDA4MDhfMjQtMy0xLTEtMTEyMjkx_007b1072-5343-4150-997c-531f245ffaa2"
      unitRef="shares">23646000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfMi0xLTEtMS0xMTIyOTE_393701f2-7f9c-4152-86db-ac0271562008"
      unitRef="usd">-9812000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfMi0zLTEtMS0xMTIyOTE_701093ac-10a9-43e3-a5fb-d2686ae496fd"
      unitRef="usd">-38068000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNC0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjozNGUwZjQ2MWYxMmE0OGE2YjliODcyYzA5YWQwYTMzMV80Nw_cf83eb64-f8f7-499c-bd31-bdd013482a3e"
      unitRef="usd">1744000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNC0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjozNGUwZjQ2MWYxMmE0OGE2YjliODcyYzA5YWQwYTMzMV81NA_5979fd18-f1b1-4c4a-9a50-06b3ea77b00b"
      unitRef="usd">-7312000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNC0xLTEtMS0xMTIyOTE_7f5d8b6d-820a-4e6c-8c27-103bb2283ef2"
      unitRef="usd">-5577000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNC0zLTEtMS0xMTIyOTE_f3f4848c-be29-4239-908f-431a82c9039e"
      unitRef="usd">23572000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNS0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjo2MjAxM2I5Mzg1NzI0NjU4ODRkODZhNGJiZWY4YmE2ZF81OQ_1a9d3f83-11c3-40e0-87be-9043c5154ed0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNS0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjo2MjAxM2I5Mzg1NzI0NjU4ODRkODZhNGJiZWY4YmE2ZF81OQ_3b75eadc-1153-42ed-938b-0cd7e775485a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNS0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjo2MjAxM2I5Mzg1NzI0NjU4ODRkODZhNGJiZWY4YmE2ZF81OQ_5e9cca33-7884-4efd-a7e1-8b96f8740be4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNS0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjo2MjAxM2I5Mzg1NzI0NjU4ODRkODZhNGJiZWY4YmE2ZF81OQ_bd27325f-fc1f-4460-ae76-5a47c0fc0283"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNS0xLTEtMS0xMTIyOTE_2768fa25-131b-4172-ad72-cb0a4936e684"
      unitRef="usd">24983000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNS0zLTEtMS0xMTIyOTE_014ec6c3-31e9-4b0c-b06c-ba94edc7173b"
      unitRef="usd">-4946000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNi0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjo1MmQyYzM0YzhjN2M0ZDRlYjI2OTY4Y2M0ZWY0MzNhMF8zNw_01ae756c-4053-47db-bbfd-9a914fb69875"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNi0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjo1MmQyYzM0YzhjN2M0ZDRlYjI2OTY4Y2M0ZWY0MzNhMF8zNw_70a13ec6-233f-41fc-b926-d1e14459437e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNi0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjo1MmQyYzM0YzhjN2M0ZDRlYjI2OTY4Y2M0ZWY0MzNhMF8zNw_769abbb1-4834-4fc0-bed9-a9a1ff517655"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNi0wLTEtMS0xMTIyOTEvdGV4dHJlZ2lvbjo1MmQyYzM0YzhjN2M0ZDRlYjI2OTY4Y2M0ZWY0MzNhMF8zNw_95c8cbf0-9f94-4719-af61-860e7853f684"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNi0xLTEtMS0xMTIyOTE_7898d8fc-b888-4e1c-a132-d8d38fe3d0a6"
      unitRef="usd">31000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNi0zLTEtMS0xMTIyOTE_cd57c7fb-187f-438b-ae6b-92cd64e41b56"
      unitRef="usd">-15000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNy0xLTEtMS0xMTIyOTE_2e85cf6f-dffa-4966-b35a-36b31c94b4d6"
      unitRef="usd">19375000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfNy0zLTEtMS0xMTIyOTE_c29f5367-c149-4d9a-b293-6650ce53fb6b"
      unitRef="usd">18641000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfOC0xLTEtMS0xMTIyOTE_e531424e-9431-4f50-a0d0-837be5cf5a91"
      unitRef="usd">9563000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yMi9mcmFnOjNkNDg1NjJmMTcxZjRiNWFhZjMzY2E4MzY1OTJkYjk1L3RhYmxlOjI0ZTQ4OTAyYmY2NjQwMDg4YTUyYjQ1MDM5NTRhZDU2L3RhYmxlcmFuZ2U6MjRlNDg5MDJiZjY2NDAwODhhNTJiNDUwMzk1NGFkNTZfOC0zLTEtMS0xMTIyOTE_cf522752-259c-41fd-9a9f-7824e5bbc7cc"
      unitRef="usd">-19427000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i07f6b061c66845509e4e6c7ff5cbe7bc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMi0yLTEtMS0xMTIyOTE_2441adc2-293d-4387-b1c8-1cd656e4de0d"
      unitRef="shares">23995000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i5638b072e2c74cecb680e1eeeb816a7f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMi00LTEtMS0xMTIyOTE_ee9c0602-5abe-40d4-bf26-966cdbe6b3dc"
      unitRef="usd">2399000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic36e92a4a4e041d789fd1e15a96fb89d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMi02LTEtMS0xMTIyOTE_a1cd0e5d-11f8-4a5c-b516-44eb5a1e592d"
      unitRef="usd">1331249000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5f732bf16f8943de8310b4900638904c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMi04LTEtMS0xMTIyOTE_6543a881-13b4-4135-839e-4e3394b51cb1"
      unitRef="usd">-243000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i905ef664618549b79a2604ba36989fa1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMi0xMC0xLTEtMTEyMjkx_849a1dde-0d95-4e58-a823-4b119dc831e1"
      unitRef="usd">837501000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2876aa14e8a049c888a7c1a7d0b9add5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMi0xMi0xLTEtMTEyMjkx_5f5292a4-0c5c-49f0-9b9a-ec29108fd7a5"
      unitRef="usd">-80978000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMi0xNC0xLTEtMTEyMjkx_771e18e5-b6ab-44eb-81a6-39f93a0129fb"
      unitRef="usd">2089928000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i0f675125f08545ed853c555497efd555_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMy0yLTEtMS0xMTIyOTE_66b01a08-a5b7-4cdf-9df7-dcba5f76b0f5"
      unitRef="shares">172000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i157787461be54c729a371db9e5f0b870_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMy00LTEtMS0xMTIyOTE_8e05e36b-94b7-4f32-8cab-c26b90d6c290"
      unitRef="usd">12000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i553e7d37da95492bb56ab18d405def24_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMy02LTEtMS0xMTIyOTE_996605a0-ea91-4bb8-87a3-bfefcf96543e"
      unitRef="usd">-503000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i076bb8ec7f8a4200aaa3d2d05b180bb7_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMy04LTEtMS0xMTIyOTE_6d6fdb23-8feb-414a-8eef-cc25f810e979"
      unitRef="usd">662000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfMy0xNC0xLTEtMTEyMjkx_c55c5ee1-4c3f-481e-8598-ed415b611b6b"
      unitRef="usd">171000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i0f675125f08545ed853c555497efd555_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfNC0yLTEtMS0xMTIyOTE_8f8f4e55-5ee3-4d5b-91d0-c6def46bf195"
      unitRef="shares">53000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i076bb8ec7f8a4200aaa3d2d05b180bb7_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfNC04LTEtMS0xMTIyOTE_6aa3cd74-0b38-478d-a525-30bffef7c1f6"
      unitRef="usd">8425000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfNC0xNC0xLTEtMTEyMjkx_dc1a3c89-71a3-47bf-afd5-2e060ddd90d3"
      unitRef="usd">8425000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i553e7d37da95492bb56ab18d405def24_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfNi02LTEtMS0xMTIyOTE_b2d30d48-c906-4f6f-b925-5e0cf859d7b7"
      unitRef="usd">9158000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfNi0xNC0xLTEtMTEyMjkx_9d948159-77a7-44b4-883a-14fc4135c4a9"
      unitRef="usd">9158000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i553e7d37da95492bb56ab18d405def24_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfNy02LTEtMS0xMjA3ODY_9393a496-4e32-4f7f-871e-cd3394bd4873"
      unitRef="usd">4000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i92f1bb64c23547f8be008ab8d3bb642a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfNy0xMi0xLTEtMTEyMjkx_aad307bb-f0e5-43ed-b6f7-d9a070021038"
      unitRef="usd">19375000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfNy0xNC0xLTEtMTEyMjkx_67d59a06-3a3a-4f65-a137-d81e776971cc"
      unitRef="usd">19379000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i85d17593813847138c47bd6a52b84d0d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOC0xMC0xLTEtMTEyMjkx_509abf3d-6443-47d9-9083-2d8027016862"
      unitRef="usd">-9812000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOC0xNC0xLTEtMTEyMjkx_537cd16f-d91c-4285-9b83-0ee775380aac"
      unitRef="usd">-9812000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i54b39f23877a4f0d862e5916dd5e87c8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOS0yLTEtMS0xMTIyOTE_3855a152-a496-440c-aed8-8025808efe97"
      unitRef="shares">24114000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i59687ae95c8c4f548a9c5ed00de7213f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOS00LTEtMS0xMTIyOTE_e7f485e3-7e85-40c4-b6e9-895202fba196"
      unitRef="usd">2411000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieccf8d651a8d422e91523860913a0c81_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOS02LTEtMS0xMTIyOTE_3b048bb7-8f39-428c-8ebe-8806cd22cb88"
      unitRef="usd">1339908000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id319fa0bb715447db5d21adda1569f95_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOS04LTEtMS0xMTIyOTE_70e9c40e-9d53-4604-8cb6-b60f16eaa874"
      unitRef="usd">-8006000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8121720b12924aeaa2d7f2161161fdc6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOS0xMC0xLTEtMTEyMjkx_0ffd339b-5f41-487a-aaa8-6239c10b2705"
      unitRef="usd">827689000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8e09221885284788959b95412b6214f4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOS0xMi0xLTEtMTEyMjkx_5b9a6b15-4e2e-48f0-bbca-7975e1f39dcb"
      unitRef="usd">-61603000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjA1ZjViYmYwMWQzNzRlOGU4M2MxOGNmNjk5YmYxMWEzL3RhYmxlcmFuZ2U6MDVmNWJiZjAxZDM3NGU4ZTgzYzE4Y2Y2OTliZjExYTNfOS0xNC0xLTEtMTEyMjkx_75852e00-21bb-45a0-898a-387e7a807208"
      unitRef="usd">2100399000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i10ebf268d4574d988d0c464474155fe0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMi0yLTEtMS0xMTIyOTE_59e110a8-aa66-49e1-ad92-0441731cfad1"
      unitRef="shares">21280000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i097914f4b8e14986872f2b29ed1ef69e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMi00LTEtMS0xMTIyOTE_6e6e8d2d-cd65-4942-8679-3a1611812c4f"
      unitRef="usd">2128000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie149bde323634e0093914839ee8ac148_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMi02LTEtMS0xMTIyOTE_8e01e30b-527a-4f1e-9382-ab00b906d631"
      unitRef="usd">721412000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5bc26a59bd7142798a8bbabd7a8aebf6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMi04LTEtMS0xMTIyOTE_4493da52-0e3b-44bb-9c1d-24cfe2256ee4"
      unitRef="usd">-27000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic079464d6d0c45109f1b5fdae21f379e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMi0xMC0xLTEtMTEyMjkx_afa6e231-fd00-4e86-893d-3578e98ed808"
      unitRef="usd">911787000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i720c98b0bc6c4647b5ec2b08163c165c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMi0xMi0xLTEtMTEyMjkx_358f2ac9-1784-469e-86db-eea3ddc396f9"
      unitRef="usd">-19269000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9fd0c26c71db4e4cb0b929a7689fb683_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMi0xNC0xLTEtMTEyMjkx_3b017bb7-6a1e-415e-a1ab-c0c1224f2b1a"
      unitRef="usd">1616031000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i864f233d9281416ea0ce16b7edf44f57_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMy0yLTEtMS0xMTIyOTE_1a7212a7-0a22-48ee-8708-70e21f089a99"
      unitRef="shares">154000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i6c0c21e62a5645398a5ae491f1716ab4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMy00LTEtMS0xMTIyOTE_14c4c2a0-8407-4bb3-bd26-80615657ce2a"
      unitRef="usd">12000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i39df97d162224e7ead2e7587ce51c1c5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMy02LTEtMS0xMTIyOTE_f2059827-cce7-4f09-adda-f34b8936a425"
      unitRef="usd">-2965000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ica718d655f94421fb3eeafd5ac5288be_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMy04LTEtMS0xMTIyOTE_4e67328c-5745-4f20-923d-ebea6d75ea26"
      unitRef="usd">5927000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfMy0xNC0xLTEtMTEyMjkx_1433ccf6-4a3b-43ab-b17f-7d33466bed1b"
      unitRef="usd">2974000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i864f233d9281416ea0ce16b7edf44f57_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNC0yLTEtMS0xMTIyOTE_c2a03016-a00c-4cc3-b25e-5faaf67062d7"
      unitRef="shares">37000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ica718d655f94421fb3eeafd5ac5288be_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNC04LTEtMS0xMTIyOTE_09873203-6291-4992-b52a-aa966463b349"
      unitRef="usd">8743000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNC0xNC0xLTEtMTEyMjkx_935c00f0-3991-466b-be9b-bbca13969eaf"
      unitRef="usd">8743000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNS0yLTEtMS0xMjA3OTM_5cc83d55-bd3b-455f-a4f8-224e3947d6d2"
      unitRef="shares">2500000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i6c0c21e62a5645398a5ae491f1716ab4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNS00LTEtMS0xMjA3OTY_21d0036b-75b8-4c05-8360-8ce26e6b112b"
      unitRef="usd">250000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i39df97d162224e7ead2e7587ce51c1c5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNS02LTEtMS0xMjA4MDA_18ee23dd-8bdb-42b8-b9bf-c35c175934ac"
      unitRef="usd">575725000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNS0xNC0xLTEtMTIwODAz_daf39d7e-e15a-438c-a5c3-95f73d0c6881"
      unitRef="usd">575975000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i39df97d162224e7ead2e7587ce51c1c5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNS02LTEtMS0xMTIyOTE_f895a3f0-1c60-4d8e-9afb-d2989a05b45d"
      unitRef="usd">12092000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNS0xNC0xLTEtMTEyMjkx_587c69ce-2f21-4d9c-8bf9-e4bacc1ea92c"
      unitRef="usd">12092000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4b0ee62d61be45c0aee4a548c96a0697_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNi0xMi0xLTEtMTEyMjkx_9a91a8b1-51c6-467f-b5d5-612d79ed6742"
      unitRef="usd">18641000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNi0xNC0xLTEtMTEyMjkx_ced6ba49-2239-4328-b3b8-c7f7bbcfb97a"
      unitRef="usd">18641000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i7f9b480e0479472aab56012880bdecd6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNy0xMC0xLTEtMTEyMjkx_7e8b77ac-f4a5-4303-bf74-b33b5cea6885"
      unitRef="usd">-38068000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfNy0xNC0xLTEtMTEyMjkx_a5fa03c5-c596-49b5-9a1f-b003e72e1ef2"
      unitRef="usd">-38068000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7a406cdd295d4bae87e1e8ec6e5620dc_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfOC0yLTEtMS0xMTIyOTE_c52360fc-7a07-49bc-a2ca-bbb49f9b63ce"
      unitRef="shares">23897000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i9a153016e3f444b4a7339a82e88bc93e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfOC00LTEtMS0xMTIyOTE_49f5c952-0825-4c2f-9645-3542146d05e3"
      unitRef="usd">2390000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i966e762ecf634e718045d1a26327c012_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfOC02LTEtMS0xMTIyOTE_c8850a5f-e6c8-4958-83fa-25f9eb6f37ae"
      unitRef="usd">1306264000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i135dbadf645845ba84e91cb70245f896_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfOC04LTEtMS0xMTIyOTE_cb99768a-c05d-4cee-b565-36afc8174429"
      unitRef="usd">-2843000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9b4d6b0874b84330ab118d8d72f89852_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfOC0xMC0xLTEtMTEyMjkx_fb842368-10d0-4efa-a0ee-5c0ffcf699b4"
      unitRef="usd">873719000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1adc8956afab4a2c82b48740ffa3c5f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfOC0xMi0xLTEtMTEyMjkx_5497addd-a581-464d-b33a-dbdf02ff5013"
      unitRef="usd">-628000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i57ae4b72e9574e4ebf63f3473590fe05_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yNS9mcmFnOjM4MjlmMjFkY2UwZDQ4MWNhNzgwMjQ4YmJmYzZmZmQzL3RhYmxlOjgwNzE2OGQ2YTk1ZjQ5ZTA5MjgyNGI3NDQ2ODhiZDg1L3RhYmxlcmFuZ2U6ODA3MTY4ZDZhOTVmNDllMDkyODI0Yjc0NDY4OGJkODVfOC0xNC0xLTEtMTEyMjkx_f7b6ac1c-31f5-41b9-be90-5a64033a276b"
      unitRef="usd">2178902000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMy0xLTEtMS0xMTIyOTE_4ffbaa88-9756-476f-95df-9735d231b3a7"
      unitRef="usd">-9812000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMy0zLTEtMS0xMTIyOTE_bd4ea782-375f-4ce3-b340-a362ff83e874"
      unitRef="usd">-38068000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNS0xLTEtMS0xMTIyOTE_03b9fccf-fda5-44f0-8b34-fdbdfe33ec53"
      unitRef="usd">55744000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNS0zLTEtMS0xMTIyOTE_b550fc00-76a3-4da1-867e-37b756ef6055"
      unitRef="usd">53138000</us-gaap:DepreciationDepletionAndAmortization>
    <icui:AmortizationOfInventoryStepUp
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNi0xLTEtMS0xMTIyOTE_a05fb4ae-8ffe-4922-a2d4-8e9fc085dbb2"
      unitRef="usd">0</icui:AmortizationOfInventoryStepUp>
    <icui:AmortizationOfInventoryStepUp
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNi0zLTEtMS0xMTIyOTE_7c46112d-253c-4ecf-8ef0-c345001608b6"
      unitRef="usd">14370000</icui:AmortizationOfInventoryStepUp>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNy0xLTEtMS0xMTIyOTE_1803e7cc-82e7-4287-bb41-608b70b53c1a"
      unitRef="usd">5656000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNy0zLTEtMS0xMTIyOTE_485b4c2e-cbd7-47b5-a3cf-45d2d2922e4c"
      unitRef="usd">5286000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfOC0xLTEtMS0xMTIyOTE_1f48df1b-b9bd-4e1d-b870-2b3811ec89be"
      unitRef="usd">666000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfOC0zLTEtMS0xMTIyOTE_39f9ca5d-bcc6-4ab6-a08a-8d7d6894cbe2"
      unitRef="usd">-548000</us-gaap:ProvisionForDoubtfulAccounts>
    <icui:ProvisionForWarrantyAndReturns
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfOS0xLTEtMS0xMTIyOTE_17a29aa0-a76f-4cd7-81d6-2db45b8175a3"
      unitRef="usd">3951000</icui:ProvisionForWarrantyAndReturns>
    <icui:ProvisionForWarrantyAndReturns
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfOS0zLTEtMS0xMTIyOTE_bc01b11c-d4bc-4537-a75e-aebbeef97c72"
      unitRef="usd">726000</icui:ProvisionForWarrantyAndReturns>
    <us-gaap:ShareBasedCompensation
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTAtMS0xLTEtMTEyMjkx_c4e553cf-902f-40aa-af1e-9aebfe71647a"
      unitRef="usd">9158000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTAtMy0xLTEtMTEyMjkx_15d195e4-19b7-4c18-a2c2-e0bc6f74d377"
      unitRef="usd">12092000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTEtMS0xLTEtMTEyMjkx_a123253b-d2e6-449e-ad26-5bb35fcacdeb"
      unitRef="usd">-367000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTEtMy0xLTEtMTEyMjkx_b7df588c-6ce0-4566-a0c2-1e130c02ffb6"
      unitRef="usd">-596000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:InvestmentIncomeAmortizationOfPremium
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTItMS0xLTEtMTEyMjkx_52ab6f1d-734c-40df-9d85-fdca2d5e3cd1"
      unitRef="usd">5000</us-gaap:InvestmentIncomeAmortizationOfPremium>
    <us-gaap:InvestmentIncomeAmortizationOfPremium
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTItMy0xLTEtMTEyMjkx_27ed57d5-5ec4-4c08-b810-52824108030c"
      unitRef="usd">130000</us-gaap:InvestmentIncomeAmortizationOfPremium>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTMtMS0xLTEtMTEyMjkx_593a0ddb-da61-4040-b774-dc8743a54cbd"
      unitRef="usd">1701000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTMtMy0xLTEtMTEyMjkx_5be56901-d027-4566-8c1b-e318f8fd2608"
      unitRef="usd">1643000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTQtMS0xLTEtMTEyMjkx_2b277a38-7c7b-45a4-b9d5-134b0d058827"
      unitRef="usd">-700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTQtMy0xLTEtMTEyMjkx_65af5d23-ebbd-4a4d-9e1a-5297835d56ca"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <icui:Sparepartsusage
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTYtMS0xLTEtMTEyMjkx_128a6ca1-6ff2-46c2-852f-348688e48b51"
      unitRef="usd">4384000</icui:Sparepartsusage>
    <icui:Sparepartsusage
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTYtMy0xLTEtMTEyMjkx_dfc6b940-98d8-4016-9a6d-8a5784e04e9e"
      unitRef="usd">2223000</icui:Sparepartsusage>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTctMS0xLTEtMTEyMjkx_436271cc-3c83-4860-a8f7-6042dfd7bde6"
      unitRef="usd">40000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTctMy0xLTEtMTEyMjkx_8a95ff3c-4785-49e9-92ef-a4c60bb366cc"
      unitRef="usd">1649000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTktMS0xLTEtMTEyMjkx_76565d0c-66cb-4914-8ed9-9c786536f598"
      unitRef="usd">-82028000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMTktMy0xLTEtMTEyMjkx_3cb7cb8f-b491-48c7-b726-6cec61ff11b6"
      unitRef="usd">-22489000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjAtMS0xLTEtMTEyMjkx_36260575-4c27-4302-90f1-33b5cc14197e"
      unitRef="usd">49370000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjAtMy0xLTEtMTEyMjkx_9b57f6b6-32db-408f-8906-bfb46f33f984"
      unitRef="usd">36170000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjEtMS0xLTEtMTEyMjkx_8bcb929d-2c8c-48ba-aef9-309117541955"
      unitRef="usd">-1907000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjEtMy0xLTEtMTEyMjkx_bcd1465c-7000-404c-bd87-5e9ee039b7a6"
      unitRef="usd">-2607000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjItMS0xLTEtMTEyMjkx_7d8ba295-2599-488a-8569-1ff1cce9fef3"
      unitRef="usd">6448000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjItMy0xLTEtMTEyMjkx_8fab9ef8-ac17-43f4-8b00-4895c377c83d"
      unitRef="usd">14371000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjMtMS0xLTEtMTEyMjkx_08012a10-b1ab-46fe-95e3-852a2e4c9551"
      unitRef="usd">-27525000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjMtMy0xLTEtMTEyMjkx_acbab4e1-e438-479b-8942-638efdd35058"
      unitRef="usd">19504000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjQtMS0xLTEtMTEyMjkx_514628a0-ae00-476a-8906-6bb6796b6b4d"
      unitRef="usd">-21099000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjQtMy0xLTEtMTEyMjkx_1c7fe842-1bc0-457b-8565-5904f375328a"
      unitRef="usd">-19238000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjUtMS0xLTEtMTEyMjkx_3cf039dd-ee86-4026-b8f0-1566b6a65bf7"
      unitRef="usd">-9328000</icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes>
    <icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjUtMy0xLTEtMTEyMjkx_3faa60f2-91a2-4f3c-b216-2fe0f6b01e46"
      unitRef="usd">-26102000</icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjYtMS0xLTEtMTEyMjkx_034a82b1-af89-46f0-81dd-76bdabcfb290"
      unitRef="usd">41245000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjYtMy0xLTEtMTEyMjkx_5097f8cd-3e8a-4e61-87bc-691a5472d0b1"
      unitRef="usd">-1342000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjgtMS0xLTEtMTEyMjkx_129d9081-4f66-4370-86eb-1105e459e38d"
      unitRef="usd">14205000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjgtMy0xLTEtMTEyMjkx_87665c4e-45ff-446a-b5fa-5820fef782bd"
      unitRef="usd">23606000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjktMS0xLTEtMTEyMjkx_bfbd3a95-6556-4773-a4b1-a15e82c45a67"
      unitRef="usd">54000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMjktMy0xLTEtMTEyMjkx_54a49228-9b02-43a5-ac3d-e1aa8e6db1da"
      unitRef="usd">900000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzAtMS0xLTEtMTEyMjkx_1078f6a9-ca28-44d1-a95f-6d68bd893d37"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzAtMy0xLTEtMTEyMjkx_6cc2c95c-35f2-4c37-b86d-44712ba9d679"
      unitRef="usd">1844164000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzEtMS0xLTEtMTEyMjkx_bf2b6a68-f41c-4877-aefc-e94b02afc9ad"
      unitRef="usd">2532000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzEtMy0xLTEtMTEyMjkx_4ffceaf0-28ab-4ac5-a7b1-dec39549e3fa"
      unitRef="usd">2387000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzMtMS0xLTEtMTEyMjkx_557d5851-09dc-4cc0-b27a-88ba9da2000e"
      unitRef="usd">0</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzMtMy0xLTEtMTEyMjkx_d3483334-ad24-4c6b-9475-f756fcdb7c81"
      unitRef="usd">1993000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzQtMS0xLTEtMTEyMjkx_c0488bf2-b449-4c77-998f-718d35b7f5b0"
      unitRef="usd">1500000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzQtMy0xLTEtMTEyMjkx_50e61ac8-40e7-4c31-ac26-c349e1adc8d6"
      unitRef="usd">3500000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzUtMS0xLTEtMTEyMjkx_4e627ac4-767e-40f2-b960-22b982145cb8"
      unitRef="usd">-15183000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzUtMy0xLTEtMTEyMjkx_55f0e3cd-c650-4aa8-82dc-5af4a79fe6a5"
      unitRef="usd">-1867750000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzctMS0xLTEtMTEyMjkx_7b5d0c0d-af04-4cd0-8316-3ed1f286ab3d"
      unitRef="usd">0</icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts>
    <icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzctMy0xLTEtMTEyMjkx_d6d4eaf5-a803-4d6e-92ca-47b6a918540b"
      unitRef="usd">1672698000</icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzgtMS0xLTEtMTEyMjkx_145ee1b6-b143-4920-b173-302b15262678"
      unitRef="usd">7375000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzgtMy0xLTEtMTEyMjkx_90d9af59-420f-441b-9933-996d69aff522"
      unitRef="usd">16000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzktMS0xLTEtMTEyMjkx_ef9e6b54-f634-4141-9e55-67149a2836b4"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfMzktMy0xLTEtMTEyMjkx_cdf47492-b434-41bb-b6f3-a775a02f495b"
      unitRef="usd">1852000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDAtMS0xLTEtMTEyMjkx_b56d9c8a-7505-4f5a-8968-526d590e61df"
      unitRef="usd">171000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDAtMy0xLTEtMTEyMjkx_00f7b398-087c-483b-a018-a51688fd0c61"
      unitRef="usd">2974000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDEtMS0xLTEtMTEyMjkx_724eaa46-e0cf-433a-b694-aec551fc4a1f"
      unitRef="usd">208000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDEtMy0xLTEtMTEyMjkx_b4e50d21-8f45-4db8-95c2-519f4d7b9eda"
      unitRef="usd">160000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDItMS0xLTEtMTEyMjkx_c55c1226-1606-4fed-b208-971041a81054"
      unitRef="usd">8425000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDItMy0xLTEtMTEyMjkx_f6147bd8-5608-4b35-bd4c-868c4cb61475"
      unitRef="usd">8743000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDMtMS0xLTEtMTEyMjkx_f0d97967-d0ae-4034-94c1-f350b6aa1996"
      unitRef="usd">-15837000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDMtMy0xLTEtMTEyMjkx_7dab6f78-6613-4d9f-aa5c-bdb489dcc21b"
      unitRef="usd">1648917000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDQtMS0xLTEtMTEyMjkx_443e466c-88fe-454b-baf1-5f0aab36d982"
      unitRef="usd">1938000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDQtMy0xLTEtMTEyMjkx_bf0d273d-23e9-4469-baeb-992a311a5821"
      unitRef="usd">-3224000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDUtMS0xLTEtMTEyMjkx_47490ee8-e4f1-4036-98d0-2fce9e866950"
      unitRef="usd">12163000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDUtMy0xLTEtMTEyMjkx_a927f4f4-5b41-47d3-aa8f-97edc508d075"
      unitRef="usd">-223399000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDYtMS0xLTEtMTEyMjkx_7f5fdd0d-259f-4a0c-97a1-43e46e1c0483"
      unitRef="usd">208784000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9fd0c26c71db4e4cb0b929a7689fb683_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDYtMy0xLTEtMTEyMjkx_b4dc493d-ebce-4040-8924-dfbda689cea0"
      unitRef="usd">552827000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDctMS0xLTEtMTEyMjkx_ac4007be-6073-470f-9b28-250a339aa255"
      unitRef="usd">220947000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i57ae4b72e9574e4ebf63f3473590fe05_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDctMy0xLTEtMTEyMjkx_196250c5-6617-4862-ada1-0a7cd8127fd2"
      unitRef="usd">329428000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOjIyZDdlZjk3NmQzMjQ2M2ViNThjMDgyYTVhMWIzZjgxL3RhYmxlcmFuZ2U6MjJkN2VmOTc2ZDMyNDYzZWI1OGMwODJhNWExYjNmODFfNy0xLTEtMS0xMTIyOTE_857729af-8ba1-4e59-af10-b6a5e8aabb25"
      unitRef="usd">2223000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOjIyZDdlZjk3NmQzMjQ2M2ViNThjMDgyYTVhMWIzZjgxL3RhYmxlcmFuZ2U6MjJkN2VmOTc2ZDMyNDYzZWI1OGMwODJhNWExYjNmODFfNy0zLTEtMS0xMTIyOTE_720969a2-1e91-4310-a5f2-b5636c78f531"
      unitRef="usd">5178000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOjIyZDdlZjk3NmQzMjQ2M2ViNThjMDgyYTVhMWIzZjgxL3RhYmxlcmFuZ2U6MjJkN2VmOTc2ZDMyNDYzZWI1OGMwODJhNWExYjNmODFfMTItMy0xLTEtMTIwODA4_7501329f-9721-4a6d-9b1a-ef2a421c14f3"
      unitRef="usd">1594776000</us-gaap:FairValueOfAssetsAcquired>
    <icui:NetCashPaidReceivedforcurrentandprioracquisitions
      contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOjIyZDdlZjk3NmQzMjQ2M2ViNThjMDgyYTVhMWIzZjgxL3RhYmxlcmFuZ2U6MjJkN2VmOTc2ZDMyNDYzZWI1OGMwODJhNWExYjNmODFfMTMtMy0xLTEtMTIwODA4_726f0984-15b7-4d88-80aa-ccc73a78f61d"
      unitRef="usd">1844164000</icui:NetCashPaidReceivedforcurrentandprioracquisitions>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOjIyZDdlZjk3NmQzMjQ2M2ViNThjMDgyYTVhMWIzZjgxL3RhYmxlcmFuZ2U6MjJkN2VmOTc2ZDMyNDYzZWI1OGMwODJhNWExYjNmODFfMTQtMy0xLTEtMTIwODA4_13993e3a-1ee6-43de-9207-1b35bc1036a7"
      unitRef="usd">575975000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="i0c6fdad0ae1f42cdb0e49e14d48fc939_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOjIyZDdlZjk3NmQzMjQ2M2ViNThjMDgyYTVhMWIzZjgxL3RhYmxlcmFuZ2U6MjJkN2VmOTc2ZDMyNDYzZWI1OGMwODJhNWExYjNmODFfMTUtMy0xLTEtMTIwODA4_8b47153d-d1ac-48e6-b7ca-e72eaa1ef9d0"
      unitRef="usd">55158000</us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOjIyZDdlZjk3NmQzMjQ2M2ViNThjMDgyYTVhMWIzZjgxL3RhYmxlcmFuZ2U6MjJkN2VmOTc2ZDMyNDYzZWI1OGMwODJhNWExYjNmODFfMTYtMy0xLTEtMTIwODA4_1f4cab32-696c-47d3-83f5-cd3201e2fbe0"
      unitRef="usd">1485987000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOjIyZDdlZjk3NmQzMjQ2M2ViNThjMDgyYTVhMWIzZjgxL3RhYmxlcmFuZ2U6MjJkN2VmOTc2ZDMyNDYzZWI1OGMwODJhNWExYjNmODFfMTctMy0xLTEtMTIwODA4_f2d4c81a-ec17-407c-a1d9-acf45923b819"
      unitRef="usd">605466000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8zNC9mcmFnOjIzMWQ0OWQ1NTAyYzQwNTM4MTczNWRkYzljZjVjYTExL3RleHRyZWdpb246MjMxZDQ5ZDU1MDJjNDA1MzgxNzM1ZGRjOWNmNWNhMTFfMjg4Mg_148ea8f3-8bed-41ea-99fb-046f120a8341">Basis of Presentation&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited interim condensed consolidated financial statements of ICU Medical, Inc., ("ICU" or the "Company"), a Delaware corporation, have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S.") and pursuant to the rules&#160;and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and reflect all adjustments, consisting of only normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the consolidated results for the interim periods presented. Results for the interim period are not necessarily indicative of results for the full year. Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules&#160;and regulations. The condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report on Form&#160;10-K of ICU for the year ended December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We develop, manufacture and sell innovative medical products used in infusion therapy, vascular access, and vital care applications. ICU's product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. We sell the majority of our products through our direct sales force and through independent distributors throughout the U.S. and internationally.&#160;We also sell certain products on an original equipment manufacturer basis to other medical device manufacturers. All subsidiaries are wholly owned and are included in the condensed consolidated financial statements.&#160;All intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain reclassifications have been made to the prior year financial statements and footnotes to conform to the presentation used in the current year. In the statements of operations we reclassified interest income to interest (expense) income, net from other (expense) income, net and in Note 5: Revenues, certain reclassifications were made to revenues disaggregated by product line and by geography. Also, in Note 9: Fair Value Measurements the table indicating the Level inputs for the assets and liabilities measured at fair value on a recurring basis was updated to correct the Level input identified for the hedge assets and liabilities.  These reclassifications had no impact on total revenues, net loss, shareholder's equity or cash flows as previously reported.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8zNy9mcmFnOmE3NTc2YTA3ZGYzZjRhYjdhNjc0NGQ5NTJiNDIxYWFlL3RleHRyZWdpb246YTc1NzZhMDdkZjNmNGFiN2E2NzQ0ZDk1MmI0MjFhYWVfMjU3NA_4d55563b-a682-466e-a9e2-79bee68502cb">New Accounting Pronouncements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the Financial Accounting Standards Board issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional guidance for a limited period of time to ease the potential burden for reference rate reform on financial reporting. Due to concerns about structural risks of interbank offered rates and, particularly, the risk of cessation of the London Interbank Offered Rate ("LIBOR"), regulators around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction-based and less susceptible to manipulation. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued as a result of reference rate reform. Optional expedients may be applied to contracts that are modified as a result of the reference rate reform. Modifications of contracts within the scope of Topic 470, Debt, should be accounted for by prospectively adjusting the effective interest rate. Modifications of contracts within the scope of ASC 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate (incremental borrowing rate). Exceptions to Topic 815, Derivatives and Hedging, results in not having a dedesignation of a hedging relationship if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. ASU No. 2022-06, Reference Rate Reform: Deferral of the Sunset Date of Topic 848 deferred the sunset date to December 31, 2024. In November 2021, we entered into two forward-starting swaps whereby the variable leg of the swap referenced LIBOR. These swaps were amended in early 2022 to transition to an alternative reference rate (see Note 8: Derivatives and Hedging Activities). The amendments in this ASU allow for certain expedients that will allow us to assume that our hedged interest payments are probable of occurring regardless of any expected modification in their terms related to reference rate reform and will allow us to continue hedge accounting for a cash flow hedge for which the hedged interest rate risk changes if the hedge is highly effective under ASC 815, Derivatives and Hedging, or the optional expedient under this ASU is elected. The impact of this ASU on our contracts has not been and is not expected to be material.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNTQ5NzU1ODI2NTQ5_a4517a46-f0e3-4c69-a753-cf4d6b1cc7ac">Acquisitions&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, we acquired 100.0% of the equity interests in Smiths Medical, the holding company of Smiths Group plc's global medical device business, from Smiths Group International Holdings Limited (&#x201c;Smiths&#x201d;). The acquisition of Smiths Medical aligns with our strategic growth plans, enabling us to broaden our product offerings to include syringe and ambulatory infusion devices, vascular access, and vital care products and to strengthen and expand our global market reach.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash consideration for the acquisition was $1.9&#160;billion, which was financed with existing cash balances and proceeds from the credit agreement entered into on January 6, 2022 (see Note 17: Long-Term Debt). We also issued share consideration to Smiths of 2.5&#160;million shares of our common stock. The fair value of the common shares issued to Smiths was determined based on the opening market price of our common stock on the acquisition date. Smiths may be entitled to an additional $100.0&#160;million in cash consideration contingent on our common stock achieving certain price targets for certain periods after closing in accordance with the terms of the Share Sale and Purchase Agreement (the "Purchase Agreement"). In the event that (a) on or prior to the third anniversary of closing the 30-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $300.00 per share or (b) on or prior to the fourth anniversary of closing the 45-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $300.00 per share (each a "Price Target"), and provided Smiths beneficially owns at least 50.0% of the shares of common stock issued at closing at the time the Price Target is achieved, then Smiths will be entitled to receive the additional $100.0&#160;million in cash consideration. The fair value of the contingent consideration was determined using an option pricing model, specifically the Monte Carlo Simulation. In the analysis, the determinants of payout are simulated in a risk neutral framework over a large number of simulation paths. The fair value of the contingent consideration is then calculated as the average present value across all simulated paths. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Smiths became a related party to us when we issued 2.5&#160;million shares of our common stock as partial consideration for the acquisition of Smiths Medical. Additionally, we entered into a transition services agreement ("TSA") with certain members of Smiths Group, plc. The TSA includes certain information technology, human resource and tax support services for an initial term of twelve months with the option to extend up to 24 months. During the three months ended March 31, 2023, we expensed $4.0&#160;million for services provided under the TSA. As of March 31, 2023, we have $1.5&#160;million in open payables related to the services received under the TSA.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Final Purchase Price Allocation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the final purchase price and the final allocation of the purchase price related to the assets acquired and liabilities assumed (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated cash consideration for acquired assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,922,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration payable to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of ICU Medical, Inc. common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares issued to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Price per share (ICU's opening market price on the acquisition date)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of ICU shares issued to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,552,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchase Price Allocation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173,151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,490)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill - not tax deductible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,469,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated Purchase Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,552,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Identifiable intangible assets include $510.0&#160;million of customer relationships, $400.0&#160;million of developed technology, $30.0&#160;million of internally developed software, and $5.0&#160;million of trademark. The estimated weighted-average amortization period for the total identifiable intangible assets is approximately &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjc3NQ_c58be461-15cc-4ce0-9461-a1f586d03baa"&gt;nine&lt;/span&gt; years, and, for each identifiable intangible asset is estimated as follows: &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjg1NA_dbc618ca-f89e-4749-ab68-262b22ebc7e6"&gt;eight&lt;/span&gt; years for customer relationships, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjg5MQ_cbdceafc-7a31-4a27-b09c-41ac0c8d87ec"&gt;ten&lt;/span&gt; years for developed technology, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjkyNg_15a93537-17a8-41e6-a1fe-d867b9347f66"&gt;five&lt;/span&gt; years for internally developed software, and &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjk3NA_5b7a1829-90b2-4109-8983-d52f0d255b2e"&gt;six&lt;/span&gt; months for the trademark. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accrued liabilities includes, among other things, accrued warranty reserves, accrued restructuring initiatives, accrued salaries and related benefits, deferred revenue and accrued sales and use taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The identifiable intangible assets and other long-lived assets acquired have been valued utilizing Level 3 inputs as defined in Note 9: Fair Value Measurements. The fair value of identifiable intangible assets was generally developed using the income approach and are based on critical estimates, judgments and assumptions derived from: analysis of market conditions; discount rate; discounted cash flows; royalty rates; customer retention rates; and/or estimated useful lives. Certain other intangible assets were valued using a cost to replace method, estimating the labor and non-labor costs required to replace the asset under the premise that it was not part of the transaction. Property, plant and equipment was valued with the consideration of remaining economic lives. The raw materials inventory was valued at historical cost and adjusted for any obsolescence which we estimate to approximate replacement cost, the work in process inventory was valued at estimated sales proceeds less costs to complete and costs to sell, and finished goods inventory was valued at estimated sales proceeds less costs to sell. The prepaid expenses and other current assets and assumed liabilities were recorded at their carrying values as of the date of the acquisition, as their carrying values approximated their fair values due to their short-term nature.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unaudited Pro Forma Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Smiths Medical is included in our consolidated results beginning on January 7, 2022. Total revenues and net loss attributable to Smiths Medical for the period from January 7, 2022 to March 31, 2022 were estimated to be $214.9&#160;million and &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$40.4&#160;million. The following unaudited pro forma financial information presents the combined results of operations of ICU and Smiths Medical as if the acquisition had occurred on January 1, 2022. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place on the date indicated or of results that may occur in the future. &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;The unaudited pro forma results presented above include the impact of the following adjustments: incremental amortization expense on intangible assets acquired of $3.3&#160;million for the three months ended March 31, 2022, incremental interest expense, including amortization of debt discount and debt issuance costs, on the Senior Secured Credit Facilities (as defined in Note 17: Long-Term Debt) of $0.8&#160;million for the three months ended March 31, 2022. The unaudited pro forma results include IFRS to U.S. GAAP adjustments for Smiths Medical's historical results and adjustments for accounting policy alignment, which were materially similar to the Company. Any differences in accounting policies were adjusted to reflect the accounting policies of the Company in the unaudited pro forma results presented.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNzc_a40df5b6-26de-4e7c-9e6e-3379861c8f11"
      unitRef="number">1.000</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <icui:BusinessCombinationConsiderationTransferredCash
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNTc0_26590035-5d6e-4b90-9510-73b738643d35"
      unitRef="usd">1900000000</icui:BusinessCombinationConsiderationTransferredCash>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNzc1_0cfc7e34-ba18-4f09-a91e-a895a527325b"
      unitRef="shares">2500000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfOTkz_2ef7fee7-61fe-4b74-aede-8b1ac7a5f63b"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <icui:MinimumStockPriceTargetForEarnOutPayment
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMTQwMg_6856e233-3f0e-491f-97d7-9aa21623f261"
      unitRef="usd">300.00</icui:MinimumStockPriceTargetForEarnOutPayment>
    <icui:MinimumStockPriceTargetForEarnOutPayment
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMTU5MA_5df35495-43f4-4e6d-a211-a56b62c2280b"
      unitRef="usd">300.00</icui:MinimumStockPriceTargetForEarnOutPayment>
    <icui:RequiredShareHoldingOfStockIssuedAtAcquisition
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMTY3NQ_495d4c21-99ec-4500-8643-983f1c02015f"
      unitRef="number">0.500</icui:RequiredShareHoldingOfStockIssuedAtAcquisition>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMTgyMw_2ef7fee7-61fe-4b74-aede-8b1ac7a5f63b"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNTQ5NzU1ODI2NTM3_6809886b-63b4-4e63-8ff1-6336c1b4a958"
      unitRef="shares">2500000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNTQ5NzU1ODI2NTA5_4887978f-284c-4617-bf0b-244e8148022a"
      unitRef="usd">4000000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionDueFromToRelatedParty
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNTQ5NzU1ODI2NTIz_6db4e246-e8d2-4874-b279-62902927c852"
      unitRef="usd">1500000</us-gaap:RelatedPartyTransactionDueFromToRelatedParty>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNzYxMw_70cbad78-31b3-4196-842e-391fec058b33">The following table summarizes the final purchase price and the final allocation of the purchase price related to the assets acquired and liabilities assumed (in thousands):&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated cash consideration for acquired assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,922,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration payable to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of ICU Medical, Inc. common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares issued to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Price per share (ICU's opening market price on the acquisition date)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of ICU shares issued to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,552,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchase Price Allocation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173,151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,490)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill - not tax deductible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,469,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated Purchase Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,552,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Identifiable intangible assets include $510.0&#160;million of customer relationships, $400.0&#160;million of developed technology, $30.0&#160;million of internally developed software, and $5.0&#160;million of trademark. The estimated weighted-average amortization period for the total identifiable intangible assets is approximately &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjc3NQ_c58be461-15cc-4ce0-9461-a1f586d03baa"&gt;nine&lt;/span&gt; years, and, for each identifiable intangible asset is estimated as follows: &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjg1NA_dbc618ca-f89e-4749-ab68-262b22ebc7e6"&gt;eight&lt;/span&gt; years for customer relationships, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjg5MQ_cbdceafc-7a31-4a27-b09c-41ac0c8d87ec"&gt;ten&lt;/span&gt; years for developed technology, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjkyNg_15a93537-17a8-41e6-a1fe-d867b9347f66"&gt;five&lt;/span&gt; years for internally developed software, and &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjk3NA_5b7a1829-90b2-4109-8983-d52f0d255b2e"&gt;six&lt;/span&gt; months for the trademark. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accrued liabilities includes, among other things, accrued warranty reserves, accrued restructuring initiatives, accrued salaries and related benefits, deferred revenue and accrued sales and use taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMC0yLTEtMS0xMTIyOTE_0a4df32e-32cc-47e4-a4ef-73fab4a7b06a"
      unitRef="usd">1922955000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMS0yLTEtMS0xMTIyOTE_c9d72299-6e4c-4611-8127-13fd0e36eec6"
      unitRef="usd">53520000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfNC0yLTEtMS0xMTIyOTE_accdf407-08f2-4ac8-8595-dccf187ee160"
      unitRef="shares">2500000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfNS0yLTEtMS0xMTIyOTE_07515a16-e5b9-4519-ba8d-73f503d1b59f"
      unitRef="usdPerShare">230.39</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfNi0yLTEtMS0xMTIyOTE_5a0d48a3-2d30-4032-9950-6faa937e56c8"
      unitRef="usd">575975000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfNy0yLTEtMS0xMTIyOTE_fbad058d-988b-44d2-846f-8186ef3ddfd8"
      unitRef="usd">2552450000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTAtMi0xLTEtMTEyMjkx_ae5721de-2cfc-48c6-8223-398891c3a6f6"
      unitRef="usd">78791000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTEtMi0xLTEtMTEyMjkx_10bd0ae1-8747-4ecc-8aaa-2d809d9a6649"
      unitRef="usd">106132000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTItMi0xLTEtMTEyMjkx_2a6e896f-c8c4-4b58-b1a2-7fdc5385323b"
      unitRef="usd">228919000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTMtMi0xLTEtMTEyMjkx_1c6f8330-9909-477b-bc6a-2956f4c10f1b"
      unitRef="usd">53554000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTQtMi0xLTEtMTEyMjkx_aaf2a957-3e7d-4ae0-bf71-862d162def61"
      unitRef="usd">206333000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <icui:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTUtMi0xLTEtMTEyMjkx_f8857afe-535c-4f31-94f1-a81ef969a489"
      unitRef="usd">55161000</icui:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTYtMi0xLTEtMTEyMjkx_222f9c97-a1ae-4888-b49f-dcf96258e09d"
      unitRef="usd">945000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTgtMi0xLTEtMTEyMjkx_3723e8a9-daf9-454b-bf1d-83b46cdf78e3"
      unitRef="usd">379000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMTktMi0xLTEtMTEyMjkx_4c0588e2-ee2e-4b54-97e4-aba6c11e3473"
      unitRef="usd">105291000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMjAtMi0xLTEtMTEyMjkx_431571ac-3acd-4a89-b294-00cd2ac363f5"
      unitRef="usd">173151000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <icui:BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMjEtMi0xLTEtMTEyMjkx_2649a1d9-8928-4c01-89fd-5557e5f3ea65"
      unitRef="usd">40312000</icui:BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMjItMi0xLTEtMTEyMjkx_4cc312d0-95d7-42f1-9fc2-378abb16f03a"
      unitRef="usd">85490000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMjMtMi0xLTEtMTEyMjkx_1de2f85d-41a0-44d1-8204-aba97981c85b"
      unitRef="usd">187455000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMjQtMi0xLTEtMTEyMjkx_7d38eaea-d77e-4651-be09-67167876020b"
      unitRef="usd">1082570000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <icui:BusinessCombinationGoodwillNonDeductible
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMjUtMi0xLTEtMTEyMjkx_ca9e8cb2-4b58-480f-b1de-0e35993bdceb"
      unitRef="usd">1469880000</icui:BusinessCombinationGoodwillNonDeductible>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjUxYzRlZThmZjc5NzQ2YWNhMDM0ZGZhNGRlYTA1ODk3L3RhYmxlcmFuZ2U6NTFjNGVlOGZmNzk3NDZhY2EwMzRkZmE0ZGVhMDU4OTdfMjYtMi0xLTEtMTEyMjkx_90323c1e-c64d-4abb-9fd9-303cb3c4cd11"
      unitRef="usd">2552450000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib4e4d6b3c14144aca5091606533105a7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjU0Ng_acad6819-0716-499a-934e-4cd3ec86a754"
      unitRef="usd">510000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="iad76217923724df7af4e6c43d299c300_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjU3Ng_cc24ebec-a734-48cd-a410-df70733de001"
      unitRef="usd">400000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib4201cfae6384d12823ab684fa4f93a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjYwNA_e609dc92-f71a-4633-a796-7381a9457c24"
      unitRef="usd">30000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i3908b880a83e477b9d7b162246382114_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfMjY0NQ_5b3602a5-4438-46d0-a3b1-edaf0b131e18"
      unitRef="usd">5000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Revenues
      contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNDk5NA_31d7faea-9f8e-4d53-9f42-89230c2c0f2f"
      unitRef="usd">214900000</us-gaap:Revenues>
    <us-gaap:ProfitLoss
      contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNTAwMQ_e97644cc-9775-40ae-98ce-2a6502ba78b8"
      unitRef="usd">40400000</us-gaap:ProfitLoss>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNzYxNA_8c37fb11-1110-4c37-9493-00a7f38ce6f7">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjQ2MDc1YWU3YWE3NTRmOWJhOTYyNjlhYTRiM2RkMmFkL3RhYmxlcmFuZ2U6NDYwNzVhZTdhYTc1NGY5YmE5NjI2OWFhNGIzZGQyYWRfMi0xLTEtMS0xMTIyOTE_53b91693-5a9c-4e05-8d73-f67e52fd7618"
      unitRef="usd">563743000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RhYmxlOjQ2MDc1YWU3YWE3NTRmOWJhOTYyNjlhYTRiM2RkMmFkL3RhYmxlcmFuZ2U6NDYwNzVhZTdhYTc1NGY5YmE5NjI2OWFhNGIzZGQyYWRfMy0xLTEtMS0xMTIyOTE_166578af-8250-4d3b-84f5-7be8013db520"
      unitRef="usd">-34994000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <icui:ProFormaAdjustmentAmortization
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNTcxMw_8ec29843-8276-46e2-9755-ebad4748594b"
      unitRef="usd">3300000</icui:ProFormaAdjustmentAmortization>
    <icui:ProFormaAdjustmentFinanceCosts
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80MC9mcmFnOmE5Yzc5YTk4NjNjMjQyYzA5NjU4ZjA0YTViZGNkNjFlL3RleHRyZWdpb246YTljNzlhOTg2M2MyNDJjMDk2NThmMDRhNWJkY2Q2MWVfNTk3MA_ccda8a2e-9d41-4ea6-aa3d-c19b977cf558"
      unitRef="usd">800000</icui:ProFormaAdjustmentFinanceCosts>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RleHRyZWdpb246M2NkNjliMmZmZjQ5NGM4ZjlhNmVlNzE2ODYxNDg5YTJfMjA1MQ_54fcfa48-ed5f-4998-95f1-905e23744eba">Restructuring, Strategic Transaction and Integration&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Restructuring, strategic transaction and integration expenses were $11.0 million and $33.9 million for the three months ended March 31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the three months ended March&#160;31, 2023 and 2022, restructuring charges were $2.7&#160;million and $3.2&#160;million, respectively and were primarily related to severance costs. &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity in our restructuring-related accrual by major type of cost for the three months ended March&#160;31, 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Severance Pay and Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retention and Facility Closure Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;__________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Other, primarily relates to prior year accrued restructuring charges for estimated facility closure costs that were reversed during the three months ended March 31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Strategic Transaction and Integration Expenses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;We incurred and expensed $8.3 million and $30.7 million in strategic transaction and integration expenses during the three months ended March 31, 2023 and 2022, respectively, which are included in restructuring, strategic transaction and integration expenses in our condensed consolidated statements of operations. The strategic transaction and integration expenses during the three months ended March&#160;31, 2023 were primarily related to consulting expenses and employee costs incurred to integrate our Smiths Medical business acquired in 2022. The strategic transaction and integration expenses for the three months ended March 31, 2022 were primarily related to transaction and integration expenses associated with our acquisition of Smiths Medical (see Note 3: Acquisitions) which primarily included legal expenses, bank fees, a United Kingdom stamp tax, and employee costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <icui:Restructuringstrategictransactionandintegration
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RleHRyZWdpb246M2NkNjliMmZmZjQ5NGM4ZjlhNmVlNzE2ODYxNDg5YTJfMTM2_fd6175ff-a3aa-4b79-b986-8d0f92106f5a"
      unitRef="usd">11000000</icui:Restructuringstrategictransactionandintegration>
    <icui:Restructuringstrategictransactionandintegration
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RleHRyZWdpb246M2NkNjliMmZmZjQ5NGM4ZjlhNmVlNzE2ODYxNDg5YTJfMTQz_c69f5207-89c0-4880-9cd9-e4cd6333f1c2"
      unitRef="usd">33900000</icui:Restructuringstrategictransactionandintegration>
    <us-gaap:RestructuringCosts
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RleHRyZWdpb246M2NkNjliMmZmZjQ5NGM4ZjlhNmVlNzE2ODYxNDg5YTJfMzQw_ddfb468e-dbd6-42aa-9cae-2511b1c3830d"
      unitRef="usd">2700000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RleHRyZWdpb246M2NkNjliMmZmZjQ5NGM4ZjlhNmVlNzE2ODYxNDg5YTJfNTQ5NzU1ODE2Mzky_64568a30-56c8-444e-a7d5-f19c6996e8ec"
      unitRef="usd">3200000</us-gaap:RestructuringCosts>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RleHRyZWdpb246M2NkNjliMmZmZjQ5NGM4ZjlhNmVlNzE2ODYxNDg5YTJfMjA1Mw_3855adb4-7788-4060-a5bc-212d24bec731">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity in our restructuring-related accrual by major type of cost for the three months ended March&#160;31, 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Severance Pay and Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retention and Facility Closure Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;__________________________&lt;/span&gt;&lt;/div&gt;(1) Other, primarily relates to prior year accrued restructuring charges for estimated facility closure costs that were reversed during the three months ended March 31, 2023.</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i2be2d8334179424c9dae8ef69e51861a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfMS0yLTEtMS0xMTIyOTE_4f7464c8-6d2c-4602-a68e-f1fceefcba1a"
      unitRef="usd">4416000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i2988acfe0dcd4e17a14143d0e3743733_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfMS02LTEtMS0xMTIyOTE_e97cb8d8-99a7-4d35-a32d-9b4e74660506"
      unitRef="usd">1507000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfMS04LTEtMS0xMTIyOTE_e56d917b-c559-416d-93ca-e3a19ce335d3"
      unitRef="usd">5923000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="ie97b4a8feb974d7180f4613667a93acb_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfMy0yLTEtMS0xMTIyOTE_154709f4-8d0d-444e-b86f-6970f600cea0"
      unitRef="usd">2732000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i98a8c58853e84468b76e94c8be56aa32_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfMy02LTEtMS0xMTIyOTE_ab660d09-dc6f-4180-a978-b193d8a1203a"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfMy04LTEtMS0xMTIyOTE_ff8b774a-d9d1-475f-992d-05db6478e4a2"
      unitRef="usd">2732000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="ie97b4a8feb974d7180f4613667a93acb_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNC0yLTEtMS0xMTIyOTE_0a45addb-8e53-482d-bd2e-b587c2df3c4a"
      unitRef="usd">1284000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i98a8c58853e84468b76e94c8be56aa32_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNC02LTEtMS0xMTIyOTE_c5659334-421e-4b03-8645-8c0ace6bd39e"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNC04LTEtMS0xMTIyOTE_6c8700d0-fc04-452b-8bb7-1941fb83712b"
      unitRef="usd">1284000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="ie97b4a8feb974d7180f4613667a93acb_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNS0yLTEtMS0xMjA4MzE_7b459637-283d-4abe-953a-c7f8163039cc"
      unitRef="usd">291000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i98a8c58853e84468b76e94c8be56aa32_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNS02LTEtMS0xMTg5NTk_0c79b03d-1b1d-49a2-8f0c-9402a04dc308"
      unitRef="usd">620000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNS04LTEtMS0xMjA4MzY_381137eb-e311-4a22-b127-9d53f912eb3c"
      unitRef="usd">911000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="ie97b4a8feb974d7180f4613667a93acb_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNS0yLTEtMS0xMTIyOTE_bd084845-d8b3-4d9c-a57f-adbf28defea6"
      unitRef="usd">-70000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i98a8c58853e84468b76e94c8be56aa32_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNS02LTEtMS0xMTIyOTE_68a51fb8-4e28-408d-be35-d8dd7080b82e"
      unitRef="usd">-16000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNS04LTEtMS0xMTIyOTE_f0a7eb7c-c9c7-43db-a636-08e9c82b58c6"
      unitRef="usd">-86000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i382a53a05af54e50ba7efcb611be9988_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNi0yLTEtMS0xMTIyOTE_77d90389-d757-4dc7-b4f6-cc1e396bd656"
      unitRef="usd">5643000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie6b3ba685fe640b2bf1d136426bd89dc_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNi02LTEtMS0xMTIyOTE_3987e670-1c51-4779-abae-82ffc45d834b"
      unitRef="usd">903000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RhYmxlOjcyODcyZjc2NjJkMjQ0ZWI5MWRhMjUyYTczZWZiMjNkL3RhYmxlcmFuZ2U6NzI4NzJmNzY2MmQyNDRlYjkxZGEyNTJhNzNlZmIyM2RfNi04LTEtMS0xMTIyOTE_12a15140-5b7f-4f00-a734-e68a5e1b50b6"
      unitRef="usd">6546000</us-gaap:RestructuringReserve>
    <icui:StrategicTransactionandIntegration
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RleHRyZWdpb246M2NkNjliMmZmZjQ5NGM4ZjlhNmVlNzE2ODYxNDg5YTJfOTA4_de5e584e-cdab-4eb7-8e03-4f3dfc8d5e82"
      unitRef="usd">8300000</icui:StrategicTransactionandIntegration>
    <icui:StrategicTransactionandIntegration
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80My9mcmFnOjNjZDY5YjJmZmY0OTRjOGY5YTZlZTcxNjg2MTQ4OWEyL3RleHRyZWdpb246M2NkNjliMmZmZjQ5NGM4ZjlhNmVlNzE2ODYxNDg5YTJfOTE1_50276b5f-8348-46ef-9f42-e39bee2c4527"
      unitRef="usd">30700000</icui:StrategicTransactionandIntegration>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RleHRyZWdpb246ZjI5YjljYWM4MTU2NDkwMjhlYThhYmRhYzdmMTVjYWRfMzQxNA_5531e78e-adf1-4d82-8b45-990e2fe8db48">Revenue&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As part of the integration of our acquisition of Smiths Medical, we have now migrated to our new business unit structure of Consumables, Infusion Systems and Vital Care. The vast majority of our sales of products within these business units are made on a stand-alone basis to hospitals and distributors. Revenue is typically recognized upon transfer of control of the products, which we deem to be at point of shipment. However, for purposes of revenue recognition for our software licenses and renewals, we consider the control of these products to be transferred to a customer at a certain point in time; therefore, we recognize revenue at the start of the applicable license term.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Payment is typically due in full within 30 days of delivery or the start of the contract term.  Revenue is recorded in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We offer certain volume-based rebates to our distribution customers, which we record as variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between the prices we charge our distribution customers and the contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts in order to determine the transaction price, we use information available at the time, including our historical experience.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;We also warranty products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available at that time and our historical experience. We also provide for extended service-type warranties, which we consider to be separate performance obligations. We allocate a portion of the transaction price to the extended service-type warranty based on its estimated relative selling price, and recognize revenue over the period the warranty service is provided. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue disaggregated&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents our revenues disaggregated by product line (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Product line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Infusion Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vital Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2023 and 2022, net sales to Medline made up approximately 15% of total revenues.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents our revenues disaggregated by geography (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geography&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, the Middle East and Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the changes in our contract balances for the three months ended March 31, 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance, January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,866)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of acquired deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our contract liabilities are included in accrued liabilities or other long-term liabilities in our condensed consolidated balance sheet based on the expected timing of payments.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2023, revenue from remaining performance obligations is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Recognition Timing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&amp;lt; 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&amp;gt; 12 Months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,327)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(829)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,422)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenue*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,920)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Other deferred revenue includes pump development programs, purchased training and extended warranty.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:Revenues
      contextRef="if672ca85f58b4f10ac0adfe442433dba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjU5NDA5YzYxM2Y2NzQ1ZWViNTZlYWI5OWNhNDZhZjc0L3RhYmxlcmFuZ2U6NTk0MDljNjEzZjY3NDVlZWI1NmVhYjk5Y2E0NmFmNzRfMi0xLTEtMS0xMTIyOTE_a33adf76-8f00-4a34-a86e-6b9b4b4f08d7"
      unitRef="usd">236122000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i430bf7f21dc340cc98e845a1549c6ba2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjU5NDA5YzYxM2Y2NzQ1ZWViNTZlYWI5OWNhNDZhZjc0L3RhYmxlcmFuZ2U6NTk0MDljNjEzZjY3NDVlZWI1NmVhYjk5Y2E0NmFmNzRfMi0zLTEtMS0xMTIyOTE_2fe3618b-4cf1-4f2f-9822-9cc75f790c21"
      unitRef="usd">240189000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie942e6605043489884a694f3c56a4f24_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjU5NDA5YzYxM2Y2NzQ1ZWViNTZlYWI5OWNhNDZhZjc0L3RhYmxlcmFuZ2U6NTk0MDljNjEzZjY3NDVlZWI1NmVhYjk5Y2E0NmFmNzRfMy0xLTEtMS0xMTIyOTE_bd264067-b10c-4ac6-a543-b3507e0c82fb"
      unitRef="usd">161713000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i425342db1c344b6f8cc10da8ee02d87b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjU5NDA5YzYxM2Y2NzQ1ZWViNTZlYWI5OWNhNDZhZjc0L3RhYmxlcmFuZ2U6NTk0MDljNjEzZjY3NDVlZWI1NmVhYjk5Y2E0NmFmNzRfMy0zLTEtMS0xMTIyOTE_3e6176a4-2a33-40f1-bdff-d676c8d17846"
      unitRef="usd">138227000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib3e783fa8bb34a5494c0d5d949242f64_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjU5NDA5YzYxM2Y2NzQ1ZWViNTZlYWI5OWNhNDZhZjc0L3RhYmxlcmFuZ2U6NTk0MDljNjEzZjY3NDVlZWI1NmVhYjk5Y2E0NmFmNzRfNC0xLTEtMS0xMTIyOTE_81fa12db-c851-4bc7-95c4-8e89056467c7"
      unitRef="usd">170814000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i638825fa0f98497b948ffb1c01d0e19e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjU5NDA5YzYxM2Y2NzQ1ZWViNTZlYWI5OWNhNDZhZjc0L3RhYmxlcmFuZ2U6NTk0MDljNjEzZjY3NDVlZWI1NmVhYjk5Y2E0NmFmNzRfNC0zLTEtMS0xMTIyOTE_3cac7f4b-bc39-4de7-b3bb-458a9958ba43"
      unitRef="usd">164706000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjU5NDA5YzYxM2Y2NzQ1ZWViNTZlYWI5OWNhNDZhZjc0L3RhYmxlcmFuZ2U6NTk0MDljNjEzZjY3NDVlZWI1NmVhYjk5Y2E0NmFmNzRfOS0xLTEtMS0xMTIyOTE_b7da833e-86fc-4748-a2c5-9c132677b13d"
      unitRef="usd">568649000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjU5NDA5YzYxM2Y2NzQ1ZWViNTZlYWI5OWNhNDZhZjc0L3RhYmxlcmFuZ2U6NTk0MDljNjEzZjY3NDVlZWI1NmVhYjk5Y2E0NmFmNzRfOS0zLTEtMS0xMTIyOTE_a7306438-efe1-4977-b6c9-518d40b4888f"
      unitRef="usd">543122000</us-gaap:Revenues>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RleHRyZWdpb246ZjI5YjljYWM4MTU2NDkwMjhlYThhYmRhYzdmMTVjYWRfMzQwNg_b8cf9129-81f7-40aa-b99c-29829f53213b">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents our revenues disaggregated by geography (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geography&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, the Middle East and Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i4b683b00bad4432ea43529d2de73711d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfMi0xLTEtMS0xMTIyOTE_c2166156-7177-4f31-80cc-0c3d68909b9d"
      unitRef="usd">359187000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibc639aa88692474fa875253ce1c84b6e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfMi0zLTEtMS0xMTIyOTE_bdcb102a-486c-4b99-a598-97dc1c7a8141"
      unitRef="usd">347791000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib3d0e8e0a5bb4a63b8430aaa2a4f8b17_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfMy0xLTEtMS0xMTY1MDc_e5f63959-45fa-4f69-af66-c134abf16ba8"
      unitRef="usd">98986000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifd9ef9dff7c545ad9f948e39c002b2bc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfMy0zLTEtMS0xMTY1MDc_ea76a7ca-7a5c-41b8-9e89-8311d724525f"
      unitRef="usd">86204000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idf5cc17211a944c486c24f771e6a195c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfNC0xLTEtMS0xMTY1MTE_9d683856-1fc3-4f58-9eba-3b6b031c569e"
      unitRef="usd">58624000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i45b3d6f3d0644e7d8963c40933520643_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfNC0zLTEtMS0xMTY1MTE_669d74ce-e8c1-487c-b93e-b8d2ad5d071e"
      unitRef="usd">64831000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie82e694fdb9d4433a97ad09856242b4a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfMy0xLTEtMS0xMTIyOTE_a35c3571-4d17-4bad-ac46-8a433c626d9d"
      unitRef="usd">51852000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iad04b3344f3d466bba0994502f1196e8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfMy0zLTEtMS0xMTIyOTE_ee951ebf-de93-407a-8c65-ff565fbc9f34"
      unitRef="usd">44296000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfOC0xLTEtMS0xMTIyOTE_f6ee66ae-96b2-491c-84bd-a08719d16db6"
      unitRef="usd">568649000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjAxOTE3YTRkMzNmOTQ5MjM5Y2RmYzY0Nzk0ODQ0MmFiL3RhYmxlcmFuZ2U6MDE5MTdhNGQzM2Y5NDkyMzljZGZjNjQ3OTQ4NDQyYWJfOC0zLTEtMS0xMTIyOTE_2b00f068-5e6f-437f-aa69-8c10d155cb2d"
      unitRef="usd">543122000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RleHRyZWdpb246ZjI5YjljYWM4MTU2NDkwMjhlYThhYmRhYzdmMTVjYWRfMzQwNw_13a13e9f-032e-41bf-9ca6-44bb1320ab21">The following table presents the changes in our contract balances for the three months ended March 31, 2023 and 2022 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance, January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,866)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of acquired deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMS0xLTEtMS0xMTIyOTE_077db409-c84a-458c-9ec9-f694b92dad12"
      unitRef="usd">45866000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i6f5153aa5ab442638a5c8de9a45fba7d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMy0xLTEtMS0xMTIyOTE_14ff30e9-52f4-48c4-8d3c-b219e15d418d"
      unitRef="usd">-5976000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="i6f5153aa5ab442638a5c8de9a45fba7d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfNC0xLTEtMS0xMTIyOTE_b56ae71a-1a6c-4453-984a-774122401885"
      unitRef="usd">7236000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i4de9a8d7bfc44cdfae663c1ba5da07c8_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfNS0xLTEtMS0xMTIyOTE_a6dfe98b-30c5-417e-a0cb-bd03027137f0"
      unitRef="usd">-4108000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="i4de9a8d7bfc44cdfae663c1ba5da07c8_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfNi0xLTEtMS0xMTIyOTE_8597d7f0-1d79-4719-8676-5415d6a5c983"
      unitRef="usd">5362000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:DeferredRevenueAdditions
      contextRef="if70bbd6b2087429f879753468a264309_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfNy0xLTEtMS0xMTIyOTE_36d16ee3-62ce-40a0-88aa-a02d2ab0e42a"
      unitRef="usd">861000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="if70bbd6b2087429f879753468a264309_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfOC0xLTEtMS0xMTIyOTE_b4c7742d-41f4-406a-92de-ff1f0aba8b27"
      unitRef="usd">-218000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="ida61c1e26c5d42a6a66daca8551246ff_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfOS0xLTEtMS0xMTIyOTE_98f1ef6d-929b-4fee-96a2-35e4b080ec19"
      unitRef="usd">403000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ida61c1e26c5d42a6a66daca8551246ff_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTAtMS0xLTEtMTEyMjkx_111bb3a3-8489-4dfd-8655-7235feb90af0"
      unitRef="usd">-1915000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTEtMS0xLTEtMTEyMjkx_044ee895-7a75-4437-9c81-9b2a73a5f146"
      unitRef="usd">47511000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i9fd0c26c71db4e4cb0b929a7689fb683_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTMtMS0xLTEtMTEyMjkx_785d32f4-49e1-4a33-a524-85db6a13ac27"
      unitRef="usd">7461000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i0c6fdad0ae1f42cdb0e49e14d48fc939_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTQtMS0xLTEtMTIwODQ0_77132df3-4c6b-4af2-9cf9-b72c2a7ceb16"
      unitRef="usd">51245000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="id1779a7129f64c9d9abc575b38200d77_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTQtMS0xLTEtMTEyMjkx_451df34c-0ffa-4cfa-ba99-a942c4f1d494"
      unitRef="usd">-5574000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="id1779a7129f64c9d9abc575b38200d77_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTUtMS0xLTEtMTEyMjkx_7298687e-ec5d-4355-8d2a-3e571c201aec"
      unitRef="usd">3447000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i316bfaa281dd4708b1bdb8f0f4449ed0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTYtMS0xLTEtMTEyMjkx_159551ce-7c50-40cb-8965-f2b60d060397"
      unitRef="usd">-4299000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="i316bfaa281dd4708b1bdb8f0f4449ed0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTctMS0xLTEtMTEyMjkx_a82d7996-a8bb-41b8-a8d3-b67a57f74023"
      unitRef="usd">4777000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:DeferredRevenueAdditions
      contextRef="i0115d314b99743fa9bbb604242dd25a1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTktMS0xLTEtMTIwODQw_1ee57b74-a66d-43e9-88c5-6e0d7f57873b"
      unitRef="usd">2266000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i0115d314b99743fa9bbb604242dd25a1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMjAtMS0xLTEtMTIwODQw_8ae02b78-58b5-4b90-b818-f815434809c8"
      unitRef="usd">-171000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="i908fb323327c4154bd1568d75d6f2552_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMjEtMS0xLTEtMTIwODQw_710487c2-a5a8-44bf-831f-50e62e7df76f"
      unitRef="usd">767000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i908fb323327c4154bd1568d75d6f2552_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMjItMS0xLTEtMTIwODQw_3e0faae8-413f-4451-8aac-acb788c788b5"
      unitRef="usd">-1683000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i57ae4b72e9574e4ebf63f3473590fe05_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjBkZDI0Njc4MGVhODQ3OWY4YTNmMzYwOGQ1MjcxOWI2L3RhYmxlcmFuZ2U6MGRkMjQ2NzgwZWE4NDc5ZjhhM2YzNjA4ZDUyNzE5YjZfMTgtMS0xLTEtMTEyMjkx_f536853f-512a-461b-b821-20cf5cd55e53"
      unitRef="usd">58236000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ie30632948bb140989b06da9c57314a0e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfMi0xLTEtMS0xMTIyOTE_44f73b2d-abda-4266-ab60-4efbafdfc723"
      unitRef="usd">17464000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i261befa46c644eb8a0b97033247d3bad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfMi0zLTEtMS0xMTIyOTE_7438510c-0981-46f5-8526-1321e2f09425"
      unitRef="usd">1327000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i29c2d40d68d54fa78c2000befa7864fd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfMy0xLTEtMS0xMTIyOTE_00840e02-bf24-4baa-b713-8a7c07beabb4"
      unitRef="usd">8323000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i34e4e4f1c2754f669c44df080318aa88_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfMy0zLTEtMS0xMTIyOTE_979a4a5e-6449-4286-93bd-130bdd66aad3"
      unitRef="usd">829000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i81bf02eca70549c38a41eb91ac257f95_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfNC0xLTEtMS0xMTIyOTE_c68a7045-c47d-47cc-be75-9836f929e592"
      unitRef="usd">1422000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i54a3f930a4e54803850c70dc786e2c62_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfNC0zLTEtMS0xMTIyOTE_34ebe538-b032-4a73-ab0e-a04af7c3db86"
      unitRef="usd">13441000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i5138e2e1587f44e48d749663aa9643f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfNS0xLTEtMS0xMTIyOTE_f8a92f47-e340-4612-9a36-f6fc17fabd80"
      unitRef="usd">3711000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ibaf177153834401cb429ff7ce5049e03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfNS0zLTEtMS0xMTIyOTE_7a6ee286-5a20-4d76-9dd3-11156e93286b"
      unitRef="usd">994000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i961a433f9f954f7a83f394eb9db23739_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfNi0xLTEtMS0xMTIyOTE_1ea5c6a3-2ffb-435b-a4a1-eeef370da123"
      unitRef="usd">30920000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i8fed4ca7522348e09634e4fad1da85ca_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80Ni9mcmFnOmYyOWI5Y2FjODE1NjQ5MDI4ZWE4YWJkYWM3ZjE1Y2FkL3RhYmxlOjhkZmE2NGQ3NDMzODQ4YTRiZTEzMTU3ZDZmZjI2ZTNmL3RhYmxlcmFuZ2U6OGRmYTY0ZDc0MzM4NDhhNGJlMTMxNTdkNmZmMjZlM2ZfNi0zLTEtMS0xMTIyOTE_074256d1-cd1c-4020-b80f-386eea4f1da5"
      unitRef="usd">16591000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RleHRyZWdpb246MjViYWY5NzJjZjBlNGJjMGEzYzc2YzAzNTVlOGE3MzRfMjc1OQ_bd65faa6-fef0-47b8-8f45-23999345197e">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if an arrangement is a lease at inception. Our operating lease assets are separately stated in operating lease right-of-use ("ROU") assets and our financing lease assets are included in other assets on our condensed consolidated balance sheets. Our lease liabilities are included in accrued liabilities and other long-term liabilities on our condensed &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;consolidated balance sheets. We have elected not to recognize an ROU asset and lease liability for leases with terms of twelve months or less.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Lease ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Most of our leases do not provide an implicit rate, therefore we use our incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term based on the information available at commencement date. Our lease ROU assets exclude lease incentives and initial direct costs incurred. Our lease terms include options to extend when it is reasonably certain that we will exercise that option. All of our leases have stated lease payments, which may include fixed rental increases. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Our leases are for corporate, research and development and sales and support offices, distribution facilities, device service centers and certain equipment. Our leases have original lease terms of one year to fifteen years, some of which include options to extend the leases for up to an additional five years. For all of our leases, we do not include optional periods of extension in our current lease terms for the exercise of options to extend is not reasonably certain.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of our lease cost (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost &#x2014; interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost &#x2014; reduction of ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense on our finance leases is included in interest expense, net in our condensed consolidated statements of operations. The reduction of the operating and finance ROU assets is included as noncash lease expense in selling, general and administrative expenses in our condensed consolidated statements of operations.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental cash flow information related to our leases (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,736&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,864&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,150&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,169&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,062&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,916&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,212&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,085&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,598&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;903&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;816&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,939&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,855&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,842&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,671&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ica8e78475e314beda5cd3faaa0ce02d4_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RleHRyZWdpb246MjViYWY5NzJjZjBlNGJjMGEzYzc2YzAzNTVlOGE3MzRfMTUxNA_c11659a9-7ac2-4b6b-9537-055f590939de">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i40f728bd623845f9b4ce1cfdaf7c303f_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RleHRyZWdpb246MjViYWY5NzJjZjBlNGJjMGEzYzc2YzAzNTVlOGE3MzRfMTUyMA_28fee6a0-a0a7-41a7-b537-1a4c77c8022e">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <icui:Optiontoextendinyears
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RleHRyZWdpb246MjViYWY5NzJjZjBlNGJjMGEzYzc2YzAzNTVlOGE3MzRfMTU5OQ_ebd518d3-f64e-4816-967f-0e23ae82b121">P5Y</icui:Optiontoextendinyears>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RleHRyZWdpb246MjViYWY5NzJjZjBlNGJjMGEzYzc2YzAzNTVlOGE3MzRfMjc2OA_5a0edaa9-e453-4957-84e8-24c90af8053b">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of our lease cost (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost &#x2014; interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost &#x2014; reduction of ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfMi0xLTEtMS0xMTIyOTE_f28ed3d4-68c9-4cee-b534-aa53a366ecdd"
      unitRef="usd">6150000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfMi0zLTEtMS0xMTIyOTE_d8e9e6e2-7f14-43c8-8928-67cc65a5fe9e"
      unitRef="usd">5178000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfMy0xLTEtMS0xMTIyOTE_42f2eeb6-02b8-4f82-9135-ee4c43587f93"
      unitRef="usd">29000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfMy0zLTEtMS0xMTIyOTE_4aafc712-6e42-4977-ab20-ef71c5b7b0e2"
      unitRef="usd">29000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfNC0xLTEtMS0xMTIyOTE_4ecaf86f-73e0-44e3-98a2-85d516d0618f"
      unitRef="usd">225000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfNC0zLTEtMS0xMTIyOTE_9d0e3540-6f09-4a7e-b0b1-8ff743114bae"
      unitRef="usd">170000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:ShortTermLeaseCost
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfNS0xLTEtMS0xMTIyOTE_b8498dd3-69f4-4a68-b6d5-8a5cba9a5784"
      unitRef="usd">13000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfNS0zLTEtMS0xMTIyOTE_68dd1b02-fccf-4a3d-bebe-0ea90ce7948b"
      unitRef="usd">3000</us-gaap:ShortTermLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfOC0xLTEtMS0xMTIyOTE_38316761-cb8b-43b2-ae80-3107e9ae93be"
      unitRef="usd">6417000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlZjc0MzMwNGJjNjRiODk4YjI5OTQxZTA1MmY5NjY3L3RhYmxlcmFuZ2U6N2VmNzQzMzA0YmM2NGI4OThiMjk5NDFlMDUyZjk2NjdfOC0zLTEtMS0xMTIyOTE_04c02d76-fef4-46f6-a266-a15361e98545"
      unitRef="usd">5380000</us-gaap:LeaseCost>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RleHRyZWdpb246MjViYWY5NzJjZjBlNGJjMGEzYzc2YzAzNTVlOGE3MzRfMjc2MA_e0c92106-52d4-4705-99c5-e939cb41886e">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental cash flow information related to our leases (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjU0YmE0OTNiY2U3MDRlZGNiZDc4YWRmOWE5ZTcwMzFlL3RhYmxlcmFuZ2U6NTRiYTQ5M2JjZTcwNGVkY2JkNzhhZGY5YTllNzAzMWVfMy0xLTEtMS0xMTIyOTE_47e33e32-9fdd-4dda-b338-06019f2a0a98"
      unitRef="usd">6051000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjU0YmE0OTNiY2U3MDRlZGNiZDc4YWRmOWE5ZTcwMzFlL3RhYmxlcmFuZ2U6NTRiYTQ5M2JjZTcwNGVkY2JkNzhhZGY5YTllNzAzMWVfMy0zLTEtMS0xMTIyOTE_075dffc5-51ad-48a9-bcaa-e2fbad713d64"
      unitRef="usd">6548000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjU0YmE0OTNiY2U3MDRlZGNiZDc4YWRmOWE5ZTcwMzFlL3RhYmxlcmFuZ2U6NTRiYTQ5M2JjZTcwNGVkY2JkNzhhZGY5YTllNzAzMWVfNC0xLTEtMS0xMTIyOTE_2a1f6464-4d0f-483b-b615-fd7d34dbd3bc"
      unitRef="usd">29000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjU0YmE0OTNiY2U3MDRlZGNiZDc4YWRmOWE5ZTcwMzFlL3RhYmxlcmFuZ2U6NTRiYTQ5M2JjZTcwNGVkY2JkNzhhZGY5YTllNzAzMWVfNC0zLTEtMS0xMTIyOTE_f5d03029-ced0-497f-a739-e57002d16335"
      unitRef="usd">29000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjU0YmE0OTNiY2U3MDRlZGNiZDc4YWRmOWE5ZTcwMzFlL3RhYmxlcmFuZ2U6NTRiYTQ5M2JjZTcwNGVkY2JkNzhhZGY5YTllNzAzMWVfNy0xLTEtMS0xMTIyOTE_ed19dc4c-0da2-4d25-8c5a-b15d0cd5576b"
      unitRef="usd">8979000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjU0YmE0OTNiY2U3MDRlZGNiZDc4YWRmOWE5ZTcwMzFlL3RhYmxlcmFuZ2U6NTRiYTQ5M2JjZTcwNGVkY2JkNzhhZGY5YTllNzAzMWVfNy0zLTEtMS0xMTIyOTE_0e57a590-b5e5-4c8c-98b5-2d95a21730f0"
      unitRef="usd">1493000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjU0YmE0OTNiY2U3MDRlZGNiZDc4YWRmOWE5ZTcwMzFlL3RhYmxlcmFuZ2U6NTRiYTQ5M2JjZTcwNGVkY2JkNzhhZGY5YTllNzAzMWVfOC0xLTEtMS0xMTIyOTE_31704ab2-9def-41a0-bc33-4f79fdaa3c82"
      unitRef="usd">340000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjU0YmE0OTNiY2U3MDRlZGNiZDc4YWRmOWE5ZTcwMzFlL3RhYmxlcmFuZ2U6NTRiYTQ5M2JjZTcwNGVkY2JkNzhhZGY5YTllNzAzMWVfOC0zLTEtMS0xMTIyOTE_ecba7657-389c-4755-84a6-dd4763f3cb19"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <icui:AssetsandLiabilitiesLeasesTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RleHRyZWdpb246MjViYWY5NzJjZjBlNGJjMGEzYzc2YzAzNTVlOGE3MzRfMjc3MA_e0a67e48-b93a-4360-8eb9-763a65430f9b">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,736&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,864&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,150&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,169&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,062&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,916&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,212&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,085&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,598&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;903&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;816&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,939&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,855&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,842&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,671&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</icui:AssetsandLiabilitiesLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfMy0xLTEtMS0xMTIyOTE_fd006fa4-9307-471d-97b3-e5f225bb7a98"
      unitRef="usd">79736000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfMy0zLTEtMS0xMTIyOTE_67387f33-c998-4795-a25f-976819a41e11"
      unitRef="usd">74864000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfNS0xLTEtMS0xMTIyOTE_663eda60-8aa3-4a48-b302-b3dbc797265e"
      unitRef="usd">20150000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfNS0zLTEtMS0xMTIyOTE_abd28bcf-5dac-4058-b54a-c83f3f85f6a8"
      unitRef="usd">18169000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfNi0xLTEtMS0xMTIyOTE_fde7a494-189b-4179-9a6d-d7b574a7857c"
      unitRef="usd">63062000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfNi0zLTEtMS0xMTIyOTE_33ccac95-a491-451d-a782-b09a7a660ab3"
      unitRef="usd">60916000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfNy0xLTEtMS0xMTIyOTE_228fa2cd-3cce-45dc-af7f-d10ae2d5726c"
      unitRef="usd">83212000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfNy0zLTEtMS0xMTIyOTE_c1389bbe-ca4e-4cfe-8085-49fbdfa377c1"
      unitRef="usd">79085000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfMTAtMS0xLTEtMTEyMjkx_51f03898-86ad-420b-a6d1-7a944421f6d0">P6Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfMTAtMy0xLTEtMTEyMjkx_92792b6f-519e-4772-8afc-6644b019d70b">P6Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfMTMtMS0xLTEtMTEyMjkx_8323bdfe-7124-4406-a596-71d5d11897f0"
      unitRef="number">0.0427</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmNjMDA0OGViZmE5OTRiYTVhMjJkYjc0OTIzMDY0N2MzL3RhYmxlcmFuZ2U6Y2MwMDQ4ZWJmYTk5NGJhNWEyMmRiNzQ5MjMwNjQ3YzNfMTMtMy0xLTEtMTEyMjkx_1689a59a-d8ab-4422-bf7a-cb748f1d4e61"
      unitRef="number">0.0434</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfMy0xLTEtMS0xMTIyOTE_7bdfef41-d370-47f2-83d1-983b3a05487c"
      unitRef="usd">2758000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfMy0zLTEtMS0xMTIyOTE_5195af09-37cc-4ba7-8194-ed98dc155949"
      unitRef="usd">2598000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfNS0xLTEtMS0xMTIyOTE_b5ce3579-de84-465c-92d5-44e4eb9098b5"
      unitRef="usd">903000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfNS0zLTEtMS0xMTIyOTE_32996467-441e-47ec-96af-0433d5ca11dc"
      unitRef="usd">816000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfNi0xLTEtMS0xMTIyOTE_a9f5b97f-f801-47d3-9d5a-98061167a5d4"
      unitRef="usd">1939000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfNi0zLTEtMS0xMTIyOTE_6be90806-52f5-40cb-856e-30ff04fce30c"
      unitRef="usd">1855000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfNy0xLTEtMS0xMTIyOTE_f0364fa9-6c66-4e04-92a6-18ca86be94bf"
      unitRef="usd">2842000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfNy0zLTEtMS0xMTIyOTE_87f15943-c029-48d9-9371-7f6df0c89a5d"
      unitRef="usd">2671000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfMTAtMS0xLTEtMTEyMjkx_0271c212-1e35-4ae3-8132-b83385dfb396">P4Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfMTAtMy0xLTEtMTEyMjkx_b9a045ec-be05-443b-9a09-6053c8915fb4">P4Y9M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfMTMtMS0xLTEtMTEyMjkx_5e602dae-d861-4546-86a3-0f2ae4897d5e"
      unitRef="number">0.0447</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOmU0ZjVkOTMzOGU3NTRkNDRiNGM2MDlkYjFiNjk0Mzc5L3RhYmxlcmFuZ2U6ZTRmNWQ5MzM4ZTc1NGQ0NGI0YzYwOWRiMWI2OTQzNzlfMTMtMy0xLTEtMTEyMjkx_10c63588-2b38-4137-900a-e04324d14148"
      unitRef="number">0.0423</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RleHRyZWdpb246MjViYWY5NzJjZjBlNGJjMGEzYzc2YzAzNTVlOGE3MzRfMjc2NQ_8c93af69-7a01-43db-a78d-9d5d4fa440bb">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfMS0xLTEtMS0xMTIyOTE_9c520374-24f5-4338-a3d7-f2e0a4a34747"
      unitRef="usd">17505000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfMS0zLTEtMS0xMTIyOTE_e7fcb3e3-c610-4e56-ac1c-b4390adce258"
      unitRef="usd">778000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfMi0xLTEtMS0xMTIyOTE_d94e5e82-7d24-47f3-8a37-e4ec30b1263f"
      unitRef="usd">20211000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfMi0zLTEtMS0xMTIyOTE_6f3c7cfc-b371-4792-a410-6b5c1122db5d"
      unitRef="usd">766000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfMy0xLTEtMS0xMTIyOTE_01c6d535-4c52-4359-89cd-fb7f309cec91"
      unitRef="usd">14957000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfMy0zLTEtMS0xMTIyOTE_de5aa8d9-f0dd-439d-beb9-c73acbf66e48"
      unitRef="usd">545000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfNC0xLTEtMS0xMTIyOTE_0185dd42-6b1d-4d7e-b109-0435111e15f4"
      unitRef="usd">13244000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfNC0zLTEtMS0xMTIyOTE_85446c97-14a5-4eb3-9a24-c3804b88432f"
      unitRef="usd">423000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfNS0xLTEtMS0xMTIyOTE_0091bcd4-4b30-4e45-b258-ff05aa8c5089"
      unitRef="usd">9635000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfNS0zLTEtMS0xMTIyOTE_835081fa-37c6-4c76-b45b-57f71a1ee3ca"
      unitRef="usd">198000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfNi0xLTEtMS0xMTIyOTE_eec0b432-0c36-4060-a419-2340cffc2bdd"
      unitRef="usd">14315000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfNi0zLTEtMS0xMTIyOTE_fbb540fd-1e46-4077-9902-9203fa39c480"
      unitRef="usd">189000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfNy0xLTEtMS0xMTIyOTE_86cd3954-0f1b-48f4-b940-ba89c223d5d0"
      unitRef="usd">3844000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfNy0zLTEtMS0xMTIyOTE_6e7eb4c1-27e0-4e84-876a-50fff923e1cf"
      unitRef="usd">237000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfOC0xLTEtMS0xMTIyOTE_ac6603c0-9b53-46fd-9831-b8f03fa05bef"
      unitRef="usd">93711000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfOC0zLTEtMS0xMTIyOTE_d372d702-c4df-46a2-9227-11dfabd13e5e"
      unitRef="usd">3136000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfOS0xLTEtMS0xMTIyOTE_1c79f8a1-2cfd-4aaf-8dd4-5ba3e61cd7aa"
      unitRef="usd">10499000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfOS0zLTEtMS0xMTIyOTE_38d1d41a-a609-41e4-9452-2f64b4983bd0"
      unitRef="usd">294000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfMTAtMS0xLTEtMTEyMjkx_cfe9e460-9251-4ae6-be0b-6cb316aad4c0"
      unitRef="usd">83212000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV80OS9mcmFnOjI1YmFmOTcyY2YwZTRiYzBhM2M3NmMwMzU1ZThhNzM0L3RhYmxlOjdlNDU0N2RlMDdlNDQ2MTNhNWIyODgzOGNkMDkzMmU4L3RhYmxlcmFuZ2U6N2U0NTQ3ZGUwN2U0NDYxM2E1YjI4ODM4Y2QwOTMyZThfMTAtMy0xLTEtMTEyMjkx_07273474-064b-4891-aa02-9044937d4b6f"
      unitRef="usd">2842000</us-gaap:FinanceLeaseLiability>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RleHRyZWdpb246OTY4OGYxMTdjNDFmNDVhZjhmNDExZDg4MzhkNjg5OTZfMTQzOQ_6b5f7ae7-7bc3-43ae-90e9-f63b972153ee">Net Income Per Share&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period plus dilutive securities. Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options and restricted stock units that are anti-dilutive are not included in the treasury stock method calculation. Due to the net loss for the three months ended March&#160;31, 2023 and 2022, any potentially dilutive common shares were not included in the computation of diluted earnings per share as they would have had an anti-dilutive effect; therefore, basic and diluted net loss per share are equal for each of the three months ended March 31, 2023 and 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the calculation of net earnings per common share (&#x201c;EPS&#x201d;) &#x2014; basic and diluted (in thousands, except per share data):&#160; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,812)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares outstanding (basic)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common and common equivalent shares outstanding (diluted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS &#x2014; diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Due to the net loss for the three months ended March 31, 2023 and 2022, there are no potentially dilutive common shares included in the computation of diluted earnings per share.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RleHRyZWdpb246OTY4OGYxMTdjNDFmNDVhZjhmNDExZDg4MzhkNjg5OTZfMTQzNw_655b687e-e99b-4821-9102-1da8d577c969">The following table presents the calculation of net earnings per common share (&#x201c;EPS&#x201d;) &#x2014; basic and diluted (in thousands, except per share data):&#160; &lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,812)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares outstanding (basic)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common and common equivalent shares outstanding (diluted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS &#x2014; diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Due to the net loss for the three months ended March 31, 2023 and 2022, there are no potentially dilutive common shares included in the computation of diluted earnings per share.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfMi0xLTEtMS0xMTIyOTE_393701f2-7f9c-4152-86db-ac0271562008"
      unitRef="usd">-9812000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfMi0zLTEtMS0xMTIyOTE_701093ac-10a9-43e3-a5fb-d2686ae496fd"
      unitRef="usd">-38068000</us-gaap:ProfitLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfMy0xLTEtMS0xMTIyOTE_953a4ee0-6c05-4536-9a36-585f6fed5d46"
      unitRef="shares">24014000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfMy0zLTEtMS0xMTIyOTE_40bdc8d8-215d-45c8-ac25-b0cd5d208281"
      unitRef="shares">23646000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfNC0xLTEtMS0xMTIyOTE_ee56ccfe-e09f-4273-afea-aca37b66f0fd"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfNC0zLTEtMS0xMTIyOTE_76533f5a-b790-40ff-9b00-1def22dedcb3"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfNS0xLTEtMS0xMTIyOTE_1a12ce0e-4622-4736-8639-cbd6364cae4f"
      unitRef="shares">24014000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfNS0zLTEtMS0xMTIyOTE_099018d0-4903-4bd3-9f60-4537fff9c727"
      unitRef="shares">23646000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfNi0xLTEtMS0xMTIyOTE_01d4ae51-955a-4ba9-ba2d-e0552e67e204"
      unitRef="usdPerShare">-0.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfNi0zLTEtMS0xMTIyOTE_769b0b4d-9d6b-44b3-92a4-45cd6fbf90cc"
      unitRef="usdPerShare">-1.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfNy0xLTEtMS0xMTIyOTE_cf739c99-2b8e-433f-8986-2c361c487fac"
      unitRef="usdPerShare">-0.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81Mi9mcmFnOjk2ODhmMTE3YzQxZjQ1YWY4ZjQxMWQ4ODM4ZDY4OTk2L3RhYmxlOjYwY2FiNGQ1NDc0MDRiMmM5YzhkY2ZkNDNmZjkxMGJlL3RhYmxlcmFuZ2U6NjBjYWI0ZDU0NzQwNGIyYzljOGRjZmQ0M2ZmOTEwYmVfNy0zLTEtMS0xMTIyOTE_99ee1efa-d5da-44b8-a645-fbe0af6548d9"
      unitRef="usdPerShare">-1.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNjA3NQ_ac17a367-9485-4584-b60b-6a09df1e5694">Derivatives and Hedging Activities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hedge Accounting and Hedging Program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The purposes of our cash flow hedging programs are to manage the foreign currency exchange rate risk on forecasted revenues and expenses denominated in currencies other than the functional currency of the operating unit, and to manage floating interest rate risk associated with future interest payments on the variable-rate term loans issued in January 2022. We do not issue derivatives for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions. The derivative instruments we utilize, including various foreign exchange contracts and interest rate swaps, are designated and qualify as cash flow hedges. Our derivative instruments are recorded at fair value on the condensed consolidated balance sheets and are classified based on the instrument's maturity date. We record gains or losses from changes in the fair values of the derivative instruments as a component of other comprehensive income (loss) and we reclassify those gains or losses into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. If the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, we reclassify the gain or loss on the related derivative instrument from accumulated other comprehensive loss into earnings immediately.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Exchange Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Exchange Forward Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into foreign exchange forward contracts to hedge a portion of our forecasted foreign currency-denominated revenues and expenses to minimize the effect of foreign exchange rate movements on the related cash flows. These contracts are agreements to buy or sell a quantity of a currency at a predetermined future date and at a predetermined exchange rate. Our foreign exchange forward contracts hedge exposures principally denominated in Mexican Pesos ("MXN"), Euros, Czech Koruna ("CZK"), Japanese Yen ("JPY"), Swedish Krona ("SEK"), Chinese Renminbi ("CNH"), Canadian Dollar ("CAD") and Australian Dollar ("AUD") and have varying maturities with an average term of approximately twelve months. The total notional amount of these outstanding derivative contracts as of March&#160;31, 2023 was $101.8&#160;million, which included the notional equivalent of $3.6&#160;million in MXN, $26.4&#160;million in Euros, $4.7&#160;million in CZK, $21.2&#160;million in JPY, $14.8&#160;million in CNH, $2.7&#160;million in SEK, $13.1&#160;million in CAD, $13.1&#160;million in AUD and $2.2&#160;million in other foreign currencies, with terms currently through June 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cross-currency Par Forward Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into cross-currency par forward contracts to hedge a portion of our Mexico forecasted expenses denominated in MXN. These contracts are agreements to exchange cash flows from one currency to another at specified intervals over the contract term with all exchanges occurring at the same predetermined rate. In November 2021, we entered into a one-year cross-currency par forward contract with a term from December 1, 2021 to December 1, 2022. The total notional amount of this outstanding derivative as of March 31, 2022 was approximately 311.6&#160;million MXN. This derivative instrument matures in equal monthly amounts at a fixed forward rate of 21.60 MXN/USD.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Floating Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, in anticipation of entering into the new senior secured credit facilities in January 2022, which includes a variable-rate term loan A and a variable-rate term loan B (see Note 17: Long-Term Debt), we entered into two forward-starting interest rate swaps. In February 2022, certain terms under the agreements were amended to reflect the transition from LIBOR to the Secured Overnight Financing Rate ("SOFR"), an alternative reference rate. Under the interest rate swap agreements, we exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount. Effective March 30, 2022, the term loan A swap, as amended, has an initial notional amount of $300.0&#160;million, reducing to $150.0&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2027. We will pay a fixed rate of 1.32% and will receive the greater of 3-month USD SOFR or (0.15)%. Effective March 30, 2022, the term loan B swap, as amended, has an initial notional amount of $750.0&#160;million, reducing to $46.9&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2026. We will pay a fixed rate of 1.17% and will receive the greater of 3-month USD SOFR or 0.35%. These swaps effectively convert the relevant portion of the floating-rate term loans to fixed rates.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the fair values of our derivative instruments included within the Condensed Consolidated Balance Sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Cash Flow Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Condensed Consolidated Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Exchange Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNC0wLTEtMS0xMTIyOTE_cfaec65c-7e6a-4276-963b-bd9a55c586b9"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNS0wLTEtMS0xMTIyOTE_a381aeb8-d171-4550-9ed5-50b193801e56"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOC0wLTEtMS0xMTIyOTE_31479843-5a18-4da4-b2e9-8a0ab42c6b76"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOS0wLTEtMS0xMTIyOTE_0314024e-19ca-42c9-bda0-6b9963e62d6c"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTMtMC0xLTEtMTEyMjkx_b4e70733-51f6-4cf5-a4f0-4e3344743eed"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTQtMC0xLTEtMTEyMjkx_c7f29940-14d5-49dd-8334-2995d9c76144"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTctMC0xLTEtMTEyMjkx_6e89f792-0047-409f-ae97-92f90a1a3b54"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTgtMC0xLTEtMTEyMjkx_e58a7954-fa23-4f46-8db3-028044ca9ce7"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized the following gains on our derivative instruments designated as cash flow hedges in other comprehensive income before reclassifications to net loss (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.461%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Derivatives designated as cash flow hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as cash flow hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Reclassified From Accumulated Other Comprehensive (Loss) Income into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Gain (Loss) Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Derivatives designated as cash flow hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNC0yLTEtMS0xMTIyOTE_f380e986-354b-4ae5-be66-0d8180b7e6bd"&gt;Total revenues&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,922)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNS0yLTEtMS0xMTIyOTE_e0200ea4-951a-4f15-aa0d-730e8294b71c"&gt;Cost of goods sold&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (expense) income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNy0yLTEtMS0xMTIyOTE_faab4624-13eb-4610-aa53-f7352f932ffd"&gt;Interest expense&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as cash flow hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Represents location of gain reclassified from accumulated other comprehensive income into income as a result of ineffectiveness.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Represents location of gain reclassified from accumulated other comprehensive income into income as a result of forecasted transactions no longer probable of occurring.&lt;/span&gt;&lt;/div&gt;As of March&#160;31, 2023, we expect an estimated $5.3&#160;million in deferred gains on the outstanding foreign exchange contracts and an estimated $26.3&#160;million in deferred gains on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjQ5Mg_cb54a3f4-a475-49d2-8584-921df3d78809"
      unitRef="usd">101800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i104614519533468cb1d3f4a1f7ede191_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjUzOA_47107cbd-ef54-4ff1-9073-12bf46c911e3"
      unitRef="usd">3600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ieed1db1afe2e4864acbe51f8f742e903_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjU0OQ_2085ae0a-6dab-4af4-9dca-4f025d809ee0"
      unitRef="usd">26400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ica866edd3bbb4be194fb9fbe70eab0c3_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjU2Mg_08b8f831-6f23-4108-a364-f67df83c8e28"
      unitRef="usd">4700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i98371e0ede62423e94e012fb74cce6db_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjU3Mw_922e673d-eb6f-4ec1-aad7-4dfda2841c7e"
      unitRef="usd">21200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7cacbfb1e2ec47f181ee075ab70cca83_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjU4NA_97458820-7705-4d7a-baeb-aab2118682ed"
      unitRef="usd">14800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i05b8d7e5a0c94ec0abe63ce8b2a92789_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjU5NQ_53bde34c-3b89-42b7-b8fb-380b2f956f36"
      unitRef="usd">2700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8c884f97d3444f6ea4dcd4b55692fdb4_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjYwNg_6d164dba-15a7-48a5-8a1e-bf65b4e37483"
      unitRef="usd">13100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0f2b698f9db545af9bce00c8273f5099_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjYxNw_2f092522-6a33-420d-9480-3d82b3ef36d8"
      unitRef="usd">13100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8321aa0d52a040748fa39ebb30857208_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMjYzMQ_00ae2a01-ac09-48ce-8cc2-2daa4b790a24"
      unitRef="usd">2200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i32a51ec3c4454197ad187d461dff39ee_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMzM3Ng_753da41a-20fd-461d-810a-61803e4095e1"
      unitRef="mxn">311600000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeForwardExchangeRate1
      contextRef="id1c83cae5660471ba0a2606a294d663d_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfMzQ4NA_aceac7dd-4f6f-47b3-8cc7-769e4ae1840a"
      unitRef="number">21.60</us-gaap:DerivativeForwardExchangeRate1>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i41865436086741dba4582ecb29b5d80f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNDQ4MQ_abf78f58-34f8-4b71-9737-9bbb4284a2dd"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <icui:InterestRateSwapEndingNotionalValue
      contextRef="i41865436086741dba4582ecb29b5d80f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNDQ5Nw_b1613fee-03b0-4f49-b38b-6969bf817abb"
      unitRef="usd">150000000</icui:InterestRateSwapEndingNotionalValue>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i41865436086741dba4582ecb29b5d80f_I20230331"
      decimals="6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNDYwNA_c85587ac-d51d-46e7-8251-c07e97c13e8d"
      unitRef="number">0.0132</us-gaap:DerivativeFixedInterestRate>
    <icui:DerivativeVariableRateFloor
      contextRef="i41865436086741dba4582ecb29b5d80f_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNDY1OQ_68a0572c-72e8-41a4-8a28-62c4f14875d6"
      unitRef="number">-0.0015</icui:DerivativeVariableRateFloor>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i86157d0618294ee89c1fc6807b08141e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNDc1Nw_aaf6da9c-862d-4760-ba38-56b74e990301"
      unitRef="usd">750000000</us-gaap:DerivativeNotionalAmount>
    <icui:InterestRateSwapEndingNotionalValue
      contextRef="i86157d0618294ee89c1fc6807b08141e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNDc3Mw_ed434747-e686-4e01-b7d6-71158f09bc17"
      unitRef="usd">46900000</icui:InterestRateSwapEndingNotionalValue>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i86157d0618294ee89c1fc6807b08141e_I20230331"
      decimals="6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNDg4MA_be9cbcac-639b-4387-a500-6279dcc43351"
      unitRef="number">0.0117</us-gaap:DerivativeFixedInterestRate>
    <icui:DerivativeVariableRateFloor
      contextRef="i86157d0618294ee89c1fc6807b08141e_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNDkzNQ_81d22bfa-3b4c-4c54-a139-d60388acf54f"
      unitRef="number">0.0035</icui:DerivativeVariableRateFloor>
    <us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNjA3Mw_366091e2-7e79-42f8-a5f3-e206bc53ad7f">The following table presents the fair values of our derivative instruments included within the Condensed Consolidated Balance Sheets (in thousands):&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Cash Flow Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Condensed Consolidated Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Exchange Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNC0wLTEtMS0xMTIyOTE_cfaec65c-7e6a-4276-963b-bd9a55c586b9"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNS0wLTEtMS0xMTIyOTE_a381aeb8-d171-4550-9ed5-50b193801e56"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOC0wLTEtMS0xMTIyOTE_31479843-5a18-4da4-b2e9-8a0ab42c6b76"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOS0wLTEtMS0xMTIyOTE_0314024e-19ca-42c9-bda0-6b9963e62d6c"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTMtMC0xLTEtMTEyMjkx_b4e70733-51f6-4cf5-a4f0-4e3344743eed"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTQtMC0xLTEtMTEyMjkx_c7f29940-14d5-49dd-8334-2995d9c76144"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTctMC0xLTEtMTEyMjkx_6e89f792-0047-409f-ae97-92f90a1a3b54"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTgtMC0xLTEtMTEyMjkx_e58a7954-fa23-4f46-8db3-028044ca9ce7"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized the following gains on our derivative instruments designated as cash flow hedges in other comprehensive income before reclassifications to net loss (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.461%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Derivatives designated as cash flow hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as cash flow hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="ie7f51fd80feb455d9784516bdd6b7c63_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNC0yLTEtMS0xMTIyOTE_492d0d59-2cd7-4f9b-8fc5-f76846d2bd5a"
      unitRef="usd">7433000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="id6bcc5cb934c484085e4c9d001608c4b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNC00LTEtMS0xMTIyOTE_93791020-f837-40e1-96db-01efc3506be9"
      unitRef="usd">25560000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNC02LTEtMS0xMTIyOTE_49e05355-da5a-4320-934a-8b1a4626ebb1"
      unitRef="usd">32993000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="ie7f51fd80feb455d9784516bdd6b7c63_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNS0yLTEtMS0xMTIyOTE_a02863f2-9040-4dd3-8f36-fbe1b57027f0"
      unitRef="usd">51000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="id6bcc5cb934c484085e4c9d001608c4b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNS00LTEtMS0xMTIyOTE_97905e10-db86-424c-9da1-3ca9fefa988e"
      unitRef="usd">19672000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNS02LTEtMS0xMTIyOTE_0f07bb9e-4f9e-42a1-877a-67137b9d8c3c"
      unitRef="usd">19723000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssets
      contextRef="ie7f51fd80feb455d9784516bdd6b7c63_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNi0yLTEtMS0xMTIyOTE_f3a171ed-dd8f-4279-9349-994ad08fb747"
      unitRef="usd">7484000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="id6bcc5cb934c484085e4c9d001608c4b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNi00LTEtMS0xMTIyOTE_c2551578-f43b-465b-aa9b-b2dcc76fce93"
      unitRef="usd">45232000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfNi02LTEtMS0xMTIyOTE_74cc03d3-00da-493c-aec4-ee0bb64a04ca"
      unitRef="usd">52716000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="ie7f51fd80feb455d9784516bdd6b7c63_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOC0yLTEtMS0xMTIyOTE_82034d12-92a9-422a-97d1-e3ac3504c0e7"
      unitRef="usd">2132000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="id6bcc5cb934c484085e4c9d001608c4b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOC00LTEtMS0xMTIyOTE_99ebd993-97cf-40ab-bfea-acfddcfc23e5"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOC02LTEtMS0xMTIyOTE_d56fef2c-697d-4521-bafc-2694ed98974d"
      unitRef="usd">2132000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="ie7f51fd80feb455d9784516bdd6b7c63_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOS0yLTEtMS0xMTIyOTE_95783636-5759-4b8d-b104-6a0587b269fc"
      unitRef="usd">41000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="id6bcc5cb934c484085e4c9d001608c4b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOS00LTEtMS0xMTIyOTE_d60751e0-fb73-45ca-84c0-f1a4ee2eb468"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfOS02LTEtMS0xMTIyOTE_13bb880b-64b2-4ef6-975d-2d692b9fd8db"
      unitRef="usd">41000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilities
      contextRef="ie7f51fd80feb455d9784516bdd6b7c63_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTAtMi0xLTEtMTEyMjkx_5be3df7d-d723-4ab1-8663-d2c2583b3f54"
      unitRef="usd">2173000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="id6bcc5cb934c484085e4c9d001608c4b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTAtNC0xLTEtMTEyMjkx_0aff8bc3-1d22-4e6b-a599-2b80d5ffa6fa"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTAtNi0xLTEtMTEyMjkx_96b5d8ee-1c76-41b3-8021-586b8cf69e72"
      unitRef="usd">2173000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="icc4d8e7ceb96467cae741d1df3ad1fbf_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTMtMi0xLTEtMTEyMjkx_4479e4aa-dfe5-4cde-a8e3-fc3edb664cac"
      unitRef="usd">4860000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i631e83ee61b74e3abeaa5ad6e7bab2b1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTMtNC0xLTEtMTEyMjkx_bf4eaab2-1061-4d0e-ade9-169f7008960d"
      unitRef="usd">28431000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTMtNi0xLTEtMTEyMjkx_f76b1afb-0973-4b57-ad1b-d27d8111a0fb"
      unitRef="usd">33291000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="icc4d8e7ceb96467cae741d1df3ad1fbf_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTQtMi0xLTEtMTEyMjkx_a0153dc0-8959-47e9-8b9e-4311270fb5ea"
      unitRef="usd">94000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i631e83ee61b74e3abeaa5ad6e7bab2b1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTQtNC0xLTEtMTEyMjkx_88c40b9e-dc62-4a21-81ae-7eab4774af58"
      unitRef="usd">26753000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTQtNi0xLTEtMTEyMjkx_a02d04af-5e72-4980-a4d8-10ad40790f0a"
      unitRef="usd">26847000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssets
      contextRef="icc4d8e7ceb96467cae741d1df3ad1fbf_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTUtMi0xLTEtMTEyMjkx_95d2abb4-89c2-4087-9435-839664dc93e6"
      unitRef="usd">4954000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i631e83ee61b74e3abeaa5ad6e7bab2b1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTUtNC0xLTEtMTEyMjkx_5f415341-c18f-4d0c-b079-eff66bb7e8c3"
      unitRef="usd">55184000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTUtNi0xLTEtMTEyMjkx_2c37c608-b345-4a7d-88d9-eb47c1910839"
      unitRef="usd">60138000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="icc4d8e7ceb96467cae741d1df3ad1fbf_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTctMi0xLTEtMTEyMjkx_8a842ac8-aa7e-44d0-bf7b-ae01b1b9f9ec"
      unitRef="usd">1847000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i631e83ee61b74e3abeaa5ad6e7bab2b1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTctNC0xLTEtMTEyMjkx_a008117a-f3fb-494f-afde-579dd978fe18"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTctNi0xLTEtMTEyMjkx_450f988e-3a98-4ca5-9eb2-3da2442d3627"
      unitRef="usd">1847000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="icc4d8e7ceb96467cae741d1df3ad1fbf_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTgtMi0xLTEtMTEyMjkx_17d67151-904f-43f7-8d4c-df3c6d448ed5"
      unitRef="usd">167000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i631e83ee61b74e3abeaa5ad6e7bab2b1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTgtNC0xLTEtMTEyMjkx_4490d8cc-f6b9-4606-9a99-d6e6814fa892"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTgtNi0xLTEtMTEyMjkx_a8a0e18b-741c-4843-aef3-d34e71f5ea98"
      unitRef="usd">167000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilities
      contextRef="icc4d8e7ceb96467cae741d1df3ad1fbf_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTktMi0xLTEtMTEyMjkx_b2181a8b-ef66-4091-b0e3-d5375731b870"
      unitRef="usd">2014000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i631e83ee61b74e3abeaa5ad6e7bab2b1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTktNC0xLTEtMTEyMjkx_3f347b23-12e8-43d8-bf24-d07ff9e02915"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOjM0MGNhODBhN2JiMTQzYjU5MWRhZjkxZjRlZDkzMGU3L3RhYmxlcmFuZ2U6MzQwY2E4MGE3YmIxNDNiNTkxZGFmOTFmNGVkOTMwZTdfMTktNi0xLTEtMTEyMjkx_8d3197d4-8905-4da6-93c3-2ec9ce2e3c3e"
      unitRef="usd">2014000</us-gaap:DerivativeLiabilities>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="icc9bb67f131a49a8b919336073869658_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmUzNzZhYjdjZTg4NjRmZGQ4MTY5Nzc0YTA2ZjhmOWZmL3RhYmxlcmFuZ2U6ZTM3NmFiN2NlODg2NGZkZDgxNjk3NzRhMDZmOGY5ZmZfNC0yLTEtMS0xMTIyOTE_19db966a-1d02-4dbc-ad07-fcf341782e32"
      unitRef="usd">2451000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i3e60d283c38e4b35bb0be9fcf2699bec_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmUzNzZhYjdjZTg4NjRmZGQ4MTY5Nzc0YTA2ZjhmOWZmL3RhYmxlcmFuZ2U6ZTM3NmFiN2NlODg2NGZkZDgxNjk3NzRhMDZmOGY5ZmZfNC00LTEtMS0xMTIyOTE_26267762-f3cb-4d8e-9a87-f2fffc62bb37"
      unitRef="usd">3112000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i0c2531beb9494ed7a57f1659c8d16d2a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmUzNzZhYjdjZTg4NjRmZGQ4MTY5Nzc0YTA2ZjhmOWZmL3RhYmxlcmFuZ2U6ZTM3NmFiN2NlODg2NGZkZDgxNjk3NzRhMDZmOGY5ZmZfNS0yLTEtMS0xMTIyOTE_8c08f0fc-ac2c-4b27-b152-6d48e03e7c28"
      unitRef="usd">-2584000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i8f7f6f4d53994f44b8df01e0704834c5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmUzNzZhYjdjZTg4NjRmZGQ4MTY5Nzc0YTA2ZjhmOWZmL3RhYmxlcmFuZ2U6ZTM3NmFiN2NlODg2NGZkZDgxNjk3NzRhMDZmOGY5ZmZfNS00LTEtMS0xMTIyOTE_d006b1d1-6b47-4138-aeef-099a1cbad983"
      unitRef="usd">30051000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmUzNzZhYjdjZTg4NjRmZGQ4MTY5Nzc0YTA2ZjhmOWZmL3RhYmxlcmFuZ2U6ZTM3NmFiN2NlODg2NGZkZDgxNjk3NzRhMDZmOGY5ZmZfNi0yLTEtMS0xMTIyOTE_5a3d041c-b0fa-4e98-bac4-2e4af2bd4692"
      unitRef="usd">-133000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmUzNzZhYjdjZTg4NjRmZGQ4MTY5Nzc0YTA2ZjhmOWZmL3RhYmxlcmFuZ2U6ZTM3NmFiN2NlODg2NGZkZDgxNjk3NzRhMDZmOGY5ZmZfNi00LTEtMS0xMTIyOTE_5bf56bbd-c87c-4131-9fbe-fa89199c4c03"
      unitRef="usd">33163000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNjA2NA_2f129156-1e71-46c9-891b-482b1384abb3">&lt;div style="margin-top:5pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Reclassified From Accumulated Other Comprehensive (Loss) Income into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Gain (Loss) Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Derivatives designated as cash flow hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNC0yLTEtMS0xMTIyOTE_f380e986-354b-4ae5-be66-0d8180b7e6bd"&gt;Total revenues&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,922)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNS0yLTEtMS0xMTIyOTE_e0200ea4-951a-4f15-aa0d-730e8294b71c"&gt;Cost of goods sold&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (expense) income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNy0yLTEtMS0xMTIyOTE_faab4624-13eb-4610-aa53-f7352f932ffd"&gt;Interest expense&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as cash flow hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Represents location of gain reclassified from accumulated other comprehensive income into income as a result of ineffectiveness.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Represents location of gain reclassified from accumulated other comprehensive income into income as a result of forecasted transactions no longer probable of occurring.&lt;/span&gt;&lt;/div&gt;As of March&#160;31, 2023, we expect an estimated $5.3&#160;million in deferred gains on the outstanding foreign exchange contracts and an estimated $26.3&#160;million in deferred gains on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i45dae7757b124552a2b2f3b01ce6c186_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNC00LTEtMS0xMTIyOTE_0b8db45d-aaa5-4fa2-b201-e08f321c03ef"
      unitRef="usd">1922000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i8b5bae88141345639dcc3eac627c0799_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNC02LTEtMS0xMTIyOTE_e1fed420-5029-42c6-98a6-2d42fc98e784"
      unitRef="usd">-2543000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i48a10cc5a2694f10b44bf1877ec9bebc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNS00LTEtMS0xMTIyOTE_7f915987-58e7-4a51-9dd6-70a5a4207144"
      unitRef="usd">-1500000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i108862c46a0d4e1295be73061c8600e8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNS02LTEtMS0xMTIyOTE_d8d3ab8b-ff89-4e81-8675-3084ca952097"
      unitRef="usd">513000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNi00LTEtMS0xMjA4NDc_fcbd74b1-894a-498d-a28f-1b8fd3943e6e"
      unitRef="usd">229000</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
    <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNi02LTEtMS0xMjA4NDk_7c4c5bb2-36db-4dbb-be28-caeaa11f0fe3"
      unitRef="usd">0</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
    <us-gaap:GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring
      contextRef="i974e647072aa44e980b4ed61c129befa_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNi00LTEtMS0xMTIyOTE_921634aa-4afe-4b96-a6ef-634c002ada7f"
      unitRef="usd">13000</us-gaap:GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring>
    <us-gaap:GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring
      contextRef="i0c8639dba4434deab359b7b242f47fbd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNi02LTEtMS0xMTIyOTE_adeee894-48e3-4ed4-93af-64dc8ed012dc"
      unitRef="usd">249000</us-gaap:GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i12ebce1f4c61414eb59c03244fef43b4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNy00LTEtMS0xMTIyOTE_1dc80291-fba3-4906-b6e1-6d9a929ab2ed"
      unitRef="usd">-7369000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i73bc74286d9f4e128411e29701d4efc8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfNy02LTEtMS0xMTIyOTE_8620e4d2-ac41-4925-b334-e2c62a739728"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i9c48ae5abe2f4e6caf6fbf46c2c6e69a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfOC00LTEtMS0xMTIyOTE_28fb5022-8106-46ba-8018-8885bbb3326b"
      unitRef="usd">7189000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i22bda3a55c764257a1a89a08923962af_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RhYmxlOmI5NTkwNjNkNDY0MTRiM2Q4MjRlYmIyMDdmNWI5ZDkxL3RhYmxlcmFuZ2U6Yjk1OTA2M2Q0NjQxNGIzZDgyNGViYjIwN2Y1YjlkOTFfOC02LTEtMS0xMTIyOTE_4871ce08-4a26-4ed4-a311-27b9bbd6d418"
      unitRef="usd">2279000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNTc0MQ_ce9ed75a-614a-43ab-b7ef-1b528fa20438"
      unitRef="usd">5300000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81NS9mcmFnOmRhZTk0ZGI5ZWUwNjRhNzdhODBjODlmYzI4YTdiMTVkL3RleHRyZWdpb246ZGFlOTRkYjllZTA2NGE3N2E4MGM4OWZjMjhhN2IxNWRfNTgyNQ_dcd43b1a-e997-4693-8472-2d34ce6f8352"
      unitRef="usd">26300000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfNzgwNg_829d8e57-c575-42f4-b875-74e1d100331c">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. There are three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1:  quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2:  inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3:  unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent Earn-out Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, we acquired Smiths Medical with a combination of cash consideration and share consideration issued at closing. Total consideration for the acquisition includes a potential earn-out payment of $100.0&#160;million in cash contingent on our common stock achieving certain Price Targets from the closing date to either the third or fourth anniversary of closing (see Note 3: Acquisitions for additional information) and provided Smiths beneficially owns at least 50.0% of the shares of common stock issued at closing at the time the Price Target is achieved. The initial estimated fair value of the earn-out was determined to be $53.5&#160;million. The initial fair value of the earn-out was determined using a Monte Carlo simulation model. The model utilized several assumptions including volatility and the risk-free interest rate. The assumed volatility is based on the average of the historical volatility of our common stock price and the implied volatility of certain at-the-money traded options. The risk-free interest rate is equal to the yield on U.S. Treasury securities at constant maturity for the period commensurate with the term of the earn-out. At each reporting date subsequent to the acquisition, we will remeasure the earn-out liability and recognize any changes in its fair value in our consolidated statements of operations. If the probability of achieving the Price Targets during their respective measurement periods is significantly greater than initially anticipated, the realization of an additional liability and related expense will have a significant impact on our consolidated financial statements in the period recognized. As of March&#160;31, 2023, the estimated fair value of the contingent earn-out is $20.3&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of December 31, 2022, the measurement period related to (i) above ended, and based on the actual revenue achieved during the measurement period we determined that the fair value of the contingent earn-out was zero as the minimum threshold for earning the earn-out was not met. As of March&#160;31, 2023, the estimated fair value for the contingent earn-out related to certain product-related regulatory certifications was estimated to be $1.5&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out payment shall not exceed $6.0&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of both March 31, 2023 and December 31, 2022, the estimated fair value of the contingent earn-out is $2.6&#160;million. The estimated fair value of the contingent earn-out is calculated using a probability-weighted cash flow model based on historical revenue streams and the likelihood that the revenue targets will be met.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Our contingent earn-out liabilities are separately stated on our condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide a reconciliation of the Level 3 earn-out liabilities measured at estimated fair value (in thousands):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earn-out Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of earn-out (included in income from operations as a separate line item)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earn-out Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition date fair value estimate of earn-out&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Primarily relates to Smiths Medical.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$53.5&#160;million relates to our acquisition of Smiths Medical and $1.6&#160;million relates to our acquisition of a small foreign infusions systems supplier in the fourth quarter of 2021 (see Note 3: Acquisitions).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide quantitative information about Level 3 inputs for fair value measurement of our earn-out liabilities related to Smiths Medical:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smiths Medical Earn-out Liability&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Simulation Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-Free Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments, Foreign Exchange Contracts and Interest Rate Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Our investments consist of corporate bonds and U.S treasury securities. The fair value of our corporate bonds is estimated using observable market-based inputs such as quoted prices, interest rates and yield curves or Level 2 inputs. The fair value of our U.S. treasury securities are based on quoted market prices in active markets and are included in the Level 1 fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The fair value of our Level 2 foreign exchange contracts, including forward contracts and cross-currency par forward contracts, is estimated using observable market inputs such as known notional value amounts, spot and forward exchange rates. These inputs relate to liquid, heavily traded currencies with active markets which are available for the full term of the derivative.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our Level 2 interest rate swaps is estimated using a pricing model that reflects the terms of the contracts, including the period to maturity, and relies on observable market inputs such as known notional value amounts and USD interest rate curves.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our assets and liabilities measured at fair value on a recurring basis consisted of the following Level 1, 2 and 3 inputs as defined above (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&#160;measurements&#160;as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&#160;carrying&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&lt;br/&gt;in&#160;active&lt;br/&gt;markets&#160;for&lt;br/&gt;identical&lt;br/&gt;assets&#160;(level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;other&lt;br/&gt;observable&lt;br/&gt;inputs&#160;(level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&#160;(level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTAtMC0xLTEtMTEyMjkx_f14ce4d4-85f2-4d23-a88b-1739598efd81"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTEtMC0xLTEtMTEyMjkx_d56c9d3d-0932-4348-b69d-8f57de5603f9"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTUtMC0xLTEtMTEyMjkx_6bcfe6ca-ff2c-4a0b-9003-1212bc82d7dd"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTYtMC0xLTEtMTEyMjkx_308e7868-3fa9-4233-8466-3e1183fa8b50"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out liability - LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjMtMC0xLTEtMTEyMjkx_5523e65b-55dc-41c6-8709-df1a94648036"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjQtMC0xLTEtMTIwNzE1_62efbfc3-1b08-43d2-b4de-0ebc769246ce"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&#160;measurements&#160;as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&#160;carrying&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&lt;br/&gt;in&#160;active&lt;br/&gt;markets&#160;for&lt;br/&gt;identical&lt;br/&gt;assets&#160;(level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;other&lt;br/&gt;observable&lt;br/&gt;inputs&#160;(level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&#160;(level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange forwards:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNy0wLTEtMS0xMTIyOTE_50321293-4bf5-432f-9a23-856af180772d"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out liability - LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTgtMC0xLTEtMTEyMjkx_38c2c727-8408-4048-b07a-938ff12e83e6"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <icui:Contingentconsiderationgross
      contextRef="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMTE4MQ_2718a2ef-51d7-4b1b-9075-8893b0a27a63"
      unitRef="usd">100000000</icui:Contingentconsiderationgross>
    <icui:OwnershipRequirementForEarnoutPayment
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="8"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMTQzMQ_1eabdd33-8df3-43d6-af2b-325ce5bcdf22"
      unitRef="number">0.500</icui:OwnershipRequirementForEarnoutPayment>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id05515fe4472496ab29e975ca6d18184_I20220106"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMTU5NA_58699d49-d0e0-43b7-bf23-a34a1e451b9e"
      unitRef="usd">53500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMjY2OA_01aa70b4-e9d7-4200-9410-e84f3af2bb91"
      unitRef="usd">20300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <icui:Contingentconsiderationgross
      contextRef="ie9945fc3bd5d4b24a1e69091bf0384fd_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMjgzNw_e10307a7-f5ec-4707-b669-78854c78f822"
      unitRef="usd">2500000</icui:Contingentconsiderationgross>
    <icui:ContingentConsiderationGrossST
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMjg3Nw_c35eb2fb-3f26-4987-8569-b0918ed966ec"
      unitRef="usd">1000000</icui:ContingentConsiderationGrossST>
    <icui:ContingentConsiderationGrossLT
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMzAyNA_c463bf09-1317-4a22-8eb1-bf56695860d9"
      unitRef="usd">1500000</icui:ContingentConsiderationGrossLT>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia818e4969fa7407895eb98d2469bf054_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMzE4OA_fda4c46b-a969-4ccb-b01e-1aa8e015a1a7"
      unitRef="usd">1500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <icui:Contingentconsiderationgross
      contextRef="ifb3a2f75275841ddb552fdb5a627b2b2_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMzUzMw_7375c233-bace-45fe-bf0d-9721a630db20"
      unitRef="usd">6000000</icui:Contingentconsiderationgross>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ifb41da7d968840ea810ecb453fece23f_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfMzk2Mw_4712af82-7045-4023-95a7-396b54cad560"
      unitRef="usd">2600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfNzc5NQ_0bcc0d6f-7c6c-4e31-933d-58d0fa8ad2fc">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide a reconciliation of the Level 3 earn-out liabilities measured at estimated fair value (in thousands):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earn-out Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of earn-out (included in income from operations as a separate line item)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earn-out Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition date fair value estimate of earn-out&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Primarily relates to Smiths Medical.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$53.5&#160;million relates to our acquisition of Smiths Medical and $1.6&#160;million relates to our acquisition of a small foreign infusions systems supplier in the fourth quarter of 2021 (see Note 3: Acquisitions).&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmRmZjk2YWVlYTA3MDRlZTZhODYwODhmNDhkM2QzZjQ3L3RhYmxlcmFuZ2U6ZGZmOTZhZWVhMDcwNGVlNmE4NjA4OGY0OGQzZDNmNDdfMS0yLTEtMS0xMTIyOTE_ca0e38ab-0d06-4251-b009-2f93a0decbb0"
      unitRef="usd">25572000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmRmZjk2YWVlYTA3MDRlZTZhODYwODhmNDhkM2QzZjQ3L3RhYmxlcmFuZ2U6ZGZmOTZhZWVhMDcwNGVlNmE4NjA4OGY0OGQzZDNmNDdfMy0yLTEtMS0xMTIyOTE_ff4770ef-7497-440d-95f8-d128674df06f"
      unitRef="usd">700000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <icui:CurrencyTranslationOnEarnOut
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmRmZjk2YWVlYTA3MDRlZTZhODYwODhmNDhkM2QzZjQ3L3RhYmxlcmFuZ2U6ZGZmOTZhZWVhMDcwNGVlNmE4NjA4OGY0OGQzZDNmNDdfNC0yLTEtMS0xMTIyOTE_ba510633-7b92-4fbb-8bb3-4503c78850b1"
      unitRef="usd">-33000</icui:CurrencyTranslationOnEarnOut>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ic1ae61222e1b43a5acfc276574f10056_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmRmZjk2YWVlYTA3MDRlZTZhODYwODhmNDhkM2QzZjQ3L3RhYmxlcmFuZ2U6ZGZmOTZhZWVhMDcwNGVlNmE4NjA4OGY0OGQzZDNmNDdfNS0yLTEtMS0xMTIyOTE_3dc15564-51e5-4e17-b6b5-a985ec0d2c0c"
      unitRef="usd">24905000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i6c52854a73b14fd6ae1828bd91e30fb1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOjU4YzVjYTI4MTNlMDQ4N2VhMTRhYTc0YmM5OWE0YWUyL3RhYmxlcmFuZ2U6NThjNWNhMjgxM2UwNDg3ZWExNGFhNzRiYzk5YTRhZTJfMS0yLTEtMS0xMTIyOTE_c98b9742-55aa-4bed-98b3-c09845ddd36c"
      unitRef="usd">2589000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOjU4YzVjYTI4MTNlMDQ4N2VhMTRhYTc0YmM5OWE0YWUyL3RhYmxlcmFuZ2U6NThjNWNhMjgxM2UwNDg3ZWExNGFhNzRiYzk5YTRhZTJfMi0yLTEtMS0xMjA4NTk_dbbd4791-e211-4625-a28b-5fe2a04e60b6"
      unitRef="usd">55158000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <icui:CurrencyTranslationOnEarnOut
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOjU4YzVjYTI4MTNlMDQ4N2VhMTRhYTc0YmM5OWE0YWUyL3RhYmxlcmFuZ2U6NThjNWNhMjgxM2UwNDg3ZWExNGFhNzRiYzk5YTRhZTJfNC0yLTEtMS0xMjA4NjI_fa2802ab-7bee-47bd-bf17-575c1d0024ff"
      unitRef="usd">46000</icui:CurrencyTranslationOnEarnOut>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i03a2467fbfc445cf8500c8ee1e6396ee_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOjU4YzVjYTI4MTNlMDQ4N2VhMTRhYTc0YmM5OWE0YWUyL3RhYmxlcmFuZ2U6NThjNWNhMjgxM2UwNDg3ZWExNGFhNzRiYzk5YTRhZTJfNC0yLTEtMS0xMTIyOTE_c8379908-4238-469b-882a-9e4fc0ef6a9c"
      unitRef="usd">57701000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i630c800fb1f248d5a8ce64fc1f0a262d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfOTE0Ng_1d70c050-233d-466f-820f-17cde8691e7e"
      unitRef="usd">53500000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="icbd969b02ac748cd9474589aab428a62_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfOTE1NA_93463654-0772-41f2-a122-fbe7b5b5e1c4"
      unitRef="usd">1600000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfNzgwOA_f6ff948d-f4be-407b-bdf0-2d45e837fc56">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide quantitative information about Level 3 inputs for fair value measurement of our earn-out liabilities related to Smiths Medical:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smiths Medical Earn-out Liability&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Simulation Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-Free Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="id9540454f8784e5f990147c6b769dfe8_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOjAwYzM5NGZkMmRkZjQyZDFiNmJkNzVlZWQ4YTViOTMyL3RhYmxlcmFuZ2U6MDBjMzk0ZmQyZGRmNDJkMWI2YmQ3NWVlZDhhNWI5MzJfMS00LTEtMS0xMjA4Njc_44f249b4-1bc8-49cd-9c3b-4de79170ada1"
      unitRef="number">0.3600</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="icd441dae5eb1464ebef86ea40463485d_I20220106"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOjAwYzM5NGZkMmRkZjQyZDFiNmJkNzVlZWQ4YTViOTMyL3RhYmxlcmFuZ2U6MDBjMzk0ZmQyZGRmNDJkMWI2YmQ3NWVlZDhhNWI5MzJfMS00LTEtMS0xMTIyOTE_79eb1b53-a096-4a3e-b142-885f2bc85f31"
      unitRef="number">0.3800</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ia32accdc410f475aacf8dd5d7b0e4cf3_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOjAwYzM5NGZkMmRkZjQyZDFiNmJkNzVlZWQ4YTViOTMyL3RhYmxlcmFuZ2U6MDBjMzk0ZmQyZGRmNDJkMWI2YmQ3NWVlZDhhNWI5MzJfMi00LTEtMS0xMjA4Njc_1d06c0f3-a4df-40f3-a4e8-fdd8b0a2735d"
      unitRef="number">0.0383</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i73f519574f6f4c26956379467aefa3d5_I20220106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOjAwYzM5NGZkMmRkZjQyZDFiNmJkNzVlZWQ4YTViOTMyL3RhYmxlcmFuZ2U6MDBjMzk0ZmQyZGRmNDJkMWI2YmQ3NWVlZDhhNWI5MzJfMi00LTEtMS0xMTIyOTE_c8826a61-62b4-4829-b93e-c8db3bca492a"
      unitRef="number">0.0417</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RleHRyZWdpb246NDBkNDdkYTQ0OGIyNGNhOWE3YmU0NjU2ZjRiZDdkNWNfNzc5MA_e539a143-bcd4-4d83-86b7-c3fe8afab7a9">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our assets and liabilities measured at fair value on a recurring basis consisted of the following Level 1, 2 and 3 inputs as defined above (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&#160;measurements&#160;as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&#160;carrying&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&lt;br/&gt;in&#160;active&lt;br/&gt;markets&#160;for&lt;br/&gt;identical&lt;br/&gt;assets&#160;(level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;other&lt;br/&gt;observable&lt;br/&gt;inputs&#160;(level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&#160;(level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTAtMC0xLTEtMTEyMjkx_f14ce4d4-85f2-4d23-a88b-1739598efd81"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTEtMC0xLTEtMTEyMjkx_d56c9d3d-0932-4348-b69d-8f57de5603f9"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTUtMC0xLTEtMTEyMjkx_6bcfe6ca-ff2c-4a0b-9003-1212bc82d7dd"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTYtMC0xLTEtMTEyMjkx_308e7868-3fa9-4233-8466-3e1183fa8b50"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out liability - LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjMtMC0xLTEtMTEyMjkx_5523e65b-55dc-41c6-8709-df1a94648036"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjQtMC0xLTEtMTIwNzE1_62efbfc3-1b08-43d2-b4de-0ebc769246ce"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&#160;measurements&#160;as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&#160;carrying&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&lt;br/&gt;in&#160;active&lt;br/&gt;markets&#160;for&lt;br/&gt;identical&lt;br/&gt;assets&#160;(level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;other&lt;br/&gt;observable&lt;br/&gt;inputs&#160;(level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&#160;(level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange forwards:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNy0wLTEtMS0xMTIyOTE_50321293-4bf5-432f-9a23-856af180772d"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out liability - LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTgtMC0xLTEtMTEyMjkx_38c2c727-8408-4048-b07a-938ff12e83e6"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i56f6562b611449eeb241cfb061a8fc81_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNC0xLTEtMS0xMTIyOTE_ffda1023-ff61-42cf-8bf6-35f589b7ee6d"
      unitRef="usd">1320000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ie1a170696eee4e9abdb23c78710d0758_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNC0zLTEtMS0xMTIyOTE_70ee93dc-2a94-4e6a-85fd-dd4019242a43"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i97cdcc7aea824b1db81b342d252b23dd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNC01LTEtMS0xMTIyOTE_6b319711-654b-49b1-8400-e4ec51dcde64"
      unitRef="usd">1320000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ie91c21fa692e4850bf5756c81c2f5f58_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNC03LTEtMS0xMTIyOTE_053323c0-0207-4e01-b3e5-c0b5ca077c68"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="icb57c90226d949769fdebc2b3c886a84_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNS0xLTEtMS0xMTIyOTE_511a9132-63ef-47a5-962f-78e4c8607e08"
      unitRef="usd">1417000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i74a47211e1504bfbbb2e56947d6359bc_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNS0zLTEtMS0xMTIyOTE_b6ca1da3-02c5-4af8-84fc-15ac41cabf51"
      unitRef="usd">1417000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i8ee355f953e44036b2c9823f0ddf9545_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNS01LTEtMS0xMTIyOTE_779973a5-c267-4879-b962-3ecdcc0e8a2f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i7db2b58ce0df41e787b7b142992d9f0a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNS03LTEtMS0xMTIyOTE_3657ea37-1943-4ce0-a7d2-c188f8cbf1fa"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="id251cb4f372c42deb49b98c56f091af2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNy0xLTEtMS0xMTIyOTE_456e161b-da7b-43ac-9a42-f7299f3f9c39"
      unitRef="usd">498000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i00e9c526d8a14de587543cd4d43d84ff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNy0zLTEtMS0xMTIyOTE_924a282c-65ba-425e-bba1-9a6ede451608"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i95e85068b35c4e25b71a9f1dde7f01cf_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNy01LTEtMS0xMTIyOTE_2fcc8fc4-abdf-40ba-af86-dc7e9d2d4513"
      unitRef="usd">498000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ie3677cc922444caa877f9554bf61388c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfNy03LTEtMS0xMTIyOTE_1950a43b-70cd-4563-af11-2d19e37b7c18"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ie75c1ba3ea0845429dc5b1f441156886_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTAtMS0xLTEtMTEyMjkx_5f9904f1-3c90-4e1a-a820-3c4d0dc0a1be"
      unitRef="usd">7433000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ib014b4c6ffba42ecba26116f0b36d255_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTAtMy0xLTEtMTEyMjkx_e1864872-39ff-4658-ac3a-b040beb8cece"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i7b55b633207e4c77a409427f88b494ae_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTAtNS0xLTEtMTEyMjkx_bf6106a7-2113-458c-992f-ee58e81c84ef"
      unitRef="usd">7433000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ied46de2d5cdb4f3287c1a51b1fda5f2f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTAtNy0xLTEtMTEyMjkx_cd95b55e-c66b-4068-a6f9-0bc8886844f5"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i1e83be36630a4315aa61f938a15ed93c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTEtMS0xLTEtMTEyMjkx_a485759d-3296-481e-a6e5-2bae23974275"
      unitRef="usd">51000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i73643551546848cf924dc74653a7ab10_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTEtMy0xLTEtMTEyMjkx_ba397a4e-99cd-4efa-b67a-4b05a5e1efe5"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i2ff489ffd4484b05893332bc86bb5da4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTEtNS0xLTEtMTEyMjkx_a9e3a712-0b80-4294-983f-91fed48901e6"
      unitRef="usd">51000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="id49337d44fff49da85c4746c25de0cfa_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTEtNy0xLTEtMTEyMjkx_00902aa5-03a4-4319-9931-d3de69383aee"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="ie75c1ba3ea0845429dc5b1f441156886_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTUtMS0xLTEtMTEyMjkx_ee77c835-6daa-4f07-a256-44fe5a2616ab"
      unitRef="usd">25560000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="ib014b4c6ffba42ecba26116f0b36d255_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTUtMy0xLTEtMTEyMjkx_eaa64b3b-5705-402e-993f-045d0b1298cb"
      unitRef="usd">0</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="i7b55b633207e4c77a409427f88b494ae_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTUtNS0xLTEtMTEyMjkx_51a457a3-0453-4864-b49c-c2a4defd9167"
      unitRef="usd">25560000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="ied46de2d5cdb4f3287c1a51b1fda5f2f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTUtNy0xLTEtMTEyMjkx_bf0a8245-eaf2-4478-9cc6-293ec4fb3724"
      unitRef="usd">0</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="i1e83be36630a4315aa61f938a15ed93c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTYtMS0xLTEtMTEyMjkx_112d163f-18b7-424d-9cd8-0ca42b5f2b17"
      unitRef="usd">19672000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="i73643551546848cf924dc74653a7ab10_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTYtMy0xLTEtMTEyMjkx_2fa253fb-2698-4bac-8c8c-1e344ff3e2bd"
      unitRef="usd">0</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="i2ff489ffd4484b05893332bc86bb5da4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTYtNS0xLTEtMTEyMjkx_6e5a287c-1b00-48da-84ed-336ee2557b72"
      unitRef="usd">19672000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="id49337d44fff49da85c4746c25de0cfa_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTYtNy0xLTEtMTEyMjkx_4d5f4f80-3b77-48db-ba3f-6e5d903f3de4"
      unitRef="usd">0</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTctMS0xLTEtMTEyMjkx_0023dcc4-fe8c-4f81-ac41-6b0b8fa97006"
      unitRef="usd">55951000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iefcb7fb7c4af44bd86feb62b7205f1f3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTctMy0xLTEtMTEyMjkx_2764d376-8057-48de-9131-919b222acfc0"
      unitRef="usd">1417000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i28c30abbbc564beab22d3baeae8ce04c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTctNS0xLTEtMTEyMjkx_b2d1639d-dd01-4624-a3cb-42da0d53f327"
      unitRef="usd">54534000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i83c7a5461f164badbda9aed1e171b545_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMTctNy0xLTEtMTEyMjkx_ba149beb-ef7e-4dea-8a21-b63b0e493a39"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i8f06c69e01fa4e4f8ab8986b188ec125_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjEtMS0xLTEtMTEyMjkx_4f79b2e0-b0cf-4cef-b3c4-ecafa66e7c2b"
      unitRef="usd">24905000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i5bc9662c059e4bda801cb06360c4c046_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjEtMy0xLTEtMTEyMjkx_8f0a6ba1-1714-4a8b-9986-abd68e02e499"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i4517f24d47284d07aec33cb915f14ec9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjEtNS0xLTEtMTEyMjkx_fff70e89-abfa-4042-be14-153b68b2d919"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i97bd4045255248b7a6ad2e2738cf4991_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjEtNy0xLTEtMTEyMjkx_72421364-ed98-4c7a-b116-71f5caed7c24"
      unitRef="usd">24905000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ie75c1ba3ea0845429dc5b1f441156886_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjMtMS0xLTEtMTEyMjkx_67fca38c-6ba1-4aa8-8cf0-ecdc65e97d48"
      unitRef="usd">2132000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ib014b4c6ffba42ecba26116f0b36d255_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjMtMy0xLTEtMTEyMjkx_52cd584a-8df0-4a50-bdeb-d6c89e07b2a9"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i7b55b633207e4c77a409427f88b494ae_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjMtNS0xLTEtMTEyMjkx_6615a824-0750-4e39-977b-d7e4a5de6d40"
      unitRef="usd">2132000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ied46de2d5cdb4f3287c1a51b1fda5f2f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjMtNy0xLTEtMTEyMjkx_86a252e0-c5c1-4635-b783-657d3348400a"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i1e83be36630a4315aa61f938a15ed93c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjQtMS0xLTEtMTEyMjkx_6b517775-780f-400c-b44d-636a8ea88bd4"
      unitRef="usd">41000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i73643551546848cf924dc74653a7ab10_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjQtMy0xLTEtMTEyMjkx_e6e4edb4-6ef4-4ead-a653-d70172b75a1e"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i2ff489ffd4484b05893332bc86bb5da4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjQtNS0xLTEtMTEyMjkx_017789c5-605e-4770-a038-0fdb6f24ec8f"
      unitRef="usd">41000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="id49337d44fff49da85c4746c25de0cfa_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjQtNy0xLTEtMTEyMjkx_04b57c85-f2a4-4147-9015-47fad2ce07cc"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="ic88a0d75c4324efe964e2e67a57a9956_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjctMS0xLTEtMTEyMjkx_d6405878-624d-41dc-ac71-bd5bca7c9129"
      unitRef="usd">27078000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i66bd23e34133401591e928370dd3aae3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjctMy0xLTEtMTEyMjkx_c2cb35bb-d7bc-45cb-9654-504d9be88905"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="iec00d0e32787463fa02c2beb859e4088_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjctNS0xLTEtMTEyMjkx_a24f4f18-2e87-41c2-8cee-e3fe38424580"
      unitRef="usd">2173000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i61a628145a154dd4b608eda8fef5317b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmE0ZjBmYjQzZDgyYzRmZWRhNDg2MDZmNDY5NjdjN2JjL3RhYmxlcmFuZ2U6YTRmMGZiNDNkODJjNGZlZGE0ODYwNmY0Njk2N2M3YmNfMjctNy0xLTEtMTEyMjkx_3c957b4a-c0d4-4713-afac-88a7cae63a06"
      unitRef="usd">24905000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i2421f17f678943faa6f08a99e77342d2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNC0xLTEtMS0xMTIyOTE_2cfa484e-e509-4501-8fee-b76c15273cf4"
      unitRef="usd">2314000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i51723405dbf94ff6823b0cfe6cd7a8f4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNC0zLTEtMS0xMTIyOTE_4629f4fb-b516-4d48-8e94-d2826fb3a941"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ibb5b0d8817344f0eb58f57ded4f69d76_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNC01LTEtMS0xMTIyOTE_b602ea4b-0662-4b1a-9dc6-0512ec6d4777"
      unitRef="usd">2314000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ic825a9792c0c4bb3932a15194babe436_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNC03LTEtMS0xMTIyOTE_9a4fdbb8-e416-4978-a329-870c83ff3f2b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="if6739e8ed9384ce4a0f3da9edab4d0ef_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNS0xLTEtMS0xMjA3NjI_f20ccb98-0a5f-4d3b-a846-f395d8ff6593"
      unitRef="usd">1412000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i13ee862b60df4a8182330aca4aabe86e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNS0zLTEtMS0xMjA3NzA_b763cf42-e868-44a5-a722-78a724491ec5"
      unitRef="usd">1412000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i0a1abf01d00d48a5868de1e621f7cae5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNS01LTEtMS0xMjA3NzA_af918f3a-ef95-4f24-a51b-189d1fee3f1e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ic4c34b949f374399ba510212f11790c7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNS03LTEtMS0xMjA3NzA_a65c1fe3-5df7-4d29-b272-62209f51e94f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i8d76827e236145bfa0a5caf2d4857d5c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNi0xLTEtMS0xMjA4NzQ_fb5bad47-b2f0-4e0a-8f07-27103bca383b"
      unitRef="usd">498000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i4a5293ddbff54b3d8db5d3716b9193fb_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNi0zLTEtMS0xMjA4NzQ_453955ba-2a67-4dd2-aaed-055d4c8e1352"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i5222d9d8a2924eddae7d0a5f40052ea5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNi01LTEtMS0xMjA4NzQ_e20f41d8-4995-40e7-b6c5-56d0e53e91ae"
      unitRef="usd">498000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i56274c1ac4014325b45d30ae7ad441aa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNi03LTEtMS0xMjA4NzQ_aef440c4-2261-454a-b8b7-b6c8f393abde"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNS0xLTEtMS0xMTIyOTE_aa927d35-9449-4af7-9c8b-d45b125ffc6e"
      unitRef="usd">516000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ib2d0c73330a84bb0bf6431fe51b3afda_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNS0zLTEtMS0xMTIyOTE_edcf207c-028d-490a-814d-cf1e689630ae"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ia30501eaa28f4a95a929526d40bc93df_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNS01LTEtMS0xMTIyOTE_3e00f959-763b-4244-8727-d2f087988df1"
      unitRef="usd">516000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i42bd702cc395459f81747c0a9d029d07_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNS03LTEtMS0xMTIyOTE_304be1d7-86d3-4e3b-a833-bebb97e10edf"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ia089dfcea16a47c7a301086d94a998c0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNy0xLTEtMS0xMTIyOTE_724a3914-44e4-445f-98fe-e9b529a7a0f1"
      unitRef="usd">4860000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i3032b40999034d9c8ace19cc47d82a6c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNy0zLTEtMS0xMTIyOTE_8d6040f0-3250-4fde-98db-539c35904104"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="id3344b2eee9a439b99d11085a8bad5a2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNy01LTEtMS0xMTIyOTE_c7308f45-c516-484e-8ce8-cb9a32c5862a"
      unitRef="usd">4860000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i459536a397ec41e98471e9be9d5f85de_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfNy03LTEtMS0xMTIyOTE_8eae4f0a-7134-47df-8dbc-d8f59b85a74c"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i2e94d92e01474cfeb2beeaedbd0abe84_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTEtMS0xLTEtMTIwODcy_97ededae-cdef-46cc-9d2a-77527bb7f4c4"
      unitRef="usd">94000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ib0cf77942cd1443eacbf40c493fe858d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTEtMy0xLTEtMTIwODcy_841021cd-35c5-4bdc-9f33-c86af85538f2"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i6080af93170148688d13de3d59d12ab7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTEtNS0xLTEtMTIwODcy_9b9572dd-cdaf-41f5-ba26-6afd6ab5fce8"
      unitRef="usd">94000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i7b13a58d0b3c4453995ec99b1cfe364a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTEtNy0xLTEtMTIwODcy_30737d16-08e4-42e4-a1c9-4d952cfda249"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="ica1daf3e26514068beac02afe7124cc3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTMtMS0xLTEtMTIwODcw_65d47aa5-389b-4a99-9702-533c89aeec16"
      unitRef="usd">28431000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="ib414b19de28a44c7b4896fcc6b6b46e3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTMtMy0xLTEtMTIwODcw_0d52b4b3-da14-4165-b656-3f91b58a4852"
      unitRef="usd">0</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="iab01ecb2b6ac4acc8ebcb12fdb8f8e51_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTMtNS0xLTEtMTIwODcw_9a9cd943-d597-494f-9cbf-3e9ea0127d28"
      unitRef="usd">28431000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="i79e95f455b32497bbff95f508a232d72_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTMtNy0xLTEtMTIwODcw_ad730c5e-49b1-414c-b6a1-41976931485f"
      unitRef="usd">0</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="i2e94d92e01474cfeb2beeaedbd0abe84_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTQtMS0xLTEtMTIwODcw_4e59e122-d93c-4a05-bc11-8248e550ab0f"
      unitRef="usd">26753000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="ib0cf77942cd1443eacbf40c493fe858d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTQtMy0xLTEtMTIwODcw_2f664d53-b35a-4310-822e-ab29271bbc9a"
      unitRef="usd">0</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="i6080af93170148688d13de3d59d12ab7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTQtNS0xLTEtMTIwODcw_1fce36f3-f3c0-44d6-beae-d6c9c4569fa9"
      unitRef="usd">26753000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="i7b13a58d0b3c4453995ec99b1cfe364a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTQtNy0xLTEtMTIwODcw_e9eac0a3-fe1d-4bcb-bfca-b507b2850b51"
      unitRef="usd">0</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTAtMS0xLTEtMTEyMjkx_14c8cde8-c71e-4a28-999f-974d486569e4"
      unitRef="usd">64878000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib2d0c73330a84bb0bf6431fe51b3afda_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTAtMy0xLTEtMTEyMjkx_32dfb651-069a-4739-950f-295fd4ca4228"
      unitRef="usd">1412000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia30501eaa28f4a95a929526d40bc93df_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTAtNS0xLTEtMTEyMjkx_46a95b0b-e0ee-4262-9bc3-08d419b660c1"
      unitRef="usd">63466000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i42bd702cc395459f81747c0a9d029d07_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTAtNy0xLTEtMTEyMjkx_6c454e64-c3c8-4eba-9786-0c6ec09e7b6c"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ib903abaa897142e6870b5c981c0190f9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTMtMS0xLTEtMTEyMjkx_732f9c6b-3f99-46a7-96d2-c16153374ab1"
      unitRef="usd">25572000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ib4f553481cb44e628e33717df32e0afc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTMtMy0xLTEtMTEyMjkx_c044242e-3eaa-4246-b7b5-c71df5ace894"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="iae888c38b8234f5abfc0397b9219a434_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTMtNS0xLTEtMTEyMjkx_41c2175e-2380-41d4-a7af-9309c8805599"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ib538cde976ef4ac38c558a67c9a7b8c1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTMtNy0xLTEtMTEyMjkx_fdb4bf38-f0b4-4d61-a7f2-3c0b40b61d65"
      unitRef="usd">25572000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ia089dfcea16a47c7a301086d94a998c0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMjQtMS0xLTEtMTIwNzUw_a4e1ccc1-a250-4a6e-a365-b82cd6fecedb"
      unitRef="usd">1847000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i3032b40999034d9c8ace19cc47d82a6c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMjQtMy0xLTEtMTIwNzUy_55f6255d-bfdd-4fea-81f7-4ac8d6596832"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="id3344b2eee9a439b99d11085a8bad5a2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMjQtNS0xLTEtMTIwNzU3_76ba8dd6-00d6-4f08-a4db-1cb9424f2be5"
      unitRef="usd">1847000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i459536a397ec41e98471e9be9d5f85de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMjQtNy0xLTEtMTIwNzU5_b7bf1f50-4fad-4bd0-ba37-7ceca1d59505"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ie2300372e953438fb46cce4511c00fdf_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTgtMS0xLTEtMTEyMjkx_bf0cd2df-04aa-4718-a6fd-1489da9bc67b"
      unitRef="usd">167000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i600c673eafe24f7a99360ebe80c6bd12_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTgtMy0xLTEtMTEyMjkx_9afef98f-a1d3-4e24-b48d-273c0f6898ad"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i24988b3dea184cdd8f48759556bc2274_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTgtNS0xLTEtMTEyMjkx_06bd552d-da8b-4624-b45b-2c179cea615c"
      unitRef="usd">167000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i89428e5fde134e38a53ca4bcdc2ca0ae_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTgtNy0xLTEtMTEyMjkx_e8e35111-161b-4f8f-892b-96ccfb47a31c"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ifc34907535374c3da7784002505ffd72_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTktMS0xLTEtMTEyMjkx_a1b19ced-67ca-47d0-9881-a87aea377de6"
      unitRef="usd">27586000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i00116957d0924008b381688d18b90256_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTktMy0xLTEtMTEyMjkx_71d8aa39-2f17-488f-bfc1-b3bd4efe93f4"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i513c2936b35e4be19a4d05480a1af429_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTktNS0xLTEtMTEyMjkx_40c2f2a3-df4e-4c01-a5d5-6dd69f506826"
      unitRef="usd">2014000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i25f3594cd8a446f7810b2e62cde2b514_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV81OC9mcmFnOjQwZDQ3ZGE0NDhiMjRjYTlhN2JlNDY1NmY0YmQ3ZDVjL3RhYmxlOmExMGVmMTczOTExNjQxNmE4MDJkMzc2NDI2MmIxOTYwL3RhYmxlcmFuZ2U6YTEwZWYxNzM5MTE2NDE2YTgwMmQzNzY0MjYyYjE5NjBfMTktNy0xLTEtMTEyMjkx_356cfca4-564a-4ceb-a56a-d49d24f44cbc"
      unitRef="usd">25572000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <icui:InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RleHRyZWdpb246YWNmN2MxNmIxN2FlNDM1MzhlZjI0MWZmMzA3ZjZiOGVfNDQxNg_10ca9b85-cbd8-48ae-ae5d-123b64d56dee">Investment Securities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Available-for-sale Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Our available-for-sale investment securities currently consist of short-term and long-term corporate bonds, short-term U.S. treasury securities and long-term government bonds and are considered &#x201c;investment grade&#x201d; and are carried at fair value. We assess our investment in available-for-sale debt securities for impairment each reporting period. If an unrealized loss exists, we determine whether any portion of the decline in fair value below the amortized cost basis is credit-related by reviewing several factors, including, but not limited to, the extent of the fair value decline and changes in the financial condition of the issuer. We record an impairment for credit-related losses through an allowance, limited to the amount of the unrealized loss. If we either intend to sell or it is more likely than not we will be required to sell the debt security before its anticipated recovery, any allowance is written off and the amortized cost basis is written down to fair value through a charge against net earnings. Unrealized gains and non-credit-related unrealized losses are recorded, net of tax, in other comprehensive income (loss). We did not have any investments in available-for-sale debt securities in unrealized loss positions as of March&#160;31, 2023 or December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost of the debt securities are adjusted for the amortization of premiums computed under the effective interest method. Such amortization is included in interest expense, net in our condensed consolidated statements of operations. Realized gains and losses are accounted for on the specific identification method. There have been no realized gains or losses &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on the disposal of these investments. The scheduled maturities of the debt securities are between 2022 and 2024. All short-term investment securities are callable within one year.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Holding &lt;br/&gt;Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Holding&lt;br/&gt;Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Non-Marketable Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, we acquired an approximate 20% non-marketable equity interest in a nonpublic company and entered into a three-year distribution agreement where we have the exclusive rights to market, sell and distribute the company's products in exchange for a cash payment of $3.3&#160;million. In addition, we were granted an exclusive license for all of the seller's intellectual property. At the expiration of the distribution agreement we have the right but not the obligation to acquire the remaining interest in the business.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply the equity method of accounting for investments when we determine we have a significant influence, but not a controlling interest in the investee. We determine whether we have significant influence by considering key factors such as ownership interest, representation on the board of directors, participation in policy making decisions, business relationship and material intra-entity transactions, among other factors. Our equity method investment is reported at cost and adjusted each period for our share of the investee's income or (loss) and dividend paid, if any. We eliminate any intra-entity profits to the extent of our beneficial interest. We record our share of the investee's income or (loss) on a one quarter lag. We report our proportionate share of the investee's income or (loss) resulting from this investment in other income, net in our condensed consolidated statements of operations. The carrying value of our equity method investment is reported in other assets on our condensed consolidated balance sheets (see Note 11: Prepaid Expenses and Other Current Assets and Other Assets). We assess our equity method investments for impairment on an annual basis or whenever events or circumstances indicate that the carrying value of the investment may not be recoverable. Our recorded share of the investee's loss was not material for the three months ended March&#160;31, 2023 and 2022. We did not receive any dividend distributions from this investment during the three months ended March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our non-marketable equity method investment consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</icui:InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RleHRyZWdpb246YWNmN2MxNmIxN2FlNDM1MzhlZjI0MWZmMzA3ZjZiOGVfNDQyMw_d368a622-289e-4b3e-b277-598532759755"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RleHRyZWdpb246YWNmN2MxNmIxN2FlNDM1MzhlZjI0MWZmMzA3ZjZiOGVfNDQyMA_feb0a646-c373-4aea-8bba-8b0577988608">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Holding &lt;br/&gt;Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Holding&lt;br/&gt;Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="ibfbfe2784d674d028ea89497f6d11184_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMi0xLTEtMS0xMTIyOTE_72b485ca-caec-4191-b694-e5e8380d5696"
      unitRef="usd">1320000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="idbc93354f6f64dd887efe82a4a92a59c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMi0zLTEtMS0xMTIyOTE_4adaa28a-bd62-45e4-bc7e-33cea773cb3a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ibfbfe2784d674d028ea89497f6d11184_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMi01LTEtMS0xMTIyOTE_eb0f3bed-838b-4a22-9e25-ea35973297e2"
      unitRef="usd">1320000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="icb57c90226d949769fdebc2b3c886a84_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMy0xLTEtMS0xMTIyOTE_68d90ed4-a836-4445-bedd-7baae46d275e"
      unitRef="usd">1417000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="i25eb893c69d64ec8916421287d40d7dc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMy0zLTEtMS0xMTIyOTE_26492e94-a505-439f-be1f-7b890f49bcfb"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="icb57c90226d949769fdebc2b3c886a84_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMy01LTEtMS0xMTIyOTE_78c17e61-fb78-45dc-a2b6-d9be8e7d7ef1"
      unitRef="usd">1417000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="id251cb4f372c42deb49b98c56f091af2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfNC0xLTEtMS0xMjA4NzY_4fbf281f-3211-481a-8ecf-2651c7e69884"
      unitRef="usd">498000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="i82ea280e29894ab9a463eb6fa58461c3_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfNC0zLTEtMS0xMjA4NzY_4c6fb0dd-5b1a-42e0-9533-0419c5e937f9"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="id251cb4f372c42deb49b98c56f091af2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfNC01LTEtMS0xMjA4NzY_1472568e-53af-490e-a682-d077c72f1607"
      unitRef="usd">498000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfNi0xLTEtMS0xMTIyOTE_9b038477-ff4e-4650-a347-4e469bb656f6"
      unitRef="usd">3235000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfNi0zLTEtMS0xMTIyOTE_fbc21b63-7de4-4ead-9eb0-dcc31e55e3d0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfNi01LTEtMS0xMTIyOTE_81ba4bcc-1adf-42d5-8d7a-e8eb6e73a93b"
      unitRef="usd">3235000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="iedc9227893204f5fb8adfe568b84f804_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTAtMS0xLTEtMTEyMjkx_56a3a186-da47-443b-b207-bab16d651f04"
      unitRef="usd">2314000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="i6e3979b3c1734fa6bf0c57b31b79d949_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTAtMy0xLTEtMTEyMjkx_30cee687-7276-4776-9d22-be58495ac9c4"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="iedc9227893204f5fb8adfe568b84f804_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTAtNS0xLTEtMTEyMjkx_76faff4b-c1f1-4603-b721-53d642f73b67"
      unitRef="usd">2314000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="if6739e8ed9384ce4a0f3da9edab4d0ef_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTEtMS0xLTEtMTIwODgw_a7aa9f2d-c140-4650-b449-ab98405935c4"
      unitRef="usd">1412000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="i86423b3966d94fd191b5c9416094b60c_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTEtMy0xLTEtMTIwODgw_3700e6b1-3a08-4478-9cb9-97603653434e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="if6739e8ed9384ce4a0f3da9edab4d0ef_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTEtNS0xLTEtMTIwODgw_0fa7d538-ed0d-4755-bc08-3a8d402486ba"
      unitRef="usd">1412000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="ic165dae88e744691bcce8d47fec9dbdb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTItMS0xLTEtMTIwODc4_221b7276-3f9d-4336-b5ed-25c19304d978"
      unitRef="usd">498000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="id77de8d44cca4f389a04a8b86d7c1607_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTItMy0xLTEtMTIwODc4_d4f70fb9-4120-4a14-bd41-f145742ab65f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ic165dae88e744691bcce8d47fec9dbdb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTItNS0xLTEtMTIwODc4_bb72682d-95c6-4085-95d5-a421b3f68aed"
      unitRef="usd">498000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
      contextRef="iedc9227893204f5fb8adfe568b84f804_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTEtMS0xLTEtMTEyMjkx_fa81d186-c2bb-448d-ba78-e9f05691d310"
      unitRef="usd">516000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="i6e3979b3c1734fa6bf0c57b31b79d949_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTEtMy0xLTEtMTEyMjkx_4b5f655e-3663-4d16-86a6-a8e8bbe89407"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="iedc9227893204f5fb8adfe568b84f804_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTEtNS0xLTEtMTEyMjkx_4b619373-c3be-4f90-9221-e518ec478c32"
      unitRef="usd">516000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTItMS0xLTEtMTEyMjkx_f4b2e605-5533-475b-b7ee-689516053d8a"
      unitRef="usd">4740000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="i96b4b6ca22c9441d8fd7c31c022b4666_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTItMy0xLTEtMTEyMjkx_7ec27726-3b86-4ded-94bc-917ad16db857"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOmZmMWQ3NDQzYmFhNjQ4OThhNTRjOGE4YjU0ZGE2ZjkyL3RhYmxlcmFuZ2U6ZmYxZDc0NDNiYWE2NDg5OGE1NGM4YThiNTRkYTZmOTJfMTItNS0xLTEtMTEyMjkx_fd928f41-e1f9-4296-9422-d56cb2a971a8"
      unitRef="usd">4740000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i579e1337f5894b6e9f97f1483abeb705_I20230331"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RleHRyZWdpb246YWNmN2MxNmIxN2FlNDM1MzhlZjI0MWZmMzA3ZjZiOGVfMjEzOA_f6b9a7d5-a0eb-4825-89b1-c8d45e72d7f0"
      unitRef="number">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RleHRyZWdpb246YWNmN2MxNmIxN2FlNDM1MzhlZjI0MWZmMzA3ZjZiOGVfMjM3MQ_2da434b9-df64-41cd-9ef3-aef1f1b1f991"
      unitRef="usd">3300000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RleHRyZWdpb246YWNmN2MxNmIxN2FlNDM1MzhlZjI0MWZmMzA3ZjZiOGVfNDQyNQ_68db19ba-65d1-42d4-9f15-001d7df858ce">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our non-marketable equity method investment consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOjYzYWQ1ZjgxNWEyMzRkZmE5ZmQyMzVjZWI2NjY3MmM4L3RhYmxlcmFuZ2U6NjNhZDVmODE1YTIzNGRmYTlmZDIzNWNlYjY2NjcyYzhfMi0yLTEtMS0xMTIyOTE_0f9ea671-1c4f-4370-bd80-cdcf3b576402"
      unitRef="usd">3166000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82MS9mcmFnOmFjZjdjMTZiMTdhZTQzNTM4ZWYyNDFmZjMwN2Y2YjhlL3RhYmxlOjYzYWQ1ZjgxNWEyMzRkZmE5ZmQyMzVjZWI2NjY3MmM4L3RhYmxlcmFuZ2U6NjNhZDVmODE1YTIzNGRmYTlmZDIzNWNlYjY2NjcyYzhfMi00LTEtMS0xMTIyOTE_4ca0cf7e-60e2-4ed7-8ea8-75ce1383d140"
      unitRef="usd">3178000</us-gaap:EquityMethodInvestments>
    <icui:PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RleHRyZWdpb246Yzk3ZTRlMDQxMzFlNGM4YjlkMzJlMzE1Mzk0OWQ3MWJfMjI1_0484c790-b64f-426c-baaa-ac4909783cda">Prepaid Expenses and Other Current Assets and Other Assets&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaid expenses and receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid vendor expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance and property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VAT/GST receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pump lease receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spare parts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</icui:PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RleHRyZWdpb246Yzk3ZTRlMDQxMzFlNGM4YjlkMzJlMzE1Mzk0OWQ3MWJfMjE4_78d9393c-0182-4aa9-839f-49cc29dad5ac">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaid expenses and receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid vendor expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance and property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VAT/GST receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMi0yLTEtMS0xMTIyOTE_2cf453d1-324c-4e4e-a5db-5d3ab80babfc"
      unitRef="usd">26332000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMi00LTEtMS0xMTIyOTE_acde3c6e-bec7-44cd-8236-807271464944"
      unitRef="usd">21635000</us-gaap:OtherPrepaidExpenseCurrent>
    <icui:PrepaidVendorExpenses
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMy0yLTEtMS0xMTIyOTE_5d34f77e-472d-4251-b0fa-181b63b1b42d"
      unitRef="usd">1862000</icui:PrepaidVendorExpenses>
    <icui:PrepaidVendorExpenses
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMy00LTEtMS0xMTIyOTE_40ec7063-c12c-4e08-b4e1-d75238562f82"
      unitRef="usd">3052000</icui:PrepaidVendorExpenses>
    <us-gaap:DeferredCostsAndOtherAssets
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfNC0yLTEtMS0xMTIyOTE_2cc70ff4-4d0c-43d7-a2fd-7985dd24b083"
      unitRef="usd">3638000</us-gaap:DeferredCostsAndOtherAssets>
    <us-gaap:DeferredCostsAndOtherAssets
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfNC00LTEtMS0xMTIyOTE_717f71ca-a062-49aa-805a-f9fbfad42432"
      unitRef="usd">2395000</us-gaap:DeferredCostsAndOtherAssets>
    <icui:Prepaidinsuranceandpropertytaxes
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfNS0yLTEtMS0xMTIyOTE_dbb813c8-ddb0-445c-9cf3-b5c74b0a23b9"
      unitRef="usd">10638000</icui:Prepaidinsuranceandpropertytaxes>
    <icui:Prepaidinsuranceandpropertytaxes
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfNS00LTEtMS0xMTIyOTE_6a9990ea-69a7-46af-88f0-3fb7b454af44"
      unitRef="usd">16322000</icui:Prepaidinsuranceandpropertytaxes>
    <icui:Prepaidothertaxes
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfNi0yLTEtMS0xMTIyOTE_1ab37ac3-b32c-491b-a1d6-82721be377ce"
      unitRef="usd">3030000</icui:Prepaidothertaxes>
    <icui:Prepaidothertaxes
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfNi00LTEtMS0xMTIyOTE_30dc071d-e410-4105-acb6-6735a166145a"
      unitRef="usd">3546000</icui:Prepaidothertaxes>
    <icui:Deferredtaxcharge
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfNy0yLTEtMS0xMTIyOTE_320ce422-2592-4598-bbda-9b2a3b9d855a"
      unitRef="usd">3830000</icui:Deferredtaxcharge>
    <icui:Deferredtaxcharge
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfNy00LTEtMS0xMTIyOTE_68a6ed8c-91ed-4f71-8954-2d7e7db5ad9f"
      unitRef="usd">3830000</icui:Deferredtaxcharge>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i7fef98ce304042888df7d376a7476354_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfOC0yLTEtMS0xMTIyOTE_85a3f4bc-5937-45d9-b7d6-1495e9af7bc6"
      unitRef="usd">7433000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ia69844c22aaf40cbb2a42781ead60e61_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfOC00LTEtMS0xMTIyOTE_e5c82c8f-9a47-4929-a900-0f21d3f96eab"
      unitRef="usd">4860000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="i7fef98ce304042888df7d376a7476354_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfOS0yLTEtMS0xMTIyOTE_4c128b2d-4f0d-41b1-bf7b-ec5529051713"
      unitRef="usd">25560000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="ia69844c22aaf40cbb2a42781ead60e61_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfOS00LTEtMS0xMTIyOTE_ac5e95a7-39c0-45d2-a857-35a8431d690a"
      unitRef="usd">28431000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:DepositAssets
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMTEtMi0xLTEtMTEyMjkx_32314530-d0d1-405e-98da-5f90aff327c6"
      unitRef="usd">1263000</us-gaap:DepositAssets>
    <us-gaap:DepositAssets
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMTEtNC0xLTEtMTEyMjkx_1f21af23-edd9-4f96-84b7-381377c38d49"
      unitRef="usd">1329000</us-gaap:DepositAssets>
    <us-gaap:OtherAssetsCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMTItMi0xLTEtMTEyMjkx_37d0e562-4fe7-42cf-8143-6729f05c18ee"
      unitRef="usd">3539000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMTItNC0xLTEtMTEyMjkx_a568a2f2-d0c4-4812-852d-80598e1899b3"
      unitRef="usd">3532000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMTMtMi0xLTEtMTEyMjkx_3eafa8b7-61e0-458c-907c-58af473b75b4"
      unitRef="usd">87125000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjFkMjM2OTdlMTc0NTQ0YjFhY2M3ZTg2ZGE4YzkxOTkyL3RhYmxlcmFuZ2U6MWQyMzY5N2UxNzQ1NDRiMWFjYzdlODZkYThjOTE5OTJfMTMtNC0xLTEtMTEyMjkx_83e13409-37d4-4aed-87ad-d8f6fe805635"
      unitRef="usd">88932000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RleHRyZWdpb246Yzk3ZTRlMDQxMzFlNGM4YjlkMzJlMzE1Mzk0OWQ3MWJfMjIx_e01ff0f7-26f3-447d-a0fe-da46e783fee4">&lt;div style="margin-top:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pump lease receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spare parts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfMi0yLTEtMS0xMTIyOTE_c916c0d6-86e5-4cf9-9031-4dec338aa1dd"
      unitRef="usd">28821000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfMi00LTEtMS0xMTIyOTE_b4ad03cc-d069-42e5-896d-3502c4a30d22"
      unitRef="usd">27086000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <icui:SpareParts
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfMy0yLTEtMS0xMTIyOTE_ab81baef-c20c-4e3b-acea-33b24853f252"
      unitRef="usd">40598000</icui:SpareParts>
    <icui:SpareParts
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfMy00LTEtMS0xMTIyOTE_d0015f23-16d2-43e5-ae8f-805070b4b456"
      unitRef="usd">38498000</icui:SpareParts>
    <us-gaap:EquityMethodInvestments
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfNC0yLTEtMS0xMTIyOTE_84b36bb3-ab56-4188-a5df-6a136a80a0fc"
      unitRef="usd">3166000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfNC00LTEtMS0xMTIyOTE_b85fd41b-7adb-4c27-8887-d60bc583e9cc"
      unitRef="usd">3178000</us-gaap:EquityMethodInvestments>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfNS0yLTEtMS0xMTIyOTE_da4728b6-0164-461f-abf3-136d52c29983"
      unitRef="usd">4727000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfNS00LTEtMS0xMTIyOTE_56d6f854-9600-4bc8-a0f2-a9366e0503de"
      unitRef="usd">5156000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfNi0yLTEtMS0xMTIyOTE_14c692dc-7410-4955-a45f-2c5bfef186b1"
      unitRef="usd">2758000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfNi00LTEtMS0xMTIyOTE_1bfedeb4-bd6f-4677-8546-cfebd10ee12f"
      unitRef="usd">2598000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="id6bcc5cb934c484085e4c9d001608c4b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfNy0yLTEtMS0xMTIyOTE_0a5e9f57-f900-4dd8-8ac5-e8f5d75f1354"
      unitRef="usd">19672000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i631e83ee61b74e3abeaa5ad6e7bab2b1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfNy00LTEtMS0xMTIyOTE_0099ee44-b183-4a76-9a5a-e7a171041a96"
      unitRef="usd">26753000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfOS0yLTEtMS0xMTIyOTE_4d291371-fbb4-4d4c-aa95-225afd7ea73d"
      unitRef="usd">2143000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfOS00LTEtMS0xMTIyOTE_591e39db-dd28-4b7e-a806-ecb9b27ecd52"
      unitRef="usd">2193000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfMTAtMi0xLTEtMTEyMjkx_542bb8fe-fe06-4fa1-8a5b-86d3b719cd86"
      unitRef="usd">101885000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82NC9mcmFnOmM5N2U0ZTA0MTMxZTRjOGI5ZDMyZTMxNTM5NDlkNzFiL3RhYmxlOjJiYWZkNWNmYjJhZDRhOTNhODZjZWQ3NWY4ZWU2N2RjL3RhYmxlcmFuZ2U6MmJhZmQ1Y2ZiMmFkNGE5M2E4NmNlZDc1ZjhlZTY3ZGNfMTAtNC0xLTEtMTEyMjkx_f74f18ca-ee60-4c17-9033-371223e54674"
      unitRef="usd">105462000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RleHRyZWdpb246ODIyNGRjMjA2YjcxNDM5NzhkNjI0YjZjOTliNzY4NDFfNTYz_e53d5684-7363-4fb8-acfd-e0ed82e8b0b1">Inventories&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method. Inventory costs include material, labor and overhead related to the manufacturing of our products. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RleHRyZWdpb246ODIyNGRjMjA2YjcxNDM5NzhkNjI0YjZjOTliNzY4NDFfNTcx_80566e6f-ddfa-4ff8-a056-c6c1eb8836b5">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RhYmxlOjEwNjQ5NjFlYTk0NTQ5NWI5YzQ2OGU1MDIwYWRiOGYxL3RhYmxlcmFuZ2U6MTA2NDk2MWVhOTQ1NDk1YjljNDY4ZTUwMjBhZGI4ZjFfMi0xLTEtMS0xMTIyOTE_5e5e3165-ac0d-4fbe-a283-42eb8615509e"
      unitRef="usd">317340000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RhYmxlOjEwNjQ5NjFlYTk0NTQ5NWI5YzQ2OGU1MDIwYWRiOGYxL3RhYmxlcmFuZ2U6MTA2NDk2MWVhOTQ1NDk1YjljNDY4ZTUwMjBhZGI4ZjFfMi0zLTEtMS0xMTIyOTE_b8858946-d2f1-43f0-8fd5-7157568f3a8f"
      unitRef="usd">286964000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RhYmxlOjEwNjQ5NjFlYTk0NTQ5NWI5YzQ2OGU1MDIwYWRiOGYxL3RhYmxlcmFuZ2U6MTA2NDk2MWVhOTQ1NDk1YjljNDY4ZTUwMjBhZGI4ZjFfMy0xLTEtMS0xMTIyOTE_945f91b5-e582-4176-983b-2277bc909a0b"
      unitRef="usd">73708000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RhYmxlOjEwNjQ5NjFlYTk0NTQ5NWI5YzQ2OGU1MDIwYWRiOGYxL3RhYmxlcmFuZ2U6MTA2NDk2MWVhOTQ1NDk1YjljNDY4ZTUwMjBhZGI4ZjFfMy0zLTEtMS0xMTIyOTE_4056ae76-a53e-4b5a-875c-83d9cfceb6b2"
      unitRef="usd">73795000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RhYmxlOjEwNjQ5NjFlYTk0NTQ5NWI5YzQ2OGU1MDIwYWRiOGYxL3RhYmxlcmFuZ2U6MTA2NDk2MWVhOTQ1NDk1YjljNDY4ZTUwMjBhZGI4ZjFfNC0xLTEtMS0xMTIyOTE_a175da1f-3e05-4bb5-860b-11765826c49b"
      unitRef="usd">356917000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RhYmxlOjEwNjQ5NjFlYTk0NTQ5NWI5YzQ2OGU1MDIwYWRiOGYxL3RhYmxlcmFuZ2U6MTA2NDk2MWVhOTQ1NDk1YjljNDY4ZTUwMjBhZGI4ZjFfNC0zLTEtMS0xMTIyOTE_72242301-f9b6-4269-aded-238deee622fa"
      unitRef="usd">335250000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RhYmxlOjEwNjQ5NjFlYTk0NTQ5NWI5YzQ2OGU1MDIwYWRiOGYxL3RhYmxlcmFuZ2U6MTA2NDk2MWVhOTQ1NDk1YjljNDY4ZTUwMjBhZGI4ZjFfNS0xLTEtMS0xMTIyOTE_b3794eff-76ae-4cae-a58d-8cea5317611f"
      unitRef="usd">747965000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV82Ny9mcmFnOjgyMjRkYzIwNmI3MTQzOTc4ZDYyNGI2Yzk5Yjc2ODQxL3RhYmxlOjEwNjQ5NjFlYTk0NTQ5NWI5YzQ2OGU1MDIwYWRiOGYxL3RhYmxlcmFuZ2U6MTA2NDk2MWVhOTQ1NDk1YjljNDY4ZTUwMjBhZGI4ZjFfNS0zLTEtMS0xMTIyOTE_a12bce29-be6e-408b-b2e8-248446f336f8"
      unitRef="usd">696009000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RleHRyZWdpb246ZDBiMjU0MDIxMzI4NGJlYWE4NGUzMjBjYTY5MDAyYTlfNjg3_f53d55c5-0cee-4888-b394-3b7beac3276b">Property, Plant and Equipment&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consists of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land, building and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments placed with customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,174,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,162,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(550,432)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(526,444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________________ &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Instruments placed with customers consist of drug-delivery and monitoring systems placed with customers under operating leases.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;Depreciation expense was $23.4 million and $21.4&#160;million for the three months ended March&#160;31, 2023 and 2022, respectively.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RleHRyZWdpb246ZDBiMjU0MDIxMzI4NGJlYWE4NGUzMjBjYTY5MDAyYTlfNjky_ffe1e99c-6665-4ab5-9f5b-b114ddf48aed">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consists of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land, building and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments placed with customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,174,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,162,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(550,432)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(526,444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfMi0xLTEtMS0xMTIyOTE_efbb65ab-9f6e-4831-aa1b-bbbdc4d56b95"
      unitRef="usd">430258000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfMi0zLTEtMS0xMTIyOTE_179e62d8-d272-413a-824c-408aeb9b7501"
      unitRef="usd">414811000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic24eeaf2cdd54ba28cf13e1eed409bf3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfMy0xLTEtMS0xMTIyOTE_ea89c9aa-6d7c-4cfc-ae41-d28b9bbab465"
      unitRef="usd">275463000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie470f6c922764b86925b02b2d25bd068_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfMy0zLTEtMS0xMTIyOTE_2cde25cf-622d-47cd-aa9e-08af5b45b86c"
      unitRef="usd">274063000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i66a11824ed414a45824aa3f42692576a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfNC0xLTEtMS0xMTIyOTE_62048b3b-3ecf-47f8-afcd-9e2c5cedee14"
      unitRef="usd">77557000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8748d9089ac04b8bb47719b0717b5a2b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfNC0zLTEtMS0xMTIyOTE_00a8a00a-acf6-4be4-a39a-0e4ddf3a5cd4"
      unitRef="usd">77203000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4ed218cedf4f4e30aacfc291c713a4ff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfNS0xLTEtMS0xMTIyOTE_84f92a13-167a-4000-aea9-b6aad7db09b8"
      unitRef="usd">119438000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8d4e73ec88b842f7b49cf0a4ba9fa984_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfNS0zLTEtMS0xMTIyOTE_d33bdd8a-4069-4f63-b02d-e40c599d60b0"
      unitRef="usd">115214000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfNi0xLTEtMS0xMTIyOTE_007a76d1-44a7-4f33-b1cd-e03ad37b56a1"
      unitRef="usd">30166000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfNi0zLTEtMS0xMTIyOTE_32a6660a-c8ee-4b88-b005-da008e5157f7"
      unitRef="usd">29876000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9bc8a01c792a4c0cba943cbaa9683dc5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfNy0xLTEtMS0xMTIyOTE_455da63b-eccd-409e-b146-907af43e21d5"
      unitRef="usd">102666000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i99bbc561eaf74c0bb03cf3b2367770b5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfNy0zLTEtMS0xMTIyOTE_f34b60d0-ee29-42e1-8f09-8230409882ef"
      unitRef="usd">98481000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfOC0xLTEtMS0xMTIyOTE_5cf47f12-74c0-4f0d-ae34-4c859d5bd44c"
      unitRef="usd">138996000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfOC0zLTEtMS0xMTIyOTE_aaa273f0-af66-4e8b-b098-efcad75cc6e1"
      unitRef="usd">152909000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfOS0xLTEtMS0xMTIyOTE_d9f8df83-50e1-4a59-a27f-bb5d004aa220"
      unitRef="usd">1174544000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfOS0zLTEtMS0xMTIyOTE_fa7a3091-6be6-4475-9cf5-9d9d73a2d9cc"
      unitRef="usd">1162557000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfMTAtMS0xLTEtMTEyMjkx_0e0143bb-6240-4d9b-861d-e9e73690017e"
      unitRef="usd">550432000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfMTAtMy0xLTEtMTEyMjkx_4742a091-2871-494b-b824-116162ca818a"
      unitRef="usd">526444000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfMTEtMS0xLTEtMTEyMjkx_b369ce5e-883f-40e2-a9cd-725270ba51bd"
      unitRef="usd">624112000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RhYmxlOjk5NGMyMTExYjlkNDQyYTM5MDUzY2RlMjBkZmVlODg2L3RhYmxlcmFuZ2U6OTk0YzIxMTFiOWQ0NDJhMzkwNTNjZGUyMGRmZWU4ODZfMTEtMy0xLTEtMTEyMjkx_a496fec1-804a-49ec-9694-ebfd93be34f8"
      unitRef="usd">636113000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RleHRyZWdpb246ZDBiMjU0MDIxMzI4NGJlYWE4NGUzMjBjYTY5MDAyYTlfMzEz_907cffa1-619d-4c76-b552-3015fde0d451"
      unitRef="usd">23400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83MC9mcmFnOmQwYjI1NDAyMTMyODRiZWFhODRlMzIwY2E2OTAwMmE5L3RleHRyZWdpb246ZDBiMjU0MDIxMzI4NGJlYWE4NGUzMjBjYTY5MDAyYTlfMzIw_a32893f7-6137-4a7b-a466-6bf0666829ef"
      unitRef="usd">21400000</us-gaap:Depreciation>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RleHRyZWdpb246ZjVkYjI1OWZiZjk0NDczNTliNjRiYWE5MzNkZDYwZTBfMTU0Mw_0323ae8a-5ebb-43b8-b2d6-6e3a00c0aeaf">Goodwill and Intangible Assets, Net&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the carrying amount of our goodwill (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,449,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,462,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets, Net&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Life&#160;in&#160;Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-contractual customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;550,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;584,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;461,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,209,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;285,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;924,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Internally developed software*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,242,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;285,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;957,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________________ &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Life in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-contractual customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;546,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;445,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;583,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;474,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,202,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;251,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Internally developed software*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,234,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;251,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;982,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________________ &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with definite lives are amortized on a straight-line basis over their estimated useful lives. During the three months ended March&#160;31, 2023 and 2022, intangible asset amortization expense was $32.3 million and $31.7 million, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;924,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RleHRyZWdpb246ZjVkYjI1OWZiZjk0NDczNTliNjRiYWE5MzNkZDYwZTBfMTUzMw_f31ee35e-cefe-4562-abac-31d400001ab0">The following table presents the changes in the carrying amount of our goodwill (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,449,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,462,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjk4YTc0YmUzZDEzZDRiNTlhNzFkYzZiYTIyZmU1MzU1L3RhYmxlcmFuZ2U6OThhNzRiZTNkMTNkNGI1OWE3MWRjNmJhMjJmZTUzNTVfMS0yLTEtMS0xMTIyOTE_dfcc8ca9-5a7a-47f6-a7da-ff8931ad936a"
      unitRef="usd">1449258000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjk4YTc0YmUzZDEzZDRiNTlhNzFkYzZiYTIyZmU1MzU1L3RhYmxlcmFuZ2U6OThhNzRiZTNkMTNkNGI1OWE3MWRjNmJhMjJmZTUzNTVfNC0yLTEtMS0xMTIyOTE_4137f72e-5ddb-4cc6-9581-2f781977df95"
      unitRef="usd">13468000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjk4YTc0YmUzZDEzZDRiNTlhNzFkYzZiYTIyZmU1MzU1L3RhYmxlcmFuZ2U6OThhNzRiZTNkMTNkNGI1OWE3MWRjNmJhMjJmZTUzNTVfNS0yLTEtMS0xMTIyOTE_d1d7e146-9ecc-4afc-8823-07704a04c8f0"
      unitRef="usd">1462726000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RleHRyZWdpb246ZjVkYjI1OWZiZjk0NDczNTliNjRiYWE5MzNkZDYwZTBfMTUzNQ_1ce3056e-0f2b-4e67-b9f6-0c9b8f56f719">Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Life&#160;in&#160;Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-contractual customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;550,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;584,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;461,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,209,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;285,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;924,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Internally developed software*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,242,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;285,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;957,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________________ &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Life in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-contractual customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;546,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;445,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;583,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;474,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,202,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;251,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Internally developed software*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,234,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;251,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;982,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i759eb770637645338c5cb3c69ad883ed_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMi0yLTEtMS0xMTIyOTE_4934a6ad-7715-457d-8db4-c7d5c2cdb19a">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icae7fd56151f4362ba49944b6babf4d5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMi00LTEtMS0xMTIyOTE_9927d8ad-34d6-4bb9-bbe8-4f354781c376"
      unitRef="usd">30735000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icae7fd56151f4362ba49944b6babf4d5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMi02LTEtMS0xMTIyOTE_815d6e76-c3ce-4798-92a5-3eedd92774bb"
      unitRef="usd">19092000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="icae7fd56151f4362ba49944b6babf4d5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMi04LTEtMS0xMTIyOTE_12589bf4-8141-4302-8710-e027f9520bf6"
      unitRef="usd">11643000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i9431fa63e03f4c39828dd6f5c2874b77_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMy0yLTEtMS0xMTIyOTE_afd718ad-abec-4309-bce8-6c8f64c3d8a6">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i45abd7fc6cb041539c2690484538f401_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMy00LTEtMS0xMTIyOTE_f0ce16bd-8d6a-451f-b4a8-3641503652fa"
      unitRef="usd">10046000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i45abd7fc6cb041539c2690484538f401_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMy02LTEtMS0xMTIyOTE_bca40b42-0458-42b3-81c5-6a2df8d0e579"
      unitRef="usd">6527000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i45abd7fc6cb041539c2690484538f401_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMy04LTEtMS0xMTIyOTE_9aa71289-1f97-46bc-896a-1575ab778d9e"
      unitRef="usd">3519000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iaf6dc92130324e248c5bccc98319a7dd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNC0yLTEtMS0xMTIyOTE_400ff4a7-e886-4e1b-bd8b-f686795bb1b1">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id9ddae410dbb4da9b5bbab71cde7e71a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNC00LTEtMS0xMTIyOTE_88c606e5-c67a-41bc-99cf-b2568ebfb7ef"
      unitRef="usd">550703000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id9ddae410dbb4da9b5bbab71cde7e71a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNC02LTEtMS0xMTIyOTE_d4d7a9b7-8531-48c5-9a31-05216b1192b1"
      unitRef="usd">118687000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id9ddae410dbb4da9b5bbab71cde7e71a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNC04LTEtMS0xMTIyOTE_a24d6fac-7b0c-4be6-b1f8-158432ba0665"
      unitRef="usd">432016000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie5653183732045d196de37183c40dd18_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNS0yLTEtMS0xMTIyOTE_1cd43886-ee01-4045-a46e-bd544fb8b218">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4dee8f10404243bfb8a21715c53d5167_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNS00LTEtMS0xMTIyOTE_a3e7fc9d-1d91-4f4f-bd0c-a1924309b9da"
      unitRef="usd">5425000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4dee8f10404243bfb8a21715c53d5167_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNS02LTEtMS0xMTIyOTE_423c3ef3-db6c-49d3-a452-62b0d7f5a764"
      unitRef="usd">5425000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4dee8f10404243bfb8a21715c53d5167_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNS04LTEtMS0xMTIyOTE_4376a38a-b7c9-47ad-9468-c21e53190d3b"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie66a2d4ccf9f4810ab62a157c417c4a0_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNi0yLTEtMS0xMTIyOTE_877440dc-ad29-4418-8114-bfa90c62c463">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idd805b98cb0e420da9a33f629e95ab71_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNi00LTEtMS0xMTIyOTE_ae0f29ec-9e78-470d-9f8d-76487d463f36"
      unitRef="usd">18249000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idd805b98cb0e420da9a33f629e95ab71_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNi02LTEtMS0xMTIyOTE_d27356e0-8e3f-449f-b2b2-277ddf38ab72"
      unitRef="usd">6247000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idd805b98cb0e420da9a33f629e95ab71_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNi04LTEtMS0xMTIyOTE_0b54f35b-543a-479a-be5b-e6ed70078529"
      unitRef="usd">12002000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i79338c5b72624f9e86c8250b5030dbc1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNy0yLTEtMS0xMTIyOTE_1a56a53a-1447-45bd-94fb-7af4c6cdcb0e">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie931f544d5844a66997a310a1d04e1f4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNy00LTEtMS0xMTIyOTE_97978ed2-37fc-45c2-80e1-97c5b5ab37e2"
      unitRef="usd">584957000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie931f544d5844a66997a310a1d04e1f4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNy02LTEtMS0xMTIyOTE_0bb1c3d5-0287-4675-a866-bc34287c9434"
      unitRef="usd">123357000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie931f544d5844a66997a310a1d04e1f4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfNy04LTEtMS0xMTIyOTE_cfe9881d-f143-4594-946f-cb65533db639"
      unitRef="usd">461600000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4325a768bae8472fb7bfb255f0e35276_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfOC0yLTEtMS0xMTIyOTE_6b16473c-8cfd-4bd4-98af-b38290aa9bf1">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ifb7e987c2bb9440db23dae317f15ad47_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfOC00LTEtMS0xMTIyOTE_3b9c0f7e-43ae-4133-8608-caa7641b8fc4"
      unitRef="usd">9100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifb7e987c2bb9440db23dae317f15ad47_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfOC02LTEtMS0xMTIyOTE_735eeae4-36fc-48b1-a2fb-9edf612ffbd7"
      unitRef="usd">5800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ifb7e987c2bb9440db23dae317f15ad47_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfOC04LTEtMS0xMTIyOTE_d914fae4-e786-40be-8fad-bcd094bd6e2f"
      unitRef="usd">3300000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfOS00LTEtMS0xMTIyOTE_307fa50f-bc21-450c-94af-d2483cd15844"
      unitRef="usd">1209215000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfOS02LTEtMS0xMTIyOTE_ffe8be40-914c-4163-86f9-d096e8a1209a"
      unitRef="usd">285135000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfOS04LTEtMS0xMTIyOTE_b111db33-b5e4-40cb-a38e-6b5b1f62df24"
      unitRef="usd">924080000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMTEtNC0xLTEtMTEyMjkx_77f51338-2c84-466e-a69b-7b68e2d0fb51"
      unitRef="usd">33602000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMTEtOC0xLTEtMTEyMjkx_563ee444-aee7-4957-a256-811864eabcef"
      unitRef="usd">33602000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMTMtNC0xLTEtMTEyMjkx_9b8eb8ec-98c3-4051-9f09-7f8f1fda82a4"
      unitRef="usd">1242817000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMTMtNi0xLTEtMTEyMjkx_03d2e529-be4f-434e-bfca-e57a78a4a61c"
      unitRef="usd">285135000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOmIyMDBlYzNmODE5MTQ2NmJhNTg4YzNmNTZjOGFkZTQ0L3RhYmxlcmFuZ2U6YjIwMGVjM2Y4MTkxNDY2YmE1ODhjM2Y1NmM4YWRlNDRfMTMtOC0xLTEtMTEyMjkx_3851701e-f093-42a1-a7a2-8316915f2f98"
      unitRef="usd">957682000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i0f298d4ded0646038f7f4958576511b8_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMi0yLTEtMS0xMTIyOTE_b017d50d-870d-4233-83ba-06716e9ab427">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i179a00f6e8ed4a8eb5aab9eade675698_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMi00LTEtMS0xMTIyOTE_002e0915-73b0-44d5-88ee-c7e54bd3f8e2"
      unitRef="usd">29998000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i179a00f6e8ed4a8eb5aab9eade675698_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMi02LTEtMS0xMTIyOTE_4ac06282-23a8-4781-a414-3aad5a43135e"
      unitRef="usd">18610000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i179a00f6e8ed4a8eb5aab9eade675698_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMi04LTEtMS0xMTIyOTE_93f68428-b0d9-47fa-8d4c-5748e9d99181"
      unitRef="usd">11388000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id0a7b4c978594fa7ac242ade5c6e7a65_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMy0yLTEtMS0xMTIyOTE_e6223103-0665-4f6d-b067-245ad1398d31">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i369d015daca1416f8f0547c55b9d625b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMy00LTEtMS0xMTIyOTE_9690846e-f268-42ec-8d21-a76969802a1b"
      unitRef="usd">10026000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i369d015daca1416f8f0547c55b9d625b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMy02LTEtMS0xMTIyOTE_c14cce80-9f6d-4cc6-be44-181703e85507"
      unitRef="usd">6443000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i369d015daca1416f8f0547c55b9d625b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMy04LTEtMS0xMTIyOTE_21bdaaa4-244e-4364-98d6-43c06c57f05d"
      unitRef="usd">3583000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic041286ae4d64457a61d949e2a01e553_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNC0yLTEtMS0xMTIyOTE_2ed113b4-4e24-481c-99c7-2a914aa1b7c1">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia31355a5a0a34e42adb367500b2d5d1c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNC00LTEtMS0xMTIyOTE_b32493b6-08c1-48aa-a60c-c07fdfdfdcca"
      unitRef="usd">546935000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia31355a5a0a34e42adb367500b2d5d1c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNC02LTEtMS0xMTIyOTE_76f907bd-80f3-4519-ba2f-1f066fadcfc8"
      unitRef="usd">101556000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia31355a5a0a34e42adb367500b2d5d1c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNC04LTEtMS0xMTIyOTE_a85d769e-8e79-42ca-b87e-a9f88401259a"
      unitRef="usd">445379000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5119a978c7084a25a248c39ee1944803_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNS0yLTEtMS0xMTIyOTE_042ec9ae-9d8c-4541-8563-8e9e750c16c3">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9faa2994ef5c4d8cb43ac97f50785f0e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNS00LTEtMS0xMTIyOTE_12771316-3888-4a5f-9590-857809b93ae6"
      unitRef="usd">5425000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9faa2994ef5c4d8cb43ac97f50785f0e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNS02LTEtMS0xMTIyOTE_46c16af6-db82-49f4-a6eb-c0234aed757c"
      unitRef="usd">5425000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9faa2994ef5c4d8cb43ac97f50785f0e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNS04LTEtMS0xMTIyOTE_bc9d65d3-30b2-4ba8-a5e4-e2c046d8ce15"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i92753141dc8f4c78b24dcbf4e0913b77_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNi0yLTEtMS0xMTIyOTE_70c017f0-2351-4a57-9cd4-4ebd19bf3b33">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iaba17e9a9dce424287c2e009d986cffd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNi00LTEtMS0xMTIyOTE_40195036-a03a-4e5e-b375-fe85b86e6674"
      unitRef="usd">18251000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iaba17e9a9dce424287c2e009d986cffd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNi02LTEtMS0xMTIyOTE_ca96a10f-cf21-4aa3-8ef9-5ec0c7f8fecc"
      unitRef="usd">5959000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iaba17e9a9dce424287c2e009d986cffd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNi04LTEtMS0xMTIyOTE_ad0c6bd4-db9a-4ad3-8782-f751027659fc"
      unitRef="usd">12292000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic2084d5b4c664907b48055fe916dc52e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNy0yLTEtMS0xMTIyOTE_c4c469d0-9b5b-4b28-9e86-bad09008d5f9">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id56f1f6ec46947599bc7bfc1ffe9d195_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNy00LTEtMS0xMTIyOTE_099d2fcf-d9e8-4506-a021-566da0590ca8"
      unitRef="usd">583176000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id56f1f6ec46947599bc7bfc1ffe9d195_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNy02LTEtMS0xMTIyOTE_87e974bf-dfb5-4451-9e5f-d6f4453fb79e"
      unitRef="usd">108708000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id56f1f6ec46947599bc7bfc1ffe9d195_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfNy04LTEtMS0xMTIyOTE_4bc3b73b-76dc-4d4d-be5e-b35b50e74e66"
      unitRef="usd">474468000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i89af7b8cd3d0498cbb978e49c788ff06_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfOC0yLTEtMS0xMTIyOTE_b3f8888e-9ac3-403d-b645-933d6e2c6f3a">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i74ff728885fb420389d379cc16b1717f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfOC00LTEtMS0xMTIyOTE_e83289bf-8814-4254-b456-970488fb859d"
      unitRef="usd">9100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i74ff728885fb420389d379cc16b1717f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfOC02LTEtMS0xMTIyOTE_d4c3460c-ed59-44b2-8293-26cb4bd0ecc7"
      unitRef="usd">5250000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i74ff728885fb420389d379cc16b1717f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfOC04LTEtMS0xMTIyOTE_7c95438b-eb41-4f68-93e9-970e4f807b31"
      unitRef="usd">3850000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfOS00LTEtMS0xMTIyOTE_60f97eee-de5a-4e31-8fe3-2d6a763f693b"
      unitRef="usd">1202911000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfOS02LTEtMS0xMTIyOTE_2f4f5f78-697e-49a5-b082-e0b4b1fa5ccd"
      unitRef="usd">251951000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfOS04LTEtMS0xMTIyOTE_1c05ac0f-e27c-4945-a5f3-898698a52c99"
      unitRef="usd">950960000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMTEtNC0xLTEtMTEyMjkx_247e74c6-df16-43bf-9a54-5279c15156b5"
      unitRef="usd">31806000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMTEtOC0xLTEtMTEyMjkx_f75ef94e-78e7-4a47-a40a-64628a93a2a2"
      unitRef="usd">31806000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMTMtNC0xLTEtMTEyMjkx_3b933a80-34b4-47f3-b42e-c71dea1e760b"
      unitRef="usd">1234717000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMTMtNi0xLTEtMTEyMjkx_07aaa1a8-d7b1-4ebd-ae32-0fecd14861e9"
      unitRef="usd">251951000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjliZjEyYjI0NDZkMjQxZDZiOTY1MmZkZjNhMGEyYTJmL3RhYmxlcmFuZ2U6OWJmMTJiMjQ0NmQyNDFkNmI5NjUyZmRmM2EwYTJhMmZfMTMtOC0xLTEtMTEyMjkx_fa96602c-cd9e-4a3b-b950-c0584d2bbf6f"
      unitRef="usd">982766000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RleHRyZWdpb246ZjVkYjI1OWZiZjk0NDczNTliNjRiYWE5MzNkZDYwZTBfMTA2OA_34e798e4-7163-4b32-887d-ddc787df9017"
      unitRef="usd">32300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RleHRyZWdpb246ZjVkYjI1OWZiZjk0NDczNTliNjRiYWE5MzNkZDYwZTBfMTA3NQ_bbacfa9a-4bea-42ed-a4f0-87dbcc197cd2"
      unitRef="usd">31700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RleHRyZWdpb246ZjVkYjI1OWZiZjk0NDczNTliNjRiYWE5MzNkZDYwZTBfMTU0Nw_fe8118d2-3a71-4fe5-83b5-b29d6227cd55">As of March&#160;31, 2023 estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;924,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjE2ODkyYThmMWMwZDQ5MTdiNGNhOGU2MzNjZjFmYjlmL3RhYmxlcmFuZ2U6MTY4OTJhOGYxYzBkNDkxN2I0Y2E4ZTYzM2NmMWZiOWZfMC0yLTEtMS0xMTIyOTE_585dfe11-bd4b-4cd7-be8d-eb9b99c0b759"
      unitRef="usd">98853000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjE2ODkyYThmMWMwZDQ5MTdiNGNhOGU2MzNjZjFmYjlmL3RhYmxlcmFuZ2U6MTY4OTJhOGYxYzBkNDkxN2I0Y2E4ZTYzM2NmMWZiOWZfMS0yLTEtMS0xMTIyOTE_bebb3caa-d346-4828-9e82-363f1c990479"
      unitRef="usd">131665000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjE2ODkyYThmMWMwZDQ5MTdiNGNhOGU2MzNjZjFmYjlmL3RhYmxlcmFuZ2U6MTY4OTJhOGYxYzBkNDkxN2I0Y2E4ZTYzM2NmMWZiOWZfMi0yLTEtMS0xMTIyOTE_f5126283-f436-4792-8a44-47e0ee1e2183"
      unitRef="usd">124073000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjE2ODkyYThmMWMwZDQ5MTdiNGNhOGU2MzNjZjFmYjlmL3RhYmxlcmFuZ2U6MTY4OTJhOGYxYzBkNDkxN2I0Y2E4ZTYzM2NmMWZiOWZfMy0yLTEtMS0xMTIyOTE_07ff39b6-41f1-4428-8196-16f476b82133"
      unitRef="usd">123438000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjE2ODkyYThmMWMwZDQ5MTdiNGNhOGU2MzNjZjFmYjlmL3RhYmxlcmFuZ2U6MTY4OTJhOGYxYzBkNDkxN2I0Y2E4ZTYzM2NmMWZiOWZfNC0yLTEtMS0xMTIyOTE_a9f20816-f960-42c2-964d-cf941e6d6a88"
      unitRef="usd">117400000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjE2ODkyYThmMWMwZDQ5MTdiNGNhOGU2MzNjZjFmYjlmL3RhYmxlcmFuZ2U6MTY4OTJhOGYxYzBkNDkxN2I0Y2E4ZTYzM2NmMWZiOWZfNS0yLTEtMS0xMTIyOTE_0c1d95db-ed34-406f-b181-d23104b6ab94"
      unitRef="usd">110442000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjE2ODkyYThmMWMwZDQ5MTdiNGNhOGU2MzNjZjFmYjlmL3RhYmxlcmFuZ2U6MTY4OTJhOGYxYzBkNDkxN2I0Y2E4ZTYzM2NmMWZiOWZfNi0yLTEtMS0xMTIyOTE_5dc2ac10-b10e-4eb8-9f67-f06f97321bee"
      unitRef="usd">218209000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83My9mcmFnOmY1ZGIyNTlmYmY5NDQ3MzU5YjY0YmFhOTMzZGQ2MGUwL3RhYmxlOjE2ODkyYThmMWMwZDQ5MTdiNGNhOGU2MzNjZjFmYjlmL3RhYmxlcmFuZ2U6MTY4OTJhOGYxYzBkNDkxN2I0Y2E4ZTYzM2NmMWZiOWZfNy0yLTEtMS0xMTIyOTE_8a426761-5178-49e6-963c-70b85ba6009e"
      unitRef="usd">924080000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RleHRyZWdpb246YjM3N2YzNjg3ZTk4NDE3ZmI3ZmZjOTQ5NTE0MTA0NjVfODQ3_c3fb1a8b-5632-47c9-bc2d-9c1f8296d4c1">Accrued Liabilities and Other Long-Term Liabilities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Accrued liabilities consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incentive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability-ST&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranties and returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Field service corrective action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued freight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued audit fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined benefit plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;___________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Relates to field service corrective actions associated with certain products in connection with a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#x2019;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.&lt;/span&gt;&lt;/div&gt;Other long-term liabilities consist of the following (in thousands):&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability-LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liability-LT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Field service corrective action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RleHRyZWdpb246YjM3N2YzNjg3ZTk4NDE3ZmI3ZmZjOTQ5NTE0MTA0NjVfODUz_184b37cf-e7b7-4714-8dae-4f7330c67ac8">Accrued liabilities consist of the following (in thousands):&#160;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incentive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability-ST&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranties and returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Field service corrective action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued freight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued audit fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined benefit plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;___________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Relates to field service corrective actions associated with certain products in connection with a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#x2019;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.&lt;/span&gt;&lt;/div&gt;Other long-term liabilities consist of the following (in thousands):&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability-LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liability-LT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Field service corrective action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <icui:AccruedSalariesAndBenefits
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMi0xLTEtMS0xMTIyOTE_fd074c5e-4f39-4c97-a5b9-c382138955cc"
      unitRef="usd">47808000</icui:AccruedSalariesAndBenefits>
    <icui:AccruedSalariesAndBenefits
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMi0zLTEtMS0xMTIyOTE_b7aadbd9-edd6-4fbc-943e-fa8a2d3b9afc"
      unitRef="usd">44304000</icui:AccruedSalariesAndBenefits>
    <us-gaap:AccruedBonusesCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMy0xLTEtMS0xMTIyOTE_c95ec600-ccc7-4032-8f21-43719d30a600"
      unitRef="usd">22579000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMy0zLTEtMS0xMTIyOTE_76efd27c-6d4b-43cd-ab55-4f93a40b7f0e"
      unitRef="usd">30254000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfNS0xLTEtMS0xMTIyOTE_be7b2395-1b06-47b8-8ee7-767f910cc1d1"
      unitRef="usd">20150000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfNS0zLTEtMS0xMTIyOTE_3b137b39-262b-438b-8db6-b45f2add035e"
      unitRef="usd">18169000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfOS0xLTEtMS0xMTIyOTE_6897eb71-1f27-462f-8129-ca46f7fe5de3"
      unitRef="usd">6158000</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfOS0zLTEtMS0xMTIyOTE_4485d688-fe1b-4f0c-a964-ee1d36c6515c"
      unitRef="usd">5844000</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTAtMS0xLTEtMTEyMjkx_905f7676-312d-443a-a691-f1db27938970"
      unitRef="usd">6546000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTAtMy0xLTEtMTEyMjkx_37330170-6c17-4955-ad16-7991483a4177"
      unitRef="usd">5923000</us-gaap:RestructuringReserveCurrent>
    <icui:UnfavorablecontractliabilityST
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTItMS0xLTEtMTEyMjkx_48bc676e-9752-4840-958f-ee9dc97a5fbc"
      unitRef="usd">30991000</icui:UnfavorablecontractliabilityST>
    <icui:UnfavorablecontractliabilityST
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTItMy0xLTEtMTEyMjkx_462cc668-39ab-4e01-8a18-6b0a6c21e568"
      unitRef="usd">30838000</icui:UnfavorablecontractliabilityST>
    <icui:Accruedothertaxes
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTMtMS0xLTEtMTEyMjkx_c8c49549-6f6b-4143-986c-5c5f82cec9e9"
      unitRef="usd">2524000</icui:Accruedothertaxes>
    <icui:Accruedothertaxes
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTMtMy0xLTEtMTEyMjkx_2a7312c9-3824-4130-ad15-4b1530b514cc"
      unitRef="usd">5794000</icui:Accruedothertaxes>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTQtMS0xLTEtMTEyMjkx_b9324ca0-301b-408b-8cff-0e0098606c29"
      unitRef="usd">6823000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTQtMy0xLTEtMTEyMjkx_300375c1-a008-42e1-a7f8-2b829c68fc03"
      unitRef="usd">5317000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <icui:Accruedlegalfees
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTUtMS0xLTEtMTEyMjkx_33377b71-ebfa-445b-8e81-b01829f29996"
      unitRef="usd">3137000</icui:Accruedlegalfees>
    <icui:Accruedlegalfees
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTUtMy0xLTEtMTEyMjkx_39b0f588-7569-44f4-861a-ea7c0254737c"
      unitRef="usd">3137000</icui:Accruedlegalfees>
    <icui:Outsidesalescommissions
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTctMS0xLTEtMTEyMjkx_8e8e838a-8124-4dc4-a795-60d4bdb9bf8c"
      unitRef="usd">11502000</icui:Outsidesalescommissions>
    <icui:Outsidesalescommissions
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTctMy0xLTEtMTEyMjkx_f6e3d93a-c31a-45c7-999d-7f91a3f5552e"
      unitRef="usd">17063000</icui:Outsidesalescommissions>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTgtMS0xLTEtMTEyMjkx_9be8db53-b82e-4e0b-a2ff-d3166900b606"
      unitRef="usd">3201000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTgtMy0xLTEtMTEyMjkx_e799b35d-05f7-4c1e-82f7-33ab84629502"
      unitRef="usd">3097000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <icui:FieldServiceCorrectiveAction
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTktMS0xLTEtMTEyMjkx_1826a475-cedd-4d82-860e-46f3918ed447"
      unitRef="usd">27898000</icui:FieldServiceCorrectiveAction>
    <icui:FieldServiceCorrectiveAction
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMTktMy0xLTEtMTEyMjkx_6e44f973-a560-4bd5-bf5e-4cddaf8fcc82"
      unitRef="usd">24517000</icui:FieldServiceCorrectiveAction>
    <icui:Accruedfreight
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjAtMS0xLTEtMTEyMjkx_bc26f4aa-9f25-484d-8ac2-f4607a7c9dad"
      unitRef="usd">11116000</icui:Accruedfreight>
    <icui:Accruedfreight
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjAtMy0xLTEtMTEyMjkx_cd9553e4-71d0-44c0-a882-b7052ac67948"
      unitRef="usd">17988000</icui:Accruedfreight>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i43a9c2ae467547f8811c5f92ca52a728_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjEtMS0xLTEtMTEyMjkx_da3a29c9-741d-4ef1-bb44-826b39235b0b"
      unitRef="usd">2132000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i5d8fe8f65713456c8f35230f74bceb87_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjEtMy0xLTEtMTEyMjkx_9de727d8-63aa-40c2-9d53-ca67331e35cf"
      unitRef="usd">1847000</us-gaap:DerivativeLiabilitiesCurrent>
    <icui:AccruedResearchAndDevelopment
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjMtMS0xLTEtMTEyMjkx_642688e2-0418-432a-9794-153727401beb"
      unitRef="usd">6562000</icui:AccruedResearchAndDevelopment>
    <icui:AccruedResearchAndDevelopment
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjMtMy0xLTEtMTEyMjkx_da6b8bb8-e24f-44bc-a13f-3241ed0fbd00"
      unitRef="usd">3538000</icui:AccruedResearchAndDevelopment>
    <icui:AccruedAuditFees
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjYtMS0xLTEtMTEyMjkx_c3284d96-0ba5-406a-a85c-69512904fb0d"
      unitRef="usd">6355000</icui:AccruedAuditFees>
    <icui:AccruedAuditFees
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjYtMy0xLTEtMTEyMjkx_eefd3b40-54de-439c-8c68-2a72137ae692"
      unitRef="usd">6279000</icui:AccruedAuditFees>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjctMS0xLTEtMTEyMjkx_cfb495fc-905f-44d1-8eae-b1008085980f"
      unitRef="usd">2974000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjctMy0xLTEtMTEyMjkx_04671f7b-3965-445d-9a8f-169f13be2ac7"
      unitRef="usd">2928000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjktMS0xLTEtMTEyMjkx_4c00a774-49b9-4531-8db5-185cf56d9ebb"
      unitRef="usd">693000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMjktMy0xLTEtMTEyMjkx_32a8f86a-be92-49b2-97d3-481d44653f1b"
      unitRef="usd">1033000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMzAtMS0xLTEtMTEyMjkx_62e03b94-59d1-4f4b-b0da-7800df627d06"
      unitRef="usd">16018000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMzAtMy0xLTEtMTEyMjkx_b2a65854-5cdf-48af-8cf3-a804687a4752"
      unitRef="usd">14899000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMzEtMS0xLTEtMTEyMjkx_ab2d73cb-a8c0-4bae-9bd1-a196139402e9"
      unitRef="usd">235167000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOjZkMmJhYmM1MWM5MDQxYjI5MGJlMTljY2E0NzU2NmNjL3RhYmxlcmFuZ2U6NmQyYmFiYzUxYzkwNDFiMjkwYmUxOWNjYTQ3NTY2Y2NfMzEtMy0xLTEtMTEyMjkx_81fdf2d4-7677-43dd-ad16-d616cad12a0d"
      unitRef="usd">242769000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMy0xLTEtMS0xMTIyOTE_568086a8-62c5-4d71-85b9-09b2f5f09121"
      unitRef="usd">63062000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMy0zLTEtMS0xMTIyOTE_16b6060b-d696-4b4c-a9fd-f8260b96bf92"
      unitRef="usd">60916000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfNC0xLTEtMS0xMTIyOTE_9b2ff81a-d1de-47ee-9aa8-dca6093a78c3"
      unitRef="usd">5252000</us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfNC0zLTEtMS0xMTIyOTE_e22a6a6f-0e11-463c-ad89-89c0c4a06f46"
      unitRef="usd">5314000</us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent>
    <us-gaap:AccruedRentCurrentAndNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfNS0xLTEtMS0xMTIyOTE_426c56d1-6279-4f15-87ee-bea81482a3ef"
      unitRef="usd">955000</us-gaap:AccruedRentCurrentAndNoncurrent>
    <us-gaap:AccruedRentCurrentAndNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfNS0zLTEtMS0xMTIyOTE_156b69fe-964c-409f-99fa-1a2c5b89a648"
      unitRef="usd">997000</us-gaap:AccruedRentCurrentAndNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTAtMS0xLTEtMTEyMjkx_eab66f78-7a24-4104-8e87-2b8e29548f56"
      unitRef="usd">1939000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTAtMy0xLTEtMTEyMjkx_78a0ef8b-ef99-4f4c-91c3-9da18a5c8d6c"
      unitRef="usd">1855000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTEtMS0xLTEtMTEyMjkx_ef8530da-5c86-43aa-a8c6-8c56a49a1d8f"
      unitRef="usd">16591000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTEtMy0xLTEtMTEyMjkx_1bc45fec-a449-494f-b2a4-c7fb7a7923e7"
      unitRef="usd">16239000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ProductLiabilityAccrualComponentAmount
      contextRef="i8fed4ca7522348e09634e4fad1da85ca_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTItMS0xLTEtMTEyMjkx_7bb51cca-6315-4a79-b16c-30e0ca4d0c8a"
      unitRef="usd">25294000</us-gaap:ProductLiabilityAccrualComponentAmount>
    <us-gaap:ProductLiabilityAccrualComponentAmount
      contextRef="i6cb7cc5f691a49e8b4265215896d8c03_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTItMy0xLTEtMTEyMjkx_f59efe83-9907-4ccf-b8cf-164af213f1a0"
      unitRef="usd">25294000</us-gaap:ProductLiabilityAccrualComponentAmount>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTMtMS0xLTEtMTEyMjkx_f7c5478d-8983-4893-a677-5454c392981d"
      unitRef="usd">1134000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTMtMy0xLTEtMTEyMjkx_3503659c-68bf-4760-b8a3-7ea36fbbeb8a"
      unitRef="usd">3489000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTQtMS0xLTEtMTEyMjkx_20541897-69a1-4a8a-ad77-8b27587e8a48"
      unitRef="usd">114227000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83Ni9mcmFnOmIzNzdmMzY4N2U5ODQxN2ZiN2ZmYzk0OTUxNDEwNDY1L3RhYmxlOmY4N2Q0ZTAwZTY5MDQzMjRiZDYyZDI5MjYwZGYwZGRlL3RhYmxlcmFuZ2U6Zjg3ZDRlMDBlNjkwNDMyNGJkNjJkMjkyNjBkZjBkZGVfMTQtMy0xLTEtMTEyMjkx_cbcd38b8-d8b9-48e0-bf13-ac05f92c2149"
      unitRef="usd">114104000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfMTgyNA_de8b5177-7cbc-4b53-9065-ff9d7dcc105b">Income Taxes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes were accrued at an estimated effective tax rate of 27% for the three months ended March&#160;31, 2023, as compared to 31% for the three months ended March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The effective tax rate for the three months ended March 31, 2023 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, section 162(m) excess compensation, foreign-derived intangible income ("FDII") and tax credits and the following discrete items recognized during the interim period:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Excess tax provision recognized on stock option exercises and the vesting of restricted stock units during the three months ended March&#160;31, 2023 of $0.7&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The revaluation of the contingent consideration during the three months ended March&#160;31, 2023 of $0.7&#160;million, resulted in a tax expense of $0.0&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The effective tax rate for the three months ended March 31, 2022 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, section 162(m) excess compensation, FDII and tax credits. The effective tax rate during the three months ended March 31, 2022 included a discrete tax benefit of $2.6&#160;million related to excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfOTU_d0bbc956-4df8-44e2-995b-763ccd1fb1f5"
      unitRef="number">0.27</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfMTc0_f250621e-8265-4f09-8137-0096eb722081"
      unitRef="number">0.31</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfMzM4_18c9dd86-0e6b-49cc-b103-9ac6f04af275"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfNzQ2_7d762627-d7c7-4c50-943c-a45b2eb27496"
      unitRef="usd">700000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfODY1_6752bc96-0744-4903-9faa-79fe1853451e"
      unitRef="usd">-700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <icui:ContingentConsiderationTaxExpense
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfOTE5_ef661030-41e2-4559-a68a-4c5706898c20"
      unitRef="usd">0</icui:ContingentConsiderationTaxExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfMTAzMA_32abda4b-51ca-4bca-82c4-4f893bf7a3fc"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV83OS9mcmFnOjUwZjQzMDc5OGY4OTRmNDc4ZTJjNDBmNTFhNWFiNWJjL3RleHRyZWdpb246NTBmNDMwNzk4Zjg5NGY0NzhlMmM0MGY1MWE1YWI1YmNfMTMxMQ_4e151af3-22a8-4232-b1d7-68c412fb94bb"
      unitRef="usd">2600000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTEzMjc_9ef79482-9250-44cf-9e31-3516adfeec36">Long-Term Debt&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, in connection with the acquisition of Smiths Medical, we entered into a Credit Agreement (the "Credit Agreement") with Wells Fargo Bank, National Association, Wells Fargo Securities, LLC, Barclays Bank PLC and certain other financial institutions (the &#x201c;Lenders&#x201d;) for $2.2&#160;billion of senior secured credit facilities. The senior secured credit facilities include (i) a five-year Tranche A term loan of $850.0&#160;million (the "Term Loan A"), (ii) a seven-year Tranche B term loan of $850.0&#160;million (the "Term Loan B") and (iii) a five-year revolving credit facility of $500.0&#160;million (the "Revolving Credit Facility"), with separate sub-limits of $50.0&#160;million for letters of credit and swingline loans (collectively, the "Senior Secured Credit Facilities"). We used the proceeds from borrowings under the Term Loan A and the Term Loan B (collectively, the "Term Loans") to fund a portion of the cash consideration for the purchase of Smiths Medical and the related fees and expenses incurred in connection with the acquisition. We did not incur borrowings under the Revolving Credit Facility on the closing date of the acquisition. The proceeds from any future borrowings under the Revolving Credit Facility may be used for working capital and other general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with entering into the Credit Agreement, during the period ended March 31, 2022, we incurred $37.8 million in debt discount and issuance costs, which were allocated to the Term Loan A, the Term Loan B and the Revolving Credit Facility based on lender commitment amounts relative to each type of fees paid. The lender and third-party discount and issuance costs allocated to the Term Loan A and the Term Loan B were $15.8 million and $13.4 million, respectively, and are reflected as a direct deduction from the face amount of the corresponding term loans on the condensed consolidated balance sheet. These costs are being amortized to interest expense over the respective terms of the loans using the effective interest method. The issuance costs allocated to the Revolving Credit Facility were $8.6 million, which are capitalized and included in prepaid expenses and other current assets and other assets on our condensed consolidated balance sheets. These costs are being amortized to interest expense over the term of the Revolving Credit Facility using the straight-line method. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net funds received from the Term Loan A and the Term Loan B, after deducting debt issuance costs, were $834.2 million and $836.6 million, respectively.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity Dates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity date for the Term Loan A and the Revolving Credit Facility is January 6, 2027, and the maturity date for the Term Loan B is January 6, 2029. Pursuant to the terms and conditions of the Credit Agreement, the maturity dates of the Term Loans and the Revolving Credit Facility may be extended upon our request, subject to the consent of the Lenders.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Rate Terms&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In general, the Term Loans and borrowings under the Revolving Credit Facility denominated in U.S. dollars bear interest, at our option, on either: (1) the Base Rate, as defined below, plus the applicable margin, as indicated below ("Base Rate Loans") or (2) the Adjusted Term Secured Overnight Financing Rate ("Adjusted Term SOFR"), as defined below, plus the applicable margin, as indicated below ("Term SOFR Loans"). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Base Rate is defined as the highest of (a) the Prime Rate, (b) the Federal Funds Rate plus 0.50% and (c) Adjusted Term SOFR (as defined below) for a one-month period plus, in each case, 1.00%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjusted Term SOFR is the rate per annum equal to (a) the Term SOFR plus (b) the Term SOFR Adjustment. Term SOFR is the forward-looking term rate based on SOFR and is calculated separately for Term SOFR Loans and Base Rate Loans, as specified in the Credit Agreement. The Term SOFR Adjustment is a percentage per annum of 0.10% for Base Rate Loans and between 0.10% to 0.25% for Term SOFR Loans based on the applicable interest period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facility Commitment Fee&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revolving Credit Facility has a per annum commitment fee at an initial rate of 0.25% which is applied to the available amount of the Revolving Credit Facility. Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the commitment fee will be determined by reference to the leverage ratio in effect from time to time as set forth in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Applicable Interest Margins&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan A and borrowings under the Revolving Credit Facility have an initial applicable margin of 0.75% per annum for Base Rate Loans and 1.75% per annum for Term SOFR Loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan A and borrowings under the Revolving Credit Facility will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Term SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Commitment Fee Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than 4.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 4.00 to 1.0 but greater than 3.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 3.00 to 1.0 but greater than 2.50 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 2.50 to 1.0 but greater than 2.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 2.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan B has an initial applicable margin of 1.5% per annum for Base Rate Loans and 2.5% per annum for Term SOFR Loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan B will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Term SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than 2.75 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.75 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Principal Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Principal payments on the Term Loans are due on the last day of each calendar quarter commencing on June 30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan A will amortize in nineteen consecutive quarterly installments in an amount equal to 2.50% of the original principal amount in each of the first two years, 5.00% in each of the third and fourth years and 7.50% in the fifth year, with a final payment of the remaining outstanding principal balance due on the maturity date.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan B matures in twenty-seven consecutive quarterly installments in an amount equal to 0.25% of the original principal amount, with a final payment of the remaining outstanding principal balance due on the maturity date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may borrow, prepay and re-borrow amounts under the Revolving Credit Facility, in accordance with the terms and conditions of the Credit Agreement, with all outstanding amounts due at maturity. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During March 2022, we prepaid $16.0 million in principal payments on the Term Loan A principal balance. For the three months ended March 31, 2023, we paid  total of $7.4&#160;million in principal payments on both Term Loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest payments on Base Rate Loans are payable quarterly in arrears on the last business day of each calendar quarter and the applicable maturity date. Interest periods on Term SOFR Loans will be determined, at our option, as either one, three or six months and will be payable on the last day of each interest period and the applicable maturity date. In the case of any interest periods of more than three months' duration, the interest payment will be payable on each day prior to the last day of such interest period that occurs at three-month intervals.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The commitment fee on the Revolving Credit Facility is payable quarterly in arrears on the third business day following the last day of each calendar quarter and at the maturity date. The commitment fee is included in interest expense in our condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantors and Collateral&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our obligations under the Credit Agreement are unconditionally guaranteed, on a joint and several basis, by ICU Medical, Inc. and certain of our existing subsidiaries. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Covenants&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement contains affirmative and negative covenants, including certain financial covenants. The negative covenants include restrictions regarding the incurrence of liens and indebtedness, certain merger and acquisition transactions, asset sales and other dispositions, other investments, dividends, share purchases and payments affecting subsidiaries, changes in nature of business, fiscal year or organizational documents, prepayments and redemptions of subordinated and other junior debt, transactions with affiliates, and other matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial covenants include the Senior Secured Leverage Ratio and the Interest Coverage Ratio, both defined below, and pertain to the Term Loan A and the Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Senior Secured Leverage Ratio is defined, at any measurement date, as the ratio of: (a) all Funded Debt, as defined in the Credit Agreement, that is secured by a lien on any asset or property minus the lesser of (i) all unrestricted cash and cash equivalents and (ii) $500.0&#160;million, to (b) Consolidated EBITDA, as defined in the Credit Agreement, for the most recently completed four fiscal quarters, calculated on a pro forma basis. The maximum Senior Secured Leverage Ratio is 4.50 to 1.00 until June 30, 2024. Thereafter, the maximum Senior Secured Leverage Ratio is 4.00 to 1.00, with limited permitted exception.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Interest Coverage ratio is defined, at any measurement date, as the ratio of Consolidated EBITDA, as defined in the Credit Agreement, to Consolidated Interest Expense, as defined in the Credit Agreement, paid or payable in cash, for the most recently completed four fiscal quarters. The minimum Interest Coverage ratio is 3.00 to 1.00.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We were in compliance with all financial covenants as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement contains customary events of default, including, among others: non-payments of principal and interest; breach of representations and warranties; covenant defaults; cross-defaults and cross-acceleration to certain other material indebtedness; the existence of bankruptcy or insolvency proceedings; certain events under ERISA; material judgments; and a change of control. If an event of default occurs and is not cured within any applicable grace period or is not waived, the administrative agent and the Lenders are entitled to take various actions, including, without limitation, the acceleration of all amounts due and the termination of commitments under the Senior Secured Credit Facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2017 Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On November 8, 2017, we entered into a five-year senior secured revolving credit facility with various lenders for $150.0 million, with Wells Fargo Bank, National Association as the administrative agent, swingline lender and issuing lender (the "Prior Credit Facility"). The Prior Credit Facility, which was set to mature on November 8, 2022, was terminated in connection with entering into the Credit Agreement on January 6, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of our long-term debt consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effective Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effective Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan A &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan B &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving Credit Facility &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less unamortized debt issuance costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total carrying value of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,647,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,653,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,612,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,623,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprised of $11.8 million and $11.2 million relating to the Term Loan A and the Term Loan B, respectively, as of March 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years is approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;672,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,670,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the total interest expense related to our long-term debt (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitment fee &#x2014; Revolving Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt-related  interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <icui:TotalSeniorSecuredCreditFacility
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMzQy_d9910577-2746-45fd-ad38-e02b95cb2b54"
      unitRef="usd">2200000000</icui:TotalSeniorSecuredCreditFacility>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i5601a8c75d144a43a8365d2d70291f2f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNDY2_249fb8c5-e7c6-4855-a9f7-b672ccb8a3b3"
      unitRef="usd">850000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i6f8a9cb1a64e44a89d9d73f6ad8eba74_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNTMx_7c2d9e83-83a0-49cc-83b8-d9beaf6bff85"
      unitRef="usd">850000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie8a1a1ffc693445c9e79c6e34870c622_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNjA1_87c3ecfb-ea8a-4f5a-a464-523fb72ed80f"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <icui:RevolverSubLimits
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNjcx_3da9a4fb-2e03-47b9-8246-cf7cc049a696"
      unitRef="usd">50000000</icui:RevolverSubLimits>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTQwMA_99b625d9-f993-4dec-9cf4-b0743cb8a24d"
      unitRef="usd">37800000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i59eb5fecde424d39a6b4b8dce858b9f7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTcxMQ_41153552-42d5-4645-a5c0-5b21ead18ecd"
      unitRef="usd">15800000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i514b0dbe6eac49eea9224b92e51b766b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTcxOA_e9b85425-268d-492e-984e-519a5dbb9b36"
      unitRef="usd">13400000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="ie8a1a1ffc693445c9e79c6e34870c622_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMjA2OQ_0173a2e6-69c7-4650-977a-ee8b36cb5774"
      unitRef="usd">8600000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LongTermDebt
      contextRef="i59eb5fecde424d39a6b4b8dce858b9f7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMjQ1Ng_0f33e687-1f60-496f-af1d-b0961da47a75"
      unitRef="usd">834200000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i514b0dbe6eac49eea9224b92e51b766b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMjQ2Mw_52006fd8-2983-44de-8867-838e2e759eaf"
      unitRef="usd">836600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i5601a8c75d144a43a8365d2d70291f2f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMjU3Ng_506a0046-51c7-47a1-9463-9303f8d09edb">2027-01-06</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i6f8a9cb1a64e44a89d9d73f6ad8eba74_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMjYyNQ_18650771-7a24-45fc-aec8-e0627220ac57">2029-01-06</us-gaap:DebtInstrumentMaturityDate>
    <icui:InterestPercentageAddedToFederalFundsRate
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMzM3Mw_3b777c4b-861b-4fb8-95ba-52c45756dfd6"
      unitRef="number">0.0050</icui:InterestPercentageAddedToFederalFundsRate>
    <icui:InterestPercentageAddedToBaseRate
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMzQ2NQ_48eb8743-e04e-4b02-a509-fc9fe8dd0022"
      unitRef="number">0.0100</icui:InterestPercentageAddedToBaseRate>
    <icui:TerSOFRInterestRateAdjustmentForBaseRateLoans
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMzc5Mg_2b634830-c88c-4b38-82f2-54f1a8d2ac83"
      unitRef="number">0.0010</icui:TerSOFRInterestRateAdjustmentForBaseRateLoans>
    <icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans
      contextRef="ica8e78475e314beda5cd3faaa0ce02d4_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMzgyNw_edb9ffc0-3030-4add-81c3-30f18e8e1104"
      unitRef="number">0.0010</icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans>
    <icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans
      contextRef="i40f728bd623845f9b4ce1cfdaf7c303f_I20230331"
      decimals="8"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMzgzMw_61042d42-32b5-45bb-8613-45e97242fd7e"
      unitRef="number">0.0025</icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNDAyMw_7e9242fa-157a-437f-8adb-f74a1d2bbcbf"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="i59eb5fecde424d39a6b4b8dce858b9f7_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNDUwMw_b1695915-c8f1-450f-ad12-5f46a4ae637c"
      unitRef="number">0.0075</icui:ApplicableMarginBaseRateLoans>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="i59eb5fecde424d39a6b4b8dce858b9f7_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNDU0MA_e6768f4e-da96-47d1-8945-85d5337f3537"
      unitRef="number">0.0175</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBasedOnLeverageRatioTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTEzMjY_64c473c1-bc0c-4d19-8ae7-a8f839c2e797">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan A and borrowings under the Revolving Credit Facility will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Term SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Commitment Fee Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than 4.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 4.00 to 1.0 but greater than 3.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 3.00 to 1.0 but greater than 2.50 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 2.50 to 1.0 but greater than 2.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 2.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</icui:ApplicableMarginBasedOnLeverageRatioTableTextBlock>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="i80d837b89c2344e393ee4d383e5cc11b_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMS0xLTEtMS0xMTIyOTE_dc99b6ff-3152-4f1f-b9ee-59c723d492f3"
      unitRef="number">0.0225</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="i80d837b89c2344e393ee4d383e5cc11b_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMS0yLTEtMS0xMTIyOTE_140f7a44-1deb-4180-912e-1ca078cfce1b"
      unitRef="number">0.0125</icui:ApplicableMarginBaseRateLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i27b3017a55814b6597ba4e68980a344f_D20230101-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMS0zLTEtMS0xMTIyOTE_877206eb-00c1-4dc7-b228-dc3364ae245c"
      unitRef="number">0.0035</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="i881696e2df5749c38024d0875b7c80db_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMi0xLTEtMS0xMTIyOTE_958939c5-617a-4099-8fef-1a09c3e97e3a"
      unitRef="number">0.0200</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="i881696e2df5749c38024d0875b7c80db_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMi0yLTEtMS0xMTIyOTE_c6877486-b76e-4612-87d3-51438736a997"
      unitRef="number">0.0100</icui:ApplicableMarginBaseRateLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i0d76d9c6767b4229b51c37407f83df06_D20230101-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMi0zLTEtMS0xMTIyOTE_d751dc2d-8598-44a3-970e-bbccd784c839"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="i8990fbda10824f619dc9e0bb423e9432_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMy0xLTEtMS0xMTIyOTE_90af05d2-0ad5-4b17-aeb5-15ebdc30ddae"
      unitRef="number">0.0175</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="i8990fbda10824f619dc9e0bb423e9432_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMy0yLTEtMS0xMTIyOTE_d8231b2d-eb33-4096-81d7-7977556e20f6"
      unitRef="number">0.0075</icui:ApplicableMarginBaseRateLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="if94f4bdedbf04eb0aae885e9867154ae_D20230101-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfMy0zLTEtMS0xMTIyOTE_b193a662-464a-4663-8ce6-bdfda6bd081a"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="i645c0fc8e6a548c1a7a520e2f4a6728a_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfNC0xLTEtMS0xMTIyOTE_2f18ba2b-e7fc-4265-8fa6-01faf5754a6a"
      unitRef="number">0.0150</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="i645c0fc8e6a548c1a7a520e2f4a6728a_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfNC0yLTEtMS0xMTIyOTE_3bdcf6f0-fb74-4149-9a71-22fb2d125454"
      unitRef="number">0.0050</icui:ApplicableMarginBaseRateLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i83eb7320045f4ac9af9a0028ac179e5d_D20230101-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfNC0zLTEtMS0xMTIyOTE_3a00f909-796f-4b65-b51a-fbfdfeef9fdf"
      unitRef="number">0.0020</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="i975e28cedc80423c9627a97bb37a9a95_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfNS0xLTEtMS0xMTIyOTE_e2f3e4af-722e-43e0-92c6-49c0e2ab92f5"
      unitRef="number">0.0125</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="i975e28cedc80423c9627a97bb37a9a95_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfNS0yLTEtMS0xMTIyOTE_8333278d-b716-42f5-a367-21e38f914fe7"
      unitRef="number">0.0025</icui:ApplicableMarginBaseRateLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i76e51a168e7a435c861495b1388612d0_D20230101-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjYzNzRkZDc0ZGZhNTQzYzQ5ZWI4NDkwNTkzMmQ4Zjg2L3RhYmxlcmFuZ2U6NjM3NGRkNzRkZmE1NDNjNDllYjg0OTA1OTMyZDhmODZfNS0zLTEtMS0xMTIyOTE_52d5f334-f26e-42de-bd93-381c89d4a223"
      unitRef="number">0.0015</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="i514b0dbe6eac49eea9224b92e51b766b_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNDk3OA_c472061e-36c2-4a13-b40d-1cff372e76d7"
      unitRef="number">0.015</icui:ApplicableMarginBaseRateLoans>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="i514b0dbe6eac49eea9224b92e51b766b_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNTAxNQ_ca87892a-ee59-4160-a1ba-855ed76ccf7a"
      unitRef="number">0.025</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="i808fda9aa5364d5593b95ed5ff583af5_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjFiZWU0OTQ4ODBkMTRhOGJiZTllZTBmMjUwYmY5MDM3L3RhYmxlcmFuZ2U6MWJlZTQ5NDg4MGQxNGE4YmJlOWVlMGYyNTBiZjkwMzdfMS0xLTEtMS0xMTIyOTE_5e7dc0d7-cdfd-46f1-b31d-1f72fb1b169b"
      unitRef="number">0.0250</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="i808fda9aa5364d5593b95ed5ff583af5_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjFiZWU0OTQ4ODBkMTRhOGJiZTllZTBmMjUwYmY5MDM3L3RhYmxlcmFuZ2U6MWJlZTQ5NDg4MGQxNGE4YmJlOWVlMGYyNTBiZjkwMzdfMS0yLTEtMS0xMTIyOTE_bb6060c3-725b-4d93-856c-e910ec469618"
      unitRef="number">0.0150</icui:ApplicableMarginBaseRateLoans>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="i2e764926d4b14681809efb21b544fa30_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjFiZWU0OTQ4ODBkMTRhOGJiZTllZTBmMjUwYmY5MDM3L3RhYmxlcmFuZ2U6MWJlZTQ5NDg4MGQxNGE4YmJlOWVlMGYyNTBiZjkwMzdfMi0xLTEtMS0xMTIyOTE_e70627d6-a51e-4508-80c1-6fb64cbc4956"
      unitRef="number">0.0225</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="i2e764926d4b14681809efb21b544fa30_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjFiZWU0OTQ4ODBkMTRhOGJiZTllZTBmMjUwYmY5MDM3L3RhYmxlcmFuZ2U6MWJlZTQ5NDg4MGQxNGE4YmJlOWVlMGYyNTBiZjkwMzdfMi0yLTEtMS0xMTIyOTE_cb939c47-5c31-4694-8409-d4b32b5df25b"
      unitRef="number">0.0125</icui:ApplicableMarginBaseRateLoans>
    <icui:TermAPrincipalPaymentFirst2Years
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNTU4Ng_2b614844-c60b-494e-9afc-e75ce077543e"
      unitRef="number">0.0250</icui:TermAPrincipalPaymentFirst2Years>
    <icui:TermAPrincipalPaymentYear3And4
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="8"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNTY1NA_81108e25-8366-4149-9c2f-c5c7c9e6571d"
      unitRef="number">0.0500</icui:TermAPrincipalPaymentYear3And4>
    <icui:TermAPrincipalPaymentInYear5
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNTY5OQ_a56c791e-8755-45f7-a6ae-8ac7762c6f68"
      unitRef="number">0.0750</icui:TermAPrincipalPaymentInYear5>
    <icui:TermLoanBPrincipalPayment
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNTkxNQ_ae9d6e46-3619-40bb-9c6e-7daaaae1f26c"
      unitRef="number">0.0025</icui:TermLoanBPrincipalPayment>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNjI3NQ_31d63ca3-40c6-4f48-9a2a-34ec8fe2feb0"
      unitRef="usd">16000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfNjQwMg_0fc2e750-b70e-47e6-8e5b-3e88d669fd93"
      unitRef="usd">7400000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <icui:LeverageRatioCalculationCeilingSubtractedAmount
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfODU0Ng_5194fa49-8605-4a95-9118-4dba887454f7"
      unitRef="usd">500000000</icui:LeverageRatioCalculationCeilingSubtractedAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTAxMzM_cbaa2855-8cdf-42c2-8bdf-55c1d225a45c"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTAzMzE_0fb26cfe-8bf5-4e5e-9850-86559276a5fc">2022-11-08</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTEzMjk_f3a2952e-5b7f-40e1-bc2b-2ee1a7f397f4">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of our long-term debt consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effective Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effective Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan A &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan B &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving Credit Facility &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less unamortized debt issuance costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total carrying value of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,647,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,653,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,612,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,623,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprised of $11.8 million and $11.2 million relating to the Term Loan A and the Term Loan B, respectively, as of March 31, 2023.&lt;/span&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i5601a8c75d144a43a8365d2d70291f2f_D20230101-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfMy0xLTEtMS0xMTIyOTE_acfb018d-46c1-4e99-a317-ae97deaee061"
      unitRef="number">0.0742</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i59eb5fecde424d39a6b4b8dce858b9f7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfMy0zLTEtMS0xMTIyOTE_831acf29-119a-41ba-985d-0c5a98cc8d6e"
      unitRef="usd">828750000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i50e84852d3ab4f408186915e7cf4e655_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfMy01LTEtMS0xMjA4ODQ_5500ca41-4ea0-4224-aba2-c4b7ebc8f2c3"
      unitRef="number">0.0399</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9fdf26eb4e87495fbabffe1de604c690_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfMy03LTEtMS0xMjA4ODQ_583ef2d8-3c59-473e-8ddb-19bf83c79a2d"
      unitRef="usd">834000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i6f8a9cb1a64e44a89d9d73f6ad8eba74_D20230101-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNC0xLTEtMS0xMTIyOTE_6f2abef4-8600-4678-9341-fc7b25410062"
      unitRef="number">0.0776</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i514b0dbe6eac49eea9224b92e51b766b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNC0zLTEtMS0xMTIyOTE_3f4965c3-4a1f-4532-92ce-deeeb9f04bcd"
      unitRef="usd">841500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i934b1e4c20bc460c88d531ba8e887800_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNC01LTEtMS0xMjA4ODQ_7d31e864-2af2-4de2-bc04-3c4b30f9de0b"
      unitRef="number">0.0461</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ica3646f151fa444e82e1e515a33e0f7a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNC03LTEtMS0xMjA4ODQ_e3d3eb6f-7b49-42db-8e2e-f150c7832120"
      unitRef="usd">843625000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i1881f550800444d3981abc4acd458059_D20230101-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNS0xLTEtMS0xMTIyOTE_96c05078-459c-4961-abf1-7be91acf6592"
      unitRef="number">0</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNS0zLTEtMS0xMTIyOTE_7a732604-c1c1-4aea-9084-8363a86e753e"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i21016b61e07645e9888301254ab114fa_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNS01LTEtMS0xMjA4ODQ_fd76ef0d-eedc-46fd-90b6-2fda6c8184ad"
      unitRef="number">0</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNS03LTEtMS0xMjA4ODQ_f73d63ca-1813-4466-8c5f-780fca799b7e"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNi0zLTEtMS0xMTIyOTE_96330163-85eb-48e0-bab4-c03aa8531cbe"
      unitRef="usd">-22991000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNi03LTEtMS0xMjA4ODQ_5aa4647f-9c83-4c04-89dc-ec257e100efc"
      unitRef="usd">-24262000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNy0zLTEtMS0xMTIyOTE_4ee31589-2981-48b1-8401-efd37863a54d"
      unitRef="usd">1647259000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfNy03LTEtMS0xMjA4ODQ_25f387e4-51e9-4da9-b260-074fbf016559"
      unitRef="usd">1653363000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtCurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfOC0zLTEtMS0xMTIyOTE_15ba9e09-4d69-4ecf-9181-5c64d8994bc7"
      unitRef="usd">35063000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfOC03LTEtMS0xMjA4ODQ_7e3af31a-087d-4731-96a0-5f5edf2edb24"
      unitRef="usd">29688000</us-gaap:DebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfOS0zLTEtMS0xMTIyOTE_8615952b-1717-4d87-9183-be2bf0f139b7"
      unitRef="usd">1612196000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmYxZjBkNGNmMzZkMjQ0ZDg5MmJkNmVjMDBmMDE3YjI4L3RhYmxlcmFuZ2U6ZjFmMGQ0Y2YzNmQyNDRkODkyYmQ2ZWMwMGYwMTdiMjhfOS03LTEtMS0xMjA4ODQ_b8ff2de6-f259-43ce-9da1-f852a37308ad"
      unitRef="usd">1623675000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i59eb5fecde424d39a6b4b8dce858b9f7_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTA5NjQ_e4668c64-ff93-4b14-88b2-5a44d67d6b4f"
      unitRef="usd">11800000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i514b0dbe6eac49eea9224b92e51b766b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTA5NzE_af92c971-f0ac-4d1a-b904-d1996f10afc1"
      unitRef="usd">11200000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTEzMjM_d800c9d1-13d7-4c92-93fb-87abe9b97a20">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years is approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;672,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,670,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjNkNGRiZDg3MWNjZDRkZGJiNjNkNWQ3MDBiOGM1MjBkL3RhYmxlcmFuZ2U6M2Q0ZGJkODcxY2NkNGRkYmI2M2Q1ZDcwMGI4YzUyMGRfMC0yLTEtMS0xMTIyOTE_99b14850-2bc5-44fb-9ccf-1b3356de7707"
      unitRef="usd">22312000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjNkNGRiZDg3MWNjZDRkZGJiNjNkNWQ3MDBiOGM1MjBkL3RhYmxlcmFuZ2U6M2Q0ZGJkODcxY2NkNGRkYmI2M2Q1ZDcwMGI4YzUyMGRfMS0yLTEtMS0xMTIyOTE_1c37b365-ee46-4c68-80c5-a4d6e17c2539"
      unitRef="usd">51000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjNkNGRiZDg3MWNjZDRkZGJiNjNkNWQ3MDBiOGM1MjBkL3RhYmxlcmFuZ2U6M2Q0ZGJkODcxY2NkNGRkYmI2M2Q1ZDcwMGI4YzUyMGRfMi0yLTEtMS0xMTIyOTE_d72e4514-1d34-4be2-9919-94e7a111a1ff"
      unitRef="usd">51000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjNkNGRiZDg3MWNjZDRkZGJiNjNkNWQ3MDBiOGM1MjBkL3RhYmxlcmFuZ2U6M2Q0ZGJkODcxY2NkNGRkYmI2M2Q1ZDcwMGI4YzUyMGRfMy0yLTEtMS0xMTIyOTE_017d0302-4b07-4858-829e-97b43ea5e1cd"
      unitRef="usd">72250000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjNkNGRiZDg3MWNjZDRkZGJiNjNkNWQ3MDBiOGM1MjBkL3RhYmxlcmFuZ2U6M2Q0ZGJkODcxY2NkNGRkYmI2M2Q1ZDcwMGI4YzUyMGRfNC0yLTEtMS0xMTIyOTE_404af28b-1f6e-4ab9-b632-31106918a64f"
      unitRef="usd">672563000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjNkNGRiZDg3MWNjZDRkZGJiNjNkNWQ3MDBiOGM1MjBkL3RhYmxlcmFuZ2U6M2Q0ZGJkODcxY2NkNGRkYmI2M2Q1ZDcwMGI4YzUyMGRfNS0yLTEtMS0xMTIyOTE_e8ce722a-24c4-432c-85bc-2ee859fad880"
      unitRef="usd">8500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjNkNGRiZDg3MWNjZDRkZGJiNjNkNWQ3MDBiOGM1MjBkL3RhYmxlcmFuZ2U6M2Q0ZGJkODcxY2NkNGRkYmI2M2Q1ZDcwMGI4YzUyMGRfNi0yLTEtMS0xMTIyOTE_1fe10258-b907-4a2a-9932-5503bb747103"
      unitRef="usd">792625000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOjNkNGRiZDg3MWNjZDRkZGJiNjNkNWQ3MDBiOGM1MjBkL3RhYmxlcmFuZ2U6M2Q0ZGJkODcxY2NkNGRkYmI2M2Q1ZDcwMGI4YzUyMGRfNy0yLTEtMS0xMTIyOTE_8925facb-f196-4f2a-bf93-a94f002054db"
      unitRef="usd">1670250000</us-gaap:DebtInstrumentCarryingAmount>
    <icui:InterestExpenseOnLongTermDebtTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RleHRyZWdpb246MGVmMjE4YzA5YmM1NDI3ZDhiZWJiYzUyOTRhMzFiZjlfMTEzMjQ_ced79af5-da6d-4771-8acd-a41e1499a749">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the total interest expense related to our long-term debt (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitment fee &#x2014; Revolving Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt-related  interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</icui:InterestExpenseOnLongTermDebtTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmU0NTM4YjE0MWQ5NzQ0NDY5N2EwNmU2ZmMyZWQzNjY4L3RhYmxlcmFuZ2U6ZTQ1MzhiMTQxZDk3NDQ0Njk3YTA2ZTZmYzJlZDM2NjhfMi0xLTEtMS0xMTIyOTE_2c2364b2-03cf-44cc-bb25-7b7d20f0f5ca"
      unitRef="usd">29263000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmU0NTM4YjE0MWQ5NzQ0NDY5N2EwNmU2ZmMyZWQzNjY4L3RhYmxlcmFuZ2U6ZTQ1MzhiMTQxZDk3NDQ0Njk3YTA2ZTZmYzJlZDM2NjhfMi0zLTEtMS0xMTIyOTE_92273d1b-8e60-410d-aa1f-3047245db027"
      unitRef="usd">10017000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmU0NTM4YjE0MWQ5NzQ0NDY5N2EwNmU2ZmMyZWQzNjY4L3RhYmxlcmFuZ2U6ZTQ1MzhiMTQxZDk3NDQ0Njk3YTA2ZTZmYzJlZDM2NjhfMy0xLTEtMS0xMTIyOTE_9f207187-598a-4e38-b422-427d5ee3e6a5"
      unitRef="usd">1701000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmU0NTM4YjE0MWQ5NzQ0NDY5N2EwNmU2ZmMyZWQzNjY4L3RhYmxlcmFuZ2U6ZTQ1MzhiMTQxZDk3NDQ0Njk3YTA2ZTZmYzJlZDM2NjhfMy0zLTEtMS0xMTIyOTE_f6e7e761-0416-4cd9-9748-cb7404e92d07"
      unitRef="usd">1643000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmU0NTM4YjE0MWQ5NzQ0NDY5N2EwNmU2ZmMyZWQzNjY4L3RhYmxlcmFuZ2U6ZTQ1MzhiMTQxZDk3NDQ0Njk3YTA2ZTZmYzJlZDM2NjhfNC0xLTEtMS0xMTIyOTE_15857e5f-5c51-4130-8975-3e1dd1dd6cfb"
      unitRef="usd">368000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmU0NTM4YjE0MWQ5NzQ0NDY5N2EwNmU2ZmMyZWQzNjY4L3RhYmxlcmFuZ2U6ZTQ1MzhiMTQxZDk3NDQ0Njk3YTA2ZTZmYzJlZDM2NjhfNC0zLTEtMS0xMTIyOTE_2ab588d1-ae15-44bd-b6fb-df2f5db68521"
      unitRef="usd">351000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <us-gaap:InterestExpenseDebt
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmU0NTM4YjE0MWQ5NzQ0NDY5N2EwNmU2ZmMyZWQzNjY4L3RhYmxlcmFuZ2U6ZTQ1MzhiMTQxZDk3NDQ0Njk3YTA2ZTZmYzJlZDM2NjhfNS0xLTEtMS0xMTIyOTE_94851b95-b626-408d-a119-bb5b3797577a"
      unitRef="usd">31332000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84Mi9mcmFnOjBlZjIxOGMwOWJjNTQyN2Q4YmViYmM1Mjk0YTMxYmY5L3RhYmxlOmU0NTM4YjE0MWQ5NzQ0NDY5N2EwNmU2ZmMyZWQzNjY4L3RhYmxlcmFuZ2U6ZTQ1MzhiMTQxZDk3NDQ0Njk3YTA2ZTZmYzJlZDM2NjhfNS0zLTEtMS0xMTIyOTE_808dc466-aa2c-4eff-8bba-f51c5241d834"
      unitRef="usd">12011000</us-gaap:InterestExpenseDebt>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMjU0Mw_9fcd1c92-8ca0-46c5-83ab-d8d8b692a5b1">Stockholders' Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shareholders Agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the completion of the Smiths Medical acquisition on January 6, 2022, Smiths owned approximately 10.5% of the total outstanding shares of our common stock (see Note 3: Acquisitions). At closing, in connection with the issuance of the share consideration, we entered into a Shareholders Agreement (the &#x201c;Shareholders Agreement&#x201d;) with Smiths. The Shareholders Agreement imposes certain restrictions on Smiths including prohibiting certain transfers of the shares of our common stock issued (i) for 6 months following the closing of the acquisition and (ii) to certain of our competitors and certain other parties, as well as customary standstill limitations. The Shareholders Agreement also permits Smiths to designate one individual for election to our Board of Directors (the "Board") so long as Smiths beneficially owns at least 5.0% of the total outstanding shares of our common stock. On February 1, 2022, our Board appointed a new director designated by Smiths pursuant to the Shareholders Agreement who was elected to the Board at the 2022 Annual Meeting of Stockholders held in May 2022. This appointment expanded the size of our Board from eight to nine members. See our Current Report on Form 8-K filed on February 1, 2022 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In August 2019, our Board approved a share purchase plan to purchase up to $100.0 million of our common stock. This plan has no expiration date. During the three months ended March&#160;31, 2023, we did not purchase any shares of our common stock under our share purchase plan. As of March&#160;31, 2023, all of the $100.0 million available for purchase was remaining under the plan. We are currently limited on share purchases in accordance with the terms and conditions of our Credit Agreement (see Note 17: Long-Term Debt).  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023, we withheld 52,764 shares of our common stock from employee vested restricted stock units in consideration for $8.4 million in payments made on the employees' behalf for their minimum statutory &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;income tax withholding obligations. For the three months ended March 31, 2022, we withheld&#160;37,279&#160;shares of our common stock from employee vested restricted stock units in consideration for&#160;$8.7 million&#160;in payments made on the employees' behalf for their minimum statutory income tax withholding obligations. Treasury stock is used to issue shares for stock option exercises and restricted stock grants.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive (Loss) Income ("AOCI")&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of AOCI, net of tax, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized (Losses) Gains on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,978)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97,990)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61,603)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized (Losses) Gains on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <icui:SmithsGroupOwnershipAcquisitionSharesIssued
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMTU5_294ef648-0d56-4f21-abbf-a0a205c8f854"
      unitRef="number">0.105</icui:SmithsGroupOwnershipAcquisitionSharesIssued>
    <icui:SmithsGroupOwnershipRequiredForBoardRepresentation
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfODg4_0d95334b-0e5c-4b12-abb9-3bfc99715c9a"
      unitRef="number">0.050</icui:SmithsGroupOwnershipRequiredForBoardRepresentation>
    <icui:TreasuryStockPurchasePlan
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMTQwOA_425aaaa1-a0c6-482a-9227-fbbf60c14253"
      unitRef="usd">100000000</icui:TreasuryStockPurchasePlan>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMTYwMw_81479bac-381f-4a44-a695-6440a8c9163f"
      unitRef="usd">100000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMTg0OA_74a20dee-bd24-4b2a-8b4e-aa87dbeb6ddd"
      unitRef="shares">52764</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMTk0Mw_d5029728-0172-4435-be56-e132b41562f3"
      unitRef="usd">8400000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMjExMA_e4eeb73b-8fe5-4478-ad46-41d13cfc5cd1"
      unitRef="shares">37279</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMjIwNQ_3676f057-f45f-4633-ab77-ab85f8e8b791"
      unitRef="usd">8700000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RleHRyZWdpb246NDQ2MDg0YTVhMzFkNGIyY2JhZGQ5NWJiNzQ2OTczZDJfMjU0Mg_279ca156-8432-406d-8d95-4430f4461bbf">The components of AOCI, net of tax, were as follows (in thousands):&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized (Losses) Gains on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,978)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97,990)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61,603)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized (Losses) Gains on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i053a7aa68c99417ca271343168d82c1d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMS0yLTEtMS0xMTIyOTE_6cd6bdf3-2c86-4731-831c-80bb1022b83b"
      unitRef="usd">-122973000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib548663bfdd74230aa02cd84a0db6361_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMS00LTEtMS0xMTIyOTE_baf7c814-a462-4073-9e6d-1dd86933d730"
      unitRef="usd">40779000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i114116d7f6da48e49ecb98fac66b8e6e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMS02LTEtMS0xMTIyOTE_8ce39d3e-183e-4cb1-8b35-b36a0ccacb06"
      unitRef="usd">1216000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i843ff99f0a184bdf9191fac242ba630e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMS04LTEtMS0xMTIyOTE_6af5562e-4e51-4007-8fcb-d3c7aae4e0ce"
      unitRef="usd">-80978000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9142596d6f484bf2be0ed3d89cd30684_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMi0yLTEtMS0xMTIyOTE_4df936e2-aaaa-4d49-9acf-9dba9bfc504a"
      unitRef="usd">24983000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i07609ad4dfd84093853a23ea3364cd22_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMi00LTEtMS0xMTIyOTE_ab1eb070-b1cf-4adb-99f6-15621e301236"
      unitRef="usd">-113000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7be1d8f7f3cf4eacaeeabf9eda19e43f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMi02LTEtMS0xMTIyOTE_ae21d1e3-b997-4be1-9a7a-05767dd9e3b2"
      unitRef="usd">-31000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMi04LTEtMS0xMTIyOTE_d6957eaa-7668-4f53-ae85-c981ab2f3552"
      unitRef="usd">24839000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9142596d6f484bf2be0ed3d89cd30684_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMy0yLTEtMS0xMTIyOTE_d571c4dc-abb7-4038-8a0a-06bdaa47f91f"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i07609ad4dfd84093853a23ea3364cd22_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMy00LTEtMS0xMTIyOTE_7c3a0b35-33f8-48a6-9eb1-28c9d916df30"
      unitRef="usd">-5464000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7be1d8f7f3cf4eacaeeabf9eda19e43f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMy02LTEtMS0xMTIyOTE_09b48d67-3a47-4b7d-92e5-9be6fd77f250"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfMy04LTEtMS0xMTIyOTE_ab69bc1b-df05-4ece-8ec4-af0779800873"
      unitRef="usd">-5464000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9142596d6f484bf2be0ed3d89cd30684_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfNC0yLTEtMS0xMTIyOTE_b3ae3865-aa1a-485f-af1b-775d98414407"
      unitRef="usd">24983000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i07609ad4dfd84093853a23ea3364cd22_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfNC00LTEtMS0xMTIyOTE_0f3f5412-566a-481d-9223-ad4bb055d693"
      unitRef="usd">-5577000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i7be1d8f7f3cf4eacaeeabf9eda19e43f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfNC02LTEtMS0xMTIyOTE_225817ae-1154-4ac4-ac01-51f380e9021d"
      unitRef="usd">-31000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfNC04LTEtMS0xMTIyOTE_a13a50dd-6b27-496d-a04c-d140c2c031e5"
      unitRef="usd">19375000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i857399bd08c745988830c1cc09e54a50_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfNS0yLTEtMS0xMTIyOTE_0cf856c4-3830-483e-be4f-e890bf96fb41"
      unitRef="usd">-97990000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4768bcc3c288464a9796a77d8e9884aa_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfNS00LTEtMS0xMTIyOTE_bd7f47c2-ac60-4cfd-864d-305e4fd4a0f1"
      unitRef="usd">35202000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8c285e71c3d74e8c898cbe0851162f27_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfNS02LTEtMS0xMTIyOTE_1a1701c7-2599-4b18-97d8-552381f6988e"
      unitRef="usd">1185000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOjllOGEyZjAxNTNkODRlOGM4MjYzZGYzOTdkNzk2ZWU5L3RhYmxlcmFuZ2U6OWU4YTJmMDE1M2Q4NGU4YzgyNjNkZjM5N2Q3OTZlZTlfNS04LTEtMS0xMTIyOTE_e6bef493-be7e-46a0-9199-506e339787f3"
      unitRef="usd">-61603000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic1e39a1ea3fe47daba9453de67fe8e1b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMS0yLTEtMS0xMTIyOTE_abe3714a-62e1-435a-a212-e1db1d91dd74"
      unitRef="usd">-19045000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia762d86224bd46f5b6f22478b80f66dd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMS00LTEtMS0xMTIyOTE_af5ee00d-7191-4222-b8bc-f302b33e8def"
      unitRef="usd">-237000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i86546ad81144448d9f4a7e7d42d02105_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMS02LTEtMS0xMTIyOTE_7a123a99-31a1-4cc7-acc8-b84ddf038345"
      unitRef="usd">13000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9fd0c26c71db4e4cb0b929a7689fb683_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMS04LTEtMS0xMTIyOTE_f5ec8761-161b-485f-aefc-81c82f4ee724"
      unitRef="usd">-19269000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5ac4813a471b49ff9271b2d9e810c0a1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMi0yLTEtMS0xMTIyOTE_65437fbb-9e85-4006-a288-7fe41e1dcd57"
      unitRef="usd">-4946000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icb13edf15748489f92eee0507a1fb77f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMi00LTEtMS0xMTIyOTE_e91f7305-c909-47df-a1ab-17835b82d7ad"
      unitRef="usd">25782000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3cf0fb2f948444dbbf455bbc0c6a8057_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMi02LTEtMS0xMTIyOTE_3fb7ecc9-1466-4c95-a4f5-cdaa140a40e7"
      unitRef="usd">15000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMi04LTEtMS0xMTIyOTE_463be4aa-8dcf-4c3e-b6f5-e3666d9ecdaa"
      unitRef="usd">20851000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i5ac4813a471b49ff9271b2d9e810c0a1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMy0yLTEtMS0xMTIyOTE_9ffe989e-587d-4116-8cbc-4d864c44be89"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icb13edf15748489f92eee0507a1fb77f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMy00LTEtMS0xMTIyOTE_4e93ed54-8173-45d1-91df-251ebc1d7aa1"
      unitRef="usd">-2210000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3cf0fb2f948444dbbf455bbc0c6a8057_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMy02LTEtMS0xMTIyOTE_b2ecb1ee-9708-42a3-a7f5-c9d684fd1e9c"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfMy04LTEtMS0xMTIyOTE_270fa99f-7cca-41d0-854e-342b867ce4e0"
      unitRef="usd">-2210000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5ac4813a471b49ff9271b2d9e810c0a1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfNC0yLTEtMS0xMTIyOTE_41741228-06de-48c6-a687-7dd594c51f42"
      unitRef="usd">-4946000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icb13edf15748489f92eee0507a1fb77f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfNC00LTEtMS0xMTIyOTE_60c062ca-6206-4597-ba4a-c986f5328b89"
      unitRef="usd">23572000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3cf0fb2f948444dbbf455bbc0c6a8057_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfNC02LTEtMS0xMTIyOTE_c36bd949-fce9-47c3-9cb8-e3304a0a7f67"
      unitRef="usd">15000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfNC04LTEtMS0xMTIyOTE_890c79c2-4598-4671-bd14-568692588d68"
      unitRef="usd">18641000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iaa41f9bbd9164a17afef3d0f715104cf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfNS0yLTEtMS0xMTIyOTE_3e1fe1c6-5f8f-478b-84a1-68294d79919b"
      unitRef="usd">-23991000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iaa95f20692ed474d949298d55e4d9445_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfNS00LTEtMS0xMTIyOTE_659ed33d-3414-4936-848b-2ea0636d62e7"
      unitRef="usd">23335000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5e5490aa9392486e8d4e7fa173e87574_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfNS02LTEtMS0xMTIyOTE_8a630ded-3030-470a-ad5f-2632b1d2f5b2"
      unitRef="usd">28000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i57ae4b72e9574e4ebf63f3473590fe05_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84NS9mcmFnOjQ0NjA4NGE1YTMxZDRiMmNiYWRkOTViYjc0Njk3M2QyL3RhYmxlOmYwNGZkOTg4MDQwZTRhODY4ZWY4YzAxMDA0MjIxNzQ5L3RhYmxlcmFuZ2U6ZjA0ZmQ5ODgwNDBlNGE4NjhlZjhjMDEwMDQyMjE3NDlfNS04LTEtMS0xMTIyOTE_8ad257a0-f94a-4f7c-b34d-8e737a037f8d"
      unitRef="usd">-628000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMzcxNg_57598969-7bb2-465c-bc84-a4225f4968f2">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we are involved in various legal proceedings, most of which are routine litigation, in the normal course of business.&#160;Our management does not believe that the resolution of the unsettled legal proceedings that we are involved with will have a material adverse impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Off-Balance Sheet Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters or other matters related to sales of our products.&#160;There is no maximum limit on the indemnification that may be required under these agreements.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although we can provide no assurances, we have never incurred, nor do we expect to incur, any material liability for indemnification.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, we acquired Smiths Medical. Total consideration for the acquisition includes a potential earn-out payment of $100.0&#160;million in cash contingent on our common stock achieving a certain volume-weighted average price from the closing date to either the third or fourth anniversary of closing. As of March&#160;31, 2023, the estimated fair value of the contingent earn-out is $20.3&#160;million (see Note 9: Fair Value Measurements).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to being acquired, during 2021, Smiths Medical received a Warning Letter from the FDA following an inspection of Smiths Medical&#x2019;s Oakdale, Minnesota Facility. The Warning Letter cited, among other things, failures to comply with FDA's medical device reporting requirements and failures to comply with applicable portions of the Quality System Regulation. A provision for the estimated costs related to the field service corrective action was recorded on the opening acquired balance sheet of Smiths Medical in the amount of $55.1&#160;million. The initial estimate recorded was based on a probability-weighted estimate of the costs required to settle the obligation. The actual costs to be incurred are dependent upon the scope of the work necessary to achieve regulatory clearance and could differ from the original estimate. The estimated field service corrective action recorded at March&#160;31, 2023 is $48.6&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of December 31, 2022, the measurement period related to (i) above ended and based on the actual revenue achieved during the measurement period we determined that the fair value of the contingent earn-out was zero as the minimum threshold for earning the earn-out was not met. As of March&#160;31, 2023, the estimated fair value of the contingent earn-out related to certain product-related regulatory certification was estimated to be $1.5&#160;million (see Note 9: Fair Value Measurements).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out shall not exceed $6.0&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of March&#160;31, 2023, the estimated fair value of the contingent earn-out is $2.6&#160;million (see Note 9: Fair Value Measurements).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commitments&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;We have non-cancelable operating lease agreements where we are contractually obligated to pay certain lease payment amounts (see Note 6: Leases).</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <icui:Contingentconsiderationgross
      contextRef="i65befa8db2534d539ed16ebc473a7f40_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMTA3NA_13fef6b2-c00f-4e9a-8b83-da856246a7cf"
      unitRef="usd">100000000</icui:Contingentconsiderationgross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMTMwNw_31dc9cd2-6c14-481d-b3cf-9d54a622437f"
      unitRef="usd">20300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ProductLiabilityAccrualComponentAmount
      contextRef="i4164284555e9406180057f15e0c21bc7_I20220106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMTg4MA_0e6946c8-1f2b-476f-8bae-3099ed44f31a"
      unitRef="usd">55100000</us-gaap:ProductLiabilityAccrualComponentAmount>
    <us-gaap:ProductLiabilityAccrualComponentAmount
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMjIzMQ_6338fb86-1f34-490a-a008-464d310371ba"
      unitRef="usd">48600000</us-gaap:ProductLiabilityAccrualComponentAmount>
    <icui:Contingentconsiderationgross
      contextRef="ie9945fc3bd5d4b24a1e69091bf0384fd_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMjQwMA_a6317547-0b5a-497e-8e89-d234bbf79328"
      unitRef="usd">2500000</icui:Contingentconsiderationgross>
    <icui:ContingentConsiderationGrossST
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMjQ0MA_c066f9f0-a892-4ee4-854a-ab63bfbd94ff"
      unitRef="usd">1000000</icui:ContingentConsiderationGrossST>
    <icui:ContingentConsiderationGrossLT
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMjU4Nw_9aa08e1f-4886-4b50-a207-23ebbaf4757e"
      unitRef="usd">1500000</icui:ContingentConsiderationGrossLT>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia818e4969fa7407895eb98d2469bf054_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMjc0NQ_b6987a70-edc7-41d2-9e42-38d68c6356d4"
      unitRef="usd">1500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <icui:Contingentconsiderationgross
      contextRef="id4dcda0568fa4318a8aa6122af8e00b9_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMzExOQ_11ff8664-47ad-4b5f-b3b7-fbf493f2603c"
      unitRef="usd">6000000</icui:Contingentconsiderationgross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7e28dd363d7d40519a83284765f9a3fd_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV84OC9mcmFnOjgyZWNlZTgxMDQ5OTQ0OWJhMjE5MDUxNzkyOWEzZjkzL3RleHRyZWdpb246ODJlY2VlODEwNDk5NDQ5YmEyMTkwNTE3OTI5YTNmOTNfMzUwNg_44fa32a8-0f2c-4ca0-8950-84621fed7b17"
      unitRef="usd">2600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV85MS9mcmFnOjUwMDhjMGJhMDA4ZDRkY2NhYjFiMzA0ZjJhODg4NGIyL3RleHRyZWdpb246NTAwOGMwYmEwMDhkNGRjY2FiMWIzMDRmMmE4ODg0YjJfMTk1NQ_4f4e3aa1-5c51-4623-b82a-7a9c8fa32bd2">Collaborative and Other Arrangements&#160;&#160;&#160;&#160;On February 3, 2017, we entered into two Manufacturing and Supply Agreements ("MSAs") whereby (i) Pfizer will manufacture and supply us with certain agreed upon products for an initial five-year term with a one-time two-year option to extend and (ii) we will manufacture and supply Pfizer certain agreed upon products for a term of five or ten years depending on the product, also with a one-time two-year option to extend. The MSAs provide each party with mutually beneficial interests and both of the MSAs are to be jointly managed by both Pfizer and ICU. The initial supply price, which is subject to an annual update, is in full consideration for all costs associated with the manufacture, documentation, packaging and certification of the products. On January 1, 2021, we amended our MSA with Pfizer, whereby we manufacture and supply certain agreed upon products to Pfizer. The amendments included a change to the term of the agreement to end on December 31, 2024 with Pfizer's unilateral election to extend through December 31, 2025. Other changes to the terms of the MSA included (i) amendments to our level of supply of products to Pfizer, (ii) certain changes to our manufacturing lines, (iii) updates to our supply price with added volume price tiers for annual periods and (iv) certain minimum purchase requirements for certain products. On February 1, 2022, effective as of January 1, 2022, upon our request, Pfizer executed a Product Addendum (the "Product Addendum") to our MSA, whereby Pfizer manufactures and supplies to us certain agreed upon products. The Product Addendum includes the supply of additional product to us subject to certain time and pricing terms and conditions. The Product Addendum includes a minimum purchase obligation of $29.6&#160;million and expired on November 30, 2022. As of November 30, 2022, we have satisfied the minimum purchase obligations under the Product Addendum.</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV85MS9mcmFnOjUwMDhjMGJhMDA4ZDRkY2NhYjFiMzA0ZjJhODg4NGIyL3RleHRyZWdpb246NTAwOGMwYmEwMDhkNGRjY2FiMWIzMDRmMmE4ODg0YjJfMTgxNg_180e9c38-e273-4bde-97c3-a9c3ec35f647"
      unitRef="usd">29600000</us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted>
    <us-gaap:TransfersAndServicingOfFinancialAssetsTextBlock
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xMTc0L2ZyYWc6ZjY1YjQ1YTRjNWQ1NGRiMjhmNTk2ZjEyZTdiODJhZjIvdGV4dHJlZ2lvbjpmNjViNDVhNGM1ZDU0ZGIyOGY1OTZmMTJlN2I4MmFmMl81NDk3NTU4MTkxMTI_9ae865e1-8970-441a-954a-e3142e24e1d9">Accounts Receivable Purchase Program&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 19, 2023, we entered into a revolving $150&#160;million uncommitted receivables purchase agreement with Bank of The West ("BOW") which provides for a less expensive form of capital. The discount rate applied to the sold receivables equals a rate per annum equal to the sum of (i) an applicable margin of 1.75%, plus (ii) Term SOFR for a period equal to the discount period which is calculated with respect to the payment terms of the specific receivable. The accounts receivable sold have payment terms ranging between 30 and 60 days, and are related to customer accounts with good credit history. The transfer of the purchased accounts receivable under the agreement is intended to be an absolute and irrevocable transfer constituting a true sale as the transferred receivables have been isolated beyond the reach of the Company and our creditors, even in bankruptcy or other receivership. We do not retain effective control over the sold receivables and BOW has the right upon purchase to pledge and/or exchange the transferred assets without restrictions. The Company acts as collection agent for BOW and collection services are undertaken by our accounts receivable personnel in their normal course of business and collected funds are remitted to BOW. We do not have any continuing involvement with the sold receivables other than the collection services which does not provide us with more than a trivial benefit. The discount rate has been negotiated net of consideration for the collection services, the cost of collection is immaterial to the Company; therefore, we did not separately record any related servicing assets or liabilities as of March 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2023, the carrying value of trade receivables sold to BOW in connection with the purchase program was $139.6&#160;million.  In exchange for the sale of trade receivables, we received cash of $138.8&#160;million. The sale of the receivables resulted in a loss of $0.8&#160;million recorded in other (expense) income, net in our condensed consolidated statement of operations. For the three months ended March 31, 2023, we have collected and remitted $81.6&#160;million in cash to BOW. As of March 31, 2023, cash remaining to be collected on behalf of BOW was $58.0&#160;million, which has been removed from our condensed consolidated balance sheet as of March 31, 2023 and is reflected as cash provided by operating activities in the condensed consolidated statement of cash flows. There were no such balances at December 31, 2022. The carrying value of the sold receivables approximated the fair value at March 31, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:TransfersAndServicingOfFinancialAssetsTextBlock>
    <us-gaap:FinancingReceivableRevolving
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xMTc0L2ZyYWc6ZjY1YjQ1YTRjNWQ1NGRiMjhmNTk2ZjEyZTdiODJhZjIvdGV4dHJlZ2lvbjpmNjViNDVhNGM1ZDU0ZGIyOGY1OTZmMTJlN2I4MmFmMl81NDk3NTU4MTkxOTA_36922587-9507-4a44-aa5d-f54049dee045"
      unitRef="usd">150000000</us-gaap:FinancingReceivableRevolving>
    <us-gaap:AccountsReceivableSale
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xMTc0L2ZyYWc6ZjY1YjQ1YTRjNWQ1NGRiMjhmNTk2ZjEyZTdiODJhZjIvdGV4dHJlZ2lvbjpmNjViNDVhNGM1ZDU0ZGIyOGY1OTZmMTJlN2I4MmFmMl81NDk3NTU4MTkxMzA_d610ac68-6396-481f-bc1f-31aac4f448e3"
      unitRef="usd">139600000</us-gaap:AccountsReceivableSale>
    <us-gaap:ProceedsFromSaleAndCollectionOfReceivables
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xMTc0L2ZyYWc6ZjY1YjQ1YTRjNWQ1NGRiMjhmNTk2ZjEyZTdiODJhZjIvdGV4dHJlZ2lvbjpmNjViNDVhNGM1ZDU0ZGIyOGY1OTZmMTJlN2I4MmFmMl81NDk3NTU4MTkxMTQ_c7ad7ef1-b485-4668-8fcb-42b85e037545"
      unitRef="usd">138800000</us-gaap:ProceedsFromSaleAndCollectionOfReceivables>
    <us-gaap:GainLossOnSaleOfAccountsReceivable
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xMTc0L2ZyYWc6ZjY1YjQ1YTRjNWQ1NGRiMjhmNTk2ZjEyZTdiODJhZjIvdGV4dHJlZ2lvbjpmNjViNDVhNGM1ZDU0ZGIyOGY1OTZmMTJlN2I4MmFmMl81NDk3NTU4MTkxNDY_22216ced-a834-43df-b4af-837958fa7542"
      unitRef="usd">800000</us-gaap:GainLossOnSaleOfAccountsReceivable>
    <icui:CashRemittedToPurchaser
      contextRef="i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xMTc0L2ZyYWc6ZjY1YjQ1YTRjNWQ1NGRiMjhmNTk2ZjEyZTdiODJhZjIvdGV4dHJlZ2lvbjpmNjViNDVhNGM1ZDU0ZGIyOGY1OTZmMTJlN2I4MmFmMl81NDk3NTU4MTkxNjA_2f856619-6692-48fe-85e3-1f1aacda7dc8"
      unitRef="usd">81600000</icui:CashRemittedToPurchaser>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount
      contextRef="ic896526384424866b5b8be38ae18f2f6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xMTc0L2ZyYWc6ZjY1YjQ1YTRjNWQ1NGRiMjhmNTk2ZjEyZTdiODJhZjIvdGV4dHJlZ2lvbjpmNjViNDVhNGM1ZDU0ZGIyOGY1OTZmMTJlN2I4MmFmMl81NDk3NTU4MTkxNzU_1024b469-771c-45e3-b307-faac2cfabef3"
      unitRef="usd">58000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTktMy0xLTEtMTEyMjkx_6ecf80d1-750c-4390-81b5-f5f1ac8cc377"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTktMy0xLTEtMTEyMjkx_6ecf80d1-750c-4390-81b5-f5f1ac8cc377"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzctMy0xLTEtMTEyMjkx_324fc7b1-d4a4-45c7-8174-045af2b5112b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzctMy0xLTEtMTEyMjkx_324fc7b1-d4a4-45c7-8174-045af2b5112b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzItMy0xLTEtMTEyMjkx_6471ee0c-00a4-42c7-ba9d-ec57d5196909"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzItMy0xLTEtMTEyMjkx_6471ee0c-00a4-42c7-ba9d-ec57d5196909"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjAtMy0xLTEtMTEyMjkx_229ef6be-ce62-4921-b18f-79a60092ec04"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjAtMy0xLTEtMTEyMjkx_229ef6be-ce62-4921-b18f-79a60092ec04"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzgtMy0xLTEtMTEyMjkx_debccfde-4123-4698-b79f-854066c2b056"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzgtMy0xLTEtMTEyMjkx_debccfde-4123-4698-b79f-854066c2b056"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzQtMy0xLTEtMTEyMjkx_4da36b68-c1fc-494d-820b-9fb637b9022a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzQtMy0xLTEtMTEyMjkx_4da36b68-c1fc-494d-820b-9fb637b9022a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDYtMS0xLTEtMTEyMjkx_7f5fdd0d-259f-4a0c-97a1-43e46e1c0483"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDYtMS0xLTEtMTEyMjkx_7f5fdd0d-259f-4a0c-97a1-43e46e1c0483"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMy0xLTEtMTEyMjkx_fc1bc812-1b18-4fb7-bf12-d0b72275a81e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMy0xLTEtMTEyMjkx_fc1bc812-1b18-4fb7-bf12-d0b72275a81e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNi0zLTEtMS0xMTIyOTE_b4b42f79-adc9-433b-8f62-7db731f52deb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNi0zLTEtMS0xMTIyOTE_b4b42f79-adc9-433b-8f62-7db731f52deb"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjMtMy0xLTEtMTEyMjkx_a94bd12d-e31f-4bdd-b136-251cf57b6140"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjMtMy0xLTEtMTEyMjkx_a94bd12d-e31f-4bdd-b136-251cf57b6140"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDYtMy0xLTEtMTEyMjkx_b11da195-db32-4106-b8f6-91d7659faf25"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDYtMy0xLTEtMTEyMjkx_b11da195-db32-4106-b8f6-91d7659faf25"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjItMy0xLTEtMTEyMjkx_6f9f325f-393a-47ff-ad08-b307a627d1bf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjItMy0xLTEtMTEyMjkx_6f9f325f-393a-47ff-ad08-b307a627d1bf"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjctMy0xLTEtMTEyMjkx_4921cb4d-3853-4114-b725-5db1dd93f9f8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjctMy0xLTEtMTEyMjkx_4921cb4d-3853-4114-b725-5db1dd93f9f8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDMtMy0xLTEtMTEyMjkx_75047be6-0dd1-47ed-9798-da330c8b02bf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDMtMy0xLTEtMTEyMjkx_75047be6-0dd1-47ed-9798-da330c8b02bf"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTMtMy0xLTEtMTEyMjkx_76d15de6-be5b-43b2-96c5-524893474b9d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTMtMy0xLTEtMTEyMjkx_76d15de6-be5b-43b2-96c5-524893474b9d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMy0xLTEtMTEyMjkx_35b338bd-0580-44c2-9fe3-deae3f5f796b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMy0xLTEtMTEyMjkx_35b338bd-0580-44c2-9fe3-deae3f5f796b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDctMy0xLTEtMTEyMjkx_01fae28f-4563-4565-bfe8-b29d7a556285"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDctMy0xLTEtMTEyMjkx_01fae28f-4563-4565-bfe8-b29d7a556285"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfOS0zLTEtMS0xMTIyOTE_beb57dd6-7fe1-4dee-bf23-6d0d9d0616fc"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfOS0zLTEtMS0xMTIyOTE_beb57dd6-7fe1-4dee-bf23-6d0d9d0616fc"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjgtMy0xLTEtMTEyMjkx_846aab52-7cc5-405a-bbec-efe479d462f6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjgtMy0xLTEtMTEyMjkx_846aab52-7cc5-405a-bbec-efe479d462f6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTUtMy0xLTEtMTEyMjkx_05e3014b-2fc3-4b5a-8baf-57b8e024aeb5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTUtMy0xLTEtMTEyMjkx_05e3014b-2fc3-4b5a-8baf-57b8e024aeb5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDgtMy0xLTEtMTEyMjkx_d6e2a135-c2fa-450f-a554-f6e3457190e7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDgtMy0xLTEtMTEyMjkx_d6e2a135-c2fa-450f-a554-f6e3457190e7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzAtMy0xLTEtMTEyMjkx_15d626ce-74fa-4454-86b8-9b4572ac66f0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzAtMy0xLTEtMTEyMjkx_15d626ce-74fa-4454-86b8-9b4572ac66f0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzktMy0xLTEtMTEyMjkx_4a1282af-9c82-4f9b-89f2-ff2e628b50ae"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzktMy0xLTEtMTEyMjkx_4a1282af-9c82-4f9b-89f2-ff2e628b50ae"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDQtMy0xLTEtMTEyMjkx_d6fa66ab-3258-4c34-a51f-118afd81ca95"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDQtMy0xLTEtMTEyMjkx_d6fa66ab-3258-4c34-a51f-118afd81ca95"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNy0zLTEtMS0xMTIyOTE_4572b495-5d90-4b8e-9ee8-0a59ebbf46f5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNy0zLTEtMS0xMTIyOTE_4572b495-5d90-4b8e-9ee8-0a59ebbf46f5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTAtMy0xLTEtMTEyMjkx_7d7d037a-f223-449f-903b-ffe31ed2d335"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTAtMy0xLTEtMTEyMjkx_7d7d037a-f223-449f-903b-ffe31ed2d335"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfOC0zLTEtMS0xMTIyOTE_0fe1c3ef-a99e-4fd0-ba6b-891b764bc690"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfOC0zLTEtMS0xMTIyOTE_0fe1c3ef-a99e-4fd0-ba6b-891b764bc690"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNC0zLTEtMS0xMTIyOTE_7f5fdd0d-259f-4a0c-97a1-43e46e1c0483"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNC0zLTEtMS0xMTIyOTE_7f5fdd0d-259f-4a0c-97a1-43e46e1c0483"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDUtMy0xLTEtMTEyMjkx_dded447b-f585-4c32-9b07-42383de17643"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDUtMy0xLTEtMTEyMjkx_dded447b-f585-4c32-9b07-42383de17643"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTYtMy0xLTEtMTEyMjkx_14b6f9fc-686b-45bd-bd84-0ea1ea93f551"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTYtMy0xLTEtMTEyMjkx_14b6f9fc-686b-45bd-bd84-0ea1ea93f551"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNS0zLTEtMS0xMTIyOTE_9e1c5a15-8b30-41b4-b008-d1882d344a74"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNS0zLTEtMS0xMTIyOTE_9e1c5a15-8b30-41b4-b008-d1882d344a74"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">December&#160;31, 2022 balances were derived from audited consolidated financial statements.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTktMy0xLTEtMTEyMjkx_6ecf80d1-750c-4390-81b5-f5f1ac8cc377"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzctMy0xLTEtMTEyMjkx_324fc7b1-d4a4-45c7-8174-045af2b5112b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzItMy0xLTEtMTEyMjkx_6471ee0c-00a4-42c7-ba9d-ec57d5196909"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjAtMy0xLTEtMTEyMjkx_229ef6be-ce62-4921-b18f-79a60092ec04"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzgtMy0xLTEtMTEyMjkx_debccfde-4123-4698-b79f-854066c2b056"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzQtMy0xLTEtMTEyMjkx_4da36b68-c1fc-494d-820b-9fb637b9022a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8yOC9mcmFnOjY4OWEyNGVlZjI2ODQ4ZjNiYzc1NGViZjdkMGIwMjc4L3RhYmxlOmZkMTExNjMwN2FjZDQzNWRiYWY0NjE0ZjExNWUwOGNiL3RhYmxlcmFuZ2U6ZmQxMTE2MzA3YWNkNDM1ZGJhZjQ2MTRmMTE1ZTA4Y2JfNDYtMS0xLTEtMTEyMjkx_7f5fdd0d-259f-4a0c-97a1-43e46e1c0483"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDEtMy0xLTEtMTEyMjkx_fc1bc812-1b18-4fb7-bf12-d0b72275a81e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNi0zLTEtMS0xMTIyOTE_b4b42f79-adc9-433b-8f62-7db731f52deb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjMtMy0xLTEtMTEyMjkx_a94bd12d-e31f-4bdd-b136-251cf57b6140"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDYtMy0xLTEtMTEyMjkx_b11da195-db32-4106-b8f6-91d7659faf25"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjItMy0xLTEtMTEyMjkx_6f9f325f-393a-47ff-ad08-b307a627d1bf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjctMy0xLTEtMTEyMjkx_4921cb4d-3853-4114-b725-5db1dd93f9f8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDMtMy0xLTEtMTEyMjkx_75047be6-0dd1-47ed-9798-da330c8b02bf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTMtMy0xLTEtMTEyMjkx_76d15de6-be5b-43b2-96c5-524893474b9d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDItMy0xLTEtMTEyMjkx_35b338bd-0580-44c2-9fe3-deae3f5f796b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDctMy0xLTEtMTEyMjkx_01fae28f-4563-4565-bfe8-b29d7a556285"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfOS0zLTEtMS0xMTIyOTE_beb57dd6-7fe1-4dee-bf23-6d0d9d0616fc"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMjgtMy0xLTEtMTEyMjkx_846aab52-7cc5-405a-bbec-efe479d462f6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTUtMy0xLTEtMTEyMjkx_05e3014b-2fc3-4b5a-8baf-57b8e024aeb5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDgtMy0xLTEtMTEyMjkx_d6e2a135-c2fa-450f-a554-f6e3457190e7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzAtMy0xLTEtMTEyMjkx_15d626ce-74fa-4454-86b8-9b4572ac66f0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMzktMy0xLTEtMTEyMjkx_4a1282af-9c82-4f9b-89f2-ff2e628b50ae"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDQtMy0xLTEtMTEyMjkx_d6fa66ab-3258-4c34-a51f-118afd81ca95"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNy0zLTEtMS0xMTIyOTE_4572b495-5d90-4b8e-9ee8-0a59ebbf46f5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTAtMy0xLTEtMTEyMjkx_7d7d037a-f223-449f-903b-ffe31ed2d335"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfOC0zLTEtMS0xMTIyOTE_0fe1c3ef-a99e-4fd0-ba6b-891b764bc690"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNC0zLTEtMS0xMTIyOTE_7f5fdd0d-259f-4a0c-97a1-43e46e1c0483"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNDUtMy0xLTEtMTEyMjkx_dded447b-f585-4c32-9b07-42383de17643"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfMTYtMy0xLTEtMTEyMjkx_14b6f9fc-686b-45bd-bd84-0ea1ea93f551"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RhYmxlOjUwMzJhMGNhYTY2ZTQ2ZmM5ODk2ODE1MGIzYTViZGExL3RhYmxlcmFuZ2U6NTAzMmEwY2FhNjZlNDZmYzk4OTY4MTUwYjNhNWJkYTFfNS0zLTEtMS0xMTIyOTE_9e1c5a15-8b30-41b4-b008-d1882d344a74"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmYxZjU0YWIwM2UwYzQ0YmE4NGI2NDJjMDIyYzg2ZmNhL3NlYzpmMWY1NGFiMDNlMGM0NGJhODRiNjQyYzAyMmM4NmZjYV8xNi9mcmFnOmNmYzY0NWQzYThhMTQxZjZiZDE5ODZiYTZkYzY1M2RiL3RleHRyZWdpb246Y2ZjNjQ1ZDNhOGExNDFmNmJkMTk4NmJhNmRjNjUzZGJfMzcw_4928683d-a6b1-4dc3-983f-74e89451ba7b"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>111
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M1J.GH""GQB '!YFOC<Y$IEA$_@S3QC'J@.*0]B^-DRH>U]9I34<.SC1%@YW
M!V*S,5Q@V!L:;9T"BIR:BAP<9NZ%#_F:K46"S:8'1-Q^OTN=@3EMIX AIZ8A
M!T>870/U<BDU%)4D%":KHDOFY@\\7/&3\;/0PZ/:^JRAR#F*BJ8P'LIR14#3
M+=L;-_K$%9M\G@*/G)J/G*, 2=,?X!",JBLAMT9WN,X]DRN8,'V?@Q#(!*6D
MT?$I"(G6A$2/(J1Y#%,\N<XSN)T9V^T!G4:8Q^/:^JN)B!Y%1+<QERO=,7\!
M!;6&439.66),[0'!9J.G0"!:(Q ]"H'F:PZ)Q.SA,LWV3L$\M&8>BO/)<Z@
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ME_H!N+\40NU/] NJW>WQOU!+ P04    " !+C*A6R5E7_Q$)  "[)P  &
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MT4C)#5'6&M'LH,A-X8UJF+#+.#,*WS+T,]%$B@07!1*"(RTY2ZC!R37E5,1
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M9E!("10;O?!$+24* %)XJE\'MPZ^D;UO75)I\(6*&V3C*T0L8AOP]'Y?G53
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M$M0Y4>)JIAP$@/BX1HT0_<)4=]WT\3DOFL1LWW++FDC.C+A9.;YHD+LP0N]
MDZ?.V(RSDF'_=(#Y*FNGGTPYS9)JFNU2"9QZ ?P40OI3(1$42_;!=VER?F?.
M.XZ^=5,8,$UB^*:L<9*<3DDUG=Y'\49_L/X!8/Q[@ UB%8!S&B6D,JF^!_W'
MIVEPCSIOP$>/ 1J\OG0ANX8/68(9BY544O.?9MA763N-0,[-I)J;\PS+CA',
MNU1D6N)8V#G?)8.8?3QGG&+,^9A4\_%Q6E6A+%*M$:5!S("R?G2, Y_)B_1T
M2\)DN$E4=NIQ>'LX0>NDYT9G[[OXMI>=@^5FLF.Y%RH6$=!>S.9@TKKQ )/(
M3KJR!\77Z6'1.U?PK9[>+AD-F= "\/^<<[5_T L<SAO;_P-02P,$%     @
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M-SF63?7WA7YBY*H[<I^EP0.\&S9XQ0)E W!_(:793>P#QDO;[!]02P,$%
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M]HD_:(R->/=94:.<WK%RQ@>'#5C5]ME=VX.F?&B?!'5;-DVY;E^N:,)Z-Q[
M/K\KR^;E@#]<:O<$M?._ %!+ P04    " !+C*A6$ P[*9$*  "V,   &
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M&B**T ERXA.ES)Q$M4.%PE1"ZCI;C<(.5_KR0TM0@?;J/F5_EY\R24SMPYS
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;,U6VVX;-Q#]E<&F""1
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MT4G).+\0)$(EI1*\& 6Y)#=3!8%2K Q%A&Z?:GIF$2&O:@URK0&J%$G6EHI
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M>U#MXT#]\C$0>]&@W6NN^CCM]=K#YC("1<1A.VJN(E!8#7M+A9CVXSNB766
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MU_5[@[O+5DJN2EE9I2MAY.+9R>WPYL6$QO. WY3<V.A:D"5SK3_2S>O\V<F
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M29AA*MG,IZ.6SC0B_(!2XEU>9PDH4)+>1K(AJJH.*U7I3=GT1$]FHQEFR**
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M =\7#N'2O#"#[C\-+O\#4$L#!!0    ( $N,J%:UZ$\5N ,  (P(   9
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MC+<&FA^$5(,WR$GE%^7.&7R5\',GIU5E>JK9E10+V4HGR;)WOVM']OW1U"&
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M'-<9L[GP;%Z<7H=+QD([7%G"<(4[(AEO@.^-QLH/+S[ >.L\^1=02P,$%
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M1_S^4,HMXMG#B'Q+9KX6$A<)70./;HO)\M6+\73T_@F^9SW?LZ?0'^-[B_L
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MX$O;/O9HJV.)#V-$*6%:XN"HO,96F6\40=,5H@^_< 9P%=I*$$BF7=#I:$]
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MXMGIH!?3]AF,H:U2&JE1_C^E%HZF7SBZ57@X.JCH\?^Q(AA5 /.+X1FM"[G
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MSY3]T_Y$OHP'T9UY/,[CI(:EZ#"-.5RGXQ?/$F'C$3G>>%.'8REV/0ZYX;+
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M7A6RVC%+P"SMZ\80D!+Z+;G AE:(0$=VPM;W".QH3,")(&B(F*P@5U5MD1^
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M,ENQ=:D;0H6!JKBU<BM%.Y"(0G_=2]+7;#B+IO/IZ,G[[P/H+,^BV6+1VL:
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M6^;X^P+*.N#SI91FO[$)JA^BR0]02P,$%     @ 2XRH5AD]<%7/ P  !0D
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M!P@;+*WS(.BSQ3ML&N>(8'P;?0;'D,[P='[P_L'G3KDLA<$[U?Q=5W8S#XH
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M[11(OE+*'A8NP/'/9_$O4$L#!!0    ( $N,J%9SV;_EI (  *@%   9
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M%\$T@ )WLJO<%WWXB,=\4L^7Z\KV7S@,OLDL@+RS3M=',"FH53.,\NEX#J\
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MFN<39K;WE>W&Z4VX(RRUPXTC+->XXI'Q OB_T:C\L/$&QDOCXE]02P,$%
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M$8PD]&59$+R3,H76<66E-5'+N^GN47.N@P-JM:&<2ZTAL0JU3DFM\P:U&"O
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M*H16YNIOBJ#LM_%8CT+HM:9'S#_S///3/]2L!^W,9;JR9^ 7N2UV*L&)%%.
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MFLC;%U,_D.>7E(J7'=5!]8WB[&]02P,$%     @ 2XRH5M+G=<Z7 P  ? X
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M9Q=(3#5#L3&,K-Q<64B#4\HM"_R/@+(.>+Z4TFP,FZ#[,R7_ %!+ P04
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M8 *2%O\&L).E9V2ZLN#\ARG<^U/+,8X@!$\9":J_MC"',#1*VL?/3-3*<YK
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M@ES%%]*4%Y]H7\:.9'"XY8)F%5AFD)&\_,8_*R$: ,G3#; J@'4*<)X!V!7
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MN$SD= Y,!<C[:TK%8:$>4,_[TU]02P,$%     @ 2XRH5OTP0=,] P  >0T
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MK'"6B!NZ^P%%03W%%]"$ZT^T*]9:!@HR+FA:@*6"-";Y-WXLC*@ )$\SP"D
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MI;\-,]PK)1S4RA5,33)9"VRJBA_U1?FL*46OYDU%-U?XB@E-2E@:UZ@W-G>
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M-W3:R<.:/.PDGZ<*JZ?*FK_V$(3'A_L-ON,0OYUN6-,-.^E>01H>/Y=]-VQ
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M0 ]]60*G,LGGJ.#OH<\)G22INN<]=$>?U<R4HH?N04_]*7#$9N@F$3%-T=]
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M=;!2-;3(R\.,K=!:9.5E C0&:1\P]W="Z->&/1]ICK=6_P!02P,$%     @
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MJ#<']5Z0@LOG<([3&=$&5G+U*F*LK1-K5Y]V*+1ZY:45@NZ[>%78:4IV%N%
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MOC[C7]](MLB.R1^9E"S)+N<$1X3K /7YE#'Y<J-/WHM?6L9_ %!+ P04
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M419C?J*&F*B-OEV19$YXXW!B)AX[GH#2/%":#TH+0&DA%$W736VO.N_27W5
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MU#""9MEZ'5/"&YL:U*(%I7F@-!^4%H#20BB:OM>L]FE=^SW.9%Q(<W,"2O-
M:3XH+0"EA5 T77NU*>R:3>'C9S)N@RN\OYG!G/9H.8"ZPJ"T )060M%T.=2N
ML&MVA4'G,66N-[:]F&MTM%) ?6!06@!*"Z%H6Z58.WN]$\*7Q39^H?J$+)7;
M;=_5U>JG N?%!GFK+K[]G<$5YDN:"A231Q5JMP>JJ^#;K?O;$\G6Q<[Q.9.2
M)<7ABF EJKR ^OZ1,?ERDB>H?D Q_@=02P,$%     @ 2XRH5N'3\_@N!0
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MQ$2<@C/P].B#DT^GX!/ %"PV+!6J3S&PI7HB'9<=%=&/\^C;'T3? ;>,RHT
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M12-8:"+W3+2XL&A!W#AR906BB!90E%)$"\!>#V6%R1X7ECVG;QZY\MZ'*EI
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M+@F6A,4&\OV<4K%_B -D_PLP^A]02P,$%     @ 2XRH5ERO&P&Y @   PD
M !D   !X;"]W;W)K<VAE971S+W-H965T-S4N>&ULQ59A;YLP$/TK%JNF5NH"
M@91T'4%JDU6KM&Y1LW8?IGUPR"58-9C:)C3_?F>@*.DH6JM(^P*VN??NWL/F
M" HA[U4,H,ECPE,ULF*MLS/;5E$,"54]D4&*3Y9")E3C5*YLE4F@BQ*4<-MU
M'-].*$NM,"C7IC(,1*XY2V$JB<J3A,K-!7!1C*R^];1PPU:Q-@MV&&1T!3/0
MM]E4XLQN6!8L@50QD1()RY%UWC\;#TU\&7#'H%!;8V*4S(6X-Y.KQ<AR3$'
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M.<13(JONOAIHL2K[W0>AL7LN'Y? D  C@.L+(?1N8#9HOK%,_P-02P,$%
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M%:FUYF6M5C8D6Q75RY1)50L5GTM5WP+7!FI\SIC<-?0$=<4\_ ]02P,$%
M  @ 2XRH5N\$Q504 P  H @  !D   !X;"]W;W)K<VAE971S+W-H965T-S@N
M>&ULK59=3]LP%/TK5H8F)C&2YK-E;25HQ<8#$RHP'A /;G+;6CAV9[LM_/M=
M)R'T(Y0^[*6U;^XY/L>Q[TUW)=6SG@$8\I)SH7O.S)CYF>OJ= 8YU:=R#@*?
M3*3*J<&IFKIZKH!F!2CGKN]YL9M3)IQ^MXC=J'Y7+@QG FX4T8L\I^KU KA<
M]9R6\Q88L>G,V(#;[\[I%&[!W,]O%,[<FB5C.0C-I" *)CWGO'4V;-O\(N$/
M@Y5>&Q/K9"SELYU<93W'LX* 0VHL \6_)0R <TN$,OY6G$Z]I 6NC]_8+POO
MZ&5,-0PD?V"9F?6<MD,RF- %-R.Y^@65G\CRI9+KXI>LJES/(>E"&YE78%20
M,U'^TY=J']8 K? #@%\!_$,!004(M@'!!X"P H3%SI16BGT84D/[72571-EL
M9+.#8C,+--IGPK[V6Z/P*4.<Z5^))0@C%0--CH=@*./Z&_E.[F^'Y/CH&SDB
M3)"[F5QH*C+==0VN:9%N6O%?E/S^!_S75)V2H'5"?,\/&N"#_? AI#7<WX2[
MZ+2VZ]=V_8(O^,3N*QDRG7*I%PK(X_E8&X4G\*G)7TD8-A/:6WFFYS2%GH/7
M3H-:@M/_^J45>S^:W/XGL@WO0>T]V,?^[OV$C.B*7%,#BE&N3\AO+"]R0D;E
MDHUON:2."VI;2I;]H)4$H==UE^O^=M/\=MR)PSIM0WE8*P\/5?Z 5<0>R1LE
M4]"':2_)HS5129!X[2WIC5F=J%EY5"N/#E5^R03#>YJ1GU)FAPF/=B0%4=QI
M)5O*&]*"R(^\9NEQ+3W>*_U.&LJ;5,4[[S@)DTX<;:G:3<.#X'F=S;3A?A&/
MK:<])S]QM@+MVEO[,UJL+)"/0977ZZW$8 _A5.#)(BO RI#A#5GB*YLHF1.Z
MR)C!22J%EIQEU$XF3& ^7B.B#0:P(6(7;I+LKM7H'-2TZ'4:R1;"E'>XCI;M
M=(#MM&@[6_'SY&R8-,7;5?MUW^G+WHTU>,J$)APFN)1WFN!1464_+"=&SHL.
M,98&^TTQG.$G!"B;@,\G4IJWB5V@_BCI_P-02P,$%     @ 2XRH5ET3!_.T
M!   '14  !D   !X;"]W;W)K<VAE971S+W-H965T-SDN>&ULM5A=;]LV%/TK
MA%8,+9!&(O5A.[,-I/;2!6B&H&FWAZ /C$3;1"71)2D[_?<C)5D?-L/.@?UB
M2]2]A^=>7I*''&\9_RY6A$CPG*6YF#@K*==7KBOB%<FPN&1KDJLO"\8S+-4K
M7[IBS0E.2J<L=9'G16Z&:>Y,QV7;/9^.62%3FI-[#D2199C__$!2MITXT-DU
M?*;+E=0-[G2\QDOR0.37]3U7;VZ#DM",Y(*R''"RF#C7\&J.D'8H+?ZA9"LZ
MST"'\L38=_URFTP<3S,B*8FEAL#J;T-F)$TUDN+QHP9UFCZU8_=YAWY3!J^"
M><*"S%CZ+TWD:N(,'9"0!2Y2^9EM_R)U0*'&BUDJRE^PK6T]!\2%D"RKG16#
MC.;5/WZN$]%Q@,$+#JAV0/_7P:\=_'T'_P6'H'8(RLQ4H91YF&.)IV/.MH!K
M:X6F'\IDEMXJ?)KK<7^07'VERD].[[DJ(2Y_ IPGX,\?!5VK097@[9Q(3%/Q
M#KP'7Q_FX.V;=^ -H#GXLF*%4+9B[$K5O09QX[JK#U57Z(6N[C"_!#Z\ ,A#
MOL%]9G>?D[AQ1WUW5P7=1(Z:R%&)Y_\B\@MPGV(5<C\!CY^4.;B5)!/?3*%6
MV($96T_6*['&,9DX:C8*PC?$F?[^&XR\/TR!GPBLEP:_28-O0Y]^81*G8-TM
M [++P@6(F9"F\"O,J,342\MF"N$@"(-@[&ZZD9GL(A2&@\:N1SIH2 =6TM=Q
M7&1%BB5)U"1768DIULN(B6J%%'8HO ]#+_#1'E63'8J"3D@]JF%#-;12_5NM
MW>;LFLB&!R0B%$"XS]5@YD<0^GVSN9W9(_QFJ9^HB2^RHMSA>*6:^-X*<@$^
M<B:,JT1T0#[P/10.]V(TF,%@"*%Y. 8-W8&5[DW!<RH+3DJZ-_19/PL+V\$!
M#=^#4;1']M *C8:#R,QUV' =6KG.6"XD+ZH-4JV]:L5:*K(VML,#'M ?CD;[
M= UF(1IY(S/?4<-W9.7[2:7T GPH:)K0?"G*#-]FJO@W1)>$ (]W)'LBW+B@
M6J&/75!/!-;+ O3:+=4[X\Y2@Y\H$Z="ZZ>BHR[@&7:7&K0WG09A$.VM;S.C
M7>!U[/JT6VD K5ON](ZEB;U<[0!'C](Y% !L)0#TSUFP5H%Q="I.A-9/12LL
MH%U9O+)@#\7#8-!5.75L)C/DO52NK<2 ]IU\QK)U(0GO#)HF_L 6<HO55F<M
M9"OTT:-W(K1^(EHM J-S%K)5Z1R=BA.A]5/1ZAQH%SJO+.1#(0/A*/#WQ9G1
M+D3P!;$,6\D#[9KGMI0\E5Q08Q@K@;^E<@5FY5&8\%^LRE;PHT?P1&C]5+1J
M"H[.6<PG%52G0NN?U%M%A:PRY97%7(/V3I\>B@[$N\%N-%1'#7,M(RU^^BV=
M*P>[KE!'KCF)R_JMLK.[SP!/6(UQ3 38$K5@)X33C2K]!6<9P$5"]4$W5L<!
MEM*D//4N:*[LJ<J*D*JAG#"7IER[G;LA-7^6Y1V;4&!%+JM;@J:UNL>;P:MY
M>=VUUWZ-] 6?^0O:7?VY;1?5Q>$=YDN:"Y"2A>K.NQRH)8-7=W'5BV3K\G;J
MB4DUP<O'%<$J =I ?5\P)G<ONH/F1G3Z'U!+ P04    " !+C*A6M[TM6%D"
M  "N!0  &0   'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6RM5,%NVS ,_17!
M*X86Z&+'SKJA<PPT28?M4"!HUNTP[*#83"Q4EER)2=J_'R4[7EJXV0Z[V!+%
M]_1(D4QWVMS;$@#98R65'0<E8GT9AC8OH>)VH&M0=++2IN)(6[,.;6V %QY4
MR3".HHNPXD(%6>IM<Y.E>H-2*)@;9C=5Q<W3!*3>C8-AL#?<BG6)SA!F:<W7
ML "\J^>&=F''4H@*E!5:,0.K<7 UO)R.G+]W^"Y@9P_6S$6RU/K>;;X6XR!R
M@D!"CHZ!TV\+4Y#2$9&,AY8SZ*YTP,/UGOVSCYUB67(+4RU_B ++<? Q8 6L
M^$;BK=Y]@3:>]XXOU]+Z+]LUOA=QP/*-15VU8%)0"=7\^6.;AP, \?0#XA80
MOP2,7@$D+2#Q@3;*?%@SCCQ+C=XQX[R)S2U\;CR:HA'*O>("#9T*PF$V-U00
M!I\85P6[?MB(FIX(V3=X1'8Z ^1"VC/VCMTM9NSTY(R=,*'8C9"2WL"F(9($
M1Q3F[763YKKXE>L2=J,5EI9=JP**Y_B0I'?ZX[W^27R4\(:; 4N&YRR.XJ1'
MS_3?X?$1.4F7SL3S)7])YSF;2TYY?)[5GU=+BX8J]U=?YAKF43^SZ^9+6_,<
MQ@&UJP6SA2![^V9X$7WJ"_L_D3U+PJA+PN@8>S8#(LT%=WW:%VB#'D8>[L;,
M-HN3P2@-MX<1]'D-#[P::>%!Z5=@UGXB6);KC<*FBCIK-W2N?*^]L$]H&#6S
MXP]-,\FH1M9"629A1931X .ULFFF0[-!7?L&6VJD=O7+D@8J&.= YRNM<;]Q
M%W0C.OL-4$L#!!0    ( $N,J%;4(3C:#P,  $8(   9    >&PO=V]R:W-H
M965T<R]S:&5E=#@Q+GAM;*U6WT_;,!#^5ZP,32 QTB9IRKHV4FDVA@0"\6,\
M(![<Y-I:.'9G.P3^^YV3-"M=R /:2^,[WW?^OG-RUW$AU9-> 1CRDG&A)\[*
MF/7(=76R@HSJ([D&@3L+J3)JT%1+5Z\5T+0$9=SU>KW0S2@33C0N?5<J&LO<
M<";@2A&=9QE5KR? 93%Q^L[&<<V6*V,=;C1>TR7<@+E;7RFTW"9+RC(0FDE!
M%"PFSK0_BH<VO@SXQ:#06VMBE<RE?++&63IQ>I80<$B,S4#Q\0PSX-PF0AJ_
MZYQ.<Z0%;J\WV7^4VE'+G&J827[/4K.:.,<.26%!<VZN9?$3:CT#FR^17)>_
MI*AC>PY)<FUD5H.10<9$]:0O=1VV )BG'>#5 &\7$+P#\&N OPOPWP$$-2 H
M*U-)*>L04T.CL9(%438:L]E%6<P2C?*9L-=^8Q3N,L29Z%3*M&"<$RI2<B8,
M%4LVYT"F6H/1I-F^I=:['X.AC.L#\H7<W<1D?^^ [!$FR.U*YAI3Z+%KD)7-
M[28U@Y.*@?<. Y]<2&%6FGP7*:1O\2ZJ:21Y&TDG7F?""ZJ.B-\_)%[/\UOX
MS+KA,20-W&N!Q]WPA_YCAP:_N1:_S.)_[%IBIA,N=:Z /$SGVBC\?![;2E^=
M$K2?8EO*2*]I A,'>X8&]0Q.]/E3/^Q]:ZO;?TKVIB!!4Y"@*WMT>GD9WY^=
MG[>)K)!AB;1M[CGJ!Z$W],*Q^[S-ORTN^.H-CINX-]0&#;5!-[7ZK@X)=B+L
M,X+,<J5 )*_D5E&A.2T[W"GV8+)_+K4^:!,Q^)><'X3'.Q(ZF7SP"D)GQS%L
MA \[A>.KCA\+9'-0U2&;KP8[,:<B 4T*P%<T!86]/24+)3-"\Y09-!(IM.0L
MI=98,('QC'*B#3IPK. L:Z/L;G6Z#-2RG!@:D^7"5,0;;S.4IF4OWO'/<%CU
MV_S^*/;;_,$H#MK\@U$\:/%/PU$<MOF']9!T_]*O)BRVK243FG!8H)3>T1#O
M6E53JS*,7)=]?"X-3H5RN<)!#\H&X/Y"2K,Q[ '-7X?H#U!+ P04    " !+
MC*A6NMTQFUD'   P+P  &0   'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6R]
M6EMSFS@4_BL:;V>GG4EC=..233*3Q&TW,TDFTZ2[#YT^$%NVF0+R H[;_?4K
M\$4(A%@;W)?$P#D?YQS0IP\=G:]X\CV=,Y:!'U$8IQ>#>98MSH;#=#QGD9^>
M\@6+Q94I3R(_$X?);)@N$N9/"J<H'"++LH>1'\2#R_/BW&-R><Z761C$[#$!
MZ3**_.3G-0OYZF( !]L3GX/9/,M/#"_/%_Z,/;'LR^(Q$4?#'<HDB%B<!CP&
M"9M>#*[@V8CBW*&P^"M@J[3T&^2IO'#^/3^XG5P,K#PB%K)QED/XXM\KNV%A
MF".)./[9@ YV]\P=R[^WZ!^+Y$4R+W[*;GCX=S#)YA<#=P F;.HOP^PS7_W)
M-@G1'&_,P[3X"U8;6VL QLLTX]'&6400!?'ZO_]C4XB2@\#1.Z"- ZHZV T.
M>.. JPZXP8%L'$A1F74J11U&?N9?GB=\!9+<6J#E/XIB%MXB_2#.G_M3EHBK
M@?#++C]Q/ED%80C\> )NX\R/9\%+R,!5FK(L+9U)P;.?7W@[8ID?A.D[\!Y\
M>1J!MV_>@3<@B,'SG"]3@9*>#S,16 X_'&^"N%X'@1J"P.">Q]D\!1_B"9MH
M_&_,_A 9 (:B(KNRH&U9KI$1\=Y/3@&&)P!9".L",KN/V'CGC@SAX-U3P@4>
M;L#[&,1!QM[?B2&B>TI?[X0]N,U8E'[357\-3O3@.;.<I0M_S"X&@CI2EKRR
MP>7OOT';^D.7>4]@2AW(K@[$A-Y2AQ/P*>&I]OU;P]H%;$Z%K^*=L3P$Z?GP
MM9R<U@YY$.[LE+CI+F[:*>ZK\7@9+4,_$Y>O(IYDP;]^3HNZ5-9WHJ40D4LA
MKF:B,:/0HPV)V+M$[$Z)/+!,%[-="\9#Q'*M2LP:,VIYMJ6/V=G%[!ACOA6<
M,%W''38,H+<??HS#Y22(9V!+B.]T>3BU #&V+51)0V,%7<O69^'NLG!;LM"_
M[?\[=K<6%40$N="I1*^SP\0IV2GQ>[OX/7/\#\]7#Y]NK^\^@*NGIP_/3R<@
MUK\L7FT,>M2QW6J5-68N<FQ;-1N9H_H*OQEH"5IR%K6,.(]BZ,8Y$]^SZ(4E
M6A8V0^Q+PWVAJ0F79 ,\YHRT0>^K%CVAJ;5 LA;H<%(\ 5]2-EV&X"Z8,FTI
MS.#0 C^9G^AFM9N#7-4DI0*!QHG]\*EW@UL>J-AR:O.5Q@QYGN?J60=*Q0"[
M289]IM[-K11N](2,J*:B,7-MV#"-02DB8#<5T3#Y;E 540-M@JM1Z\RPV_0
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MV>N#C"^*#<LO/,MX5/R<,U\4+#<0UZ><9]N#_ :[3?*7_P%02P,$%     @
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MI<LHBE:TF"@^S[NY(5>Z-\R',]V^@S +]/,)Y^IQ8AK$\@]!_ M02P,$%
M  @ 2XRH5JJR8;NG!@  +B0  !D   !X;"]W;W)K<VAE971S+W-H965T.#4N
M>&ULM5IM;]LV$/XKA%<,+=#%(O5B.4L,I+:"94C1H&G7#\4^T#(="Y5$CZ+S
M\N]WE&7)%FDF$91^:"SI[GC/Z73W'*6S!RY^%2O&)'K,TKPX'ZRD7)\.AT6\
M8ADM3OB:Y7!ER45&)1R*NV&Q%HPN2J4L'1+'"8893?+!Y*P\=R,F9WPCTR1G
M-P(5FRRCXND32_G#^0 /=B>^)G<KJ4X,)V=K>L=NF?R^OA%P-*RM+)*,Y47"
M<R38\GQP@4\CUU4*I<0_"7LH]GXC!67.^2]U<+4X'SC*(Y:R6"H3%/[<LRE+
M4V4)_/BO,CJHUU2*^[]WUB]+\ !F3@LVY>F/9"%7YX-P@!9L23>I_,H?_F(5
M(%_9BWE:E/^CATK6&:!X4TB>5<K@09;DV[_TL0K$G@+VCBB02H&\5,&M%-RV
M@GM$P:L4O)>NX%<*)?3A%GL9N!F5='(F^ ,22AJLJ1]E]$MMB%>2JT2YE0*N
M)J G)Q=Q+#9L@:X3.D_21":L0.]G3-(D+3Z@/]#WVQEZ_^X#>H>2''U;\4U!
M\T5Q-I2PMK(PC*MU/FW7(4?6^4S%"7+Q1T0<XAK4IW;U&8MK=6)0C^SJ?]/\
M!#F!27T( :NC1NJHD=*>^XJH_;R8%U) XO]KBL[6GF>VIZK!:;&F,3L?P.->
M,''/!I/??\.!\Z<I5GT:BWHR=A!'MXZC:[,^N:4I%2IXD%1HSG*V3*0QN;9F
M@M*,JGWW$V\4.N'9\'X_+@8ISW6\0ZG(ZE)'P%X-V+,"OLICEJO2B&*>0;$O
MJ"J7)L1;._X>%D+\T;B%6)=R'>*W$5M]ZHC8KQ'[5L1?UDP R/P.73,HZ!_K
M9^;I(YINA(!PF.#[.GP'^TX+OBZ%0QRT@A19'>P(/ZCA!\]E.*2WI(_,F->!
M!B# ?CNM=2$_]-KWV.I&1Y"C&N3("O(K@\JWB>5&J/M,57&DJ0GN2(?K>T$+
MKB[DCU7/.(!K=:@CW+"&&UKA?L^7])X+.@>VP_.RYJ>[I+[]9L(=&A[3\1BW
M@)ND0K>5#9'5MX[(QS7RL17YKN]QN6+B>%:/]8?7)ZV$G>I"4-[:66UUIR-8
M[#3<R'D1W!O!EZQ0W)BFZ)*905>V#I([;.?MU"#ENWC4@FWWJRON/4Z(K;BO
MV1T M3S'E?Y!JF)WU,;Z$JG([DM7K V3PU:",YDE4+N2^:8<6X[>6Z(W&NA&
MI W8(#9R@G;MLGO4%7'#N;"==/V@0M!<[FB78%"W<S-L5[^!T(;;J U2SEB[
MS6]!NW##N["=>%TF+%T@93>)%?D"XE&.J.6D:F9@V$#!1N&XW9U-8IZO/])O
M0<)PP\*PG8;M2ME2E*.S$:^!3<&_=GLVB8W&8;M-V?WIBK>A7=C.NV9,)/>T
MO,,O(YQ89UD$N]H3KDOAT-/N]5N0,=RP,6RG8U]4=S9BU*D5+(JUC#:(>>&X
M3:OM7G1%V9 P;&=ANXQ.FQG<B%EG5<3U<: U*X.<1T;M86+VC%<_L6G\C^Q:
M76/5T#9LYVU[C\ ,9NP<PO9I.VVCFY3F]@?#P.;&HS:;,TH1K2B\!9\C#9\C
M+^-S=+, Y,LCS9X8B)SK^RW )BG2GL\CNT-= 3=$CF#K/M5>%?QY#=?0E619
M8=Z@ZHF&5='ITUK4E[7#*.YM]CU#$5_;2XC. PV]Q"!EZ"5VW[IB;\@B<:T9
M!*// B;[!CB:PL@+8S[+XZ?GDZHGTE<%K$]K45_6#@/;$%)B)Z1Z8"^V\Q9D
M%L_6/(?<0A<9WQQ),9UU>F'@M#?([$Z\.F2>ML'J^WAOT<-8-.24V,GI52X9
M+ _-B#ZI714C8)UV!N/V=&T0PH[;GK_LWG2]\PTU)79J2JLNI&Q3$:_**6S!
M[EG*U]FQBF+8*/0#K:+H4JZO;2#9W>L*OV&GQ,Y.+[D:07(4/<8K"G7$"+<G
M:EF%I4]K45_6#L/7T%X2]OWJJ2?N606S3VM17]8.@]GP8F+GQ:_O[ :::^CL
MNI2IL[\%&78;,NPZ?7%#MR<66[VEZ]-:U)>UPR@V#-NU;Y6^.H,J>X$]@PQ2
MA@RR^]85N^+%AV?V7N?:MQ9A^IVQF&5S)K;K[%[9HSF%.3.&6O4 G1ZZ'42M
MW(WBV78:@X.8YP5/DP55!S"D@GQ"4U1(.*'Z8G%B\GJX]^U#QL1=^=%) <:
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MJ8@)!@V.VBHZ<O1+CKZ68XA9_(CD0G=\2_LM3BYLT&Z'0+])6UM81]J#DO9
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MN^/[ :>;?+_X@7+AG_+#-48+S&2 N+ZDE#\/Y!9T^3^*R?]02P,$%     @
M2XRH5D BI_EO P  [0L  !D   !X;"]W;W)K<VAE971S+W-H965T.#<N>&UL
MO5;;;MLX$/V5@;98M( 3W1([26T!L=.@ 1K B'MY*/:!D48648ET2<IV_KXD
MI<BRHZ@79/MBD]3,F7-&P]&,-UQ\DQFB@FV1,SEQ,J56%ZXKXPP+(H_Y"IE^
MDG)1$*6W8NG*E4"26*<B=P//&[H%H<R)QO9L+J(Q+U5.&<X%R+(HB'B88LXW
M$\=W'@_NZ#)3YL"-QBNRQ 6J3ZNYT#NW04EH@4Q2SD!@.G$N_8N9;QVLQ6>*
M&]E:@Y%RS_DWL[E))HYG&&&.L3(01/^M<89Y;I TC^\UJ-/$-([M]2/ZM16O
MQ=P3B3.>?Z&)RB;.F0,)IJ3,U1W?O,=:T*G!BWDN[2]L:EO/@;B4BA>ULV90
M4%;]DVV=B):#QNEV"&J'X-#AY!F'L'8(K="*F95U112)QH)O0!AKC686-C?6
M6ZNAS+S&A1+Z*=5^*KIA,2\0/I(M2GB7IFC3"HIL01"%\/H*%:&Y? -'\&EQ
M!:]?O8%70!E\S'@I"4ODV%6:AT%SXSKFM(H9/!,SA%O.5*;CL023?7]7\V]$
M!(\BID$OX"T1QQ#Z PB\(.S@,_MU]Z"'3MCD-+1XX3-XTU+J$RGA,OY>4DE-
MO0Y@IC53MD2FS%+2!'6"325__:"MX49A(?_K2F85[*0[F+GF%W)%8IPX^AY+
M%&MTHG__\8?>VZY,O!#87EY.FKR<]*%'LXQH_:9X4D(%K$E>(O 4XEUFD AV
MI+M-5QXJ\*$%-]UI'1V-/&_LKMOZGAKM+/9(GS:D3WM)[^[$[JK G;X:710K
MJ/-V].-@=$"QRRCTNUD.&Y;#/V,)=ZC3&].<DJH,B8)K-+67PT(152HN'@Z=
M!C!'$>OWT:5QV*71/]#X$Z,]C:-&XZA7XR(C H],STY@3AX*4R^70IB:,NL!
MO-OJCYO4[(V.*3),::>"T9,:>5I'3VV"H?=,*9TU LYZ!;3J/&YW@(%MMUBQ
M[R)<P9YV%G5%MS?P'U[K\T;6>?][*:ANYK>8T)CD7?1[W7^W@;T0V)Y2W]M]
M+;V_V=KK:"^4FI="V\]-:Y+P_\_V7J/_I+_W<_A=C6YK<"I0+.T\*37CDJEJ
M_&A.FYGUTDYJ!^=3,\O:@6P'4PW">KA84B8AQU1#>L<C?8U%-5M6&\57=CR[
MYTH/>W:9Z7D<A3'0SU/.U>/&!&@F_.@'4$L#!!0    ( $N,J%;R>]M6I@0
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MS<(4=9!V@GF?"Z'7'5MGNK\)R1]02P,$%     @ 2XRH5CA@X?'L @  \P<
M !D   !X;"]W;W)K<VAE971S+W-H965T.3,N>&ULK55M3]LP$/XK5C9-(!7R
MUJ; VDA] 0T)- 1C^S#M@YM<4PN_=+;3PG[];*?- DVK:=J7Q.?</?<\9^=N
ML!;R22T -'IFE*NAM]!Z>>'[*EL P^I4+(&;+W,A&=;&E(6OEA)P[H(8]:,@
M2'R&"??2@=N[D^E E)H2#G<2J9(Q+%_&0,5ZZ(7>=N.>% MM-_QTL,0%/(!^
M7-Y)8_DU2DX8<$4$1Q+F0V\47DSZUM\Y?"6P5HTULDIF0CQ9XSH?>H$E!!0R
M;1&P>:U@ I1:($/CYP;3JU/:P.9ZBW[EM!LM,ZQ@(N@WDNO%T#OS4 YS7%)]
M+]:?8*.G9_$R095[HG7EVSOW4%8J+=@FV#!@A%=O_+RI0R/ X+0'1)N Z&U
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MKDA<60@DL77*,]?WO*&;$\J<<&K'EB*<\E)EE.%2@"SSG(B[!69\,W-ZSOW
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MZ0,CJLJEZBA>V,M_Q94N)6PSU<4>"F.@WZ\Y5_<=,T%3/H9_ %!+ P04
M" !+C*A6SM*&JE<&  #H*0  &0   'AL+W=O<FMS:&5E=',O<VAE970Y."YX
M;6S-6EUSFS@4_2L:;V<GG7%B),R7-_%,8L*V,\UNIA^[#YD^R"#'; &Y2([;
M?[\"8V- 44RK9/<E 7'OD73NM70/Z'Q#\R]L20@'W](D8Q>#)>>KR6C$PB5)
M,3NC*Y*))PN:IYB+V_Q^Q%8YP5'IE"8C9!CV*,5Q-IB>EVVW^?2<KGD29^0V
M!VR=ICC_?D42NKD8P,&NX7U\O^1%PVAZOL+WY /AGU:WN;@;[5&B."49BVD&
M<K*X&%S"28#<PJ&T^"LF&W9P#8JIS"G]4MR\C2X&1C$BDI"0%Q!8_'L@,Y(D
M!9(8Q]<*=+#OLW \O-ZA!^7DQ63FF)$93?Z.([Z\&+@#$)$%7B?\/=V\(=6$
MK (OI DK_X)-96L,0+AFG*:5LQA!&F?;__A;1<2!@\"1.Z#* ;4=QH\XF)6#
M>:S#N'(8MQW,1QRLRL$ZM@>[<K!+[K=DE4S[F./I>4XW("^L!5IQ48:K]!8$
MQUF161]X+I[&PH]/K[^N8_X=7(;A.ETGF),(_,F7) <SFHI4718Y]$# VRRD
M*0$G[RACK\&)3SB.$W%U"CY]\,')J]?@%8@S\'%)UPQG$3L?<3&XHHM16 WD
M:CL0],A 3'!#,[YDX#J+2-3T'XE)[6>&=C.[0DK &YR? 1,. 3*0*1G/['AW
M)''WU>X^"97NP?'N4$&&N0^S6>*9C^#UB^_=.^$.WG*2LL^R2&[[&LO[*M;"
M"5OAD%P,1 ^,Y ]D,/WU%V@;O\G"H!/,UPD6: )K!&R\#]A8A=X(&"T#%C8"
MEHA R4*S1;5+U&)7>9B>VF)(X@?P<$BZS RY32-?8N0:GM,RNU9/Y [*4BB0
M8$,/V=X>N\&:M6?-4G;V9&H/P9R([9B ]R1,,&/Q(@YQL<6Q(?A#[.-T 3[B
M;S)BMQU;!P-&8]?T6KQ*K S7@BUBE9/HFZ6:P!I\VWN^;27?;1;!(J?ID9O)
M$,S6>4XR#FY)'M/HJ0#8'6I/K;$];@5 8H40-%H!4,ZJ;P T@34"X.P#X/1.
M^+A*^&2;\)F25:?#%_1,QVJQ*K%R[7$[K95#[<NJ)K &J^Z>5??HQ5?4KZ(Z
MS:ID#46I%/TCRK*T2-Q+SO-XON9XGA# *;C%93[?W9!T3G+IUJGLN._6J1/,
MUPD6: )K1,_;1\][P5K'TQDPG6"^3K! $U@C8-"H18CQ+-5.!=M8[CW'\UKK
M_4QFATS/:Z]@,CN(D.>TZJ= :N@98TM>O\ #.0;_JPJFZKE9PGANNS24F)V.
MO;'=IDHYC[[IIPNMR3JJ64?_FSJF&LHAOYUT?=+$5T^H-_V:T)KTU^(4*J74
MSU<Q%?Z3J=TUDZ:V5A6I"ZW);:TCX?%"LDC,WW&<[?:^,LMGF"U!D C<-R2Z
M)^Q'JAKU&/KNDEK1?*UH@2ZT9C1K?0NM%ZQMH$XA.M.*YFM%"W2A-<-6RV2H
MULD_7-]TY:QI(0.UU[6N&3)-TVJO:UVSL>$X7KNVD6EHTWFDLJF5*NPO5755
M-EU]>@IA9_7O6B'+<5&;):TR5A=:D_1:R$*UDGW1PL8]Z@V-S$SRBD8]L=YA
M> Y!"FM%"I7Z24.!XTFXM1RGS6W7#)F6TTEQK=)1%UKS*T^M'='QVM$G"_$T
M E<D$U<B<1.<L9]\8Z/NON\FJ17-UXH6Z$)K!K*6O@B^8&V#=.K3F58T7RM:
MH NM&;9:.R.U=O[1V@9U12Z$;OO-L\2J\YVJLCG\F 01;*FZ0&9ERHL:5"M7
MU%^Y:BIJD$2LFK!-3]<(MLL^]11Z9]MSR%E4RUFDEK,O6=!40U&]J7G:Q%=/
MJ#?]SZ$_4:T_4?\/K+T*&35^[V79ZOZF.^FO54CJ0FOR7PM)I!:2,OY/MMG]
M&A0+SE!: PT!7G#A*(("<!9U%J.#$FGX2(TD#:;=_8K?7:)T?FSUM:(%NM":
MT2PD<;.EUFM(K=?NX&>?A&4QNNUG=X0(S+&(8T@8V!"QFT1B 7L002Y7/[R.
MXF+E"\6N0I,X*I=!D03"/L8)8%PT%*%E9[)1CPX.CZ4DOR^/^3$!ML[X]B3
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M]GC%ZNI61^Z/N](B3E+WL,ZFJ^MS>^Q&7BFV'I_?'__WP-M_ %!+ P04
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M:8:U@-:&7!L!KPW!-@)B&Y)M!,PV1-L(J&W(MA%PVQ!N(R"W(=U&P&Y#O(V
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M3+VS@-Z%>A<!O0OU+@)Z%^I=!/0NU+L(Z%VH=Q'0NU#O(J!WH=Y%0.]"O8N
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MGZ;]/XY?GNE0=^-+?K;\8_#V)U!+ 0(4 Q0    ( $N,J%8'04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ 2XRH5ELYR ?O    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ 2XRH5IE<G",0!@  G"<  !,
M     ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !+C*A6
M+R>J]MP%  #I'@  &               @($."   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ 2XRH5LE95_\1"0  NR<  !@
M     ("!( X  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    (
M $N,J%8$AWD9:@,  !L,   8              " @6<7  !X;"]W;W)K<VAE
M971S+W-H965T,RYX;6Q02P$"% ,4    " !+C*A6?:+44)@%  ![%   &
M            @($'&P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#
M%     @ 2XRH5GTG4<51 P  P D  !@              ("!U2   'AL+W=O
M<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( $N,J%8Q4L&*[P(  .('
M   8              " @5PD  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q0
M2P$"% ,4    " !+C*A6?\-<%@H)  !-30  &               @(&!)P
M>&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ 2XRH5A ,.RF1
M"@  MC   !@              ("!P3   'AL+W=O<FMS:&5E=',O<VAE970X
M+GAM;%!+ 0(4 Q0    ( $N,J%8LLBDT[ 8  !\0   8              "
M@8@[  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " !+C*A6
MMTBAW%L&  !V#P  &0              @(&J0@  >&PO=V]R:W-H965T<R]S
M:&5E=#$P+GAM;%!+ 0(4 Q0    ( $N,J%8Z#KI\7PP  (L?   9
M      " @3Q)  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%
M  @ 2XRH5H%BY5F>!   N P  !D              ("!TE4  'AL+W=O<FMS
M:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " !+C*A6R81I#"8)  #9%P
M&0              @(&G6@  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+
M 0(4 Q0    ( $N,J%8)@,8!]0<  ',5   9              " @01D  !X
M;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ 2XRH5C8WP!1#
M!   =PL  !D              ("!,&P  'AL+W=O<FMS:&5E=',O<VAE970Q
M-2YX;6Q02P$"% ,4    " !+C*A6QX([?>\+  #/(0  &0
M@(&J<   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( $N,
MJ%;HR?^Z( T  - G   9              " @=!\  !X;"]W;W)K<VAE971S
M+W-H965T,3<N>&UL4$L! A0#%     @ 2XRH5IV[AC__"   0!@  !D
M         ("!)XH  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4
M    " !+C*A6M>A/%;@#  ","   &0              @(%=DP  >&PO=V]R
M:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( $N,J%81$>>Z!P,  '4&
M   9              " @4R7  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL
M4$L! A0#%     @ 2XRH5NYM;L=R P  PP<  !D              ("!BIH
M 'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " !+C*A6\:2.
M\I8%   D#@  &0              @($SG@  >&PO=V]R:W-H965T<R]S:&5E
M=#(R+GAM;%!+ 0(4 Q0    ( $N,J%8TLZR3W 0  ($*   9
M  " @0"D  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @
M2XRH5F/*D&NN P  $@H  !D              ("!$ZD  'AL+W=O<FMS:&5E
M=',O<VAE970R-"YX;6Q02P$"% ,4    " !+C*A6:[Y17S$1   S-@  &0
M            @('XK   >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4
M Q0    ( $N,J%:O[@_Y(0@  ) 4   9              " @6"^  !X;"]W
M;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ 2XRH5L"N>'$X!0
MLPP  !D              ("!N,8  'AL+W=O<FMS:&5E=',O<VAE970R-RYX
M;6Q02P$"% ,4    " !+C*A6!WLX(S('   =$@  &0              @($G
MS   >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( $N,J%8C
M=^@J308   (/   9              " @9#3  !X;"]W;W)K<VAE971S+W-H
M965T,CDN>&UL4$L! A0#%     @ 2XRH5MC@3[N<!0  H P  !D
M     ("!%-H  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $N,J%;^T6#;A@4  ,8/   9              "
M@=?P  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ 2XRH
M5L2(9C-0!@  BA(  !D              ("!E/8  'AL+W=O<FMS:&5E=',O
M<VAE970S-BYX;6Q02P$"% ,4    " !+C*A6""D.*F8#   <"0  &0
M        @($;_0  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0
M   ( $N,J%89/7!5SP,   4)   9              " @;@  0!X;"]W;W)K
M<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ 2XRH5G/9O^6D @  J 4
M !D              ("!O@0! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q0
M2P$"% ,4    " !+C*A6E[< 0D4#   7!P  &0              @(&9!P$
M>&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( $N,J%;J((F&
M< 4  -P-   9              " @14+ 0!X;"]W;W)K<VAE971S+W-H965T
M-#$N>&UL4$L! A0#%     @ 2XRH5E%Q"GS"!   0 H  !D
M ("!O! ! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " !+
MC*A6FRJE)/P%  !5#P  &0              @(&U%0$ >&PO=V]R:W-H965T
M<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( $N,J%:6>=R&BP,  $L(   9
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M970T."YX;6Q02P$"% ,4    " !+C*A6!5+\SHT"  "E!@  &0
M    @('\,P$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    (
M $N,J%8E%__^Z0,  .<0   9              " @< V 0!X;"]W;W)K<VAE
M971S+W-H965T-3 N>&UL4$L! A0#%     @ 2XRH5ACZU<5F @  Y04  !D
M             ("!X#H! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"
M% ,4    " !+C*A62E)'BH<#  #[#P  &0              @(%]/0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( $N,J%;],$'3/0,
M 'D-   9              " @3M! 0!X;"]W;W)K<VAE971S+W-H965T-3,N
M>&UL4$L! A0#%     @ 2XRH5FXGQ]IW!@  E30  !D              ("!
MKT0! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    " !+C*A6
MG42':8D"  "V"   &0              @(%=2P$ >&PO=V]R:W-H965T<R]S
M:&5E=#4U+GAM;%!+ 0(4 Q0    ( $N,J%8%/S.IT0(  "((   9
M      " @1U. 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%
M  @ 2XRH5C5=;^'B @  "0@  !D              ("!)5$! 'AL+W=O<FMS
M:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " !+C*A68JIRS1H$   &#P
M&0              @($^5 $ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+
M 0(4 Q0    ( $N,J%89FO9'*@0  'P6   9              " @8]8 0!X
M;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ 2XRH5KF(;H]+
M P  8@D  !D              ("!\%P! 'AL+W=O<FMS:&5E=',O<VAE970V
M,"YX;6Q02P$"% ,4    " !+C*A6G]@9Y;$"  "@!P  &0
M@(%R8 $ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( $N,
MJ%83BNNOL0,  .H2   9              " @5IC 0!X;"]W;W)K<VAE971S
M+W-H965T-C(N>&UL4$L! A0#%     @ 2XRH5ME# ;EM P  3P\  !D
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M=#8W+GAM;%!+ 0(4 Q0    ( $N,J%8%Q(^YR 4  $PQ   9
M  " @:-\ 0!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%     @
M2XRH5N'3\_@N!0  VB0  !D              ("!HH(! 'AL+W=O<FMS:&5E
M=',O<VAE970V.2YX;6Q02P$"% ,4    " !+C*A60932&5($   ]%P  &0
M            @($'B $ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4
M Q0    ( $N,J%8=WCX3S (  )$)   9              " @9", 0!X;"]W
M;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ 2XRH5C+A2TJ\#@
ME:<  !D              ("!DX\! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX
M;6Q02P$"% ,4    " !+C*A6!YSRC#H"  #'!   &0              @(&&
MG@$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( $N,J%:7
M/9*N( 4  !<@   9              " @?>@ 0!X;"]W;W)K<VAE971S+W-H
M965T-S0N>&UL4$L! A0#%     @ 2XRH5ERO&P&Y @   PD  !D
M     ("!3J8! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $N,J%:WO2U860(  *X%   9              "
M@8JZ 0!X;"]W;W)K<VAE971S+W-H965T.# N>&UL4$L! A0#%     @ 2XRH
M5M0A.-H/ P  1@@  !D              ("!&KT! 'AL+W=O<FMS:&5E=',O
M<VAE970X,2YX;6Q02P$"% ,4    " !+C*A6NMTQFUD'   P+P  &0
M        @(%@P $ >&PO=V]R:W-H965T<R]S:&5E=#@R+GAM;%!+ 0(4 Q0
M   ( $N,J%:?V0%H6P(  ,\%   9              " @?#' 0!X;"]W;W)K
M<VAE971S+W-H965T.#,N>&UL4$L! A0#%     @ 2XRH5GN28O0' P  ' P
M !D              ("!@LH! 'AL+W=O<FMS:&5E=',O<VAE970X-"YX;6Q0
M2P$"% ,4    " !+C*A6JK)ANZ<&   N)   &0              @(' S0$
M>&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0    ( $N,J%9):%V'
M@@0  *\8   9              " @9[4 0!X;"]W;W)K<VAE971S+W-H965T
M.#8N>&UL4$L! A0#%     @ 2XRH5D BI_EO P  [0L  !D
M ("!5]D! 'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6Q02P$"% ,4    " !+
MC*A6\GO;5J8$  "B&   &0              @(']W $ >&PO=V]R:W-H965T
M<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    ( $N,J%9(:I=I'P@  'I'   9
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M970Y,RYX;6Q02P$"% ,4    " !+C*A6EJ(W=>0"   W"0  &0
M    @('7]P$ >&PO=V]R:W-H965T<R]S:&5E=#DT+GAM;%!+ 0(4 Q0    (
M $N,J%8*YPPE\0,  .X2   9              " @?+Z 0!X;"]W;W)K<VAE
M971S+W-H965T.34N>&UL4$L! A0#%     @ 2XRH5N?P[%E# @  @ 0  !D
M             ("!&O\! 'AL+W=O<FMS:&5E=',O<VAE970Y-BYX;6Q02P$"
M% ,4    " !+C*A6B$M?4%,#  !*"@  &0              @(&4 0( >&PO
M=V]R:W-H965T<R]S:&5E=#DW+GAM;%!+ 0(4 Q0    ( $N,J%;.TH:J5P8
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M<F5L<R\N<F5L<U!+ 0(4 Q0    ( $N,J%:+!#C)]08  /]    /
M      "  4$3 @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !+C*A6M_K&
M\-$"   R.@  &@              @ %C&@( >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    " !+C*A6%8LHOU0"   Y.   $P
M    @ %L'0( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     :P!K &0=  #Q
%'P(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>304</ContextCount>
  <ElementCount>454</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>89</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - DEI Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DEIDocument</Role>
      <ShortName>DEI Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome</Role>
      <ShortName>Condensed Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Consolidated Statements of Comprehensive Income (Paranthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Paranthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Condensed Consolidated Statements of Stockholders' Equity Statement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity Statement</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Basis of Presentation:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - New Accounting Pronouncements:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Business Combinations and Asset Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions</Role>
      <ShortName>Business Combinations and Asset Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Restructuring, Strategic Transaction and Integration (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Revenue (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/RevenueNotes</Role>
      <ShortName>Revenue (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Leases (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/LeasesNotes</Role>
      <ShortName>Leases (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Net Income Per Share:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/NetIncomePerShare</Role>
      <ShortName>Net Income Per Share:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Derivative Financial Instruments (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes</Role>
      <ShortName>Derivative Financial Instruments (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Fair Value Measures and Disclosures (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes</Role>
      <ShortName>Fair Value Measures and Disclosures (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Investment Securities (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/InvestmentSecuritiesNotes</Role>
      <ShortName>Investment Securities (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Prepaids and Other Current Assets (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes</Role>
      <ShortName>Prepaids and Other Current Assets (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Inventories:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/Inventories</Role>
      <ShortName>Inventories:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Property and Equipment:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Goodwill and Intangible Assets (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes</Role>
      <ShortName>Goodwill and Intangible Assets (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Accrued Liabilities (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/AccruedLiabilitiesNotes</Role>
      <ShortName>Accrued Liabilities (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Income Taxes:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Long-Term Obligations (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsNotes</Role>
      <ShortName>Long-Term Obligations (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Commitments and Contingencies:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Collaborative and Other Arrangements (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes</Role>
      <ShortName>Collaborative and Other Arrangements (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Transfers and Servicing</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/TransfersandServicing</Role>
      <ShortName>Transfers and Servicing</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Business Combinations and Asset Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables</Role>
      <ShortName>Business Combinations and Asset Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Restructuring, Strategic Transaction and Integration (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/RevenueNotes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/LeasesNotes</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Net Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/NetIncomePerShareTables</Role>
      <ShortName>Net Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/NetIncomePerShare</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Derivative Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsTables</Role>
      <ShortName>Derivative Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Fair Value Measures and Disclosures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables</Role>
      <ShortName>Fair Value Measures and Disclosures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Investment Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/InvestmentSecuritiesTables</Role>
      <ShortName>Investment Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/InvestmentSecuritiesNotes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Prepaids and Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables</Role>
      <ShortName>Prepaids and Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/Inventories</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/PropertyandEquipment</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AccruedLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/AccruedLiabilitiesNotes</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Long-Term Obligations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsTables</Role>
      <ShortName>Long-Term Obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/LongTermObligationsNotes</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/Equity</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails</Role>
      <ShortName>Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Business Combinations and Asset Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails</Role>
      <ShortName>Business Combinations and Asset Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails</Role>
      <ShortName>Business Combinations and Asset Acquisitions Smiths Medical (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails</Role>
      <ShortName>Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Restructuring, Strategic Transaction and Integration Restructuring (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration Restructuring (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Restructuring, Strategic Transaction and Integration Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Strategic Transaction and Integration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/StrategicTransactionandIntegrationDetails</Role>
      <ShortName>Strategic Transaction and Integration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Revenue Disaggregated Revenue by Geography (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails</Role>
      <ShortName>Revenue Disaggregated Revenue by Geography (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Revenue Disaggregated Revenue by Product Line (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails</Role>
      <ShortName>Revenue Disaggregated Revenue by Product Line (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Revenue Contract Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueContractLiabilitiesDetails</Role>
      <ShortName>Revenue Contract Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Leases Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesTextDetails</Role>
      <ShortName>Leases Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/LeasesTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Leases Cash Flow, Operating Activities, Lessee (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails</Role>
      <ShortName>Leases Cash Flow, Operating Activities, Lessee (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Leases Assets and Liabilities, Lessee (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails</Role>
      <ShortName>Leases Assets and Liabilities, Lessee (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Leases Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesMaturityDetails</Role>
      <ShortName>Leases Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/NetIncomePerShareDetails</Role>
      <ShortName>Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/NetIncomePerShareTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Net Income Per Share (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/NetIncomePerShareDetails1</Role>
      <ShortName>Net Income Per Share (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/NetIncomePerShareTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails</Role>
      <ShortName>Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Derivative Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails</Role>
      <ShortName>Derivative Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/DerivativeFinancialInstrumentsTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Derivative Financial Instruments Interest Rate Swaps (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails</Role>
      <ShortName>Derivative Financial Instruments Interest Rate Swaps (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails</Role>
      <ShortName>Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails</Role>
      <ShortName>Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Fair Value Measures and Disclosures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails</Role>
      <ShortName>Fair Value Measures and Disclosures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails</Role>
      <ShortName>Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails</Role>
      <ShortName>Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Fair Value Measures and Disclosures Liability Measurement Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails</Role>
      <ShortName>Fair Value Measures and Disclosures Liability Measurement Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails</Role>
      <ShortName>Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Investment Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/InvestmentSecuritiesDetails</Role>
      <ShortName>Investment Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/InvestmentSecuritiesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Investment Securities Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/InvestmentSecuritiesTableDetails</Role>
      <ShortName>Investment Securities Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Equity Method Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/EquityMethodInvestmentsDetails</Role>
      <ShortName>Equity Method Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Prepaids and Other Current Assets Prepaids and Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails</Role>
      <ShortName>Prepaids and Other Current Assets Prepaids and Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Other Assets Noncurrent(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/OtherAssetsNoncurrentDetails</Role>
      <ShortName>Other Assets Noncurrent(Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/InventoriesTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Property and Equipment Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PropertyandEquipmentTextDetails</Role>
      <ShortName>Property and Equipment Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Goodwill and Intangible Assets Goodwill Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails</Role>
      <ShortName>Goodwill and Intangible Assets Goodwill Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Goodwill and Intangible Assets Intangibles Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails</Role>
      <ShortName>Goodwill and Intangible Assets Intangibles Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - Goodwill and Intangible Assets Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails</Role>
      <ShortName>Goodwill and Intangible Assets Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - Goodwill and Intangible Assets 5-Year Amortization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails</Role>
      <ShortName>Goodwill and Intangible Assets 5-Year Amortization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000089 - Disclosure - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/AccruedLiabilitiesTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000090 - Disclosure - Accrued Liabilities Long-term liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails</Role>
      <ShortName>Accrued Liabilities Long-term liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000091 - Disclosure - Income Taxes Effective tax rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails</Role>
      <ShortName>Income Taxes Effective tax rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000092 - Disclosure - Long-Term Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsDetails</Role>
      <ShortName>Long-Term Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/LongTermObligationsTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0000093 - Disclosure - Long-Term Obligations Interest Rate Terms (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails</Role>
      <ShortName>Long-Term Obligations Interest Rate Terms (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0000094 - Disclosure - Long-Term Obligations Terminated Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails</Role>
      <ShortName>Long-Term Obligations Terminated Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0000095 - Disclosure - Long-Term Obligations Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsTableDetails</Role>
      <ShortName>Long-Term Obligations Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0000096 - Disclosure - Long-Term Obligations Schedule of Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails</Role>
      <ShortName>Long-Term Obligations Schedule of Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0000097 - Disclosure - Long-Term Obligations Interest Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails</Role>
      <ShortName>Long-Term Obligations Interest Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0000098 - Disclosure - Long-Term Obligations Principal Payment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails</Role>
      <ShortName>Long-Term Obligations Principal Payment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0000099 - Disclosure - Commitments and Contingencies Contingency (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails</Role>
      <ShortName>Commitments and Contingencies Contingency (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0000100 - Disclosure - Collaborative and Other Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails</Role>
      <ShortName>Collaborative and Other Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>0000101 - Disclosure - Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/EquityDetails</Role>
      <ShortName>Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/EquityTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>0000102 - Disclosure - Equity Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Equity Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="icui-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>0000103 - Disclosure - Transfers and Servicing (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/TransfersandServicingDetails</Role>
      <ShortName>Transfers and Servicing (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/TransfersandServicing</ParentRole>
      <Position>99</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept TreasuryStockShares in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. icui-20230331.htm 4</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept TreasuryStockMember in us-gaap/2022 used in 8 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. icui-20230331.htm 4</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept RelatedPartyTransactionDueFromToRelatedParty in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. icui-20230331.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 6 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName, us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife -  icui-20230331.htm 4</Log>
    <Log type="Warning">[dq-0712-Presentation-Base-Set-Order] Role '0000046 - Disclosure - Equity (Tables)', a level 3, Table role, appears before '0000048 - Disclosure - Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)', a level 1, Note role. icui-20230331.xsd 293, 305</Log>
    <Log type="Warning">[dq-0712-Presentation-Base-Set-Order] Role '0000065 - Disclosure - Net Income Per Share (Details 1)', a level 4, Detail role, appears before '0000066 - Disclosure - Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)', a level 1, Note role. icui-20230331.xsd 407, 413</Log>
    <Log type="Warning">[dq-0712-Presentation-Base-Set-Order] Role '0000080 - Disclosure - Prepaids and Other Current Assets Prepaids and Other Assets (Details)', a level 4, Detail role, appears before '0000081 - Disclosure - Other Assets Noncurrent(Details)', a level 1, Note role. icui-20230331.xsd 497, 503</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="icui-20230331.htm">icui-20230331.htm</File>
    <File>exhibit10133123.htm</File>
    <File>icui-20230331.xsd</File>
    <File>icui-20230331_cal.xml</File>
    <File>icui-20230331_def.xml</File>
    <File>icui-20230331_lab.xml</File>
    <File>icui-20230331_pre.xml</File>
    <File>icui-ex31133123.htm</File>
    <File>icui-ex31233123.htm</File>
    <File>icui-ex32133123.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1050">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>117
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "icui-20230331.htm": {
   "axisCustom": 5,
   "axisStandard": 20,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1050,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 304,
   "dts": {
    "calculationLink": {
     "local": [
      "icui-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "icui-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "icui-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "icui-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "icui-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "icui-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 701,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 24,
    "http://xbrl.sec.gov/dei/2022": 6,
    "total": 30
   },
   "keyCustom": 62,
   "keyStandard": 392,
   "memberCustom": 34,
   "memberStandard": 55,
   "nsprefix": "icui",
   "nsuri": "http://www.icumed.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - DEI Document",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.icumed.com/role/DEIDocument",
     "shortName": "DEI Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - New Accounting Pronouncements:",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.icumed.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Business Combinations and Asset Acquisitions",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions",
     "shortName": "Business Combinations and Asset Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Restructuring, Strategic Transaction and Integration (Notes)",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes",
     "shortName": "Restructuring, Strategic Transaction and Integration (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Revenue (Notes)",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.icumed.com/role/RevenueNotes",
     "shortName": "Revenue (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Leases (Notes)",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.icumed.com/role/LeasesNotes",
     "shortName": "Leases (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Net Income Per Share:",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.icumed.com/role/NetIncomePerShare",
     "shortName": "Net Income Per Share:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Derivative Financial Instruments (Notes)",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes",
     "shortName": "Derivative Financial Instruments (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Fair Value Measures and Disclosures (Notes)",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes",
     "shortName": "Fair Value Measures and Disclosures (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Investment Securities (Notes)",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.icumed.com/role/InvestmentSecuritiesNotes",
     "shortName": "Investment Securities (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Prepaids and Other Current Assets (Notes)",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes",
     "shortName": "Prepaids and Other Current Assets (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i843ff99f0a184bdf9191fac242ba630e_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Inventories:",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.icumed.com/role/Inventories",
     "shortName": "Inventories:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Property and Equipment:",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.icumed.com/role/PropertyandEquipment",
     "shortName": "Property and Equipment:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Goodwill and Intangible Assets (Notes)",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes",
     "shortName": "Goodwill and Intangible Assets (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Accrued Liabilities (Notes)",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.icumed.com/role/AccruedLiabilitiesNotes",
     "shortName": "Accrued Liabilities (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Income Taxes:",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.icumed.com/role/IncomeTaxes",
     "shortName": "Income Taxes:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Long-Term Obligations (Notes)",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.icumed.com/role/LongTermObligationsNotes",
     "shortName": "Long-Term Obligations (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Commitments and Contingencies:",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.icumed.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Collaborative and Other Arrangements (Notes)",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes",
     "shortName": "Collaborative and Other Arrangements (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Equity",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://www.icumed.com/role/Equity",
     "shortName": "Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TransfersAndServicingOfFinancialAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Transfers and Servicing",
     "menuCat": "Notes",
     "order": "29",
     "role": "http://www.icumed.com/role/TransfersandServicing",
     "shortName": "Transfers and Servicing",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TransfersAndServicingOfFinancialAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Business Combinations and Asset Acquisitions (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables",
     "shortName": "Business Combinations and Asset Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Restructuring, Strategic Transaction and Integration (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables",
     "shortName": "Restructuring, Strategic Transaction and Integration (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Revenue (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.icumed.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.icumed.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Net Income Per Share (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.icumed.com/role/NetIncomePerShareTables",
     "shortName": "Net Income Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Derivative Financial Instruments (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsTables",
     "shortName": "Derivative Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Fair Value Measures and Disclosures (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables",
     "shortName": "Fair Value Measures and Disclosures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Investment Securities (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.icumed.com/role/InvestmentSecuritiesTables",
     "shortName": "Investment Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Prepaids and Other Current Assets (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables",
     "shortName": "Prepaids and Other Current Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Inventories (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.icumed.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Consolidated Statements of Income",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
     "shortName": "Condensed Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Property and Equipment (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.icumed.com/role/PropertyandEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Accrued Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://www.icumed.com/role/AccruedLiabilitiesTables",
     "shortName": "Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Long-Term Obligations (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://www.icumed.com/role/LongTermObligationsTables",
     "shortName": "Long-Term Obligations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Equity (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://www.icumed.com/role/EquityTables",
     "shortName": "Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
     "shortName": "Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Business Combinations and Asset Acquisitions (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
     "shortName": "Business Combinations and Asset Acquisitions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "icui:MinimumStockPriceTargetForEarnOutPayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
     "shortName": "Business Combinations and Asset Acquisitions Smiths Medical (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i5ba4c0299bfe47f4b9c97b2aa142eab8_I20230331",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionSharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
     "shortName": "Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "id9c93e74b7c9437aa40e7c8a8c213dd1_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:Restructuringstrategictransactionandintegration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Restructuring, Strategic Transaction and Integration Restructuring (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails",
     "shortName": "Restructuring, Strategic Transaction and Integration Restructuring (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:Restructuringstrategictransactionandintegration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i843ff99f0a184bdf9191fac242ba630e_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Restructuring, Strategic Transaction and Integration Liability (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails",
     "shortName": "Restructuring, Strategic Transaction and Integration Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i843ff99f0a184bdf9191fac242ba630e_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "icui:StrategicTransactionandIntegration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Strategic Transaction and Integration (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.icumed.com/role/StrategicTransactionandIntegrationDetails",
     "shortName": "Strategic Transaction and Integration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "icui:StrategicTransactionandIntegration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Revenue Disaggregated Revenue by Geography (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails",
     "shortName": "Revenue Disaggregated Revenue by Geography (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ib3d0e8e0a5bb4a63b8430aaa2a4f8b17_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Revenue Disaggregated Revenue by Product Line (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails",
     "shortName": "Revenue Disaggregated Revenue by Product Line (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "if672ca85f58b4f10ac0adfe442433dba_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i843ff99f0a184bdf9191fac242ba630e_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Revenue Contract Liabilities (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
     "shortName": "Revenue Contract Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i843ff99f0a184bdf9191fac242ba630e_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:Optiontoextendinyears",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Leases Text (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.icumed.com/role/LeasesTextDetails",
     "shortName": "Leases Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:Optiontoextendinyears",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Leases (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.icumed.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Leases Cash Flow, Operating Activities, Lessee (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails",
     "shortName": "Leases Cash Flow, Operating Activities, Lessee (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:AssetsandLiabilitiesLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Leases Assets and Liabilities, Lessee (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails",
     "shortName": "Leases Assets and Liabilities, Lessee (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:AssetsandLiabilitiesLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Leases Maturity (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.icumed.com/role/LeasesMaturityDetails",
     "shortName": "Leases Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Condensed Consolidated Statements of Comprehensive Income (Paranthetical)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Paranthetical)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Net Income Per Share (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.icumed.com/role/NetIncomePerShareDetails",
     "shortName": "Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Net Income Per Share (Details 1)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.icumed.com/role/NetIncomePerShareDetails1",
     "shortName": "Net Income Per Share (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails",
     "shortName": "Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8321aa0d52a040748fa39ebb30857208_I20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Derivative Financial Instruments (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
     "shortName": "Derivative Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i7cacbfb1e2ec47f181ee075ab70cca83_I20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Derivative Financial Instruments Interest Rate Swaps (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
     "shortName": "Derivative Financial Instruments Interest Rate Swaps (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i41865436086741dba4582ecb29b5d80f_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
     "shortName": "Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
     "shortName": "Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i843ff99f0a184bdf9191fac242ba630e_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Fair Value Measures and Disclosures (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
     "shortName": "Fair Value Measures and Disclosures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "8",
      "lang": "en-US",
      "name": "icui:OwnershipRequirementForEarnoutPayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i843ff99f0a184bdf9191fac242ba630e_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails",
     "shortName": "Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "icbd969b02ac748cd9474589aab428a62_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i10ebf268d4574d988d0c464474155fe0_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Condensed Consolidated Statements of Stockholders' Equity Statement",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity Statement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i10ebf268d4574d988d0c464474155fe0_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i843ff99f0a184bdf9191fac242ba630e_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
     "shortName": "Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ia32accdc410f475aacf8dd5d7b0e4cf3_I20230331",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Fair Value Measures and Disclosures Liability Measurement Inputs (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails",
     "shortName": "Fair Value Measures and Disclosures Liability Measurement Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ia32accdc410f475aacf8dd5d7b0e4cf3_I20230331",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
     "shortName": "Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Investment Securities (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.icumed.com/role/InvestmentSecuritiesDetails",
     "shortName": "Investment Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Investment Securities Table (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.icumed.com/role/InvestmentSecuritiesTableDetails",
     "shortName": "Investment Securities Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentAggregateCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Equity Method Investments (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.icumed.com/role/EquityMethodInvestmentsDetails",
     "shortName": "Equity Method Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentAggregateCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherPrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Prepaids and Other Current Assets Prepaids and Other Assets (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails",
     "shortName": "Prepaids and Other Current Assets Prepaids and Other Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherPrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetsNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Other Assets Noncurrent(Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.icumed.com/role/OtherAssetsNoncurrentDetails",
     "shortName": "Other Assets Noncurrent(Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Inventories (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.icumed.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Property and Equipment (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.icumed.com/role/PropertyandEquipmentDetails",
     "shortName": "Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Condensed Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Property and Equipment Text (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.icumed.com/role/PropertyandEquipmentTextDetails",
     "shortName": "Property and Equipment Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Goodwill and Intangible Assets Goodwill Table (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails",
     "shortName": "Goodwill and Intangible Assets Goodwill Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Goodwill and Intangible Assets Intangibles Table (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails",
     "shortName": "Goodwill and Intangible Assets Intangibles Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - Goodwill and Intangible Assets Text (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails",
     "shortName": "Goodwill and Intangible Assets Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - Goodwill and Intangible Assets 5-Year Amortization (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails",
     "shortName": "Goodwill and Intangible Assets 5-Year Amortization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:AccruedSalariesAndBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - Accrued Liabilities (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.icumed.com/role/AccruedLiabilitiesDetails",
     "shortName": "Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:AccruedSalariesAndBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:AssetsandLiabilitiesLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiabilityNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - Accrued Liabilities Long-term liabilities (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
     "shortName": "Accrued Liabilities Long-term liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000091 - Disclosure - Income Taxes Effective tax rate (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails",
     "shortName": "Income Taxes Effective tax rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "icui:TotalSeniorSecuredCreditFacility",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000092 - Disclosure - Long-Term Obligations (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.icumed.com/role/LongTermObligationsDetails",
     "shortName": "Long-Term Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "icui:TotalSeniorSecuredCreditFacility",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "icui:InterestPercentageAddedToFederalFundsRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000093 - Disclosure - Long-Term Obligations Interest Rate Terms (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails",
     "shortName": "Long-Term Obligations Interest Rate Terms (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "icui:InterestPercentageAddedToFederalFundsRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Basis of Presentation:",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.icumed.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000094 - Disclosure - Long-Term Obligations Terminated Credit Agreement (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails",
     "shortName": "Long-Term Obligations Terminated Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000095 - Disclosure - Long-Term Obligations Table (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://www.icumed.com/role/LongTermObligationsTableDetails",
     "shortName": "Long-Term Obligations Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000096 - Disclosure - Long-Term Obligations Schedule of Maturities (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails",
     "shortName": "Long-Term Obligations Schedule of Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:InterestExpenseOnLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000097 - Disclosure - Long-Term Obligations Interest Expense (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails",
     "shortName": "Long-Term Obligations Interest Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:InterestExpenseOnLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "icui:TermAPrincipalPaymentFirst2Years",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000098 - Disclosure - Long-Term Obligations Principal Payment (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails",
     "shortName": "Long-Term Obligations Principal Payment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "icui:TermAPrincipalPaymentFirst2Years",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i8b0ab8c9d8a7444899c926821dab8b6b_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "icui:ContingentConsiderationGrossST",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000099 - Disclosure - Commitments and Contingencies Contingency (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
     "shortName": "Commitments and Contingencies Contingency (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "id4dcda0568fa4318a8aa6122af8e00b9_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "icui:Contingentconsiderationgross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000100 - Disclosure - Collaborative and Other Arrangements (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails",
     "shortName": "Collaborative and Other Arrangements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "icui:TreasuryStockPurchasePlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000101 - Disclosure - Equity (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://www.icumed.com/role/EquityDetails",
     "shortName": "Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "icui:TreasuryStockPurchasePlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000102 - Disclosure - Equity Accumulated Other Comprehensive Income (Loss) (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Equity Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "i57ae4b72e9574e4ebf63f3473590fe05_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000103 - Disclosure - Transfers and Servicing (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://www.icumed.com/role/TransfersandServicingDetails",
     "shortName": "Transfers and Servicing (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20230331.htm",
      "contextRef": "ic896526384424866b5b8be38ae18f2f6_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 89,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AUD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Australia, Dollars",
        "terseLabel": "Australia, Dollars"
       }
      }
     },
     "localname": "AUD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CAD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canada, Dollars",
        "terseLabel": "Canada, Dollars"
       }
      }
     },
     "localname": "CAD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CNY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "China, Yuan Renminbi",
        "terseLabel": "China, Yuan Renminbi"
       }
      }
     },
     "localname": "CNY",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CZK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Czech Republic, Koruny",
        "terseLabel": "Czech Republic, Koruny"
       }
      }
     },
     "localname": "CZK",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro Member Countries, Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_JPY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Japan, Yen",
        "terseLabel": "Japan, Yen"
       }
      }
     },
     "localname": "JPY",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_MXN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mexico, Pesos",
        "terseLabel": "Mexico, Pesos"
       }
      }
     },
     "localname": "MXN",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_SEK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sweden, Kronor",
        "terseLabel": "Sweden, Kronor"
       }
      }
     },
     "localname": "SEK",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "verboseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "icui_AccruedAuditFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued audit fees",
        "label": "Accrued audit fees",
        "terseLabel": "Accrued audit fees"
       }
      }
     },
     "localname": "AccruedAuditFees",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_AccruedResearchAndDevelopment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "accrued research and development",
        "label": "accrued research and development",
        "terseLabel": "accrued research and development"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopment",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_AccruedSalariesAndBenefits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued salaries and benefits",
        "label": "Accrued salaries and benefits",
        "terseLabel": "Salaries and benefits"
       }
      }
     },
     "localname": "AccruedSalariesAndBenefits",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Accruedfreight": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued freight",
        "label": "Accrued freight",
        "terseLabel": "Accrued freight"
       }
      }
     },
     "localname": "Accruedfreight",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Accruedlegalfees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued legal fees",
        "label": "Accrued legal fees",
        "terseLabel": "Legal accrual"
       }
      }
     },
     "localname": "Accruedlegalfees",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Accruedothertaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued other taxes",
        "label": "Accrued other taxes",
        "terseLabel": "Accrued other taxes"
       }
      }
     },
     "localname": "Accruedothertaxes",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_AmortizationOfInventoryStepUp": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Inventory Step-up",
        "label": "Amortization of Inventory Step-up",
        "terseLabel": "Amortization of Inventory Step-up"
       }
      }
     },
     "localname": "AmortizationOfInventoryStepUp",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ApplicableMarginBaseRateLoans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applicable Margin Base Rate Loans",
        "label": "Applicable Margin Base Rate Loans",
        "terseLabel": "Applicable Margin Base Rate Loans"
       }
      }
     },
     "localname": "ApplicableMarginBaseRateLoans",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_ApplicableMarginBasedOnLeverageRatioLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applicable Margin Based on Leverage Ratio [Line Items]",
        "label": "Applicable Margin Based on Leverage Ratio [Line Items]",
        "terseLabel": "Applicable Margin Based on Leverage Ratio [Line Items]"
       }
      }
     },
     "localname": "ApplicableMarginBasedOnLeverageRatioLineItems",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_ApplicableMarginBasedOnLeverageRatioTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applicable Margin Based on Leverage Ratio [Table]",
        "label": "Applicable Margin Based on Leverage Ratio [Table]",
        "terseLabel": "Applicable Margin Based on Leverage Ratio [Table]"
       }
      }
     },
     "localname": "ApplicableMarginBasedOnLeverageRatioTable",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applicable Margin Based on Leverage Ratio",
        "label": "Applicable Margin Based on Leverage Ratio [Table Text Block]",
        "terseLabel": "Applicable Margin Based on Leverage Ratio"
       }
      }
     },
     "localname": "ApplicableMarginBasedOnLeverageRatioTableTextBlock",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_ApplicableMarginTermSOFRLoans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applicable Margin Term SOFR Loans",
        "label": "Applicable Margin Term SOFR Loans",
        "terseLabel": "Applicable Margin Term SOFR Loans"
       }
      }
     },
     "localname": "ApplicableMarginTermSOFRLoans",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_AssetsandLiabilitiesLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets and Liabilities, Leases [Table Text Block]",
        "label": "Assets and Liabilities, Leases [Table Text Block]",
        "terseLabel": "Assets and Liabilities, Leases [Table Text Block]"
       }
      }
     },
     "localname": "AssetsandLiabilitiesLeasesTableTextBlock",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_BusinessCombinationConsiderationTransferredCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Cash",
        "label": "Business Combination, Consideration Transferred, Cash",
        "terseLabel": "Business Combination, Consideration Transferred, Cash"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredCash",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_BusinessCombinationGoodwillNonDeductible": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination, goodwill- non deductible",
        "label": "Business combination, goodwill- non deductible",
        "terseLabel": "Business combination, goodwill- non deductible"
       }
      }
     },
     "localname": "BusinessCombinationGoodwillNonDeductible",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "business combination, recognized identifiable asset acquired and liability assumed,",
        "label": "business combination, recognized identifiable asset acquired and liability assumed,",
        "terseLabel": "business combination, recognized identifiable asset acquired and liability assumed,"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable",
        "label": "Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable",
        "negatedTerseLabel": "Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable"
       }
      }
     },
     "localname": "BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_CashRemittedToPurchaser": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Remitted to Purchaser",
        "label": "Cash Remitted to Purchaser",
        "terseLabel": "Cash Remitted to Purchaser"
       }
      }
     },
     "localname": "CashRemittedToPurchaser",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/TransfersandServicingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ClassificationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "classification",
        "label": "classification [Axis]",
        "terseLabel": "classification [Axis]"
       }
      }
     },
     "localname": "ClassificationAxis",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_ClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "classification [Domain]",
        "label": "classification [Domain]",
        "terseLabel": "classification [Domain]"
       }
      }
     },
     "localname": "ClassificationDomain",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_CommonStockSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Shares [Member]",
        "label": "Common Stock Shares [Member]",
        "terseLabel": "Common Stock Shares [Member]"
       }
      }
     },
     "localname": "CommonStockSharesMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ComputerEquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer Equipment and Software [Member]",
        "label": "Computer Equipment and Software [Member]",
        "terseLabel": "Computer Equipment and Software [Member]"
       }
      }
     },
     "localname": "ComputerEquipmentAndSoftwareMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ContingentConsiderationGrossLT": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Gross LT",
        "label": "Contingent Consideration, Gross LT",
        "terseLabel": "Contingent Consideration, Gross LT"
       }
      }
     },
     "localname": "ContingentConsiderationGrossLT",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ContingentConsiderationGrossST": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Gross ST",
        "label": "Contingent Consideration, Gross ST",
        "terseLabel": "Contingent Consideration, Gross ST"
       }
      }
     },
     "localname": "ContingentConsiderationGrossST",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ContingentConsiderationTaxExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "contingent consideration, tax expense",
        "label": "contingent consideration, tax expense",
        "terseLabel": "contingent consideration, tax expense"
       }
      }
     },
     "localname": "ContingentConsiderationTaxExpense",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Contingentconsiderationgross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "contingent consideration gross",
        "label": "contingent consideration gross",
        "terseLabel": "contingent consideration gross"
       }
      }
     },
     "localname": "Contingentconsiderationgross",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ContractassetandliabilitybalancesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Contract asset and liability balances [Table]",
        "label": "Contract asset and liability balances [Line Items]",
        "terseLabel": "Contract asset and liability balances [Line Items]"
       }
      }
     },
     "localname": "ContractassetandliabilitybalancesLineItems",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_ContractassetandliabilitybalancesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract asset and liability balances [Table]",
        "label": "Contract asset and liability balances [Table]",
        "terseLabel": "Contract asset and liability balances [Table]"
       }
      }
     },
     "localname": "ContractassetandliabilitybalancesTable",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_CurrencyTranslationOnEarnOut": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency translation on earn-out",
        "label": "Currency translation on earn-out",
        "negatedTerseLabel": "Currency translation on earn-out"
       }
      }
     },
     "localname": "CurrencyTranslationOnEarnOut",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_CurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "current",
        "label": "current [Member]",
        "terseLabel": "current"
       }
      }
     },
     "localname": "CurrentMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Deferredtaxcharge": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax charge",
        "label": "Deferred tax charge",
        "terseLabel": "Deferred tax charge"
       }
      }
     },
     "localname": "Deferredtaxcharge",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_DerivativeVariableRateFloor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "derivative variable rate floor",
        "label": "derivative variable rate floor",
        "terseLabel": "derivative variable rate floor"
       }
      }
     },
     "localname": "DerivativeVariableRateFloor",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_DevelopedTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "developed technology",
        "label": "developed technology [Member]",
        "terseLabel": "developed technology"
       }
      }
     },
     "localname": "DevelopedTechnologyMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Document And Entity Information [Abstract]",
        "label": "Document And Entity Information [Abstract]",
        "terseLabel": "Document And Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.icumed.com/20230331",
     "xbrltype": "stringItemType"
    },
    "icui_EarnoutliabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earn-out liability [Member]",
        "label": "Earn-out liability [Member]",
        "terseLabel": "Earn-out liability [Member]"
       }
      }
     },
     "localname": "EarnoutliabilityMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_EquipmentrevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment revenue [Member]",
        "label": "Equipment revenue [Member]",
        "terseLabel": "Equipment revenue [Member]"
       }
      }
     },
     "localname": "EquipmentrevenueMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_FieldServiceCorrectiveAction": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Field service corrective action",
        "label": "Field service corrective action",
        "terseLabel": "Field service corrective action"
       }
      }
     },
     "localname": "FieldServiceCorrectiveAction",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ForeignInfusionSystemSupplierMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Infusion System Supplier",
        "label": "Foreign Infusion System Supplier [Member]",
        "terseLabel": "Foreign Infusion System Supplier"
       }
      }
     },
     "localname": "ForeignInfusionSystemSupplierMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_GovernmentGrantRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Grant Revenue",
        "label": "Government Grant Revenue [Member]",
        "terseLabel": "Government Grant Revenue"
       }
      }
     },
     "localname": "GovernmentGrantRevenueMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_GreaterThan275To100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "greater than 2.75 to1.00",
        "label": "greater than 2.75 to1.00 [Member]",
        "terseLabel": "greaterthan2point75to1"
       }
      }
     },
     "localname": "GreaterThan275To100Member",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Greaterthan400to100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "greaterthan4.00to1.00",
        "label": "greaterthan4.00to1.00 [Member]",
        "terseLabel": "greaterthan 4to1"
       }
      }
     },
     "localname": "Greaterthan400to100Member",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Hedge2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge 2 [Member]",
        "label": "Hedge 2 [Member]",
        "terseLabel": "Hedge 2 [Member]"
       }
      }
     },
     "localname": "Hedge2Member",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change during the reporting period in the carrying amount as of the balance sheet date of payments made for taxes. Also includes the net change during the reporting period in the account that represents the temporary difference that results from income (loss) that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase Decrease in income taxes, including excess tax benefits and deferred income taxes",
        "terseLabel": "Income taxes, including excess tax benefits and deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_InfusionConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infusion Consumables [Member]",
        "label": "Infusion Consumables [Member]",
        "terseLabel": "Infusion Consumables [Member]"
       }
      }
     },
     "localname": "InfusionConsumablesMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InfusionSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infusion Systems [Member]",
        "label": "Infusion Systems [Member]",
        "terseLabel": "Infusion Systems [Member]"
       }
      }
     },
     "localname": "InfusionSystemsMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/RevenueDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InstrumentsPlacedwithCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instruments Placed with Customers [Member]",
        "label": "Instruments Placed with Customers [Member]",
        "terseLabel": "Instruments Placed with Customers [Member]"
       }
      }
     },
     "localname": "InstrumentsPlacedwithCustomersMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InterestExpenseOnLongTermDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest expense on long term debt",
        "label": "Interest expense on long term debt [Table Text Block]",
        "terseLabel": "Interest expense on long term debt"
       }
      }
     },
     "localname": "InterestExpenseOnLongTermDebtTableTextBlock",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_InterestPercentageAddedToBaseRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Percentage Added to Base Rate",
        "label": "Interest Percentage Added to Base Rate",
        "terseLabel": "Interest Percentage Added to Base Rate"
       }
      }
     },
     "localname": "InterestPercentageAddedToBaseRate",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_InterestPercentageAddedToFederalFundsRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Percentage Added to Federal Funds Rate",
        "label": "Interest Percentage Added to Federal Funds Rate",
        "terseLabel": "Interest Percentage Added to Federal Funds Rate"
       }
      }
     },
     "localname": "InterestPercentageAddedToFederalFundsRate",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_InterestRateSwapEndingNotionalValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Ending Notional Value",
        "label": "Interest Rate Swap Ending Notional Value",
        "terseLabel": "Interest Rate Swap Ending Notional Value"
       }
      }
     },
     "localname": "InterestRateSwapEndingNotionalValue",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_InternationalDistributorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Distributor",
        "label": "International Distributor [Member]",
        "terseLabel": "International Distributor"
       }
      }
     },
     "localname": "InternationalDistributorMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "investments in Debt and Marketable Equity Securities and Equity Method Investments",
        "label": "investments in Debt and Marketable Equity Securities and Equity Method Investments [Text Block]",
        "terseLabel": "investments in Debt and Marketable Equity Securities and Equity Method Investments [Text Block]"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_LOngTermObligationsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LOng-Term Obligations Disclosure [Abstract]",
        "label": "LOng-Term Obligations Disclosure [Abstract]",
        "terseLabel": "LOng-Term Obligations Disclosure [Abstract]"
       }
      }
     },
     "localname": "LOngTermObligationsDisclosureAbstract",
     "nsuri": "http://www.icumed.com/20230331",
     "xbrltype": "stringItemType"
    },
    "icui_LessThan275To100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "less than 2.75:1.00",
        "label": "less than 2.75 to1.00 [Member]",
        "terseLabel": "lessthan2point75to1"
       }
      }
     },
     "localname": "LessThan275To100Member",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LessThanOrEqual300To100ButGreaterThan250to100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "less than or equal 3.00 to 1.00 but greater than 2.50to1.00",
        "label": "less than or equal 3.00 to 1.00 but greater than 2.50to1.00 [Member]",
        "terseLabel": "lessthanorequal3to1butgreaterthan2point5to1"
       }
      }
     },
     "localname": "LessThanOrEqual300To100ButGreaterThan250to100Member",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LessThanOrEqualTo200To100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "less than or equal to 2.00 to 1.00",
        "label": "less than or equal to 2.00 to 1.00 [Member]",
        "terseLabel": "lessthanorequalto2to1"
       }
      }
     },
     "localname": "LessThanOrEqualTo200To100Member",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "less than or equal to 2.50 to1.00 but greater than 2.00 to1.00",
        "label": "less than or equal to 2.50 to1.00 but greater than 2.00 to1.00 [Member]",
        "terseLabel": "lessthanorequalto2point5to1butgreaterthan2to1"
       }
      }
     },
     "localname": "LessThanOrEqualTo250To100ButGreaterThan200To100Member",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "less than or equal to 4.00 to 1.00 but greater than 3.00 to100",
        "label": "less than or equal to 4.00 to 1.00 but greater than 3.00 to100 [Member]",
        "terseLabel": "lessthan4to1butgreaterthan3to1"
       }
      }
     },
     "localname": "LessThanOrEqualTo400To100ButGreaterThan300To100Member",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LeverageRatioCalculationCeilingSubtractedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Calculation Ceiling Subtracted Amount",
        "label": "Leverage Ratio Calculation Ceiling Subtracted Amount",
        "terseLabel": "Leverage Ratio Calculation Ceiling Subtracted Amount"
       }
      }
     },
     "localname": "LeverageRatioCalculationCeilingSubtractedAmount",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_LeverageRatioLevelAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Level",
        "label": "Leverage Ratio Level [Axis]",
        "terseLabel": "Leverage Ratio Level [Axis]"
       }
      }
     },
     "localname": "LeverageRatioLevelAxis",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_LeverageRatioLevelDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Level [Domain]",
        "label": "Leverage Ratio Level [Domain]",
        "terseLabel": "Leverage Ratio Level [Domain]"
       }
      }
     },
     "localname": "LeverageRatioLevelDomain",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LongTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term",
        "label": "Long Term [Member]",
        "terseLabel": "Long Term"
       }
      }
     },
     "localname": "LongTermMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_MinimumStockPriceTargetForEarnOutPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum Stock Price Target for Earn-out Payment",
        "label": "Minimum Stock Price Target for Earn-out Payment",
        "terseLabel": "Minimum Stock Price Target for Earn-out Payment"
       }
      }
     },
     "localname": "MinimumStockPriceTargetForEarnOutPayment",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_MoldsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molds [Member]",
        "label": "Molds [Member]",
        "terseLabel": "Molds [Member]"
       }
      }
     },
     "localname": "MoldsMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_NetCashPaidReceivedforcurrentandprioracquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Cash Paid (Received) for current and prior acquisitions",
        "label": "Net Cash Paid (Received) for current and prior acquisitions",
        "negatedTerseLabel": "Net Cash Paid (Received) for current and prior acquisitions"
       }
      }
     },
     "localname": "NetCashPaidReceivedforcurrentandprioracquisitions",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_NonPublicCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Public Company",
        "label": "Non Public Company [Member]",
        "terseLabel": "Non Public Company"
       }
      }
     },
     "localname": "NonPublicCompanyMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/EquityMethodInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_NoncurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "noncurrent",
        "label": "noncurrent [Member]",
        "terseLabel": "noncurrent"
       }
      }
     },
     "localname": "NoncurrentMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Optiontoextendinyears": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Optiontoextendinyears",
        "label": "Optiontoextendinyears",
        "terseLabel": "Lessee, Operating Lease, Option to Extend"
       }
      }
     },
     "localname": "Optiontoextendinyears",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "icui_OtherCurrenciesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "other currencies",
        "label": "other currencies [Member]",
        "terseLabel": "other currencies"
       }
      }
     },
     "localname": "OtherCurrenciesMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_OtherDeferredRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other deferred revenue",
        "label": "Other deferred revenue [Member]",
        "terseLabel": "Other deferred revenue"
       }
      }
     },
     "localname": "OtherDeferredRevenueMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_OtherforeigncountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other foreign countries [Member]",
        "label": "Other foreign countries [Member]",
        "terseLabel": "Other foreign countries [Member]"
       }
      }
     },
     "localname": "OtherforeigncountriesMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Outsidesalescommissions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outside sales commissions",
        "label": "Outside sales commissions",
        "terseLabel": "Distribution Fees"
       }
      }
     },
     "localname": "Outsidesalescommissions",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_OwnershipRequirementForEarnoutPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership requirement for Earnout Payment",
        "label": "Ownership requirement for Earnout Payment",
        "terseLabel": "Ownership requirement for Earnout Payment"
       }
      }
     },
     "localname": "OwnershipRequirementForEarnoutPayment",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_PrepaidVendorExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid vendor expenses",
        "label": "Prepaid vendor expenses",
        "terseLabel": "Prepaid vendor expenses"
       }
      }
     },
     "localname": "PrepaidVendorExpenses",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Prepaidinsuranceandpropertytaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid insurance and property taxes",
        "label": "Prepaid insurance and property taxes",
        "terseLabel": "Prepaid insurance and property taxes"
       }
      }
     },
     "localname": "Prepaidinsuranceandpropertytaxes",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Prepaidothertaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid other taxes",
        "label": "Prepaid other taxes",
        "terseLabel": "Prepaid Taxes"
       }
      }
     },
     "localname": "Prepaidothertaxes",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaids, other current assets and other noncurrent assets",
        "label": "Prepaids, other current assets and other noncurrent assets [Text Block]",
        "terseLabel": "Prepaids, other current assets and other noncurrent assets [Text Block]"
       }
      }
     },
     "localname": "PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_ProFormaAdjustmentAmortization": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pro Forma Adjustment - Amortization",
        "label": "Pro Forma Adjustment - Amortization",
        "terseLabel": "Pro Forma Adjustment - Amortization"
       }
      }
     },
     "localname": "ProFormaAdjustmentAmortization",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ProFormaAdjustmentFinanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pro Forma Adjustment - Finance Costs",
        "label": "Pro Forma Adjustment - Finance Costs",
        "terseLabel": "Pro Forma Adjustment - Finance Costs"
       }
      }
     },
     "localname": "ProFormaAdjustmentFinanceCosts",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of long-term debt, net of lender debt issuance costs",
        "label": "Proceeds from issuance of long-term debt, net of lender debt issuance costs",
        "terseLabel": "Proceeds from issuance of long-term debt, net of lender debt issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ProvisionForWarrantyAndReturns": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for warranty and returns",
        "label": "Provision for warranty and returns",
        "terseLabel": "Provision for warranty and returns"
       }
      }
     },
     "localname": "ProvisionForWarrantyAndReturns",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_PursuitVascularInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pursuit Vascular, Inc. [Member] [Member]",
        "label": "Pursuit Vascular, Inc. [Member]",
        "terseLabel": "Pursuit Vascular, Inc. [Member]"
       }
      }
     },
     "localname": "PursuitVascularInc.Member",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_RequiredShareHoldingOfStockIssuedAtAcquisition": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Required Share Holding Of Stock Issued At Acquisition",
        "label": "Required Share Holding Of Stock Issued At Acquisition",
        "terseLabel": "Required Share Holding Of Stock Issued At Acquisition"
       }
      }
     },
     "localname": "RequiredShareHoldingOfStockIssuedAtAcquisition",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_Restructuringandstrategictransaction": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and strategic transaction expenses",
        "label": "Restructuring and strategic transaction",
        "terseLabel": "Restructuring, strategic transaction and integration"
       }
      }
     },
     "localname": "Restructuringandstrategictransaction",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Restructuringstrategictransactionandintegration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring, strategic transaction and integration",
        "label": "Restructuring, strategic transaction and integration",
        "terseLabel": "Restructuring, strategic transaction and integration"
       }
      }
     },
     "localname": "Restructuringstrategictransactionandintegration",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_RevolverSubLimits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolver Sub limits",
        "label": "Revolver Sub limits",
        "terseLabel": "Revolver Sub limits"
       }
      }
     },
     "localname": "RevolverSubLimits",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ShortTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short Term",
        "label": "Short Term [Member]",
        "terseLabel": "Short Term"
       }
      }
     },
     "localname": "ShortTermMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_SmithsGroupOwnershipAcquisitionSharesIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smiths Group Ownership % Acquisition Shares Issued",
        "label": "Smiths Group Ownership % Acquisition Shares Issued",
        "terseLabel": "Smiths Group Ownership % Acquisition Shares Issued"
       }
      }
     },
     "localname": "SmithsGroupOwnershipAcquisitionSharesIssued",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_SmithsGroupOwnershipRequiredForBoardRepresentation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smiths Group Ownership % Required for Board Representation",
        "label": "Smiths Group Ownership % Required for Board Representation",
        "terseLabel": "Smiths Group Ownership % Required for Board Representation"
       }
      }
     },
     "localname": "SmithsGroupOwnershipRequiredForBoardRepresentation",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_SmithsMedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SmithsMedical",
        "label": "SmithsMedical [Member]",
        "terseLabel": "SmithsMedical"
       }
      }
     },
     "localname": "SmithsMedicalMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails",
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_SoftwarerevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Software revenue [Member]",
        "label": "Software revenue [Member]",
        "terseLabel": "Software revenue [Member]"
       }
      }
     },
     "localname": "SoftwarerevenueMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_SpareParts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Spare parts",
        "label": "Spare parts",
        "terseLabel": "Spare parts"
       }
      }
     },
     "localname": "SpareParts",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Sparepartsusage": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sparepartsusage",
        "label": "Sparepartsusage",
        "terseLabel": "Sparepartsusage"
       }
      }
     },
     "localname": "Sparepartsusage",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Srt_MultipleCurrencyAxisAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "srt_MultipleCurrencyAxis",
        "label": "srt_MultipleCurrencyAxis [Axis]",
        "terseLabel": "srt_MultipleCurrencyAxis [Axis]"
       }
      }
     },
     "localname": "Srt_MultipleCurrencyAxisAxis",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_Srt_MultipleCurrencyAxisDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "srt_MultipleCurrencyAxis [Domain]",
        "label": "srt_MultipleCurrencyAxis [Domain]",
        "terseLabel": "srt_MultipleCurrencyAxis [Domain]"
       }
      }
     },
     "localname": "Srt_MultipleCurrencyAxisDomain",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_StrategicTransactionandIntegration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Transaction and Integration",
        "label": "Strategic Transaction and Integration",
        "terseLabel": "Strategic Transaction and Integration"
       }
      }
     },
     "localname": "StrategicTransactionandIntegration",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/StrategicTransactionandIntegrationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_TerSOFRInterestRateAdjustmentForBaseRateLoans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ter SOFR Interest Rate % Adjustment for Base Rate Loans",
        "label": "Ter SOFR Interest Rate % Adjustment for Base Rate Loans",
        "terseLabel": "Ter SOFR Interest Rate % Adjustment for Base Rate Loans"
       }
      }
     },
     "localname": "TerSOFRInterestRateAdjustmentForBaseRateLoans",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TermAPrincipalPaymentFirst2Years": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term A principal payment % First 2 Years",
        "label": "Term A principal payment % First 2 Years",
        "terseLabel": "Term A principal payment % First 2 Years"
       }
      }
     },
     "localname": "TermAPrincipalPaymentFirst2Years",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TermAPrincipalPaymentInYear5": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term A Principal Payment % in Year 5",
        "label": "Term A Principal Payment % in Year 5",
        "terseLabel": "Term A Principal Payment % in Year 5"
       }
      }
     },
     "localname": "TermAPrincipalPaymentInYear5",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TermAPrincipalPaymentYear3And4": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term A Principal Payment % Year 3 and 4",
        "label": "Term A Principal Payment % Year 3 and 4",
        "terseLabel": "Term A Principal Payment % Year 3 and 4"
       }
      }
     },
     "localname": "TermAPrincipalPaymentYear3And4",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TermLoanAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan A",
        "label": "Term Loan A [Member]",
        "terseLabel": "Term Loan A"
       }
      }
     },
     "localname": "TermLoanAMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TermLoanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan",
        "label": "Term Loan [Axis]",
        "terseLabel": "Term Loan [Axis]"
       }
      }
     },
     "localname": "TermLoanAxis",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_TermLoanBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B",
        "label": "Term Loan B [Member]",
        "terseLabel": "Term Loan B"
       }
      }
     },
     "localname": "TermLoanBMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TermLoanBPrincipalPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B Principal Payment %",
        "label": "Term Loan B Principal Payment %",
        "terseLabel": "Term Loan B Principal Payment %"
       }
      }
     },
     "localname": "TermLoanBPrincipalPayment",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TermLoanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan [Domain]",
        "label": "Term Loan [Domain]",
        "terseLabel": "Term Loan [Domain]"
       }
      }
     },
     "localname": "TermLoanDomain",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans",
        "label": "Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans",
        "terseLabel": "Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans"
       }
      }
     },
     "localname": "TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TimingAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing",
        "label": "Timing [Axis]",
        "terseLabel": "Timing [Axis]"
       }
      }
     },
     "localname": "TimingAxis",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_TimingDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing [Domain]",
        "label": "Timing [Domain]",
        "terseLabel": "Timing [Domain]"
       }
      }
     },
     "localname": "TimingDomain",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TotalSeniorSecuredCreditFacility": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TotalSeniorSecuredCreditFacility",
        "label": "TotalSeniorSecuredCreditFacility",
        "terseLabel": "TotalSeniorSecuredCreditFacility"
       }
      }
     },
     "localname": "TotalSeniorSecuredCreditFacility",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_TreasuryStockPurchasePlan": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock Purchase Plan",
        "label": "Treasury Stock Purchase Plan",
        "terseLabel": "Treasury Stock Purchase Plan"
       }
      }
     },
     "localname": "TreasuryStockPurchasePlan",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_UnfavorablecontractliabilityST": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UnfavorablecontractliabilityST",
        "label": "UnfavorablecontractliabilityST",
        "terseLabel": "UnfavorablecontractliabilityST"
       }
      }
     },
     "localname": "UnfavorablecontractliabilityST",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_VitalCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vital Care",
        "label": "Vital Care [Member]",
        "terseLabel": "Vital Care"
       }
      }
     },
     "localname": "VitalCareMember",
     "nsuri": "http://www.icumed.com/20230331",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r270",
      "r309",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r329",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r405",
      "r407",
      "r409",
      "r410",
      "r789",
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r270",
      "r309",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r329",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r405",
      "r407",
      "r409",
      "r410",
      "r789",
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityMethodInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r395",
      "r396",
      "r397",
      "r398",
      "r474",
      "r632",
      "r651",
      "r689",
      "r690",
      "r711",
      "r724",
      "r733",
      "r791",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r395",
      "r396",
      "r397",
      "r398",
      "r474",
      "r632",
      "r651",
      "r689",
      "r690",
      "r711",
      "r724",
      "r733",
      "r791",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r330",
      "r633",
      "r712",
      "r731",
      "r786",
      "r787",
      "r794",
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r330",
      "r633",
      "r712",
      "r731",
      "r786",
      "r787",
      "r794",
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r395",
      "r396",
      "r397",
      "r398",
      "r467",
      "r474",
      "r478",
      "r479",
      "r480",
      "r592",
      "r632",
      "r651",
      "r689",
      "r690",
      "r711",
      "r724",
      "r733",
      "r780",
      "r791",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails",
      "http://www.icumed.com/role/LeasesTextDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r395",
      "r396",
      "r397",
      "r398",
      "r467",
      "r474",
      "r478",
      "r479",
      "r480",
      "r592",
      "r632",
      "r651",
      "r689",
      "r690",
      "r711",
      "r724",
      "r733",
      "r780",
      "r791",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails",
      "http://www.icumed.com/role/LeasesTextDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r288",
      "r475",
      "r740",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r331",
      "r332",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r713",
      "r732",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r331",
      "r332",
      "r675",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r713",
      "r732",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r288",
      "r475",
      "r740",
      "r741",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r17",
      "r730"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r334",
      "r335"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, net of allowance for doubtful accounts"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableSale": {
     "auth_ref": [
      "r349"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease from sale of accounts receivable.",
        "label": "Accounts Receivable, Sale",
        "terseLabel": "Accounts Receivable, Sale"
       }
      }
     },
     "localname": "AccountsReceivableSale",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/TransfersandServicingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedBonusesCurrent": {
     "auth_ref": [
      "r21"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Bonuses, Current",
        "terseLabel": "Incentive compensation"
       }
      }
     },
     "localname": "AccruedBonusesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent": {
     "auth_ref": [
      "r200",
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them.",
        "label": "Accrued Employee Benefits",
        "terseLabel": "Accrued Employee Benefits"
       }
      }
     },
     "localname": "AccruedEmployeeBenefitsCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r2",
      "r195",
      "r211"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income tax liability"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r4",
      "r195",
      "r211"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "INCOME TAX LIABILITY"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities [Abstract]",
        "terseLabel": "Accrued Liabilities [Abstract]"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "auth_ref": [
      "r200",
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.",
        "label": "Accrued Professional Fees",
        "terseLabel": "Accrued Professional Fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRentCurrentAndNoncurrent": {
     "auth_ref": [
      "r2",
      "r4",
      "r196",
      "r210"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements.",
        "label": "Accrued Rent",
        "terseLabel": "Accrued Rent"
       }
      }
     },
     "localname": "AccruedRentCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r33",
      "r39",
      "r151",
      "r747",
      "r748",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r100",
      "r231"
     ],
     "calculation": {
      "http://www.icumed.com/role/PropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r32",
      "r39",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r36",
      "r38",
      "r39",
      "r238",
      "r646",
      "r656",
      "r659"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r254",
      "r255",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r35",
      "r39",
      "r151",
      "r583",
      "r652",
      "r653",
      "r747",
      "r748",
      "r749",
      "r758",
      "r759",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "AOCI Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r30",
      "r39",
      "r151",
      "r255",
      "r256",
      "r552",
      "r553",
      "r554",
      "r555",
      "r558",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r8"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r482",
      "r483",
      "r484",
      "r758",
      "r759",
      "r760",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Adjustments to Additional Paid in Capital, Other"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r122",
      "r123",
      "r476"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r239",
      "r336",
      "r348",
      "r351",
      "r353"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r44",
      "r427",
      "r560",
      "r753"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Debt Issuance Costs amortization"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r427",
      "r560",
      "r709",
      "r710",
      "r753"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of Debt Issuance Costs and Discounts"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r61",
      "r88",
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r194",
      "r209",
      "r235",
      "r267",
      "r317",
      "r322",
      "r328",
      "r344",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r406",
      "r408",
      "r410",
      "r411",
      "r517",
      "r522",
      "r542",
      "r730",
      "r789",
      "r790",
      "r810"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r227",
      "r242",
      "r267",
      "r344",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r406",
      "r408",
      "r410",
      "r411",
      "r517",
      "r522",
      "r542",
      "r730",
      "r789",
      "r790",
      "r810"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "TOTAL CURRENT ASSETS"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "CURRENT ASSETS:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r180"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets, Fair Value Disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r340",
      "r359"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "terseLabel": "Debt Securities, Available-for-sale, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss",
        "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesGrossUnrealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r73",
      "r339",
      "r359",
      "r640"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Debt Securities, Available-for-sale"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r72",
      "r359"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Current",
        "terseLabel": "Short-term investment securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r72",
      "r229",
      "r359"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-Sale, Noncurrent",
        "terseLabel": "Long-term investment securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r160",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r507",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails",
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r126",
      "r127",
      "r507",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails",
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Contingent Consideration [Line Items]",
        "terseLabel": "Business Acquisition, Contingent Consideration [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [
      "r144"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Business Acquisition, Percentage of Voting Interests Acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r795",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business Acquisition, Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Business Acquisition, Share Price"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r505",
      "r506"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Business Acquisition, Pro Forma Net Income (Loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r505",
      "r506"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Business Acquisition, Pro Forma Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r139",
      "r140",
      "r143"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business Combination, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r139",
      "r140"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "negatedTerseLabel": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r137",
      "r139",
      "r140",
      "r510"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Business Combination, Consideration Transferred, Liabilities Incurred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r512",
      "r752"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in fair value of contingent earn-out"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r138",
      "r141",
      "r511"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Business Combination, Contingent Consideration, Liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Measurement Input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r138",
      "r142"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Contingent Earn-Out Liability, Noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r146",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combination Disclosure"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity.",
        "label": "Business Combination, Liabilities Arising from Contingencies, Amount Recognized",
        "negatedTerseLabel": "Business Combination, Liabilities Arising from Contingencies, Amount Recognized"
       }
      }
     },
     "localname": "BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r128",
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r128",
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r128",
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r128",
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r64",
      "r65",
      "r66"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Capital Expenditures Incurred but Not yet Paid"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r746"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-Term Investments",
        "totalLabel": "TOTAL CASH, CASH EQUIVALENTS AND INVESTMENT SECURITIES"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r58",
      "r63",
      "r67"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]",
        "terseLabel": "Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r58",
      "r187"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect [Abstract]",
        "terseLabel": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "Cash Flow, Supplemental Disclosures [Text Block]"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r513",
      "r514",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Collaborative Arrangement Disclosure [Text Block]"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r26",
      "r201",
      "r217"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r106",
      "r393",
      "r394",
      "r676",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies [Text Block]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r758",
      "r759",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r7",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common stock, shares outstanding",
        "periodStartLabel": "Common stock, shares outstanding",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r7",
      "r730"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.10 par value - Authorized-80,000 shares; Issued 23,899 shares at June 30,2022 and 21,280 shares at December 31, 2021 and outstanding 23,898 shares at June 30, 2022 and 21,280 shares at December 31, 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r40",
      "r251",
      "r253",
      "r260",
      "r642",
      "r648"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r99"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction in Progress, Gross"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract with Customer, Asset and Liability [Table Text Block]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r448",
      "r449",
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "negatedPeriodEndLabel": "Contract with Customer, Liability",
        "negatedPeriodStartLabel": "Contract with Customer, Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r448",
      "r449",
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Contract with Customer, Liability, Noncurrent"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue": {
     "auth_ref": [
      "r6",
      "r113"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding nonredeemable convertible preferred stock or outstanding convertible preferred stock that is redeemable solely at the option of the issuer.",
        "label": "Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value",
        "verboseLabel": "Convertible preferred stock, $1.00 par value Authorized-500 shares; Issued and outstanding - none"
       }
      }
     },
     "localname": "ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate Bond Securities"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r719",
      "r721",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Debt Securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r46",
      "r267",
      "r344",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r406",
      "r408",
      "r410",
      "r411",
      "r542",
      "r789"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerContractsMember": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's established relationships with its customers through contracts.",
        "label": "Customer Contracts [Member]",
        "terseLabel": "Customer Contracts [Member]"
       }
      }
     },
     "localname": "CustomerContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.",
        "label": "Customer-Related Intangible Assets [Member]",
        "terseLabel": "Customer-Related Intangible Assets [Member]"
       }
      }
     },
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r236"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "terseLabel": "Debt, Current"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r3",
      "r197",
      "r208",
      "r429"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Long-term Debt, Gross"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r23",
      "r189",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Debt Instrument, Interest Rate During Period"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r243",
      "r706",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Debt Instrument, Maturity Date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Debt Instrument, Periodic Payment, Principal"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r24",
      "r113",
      "r114",
      "r115",
      "r116",
      "r188",
      "r189",
      "r191",
      "r207",
      "r270",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r561",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r190",
      "r418",
      "r430",
      "r707",
      "r708"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "terseLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-Term and Short-Term, Combined Amount",
        "terseLabel": "Debt, Long-term and Short-term, Combined Amount"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent": {
     "auth_ref": [
      "r359",
      "r763"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Current",
        "terseLabel": "Debt Securities, Available-for-sale, Amortized Cost, Current"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent": {
     "auth_ref": [
      "r359",
      "r763"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Noncurrent",
        "terseLabel": "Debt Securities, Available-for-sale, Noncurrent"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsAndOtherAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred cost assets and assets classified as other.",
        "label": "Deferred Costs and Other Assets",
        "terseLabel": "Deferred Costs and Other Assets"
       }
      }
     },
     "localname": "DeferredCostsAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Table Text Block]"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r190"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt Issuance Costs, Gross"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r190"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "terseLabel": "Debt Issuance Costs, Noncurrent, Net"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r485",
      "r486"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred Income Tax Assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r485",
      "r486"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "DEFERRED INCOME TAXES"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueAdditions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.",
        "label": "Deferred Revenue, Additions",
        "negatedTerseLabel": "Deferred Revenue, Additions"
       }
      }
     },
     "localname": "DeferredRevenueAdditions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositAssets": {
     "auth_ref": [
      "r743"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.",
        "label": "Deposit Assets",
        "terseLabel": "Deposit Assets"
       }
      }
     },
     "localname": "DepositAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r61",
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r61",
      "r312"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes derivative asset classified as current.",
        "label": "Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes derivative asset classified as noncurrent.",
        "label": "Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r797",
      "r798",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Derivative Asset, Notional Amount"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r244",
      "r245",
      "r541",
      "r696"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative Asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsCurrent": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Current",
        "terseLabel": "Derivative Asset, Current"
       }
      }
     },
     "localname": "DerivativeAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsNoncurrent": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Noncurrent",
        "terseLabel": "Derivative Asset, Noncurrent"
       }
      }
     },
     "localname": "DerivativeAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Derivative, Fixed Interest Rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeForwardExchangeRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual rate at which a foreign currency can be purchased or sold.",
        "label": "Derivative, Forward Exchange Rate",
        "terseLabel": "Derivative, Forward Exchange Rate"
       }
      }
     },
     "localname": "DerivativeForwardExchangeRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from effective portion of derivative instrument reclassified from accumulated other comprehensive income (AOCI) into income.",
        "label": "Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r161",
      "r162",
      "r168",
      "r170",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r179",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Text Block]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r158",
      "r161",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r158",
      "r161",
      "r168",
      "r170",
      "r174",
      "r176",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r166",
      "r169"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion": {
     "auth_ref": [
      "r166"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of gain reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion",
        "terseLabel": "Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion": {
     "auth_ref": [
      "r166"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of loss reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion",
        "negatedTerseLabel": "Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion"
       }
      }
     },
     "localname": "DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r244",
      "r245",
      "r541",
      "r696"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative Liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Current",
        "terseLabel": "Derivative Liability, Current"
       }
      }
     },
     "localname": "DerivativeLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Noncurrent",
        "terseLabel": "Derivative Liability, Noncurrent"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes derivative liability classified as current.",
        "label": "Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes derivative liability classified as noncurrent.",
        "label": "Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails",
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNetHedgeIneffectivenessGainLoss": {
     "auth_ref": [
      "r167",
      "r175"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from the ineffectiveness of the hedge.",
        "label": "Derivative, Net Hedge Ineffectiveness Gain (Loss)",
        "terseLabel": "Derivative, Net Hedge Ineffectiveness Gain (Loss)"
       }
      }
     },
     "localname": "DerivativeNetHedgeIneffectivenessGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r798",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r158",
      "r159",
      "r164",
      "r168",
      "r172",
      "r173",
      "r176",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails",
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed Technology Rights [Member]"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RevenueDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r460",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RevenueDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA [Member]"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "NET INCOME PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r261",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r291",
      "r293",
      "r298",
      "r299",
      "r300",
      "r304",
      "r531",
      "r532",
      "r643",
      "r649",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "EPS - basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/NetIncomePerShareDetails",
      "http://www.icumed.com/role/NetIncomePerShareDetails1"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r261",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r293",
      "r298",
      "r299",
      "r300",
      "r304",
      "r531",
      "r532",
      "r643",
      "r649",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted (In dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/NetIncomePerShareDetails",
      "http://www.icumed.com/role/NetIncomePerShareDetails1"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r301",
      "r302",
      "r303",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income Per Share [Text Block]"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r549"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]",
        "terseLabel": "Effect of Exchange Rate on Cash [Abstract]"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective Income Tax Rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r268",
      "r488",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Share-based Payment Arrangement, Expense, Tax Benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Severance [Member]"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r112",
      "r222",
      "r254",
      "r255",
      "r256",
      "r271",
      "r272",
      "r273",
      "r277",
      "r285",
      "r287",
      "r306",
      "r345",
      "r447",
      "r482",
      "r483",
      "r484",
      "r492",
      "r493",
      "r530",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r558",
      "r583",
      "r652",
      "r653",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement",
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "auth_ref": [
      "r16"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Aggregate Cost",
        "terseLabel": "Equity Method Investment, Aggregate Cost"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityMethodInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r226",
      "r267",
      "r344",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r226",
      "r267",
      "r344",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityMethodInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity Method Investment, Ownership Percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityMethodInvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r81",
      "r318",
      "r742"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityMethodInvestmentsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity Method Investments [Table Text Block]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity Securities without Readily Determinable Fair Value [Line Items]",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value [Line Items]"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable": {
     "auth_ref": [
      "r764",
      "r765",
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value [Table]",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value [Table]"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FacilityClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Facility Closing [Member]",
        "terseLabel": "Facility Closing [Member]"
       }
      }
     },
     "localname": "FacilityClosingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r180",
      "r185",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r180",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r420",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r536",
      "r588",
      "r589",
      "r590",
      "r707",
      "r708",
      "r719",
      "r720",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r183",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Disclosures"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r420",
      "r468",
      "r473",
      "r536",
      "r588",
      "r719",
      "r720",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r420",
      "r468",
      "r473",
      "r536",
      "r589",
      "r707",
      "r708",
      "r719",
      "r720",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r420",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r536",
      "r590",
      "r707",
      "r708",
      "r719",
      "r720",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3) and still held.",
        "label": "Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)",
        "negatedTerseLabel": "Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r182",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r182",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r182"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "terseLabel": "CONTINGENT EARN-OUT LIABILITY"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r420",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r588",
      "r589",
      "r590",
      "r707",
      "r708",
      "r719",
      "r720",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r64",
      "r65",
      "r66"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair Value of Assets Acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r160",
      "r164",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r566",
      "r571",
      "r729"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Finance Lease, Interest Expense"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r568",
      "r574"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Finance Lease, Interest Payment on Liability"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r565",
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance Lease, Liability"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails",
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance Lease, Liability, Current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "terseLabel": "Finance Lease, Liability, Payment, Due"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Finance Lease, Liability, Payments, Due after Year Five"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "Finance Lease, Liability, Payments, Due Next Twelve Months"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year Five"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year Four"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year Three"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year Two"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r808"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Finance Lease, Liability, Payments, Remainder of Fiscal Year"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Finance Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r567",
      "r574"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Finance Lease, Principal Payments"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r564"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r566",
      "r571",
      "r729"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r577",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r576",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r341",
      "r342",
      "r350",
      "r354",
      "r355",
      "r356",
      "r357",
      "r360",
      "r361",
      "r362",
      "r428",
      "r445",
      "r527",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r592",
      "r593",
      "r594",
      "r598",
      "r599",
      "r600",
      "r601",
      "r605",
      "r608",
      "r613",
      "r614",
      "r615",
      "r616",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r628",
      "r629",
      "r630",
      "r702",
      "r764",
      "r765",
      "r766",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Financial Liabilities Fair Value Disclosure"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableRevolving": {
     "auth_ref": [
      "r358",
      "r701"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of financing receivable that can be withdrawn, repaid, and redrawn.",
        "label": "Financing Receivable, Revolving",
        "terseLabel": "Financing Receivable, Revolving"
       }
      }
     },
     "localname": "FinancingReceivableRevolving",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/TransfersandServicingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-Lived Intangible Asset, Useful Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r233",
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, after Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Four"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Two"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r374",
      "r375",
      "r376",
      "r377",
      "r634",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r93",
      "r638"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-Lived Intangible Assets, Gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r89",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r93",
      "r634"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-Lived Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": {
     "auth_ref": [
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months",
        "terseLabel": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign Currency Contract, Asset, Fair Value Disclosure"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Foreign Currency Contracts, Liability, Fair Value Disclosure"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r696",
      "r719",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeMember": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading of derivative or nonderivative instruments whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange [Member]",
        "terseLabel": "Foreign Exchange"
       }
      }
     },
     "localname": "ForeignExchangeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r99"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and Fixtures, Gross"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfAccountsReceivable": {
     "auth_ref": [
      "r604"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale of accounts receivable.",
        "label": "Gain (Loss) on Sale of Accounts Receivable",
        "terseLabel": "Gain (Loss) on Sale of Accounts Receivable"
       }
      }
     },
     "localname": "GainLossOnSaleOfAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/TransfersandServicingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfInvestments": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
        "label": "Gain (Loss) on Sale of Investments",
        "terseLabel": "Gain (Loss) on Sale of Investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss on disposal of property and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring": {
     "auth_ref": [
      "r178"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of gain reclassified into earnings in the period when cash flow hedge is discontinued because it is probable that the original forecasted transactions will not occur by the end of the original period or an additional two month time period.",
        "label": "Gain on Discontinuation of Cash Flow Hedge Due to Forecasted Transaction Probable of Not Occurring",
        "terseLabel": "Gain on Discontinuation of Cash Flow Hedge Due to Forecasted Transaction Probable of Not Occurring"
       }
      }
     },
     "localname": "GainOnDiscontinuationOfCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r232",
      "r364",
      "r639",
      "r704",
      "r730",
      "r769",
      "r776"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "GOODWILL"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r370"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Goodwill, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "auth_ref": [
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Period Increase (Decrease)",
        "terseLabel": "Goodwill, Period Increase (Decrease)"
       }
      }
     },
     "localname": "GoodwillPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r45",
      "r267",
      "r317",
      "r321",
      "r327",
      "r329",
      "r344",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r406",
      "r408",
      "r410",
      "r411",
      "r542",
      "r700",
      "r789"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross Profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r158",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r42",
      "r193",
      "r202",
      "r220",
      "r317",
      "r321",
      "r327",
      "r329",
      "r644",
      "r700"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "(Loss) Income from Continuing Operations before Income Taxes, Noncontrolling Interest"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r378",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r268",
      "r489",
      "r490",
      "r491",
      "r497",
      "r500",
      "r502",
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax Disclosure [Text Block]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r269",
      "r286",
      "r287",
      "r315",
      "r487",
      "r498",
      "r501",
      "r650"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "BENEFIT (PROVISION) FOR INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r697"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "negatedTerseLabel": "Increase (Decrease) in Deferred Revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Increase (Decrease) in Other Operating Assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r294",
      "r295",
      "r296",
      "r300",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive securities"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails",
      "http://www.icumed.com/role/NetIncomePerShareDetails1"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r232"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Intangible Assets, Gross (Excluding Goodwill)"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r87",
      "r91"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "INTANGIBLE ASSETS, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r190",
      "r204",
      "r257",
      "r311",
      "r559"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r49",
      "r425",
      "r432",
      "r709",
      "r710"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest Expense, Debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r50",
      "r426",
      "r709",
      "r710"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Interest Expense, Debt, Excluding Amortization"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r200",
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.",
        "label": "Interest Payable",
        "terseLabel": "Interest Payable"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateDerivativeAssetsAtFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of interest rate derivative assets, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as assets.",
        "label": "Interest Rate Derivative Assets, at Fair Value",
        "terseLabel": "Interest Rate Derivative Assets, at Fair Value"
       }
      }
     },
     "localname": "InterestRateDerivativeAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories [Text Block]"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r85",
      "r693"
     ],
     "calculation": {
      "http://www.icumed.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Inventory, Finished Goods, Net of Reserves"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r240",
      "r691",
      "r730"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.icumed.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r85",
      "r695"
     ],
     "calculation": {
      "http://www.icumed.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Inventory, Raw Materials, Net of Reserves"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r85",
      "r694"
     ],
     "calculation": {
      "http://www.icumed.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Inventory, Work in Process, Net of Reserves"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeAmortizationOfPremium": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization of purchase premium on nonoperating securities.",
        "label": "Investment Income, Amortization of Premium",
        "terseLabel": "Bond premium amortization"
       }
      }
     },
     "localname": "InvestmentIncomeAmortizationOfPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LandBuildingsAndImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate held and additions or improvements to real estate held and structures used in the conduct of business.",
        "label": "Land, Buildings and Improvements [Member]",
        "terseLabel": "Land, Buildings and Improvements [Member]"
       }
      }
     },
     "localname": "LandBuildingsAndImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r578",
      "r729"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost [Table Text Block]"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due after Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Four"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Three"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Two"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r808"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Lessee, Operating Leases [Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceived": {
     "auth_ref": [
      "r581"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payments to be received by lessor for operating lease.",
        "label": "Lessor, Operating Lease, Payments to be Received",
        "terseLabel": "Lessor, Operating Lease, Payments to be Received"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r12",
      "r199",
      "r215",
      "r730",
      "r755",
      "r767",
      "r803"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r64",
      "r65",
      "r66"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "negatedTerseLabel": "Liabilities Assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r22",
      "r228",
      "r267",
      "r344",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r406",
      "r408",
      "r410",
      "r411",
      "r518",
      "r522",
      "r523",
      "r542",
      "r730",
      "r789",
      "r810",
      "r811"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "TOTAL CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "CURRENT LIABILITIES:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.",
        "label": "Liabilities, Other than Long-Term Debt, Noncurrent",
        "terseLabel": "OTHER LONG-TERM LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesOtherThanLongtermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesTotalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of total liabilities, when it serves as a benchmark in a concentration of risk calculation. Sum of all reported liabilities as of the balance sheet date.",
        "label": "Liabilities, Total [Member]",
        "terseLabel": "Liabilities, Total [Member]"
       }
      }
     },
     "localname": "LiabilitiesTotalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liability [Member]",
        "terseLabel": "Liability"
       }
      }
     },
     "localname": "LiabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": {
     "auth_ref": [
      "r19"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Commitment Fee Amount",
        "terseLabel": "Line of Credit Facility, Commitment Fee Amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Line of Credit Facility, Commitment Fee Percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationDate1": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.",
        "label": "Line of Credit Facility, Expiration Date",
        "terseLabel": "Line of Credit Facility, Expiration Date"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r541"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Line of Credit Facility, Fair Value of Amount Outstanding"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r19"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r3",
      "r197",
      "r212",
      "r419",
      "r431",
      "r707",
      "r708"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Long-term Debt, Current Maturities"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r109",
      "r270",
      "r792"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Long-Term Debt, Maturity, after Year Five"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r109",
      "r270",
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "Long-Term Debt, Maturity, Year One"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r109",
      "r270",
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "Long-Term Debt, Maturity, Year Five"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r109",
      "r270",
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "Long-Term Debt, Maturity, Year Four"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r109",
      "r270",
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "Long-Term Debt, Maturity, Year Three"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r109",
      "r270",
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "Long-Term Debt, Maturity, Year Two"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r757"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "Long-Term Debt, Maturity, Remainder of Fiscal Year"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r237"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term Debt, Excluding Current Maturities"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-Term Debt [Text Block]",
        "terseLabel": "Long-term Debt [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r24",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r99"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Machinery and Equipment, Gross"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Measurement Input, Price Volatility"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Measurement Input, Risk Free Interest Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInDeferredRevenueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Deferred Revenue [Roll Forward]",
        "terseLabel": "Movement in Deferred Revenue [Roll Forward]"
       }
      }
     },
     "localname": "MovementInDeferredRevenueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r265"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r265"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r58",
      "r59",
      "r62"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r43",
      "r62",
      "r203",
      "r219",
      "r226",
      "r249",
      "r252",
      "r256",
      "r267",
      "r276",
      "r280",
      "r281",
      "r282",
      "r283",
      "r286",
      "r287",
      "r297",
      "r317",
      "r321",
      "r327",
      "r329",
      "r344",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r406",
      "r408",
      "r410",
      "r411",
      "r532",
      "r542",
      "r700",
      "r789"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net Income Attributable to Parent"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r224",
      "r274",
      "r275",
      "r278",
      "r279",
      "r288",
      "r289",
      "r290",
      "r337",
      "r338",
      "r346",
      "r347",
      "r494",
      "r495",
      "r496",
      "r529",
      "r533",
      "r534",
      "r535",
      "r543",
      "r544",
      "r545",
      "r562",
      "r563",
      "r582",
      "r584",
      "r635",
      "r636",
      "r637",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Text Block]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "NON-CASH INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Noncompete Agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonfinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of obligations not classified as financial liabilities. Includes, but is not limited to, accounts payable and accrued liabilities, commitments, obligations, and other liabilities.",
        "label": "Nonfinancial Liabilities Fair Value Disclosure",
        "terseLabel": "Nonfinancial Liabilities Fair Value Disclosure"
       }
      }
     },
     "localname": "NonfinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "OTHER (EXPENSE) INCOME, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "TOTAL OPERATING EXPENSES"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "OPERATING EXPENSES:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r317",
      "r321",
      "r327",
      "r329",
      "r700"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "(LOSS) INCOME FROM OPERATIONS"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r572",
      "r729"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating Lease, Liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails",
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r569",
      "r574"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r753"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Noncash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r577",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r576",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Basis of Presentation [Text Block]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r21"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r25"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other Accrued Liabilities, Noncurrent"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r241",
      "r730"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other Assets, Current"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "terseLabel": "Other Assets, Miscellaneous, Noncurrent"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r234"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "OTHER ASSETS"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r34",
      "r36",
      "r149",
      "r150"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r31",
      "r36",
      "r546",
      "r547",
      "r550"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Other Comprehensive (Loss) Income, Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Axis]",
        "terseLabel": "Other Comprehensive Income Location [Axis]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Domain]",
        "terseLabel": "Other Comprehensive Income Location [Domain]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r39",
      "r41",
      "r255",
      "r551",
      "r553",
      "r558",
      "r747"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r82",
      "r259",
      "r551",
      "r556",
      "r558",
      "r641",
      "r647",
      "r747",
      "r748"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r246",
      "r247"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r248"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment, net of taxes of $0 for all periods"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r29",
      "r37",
      "r548",
      "r557"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r41",
      "r112",
      "r250",
      "r253",
      "r259",
      "r551",
      "r556",
      "r558",
      "r641",
      "r647",
      "r747",
      "r748"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other Comprehensive income (loss), net of Tax",
        "totalLabel": "Other comprehensive income (loss), net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement",
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "verboseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r34",
      "r36"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Other Comprehensive Income (Loss), Other Adjustments, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r34",
      "r37",
      "r149"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other Noncash Income (Expense)"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r745",
      "r768"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Other Prepaid Expense, Current"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r382",
      "r751"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "terseLabel": "Payments for Restructuring"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payments of Debt Issuance Costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r263"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "terseLabel": "Payment, Tax Withholding, Share-based Payment Arrangement"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r53",
      "r509"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to Acquire Businesses, Gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Intangible assets additions"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Purchases of investment securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r2",
      "r464",
      "r465",
      "r466",
      "r721"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "terseLabel": "Liability, Defined Benefit Plan, Current"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r6",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Convertible preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Convertible preferred stock, authorized shares"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r6",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Convertible preferred stock, issued shares"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Convertible preferred stock, outstanding shares"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets [Abstract]"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r746"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Member]"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r692",
      "r703",
      "r768"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r750"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from Issuance of Debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndCollectionOfReceivables": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the proceeds from sale and collection of receivables during the period.",
        "label": "Proceeds from Sale and Collection of Receivables",
        "terseLabel": "Proceeds from Sale and Collection of Receivables"
       }
      }
     },
     "localname": "ProceedsFromSaleAndCollectionOfReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/TransfersandServicingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sale of investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of asset"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r55",
      "r121"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductLiabilityAccrualComponentAmount": {
     "auth_ref": [
      "r705"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recorded amount of the accrual for a material component of a product liability contingency.",
        "label": "Product Liability Accrual, Component Amount",
        "terseLabel": "Product Liability Accrual, Component Amount"
       }
      }
     },
     "localname": "ProductLiabilityAccrualComponentAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductLiabilityContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Liability Contingency [Line Items]",
        "terseLabel": "Product Liability Contingency [Line Items]"
       }
      }
     },
     "localname": "ProductLiabilityContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductLiabilityContingencyTable": {
     "auth_ref": [
      "r397",
      "r784",
      "r785",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from product liability related to an individual product.",
        "label": "Product Liability Contingency [Table]",
        "terseLabel": "Product Liability Contingency [Table]"
       }
      }
     },
     "localname": "ProductLiabilityContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductWarrantyAccrualClassifiedCurrent": {
     "auth_ref": [
      "r21",
      "r107",
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Product Warranty Accrual, Current",
        "terseLabel": "Warranties and returns"
       }
      }
     },
     "localname": "ProductWarrantyAccrualClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r226",
      "r249",
      "r252",
      "r264",
      "r267",
      "r276",
      "r286",
      "r287",
      "r317",
      "r321",
      "r327",
      "r329",
      "r344",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r406",
      "r408",
      "r410",
      "r411",
      "r516",
      "r519",
      "r520",
      "r532",
      "r542",
      "r644",
      "r700",
      "r725",
      "r726",
      "r749",
      "r789"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net (Loss) Income",
        "totalLabel": "NET (LOSS) INCOME"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r102",
      "r677",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment [Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r99",
      "r230"
     ],
     "calculation": {
      "http://www.icumed.com/role/PropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total property and equipment, cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r101",
      "r216",
      "r645",
      "r730"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.icumed.com/role/PropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "PROPERTY AND EQUIPMENT, net",
        "totalLabel": "Net property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment [Table Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r262",
      "r352"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted": {
     "auth_ref": [
      "r5",
      "r198",
      "r213"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.",
        "label": "Purchase Commitment, Remaining Minimum Amount Committed",
        "terseLabel": "Purchase Commitment, Remaining Minimum Amount Committed"
       }
      }
     },
     "localname": "PurchaseCommitmentRemainingMinimumAmountCommitted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r39",
      "r41",
      "r255",
      "r551",
      "r555",
      "r558",
      "r747"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionDueFromToRelatedParty": {
     "auth_ref": [
      "r401",
      "r402",
      "r403",
      "r409",
      "r410",
      "r411",
      "r756",
      "r809"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.",
        "label": "Related Party Transaction, Due from (to) Related Party",
        "terseLabel": "Related Party Transaction, Due from (to) Related Party"
       }
      }
     },
     "localname": "RelatedPartyTransactionDueFromToRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Purchases from Related Party",
        "terseLabel": "Related Party Transaction, Purchases from Related Party"
       }
      }
     },
     "localname": "RelatedPartyTransactionPurchasesFromRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "terseLabel": "Repayments of Long-term Debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r124",
      "r221",
      "r819"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r380",
      "r382",
      "r385",
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Related Activities Disclosure"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r61",
      "r386",
      "r388",
      "r781"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r381",
      "r382",
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "terseLabel": "Restructuring Costs"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r382",
      "r387"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Restructuring Reserve",
        "periodStartLabel": "Restructuring Reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "auth_ref": [
      "r382",
      "r389"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "negatedTerseLabel": "Restructuring Reserve, Accrual Adjustment"
       }
      }
     },
     "localname": "RestructuringReserveAccrualAdjustment1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r744",
      "r782",
      "r783"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Restructuring accrual"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAdjustment": {
     "auth_ref": [
      "r782",
      "r783"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.",
        "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r9",
      "r117",
      "r214",
      "r655",
      "r659",
      "r730"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r222",
      "r271",
      "r272",
      "r273",
      "r277",
      "r285",
      "r287",
      "r345",
      "r482",
      "r483",
      "r484",
      "r492",
      "r493",
      "r530",
      "r652",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r308",
      "r309",
      "r320",
      "r325",
      "r326",
      "r330",
      "r331",
      "r333",
      "r459",
      "r460",
      "r633"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue from Contract with Customer, Excluding Assessed Tax"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r457",
      "r458",
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RevenueNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r456"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "negatedTerseLabel": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, Remaining Performance Obligation, Amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r258",
      "r267",
      "r308",
      "r309",
      "r320",
      "r325",
      "r326",
      "r330",
      "r331",
      "r333",
      "r344",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r406",
      "r408",
      "r410",
      "r411",
      "r542",
      "r644",
      "r789"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "REVENUES:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r575",
      "r729"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r575",
      "r729"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r200",
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.",
        "label": "Sales and Excise Tax Payable",
        "terseLabel": "Sales taxes"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r39",
      "r804",
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r205",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-Sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r126",
      "r127",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r24",
      "r113",
      "r114",
      "r115",
      "r116",
      "r188",
      "r189",
      "r191",
      "r207",
      "r707",
      "r709",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r89",
      "r92",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r704",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r1",
      "r13",
      "r14",
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory, Current [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Schedule of Other Assets, Noncurrent[TableTextBlock]"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r381",
      "r382",
      "r383",
      "r384",
      "r388",
      "r389",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r103",
      "r104",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r333",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r384",
      "r390",
      "r704",
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedLabel": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "terseLabel": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement",
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r573",
      "r729"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-Term Lease, Cost",
        "terseLabel": "Short-term Lease, Cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Software and Software Development Costs"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "Software Development"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r225",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r333",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r379",
      "r384",
      "r390",
      "r704",
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r28",
      "r112",
      "r222",
      "r254",
      "r255",
      "r256",
      "r271",
      "r272",
      "r273",
      "r277",
      "r285",
      "r287",
      "r306",
      "r345",
      "r447",
      "r482",
      "r483",
      "r484",
      "r492",
      "r493",
      "r530",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r558",
      "r583",
      "r652",
      "r653",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement",
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r271",
      "r272",
      "r273",
      "r306",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r6",
      "r7",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Stock Issued During Period, Shares, Acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r6",
      "r7",
      "r112",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r28",
      "r112",
      "r117"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Stock Issued During Period, Value, Acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r6",
      "r7",
      "r112",
      "r117"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Stock Issued During Period, Value, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock Repurchase Program, Remaining Authorized Repurchase Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r7",
      "r10",
      "r11",
      "r70",
      "r730",
      "r755",
      "r767",
      "r803"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Stockholders' Equity Attributable to Parent",
        "periodStartLabel": "Stockholders' Equity Attributable to Parent"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r147",
      "r148",
      "r152",
      "r222",
      "r223",
      "r255",
      "r271",
      "r272",
      "r273",
      "r277",
      "r285",
      "r345",
      "r447",
      "r482",
      "r483",
      "r484",
      "r492",
      "r493",
      "r530",
      "r551",
      "r552",
      "r558",
      "r583",
      "r653",
      "r654",
      "r755",
      "r767",
      "r803"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "TOTAL STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "STOCKHOLDERS' EQUITY:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r120",
      "r266",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r446",
      "r447",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity Note Disclosure"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/Equity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names [Member]"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and Trade Names"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks [Member]"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingRevenueMember": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which reported facts about trading revenue have been included.",
        "label": "Trading Revenue [Member]",
        "terseLabel": "Trading Revenue"
       }
      }
     },
     "localname": "TradingRevenueMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount": {
     "auth_ref": [
      "r192"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before counterparty netting, of cash proceeds received in transfers of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.",
        "label": "Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount",
        "terseLabel": "Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/TransfersandServicingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transfers and Servicing [Abstract]"
       }
      }
     },
     "localname": "TransfersAndServicingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialAssetsTextBlock": {
     "auth_ref": [
      "r585",
      "r586",
      "r591",
      "r595",
      "r596",
      "r597",
      "r602",
      "r603",
      "r606",
      "r607",
      "r609",
      "r610",
      "r611",
      "r612",
      "r617",
      "r618",
      "r625",
      "r627",
      "r631",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a transferor's continuing involvement in financial assets that it has transferred in a securitization or asset-backed financing arrangement, the nature of any restrictions on assets reported by an entity in its statement of financial position that relate to a transferred financial asset (including the carrying amounts of such assets), how servicing assets and servicing liabilities are reported, and (for securitization or asset-backed financing arrangements accounted for as sales) when a transferor has continuing involvement with the transferred financial assets and transfers of financial assets accounted for as secured borrowings, how the transfer of financial assets affects an entity's financial position, financial performance, and cash flows.",
        "label": "Transfers and Servicing of Financial Assets [Text Block]",
        "terseLabel": "Transfers and Servicing of Financial Assets"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/TransfersandServicing"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r341",
      "r342",
      "r428",
      "r445",
      "r527",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r592",
      "r593",
      "r594",
      "r598",
      "r599",
      "r600",
      "r601",
      "r605",
      "r608",
      "r613",
      "r614",
      "r615",
      "r616",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r628",
      "r629",
      "r630",
      "r764",
      "r765",
      "r766",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r27",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r27",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r27",
      "r118",
      "r119"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury Stock, at cost (12,684 and 119 shares, respectively)"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r381",
      "r382",
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by the United States government.",
        "label": "US Government Debt Securities [Member]",
        "terseLabel": "US Government Debt Securities"
       }
      }
     },
     "localname": "USGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r698",
      "r719",
      "r721",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "US Treasury Securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r292",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/NetIncomePerShareDetails",
      "http://www.icumed.com/role/NetIncomePerShareDetails1"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "WEIGHTED AVERAGE NUMBER OF SHARES"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r291",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding (for basic calculation)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907644&loc=d3e11281-110244",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12524-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "c",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(17))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919232-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "https://asc.fasb.org/topic&trid=5833765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(cc)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107425-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122596-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(d)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122596-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(d)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "860",
   "URI": "https://asc.fasb.org/topic&trid=2197590",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "https://asc.fasb.org/topic&trid=2134446",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "79",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922352-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r734": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r735": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r736": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r737": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r738": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r739": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122596-111746",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r823": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r824": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r825": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r826": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r827": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r828": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r829": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>118
<FILENAME>0000883984-23-000022-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000883984-23-000022-xbrl.zip
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ML.ZH/UIB-,!GV$<6G25L.!HF9\EPF;#^&?_4ZQ'*@/S;(.LJB<\[F5!>BC6
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MT<GA_M%^OWNY#?MOGA]W>J_/^7[7W_F5[V6&^[W117?PZV!GB^]S^?)R?^-
M="_S8.?-\T%WL*T[1X<G>V]>GG=[FQ=[TE^\Z&U..Z_$.?][WCG:-IV7O^FD
MI#0*&^^S:R!*]M)9B"8K%8ALL,KBHQ\%__%>!P\_//D(UOM'>9<.^I-J[=,N
M'UF!_#60+V\!F?%-X"DV&DEP*/:J\>BI,4XE&SC><DQ^]./VL]=KG<V-[6?K
M+]:VN\^>;&P^(-CKK$]RU2C/3_#@T=J59^?+GD^?EOXYY:;@R60%_U?A%[?
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M::"91Q_GW<&4M0P%J[:4!L#E:+*2F#-*8T,)9FE@>K@^SKL#QTLEG1)1JJ
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M?!*+B];\EX[?'0I::!5!A!"$AAR2QT0RI 0N>X4V+3<*JZ!W"R6RU@!1$5%
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M=UCFB( 9<F$'*X+V'"N5)DXB+*2LU%*CO!!.=_X<<)'J/MJNZ-I9A@F),)9
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MB$<DP*_6I:_)<C9F.0+KHY?/$-P55L>WC*'[]SEX#UGV+^NQ/X#+NA'^.!K
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M&8QVY]+;,_9'K]_S8 RZ'O;1MXJ7]E1G9.$TOWJ!52<JGC8#E:72>,/,]/0
MWNWU1YDG1P/HSB /#R?ND;8B5EL,O7/CP?W*C/>P#NQD>0-[?!0\V]YL+LZ,
M&A9'Y]I+I.FD)H'/;ENKO2096;.YZ;7:9F#R1^35:_-+;,7:_!)/P'^VW\3.
M5"XFG4),;FZKN"OP!^\\A2'KN?N[1O3L5?:4 FB.'0<2;N=S8"8CX-MJ:+_%
M,:453T 3X)':Z(IK^O6MN#KCUNJ%:HO>L9EX!IM^!HQ85UP"=D!3T^32/J3K
MR4O/CO&Q=][/8-P'(]6V-V[8'<(J/8.>53:\#3=R/]W'?%3=I\$P[187I*"V
M/6T_G75$S_Y]GG8Z]F\%\IGV1B;_/.JXBZ =\)>;DTMOD(+0"S=?F7'2-+B9
MT<GI$&D71.6X+XJM2?95 S=YWOUSXF9."EL\K9_/2'J3P.S!$(+ #4$%Q$\!
MK0 +9 NNC?(7B,%@U#W+!6@L=,50N,<"A@[Z/7M3!435_:S[7J\_]/+Q<*^;
M: H\6=J[;#_AB[%HNA\*.<MR_7"]NBQ4$)YN!<H.00?&*K^O,C4^[Y^&4K?J
M]UF8^C")6PA'+P9<3IN":]ZW_"9\N#4VF&UR.Q8WP.$=9_WS8?O#^)_]'-%
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MCI@? ZP*'B'B^SR)P(_34MBC.R(PCQ]6R'DKXS"K29&>HMNE#C].A^]2(R!
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M$QBGJ\85].?DE#:_5VF=_ WM_ AFL_Z# IV)8VJ0(+Z/6"@XDHD$JNM'&D1
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MD889-I.6N"@A;'X0-N/P1J4!HV28H%A+'S%+1R0) I103K46?A(F9F,KP)7
M7Q$WJ0QAK$P(H]3P%=3PNR1%8JR%W5>E)? 3AOT R2@)4(QU&/ X$0GA;G-?
M'$[G@*Q]( 233;+B_*35;&U_\29K&O^?HIKQ<T(BLI]IDZ%A_^R]'8M!OY-J
M;]R7]0.T%XB7N%!LN]^!81Q4_SM*AY> 79V1';BO_<RV8GLXS%(Y&MH2&:V^
M/?4%VI'U.]#\XQJT*#.#T@6;([K-."0R9&$4L2!&TJ;1,\8B)&+&$!72,!5B
M;MS6T0I(T3P2<1^K7&L4<GF[@#&O>$P)&"L(&'?ID ]3:TB4(,8#:O^P!:M-
M!%Y/K$/!>4 BNRA4\:.X$I-Y9<4N'##>P*D/.4\:GU!ICY&R!TL]A#?];A"*
MV<D[]Y["%.C^R!;$'_?I>=BX:@/Y[Q<<G]=B,^9%,B?.(-[NZ6D+4EJ#^5F#
M&4>!2A''?F@DXBH.$".8HM@7X!QK2RM](H%1;FRQ"@O]2D#)G/9QS4^?7CB(
M5@)K":PK2L9+8%TJL$[G7H'CC2E'BB0":+:?("#7#"6!H8R'./9-:(&58UX)
MV+QVM[\\L#H>_J=S\,;YSA-;4;HB.TY[$^V;MSIB_W?Z2*P^_GC2_VZG<;L_
MEHLEKNWO\!^%<(#()/W^L&?/DEU'+;U=;X4<G<"S\=%NH]T$C6SL?H*G_7U:
M;YW">_YN-[I[\/O!U=%GFZ6OSG\P\$Z#B&HD HD1TPJH2T03%#(3Q8QC*4)I
M02X?H+V^G:+V<'CV_L\_S\_/-R]DUMGL9\=_$M^G?V;P\Y_C:S>V9M=@\:3H
MB)Z"F3PWF0'TS=*?1GM)UN]Z8J13N\ .6.Z4RJVV)VD/KD]%!T0$OG '6&XZ
M51^_:FM*INZHBM74X+;55\9&2I9NR)SPM=K&$\KF#XC>I:W?93LQ\ 0,![0E
MA88=9VZO>3;T^HDW;)N!L6.B36_PP-&Y9SR*9C"2YUN<]0=N*^;[S'2$W6;Q
MX3S5P_;8WD[<6("-?W.+D-"(T?#^6Q8^V ^$J>#.QI&)/VUKG<XG..%,2)\:
M7S$F!9"&@!$%XJJB(%'B!XXWQC>ULYL]@<<&R<R(4R02Z.![T3D7EX.-/V_+
M( C@G7&_.V3W#DR2+&Q@<F4 JM+/A)M0,(0FLU=!F\3*M,5K9Y;1_>OW4P1,
MH&4MIE49>[JMU83__"GN'OYP5R66+Z;A3#&M[1QX]>IN;6?[2\6K-78V\\#4
MP<?]VFYM>Z]6W;]7JU>E"SO-QFZUL5]U![7O-[_4=K=;51M<@[_R0]R;G[SF
MU^K>=JL&%WCO#GH%XO^Q0GV[AS#4>@#$_1$\0P\JGKE0!LC=F<GRS6H>H+%8
M_5[<(<2_,)?\'G/I2.F-57!$&%K?$6<#\W[\X8-.!V<=<?D^[;DVN)L^W.:M
M]@5W2+![7_YS 9%QO,D#;%&RB$H7+RX =-,!Z!U>G_\6TLTPBN_]V=_$]_[V
MJ\=B^#$*G_387__&*5M(8^/[?[[SV!FAG/$TVG-X5N/*WZQ0K,1"!/X=6#[D
M[.7X(7W*M7))O?JM#<C75\!>&Z\+U[4'G@$SKKW_R.S/+5<AU ,GX &G39<B
M\MCCN1\1D%AQ^;$+'O/J\4,.)7]5(T<6KEPOH+"KO>K\>^(UL>R\5_VGVCB8
M8/*/BTBN_ +' P?CJ2L<J[N \<"./V8%0_I"1BK6D0AM0EH<JY@$$<$:OI:!
M_+'KEH:QC]%#-V[^-+V1^93UN]8[MDWXG@[;.Z,!C(?)JA=%DM'V8&#@_WIM
M<JJ;^T7<]&2;UZ].KQHM^/W[MZOZ[C=>/SG@AU?J_.A[X[2Q>W!^=+)W>G12
MIS>K&]NDN?LI;7[_=GFT^Q'>]PW:U&C7/Q]>'%X=X*/O-;^Y^^V\N;O-[JYN
MU'</6?U[C1_M_GU:_UP[;^P>^G52A7=\.FFT_ND<GGQC#;BOOMM.ZFFQLK'O
M7]1;M<MFJ_I#ZS !<1,HCF6"6,($BJ2*411P1644"2[#C2T>1)7@^46X'JM(
MZ[$D7 +BVP%$#0!(3<ADJ&)&0R&8;T(5B4@13+7&#A#)&!!)"8BK#HA7=P'1
M3Y(P\@.&(I9P ,0H1H"'"DD1V7-3B,!" 2 R6L%DSDDTRP;$5T#"9V^766F8
MW6GNMVP(^G.SN;OO[3>_[+Z6<B%KP#]W^H-A,RE MP32N0'IY0QF&5!?PSRA
M@-D4]2 F2&(9(Q%10X@)$TKIQA8-@TI05FQ^S4H\=\Y4*O&BE'B*#0D_P9C2
M !F 7,245$A@T.20<4*C6$F>:*O$K$)F'"*W:DK\"@C/BI8O>2!J?-YK[N][
M7_>:GVJMY]0I69L-?FM B3YG_<'@:]9/UJ7&TCI@:6-GFA"9.) Q]P6*3!(@
M%F&!8L(5(C*(@RCA"8CVQA:@:\6?=Q;QRH?:2N5_&2I5*O]BE'^*2(6A44Q+
M@A2-?7LN=(PD#7T4QMI72F(61@24/X@J$0G76_E? <M:P[!2D='8^.Q5__>K
MS7_<?_^0#(9Y[/)^*7A]T+@\/'WER1Y^.9RO$P76V]?:-ZX61\4[-CUC=W+8
M8U.$[J:]=##,W$:+UU(J<@V\K&(V/N=SL=W3V[=FHGIQ9K?5E!QL;AQL1JY#
MQ"D.X'^(L< @%F &#A@AR'"C$HP9T# *'(R3"@_GM;2WIC[6Z];NN;M1I78O
M7;NG/*S(2")C/T$F9APQXX<HP@:C*,%$T43"E#OMIA6"5U^[7P%]6M$S/1X(
M)WMF8-QN 4N;M/EI.OTSNZ^U7*Q?8K)H/@6 I[LW$U""Z;S!=,;B?:"E(0&F
M"&/*$%,104(:#1.G DK#R->QMK'J2ABLTFD Y=K]JC.E4J>7I=-3!$D%H,;&
M2.1SJH$@)0J)6/C(3X@ IT?!/Z*-+4(K4;CZ.OT*^-%ZAY= D8?92 U'F0LR
M.5?''*?*@P^]08$LECL5E43LO\MXT\*Y4ZI&Z?M;<V-+!8PG9V)N2JR=%]8V
M9ZSU)SY.5$@Y"@)A0TV)CV+LQPA,9R!#[2>"<>!/N.+CZ;-(5LT7+2--+\^?
M2KU^";V>7L:/N8I- *0I,':[G% H]C5#&K[4.F)^I).-+4HKL?_L=,@RQO3:
M8TP[;=$[-L"0O$2DF??3GI5L"T=9"('N@&/DCI1%_=%;"SL]ZM"GYW.G>TY_
M^C@:0,L&@YU^5Z8]1V%WKJ<&/@U2;7)FNYUE=BI=X;M\5FN][2[,Q;"9W'/+
MN*KK)2Y1^3&HO#_-M@AG4A@-@"R3$#$E(A0+$R+N2^[S4"8^9QM;H>\_XU"H
M,DKU!EC6TA5_DJLEZ871Z,ID_1(0'@<(4S0M$'X44R&0L)X7BP5&$>,&"<&U
M(;;*@3V>^G_^!4:"?"AC7?/F::O7X'6Y\NU4(9K.5UW(AJ!7;OGFON;:/'-6
MJG=<+,D,RGC"W/97%D;JUN$")O(#035'@BF#&/'A4XP)DK&4H<%<&6X#A1&I
M!"Q8]+Z =8TAOE7MGSOO+;5_L=H_=8(?#7FD<8Q"XVOP7H&QQIR$R \B7_!
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M ?!R*56HE L1,#*'6@*KBJ\KZBE,'=@TOF-5CM<HCW+ZS5%.]XW EBO'7YX
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M(HHPPE0RQ##E**(QT%9#:<P 697$MICU],::=3DMO 2R$LB>1Q5CGYLD"%B
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M5,!$"J%I@"Y2%<\4XLXQ+X65N9[0-7S$+_O'Q_U>/IA7Y>3:&X^&(]U+@U<
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M5J;@<V$9 4.F)!8@6A!1P0-4(-75!(%0(Q7AFF*6@MX49[?P !7UKNW";+5
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M6-M038GF#QDM?3#S$1VP+(A4GU>K1Z+\@DAW@D@_+B.2<=1K(3$@@H64]X@
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MC4HFQ=]Q+_LJLX#T82*4S9Y[6TFE6#TKPZL%H1U(:*RTAD"G>&YJH^DCD>,
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MX\[X^/9G8Y^#A;1R;T<*7*\.V^_T;/_87PQK?U/)IF#14EBT,\\H&-:&!^2
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MK!62,\(#4W)M0^(FQ.64^M/5\;L[&59T_-YU_#)_)C:*U<@ 3-3O: =; 8S
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ML-! RF32:1SGG2^NFT>JU_4B3;]6[$*<;JG=<T7O"96$$ JTPS1J-S= 4<%
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M-;=*I12)9(P..P,'3O1@=%J\)G6(F=\+Q2MR-T"U(,62#\ISPR@(G%! $45
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M@KD%<U>,N4QH3XW 7C$1V;<W@9- J"!,P> AJRSM@KF/"7,OLV^D>(17RU)
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M<:<'+HWAY=>_\B5#N+.7K  B+AO]03ZI]F*<*B6D5K%/NC9]:1P.TM+[7YV
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MLZZFP9-9-:)2S@0N7YAB^1#$W9ODUYY56V.?YE.[7V;4<C-JY\=G[@SU\2;
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M*<TY52G1#6\B@I_>)D^M<7&GEW)&]E.=\A*6]-SP<"K\:Z8O* !X'0#<F0=
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M\+UV*887O \6U?Y)V"V;-+P\JU[')56!5_3*(4F][N$'^-9VSOK &:&E&::
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MK_#&^?H/F#5A)%.(:A80MRXB(YA%7B5-),R3\7YAF1I2Y<R9]?E/M<#@>0^
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MP9&FJ(/C>M*\$ 3WGED)(,( 5)15FCIJ %%XU-*Y!="EO3W.@@,Z=RY'7,[
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ME^I;CT-_</_?3+!YDHIZJT42VO%$L/78AA1SZ#ECP=E'9/(>LO+7$6G^R,/
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M&&],BIFQO ;@K7[!3$!]C[G_#=]OO!F*BLS(!T"P.X5Z/22$?W)N;$4',^A
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M;TFP#%02+Q"W28/AE#PBPGI.O 65DU2\_>)Y6\?(A$A&L,@Y9M)1;S1E"8<
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MD@>F)-)8%)IF1(8P O\81RFU/GF\H":E%<95&+<ZL[Z+LTQ[AJUSS@O)7;3
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MLP".%"=.@D;<9 < CB"?I1=(R("C8-$0&XM4?N[@E51Q3ZSGF'!&A>,@E#%
M&/0U3JPM4KG1H&:SH+8Q<8X]1Y1*@KC@%CGM:F3KQ RS+C2RF-2+BA_X<%:_
M\B>'=HJ3\LSTYRPE8Q*V1',7$M@,)%E/.756,KSPG<7VH.^+GO%[L0'3D"9K
M#56!"60X-XC;I)#QVJ' A2-4I.0E4)(@LD&^R++)L.B0:AJP5RR' P!^'79)
M<D92%,0QFX*]3_P656.Q<0%37,?@$\7*(TQU ",B>_4(AV6=2)3:Y#+#90/Q
M)6#;,BPPB=92G;@U OC>""H#Q\X;%A8>T5=D\^\' 4PQS"+&R0B#E&0.<<HY
MTHHJ%&C"6AFM0R)%-C]S_((.'12FWC,CN#!)$\65Q]8$3.&_A0< %-E\?S$
MI[C&W$42%-(R,,1C'8_+&'+1.:,BP3$T.0;@]%FG*UK4R'V$M#OE'D_H'B\I
MX]&T0G 5?_@=V_\6,Y$>V6$HB8Y>S#U>5+S4I8?"33SJ_D [W1!B_W71#F[2
M#H[QT:QV(# #N6] ,7!)(,YH0L92AK20-A&-E:+AU9O_#..![0:@F(/8'\%4
MVGZHZG2:U51]JR;)2\\8I\2M76,@8VU"\M$2:4&S5F P$PR:F0%KV6B/;ZM@
M7U,6OLXF^5++M3P4B.;<VHIRRPSAB/.87P2 2*>(HG&"&JLLSJ8S7](2-VB?
MK6R@+QC;#+C4<6R,P8P'X[7UD1CON0J:6ND?!-O%<OY56,]YM760F..$$:,"
M(YY"!%@'AP0SG@F#.<&\B1OH!=@+!G9@C'-'8XS&<F:<,8& U!96.QN$O75>
MQ2*T'P_=<_YNKQC6B0ODZXQE.<.B]E$C[XQEU LMJ2U"^]ECFPLCF 3U347/
M232:*WAUT021M BWCB8I0OM18#WG[M;11IZP18JP7#DQ) 0RVZ.@DS ..%MQ
MWT2A_:*BWC9JU\&,RZ!LQLVF<XX&S @:,>&P:%-TU$58W<$%G'-H\-L&Y-Z9
MF@H%W9J"6E/ZF51O73_:6/7'7T&6A!AL1#[$A+CT'IE @9*4H,HYE;@'P\'\
M=G+!LI/>7/#F;,9*&4Y]()RS:+U+.1K;L!2UT.'>P%OTBL6 ^G@&U)KG5 @^
M(":\0-P% '5B#'DM+6B*@NFTN$-N!=G-1;;$&MMD&%$@F+74.A 6(@O"!$*M
M4T4L-P/![3FQ[(Q0-,!J#1;$,DD".4LE OP&:9U(8/X7L?R\P:L<81;$+W;,
M\WQNV8CHC7$$]&LF^:T/N16Q_$B@GA7+#"NF I$(Z[SW1N'%$F\06$Z"^A0L
MY::)8GF1(1M-CU!:SQ4JXVA<U<?;_!0KOU?TL-'A9^4>]Q>.UWCGUMV#98J4
MGLU#9PFH:"Q2*0C'4CLPGS&U*2I"N??LME+ZE'@^ >^L0JN_VUR/>5)R=>5<
M3I>-ML6)Z-:L.^SHJQ2!*VL%8MHXE .=D%&8(L&8U\;&Z(E\]8;J)<Y(@R1T
MT;T7[1+CA#MB0J3:<NZ5X]K(Y+UTTG$9[Q?51>?^=4 ?SP :!T$==PP%FX/>
MB 1#6@J)6#+$"9A<O<!\3P71S46T=9A$[ZB3UG/KO8[..T)3<#KI*$B1TPV&
M=7M63AMK?# <8"V,0MSPA(QW";%HHL6$JD!UD=//']7*1",2%\(QRHUR+B7X
M6V!M*:-!T2*G&PKH63EM@V+8BPA8=@3D-/<@IVU^9Y0TC("<;O+1S\4<9Z++
M5#3<8_#;X3 O(E)O4>$P1=EX<&[Z..\4X%&82"A%P3"/N,5@0WA"D*8<-$<!
M4XJ!FZA<4H(U*$ROQ-\V-$ZF*!L/#.A998,F*7D0##DF+ (3 0.6:43644,5
M<<X;V\3 VX+HAL;'%#G]"+"><PJ0Y".3B:'$/$:<!XD<:%TH2&\\%](D:XJ<
M?OZH7E3@3)'3#PSH63F=G7D>6P!T) %QYQURR5OD!%:.:H&=($V4TPO)!_44
MDKF4>S0V04ZCO4B=P=CVJI4KO4@_ZZ<;#$,<HO'@X'7&YVC0ZX8J-_GG4JUQ
MX_!?]]3Y9R/*%Y9 O5YJY>#ZO4KPE0NNL[7CUN[>CZ^$>^U#/JJN2$3<4HT,
M3"<RB@<PN$ GC_S5&\F7M%I4P9;;0>21E?5"<H7D%I]EOI#<@Y#<\0S),1J2
MDX(@+(U%7#&#C, )42-2X-YRFH,1%E)JOG!<X;CF]/HQLNT7CGL(CFO/*G)<
MPJ2!:$(11U#DJ*3(.,\0UH$3XZ3$GH BQY:X_.VL^X7D"LDUI]>/49+@=B17
M7,V_SF^S.IST7/ H.?+,:\2CLV"C:HFPE]%C$Y63"\_%=+\$US0G](7>,NA2
M&!RZ7KS<W<?VQY8F/D837X+#^T/7NFZOKB-3CA*_E'N\I,H>.:L$M#F?&(YV
MV$>#PW'5FR[ZXPI5'SJ_$YW]W/3CJ[KX;+1@9S"SSEIM%.$T2JVP$]YHXC$Q
M.)G;:L'M03]U^[;ON[9W@3^+[?]@AZ*GNK%B-!DO73XT:1"75B$C T6>2"(8
M4]PZL/VI6!+JMQV<S3ML57CJN?(43T(P#KSD.)A^5$=8RT2%Q&C$-MVZ!L*O
M\E0QWQ=PS'M*41YS3D'8(!:MS15!)7+*B;SM')*P/FJSN/H'A:,*1SW4MDG4
M6GNFG:8,Z,JZY#$SRAE*<GT'7CBJL1PUOX5"/"5*1$29QHB3P)%5-B'#L/%:
M8R%,(]._%8XJ''6C'B58CO$R2L;$+9"5%T);J;RQRFE/BKW7<**:5:92<-PE
MIE'"CB,>) &B2A0Q#W]C)TF0HH'VWD_<;:$[.NC9X]S8>#.UE2LO7UD&M@SL
MT[KR)66LG:NI79+6OKA[O*BDM2O>#P]C.-M> AVQI*=]I"+.HU-%_;BHZ?>I
MIN]>3DO3/OE\]-7R2+SWH)S7-5^MC,BRG-]24Q]DBCX&E\/.-5<-TM)+"KQF
ME'*6BT=X<1;^.KB/+X'[^*L025(A G(I!,13M$B3I #F7H/Y;:1F)6_M2X#W
M/1=T+@+\P3#>OBS V5<EG=4A2(0QO/"$-;(\.$2\,YSR1%T418 _>X3_8EGG
M(L ;!>[+ EQ\=<HEDK)BGFS.71,P<I8II'S,)4-@SK%HH@!?:$+;IKL2+CT4
M;N)1]P?:Z880^Z_+DK]QW^C;N/5V]ART]M0KJI#F(,HXYAHYK"PR3*=$:-0L
MRM,,PKU!_QL:Q^'^E6Z<7_#FO(C,9I$RC)FB$20&AU%UN6!SY((0CW&Z_2G:
M7Q,5123<#1^S 2 N81]H2 CS'*2F".A[,@5$N#;!&N>ER@X;^=O:7DE.V%P(
M2XQAGEFT*8**KZPQ3.+HHH:/72 /:,\5;>_7H3T;,F%@.I/1"8%JQQ"'J46.
MZX"H8AXGJ8VVH8F9"@N\%YWYGQNM'0LQ)RSS(>C$M0)E7TCG*56W#M@L$OH!
M8#P7HHF!@H6@ 06K'>*RAK%PB'JBC(]6$N&+A'[F$-:&4QU%"I$P'IFV@GG+
MG0]@W5AL;YUSL$CHQX3VK(2..C*PDP@BD@"T$\AJ;:A#!BPHL*.4963A"1X>
MQ1]SM2^HT6Z823K8#]?'<]PRY<"D$[-9!W+;KTVU\=PS\2Q^@)X-SR?/N,%*
M,,$4]RQ8I33<E HL4CJK'5?BUIM)\7OS_A5+' $M+2"I?/:O!(Q &2?(:F6C
M94J%['^D:DGHW\Y1MG!<-?QT3F'8PK!W9EB,"9%& ! -A9N!7:Q)761'.P,\
M*\OIQ>:2ZZS^K$C0UC*#:"(*<0WZLTN>(,=<X#%%P]+"3U@7=BWL6MCU.G85
MA'EJF'1,1.YB/A >L. :6V(3IR7/3L,I=OZ ./8T4<M02#PB[C&HKB(()$.0
M)@DL-<WZZQ(FO!!L(=A"L/>]ER,2$X9[4'PXETEI@AV-DOH0J1/DWI-O%(+]
M38*=*]0@I$_><B0DMT"PT0'!2HL"-X'RQ+EW?L$'VQ^?86L'\K_&%A[ZINZ4
MKU,U'MJZ5U=]$KK?W_Q/_?+  *49H)-QGG\]&_G3YDU D(,LN7681>PY=[F"
MBN34 S"]EC#97R5Y]8!]4E?VJ3T8QXK@UU4UI9_VX3[<R<]L/#ELG?8&^$9Q
MSK4QWE 0^B3 QTZZKZO -_G\'D'UF[J Y81JNOZP^WJ]_SV.QONQ/QZM]U>C
M&Z_T0\L.]V(]^6O_=]@='V]&?SBLZ0>^G'S4BN.=0;CPXPZTZ._>P.\]+L_0
MUN:49_;?[6[OAMU69[O;ZH2=[0[@O=/BP 7'[=5W<'7KJ$VWZ-;N3@\XHQ?_
M]]/Q]I=PX"B76U_:^VW: HY9_]&F[X"76J1ULM/;WEW'K2_;^ZV3%;:]N]W=
M>/]/:J\"%WW[2K"WQFF!O L:+%T;D8TB("!ZE\M&RQ#C1%( 9F)8&4]\R81+
MZX1QD6N?K.4DAD"=28QQHE]5$<C[ &9J/#R,K]Z<CW9U/B.GE#-='&_F5OQD
M\;[Y'S?\U\R7,R">0N.GC;K<">4]]$X$[+T#@X+I@)F1UB?H.-"D?G6_"*KO
M^+H[!A+SM^")"PNVZO:KE>^VV\OK'($(12,0E)=&=I8[ILVOJ;3;#W"7UTS6
M*N5U0]PX0MPX'%9VOM?=\Z4U.AN RM>[T./><9[S47<TK@:I&NT,AN-)%*[M
MAPLQN7XP/!@,+9"6&_3#:.GBE9^7-Y>K\3!:4%B.+S[B\BV^#4 J]>MFU/>H
MO[;#.'D^B+P8JNPMHOBO"RW^-K0AUA^3O\Y_88?#+EQNQU4"G:GZGI6FY>I+
MK.QH%$>C:@ C<>$FL!JN&)< A'BQN?!%U=T_@!ON3[(6^YUJ&*';.8]Q=0!S
M-0C+U7J"9H"2"/WMP9SE'L(#XP\801B6HWS;W%V8M.IH)]:AS;9_7-6W 1S"
M(,-G63O,\YI;=MZ#RL7>X*C^WN[GZ_/M_0"FQEF8H0K^[V&4NF,TC#V8BU"Y
M8VCA]VX\RBT<11A@VX,;^O%@"(WI]GWO,*L+2Y4['%?]0<[ O-_-/QP/ENKG
MP&K/?9VVZD)33AN8AWR21J(&57W5J>J:9PY:<Z%;W='H, [KF1A&6#,AC]6%
M,<U#/-.%/'QP[_$.*$O?=O+UM@>C $^(2Q>:>SHJA^>MG9F#>FI@_&.W'O0N
MR-%^_<M1[/6J/+?C/((PL!'NNQ=AY8^A8_6PP,^.NG"5R^T&&3B,Y[^<3-?Y
M4CF&JU*^27><US#H6=V#NB>YQS #QTOUA)_U(C_T"'X'S8&6IWI$;YKBTVO#
MX*B?&W%A4LX&*4_)\!O<XYOM]N''_3C)L@US#>/P^7Q@ZN_K1X(803-#/S.
M&;'#TXF+8:F^:QYK^R.OI6I0CZL?[!\,XTX$S'[/ZQ?^CM4?^?=_UO,>NJ$>
MTAW[/=8#T;U,R[< 8G<>7P>#4;W0H(FCW";08OS.A/486:JR]I.G>#7ZN.^@
ME=,/Z?(=1.;/I<!#$WUG?IF<\<?E(<L39\/NX2C/:T;9A15F3Q$*\[;?/=P?
MU7-X.%D!P+L3(D@I^O%D2B=%SJO]6@U<KC8/@0@OW2LOU)I;X!8P66>_B#\.
M8%W$R<K)*^9P6'-$_C#4/)^-F7KMC<;PSV110,L&P*[UK6'U?II?NQ=6I_4^
M<\"TEX,)(XT.P"!.H#UW\XSE=Y-VGO8 QA%^6J](%P%:=XG]^A45_*9#>>^A
M5Q^@/QO]35C[&^F"UG+)V,^'C[+!?P1@',7^R].\CUM'7P.3VDI*$=4F(NY8
M1(XJA831@E$EC!+BU9O^8,XVKV88<# \7427,3]O[%Y@@2D6N0"PGA+0ZYH\
M 2=_'77#>.?4AW3A5U/+'I__Q#I8]X"W:W]RP7[W,8/ID?B&RIG1N?"Z<U8X
MZ,!^@VF  =Y#-D%C7]O>D3T>O?K7I3Z!!G1Z<\'AZ<WI^]46^?K;SU5K;77]
M[<J'I6J]_7:Y6FFO5IN?_]Y<7UU?^;2^MGFSM&A %]H;G;7-JK-1O=UHKZZU
M-]=6\[O-C0_KJRL=^./=>GNE_79]Y4.UV8$/6FOMSF;UQ]M3D^_/JR;_2COR
MD>W"&]?P5"3D)' #T"ZF G-TT0P:U1*A&OF=& Y[P!' N:>"] ;YZN+X*$N/
MK%?48@G><%@FH"->L(:NMK8F5DNO5GQ U1SO9.D(ZO4Q:&W+574WP_X>W$6G
MTFES.B8;Z<Q\?C<89DEU;CM_ @41]/]>MUX1G7S-"W80';=6OJ8((R^Y1)XI
MAKC-N5F<RR]8*&6TEGC.X=- =3/[#Z[U /Q<C;_H7#AW*=06XR ;0]E&_:.V
M(0>'T,PP^O/UM92Z#^8-")#L!)_6IZN1<R9B:Q<YC$O/'HSBZ],W?YVF?NSV
MZ][5/_IK>J^I7,["?,8]7@__Y.MS,;6,)Z)J&FD]??+TZ^7ZJQF7_^0[+I8I
M%]=^C9?)M=_==%LBEZE1OW3;F[\3[/J'OI3& B?>ZK8_";W_Z4D:(N:NO>O>
M\4.J'>9G6L<D^^)U!OF,.K&( ;P0$'"'7;*_YD;J83:@;SE^9P;^6S#P;Y.A
M]39=?U%#>,'A];^#7FYW56M.[VO;[X\/M>7W9QG:7QC:')-0U4$)EX;O)93H
MW#Q7A6:V/Q96U_>YQQ+=N?_/)E3()9<B59H'J7C 5$>K#3<JR4 (T9-0H7EW
MX5RH4-ZUO[!%/V.4G<F.+#HFYTK'3R)DZ%<MM6G($%AA7SXRL+Y.MO;?[<#]
M^49G9Z?=^;2[\7Z-;T&[M]^OT>W=O>/9D*'MW*]5C]NK[>[6EQPR]$W ;Z#=
M+;[5V>G"/?:V.MO[&YU_IU9W&BZTB7^T.NO'&YVUKXHZKH6WR-OH$2>&("<-
M1U%$S30.0AJ94_0QBN^[*/BBXH'N2.&_)",+0Q:&G,UCZKQA3/ DD^0A:*UB
MBII:;@VUPOB?[:S,4>4L.5ZFSO=#T +/%<6L$S;];-!3(<F369+D-EA+M44N
M2(JXB!PYKR)BS$>K%/..V44?K2\T66CR.=+DHA3)Z_WYEWFR:)&+)T@R2Y#1
MX<0<B!O0&1WBEE)D(A4H6B:,8M2H2)^8%OD2TI)L_CSHL12>N8[(O!/*&TQI
MKC5CE#0I1.>I8UYK:8M%_"2X['C>(I8Z&!QS[5K-).*<"P3,%I!RUD8N U4B
M9B[CI"2M?\;PIB(Z;9B7)D@>O39$<E#OM0H<!Q6*.?=D$#YGSE')#8T&$"ZP
M0)R9! @G"1"N#4[<.)]<$S/7%XPW5(076^3QT#UGBRCMB8J2H.241EP$CRQU
M$@7CHHXJJ)A(\^3W"]N G#T\52HB7.M6IH)XQQ-3U',*_ 3RR6@O9,*&V$3O
MT\PH3'1K)FJ_O6!)[*[P]LG65YY<HAH4"T8)05P3BW3T"5$)4PH49;3FK]YP
MHQN4C;4D6UYTLF4:+=4X4J,-M\Y8+EET,EFAN22>%3OBJ>#[9 [?7B:'0T#"
M ;0YC1@9P1C"G!@OHF$JF29F7"X8;ZB,OK,=40!\%P"360 3KJB0.B+!;$+<
MX(BLU!0%K)17- % 5=,$]$\,A=,3 ]#8>#/>G_*5"]J<J2= +2O1<,-IDC[^
MRI-8OYBN:7[?[%EOM]^M\\]&+GEMI*"2:<XIUU(ZX70^WF@CT8DF^:MR:<:6
MO&@[_IW3/A0'U\*DUA4AF\9AF%&E4*JS:$J!D65<(1ZY-,Y)4#ODJS=LB3*Q
MV!QO/\'-T\B069CO)3#?[Z:Y*%9W4^AO;O<N.4^)DPRI$#F0G@W(1(=1\)Z1
M*$1D =]3GO9"@$VA@D* CZ3Z7>>2*"K? CEO;D]3$Y<+]'E$;$B(TR"0#LJB
MJ*.343%KF'M**M_4?I])3$2FJ1$6>)9Z)A_Q7<Z\/J<'/LQ!_^:=]IV<Y9_+
MHG>7H[\O\I1T.<-_#V?XRQ'^<H2_'.%_;'O@Y9Z\BL$;2I4VC&*>1'(:E,DH
MI'::)XUO7>VC'%AXQ(#'SLI\65 A+;-$2Q1L=@-SYI"C6"%G'9%!"I(PSV65
MV.^752J'4PM%/F.*E)$991SS1#&>K'0)>Z$<(TZ9'")>NXWIJ=OX%EQ9W,:/
MQI)SM9$P+&NI%5)42<05O)A *7)1:&Z$]<8OKKYGX<G"D\^8)Q>E2I:#,X_(
MD'/E.95,-B7ND">)("XQ0TY1@@0+DM.DF)/JB>F1Y11_.<5_(Y,EJ9B).@;#
M-/>16YQ8L"8&ZWC ,16C^"F0V=H%HWC]:&/UV]%7JZPUB<)J)AQ/HJ0<YP99
M9S3'PC"1U;U\#'!1E3 ;% I0\'T6" 22BSEF9#[BFP(QQ EO.,ROX4YB7RRZ
MIP/QXQF(,X5QE(X@9K%&G"N-C'<&&06JBQ2,,Q[+.?X7 /)%"?%BCCPBO-NS
M$APGJX)@&L6  ^)*".0\ )U9'3C.44W.-D^"O[!MR'*0_]81>42*8*/647$N
M00^!7L-"5BEZ$UQP]VEI%"JZ Q6MSQ@3GG^%>7&UVY@E U3$F$1.@!Y'A2>&
M81Z,TDT[*%A.^2[ZE*]2(2.6>V]Y8MI8S*UV6@;E\TG18DH\'8 ?SP \\*1P
M ML!E F,N"4<N< )2H0+Q:EU4J1RE/\%@'Q14KH<Y;]?!+=G1;0# 2TU#<@(
M+Q''6L"[()#E(+M9DMK&T#01_1)V)SZ<55S\2<1B<6<\8J!>>]#WA8E^<^=A
MNHV:K"8AA^-YZASB7 ?DK-(HFH0%B)3 "'[U1A#9(*]%<4F62+("\)_M.TP!
MSIU(4HB(F)0,\4 DTM)*9'74SD5M>$X;5/8=GCW('SH,JDCI!>PNG(%8$I/+
MFWOF(N+)8 1S25 41$?/E?:,-DU*+VAOX26EO;H<:#:MF3YS9C;WH@2Q+FR
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M3WNP7&T<#F?FZ,*.4S<_Z6 PK*$WAF& (<U/LV'W<)0_C!8& '#5A=_EV1S
MW48[%A PQ=3IR-=P!&$ 7PRK/WJ#T>C/J;CX#@,+;PYL-RQ575@?_>-ZFF*O
M"Y.4U9DLPBYU"["<NA/Y,T'R>"HX\N-=[$>8P^E8U)-1WP^&>Y"'_BXMS#P
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M+R+%^-/*+U[+]=-: >QW4K0O)#_[TQJ\WZJU\"R2(ZQ=(V=OLY#N:8?XI6\
MOZ3]W?MU![^$[=S=K9.M+Q_)]NZW'^TO:\>MDT][V_MK8GO_([S_9W?["[1Q
M%WH#SYO=SFWOMG>V5__9WUA=(UN=]9/V^T_[6YW>_O8JO/\"_=C=@M]Z:.].
M:G7Q\6R=)YQ,M%(11#Q/B#.%D0L:(Q]\8DXHR3'-=9Z(_.VP](9F*"Y,5YCN
M@2-9"M/=/]/A6:;CWF*?5$021XIX# KI:#52PD?"- N$XYKIU*(.[#<A+"7_
MG==PMW]8NZ9_RXOR&'ZER=#/OU[K&IK^FF=/S<%@5.]JOIYLWGR/YPZ:_[[L
M19NZ=_#Y3ZR#"3L<7_^3.:OHD3QO5%T>BXNON;DU6R22!+<.LX@]Y\X"?TE.
M<\2SUS)Y^U7R5Z<_VAF>F^+?(G+#:/>03=##U[9W9(]'K_YU.7:IVS]MD>#0
MY.8,V)S%. EJ>ONY:JVMKK]=^;!4K;??+E<K[=5J\_/?F^NKZRN?UM<V;_8[
M-J +;6"TS:JS4;W=:*^NM3?75O.[S8T/ZZLK'?CCW7I[I?UV?>5#M=F!#UIK
M[<YF]<?;"1'$\.=5*^8!('Y-9Z9;5==!O:KN:6.BZP^[KZ?[8Z-ZYVNZ(S;9
M_UKIA_K#\T.PD\^;LF'1?GLJB5NB33_C[<X*;G5:/[;K,-!UL;W:.MZ&OT$J
MB_9J;Z]]\JX[MV%QLL?@^EYK]>./ULF[7AT&NMO;:YW\N]<Z62.MDSV\\>4C
M:WWY=VKMKI.OF&ONE0$S06:#@4J/G+466<\--DHS'^Q$;:I7VDK69J(ER2E&
MG8Z!$PV74\>"$I(%:EU2L]L;O[YE.2__;AV0.",H)U/[TY;?]Y[9:DP1>EP?
MU1N]M0=UY.9)#-,A.EVBD]ZO=D>^-Q@=#N/+7:)K_*O2P3##/,)$@Z9GK4&:
M&5BLQGMJ@@W"^B>PHW:*@G@1!9.H@"D=G48'3/?3?KJ=]A/-:2X&N>R:E5VS
MLFO6@%VSQW4@W:IO5YO(97NO;.^5[;W?<U!.]-N#J[2!29A9%KC7)S<L+O#B
M F_>9E^]J*<:[M3,>U(U+G[1L)EZP=_MM79;=*,3>JV.Q^T.M&WWW<X6;8&A
M VW*1SA/]GYL=.:/;[:^9$_Y5G[FC_;)1]*&]K6^O-O=.@F]C=7MO:W.SNY&
M9TW4QS>OV.^C/G'! D&,<H]XY!%9$1P2@8%-BAT8M?[5&RJ7&/OM&A=EPZ^P
MW=-FNT5M^!6V>Q"VF]OSLSY$YF5$+OI<I]X'I"F32&-%%>&2&Y[KU),ER<13
M8;N7D,+[U/7U/?;#8'BF\_Z2CEMRBSZ0:G=Q-^6?>N)._?>%Y!9&<L?S*AVH
M;CPI%1%7-"!.!4$.)XN()DXR1QRG(5<MT[))5<L*?!NFJQ3X/@A\Y^.2,.@F
M6#+D"<T6&=;(\4A04((R+21-NH[ Q*))\'T)CK?3O=?Z$/:].-ANQ5XOHPK2
M@OQ*E_;++^^.%QI;%(VUWU[E6 (62XDC'C#0& L*69H"4D:+$"AW6+-,8S#%
M#:J'5'#<,"VDX/AA<3RGCBBBDB+>(HLE1=Q8BS06%B637+(!V#E7*:!+S"S*
M8U*<(G=SBG3[H\-AG>\C;P&>)EFJQO9'\9 T6TFY:&*=S2),XND<UE-8Z&UA
M]+8YKZ8$YS1A7J,0'$:<"X^,3PPYX17H*)8R9UZ](7@1>DKQEC07RHOTEA0H
M/P24YS05:8TQ.%HDC56(2YN0U@DCEIQR7'";\N8.D4N,%L_)PP+QGY7.O]YO
M=B[$)Q7OR5-13.H(\T)?BZ6O*R)QB'5,60^J!\M^7T,<LB1(I*FB!"9/*1]K
MOR];5![UXC!I('07J8@4Z-X+=.<T#X:#QXH$%#D!(X)@@:QW$DG%A"52$BYL
MAJ[@BTJ:47PD=]RR 114?L<.O_V:YE'LJ(?4/$YG#29M,F>%OA9&7U<$C#"*
M?<PE6Z@P%'%A-'(N6&0<M<R9H,6$OO3O:Q[%!=)<Z"Y$\RC0O4_HSOL\M)4Q
MZ%S.+@;$DR)(&\$1#2JJX(0-)C4/NB_!Y?%N,(0_+]19J8LCP-"7P)%[93&5
M8C+:1X8YYE1K'9(*3$FKN)),\-L&CDSG;Q*6[X_?3F>OWG)^9[O#?W("^O,$
M"X7F%D5S&U<$DVAA6<I5.X5A"C248)!302+"C8C&)N6\?/5&+7%V76V;XAMY
M!MBVTH!=X2FU-G'L'>BGG"I-H@T21TEN&TQ2L/UXV)Y38:+PFGJ=D+$<L&VH
M0=9@C'"B)+!D9+0NUX_4LDE^SY?@/%D_+>$TS#58?D]_*5;8 ^LOIY/W">9N
M%5K]O<YW.$UD=LYRA=L6QFU71)=P3ZAV^11.PO!"'$$.E!44O1#48$$48:_>
M4+$D?I_<BFNEN:!>E.)20/WPH+[B$#'8',(JQ(S'V1BAR&H!?PJK.2-!&FP!
MU!JL$=(@4/]$8SG-V@:-C3?S0/.N? G^I-589R(NWJ-&;U^='U>H9ZL<4%CP
M><E,Q5W\HZ;DSMIQ:W?OQU<&8I,+AE' N6 >%A$9'2P2"8@X)495=@Z1)9C6
M!AF0!;H-V[XJT+UWZ+;?SD"7)$ILH@S%$ P8248BF#M0I33)\6Y,!YZC[Y<8
M-0V"[DOP_=3GZXJGYRGH&A>.0I8D4@MGK?4K% X5<!3Y-&2*"G'J$]*$,R05
M!?$C/-&QCM05[+=9JSAUFHO?A2:#*_B]-_S.:1U62&UIHF P>(ZX)A1I04,^
MUVPTD*\QCDWP6\X)W5/.\*O!=^N<X?>5RW-:GH#!%(7!82YV<-KGDNQS80/T
M; 3 HA2XRXE +R>W*!)AX1*A=85&%VVR&@Q/26)VZ>> 2JP\$MHFKIA3PO%7
M;[1:(G3!>4$7 *BGD2:Y4&NAUH?7K0NU/C"USBG;FD7".#8(K&90MFT$/5O9
M@().,D50N2430*UZR2PZP?PC4NLM"K%>6V?KKSM48;W?6G.;?B>&PU[<2!=0
M<U[\\.76E%O_\35BDA)."E&9&.)<!61QBBA8+J/2+,7(;ZHI=[LY?T"&IN>E
M9>Y81:[4C[O]=Z5^7*D?UX#Z<8L8LV=76:R492MEV7XG'>/A_D'5BW842QFV
M1AC4+\E>7I0K\D,<C0;#C8,XM&,8I0]Y.?_''N\#WXPZ@[_CIWIEQ_ 2C.9_
M=[>^;.^UO[3WMW;_O;.]^FEGH].&9VWO;H,ET/ZRQ;>_?*9M^FEWSFC>A^OW
M/Y(MNMUM[;_;:[]?$RT*_=IO][97/=G>W>EM=[;8]OOVE479O"'2XYS[24:!
MN$\&&<P(XC# #";5DA#J"&,PYYY*F:+"?87[FNTK+-SW"-PW=[K"<1LP\QX%
M+ WB% @09%M 3&#JN64XT)QO7"UAO:AD6J5$VP( NWE@A[&"EW) M-FJ7IVF
MIYZM_^3)*FRV,#:[(K66=9HX&Q/R-%=!B<PAZZ-%C#F8/,$2%<!F'"\)4]*+
M/V/0+B2W5@'MO8!V3@4)&!.13R40&2CB#%00&W7*\8%88<<=%_+5&Z:7>*-
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M]ZF?;^T([BG:N^]Z6YV]7 I'M+^L"V@CW7C_F4#;CK:^?.INO-_Z,>?GZZQ
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MRI&Y!8,Y<H63](92);G3TE#A,'4TP+\!2WU;/:2 ^<' /*>+ !-'*GQ"DM*
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M*Z.1H58@%F,(@(\*8!%HEFE@<^=R;@4#"P86#+P2 Y].K;6G@7=\$N\(%=K
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MMWLVQ$/;^U9.V^=EJ@M"C#5*>X4UMU18RK5G)D9B.->XF.H+ %);TZ8ZSJ>
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M/+>&5(DAQVE$7I$0+8E*XF$4!>,-1=1\_>EST*JG<<)8X+7 ZP*=499 C8>
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MQO.ZW?7?7IPH?\;-D[T4-2$Z4,2LREGI42#-G$".FB I!4D68@A%0$!C6,V
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MO@OXS ]\-J9IA-<>3"YND$P2P(=PAHR6'@DODJ8^>A/-T@IM"#JO=([B1EE
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M[2[LMR!PAU7[G-OF:_5;_4%&W S*YX#\!X#]8+][#!,9^G^^&F]D-T#%:RC
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M+R[RS7A%OM9_W<8W>S?L0V(*_$;%W[:&;HRM?2 XKVT_AC<7E 10;E0<[AV
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MZT]YM][.;[_L<EX[>Y+GRLF>(.>Q1SP0 T0P*F1UTLQX&I51D^ET&N>,.PN
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M(%[^9/-B";6.J1+)[T3J93N10(6PGK,)8V,K<VP3(UY,OF\9+TV=^)G(#(\
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M@J,VMUPR,$-%539%(#* 8E;9N6>R\IK@E^_QO+XP!VWP>3K,X%6HL[-S:5V
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M]]N7]F7[W=?+]JE(VS^ZV)Y\H08CXRIQ2(3UB#FQJ8QCFWDDM)F,0R&9E$Y
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M:EE,]T*<;:*Y.Q9$"]K90]HS_ZX6Y6TV'!6Z<=ZQFC;^3E&1?MX-R]O?1>2
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M_I "DS^6Q[$_K[#S.-ZEQ+]/U'D0[!+'?XSX\-B-'R68_7$&Z]UZ0&M/=]]
MJ:\;70WQPJ5+-.:*^C>C&2ZD(E>>F$)*JZ?#_2P)'"DLS<SC1*];&"Z;7?DI
M ^JVA1LVM2?QK;;DMND0-\[V62V9^^B$NA45!I^@LQ?K%J!M,9K22^[J=GJV
MGHH[S_^/<43<RR2Z-D5]SDA"T^CP9Y6_N6?2U77V\C-P3_0^.YW3-OWZX]!I
M?_GH=V!LG8.O?L<]O.ST/L.8VF!L??S5^?%UL>33Z4?2_M5-VZ<??WX[./<Z
M!W#OCW/OZ^F>^^WT6^_KK[^S;P=MM_.CB_&A/^?=$RYWO8 FKNUX7-F4<FXG
MB>O;81(*UU&.\CG3]67=M44;/+KKX3<E+#[/HG=WF_P?@W\"\,Z3(4U"'E,O
M9(PZ,N01B[A+/"'(7*_Z!O^V$_\6FWNZ;N@)DMB1#!R;$D?8C!%E>PX-7>J+
MQ'&Q<*G3<DCXV/BWM17MMD+7?H+Q8M-LC*GUUW2J;D+!'E_CG-X.3!SOPS;
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M\).37HH),6TI4%Q9C .]F$YR%OS_WPRVO;BR MU*QFW5E^>7?2GF.KJL5-E
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M(]H@]CP1>L[.:^JTPI7'6@T$-A#X3""0$$I(($(5"$8C26/)DSA2C =!$LE
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MF<21 (*.07GQZ6W-@N:T8&W8P)W.Q^])$$<A"QU;"AYB37O7CB5U;0_+M/'
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MCX_M%>RKT;51<:_"5M!HMDWF5:V)YP.3SY";- WCX],.ZDMY[:"J<=\\)C,
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M:2*PHS;W;- 6/<D]7P44?13QC4X*I"SY<Z!#=_*IP![/,1Q9.\D6OIBD"Y9
M5Z5*M7].7D=ZTUZX>>J]E3GV?#,8HM49#+>W1 D)Z<X:$A^HNQOZ3>[#4\U]
MV+01=YV+@KQZ;$_$*=BZI0+%9Z\O3G0,+TB@8_6VKKJP5Y9R6&Z)-^)G^Y0[
M[]UO5U^_\  ^(5]_?"1?3S_]Z'SY",_XE+9_='N=TW/WVX_#JV^G(CT^^+O[
M[<?1A7CW#Q7_^3O[YF87R8]!K_/CG[1S\$^W\ZY-OAU\=KZ!&#I^]Y4<GW[K
MM4__SCKN$6WWWO;:640Z!^=>Y_0S;9^>8\'9[S&34>!+8D=QZ-B4$F;'&'HE
M,2U&NE02$<^[)ER1P/_QV',<29,D8DR%Q'4)4TX ,.3.NR;V.#>NND\ZTT2[
M!FN- 67%6<%ZZRX?<^,8M_',?-I2B^O#JH6#<SSQRS.=1_L;=+U@GL<J9NJ?
M37;S4SV@)Z'6;9SOCD_WOGM![+I^% *W.:%-&:4V8[ZP0<H[-!92.M3'1J W
MA3R.L/YV586C&&](.='0YH(LWK#^.:I\.OT*3WM?[+PY_J(]6.C/J)PMM:,'
MGE3JNA"ZUK?>7!U&R09XP&),%9&6FKTM#(8TB523=*<2P[>FQP6&'] 5$C%>
M/9#&/.V9S\=WC7KC"-_^=&Y6CQ5GJ;9R"&@I_]6R!AF86MJJ/D7_P<GQVT_5
MT.L8SNGGCH=:AZW5/AR@2VXJG)M5 K.QKH6A?2G5D<.,5V <4#*97IWL4L'=
MY NS#EJAGGT6^F:1D1,YO)2R#PJX5MH#QQ*@I;7T'[H<TE0P6E5'9?(>/>2S
M'";$ 272H=5-2PQPJ0)5*IDX=@Q5E"&6#G3)4;IQ8@V-M\BXSW!7*O5:#S$M
M$)/,'HW?APZO83H<#4W&/\H"7;*ECO.K+RSF2%<O4X*KD<(K]+03>97W156T
M"?V U5PPOP6KE. 8=-2"GG]>P,IA5 3ZWA(@^&(T&/*K22V9*N.Q*+OI8!?8
M  N@8,Q-(;6=/O%CZ(.I/#/1#DOI&=\,# 2#-I/2A<\KAT+-@GB,E4EQIM?J
MWQC+^+/V?<TM ]/ZB=Y0$X*(D1!\RB\PGC#77D.LJ5@[NYB.5T#BQ_$8I\+X
MRRJAR;A ]1X/V3DL4&+*_BRC!."1,N_W99U.F!:K"PM-OPXC*N -946W%3;!
M&L"PIA?;U"&"N53"&ZFDJJLU@:NE:UZGAK(JQF3)- UGCTM_U3[DVN_>RPMI
M'H!TF5Z@>]>XD8?+0 TW5Q-D7Y[E0^.G[9O,R^4)+DN&U!IGS9G;QA<@=_7&
M978JQ*GV^2_\HY"8;J,5 9&:"+=)['F5D*87L@:)LM9\:WJ"4=7E>] 'MJ1G
MJ;>N4(4MTZC>YG61$  S2P=#E57H\^S\J^UA17&%"S<)!RJ8D#/4I\G1D+.)
M30(>J7)W:XH=<_[ *+<Z'G@CR0!3/3PT@T]TMA- XD9=NY69]&OONPB(PW@0
MV8$7!U@F1-D)AQ\>88Q3!5LD/5#7O!M]<KN6==2?"( :,+1<7$9NFNW'&?HZ
MP613B253N:88FEIBU4>D(EV3M8:S8S4AL:<1)KIY^CK]^)V'3(12$3NAD6_3
M "@M4CRQJ9M$OG2\T-?F@!?MKNJ9-9/J/2:G[BQVF4*3IAPG:/=Y66Z<FMZ!
MQH7M@X[[2$O':A&I&BJZ#15U#KY^=UV7!%P*FT68PNP)0"G*E!UY8>Q'B@$5
MN3NOG9MH:)+DCK:65K9>&"-0OL2#J!P+O*+^D]9%OE#.E[KD15]W"3)JR!#^
MJ5/AINJ:6G<0RO4QQ$2W1$USK%5N,,$.D/A3-8S3O/9F%0VMWHI6?^Q]=U7D
M!P&)[2# G,](21N0SK.)0I$J6"AXM/,Z(C<><M7%YVH+8V^)=MLREQ3UH61E
MQDZH"IZ3R"[+%-Z+FMU=-;9UG:36'NP%IW6%BU( ]^R5B)4ETF MC#]5*H+^
M%J\_D,C%9WU0EL43JOZP>=K\]?D[<5R:4"RF'A)N4R3+Q'-",%$8=[EBB52@
M[?G1;5,XQO8C$&".>IRN1W(-=,X6^%EFKQFW"TIT50-C6>4?UPD5:-N/ W!Q
M>!?&_$MKL_EFU-8/5%E^:=P/.F*WT*5ERQ$,IAIFB<50%M)1JR2G18MJJ1ME
M ,/^6>=+SJ:.UI565MFJUU;1FSO5?!X'RO$Z#I3CM1PG+ZVCMW)9E'JT93'=
M"05J-II*7FDO&%X%8V);,Q8+="*0)__GYOT)=UZ?FBA[I3LQF !?]OJIG I?
MMR%'6&D-$ 2#<*LZ_N.J<AA5/BK+.KYEK\^RJS+5$#D6F;@@)IY*7_-I4E__
M>*R';DE\\U;5$E^=I?*H.2EWS-GYFH] ,NIT7T"B2EZ,JQ.*6?I@4_0QVX&!
MS]#(TAX,H">>26T C7U[*\3FY+%C 6J\XNA:U[Y<'%L_']8"&$;TT>159E=
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M 2U0O,#O^/8GT\!06^& OAYF_#S,PX$B8;"MC#'D7QEI7$GOO0#>-LY(!60
M+QJP3!^\V&.N/>PD,U<1TUQ&>H0\,T.8$1X742/<:QHWLI>%:5D8% $2*#H#
M&M<<_2 *M= Y^"N8JE'J8S?18L;$8X+V1PRPEVB-E#;%FO0(9).@@46E]T93
MU6%MI/*= ZWJHFRRF5><+.J;1&N4'R*ATN+C,#L3>"!2S_TG?(*$+7=R;B)Y
MQX+7>G'"[(6"&(5H[/#'*$0^"!AAUC)1D_C9.SV)9$-2K8$14F$R570^O3'M
M#7,$0)JX23/&Q/?$R]=7O8&)9@*GPD)M4#NT:Q('I9>D"7)B1(VLE8BH5/B7
MAFXOH]MK&[J]"O2EMG1[Y5HE!C#&(9EJ(D##7<?..7Q6[%0-9C3+N'' -(P;
M11HJM8>@!) HU8/>"SS0P)+WY5!O:&2-B3<N5/2O\*O 4R1EFN(T>QAD"<:0
MK#GV6;U<69FRL>R+Y=,;_M>+]7-^W7M102<4^9G2,<Y$K8F82LF3TC$<]:'Q
MF'9BYC+Z%(Q2(MPJ##QSYRZ03]CS?722+M]L2'2TR$@!\_R\U$?7UW:OV4,#
MO2WS4:=G7U_OGTSHRNZYAR$^:IUY7]L[4C\=IZ\;MUJ+L&)=GGPJ[Y7K+#Q[
M9/:=Z]/BO3H13J3-9L602>TNN$VXI(S@Y@7WTF(@,R.\'83W:G/A56_GJ\N3
MM:Z4F=>C)5B")0?+?9?=EA8:5$T0+P\W_"/5#FPV;K?5M;>MYWR&NNM]EM<8
M13X+16XW[7VC;QE%-HK\[..^:-L[%V)67H5/\F[3AO/JV#N7,E:_4G$S&=2S
M4+$N3Y875%8K!53AHB3'G3T090FGH1Q$4F"2$ZLNL((B68QA4OB2Q]AR&A;&
MTQH69EA5<1*5'67%>*IN1-7G<8W(5(JH@7_&?)@_M88IY5U%]GY=K?(_(AZD
MOHBL&[ 2<5PH-PF&\P5%JM9FIMQ$%^/HX@_=/F:#(^B- 'LA?!^+?4:Q3#"U
M"Q/A!7DOLOP<UFB*R93>_%LD!O<RQ%+&Z?(^%6JZ1MBLKBP1OD7S8/4]H@^T
MAF*:E6#J<IL_N:C6HC(1%NGMV,-)^$4.T<:I@L8?6)XR^#/U4.[PRK^+ 'XY
MM;HT,:YM?5F9%R]3 FSRI=MV[&N=?&S,2 5&\Q(LO/[2@@EMVKU7,(N1+H?:
M5&NV51J[IJ65F1;=3N-$CL\LM:T&O6U:NQ)Y[$[7V3&/W6H?)#?<NCI(OG6W
MC+/IZU'ZVMZX/[7PYNKRI,ECFSQV=6;%Y+%-'MODL6LC/)/'/OX.?0IY[*5'
M29,Z.:/4B=-U[)[) 1I%KKTBMZY,,MLH<OT5V6W9G=/6XS/.:#L]NUF]R35I
M[1-[TJ2UGY[67IIUTOG+[7/;>TAMWT,/9:1P>!2HCACW4U\0!HZG.XTYY'B*
M>51H,!U/-)1.%;++<ZGE!K88YW)=D5/?*E._.F&]='HI:^UTNZNRUN[5;-K:
MI;SUH=5A\5YW+7+6_X-/6N]@F!7I_V&SU?EP3^'ZM4E;F[Y6KJ\F;5W%H+A)
M6U=6\J>8!S-I:Y.V-FGKV@C/I*V/OT.?0MJZY#1ITB-GE!YQ>DW[JGHA=)/G
M,XJ\;>5%VU1>&$6NOR*?/!K&&>>K6U4T429=?6)/FG3UT]/5)6FG/%%=E4SU
M(/)H15L#["=EHN68^%*0Y@%D(.[DF$@"3+9Z)EM=,KN<I^ZU5]ZN;MIN,4_=
MM=WU:6IKGQGJ-:NDXJGKOT9(:OX+94X-&]4Z$[3,='[<ROC0DN>5=D?BY\2U
M6F>MEGWUBAYI.;;SB@@TD-'*>Y"^XJ IHB[,MG!X*XB+LF )F<VJ/UVA.J/1
M@6?%.I+>TLN95R=.8)H&X5W@:5X@DEL*(L=Y0@Z#-"#*K!^P0<C7Z02?R9F]
M0-"9Z=W4HC(-6 A*8XTBWAJP(^N5P,H5\;#U.7HNSH_5I6-872K0E_JQNFRY
M>]]*<@4;UE]E #ZF3R;A9@@JX\6)(OJZ^,M_7+EN\^?;O_Y%C"<_W]!?G9\O
MK0^*)_# UG/ID*KM!VS9[76'JF-8H8T+^K1J9"I1YWH^MWN]8ST?+(M#U')U
M>P>I.^N:OM:GK[V-J5]J$<ZJRY.FGL_4\U5G5DP]GZGG,_5\M1&>J><[_@Y]
M"O5\^G1EJOG.L7;$Z;AVMWH5!J8(RBCRMHK<,O S1I'KK\@73;M;*<X-4\FW
MKWEM5VI>317?B3UIJOB>WN\LUR1UKBGV\6LL)EE)J<+#VRM#QG9E.PWHH/"Q
MVD)"K_/.OFP7H%((E28)!]^I+S! RDD7GV[9;?WT$JZ5<1@G2XE6")S%[F8O
MA&'-O(E*0%:SD/!/QEZ,Z#!<1K+X>*?X^%!.(CGP^ WT_#@$F_=O^L"VWI?*
MI92J)J. @6^&F*3V^FD21K%MW9+4^O33);+3+>85D3,/*HVB2IP()U%-^4HM
MT(WJHIKL@; O^I[O)3@1^&O025#^ 31W#RH6T]L&JL:R+RUH*I!#VWJW,!F%
M*M40MHH-NK1(]S/+M -_AE6,R?V9\>>EG2Q%G"O+%]$=O%2.)WXX!2V?A!.$
M4E(36ZP=Y5=3GV@8F8+D_5?=2>9JT&9X?5;J2J&MK(_8VLR/0-ZJM';D/<(S
M(J9U('P4O])7:Y3Z?E;N"K^ 7?=^MAFM#@M]R/5DMDCV/_,JV:PV5B34O[Z\
M\X( T^CP*F(+.K$ZT&]@AR@YA-)Z#_/IAQ.J4];E(]_(;+_7U2.5*!6MANCF
MZVBJ6KA2WOM:%ZXHI3R)NI7=<:B:[>N]URQ<V\V6>Y#ZBK/'=JI37PT.516S
M8J9NI;*2/\5$N*E;,74KIFZE-L(S=2O'WZ%/H6Y%':Y,V<HY)DF=:X-!9?2X
M_GKLMNQKH\=&C^NNQQ=MVZE4<8,I6MG/O#H]VZW4Q)JJE1-[TE2M/+W?.M&4
M%:VLKE79*R>.M?CR%&F/..7-/RMBLG!:FP"JI!@2\ AE=;D$@)*Z.@,.+XO3
MR22,"&TD#.Y";%>_;Q*%?\A!$M>4E>>;C),H'20DK(9UBX (\LX;6+]%\!XQ
MR H4/@7P.8-'+( BU&O(54SFSDU#G$U#,C<-7F$:,E6G@JB7CF,W9TJL7K9:
M.2K8EDNP +\T ZU4]2G?0+Q8Q13=549[=]H*2@>D],"=J[1[V2J@O^U%"QKT
M.0/>S5E4,M>Q!+^)RL"HMLNV_B55)1A^.Q&,B3<6?X21*AU+@XD [RPJ'98@
MX,!Y6"9EW[&E2(X%;G^1*CS*^MVVER&E/'LYCO6,/=ER==QN96WJO&RV&ZE:
M3U=V:VX]-0LK;#]FE1#KMK3ZA06PX<N7KUA$G$Q]PE[+VL_=(2GS(DVL@Z2?
MZ#Y)*C6: ]#LIS%,2ES SU3@;3N-=%.L-G?%"#=ZD8CC$"LCX2<_8#Q,JXDC
MB#/(NKF!PH=SR*"JPC3O! C-3[&OOKQ#?%+ULH;5%\%WJ@<&>VK]'GCXVG_
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M#UZLHF$SL!MSB!EJ1/B;O@SD"'I%_(EW 4P\%3$QFV4X47 R,AIX&D('&WA
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MVJC\E=,-Z[/>BM9/\/^GB/-41'%+^^'3%E2E"Z#+%]1'+QG<[S3_F][:>9K
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M7W4*1\_&BM^]7?$[/BW Z?0A]!\H<<-#F/E%IWC(M:U_P2X;8:AQ0NX[B*(
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M2IHL&J3Y171##5*TL*#Q0:@5B&<?[60+[23K6V:6H8\IU?525+,S_X %_0M
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M4B\ ->'SK;TNVJMR>W>1E6N"=?A%/F(RW?HJXQ#T_4,:X7_>_5N"VO\CC-)
M-*R_"Q 5+M+_+^$,0Z;B/9D*>/#>HV^^R0!>VO?@$UBG0P]:U(_<_I#@0T%K
M$9@'ZLE-B@S3?O[0)>BG2,#5 E,5Y36$)49%VZM9\Z.=MF%V#BG($)40.>+O
M6";8@3\Q63::4O&3IK)D6<>%LN\C'&S^F1WZ%JL!_GE)=A &CK7B*Z-+NC"B
M&*0D@0HO L_63V51DV;6[[ P8K4J)R%&OHL5$-!< ,N8<=K7[&>P;R7+HU)2
ME7=@#/A^.L%MAXLJG.8KL#M@L@.VB<J133!PM6X'I=C;2%4Y%\)TQ5V2'%]V
M:[%U4$4MM&$652L7&^]789K C 9T("]5.]@:YD-C=B>+C.WKJ+9AIMYQ3RI3
MWZY1IAX31U'HL_V@.NDANAOU/#M]]L949(#>!9BF#[1Z0>_);U=9LB</MF)[
M]J= ;1^4TL*-%$T!;SYH0H=9M06O?CW\23;\AG)>Z?X$[-PAM,4<R[#IB6":
M_:XBI[7YWG,1'(8$P2,$JPS^'$M$;:>\&<MAPT)/0H$]@'[XZ%^*&#9PM+Y8
MGQ=IGC0.4ZMBZ(H,&\<4R:&>#2LDEQ5W0ML")= )%-ZX6  XE/7S#Z=8C-/+
MD:^#1A@JXNG'XT15!(">$G07E'K 1VK8RN  '>L %G2WH,@>'@K_3$EDG >"
M^?XC'=[QMT%QG>"8^V E1AX'D>",$'N@%*8X)"L.<4UQ2 7Z<F+%(<L,TEPT
MQXOF2"RJ$"VLK!/T0=DU/H_GQ99;>C\5D6K%O"V,D.2;3",O7*(KW!BU* 9"
M\HNG\E$.4E+I<#3R!C)2*J^_SP_BZOL&Y7#5'J7N(\AY?W8S_\ZZ$'@_:W#/
M>6(/@\;P/@X8?TLQT>*TQ&NG<R$OZ:=.9ZC^5KS&/L!<+AY.LX3$#1^-G>M6
MNX'!"C'FFV(7^(,7Q<=>7%[2$RH\(JD8@>7&MRH'X0.%QREB61)I.-")RMUH
MTH][0?%M\<*IS!9WXZD:ANJ".7O)OI.>G_G[W1OJ&.$ 9 IJL>M8[E^KH'G5
M,T;;5B/GP:=/G-7QM<6UOF"8.K_=P"H-CN?)9<0=EVON(KYA%^@Z1'VAR-.2
MR0XQ*)E<-2,M&;)9R\S4:,9,C8IFJFAT+JUA?J%5U:LLO];+!P@TNCK)7$A.
M-;"RA$X42I^GEN]]Q[!9$BX^W]ANK/NK$MDTW-8Y_G7#KS???E.5P)^LU]:7
MW_[VX9OUZ=>/7[[]<O/;IR^_;AF3V73D5R<5:'1J%&C\+.] Z142 R;8JNUW
M5JL0X9V,$@%FT"<A3G(AHFWD)+!*K'L!EHU+3F[BOIW&ZD+G;$YGR76[%XM%
M;/A;QAFZMF%'&X^]A/-$:(-QAX-^J+2%2C:]RY)-[XK)IK+W<>R&2E!!:28A
M!>HLW$#@K7T,T(TD)D7DTCKTJDS1SC;)==;:I/8\H,#K=J>R-NFF,D:I9U^M
MMDE83(570Q"5H%+J5:G.E%[>*41/J= 8P3QT9'41&(*_1^R'^)Y2F[HBRAJ
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MN5G*!PV]33A#$61 C)Q0WOIB<CBUA&(TE?=U.2C"$=HG$JV8#^!\A5S.X7<
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M<07.!;* (4N>6++2MUX2^RJ@&[98^2Y,3CL--9^C7N/Z9-"W2PH/:U5S;;=
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M<H0S,G-^"9/1F]/9,I8_"**@%L*!Y$F244-(HQ %.-WHUEA'NV:SNW'3-QZ
M>/2C<,/@R!SD.URH:_/3\-\73>+I;*R8EY7ZEPV= <LH=>T2ST+RM>TC@V =
M@?8V%Y6B2V8S8=CNO8<B$AVIW:'V?#E#X&V8S+[.-;B0YLK_Z21]#%.<3SVY
M_#L#K7*)CCO0):3J_X@0<FW8AC(KG55(NG7)\;88#T"2]L*>#D7J:_"^.,6*
M],/X"M:00RXVD$G <@3%6(&@7)J75@=CN3+-JY>WP7?X8K0[6WJ4N&\;,T1M
M0W;S/+2,M3>WJ&.[)&CE1?(\)MV^)^M3C./O(D!=F?+8X_B2-#6C&0/)>*R=
M!B)$61 $3XH%+VP(K07LJ<?QMV+_AG'\;=CP(&'930!^C^-OS<JMX[/WX</#
M"(SCR=)M"R(*TOB-%Q!82>"8UX:4?\-DZV:M3RN.WUE.MB!_ZSC^JEHS;HPS
MVF>0W#)0F!R9@B&"S])*G[/QY5I:Q],NU-N*_G<5ZFU#O,<4E[^RECT$Z5>^
M;V\1^[M7>RU\GYA :9EQ60;%O \E"I/)*)&V=H%(&X?O5[ZY8RP?B9#2Y@0I
M25$[E) &E&P$5-FSXA@O;@\Y6N=XNA?=<64#4]F"]\R#\I*!#YKVGZ6]%YEB
M9&HT7N\3*[K;1B*V+KK;AOP-(_'W*!2XU%7O;#S#(&IF%$H'*&K=O&,*HK:9
M;GS:^S*KH&7K00>[(3X@T=HCZQYOF%](+TGC".!9H%5$SB"B9Z2*6!MK3KKG
MW\/\>Q+$/;)R/\V<YO#FT<%!MH('+0*PVJ]="44G=!(%0K".!:5D,JU+TV\%
M=-CB<T_"=ZQO7"O;UT5[/B*"E-CAT:@>LC(CHC>0I4G54@H0>*1U6!Z--2%$
MM0>QV0+Q8<M5+];MI_/]1>/S5YETRF$95M17AY$\&^6;W8^70_PNC^UC@1=:
M&&F<AI1-Y9,$;X($4UQ0WKO@?>ZON#5<T0$*[B-@?8?$A::K6^1J+7YS,7ZE
M_LWI0'/O=23R%Y5#C65X\%(CZ$QF%FII(NYAX$/S=7T7\GYBT"&IHN4::\O\
M$;WNZ\ ;C%Z@!5DX;6)&7T6=(I1@K9%91NP6?&BZD._"W)#1'?(YNNW0MQ/\
M%(9Y/N]SBO3[;V8?<;+XV8!KGYDQ@MA0DQU"D>"B(Z-0\DC\,,J*7@;]7A?Z
M7?KW*"@W=X=[3+OC[63\"2>SKV^/ RU]H:U]FF<?JRR+=;$V8D,%"GV&H+0#
M7EL;&NN1BUZ=*+HN[+OT=Q2$F]+N6Q?LW;+"%0O\NES>0 7O%$\),F<:E&2T
M9[G.P+./I@CN4-T9+VT+Z0 $\0%YM"(NT",BM8,N-0NCH^'<%L @>?%9U;%#
M-25%5EM (*!6BN=@C9%[F%798BD'(+./B=DKA+A9=*O%NN9*ST5AVE+]$5D)
MIT,"'G0"(C4'K^L,8HPI!X^%;(='+,XK%_5=L#L)P H1[U$6NZO6?_D'*=59
MG].WX>L\+SGQ@DD92=>0JKWL8H2@@R;36!0>T F=]E!&VV^!WT5_#X*Q8AOT
M:(#:<+4#ZTWD47C0HHXQ(&T?O,D"I)+.:Y<RNYY:^LCE_KN@]V#]"LG>K?1X
M57;FV9(P+T%?0GMIX:,T/L$/X<O9#C4I:6FMA8R*T465.42O-&B5M,J.?NHV
MZVK6#M,!".%#<FF%M#VJL."%KG3I9W,M:J!#[2$H)&#P&12S'((B.U=(S"8Z
MYS3O51+6=V4'(-*/6!162/RCB@Z^P$6B)VWHRU>(H(4$[U7=Q;2IHXX0%6>
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M /7A48>&6!>GX,]ANH(PRV&[$0M1PH/EC$!&7W.7.0<N(IV94M&UTKI'Q4;
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MHKB\D:&TA0]FH\&?3]]N:DGY#B[JNR>%;@+P<<Q)W5<K_B:LW'H6^WWXT"$
M=C?0G'S4R7,P6L<:PC40,AUQC"Z F!*I)*IU<..!!.6.UOP/(R?;D+]Y1ZX5
M0W@%HA>) ,ADZ=#4J,$)K>D"U"G89(L,:3/%?MT0WGW6P32F_[@A\5K;:1^&
M)W46S=R5D'+6M7,CC\A(8I.MK?HDH$X8?3+1IK 1#R^>>6CW_"XD:ZCH78)Q
MYJG; ,CJ^_M6'C[$!;P3C6_R:0<"M3XXKP 20>1DBB-YJST5#2O@2S#@(YT?
MANZ.+#<SL?IS:LT-V(=1V]"E^<WV<3R9?<#)R5D'T^B8,-:"U1[K*<_ ^Z!J
M'H%CL?:[+1N.EK_ZX#T'G>]/WW$CXK2^M5Z/1T>7H'@M<S92@Z@ E"<;WCLN
MP')I=(J&:[.9]G'UN4^233N09A]S7%[7'*[I!_PRVR'G^^9#=L[QO@/7M9QN
M+;5B3BK!0E$A&(=%VH AZJ*<969P\W&[&62O21M%?+U(A)NFR?#3<H'+1 $;
MN':!![(V/.FC0@7P,A"O-6$S,IBH6R<5W0%I-]?D_%FS\8+LP]%7#)/IP(G@
M7=*T2#YOAYO(I,)H(#.F7/)>LK29OWGEX_=O9K1DZE77Y,[DZY!UO5CM&]+B
MPXS.N?FRZT'UIIPI[ -'>D+0#L&5:@@9LJIBG:>;LG?.:K0QM&ZV<#>JPY"+
M3ESHX'M:O?J%S>:E=8E;TBE+J/UCI:ON%0&9I\RSXXJ.Y;T<<WOMSM!?'G:G
M]F/(#GL71D?+TF0M!%<6H>1L2>O1AH29OF*!LQ0,VJQ;3.(Y?^%#=6%HQKWQ
MKE1LG/8S!W$63=L 1L,TKTNOWG]BUSV)?YU].U"N(R-#)BU9R>KB%"211M6P
M*/=@B_&(Q4556K1)Z<[ 6W*TVO)O&X(UYMMOX<OPY/3,BBP9A4PF0S2!UV &
MJ011"F!%.Z6C1B4VJHF[@W-77KK?!(%[DWW<@F8-U>TY$"+5!9 <E7%$9D I
MD-0#EB FTA:D-;%$I;UQ&[5GNXMYEU_Z!)EW;YKMPVWR.\Y>C>@[?(N3]Q_#
M9)?>B&N?M;,393.4UWPI1DBGN45EA58R)U)::GF#L8R$6GDS6/O4W>R,9Z/9
M, ^/3V?#S_@>T^ED7G+_RY=T?$K@7I* /1^??#J=+1M<_1(FM9)F>@;B0OW&
MG+S*2/IV(2M)H4G@:;M7O[>V#@-7>2-E<PNCI!7V76VUMY-Q&<Y>CZ?3@;>,
M+ \R/6CCB)J(K,&SK$!R[TWBVICF32 OWKY_&_U!I.>Z\79/\G=P[OP#AT<?
M9YB?U0'R1_C[::7>FS)?Z_3-Z6Q: [%$@)_#=)@&5GO%L<X$-35I/<0(GB="
MK'+BW!N?L+6L; 7P&Q6G?DSL5:-?/0;AF$AS,AXM8#Z;S2;#2(0B$_C#>/X9
MP<7\-GRMO_QL,JFZ0OUR.@B^N#JH  36/6.MAEC]7N@YM]9Q$YK/=MH=]3<J
MFWMF=X<DS#6[ZT6E+.8;FVQ@$TNZB$@6HR0#4FNB%D<)1GFI-(8D?.L^)%M"
M_$9%L2<C.V2#7R?"XO1.2A,%R*(I6.CT%E*2@5.=CDC*0M E^^L)>[O/,5D%
MY!N5H=V9<E-25&M)64KTH(A</)EF0 8:HYM>(;C$!/ <0]$%L\P;33;;05:6
M4+Y+R[T9T["!PQFL]^DCYM-C?%-VI-(B8&$RZFA5 N6\HOL9J\^%%; ^!HG%
M9!U:EZ>T7<&^XH&/0B8?D/D/'6MLQ(>?OZY^P#Q\(-$*Q>N&#C5ZQ[0#%YV%
M8%(FI2&QH$3CS=!Q.0\5'WU((1T_3F'I8(JO1O9[.#FKEM@$7Z?JLKNP/4QQ
MV:,1AHV$=$=./H3$12\C]Y(#*E%O-JQ5O5P ,TEK(43PL74FV<-(VAW5:4]6
MT+9AX#X"<"]P,OP<*MR7PU$8I6$X?C6:DI8Q]RV]7 Q>([I^K/ZF99_;LXRZ
M7=I;-WGOSH&]]JN_%@24+'L><N0Z,X7.!B$M1Q]<U"ZXH@=-$.S:Z/,,PH4&
MS7A!+=& QEKE6>L]72Z.I-9GII6.AK4VC5? V+V%Z=DC?Q]7T0C'ST[J#,%!
MXB5JY@1@B;3%8U80?*"MZ+1G(CGI<NNT\G58'F :VH[\OMFNM &5>PQ$.\>U
MT'()@& :'1BC2,M-6M )3ZMUW&1IZUA>T;YO[14(>QM[UHW#VU/RH8W:F@/S
M_'0RP5'ZNBCGD]&@SP6XHN6KPHD0U@6B"]D]3EHM-POHWY$V=/F=#S;,;!>^
MC1O0KZ&*G)88!L^.CY=XAA<-_3; M($A=C[W>OFNY>#KY7>7)E_?@F7_N;7W
MY\ZX$VGWQ7;FZ69!1E(<4U@X+UP2%I#+Z'BV,NC;M)3'R^Y;,G'[<GL;BO;@
M\F__\?M \CJZ.5H0)7A:%!8(*47Z%T\\LRQEV6AX_:9<I7?N3PEK1_WK[-R6
M= TUKG,,O_SQ;F!SX28R"U$I 4HQ!YY6!4*3WJ<DST7>YN'=FGWTSD-@W[:D
MZ['[GO^?_SVP:+DK"NG-O#J$DP(O; (1A1=**N_\;1- MF8?O?,0V+<MZ1HF
MXIQC^%]O_W,@DU4V)0N*81U"37=#=#62JICVR7+,M\[UWII]],Y#8-^VI&N8
MSW(A0L]>#*3UQDA"S7UM;9M<IK. +G03 G+#I#+ZMN2H[7??LQ>'P+YM2=<P
MR>1B47^\&&@16? \0/ B@[)T=GMZ?6V.QH*)UJ1;.U%NKY#^<1#LVY9T#7,^
MSC&\_^5_#P)CEE6K&&.N76N%@L +0E#,<AV<E=?[K>S&/GKG(;!O6]+=9)_9
MK;U1+7,B\W/XZ1@OFT=S$XE47\Y2G;96HRZ*^0(^D;$4!&H>:^,(O]E8W-O>
M\I0=/&U)V+J9\SI@2[G=!-I6_>%N?]\#=(QKQYE-^+T#69LW+;L#8F9%Y%!(
MNW8DZJ)HTM;HU!'*&\F4U%JZ1\OQVSK//0S#MZ!F:T;/&XY?W$AG9<9<):9*
M "<*KS,!Z"ZIO1XD(Y@^FE+XADV15CU^SRW06E+_1J_VG4BWU@NTMQR#;DD$
M>\H2V"0-( JF MF0VF%01=O(1:[E9*4D%T,(=Z0!](OS<R-C=-HN=&U%NAX$
MM*GZGK)+7,HL^\5$7[>/\R\S),X2)MZ%&?(!,RH7M P",ZG&H04$8VBE,7/%
MG<V6M1Z4?3NBQQ'SWX;WZR/".U.\:^3_6>V5?"TM 7WUI3(%,O/:@E(5B(IL
M'4''BG"6%FY:IR#?"NB0I&%7>G?(J5SF4)U=N\_#]./+X_&?_X[Y"'\E:M4R
M\P_CG^DV2\=A.AV6(>87IY/AZ.AW.L6Y^&T\FGV<#JS@CD[O0K=HG6/#7 #O
MR,AB(3E#WR'>ZA>_C]2T0?[TQ>L!.-AEGO::-*G H@F22).<%$0:7_M7$CA)
M>(O0M:UMZ^9_CSL9K<U1M .5.U2KWO#4%*V##PD*U[5_L8QDPW$&UD6)*10K
M=.L:_4>4C-:&P]M3\J&3T6ZNX4++?S><_G-NXY/Y1O]H#9I7)YXDXD3&+5AI
MBU.83/&ZFVC<Q/-H?)O;\'FMS.Q([P[ZR06VL[SN#_0WEYZ!3;!UJC"Z#=?#
M5!>UX^):\6C$@KV+26;&<[*W$%5MRH@.?+(9<K3%9N[0E'X6[K[$XXZ2H >2
MCBTHW]IQ.E> Q=+IAU)GYG4&8^ML1E&S%[Q*(%SD2,J-TV&SN2N7G_J0^N"N
MQ!ZWH%3C!I97DC>]-8+'.EE$N,746W#",>!))V()X\GG0TU$O\==OA/]>J1;
MK8JC;X+IVTA$WXH[FZ0FWX>T^TI$=Z'&VIT"BU&3/6,">&,,F( ^2@)7KD^,
M?B+LWC01O3FWMZ%HKT1T+;FA]TG0QM!UHQ#!VXR@1<)BR$IUM[9S?,*)Z%M1
M?U4B^C:DZY&(_OSW_QQ(+X6H(V%TK-J"3AQ\G4&)WA2;+&HM;_.K;9]+^?MC
M287=B7W;DN[AJ]1?C68XP>FLQI[>_QD^]0LIKWU3YQCS9BN\%G0NCMD8M<<D
MN/+%!L^%UMG9VH#-J;N"SFO?V3X*;;,7I) ;*-*(.JO>UY&E$7*M>4"M/%=/
MN=K<"&94'9E@=*P]'U*H 3 .:,@0M1Y59OV"[(_1P;\-OS=V\&]#Y=9S&Z_O
ME5_F'3+/ /X]')_BP,K$+9VG( LC%4G[ *$P"<(ZPRTO&"._ZW3:]&5/E\U=
MR-G5'?=R^ 7S9<0#GUS($BV$>2%)+ 0M)@^Z3G"@4SDB;]VDYQ8X3U<66M.Z
M=6[R!:Z_A\FP.C8JI)?'X_%D$&7A60@!4;*:B1U+[1^D@*L<;'%6"KO9Z-9;
M7O)T.=N4?'N(UG)OHE1DV4H; DE9+5,)UH,/QC-91\[F?O[U!X_6MMF[VU/R
M241KN7>")6_!VB*).%: EXI#4<PZ%WS1L5\VV>.-UF[%YVVBM=O0>]]AN$VP
M?8_6;LW%;>)Q]V'!OL4DE:P\:@^H9:H!*+)4:#L [1FR7:)2OJ,]^!2BM=VD
M8QO*=YGM<M6N.0M(.A1*90FRMDA3CA8>-9? JMVJ';<26\O#:B2/+-R[%;=N
MS%79F=2MG01U'/7K<1C-15RS&G@6>6F^(HL0,U\,+1>1<&1SIZ_RQE.?\N6_
M&XE:FW9G0):2N F4K<I,KS[_ <I*[T_I5?S:@4RMDV*N08I.<N2>[HY,LJP<
M0[)=@JU.0J%+0JU3>#0<NZTLM O#MJ%.+T8]6Q[-2=LHK H@0LS_O[TW;7(C
M1](&O^]_\5W<QY<UDU15/3*K;FE+ZNF/:3@<$M])D6J265V:7[\.,ID'169&
MD(@@DY+-M"QU5,0#]R< O^!>"[0UQ) <J" DJESC =T*F+8>//)5SV,DO',K
M/$ \0YU<KV^Q6),L&J$@J2AH44'1H@H#GUW*7OI0O.JEJM<7H:I#Q'/Z[.DN
M2WP1IKG6S$VFGUXE^JM5%_/?_GM6=O[CM]-UV_5_39:?)U,RY!:SZTDFPRN_
M#M?T/OSP&7$YX#W?<1<P^'WB$^IC*X6,V096!$^R]C4+V6O)'(M$Y%SHJ+'/
MWEL>=RFM?/;%;V$R7Z69[H.@"J.BKYH\AZ1-[0Y&SDA4$I+Q-IFD"J;A6H;O
M -3XCNSBRC'R@((70*NB70OIJ/&Q6+(I/,\A%47GS& +7&,XI?]YK,Z?N1/;
M3[Z#WHG^?1+BY'JR_+:N&UI^6-+W5+^V=^7N(WX_6ZPD_VO=#Q83<NI^G=(7
M.5_-T[AB#%G.*@&+KH#B6,#9F,B5CAAD<;&(UG=A&\*_3):-J]5!0Z;K#^9V
M'5<^1JF-<< +&5+*6/)U? R VC*NT F;A[L.]PC*91+G<&D/>DEZ#>L?LVFZ
M168T%\9Y!\5:6FWR9% K<GRU5\9)U%*&X8K$MM%<,A4.E/F@:?C-[D:VXH:I
MW-E@R#Z%D)@&E3,"F:8)N%1*DR.'-K6>(_T4GLMDQ)%R;]AG]8D3[YZP_0\]
M$E')JG:JX8K$%.GXB]XY2*Q$F422Q@Y9>GK\"BZ;=Z/IMF%+V2>_H@>;JV,%
M7?(%F([U-J/Q$#2WP%TVR0EF$VL]%_@92)?-I<.EW[!A[9/PKJ3*VM3$-XL6
M:^*;N!N# R;I1T,>8L;A?/ '0"Z>"+TD_;WZ;6,[]V"?36?K$_$6(J]3O6PA
MP9"@P&J;N ^!%RN'-8I_>N&GT>;WI'3-V^8=?O1J;@1Z7[=31]+TT=5@%X)G
MED7G,X8T7(G3L>@OF)ICZ?1[=OJC^_AM!/,@K;!XF 7XO3Z"@+[^MKNJZ/6W
MV[S#+[B8?)JN_NVZ7B7(J)$Q"<QZ4YM0D8!YM19S5B8R3OY.ZPL;PZUF_$KQ
MUIP]$TV_B/)SA=*@(A$7HSTHX05XS *,%&BC5(R6]0.4GY\+9?I4LO=1W=@E
MREVP_:QD[ZW%/K7*AZA@;)JP9++-7H(1DC R<J!"= &R-RZ68)F5P\5@7T(E
M^V#LZ"/YX9HJ;[I^;P#>%D YM"[DPL&2#LA2S 9JNT]@7"#MEDYZUSJ,\22@
M,ZMK[Z6[W;V0&PA^@!J#/47WQAF_:O^./-=ZN.3!^YR!2V&4XDZ0__ CWF\X
MA@<-1#WH8?&@AFO3HOO.Q/H#KU?VU>+SY.MJE[0%K8^!U6%5CDRLHLBI-!ET
M*2X81WMH&*X9<A^D/\W;L=4]0(W!#EBW'V078 -9O7M!G8_)VUJSLR'5,L#F
MMA^@8)+G$!/(7$>/LAC)RBL!I,087 C2-K_0.3)?#K"!3T:7/MIX0>7WC\9>
MW/[QMTU]]&3Z*M%K;ZYK:?1Z*MCLR]<Y?JX*K(\F-%B5<?HJ_+;K.)=B_ &U
MLU63[Z-50MO$%.=*H7<:,;+,O+$14\!6-?EM5S2 7?EJ!^A?)HL:FKTAT_@^
M%IV<*T'X H@Y@DJV#DVL\_"2$<%PY_*3W5F;F9== 1][4#VEC]=8R(/\&/ZZ
MXF@2>0D.M&3D*RJ23T0IP)/1YVC3]-JU;ES2"=@IG;2AV;5]B+77U* W![J+
M9^U;5$>B"*4@2E%G[@A-F+4#VK28*-*3:SJ*7]<%[/AIL[')-HX>7T36S(>0
M!"L>E$ST1=71J\Z1& 47B>D8-,;AZJS.)VLV$B/Z),7Z:&;L;$<7;#^38KVU
MV"?M<8@*1A_&H]%)EC7D$@TH4QO11IWH4XD8I4,6FE>3O*RDV&#LZ"/YT9-B
MT119!*'A(4I0)2MPA5LP%HUE+(M46F=!7E)2K)?N>B7%^@A^O*08SVATK*P7
MI0X^E @A>@-&!Q]C,CF:IX9+7&Q2[!@>-!#U"PH(KON>+UZ5@O1GTT\/NR/<
M57<N9F7M4IX^\'<8WG,)\#60]E8@+P8OHM,BV6"4%,HY])(9P<FKMPECJT#>
M8<@'3 3?N[.NQC7DJLR]%KQG*<!903LURER[_'$GQO##OD<V6"+\X8SJWVAG
M?!A&??.6-K#96@V_KK7U)[Z?S5?5UT&0C80"H>3:\LO4PFL5 A@6G):N%,E;
MGQ?-%W$FH;WC>-@Y"3Z*JL>*]U5Y';P@E1&+3PQB'<&I9.3K60U9%V>9IWW0
M=IIT>"QWCUG$C\/=T50]G NVF4WW*(>U$=W'V6M\N+Y?;N9UN@B=SES\G0S2
MSR13'<D-)=/3*\- :2=I%=E"\%)Y4X(RN?6UNC;(+Y*E)U#J &5'#YV3 Y?P
M#UQ>25&",]P RU*1()T#CT&!289%4G@MVQK0;SP<^452\P1*';3/R@Y!'7H4
MU'4EU,(:BX"JMI1*N4"P 2$SA3$6GET>KKM&V[5<)'W/0O$#-(FI2W@WK5DK
M^L0FTYM5B=B[\N@+_>4&/\[JT9+"@I;T<1ZFBY#J/WP_G\6:Y7I7_C%;ODOU
MPBQ]LU?6:NU-3."=J[755="%*6""813%B-!\2N$0Z[A((I]<X8/VC[D7V]YO
M<Y8F^[_(!W>]U__@W:ZBD]VWOB-G.D?'(!43H+;]@NAEJ'%THY ;B7ZX+C4G
M7/A%?B9G(=E>E!JT]0Z=5*N=X>T4-\N;XN).YE?>!$Q%%BBH$RB6)#BI)&#T
M)OOLHA'#]?Q]!MR%\[.E:@;MW].UX/WUM_4G<??A[+JR\SA9OBZU$:&@,Z&
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MW'S]>CW!^2V^4J\:.)N!JVA!&:SS4PBDXBER:R*J%#HIM\/++DK9K84[P#W
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MZSE&,D:<(-N$).MUB$*.40%R2>FB7O3H6'K61TVGJ23J /!GZ5EO5?8O*3I
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MHC(,(5K'H7A3DO5!N^UV?'MT_/1[+DK1#44Z\DQS)H4R-A20J"(H)+/(6\9
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M3]X#OBJ:>V=T!!D5P1351XO:@S3T803%?=GNB-[@WFHG:#\8OX90V "W$]>
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M2SZDSYAOKO%=V3_"X_>[KD3<,D6D2^"D)G,KU^;2NN9<C0\\$FM2:GTAHQ?
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MM:&635+)6D.RW;NHX8<Q:GJEM>*/D>2Y)$/VC@YGCL>8K2!N6A*,I9,_6%;
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M+_E>&NO61_P0<8_72]XK:S)G#*PVHE8@. C2<HC&%B:MT3$U;Z1UYKWD!^!
M'RF/WDN>1Z]5CAZXDEB'(B.X0D<4JE0,&BLCM@Y.OXQ>\KVTUJN7?!^1[[7=
M&M;]W/=P6X1I?C.;+@DY3M,$%_>_^79$%5"_%QQ=$W3$>K8JA()/MA3.3%)6
MT;<?8@[1&RTL"L]MNNKWJN.^XQW3TN_>L:2?%A/B1[@5UB;2QFSF7"A@VA'5
M;!00G [ DDDF2!.S:)WI/@#F4=[(_</3PX=_6HUXS$JP5:=K(^OHYD3FH0_T
MT3F7C>2Z-K[NUOCBJ;>,OV4-385'_DPS ;?V0_<L>37<\\/'VB4I2R$8)"5<
M=9%K%X&$H.NE%%E2=MNC5)_5_:[W_##:/UK(K4-&3T'[_>.5*R46\M+!8R)H
MILZ!T2("K54:%5AQ[MF3J\-[?F#]]Q3R $[N1A3KXH_PI"A"7!EA5RYP:854
M4!2OESP-K^ %2".$YM[X@JT3]0? O%Q:C:6[ :IZWL]G^28M[_"\2FE^$ZYI
M!5]G4T*]*;2E#9&QDD'JVA4U20\QT<Y8LHNF1,.T:AU=ZX;L\DDU@(8&*"'Z
MD#YCOKG&=V6'?!:OOSTOK77,TBO%"GT/D+@@'[68 *[6O-F$N0X>819;3PUO
M!'VL$H2Q^7<*S9ZZI.$)6:]":E*EPDH-=:PFNFF6(=;Q D:8$A@37-G612][
MH)PJWW 25NPY;H_1S@#1R5VPZH]SW 3BN@ <*&/Q++C3)"^:J+(#/8[7PTD(
M8XHLQ4L+#&,!%:P!.M03V.*+"())'EMG-4Y$E&<2'*?A21_QMPX)?/@R67Y>
M_!WS)(7K3:/ E)WPC(.S6 ?;H*FM> D>T[PPIJ32W=JM['CX61C4Q\A_UE!X
MK>-[O\WF./DT?3LM-Y7N'[XMR#S[<%.;D^!\4P>#O#B9%.10Z$0,Y!6&'!(P
MEZ-CSF@4W<J$.KSLHI3=6KBMO^155?<Z*A"N?YDLEO-)O*%_O^F'3AM8TL&"
MUZA J=JU+Z0$F8E<I) AQVZ!_:??<U$J;RC2O:&\AFG)7VG5*P?^YLO-=5AB
M?K?\C//JR<_Q<ST!_\2W4_K7^/ML<<P(RH/><W22\OC5;>4JC4[%*L69ED$)
M8@*ZD (R'GC,SLBK@]YXG*W6\67WKG<N5DM=KW856V\&. \^T&\=BXFI8B7F
MUJYB7XS'VJ\=W_</7+XK'\-?5UG9:&5B8$*]],JMJVW4$'@,)B7)LA>M8SP]
M(8Z_20[*JVV+=TB%#=!FX2F,K['0L?\'INNP6$P*V7FK ,0==,^+<H'1@<+K
MW$\I/#A7@PS.<V-#BAQ;WUL[ NZ%\VXL10Y2<O88V&\DR0ZRN[W@N[Z^=[<6
MBT(F;^J\>HW56Z7OR94,B4D,'BTMTS<F94O\%\[2DZEZ@&QRI^W=YFB\= 68
M*20LG6NQBTRU=9?4AM5RF-;G\<]#N+UJ!L@.[\/X2U4&YM<XI1^6[Z_#='$_
M^G0#_GUMA4+J6JZ]LAKN_SA['U:7WB-&D77MLBKJ+XH5B#)GT,Y;X2)JSUM7
M\0VUEA^4IJ-28("$=4<AKK-4R+6R,CA(/$I0SA0(S@D0REJI//=%ZM-X+*.F
MGL_12>FOH'-)+G]8TMKJ@]9AC+N"CL4JH^%S+(S\+? BIAH3JW5!Q9,DL]<F
ML))3:QOQ24"G2C0/1X/M.H=FZAC _=C"M+G0T0'40'GDG8!.DSMNJ+C94%(?
MC1*6#DYF4(#S7H#*2.!$9A!=,8RV8B>2>[E4>"8[/#83^@A[  8\V!H_SLG^
MNEZYJ_=6V.9RE@[2*E] >\9 &<P0:X]!Q63PP=29<P,:+T\@&]]R;J#&_59*
M*QT,$$%]@)),\[_1HNN960,;O^!B\FFZ.EWG_]]-N)Z4VE[W35A\_NUZ]I__
MPOP)%YNQ"*84+,J 58&0)Y?!D7QJBW 9LLPN=&N(?AB/#L9]82P;1W_#[E9/
M^HZW:*./.GMD8+DD4TY;35Z#1@BF]C)7VC#5^DY#/X07QJO6.FF=3_].H2O)
M(>8O_\^O-6V\F) #\.OTYLM=\?-BV2%YWH,T]86+>];45_=+FC=8PEV&_-C&
MY>O+!/52[SIL_2HNEO.0FC?(V/^BX[<3\M'S]R]HORGL><_XU_J?U=J.[_MI
M(0VPSZ]]\CM3?"!B[7O+\9TE<'J#]62M9>OUD?^:+#^_H7V07C?_]:]T?5/[
MQ;]:+)#^/]<T1>M$77\$HS/Q&1WO:!YQJ%3[3HFY_>/Z2PP+_'__K_\?4$L#
M!!0    ( $N,J%;\+V&6P38! #9)#0 5    :6-U:2TR,#(S,#,S,5]L86(N
M>&ULY+U[<^0XDB?X_WX*7.V-;;>94,4'0()],[.FS%16:R<SE9=2=\]LV5D8
MGA*G0A&:B% ^^M,?P$<\%!$,  %2[+LQFZZ41,+=?R!^<  .]W_^G]\?I^"K
M7"S+^>Q??HI_CGX"<L;GHIS=_\M/?[E[#\E/__-?_]M_^^?_ \)_?_/E W@W
MY\^/<K8";Q>2KJ0 W\K5 _B;D,O?@5K,'\'?YHO?RZ\4PG^M7GH[?_JQ*.\?
M5B")DO3E7Q=_8C17@J<I3'"20)2I')(L1S")&(TC%K-$\8O[/Z$$13*-&:2Y
M+"!*TQRRG,60)Q+1M$!Y'.=5H]-R]ON?S/\PNI1 &S=;5C_^RT\/J]73GW[Y
MY=NW;S]_9XOIS_/%_2])%*6_M$__U#S^?>_Y;VGU=%P4Q2_57]>/+LM##^IF
MXU_^_>.'6_X@'RDL9\L5G7$C8%G^:5G]\L.<TU6%^4F]P-$GS$^P?0R:7\$X
M@6G\\_>E^.E?_QL -1R+^51^D0J8__[ER_51D<4OYHE?9O+>].QGN2CGXG9%
M%ZL/E,FIUKYJ;?7C2?[+3\OR\6DJV]\]+*0ZW.QTL=AIU6A9&"WCS&CYWX\)
M^^4,]0/IN]K7-8!RE;F?0NG8A>FG8.K>:7Z0_2N\)>9LE>L/ZFHFAOIVUZ+.
M5KU_C4-]%O,5G0[P66S$;*D\-;_XH/_5B#$-=9!I):>A[BU5Y?>5G E9L^5.
MTZ 4__*3_M?D>0GO*7V:O'E>EC.Y7%[R_WHNEZ4A[\OOY7)2Y%@)BA-(HIQ#
M5$0YI$D104&2C*0(15AED]7ZTY[(&?S+;:M%)<I*SD\.=JZ.C->%7,Z?%WPS
MTSU.#TU?>N8R<QWY948?Y?*)-B]H98U34.O_KZV:8$M/\)O1]/_YYU\VMOGC
M.AT*K>GX@)KS'76FQEF8+U[",.>V,&S&X%);4&&@Z))51C1-:$"2Y!<Y72W;
MWT#SFVH@GI+RRUXO7RY:"^B"G^B$YHE?^%S[2$\KN-,?QJ=T,G4U=_I :H"U
M"C^!^4+(A?:!#YBS]]%^D7Q*E\M2E;4;]UZK><FU:_P\-91ULWJ0B[?SQZ>%
M?)"S9?E57FNG^E&^?5XLM/-<SQAZ?KY1=_3[I!!21E([;Q1)#)'F$T@Q(I#S
M(A4DQPE3L0N#A%1N;+3STK9ZT;%E':C, SOV@=K "]"8"&H;+X"V$LP5T':Z
M<5;0[K<CNM?JU)[9<?#^=*;6/H /Q,=!51N4Q/L ]27S]R+#;;HH^7,Y^:!G
MG[L'.DMR?#>/H^BC?&1R,2FH]@Q3P:%$0K,^E1025@B(%*,L*R3GN;)A_0X9
M8R/OJ=9R9;1\FI>S58Y7\]B.=[MP[*;/0.CTS((&&&"0 <G/.08:EY^C"/Q6
MZVGI3W=A))I=NVH<](W5CK"A,/N30>Q\TK> H.9N\Z AY#1*Z_VV_][UZB#<
M:J%[2Y$VC_HYQII#%Y(NY3M9__=Z=KN:\]\?YE/=QO)*^^"K'U_FT^G[^>(;
M78@)(UG,XY1"Q$6F_R=#D+$H@9S$*,\48AEV\GT=Y8^-(5OUP1]: _X(RAG8
MMN%_@-H*\)NQ S2&."ZZ7;O)SD?M$?R>";@'W)T=34_T OF2KM('=1<]H7GI
M$?HVX^'T:4=S\2R%6DAS^#5),:)QRE,H<Q1!%)GSJS0ED"#&,J6DB')B[>SM
MMCTV"FNT XUZ#L[+"\PL'#M_)'KFDV @.'AN_F ,Y+'9@N+FK1TVN]-+>_'*
M<-[985UWO+(CC_AY8\;%D_+F22YTU\[N/QC2^U!25DXUTWVF/TRG+]\]RPE.
M&5521C!"--?\1#/(%*90L8PK(606*>KBAMD*'AMYU7I?@+7FH%+] JR5OP"M
M^A= &^#F=EGWAYV_U0?*/1.C#<"K.6!2PUR*<,Z5*U2!O"IKL8.Z4ZY@O/2C
MG-_W8Z_/B[DJ5Q_FR^6$YB)3N<"0**K7BGE:0$*8A%S%@IJUHDCT,G%]4'QR
MY&R:=F*@(P?>(0?(IZL[\(</-[>W?P37G][>?+QR8Y@MS HATR)*(J@PXA#%
M)(4TSP6D N$,<>UUILB%TSTQ&X"US;;_'XQB?VQ.!KPQL^-=/R1Z9E8#0FU]
M@\6%^7'Z;$+YP.?YHCI=N5RM%B5[7E$VE89G/VG"F,]66K^I>>QZIKM++@.X
M9L>A"L2L6PT/RIW[!KUDQP-/>//?U]($9NKUZ+OY,UNIYZEV#^?/FETG*L=9
MS&0&4Q+K%66J!&0959H;29QF"<MB63B.[J/"QC;>U[H"-5\ T6@+:*.N\^@_
MCK(U'P3!KO]%::42^"*Y++\:#K@P<;RB7 'SN8*K[T]R9C;!OD@3$DRG?PQ*
M!"<Q"D<-QT4-318GC3Y 'Z??\2.4=U+)A>[O>IJXH]\OM1^W6NJ98Y*FN8RS
MG$.FW0--)XA 6A &LT(4VHU@*LFY"YT<%S4V,FDU;2=/K2NHE77CD0YP[5@D
M#&0]<\AQM*KHBW!\<1J-0&S1(6A0KCAM\$NFL'C#ER?8ZGJV7"VJ7<&W=+'X
MH;W#RT?#01,5)4+2(H6,D,S<V)"0F/\16<HP3W(D"J<3NRYA8^.*#_/9/=2"
M'H'1^@+\NM#3IBM-=&!K2Q1A$.M[J\> =6<+E@=!G$8A&$5TB!J8)$X;O4\3
M%N]X''&9KOTPI[,WGQ?EC)=/=-IL_4PHXB*-*(8J3\VEKCB#-"$<1DIFDBK*
M$F2UF]PM9FSD4'WJ1E/P!JQU;7>+P3\YG $=1];B3"P(7CU3PQ!0.9R<!8%L
MH$,T7^C<#M5.(M)YOG;\[>&.VDY:L'/J=OII-X(4LIQ<S5;EZL>E$+K[EY_G
MRQ6=_N_RZ>U<R D2.),BH9!0IB"2@D$BI((ICICB0B*.K,(!NL6,C2!K34&C
MZ@6HE05:6V#4M1OU)Y#M)LAP>/5,D+Y068]R.R0.^$]+R7^^GW_]13=0NT[Z
M'QN/Z42S@PQ_.]/:X6_YM-]"ZGTY,Q>_JP.R+^8\_T;]92FK9=I$D%P63"(8
M4QE!1 H)*><I%!SK\:\P)G8A01:RQD8$C:KMT6^E+9PKJ/6M-Q/<EE1=*-NM
MJ )AUS,IG(3M E"E^V_G^HSV\Q>K\N^55Q)N\64!6*"U5Y>D09=>%B:_7'G9
MO.*Q\*I.Z695C]+INW)9'^G-%TVP?YJIE-,BAH0SJHF%9["(BPPR1J,D2CG"
MW.I"LH6LL1'+CK9@2UV'%<4)="U68.$PZYE0CL+E<_7D!&X.R[%P^ VT)G/_
M[-Q68W: ="[)3C0QW+K,SI:=Q9GE*UY,^E4N5U6XTO7,[)-=SL1'NOA=5@$2
M=4#XK>3/BW)5RJ7^8_VKCW+U,!=;+]_)[ZLWVL3?)SRC1#*50KV2(Q A6D""
M90X++K% J. 4Y0[D&UB]L?%UN='17+<P)@(Z$V!C9'OI8F-F]4#SV]I2L&4J
M^,T8"RIKW=@K])=@-5&\8O_V/+?\?[EKG>:R5^SB@::_\%T=;-[L"?P34VUH
MJ4/.SCTA]F)"[TN*;S87<SK&5UK@[%[_(!=?974/@TXOQ7\^U]+B24XHB5G$
M89$E,421PI":,_"8%$66BEAF<3K9RV5FD=G#1KK5N+=+VQ8V?\>6\J#1_@(T
M^H.- :X)5JQZQ&YW)R# 0R5%.1=4CRPG+A@%RU]B)73@S"0N0.SG''%ZVSLN
M^$DN5C\^ZX]FU;#CDVGXDFGIE*\F-$(X+9B$"4>:J1)!($NR" I%HB13$D4)
M<PP.[I8XMH5%J_ %J%1>>QN5TN"W5FW'6_.G@;<CI*!P]LQ%9R/I$RELATZX
M<.$3\H:.&;8S_T#@L.6+OK33Q!M6E^9O'ZC^S&Z>5R:WL;EC,LF$3 H4$2@T
MZT"$&(4LCA&4.(XI5YPEJ70CG4YY8Z.<MW/MF"Y6I5GN/+6J@Z71_0+,-WJ#
M966)*_-T8V_+.\$0[9UU6@!O:P!K9<&6MB$)QPJ68'33+6U@LK$R?9]J[%[S
MO+4^G]V;@!RS,OQ(5\TR\(M\:FZ6WJAUE,[U[#\D7=Q]FT\P%4K$3'L[C!!S
M0Y1 PAB#&:)YG&%"&!=.-]@]E!@;);V,P&WLT'.Y41AHC1VOK_MTC!TU]0UW
MSWQU!M+N5]G/@"K4M78?%8:]XGX&2'O7W<]I*_ 2KPJBGPC$%,O3&,I(\QSB
M60Y)CB7,<E80'!49+J(@Z[M*W-AHK4H(KWVL6N=J12);A2\ GW?<7_8!^\PU
MG3.$K[F@"WY+PPZ6OE=RM;!Q+.-V#+=>P^V^=7XTXCI=QX3$)&>,*A@7YN8G
MCB4L6!Y#+A2.I!0\04Y[10>EC(U"7H32K?7T#SS< &K'%V?#U#--."-T5@SA
M'@(]1 ]N9+Q:W.">F5T1@_L/>RZGRIF\4?4]__>45TU^I-_+Q^?'-_/%8OY-
MK]C>4OT9F(]7R%2@&#$8\5Q[%DR:FPDQA44FA.8&EN3<Z7:GB_"QD831W:23
M;U(DM.H;[[XR *PM *T)CNLIEYZQ7$?UA'??ZZ> 4+LOJ#PP"[60<A$][ +*
M Y2]A9-/&WXW46]OWG]ILQ=]H2NY.6U[/U^\,?'7^I?FAI=>/!&$"\PDC$61
M0X10#@M3?44)%M%"I"2*[!/O.XD>&\%IY8'1?IWW"1A5P3]MG3!7&7:,$?6?
M*C/<KF<Z]$PWQ?6+=\\$-S:HW6[']@/Y<#=F@T+O?)/6';U3MVL=6ASTQJV[
MI2]OX7JTX%VHH$Z:\JY<\NE\^;R0ZU-\3I)88&Y*$<091#0AD)(B@3R/HHS1
MA!:)TUE"AZRQ30E;:7TVRGH'3'2!;.?/!H*N9W;W1LVG2, I/,(5!#@J:>CD
M_Z=,/I#H_^0K?K31EA-\.W]D97TGY8OD\_M9^7<IKH7FJ5*5)HJUSL5451W4
M_N_E3+3+>1/1NESJB4\TE:;J)S\OY!,M19."3S]?U:>J_S:)HEB0)&$P$ZJ
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MSQ??Z$)L^V[Q)$IEG.8Q@H*0'")&%"PPCZ!@<4I3B7 6.\5X=HL;&\UMM+T
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MAI@0G!7(5-]S.KTX(&-L_%W5N5UMZMPV:H)-.53_JL)N:]HSP>J9CU_6 W;
MZ:QJP/VL9@])>+4ZOB=6L%V/>@Y]S2Y2WCQ5X5FS^P^2ZF'6EJK[W-3^??<L
M3<7?]^57.2E$(@1/%%2<F)S?*(/$7&+ $8XHPASAR*GJ@*L"HR.-2O\+L+8
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M%F:]G!4ZY[DHJ73*\O24.S0"W*@-_EG94UQKQ4=@J_H([)3WS2-RFPDWJNL
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M&@$=]-DRK\=)*R[/;C+M6+M13CP$.V:;</#\&\8X81*K04R[L'X;PC@9?M(
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M,?EL(?V\!VF3RG-W@.A;>Z1[N<X >AL[4=,%K5@IWVVB^LW\=C#Z) '<Y9[
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MPSL"%YR0)(,$F2473DL*64$I%"65,B<68J]3"MX:#(T>&@- 8P'8F3 "1T:
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MGMUO-]=]F+'I8LQR4G)#O9#EDAC>I39E7""8Y(23)),YHDY)1.$J#(V-K7+
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M^&2PP(+G94%UFB+W?8/MN$.CF48SKS3@8Z1<5NQ!]G>]#+_==)^U<A $?2V
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MHR]H% 9[&M]\O/DJ]&ZD$Q/0CCDG"I;>U.,*4"3FN2JN5^)Q-?Z8=YSON[D
M=)->TA3''4LN*<\D@P)1>SPA%Y"AM(0<,80PTE1A[KO%<T;.T$CFL!3TNK!R
MU5XOV M7]UV:&]'J83MF5UBY4;+3RLKG<(A?8/E RFO563YG:DNYY;.71W5"
MQ@HEA6(B@YQ0FVJ*4D@*3B!)",MHF8DT0Q%\CZ&QP<7/9!3_XC:W8D!<X ]3
M+->A'X]A$(Z"IW]P(Q$\SYEM0O!9?5?3E5I7(M.98H4L"4RX)C8(+ T?I 0B
MPE.>)BHMF5.9VC8A0Z. M8Y@K:3?BW\61;>W_E9L.G[ECV")6-G-!8!(K_M9
M$;V^ZVU&'K_HK=<&YWIL"OE\5,O?6#6M4T^,FN_4HOHRK2O\S/]MQ2:5_FED
M'Q8$VK "*U))&(99F=BJL;F&A"@&\[*@F4X2K"7U3 VY6:FAL<A^W2Z;(&:M
MVE3IJK?]3JI^W2V7\XJOEO5J?#D#GU@3:+CVGG4WSVZ\U??L=<QS_4U<2&Y,
M-*3CI=+<KE+?F3?10#R3J!-O[/C)Y ?B-MK=:4.'GY68L,7"%AE=GV7\,<XI
M*\J,%U P87R_D@A(!,EAH@@B.DMRE7GY?M$T&QK5.^06'W'&:)]51H!90\&Q
MI:/6C.*.)]^-^E]E2COF_U>9S:CYX4'(]Y 2[J?78++ @^#T2?P.$Q!8NZ3I
M)EF70GF8&A%JL;S_83.=U;C,<BXU8E#14D)<( F90 54.$&(IT6>EGYE2"[+
M&AJ%KU7=U.+9: O6ZGJ6!&G!V(U7(R'7,5.&@N9?:>,Z'+&*9K1(ZK?^Q763
M3TI9.-P2>FS\I5JR23V8K):K>5T:V*9?R3>KY<?9\C_4\A.KY)@PPA7/"X@4
MR2"FDD&>4!M'3$1JO,F$*R^7T57PT.ADK3?85QQL- =FJ0B,[N"G65U:[7W/
M?#M.AF/<L0.(NPY$QD$WX+RV'U31CF8[BNWY%+8?&*<'KCWO#Z.NQLMZ6IJ5
MMPV2?)@UCM2Z#1.B::X5*6&),P8QP\1X/#B#7.>I*)#F2GI59&R5-C226B]J
MMMJ"C;J!7:_:H79CHV@ =DQ!-V#G33M.F$3BFG99O1*,D]G'K.)V4WCQG,TR
MK9I^6>^12YTHI40"*;9%77FA(4M):@.FF: DY3CUBH6<E3(TZCC< *F[.09%
M*<Y#ZNJXW A4YUZ*-T9!%60N8A"Q,LRIC-XKOEPT\UPEE\L7W[YKLNW2L#G9
MG7"&D<RX[6Z'(,XT@RPK%,PE84Q+A5*_QE=MPH9&!$=; 'L=+(+ZAK3B[+]U
M<@MZ_>Z=> !WT^[))40ZV#XY$?5J^R>7C&[;0+EX3VC):-&,-IDM=A\ZQ%A2
M9!I!@91MCFD+>XI,0YX6.&6ET"3U*N=Y5LK@*&.M)%AK&>@ZG$?4D2-NQ:EK
M<O"&**!X<0L$T2H0GY/1<QGA%C-/:P&W7>SWXDM5C>_,$D3:9<C["?LRQGE)
M%6?V[4X%Q,3F4M,LAZC B42D%&7FU GW9.2AO>!;Y8#5SNVM/H6K_4V^"82.
MWUY'^YU?V8NVGGE-%TK\Y<OL^_\P]S1OJ/EA]V*>CM3+RWC1@,T+>/F"8'>]
M6II/^'?;NG!IYL:6C+Y;+-3RCX72J\F'2JMQFM*4"(PAYQF!V*S<(=-(PT(Q
MA;7")1->"W<7H4-[51N=8:TTV&D-:K5'H%$<6,V]_?CK$^#LST>%M7N__E9$
M0QQ\9XCB.?K71?;M\#N#<,;Q=[\WC)(^JJ7=F/@TGWVOI))O?IJ1C;#F^(9Q
M-FS/J>]-YTN14JHRE$/;$,HX"HF -"T9-,Y"66B<$2S8>#E;LHD;,;F+]J*G
MK0+=O4PV_5;8;;35HFF&7&UTKON?-4K[,9/'/+CQ4S?H=LQ2%MAZ?W*C-N _
MP2]_-"C_"K;*@[OK,'O3E3]BD4C+0W"OU.4/R#&!!8P0F%W\HN;,CKAKQD8)
M010I:1PGF4!<J!(RVY@DHQG)4T*4PGYIPB<BAN8U;34,;VIW!D<WNKD-G8YI
MQ0\8_YS7B[;'2EX]%=!O%NI% T_222]?&9HGL3E'^FP&N/M1+<9$YR(1:0I9
MFMAZ$%A#9F.<E%-2YB1EO/!,CC@6,;07>Z<AL"J"/ZV2WED0)T"ZO=FWP=/Q
MF^V)3$".PR7CHR4VG CH.9OADH&G*0P7KXQ_(FC;)J L95K0W'S%B:V"R5,$
M"4(<:L0+*IDF5'"?18>+T*$M-YJ3'^+@Y$>U/ODQ:<YV[#=]B'<T9SL+*LO2
M1!(&"2THQ(PGD)"<0Y*AQ/Q;I#KQJKD>?19>Z335^5F(>CPJ8L.,_S?;7_3=
MQ>(5>E(,K\/$+?TB(G5_.#/Z]EW(2B6S3&EH/@'&!50Z@8PP!;DJ,I5DI9"Y
MUU>A1=;0/@;GWA7O>F 7@74CF4AP=<PMCJPRNG!./FKIL&MPQ2L?=E%2WR7$
MKIE\IHS8U5O"F.3-:E%-U6)Q)_ZQJA9572OUTWSV?C;_QM8U3,928E4HJ6')
M!8.8" )Y27/(,1<($TPRZ55DT$'FT!R<C<I@3^>1W8D%M=9A=8=<L'<CG<B(
M=DP^MX+I33(>\$0B&Q>)O9*.!P3'Y.-S:Q@)U4T:5V*YFM>5DVR_;K7)(!5%
M1DMM>SOD>0JQ+G/($#/DPY)29SG)-2,^Y-,B:VBD<Z J8+:A$)OX44P;LF[4
M$@FOCBGE$*JUFAWDY3J@$8E!VB3URAP.)A\SALLM\??%/ME?U(WWZJL^S8P2
M:EG-ZU-%;]14Z6KYR3PU"^O,<T+R/,M22',M(,Y3VV@UT3!+M1 :IX747G43
M8BDV- XZMPGQ2V/:K\ :-P+OC/Y3VU^NL0184RY55#GHP1EU+\AK]F_?+^IJ
M3E]A3ZF/Z8RZ"Q6"?0\[55YJ#68W*P1,GQVOH/']\[;OI\O=P8_/ZF4VMY%6
M>ZATM1C+/*-:&Z=1$RTASI1Q'PNE(,F+'!<4E3DO7-.XVP0-C;P;7;?MK[;:
M@D9=]S3O5G3;R30F9AV38RA<7EGA+E@$)8FW#MQ;SKB+>?LIY$[7A_F*O\UF
M\I_59&*HYRA#=*]9X;;W'=*$)PE'4!!;-3NEQC5$90*Q3!-6YI3JTJMVOI?T
MH1''1OFZA>=Q1O1A&\_K+?4B3(Z;O]89Y!WS3E2TO3VM(-0BN5-^LGOUF8)@
M.7:,P@:Y;2??^&&\FM;NN7'79U^FU;^4?)"&7HW;SK;RZ]V\N9)&M;W^C.9O
MJV]*FC6 LE5]C$^V]\=Q6F*69*6- 90*8H2-'T7-3Z@@B.4D)5F&QE/UQ9;,
M??:/!W2GN=/+3IN7_43_'C;"]RP?@9WM8-_X#1ULS*_98L]&L$:@7L'5&-@5
MV?X58=&)#I\GO^#&*S\>/<=&7OF1"(ZQ=#]+D4,T'2K\*A&>[B?@4H"H!\DW
M[!HWPC_.FH)UT^6X1)@F)2IA)ICQ^ G%D-HBNK9_)\XU0DGN50/FK)2A>?:/
MSW^]_PSNGI[NGY\"-E]/0/382;T%FEZV11L%1V"G8N3]S$L(Q-R</)'1_T[C
M)3//;AM>O-CO5:_$JAJ_G4WM[H$9Q?RTJ&1]WF(V_6T^6RR>GL>*%X1C(B!*
M$3?N*Q>095D!2YTKFB24L,0IE.P@:VBO_4Y;<*#N"-0*@Z=G-S)P@;F=$B*#
MUS$Q](F;G(F5W12O?]D7?@="!XFC,]5Z(-,0KKW!LFB&LBRIF=1EB%[XU,.6
M#:OZW!+"K34]BY_/<S9=3.I1'Z?W;#Y]7"W'DA8X564!*>>V)B\J(-%"P[+,
M"IJ03.=YX;$Q<%7@0-?S&Y7!<J<S,/^GC-9PMG(\;WH=;A>&O16]GOBU)\1\
MN#42<GTQ:RB"GKSJ@$H[J[8-T".G.MAQR*@N-P2V<=9:B>6COO\AOIHI59\-
M3SU.;5$ ^S_;,?8[F]@NL74^524,B]D_F'7SX2_VKGR8BLGJ_^?NV[K;QK%T
M_PI>SIKJM8P>@@1)X+PYCE/M=5*Q)W9UGU[UH(6KHQE9<DMR*IE??P"*U%T4
M ($TY\PEE=@D]MX?R(\;P+[8_I,?QXO7V8)-#/._O9H[['9S]6UX4[).1#8?
MB/4!B^0D26T5]9(B"7$I;.=H6QLY2Y5*->4L]0KQ'HYI0_/$5\C8_(H&&V#!
ML:]L5=TC]$!M.(B[-LP>C,(#^AZ>>3KJ-F9;)MN]X0:-^A*[";SWP]T[UC"!
M!B=0 57=N0T5V&#5R='C\!Z!6!W*AV-8OTW1AV/WB3VG 6H8YCP\L)]5!_E/
ML_E.N/4H0XA*6A4T3RG$*<D@11F%N> \*72.4.J5,'%*T- ^K(V>0,_F8$=3
MOP_I26#=/FLQX.KX(Q. E#>UGX,A$M&>%-,K[9TS=I^$SEX?1@F_S;Y74;5W
MT^84K4[/^CJ;3(RL/]E<CGB>%85D"=09PA"S$D&&,(*I3E.F2H+R-/6A!Q>A
M0Z.*1F=;GG!],EZK#?ZPBH-:<T\GW&D&W'@D-JX=<TH,2+U)Q@>C2(3C)+)7
M\O$!89^(O.X-S>VL6JL_L/ERM8=BJX#.I@_FP?O&%JIJM+Y]S:C,"#&L9!R6
MLB@A%GD*J4XY+'E2(O,740JO!@N^"@R-K&K=0*4<V++@"JQM /:Q #M7^N:)
M>LZ2&XEUB7W'A!8;]H!4TS#LHN6?>HKO.2DU#)S#3-7 <2+VI&J\P8]OZHOZ
ML7SZ4TV^J]_,PO';8B03HG&B4\A3R2'.BQQR31*HL@P1D28:8[]N,YX*#(T,
M3[=@:HRX L8,8.T *T/ RI((3:W:)LJ-#[N$OV,^/(W\<@:XJMKV7H%_*C8'
M]]..^HC[0-9E=ZPV\>_?,<L!'*<N6B[CA-'@1_4Z5V*\:O.I7B=JN<H0O7ZQ
MZ5__O3JDS:G,,BH-X>744%]A2RI2SF!BCZ/L$I9CI]X[/D*'1G?;.E>[\VQ+
M63]&<\+<C<5B(]DQ<VVK:R/A:X4K/*]=\/3F+!^ (O&4D\A>N<D'A'T^\KK7
MCX-$?9X_NOGRSQ%GNL@REL T1P)BG I(S;]A63"4:D;3PLV]VAYT:!QR\\V0
MN_DRO[&I6:I,7\93/G:CCAVHVJDA%(".7WTOVYU?\V/&MJ1L-Y>O7N/F7YM7
M>&>X7E[18P8TK^#1WP5^YL<+]OP\M_%W-FI&UWM+3S859%1H06PX-B0YLPF%
M%)D/O:Z:462L%)BJTJM2?9NPH;V2N[K:T_[U3FFEK^>N<RO.CI_T2.AU_2D/
M!L[_&^Z 2*QO=YNH?K_9#D8??*M=[KDD0&Y=3N:)_;#']3:W;&J[?E8"KY>?
ME USGE0U(\R<_MRY>%3D5+%,"9AH:7@&9SED>8I@8K[V)"&2$N'5ZB:"3D.C
MH[5)32%@FR1:A1WMFG4%V!+4EH&U:?LW78$'913S;2,>8Z[=N*[G&>R8$ON>
MO, @KRAP1XW.NDRC=PBKB@+A\7BH.$,'DOS+ZV3V4ZE'\]V8VUVHNBTXS?)<
M*TUA+G$.,:,,4H$**!BF,C&,7I1>^S\GY R.C&LUP5K/P&;KIW!U),G+T>J:
M^ * \B>O=AAB$=()*?V23+NI!\1QYO+@%+-E_9PFA1",*@293%*S+-0)I!G-
MH2@Y%7E1,"&=*K0>#CVT5_Y<LODYI-K?Z,OL[_@EKDWWI+@C&'@G> 5@T5-&
M5[3: Z>M=<C46O;)0:<U/9*+M7]%['[SB^U=YML?KVJZ4->V_*T]W/QD;ABA
M,L\Q11AF::X@+K6M'*(+J!E)&6)*HR)2&_JSN@R-RUI[J2^N=@Y<0&U04UVX
M.CRV1L5J7']^)MV<H9[FIV.N/=/FWFI?)0QMF^0^-2$'^Y>"&N^,/UB3OH_[
M+X7LR,G_Q4.&$?!G9:2HW::X3VK^<J]M$8,JD1"7PO!LF4(J2P*Q3(PSJ(L,
M9@DKJ"Z+//.+?CHO<FATNM+X"AQT:;9JV_WO1G$_RG3 WHT9XR+:,0%>#J8W
MR;GC$XG+' 3V2EGN .PSD\>=@:6B[!C,4AV;RDD3]<39Q*YF%ZO3,UR2C.6(
MP(38?MJ,)9!+5$"S)"4EUX1PZK0)Y2%S:!34: TJM:NHF;7BH-'<[^#29P9<
M%K?1<>V8B-X94L]"4W&A[;'@U.40^]>><@?K; TJAZ'ZK47E;MM!32J/6\.\
MR4?Q3<FWB;+GS_NE1Y5T*#Q:*?&D?BP_&)O_:X3R)$TP4E!Q:5S/1%%(L4V3
M%$A)KK,D%5YIDI'U&]I'HC%O%9)Q4*S8KBK=2A7[^;&Q9]W-Z7W'N>SXPQ1M
M&FMF!=9(4%D9\5"F(_PC>>"QM>O57>\(VGW?OBLQH>D(\_%W9@_!5_Z1D'G!
M5<Y@026%6-H.Z@FA,$VSC&A&RQQ[M8+9&W]HW+U1+S#\< \^-Q*] )2.2= #
MCX#,@*-61TL"V!V]YWC_HZ8=AO8?ORSLU;T69C7Q5N5GMC6A6SV83 A[8%/"
M,J?&IT,XAXS9<G=(:RD3A%GIY=/Y"!_:2[^E.SC6%+*."_O%&O"7,%[PFALW
MTN@*\8X9)2[8WJ03@EHD1O(2W2M=A8"RSV5!8X3Z*'QY-[6U@NSFR>_3.A%0
MK8J,O4V7#W/U,GY[L67'[*7&3;)KZYO98KGXHI8CP4@N<^/.4&G+>IJ_0U*5
M^J2JT)(3I7+/;,J+]!D:'5H=P<:>*[!E$6A, K_41OUE52FQNJ<V#%2670%C
MFZ_W=-G$NGI;O4U7Y]Y9#S,5X-=%P3>:'WB9-CW[C5&@._0SXPP;1M=?9E-=
MY=2/V61K]?J)C>=_9Y,WM>G^-Y**Z"+-2LAPQFPP$8%<, 4U33)2T 2GR(N9
MW44/C82W-=_95+*Z@TKYK6:8?C3K,2%NC-H-S!V39R2$O>G1'ZQ(3.@AN%?2
M\P=DG]\"1KCT9,76O?TTF?WY-R6?Q]/G#;LN;&)(54AN<:\_-5H]J+F>S5\L
MJQJ2W?QXMAC;L[_/]JDQ_]W;@A>EK3ZOC:.*2 %QEI20) F#6:YQF>HL55D>
M=O#2A_I#H]3M#?VJ$+@% -0(;+E1QA_:@& O7ML+MG"HG*FMW]107($&#)]M
M_R$\;+[G/4-[A'H\#AK8TW/!H5&?DQC]3*D7Y=_IR*G/B3E](M6K%N_?ZGL3
M];L8$4HXR3"#*BLDQ$620(J5A$0DI1((8TF9S[>W(SV']I'MJ&?SB7C]=VSC
MO?VLN'TZ!_ $=/R-',KDOVO#[B-3,\ NW=M:_H]MS7T$ZB[[<1\3%Q!N_3"?
M":5D54^WV6J[UY]GTV<;TFTWX+ZHI?F!FIH!#_;C1I@419HE%&:R:EJ0I9!)
M+B!7F>2(Y4IF3JVZ(^@RM(]/8\VJ%O6XV>0V3OC$6 27-K5!&B.NP%15C:4F
ME5W5SS:7"VN:1Z3QA?/9_O'H>98Z_D#\CYP@CQ#Q_B:JI]#Q/B;,+[ \#L2M
M ><7BN@O$#T.%CL!ZI&&]/LL2C4>W9HO\;(JIC-_G:W:@U5KS!M[/C7_>3.3
M:L2I2%#&2XBP_?1QED&.$P539+Z(A- RS9QR(!WE#>WSME(9[.A<[S89F$&M
M.;"JN[&C*^[MGZ@.T.SX,Q0#2&?6\H2GI7BJ&6FU3#!_V:P.7,?OA98\C6VH
MQ_>V;CI.V&3NIS]G(Y;K%!-1PB1#!&);:)WE,H4YRV0B1*D%]8J-=)0[-+IQ
M[2]1U4,P^L?M*M%,AMO>2@<0=\Q!'CTDVK"-WD-B#ZF>6D<T4@?5,6(/"M]&
M$?NW!VP5_#K[KN93.^"O<S9=UN5DFZ* *=4E1X59^6MN0[@SR*0HH!9<I"@5
M"45.J1EG)0V-F#:Z@DK9IO"QQY*P%5B'%7DLN#HFF5-(A=08:X7,8XT<"[J>
M5L#>#YO?<M8%C=;%:NL _2U%7>S866@ZW1!"F7-EG,;Y\AN;XB19SE"2-$44
MM<:ESG)(N8VF$8I#9IM!EQDS+)IPG%.GU6.[F*&1Y?-&48"-GCYO_$DH71@R
M!D =T^,6-OBOE9+FSR!N/(F4#S'&0*PG5CR*7"Q*/(=#.Q^>O+M',CQGP2X3
MGKWZDHX!]_KVAS!#/RM;G_I^:D,Z[/_?_NMM_)U-K*]:]=T>VWIW]A?74[G[
M@ZTK1Y+(LM!:0RE48GS.0D+";%$(+9$2N:((>T5%=*#CT AX9:+=&V^,7)6D
MGTVK.+*K5339E@%78&-;?8D]&M_[X>X=MJ[(>/IF0]'J*E&SJ6=P1!>/B]OB
M_9T?@JXW&X<W_X%]"SJ9H:A]#.)J^ Y]#3J!^'B?@VY$A7VJ'N8S\]0N?SZ8
M-V=IY-B17ZT;8[/Z>%XF"4T4+!4M(<YH 3G.[/D/10CEB<PR[O/-:1,VM(_'
MP]?[A]NO3_\$UU\^@MO_^/WNX;?;+T_5::L?N[<B3"G."2\PY&EJON59BB"5
M,H$IPBA-2R$2E8R6LR6;](SP6F1W"!N5P&NM;\6SJE$V(L!NW\%8L'7\06O4
MO *5HA5H:U4CYY*Z0!+I"](JJM=/@8O1^YSN=$\8.3=!X(]OKZ^3*N:;3389
M58M-!HDA:HI3RB#G)8<XY1FD!9=0ZS(57"E<9%[G9JZ"AT;:Z_20*["M^E8V
MH:VV&)H6Y#P=;J33!<@=$U T?+WIR!>L2-3D++97FO(%8Y^RO._WHZ_%?%DW
MR1 _KW^,%R.=<4ESXT=2C J(,2&0,YM-612RR'(A"7;*IMP?>'#T4^L&_K#:
M.;++ 5KM['$)!EVS@Z/YSB__*5O;7FYSS]:+;?ZU>:D/ANOEI3UE1/-2GOQ]
MF,^P6ZJ\.10?<5&HM$@0),R\?9@Q!5F*S*).)%DA:9F+S*L!Z7$Q0WLA#VKL
M-XKZ??A/8.KVF;\<J8Y?6W^0O+_>[1A$^E:?$-+KE[G=T/WO\)FK \Y@OZI5
M%LWC-S97?YM-I!G\7C\NS<?<A@LK>;VL$FU6::&CO!0(<T*A(84,8I7DD*L"
M0T)SG2C*A'8[5 B0/32J:+0'E?J@UA_<:U!9 %8F@.LEV#+"XZ#2<V8<SGF[
MP[MCPAD8U!X'Q=U!WM/I<5SH_4Z7P\!K/7+V'+*_<^@P6W<.IP.'"/,:OZK7
M^NNSFW(RDBS%!'$"*:/4^(U809YJ#2G*,Y0DB2B85UVP4X*&]SEH]+3GAY_7
M*5=65S_G\22T;NYC#, ZY_,#K)[.8N7M0YX#(I(7>5),KW[D.6/W/<FSUU]6
M=6NF6SKT?7I;OLW5D3Y]>V6.4HYEDJ<Y5(DL(-9*0&HS/ I%D!:R3*@*:F82
M0[FAT<]VS:-SS4Q7)A[M:1JM$E:4!\"-\-YK6CLFR7>8T>#J5#&ACUQ[*HIJ
M[U)9*B:HI^I&1941]LEXFBNV>)O_K!S5J@;D*%&2*\X(Y"JUX=](0L8QAZ6F
MO&0R53S/1U/U;"N8/[GS_Z$DI]>=KE[W WG=O?J-HJLUUA5@RRHO'_R"TJN"
MX.H8'R$*%M;3-Z^_^<,V039S./GY%S^^/H*^&^L&@MD/=^X#6.D7C_9.VQZ)
MO(X(Z)6"3ANX3R0M5P8>1[1T)'BP/YA-KZ>KO@4/YIV8JZ59\UI']H.:*CU>
MVJB*Q;7\S[?%LHZIN-=/[,>(I&F&;"MF74@!S1(50\XPAJA4(BESS7(I&TYQ
M/-'H1M, 3NKZ4.1<[X^KNCW(QIA%TX'=&.1Y=-+1_#N>O;SCG/9T>'-D,G]9
M&?D78,V\,LMP/9X:1[.VJ8H=:^;SJQ(3MEB,];@N?KHQUF7*_0^"NIV06"=)
M'6G9[U%4MU ?G&5U+"[4&S6C:N/C&=F/:OY]+,;3YVN^\.DNWSK&@*A@K6?E
M4*XU!7\TND9<*3IA$LU[:I/5LR/E8/:A3^5R4\!A[^?[U4;?/9^,GU>))YLH
MKO5#7J1"8J03R#FFMN=2:6-#.<PDYUHC4J1$.Y_Q.HD<VF::57JU([VE]E;,
MHLL;$HJ^PSEN=$P[YIGWA-/CK#8ZK#T=T<: U^]@U@NIUO-8MY'Z.X;ULFSG
M]-7OSC#G9.<T$)<RR;40L&"<VJQ>!FE"4RBQ3@@K$XU*ZG,Z,N3#U4N.4P..
M4 =Z;-K506F'AZ/O=R#J<@@:\>#S YO8"E./WY1:-LT3JN!LBH7.4L*A2!2'
MV+ ?I"BS0>UI0K(\*U&9>34G."%H:*]LK2>H%-WJE>(1Z'X66[>W.09B';_9
M86#YU\X_@T2LXO>GQ/1;O?Z,L0?EY\]='QHH91NQB.7;W"[B;%YVU7CWVA[7
M5!7K-U["YN!;I0(K660P130WI,%*2!!6YMM>$H4R:AG%+XC*7XFA$<J.#769
MA55OZHT9P7T6@V;)C7ZZQKYC:O*$O:-LODM C!;G%:!"SS%@X2 =QH==,%9@
M\O+LY<46$C8C52&LB^NWY;?9W';_&&E=4%HF.4Q(P2 N2 :)*! 4)4-IFMNR
M$U[%C%ID#8WW5JJ"Q>HD>W7D#]A:7<^,Y!:,W>@L$G(=LU8-6GW\OU(47)\'
MS3_-^#P<L3*+6R3UFTQ\WN2#_&&'6Z+UE%L56'I6TZ7YVV(LZQI+Z[J_7XR9
M5?KD<J1TH1.<9%!@GD#,20H)E@AFO$AHD@F"E-<>RD7:#(]X&LW!+9M/X?W;
M<KOV]4;QBSN[><R8XY*OKWGH>EUXM$O;UL3LV'+E.3TQ>J_YP]I=AS4/7=Z[
MCYH_; [=T@(&#8SR;SJ*WNO5F;UQ$(^<Y*\/81*!"L'*'"*A),2)8I DHH!2
MY&5:E 5)J%,?M$#Y0R/6M?I5@^)C856^!V*A$^/&IAW"W3%_1D':/RH^#*]8
M@>^>TON-;0^#YB!\/7"8,+J[%F+^9L/C[9A/[(=:W-3>2*%*G16)@#PO",2*
M*LB,3PD9XUE*)&:\+'R([:2DH5%8_?8LV0\P:3XO?E1U&E0W4HH"5<?T4^O8
M<$VEI7'?8KME9Z&(Q"RGY?3*(6?-W6>+\S=<6#FG3HM9C$21&3>':*B5,GQ0
M8F&#S"4L-4GS0F>T+$J?ZIP'$KQXH(>2G$_W3]>?@2U\>OUT]^57</M_'VZ_
M/-X^!I;+60/IQ@$7P=/QN[\IDM,HUT%UG'V[8Q?&68__/C5Q]LT[60[GX$+_
M^G._L1_CE[>7NA<$TZ0DB=(PD=R>U5,":4I2F*&2YSEB6BJG [B#D8?V(:^5
M\^RD<0A8^PM[$0P=OZC."'A5H3MJ[05EZ';'ZZT.W5$SM@O1';\@['OZ4<W'
MW]FR<M_MZ5.52&0\^[\I^6Q/H8Z</2T^CZ?JSJP%%B-,$<%2I#!!2$%,L88,
MX1R*PGZ1M:*(E3Z^^$7:#.TUWQ@#MJRICG-K>XX?YR[ ']8F4!GEN1EQV72Z
M>0"]35+')-3Q_'A[&%%PC>2-7*9+KYY+%-CVO9PX@P9O?;R]O%5'_VWY6NLL
M2YIRA452P*3(N,VR5=#\?PGSO"P3@6W1%J\&$)[RAT:[6^J#695X*78V(<UL
M>586]9T0Y\V4KF#N?HMEC;!#GK)M(3'3<5-4 \&+MRGC);WOK9H0:(YLX 0-
M$Y B]VA]VK?)<OPZ4=M%EC_.7MAX.E*);9/ %2PSJ6W2!8<\Y0G,%9.:DUSH
MU*DJLH.LH7'9XH2VX(^5OCZY6V=0;B>MR-AU3% ]PN:1ZQ8/OIZ2W,)A]$MM
M<P.F-:?MS!#]);.YV;*3Q>9X2V#ZFG%*[_7-7,GQ\A,3U:'1)S:>5V5C[O7U
MR^QMNKQ_6RZ69MUC/-M1SH@04N>V?YB$N$@1)$(+R)'BJ%1,Z,PK#-Y7@:%1
M<+74LR?9E06@,>$*6"-618[LKU=V@"U#/#/F?.?)S<GL$OV.23P^\/Y)>H'H
MQ4KD\Q7?;[)?(#@'"8&AXUQ6+?5>-]%<6P6:%Q]^;OVK*KDW0DF.%3*>9\Z3
M<DV(#!*>89U)0Y.E5U,.7P6&1HC;-3+7L9+;)EP!_G/[!W4US,"BIL[SY$:(
M7:+?,2'&!SZX]J@O>I'KBSJ+?Y<:HK[@G*H3ZCU.X'9C57>T"00BA+",,MM(
M%F<0&V_01E=AR$0ITU)1C'.O:(J=T8<927'S^]>OMU^>P/7CX^V39Q3%+GB.
M&W^AD'2]K5<7-HX?*W7,X%A;<3MC][O1=LRL@VVTHQ>%GM7RY>8XXC=F$P67
M/S^RI1I)43(I,PX+0A7$.*.0:(G,:YN7J<BDD@KY'<2>$C4T=\1JNG5^=P4:
M98'5UO?T]"3 KD>C,6#K_-PS"+& \\QS8$0[K#PIJ.>3R',&'QXSGKWCLA2]
M+5_A\_J8GZ6I*$N&8%HFF26+%!*&2\@04V5!"XV8UXJF3=C0Z.*8XWQ!O$4K
MSFZ<$0N]CEDC'+C@E+<V1")GM!T5]2X):VU&G\I':[W'CT"D&H]NITO#0H\O
M;#)I)(S*)+?_IV"1&KK 0BG(54ZA2*1B"F>YSA,7SC@Q_M!H8J4BJ'1<+[;=
MJ.$4@NUL$ &7C@G #Q+GE_Z,X4?>\X42?WV>??]W<^?J%3=_V;S9I\;KY64^
M8TSS_IZ[+. ,W994^SQCT^LZ-I@7!9(E49"D!8(XS1-H5O6)^<:KK&",))0[
M=?,^-OC07M:J/)_5#UQ['.SN(];^?EZ*0\<OYQ8$GF'E1['P.-6^ ).>CK%=
M'@^_ ^L3-K>>4._?T]^1] EM=\Z@3UT3FJL^$__U;38Q=RQNC6MBT^"7ZE@Y
M+U+@+,N5ABS)$HBEII#Q3,&,$H%8@;#@7@'DSI*'QF';BO\;6*D.K.[!Y=7<
M)\'QY*0+:+L^,G% M:/J:=YP14M%=Y7;<Q*Z)QR'Z>>^ UR88%JU>_\Z?OZV
MO->_+U;MV8[T91MA(HA"+($"E0QB0H6AL$)"DB58%H)BY1<PXZO T)C,5CQA
MBV]@8M4':J5D8&ZJZQRX,5B7R'9,9)O,UDKW*U!I#V<:&OU7+2FOCK:B[" !
MUA.]V/FQKN+?)WW6$YR3V;6^XX21W:?QE$UMIY.O2JCQ=WN:_%5]GTV^VP@S
MQ#-)A$2P3+7QS;*40T:U@D4B"JQ00I/4RS=K$S8T$EOK"C;*FI>N4=>/SEI1
M=J.N6-AU3%.AL'F3D0L>D8BG552O).-B]#ZA.-T36F7[NYJ^J<6ZLA5--<U+
M(J%,"F[WG&S)L9+#DA*D\I)SQ)SVG$X)&!I)?+W]^^V7WV\?_[=OW>L]W-PH
MX!(T.G[M&]4ZJ>QURNYH):;WAN^Y?/1QXPY+0Y^X+OB[?ZH!]1=E7N0R+W$N
MS?>^Y&9)@_,2$B8(Y)QABKEB''N]R.WBAO9:GVO\;E3V_OZWH>WL 43"L'L?
M(!B^$#_  95XGD";L+Y] 0?#CW@#+G<%G#^9X91YBI;UNN1^NMWG9[=W_2BG
MB"9%F4/!\PQBFN20,[.ZP%3ER("!TM+];,I#\-"(IE&]V20!9MD^,=J#JNN6
M=.ZZY3T!#D=='<':,?><1[2.B0<N>[Z7@>QQAM81V#V=KUWP&/L=NP7 U'HD
MYS->?\=U 5;N'.6%W']I[:CJ$U('.6_5B:T7GVSR,%M%)]W^6-H" D:'VZEY
M-%>ULD<D$X5 6L,,IQKB!"/(%%=0,%2FG)DY0UX[Z)'T&MKG8JM>4;WA6UMV
M!79J+J^M XUYX(^-@6#+PN#B4I?-MYO#^PZSV/'7J<\)O*#Z5!2XH]>ANDRK
M=ZI(%07*T[6IX@P?X.T_S&>?9O,7=BW_\VVQM%)7,M7-;+%<C+3*:9+J$J(4
M28@1TY#DF89YR91(59$P#P>_7=;02-IH"RIUP49? .M76H%*9P^'\PS0#HY\
M//@Z9L=^D?/PSN,AV)-#?A&2?BZY&S:M7OB9(?ISO-ULV?&U'6^)XEY_F=FG
MADU6!1%&/$?&-48%5(4L(.8)@D13!3,M$24Z9:GVZG'<*FUH+'OH237ZUO5
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M M&,)1HF,I,0LS*'#$L%)<<Y*[0L,/)*S6B1-30VWDZ\7&E[!2I]0>;)(2Y
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M'?.%/TP7E-8_"D+TROJ[4MZIL/Y14T_7U3]^>1@1V.@FV[[R]H<8+]03^_'
M?MKSM7IT\YNMZ+X,82R5/0)#=@VCD@1R3#%D3"2I*&2!F-=JQD?XT"BCTATL
MV0_?=8P7XF[,T16.'=/)"L*JJGZEN*V-"6K5XS%*"#B1:,9+=*_<$P+*/B$%
MC1&2\#=AB\58CT7E_JS<U!%!4DE>EE AFP$L%(<TRW.8"<Y2QG/SIW1/\3LB
M86A\(W9T]%SFG,:QG6"BH-,QBW0$C$\BWH4 ]91ZYPN49Z9="PCMN77';NPQ
MFZY%[]W\N;8+ VC-KUK[D6+M/^M2[:.BT)H@E4.6(V8#*@FDLC!_*,Z%)41&
M<F<NC*;6T B4-Y4;Q7;EQOFFQ<-XN\4#L]8!MMWA8=(8:']9]7?PX)AXL^W
MV.\RAQW3_/\OT^?Q77F7:>SI8]3G=/I]R**CWOKUBR>MOT]F=(1VOK/Q1P_X
M.*^V6-A.9Y0J(F91U2_9!$(HQ3*IR@*FV"Q&,!<)I%3D4.LJ,J54TBV9P4OJ
MT#ZM=3^DO39(5ZL(L::^#O".2O&;"8?O8A?X=OS9&P2T'M^L+B#NZ9,4#VJ_
M#XXO9*W?$^?!^OM<^-JW\S7POCFPNRS[61V#UJEQ3[,G]L,&#'V;36Q'%YL&
M_(W-U0<C6-I"*FJZ6+T,A#**$ZJ@D%1"K)" A!$.$ZS,WZ7$6'LEB80J,K1/
M0FW'5;6GNV7 %:CTA]P: .JKP/5\;FZNFHE[-J8-G3>WC?4^9J/C#\BYB?C@
M/1'^/6TO1#%6I]M0-?KM?WLA6 ==<2\=+XQ0MSL*3N7CTE"TE6B89]7!8)3H
M! O%*&0),L192 2)$ IFJ>0H*3.:6.*<+=G$C3C/"?0BR+78[M[+I_NGZ\_@
M\]WUA[O/=T]WMX_@^LM'\/AT?_-__G;_^>/MU\=_ [?_\?O=TS_]&/$L\&[,
M%Q/.CAENN_-JTZ)[^3,>?;E"$8FFSHKKE8Y<C=^G'>?[ A;G#_/9]_'"<)0A
MKW\P^\4R:WY;UF#Y-I\N1D2FC!N_#"+%&,1EJB!C*H6T8 @I7F2H=,J/<Y U
M.*^KT;;*<O^SUK=Z*^8KC3V6AV=@=EAOQP.O:R>I1]P\%M/Q\.MI"7T!CGYK
M9C=D6E?*9X;H;WWL9LO.JMCQEL R+B^S^;(.-KW7JW1 XRG>S!;+Q:BD@LJR
MQ%"7B8(8T0)RE!+CMF&5%F;%B]/$JWA+B["AL>NJ<+AMM&737RL5 =O2W[-(
M2QO,;DY:+/"ZWL/<4M-6.#B"8\0J+ Z8Q*J]TB:JWXHK#D8?U%EQN2=P\3>;
M/MLBE':B;0#[]8_Q8J33 B>BS"'6!848YQDD:9G!$N&L3#C+BLPI8JM-R- 8
M8[=1PQ6P>H(_K*:>^2E'$75<R5V(4]>KMYV^#&X0^2_A6C"(M6P[)J+?I5J+
MD0?+L[9K R/)[1KOJWHU#\8WME#&17F>LY>ORL9)V;IS;\MO-H=%R<TUAH+>
MIDLT2I7(:,8E+'"1VP F":DM%L[23&">,<J(5W7P<%6&1B"5)6"C)JAMN0)K
M:\#&G.T+5P9YAJ:'3Z$;%_4S,1TS5F=SXA_:?C&<L0+=PQ7I-^S]8L .@N O
M'S$T,5C,JW,:-KF9O;S,IM4V_N)ZN9R/^=NR.AR=;;;VZV. K?,=LY8K.4DI
MU1#E/('8.&&0($)AKBE5)!.:$Z]DO\M5&AK]?AQ/WJITM] 2ZA%FR8U9^\6^
M8X;=,@:LK%D=5B[ MCU@.0/K";K56HFJ?MZ98\VH=?5B81XM ?IBA7I.D(X%
MX&$"=;21P^CY?O[,IO7JVO9RGTW&LOK']50^&$V:O=CURIM-'LU/5K+7Q<5S
M1I0V"V>89\262LY*R%!&(&.D*+B4-*%>I?ZB:#4TDMXVZ@KLF%7M/&\;9@EB
M;1K8V!9<*#[./+MQ?.^SUS'-]S5QWL0>%>A(W!Y'IU[I/2J,^PP?=_ PDF_*
MB34EQC95OTJ9H91#6] >XC0QC(T*#DO$14ER7&3**2'KC)RA$?&Z0-Y:S\ &
M9Z=P=:/)"&AU3'PA0'F3V!D8(M'2*2F]$LT94_>IX]SE04UIITNSW#?<8KEH
M;.ZJR.?7^6RQ^/PT2D16:(E+F,JT-(1@J('9.J8::YKFW+;T<0]):9<U.%)8
M:PMVU+T"E<+@\Y-7 ]56F-OY(3)X77-$C[AY-9V-A5]O#6>#<?1M->N"S)DV
MLZU#]-EBUL66O?:R3K=<EI[Q-*OS_9HD0;4JQ'_#%M^:3,!1@E(E<)Y#R6@*
M<9Y22$E90$P+(BA%'&,]FJKG*AS:/S/#10>G]X"NWH,#33H,SZI-L#MGM:I@
M8\6Z X6UI/F]#,O'<)HH-W<N.NZ]YEW$P3HXY<('M,AI%DZBWR6UP@>44^D4
M7F/$ZZ>=UBLAI%E.1";-"E,89B,E@H2E.4Q2IH3,,,ZY5]I9BZRA.92GNT*G
M$?MIIUY+SDCP=4Q)%R$7I9]VVLD:M$W2N_?33MO7HBZW^-&'5,896U5=^S1>
M"#;YIV+SVZG\:+R,4<F92I(4PU0D&&)I*(,7VOR-99B6I=0)1BZ\T29D:(11
MZPE6B@*K*3"J JNK&U&T0MK.$+& ZGQ'*@ C9TIP >$(%RR4^.OS[/N_F]M7
M-&#^LGG[6P?MY;5W,:MYWYVN#8S7KYLCUN47KZ?2_&3^IK93YFWGGLEL\3;?
MJNI $R2+$FE8%IQ#K%,!"<$(:H2Y2C(N4NG54B=0CZ'1Q;I]:&U'=1156[)=
M& )L;+F@XT[HY+GY)3U,2<?$U-EL^"<67(9EK)R#0"WZ34>X#*J#3(4+APM,
M8K"+.G7_6FUD39^KHB/K$E._3V7="TW9^K?FTE54WTBE><:*C,$\*Q3$&5.0
ME )#429*YTQP)+* S:<@90:Z"[6RY0JLK6DZ":X-N@+;)H&534$1S6&3Z$:N
MW<U)3YD7W<R#?W+&)3C&RMX(TJ'?](Y+8#K(_[AHL. VM^.ED?)=R;OITCR)
MXZ:(W^+S>*KNENIE,2H5447*4ICR4IIE:<(@XY1#BG1!=5+2@GDU,W(1.C0/
M=*4SK)0&&ZU!7:#L#ZLXJ#3WW>ARF0''':_(N':]]14!TI!&M<X8Q6M/>UYD
MWTUIG4$XTHK6_=XP4KIE<YNGL7A0JSI(54"YDB,M"RI(F4##.PCB!&%(2Y'
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MF4%<Y!)2IC5,,F63O,WG7V>[<W [=>P4V\T,-.+_/\'?=??C4BA[:XP5"%W
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M%"GA$"59F1&L$T7]-H=<9IT:?QT+;0.A&K%[IRBY+8*CK1,;VJ&MGABH^IM
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M?VUY2:4N%(-"E"G$19%!1I"&#%&M$95,95Z5E":AU=0(\&P5RZM%+%TJ5^Y
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M?6?KZ=W^G&]F".=<B<2PCBP$Q&7"(2M* 5%1Y)SG!<.)5_T*C[FG1D#=.T)
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M@?FD$A2T(>P'HAHSJ!8V'I.X@1*)1*Y,-BI_N"G^DCH<[PICC9<)1P]FF.K
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M)1M 9_OJNT'GQ>9X&XA\$-"IN>KY:_+(SV;S[R,61+:!/'"=/!E-ZQS%_D$
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MKBCHI_-!9TBXMCH-Q-WC ;68+V\I_Y1P&LABOOHVIA.V%(66D_%-HEY5<83
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M7"U;>_*?X^?P[8:UD>2:HLGL(0=!1S6&"-X'A"*X,V@+8ZGU0?8X-4.(Y9N
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MV ZRSI0T !R^GBV6[\L5HZ/D=&%>U]ZFB83%O(?(8ZT+31@SG<),MN\JL$%
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M=C=F<8BH&,!F>2#LD<F:22$RL")JSS'BPIO@P2B58HH48+G6L'Y 1+^5V]T
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M7O'6NZ^54ZFE52$% 38I71L"EGJ/QJ%H%0P3Z+-LG>V_77T@;Y':H.- H0[
M4[_N='K]D/,FTD7O?=3)0RHUXG#U88O4=52X=UR;;#&V;@O_&"T#>634!BI-
M!#Z \^<^'[^$Q3B-;&3)RFK_5DS(J,"C(S<2A4/,2OOF*=&MA/1[7]A&Q\\
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M5= PH8ODS5_H[4+7D0.]UO)^*.SKQ>KCJ<WOW^Z47#@S(<@Z;#R DBF#1Z$
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MKML>Y/T('63W0>%#N]F-)H=I--?EJX<8Q:O?;&#TMM'0ZO7RZJ,W<)%B9#&
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M2/*9@<PV)6F<<ZEU$NE$K<_?C!?A[&R.9U<769LRWRAKQL"5)_?"\^) .5O
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MX"%P.OUXYAEY82&EUH\N!GY+@]J&[%8.8EXU+:3-Q8H$K;Q(GL>D77=]IW[
M6YI]$';T+<T^RAO0P7P_.RRC$$8S!I+Q2+RD"%$6!,&38L$+&^Y7X_Z?6YK]
M];_C+<T^RA@HINYFD,E#33:'#"+69DVFUA:QDL QKTU1R3#9E<U_8;<T>ZE^
M[UN:??30=ZCYZ7R\_++X'?,XA<G590$WQAGM,TAN&2A,=6(E14$^2RM]SL87
M\YR7]MB'#P\/1^ANUE"0P[0PMT%0Y-8*CA:2BQ0$):0@R%$0%!/SC.RQ1M55
MV<\/<.O2^/PZ3"W#A-@'G*>JNS.2YK_/EJMIC>M7-HNKO9E'B"+XE9M)3B4H
MI\G7U"R %"Z*@,5GX[H'WPZ4#LZ\'8B4YR'86FU]'X1[)&KJF,01SXZ36:_O
MX^M50W$6O)86K#(Q91$,)K;3(;GGP@.^W3D$89W+?IA&;_T.X6;'O%TL+C&_
MG]?_UO/BC\OJ/[POJ_'B5W\[8N1+A*0"^$+^B2J>@Z= &TSTW.0L%7<GJ'LX
M@/(!WS8U-HI=JW5 8+Z[5[==JEPW&/E^V\EDI+1U(M%6=:LZI& *>.\CR,2U
MI3B,6]WZO=)1! _X#JP%=+M78M_'^N_CZ?C\\OS3<I;^^6$^3O@YS,]P^=ML
M_FN83]]?+J^*3T9!%-1".(K54NW;19S5,<7 R6NQQCK:H;N=Y[NN.. +KX,/
M\DZDW3>$/N+:G5U9[?\ZFV3:)F3#*X]K$_YJ,S\^8AFE3ED""\F3\"2CH-\1
MD][FHE)TR>P&I/W6W0E.YF7!J4/)#^ D_8BK)Z,?PGSY?>7AAK0*K"[GZ4M8
MX.(WDO+FSXRTRB4Z[D"7D&H1;X20,8!!F97.*B3M&Q^>^]*X$PKMBT'A250U
M7"B^N<3*V>?9'=Y"#KG80.$6RQ$48P6"<@FL($?66*Z,;IV,V8>^G2#H?A0(
M'J^BEUU(<B?M?H*JDJWKG;#$Y'E^^ZDW49K7*PT//EDR>$I13% (Z9Q1K%!"
M\"G^;U9OHIQEWA0)+M<!%;5T+&H7@6D,,N4DZ!CX/_4FW2#LZ'J3?90W@//[
ML7MN'Y!S$9&(SR2S%$EFB=F:,E7<I<*4Z"K=\K+K3?;2_X[U)OLH8Z"8NGM7
MGA5/W'@/+#-!.])G<.@\<,$<>A\CIO_S*GA_U>]=;[*/'OI.IFPKDW I<9TX
M@R(,@JKO4B-F#M9*)4,TR=G=6@Z_P'J3O73W7+W)/H(<@(5Y8MK"+]]_#_]S
M-G\]"22\U0ZRB6>/!ICW$E10N;[,L!",REP&H75H?9+M0=X+JT8YYG3K2FG#
MQN,M8W^$\^N]ZZ0-DB0)N:9V5&9UM(UC=1R3*PK)K#<___8DL5_KUQE4=H?D
MT7H; "Q?7RZ6LW.<KS(\=4=_&5\LKBL,M7)<D2=!%KY.+:23PS%C0&BIM!)T
MA*C6;7^>(&>P<#L>!K-N=-*W._8&O^)D=H'Y,Z8OT]ED=O;]BHN 3/JH$F2_
M:E H$9PKG@Z*PLFQ8/17NQ4!/[I$OX?F*=#24,0#L$.?YR'C>9C_LS:07/VA
MBN<:]4'GZ!GYGC%RNWIZ#T&3/==)9LL,>::L]=.6)PGJM^CHE+:HG5X& +)/
ML[+\DT1<>Y1>?7FU@<Y7I2F+Y35C1?DBK%50ZGQRA5Z#=T%##E@X9F94^^%Z
MNQ+7;]G0*<'7C;X& ,1;:[UJPO] D%=]M2(6DIP'RQDQ%;T%;SBG\#V2;9>*
MCL+6UQX[$=9O<=%)K5]S/0T ?%NVTK4Y3\;(1*&[ETCF/!>$6'( 3"I:GIR+
M.G9D]1X0TV_)41]6[CA]# !8M[["3<I01Y83667A."B>ZGLWDHI11>4DD ?>
MNJC\/@W]U@SUXZD=(/T!H.?)XA;,6*3-"5*2 E02 F*=\(8J>U8<XZ6Y/W;T
M \'._/^^+QP/4\L (/9L+T"N;& JT_GM:1,J+QGXH"-XF[.)3#&G6V>\7G!;
MQKVTOV];QGU4,0!H[?'*;&,V[MOULX<\BII"%)0.4- AKQQ3M$-M3?#1<2"S
M"EJV]KR.HWC +P6/@>4)U3@@T![YR$Q0D%-4"N!9(*YCS0>A9^"8M;'VMO/-
MW;P?_NU@"Q"?4*W#!/.*G=53H5&V@@<M OD\DIQAH>@D2:) "-:QH)1,IG7#
MY2<)&O#;O\;0.U )PT34W7UT?QO]>YA<UO!N?#:MAX',B.@-9&E2[?9"P1R/
MQ+?ET5@30E0G@-P>% _XT6"GYK"=&@<$V@T/YB.FV=ET_!^8WV92Q+B,PTT:
MXKJ=QJOIID-#?U=?$-1^"/0755I?PZ2ZZR,6>"%!D$=NR!E7/DGP)D@PQ07E
MO0O>MQXMURU' W[:V-B1[0L&/]JF6#]47_\D?0J24.J<QY'FWNM(ZBHJA]J+
MR8.7&D%G"F%12Q,Q#'EK/,+7@%]=#F:#M(#$#[9-WDZ_TL_/YM]'WF#T BW(
MPLE@,/HJZA2A!&N-S#)B9YTCFS(RX+>?0]D(ARG]!T/^'6OP88X789Q__7:!
MTT4M9%B/;E_]W8AKGYDQ@M16G^R&FJ&/C@)NR2/ISR@KNDJ<G)31G7:._]]Z
MYW0#FA]L9WV8SRYPOOS^81)(5&N/='5?/E)9%NMB'=V$JM;_9 A*.^"6_F>L
M1RZZFE#:*6.[W?ZP_ZVW3AM4]%TLO9]$M@CD^Y4X1BIXIWA*D#G3H"0C \%U
M!IY]-$5PA^K9C@5M2=H-Q2_G$K-'A?U@%OVV*H8T$20OM5B=6U'[ILL:+ D$
MU$KQ'&RMA1JP#=]@93>\_Q"WHR?7_ ^V 5:>W6W[PRL?3V0EW/_/WIMNN74C
MZ:)/%'TP#S]EV:KV/;+E9=E5M^\?+@P!B?>D2#69:5OU]"= YJQ,)C>)S0W*
MW:N[VI9=W(&(#S$C0H<$/.@$)!D.7FL&$F/*P=.Q8^MA7*,?:K]+<;[5UC[0
M\(U=C^NPZ/X_2&EYM: 8*7S9]+8E7C I(\E:JKH_+48(.FB0110>T F=3C#T
M=;P#[G=MSK=2W!]*OODK-+/>1!Z%!RUJFS%%0^!-%B"5=%Z[E-GC'2R=WYG]
M+LGYEJX[P$&'\?'ZA@.8K\]X[W#W^+1(RT_X6_CK1AF8E+2TUD)&Q<B>9@[1
M*PU:):VRHW_JU*$!\H$T[0?@\RE#3RFRX4CU6Z0N\$.=<OE;EVK\SBN\]\\V
M_N),!Y]2%A(P^ R*60Y!,0U"8C;1.:?Y6(O_QCW9?K?B[UU[;H2+;_/2?']]
M$M(D]^V>H.,'[U55'Z1-HHX0%6> WI$[R)/5K.=.C:=/M=]E^7O7IQO@X=N\
M*#_CY4RAL9)I!KS4[4>H2%TXQT#D;$HH')GHVHS@GM6ROW>A>:BD._3[_[%<
MYC_G%Q=D^K['?)4N:Q9YIEF*1><,!K6F$)_^(Z N=#(9>')HD9M#O?HGO[C?
M$ZCSJ<V.Q^X^,RK//>SBLT"A+_<B0RBFQL6HP-G@H'BGD14?6#[-(JFGZ=L/
M>.=33AU=1AW@[T8G[Y@(\"^<?_A('L*K/^B\'_#W-9:KB[?S@K/D/>="<S I
MU-4.2D)T)@+]'^.,IU)BZZ;[8^C=#Y_G5_X\F0R_H:T9OZR6;Y:K3^'4VS,>
M?W>J+1H[SS_--@VM18F)<9"N/N 0*8+7RD)(6F@=N9;YO+=I/#45XT8.O^(?
MN+C"F5,^.Z\%\*1K;D21^5#)D U!*Z7T(K(R_N.\QV3U,>QA!!SM\2;O*!%U
M8.$'3V7)UNI$O /R72*H+,UV9AU/*+@)I63;^AZ>YPZ79B Y=G'+$(EU@,CG
M%D;P[(K2@D%M'(&Z<!4<"Q*D+,GEK)P8;=C(>2]N&23_/1>W#!%&IYAZN'1"
M&N>34AK0U+%C22;R<3V=S\B,@2XH5V.U<9[9XI9!HA^\N&6('*9.\CVU;T1;
M1@&2U.!*J .L2<=';QS8PB7*+)+P]J70X5P7MPR2W4N+6X8PLD\-<Q>^FV*X
M#S7A(YTE<T_W)@JG@.M"!E\SIOT)=H[=TG-FJUD:VZ_#Q-(!Q*Z=Q_5,T=5"
MA0PP"P/*E$ATQP!T^;P,RC#!VR\]WGZ[.Q5TH#2_VB1[ &L[@ 3%%65^^78S
M>5 *CDR2MF6Q3LL,N4[+)*49I?4AN21RZ]3 W=<[GJMW#"P.9&\'P-@5A/Z,
ME]M.M<W!E%;99F5!A$C:M8Y#(?\N E,I>I95XN8$CN_3Q/4!JXD32X>+:VK_
M^.8$K_+_?[6^K&];7WU:KB[G_][P<E9OC@F!@S:%@7*D:T-@Y/!EEKS(WNG'
MR'O&5=[]G3[&)8X(HM:\[@\V;XASBX2;U1FS' /1' 18G9$" R/ :6O!*EZL
M3=(7)PZ$S?WO]#'J\/2P.9C7'5B]P:%%+%$&JRU$DZJ[QSWX["3HE(70@B?;
MO =YE&3VZ&]$3F #1Q5>!^!\+I^F,O%&, 7%>?)2$]9GQ*% \CRS$)!YR<9W
MP+[.:X^1967DM' E)9B8-:C !00K"E@9@RZ13IO&FL.X9Y:U00J0I0J?HNO\
M*,)ET&1F;1&03?;&%DXA"-O+0+V8 FR<IK+%LI""AB1* E5T A\#Q4N6N:R=
M=N1=3I:F.B)?DH(I7%NL+@^K^][J["$3@715R)D9%])I\B5'!?A!9XM!.7";
M>1O.*_#>,$B&)<ZU#W2%1@[PFS;F_(ID-*[2Y=5JOOCPGNS')7Z8ITVW')D2
M^NFPJ(U*^&%UW3I\[U\_HB^GQ6<;M.4T/WVCKIP''R)3O]GFBOD5T?3'MB'[
MQM87GJW,%']F)).E,#$(U?R:HHV,TLC0? S<WL0=I=,??&5](YK+!Z*9WXEF
M)@L&)NE.<A=(O1AA(&A6]]0(+,&F%!7?2]\/_/"TN=AQ@/(@.!E3$!TXA ^.
MMXVW$M,.E4]@-!DII:R&(",#%XHQW-25D*V?>'U-Q;19MW%QU8CW?;:Z#K0I
MMQ.]3F=-O_KDZ2WI[E.?WHI&"I*Q<+"L3LDIMD!4B!"#$CD73!+/SHI^'=$_
M\\G-Q;LN\J*U]+\&9#&<?'0LI+MS FXU4S(YQ^QXF9@7R3L;4SL 3<_G7]I*
MJT=+NSG4&E=_X"8%DP5766Y4?\E5]=>%\P)!>'(HF+"!^];@>X&D7EH,&T/A
M)2M\A%PZ@-EO].\]8MEUWHO8XDKB"$4Y!!7H(#[( CHI\E,TBIA:%UF?):8C
M77:LR!_ODFW"_PZ ] .Y7LLOB.^Q/LA:)+S.+"HIA<9HP7)1=^,Z#Z$H!2P6
M5KQ(WFK7&$;/D#(MB!H)>MF>ZQV YTU(&__V]<5R38RY/H3)";T(' P+J0[-
M,L08+R%R(R3293.N=0[T24*F#2[' <[Q'.\ -CL4\UV%(,>L!3,:<IT[HJ1@
M$&N;KS69432N/7_<W3RFH_1,I6"ZAM;)O*7#)-0;ZJX/,RO)%54+:+JF8U0(
M&J+0@;1N)K99(TMH725\BHYN':4#I;T+3H>P_F#X?,;5?)G?7X;5Y0BJZV-8
M?<#US"C&7#8&=' "5*3CT-]FL&2N?0[<,-_:Y7Z*CHZ2J:.#Z!#6=Z"#;I:Z
MOUFN'AQGEB6Q!C79;5:W8?/HP)=2#Z.\4%X:X55C"#U'R[1-C*/#J(D(.H#2
M4SIUDXF^V,KJMLN.@@K.HW0:,):Z5#B28R@P0<(ZW:,P9T1K;.U-W+2MCY,8
MON.%U"GZ9F3.DZW;&T6NRQQC30G79=8*A2?>A:3UJ"7%(<[4:&V,$SE3 UA_
MI#/UPR*/!J%7*:VNPL7=O> S)60A(Y[I)F2Z&)G4<GWV"]'P5*RUF35?7+8?
M9=/N19X$9D>*I_5DT*85[9?+N4?4KO?_\095Z@-/<O)ZM-8J:&<0DC0.E)*U
MW]"2_Q5S-(XK'NRH?LEH75TO"V 6ZQL9B:(^IJ)K8YR%6G4 IJU2.J9L;'D)
M5'M^JZ/<0C,X/'S2WY;=O3;<;+I\C^J?>? +3=IAGJ>IF3;9?.(-X>KU<K$!
MRK_FEQ]?D_U9?L+5+7A2U"$Q2_:-8ZP#>VL'=FU.$-9E9":QY@,@]R3M6#?I
M^_DZ?/BPJA:0Q%,3OYO/;G.\UDJ699)@9/)D?;F%*(L!G4M$(:QVS1\5[:)G
M:E73'BN/O:)FTI@PAENO+FN[?1U4_&[UGORZ>=H6Q$T23AFB6MI,[F*4F=Q%
M+:$HK8CZ9++=:^P5?> >DNCO[E#TW+>G14X[J2X;LK@/B*S):%^?8'U=P,S)
MEEB$!^O)I*J:>?5.UU='MI3@LH]EKP+O?CCYFH!IP-)&IE\#Y$@&3_V$^L=%
MN5H3Z]]_6=>8\[HB+1/+VCH/R%D"Q7,=?B[J,%].,2D+0<?]-D@]^?.3 ^!8
MF2V;,G!J"-SN$U]M]>;U$7CATEB[R4DAW8NZ1$$K!25C"E%*\NCWBW&>_OUI
MRETC@: !"Z=&P?MEN?R3>/?X!$QHX1@$;S6=P-0J+X&9R3I=C65KV7Z*X,F?
MGZ96-1(&CF=@!X6!9URINYQDXHX"<<^ VU! ,;*6OEA+WA7S)0:C7/..BY=H
MFK9PWMSY'$44'4#KFOY?L5ZS^>+#+[@J=:#((N&[>#'?'G.6T4AAO02I:QJ)
MU"49SB3 6>U++DC!W4B9@-V$=1GA'(B%IT?:-11,WSFX.UYBOOZS^.4?N/RP
M"I\_'O?$;<@'&F;P#CC1B1-\N8B8>5U-K4U];A00O)6E3I42$8OG)HPT6&'2
M!!_#S 7:0'Z_J(OW) .?I 2G@[,JZ6!DZS=[YY_@&X*500F^(=*8.'OSGL2"
M-:"XN<5UL,LF7>&])$\R!\@<Z^AD7\ KXE.QRCB#)9JX5Y?&"]F;9PGHTA >
M(-]E:V9/C1C\\/@(-P\6HHQ(1@I"W7VN(E(($F*H(8AW)D5CU%XSI5]"S',$
M3)?N:23896LN=^"-__#3#Z^N0]1LI#<B%S"^3C+6O+9_D"MIO;#TY]'8QU-)
MCG\K=OOU"<'11I2/GX8=QM<)$9&65V2,O\Q^?S]3)D16K(&L'441JI#1+3Y#
M\"ZHD%7A<5<G_!K3?WQ8_O&_KG]Q"X3KO[G#P-WWIDL!MI7]@1R<V&"\6L_#
M+R'-RSQ= S8I%HE,"YII2R%>'?U*0 4MH\:HK8C.-# 47WUXNC1@6QP<S]6I
MD\#O+C]N@G^<?UAL43W'FY*&D]+H4D=$%&9K@WV"Z.L()0S2YY24,X^FRCV3
M"M[QD6GZR=LCH2DS._ 67LX_:6$E:@Y%AP#*20&1>PM"DEME.4O2GBC0/8>T
M\"&!RBBBZ !:M[,WO?*2"T=A?VV$5ZI.D)99D;M46$[!!/ZXI_(;V5725J+/
M[2L9PMXSS-]>%_0JT\;*X#[QB;%SN"^=ZL197%MT"8K7AP(Z5KTE2&\%,EV8
M36W09:C:/^:8/HLK> HN< \\UWFZ,3D(.B XYY00SB;5?!;U^6=QAV!E4!9W
MB#3ZZ,%[V&^6&8LEL0PIQPRJ5->O3ONPRM.?6N=0[F7GOJTVS4%2?:E-<PB+
M^X#($XTHK,CBN(J@1>US]G226.BO#)>*%:N5]WMIG6^D37.03/=JTQS"X*D#
M\YLN0U*YZZM/]<;<1)+D"5(4X20HC*KZ=09"G6Q,0F;191FURR^Y/;L_,3D0
MCI7=4^V:QS&R%S@\;#H-')F.K&[95116,J; 1Q4@"U0Y%.0E[K?OZ/"NW1,W
M;!X-@\,9.#4$_CF_#!>OB7>W0\0TLY[THT^$7*6RA^#JKA@9A7%.H&?[K1-^
M],,]]F@>+/9CF-9!KN3%3(&6,I=L!>106R=J6C&((D&DH+%4-99;CWT\XS3<
M(3[G**+H %IW>2)44J%&D,;4\891@@\Z@9-1!NF+5:G]L^ZS2,,-DNBS:;@!
M[.TZ#7<3_-],R9^3=CXZ\;;C1]NEVO:E_,3)-1.,SN@MT/]S%.#P4HL"A8 2
MI0A%2"'$.!=OK.3:QN3>_'"HFP##(E_<;%6(X:*V&%^/N\124)'_#1[KN,N0
MD2Z7*9"D#LK)+'C9[Z')?M\[CQS:$$@\\'-&8'H?>9*'.8%D6-%"*3 %,ZBJ
M4;TE?UV8:(IS$F-IT;#03RIM-.&^E%$;PND^D/)$V&"M53%' =P:\O>X9^"4
MDB"],=JIR+/8:W_F-Y)1&R33O3)J0Q@\=?S\S)--Q@KJK.H1'!U!A^KDU6E^
M,M1W@9GE_*(S<^RKUQ/GT@9);8]7KT-8.#4*GGZTF83E264#-O) )TCDI"/?
M3!4U2NB:$#1[@>#P5Z\G3J0=C('C&3@U!/ZQ_ -7BTWSURHL+G]]<!#!+.J"
M!0J:2GZI[_AKX,;I3QT%?NSQK(QGD+#K*SVFV X&1#-V3HV+3?O>]]<??GB,
M;!QZ3&0O>1W2&06'*&I!BGM!JJ_PY.)>J'C^&]-U0HZ B4:L["!-]MQJ=I.$
MCZ[4+DY1ZCHU65=(UQTAQG-31'%YKTAD0/"^UVKV4UF7L0.3EOSO%$8/5LW/
M<O)1)\\I]*_M,ZENJ,UT+QAID)@2V4_5>BG!BT1-FS1I(OH]X'2X'*:V6.\_
MS2\_KG_"7+O7;RPNHA>)");)TF73J,$)K4G=ZA1LLD6&M)\K^_6/]X>'(V2W
M;,C(J8'PV_Q3'=>Z"?)3SKJ.,^,1&=V.9.L,*@FH$T:?3+0I["7_N]^<QET=
MV\(<P[@^Y'V->A%$3J8X.FT=.F58 5]"'<1+F#>D*[/<SSF]_ZL3ICL/E<G7
M<CV 05-+]OW'Y>KR-UQ]NIDK%QT3QEJPVF-5:0R\#PI$,H[%.L&PL/W4^<,?
MGER^A\AFV8A14POY[7+QX1[I7LN<C=0@*L'*4YCE'1=@N30Z1<.UV<]D/_S=
M"0.#-B(^@DU32_A%N_7VMLM 9H<A^0Q&67)G@R$=)^KF!UVB#M:I\+@]_-!"
MZ-M!+3K-<PTG,>@C,;Z#$/*GY1^;T18_+AXE5GY=7ER\6:[^#*L\T\HE68P$
M([2I6C"3%DP*0IUQX8K-0NXU^F- %+D/73T73P\$Q')DZ72 N*=:%6YZ:+[,
M"AJ'TJ8Z<H[4>G84&J%FX'*069)6S[+UV["=!/6<!VN#L7;R.':SSR^-UW3^
MN$@K#&O\'K?__ZM;-/,\LD+'(/^AF.V\0U<W@B!=G4PA>3&Z]3RY%XGJ.2YN
M@[BV<FF]3^J(ONJ'IWB5\R:=M)Z%[!QF1<ZI#IF.8^@2:65K%"&]Q6)QYT"<
M@_JIGZ&E9R>M#;J:2*$?4.U6SU:JS%2="\6]IMM"@4L,4H(D5]?7A491M!ZZ
M=;RY;+YUL1]S.40>;<QENT6,^XSO1;1"9./ ECKPSI+7&42BDTJ+7G#&B]RK
M]VV2N<K-US">$G?MY=/U(L:WU3%8_X9_71[Q'.#K'VG0_O\"98W:_;=?N6WA
MCH&5%- #MUI5KXB17'D!IY"1(2-,Y=93;1Y2<*QZ>8MT/?#MUNU;I]7\<^7[
M-BWCI76)6PE80ATL(UTMP@K(/&6>'5=:M58J.\B9MAQYA-P?:XQ6+)^X$?O7
ML/AP_79?"\&512@Y6U!>&W"%_HH%SE(P:+-NL9GL]H-3(Z&1^);'\K(' -P\
MK<Y%6B5KY5S0P8VJ?5[<D[DS'K&XJ$J+J2?W/CE=J_6!PGHL[@,X-[' ?PI_
MS3]=W11H2D8AD\D03>"U,<= K&. 6-%.Z:A1[;?Z^P61/_CHQ$(_1&3+%OR;
M6O#DV=X1GJ,RCD0$* 6"$BQ!3#R M":6J+0W;J]7Z"\)_OY'IVNJ;R+X@_G7
M05W@:7MW%SS9P+4+1'_T/M)Q5  O P/2A@Z-#";JUJF.%TB:=B9!:_]@##E,
M73!_MZ']<KD-RN:++QA6ZYD3P;ND0UW]6W>S)0J2,1K(C"F7O)<L[?<:X\F?
M[]%K/%!ZRZ:L[$;'O/N,=2/\XL.&3;47Y%VYR>+,'$8?M$/RL&J#IA&FSAKD
MD+)WSFJT,;0>7/$R53UJFN,P-9)$^IQUL0WJCTYD-4]BG3"!Y9E/19(0K:CM
M]:$^U=&INB59$$B25H]7 7>6P'H(T=?+-9U)6<TL&5A'\ >%3(,7J9#R"[JH
M:+,K>^4C!ISI:RJF-C<'2_FQ)CB2P1U8ES?S14W'O]W6M.EW<7WYPU^?<;'&
M68E::*L=)(WDD:6DP:'/D#S'))WEOOED^QWD3&U/FH&F%<L[0\^O\P\?+]^5
MW]?XJE:57GU:KB[G_]Z6>$S6@6&*P'F=M^!< 4<F$ABSW@=I>5&M>U;V)&V:
MSI614=5*%!T@[+:Y_4[#,A.2LCE#L89<MRQD#10M..5,J,/K=//.E*^IF*8G
M903<',G@#B!RCW!KDB'?FBQNK3S1QR"$R&J3*6K-B"?[I5V'.FQ[ Z)Y%\D(
M@#B,G3T',:_#^N.;B^6?M][:JW0Y_V,S_6X;RAT=Y>S]A69AT&%G&B=.XCJE
M;+#.#F:UX!L%.;_*@[+H7;8L&=-Z].J8<=(OX4OM7U_/=/%<EL3H%F%]9D/.
M6&#2DS)$X8IP&57KR09/4])5O#1$VKOCI8,8W8'!><J!OS[+N\5=7YU/2DM2
MD^1?>4.1H%403$E@$P]%<:^DU",ZO<]3UE4D=0R<1A!$!_!ZY+V_BZ3(%YA_
M7/SP5_I8*VYOEJN'%^E>+Z>2PG/+@:L2ZG)?1GPM$H(**DD6C<#6Z9TCR.TJ
M^#H&B*<2V9F@\_Z]O#MHUL++Z#G(VA:BN(MU\:, KE6PD@FEVO?A'DIL5^'=
MV,@\7EP]>_^;<Z_#(M\;>MW([7_YIYOY^P-/,8ZC3V(/65H+J=9+5<D9'*]5
M+5E7>DK+<+]FQDX<_4=W8Y:5Y,X9BIHCTO&LLO5YOJ33>K1,>"-B:P6UDZ"N
MW/XALM_M]A_#]@X,X#-V_/75JG)UICC+CB<%VCE.YIQ9"-D7$*1.G<=2.&]=
M--E-45?>?CL4'<7X?F'T\W*1K@]41U$S+@V8)'1]4*K) .L(*;JB#5,NJ-;Q
MXXM$=>6QCP"F ]G?+YYFNHZ=5M;7=_ 1E*I31JW)(+5(R*4JBK7>X'I,M'<J
MGWH$[ QB=7>(^1=6LXSYU1_TIQ_NWNS==C?Q&4_1%DM'R\Q+BD-< >)4(  H
M.IL/J%GK*NY0&KNJPK3#6&/A] Z^[^?KM+Q:7/X:+O$77*6JCJ4O*<9 S"S<
MU,5W'CQG''+=7:EM2<6.J\=>IG&:![VG!M^QPND ?#MZ)6:^V%AB%L %!E .
M$WBZ0L0WP[S0O,[T.%VKREZ0LF< J58L[PP]7T4A60<>Z7\@JF)!"5/_R@OP
MV1F1)1;>_%WP+GKVPH\[,_P<Q?1> 70O\DC*%9$HB*48MMX'[R"$0I%LQBP-
M9OIGK=?AO4#27C#RYPJC UG?*Y)F7 IGZZH1C9F!2L5!9*JRB@<=&$6UV+IO
M_? B"F?G"IM!?.X,+'L$%-I$;^O*17+?S/:9E(\!(4;-M([HK1U3"S6*]?@Y
MY,='E$S?N'LJEB#_SQB?"SC+R9ACU. M.C!&!2FY1=1COCIH%.;Q<\BHCRB9
MGBO"/X7+JQ4I\*/KOX]_J%FU=R>%(SUVXSH'5Q@(O5GQ3>HE*A9!4U@OL[84
MI+5N=AQC6M,SN=F;5L.M.J4;^JZ\(82'B__"L)H5%W54='.8IRA4:5[[#QD%
MH"[7%3O>*][^[(=2VU55> AJ]GE&.X+ .K" >YWT^RO\F:[V;W_BQ1_XTW)Q
M^7$]"U:112_UZ45=&!!97>5 ?^5XD#P$)@IO70(\E-:NRLRCP_)889T1*.N%
M^^W/Y4QS9B03D2##Z,[5*H/C"J%XY86*,44SB9*\([&KXO0I('B(:,X->00E
MG(G E9(N@<TUXC%*@].:PAYOA$"7= FMESD,)K*K\O;)T#=8/&>&OS?+J]5,
M%%>,BAY*J*.)4IUEQ[,"%XF1B=R/$-L_<!I&8U>%[U.A;[!PS@U\\S]P1OI;
M9.X4&*RO,!,YO+ZZODF0JVO1N*RFU'V5QJX*WR<#WU#AG!'X7A7ZYNTA?=9H
M=? @49-C*[6K>WHLH-?('#>QI*FBD >$=E4L/P4,#Q?3&6%QEAW]ESWS$#(Y
M%A17&0CH+07[*F"1FB<WSJCMEVGKJKQ^"L0-$D;O(/M]D:^SW)A_^"O5A<J?
MZM_-##$K9\W!!47QE/3DST;.P"5;]V%@LLT??A]$:%=E^='@UT1,_2S'>:Y[
MF$4F@F8%N*_J.T8#OC 'EKM:7<D\CMS@V&G=_AA<M>!U!UKLR?:#W1GRY%"+
M4$A%.TE1$3H!KL@(%*K[G#!B$B?I0VM0RCB'6L;($NH=@T^EPY/RRMI4QQ_*
M0.Q4%NH@#R@FYU*81,-;C^D:2F-?E?S1\'>L=,X ?3>9\.1D*)(TN10AU?X]
M";Z^@H@^F52TU<J>&G1#BA/\'*H38\CB7""V27?'4+/:O$"F X+*/D-,4@/6
ME2?2Z9Q3Z_!@;^+V@]DYE"'&D<>9 &V3V4Z,HFI'%TC711HJF@Q>I4!.:TDV
M9/I?,84RV[O<P,^AWC"*-,X%935M*$/4G 4!)OLZYT4YB+)XTMK%>$MG]:EU
MW+DO;?NA[!P*"Z-(XPQ0]C!#32Y B8+N3,"ZF%TD"S$X7[?[)"6\$Z)Y"\D@
M O?#VSE4$,:3RQF ;E:0M''P= !5'Q1Z2\%-5 @A6*VS+CHV7W+P$DW[0>L<
M2@5-N=\KFI[-.4LC30[: 2]6DJ^)#()S$9"'PBB@+EZ'4T#KJ)( /X>:P'AR
MZ:<6\/2[LI*9-"87*"$[ND#90-!:0W(E,6E%IGCG%!C;KZ7W'.H Q_.YS_<L
M/^/ECPOZN_I$Y_U'XNH13UJ>_:T&KUKVH[/1PY8?PJH^F%O??.L60485YB(*
MPDVHDU:+ E\GK2IF' ^\Q.);WZOG:#EZ+4;ZB/GJ M^55XO+>9Y?7%V2(_<>
M4WTV-,<UZ<:+*V+E&[I5KY>?/E]M9?:N/"9HNWO19-31JDV63M6YHG7M)BM@
M?0P22]T9TMHQ;WN":1_%-$'<5XLYIA-Q!U[9D6?^[LO3/[!932W1"E7[X]VF
M8Y21U^"BLQ!,RDIC8D&UU@,C'F=:Z$^)TF6?D.GV]OP</N'WRUJ+GD4O(_>2
M ]8I=0K)77:*"V F:2V$"+[Y:L.7:)H6Q]V 9R]0'RC);I&Y-Y_?WBYPQ9S\
M)LSS)==S4TS@Z_0?U$E;AX&KW#K'TXKV:9]*?CL:^S P=' )?EDMR_SR[7*]
MGGG+E% JU(F-@O[#:/(0LP+)O3>):XI/6S\MNOOZ6:O< Z6_;"**#D#T:&#'
MSU>?8NTPV_!F_>[J<GT9ZL[S#]^%]3S-K/:*8_)TKKKV,<0(GM?V'Y43Y][X
MA*UQ-HC :75B%U <3Z 'HY4HB<M&>/UQD598BP3A@ICY:;G8'NS5Y>5J'HFU
M9$Q^6VZ=J;#&?%U1>+5:U2TEVSUAP1?GK<X@:K>DLE9#K$O6T7-NK>,FV-(8
MQ,=3/>VK]"Z0?6+1]ZN<OZ^2P/S5E9[9Q)(N(@(+TH+2FKC+48)17E*($)+P
MK3>7#B1QVN?M7<!X3*%V@-FO8MJ-G4E*$\=X@(*%[(R0DOS[B)"17**@2_:A
M=1/:DX1,^\"]"_P=+Z N'(''Q[B^/[,B<O%*DHK7BI%'4Q,FJ2X<RS$473#+
MW+JT_@PIT[YG[Q)KAPBI(=I.4C7E#PD_KFS*QZR;/J)T[,)IB:1+>*P;4^M4
M9)\$A"PY,<+PJ&Q),K<N#XY5.&W@BKJH)/>J;GA19-8C1HA!N1J#%5-"22Z?
M:11R^@+I$&2-$%4,$64''MI0!U0YK;C+-2UK"G%7;]9R>,B\1"FS8+KY+KHQ
MHHK1TCZCP'),(76 P:>=T!BC5!X3.&=<;;_S]5&^ Z10Q^; BI&MAQ0='B6,
MEFP9!4_',[Q#U-RXDR*A+\'&VAQ,"EAY#X$GA!2,5D4SYEEK6WJ,SS]:?N,D
MR#F$Z7WV/7Z/J_D?H09(V\[.>;CX<4$<N]J8]3?+%>G@^QNN_PRK_'JYV+!T
M?42/9)/O-H@+VI^_40AQ1]@]>EXM\G]B_D!0?)7H'VW"V3I?_F*YOKH']:"8
MMB4H*+&0(60Q@LO" DO>&RNU2:'UF+$CR#U6(]Y]>EM'5[&:^NTT_3I)3@M2
MZ** XR:31H_&-G_L^8B$:4.$4R'GL9(\1@X3&M;UZG*V77^5OFR:C)*,!NMR
M!JZ*JRMHR#6P+H!&B\E)J^5^C03TP_>P0W]WAYO'W^P%, <(;MF BQ-*/UW3
M/'MU<7%-?[T9VXXPYI&\!D;'CRELVW)<HMN 7$;'LY5AYQ.E-:;_^+#\XW_=
M?&.+AIN_NT/#+AJF0<9QTEPV9FT/\/CI__UY)GE*RD4+H@1/3, "(25R_A)/
M/+,L9=EE6 ;#@;XYC?C;2>XQ%(:RL0?1__#[KS.;"S>168BJ#LA3S($G+H#0
MSFDE>2YR5Z/[8-'3-Z=)Z(PG^J%L[$'TK_^__SVS:+DK"HE27GLSDP(O; (1
MA1=**N_\KEW=@T5/WYPF]S*>Z(>RL0?1_S^__-=,)JML2A39,T10@>Q?=+5B
M1UZR3Y9C3KMZ^P>+GKXY3?)D/-$/96,/HG_]ZON9M-X82:?DWFGR@5TFG44.
MCPD!N6%2&;VKC6CXK7_U_31]&2/>^H%L[$'TKW[_?J9%9,'S ,&+#,J2??)$
M+A1E6##1FK2S1CO<Z_]]/]$W;Y,83_1#V=B#Z-__\+]G@3'+:KR+,1/-7"@(
MO" $Q2S7P5EIFGKX],UI1NV/)_JA;)Q0]#4K/7M/H>Y/5Q>7\\\7>#_DW82]
M%))PENHDG_HN3#%?P-?EQ$&@YM&[I!^_<_\ZT_WB5Z:MW+9(_K1E9*^(N+X=
M(;,B<BCDN3IBD"B:O!E"N%#>2*:DUM(=A8DI$S^-);D//@Y@Z]0(>7?Y$5=W
M:O,GK(T)L\)58JH$<*(09S@9O""E \GH6#Z:4KC?"QA/_GR'>#A$<LNF;.R@
M'G^G/]_>MHLR,G9:H@&-I#F5*PE<+IN6@LRTTI$\H-$J4&\'/8X=K8.CA5UI
MQ>.N8/+SLHH@7%R/VTJ\1,T<^4HE.B ND:_D P/GM&<B.>DR'PTK#VGII0IU
MH)"?!<T1'#_'IHW1NC).UG;1:U\%&:00LC!@N$Z$'*DII*'_<(5GY$5J%EJ/
MN^FIKZ)H31<E0>%U0Y^7D9P^SL"Z*#&%8H5NW6'VS?15#$'.BWT5 ^30E>6[
M8]NO\_7_V403Y.S1_VH-FE>O0#H.D7$+5MKB%"93_"DZE6[HZ05@!PCZ6= <
MR?6N$'33>?<;_3>OHX^2F?'<,D"L#P\\>9@^V0PYVF(S=VA*ZW[I7?3T@J!C
MI?XLG(X4P=2A>U76**Y#390Z,Z\S4/ 1*'*MA2FO$@@7.3HNG [Q)9?IJU_M
M!0''"FK9@FL]]?5Y:P2/08$0KF:EHP$G' .>=")Q,I[\7NL96O?UG2ZU>X ]
M.8J+/91UGBIPN%#S#TZ!Q5A7KYH WAARS@+Z*.D0I31MZ>BWKV^0-/?IZQO"
MVA[@41O2M.2&Z).@C:FO.!#!VXR@1<)BN)1NYT2G;Z2O;Y#DGNKK&\+&'D3_
M^N?_FDDOA> H0,=J$77BX#5J0&^*31:UEKN6>PYO\_AYOPZ?T_;U'27ZH6SL
M*J"X2S5R(V-TVFZ;%%0D[SB@3;5),;M$Z,URO%<CO>;LFP2@A_&X*YA</_RZ
M>0?V:[A$/F-&Y8+D30=6URC$+" 80T>*F2ON;+9LO,CS*8IZB3P.%/BS #J:
M^UUAZ=5ZC9>/2A+H:_<S4R S)SX953=R" N"HDSA+#'*C)=8?H*@7N*6UD@Z
MEO<= .GZ2>J-%_\ZK#^^N5C^N8G0_T'&O Y@_6WY'?Z*Z2*LU_,RQ_S]U6J^
M^% W%W-QO;78"NX<A@*2&3HU<V3RG5+ 0G*&_@YQ9U?[09MQFE#>BX5L \T)
MI-D!AI\MS09&OJ<D5B8G!;'22V(E'4;2^8K0WG&QRQT_>3%\M"D&XZG (SA^
MCL7P'Q?T<5Q?5J?A_9_A\WC5\6>_-'JY?+\S=E _S]%RJPAL!#-'IK:0J27U
M!*)NS61.^RA:SV;MJ'[.O8E2N0S2UA5&L;;&!^OI.AO/))=&Y_'BA3.OGP]!
MSDOU\R%RZ,I8/E'3X]X)EKP%:^LR+&X%>*DX%,6L<\$7'4_1D=)G_7R0H(?4
MSX=PO2L$/5$33"4KC]H#:IEJ-2] )+X ,<_H&)7R;+R\UUG5SP=)?4C]?(@(
M.H#38W?CIBSL4"B5)<C:4:D<,2IJ+H%)9[UVW$IL#:2G*>D%0L=*^JLAG4>S
M?>KFB]]P]>GM,BPVUTFSVCH@2#L7ED$ABQ S-Y 9_8-(=&?SHD?^U:_VDK@Z
MW  =QZA>)'RS4LU)CMR3CLR10E;'$(((%@CL0I>$6J<P2,:3OXTZ7#)/R?<
M-O4BX5?7^B=I2[ZW"B!"S#6!H"&&5 ?_"HDJ%Y[%?CU4CWZX QD?(ITG;_$!
MK.I%S-]=TVY-LFB$@J2B("8$14PH#'QV*7OI0_%JD)B_&R#FY@I[%#$?PJH.
MW+FG4HTV>^%U-E"DH2/P.M=4F BYSNA!K3Q7?[L';&VBR<-XW!5,'F60C6!&
M*8OUHM3=&"G4^AD'-*JZH*381@P@>W_ -DC(^^;LAW!\:COR.&KY83.J_>9
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MX7R' /IYN4C7)S&:"^.\@V(M<2=Y!IX\5=!>&2=12QG&ZR!]3$TO;1ECP^A
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MW$S%NSO@K&CNG=$1)#G^H$0=C1NU!VGH$@;%?1'MNQ;W(JV7GM@)L#F&\#K
MY/8 3UVN[$KAY-)#TI*#8BZ X]) <)BUYUGKW/I)^[/$]-+I,84);R*@#I!&
M/D:YX=6]EPM/G4RRS%*JFU5B;<7C(A._9)VOJ1VSA51[:MT/N3]UO10!)L#B
M2"+L )S/>!YW.RJ?/*/E;K-Y2IKD:F). FEX!H9K5"XHHU/KZ.<0.GM)*?7C
M4+83:P_0W?-&%L\\*R:!BG6+9+1T-TNF$ ]=R#[FF%3SP>\--:K[-@$Z@O Z
MP.0C!_DZ(7;+PWN]#;\LMYNZ?JBSD-?S>($_+*X^78_<GC$E6#!6 [,:ZW@H
M!M$&6=L3=4%DUCRNY1^-V4:D[X5I_TUB>@KA]X?YNY3:\)-C+((7'\!+2R</
MH<YS#+4A%YDT06=F6CL6[:C?KT# _@[0/Q4&ND+_W3/W0X\>T&=6-RO:NLI!
M2>$@F*! JXBZ,%E7G8T&_Z/)WP__WV:%;"H4]'D!CKG^EM@=60I (8<%E0H'
MXK^COT6-"94-OG7[=ML3['<-OLVRVX18Z'._S-W3R_L5R(-7Q>SZN09;7_:F
MMM$"E[OO;<JRKQ;YA_^^(LS<??UV48=UD?1>"6"DX:!*,N",99 XYYX;&:1M
M7;[<G[IC5>@_PGSQ=KE>OUO46O6[<N_+,QZX*MI*0*YJJZ)"H)!8 7I1<D&+
MJ?DNSQWD]#)UH2E>'FNQ5N(X'Y6TZ6]KK)<>_.9(RNEYND^OH7S43D=%R$!%
MB,N&HG8T$4J0TLH<C6[NO)].0[U/'S%?U<OP?&?-MDFRF&1#UA%2HO]0W&N(
M-E(T)[+BD3&61>LAJ'L3=S;::PB6'FNO<4350:#QW"ON@!R+,H(4/ N@C")F
M*>TA16X+1Q6R:VTACYG+,!J^1A+\GL,9ADBA S U?948G:1()'!P&&K*BC-P
M&4-=4*^T%"DE;#T9Y-L?SC (4&,.9Q@BW0Z0??O._\DWKCGQ% )#L+*V9I>(
M$'R1Q&3#>6!.%L,:0W4G0=_0<(9!.'EN.,/10NL @3M>^S.;F4A.@O%(X9,/
M"7Q!#E)+*61P9'I:+V/X6PQG. 9[C<35!?!>>.&/(DI7# +=&G)\G'00B@Z@
M8RBF+KS0H75P\C<:SG <"!N*K@,H[N.,W^7<N64JU=OEI+84[]6F05T'?!H?
M>/2*6#=%T/QVT./,T33E:0*;\236 1P?7JG'!WSU:;FZG/\;\^OE^J9M999E
MSB&K#,S'NK\"!02+%D3DT::0B\RM,^[#J>P_XCX0,E\5UD:5WWDA]-ZC/?)
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M '2NGN]7-YTM] Z0<_?2[;IW)?HBA; 6(EED4)G<>F^% ,V"U JUL,V;Y3U
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M)+ D)%PS82<P09/RT!F(>E,P33&8YA2Z,3*:KR[#"W@+Y_4# R_9B5Y.(I$
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M$1D\BH BBRGLJ=E"=1\XT1Y1WS]N9[\.Z] 1(K;Q''ND,KO;@GWR$GV0YEA
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M9FZT=35R+CX"C^.Z!,9+FAK>67PYA3R72CKOB,29X#J=YLI'REH5._U33)9
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MN\N*Q5C3<[W;PK5/?W/9W:$^_Q-02P,$%     @ 2XRH5AEBA26A!0  ]"P
M !,   !I8W5I+65X,S(Q,S,Q,C,N:'1M[5I9;]LX$'[?7\$ZV#8!K--'?#6
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M4$L! A0#%     @ 2XRH5KG*W1?PNP( 2T0@ !$              ( !4@,
M &EC=6DM,C R,S S,S$N:'1M4$L! A0#%     @ 2XRH5L5TC-B%%P  &"0!
M !$              ( !<;\" &EC=6DM,C R,S S,S$N>'-D4$L! A0#%
M  @ 2XRH5CLYB+'E&   '.L  !4              ( !)=<" &EC=6DM,C R
M,S S,S%?8V%L+GAM;%!+ 0(4 Q0    ( $N,J%:Y/UT%(I4  )")!@ 5
M          "  3WP @!I8W5I+3(P,C,P,S,Q7V1E9BYX;6Q02P$"% ,4
M" !+C*A6_"]AEL$V 0 V20T %0              @ &2A0, :6-U:2TR,#(S
M,#,S,5]L86(N>&UL4$L! A0#%     @ 2XRH5J?8%U?)U@  M;@) !4
M         ( !AKP$ &EC=6DM,C R,S S,S%?<')E+GAM;%!+ 0(4 Q0    (
M $N,J%;Q=P6A5 @  'PJ   3              "  8*3!0!I8W5I+65X,S$Q
M,S,Q,C,N:'1M4$L! A0#%     @ 2XRH5CA5EEYN"   GBT  !,
M     ( !!YP% &EC=6DM97@S,3(S,S$R,RYH=&U02P$"% ,4    " !+C*A6
M&6*%):$%  #T+   $P              @ &FI 4 :6-U:2UE>#,R,3,S,3(S
:+FAT;5!+!08     "@ * (X"  !XJ@4    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
